Psyllid ID: psy501
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 962 | 2.2.26 [Sep-21-2011] | |||||||
| P20794 | 623 | Serine/threonine-protein | yes | N/A | 0.182 | 0.282 | 0.634 | 9e-63 | |
| Q04859 | 622 | Serine/threonine-protein | yes | N/A | 0.182 | 0.282 | 0.639 | 1e-62 | |
| P20793 | 622 | Serine/threonine-protein | yes | N/A | 0.182 | 0.282 | 0.634 | 2e-62 | |
| Q9JKV2 | 629 | Serine/threonine-protein | no | N/A | 0.153 | 0.235 | 0.758 | 9e-62 | |
| Q62726 | 629 | Serine/threonine-protein | no | N/A | 0.153 | 0.235 | 0.758 | 1e-61 | |
| Q9UPZ9 | 632 | Serine/threonine-protein | no | N/A | 0.153 | 0.234 | 0.751 | 4e-61 | |
| Q55FJ6 | 507 | Probable serine/threonine | yes | N/A | 0.152 | 0.289 | 0.590 | 7e-46 | |
| Q6Z8C8 | 459 | Cyclin-dependent kinase F | yes | N/A | 0.135 | 0.283 | 0.598 | 1e-42 | |
| Q84SN3 | 433 | Cyclin-dependent kinase F | no | N/A | 0.151 | 0.337 | 0.58 | 6e-41 | |
| P43294 | 443 | Serine/threonine-protein | no | N/A | 0.135 | 0.293 | 0.553 | 9e-38 |
| >sp|P20794|MAK_HUMAN Serine/threonine-protein kinase MAK OS=Homo sapiens GN=MAK PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 242 bits (618), Expect = 9e-63, Method: Compositional matrix adjust.
Identities = 118/186 (63%), Positives = 139/186 (74%), Gaps = 10/186 (5%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S DE + KSLKKL+HAN++KLKEVIREND LYF+FEYMKENLYQL++DR+
Sbjct: 35 MKRKFYSWDECMNLREVKSLKKLNHANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRN 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457
K PES+IRN+MYQ+LQGLAF+H+HGFFHRDMKPENLLCMG ELVKIADFGLARE+RS+
Sbjct: 95 KLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQP 154
Query: 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQF---------LFYSIDHVPPIQTTCL 508
PYTDYVSTRWYRAPEVLL S+ YS+PI + LF V I C
Sbjct: 155 PYTDYVSTRWYRAPEVLLRSSVYSSPIDVWAVGSIMAELYMLRPLFPGTSEVDEIFKICQ 214
Query: 509 LAGTER 514
+ GT +
Sbjct: 215 VLGTPK 220
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Could play an important function in spermatogenesis. May play a role in chromosomal stability in prostate cancer cells. Homo sapiens (taxid: 9606) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 2 |
| >sp|Q04859|MAK_MOUSE Serine/threonine-protein kinase MAK OS=Mus musculus GN=Mak PE=1 SV=2 | Back alignment and function description |
|---|
Score = 242 bits (617), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 119/186 (63%), Positives = 139/186 (74%), Gaps = 10/186 (5%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S DE + KSLKKL+HAN++KLKEVIREND LYFVFEYMKENLYQL++DR+
Sbjct: 35 MKRKFYSWDECMNLREVKSLKKLNHANVIKLKEVIRENDHLYFVFEYMKENLYQLMKDRN 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457
K PES+IRN+MYQ+LQGLAF+H+HGFFHRDMKPENLLCMG ELVKIADFGLARE+RS+
Sbjct: 95 KLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQP 154
Query: 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQF---------LFYSIDHVPPIQTTCL 508
PYTDYVSTRWYRAPEVLL S+ YS+PI + LF V I C
Sbjct: 155 PYTDYVSTRWYRAPEVLLRSSVYSSPIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQ 214
Query: 509 LAGTER 514
+ GT +
Sbjct: 215 VLGTPK 220
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors. Could have an important function in sensory cells and in spermatogenesis. May participate in signaling pathways used in visual and olfactory sensory transduction. Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P20793|MAK_RAT Serine/threonine-protein kinase MAK OS=Rattus norvegicus GN=Mak PE=1 SV=2 | Back alignment and function description |
|---|
Score = 241 bits (616), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 118/186 (63%), Positives = 139/186 (74%), Gaps = 10/186 (5%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S DE + KSLKKL+HAN++KLKEVIREND LYF+FEYMKENLYQL++DR+
Sbjct: 35 MKRKFYSWDECMNLREVKSLKKLNHANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRN 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457
K PES+IRN+MYQ+LQGLAF+H+HGFFHRDMKPENLLCMG ELVKIADFGLARE+RS+
Sbjct: 95 KLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQP 154
Query: 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQF---------LFYSIDHVPPIQTTCL 508
PYTDYVSTRWYRAPEVLL S+ YS+PI + LF V I C
Sbjct: 155 PYTDYVSTRWYRAPEVLLRSSVYSSPIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQ 214
Query: 509 LAGTER 514
+ GT +
Sbjct: 215 VLGTPK 220
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Could play an important function in spermatogenesis. Phosphorylates FZR1 in a cell cycle-dependent manner (By similarity). Plays a role in the transcriptional coactivation of AR. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9JKV2|ICK_MOUSE Serine/threonine-protein kinase ICK OS=Mus musculus GN=Ick PE=2 SV=2 | Back alignment and function description |
|---|
Score = 239 bits (610), Expect = 9e-62, Method: Compositional matrix adjust.
Identities = 113/149 (75%), Positives = 129/149 (86%), Gaps = 1/149 (0%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S +E + KSLKKL+HAN+VKLKEVIREND LYF+FEYMKENLYQLI++R+
Sbjct: 35 MKRKFYSWEECMNLREVKSLKKLNHANIVKLKEVIRENDHLYFIFEYMKENLYQLIKERN 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457
K PES IRN+MYQ+LQGLAF+H+HGFFHRD+KPENLLCMG ELVKIADFGLAREIRSR
Sbjct: 95 KLFPESAIRNIMYQILQGLAFIHKHGFFHRDLKPENLLCMGPELVKIADFGLAREIRSRP 154
Query: 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHL 486
PYTDYVSTRWYRAPEVLL ST YS+PI +
Sbjct: 155 PYTDYVSTRWYRAPEVLLRSTNYSSPIDI 183
|
May play a role in cardiac development. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q62726|ICK_RAT Serine/threonine-protein kinase ICK OS=Rattus norvegicus GN=Ick PE=1 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (609), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 113/149 (75%), Positives = 129/149 (86%), Gaps = 1/149 (0%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S +E + KSLKKL+HAN+VKLKEVIREND LYF+FEYMKENLYQLI++R+
Sbjct: 35 MKRKFYSWEECMNLREVKSLKKLNHANIVKLKEVIRENDHLYFIFEYMKENLYQLIKERN 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457
K PES IRN+MYQ+LQGLAF+H+HGFFHRD+KPENLLCMG ELVKIADFGLAREIRSR
Sbjct: 95 KLFPESAIRNIMYQILQGLAFIHKHGFFHRDLKPENLLCMGPELVKIADFGLAREIRSRP 154
Query: 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHL 486
PYTDYVSTRWYRAPEVLL ST YS+PI +
Sbjct: 155 PYTDYVSTRWYRAPEVLLRSTNYSSPIDV 183
|
May play a role in cardiac development. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9UPZ9|ICK_HUMAN Serine/threonine-protein kinase ICK OS=Homo sapiens GN=ICK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 237 bits (604), Expect = 4e-61, Method: Compositional matrix adjust.
Identities = 112/149 (75%), Positives = 129/149 (86%), Gaps = 1/149 (0%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S +E + KSLKKL+HAN+VKLKEVIREND LYF+FEYMKENLYQLI++R+
Sbjct: 35 MKRKFYSWEECMNLREVKSLKKLNHANVVKLKEVIRENDHLYFIFEYMKENLYQLIKERN 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457
K PES IRN+MYQ+LQGLAF+H+HGFFHRD+KPENLLCMG ELVKIADFGLAREIRS+
Sbjct: 95 KLFPESAIRNIMYQILQGLAFIHKHGFFHRDLKPENLLCMGPELVKIADFGLAREIRSKP 154
Query: 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHL 486
PYTDYVSTRWYRAPEVLL ST YS+PI +
Sbjct: 155 PYTDYVSTRWYRAPEVLLRSTNYSSPIDV 183
|
May play a key role in the development of multiple organ systems and particularly in cardiac development. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q55FJ6|Y8078_DICDI Probable serine/threonine-protein kinase DDB_G0268078 OS=Dictyostelium discoideum GN=DDB_G0268078 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (472), Expect = 7e-46, Method: Compositional matrix adjust.
Identities = 88/149 (59%), Positives = 114/149 (76%), Gaps = 2/149 (1%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ + S E + K+LKKL H N+VKL E+I E D L+FVFEY++ NLY+ I+DR
Sbjct: 35 MKKKFSDWKECIQLREIKALKKLKHPNIVKLLEIILERDELFFVFEYLENNLYESIKDRT 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457
K LPE+ IRN++YQ+LQ L FMH +GFFHRD+KPEN++ +G E +KIADFGLAREI S+
Sbjct: 95 KLLPETTIRNIIYQILQALHFMHTNGFFHRDLKPENIMLVG-ERLKIADFGLAREIESKP 153
Query: 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHL 486
P+TDY+STRWYRAPEVLL T Y+API +
Sbjct: 154 PFTDYISTRWYRAPEVLLRCTYYNAPIDI 182
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q6Z8C8|CDKF4_ORYSJ Cyclin-dependent kinase F-4 OS=Oryza sativa subsp. japonica GN=CDKF-4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 175 bits (444), Expect = 1e-42, Method: Compositional matrix adjust.
Identities = 79/132 (59%), Positives = 107/132 (81%), Gaps = 2/132 (1%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
KSL++++H N+VKLKEVIREND LYF+ EYM+ NLYQL++DR K E+ +RN +Q+ Q
Sbjct: 52 KSLRRMNHPNIVKLKEVIRENDILYFIMEYMECNLYQLMKDRVKPFSEAEVRNWCFQIFQ 111
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPEVL 474
LA+MH+ G+FHRD+KPENLL + +++K+ADFGLARE+ S PYT+YVSTRWYRAPEVL
Sbjct: 112 ALAYMHQRGYFHRDLKPENLL-VSKDVIKLADFGLAREVTSVPPYTEYVSTRWYRAPEVL 170
Query: 475 LHSTAYSAPIHL 486
L S+ Y + + +
Sbjct: 171 LQSSIYDSAVDM 182
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q84SN3|CDKF3_ORYSJ Cyclin-dependent kinase F-3 OS=Oryza sativa subsp. japonica GN=CDKF-3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (430), Expect = 6e-41, Method: Compositional matrix adjust.
Identities = 87/150 (58%), Positives = 108/150 (72%), Gaps = 4/150 (2%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R +E + K+L+KL+H N+VKLKEV EN L+F+FE M+ NLY +IR+R
Sbjct: 35 MKRKFFQWEECISLREVKALQKLNHPNIVKLKEVTMENHELFFIFENMECNLYDVIRERQ 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM-GTELVKIADFGLAREIRSR 457
E IRN M Q+LQGLA+MH +G+FHRD+KPENLL GT VKIADFGLARE+ S
Sbjct: 95 AAFSEEEIRNFMVQILQGLAYMHNNGYFHRDLKPENLLVTDGT--VKIADFGLAREVSSS 152
Query: 458 -PYTDYVSTRWYRAPEVLLHSTAYSAPIHL 486
PYTDYVSTRWYRAPEVLL S+AY+ I +
Sbjct: 153 PPYTDYVSTRWYRAPEVLLQSSAYTPAIDM 182
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|P43294|MHK_ARATH Serine/threonine-protein kinase MHK OS=Arabidopsis thaliana GN=MHK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 159 bits (402), Expect = 9e-38, Method: Compositional matrix adjust.
Identities = 73/132 (55%), Positives = 106/132 (80%), Gaps = 2/132 (1%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
K+L+KL+H +++KLKE++RE++ L+F+FE M NLY ++++R++ E IR+ M Q+LQ
Sbjct: 60 KALRKLNHPHIIKLKEIVREHNELFFIFECMDHNLYHIMKERERPFSEGEIRSFMSQMLQ 119
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPEVL 474
GLA MH++G+FHRD+KPENLL + ++KIADFGLARE+ S PYT+YVSTRWYRAPEVL
Sbjct: 120 GLAHMHKNGYFHRDLKPENLL-VTNNILKIADFGLAREVASMPPYTEYVSTRWYRAPEVL 178
Query: 475 LHSTAYSAPIHL 486
L S+ Y+ + +
Sbjct: 179 LQSSLYTPAVDM 190
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 962 | ||||||
| 383848795 | 570 | PREDICTED: serine/threonine-protein kina | 0.153 | 0.259 | 0.791 | 2e-63 | |
| 332018938 | 580 | Serine/threonine-protein kinase ICK [Acr | 0.153 | 0.255 | 0.791 | 2e-63 | |
| 328787943 | 590 | PREDICTED: serine/threonine-protein kina | 0.153 | 0.250 | 0.785 | 7e-63 | |
| 345479263 | 624 | PREDICTED: cyclin-dependent kinase-like | 0.153 | 0.237 | 0.778 | 2e-62 | |
| 350419850 | 576 | PREDICTED: serine/threonine-protein kina | 0.153 | 0.256 | 0.778 | 2e-62 | |
| 380012701 | 484 | PREDICTED: serine/threonine-protein kina | 0.153 | 0.305 | 0.785 | 2e-62 | |
| 340718784 | 576 | PREDICTED: serine/threonine-protein kina | 0.153 | 0.256 | 0.778 | 2e-62 | |
| 395830472 | 636 | PREDICTED: serine/threonine-protein kina | 0.182 | 0.276 | 0.639 | 2e-61 | |
| 449493434 | 652 | PREDICTED: serine/threonine-protein kina | 0.182 | 0.269 | 0.645 | 2e-61 | |
| 395830470 | 661 | PREDICTED: serine/threonine-protein kina | 0.182 | 0.266 | 0.639 | 2e-61 |
| >gi|383848795|ref|XP_003700033.1| PREDICTED: serine/threonine-protein kinase MAK-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 251 bits (640), Expect = 2e-63, Method: Compositional matrix adjust.
Identities = 118/149 (79%), Positives = 131/149 (87%), Gaps = 1/149 (0%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S +E + KSLKKLSHAN+VKLKEVIREND LYFVFEYMKENLYQL++DRD
Sbjct: 35 MKRKYYSWEEAMNLREVKSLKKLSHANVVKLKEVIRENDVLYFVFEYMKENLYQLMKDRD 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457
K PES+IRN++YQVLQGLAFMH+HGFFHRDMKPENLLCMG ELVKIADFGLAREIRSR
Sbjct: 95 KLFPESVIRNIVYQVLQGLAFMHKHGFFHRDMKPENLLCMGPELVKIADFGLAREIRSRP 154
Query: 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHL 486
PYTDYVSTRWYRAPEVLLHST Y++PI +
Sbjct: 155 PYTDYVSTRWYRAPEVLLHSTTYNSPIDI 183
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332018938|gb|EGI59484.1| Serine/threonine-protein kinase ICK [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 250 bits (639), Expect = 2e-63, Method: Compositional matrix adjust.
Identities = 118/149 (79%), Positives = 130/149 (87%), Gaps = 1/149 (0%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S +E + KSLKKLSHAN+VKLKEVIREND LYFVFEYMKENLYQL++DRD
Sbjct: 35 MKRKYYSWEEAMNLREVKSLKKLSHANVVKLKEVIRENDVLYFVFEYMKENLYQLMKDRD 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457
K PE +IRNM+YQVLQGLAFMH+HGFFHRDMKPENLLCMG ELVKIADFGLAREIRSR
Sbjct: 95 KLFPEPVIRNMVYQVLQGLAFMHKHGFFHRDMKPENLLCMGPELVKIADFGLAREIRSRP 154
Query: 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHL 486
PYTDYVSTRWYRAPEVLLHST Y++PI +
Sbjct: 155 PYTDYVSTRWYRAPEVLLHSTTYNSPIDI 183
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328787943|ref|XP_003251030.1| PREDICTED: serine/threonine-protein kinase ICK-like [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 249 bits (635), Expect = 7e-63, Method: Compositional matrix adjust.
Identities = 117/149 (78%), Positives = 130/149 (87%), Gaps = 1/149 (0%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S +E + KSLKKLSHAN+VKLKEVIREND LYFVFEYMKENLYQL++DRD
Sbjct: 35 MKRKYYSWEEAMNLREVKSLKKLSHANVVKLKEVIRENDVLYFVFEYMKENLYQLMKDRD 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457
K PE +IRN++YQVLQGLAFMH+HGFFHRDMKPENLLCMG ELVKIADFGLAREIRSR
Sbjct: 95 KLFPEPVIRNIVYQVLQGLAFMHKHGFFHRDMKPENLLCMGPELVKIADFGLAREIRSRP 154
Query: 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHL 486
PYTDYVSTRWYRAPEVLLHST Y++PI +
Sbjct: 155 PYTDYVSTRWYRAPEVLLHSTTYNSPIDI 183
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|345479263|ref|XP_001605096.2| PREDICTED: cyclin-dependent kinase-like 5-like [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 247 bits (631), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 116/149 (77%), Positives = 129/149 (86%), Gaps = 1/149 (0%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S +E + KSLKKLSH N+VKLKEVIREND LYFVFEYMKENLYQL++DRD
Sbjct: 37 MKRKYYSWEEAMNLREVKSLKKLSHTNVVKLKEVIRENDVLYFVFEYMKENLYQLMKDRD 96
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457
K PE +I+NM+YQVLQGLAFMH+HGFFHRDMKPENLLCMG ELVKIADFGLAREIRSR
Sbjct: 97 KLFPEPVIKNMVYQVLQGLAFMHKHGFFHRDMKPENLLCMGPELVKIADFGLAREIRSRP 156
Query: 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHL 486
PYTDYVSTRWYRAPEVLLHST Y++PI +
Sbjct: 157 PYTDYVSTRWYRAPEVLLHSTNYNSPIDI 185
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350419850|ref|XP_003492323.1| PREDICTED: serine/threonine-protein kinase ICK-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 247 bits (631), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 116/149 (77%), Positives = 130/149 (87%), Gaps = 1/149 (0%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S +E + KSLKKLSHAN+VKLKEVIREND LYFVFEYMKENLYQL++DRD
Sbjct: 37 MKRKYYSWEEAMNLREVKSLKKLSHANVVKLKEVIRENDVLYFVFEYMKENLYQLMKDRD 96
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457
K PE +I+N++YQVLQGLAFMH+HGFFHRDMKPENLLCMG ELVKIADFGLAREIRSR
Sbjct: 97 KLFPEPVIKNIVYQVLQGLAFMHKHGFFHRDMKPENLLCMGPELVKIADFGLAREIRSRP 156
Query: 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHL 486
PYTDYVSTRWYRAPEVLLHST Y++PI +
Sbjct: 157 PYTDYVSTRWYRAPEVLLHSTTYNSPIDI 185
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380012701|ref|XP_003690416.1| PREDICTED: serine/threonine-protein kinase ICK-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 247 bits (631), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 117/149 (78%), Positives = 130/149 (87%), Gaps = 1/149 (0%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S +E + KSLKKLSHAN+VKLKEVIREND LYFVFEYMKENLYQL++DRD
Sbjct: 35 MKRKYYSWEEAMNLREVKSLKKLSHANVVKLKEVIRENDVLYFVFEYMKENLYQLMKDRD 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457
K PE +IRN++YQVLQGLAFMH+HGFFHRDMKPENLLCMG ELVKIADFGLAREIRSR
Sbjct: 95 KLFPEPVIRNIVYQVLQGLAFMHKHGFFHRDMKPENLLCMGPELVKIADFGLAREIRSRP 154
Query: 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHL 486
PYTDYVSTRWYRAPEVLLHST Y++PI +
Sbjct: 155 PYTDYVSTRWYRAPEVLLHSTTYNSPIDI 183
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340718784|ref|XP_003397843.1| PREDICTED: serine/threonine-protein kinase ICK-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 247 bits (630), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 116/149 (77%), Positives = 130/149 (87%), Gaps = 1/149 (0%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S +E + KSLKKLSHAN+VKLKEVIREND LYFVFEYMKENLYQL++DRD
Sbjct: 37 MKRKYYSWEEAMNLREVKSLKKLSHANVVKLKEVIRENDVLYFVFEYMKENLYQLMKDRD 96
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457
K PE +I+N++YQVLQGLAFMH+HGFFHRDMKPENLLCMG ELVKIADFGLAREIRSR
Sbjct: 97 KLFPEPVIKNIVYQVLQGLAFMHKHGFFHRDMKPENLLCMGPELVKIADFGLAREIRSRP 156
Query: 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHL 486
PYTDYVSTRWYRAPEVLLHST Y++PI +
Sbjct: 157 PYTDYVSTRWYRAPEVLLHSTTYNSPIDI 185
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|395830472|ref|XP_003788350.1| PREDICTED: serine/threonine-protein kinase MAK isoform 2 [Otolemur garnettii] | Back alignment and taxonomy information |
|---|
Score = 244 bits (623), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 119/186 (63%), Positives = 140/186 (75%), Gaps = 10/186 (5%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S DE + KSLKKL+HAN++KLKEVIREND LYF+FEYMKENLYQL++DR+
Sbjct: 35 MKRKFYSWDECMNLREVKSLKKLNHANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRN 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457
KF PES+IRN+MYQ+LQGLAF+H+HGFFHRDMKPENLLCMG ELVKIADFGLARE+RS+
Sbjct: 95 KFFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQP 154
Query: 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQF---------LFYSIDHVPPIQTTCL 508
PYTDYVSTRWYRAPEVLL S+ YS+PI + LF V I C
Sbjct: 155 PYTDYVSTRWYRAPEVLLRSSVYSSPIDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQ 214
Query: 509 LAGTER 514
+ GT +
Sbjct: 215 VLGTPK 220
|
Source: Otolemur garnettii Species: Otolemur garnettii Genus: Otolemur Family: Galagidae Order: Primates Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
| >gi|449493434|ref|XP_002187269.2| PREDICTED: serine/threonine-protein kinase MAK [Taeniopygia guttata] | Back alignment and taxonomy information |
|---|
Score = 244 bits (623), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 120/186 (64%), Positives = 139/186 (74%), Gaps = 10/186 (5%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S DE + KSLKKL+HAN++KLKEVIREND LYFVFEYMKENLYQL++DR+
Sbjct: 35 MKRKFYSWDECMNLREVKSLKKLNHANVIKLKEVIRENDHLYFVFEYMKENLYQLMKDRN 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457
KF PES+IRNMMYQ+LQGLAF+H+HGFFHRDMKPENLLC G ELVKIADFGLARE+RS+
Sbjct: 95 KFFPESVIRNMMYQILQGLAFIHKHGFFHRDMKPENLLCSGPELVKIADFGLARELRSQP 154
Query: 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQF---------LFYSIDHVPPIQTTCL 508
PYTDYVSTRWYRAPEVLL S+ YS+PI + LF V I C
Sbjct: 155 PYTDYVSTRWYRAPEVLLRSSVYSSPIDIWAVGSIMAELYTLRPLFPGTSEVDEIFKICQ 214
Query: 509 LAGTER 514
+ GT +
Sbjct: 215 VLGTPK 220
|
Source: Taeniopygia guttata Species: Taeniopygia guttata Genus: Taeniopygia Family: Estrildidae Order: Passeriformes Class: Aves Phylum: Chordata Superkingdom: Eukaryota |
| >gi|395830470|ref|XP_003788349.1| PREDICTED: serine/threonine-protein kinase MAK isoform 1 [Otolemur garnettii] | Back alignment and taxonomy information |
|---|
Score = 244 bits (623), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 119/186 (63%), Positives = 140/186 (75%), Gaps = 10/186 (5%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S DE + KSLKKL+HAN++KLKEVIREND LYF+FEYMKENLYQL++DR+
Sbjct: 35 MKRKFYSWDECMNLREVKSLKKLNHANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRN 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457
KF PES+IRN+MYQ+LQGLAF+H+HGFFHRDMKPENLLCMG ELVKIADFGLARE+RS+
Sbjct: 95 KFFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQP 154
Query: 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQF---------LFYSIDHVPPIQTTCL 508
PYTDYVSTRWYRAPEVLL S+ YS+PI + LF V I C
Sbjct: 155 PYTDYVSTRWYRAPEVLLRSSVYSSPIDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQ 214
Query: 509 LAGTER 514
+ GT +
Sbjct: 215 VLGTPK 220
|
Source: Otolemur garnettii Species: Otolemur garnettii Genus: Otolemur Family: Galagidae Order: Primates Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 962 | ||||||
| UNIPROTKB|E1BDG4 | 623 | MAK "Uncharacterized protein" | 0.151 | 0.234 | 0.761 | 1.3e-71 | |
| UNIPROTKB|Q2YDJ7 | 382 | MAK "Uncharacterized protein" | 0.151 | 0.382 | 0.761 | 1.3e-71 | |
| UNIPROTKB|F1RV90 | 624 | MAK "Uncharacterized protein" | 0.151 | 0.233 | 0.755 | 2.1e-71 | |
| UNIPROTKB|E2RE89 | 589 | MAK "Uncharacterized protein" | 0.151 | 0.247 | 0.755 | 2.6e-71 | |
| UNIPROTKB|E2RP10 | 623 | MAK "Uncharacterized protein" | 0.151 | 0.234 | 0.755 | 2.6e-71 | |
| UNIPROTKB|P20794 | 623 | MAK "Serine/threonine-protein | 0.151 | 0.234 | 0.755 | 2.6e-71 | |
| UNIPROTKB|Q8IXN4 | 457 | MAK "MAK protein" [Homo sapien | 0.151 | 0.319 | 0.755 | 2.6e-71 | |
| UNIPROTKB|E1BWM1 | 625 | MAK "Uncharacterized protein" | 0.153 | 0.236 | 0.751 | 1.1e-70 | |
| MGI|MGI:96913 | 622 | Mak "male germ cell-associated | 0.151 | 0.234 | 0.761 | 1.4e-70 | |
| RGD|3036 | 622 | Mak "male germ cell-associated | 0.151 | 0.234 | 0.755 | 3.8e-70 |
| UNIPROTKB|E1BDG4 MAK "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 592 (213.5 bits), Expect = 1.3e-71, Sum P(2) = 1.3e-71
Identities = 112/147 (76%), Positives = 130/147 (88%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S DE + KSLKKL+HAN++KLKEVIREND LYF+FEYMKENLYQL++DR+
Sbjct: 35 MKRKFYSWDECMNLREVKSLKKLNHANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRN 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP 458
K PES+IRN+MYQ+LQGLAF+H+HGFFHRDMKPENLLCMG ELVKIADFGLARE+RS+P
Sbjct: 95 KLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQP 154
Query: 459 -YTDYVSTRWYRAPEVLLHSTAYSAPI 484
YTDYVSTRWYRAPEVLL S+AYS+PI
Sbjct: 155 PYTDYVSTRWYRAPEVLLRSSAYSSPI 181
|
|
| UNIPROTKB|Q2YDJ7 MAK "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 592 (213.5 bits), Expect = 1.3e-71, Sum P(2) = 1.3e-71
Identities = 112/147 (76%), Positives = 130/147 (88%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S DE + KSLKKL+HAN++KLKEVIREND LYF+FEYMKENLYQL++DR+
Sbjct: 35 MKRKFYSWDECMNLREVKSLKKLNHANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRN 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP 458
K PES+IRN+MYQ+LQGLAF+H+HGFFHRDMKPENLLCMG ELVKIADFGLARE+RS+P
Sbjct: 95 KLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQP 154
Query: 459 -YTDYVSTRWYRAPEVLLHSTAYSAPI 484
YTDYVSTRWYRAPEVLL S+AYS+PI
Sbjct: 155 PYTDYVSTRWYRAPEVLLRSSAYSSPI 181
|
|
| UNIPROTKB|F1RV90 MAK "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 588 (212.0 bits), Expect = 2.1e-71, Sum P(2) = 2.1e-71
Identities = 111/147 (75%), Positives = 129/147 (87%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S DE + KSLKKL+HAN++KLKEVIREND LYF+FEYMKENLYQL++DR+
Sbjct: 35 MKRKFYSWDECMNLREVKSLKKLNHANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRN 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP 458
K PES+IRN+MYQ+LQGLAF+H+HGFFHRDMKPENLLCMG ELVKIADFGLARE+RS+P
Sbjct: 95 KLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQP 154
Query: 459 -YTDYVSTRWYRAPEVLLHSTAYSAPI 484
YTDYVSTRWYRAPEVLL S+ YS+PI
Sbjct: 155 PYTDYVSTRWYRAPEVLLRSSVYSSPI 181
|
|
| UNIPROTKB|E2RE89 MAK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 588 (212.0 bits), Expect = 2.6e-71, Sum P(2) = 2.6e-71
Identities = 111/147 (75%), Positives = 129/147 (87%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S DE + KSLKKL+HAN++KLKEVIREND LYF+FEYMKENLYQL++DR+
Sbjct: 35 MKRKFYSWDECMNLREVKSLKKLNHANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRN 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP 458
K PES+IRN+MYQ+LQGLAF+H+HGFFHRDMKPENLLCMG ELVKIADFGLARE+RS+P
Sbjct: 95 KLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQP 154
Query: 459 -YTDYVSTRWYRAPEVLLHSTAYSAPI 484
YTDYVSTRWYRAPEVLL S+ YS+PI
Sbjct: 155 PYTDYVSTRWYRAPEVLLRSSVYSSPI 181
|
|
| UNIPROTKB|E2RP10 MAK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 588 (212.0 bits), Expect = 2.6e-71, Sum P(2) = 2.6e-71
Identities = 111/147 (75%), Positives = 129/147 (87%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S DE + KSLKKL+HAN++KLKEVIREND LYF+FEYMKENLYQL++DR+
Sbjct: 35 MKRKFYSWDECMNLREVKSLKKLNHANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRN 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP 458
K PES+IRN+MYQ+LQGLAF+H+HGFFHRDMKPENLLCMG ELVKIADFGLARE+RS+P
Sbjct: 95 KLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQP 154
Query: 459 -YTDYVSTRWYRAPEVLLHSTAYSAPI 484
YTDYVSTRWYRAPEVLL S+ YS+PI
Sbjct: 155 PYTDYVSTRWYRAPEVLLRSSVYSSPI 181
|
|
| UNIPROTKB|P20794 MAK "Serine/threonine-protein kinase MAK" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 588 (212.0 bits), Expect = 2.6e-71, Sum P(2) = 2.6e-71
Identities = 111/147 (75%), Positives = 129/147 (87%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S DE + KSLKKL+HAN++KLKEVIREND LYF+FEYMKENLYQL++DR+
Sbjct: 35 MKRKFYSWDECMNLREVKSLKKLNHANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRN 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP 458
K PES+IRN+MYQ+LQGLAF+H+HGFFHRDMKPENLLCMG ELVKIADFGLARE+RS+P
Sbjct: 95 KLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQP 154
Query: 459 -YTDYVSTRWYRAPEVLLHSTAYSAPI 484
YTDYVSTRWYRAPEVLL S+ YS+PI
Sbjct: 155 PYTDYVSTRWYRAPEVLLRSSVYSSPI 181
|
|
| UNIPROTKB|Q8IXN4 MAK "MAK protein" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 588 (212.0 bits), Expect = 2.6e-71, Sum P(2) = 2.6e-71
Identities = 111/147 (75%), Positives = 129/147 (87%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S DE + KSLKKL+HAN++KLKEVIREND LYF+FEYMKENLYQL++DR+
Sbjct: 35 MKRKFYSWDECMNLREVKSLKKLNHANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRN 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP 458
K PES+IRN+MYQ+LQGLAF+H+HGFFHRDMKPENLLCMG ELVKIADFGLARE+RS+P
Sbjct: 95 KLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQP 154
Query: 459 -YTDYVSTRWYRAPEVLLHSTAYSAPI 484
YTDYVSTRWYRAPEVLL S+ YS+PI
Sbjct: 155 PYTDYVSTRWYRAPEVLLRSSVYSSPI 181
|
|
| UNIPROTKB|E1BWM1 MAK "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 589 (212.4 bits), Expect = 1.1e-70, Sum P(2) = 1.1e-70
Identities = 112/149 (75%), Positives = 130/149 (87%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S DE + KSLKKL+HAN++KLKEVIREND LYFVFEYMKENLYQL++DR+
Sbjct: 35 MKRKFYSWDECMNLREVKSLKKLNHANVIKLKEVIRENDHLYFVFEYMKENLYQLMKDRN 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP 458
K PES+IRNMMYQ+LQGLAF+H+HGFFHRDMKPENLLC+G ELVKIADFGLARE+RS+P
Sbjct: 95 KLFPESVIRNMMYQILQGLAFIHKHGFFHRDMKPENLLCIGPELVKIADFGLARELRSQP 154
Query: 459 -YTDYVSTRWYRAPEVLLHSTAYSAPIHL 486
YTDYVSTRWYRAPEVLL S+ YS+PI +
Sbjct: 155 PYTDYVSTRWYRAPEVLLRSSIYSSPIDI 183
|
|
| MGI|MGI:96913 Mak "male germ cell-associated kinase" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 589 (212.4 bits), Expect = 1.4e-70, Sum P(2) = 1.4e-70
Identities = 112/147 (76%), Positives = 129/147 (87%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S DE + KSLKKL+HAN++KLKEVIREND LYFVFEYMKENLYQL++DR+
Sbjct: 35 MKRKFYSWDECMNLREVKSLKKLNHANVIKLKEVIRENDHLYFVFEYMKENLYQLMKDRN 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP 458
K PES+IRN+MYQ+LQGLAF+H+HGFFHRDMKPENLLCMG ELVKIADFGLARE+RS+P
Sbjct: 95 KLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQP 154
Query: 459 -YTDYVSTRWYRAPEVLLHSTAYSAPI 484
YTDYVSTRWYRAPEVLL S+ YS+PI
Sbjct: 155 PYTDYVSTRWYRAPEVLLRSSVYSSPI 181
|
|
| RGD|3036 Mak "male germ cell-associated kinase" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 588 (212.0 bits), Expect = 3.8e-70, Sum P(2) = 3.8e-70
Identities = 111/147 (75%), Positives = 129/147 (87%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
+ R S DE + KSLKKL+HAN++KLKEVIREND LYF+FEYMKENLYQL++DR+
Sbjct: 35 MKRKFYSWDECMNLREVKSLKKLNHANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRN 94
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP 458
K PES+IRN+MYQ+LQGLAF+H+HGFFHRDMKPENLLCMG ELVKIADFGLARE+RS+P
Sbjct: 95 KLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPENLLCMGPELVKIADFGLARELRSQP 154
Query: 459 -YTDYVSTRWYRAPEVLLHSTAYSAPI 484
YTDYVSTRWYRAPEVLL S+ YS+PI
Sbjct: 155 PYTDYVSTRWYRAPEVLLRSSVYSSPI 181
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 962 | |||
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-83 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-60 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-49 | |
| pfam09766 | 352 | pfam09766, FimP, Fms-interacting protein | 4e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-43 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-43 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-42 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-39 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-38 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-36 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-34 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-34 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-34 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-34 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-34 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-33 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-32 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-31 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-31 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-30 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-29 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-29 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-29 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-29 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-29 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-29 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-28 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-28 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-28 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-28 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-26 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-26 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-26 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-26 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-26 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-26 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-26 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-25 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-25 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-25 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-24 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-24 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-24 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-23 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-22 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-22 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-21 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-21 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-21 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-20 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-20 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-20 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-19 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-19 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-18 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-18 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-18 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-17 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-17 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-14 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-12 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-11 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-11 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-09 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-08 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-08 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-08 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-08 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-07 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-07 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-05 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-05 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-05 | |
| pfam11912 | 204 | pfam11912, DUF3430, Protein of unknown function (D | 6e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-05 | |
| pfam11593 | 381 | pfam11593, Med3, Mediator complex subunit 3 fungal | 6e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-04 | |
| COG5253 | 612 | COG5253, MSS4, Phosphatidylinositol-4-phosphate 5- | 4e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-04 | |
| PRK08486 | 182 | PRK08486, PRK08486, single-stranded DNA-binding pr | 6e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-04 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-04 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 0.001 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.001 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.001 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.001 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.001 | |
| PRK08486 | 182 | PRK08486, PRK08486, single-stranded DNA-binding pr | 0.002 | |
| pfam12498 | 112 | pfam12498, bZIP_C, Basic leucine-zipper C terminal | 0.002 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 0.002 | |
| pfam05048 | 238 | pfam05048, NosD, Periplasmic copper-binding protei | 0.002 | |
| PRK07034 | 536 | PRK07034, PRK07034, hypothetical protein; Provisio | 0.002 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.003 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.003 | |
| pfam08601 | 344 | pfam08601, PAP1, Transcription factor PAP1 | 0.003 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 0.003 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 0.004 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 0.004 | |
| pfam09731 | 493 | pfam09731, Mitofilin, Mitochondrial inner membrane | 0.004 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 268 bits (687), Expect = 9e-83
Identities = 97/132 (73%), Positives = 115/132 (87%), Gaps = 3/132 (2%)
Query: 356 KSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD-KFLPESIIRNMMYQV 413
KSL+KL H N+VKLKEV REND LYFVFEYM+ NLYQL++DR K ES+IR+++YQ+
Sbjct: 49 KSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQI 108
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPE 472
LQGLA +H+HGFFHRD+KPENLL G E+VKIADFGLAREIRSR PYTDYVSTRWYRAPE
Sbjct: 109 LQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPE 168
Query: 473 VLLHSTAYSAPI 484
+LL ST+YS+P+
Sbjct: 169 ILLRSTSYSSPV 180
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 8e-60
Identities = 75/133 (56%), Positives = 97/133 (72%), Gaps = 2/133 (1%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
K LK+L+H N++KL +V R LY VFE+M +LY+LI+DR + LPES+I++ +YQ+LQ
Sbjct: 50 KLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQ 109
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAPEV 473
GLAF H HG HRD+KPENLL ++K+ADFGLAR S RPYT YV TRWYRAPE+
Sbjct: 110 GLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPEL 169
Query: 474 LLHSTAYSAPIHL 486
LL YS P+ +
Sbjct: 170 LLGDKGYSTPVDI 182
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 8e-49
Identities = 60/129 (46%), Positives = 82/129 (63%), Gaps = 2/129 (1%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
LK+L H N+VKL +VI LY VFEY +L + + R L ++I+++MYQ+L+GL
Sbjct: 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGL 111
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAPEVLL 475
A+ H H HRD+KP+N+L ++K+ADFGLAR R YT V T WYRAPE+LL
Sbjct: 112 AYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILL 171
Query: 476 HSTAYSAPI 484
S YS +
Sbjct: 172 GSKHYSTAV 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|220388 pfam09766, FimP, Fms-interacting protein | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 4e-47
Identities = 76/143 (53%), Positives = 95/143 (66%)
Query: 817 VLLKKLNRLEKYRLKNARETLQAKKSKVDSFNLQLQNLKYEIFHLKKEVVKCLQFKSKDE 876
+ LKK NRL R++ R+ +K KVDS LQLQNL YE HL+KE+ +CL FKSKDE
Sbjct: 1 ITLKKANRLAHIRIEKGRDKTHEEKDKVDSLRLQLQNLLYEKSHLEKEINRCLDFKSKDE 60
Query: 877 DIDLVDEETFFKDAPESISRPEVTKEDPHQLKLARLEWELKQRKELADECSLVERENESV 936
+I+LV E F+ APE ISRPE T D H L LARLEWEL+QRKELA++ +E E E +
Sbjct: 61 EIELVPLEEFYAQAPEDISRPEKTPLDEHNLMLARLEWELEQRKELAEKLKELESEKEKL 120
Query: 937 AANINKKRGQLDNLAPLLKQLLS 959
+I KK+ L +L P LK L
Sbjct: 121 QQDIEKKKEFLSSLPPKLKDLKK 143
|
This entry carries part of the crucial 144 N-terminal residues of the FmiP protein, which is essential for the binding of the protein to the cytoplasmic domain of activated Fms-molecules in M-CSF induced haematopoietic differentiation of macrophages. The C-terminus contains a putative nuclear localisation sequence and a leucine zipper which suggest further, as yet unknown, nuclear functions. The level of FMIP expression might form a threshold that determines whether cells differentiate into macrophages or into granulocytes. Length = 352 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 54/129 (41%), Positives = 73/129 (56%), Gaps = 4/129 (3%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDRDKFLPESIIRNMMYQVLQG 416
LKKL H N+V+L +V + D LY V EY +L+ L++ R L E R + Q+L
Sbjct: 51 LKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR-GRLSEDEARFYLRQILSA 109
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS-RPYTDYVSTRWYRAPEVLL 475
L ++H G HRD+KPEN+L VK+ADFGLAR++ T +V T Y APEVLL
Sbjct: 110 LEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169
Query: 476 HSTAYSAPI 484
Y +
Sbjct: 170 -GKGYGKAV 177
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 2e-43
Identities = 65/129 (50%), Positives = 91/129 (70%), Gaps = 5/129 (3%)
Query: 357 SLKKLS-HANLVKLKEVI--RENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQV 413
+L++LS H N+++L EV+ R+ L VFE M NLY+LI+ R + LPE +++ MYQ+
Sbjct: 50 ALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQL 109
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPE 472
L+ L MHR+G FHRD+KPEN+L +++K+ADFG R I S+ PYT+Y+STRWYRAPE
Sbjct: 110 LKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPE 168
Query: 473 VLLHSTAYS 481
LL Y
Sbjct: 169 CLLTDGYYG 177
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 53/132 (40%), Positives = 77/132 (58%), Gaps = 4/132 (3%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVL 414
+ L++LSH N+V+L + + D LY V EY + +L+ + R L E + + Q+L
Sbjct: 50 RILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQIL 108
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR--EIRSRPYTDYVSTRWYRAPE 472
+GL ++H +G HRD+KPEN+L +VKIADFGLA+ S T +V T WY APE
Sbjct: 109 RGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPE 168
Query: 473 VLLHSTAYSAPI 484
VLL Y +
Sbjct: 169 VLLGGNGYGPKV 180
|
Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 6e-42
Identities = 60/132 (45%), Positives = 86/132 (65%), Gaps = 3/132 (2%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
K L++L H N+V LKE R LY VFEY++ L +L+ LP +R+ ++Q+LQ
Sbjct: 52 KVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQ 111
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYVSTRWYRAPE 472
+A+ H H HRD+KPEN+L + ++K+ DFG AR +R+R P TDYV+TRWYRAPE
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171
Query: 473 VLLHSTAYSAPI 484
+L+ T Y P+
Sbjct: 172 LLVGDTNYGKPV 183
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 4e-39
Identities = 56/134 (41%), Positives = 83/134 (61%), Gaps = 3/134 (2%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
K+L+ H +VKL +V V EYM +L +++RD ++ LPE+ +++ M +L+
Sbjct: 51 KALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLK 110
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR---EIRSRPYTDYVSTRWYRAPE 472
G+A+MH +G HRD+KP NLL ++KIADFGLAR E R Y+ V+TRWYRAPE
Sbjct: 111 GVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
Query: 473 VLLHSTAYSAPIHL 486
+L + Y + L
Sbjct: 171 LLYGARKYDPGVDL 184
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 4e-38
Identities = 56/134 (41%), Positives = 81/134 (60%), Gaps = 5/134 (3%)
Query: 356 KSLKKLSHANLVKLKEVIREND--TLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQV 413
K L+KL H N+V+LKE++ ++Y VFEYM +L L+ + ES I+ M Q+
Sbjct: 50 KLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQL 109
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI---RSRPYTDYVSTRWYRA 470
L+GL ++H +G HRD+K N+L ++K+ADFGLAR S YT+ V T WYR
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRP 169
Query: 471 PEVLLHSTAYSAPI 484
PE+LL +T Y +
Sbjct: 170 PELLLGATRYGPEV 183
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 9e-36
Identities = 58/132 (43%), Positives = 81/132 (61%), Gaps = 4/132 (3%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
+ LK+L H NLV L EV R L+ VFEY + + + +PE +I+ +++Q LQ
Sbjct: 52 RMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQ 111
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---YTDYVSTRWYRAPE 472
+ F H+H HRD+KPEN+L +K+ DFG AR I + P YTDYV+TRWYRAPE
Sbjct: 112 AVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFAR-ILTGPGDDYTDYVATRWYRAPE 170
Query: 473 VLLHSTAYSAPI 484
+L+ T Y P+
Sbjct: 171 LLVGDTQYGPPV 182
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 59/134 (44%), Positives = 85/134 (63%), Gaps = 8/134 (5%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKF---LPESIIRNMMYQ 412
+ LK+L H NLV L EV R LY VFE++ + ++ D +K+ L ES +R ++Q
Sbjct: 52 RMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD---HTVLDDLEKYPNGLDESRVRKYLFQ 108
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRA 470
+L+G+ F H H HRD+KPEN+L + +VK+ DFG AR + + YTDYV+TRWYRA
Sbjct: 109 ILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRA 168
Query: 471 PEVLLHSTAYSAPI 484
PE+L+ T Y +
Sbjct: 169 PELLVGDTKYGRAV 182
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 1e-34
Identities = 51/137 (37%), Positives = 79/137 (57%), Gaps = 11/137 (8%)
Query: 358 LKKLSHANLVKLKEVIREND-----TLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQ 412
L+ L H N++ L +++R +Y V E M+ +L+++I+ L + I+ +YQ
Sbjct: 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQP-LTDDHIQYFLYQ 111
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY-----TDYVSTRW 467
+L+GL ++H HRD+KP N+L +KI DFGLAR + T+YV TRW
Sbjct: 112 ILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171
Query: 468 YRAPEVLLHSTAYSAPI 484
YRAPE+LL S+ Y+ I
Sbjct: 172 YRAPELLLSSSRYTKAI 188
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 51/128 (39%), Positives = 77/128 (60%), Gaps = 2/128 (1%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
K L++L H N++ L +V + VFE+M+ +L ++I+D+ L + I++ M L+
Sbjct: 54 KLLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLR 113
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAPEV 473
GL ++H + HRD+KP NLL ++K+ADFGLAR S R T V TRWYRAPE+
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPEL 173
Query: 474 LLHSTAYS 481
L + Y
Sbjct: 174 LFGARHYG 181
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 54/130 (41%), Positives = 76/130 (58%), Gaps = 4/130 (3%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDRDKFLPESIIRNMMYQVL 414
+ LKKL+H N+VKL V + + LY V EY +L L+++ + L E I ++ Q+L
Sbjct: 43 EILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQIL 102
Query: 415 QGLAFMHRHGFFHRDMKPEN-LLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAP 471
+GL ++H +G HRD+KPEN LL VK+ADFGL++ + S V T Y AP
Sbjct: 103 EGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAP 162
Query: 472 EVLLHSTAYS 481
EVLL YS
Sbjct: 163 EVLLGKGYYS 172
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 4e-34
Identities = 62/135 (45%), Positives = 85/135 (62%), Gaps = 14/135 (10%)
Query: 358 LKKLS-HANLVKLKEVIR-ENDT-LYFVFEYMKENLYQLIRDRDKFLPESI-IRNMMYQV 413
L++L H N+VKL VI+ END +Y VFEYM+ +L+ +IR + E + R +MYQ+
Sbjct: 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIR---ANILEDVHKRYIMYQL 116
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP-------YTDYVSTR 466
L+ L ++H HRD+KP N+L VK+ADFGLAR + TDYV+TR
Sbjct: 117 LKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 467 WYRAPEVLLHSTAYS 481
WYRAPE+LL ST Y+
Sbjct: 177 WYRAPEILLGSTRYT 191
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 57/130 (43%), Positives = 83/130 (63%), Gaps = 3/130 (2%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKF-LPESIIRNMMYQVLQG 416
LK+L+H N+V+L +V+ + LY VFE++ +L + + L +I++ +YQ+LQG
Sbjct: 52 LKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE--IRSRPYTDYVSTRWYRAPEVL 474
+A+ H H HRD+KP+NLL +K+ADFGLAR + R YT V T WYRAPE+L
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 171
Query: 475 LHSTAYSAPI 484
L S YS P+
Sbjct: 172 LGSRQYSTPV 181
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 56/131 (42%), Positives = 83/131 (63%), Gaps = 4/131 (3%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENL--YQLIRDRDKFLPESIIRNMMYQVLQ 415
LK+L H N+V L++V+ + LY +FE++ +L Y + +++ ++++ +YQ+LQ
Sbjct: 53 LKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQ 112
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE--IRSRPYTDYVSTRWYRAPEV 473
G+ F H HRD+KP+NLL ++K+ADFGLAR I R YT V T WYRAPEV
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEV 172
Query: 474 LLHSTAYSAPI 484
LL S YS P+
Sbjct: 173 LLGSPRYSTPV 183
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 57/129 (44%), Positives = 80/129 (62%), Gaps = 2/129 (1%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
LK L HAN+V L ++I TL VFEY+ +L Q + D L +R ++Q+L+GL
Sbjct: 57 LKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR--EIRSRPYTDYVSTRWYRAPEVLL 475
A+ H+ HRD+KP+NLL +K+ADFGLAR + S+ Y++ V T WYR P+VLL
Sbjct: 117 AYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLL 176
Query: 476 HSTAYSAPI 484
ST YS +
Sbjct: 177 GSTEYSTSL 185
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 58/130 (44%), Positives = 83/130 (63%), Gaps = 3/130 (2%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKF-LPESIIRNMMYQVLQG 416
LK+L+H N+VKL +VI + LY VFE++ ++L + + +P +I++ ++Q+LQG
Sbjct: 53 LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE--IRSRPYTDYVSTRWYRAPEVL 474
LAF H H HRD+KP+NLL +K+ADFGLAR + R YT V T WYRAPE+L
Sbjct: 113 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 172
Query: 475 LHSTAYSAPI 484
L YS +
Sbjct: 173 LGCKYYSTAV 182
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 56/131 (42%), Positives = 79/131 (60%), Gaps = 4/131 (3%)
Query: 358 LKKLSHANLVKLKEVI--RENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
L KL H N+V +KEV+ D +Y V EY++ +L L+ + +S ++ +M Q+L
Sbjct: 58 LLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLS 117
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAPEV 473
G+A +H + HRD+K NLL ++KI DFGLARE S +PYT V T WYRAPE+
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPEL 177
Query: 474 LLHSTAYSAPI 484
LL + YS I
Sbjct: 178 LLGAKEYSTAI 188
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 55/131 (41%), Positives = 79/131 (60%), Gaps = 4/131 (3%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENL--YQLIRDRDKFLPESIIRNMMYQVLQ 415
+K+L H N+V+L +VI + L VFEYM ++L Y L + +++ YQ+L+
Sbjct: 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLK 111
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE--IRSRPYTDYVSTRWYRAPEV 473
G+AF H + HRD+KP+NLL +K+ADFGLAR I +++ V T WYRAP+V
Sbjct: 112 GIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDV 171
Query: 474 LLHSTAYSAPI 484
LL S YS I
Sbjct: 172 LLGSRTYSTSI 182
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 52/141 (36%), Positives = 81/141 (57%), Gaps = 11/141 (7%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTL----YFVFEYMKENLYQLIRDRDKFLPESIIRNMMY 411
K L+ H N++ +++++R Y V + M+ +L+ +I D+ L E IR +Y
Sbjct: 56 KILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLY 114
Query: 412 QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP------YTDYVST 465
Q+L+GL ++H HRD+KP NLL ++I DFG+AR + S P T+YV+T
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 466 RWYRAPEVLLHSTAYSAPIHL 486
RWYRAPE+LL Y+ I +
Sbjct: 175 RWYRAPELLLSLPEYTTAIDM 195
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 57/131 (43%), Positives = 82/131 (62%), Gaps = 4/131 (3%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPE-SIIRNMMYQVLQG 416
LK++ H N+V+L++V+ LY VFEY+ +L + + F +I+ +YQ+L+G
Sbjct: 55 LKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRG 114
Query: 417 LAFMHRHGFFHRDMKPENLLC-MGTELVKIADFGLARE--IRSRPYTDYVSTRWYRAPEV 473
+A+ H H HRD+KP+NLL T +K+ADFGLAR I R +T V T WYRAPE+
Sbjct: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEI 174
Query: 474 LLHSTAYSAPI 484
LL S YS P+
Sbjct: 175 LLGSRHYSTPV 185
|
Length = 294 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 54/150 (36%), Positives = 78/150 (52%), Gaps = 21/150 (14%)
Query: 356 KSLKKLSHANLVKLKEVI--------RENDTLYFVFEYMKENLYQLIRDRDKFLPESIIR 407
K LKKL H N+V L ++ R+ ++Y V YM +L L+ + L ES I+
Sbjct: 59 KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK 118
Query: 408 NMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--------- 458
M Q+L+G+ ++H + HRD+K N+L ++KIADFGLAR P
Sbjct: 119 CYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 459 ----YTDYVSTRWYRAPEVLLHSTAYSAPI 484
YT+ V TRWYR PE+LL Y+ +
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAV 208
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 55/137 (40%), Positives = 78/137 (56%), Gaps = 10/137 (7%)
Query: 356 KSLKKLSHANLVKLKEVIRENDT-----LYFVFEYMKENLYQLI-RDRDKFLPESIIRNM 409
K L+ H N+V+L +V T L VFE++ ++L + + LP I+++
Sbjct: 53 KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDL 112
Query: 410 MYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR--EIRSRPYTDYVSTRW 467
M Q+L+G+ F+H H HRD+KP+N+L VKIADFGLAR T V T W
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLW 171
Query: 468 YRAPEVLLHSTAYSAPI 484
YRAPEVLL S+ Y+ P+
Sbjct: 172 YRAPEVLLQSS-YATPV 187
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 54/131 (41%), Positives = 81/131 (61%), Gaps = 4/131 (3%)
Query: 358 LKKLSHANLVKLKEVI--RENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
L L H N+V+LKEV+ + D+++ V EY +++L L+ + ES ++ +M Q+L+
Sbjct: 60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLR 119
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR--EIRSRPYTDYVSTRWYRAPEV 473
GL ++H + HRD+K NLL +KIADFGLAR + ++P T V T WYRAPE+
Sbjct: 120 GLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPEL 179
Query: 474 LLHSTAYSAPI 484
LL T Y+ I
Sbjct: 180 LLGCTTYTTAI 190
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 50/142 (35%), Positives = 83/142 (58%), Gaps = 15/142 (10%)
Query: 358 LKKLSHANLVKLKEVIRENDT--LYFVFEYMKENLYQLIRD----RDKFLPESIIRNMMY 411
L++L H N+V L EV E+ +Y +F+Y + +L+Q+I+ + +P S+++++++
Sbjct: 56 LRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 412 QVLQGLAFMHRHGFFHRDMKPENLLCMGTE----LVKIADFGLAREIRSRPYTDY----- 462
Q+L G+ ++H + HRD+KP N+L MG +VKI D GLAR +
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 463 VSTRWYRAPEVLLHSTAYSAPI 484
V T WYRAPE+LL + Y+ I
Sbjct: 176 VVTIWYRAPELLLGARHYTKAI 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 54/129 (41%), Positives = 78/129 (60%), Gaps = 2/129 (1%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
LK+L H N+V+L +V+ + L VFEY ++L + + + I+++ M+Q+L+GL
Sbjct: 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE--IRSRPYTDYVSTRWYRAPEVLL 475
AF H H HRD+KP+NLL +K+ADFGLAR I R Y+ V T WYR P+VL
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 172
Query: 476 HSTAYSAPI 484
+ YS I
Sbjct: 173 GAKLYSTSI 181
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 61/140 (43%), Positives = 86/140 (61%), Gaps = 13/140 (9%)
Query: 358 LKKLSHAN-LVKLKEV--IREND---TLYFVFEYMKENLYQLI----RDRDKFLPESIIR 407
L+ LS + +V+L +V + E + +LY VFEY+ +L + + R + LP I+
Sbjct: 54 LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 408 NMMYQVLQGLAFMHRHGFFHRDMKPENLLC-MGTELVKIADFGLAR--EIRSRPYTDYVS 464
+ MYQ+L+G+A H+HG HRD+KP+NLL L+KIAD GL R I + YT +
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 465 TRWYRAPEVLLHSTAYSAPI 484
T WYRAPEVLL ST YS P+
Sbjct: 174 TLWYRAPEVLLGSTHYSTPV 193
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 4e-28
Identities = 60/129 (46%), Positives = 82/129 (63%), Gaps = 6/129 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
LK L HAN+V L ++I +TL FVFEYM +L Q + L +R M+Q+L+GL
Sbjct: 57 LKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGL 116
Query: 418 AFMHRHGFFHRDMKPENLL--CMGTELVKIADFGLAR--EIRSRPYTDYVSTRWYRAPEV 473
A++H HRD+KP+NLL +G +K+ADFGLAR I S+ Y+ V T WYR P+V
Sbjct: 117 AYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDV 174
Query: 474 LLHSTAYSA 482
LL +T YS+
Sbjct: 175 LLGATDYSS 183
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 54/131 (41%), Positives = 81/131 (61%), Gaps = 2/131 (1%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
LK L HAN+V L ++I L VFEY+ +L Q + + + ++ M+Q+L+GL
Sbjct: 57 LKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGL 116
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR--EIRSRPYTDYVSTRWYRAPEVLL 475
++ H+ HRD+KP+NLL +K+ADFGLAR + ++ Y++ V T WYR P+VLL
Sbjct: 117 SYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 176
Query: 476 HSTAYSAPIHL 486
ST YS PI +
Sbjct: 177 GSTEYSTPIDM 187
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 51/123 (41%), Positives = 82/123 (66%), Gaps = 3/123 (2%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
K L+ L N+V+LKE R LY VFEY+++N+ +L+ + +P +R+ +YQ+++
Sbjct: 52 KMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIK 111
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR---EIRSRPYTDYVSTRWYRAPE 472
+ + H++ HRD+KPENLL +++K+ DFG AR E + YT+YV+TRWYR+PE
Sbjct: 112 AIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
Query: 473 VLL 475
+LL
Sbjct: 172 LLL 174
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 56/142 (39%), Positives = 78/142 (54%), Gaps = 13/142 (9%)
Query: 356 KSLKKLSHANLVKLKEVI----------RENDTLYFVFEYMKENLYQLIRDRDKFLPESI 405
K L++L+H N+V LKE++ ++ Y VFEYM +L L+ E
Sbjct: 58 KILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH 117
Query: 406 IRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR---EIRSRPYTDY 462
I++ M Q+L+GL + H+ F HRD+K N+L +K+ADFGLAR SRPYT+
Sbjct: 118 IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 463 VSTRWYRAPEVLLHSTAYSAPI 484
V T WYR PE+LL Y I
Sbjct: 178 VITLWYRPPELLLGEERYGPAI 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 54/131 (41%), Positives = 81/131 (61%), Gaps = 2/131 (1%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
LK L HAN+V L ++I +L VFEY+ ++L Q + D + ++ ++Q+L+GL
Sbjct: 58 LKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGL 117
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR--EIRSRPYTDYVSTRWYRAPEVLL 475
+ HR HRD+KP+NLL +K+ADFGLAR I ++ Y++ V T WYR P++LL
Sbjct: 118 NYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILL 177
Query: 476 HSTAYSAPIHL 486
ST YS I +
Sbjct: 178 GSTDYSTQIDM 188
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 54/131 (41%), Positives = 83/131 (63%), Gaps = 2/131 (1%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
LK L HAN+V L +++ + +L VFEY+ ++L Q + D + ++ +YQ+L+GL
Sbjct: 58 LKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGL 117
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR--EIRSRPYTDYVSTRWYRAPEVLL 475
A+ HR HRD+KP+NLL +K+ADFGLAR + ++ Y++ V T WYR P+VLL
Sbjct: 118 AYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 177
Query: 476 HSTAYSAPIHL 486
S+ YS I +
Sbjct: 178 GSSEYSTQIDM 188
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 9e-26
Identities = 53/139 (38%), Positives = 81/139 (58%), Gaps = 12/139 (8%)
Query: 356 KSLKKLSHANLVKLKEVIREND-----TLYFVFEYMKENLYQLIRDRDKFLPESIIRNMM 410
K L++ H N++ + ++IR +Y V E M+ +LY+LI+ + L I+ +
Sbjct: 55 KILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH--LSNDHIQYFL 112
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR-----EIRSRPYTDYVST 465
YQ+L+GL ++H HRD+KP NLL +KI DFGLAR + T+YV+T
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172
Query: 466 RWYRAPEVLLHSTAYSAPI 484
RWYRAPE++L+S Y+ I
Sbjct: 173 RWYRAPEIMLNSKGYTKAI 191
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 9/133 (6%)
Query: 358 LKKLSHANLVKLK--EVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVL 414
L L H N+V+ E E +TL EY+ +L L++ K PE +IR Q+L
Sbjct: 53 LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKL-PEPVIRKYTRQIL 111
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTR----WYRA 470
+GLA++H +G HRD+K N+L +VK+ADFG A+ + + + ++ A
Sbjct: 112 EGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 471 PEVLLHSTAYSAP 483
PEV + Y
Sbjct: 172 PEV-IRGEEYGRA 183
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 55/129 (42%), Positives = 77/129 (59%), Gaps = 9/129 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKEN--LYQLIRDRDKFLPESIIRNMMYQVLQ 415
LK L H N+VK I +D+LY + EY EN L Q+I+ F PES++ +YQVLQ
Sbjct: 53 LKNLKHPNIVKYIGSIETSDSLYIILEYA-ENGSLRQIIKKFGPF-PESLVAVYVYQVLQ 110
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR--SRPYTDYVSTRWYRAPEV 473
GLA++H G HRD+K N+L +VK+ADFG+A ++ S+ V T ++ APEV
Sbjct: 111 GLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEV 170
Query: 474 LL---HSTA 479
+ STA
Sbjct: 171 IEMSGASTA 179
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 52/136 (38%), Positives = 80/136 (58%), Gaps = 8/136 (5%)
Query: 356 KSLKKLSHANLVKLKEVIRENDT-----LYFVFEYMKENLYQLIRDRDKFLPESIIRNMM 410
K L+ L H N++ +K+++ +Y V+E M +L+Q+IR + L + + +
Sbjct: 56 KLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFL 114
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--YTDYVSTRWY 468
YQ+L+GL ++H HRD+KP NLL +KI DFGLAR + T+YV TRWY
Sbjct: 115 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWY 174
Query: 469 RAPEVLLHSTAYSAPI 484
RAPE+LL+ + Y+ I
Sbjct: 175 RAPELLLNCSEYTTAI 190
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 6/125 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
++KL H N+VKL V E + LY V EYM+ +L +R L S + + Q+ +G
Sbjct: 55 MRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARG 114
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST----RWYRAPE 472
+ ++ F HRD+ N L +VKI+DFGL+R++ Y RW APE
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APE 173
Query: 473 VLLHS 477
L
Sbjct: 174 SLKEG 178
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-25
Identities = 53/128 (41%), Positives = 79/128 (61%), Gaps = 11/128 (8%)
Query: 356 KSLKKLSHANLVKLKEVI-----RENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMM 410
K L+ L H ++V++K ++ RE +Y VFE M+ +L+Q+I+ D PE + +
Sbjct: 51 KLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH-QFFL 109
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR-EIRSRP----YTDYVST 465
YQ+L+ L ++H FHRD+KP+N+L +KI DFGLAR P +TDYV+T
Sbjct: 110 YQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 169
Query: 466 RWYRAPEV 473
RWYRAPE+
Sbjct: 170 RWYRAPEL 177
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 44/129 (34%), Positives = 63/129 (48%), Gaps = 11/129 (8%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRD-RDKFLPESIIRNMMYQVLQ 415
++KL H N+VKL V E + L V EYM +L +R R K L S + + Q+ +
Sbjct: 55 MRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR 114
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST------RWYR 469
G+ ++ F HRD+ N L +VKI+DFGL+R++ Y Y RW
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY--YKVKGGKLPIRWM- 171
Query: 470 APEVLLHST 478
APE L
Sbjct: 172 APESLKEGK 180
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 104 bits (259), Expect = 3e-24
Identities = 55/126 (43%), Positives = 80/126 (63%), Gaps = 2/126 (1%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
LK L HAN+V L ++I +TL VFEY+ +L Q + L ++ ++Q+L+GL
Sbjct: 57 LKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGL 116
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR--EIRSRPYTDYVSTRWYRAPEVLL 475
+++H+ HRD+KP+NLL T +K+ADFGLAR + S Y++ V T WYR P+VLL
Sbjct: 117 SYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 476 HSTAYS 481
ST YS
Sbjct: 177 GSTEYS 182
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 55/145 (37%), Positives = 80/145 (55%), Gaps = 14/145 (9%)
Query: 356 KSLKKLSHANLVKLKEVIR-----END---TLYFVFEYMKENLYQLIRDRDKFLPESIIR 407
K L+ L H N+V L E+ R N + Y VFE+ + +L L+ +++ S I+
Sbjct: 63 KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIK 122
Query: 408 NMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR----EIRSRP--YTD 461
+M +L GL ++HR+ HRDMK N+L ++K+ADFGLAR S+P YT+
Sbjct: 123 KVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 462 YVSTRWYRAPEVLLHSTAYSAPIHL 486
V T WYR PE+LL Y PI +
Sbjct: 183 RVVTLWYRPPELLLGERDYGPPIDM 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 54/125 (43%), Positives = 79/125 (63%), Gaps = 6/125 (4%)
Query: 354 YR--KSLKKLSHANLVKLKEV-IRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMM 410
YR K LK L H N++ L ++ I + +YFV E + +L++L+ R L + I+ +
Sbjct: 57 YRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRP--LEKQFIQYFL 114
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRA 470
YQ+L+GL ++H G HRD+KP N+L +KI DFGLAR I+ T YVSTR+YRA
Sbjct: 115 YQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLAR-IQDPQMTGYVSTRYYRA 173
Query: 471 PEVLL 475
PE++L
Sbjct: 174 PEIML 178
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-22
Identities = 54/138 (39%), Positives = 83/138 (60%), Gaps = 8/138 (5%)
Query: 356 KSLKKLSHANLVKLKEVIRENDT-----LYFVFEYMKENLYQ-LIRDRDKFLPESIIRNM 409
+ L+ H N+V+L +V + T L VFE++ ++L L + + +P I++M
Sbjct: 56 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 115
Query: 410 MYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD-YVSTRWY 468
M+Q+L+GL F+H H HRD+KP+N+L + +K+ADFGLAR + V T WY
Sbjct: 116 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 175
Query: 469 RAPEVLLHSTAYSAPIHL 486
RAPEVLL S+ Y+ P+ L
Sbjct: 176 RAPEVLLQSS-YATPVDL 192
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 11/128 (8%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+KKLSH N+V+L V + + LY V EYM +L +R + L + M Q+ +G
Sbjct: 55 MKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKG 114
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST-------RWYR 469
+ ++ F HRD+ N L +VKI+DFGL+R+I Y Y +W
Sbjct: 115 MEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY--YRKRGGGKLPIKWM- 171
Query: 470 APEVLLHS 477
APE L
Sbjct: 172 APESLKDG 179
|
Length = 258 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-21
Identities = 48/130 (36%), Positives = 73/130 (56%), Gaps = 11/130 (8%)
Query: 354 YR--KSLKKLSHANLVKLKEVIRENDTL------YFVFEYMKENLYQLIRDRDKFLPESI 405
YR + LK + H N++ L +V +L Y V M +L +++ + L +
Sbjct: 62 YRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK--LSDDH 119
Query: 406 IRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST 465
I+ ++YQ+L+GL ++H G HRD+KP N+ +KI DFGLAR T YV+T
Sbjct: 120 IQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-MTGYVAT 178
Query: 466 RWYRAPEVLL 475
RWYRAPE++L
Sbjct: 179 RWYRAPEIML 188
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 2e-21
Identities = 58/137 (42%), Positives = 80/137 (58%), Gaps = 10/137 (7%)
Query: 356 KSLKKLSHANLVKLKEVIRENDT-----LYFVFEYMKENLYQ-LIRDRDKFLPESIIRNM 409
K L+ H N+V+L +V + T + VFE++ ++L L + LP I+++
Sbjct: 54 KRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDL 113
Query: 410 MYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRW 467
M Q L+GL F+H + HRD+KPEN+L VK+ADFGLAR I S T V T W
Sbjct: 114 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR-IYSCQMALTPVVVTLW 172
Query: 468 YRAPEVLLHSTAYSAPI 484
YRAPEVLL ST Y+ P+
Sbjct: 173 YRAPEVLLQST-YATPV 188
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 42/126 (33%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKFLPESIIRNMMYQVL 414
K + KLSH NLV+L V + ++ V EYM L +R+R L + +M V
Sbjct: 51 KVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVC 110
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRW---YRAP 471
+ + ++ +GF HRD+ N L +VK++DFGLAR + YT T++ + P
Sbjct: 111 EAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPP 170
Query: 472 EVLLHS 477
EV +S
Sbjct: 171 EVFDYS 176
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-21
Identities = 47/142 (33%), Positives = 72/142 (50%), Gaps = 17/142 (11%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
K + ++ H N++ L +V E D + V + M +L +++ DR L ES ++ ++ Q+L
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVV-DRKIRLTESQVKCILLQILN 130
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI----------------RSRPY 459
GL +H+ F HRD+ P N+ + KIADFGLAR R
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 460 TDYVSTRWYRAPEVLLHSTAYS 481
T V T WYRAPE+L+ + Y
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYH 212
|
Length = 335 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 46/114 (40%), Positives = 68/114 (59%), Gaps = 7/114 (6%)
Query: 377 DTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLL 436
+ LY E M+ +L+Q+IR + L ++ ++ +YQ+L GL ++H HRD+KP NLL
Sbjct: 79 NELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLL 137
Query: 437 CMGTELVKIADFGLAREIRSRPY------TDYVSTRWYRAPEVLLHSTAYSAPI 484
+KI DFGLAR P T+YV+TRWYRAPE++L +Y+ I
Sbjct: 138 VNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAI 191
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-20
Identities = 52/152 (34%), Positives = 80/152 (52%), Gaps = 24/152 (15%)
Query: 356 KSLKKLSHANLVKLKEVI--------------RENDTLYFVFEYMKENLYQLIRDRDKFL 401
K +++L H N+VK+ EV+ E +++Y V EYM+ +L ++ L
Sbjct: 54 KIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP--L 111
Query: 402 PESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELV-KIADFGLAREIRSRPY- 459
E R MYQ+L+GL ++H HRD+KP N+ +LV KI DFGLAR I Y
Sbjct: 112 SEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR-IVDPHYS 170
Query: 460 -----TDYVSTRWYRAPEVLLHSTAYSAPIHL 486
++ + T+WYR+P +LL Y+ I +
Sbjct: 171 HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDM 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 5e-20
Identities = 54/136 (39%), Positives = 79/136 (58%), Gaps = 11/136 (8%)
Query: 354 YR--KSLKKLSHANLVKLKEVIRENDTL------YFVFEYMKENLYQLIRDRDKFLPESI 405
YR + LK + H N++ L +V + +L Y V +M +L +L++ L E
Sbjct: 62 YRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK--LSEDR 119
Query: 406 IRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST 465
I+ ++YQ+L+GL ++H G HRD+KP NL +KI DFGLAR+ S T YV T
Sbjct: 120 IQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-MTGYVVT 178
Query: 466 RWYRAPEVLLHSTAYS 481
RWYRAPEV+L+ Y+
Sbjct: 179 RWYRAPEVILNWMHYT 194
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 3e-19
Identities = 54/173 (31%), Positives = 93/173 (53%), Gaps = 19/173 (10%)
Query: 333 DQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVI--RENDTLYFVFEYMKENL 390
D+ + L + + M C L++L H N++ L++V + ++ +F+Y + +L
Sbjct: 27 DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDL 86
Query: 391 YQLIR--------DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT-- 440
+ +I+ + LP S++++++YQ+L G+ ++H + HRD+KP N+L MG
Sbjct: 87 WHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGP 146
Query: 441 --ELVKIADFGLAREIRS--RPYTDY---VSTRWYRAPEVLLHSTAYSAPIHL 486
VKIAD G AR S +P D V T WYRAPE+LL + Y+ I +
Sbjct: 147 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDI 199
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 5e-19
Identities = 50/130 (38%), Positives = 71/130 (54%), Gaps = 10/130 (7%)
Query: 358 LKKLSHANLVKLKEV------IRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMY 411
LK + H N++ L +V E Y V YM+ +L ++ L E ++ ++Y
Sbjct: 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI---MGHPLSEDKVQYLVY 124
Query: 412 QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAP 471
Q+L GL ++H G HRD+KP NL +KI DFGLAR + T YV TRWYRAP
Sbjct: 125 QMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-MTGYVVTRWYRAP 183
Query: 472 EVLLHSTAYS 481
EV+L+ Y+
Sbjct: 184 EVILNWMHYN 193
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 8/155 (5%)
Query: 331 NLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-N 389
+L D V ++ + L KL H N+V+ RE D LY E + +
Sbjct: 34 SLADDGQTGQEAVKQLEQEI-----ALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGS 88
Query: 390 LYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFG 449
L +L++ F PE +IR Q+L GL ++H HRD+K N+L +VK+ADFG
Sbjct: 89 LAKLLKKYGSF-PEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFG 147
Query: 450 LAREIRSRPYT-DYVSTRWYRAPEVLLHSTAYSAP 483
+A+++ + + + ++ APEV+ Y
Sbjct: 148 MAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLA 182
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 40/120 (33%), Positives = 69/120 (57%), Gaps = 4/120 (3%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDRDKFLPESIIRNMMYQVLQG 416
LKK H N+VK + D L+ V E+ +L L++ ++ L ES I + ++L+G
Sbjct: 51 LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKG 110
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTE-LVKIADFGLAREIRSRPYTD-YVSTRWYRAPEVL 474
L ++H +G HRD+K N+L + ++ VK+ DFGL+ ++ + V T ++ APEV+
Sbjct: 111 LEYLHSNGIIHRDIKAANIL-LTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVI 169
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 9e-19
Identities = 42/125 (33%), Positives = 63/125 (50%), Gaps = 10/125 (8%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDR---DKFLPESIIRNMMYQV 413
LKKL+H N++K E E L V EY +L Q I+ + K PE I + Q+
Sbjct: 53 LKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL 112
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDY----VSTRWYR 469
L ++H HRD+KP+N+ LVK+ DFG+++ + S D V T +Y
Sbjct: 113 CLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST--VDLAKTVVGTPYYL 170
Query: 470 APEVL 474
+PE+
Sbjct: 171 SPELC 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 42/125 (33%), Positives = 65/125 (52%), Gaps = 5/125 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDRD-KFLPESIIRNMMYQVLQ 415
+KKL H LV+L V E + +Y V EYM K +L ++ + K L + +M Q+ +
Sbjct: 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAE 114
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRW---YRAPE 472
G+A++ + HRD+ N+L + KIADFGLAR I YT ++ + APE
Sbjct: 115 GMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPE 174
Query: 473 VLLHS 477
+
Sbjct: 175 AANYG 179
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 53/173 (30%), Positives = 92/173 (53%), Gaps = 19/173 (10%)
Query: 333 DQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVI--RENDTLYFVFEYMKENL 390
D ++ L + + M C L++L H N++ L++V + ++ +F+Y + +L
Sbjct: 27 DDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDL 86
Query: 391 YQLIR--------DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT-- 440
+ +I+ + LP ++++++YQ+L G+ ++H + HRD+KP N+L MG
Sbjct: 87 WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGP 146
Query: 441 --ELVKIADFGLAREIRS--RPYTDY---VSTRWYRAPEVLLHSTAYSAPIHL 486
VKIAD G AR S +P D V T WYRAPE+LL + Y+ I +
Sbjct: 147 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDI 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 45/134 (33%), Positives = 68/134 (50%), Gaps = 13/134 (9%)
Query: 358 LKKLSHANLVKL--KEVIRENDTLYFVFEYMKE-NLYQLI---RDRDKFLPESIIRNMMY 411
L++L H N+V+ + + R N TLY V EY + +L QLI + K++ E I ++
Sbjct: 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT 112
Query: 412 QVLQGLAFMHR-----HGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY--TDYVS 464
Q+L L H + HRD+KP N+ VK+ DFGLA+ + YV
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVG 172
Query: 465 TRWYRAPEVLLHST 478
T +Y +PE L H +
Sbjct: 173 TPYYMSPEQLNHMS 186
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 341 RHVSSRDEMVVCFYRKS-LKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRD 398
+ + R E+ ++ L +++H +VKL + + LY V EY L+ +
Sbjct: 29 KKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG 88
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI---R 455
+F E R +++ L ++H G +RD+KPEN+L +K+ DFGLA+E+
Sbjct: 89 RF-SEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG 147
Query: 456 SRPYTDYVSTRWYRAPEVLL---HSTA 479
SR T + T Y APEVLL + A
Sbjct: 148 SRTNT-FCGTPEYLAPEVLLGKGYGKA 173
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 41/138 (29%), Positives = 63/138 (45%), Gaps = 21/138 (15%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYM---------KENLYQLIRDRDKFLPESII 406
+ +KKL H N+V+L V E + LY V EYM +++ L +
Sbjct: 48 RVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDL 107
Query: 407 RNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL-VKIADFGLAREIRSRPYTDYVST 465
+ Q+ +G+ ++ F HRD+ N L +G +L VKI+DFGL+R++ Y
Sbjct: 108 LSFAIQIAKGMEYLASKKFVHRDLAARNCL-VGEDLVVKISDFGLSRDVYD--DDYYRKK 164
Query: 466 -------RWYRAPEVLLH 476
RW APE L
Sbjct: 165 TGGKLPIRWM-APESLKD 181
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-18
Identities = 53/170 (31%), Positives = 88/170 (51%), Gaps = 18/170 (10%)
Query: 358 LKKLSHANLVKLKEV------IRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMY 411
LK + H N++ L +V + E + +Y V M +L +++ + L + ++ ++Y
Sbjct: 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIY 127
Query: 412 QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAP 471
Q+L+GL ++H HRD+KP NL +KI DFGLAR T YV+TRWYRAP
Sbjct: 128 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT-DDEMTGYVATRWYRAP 186
Query: 472 EVLLHSTAYSAPIHLSR---------SQQFLFYSIDHVPPIQTTCLLAGT 512
E++L+ Y+ + + + + LF DH+ ++ L GT
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 51/136 (37%), Positives = 71/136 (52%), Gaps = 22/136 (16%)
Query: 354 YR--KSLKKLSHANLVKLKEVIRENDTL------YFVFEYMKENLYQLIR-----DRDKF 400
YR +K ++H N++ L V +L Y V E M NL Q+I+ +R +
Sbjct: 63 YRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSY 122
Query: 401 LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR-EIRSRPY 459
L +YQ+L G+ +H G HRD+KP N++ +KI DFGLAR S
Sbjct: 123 L--------LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 174
Query: 460 TDYVSTRWYRAPEVLL 475
T YV TR+YRAPEV+L
Sbjct: 175 TPYVVTRYYRAPEVIL 190
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 84.4 bits (207), Expect = 3e-17
Identities = 48/140 (34%), Positives = 71/140 (50%), Gaps = 13/140 (9%)
Query: 356 KSLKKLSHA-NLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRD--KFLPESIIRNMMY 411
+ L L+H N+VKL + ++ +LY V EY+ +L L++ L ES ++
Sbjct: 49 QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILA 108
Query: 412 QVLQGLAFMHRHGFFHRDMKPEN-LLCMGTELVKIADFGLAREIRS--------RPYTDY 462
Q+L L ++H G HRD+KPEN LL +VK+ DFGLA+ + +
Sbjct: 109 QILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168
Query: 463 VSTRWYRAPEVLLHSTAYSA 482
V T Y APEVLL + A
Sbjct: 169 VGTPGYMAPEVLLGLSLAYA 188
|
Length = 384 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 42/143 (29%), Positives = 73/143 (51%), Gaps = 8/143 (5%)
Query: 338 ILSRHVSSRD--EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLI 394
+ RH+ E + ++ L++ +H +VKL ++ +Y + EY L+ ++
Sbjct: 26 VKKRHIVETGQQEHIFS-EKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTIL 84
Query: 395 RDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI 454
RDR F E R + V+ ++H G +RD+KPENLL VK+ DFG A+++
Sbjct: 85 RDRGLF-DEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL 143
Query: 455 --RSRPYTDYVSTRWYRAPEVLL 475
+ +T + T Y APE++L
Sbjct: 144 KSGQKTWT-FCGTPEYVAPEIIL 165
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 8e-17
Identities = 45/135 (33%), Positives = 77/135 (57%), Gaps = 9/135 (6%)
Query: 358 LKKLSHANLVKLKEV------IRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMY 411
LK + H N++ L +V I + +Y V M +L +++ + L + ++ ++Y
Sbjct: 68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK--LSDEHVQFLIY 125
Query: 412 QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAP 471
Q+L+GL ++H G HRD+KP N+ ++I DFGLAR+ T YV+TRWYRAP
Sbjct: 126 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-MTGYVATRWYRAP 184
Query: 472 EVLLHSTAYSAPIHL 486
E++L+ Y+ + +
Sbjct: 185 EIMLNWMHYNQTVDI 199
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 55/161 (34%), Positives = 82/161 (50%), Gaps = 32/161 (19%)
Query: 355 RKSLKKLSHA--NLVKLKEVIRENDTL--------------------------YFVFEYM 386
R +LKK+ + NLV K V RE L Y V E M
Sbjct: 27 RVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELM 86
Query: 387 KENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIA 446
+ +L+++I + L ++ +YQ+L+GL ++H G HRD+KP NLL ++KI
Sbjct: 87 QSDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKIC 145
Query: 447 DFGLAR--EIR-SRPYTDYVSTRWYRAPEVLLHSTAYSAPI 484
DFGLAR E S+ T V T++YRAPE+L+ S Y++ +
Sbjct: 146 DFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAV 186
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 39/134 (29%), Positives = 68/134 (50%), Gaps = 9/134 (6%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDR--DKFLPESIIRNMMYQ 412
+++ + +H N+VK D L+ V Y+ +L +++ L E+II ++ +
Sbjct: 51 QAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKE 110
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLA------REIRSRPYTDYVSTR 466
VL+GL ++H +G HRD+K N+L VKIADFG++ + + +V T
Sbjct: 111 VLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170
Query: 467 WYRAPEVLLHSTAY 480
+ APEV+ Y
Sbjct: 171 CWMAPEVMEQVHGY 184
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 38/141 (26%), Positives = 63/141 (44%), Gaps = 13/141 (9%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQV 413
R L + +VKL + LY V EY+ +L L+ + E + R + ++
Sbjct: 44 RDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSL-DEDVARIYIAEI 102
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLA----------REIRSRPYTDYV 463
+ L ++H +G HRD+KP+N+L +K+ DFGL+ + V
Sbjct: 103 VLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162
Query: 464 STRWYRAPEVLLHSTAYSAPI 484
T Y APEV+L +S +
Sbjct: 163 GTPDYIAPEVIL-GQGHSKTV 182
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 49/143 (34%), Positives = 74/143 (51%), Gaps = 7/143 (4%)
Query: 338 ILSRH--VSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQL 393
ILS+ V + V ++ L+ + H LV L +++ LY V EY+ E L+
Sbjct: 33 ILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGE-LFSH 91
Query: 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE 453
+R +F PE + R QV+ L ++H +RD+KPENLL +KI DFG A+
Sbjct: 92 LRKSGRF-PEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR 150
Query: 454 IRSRPYTDYVSTRWYRAPEVLLH 476
++ R YT T Y APE++L
Sbjct: 151 VKGRTYT-LCGTPEYLAPEIILS 172
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 39/132 (29%), Positives = 66/132 (50%), Gaps = 6/132 (4%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDRDKFLPESIIRNMMYQVL 414
K+L+ +VK + + V EYM +L L++ + +PE ++ + Q+L
Sbjct: 51 KTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLK-KVGKIPEPVLAYIARQIL 109
Query: 415 QGLAFMHR-HGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAP 471
+GL ++H HRD+KP NLL VKIADFG+++ + + +V T Y +P
Sbjct: 110 KGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSP 169
Query: 472 EVLLHSTAYSAP 483
E + +YS
Sbjct: 170 ERIQ-GESYSYA 180
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 6e-16
Identities = 47/125 (37%), Positives = 69/125 (55%), Gaps = 10/125 (8%)
Query: 358 LKKLSHANLVKL------KEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMY 411
LK ++H N++ L ++ + E +Y V E M NL Q+I L + ++Y
Sbjct: 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME---LDHERMSYLLY 130
Query: 412 QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRA 470
Q+L G+ +H G HRD+KP N++ +KI DFGLAR + T YV TR+YRA
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRA 190
Query: 471 PEVLL 475
PEV+L
Sbjct: 191 PEVIL 195
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 27/52 (51%), Positives = 37/52 (71%)
Query: 755 YTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSL 806
Y LAS + F+FPQF +IP+ASP+AI L++ ML ++P KRPTA Q+L
Sbjct: 227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL 278
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 46/127 (36%), Positives = 64/127 (50%), Gaps = 6/127 (4%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKFLPESIIRNMMYQVL 414
K + KLSH LV+L V + +Y V EYM L +R+ K S + M V
Sbjct: 51 KVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVC 110
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST----RWYRA 470
+G+A++ F HRD+ N L VK++DFGL+R + YT V + RW
Sbjct: 111 EGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-SP 169
Query: 471 PEVLLHS 477
PEVLL+S
Sbjct: 170 PEVLLYS 176
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 36/100 (36%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 355 RKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQ 412
++ L +L+ H ++KL ++ + LYFV EY L Q IR L E R +
Sbjct: 52 KEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAE 110
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR 452
+L L ++H G HRD+KPEN+L +KI DFG A+
Sbjct: 111 ILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAK 150
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 4e-15
Identities = 28/39 (71%), Positives = 33/39 (84%), Gaps = 1/39 (2%)
Query: 42 KMKRKYYSWEEAMNLREVKSLKKL-SHANLVKLKEVILD 79
KMK+K+YSWEE MNLREVKSL+KL H N+VKLKEV +
Sbjct: 31 KMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE 69
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 41/129 (31%), Positives = 62/129 (48%), Gaps = 7/129 (5%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLI---RDRDKFLPESIIRNMMYQV 413
LK+L H N++K EN+ L V E +L ++I + + + +PE I Q+
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDY--VSTRWYRAP 471
L MH HRD+KP N+ T +VK+ D GL R S+ + V T +Y +P
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 472 EVLLHSTAY 480
E +H Y
Sbjct: 176 ER-IHENGY 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 39/131 (29%), Positives = 65/131 (49%), Gaps = 5/131 (3%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKFLPESIIRNMMYQVL 414
+ + KLSH LV+L V E + VFE+M+ L +R + + + M V
Sbjct: 51 QVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVC 110
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRW---YRAP 471
+G+A++ HRD+ N L ++VK++DFG+ R + YT T++ + +P
Sbjct: 111 EGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSP 170
Query: 472 EVLLHSTAYSA 482
EV S YS+
Sbjct: 171 EVFSFSK-YSS 180
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 6e-15
Identities = 48/125 (38%), Positives = 68/125 (54%), Gaps = 10/125 (8%)
Query: 358 LKKLSHANLVKLKEVIRENDTL------YFVFEYMKENLYQLIRDRDKFLPESIIRNMMY 411
+K ++H N++ L V +L Y V E M NL Q+I+ L + ++Y
Sbjct: 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLY 126
Query: 412 QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI-RSRPYTDYVSTRWYRA 470
Q+L G+ +H G HRD+KP N++ +KI DFGLAR S T YV TR+YRA
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 471 PEVLL 475
PEV+L
Sbjct: 187 PEVIL 191
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 50/142 (35%), Positives = 70/142 (49%), Gaps = 18/142 (12%)
Query: 346 RDEMVVCFYRKSLKKLSHANLVKLK--EVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLP 402
DEM V L+ L H NLVK EV RE +Y EY L +L+ + L
Sbjct: 47 ADEMKV------LELLKHPNLVKYYGVEVHREK--VYIFMEYCSGGTLEELLEHG-RILD 97
Query: 403 ESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT-- 460
E +IR Q+L+GLA++H HG HRD+KP N+ ++K+ DFG A ++++ T
Sbjct: 98 EHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157
Query: 461 ----DYVSTRWYRAPEVLLHST 478
T Y APEV+
Sbjct: 158 EEVQSLAGTPAYMAPEVITGGK 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-15
Identities = 36/126 (28%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDK-FLPESIIRNMMYQVLQ 415
+K++ H NLV+L V Y + E+M NL +R+ ++ + ++ M Q+
Sbjct: 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 115
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRW---YRAPE 472
+ ++ + F HRD+ N L LVK+ADFGL+R + YT + ++ + APE
Sbjct: 116 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175
Query: 473 VLLHST 478
L ++
Sbjct: 176 SLAYNK 181
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-14
Identities = 48/125 (38%), Positives = 69/125 (55%), Gaps = 10/125 (8%)
Query: 358 LKKLSHANLVKLKEV------IRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMY 411
+K ++H N++ L V + E +Y V E M NL Q+I+ L + ++Y
Sbjct: 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLY 133
Query: 412 QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI-RSRPYTDYVSTRWYRA 470
Q+L G+ +H G HRD+KP N++ +KI DFGLAR S T YV TR+YRA
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 471 PEVLL 475
PEV+L
Sbjct: 194 PEVIL 198
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 39/121 (32%), Positives = 58/121 (47%), Gaps = 3/121 (2%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKFLPESIIRNMMYQVLQG 416
+K H N+V + D L+ V EYM L +I + E I + +VLQG
Sbjct: 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQG 128
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY--TDYVSTRWYRAPEVL 474
L ++H HRD+K +N+L VK+ADFG A ++ V T ++ APEV+
Sbjct: 129 LEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI 188
Query: 475 L 475
Sbjct: 189 K 189
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 41/130 (31%), Positives = 64/130 (49%), Gaps = 5/130 (3%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRD---KFLPESIIRNMMYQV 413
L ++H N++ KE + + L V EY +L + I R K +PE I + Q+
Sbjct: 53 LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL 112
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEV 473
L+GL +H HRD+K N+L + +LVKI D G+++ ++ + T Y APEV
Sbjct: 113 LRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEV 172
Query: 474 LLHSTAYSAP 483
YS
Sbjct: 173 -WKGRPYSYK 181
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 40/127 (31%), Positives = 65/127 (51%), Gaps = 9/127 (7%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDK---FLPESIIRNMMYQV 413
+KKL H L++L V + +Y V E MK +L + ++ LP+ I +M QV
Sbjct: 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQV 112
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRW---YRA 470
G+A++ + HRD+ N+L + K+ADFGLAR I+ Y ++ + A
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTA 172
Query: 471 PEVLLHS 477
PE L++
Sbjct: 173 PEAALYN 179
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 41/126 (32%), Positives = 65/126 (51%), Gaps = 4/126 (3%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKFLPESIIRNMMYQVL 414
K + KLSH LV+L V + LY V E+M+ L +R R L + ++ +M V
Sbjct: 51 KVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVC 110
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRW---YRAP 471
+G+ ++ R+ F HRD+ N L T +VK++DFG+ R + YT ++ + P
Sbjct: 111 EGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPP 170
Query: 472 EVLLHS 477
EV S
Sbjct: 171 EVFNFS 176
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 11/129 (8%)
Query: 362 SHANLVKLKEVIRENDTLYFVFEYMKEN--LYQLIRDRD-KFLPESIIRNMMYQVLQGLA 418
H N+++L+ V+ ++ + + EYM EN L + +R+ D KF ++ M+ + G+
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYM-ENGSLDKFLRENDGKFTVGQLVG-MLRGIASGMK 120
Query: 419 FMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDY---VSTRWYRAPEV 473
++ + HRD+ N+L + K++DFGL+R + YT + RW APE
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW-TAPEA 179
Query: 474 LLHSTAYSA 482
+ + SA
Sbjct: 180 IAYRKFTSA 188
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 44/124 (35%), Positives = 69/124 (55%), Gaps = 6/124 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDRD-KFLPESIIRNMMYQVLQ 415
+KKL H LV L V+ E + +Y V E+M K +L +++ D K+L + +M Q+
Sbjct: 55 MKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRW---YRAPE 472
G+A++ R + HRD++ N+L + KIADFGLAR I YT ++ + APE
Sbjct: 114 GMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 473 VLLH 476
L+
Sbjct: 174 AALY 177
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 44/120 (36%), Positives = 64/120 (53%), Gaps = 2/120 (1%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
K L++L H N ++ K + T + V EY + L+ K L E I + + LQ
Sbjct: 73 KFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ 132
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLL 475
GLA++H H HRD+K N+L VK+ADFG A +S P +V T ++ APEV+L
Sbjct: 133 GLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSAS--KSSPANSFVGTPYWMAPEVIL 190
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 9e-14
Identities = 38/131 (29%), Positives = 65/131 (49%), Gaps = 5/131 (3%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYM--KENLYQLIRDRDKFLPESIIRNMMYQ 412
R+ L++L+H LV L ++ + +Y V + + + Y L + + KF E ++ + +
Sbjct: 51 RRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ-KVKF-SEEQVKFWICE 108
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY-TDYVSTRWYRAP 471
++ L ++H G HRD+KP+N+L V I DF +A ++ T T Y AP
Sbjct: 109 IVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAP 168
Query: 472 EVLLHSTAYSA 482
EVL A
Sbjct: 169 EVLCRQGYSVA 179
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 13/157 (8%)
Query: 338 ILSRHVSSRDEMVVCFYRK--SLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLI 394
I RH S + +MV + +LK L H N+V+ + L EY+ ++ +
Sbjct: 40 IAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL 99
Query: 395 RDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI 454
R +F E ++R QVL+GLA++H G HRD+K +NLL + KI+DFG+++
Sbjct: 100 RTYGRF-EEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK-- 156
Query: 455 RSRPYTDYVS------TRWYRAPEVL-LHSTAYSAPI 484
+S D + ++ APEV+ +S YSA +
Sbjct: 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKV 193
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 42/120 (35%), Positives = 62/120 (51%), Gaps = 2/120 (1%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
+ L+KL H N ++ + T + V EY + L+ K L E I + + LQ
Sbjct: 67 RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ 126
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLL 475
GLA++H H HRD+K N+L LVK+ DFG A + P +V T ++ APEV+L
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM--APANXFVGTPYWMAPEVIL 184
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 39/131 (29%), Positives = 64/131 (48%), Gaps = 7/131 (5%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKFLPESIIRNMMYQVLQG 416
L + H N+V L E + L+ + E+ L ++ + ++ L E IR + Q+L+
Sbjct: 56 LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEA 115
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFG----LAREIRSRPYTDYVSTRWYRAPE 472
L F+H H HRD+K N+L VK+ADFG ++ R ++ T ++ APE
Sbjct: 116 LNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMAPE 173
Query: 473 VLLHSTAYSAP 483
V+ T P
Sbjct: 174 VVACETFKDNP 184
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 45/124 (36%), Positives = 69/124 (55%), Gaps = 6/124 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDRD-KFLPESIIRNMMYQVLQ 415
+KKL H LV+L V+ E + +Y V EYM K +L ++D + + L + +M QV
Sbjct: 55 MKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 113
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRW---YRAPE 472
G+A++ R + HRD++ N+L + KIADFGLAR I YT ++ + APE
Sbjct: 114 GMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 473 VLLH 476
L+
Sbjct: 174 AALY 177
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 39/156 (25%), Positives = 76/156 (48%), Gaps = 22/156 (14%)
Query: 331 NLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENL 390
D D+ + V++ + + + LK L H +V+ +R+++TL EYM
Sbjct: 36 PFDPDSPETKKEVNALECEI-----QLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGS 90
Query: 391 YQLIRDRDKF---LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIAD 447
++D+ K L E++ R Q+L+G+ ++H + HRD+K N+L VK+ D
Sbjct: 91 ---VKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGD 147
Query: 448 FGLAREIRS--------RPYTDYVSTRWYRAPEVLL 475
FG ++ +++ + T T ++ +PEV+
Sbjct: 148 FGASKRLQTICSSGTGMKSVT---GTPYWMSPEVIS 180
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 39/115 (33%), Positives = 58/115 (50%), Gaps = 10/115 (8%)
Query: 365 NLVKLKEVIRENDTLYFVFEYMK----ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFM 420
+ KL + D LY V EY+ +L + + LPE + + +V+ G+ +
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDL 113
Query: 421 HRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLL 475
H+ G HRD+KPENLL T +K+ DFGL+R +V T Y APE +L
Sbjct: 114 HQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK--KFVGTPDYLAPETIL 166
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 45/132 (34%), Positives = 73/132 (55%), Gaps = 9/132 (6%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDRD-KFLPESIIRNMMYQV 413
++LK+L H +L+ L V + +Y + E M K +L +R + + LP + + +M QV
Sbjct: 54 QALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQV 113
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELV-KIADFGLAREIRSRPYTDY---VSTRWYR 469
+G+A++ HRD+ N+L +G +LV K+ADFGLAR I+ Y + +W
Sbjct: 114 AEGMAYLEEQNSIHRDLAARNIL-VGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW-T 171
Query: 470 APEVLLHSTAYS 481
APE H T +S
Sbjct: 172 APEAASHGT-FS 182
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 41/120 (34%), Positives = 62/120 (51%), Gaps = 2/120 (1%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
+ L++L H N ++ K T + V EY + ++ K L E I + + LQ
Sbjct: 67 RFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQ 126
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLL 475
GLA++H H HRD+K N+L VK+ADFG A + P +V T ++ APEV+L
Sbjct: 127 GLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV--SPANSFVGTPYWMAPEVIL 184
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 35/123 (28%), Positives = 61/123 (49%), Gaps = 3/123 (2%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKFLPESIIRNMMYQVLQG 416
LK+ +VK +N L+ V EY + +++ +K L E I ++YQ L+G
Sbjct: 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKG 111
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI--RSRPYTDYVSTRWYRAPEVL 474
L ++H + HRD+K N+L K+ADFG++ ++ + T ++ APEV+
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVI 171
Query: 475 LHS 477
Sbjct: 172 QEI 174
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 40/124 (32%), Positives = 68/124 (54%), Gaps = 9/124 (7%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDRDK---FLPESIIRNMMYQV 413
+K L H LV+L V+ + + +Y + EYM K +L ++ + LP+ I + Q+
Sbjct: 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI--DFSAQI 112
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRW---YRA 470
+G+A++ R + HRD++ N+L + + KIADFGLAR I YT ++ + A
Sbjct: 113 AEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTA 172
Query: 471 PEVL 474
PE +
Sbjct: 173 PEAI 176
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 32/120 (26%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLI-RDRDKFLPESIIRNMMYQVLQ 415
L L H N++ +++TL EY LY I R + + E ++ ++Q++
Sbjct: 53 LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVS 112
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY--TDYVSTRWYRAPEV 473
++++H+ G HRD+K N+ L+K+ DFG+++ + S V T +Y +PE+
Sbjct: 113 AVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPEL 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 9e-13
Identities = 42/120 (35%), Positives = 61/120 (50%), Gaps = 2/120 (1%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
K L+++ H N ++ K T + V EY + L+ K L E I + + LQ
Sbjct: 77 KFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ 136
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLL 475
GLA++H H HRD+K N+L VK+ADFG A P +V T ++ APEV+L
Sbjct: 137 GLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA--SPANSFVGTPYWMAPEVIL 194
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-12
Identities = 44/142 (30%), Positives = 82/142 (57%), Gaps = 13/142 (9%)
Query: 358 LKKLSHANLVKLK-----EVIRENDTLYF---VFEYMKENLYQLIR---DRDKFLPESII 406
+K L+H N++ LK E ++N+ F V E++ + +++ ++ + LP ++
Sbjct: 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV 172
Query: 407 RNMMYQVLQGLAFMHRHGFFHRDMKPENLLC-MGTELVKIADFGLAREIRS-RPYTDYVS 464
+ YQ+ + LA++H HRD+KP+NLL T +K+ DFG A+ + + + Y+
Sbjct: 173 KLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC 232
Query: 465 TRWYRAPEVLLHSTAYSAPIHL 486
+R+YRAPE++L +T Y+ I L
Sbjct: 233 SRFYRAPELMLGATNYTTHIDL 254
|
Length = 440 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 41/126 (32%), Positives = 67/126 (53%), Gaps = 6/126 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKEN--LYQLIRDRDKFLPESIIRNMMYQVLQ 415
+K+L H LV+L V+ + + +Y + EYM+ + L L + + +M Q+ +
Sbjct: 55 MKQLQHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRW---YRAPE 472
G+AF+ R + HRD++ N+L T KIADFGLAR I YT ++ + APE
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 173
Query: 473 VLLHST 478
+ + T
Sbjct: 174 AINYGT 179
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 35/118 (29%), Positives = 63/118 (53%), Gaps = 3/118 (2%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEY-MKENLYQLIRDRDKFLPESIIRNMMYQVLQG 416
L +LSH +V + ++ + +YF+ E+ + L+ +R +F P + + +++
Sbjct: 72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRF-PNDVAKFYHAELVLA 130
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVL 474
++H +RD+KPENLL VK+ DFG A+++ R +T T Y APEV+
Sbjct: 131 FEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-LCGTPEYLAPEVI 187
|
Length = 329 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 43/124 (34%), Positives = 69/124 (55%), Gaps = 6/124 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIR-DRDKFLPESIIRNMMYQVLQ 415
+KKL H LV+L V+ E + +Y V EYM K +L ++ + K+L + +M Q+
Sbjct: 55 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRW---YRAPE 472
G+A++ R + HRD++ N+L + K+ADFGLAR I YT ++ + APE
Sbjct: 114 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 473 VLLH 476
L+
Sbjct: 174 AALY 177
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 3/120 (2%)
Query: 360 KLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDRDKFLPESIIRNMM-YQVLQGL 417
L H NLV+L V+ + + LY V EYM K +L +R R + + + V +G+
Sbjct: 56 TLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGM 115
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHS 477
++ F HRD+ N+L + K++DFGLA+E + + +W APE L
Sbjct: 116 EYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKW-TAPEALREK 174
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-12
Identities = 43/142 (30%), Positives = 60/142 (42%), Gaps = 19/142 (13%)
Query: 346 RDEMVVCFYRKSLKKLSHANLVKL-KEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPES 404
R E +C +L H N+V L L+ VFEY+ + + D LP
Sbjct: 26 RRETALC------ARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAG 79
Query: 405 IIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL---VKIADFGL---------AR 452
+M QVL LA H G HRD+KP+N++ T + K+ DFG+ A
Sbjct: 80 ETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDAD 139
Query: 453 EIRSRPYTDYVSTRWYRAPEVL 474
T+ + T Y APE L
Sbjct: 140 VATLTRTTEVLGTPTYCAPEQL 161
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 40/120 (33%), Positives = 61/120 (50%), Gaps = 4/120 (3%)
Query: 358 LKKLSHANLVKLKEVI-RENDTLYFVFEYM-KENLYQLIRDRDK-FLPESIIRNMMYQVL 414
+ +L H+NLV+L VI E LY V EYM K +L +R R + L + V
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 112
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVL 474
+ + ++ + F HRD+ N+L + K++DFGL +E S T + +W APE L
Sbjct: 113 EAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKW-TAPEAL 171
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 46/135 (34%), Positives = 63/135 (46%), Gaps = 12/135 (8%)
Query: 344 SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRD-RDKFL 401
SR E V+ L K+ H N+V KE + LY V EY +L Q I+ R K
Sbjct: 44 DSRKEAVL------LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLF 97
Query: 402 PESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT- 460
PE I Q+ G+ +H HRD+K +N+ VK+ DFG AR + + P
Sbjct: 98 PEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR-LLTSPGAY 156
Query: 461 --DYVSTRWYRAPEV 473
YV T +Y PE+
Sbjct: 157 ACTYVGTPYYVPPEI 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 34/122 (27%), Positives = 63/122 (51%), Gaps = 6/122 (4%)
Query: 359 KKLSHANLVKLKEVIRENDTLYFVFEYMK----ENLYQLIRDRDKFLPESIIRNMMYQVL 414
++L H N+V+ + END LY V + ++ + ++++ + E I N+ Q++
Sbjct: 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 415 QGLAFMHRHGFF-HRDMKPENLLCMGTELVKIADFGLAREIRSRPY-TDYVSTRWYRAPE 472
L ++H+ HRD+ P N++ + V I DFGLA++ + T V T Y PE
Sbjct: 124 LALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPE 183
Query: 473 VL 474
++
Sbjct: 184 IV 185
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 43/121 (35%), Positives = 64/121 (52%), Gaps = 6/121 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDR-DKFLPESIIRNMMYQVLQ 415
LK LSH N+++ E E+ L V EY L + I+ R + L E I + Q+L
Sbjct: 53 LKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILL 112
Query: 416 GLAFMHRHGFFHRDMKPEN-LLCMGTELVKIADFGLAREI--RSRPYTDYVSTRWYRAPE 472
L +H HRD+K +N LL +VKI DFG+++ + +S+ YT V T Y +PE
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPE 171
Query: 473 V 473
+
Sbjct: 172 L 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 40/130 (30%), Positives = 69/130 (53%), Gaps = 15/130 (11%)
Query: 358 LKKLS-HANLVK-----LKEVIR-ENDTLYFVFEYMK----ENLYQLIRDRDKFLPESII 406
L+K S H N+ +K+ +D L+ V E +L + +R + K L E I
Sbjct: 56 LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWI 115
Query: 407 RNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS---RPYTDYV 463
++ + L+GLA++H + HRD+K +N+L VK+ DFG++ ++ S R T ++
Sbjct: 116 AYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT-FI 174
Query: 464 STRWYRAPEV 473
T ++ APEV
Sbjct: 175 GTPYWMAPEV 184
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 36/119 (30%), Positives = 54/119 (45%), Gaps = 17/119 (14%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIR------------DRDKF-LPE 403
L H N+VK V E D VFEYM+ +L + +R D L
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 404 SIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDY 462
S + + Q+ G+ ++ F HRD+ N L +VKI DFG++R++ + TDY
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT---TDY 177
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 38/134 (28%), Positives = 69/134 (51%), Gaps = 13/134 (9%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
LK+L H N+V+ + D L EY+ + + E+++RN + Q+L+GL
Sbjct: 60 LKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGL 119
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI----------RSRPYTDYVSTRW 467
++H G HRD+K N+L +KI+DFG+++++ +RP + +
Sbjct: 120 NYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP--SLQGSVF 177
Query: 468 YRAPEVLLHSTAYS 481
+ APEV + T+Y+
Sbjct: 178 WMAPEV-VKQTSYT 190
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 36/121 (29%), Positives = 65/121 (53%), Gaps = 3/121 (2%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQV 413
++ LK++SH +++L + LY + EY+ L+ +R+ +F S ++
Sbjct: 52 KRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRF-SNSTGLFYASEI 110
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEV 473
+ L ++H +RD+KPEN+L +K+ DFG A+++R R +T T Y APEV
Sbjct: 111 VCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-LCGTPEYLAPEV 169
Query: 474 L 474
+
Sbjct: 170 I 170
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 37/128 (28%), Positives = 62/128 (48%), Gaps = 8/128 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
LK L H N+V+ +++T+ E++ I +R LPE + Q+L G+
Sbjct: 56 LKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGV 115
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI--------RSRPYTDYVSTRWYR 469
A++H + HRD+K N++ M ++K+ DFG AR + S T ++
Sbjct: 116 AYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 470 APEVLLHS 477
APEV+ S
Sbjct: 176 APEVINES 183
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 41/121 (33%), Positives = 57/121 (47%), Gaps = 4/121 (3%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDRDKFL-PESIIRNMMYQVLQ 415
+ KL H NLV+L VI N LY V E M K NL +R R + L + V +
Sbjct: 53 MTKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAE 111
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLL 475
G+ ++ HRD+ N+L + K++DFGLAR + +W APE L
Sbjct: 112 GMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKW-TAPEALK 170
Query: 476 H 476
H
Sbjct: 171 H 171
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 39/124 (31%), Positives = 65/124 (52%), Gaps = 11/124 (8%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK----ENLYQLIRDRDKFLPESIIRNMMYQV 413
LK+ H N+V D L+ V EY +++YQ+ R L E I + +
Sbjct: 54 LKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRET 110
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR---SRPYTDYVSTRWYRA 470
L+GLA++H G HRD+K N+L VK+ADFG++ ++ ++ + ++ T ++ A
Sbjct: 111 LKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS-FIGTPYWMA 169
Query: 471 PEVL 474
PEV
Sbjct: 170 PEVA 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 34/117 (29%), Positives = 59/117 (50%), Gaps = 2/117 (1%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
L K + +V N + EYM +L +++++ +PE I+ + VL+G
Sbjct: 53 LHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKG 112
Query: 417 LAFMHR-HGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPE 472
L ++H H HRD+KP N+L +K+ DFG++ ++ + +V T Y APE
Sbjct: 113 LTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPE 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 38/117 (32%), Positives = 60/117 (51%), Gaps = 6/117 (5%)
Query: 363 HANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFM 420
H L +L + D L+FV EY+ + ++ + R +F E R +++ GL F+
Sbjct: 55 HPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RF-DEPRARFYAAEIVLGLQFL 112
Query: 421 HRHGFFHRDMKPENLLCMGTELVKIADFGLARE-IRSRPYTD-YVSTRWYRAPEVLL 475
H G +RD+K +N+L +KIADFG+ +E I T + T Y APE+L
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILS 169
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 10/133 (7%)
Query: 345 SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFL-P 402
SR E+ V L + H N+V+ +E EN LY V +Y + +LY+ I + L P
Sbjct: 46 SRKEVAV------LSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFP 99
Query: 403 ESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYT 460
E I + Q+ L +H HRD+K +N+ +K+ DFG+AR + S
Sbjct: 100 EDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159
Query: 461 DYVSTRWYRAPEV 473
+ T +Y +PE+
Sbjct: 160 TCIGTPYYLSPEI 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 23/52 (44%), Positives = 33/52 (63%)
Query: 755 YTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSL 806
+LA N F FP+ +P + P+ASP A+ L+ ML Y+P KR TA+Q+L
Sbjct: 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 39/124 (31%), Positives = 61/124 (49%), Gaps = 12/124 (9%)
Query: 362 SHANLVKLKEVIRENDTLYFVFEY--MKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAF 419
+H N+V L + + EY + L L R R+ FL + + YQV +G+AF
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 420 MHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVS-------TRWYRAPE 472
+ HRD+ N+L ++VKI DFGLAR+I + ++YV +W APE
Sbjct: 157 LASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND--SNYVVKGNARLPVKWM-APE 213
Query: 473 VLLH 476
+ +
Sbjct: 214 SIFN 217
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-11
Identities = 48/144 (33%), Positives = 73/144 (50%), Gaps = 9/144 (6%)
Query: 338 ILSRHVSSRDEMVVC-FYRKSLKKLS--HANLVKLKEVIRENDTLYFVFEYMK--ENLYQ 392
+L + V +D+ V C K + L+ H L L + D L+FV EY+ + ++Q
Sbjct: 27 VLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQ 86
Query: 393 LIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR 452
+ R R KF E R +V L F+HRHG +RD+K +N+L K+ADFG+ +
Sbjct: 87 IQRSR-KF-DEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCK 144
Query: 453 E--IRSRPYTDYVSTRWYRAPEVL 474
E + T + T Y APE+L
Sbjct: 145 EGILNGVTTTTFCGTPDYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 39/130 (30%), Positives = 65/130 (50%), Gaps = 7/130 (5%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLI---RDRDKFLPESIIRNMMYQV 413
LK+L+H N++K + E++ L V E +L Q+I + + + +PE + Q+
Sbjct: 56 LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDY--VSTRWYRAP 471
+ MH HRD+KP N+ T +VK+ D GL R S+ + V T +Y +P
Sbjct: 116 CSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 472 EVLLHSTAYS 481
E +H Y+
Sbjct: 176 E-RIHENGYN 184
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 39/130 (30%), Positives = 64/130 (49%), Gaps = 7/130 (5%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIR---DRDKFLPESIIRNMMYQV 413
LK+L+H N++K E++ L V E +L ++I+ + + +PE + Q+
Sbjct: 56 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL 115
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDY--VSTRWYRAP 471
L MH HRD+KP N+ T +VK+ D GL R S+ + V T +Y +P
Sbjct: 116 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 472 EVLLHSTAYS 481
E +H Y+
Sbjct: 176 E-RIHENGYN 184
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 38/122 (31%), Positives = 62/122 (50%), Gaps = 8/122 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIR-DRDKFLPESIIRNMMYQVLQ 415
L KL + +++ E + L V EY +L++L++ R + LPE + Q+L
Sbjct: 53 LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL 112
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDY----VSTRWYRAP 471
GLA +H HRD+K NL + VKI D G+A+ + T++ V T +Y +P
Sbjct: 113 GLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSP 170
Query: 472 EV 473
E+
Sbjct: 171 EL 172
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 34/110 (30%), Positives = 58/110 (52%), Gaps = 13/110 (11%)
Query: 375 ENDTLYFVFEYMK----ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDM 430
+ L+ + EY +L + + L E+ I ++ +VL GL ++H G HRD+
Sbjct: 70 KGSKLWIIMEYCGGGSCLDLLKPGK-----LDETYIAFILREVLLGLEYLHEEGKIHRDI 124
Query: 431 KPENLLCMGTELVKIADFGLAREI---RSRPYTDYVSTRWYRAPEVLLHS 477
K N+L VK+ADFG++ ++ S+ T +V T ++ APEV+ S
Sbjct: 125 KAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMAPEVIKQS 173
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 7/131 (5%)
Query: 351 VCFYRKSLKKLSHAN---LVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESII 406
V F+ + LS +N + +L+ ++ D LY V EY +L L+ + E +
Sbjct: 45 VSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA 104
Query: 407 RNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY---TDYV 463
+ + +++ + +H+ G+ HRD+KPEN+L T +K+ADFG A + + V
Sbjct: 105 QFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV 164
Query: 464 STRWYRAPEVL 474
T Y APEVL
Sbjct: 165 GTPDYIAPEVL 175
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 38/117 (32%), Positives = 61/117 (52%), Gaps = 6/117 (5%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
L+ ++H N+VK ++ N + + E+M + D E + ++ Q+L G+
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD----EQFLADVARQILSGI 181
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPE 472
A++HR HRD+KP NLL + VKIADFG++R + P V T Y +PE
Sbjct: 182 AYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPE 238
|
Length = 353 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 42/124 (33%), Positives = 61/124 (49%), Gaps = 10/124 (8%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
LK + H LV L + D LYFV +Y+ E + L R++ PE R ++
Sbjct: 50 LKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAEIAS 107
Query: 416 GLAFMHRHGFFHRDMKPENLL--CMGTELVKIADFGLARE--IRSRPYTDYVSTRWYRAP 471
L ++H +RD+KPEN+L G V + DFGL +E S+ + + T Y AP
Sbjct: 108 ALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAP 165
Query: 472 EVLL 475
EVL
Sbjct: 166 EVLR 169
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 44/160 (27%), Positives = 68/160 (42%), Gaps = 30/160 (18%)
Query: 347 DEMVVCFYRKS--LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPE 403
+M F R++ + + H N+VKL V + +FEYM +L + +R R
Sbjct: 49 ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQC 108
Query: 404 SIIRN---------------------MMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL 442
S+ + + QV G+A++ F HRD+ N L +
Sbjct: 109 SLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMV 168
Query: 443 VKIADFGLAREIRSRPY-----TDYVSTRWYRAPEVLLHS 477
VKIADFGL+R I S Y D + RW PE + ++
Sbjct: 169 VKIADFGLSRNIYSADYYKASENDAIPIRWM-PPESIFYN 207
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 32/118 (27%), Positives = 56/118 (47%), Gaps = 1/118 (0%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
L+ ++H +++++K+ + V + +LY + R + LP + Q+L+GL
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGL 170
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP-YTDYVSTRWYRAPEVL 474
++H HRD+K EN+ + V I D G A+ P + T APEVL
Sbjct: 171 RYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVL 228
|
Length = 357 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-10
Identities = 40/121 (33%), Positives = 56/121 (46%), Gaps = 6/121 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
L+ H L LK + +D L FV EY E + L R+R E R +++
Sbjct: 49 LQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVS 106
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAPEV 473
L ++H +RD+K ENL+ +KI DFGL +E S + T Y APEV
Sbjct: 107 ALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 166
Query: 474 L 474
L
Sbjct: 167 L 167
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 37/139 (26%), Positives = 71/139 (51%), Gaps = 5/139 (3%)
Query: 341 RHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIR-ENDTLYFVFEYMKE-NLYQLIRD-R 397
R+ S R+ + L +L H N+V +E E+ LY V + + +LY +++ +
Sbjct: 36 RNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQK 95
Query: 398 DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR 457
K LPE+ + Q+ L ++H HRD+K +N+ T ++K+ D G+AR + ++
Sbjct: 96 GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155
Query: 458 --PYTDYVSTRWYRAPEVL 474
+ + T +Y +PE+
Sbjct: 156 CDMASTLIGTPYYMSPELF 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 43/127 (33%), Positives = 59/127 (46%), Gaps = 10/127 (7%)
Query: 360 KLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMY--QVLQGL 417
H LV L + D + FV EY + D F S R + Y V+ GL
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF---SEPRAVFYAACVVLGL 114
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE---IRSRPYTDYVSTRWYRAPEVL 474
++H + +RD+K +NLL VKIADFGL +E R T + T + APEVL
Sbjct: 115 QYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLAPEVL 173
Query: 475 LHSTAYS 481
T+Y+
Sbjct: 174 T-ETSYT 179
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 7e-10
Identities = 35/140 (25%), Positives = 63/140 (45%), Gaps = 9/140 (6%)
Query: 328 YTCNLDQDNHILSRHVSSRDEMV-------VCFYRKSLKKLSHANLVKLKEVIRENDTLY 380
+ L + + V + EM+ V ++ L L H L L + L
Sbjct: 18 FLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLC 77
Query: 381 FVFEY-MKENLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM 438
V +Y L++L++ + K L E + R +VL L ++H G +RD+KPEN+L
Sbjct: 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH 137
Query: 439 GTELVKIADFGLAREIRSRP 458
+ + ++DF L+++ P
Sbjct: 138 ESGHIMLSDFDLSKQSDVEP 157
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 39/127 (30%), Positives = 60/127 (47%), Gaps = 9/127 (7%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYM-----KENLYQLIRDRDKFLPESIIRNM 409
+K L+K+S +V L D L V M K ++Y + + PE+
Sbjct: 44 KKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNV---GEPGFPEARAIFY 100
Query: 410 MYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS-RPYTDYVSTRWY 468
Q++ GL +H+ +RD+KPEN+L V+I+D GLA E++ + T Y
Sbjct: 101 AAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160
Query: 469 RAPEVLL 475
APEVL
Sbjct: 161 MAPEVLQ 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 37/134 (27%), Positives = 67/134 (50%), Gaps = 12/134 (8%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKEN--LYQLIRDRD-KFLPESIIRNMMYQVL 414
+ + SH N+++L+ V+ + + EYM EN L + +RD D +F ++ M+ +
Sbjct: 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYM-ENGALDKYLRDHDGEFSSYQLV-GMLRGIA 117
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST------RWY 468
G+ ++ + HRD+ N+L K++DFGL+R + P Y ++ RW
Sbjct: 118 AGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW- 176
Query: 469 RAPEVLLHSTAYSA 482
APE + + SA
Sbjct: 177 TAPEAIAYRKFTSA 190
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 28/98 (28%), Positives = 43/98 (43%), Gaps = 3/98 (3%)
Query: 357 SLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDK-FLPESIIRNMMYQVL 414
+ L H NL++L V+ L V E +L +R S + + Q+
Sbjct: 49 IMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA 107
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR 452
G+ ++ F HRD+ N+L + VKI DFGL R
Sbjct: 108 NGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 35/113 (30%), Positives = 48/113 (42%), Gaps = 16/113 (14%)
Query: 363 HANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDR-------DKFLPESIIRNMM---- 410
H N++ L V + LY V EY NL +R R P +
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 411 ----YQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY 459
YQV +G+ F+ HRD+ N+L ++KIADFGLAR+I Y
Sbjct: 135 VSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY 187
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 46/148 (31%), Positives = 73/148 (49%), Gaps = 25/148 (16%)
Query: 345 SRDEMV----VCFYRKSLKKLSHAN---LVKLKEVIRENDTLYFVFEYMKE-NLYQLIRD 396
S+ EM+ F+ + ++HAN +V+L +++ LY V EYM +L L+ +
Sbjct: 77 SKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN 136
Query: 397 RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADF-------- 448
D +PE R +V+ L +H GF HRD+KP+N+L + +K+ADF
Sbjct: 137 YD--IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194
Query: 449 -GLAREIRSRPYTDYVSTRWYRAPEVLL 475
G+ R + DY+S PEVL
Sbjct: 195 NGMVRCDTAVGTPDYIS------PEVLK 216
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 40/124 (32%), Positives = 69/124 (55%), Gaps = 10/124 (8%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDRD---KFLPESIIRNMMYQV 413
+K L H LVKL V+ + + +Y + E+M K +L ++ + + LP+ I + Q+
Sbjct: 55 MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI--DFSAQI 111
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRW---YRA 470
+G+AF+ + + HRD++ N+L + + KIADFGLAR I YT ++ + A
Sbjct: 112 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 171
Query: 471 PEVL 474
PE +
Sbjct: 172 PEAI 175
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 41/136 (30%), Positives = 67/136 (49%), Gaps = 8/136 (5%)
Query: 361 LSHAN---LVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
L+ A+ +VKL ++ + LY V EYM +L L+ +D F PE R + +++
Sbjct: 55 LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVF-PEETARFYIAELVLA 113
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS---RPYTDYVSTRWYRAPEV 473
L +H+ GF HRD+KP+N+L +K+ADFGL +++ R Y S V
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 474 LLHSTAYSAPIHLSRS 489
L+ + + S
Sbjct: 174 LVRRRDHKQRRVRANS 189
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 37/125 (29%), Positives = 61/125 (48%), Gaps = 7/125 (5%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK----ENLYQLIRDRDKFLPESIIRNMMYQV 413
L KL H +VK E D + EY + + + ++ K L E+ + Q+
Sbjct: 56 LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--YTDYVSTRWYRAP 471
L G+ +MH+ HRD+K +N+ + L+KI DFG++R + T + T +Y +P
Sbjct: 116 LLGVHYMHQRRILHRDLKAKNIF-LKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174
Query: 472 EVLLH 476
E L H
Sbjct: 175 EALKH 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 40/121 (33%), Positives = 60/121 (49%), Gaps = 6/121 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
LK + H LV L + + LYFV +++ E + L R+R PE R ++
Sbjct: 50 LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERS--FPEPRARFYAAEIAS 107
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE--IRSRPYTDYVSTRWYRAPEV 473
L ++H +RD+KPEN+L V + DFGL +E +S T + T Y APEV
Sbjct: 108 ALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV 167
Query: 474 L 474
+
Sbjct: 168 I 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 41/128 (32%), Positives = 59/128 (46%), Gaps = 27/128 (21%)
Query: 353 FYRKS--LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFL--------- 401
F+R++ L L H ++VK V E D L VFEYMK D +KFL
Sbjct: 54 FHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG------DLNKFLRAHGPDAVL 107
Query: 402 ------PESIIRNMMYQVLQ----GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLA 451
P + ++ M + Q G+ ++ F HRD+ N L LVKI DFG++
Sbjct: 108 MAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS 167
Query: 452 REIRSRPY 459
R++ S Y
Sbjct: 168 RDVYSTDY 175
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 332 LDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLY 391
L++ H+L+ RD + LVKL ++++ LY EY+ +
Sbjct: 42 LNEVRHVLTE----RDILTTT---------KSEWLVKLLYAFQDDEYLYLAMEYVPGGDF 88
Query: 392 QLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLA 451
+ + + L E R M ++ + + +H G+ HRD+KPEN L + +K+ DFGL+
Sbjct: 89 RTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
Query: 452 REIRSRPYTDYVSTRWYRAPEVL 474
+ I + + V + Y APEVL
Sbjct: 149 KGIVTYANS-VVGSPDYMAPEVL 170
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 41/131 (31%), Positives = 61/131 (46%), Gaps = 30/131 (22%)
Query: 353 FYRKS--LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFL----PESII 406
F R++ L L H ++VK V + D L VFEYMK D +KFL P+++I
Sbjct: 54 FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHG------DLNKFLRAHGPDAMI 107
Query: 407 ---------------RNMMY---QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADF 448
M++ Q+ G+ ++ F HRD+ N L LVKI DF
Sbjct: 108 LVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDF 167
Query: 449 GLAREIRSRPY 459
G++R++ S Y
Sbjct: 168 GMSRDVYSTDY 178
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 36/135 (26%), Positives = 59/135 (43%), Gaps = 22/135 (16%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDR-------DKFLPESIIR-- 407
+K+ + ++V+L V+ V E M + +L +R R P ++ +
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 408 NMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDY----- 462
M ++ G+A++ F HRD+ N + VKI DFG+ R+I TDY
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY---ETDYYRKGG 179
Query: 463 ---VSTRWYRAPEVL 474
+ RW APE L
Sbjct: 180 KGLLPVRWM-APESL 193
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 36/164 (21%), Positives = 67/164 (40%), Gaps = 18/164 (10%)
Query: 329 TCNLDQDNHILSRHVSSRDEMVVC--FYRKS--LKKLSHANLVKLKEVIRENDTLYFVFE 384
+ +L + + + + F R+ +KLSH N+V+L + RE + Y + E
Sbjct: 29 IEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE 88
Query: 385 Y-----MKENLYQLIRDRDKFLPESI----IRNMMYQVLQGLAFMHRHGFFHRDMKPENL 435
Y +K+ L +K P + + Q+ G+ + F HRD+ N
Sbjct: 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNC 148
Query: 436 LCMGTELVKIADFGLAREIRSRPYTDYVST----RWYRAPEVLL 475
L VK++ L++++ + Y + RW APE +
Sbjct: 149 LVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWL-APEAVQ 191
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 38/118 (32%), Positives = 57/118 (48%), Gaps = 2/118 (1%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
+K+ H N+V + L+ EY Q I L E I + + LQGL
Sbjct: 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGL 119
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEV 473
A++H G HRD+K N+L VK+ADFG+A +I + ++ T ++ APEV
Sbjct: 120 AYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 28/84 (33%), Positives = 44/84 (52%), Gaps = 2/84 (2%)
Query: 401 LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE--IRSRP 458
+ E I ++ +VL L ++H+ G HRD+K N+L T VK+ DFG+A S
Sbjct: 98 IAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK 157
Query: 459 YTDYVSTRWYRAPEVLLHSTAYSA 482
+ +V T ++ APEV+ Y
Sbjct: 158 RSTFVGTPYWMAPEVITEGKYYDT 181
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 37/122 (30%), Positives = 59/122 (48%), Gaps = 1/122 (0%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVL 414
RK L ++H V L ++ LY V E++ + R+K P + Q++
Sbjct: 82 RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV 141
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVL 474
++ +RD+KPENLL +K+ DFG A+ + +R YT T Y APE+L
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT-LCGTPEYIAPEIL 200
Query: 475 LH 476
L+
Sbjct: 201 LN 202
|
Length = 340 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 5e-09
Identities = 18/44 (40%), Positives = 29/44 (65%)
Query: 764 KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
P+ + P + + P ASP+AI L+E ML ++P KR TA ++L+
Sbjct: 245 SLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 43/145 (29%), Positives = 75/145 (51%), Gaps = 12/145 (8%)
Query: 341 RHVSSRDEMVVCFYRKSLK---KLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRD 396
R+ SS E VV RK ++ +L+H +++++ E+ E+M ++ L+
Sbjct: 37 RNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK 96
Query: 397 RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT-ELVKIADFGLAREIR 455
F E++I N Q+L+GL+++H + HRD+K NLL T + ++IADFG A +
Sbjct: 97 YGAF-KEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155
Query: 456 SRPYT------DYVSTRWYRAPEVL 474
++ + T + APEVL
Sbjct: 156 AKGTGAGEFQGQLLGTIAFMAPEVL 180
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 41/137 (29%), Positives = 62/137 (45%), Gaps = 22/137 (16%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDK------FLPESIIRNMM 410
+ +H N+VKL V N+ Y + E M+ +L +RD L + ++
Sbjct: 53 MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLLCMGTE-------LVKIADFGLAREIRSRPY---- 459
V +G ++ + F HRD+ N C+ +E +VKI DFGLAR+I Y
Sbjct: 113 LDVAKGCVYLEQMHFIHRDLAARN--CLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170
Query: 460 -TDYVSTRWYRAPEVLL 475
+ RW APE LL
Sbjct: 171 GEGLLPVRWM-APESLL 186
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 9e-09
Identities = 37/118 (31%), Positives = 57/118 (48%), Gaps = 2/118 (1%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
+K H+N+V D L+ E+ Q I L ES I + + LQGL
Sbjct: 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGL 119
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEV 473
++H G HRD+K N+L VK+ADFG++ +I + ++ T ++ APEV
Sbjct: 120 YYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 49/165 (29%), Positives = 70/165 (42%), Gaps = 23/165 (13%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
LK L H LV L + + LYFV +Y+ E + L R+R P + R +V
Sbjct: 50 LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRA--RFYAAEVAS 107
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT--DYVSTRWYRAPEV 473
+ ++H +RD+KPEN+L V + DFGL +E T + T Y APEV
Sbjct: 108 AIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEV 167
Query: 474 L-----------------LHSTAYSAPIHLSRSQQFLFYSIDHVP 501
L L+ Y P SR ++ +I H P
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP 212
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-08
Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 17/157 (10%)
Query: 341 RHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV---------------FEY 385
+H S M +K +++ +V+ E ++ Y V E+
Sbjct: 25 QHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84
Query: 386 MKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFM-HRHGFFHRDMKPENLLCMGTELVK 444
M + K +PE I+ + VL+GLA++ +H HRD+KP N+L +K
Sbjct: 85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIK 144
Query: 445 IADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYS 481
+ DFG++ ++ +V TR Y +PE L T YS
Sbjct: 145 LCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQGTHYS 180
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 39/121 (32%), Positives = 59/121 (48%), Gaps = 5/121 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLI-RDRDKFLPESIIRNMMYQVLQ 415
L K+ H N+V +EN L+ V EY +L + I R R E I + Q+
Sbjct: 53 LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL 112
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELV-KIADFGLAREIRSRPYTDY--VSTRWYRAPE 472
GL +H HRD+K +N+ +V K+ DFG+AR++ Y V T +Y +PE
Sbjct: 113 GLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPE 172
Query: 473 V 473
+
Sbjct: 173 I 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 28/99 (28%), Positives = 54/99 (54%), Gaps = 4/99 (4%)
Query: 378 TLYFVFEYMK----ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPE 433
++ EY + +++Y+ ++ R + E ++ + VL+GL+++H HRD+KP
Sbjct: 75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPS 134
Query: 434 NLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPE 472
N+L VK+ DFG++ E+ + + T +Y APE
Sbjct: 135 NILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 37/129 (28%), Positives = 67/129 (51%), Gaps = 3/129 (2%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQ-LIRDRDKFLPESIIRNMMYQVLQG 416
L H N+VKL + + L+ + E+ ++ + ++ L E IR + Q L+
Sbjct: 56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA 115
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGL-AREIRSRPYTD-YVSTRWYRAPEVL 474
L ++H + HRD+K N+L +K+ADFG+ A+ R+ D ++ T ++ APEV+
Sbjct: 116 LNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 475 LHSTAYSAP 483
+ T+ P
Sbjct: 176 MCETSKDRP 184
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 2e-08
Identities = 25/90 (27%), Positives = 41/90 (45%), Gaps = 9/90 (10%)
Query: 757 LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS--------- 807
A+ M P R P ++P AS DA+ L++ +L +NP+KR TA+++L
Sbjct: 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303
Query: 808 IKREVSLSFVLLKKLNRLEKYRLKNARETL 837
E L + + L+ K + R L
Sbjct: 304 PSDEPVLPYPITIPLDDNVKLSVAEYRNKL 333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 44/127 (34%), Positives = 61/127 (48%), Gaps = 7/127 (5%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
LK + H LV L + D LYFV +Y+ E Y L R+R P + R ++
Sbjct: 50 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA--RFYAAEIAS 107
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE-IRSRPYTD-YVSTRWYRAPEV 473
L ++H +RD+KPEN+L + + DFGL +E I T + T Y APEV
Sbjct: 108 ALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167
Query: 474 LLHSTAY 480
LH Y
Sbjct: 168 -LHKQPY 173
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 42/145 (28%), Positives = 71/145 (48%), Gaps = 11/145 (7%)
Query: 339 LSRHVSSRDEMVVC-FYRKSLKKLSHAN--LVKLKEVIRENDTLYFVFEYMKE-NLYQLI 394
L + V D+ V C K + L+ N L L + + L+FV E++ +L I
Sbjct: 28 LKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHI 87
Query: 395 RDRDKFLPESIIRNMMY--QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR 452
+D+ +F + R Y +++ GL F+H G +RD+K +N++ +KIADFG+ +
Sbjct: 88 QDKGRF---DLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCK 144
Query: 453 E--IRSRPYTDYVSTRWYRAPEVLL 475
E + + T Y APE+L
Sbjct: 145 ENVFGDNRASTFCGTPDYIAPEILQ 169
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 34/132 (25%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+ + H N++ L+ V+ ++ + V EYM+ +L +R D + M+ + G
Sbjct: 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASG 118
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST------RWYRA 470
+ ++ G+ HRD+ N+L + K++DFGL+R + P Y + RW A
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TA 177
Query: 471 PEVLLHSTAYSA 482
PE + + SA
Sbjct: 178 PEAIAYRKFTSA 189
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 35/119 (29%), Positives = 61/119 (51%), Gaps = 4/119 (3%)
Query: 366 LVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHG 424
+V LK + + LY V +YM L+ ++ +F E + + +++ L +H++
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRF-SEDRAKFYIAELVLALEHLHKYD 116
Query: 425 FFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT--DYVSTRWYRAPEVLLHSTAYS 481
+RD+KPEN+L T + + DFGL++ + T + T Y APEVLL Y+
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYT 175
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 28/92 (30%), Positives = 49/92 (53%), Gaps = 1/92 (1%)
Query: 384 EYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMH-RHGFFHRDMKPENLLCMGTEL 442
E+M + + +PE+I+ + VL+GL ++ +H HRD+KP N+L
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE 138
Query: 443 VKIADFGLAREIRSRPYTDYVSTRWYRAPEVL 474
+K+ DFG++ ++ +V TR Y +PE L
Sbjct: 139 IKLCDFGVSGQLIDSMANSFVGTRSYMSPERL 170
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 34/121 (28%), Positives = 62/121 (51%), Gaps = 7/121 (5%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
++ H N+V++ D L+ V E+++ I + + E I + VL+ L
Sbjct: 70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLAVLKAL 128
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFG----LAREIRSRPYTDYVSTRWYRAPEV 473
+F+H G HRD+K +++L VK++DFG +++E+ R V T ++ APEV
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPEV 186
Query: 474 L 474
+
Sbjct: 187 I 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 41/123 (33%), Positives = 58/123 (47%), Gaps = 6/123 (4%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQV 413
+ LK H L LK + D L FV EY+ E + L R+R E R ++
Sbjct: 47 RVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER--VFSEDRTRFYGAEI 104
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT--DYVSTRWYRAP 471
+ L ++H +RD+K ENL+ +KI DFGL +E + T + T Y AP
Sbjct: 105 VSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAP 164
Query: 472 EVL 474
EVL
Sbjct: 165 EVL 167
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 38/134 (28%), Positives = 68/134 (50%), Gaps = 10/134 (7%)
Query: 358 LKKLSHANLVKLKEVIREN--DTLYFVFEYMKENLYQ--LIRDRDKFLPESIIRNMMYQV 413
L+ L H N+VK K + E+ + + + E++ + L R+++K + ++ + Q+
Sbjct: 60 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV-QI 118
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--YT---DYVSTRWY 468
+G+ ++ + HRD+ N+L VKI DFGL + I + YT D S ++
Sbjct: 119 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFW 178
Query: 469 RAPEVLLHSTAYSA 482
APE L+ S Y A
Sbjct: 179 YAPECLIQSKFYIA 192
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 5e-08
Identities = 22/62 (35%), Positives = 32/62 (51%), Gaps = 10/62 (16%)
Query: 746 LHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQS 805
+ +LP Y + FP P I P AS DA+ L++ +L NP+KR TA+Q+
Sbjct: 230 VTSLPDYVEFK-------PFPP---TPLKQIFPAASDDALDLLQRLLTLNPNKRITARQA 279
Query: 806 LS 807
L
Sbjct: 280 LE 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 41/123 (33%), Positives = 58/123 (47%), Gaps = 6/123 (4%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQV 413
+ L+ H L LK + +D L FV EY E + L R+R E R ++
Sbjct: 47 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEI 104
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT--DYVSTRWYRAP 471
+ L ++H +RD+K ENL+ +KI DFGL +E S T + T Y AP
Sbjct: 105 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 164
Query: 472 EVL 474
EVL
Sbjct: 165 EVL 167
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 35/122 (28%), Positives = 60/122 (49%), Gaps = 14/122 (11%)
Query: 360 KLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKFLPESIIRNMMYQVLQGLA 418
+L H +V+L V + + L V E L + ++ R + P S ++ + +QV G+A
Sbjct: 52 QLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREI-PVSDLKELAHQVAMGMA 109
Query: 419 FMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST--------RWYRA 470
++ F HRD+ N+L + KI+DFG++R + +DY +WY A
Sbjct: 110 YLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL--GAGSDYYRATTAGRWPLKWY-A 166
Query: 471 PE 472
PE
Sbjct: 167 PE 168
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 22/140 (15%)
Query: 358 LKKLSHANLVKLKEVIRE--NDTLYFVFEYMKENLYQLIRDRDKFLPE-----SIIRNMM 410
L+ L H N+VK K V + +L + EY+ +RD +L ++ R ++
Sbjct: 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLP---SGSLRD---YLQRHRDQINLKRLLL 113
Query: 411 Y--QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST--- 465
+ Q+ +G+ ++ + HRD+ N+L +LVKI+DFGLA+ + YV
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGE 173
Query: 466 ---RWYRAPEVLLHSTAYSA 482
WY APE L S SA
Sbjct: 174 SPIFWY-APECLRTSKFSSA 192
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 401 LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT 460
+PE ++ + V++GL ++ HRD+KP N+L VK+ DFG++ ++ +
Sbjct: 92 IPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK 151
Query: 461 DYVSTRWYRAPEVLL------HSTAYSAPIHL 486
YV T Y APE + HS +S I
Sbjct: 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISF 183
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-08
Identities = 38/113 (33%), Positives = 59/113 (52%), Gaps = 6/113 (5%)
Query: 366 LVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHG 424
+V+L +++ LY V EYM +L L+ + D +PE R +V+ L +H G
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIHSMG 162
Query: 425 FFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT---DYVSTRWYRAPEVL 474
F HRD+KP+N+L + +K+ADFG ++ V T Y +PEVL
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 215
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 34/120 (28%), Positives = 59/120 (49%), Gaps = 5/120 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+++ H N+V + D L+ V EY+ +L ++ + + E I + + LQ
Sbjct: 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQA 127
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI--RSRPYTDYVSTRWYRAPEVL 474
L F+H + HRD+K +N+L VK+ DFG +I + V T ++ APEV+
Sbjct: 128 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 7e-08
Identities = 17/49 (34%), Positives = 33/49 (67%)
Query: 758 ASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSL 806
+ +MN+ FP + ++P+AS + + L++ +LAY+P +R TA+Q+L
Sbjct: 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 36/129 (27%), Positives = 65/129 (50%), Gaps = 3/129 (2%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIR-DRDKFLPESIIRNMMYQVLQG 416
L +H +VKL + L+ + E+ I + D+ L E I+ + Q+L+
Sbjct: 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEA 122
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGL-AREIRSRPYTD-YVSTRWYRAPEVL 474
L ++H HRD+K N+L +K+ADFG+ A+ +++ D ++ T ++ APEV+
Sbjct: 123 LQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVV 182
Query: 475 LHSTAYSAP 483
+ T P
Sbjct: 183 MCETMKDTP 191
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 35/116 (30%), Positives = 59/116 (50%), Gaps = 12/116 (10%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRD---KF-----LPESII 406
K + +L + N+++L V +D L + EYM+ +L Q + R+ F +P I
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 407 RNMMY---QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY 459
N++Y Q+ G+ ++ F HRD+ N L +KIADFG++R + S Y
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 44/149 (29%), Positives = 67/149 (44%), Gaps = 29/149 (19%)
Query: 353 FYRKS--LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRD---KFLPES-- 404
F R++ L L H ++V+ V E L VFEYM+ +L + +R K L
Sbjct: 54 FQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED 113
Query: 405 ------IIRNMMY---QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR 455
+ M+ Q+ G+ ++ F HRD+ N L +VKI DFG++R+I
Sbjct: 114 VAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 173
Query: 456 SRPYTDY--------VSTRWYRAPEVLLH 476
S TDY + RW PE +L+
Sbjct: 174 S---TDYYRVGGRTMLPIRWM-PPESILY 198
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 37/134 (27%), Positives = 61/134 (45%), Gaps = 22/134 (16%)
Query: 363 HANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDR---------------DKFLPESII 406
H N++ L ++ LY + EY K NL + +R R D+ + +
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 407 RNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST- 465
+ YQV +G+ ++ HRD+ N+L ++KIADFGLAR++ + Y +
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 466 ----RWYRAPEVLL 475
+W APE L
Sbjct: 200 RLPVKWM-APEALF 212
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 33/122 (27%), Positives = 57/122 (46%), Gaps = 11/122 (9%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFE-YMKENLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+++ H ++VKL VI + ++ V E L ++ L + + YQ+
Sbjct: 61 MRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA 119
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTR------WYRA 470
LA++ F HRD+ N+L + VK+ DFGL+R + Y Y +++ W A
Sbjct: 120 LAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY--YKASKGKLPIKWM-A 176
Query: 471 PE 472
PE
Sbjct: 177 PE 178
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-08
Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 23/158 (14%)
Query: 333 DQDNHILSRHVSSRDEMVVCFYRKSLKKLS---HANLVKLKEVIRENDTLYFVFEY---- 385
D ++++ V DE + R L L+ H +VK + + +D L + EY
Sbjct: 91 DPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG 150
Query: 386 -MKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVK 444
+ + + Q +++ F E + + YQ++ L +H HRD+K N+ M T ++K
Sbjct: 151 DLNKQIKQRLKEHLPF-QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIK 209
Query: 445 IADFGLAREIRSRPYTDYVS---------TRWYRAPEV 473
+ DFG S+ Y+D VS T +Y APE+
Sbjct: 210 LGDFGF-----SKQYSDSVSLDVASSFCGTPYYLAPEL 242
|
Length = 478 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 36/116 (31%), Positives = 59/116 (50%), Gaps = 4/116 (3%)
Query: 363 HANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMH 421
H L L + + L+FV EY+ +L I+ +F E+ R +++ GL F+H
Sbjct: 55 HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRF-DEARARFYAAEIICGLQFLH 113
Query: 422 RHGFFHRDMKPENLLCMGTELVKIADFGLARE--IRSRPYTDYVSTRWYRAPEVLL 475
+ G +RD+K +N+L +KIADFG+ +E + + T Y APE+L
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILK 169
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 41/163 (25%), Positives = 77/163 (47%), Gaps = 4/163 (2%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
++ H N+V++ + + L+ + E+++ I + + L E I + VLQ L
Sbjct: 72 MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQAL 130
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI-RSRP-YTDYVSTRWYRAPEVLL 475
++H G HRD+K +++L VK++DFG +I + P V T ++ APEV +
Sbjct: 131 CYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEV-I 189
Query: 476 HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSS 518
T Y + + + +D PP + + +RL+ S
Sbjct: 190 SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS 232
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-07
Identities = 34/124 (27%), Positives = 60/124 (48%), Gaps = 7/124 (5%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESII----RNMMYQV 413
L +L+H N++K++E++R Y + + +LY + D + + R +M Q+
Sbjct: 217 LGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQL 276
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI-RSRPYTDY--VSTRWYRA 470
L + ++H HRD+K EN+ + + DFG A + R DY V T +
Sbjct: 277 LCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNS 336
Query: 471 PEVL 474
PE+L
Sbjct: 337 PEIL 340
|
Length = 501 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 42/134 (31%), Positives = 65/134 (48%), Gaps = 11/134 (8%)
Query: 359 KKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLP----ESIIRNMMYQV 413
L H N+V+ EN E + +L L+R K+ P E I Q+
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRS--KWGPLKDNEQTIIFYTKQI 117
Query: 414 LQGLAFMHRHGFFHRDMKPENLLC-MGTELVKIADFGLAREI-RSRPYTD-YVSTRWYRA 470
L+GL ++H + HRD+K +N+L + +VKI+DFG ++ + P T+ + T Y A
Sbjct: 118 LEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMA 177
Query: 471 PEVLLHST-AYSAP 483
PEV+ Y AP
Sbjct: 178 PEVIDKGPRGYGAP 191
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 34/116 (29%), Positives = 55/116 (47%), Gaps = 4/116 (3%)
Query: 362 SHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMH 421
+H LV L + L+FV EY+ R + LPE R ++ L ++H
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 113
Query: 422 RHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---YTDYVSTRWYRAPEVL 474
G +RD+K +N+L +K+ D+G+ +E RP + + T Y APE+L
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 29/90 (32%), Positives = 48/90 (53%)
Query: 366 LVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGF 425
+VKL ++ D LYFV +Y+ + R + PE + R + ++ + +H+ GF
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 426 FHRDMKPENLLCMGTELVKIADFGLAREIR 455
HRD+KP+N+L +K+ DFGL R
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFR 152
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 16/42 (38%), Positives = 28/42 (66%)
Query: 766 PQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
P +VP+ + P+A P A+ L++ ML +NP KR T +++L+
Sbjct: 250 PFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 28/82 (34%), Positives = 46/82 (56%), Gaps = 2/82 (2%)
Query: 401 LPESIIRNMMYQVLQGLAFM-HRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY 459
+PE I+ + V++GL ++ +H HRD+KP N+L +K+ DFG++ ++
Sbjct: 100 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159
Query: 460 TDYVSTRWYRAPEVLLHSTAYS 481
+V TR Y +PE L T YS
Sbjct: 160 NSFVGTRSYMSPE-RLQGTHYS 180
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-07
Identities = 32/84 (38%), Positives = 45/84 (53%), Gaps = 4/84 (4%)
Query: 404 SIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE----IRSRPY 459
++I+ +M QVL GL +HR G HRD+KPENLL VKI DFG A + I P
Sbjct: 309 NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPL 368
Query: 460 TDYVSTRWYRAPEVLLHSTAYSAP 483
+ R+ E+++ + AP
Sbjct: 369 YGMLDPRYSPPEELVMPQSCPRAP 392
|
Length = 507 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 14/117 (11%)
Query: 366 LVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFL-PESIIRNMMYQVLQGLAFMHRH 423
L +L + D LYFV EY+ +L I+ KF P+++ ++ GL F+HR
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF--YAAEISVGLFFLHRR 120
Query: 424 GFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRW------YRAPEVL 474
G +RD+K +N++ +KIADFG+ +E D V+TR Y APE++
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKE----HMVDGVTTRTFCGTPDYIAPEII 173
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 32/106 (30%), Positives = 48/106 (45%)
Query: 377 DTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLL 436
D L F+ + M + E+ +R +++ GL MH +RD+KP N+L
Sbjct: 70 DKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 129
Query: 437 CMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSA 482
V+I+D GLA + + V T Y APEVL AY +
Sbjct: 130 LDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDS 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 41/134 (30%), Positives = 60/134 (44%), Gaps = 22/134 (16%)
Query: 363 HANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDR------DKF----LPESIIR---- 407
H N++ L V + LY + EY K NL + +R R F +PE +
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 408 -NMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST- 465
+ YQV +G+ ++ HRD+ N+L ++KIADFGLAR + Y S
Sbjct: 137 VSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 466 ----RWYRAPEVLL 475
+W APE L
Sbjct: 197 RLPVKWM-APEALF 209
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 40/119 (33%), Positives = 60/119 (50%), Gaps = 10/119 (8%)
Query: 363 HANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKF-LPESIIRNMMY--QVLQGLA 418
H L L + + L+FV EY+ +L I+ KF LP R Y +++ GL
Sbjct: 55 HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLP----RATFYAAEIICGLQ 110
Query: 419 FMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE--IRSRPYTDYVSTRWYRAPEVLL 475
F+H G +RD+K +N+L +KIADFG+ +E + + T Y APE+LL
Sbjct: 111 FLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL 169
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 35/125 (28%), Positives = 56/125 (44%), Gaps = 7/125 (5%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVL 414
+ LK+ H N+VKL V + +Y V E + +L +R + L + M
Sbjct: 44 EILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAA 103
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT-----DYVSTRWYR 469
G+ ++ HRD+ N L ++KI+DFG++RE YT + +W
Sbjct: 104 AGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-T 162
Query: 470 APEVL 474
APE L
Sbjct: 163 APEAL 167
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 6/115 (5%)
Query: 366 LVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRH 423
L +L + D LYFV EY+ + +Y I+ KF E ++ GL F+H
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYH-IQQVGKF-KEPHAVFYAAEIAIGLFFLHSK 120
Query: 424 GFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT--DYVSTRWYRAPEVLLH 476
G +RD+K +N++ +KIADFG+ +E T + T Y APE++ +
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY 175
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 30/104 (28%), Positives = 52/104 (50%), Gaps = 6/104 (5%)
Query: 374 RENDTLYFVFEYMKENLYQLIR---DRDKFLPESIIRNMMYQVLQGLAFMH-RHGFFHRD 429
RE D ++ E M +L + + D+ +PE I+ + +++ L ++H + HRD
Sbjct: 71 REGD-VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRD 129
Query: 430 MKPENLLCMGTELVKIADFGLARE-IRSRPYTDYVSTRWYRAPE 472
+KP N+L VK+ DFG++ + S T + Y APE
Sbjct: 130 VKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 30/101 (29%), Positives = 51/101 (50%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVL 414
R L + + +V+L ++ D LYFV +Y+ + R PE + R + ++
Sbjct: 52 RDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELT 111
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR 455
+ +H+ GF HRD+KP+N+L +K+ DFGL R
Sbjct: 112 CAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 34/116 (29%), Positives = 56/116 (48%), Gaps = 6/116 (5%)
Query: 379 LYFVFEYMK----ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFM-HRHGFFHRDMKPE 433
+Y EYM + LY + +PE ++R + Y V++GL F+ H HRD+KP
Sbjct: 74 VYMCMEYMDAGSLDKLYAGGVATEG-IPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPT 132
Query: 434 NLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRS 489
N+L G VK+ DFG++ + + + + Y APE + P + +S
Sbjct: 133 NVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQS 188
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 33/106 (31%), Positives = 48/106 (45%)
Query: 377 DTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLL 436
D L F+ + M + E +R +++ GL MH +RD+KP N+L
Sbjct: 70 DKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANIL 129
Query: 437 CMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSA 482
V+I+D GLA + + V T Y APEVL TAY +
Sbjct: 130 LDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDS 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 36/133 (27%), Positives = 67/133 (50%), Gaps = 6/133 (4%)
Query: 346 RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPES 404
RD + R L +++H +VKL + LY + ++++ +L+ + F E
Sbjct: 40 RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED 99
Query: 405 IIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI---RSRPYTD 461
+ + + ++ L +H G +RD+KPEN+L +K+ DFGL++E + Y+
Sbjct: 100 V-KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS- 157
Query: 462 YVSTRWYRAPEVL 474
+ T Y APEV+
Sbjct: 158 FCGTVEYMAPEVV 170
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 4e-07
Identities = 37/121 (30%), Positives = 55/121 (45%), Gaps = 15/121 (12%)
Query: 353 FYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKEN--LYQLIRDRD---------- 398
F + K L +LS N+ +L V + L + EYM EN L Q ++
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYM-ENGDLNQFLQKHVAETSGLACNS 124
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP 458
K L S + M Q+ G+ ++ F HRD+ N L +KIADFG++R + S
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 459 Y 459
Y
Sbjct: 185 Y 185
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 13/106 (12%)
Query: 356 KSLKKLSHANLVKLKEVIRE--NDTLYFVFEYMKENLYQLIRDRDKFLPE---SIIRNMM 410
LK L H N+VK K E L + EY+ L L +LP+ ++ + ++
Sbjct: 58 NILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP--LGSLR----DYLPKHKLNLAQLLL 111
Query: 411 Y--QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI 454
+ Q+ +G+A++H + HRD+ N+L LVKI DFGLA+ +
Sbjct: 112 FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 36/127 (28%), Positives = 64/127 (50%), Gaps = 13/127 (10%)
Query: 358 LKKLSHANLVKLKEVIREN--DTLYFVFEYMKENLYQLIRDRDKF---LPESIIRNMMYQ 412
LK L H +V+ +R+ TL EYM ++D+ K L ES+ R Q
Sbjct: 58 LKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGS---VKDQLKAYGALTESVTRKYTRQ 114
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT-----DYVSTRW 467
+L+G++++H + HRD+K N+L VK+ DFG ++ +++ + T +
Sbjct: 115 ILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174
Query: 468 YRAPEVL 474
+ +PEV+
Sbjct: 175 WMSPEVI 181
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 5e-07
Identities = 14/43 (32%), Positives = 24/43 (55%)
Query: 765 FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
FP + F S +P + + L++ ML +NP KR +A ++L
Sbjct: 241 FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 42/130 (32%), Positives = 67/130 (51%), Gaps = 14/130 (10%)
Query: 358 LKKLS-HANLVKL-----KEVIRENDTLYFVFEYMK----ENLYQLIRDRDKFLPESIIR 407
LK LS H N+VK K+ ++ D L+ V E +L + R + + E II
Sbjct: 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIA 127
Query: 408 NMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI---RSRPYTDYVS 464
++++ L GL +H + HRD+K N+L VK+ DFG++ ++ R R T V
Sbjct: 128 YILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VG 186
Query: 465 TRWYRAPEVL 474
T ++ APEV+
Sbjct: 187 TPFWMAPEVI 196
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 6e-07
Identities = 23/94 (24%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 363 HANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMH 421
+ N +KL + + +Y+K+ +L+ L++ ++ L E+ ++ ++ Q+++ L +H
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK-KEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 422 RHGFFHRDMKPENLLCMGTEL-VKIADFGLAREI 454
+H H D+K EN+L + + + D+GL + I
Sbjct: 127 KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160
|
Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 33/106 (31%), Positives = 57/106 (53%), Gaps = 8/106 (7%)
Query: 375 ENDTLYFVFEYMKE-NLYQLIRD-RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKP 432
+D L+ V E+ ++ L+++ + L E I + ++L+GLA +H H HRD+K
Sbjct: 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKG 149
Query: 433 ENLLCMGTELVKIADFG----LAREIRSRPYTDYVSTRWYRAPEVL 474
+N+L VK+ DFG L R + R ++ T ++ APEV+
Sbjct: 150 QNVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYWMAPEVI 193
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 41/138 (29%), Positives = 61/138 (44%), Gaps = 22/138 (15%)
Query: 360 KLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQ-LIR------------DRD--KFLPE 403
L H N+V L V + +FEY+ +L++ L+R D L
Sbjct: 64 DLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123
Query: 404 SIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYV 463
S ++ Q+ G+ ++ H F HRD+ N L VKI+DFGL+R+I S Y
Sbjct: 124 SDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 464 S-----TRWYRAPEVLLH 476
S RW PE +L+
Sbjct: 184 SKSLLPVRWM-PPEAILY 200
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 33/105 (31%), Positives = 58/105 (55%), Gaps = 8/105 (7%)
Query: 376 NDTLYFVFEYMKE-NLYQLIRD-RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPE 433
+D L+ V E+ ++ LI++ + L E I + ++L+GL+ +H+H HRD+K +
Sbjct: 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ 140
Query: 434 NLLCMGTELVKIADFG----LAREIRSRPYTDYVSTRWYRAPEVL 474
N+L VK+ DFG L R + R ++ T ++ APEV+
Sbjct: 141 NVLLTENAEVKLVDFGVSAQLDRTVGRR--NTFIGTPYWMAPEVI 183
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 35/149 (23%), Positives = 68/149 (45%), Gaps = 22/149 (14%)
Query: 332 LDQDNHILSRHVSSRDEMVVC-------FYRKS--LKKLSHANLVKLKEVIREND----- 377
L+QD+ IL V + ++ +C F ++ +K+ H N+++L V +
Sbjct: 20 LNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY 78
Query: 378 -TLYFVFEYMKEN------LYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDM 430
+ + +MK LY + D ++LP ++ M + G+ ++ F HRD+
Sbjct: 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDL 138
Query: 431 KPENLLCMGTELVKIADFGLAREIRSRPY 459
N + V +ADFGL+++I + Y
Sbjct: 139 AARNCMLNENMNVCVADFGLSKKIYNGDY 167
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 7e-07
Identities = 36/136 (26%), Positives = 68/136 (50%), Gaps = 11/136 (8%)
Query: 336 NHILSRHVSSRDEMV----VCFYRKSLKKLSHAN---LVKLKEVIRENDTLYFVFEYMK- 387
HI + + EM+ V R L+ A+ +VKL ++ + LY + EY+
Sbjct: 26 GHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG 85
Query: 388 -ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIA 446
+ + L++ +D F E R + + + + +H+ G+ HRD+KP+NLL +K++
Sbjct: 86 GDMMTLLMK-KDTF-TEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLS 143
Query: 447 DFGLAREIRSRPYTDY 462
DFGL ++ T++
Sbjct: 144 DFGLCTGLKKSHRTEF 159
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 27/76 (35%), Positives = 40/76 (52%), Gaps = 6/76 (7%)
Query: 412 QVLQGLAFMHRHGFFHRDMKPENLL--CMGTELVKIADFGLAREIRS-RPYTDYVSTRWY 468
Q+ G+ +H +RDMKPEN+L G +++D GLA E++ + T T Y
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGKTITQRAGTNGY 160
Query: 469 RAPEVLLHSTAYSAPI 484
APE+L YS P+
Sbjct: 161 MAPEILKEEP-YSYPV 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 39/127 (30%), Positives = 60/127 (47%), Gaps = 6/127 (4%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQ 412
R L+ + H +V L + LY + EY+ E L +R+ E + +
Sbjct: 51 RNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL--EREGIFMEDTACFYLSE 108
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE-IRSRPYT-DYVSTRWYRA 470
+ L +H+ G +RD+KPEN+L VK+ DFGL +E I T + T Y A
Sbjct: 109 ISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMA 168
Query: 471 PEVLLHS 477
PE+L+ S
Sbjct: 169 PEILMRS 175
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 8e-07
Identities = 28/90 (31%), Positives = 46/90 (51%)
Query: 366 LVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGF 425
+VKL ++ D LYFV +Y+ + R E + R + ++ + +H+ GF
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 426 FHRDMKPENLLCMGTELVKIADFGLAREIR 455
HRD+KP+N+L +K+ DFGL R
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (124), Expect = 9e-07
Identities = 16/45 (35%), Positives = 26/45 (57%)
Query: 762 NFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSL 806
FP+F ++P P+ I L+ ML YNP+KR +A+++L
Sbjct: 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEAL 277
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 24/66 (36%), Positives = 37/66 (56%), Gaps = 2/66 (3%)
Query: 412 QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYR 469
Q++ GL +H+ +RD+KPEN+L V+I+D GLA E++ Y T +
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFM 164
Query: 470 APEVLL 475
APE+L
Sbjct: 165 APELLQ 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 39/165 (23%), Positives = 74/165 (44%), Gaps = 8/165 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
++ H N+V + D L+ V E+++ I + + E I + VL+ L
Sbjct: 73 MRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLSVLRAL 131
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFG----LAREIRSRPYTDYVSTRWYRAPEV 473
+++H G HRD+K +++L +K++DFG +++E+ R V T ++ APEV
Sbjct: 132 SYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR--KSLVGTPYWMAPEV 189
Query: 474 LLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSS 518
+ Y + + + ID PP L R++ +
Sbjct: 190 -ISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 22/134 (16%)
Query: 363 HANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDR---------------DKFLPESII 406
H N++ L ++ LY + EY K NL + +R R ++ L +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 407 RNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST- 465
+ YQV +G+ ++ HRD+ N+L ++KIADFGLAR+I Y +
Sbjct: 143 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 466 ----RWYRAPEVLL 475
+W APE L
Sbjct: 203 RLPVKWM-APEALF 215
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 15/40 (37%), Positives = 24/40 (60%), Gaps = 1/40 (2%)
Query: 42 KMKRKYYS-WEEAMNLREVKSLKKLSHANLVKLKEVILDP 80
K+K ++ S LRE+K LK+L+H N++KL +V
Sbjct: 31 KIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK 70
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 36/117 (30%), Positives = 59/117 (50%), Gaps = 6/117 (5%)
Query: 362 SHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAF 419
+H LV L + L+FV E++ + ++ + R R LPE R ++ L F
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRK--LPEEHARFYSAEISLALNF 111
Query: 420 MHRHGFFHRDMKPENLLCMGTELVKIADFGLARE-IRSRPYTD-YVSTRWYRAPEVL 474
+H G +RD+K +N+L +K+ D+G+ +E IR T + T Y APE+L
Sbjct: 112 LHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 22/134 (16%)
Query: 363 HANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDRDK----------FLPESIIR---- 407
H N++ L ++ LY + EY K NL + +R R LPE +
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 408 -NMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST- 465
+ YQV +G+ ++ HRD+ N+L ++KIADFGLAR++ + Y +
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 466 ----RWYRAPEVLL 475
+W APE L
Sbjct: 197 RLPVKWM-APEALF 209
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 37/121 (30%), Positives = 59/121 (48%), Gaps = 14/121 (11%)
Query: 348 EMVVCFYRKSL--KKLSHANLVKLKEVIRENDTL-YFVFEYMKE-NLYQLIRDRDKFLPE 403
E V F ++ + K SH N++ L + ++ V YMK +L IR
Sbjct: 38 EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH---N 94
Query: 404 SIIRNMM---YQVLQGLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLAREIRSRP 458
+++++ QV +G+ ++ F HRD+ N CM E VK+ADFGLAR+I +
Sbjct: 95 PTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARN--CMLDESFTVKVADFGLARDIYDKE 152
Query: 459 Y 459
Y
Sbjct: 153 Y 153
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 25/64 (39%), Positives = 35/64 (54%), Gaps = 1/64 (1%)
Query: 412 QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS-RPYTDYVSTRWYRA 470
++ GL +HR +RD+KPEN+L ++I+D GLA EI V T Y A
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMA 169
Query: 471 PEVL 474
PEV+
Sbjct: 170 PEVV 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 34/115 (29%), Positives = 54/115 (46%), Gaps = 11/115 (9%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQ-LIRDRDKFLPE---------S 404
K + +L N+++L V +D L + EYM+ +L Q L R + E S
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 405 IIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY 459
+ M Q+ G+ ++ F HRD+ N L +KIADFG++R + S Y
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 38/127 (29%), Positives = 62/127 (48%), Gaps = 13/127 (10%)
Query: 358 LKKLSHANLVKLKEVIR--ENDTLYFVFEYMKENLYQLIRDRDKF---LPESIIRNMMYQ 412
LK L H +V+ +R E L EYM I+D+ K L E++ R Q
Sbjct: 58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGS---IKDQLKAYGALTENVTRRYTRQ 114
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS-----RPYTDYVSTRW 467
+LQG++++H + HRD+K N+L VK+ DFG ++ I++ T +
Sbjct: 115 ILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 468 YRAPEVL 474
+ +PEV+
Sbjct: 175 WMSPEVI 181
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 37/121 (30%), Positives = 58/121 (47%), Gaps = 5/121 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
LK +SH ++ L R T+ V K +L+ + DR LP + ++L+ L
Sbjct: 140 LKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYV-DRSGPLPLEQAITIQRRLLEAL 198
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT--DY--VSTRWYRAPEV 473
A++H G HRD+K EN+ E + DFG A ++ + P T Y T +PE+
Sbjct: 199 AYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPEL 258
Query: 474 L 474
L
Sbjct: 259 L 259
|
Length = 392 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 37/121 (30%), Positives = 58/121 (47%), Gaps = 4/121 (3%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
L++LSH ++ L +V V + +LY + R + L + + + Q+L +
Sbjct: 214 LRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAI 273
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFG---LAREIRSRP-YTDYVSTRWYRAPEV 473
++H G HRD+K EN+L G E + + DFG AR S P + T APEV
Sbjct: 274 DYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEV 333
Query: 474 L 474
L
Sbjct: 334 L 334
|
Length = 461 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 51/188 (27%)
Query: 339 LSRHVSSRDEMVVCFYRKSLKKLSHANLV---KLKEVIRENDTLYF-------------- 381
L RH +R R ++KK++ NL+ ++++V E D L F
Sbjct: 19 LVRHKETRQ-------RFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71
Query: 382 -------VFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPE 433
V EY++ + L+++ LP + R + + L ++H +G HRD+KP+
Sbjct: 72 TKRHLCMVMEYVEGGDCATLLKNIGA-LPVDMARMYFAETVLALEYLHNYGIVHRDLKPD 130
Query: 434 NLLCMGTELVKIADFGLAR---------------EIRSRPYTD--YVSTRWYRAPEVLLH 476
NLL +K+ DFGL++ E +R + D T Y APEV+L
Sbjct: 131 NLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR 190
Query: 477 STAYSAPI 484
Y P+
Sbjct: 191 Q-GYGKPV 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 32/111 (28%), Positives = 51/111 (45%), Gaps = 2/111 (1%)
Query: 366 LVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGF 425
LV L + L+ V EY+ R + LPE R ++ L F+H G
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGI 117
Query: 426 FHRDMKPENLLCMGTELVKIADFGLARE-IRSRPYTD-YVSTRWYRAPEVL 474
+RD+K +N+L +K+ D+G+ +E + T + T Y APE+L
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 37/127 (29%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 344 SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIR------D 396
S +DE + K +H N+V+L V E + + E M +L +R +
Sbjct: 49 SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPE 108
Query: 397 RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLL--CMG-TELVKIADFGLARE 453
R L + V +G ++ + F HRD+ N L C G + KIADFG+AR+
Sbjct: 109 RPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARD 168
Query: 454 I-RSRPY 459
I R+ Y
Sbjct: 169 IYRASYY 175
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-06
Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 10/94 (10%)
Query: 405 IIRNMMYQVLQGLAFMHRHGFFHRDMKPENLL-CMGTELVKIADFGLAREIRS----RPY 459
II+ +M Q+L L +H G HRD+KP+N++ G+ KI D G A ++R P
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPK 315
Query: 460 TDYVSTRWYRAPEVLLHST----AYSAPIHLSRS 489
+ R Y APE + ST A SAP+ + S
Sbjct: 316 EFLLDPR-YAAPEQYIMSTQTPSAPSAPVATALS 348
|
Length = 566 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 2/91 (2%)
Query: 384 EYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFM-HRHGFFHRDMKPENLLCMGTEL 442
E M L +L++ +PE I+ M +++ L ++ +HG HRD+KP N+L +
Sbjct: 94 ELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN 153
Query: 443 VKIADFGLA-REIRSRPYTDYVSTRWYRAPE 472
VK+ DFG++ R + S+ T Y APE
Sbjct: 154 VKLCDFGISGRLVDSKAKTRSAGCAAYMAPE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 35/120 (29%), Positives = 61/120 (50%), Gaps = 5/120 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+K+L + N+V + D L+ V EY+ +L ++ + + E+ I + + LQ
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQA 127
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI--RSRPYTDYVSTRWYRAPEVL 474
L F+H + HRD+K +N+L VK+ DFG +I + V T ++ APEV+
Sbjct: 128 LEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 36/149 (24%), Positives = 64/149 (42%), Gaps = 36/149 (24%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESI----IRNMMY- 411
LK+++H +++KL ++ L + EY K +L +R+ K P + RN Y
Sbjct: 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116
Query: 412 ------------------QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE 453
Q+ +G+ ++ HRD+ N+L +KI+DFGL+R+
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 454 I--------RSRPYTDYVSTRWYRAPEVL 474
+ RS+ + +W A E L
Sbjct: 177 VYEEDSYVKRSK---GRIPVKWM-AIESL 201
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 35/127 (27%), Positives = 63/127 (49%), Gaps = 13/127 (10%)
Query: 358 LKKLSHANLVKLKEVIRE--NDTLYFVFEYMKENLYQLIRDRDK---FLPESIIRNMMYQ 412
LK L H +V+ +R+ TL E+M I+D+ K L E++ R Q
Sbjct: 58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGS---IKDQLKSYGALTENVTRKYTRQ 114
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS-----RPYTDYVSTRW 467
+L+G++++H + HRD+K N+L VK+ DFG ++ +++ T +
Sbjct: 115 ILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174
Query: 468 YRAPEVL 474
+ +PEV+
Sbjct: 175 WMSPEVI 181
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 33/123 (26%), Positives = 55/123 (44%), Gaps = 7/123 (5%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQ-LIRDRDKFLPESIIRNMMYQVLQG 416
LK+ SH N+V+L V + +Y V E ++ + +R L + M+ G
Sbjct: 47 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAG 106
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD-----YVSTRWYRAP 471
+ ++ HRD+ N L ++KI+DFG++RE Y + +W AP
Sbjct: 107 MEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAP 165
Query: 472 EVL 474
E L
Sbjct: 166 EAL 168
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 19/149 (12%)
Query: 338 ILSRHVSSRDEMVVC-FYRKSLKKLSHAN--LVKLKEVIRENDTLYFVFEYMK--ENLYQ 392
IL + V +D+ V C K + LS L +L + D LYFV EY+ + +YQ
Sbjct: 32 ILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQ 91
Query: 393 LIRDRDKFL-PESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLA 451
I+ +F P ++ ++ GL F+H G +RD+K +N++ +KIADFG+
Sbjct: 92 -IQQVGRFKEPHAVF--YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 148
Query: 452 REIRSRPYTDYVSTRW------YRAPEVL 474
+E D V+T+ Y APE++
Sbjct: 149 KE----NMWDGVTTKTFCGTPDYIAPEII 173
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 20/49 (40%), Positives = 33/49 (67%), Gaps = 2/49 (4%)
Query: 35 NGPSISIK-MKRKYYSWEEAMNLREVKSLKKLS-HANLVKLKEVILDPP 81
G +IK MK+ + S E+ NLRE+++L++LS H N+++L EV+ D
Sbjct: 23 TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK 71
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 19/41 (46%), Positives = 27/41 (65%)
Query: 766 PQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSL 806
P R F + PHA+P AI L+E ML ++PSKR T +++L
Sbjct: 249 PYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEAL 289
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 19/50 (38%), Positives = 32/50 (64%)
Query: 758 ASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
A N P + PF SI P+A+P A+ L+E +LA++P+KR + +++L
Sbjct: 242 AQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 34/93 (36%), Positives = 46/93 (49%), Gaps = 12/93 (12%)
Query: 396 DRDKFLPESIIRNMM------YQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFG 449
RD + ES + M YQV G+ F+ HRD+ N+L +LVKI DFG
Sbjct: 225 RRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFG 284
Query: 450 LAREI-RSRPYTDYVST----RWYRAPEVLLHS 477
LAR+I R Y ST +W APE + ++
Sbjct: 285 LARDIMRDSNYISKGSTFLPLKWM-APESIFNN 316
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 40/124 (32%), Positives = 57/124 (45%), Gaps = 7/124 (5%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQV 413
+ L+ H L LK + +D L FV EY E + L R+R E R ++
Sbjct: 47 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEI 104
Query: 414 LQGLAFMH-RHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT--DYVSTRWYRA 470
+ L ++H +RD+K ENL+ +KI DFGL +E T + T Y A
Sbjct: 105 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 164
Query: 471 PEVL 474
PEVL
Sbjct: 165 PEVL 168
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 24/67 (35%), Positives = 36/67 (53%), Gaps = 4/67 (5%)
Query: 745 LLHTLPLYTCYTLASNMNFKF----PQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRP 800
LL T P T+ S +F P+ VPF+ +A P AI L+E ML ++P KR
Sbjct: 221 LLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI 280
Query: 801 TAQQSLS 807
+A ++L+
Sbjct: 281 SAAEALA 287
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 38/142 (26%), Positives = 70/142 (49%), Gaps = 25/142 (17%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLI------------RDRDKFLPES 404
+ +L H N+V L V+ + + +FEY+ + +L++ + D D + S
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 405 I----IRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL-VKIADFGLAREIRSRPY 459
+ ++ Q+ G+ ++ H F H+D+ N+L +G +L VKI+D GL+REI S Y
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNIL-IGEQLHVKISDLGLSREIYSADY 179
Query: 460 -----TDYVSTRWYRAPEVLLH 476
+ RW PE +++
Sbjct: 180 YRVQPKSLLPIRWM-PPEAIMY 200
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 28/79 (35%), Positives = 45/79 (56%), Gaps = 3/79 (3%)
Query: 406 IRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY--TDYV 463
I M+ ++L+GL ++H HRD+K N+L VK+ADFG+A ++ +V
Sbjct: 103 IATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162
Query: 464 STRWYRAPEVLLHSTAYSA 482
T ++ APEV+ S AY +
Sbjct: 163 GTPFWMAPEVIQQS-AYDS 180
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 25/61 (40%), Positives = 33/61 (54%), Gaps = 2/61 (3%)
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRA 470
+QV +G+ F+ HRD+ N+L +VKI DFGLAR+I P DYV R
Sbjct: 181 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP--DYVRKGSARL 238
Query: 471 P 471
P
Sbjct: 239 P 239
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 29/105 (27%), Positives = 56/105 (53%), Gaps = 4/105 (3%)
Query: 374 RENDTLYFVFEY-MKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKP 432
++ + LY V +Y + +L L+ + LPE + R + +++ + +H+ G+ HRD+KP
Sbjct: 71 QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKP 130
Query: 433 ENLLCMGTELVKIADFGLAREIRSRPYTDY---VSTRWYRAPEVL 474
+N+L +++ADFG + + V T Y +PE+L
Sbjct: 131 DNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL 175
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 2/79 (2%)
Query: 401 LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY- 459
L E+ I ++ ++L+GL ++H HRD+K N+L VK+ADFG+A ++
Sbjct: 98 LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157
Query: 460 -TDYVSTRWYRAPEVLLHS 477
+V T ++ APEV+ S
Sbjct: 158 RNTFVGTPFWMAPEVIKQS 176
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 14/44 (31%), Positives = 27/44 (61%)
Query: 764 KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
FP++ R + ++P+ D + L+ ML Y+P+KR +A+ +L
Sbjct: 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 39/129 (30%), Positives = 64/129 (49%), Gaps = 9/129 (6%)
Query: 353 FYRKSLKKLSHAN---LVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRN 408
F+ + ++ AN +V+L +++ LY V EYM +L L+ + D +PE +
Sbjct: 89 FFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKF 146
Query: 409 MMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT---DYVST 465
+V+ L +H G HRD+KP+N+L +K+ADFG ++ V T
Sbjct: 147 YTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGT 206
Query: 466 RWYRAPEVL 474
Y +PEVL
Sbjct: 207 PDYISPEVL 215
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 32/121 (26%), Positives = 61/121 (50%), Gaps = 7/121 (5%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
++ H N+V++ D L+ V E+++ I + + E I + VL+ L
Sbjct: 71 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLKAL 129
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFG----LAREIRSRPYTDYVSTRWYRAPEV 473
+ +H G HRD+K +++L VK++DFG +++E+ R V T ++ APE+
Sbjct: 130 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPEL 187
Query: 474 L 474
+
Sbjct: 188 I 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 25/61 (40%), Positives = 33/61 (54%), Gaps = 2/61 (3%)
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRA 470
+QV +G+ F+ HRD+ N+L +VKI DFGLAR+I P DYV R
Sbjct: 180 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP--DYVRKGDARL 237
Query: 471 P 471
P
Sbjct: 238 P 238
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 34/125 (27%), Positives = 60/125 (48%), Gaps = 8/125 (6%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQV 413
+ LK+ H N+VKL V + +Y V E + + L L + +D+ + +++
Sbjct: 44 RILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVK-FALDA 102
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE----IRSRPYTDYVSTRWYR 469
G+A++ HRD+ N L ++KI+DFG++R+ I S + +W
Sbjct: 103 AAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW-T 161
Query: 470 APEVL 474
APE L
Sbjct: 162 APEAL 166
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 7e-06
Identities = 32/127 (25%), Positives = 54/127 (42%), Gaps = 11/127 (8%)
Query: 359 KKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKF-LPESIIRNMMYQVLQG 416
++L H N++ + LY V M + L++ LPE I ++ VL
Sbjct: 54 RQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNA 113
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI-----RSRPYTDY----VSTRW 467
L ++H GF HR +K ++L G V ++ + + R R D+ V
Sbjct: 114 LDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 468 YRAPEVL 474
+ +PEVL
Sbjct: 174 WLSPEVL 180
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 7e-06
Identities = 26/87 (29%), Positives = 48/87 (55%), Gaps = 2/87 (2%)
Query: 366 LVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHG 424
+V L ++ LY + E++ +L ++ D F E + R M + + + +H+ G
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTF-SEDVTRFYMAECVLAIEAVHKLG 121
Query: 425 FFHRDMKPENLLCMGTELVKIADFGLA 451
F HRD+KP+N+L +K++DFGL+
Sbjct: 122 FIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 8e-06
Identities = 29/84 (34%), Positives = 48/84 (57%), Gaps = 3/84 (3%)
Query: 401 LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY- 459
L E+ I ++ ++L+GL ++H HRD+K N+L VK+ADFG+A ++
Sbjct: 98 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157
Query: 460 -TDYVSTRWYRAPEVLLHSTAYSA 482
+V T ++ APEV+ S AY +
Sbjct: 158 RNTFVGTPFWMAPEVIKQS-AYDS 180
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 25/61 (40%), Positives = 33/61 (54%), Gaps = 2/61 (3%)
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRA 470
+QV +G+ F+ HRD+ N+L +VKI DFGLAR+I P DYV R
Sbjct: 186 FQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP--DYVRKGDARL 243
Query: 471 P 471
P
Sbjct: 244 P 244
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 17/44 (38%), Positives = 25/44 (56%)
Query: 764 KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
PQ + F + A+P AI L+E ML +P KR TA ++L+
Sbjct: 254 SLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 15/151 (9%)
Query: 343 VSSRDEMVVCFYRKSLKKLSHANLVKLKEVIREND-----TLYFVFEY-----MKENLYQ 392
+S DE + Y +H N+VK + + D L+ V E + E +
Sbjct: 58 ISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG 117
Query: 393 LIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR 452
L+ + L E++I ++Y L GL +H + HRD+K N+L VK+ DFG++
Sbjct: 118 LLI-CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176
Query: 453 EI---RSRPYTDYVSTRWYRAPEVLLHSTAY 480
++ R R T V T ++ APEV+ Y
Sbjct: 177 QLTSTRLRRNTS-VGTPFWMAPEVIACEQQY 206
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 26/76 (34%), Positives = 41/76 (53%), Gaps = 10/76 (13%)
Query: 408 NMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYV---- 463
+ YQV +G++F+ HRD+ N+L + KI DFGLAR+IR+ ++YV
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND--SNYVVKGN 275
Query: 464 ---STRWYRAPEVLLH 476
+W APE + +
Sbjct: 276 ARLPVKWM-APESIFN 290
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 35/133 (26%), Positives = 63/133 (47%), Gaps = 12/133 (9%)
Query: 360 KLSHANLVKLKEVIRENDTLYFVFEYMKEN--LYQLIRDRDKFLPESIIRNMMYQVLQGL 417
+ H N++ L+ V+ ++ + + E+M EN L +R D + M+ + G+
Sbjct: 61 QFDHPNIIHLEGVVTKSRPVMIITEFM-ENGALDSFLRQNDGQFTVIQLVGMLRGIAAGM 119
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR---EIRSRP-YTDY----VSTRWYR 469
++ + HRD+ N+L + K++DFGL+R + S P YT + RW
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW-T 178
Query: 470 APEVLLHSTAYSA 482
APE + + SA
Sbjct: 179 APEAIAYRKFTSA 191
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 47/161 (29%), Positives = 70/161 (43%), Gaps = 27/161 (16%)
Query: 327 LYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386
+Y C + I R + E + ++ L+K++ +V L D L V M
Sbjct: 27 MYACKRLEKKRIKKR----KGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82
Query: 387 -----KENLYQLIRDRDKFLPESIIRNMMY--QVLQGLAFMHRHGFFHRDMKPENLLCMG 439
K ++Y + F E R + Y ++L GL +HR +RD+KPEN+L
Sbjct: 83 NGGDLKFHIYNM--GNPGFEEE---RALFYAAEILCGLEDLHRENTVYRDLKPENILLDD 137
Query: 440 TELVKIADFGLA------REIRSRPYTDYVSTRWYRAPEVL 474
++I+D GLA IR R V T Y APEVL
Sbjct: 138 YGHIRISDLGLAVKIPEGESIRGR-----VGTVGYMAPEVL 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 36/118 (30%), Positives = 59/118 (50%), Gaps = 15/118 (12%)
Query: 366 LVKLKEVIRENDTLYFVFEY-----MKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFM 420
LV L + + L+ + +Y + +LYQ R+ F ES +R + +++ L +
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ----REHF-TESEVRVYIAEIVLALDHL 121
Query: 421 HRHGFFHRDMKPENLLCMGTELVKIADFGLAREI----RSRPYTDYVSTRWYRAPEVL 474
H+ G +RD+K EN+L V + DFGL++E R Y + T Y APEV+
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY-SFCGTIEYMAPEVI 178
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 1/90 (1%)
Query: 384 EYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMH-RHGFFHRDMKPENLLCMGTEL 442
E+M I + +P I+ + V++GL +++ H HRD+KP N+L
Sbjct: 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ 142
Query: 443 VKIADFGLAREIRSRPYTDYVSTRWYRAPE 472
+K+ DFG++ E+ + +V T Y +PE
Sbjct: 143 IKLCDFGVSGELINSIADTFVGTSTYMSPE 172
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 41/138 (29%), Positives = 62/138 (44%), Gaps = 24/138 (17%)
Query: 356 KSLKKLSHANLVKLKEVI----RENDTLYFVFEYMKENLYQ--LIRDRDKFLPESIIRNM 409
+ LK L H N+VK K V R N L V EY+ + L + R++ + +
Sbjct: 57 EILKSLQHDNIVKYKGVCYSAGRRN--LRLVMEYLPYGSLRDYLQKHRERL---DHRKLL 111
Query: 410 MY--QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTR- 466
+Y Q+ +G+ ++ + HRD+ N+L VKI DFGL + + +Y R
Sbjct: 112 LYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD--KEYYKVRE 169
Query: 467 -------WYRAPEVLLHS 477
WY APE L S
Sbjct: 170 PGESPIFWY-APESLTES 186
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-05
Identities = 17/43 (39%), Positives = 29/43 (67%)
Query: 764 KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSL 806
P+ + VP++ I P ASP+A+ L+ ML ++P +R T +Q+L
Sbjct: 250 NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL 292
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 24/64 (37%), Positives = 37/64 (57%), Gaps = 13/64 (20%)
Query: 759 SNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSL---------SIK 809
S+M K P VPF+ P+A P A+ L+E +LA++P RPTA+++L ++
Sbjct: 245 SSMRKKQP----VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE 300
Query: 810 REVS 813
RE S
Sbjct: 301 REPS 304
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 19/44 (43%), Positives = 25/44 (56%)
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI 454
QV QG+ F+ HRD+ N+L + KI DFGLAR+I
Sbjct: 219 SQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI 262
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 26/77 (33%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 378 TLYFVF---EYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPEN 434
+Y+ F E + EN ++ + R K + +I+N+M +L L ++H HG H D+KPEN
Sbjct: 98 RMYYRFILLEKLVENTKEIFK-RIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPEN 156
Query: 435 LLCMGTELVKIADFGLA 451
++ G I D+G+A
Sbjct: 157 IMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 36/141 (25%), Positives = 68/141 (48%), Gaps = 13/141 (9%)
Query: 344 SSRDEMVVCFYRKS--LKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKF 400
S RDEM+ R++ + +L + +V++ V E + L V E L + + +
Sbjct: 37 SVRDEMM----REAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDE 91
Query: 401 LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP-- 458
+ S + +M+QV G+ ++ F HRD+ N+L + KI+DFGL++ + +
Sbjct: 92 ITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY 151
Query: 459 YTDYVSTRW---YRAPEVLLH 476
Y + +W + APE +
Sbjct: 152 YKARSAGKWPLKWYAPECINF 172
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 33/115 (28%), Positives = 55/115 (47%), Gaps = 2/115 (1%)
Query: 362 SHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMH 421
+H L +L + D L+FV E++ + + E+ R ++ L F+H
Sbjct: 54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH 113
Query: 422 RHGFFHRDMKPENLLCMGTELVKIADFGLARE-IRSRPYTD-YVSTRWYRAPEVL 474
G +RD+K +N+L K+ADFG+ +E I + T + T Y APE+L
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 32/123 (26%), Positives = 54/123 (43%), Gaps = 19/123 (15%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDR---------------DK 399
K L +L N+++L V + D L + EYM+ +L Q +
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 400 FLPE---SIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS 456
LP S + ++ Q+ G+ ++ F HRD+ N L +KIADFG++R + +
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
Query: 457 RPY 459
Y
Sbjct: 191 GDY 193
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 23/92 (25%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 363 HANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRD-RDKFLPESIIRNMMYQVLQGLAFM 420
H ++V+L + + + + + M L +R+ +D + ++ N Q+ +G++++
Sbjct: 68 HPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLL-NWCVQIAKGMSYL 125
Query: 421 HRHGFFHRDMKPENLLCMGTELVKIADFGLAR 452
HRD+ N+L + VKI DFGLA+
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 2e-05
Identities = 43/173 (24%), Positives = 75/173 (43%), Gaps = 33/173 (19%)
Query: 338 ILSRHVSSRDEMVVCFYRKSLKKLSHANLVKL--KEVIRENDTLYFVFEY-----MKENL 390
I R + R++ + +++L H N+V+ + + + N LY + E+ + N+
Sbjct: 46 ISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI 105
Query: 391 YQLIRDRDKFLPESIIRNMMYQVLQGLAFMHR-------HGFFHRDMKPENLLCM----- 438
+ + K + E I ++ Q+L LA+ H HRD+KP+N+
Sbjct: 106 QKCYKMFGK-IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164
Query: 439 ------------GTELVKIADFGLAREIRSRPYT-DYVSTRWYRAPEVLLHST 478
G + KI DFGL++ I V T +Y +PE+LLH T
Sbjct: 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHET 217
|
Length = 1021 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 30/120 (25%), Positives = 55/120 (45%), Gaps = 4/120 (3%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
L+ ++H ++++LK N + K +LY + + + I + VL+ +
Sbjct: 137 LRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRN-IAICDILAIERSVLRAI 195
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLA---REIRSRPYTDYVSTRWYRAPEVL 474
++H + HRD+K EN+ V + DFG A +I + Y + T APE+L
Sbjct: 196 QYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELL 255
|
Length = 391 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 41/165 (24%), Positives = 65/165 (39%), Gaps = 30/165 (18%)
Query: 341 RHVSSRDEMVVCFYR-----KSLKKLSHANLVKLKEVIRENDTLYFV------------- 382
H S M V R K K+L L+ L V+R +D Y V
Sbjct: 24 LHKPSGTIMAVKRIRSTVDEKEQKRL----LMDLDVVMRSSDCPYIVKFYGALFREGDCW 79
Query: 383 --FEYMK---ENLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHR-HGFFHRDMKPENL 435
E M + Y+ + + +PE I+ + ++ L ++ HRD+KP N+
Sbjct: 80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNI 139
Query: 436 LCMGTELVKIADFGLARE-IRSRPYTDYVSTRWYRAPEVLLHSTA 479
L +K+ DFG++ + + S T R Y APE + S
Sbjct: 140 LLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAR 184
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 23/74 (31%), Positives = 40/74 (54%)
Query: 379 LYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM 438
+Y V EY+ + + + E + + +V L ++HRHG HRD+KP+N+L
Sbjct: 79 VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS 138
Query: 439 GTELVKIADFGLAR 452
+K+ DFGL++
Sbjct: 139 NEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 23/62 (37%), Positives = 36/62 (58%), Gaps = 8/62 (12%)
Query: 746 LHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQS 805
L +LP Y T FP+ + +P I P ASP+A+ L++ +L Y+PSKR +A ++
Sbjct: 228 LTSLPDYNKIT--------FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEA 279
Query: 806 LS 807
L
Sbjct: 280 LR 281
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 31/137 (22%), Positives = 61/137 (44%), Gaps = 6/137 (4%)
Query: 344 SSRDEMVVCFYRK--SLKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKF 400
D+ F + +L + H+N+V+L+ VI +T+ V EYM L +R +
Sbjct: 44 GCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ 103
Query: 401 LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT 460
L + M+ + G+ ++ G+ H+ + +L + KI+ F +E +S
Sbjct: 104 LVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY 163
Query: 461 DYVSTR---WYRAPEVL 474
+S + + APE +
Sbjct: 164 TTMSGKSPVLWAAPEAI 180
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 31/118 (26%), Positives = 59/118 (50%), Gaps = 2/118 (1%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQV 413
R L + A +VK+ ++ LY + E++ ++ L+ +D L E + + +
Sbjct: 52 RDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT-LSEEATQFYIAET 110
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAP 471
+ + +H+ GF HRD+KP+NLL VK++DFGL ++ T++ + P
Sbjct: 111 VLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP 168
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 33/120 (27%), Positives = 59/120 (49%), Gaps = 5/120 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+++ + N+V + D L+ V EY+ +L ++ + + E I + + LQ
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQA 128
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI--RSRPYTDYVSTRWYRAPEVL 474
L F+H + HRD+K +N+L VK+ DFG +I + V T ++ APEV+
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 15/118 (12%)
Query: 366 LVKLKEVIRENDTLYFVFEY-----MKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFM 420
LV L + L+ + +Y M +LYQ RD F E +R +++ L +
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNF-SEDEVRFYSGEIILALEHL 121
Query: 421 HRHGFFHRDMKPENLLCMGTELVKIADFGLAREI----RSRPYTDYVSTRWYRAPEVL 474
H+ G +RD+K EN+L V + DFGL++E + R Y+ + T Y APE++
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEII 178
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 36/128 (28%), Positives = 55/128 (42%), Gaps = 18/128 (14%)
Query: 358 LKKLSHANLVKLKEVIRENDTL------YFVFEYMKEN------LYQLIRDRDKFLPESI 405
+K H N++KL V E +L + +MK LY + + LP
Sbjct: 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQT 114
Query: 406 IRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLAREIRSRPYTDYV 463
+ M + G+ ++ F HRD+ N CM E V +ADFGL+++I S Y Y
Sbjct: 115 LLKFMVDIALGMEYLSNRNFIHRDLAARN--CMLREDMTVCVADFGLSKKIYSGDY--YR 170
Query: 464 STRWYRAP 471
R + P
Sbjct: 171 QGRIAKMP 178
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 24/84 (28%), Positives = 44/84 (52%), Gaps = 7/84 (8%)
Query: 397 RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS 456
++K + E I +++QV G+ ++ F HRD+ N+L + KI+DFGL++ + +
Sbjct: 88 KNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGA 147
Query: 457 -RPYTDYVST-----RWYRAPEVL 474
Y + +WY APE +
Sbjct: 148 DENYYKAKTHGKWPVKWY-APECM 170
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-05
Identities = 22/58 (37%), Positives = 34/58 (58%), Gaps = 10/58 (17%)
Query: 749 LPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSL 806
LPLYT +T + K +I P+AS DAI L++S+L NP +R +A+++L
Sbjct: 264 LPLYTEFTPRKPKDLK----------TIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311
|
Length = 335 |
| >gnl|CDD|221309 pfam11912, DUF3430, Protein of unknown function (DUF3430) | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 29/150 (19%), Positives = 50/150 (33%), Gaps = 10/150 (6%)
Query: 138 ILLSNPANSMLANNSMVSTNNAVYVNQNPHNN--NPNISQYNNPNNYDPTTSQNNNISQY 195
I N N ++ S S N + N +N IS +S +
Sbjct: 53 ITNDNGNNYSFSSFSDSSDGNIIKYNYYEDSNCSGKPISTETFEIGSCVYSSSYSGSYYS 112
Query: 196 MPNNTSQNNNNTQYNPNSSQNMPNNISQNANNTQNNPNNSHYNPNNIQ-NNPNNFSQN-N 253
S ++ + NS + ++ + +N Y NN NN N FS
Sbjct: 113 Y---ISSCTDSPEIPSNS---LVTVYYNGSDCSNDNFLYIEYFTNNTCINNNNGFSFTYY 166
Query: 254 ISQNNTNNTQINKTTQYNPPPYPININKEN 283
+ N T K++ N P ++ ++ N
Sbjct: 167 CNSTNQPYTTYCKSSNCNNSPITLSCSQNN 196
|
This family of proteins are functionally uncharacterized. This protein is found in eukaryotes. Proteins in this family are typically between 209 to 265 amino acids in length. Length = 204 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 27/98 (27%), Positives = 53/98 (54%), Gaps = 2/98 (2%)
Query: 366 LVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHG 424
+VK+ ++ LY + E++ ++ L+ +D L E + + + + + +H+ G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT-LTEEETQFYIAETVLAIDSIHQLG 121
Query: 425 FFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDY 462
F HRD+KP+NLL VK++DFGL ++ T++
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|221143 pfam11593, Med3, Mediator complex subunit 3 fungal | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 27/119 (22%), Positives = 42/119 (35%), Gaps = 11/119 (9%)
Query: 145 NSMLANNSMVSTNNAVYVNQNPHNNN--PNISQYNNPNNYDPTTSQNNNISQYMPNNTSQ 202
N + NN+M S N + +N + N Q N +Q+ N+ +Q
Sbjct: 253 NGVSPNNAMASPLNNMSPMRNLNQMGNQNNGGQMTPSANNGNMNNQSRE------NSMNQ 306
Query: 203 NNNNTQYNPNSSQNMPNNISQNANNTQNNPNNSHYNPNNIQNNPNNFSQNNISQNNTNN 261
+ N + P NI N + N + P Q P N N+ N+ NN
Sbjct: 307 GMTPSASMINLNNITPANI-LNMSLNLAFDLNQNQTPQ--QLQPQNQQNMNMGMNDVNN 362
|
Mediator is a large complex of up to 33 proteins that is conserved from plants to fungi to humans - the number and representation of individual subunits varying with species. It is arranged into four different sections, a core, a head, a tail and a kinase-activity part, and the number of subunits within each of these is what varies with species. Overall, Mediator regulates the transcriptional activity of RNA polymerase II but it would appear that each of the four different sections has a slightly different function. Mediator subunit Hrs1/Med3 is a physical target for Cyc8-Tup1, a yeast transcriptional co-repressor. Length = 381 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 29/113 (25%), Positives = 57/113 (50%), Gaps = 4/113 (3%)
Query: 366 LVKLKEVIRENDTLYFVFEY-MKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHG 424
+ L ++ + LY V +Y + +L L+ + LPE + R + +++ + +H+
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 425 FFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDY---VSTRWYRAPEVL 474
+ HRD+KP+N+L +++ADFG ++ V T Y +PE+L
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 8e-05
Identities = 33/120 (27%), Positives = 59/120 (49%), Gaps = 5/120 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+++ + N+V + D L+ V EY+ +L ++ + + E I + + LQ
Sbjct: 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQA 127
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI--RSRPYTDYVSTRWYRAPEVL 474
L F+H + HRD+K +N+L VK+ DFG +I + V T ++ APEV+
Sbjct: 128 LDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 39/139 (28%), Positives = 66/139 (47%), Gaps = 7/139 (5%)
Query: 342 HVSSRDEMVVCFY-RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRD 398
H+ SR E+ R L +++ +V LK + + LY V ++ E + L R+
Sbjct: 30 HIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHL--QRE 87
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR-EIRSR 457
S R ++L L +H+ +RD+KPEN+L + + DFGL + ++
Sbjct: 88 GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD 147
Query: 458 PYTD-YVSTRWYRAPEVLL 475
T+ + T Y APE+LL
Sbjct: 148 DKTNTFCGTPEYLAPELLL 166
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 15/43 (34%), Positives = 27/43 (62%)
Query: 765 FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
FP++ R F+ ++P D L+ ML Y+P+KR +A+ +L+
Sbjct: 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 14/43 (32%), Positives = 21/43 (48%)
Query: 764 KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSL 806
FP++ + PHA P I L+ +L NP R +A +L
Sbjct: 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL 279
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 19/50 (38%), Positives = 33/50 (66%)
Query: 758 ASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
A N K P+FR+ F S++P+A+P A++++E ML + R TA ++L+
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 40/156 (25%), Positives = 68/156 (43%), Gaps = 17/156 (10%)
Query: 327 LYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386
+Y C + I R + E + ++ L+K++ +V L D L V M
Sbjct: 27 MYACKKLEKKRIKKR----KGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82
Query: 387 -----KENLYQLIRDRDKFLPESIIRNMMY--QVLQGLAFMHRHGFFHRDMKPENLLCMG 439
K ++Y + + E R + Y ++ GL +H+ +RD+KPEN+L
Sbjct: 83 NGGDLKFHIYHM---GEAGFEEG--RAVFYAAEICCGLEDLHQERIVYRDLKPENILLDD 137
Query: 440 TELVKIADFGLAREI-RSRPYTDYVSTRWYRAPEVL 474
++I+D GLA + + V T Y APEV+
Sbjct: 138 HGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 23/54 (42%), Positives = 33/54 (61%), Gaps = 2/54 (3%)
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVS 464
YQV +G+ F+ HRD+ N+L ++VKI DFGLAR+I ++YVS
Sbjct: 244 YQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD--SNYVS 295
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 34/131 (25%), Positives = 55/131 (41%), Gaps = 25/131 (19%)
Query: 361 LSHANLVKLKEVIRENDTLYFVFE---------YMKENLYQLIRDRDKFLPESIIRNMMY 411
L+H N+++ E+ V E Y++ N + + K + ++ M
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV----LQRMAC 107
Query: 412 QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST------ 465
+V GL ++H+ F H D+ N VKI D+GLA E + DY T
Sbjct: 108 EVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALE---QYPEDYYITKDCHAV 164
Query: 466 --RWYRAPEVL 474
RW APE++
Sbjct: 165 PLRWL-APELV 174
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 30/114 (26%), Positives = 57/114 (50%), Gaps = 7/114 (6%)
Query: 366 LVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHG 424
LV L + + L+ + +Y+ L+ + R++F E ++ +++ L +H+ G
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF-KEQEVQIYSGEIVLALEHLHKLG 125
Query: 425 FFHRDMKPENLLCMGTELVKIADFGLAREIRS----RPYTDYVSTRWYRAPEVL 474
+RD+K EN+L V + DFGL++E R Y + T Y AP+++
Sbjct: 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY-SFCGTIEYMAPDIV 178
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 29/113 (25%), Positives = 57/113 (50%), Gaps = 4/113 (3%)
Query: 366 LVKLKEVIRENDTLYFVFEY-MKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHG 424
+ L ++ + LY V +Y + +L L+ + LPE + R + +++ + +H+
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 425 FFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDY---VSTRWYRAPEVL 474
+ HRD+KP+N+L +++ADFG ++ V T Y +PE+L
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 31/126 (24%), Positives = 54/126 (42%), Gaps = 11/126 (8%)
Query: 359 KKLSHANLVKLKEVIRENDTLYFVFEYMK----ENLYQLIRDRDKFLPE-SIIRNMMYQV 413
+ L H+NL++ E V E+ + + R + P+ + ++ M ++
Sbjct: 50 RSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI 109
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY-----TDYVSTRWY 468
GL +H++ F H D+ N L VKI D+GL+ Y +V RW
Sbjct: 110 ALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI 169
Query: 469 RAPEVL 474
APE++
Sbjct: 170 -APELV 174
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 25/65 (38%), Positives = 34/65 (52%), Gaps = 11/65 (16%)
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI------RSRPYTDYVSTRWYR 469
GL + R +RD+KPEN+L ++I+D GLA +I R R V T Y
Sbjct: 114 GLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR-----VGTVGYM 168
Query: 470 APEVL 474
APEV+
Sbjct: 169 APEVI 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 34/138 (24%), Positives = 63/138 (45%), Gaps = 22/138 (15%)
Query: 360 KLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLI-----------RDRDKFLPESI-- 405
+L H N+V L V+ + L +F Y +L++ + D DK + ++
Sbjct: 64 RLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEP 123
Query: 406 --IRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY---- 459
+++ Q+ G+ F+ H H+D+ N+L VKI+D GL RE+ + Y
Sbjct: 124 ADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 460 -TDYVSTRWYRAPEVLLH 476
+ RW +PE +++
Sbjct: 184 GNSLLPIRWM-SPEAIMY 200
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|227578 COG5253, MSS4, Phosphatidylinositol-4-phosphate 5-kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-04
Identities = 30/158 (18%), Positives = 53/158 (33%), Gaps = 12/158 (7%)
Query: 156 TNNAVYVNQNPHNNNPNISQYNNPNNYDPTTSQNNNISQYMPNNTSQNNNNTQYNPNSSQ 215
N Y + P + + N + N ++ NN S N T P
Sbjct: 84 LNKRKYQAIRLQTSTPIVEIFKNNKDAV----DPPNHTRSSGNNLSNANVKTLSAPVGEH 139
Query: 216 NMPNNISQNANNTQNNPNNSHYNPNNIQNNPNNFSQNNISQNNTNNTQINKTTQYNPPPY 275
+ NN N P +S +Q NP+ + + SQ + T N ++ +
Sbjct: 140 SRSNNPPNLDQNLDTEPESSISQWGELQLNPSGKTLS--SQPSRKPTSENPKSESDNSKL 197
Query: 276 PININK---ENTPAWLTNSATDGD---TTWFPTGHTTC 307
P ++N + + T S + W P + +C
Sbjct: 198 PTSVNSPLPDKSLLKRTLSNFWAERNSYNWKPLVYPSC 235
|
Length = 612 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 26/96 (27%), Positives = 46/96 (47%), Gaps = 2/96 (2%)
Query: 357 SLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQ 415
++ L HA +V+L I +L V + +L +R L + N Q+ +
Sbjct: 62 AMGSLDHAYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAK 120
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLA 451
G+ ++ H HR++ N+L +V+IADFG+A
Sbjct: 121 GMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 26/96 (27%), Positives = 45/96 (46%), Gaps = 2/96 (2%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKFLPESIIRNMMYQVLQG 416
+ + H +LV+L V + T+ V + M L + + + ++ N Q+ +G
Sbjct: 63 MASMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKG 121
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR 452
+ ++ HRD+ N+L VKI DFGLAR
Sbjct: 122 MMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|236275 PRK08486, PRK08486, single-stranded DNA-binding protein; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 19/77 (24%), Positives = 34/77 (44%), Gaps = 7/77 (9%)
Query: 214 SQNMPNNISQNANNTQNNPNNSHYNPNNIQNNPNNFSQNNISQNNTNNTQINKTTQYNPP 273
S++ + +N+ + N++Y N NNP+ N +Q+ N + Q PP
Sbjct: 107 SKSDNPQANAMQDNSFHENFNNNYPGN--YNNPSQDPYMNQAQSYNQNAYAKENQQAQPP 164
Query: 274 PYP-----ININKENTP 285
Y I+I++E P
Sbjct: 165 KYENSVPEIDIDEEEIP 181
|
Length = 182 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 30/112 (26%), Positives = 52/112 (46%), Gaps = 7/112 (6%)
Query: 365 NLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFL--PESIIRNMMYQVLQGLAFMH 421
N+V L + I D+++ V ++ + L+ I KFL PE ++ +++ L +H
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI---SKFLNIPEECVKRWAAEMVVALDALH 102
Query: 422 RHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEV 473
R G RD+ P N+L +++ F E+ + V Y APEV
Sbjct: 103 REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVE-NMYCAPEV 153
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 41.7 bits (99), Expect = 9e-04
Identities = 19/64 (29%), Positives = 29/64 (45%), Gaps = 1/64 (1%)
Query: 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTA 802
Y LL P + + FK + PF SP+A L+ +L +P KR TA
Sbjct: 187 YELLTGKPPFPGDDQLLEL-FKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTA 245
Query: 803 QQSL 806
+++L
Sbjct: 246 EEAL 249
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 0.001
Identities = 13/25 (52%), Positives = 17/25 (68%)
Query: 56 LREVKSLKKLSHANLVKLKEVILDP 80
LRE+ LK+L H N+VKL +VI
Sbjct: 46 LREISLLKELKHPNIVKLLDVIHTE 70
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 33/126 (26%), Positives = 53/126 (42%), Gaps = 16/126 (12%)
Query: 361 LSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKFLPES---IIRNMMYQVLQG 416
L H N+++ E VFEY + +L + S +++ M ++ G
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST--------RWY 468
+ MH+H F H D+ N VK+ D+G+ SR DY+ T RW
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIG---PSRYKEDYIETEDDKCVPLRWL 168
Query: 469 RAPEVL 474
APE++
Sbjct: 169 -APELV 173
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 37/125 (29%), Positives = 51/125 (40%), Gaps = 19/125 (15%)
Query: 363 HANLVKLKEVIREN-DTLYFVFEYMKE-NLYQLIRDRDKF---LPESIIRNMMYQVLQGL 417
H + K EN + V +Y +L Q I+ R K E + QVL +
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVS---------TRWY 468
+H HRD+K N+L LVK+ DFG S+ Y VS T +Y
Sbjct: 157 HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF-----SKMYAATVSDDVGRTFCGTPYY 211
Query: 469 RAPEV 473
APE+
Sbjct: 212 VAPEI 216
|
Length = 496 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 27/83 (32%), Positives = 38/83 (45%), Gaps = 14/83 (16%)
Query: 409 MMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDY------ 462
M ++ G+A+++ F HRD+ N + VKI DFG+ R+I TDY
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE---TDYYRKGGK 180
Query: 463 --VSTRWYRAPEVLLHS--TAYS 481
+ RW APE L T S
Sbjct: 181 GLLPVRWM-APESLKDGVFTTSS 202
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 27/76 (35%), Positives = 39/76 (51%), Gaps = 16/76 (21%)
Query: 409 MMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLAREIRSRPYTDY---- 462
M ++ G+A+++ + F HRD+ N CM E VKI DFG+ R+I TDY
Sbjct: 124 MAGEIADGMAYLNANKFVHRDLAARN--CMVAEDFTVKIGDFGMTRDIYE---TDYYRKG 178
Query: 463 ----VSTRWYRAPEVL 474
+ RW +PE L
Sbjct: 179 GKGLLPVRWM-SPESL 193
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|236275 PRK08486, PRK08486, single-stranded DNA-binding protein; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 19/68 (27%), Positives = 28/68 (41%), Gaps = 2/68 (2%)
Query: 146 SMLANNSMVSTNNAVYVNQNPHNNNPNI-SQYNNPNNYDPTTSQNNNISQYMPNNTSQNN 204
ML + S NA+ N N N N YNNP+ DP +Q + +Q +Q
Sbjct: 103 QMLDSKSDNPQANAMQDNSFHENFNNNYPGNYNNPS-QDPYMNQAQSYNQNAYAKENQQA 161
Query: 205 NNTQYNPN 212
+Y +
Sbjct: 162 QPPKYENS 169
|
Length = 182 |
| >gnl|CDD|221605 pfam12498, bZIP_C, Basic leucine-zipper C terminal | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.002
Identities = 11/77 (14%), Positives = 28/77 (36%), Gaps = 2/77 (2%)
Query: 145 NSMLANNSMVSTNNAVYVNQNPHNNNPNISQYNNPNNYDPTTSQNNNISQYMPNNTSQNN 204
N +L S +S+ + + +++ ++ +N +NY + N I+ +
Sbjct: 20 NPLLQAISEMSSMGMPFSGPSDASSDASVPIQDNSSNYFQQPAVNPGITVHDDQPELGGA 79
Query: 205 NNTQYN--PNSSQNMPN 219
S Q + +
Sbjct: 80 TAGGKMGRTPSLQRVAS 96
|
This family of proteins is found in eukaryotes. Proteins in this family are typically between 174 and 411 amino acids in length. The family is found in association with pfam00170. There is a conserved KVK sequence motif. There is a single completely conserved residue K that may be functionally important. Various bZIP proteins have been found and shown to play a role in seed-specific gene expression. bZIP binds to the alpha-globulin gene promoter, but not to promoters of other major storage genes such as glutelin, prolamin and albumin. Length = 112 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 21/61 (34%), Positives = 31/61 (50%), Gaps = 4/61 (6%)
Query: 401 LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLAREIRSRP 458
LP + M + G+ ++ F HRD+ N CM E V +ADFGL+++I S
Sbjct: 110 LPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARN--CMLNENMTVCVADFGLSKKIYSGD 167
Query: 459 Y 459
Y
Sbjct: 168 Y 168
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|218400 pfam05048, NosD, Periplasmic copper-binding protein (NosD) | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 52/194 (26%), Positives = 73/194 (37%), Gaps = 50/194 (25%)
Query: 128 PVTLYSHDYDILLSNPANSMLANNSMVSTNNAVYVNQNPHNNNPNISQYNNPNNYDPTTS 187
+ +Y+ I LSN +N+++ NN++++ + +Y+N + +N N + NN S
Sbjct: 9 TIGIYNGRGGIYLSNSSNNVIINNTIINVRDGIYLNNSSNNTITNNTISNNRYGIHLMYS 68
Query: 188 QNNNISQYMPNNTSQNNNNTQYNPNSSQNM--PNNISQN--------------ANNT-QN 230
NN IS NNT+ NN NSS N N IS N +NNT N
Sbjct: 69 SNNTIS----NNTASNNGYGIALMNSSNNTIRNNTISNNTYGILLSDSSNNTISNNTISN 124
Query: 231 NPN-----NSHYNP---NNIQNNP---------------NNFSQNNI------SQNNTNN 261
N NS N N I +N N F N S NT N
Sbjct: 125 NGKGIFLYNSSNNTITGNRISSNGIGIHLAGSNGNLIYNNYFINNTENVKYVGSNGNTWN 184
Query: 262 TQINKTTQYNPPPY 275
+ PY
Sbjct: 185 STKTAGYNIVGGPY 198
|
NosD is a periplasmic protein which is thought to insert copper into the exported reductase apoenzyme (NosZ). This region forms a parallel beta helix domain. Length = 238 |
| >gnl|CDD|168775 PRK07034, PRK07034, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (96), Expect = 0.002
Identities = 23/83 (27%), Positives = 37/83 (44%), Gaps = 10/83 (12%)
Query: 179 PNNYDPTTSQNNNISQYMPNNTSQNNNNT----------QYNPNSSQNMPNNISQNANNT 228
P + +TSQ N + + + + NN Q PN++ + PN + N N
Sbjct: 45 PRSGSSSTSQAENYKEGLADQAASGNNMARTSAPPVTLYQQQPNANDSYPNGNNNNPNGD 104
Query: 229 QNNPNNSHYNPNNIQNNPNNFSQ 251
NNPN S+ N +Q P+ S+
Sbjct: 105 NNNPNGSNNNIARVQRMPHGISR 127
|
Length = 536 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 40/145 (27%), Positives = 63/145 (43%), Gaps = 20/145 (13%)
Query: 382 VFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE 441
+ +Y++EN +DR + + N Q+ +G++++ HRD+ N+L
Sbjct: 95 LLDYVREN-----KDR---IGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN 146
Query: 442 LVKIADFGLAR--EIRSRPY---TDYVSTRWYRAPEVLLH------STAYSAPIHLSRSQ 490
VKI DFGLAR +I Y V +W A E +LH S +S + +
Sbjct: 147 HVKITDFGLARLLDIDETEYHADGGKVPIKWM-ALESILHRRFTHQSDVWSYGVTVWELM 205
Query: 491 QFLFYSIDHVPPIQTTCLLAGTERL 515
F D +P + LL ERL
Sbjct: 206 TFGAKPYDGIPAREIPDLLEKGERL 230
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 15/46 (32%), Positives = 33/46 (71%)
Query: 401 LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIA 446
+ E++I N+++ L+GL ++H++G+ HR++K ++L G LV ++
Sbjct: 98 MSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|219927 pfam08601, PAP1, Transcription factor PAP1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 22/122 (18%), Positives = 48/122 (39%), Gaps = 2/122 (1%)
Query: 140 LSNPANSMLANNSMVSTNNAVYVNQNPHNNNPNISQYN-NPNNYDPTTSQNNNISQYMPN 198
+ NS +N S + N Y + + N + +P+ S N+
Sbjct: 57 VPGLLNSTESNVSSPNNNPNGYTSPSSAAMNNKSNNRAVDPSANASAASTNSPNGLQSSA 116
Query: 199 NTSQNNNNTQYNPNSSQNMPNNISQNANNTQNNPNNSHYNPNNIQNNPNNFSQNNISQNN 258
+N+N+ + SS + +Q ++ +P S +P + + N + N +++N
Sbjct: 117 TQYNSNDNSSSDSPSSGS-DGFTNQLLSSLGTSPEPSTESPPQLASVNNFAAIRNNAESN 175
Query: 259 TN 260
+N
Sbjct: 176 SN 177
|
The transcription factor Pap1 regulates antioxidant-gene transcription in response to H2O2. This region is cysteine rich. Alkylation of cysteine residues following treatment with a cysteine alkylating agent can mask the accessibility of the nuclear exporter Crm1, triggering nuclear accumulation and Pap1 dependent transcriptional expression. Length = 344 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 33/124 (26%), Positives = 50/124 (40%), Gaps = 20/124 (16%)
Query: 363 HANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFL---PESIIRNMMYQVL---- 414
H N++ L LY EY NL +R + + L P I N L
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQ 125
Query: 415 ---------QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR--EIRSRPYTDYV 463
+G+ ++ + F HRD+ N+L + KIADFGL+R E+ + +
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 185
Query: 464 STRW 467
RW
Sbjct: 186 PVRW 189
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.004
Identities = 13/38 (34%), Positives = 22/38 (57%)
Query: 44 KRKYYSWEEAMNLREVKSLKKLSHANLVKLKEVILDPP 81
KR S ++ RE++ L++LSH N+V+L + D
Sbjct: 34 KRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKD 71
|
Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.004
Identities = 13/48 (27%), Positives = 21/48 (43%), Gaps = 3/48 (6%)
Query: 760 NMNFKFPQFRRVPFTSIIPH---ASPDAIHLMESMLAYNPSKRPTAQQ 804
+ + P P S +A L++ L +PSKRPTA++
Sbjct: 206 DQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEE 253
|
Length = 260 |
| >gnl|CDD|220369 pfam09731, Mitofilin, Mitochondrial inner membrane protein | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.004
Identities = 44/205 (21%), Positives = 75/205 (36%), Gaps = 37/205 (18%)
Query: 773 FTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIKREVSLSFVLLKKLNRLE------ 826
S+I A + L + + + +++L KRE LS + + L RLE
Sbjct: 161 LESLIASAKEELDQLSKKLAELKAEEEEELERALKEKREELLSKLEEELLARLESKEAAL 220
Query: 827 --KYRLKNARETLQAKKSKVDSFNLQLQNLKYEIF-HLKKEV--VKCLQFKSKDEDI-DL 880
+ RL+ RE + +K + +L+ LK E+ + +++I +
Sbjct: 221 EKQLRLEFEREKEELRKKYEEKLRQELERQAEAHEQKLKNELALQAIELQREFNKEIKEK 280
Query: 881 VDEETFFKDAPESISRPEVTKEDPHQLKLARLEWELKQRKELADECSLVERENESVAA-- 938
V+EE + KLA L LK ++ D S E EN V
Sbjct: 281 VEEE-----------------RNGRLAKLAELNSRLKGLEKALDSRSEAEDENHKVQQLW 323
Query: 939 ----NINKK--RGQLDNLAPLLKQL 957
+ G + PL+K+L
Sbjct: 324 LAVEALKSALKSGSAGSPRPLVKEL 348
|
Mitofilin controls mitochondrial cristae morphology. Mitofilin is enriched in the narrow space between the inner boundary and the outer membranes, where it forms a homotypic interaction and assembles into a large multimeric protein complex. The first 78 amino acids contain a typical amino-terminal-cleavable mitochondrial presequence rich in positive-charged and hydroxylated residues and a membrane anchor domain. In addition, it has three centrally located coiled coil domains. Length = 493 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 962 | |||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0659|consensus | 318 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| PF09766 | 355 | FimP: Fms-interacting protein; InterPro: IPR019163 | 99.98 | |
| KOG0580|consensus | 281 | 99.98 | ||
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.98 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.98 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.98 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.98 | |
| KOG0658|consensus | 364 | 99.98 | ||
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.98 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.98 | |
| KOG1026|consensus | 774 | 99.98 | ||
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.98 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.98 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.98 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.98 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0599|consensus | 411 | 99.97 | ||
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0577|consensus | 948 | 99.97 | ||
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1095|consensus | 1025 | 99.97 | ||
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4279|consensus | 1226 | 99.97 | ||
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0033|consensus | 355 | 99.97 | ||
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| KOG4717|consensus | 864 | 99.97 | ||
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0579|consensus | 1187 | 99.97 | ||
| KOG0193|consensus | 678 | 99.97 | ||
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| KOG0596|consensus | 677 | 99.97 | ||
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| KOG0574|consensus | 502 | 99.97 | ||
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0032|consensus | 382 | 99.97 | ||
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| KOG0667|consensus | 586 | 99.97 | ||
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| KOG1187|consensus | 361 | 99.97 | ||
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG2345|consensus | 302 | 99.97 | ||
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0584|consensus | 632 | 99.97 | ||
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG2216|consensus | 303 | 99.97 | ||
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0983|consensus | 391 | 99.97 | ||
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1035|consensus | 1351 | 99.97 | ||
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| KOG0194|consensus | 474 | 99.96 | ||
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| KOG4257|consensus | 974 | 99.96 | ||
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| KOG4278|consensus | 1157 | 99.96 | ||
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0612|consensus | 1317 | 99.96 | ||
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| KOG0196|consensus | 996 | 99.96 | ||
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0603|consensus | 612 | 99.96 | ||
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG4645|consensus | 1509 | 99.96 | ||
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.96 | |
| KOG0986|consensus | 591 | 99.96 | ||
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| KOG1094|consensus | 807 | 99.96 | ||
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0199|consensus | 1039 | 99.96 | ||
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0690|consensus | 516 | 99.95 | ||
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| KOG0604|consensus | 400 | 99.95 | ||
| KOG0586|consensus | 596 | 99.95 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| KOG0607|consensus | 463 | 99.95 | ||
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| KOG0666|consensus | 438 | 99.95 | ||
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0662|consensus | 292 | 99.95 | ||
| KOG0603|consensus | 612 | 99.95 | ||
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| KOG1006|consensus | 361 | 99.94 | ||
| KOG0614|consensus | 732 | 99.94 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| KOG4236|consensus | 888 | 99.94 | ||
| KOG4250|consensus | 732 | 99.94 | ||
| KOG0200|consensus | 609 | 99.94 | ||
| KOG0696|consensus | 683 | 99.94 | ||
| KOG1025|consensus | 1177 | 99.94 | ||
| KOG0608|consensus | 1034 | 99.94 | ||
| KOG0669|consensus | 376 | 99.94 | ||
| KOG0576|consensus | 829 | 99.94 | ||
| KOG0587|consensus | 953 | 99.94 | ||
| KOG0984|consensus | 282 | 99.93 | ||
| KOG1151|consensus | 775 | 99.93 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.93 | |
| KOG1290|consensus | 590 | 99.93 | ||
| KOG1027|consensus | 903 | 99.93 | ||
| KOG0659|consensus | 318 | 99.92 | ||
| KOG2052|consensus | 513 | 99.91 | ||
| KOG0695|consensus | 593 | 99.91 | ||
| KOG0671|consensus | 415 | 99.91 | ||
| KOG3653|consensus | 534 | 99.91 | ||
| KOG1152|consensus | 772 | 99.91 | ||
| KOG0663|consensus | 419 | 99.91 | ||
| KOG1024|consensus | 563 | 99.91 | ||
| KOG0660|consensus | 359 | 99.91 | ||
| KOG0664|consensus | 449 | 99.9 | ||
| KOG0661|consensus | 538 | 99.9 | ||
| KOG0670|consensus | 752 | 99.9 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.9 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| KOG0665|consensus | 369 | 99.9 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.89 | |
| KOG0593|consensus | 396 | 99.89 | ||
| KOG0600|consensus | 560 | 99.89 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| KOG0658|consensus | 364 | 99.88 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| KOG0668|consensus | 338 | 99.87 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.87 | |
| KOG1167|consensus | 418 | 99.86 | ||
| KOG0590|consensus | 601 | 99.84 | ||
| KOG0662|consensus | 292 | 99.82 | ||
| KOG1345|consensus | 378 | 99.81 | ||
| KOG0666|consensus | 438 | 99.8 | ||
| KOG1164|consensus | 322 | 99.78 | ||
| KOG1163|consensus | 341 | 99.77 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.76 | |
| KOG1165|consensus | 449 | 99.74 | ||
| KOG0669|consensus | 376 | 99.73 | ||
| KOG0667|consensus | 586 | 99.73 | ||
| KOG0590|consensus | 601 | 99.72 | ||
| KOG4158|consensus | 598 | 99.71 | ||
| KOG0195|consensus | 448 | 99.69 | ||
| KOG0615|consensus | 475 | 99.69 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.67 | |
| KOG0578|consensus | 550 | 99.66 | ||
| KOG0594|consensus | 323 | 99.65 | ||
| KOG0665|consensus | 369 | 99.64 | ||
| KOG0664|consensus | 449 | 99.63 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.62 | |
| KOG1023|consensus | 484 | 99.62 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.62 | |
| KOG1240|consensus | 1431 | 99.6 | ||
| KOG0575|consensus | 592 | 99.57 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.57 | |
| KOG0591|consensus | 375 | 99.57 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.55 | |
| KOG0033|consensus | 355 | 99.55 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.55 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.54 | |
| KOG0201|consensus | 467 | 99.53 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.52 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.52 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.51 | |
| KOG0671|consensus | 415 | 99.5 | ||
| KOG0606|consensus | 1205 | 99.49 | ||
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.48 | |
| KOG1033|consensus | 516 | 99.48 | ||
| KOG0596|consensus | 677 | 99.48 | ||
| KOG0581|consensus | 364 | 99.47 | ||
| KOG0599|consensus | 411 | 99.47 | ||
| KOG1166|consensus | 974 | 99.46 | ||
| KOG4717|consensus | 864 | 99.45 | ||
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.45 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.44 | |
| KOG0668|consensus | 338 | 99.44 | ||
| KOG0579|consensus | 1187 | 99.43 | ||
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.42 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.42 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.41 | |
| KOG0601|consensus | 524 | 99.41 | ||
| KOG0198|consensus | 313 | 99.41 | ||
| KOG1035|consensus | 1351 | 99.4 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.4 | |
| KOG0598|consensus | 357 | 99.39 | ||
| KOG0588|consensus | 786 | 99.39 | ||
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.38 | |
| KOG0589|consensus | 426 | 99.37 | ||
| KOG0670|consensus | 752 | 99.37 | ||
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.36 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.36 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.35 | |
| KOG0597|consensus | 808 | 99.34 | ||
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.34 | |
| KOG0604|consensus | 400 | 99.34 | ||
| KOG0577|consensus | 948 | 99.33 | ||
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.33 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.33 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.32 | |
| KOG0592|consensus | 604 | 99.32 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.32 | |
| KOG0616|consensus | 355 | 99.32 | ||
| KOG0585|consensus | 576 | 99.31 | ||
| KOG0582|consensus | 516 | 99.3 | ||
| KOG4645|consensus | 1509 | 99.3 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.29 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.29 | |
| KOG0032|consensus | 382 | 99.28 | ||
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.28 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.26 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.26 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.25 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.25 | |
| KOG0583|consensus | 370 | 99.24 | ||
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.23 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.23 |
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=355.60 Aligned_cols=245 Identities=19% Similarity=0.204 Sum_probs=205.7
Q ss_pred EecCCcccEEEEEecCCceEEEEecc-----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-EEEEEEecCCCCHHH
Q psy501 319 YILPHTLPLYTCNLDQDNHILSRHVS-----SRDEMVVCFYRKSLKKLSHANLVKLKEVIREND-TLYFVFEYMKENLYQ 392 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~-~~~LV~Ey~~g~Ll~ 392 (962)
++.|.++.||+|..+.+.++++.|.. +....++.+|++++++++||+||.+|++|...+ .++|+||||+|+.++
T Consensus 87 lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd 166 (364)
T KOG0581|consen 87 LGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLD 166 (364)
T ss_pred cccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHH
Confidence 33344555888888888887776654 233567999999999999999999999999998 599999999976666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHhhccc-ceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccccCh
Q psy501 393 LIRDRDKFLPESIIRNMMYQVLQGLAFMHR-HGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAP 471 (962)
Q Consensus 393 ~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~-~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~AP 471 (962)
.+....+.+++..+..++.+|++||.|||+ ++||||||||+|||++..|.|||||||.+..+......+++||..||||
T Consensus 167 ~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~tfvGT~~YMsP 246 (364)
T KOG0581|consen 167 DILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIANTFVGTSAYMSP 246 (364)
T ss_pred HHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhcccccccccccCh
Confidence 666555779999999999999999999995 9999999999999999999999999999998888888889999999999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCc-----ChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCC
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTT-----CLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTER 546 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dper 546 (962)
|.+.+. .|+.++||||||++++||.+|+.||... ...+....|..+.........++.+++.++..||+++|.+
T Consensus 247 ERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~ 325 (364)
T KOG0581|consen 247 ERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSE 325 (364)
T ss_pred hhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCccc
Confidence 999875 7999999999999999999999999885 5566677776653322222248888999999999999999
Q ss_pred CCcHHHHHhhccccccCC
Q psy501 547 LKSSYILLHTLPLYTYHV 564 (962)
Q Consensus 547 RPs~~~Ll~~l~~~~~~~ 564 (962)
||++.+|++.=....+..
T Consensus 326 R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 326 RPSAKQLLQHPFIKKFED 343 (364)
T ss_pred CCCHHHHhcCHHHhhccc
Confidence 999999887553443443
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=358.43 Aligned_cols=237 Identities=22% Similarity=0.300 Sum_probs=204.1
Q ss_pred EecCCcc-cEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CC
Q psy501 319 YILPHTL-PLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-EN 389 (962)
Q Consensus 319 ~i~~~~~-~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~ 389 (962)
++++|++ .+|.++....+.+++.|+..+ ..+.+.+||+|.++|+|||||+++++|++...+|||+|+|. |+
T Consensus 25 ~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~s 104 (592)
T KOG0575|consen 25 FLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGS 104 (592)
T ss_pred eeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCcc
Confidence 3344444 377777655665555554433 45679999999999999999999999999999999999999 55
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCcc
Q psy501 390 LYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRW 467 (962)
Q Consensus 390 Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~ 467 (962)
|.+++. +.++++|.+++.+++||+.||.|||+.+|+|||||..|++++++..+||+|||+|..+..+ ...+.+||+.
T Consensus 105 L~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPN 183 (592)
T KOG0575|consen 105 LMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPN 183 (592)
T ss_pred HHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccceecCCCc
Confidence 555555 6678999999999999999999999999999999999999999999999999999988643 6677899999
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCC
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERL 547 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperR 547 (962)
|.|||++.. ...+..+||||+|||+|-|+.|++||...+..+...+|+......|. ..+....+||...|..+|.+|
T Consensus 184 YIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~--~ls~~A~dLI~~lL~~~P~~R 260 (592)
T KOG0575|consen 184 YIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS--HLSAEAKDLIRKLLRPNPSER 260 (592)
T ss_pred ccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc--ccCHHHHHHHHHHhcCCcccC
Confidence 999999974 57999999999999999999999999999999999999999887775 667788899999999999999
Q ss_pred CcHHHHHhhccc
Q psy501 548 KSSYILLHTLPL 559 (962)
Q Consensus 548 Ps~~~Ll~~l~~ 559 (962)
|++.+++..-.+
T Consensus 261 psl~~vL~h~Ff 272 (592)
T KOG0575|consen 261 PSLDEVLDHPFF 272 (592)
T ss_pred CCHHHHhcCHhh
Confidence 997776654434
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=336.01 Aligned_cols=229 Identities=21% Similarity=0.331 Sum_probs=195.6
Q ss_pred cEEEEEecCCceEEEEec------cchhHHHHHHHHHHHHhcCCCCcccEEE-EEEeCCE-EEEEEecCC-CCHHHHHH-
Q psy501 326 PLYTCNLDQDNHILSRHV------SSRDEMVVCFYRKSLKKLSHANLVKLKE-VIRENDT-LYFVFEYMK-ENLYQLIR- 395 (962)
Q Consensus 326 ~Vy~~~~~~~~kvv~~k~------~~~~~~~~~~Ei~iL~~L~HpnIv~l~~-~~~~~~~-~~LV~Ey~~-g~Ll~~l~- 395 (962)
.||++....+++.++.|- ...+...+..|+.+|++|+|||||++++ .|.++.. ++||||+|+ |+|...+.
T Consensus 34 ~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~ 113 (375)
T KOG0591|consen 34 EVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKH 113 (375)
T ss_pred heEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHH
Confidence 488888877777665433 2344567999999999999999999999 5655554 999999998 67766553
Q ss_pred --hcCCCCCHHHHHHHHHHHHHHHhhccc--ce--eeeccCCCcccccccccceeeecccccccccCC--CcccccCCcc
Q psy501 396 --DRDKFLPESIIRNMMYQVLQGLAFMHR--HG--FFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRW 467 (962)
Q Consensus 396 --~~~~~ls~~~i~~i~~qI~~aL~yLH~--~g--IvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~ 467 (962)
+..+.+++..+|+++.|++.||.++|+ .+ |+||||||.||+++..|.+||+|||+++.+.+. ...+.+|||.
T Consensus 114 ~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPy 193 (375)
T KOG0591|consen 114 FKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPY 193 (375)
T ss_pred HHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCc
Confidence 345679999999999999999999999 55 999999999999999999999999999988766 5566899999
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCC
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERL 547 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperR 547 (962)
||+||.+.+ .+|+.+|||||+||++|||+.-++||.+.+......+|.++...+-....++..+..|+..|+..|++.|
T Consensus 194 YMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~R 272 (375)
T KOG0591|consen 194 YMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQR 272 (375)
T ss_pred ccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccC
Confidence 999999976 4899999999999999999999999999999999999999965443335788999999999999999999
Q ss_pred CcHHHHHh
Q psy501 548 KSSYILLH 555 (962)
Q Consensus 548 Ps~~~Ll~ 555 (962)
|+.-.+++
T Consensus 273 P~t~~~v~ 280 (375)
T KOG0591|consen 273 PDTVPYVQ 280 (375)
T ss_pred CCcchHHH
Confidence 98443443
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=348.20 Aligned_cols=253 Identities=24% Similarity=0.309 Sum_probs=204.8
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecC
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
.++.|.++.+.....+.++..|+++.....+.............+.+|+++|++|.||+||+++++|+.++..||||||+
T Consensus 179 ~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v 258 (475)
T KOG0615|consen 179 TLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYV 258 (475)
T ss_pred eecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEe
Confidence 45666777776666677777777766555554332221222335789999999999999999999999999999999999
Q ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc---cceeeecccccccccCC-Cccc
Q psy501 387 K-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT---ELVKIADFGLAREIRSR-PYTD 461 (962)
Q Consensus 387 ~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~---g~vKL~DFGla~~~~~~-~~~~ 461 (962)
+ |+|++.+...+ .+.++.-+.+++|++.|+.|||+.||+||||||+|||+..+ ..+||+|||+|+..+.. .+.+
T Consensus 259 ~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~T 337 (475)
T KOG0615|consen 259 EGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKT 337 (475)
T ss_pred cCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccceehhh
Confidence 8 67888887764 58999999999999999999999999999999999999766 67999999999988654 6677
Q ss_pred ccCCccccChhhhccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhh-hHHHHHhccccccCC--CCCCCCcHHHH
Q psy501 462 YVSTRWYRAPEVLLHS--TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLA-GTERLKSSYILLHTL--PLYTYHVPPIQ 536 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~--~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~--~~~s~~l~~li 536 (962)
.|||+.|.|||++.+. ..+..++||||+||+||-+++|.+||.+..... ..+.|..+.+.+..+ ...+.....+|
T Consensus 338 lCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI 417 (475)
T KOG0615|consen 338 LCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLI 417 (475)
T ss_pred hcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHH
Confidence 8999999999999743 235568999999999999999999999877666 778888887766533 35566778899
Q ss_pred HHHhccCCCCCCcHHHHHhhccccc
Q psy501 537 TTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 537 ~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
..+|..||++||++.+.+.+ ||+.
T Consensus 418 ~~mL~VdP~~R~s~~eaL~h-pW~~ 441 (475)
T KOG0615|consen 418 NWMLVVDPENRPSADEALNH-PWFK 441 (475)
T ss_pred HHhhEeCcccCcCHHHHhcC-hhhh
Confidence 99999999999996655543 3543
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=348.66 Aligned_cols=240 Identities=22% Similarity=0.299 Sum_probs=203.4
Q ss_pred cccEEEEEecCCceEEEEeccchh-----HHHHHHHHHHHHhcCCCCcccEEEEEEeCC-EEEEEEecCC-CCHHHHHHh
Q psy501 324 TLPLYTCNLDQDNHILSRHVSSRD-----EMVVCFYRKSLKKLSHANLVKLKEVIREND-TLYFVFEYMK-ENLYQLIRD 396 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~-~~~LV~Ey~~-g~Ll~~l~~ 396 (962)
.+.||.+.+.....++++.+...+ ...+.+|+.+|.+++|||||+++|++.+.. .++|||||++ |+|.+++..
T Consensus 54 ~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~ 133 (362)
T KOG0192|consen 54 FGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHK 133 (362)
T ss_pred ceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhh
Confidence 345777776666545555444332 458999999999999999999999999887 7999999998 566666666
Q ss_pred -cCCCCCHHHHHHHHHHHHHHHhhcccce-eeeccCCCccccccccc-ceeeecccccccccC--CCcccccCCccccCh
Q psy501 397 -RDKFLPESIIRNMMYQVLQGLAFMHRHG-FFHRDMKPENLLCMGTE-LVKIADFGLAREIRS--RPYTDYVSTRWYRAP 471 (962)
Q Consensus 397 -~~~~ls~~~i~~i~~qI~~aL~yLH~~g-IvHrDLkp~NILl~~~g-~vKL~DFGla~~~~~--~~~~~~~gt~~Y~AP 471 (962)
....++...++.|+.||++||.|||+++ ||||||||+|||++.++ ++||+|||+++.... ...+...||+.||||
T Consensus 134 ~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAP 213 (362)
T KOG0192|consen 134 KRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAP 213 (362)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccCh
Confidence 3678999999999999999999999999 99999999999999998 999999999987765 344557899999999
Q ss_pred hhhcc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcH
Q psy501 472 EVLLH-STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 550 (962)
Q Consensus 472 E~l~~-~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~ 550 (962)
|++.+ ...|+.|+||||||++||||+||+.||.+.........+......+.....++..+..++..||..+|++||+.
T Consensus 214 Ev~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f 293 (362)
T KOG0192|consen 214 EVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSF 293 (362)
T ss_pred hhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCH
Confidence 99975 35799999999999999999999999999988777777766656665555688899999999999999999999
Q ss_pred HHHHhhccccccC
Q psy501 551 YILLHTLPLYTYH 563 (962)
Q Consensus 551 ~~Ll~~l~~~~~~ 563 (962)
.+++..|..+..+
T Consensus 294 ~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 294 LEIVSRLESIMSH 306 (362)
T ss_pred HHHHHHHHHHHHh
Confidence 9999988655443
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=339.68 Aligned_cols=246 Identities=28% Similarity=0.477 Sum_probs=206.2
Q ss_pred cEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcCCCC-cccEEEEEEeCC------EEEEEEecCCCCHHH
Q psy501 326 PLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHAN-LVKLKEVIREND------TLYFVFEYMKENLYQ 392 (962)
Q Consensus 326 ~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~------~~~LV~Ey~~g~Ll~ 392 (962)
.||+++...+++.++.+...- ......+|+.+|+.|+|++ |+++++++.+.. .+++|+||++-+|..
T Consensus 26 ~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ 105 (323)
T KOG0594|consen 26 VVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKK 105 (323)
T ss_pred EEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecccHHH
Confidence 466666666665444333211 2235799999999999999 999999998877 899999999999999
Q ss_pred HHHhcC---CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCcccc
Q psy501 393 LIRDRD---KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYR 469 (962)
Q Consensus 393 ~l~~~~---~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~ 469 (962)
++.... ..++...++.+++||+.||+|||+++|+||||||.||+|+.+|.+||+|||+|+...-+..
T Consensus 106 ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~---------- 175 (323)
T KOG0594|consen 106 YMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR---------- 175 (323)
T ss_pred HHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCcc----------
Confidence 998766 3588899999999999999999999999999999999999999999999999972211100
Q ss_pred ChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCc
Q psy501 470 APEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 549 (962)
Q Consensus 470 APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs 549 (962)
+
T Consensus 176 --------------~----------------------------------------------------------------- 176 (323)
T KOG0594|consen 176 --------------T----------------------------------------------------------------- 176 (323)
T ss_pred --------------c-----------------------------------------------------------------
Confidence 0
Q ss_pred HHHHHhhccccccCCCCcchhhhccccccccccceeecccccccccCCCcccccccccccccccceeEeecccccccccC
Q psy501 550 SYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVP 629 (962)
Q Consensus 550 ~~~Ll~~l~~~~~~~~~~~~~~~l~g~~~l~ssy~~~~~lpl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (962)
T Consensus 177 -------------------------------------------------------------------------------- 176 (323)
T KOG0594|consen 177 -------------------------------------------------------------------------------- 176 (323)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcceeecccccccccceeeeeeecceEEEecCCceeEEeeccccccceeeEEEEEEeeeeeecCCCceeeeccCCCcccc
Q psy501 630 PIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 709 (962)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~~~~ 709 (962)
.+....|.|||
T Consensus 177 ---------------------------------------------------------------------yt~evvTlWYR 187 (323)
T KOG0594|consen 177 ---------------------------------------------------------------------YTPEVVTLWYR 187 (323)
T ss_pred ---------------------------------------------------------------------ccccEEEeecc
Confidence 34445578899
Q ss_pred cceeeecCCCCCCCCCceeeeeEee----------cCCchhHHHHHHHhcCCCchhhhccccc---c--cCCCcc-cCCc
Q psy501 710 SYILLHTLPLYTYHVPPIQTTCLLA----------GTERLKSSYILLHTLPLYTCYTLASNMN---F--KFPQFR-RVPF 773 (962)
Q Consensus 710 ~~~lLlg~~~Y~~~vDIWSlGCIl~----------G~~~~~ql~~I~~~lG~p~~~~~~~~~~---~--~~~~~~-~~~l 773 (962)
||++|||++.|++.|||||+||||+ |.++.+|+..|++++|+|+.+.|+.... + .++.++ +.++
T Consensus 188 aPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l 267 (323)
T KOG0594|consen 188 APEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDL 267 (323)
T ss_pred CHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccch
Confidence 9999999999999999999999999 9999999999999999999998877443 2 355565 6778
Q ss_pred cccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 774 TSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 774 ~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
...+|..++++.||+.+||+++|++|.||..+|++.
T Consensus 268 ~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~ 303 (323)
T KOG0594|consen 268 SSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHP 303 (323)
T ss_pred HHhccccCccHHHHHHHHhccCcccCcCHHHHhcCh
Confidence 888888899999999999999999999999999854
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=346.38 Aligned_cols=290 Identities=27% Similarity=0.387 Sum_probs=231.2
Q ss_pred CCCCCCCCCcccccCccCCCCCccccCCCceEEecCceeeEEEEecCCcc-cEEEEEecCCceEEEEeccchh------H
Q psy501 276 PININKENTPAWLTNSATDGDTTWFPTGHTTCLLAGTERLKFSYILPHTL-PLYTCNLDQDNHILSRHVSSRD------E 348 (962)
Q Consensus 276 pi~~~~~~~~~~l~~~~~~~~~~~~~~g~~~~l~~g~~~~~~~~i~~~~~-~Vy~~~~~~~~kvv~~k~~~~~------~ 348 (962)
.......+|+.|+....++...+|.+.....+-. ...++.|++ .||+++...++++++.|...-+ .
T Consensus 88 e~~~~~a~~p~~l~~~~ge~~~~w~~r~~~~fek-------i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~ 160 (560)
T KOG0600|consen 88 EAEQVAAGWPAWLSSVAGEALHGWGPRRADSFEK-------IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFP 160 (560)
T ss_pred hhhhhhccCccccccccccccccccccchHHHHH-------HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcch
Confidence 3356678999999999999999998776553311 112333333 4899988888887766543332 2
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeC--CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceee
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIREN--DTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFF 426 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIv 426 (962)
....|||.||++|.||||+++.+...+. +.+|||+|||+.+|.-.+...+-.|++.+++.++.||+.||+|||++||+
T Consensus 161 ~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvl 240 (560)
T KOG0600|consen 161 ITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVL 240 (560)
T ss_pred HHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCee
Confidence 3589999999999999999999999876 78999999999999999998888899999999999999999999999999
Q ss_pred eccCCCcccccccccceeeecccccccccCC---CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q psy501 427 HRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPI 503 (962)
Q Consensus 427 HrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf 503 (962)
|||||.+|||||.+|.+||+|||+|+++... ..+..+-|++|+|||++.|...|+.++|+||.||||.||++|++.|
T Consensus 241 HRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~ 320 (560)
T KOG0600|consen 241 HRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPIL 320 (560)
T ss_pred eccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCc
Confidence 9999999999999999999999999977654 4677888999999999999999999999999999999999999999
Q ss_pred CCcChhhhHHHHHhcccccc-------CCC--------------------CCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 504 QTTCLLAGTERLKSSYILLH-------TLP--------------------LYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 504 ~~~~~~~~~~~i~~~~~~~~-------~~~--------------------~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.+....+....|....-.+. .+| .++...-.|+..+|..||.+|.++...++.
T Consensus 321 ~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 321 QGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 99988887777754332221 111 111123337778999999999998877776
Q ss_pred ccccccCCCCcchhhhc
Q psy501 557 LPLYTYHVPPIQTTCLL 573 (962)
Q Consensus 557 l~~~~~~~~~~~~~~~l 573 (962)
. ++...+.+..+.++.
T Consensus 401 e-yF~t~p~~~~p~~Lp 416 (560)
T KOG0600|consen 401 E-YFTTEPLPCDPSSLP 416 (560)
T ss_pred c-ccccCCCCCCcccCC
Confidence 5 334444444443333
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=331.33 Aligned_cols=235 Identities=28% Similarity=0.476 Sum_probs=198.9
Q ss_pred CcccEEEEEecCCceEEEEec-cchh-----HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHh
Q psy501 323 HTLPLYTCNLDQDNHILSRHV-SSRD-----EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRD 396 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~-~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~ 396 (962)
..+.||+|+.+.++.+++.+. .+++ .....||+++|++|+|||+|.++++|.....+++|+|||+.+.++.+..
T Consensus 14 SYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~ 93 (396)
T KOG0593|consen 14 SYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELER 93 (396)
T ss_pred cceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHHh
Confidence 344588898888888766543 3322 2358999999999999999999999999999999999999999999998
Q ss_pred cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC--CCcccccCCccccChhhh
Q psy501 397 RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAPEVL 474 (962)
Q Consensus 397 ~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~--~~~~~~~gt~~Y~APE~l 474 (962)
....++.+.+..++.|++.|+.|+|+++++||||||+||||+.+|.+||||||+|+.+.. +..+.++.|.+|+|||++
T Consensus 94 ~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELL 173 (396)
T KOG0593|consen 94 YPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELL 173 (396)
T ss_pred ccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhh
Confidence 887899999999999999999999999999999999999999999999999999998763 367788999999999999
Q ss_pred ccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhc--ccc-----------------ccC----------C
Q psy501 475 LHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSS--YIL-----------------LHT----------L 525 (962)
Q Consensus 475 ~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~--~~~-----------------~~~----------~ 525 (962)
.|+..|+.++||||+||++.||++|.+.|.+.+..+....|+.. .++ +|. .
T Consensus 174 vGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~ 253 (396)
T KOG0593|consen 174 VGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKY 253 (396)
T ss_pred cccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhc
Confidence 99999999999999999999999999999998887776555432 111 111 1
Q ss_pred CCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 526 PLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 526 ~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
|..+.-.-++++.||..||.+|+++++|++.-
T Consensus 254 p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~ 285 (396)
T KOG0593|consen 254 PKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP 285 (396)
T ss_pred ccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence 11122344588999999999999999988854
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=333.89 Aligned_cols=223 Identities=21% Similarity=0.327 Sum_probs=190.2
Q ss_pred CcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCC-HHHHH
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLI 394 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~-Ll~~l 394 (962)
+.++|+.++...++++++.|+..+ +......|..||.+++||+||.++..|++.+.+|+|+||+.|+ |..++
T Consensus 37 ~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL 116 (357)
T KOG0598|consen 37 SFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHL 116 (357)
T ss_pred CCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHH
Confidence 334467776666666666554332 3456899999999999999999999999999999999999864 55555
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC--CCcccccCCccccChh
Q psy501 395 RDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAPE 472 (962)
Q Consensus 395 ~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~--~~~~~~~gt~~Y~APE 472 (962)
++.+.|+++.++.++..|+.||.|||++|||||||||+|||+|.+|.++|+|||+|+.... ......+||+.|||||
T Consensus 117 -~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPE 195 (357)
T KOG0598|consen 117 -QREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPE 195 (357)
T ss_pred -HhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChH
Confidence 4456799999999999999999999999999999999999999999999999999985433 2555679999999999
Q ss_pred hhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCC
Q psy501 473 VLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK 548 (962)
Q Consensus 473 ~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRP 548 (962)
++.+. +|+.++|.||||+++|||++|.+||.+.+......+|..+....+ ....+...+++++..|..+|++|-
T Consensus 196 il~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~-p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 196 ILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLP-PGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCC-CccCCHHHHHHHHHHhccCHHHhc
Confidence 99875 899999999999999999999999999999999999988863222 234778889999999999999993
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=333.87 Aligned_cols=246 Identities=26% Similarity=0.372 Sum_probs=197.9
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
.|.|.....++.|....||+++.......++.|.... ..+-+..|+.+|+.++|||||.+++++.+++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 3445555554444445588887777666555444332 3456899999999999999999999999999999999
Q ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc------cceeeecccccccccC
Q psy501 384 EYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT------ELVKIADFGLAREIRS 456 (962)
Q Consensus 384 Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~------g~vKL~DFGla~~~~~ 456 (962)
|||. |+|.+++..++ .+++..++.++.||+.||++||+++||||||||+|||++.. -.+||+|||+|+.+..
T Consensus 89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 9999 56777776654 59999999999999999999999999999999999999865 4689999999999876
Q ss_pred C-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCC-CCCCCcHH
Q psy501 457 R-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLP-LYTYHVPP 534 (962)
Q Consensus 457 ~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~s~~l~~ 534 (962)
. .....+|++.|||||+++. ..|+.|+|+||+|++||+|++|++||+.....+....+.++....+.++ ..+.....
T Consensus 168 ~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~ 246 (429)
T KOG0595|consen 168 GSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRE 246 (429)
T ss_pred hhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhh
Confidence 5 4556799999999999975 4799999999999999999999999999999999888888877776655 33444446
Q ss_pred HHHHHhccCCCCCCc-HHHHHhhc
Q psy501 535 IQTTCLLAGTERLKS-SYILLHTL 557 (962)
Q Consensus 535 li~~Cl~~dperRPs-~~~Ll~~l 557 (962)
++...+..++..|-+ ...+.+.+
T Consensus 247 Ll~~ll~~~~~~~~~~~~~~~~~~ 270 (429)
T KOG0595|consen 247 LLISLLQRNPKDRISFEDFFDHPF 270 (429)
T ss_pred hhhHHHhcCccccCchHHhhhhhh
Confidence 666666666555544 66666655
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=335.42 Aligned_cols=244 Identities=20% Similarity=0.269 Sum_probs=207.7
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccchh-------HHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD-------EMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~-------~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
++.++..++.|....|+++......+.++.|+..+. ...+.+|..+|.+| .||.|+++|..|+++..+|+|+
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL 153 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL 153 (604)
T ss_pred hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence 334444444444445677776667766666665443 33588999999999 7999999999999999999999
Q ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-----
Q psy501 384 EYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----- 457 (962)
Q Consensus 384 Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----- 457 (962)
||++ |+|++++.+- +.|++...+.++.+|+.||+|||++|||||||||+|||+|++|+++|+|||.|+.+...
T Consensus 154 e~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~ 232 (604)
T KOG0592|consen 154 EYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQE 232 (604)
T ss_pred EecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcccc
Confidence 9998 7899988876 45999999999999999999999999999999999999999999999999999876432
Q ss_pred ----------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCC
Q psy501 458 ----------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPL 527 (962)
Q Consensus 458 ----------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 527 (962)
....++||..|.+||++.. ...+..+|||+|||+||.|+.|.+||.+.+.....++|....+.++ +.
T Consensus 233 ~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp--~~ 309 (604)
T KOG0592|consen 233 NPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP--EG 309 (604)
T ss_pred CccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC--CC
Confidence 1145799999999999965 4789999999999999999999999999999999999998877666 78
Q ss_pred CCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 528 YTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 528 ~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
++....+|++..|..||.+|.++++|.+...+
T Consensus 310 fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF 341 (604)
T KOG0592|consen 310 FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFF 341 (604)
T ss_pred CCHHHHHHHHHHHccCccccccHHHHhhCccc
Confidence 88999999999999999999999888765543
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=338.59 Aligned_cols=233 Identities=23% Similarity=0.290 Sum_probs=201.6
Q ss_pred cccEEEEEecCCceEEEEecc--chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHh-cCC
Q psy501 324 TLPLYTCNLDQDNHILSRHVS--SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRD-RDK 399 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~--~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~-~~~ 399 (962)
-+.||.+.+....++..+.+. ....+.+.+|+++|++|+|++||++++++..++.+||||||+. |+|++++.. .+.
T Consensus 219 FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~ 298 (468)
T KOG0197|consen 219 FGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGG 298 (468)
T ss_pred cceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCC
Confidence 335788877776555443332 3445678899999999999999999999999889999999998 899999987 556
Q ss_pred CCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCccccc---CCccccChhhhcc
Q psy501 400 FLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYV---STRWYRAPEVLLH 476 (962)
Q Consensus 400 ~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~---gt~~Y~APE~l~~ 476 (962)
.+...+.+.++.|||+|++||+++++|||||.++||||+++..+||+|||+|+....+...... -...|.|||++..
T Consensus 299 ~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~ 378 (468)
T KOG0197|consen 299 LLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNY 378 (468)
T ss_pred ccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhh
Confidence 7999999999999999999999999999999999999999999999999999966655433332 3456999999976
Q ss_pred CCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHh
Q psy501 477 STAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLH 555 (962)
Q Consensus 477 ~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~ 555 (962)
+ .++.|||||||||+||||+| |+.||.+....+....+..+.. .+.++.+|..+..++..||..+|++|||++.|..
T Consensus 379 ~-~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR-lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 379 G-KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR-LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred C-CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc-CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 5 69999999999999999999 9999999999999999998854 5557789999999999999999999999998887
Q ss_pred hcc
Q psy501 556 TLP 558 (962)
Q Consensus 556 ~l~ 558 (962)
.+.
T Consensus 457 ~l~ 459 (468)
T KOG0197|consen 457 VLE 459 (468)
T ss_pred HHH
Confidence 663
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=333.83 Aligned_cols=252 Identities=20% Similarity=0.276 Sum_probs=213.4
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEeccch---------hHHHHHHHHHHHHhcC-CCCcccEEEEEEeCC
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR---------DEMVVCFYRKSLKKLS-HANLVKLKEVIREND 377 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~---------~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~ 377 (962)
...|.+..+..++.+..+.|+.+....++..++.++..+ ....+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345666666666666666788876665544444444332 2345779999999999 999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc-cceeeeccccccccc
Q psy501 378 TLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT-ELVKIADFGLAREIR 455 (962)
Q Consensus 378 ~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~-g~vKL~DFGla~~~~ 455 (962)
.+++|||||. |+|++++.. .+++.+..+..+++|++.|++|||++||+||||||+||+++.+ +.+||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 9999999998 489999988 6779999999999999999999999999999999999999999 999999999999873
Q ss_pred --CCCcccccCCccccChhhhccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCc
Q psy501 456 --SRPYTDYVSTRWYRAPEVLLHST-AYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHV 532 (962)
Q Consensus 456 --~~~~~~~~gt~~Y~APE~l~~~~-~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 532 (962)
.......+||+.|+|||++.+.. .-+.++||||+||+||.|++|+.||..........+|..+....+..-. +...
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~-S~~~ 251 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL-SPEA 251 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcC-CHHH
Confidence 34677789999999999998765 3358999999999999999999999999988888998888777764333 8888
Q ss_pred HHHHHHHhccCCCCCCcHHHHHhhcccccc
Q psy501 533 PPIQTTCLLAGTERLKSSYILLHTLPLYTY 562 (962)
Q Consensus 533 ~~li~~Cl~~dperRPs~~~Ll~~l~~~~~ 562 (962)
..++..|+..+|.+|++..+++ .-+|+..
T Consensus 252 ~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 252 RSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred HHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 9999999999999999999888 5667665
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=336.34 Aligned_cols=245 Identities=19% Similarity=0.248 Sum_probs=217.6
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh-------HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD-------EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
.|-|.++..++.|+++.|..++...++..++.|+.... ...+++|+-+|+-+.||||+++|++|++..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 46677777777777888888888888877777665554 56799999999999999999999999999999999
Q ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-Ccc
Q psy501 383 FEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYT 460 (962)
Q Consensus 383 ~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~ 460 (962)
+||++ |.|++++..++ ++++.+..++++||+.|+.|+|..+|+||||||+|+|+|..+.+||+|||+|..-... ...
T Consensus 91 lEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLe 169 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLE 169 (786)
T ss_pred EEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcccc
Confidence 99998 67888888765 5999999999999999999999999999999999999999999999999999765443 566
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHh
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCL 540 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl 540 (962)
+.||++.|.|||+++|....+.++||||.|||||.|+||+.||++.+......++..|.+..| ...+...++|+..++
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP--s~Is~eaQdLLr~ml 247 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP--SNISSEAQDLLRRML 247 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC--CcCCHHHHHHHHHHh
Confidence 789999999999999987788999999999999999999999999999999999999976665 678889999999999
Q ss_pred ccCCCCCCcHHHHHhhc
Q psy501 541 LAGTERLKSSYILLHTL 557 (962)
Q Consensus 541 ~~dperRPs~~~Ll~~l 557 (962)
..||++|-+.+++++.-
T Consensus 248 ~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 248 DVDPSTRITTEEILKHP 264 (786)
T ss_pred ccCccccccHHHHhhCc
Confidence 99999999977776543
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=327.28 Aligned_cols=234 Identities=21% Similarity=0.269 Sum_probs=190.3
Q ss_pred cccEEEEEecCCceEEEEeccchh----HHHHHHHHHHHHhcCCCCcccEEEEEEeCC--EEEEEEecCC-CCHHHHHHh
Q psy501 324 TLPLYTCNLDQDNHILSRHVSSRD----EMVVCFYRKSLKKLSHANLVKLKEVIREND--TLYFVFEYMK-ENLYQLIRD 396 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~--~~~LV~Ey~~-g~Ll~~l~~ 396 (962)
.+.||.+.....+...+.|..... ...+.+|+.+|++++||+||+++|...... .+++.|||++ |+|.+.+..
T Consensus 30 ~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~ 109 (313)
T KOG0198|consen 30 FGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKR 109 (313)
T ss_pred ceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHH
Confidence 344777776665555444444333 456899999999999999999999854444 6999999998 577777777
Q ss_pred cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc-ccceeeecccccccccC-----CCcccccCCccccC
Q psy501 397 RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG-TELVKIADFGLAREIRS-----RPYTDYVSTRWYRA 470 (962)
Q Consensus 397 ~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~-~g~vKL~DFGla~~~~~-----~~~~~~~gt~~Y~A 470 (962)
.++.+++..++.+.+||++||.|||++||||+||||+|||++. ++.+||+|||++..... .......||+.|||
T Consensus 110 ~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~ma 189 (313)
T KOG0198|consen 110 YGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMA 189 (313)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccC
Confidence 6657999999999999999999999999999999999999999 79999999999987663 23456789999999
Q ss_pred hhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCC-cChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCc
Q psy501 471 PEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQT-TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 549 (962)
Q Consensus 471 PE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs 549 (962)
||++..+.....++|||||||++.||+||++||.. .........+......+..+...+...++++..|+..+|+.||+
T Consensus 190 PEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpt 269 (313)
T KOG0198|consen 190 PEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPT 269 (313)
T ss_pred chhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcC
Confidence 99997543344699999999999999999999988 45555555555554444445567778899999999999999999
Q ss_pred HHHHHhhc
Q psy501 550 SYILLHTL 557 (962)
Q Consensus 550 ~~~Ll~~l 557 (962)
+.+|+...
T Consensus 270 a~eLL~hp 277 (313)
T KOG0198|consen 270 AEELLEHP 277 (313)
T ss_pred HHHHhhCh
Confidence 88888755
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=330.25 Aligned_cols=233 Identities=42% Similarity=0.677 Sum_probs=198.8
Q ss_pred ccEEEEEecCCceEEEE-----eccchhHHHHHHHHHHHHhcC-CCCcccEEEEEEeCC-EEEEEEecCCCCHHHHHHhc
Q psy501 325 LPLYTCNLDQDNHILSR-----HVSSRDEMVVCFYRKSLKKLS-HANLVKLKEVIREND-TLYFVFEYMKENLYQLIRDR 397 (962)
Q Consensus 325 ~~Vy~~~~~~~~kvv~~-----k~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~-~~~LV~Ey~~g~Ll~~l~~~ 397 (962)
+.||.++.......++. ++...++..-.||++.|++|. ||||+++.+++.+.+ .+++|||||++.|++.+..+
T Consensus 24 GsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~NLYqLmK~R 103 (538)
T KOG0661|consen 24 GSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDCNLYQLMKDR 103 (538)
T ss_pred eeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhhhHHHHHhhc
Confidence 34777776666665554 444555667889999999998 999999999998877 99999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCccccChhhhcc
Q psy501 398 DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPEVLLH 476 (962)
Q Consensus 398 ~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~APE~l~~ 476 (962)
...|++..++.|+.||++||+|+|.+|+.|||+||+|||+.....+||+|||+|+.+.+. +.+.++.|.+|+|||++..
T Consensus 104 ~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLr 183 (538)
T KOG0661|consen 104 NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLR 183 (538)
T ss_pred CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcchhhhcccccchHHhhh
Confidence 999999999999999999999999999999999999999998899999999999988765 7888999999999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc-------------------cc---------CCCCC
Q psy501 477 STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL-------------------LH---------TLPLY 528 (962)
Q Consensus 477 ~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------~~---------~~~~~ 528 (962)
...|+.+.||||+|||++|+.+-++.|.|.+..+...+|...-.. ++ .++..
T Consensus 184 s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~ 263 (538)
T KOG0661|consen 184 SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNA 263 (538)
T ss_pred ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCccc
Confidence 889999999999999999999999999999888877777532111 11 11123
Q ss_pred CCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 529 TYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 529 s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+.....++..|+.+||.+||++.+.++..
T Consensus 264 s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 264 SSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred CHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 33455689999999999999988777644
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=335.49 Aligned_cols=245 Identities=21% Similarity=0.296 Sum_probs=206.9
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccch----hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHH
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSSR----DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQL 393 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~ 393 (962)
+++.+.++.||.+......+.++.+.... ..+-+..|+.+|+..+|+|||.+++.|..++.+|+||||++|+.+..
T Consensus 280 kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTD 359 (550)
T KOG0578|consen 280 KIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTD 359 (550)
T ss_pred hhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhh
Confidence 44555667799998888777766554332 24569999999999999999999999999999999999999655555
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccCh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAP 471 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~AP 471 (962)
+... ..++|.++..|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+... .....+||++||||
T Consensus 360 vVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAP 438 (550)
T KOG0578|consen 360 VVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAP 438 (550)
T ss_pred hhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccch
Confidence 5443 34999999999999999999999999999999999999999999999999999887654 56678999999999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHH-hccccccCCCCCCCCcHHHHHHHhccCCCCCCcH
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLK-SSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 550 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~ 550 (962)
|++.. ..|+.++||||||++++||+-|++||-.+.+......|. .+...+......+..+++++..||+.|+++|+++
T Consensus 439 EVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA 517 (550)
T KOG0578|consen 439 EVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASA 517 (550)
T ss_pred hhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCH
Confidence 99965 579999999999999999999999999887777766664 4656666677888999999999999999999999
Q ss_pred HHHHhhccccccCCC
Q psy501 551 YILLHTLPLYTYHVP 565 (962)
Q Consensus 551 ~~Ll~~l~~~~~~~~ 565 (962)
.+||+.- ++....+
T Consensus 518 ~eLL~Hp-Fl~~a~p 531 (550)
T KOG0578|consen 518 KELLEHP-FLKMAKP 531 (550)
T ss_pred HHHhcCh-hhhhcCC
Confidence 9999854 3344433
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=333.09 Aligned_cols=236 Identities=21% Similarity=0.299 Sum_probs=203.6
Q ss_pred ecCCcc-cEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHH
Q psy501 320 ILPHTL-PLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQ 392 (962)
Q Consensus 320 i~~~~~-~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~ 392 (962)
++.|.+ .||+++.+.+.++++.++..+ +...+.+|++|+++++||||+.++++|++..++|+|+|||.|+|..
T Consensus 10 iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g~L~~ 89 (808)
T KOG0597|consen 10 IGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVGDLFT 89 (808)
T ss_pred hcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhhhHHH
Confidence 333333 377777777777776665432 3345999999999999999999999999999999999999998888
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccC
Q psy501 393 LIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRA 470 (962)
Q Consensus 393 ~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~A 470 (962)
.+... +.++++.+..++.|++.||.|||+.+|+|||+||.|||++..|.+|+||||+|+.+... ..+...||+.|||
T Consensus 90 il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmA 168 (808)
T KOG0597|consen 90 ILEQD-GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMA 168 (808)
T ss_pred HHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccC
Confidence 77665 55999999999999999999999999999999999999999999999999999987654 4556789999999
Q ss_pred hhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcH
Q psy501 471 PEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 550 (962)
Q Consensus 471 PE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~ 550 (962)
||++.+ .+|+..+|+|||||++|||++|++||...........|......++ +..+..+..+++..|..||..|-+-
T Consensus 169 PElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p--~~~S~~f~nfl~gLL~kdP~~RltW 245 (808)
T KOG0597|consen 169 PELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP--STASSSFVNFLQGLLIKDPAQRLTW 245 (808)
T ss_pred HHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc--ccccHHHHHHHHHHhhcChhhcccH
Confidence 999975 5899999999999999999999999999999999999998876665 3667788889999999999999996
Q ss_pred HHHHhhccc
Q psy501 551 YILLHTLPL 559 (962)
Q Consensus 551 ~~Ll~~l~~ 559 (962)
.+|+..-.|
T Consensus 246 ~~Ll~HpF~ 254 (808)
T KOG0597|consen 246 TDLLGHPFW 254 (808)
T ss_pred HHHhcChHH
Confidence 666644334
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=308.42 Aligned_cols=232 Identities=21% Similarity=0.321 Sum_probs=199.4
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecC
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
.++.|+.+.+..+..+.++..|+.+.-...++++. +..+...+|..+|+.+.||+++++++.|.+.+.+++||||.
T Consensus 51 tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVkl----KQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv 126 (355)
T KOG0616|consen 51 TLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKL----KQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYV 126 (355)
T ss_pred eeccCccceEEEEEEccCCceeehhhcCHHHHHHH----HHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEecc
Confidence 44455555555555555555666555444444433 34456899999999999999999999999999999999999
Q ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCC
Q psy501 387 KE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST 465 (962)
Q Consensus 387 ~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt 465 (962)
+| .+..++++. ++|++..++.++.||+.||+|||+++|++|||||+|||+|..|.+||+|||.|+..... ....|||
T Consensus 127 ~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-T~TlCGT 204 (355)
T KOG0616|consen 127 PGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-TWTLCGT 204 (355)
T ss_pred CCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-EEEecCC
Confidence 85 566666554 56999999999999999999999999999999999999999999999999999988766 6668999
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCC
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTE 545 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dpe 545 (962)
+.|+|||++.. ++|+.++|.|||||++|||+.|.+||.+......+.+|..+.+.+| +.++....+|++..|+.|-.
T Consensus 205 PeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP--~~fs~~~kdLl~~LL~vD~t 281 (355)
T KOG0616|consen 205 PEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP--SYFSSDAKDLLKKLLQVDLT 281 (355)
T ss_pred ccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC--cccCHHHHHHHHHHHhhhhH
Confidence 99999999975 5899999999999999999999999999999999999999988877 67888999999999999999
Q ss_pred CC
Q psy501 546 RL 547 (962)
Q Consensus 546 rR 547 (962)
+|
T Consensus 282 ~R 283 (355)
T KOG0616|consen 282 KR 283 (355)
T ss_pred hh
Confidence 88
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.54 Aligned_cols=252 Identities=17% Similarity=0.219 Sum_probs=203.0
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccchh-----HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEec
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD-----EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEY 385 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey 385 (962)
..|....+++.|....||++.......+++.|+..-+ ...+.+|+..|+.++||||++++..|..+..+|+||+|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 4555555566666667999988877777777664432 35799999999999999999999999999999999999
Q ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC------
Q psy501 386 MK-ENLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR------ 457 (962)
Q Consensus 386 ~~-g~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~------ 457 (962)
|. |++++.+... ...|+|..+..|++++++||.|||.+|.+|||||+.||||+.+|.|||+|||.+..+...
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~ 185 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVT 185 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeE
Confidence 98 6788777654 234999999999999999999999999999999999999999999999999998655332
Q ss_pred CcccccCCccccChhhh-ccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--------CCCCC
Q psy501 458 PYTDYVSTRWYRAPEVL-LHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--------TLPLY 528 (962)
Q Consensus 458 ~~~~~~gt~~Y~APE~l-~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------~~~~~ 528 (962)
.....+||+.|||||++ ..-..|+.|+||||||++..||.+|..||....+......-.++.+..+ ....+
T Consensus 186 rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~ 265 (516)
T KOG0582|consen 186 RFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKF 265 (516)
T ss_pred eeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhh
Confidence 11456899999999995 4455799999999999999999999999998876655444334433211 11245
Q ss_pred CCCcHHHHHHHhccCCCCCCcHHHHHhhcccccc
Q psy501 529 TYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTY 562 (962)
Q Consensus 529 s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~ 562 (962)
+..+..++..||+.||.+||++..|+..-.+...
T Consensus 266 ~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 266 SKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred cHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 5578889999999999999999988876544333
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=316.15 Aligned_cols=254 Identities=23% Similarity=0.245 Sum_probs=206.7
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchhH------------------HHHHHHHHHHHhcCCCCcccE
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDE------------------MVVCFYRKSLKKLSHANLVKL 369 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~------------------~~~~~Ei~iL~~L~HpnIv~l 369 (962)
.....|.....++.|..+.|..+....+++.++.|+..+.+ +.+.+||.||++|.|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 33444445545555555557777777777766666544321 368999999999999999999
Q ss_pred EEEEEeC--CEEEEEEecCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeee
Q psy501 370 KEVIREN--DTLYFVFEYMKENLYQLIRDRDKF-LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIA 446 (962)
Q Consensus 370 ~~~~~~~--~~~~LV~Ey~~g~Ll~~l~~~~~~-ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~ 446 (962)
+++..+. +.+|||+|||..+-..+.-. .++ +++.+++.++++++.||+|||.+||+||||||+|+|++++|++||+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 9999764 57999999998544433332 344 9999999999999999999999999999999999999999999999
Q ss_pred cccccccccCC-------CcccccCCccccChhhhccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHH
Q psy501 447 DFGLAREIRSR-------PYTDYVSTRWYRAPEVLLHST---AYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLK 516 (962)
Q Consensus 447 DFGla~~~~~~-------~~~~~~gt~~Y~APE~l~~~~---~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~ 516 (962)
|||.+..+... .....+||+.|+|||+..++. ..+.+.||||+||+||.|+.|+.||.+........+|.
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 99999866322 233468999999999997633 35679999999999999999999999999999999999
Q ss_pred hccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccccC
Q psy501 517 SSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYH 563 (962)
Q Consensus 517 ~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~~ 563 (962)
...+.+|..+.....++++|+.+|.+||+.|-+..++... +|.+..
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H-pwvt~~ 378 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH-PWVTRD 378 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec-ceeccC
Confidence 9999999888888999999999999999999997765443 354443
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=308.13 Aligned_cols=246 Identities=26% Similarity=0.347 Sum_probs=191.4
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecC
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
.+.....++.++.+.||.+.....++.++.|... .....+.+|+.+++.++||||+++++++.++...++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 3444445555556678888877666555544422 12345788999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccC
Q psy501 387 KENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVS 464 (962)
Q Consensus 387 ~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~g 464 (962)
++++.+.+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...... ......+
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 165 (303)
T cd07869 86 HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV 165 (303)
T ss_pred CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcc
Confidence 99999998877777999999999999999999999999999999999999999999999999998754332 3344578
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh-HHHHHhccccc----------------cC---
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG-TERLKSSYILL----------------HT--- 524 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~-~~~i~~~~~~~----------------~~--- 524 (962)
++.|+|||++.+...++.++|||||||++|||++|..||.+...... ...+......+ ..
T Consensus 166 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (303)
T cd07869 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTL 245 (303)
T ss_pred cCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccc
Confidence 89999999997766789999999999999999999999987543221 11111100000 00
Q ss_pred -----------CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 525 -----------LPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 525 -----------~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
...++....+++..||..+|++||++.+++..-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~ 289 (303)
T cd07869 246 YSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHE 289 (303)
T ss_pred cCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCc
Confidence 001233566899999999999999988887643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=322.43 Aligned_cols=230 Identities=20% Similarity=0.294 Sum_probs=194.6
Q ss_pred cccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCC
Q psy501 324 TLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKFLP 402 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~~~ls 402 (962)
.+.||.++..... ++++|+. +.-+.+|+-|++|+||||+.|.|+|...-.+|||||||. |-|...+.. +.++.
T Consensus 137 QGAVF~Grl~net-VAVKKV~----elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka-~~~it 210 (904)
T KOG4721|consen 137 QGAVFLGRLHNET-VAVKKVR----ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKA-GRPIT 210 (904)
T ss_pred ccceeeeeccCce-ehhHHHh----hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhc-cCccC
Confidence 3446666654332 3333332 223557788999999999999999999999999999998 667666655 45689
Q ss_pred HHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCccccChhhhccCCCCC
Q psy501 403 ESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPEVLLHSTAYS 481 (962)
Q Consensus 403 ~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~t 481 (962)
...+..|..+|+.|+.|||.+.|+|||||.-||||+.+..|||+|||.++..... ....++||..|||||++.. .+.+
T Consensus 211 p~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrn-ePcs 289 (904)
T KOG4721|consen 211 PSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRN-EPCS 289 (904)
T ss_pred HHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhc-CCcc
Confidence 9999999999999999999999999999999999999999999999999876554 5567899999999999965 5899
Q ss_pred chhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 482 APIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 482 ~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
.|+||||||||||||+||+.||.+.+.......+-...+..+-+..+|..+..|++.||...|..||++.+++..|.+.
T Consensus 290 EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 290 EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 9999999999999999999999998887777776666667777789999999999999999999999999888877443
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=305.89 Aligned_cols=244 Identities=25% Similarity=0.348 Sum_probs=192.6
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
|.....+..++.+.||++....++..++.+... .....+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 334444444555568888776666555444322 223467899999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCC
Q psy501 388 ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVST 465 (962)
Q Consensus 388 g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt 465 (962)
|++.+.+......+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++...... ......++
T Consensus 87 ~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~ 166 (288)
T cd07871 87 SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVT 166 (288)
T ss_pred cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceec
Confidence 9999988877667899999999999999999999999999999999999999999999999999765432 23345688
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc-------------------cc---
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL-------------------LH--- 523 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------~~--- 523 (962)
+.|+|||++.+...++.++|||||||++|+|++|++||.+.........+...... .+
T Consensus 167 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
T cd07871 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYR 246 (288)
T ss_pred ccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccC
Confidence 99999999977667899999999999999999999999887655444333221100 00
Q ss_pred ------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 524 ------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 524 ------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
..+..+....+++..||..+|.+||++.+++..
T Consensus 247 ~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 247 AQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred CCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 012334556789999999999999998887753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=315.91 Aligned_cols=244 Identities=19% Similarity=0.213 Sum_probs=200.6
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh-------HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD-------EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
..++..-..++.|+.+.||.|+...++.+++.|+..+. ...+..|..+|...++|.||++|..|++..++|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 34444444444445555999999999999888776543 24588999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC------
Q psy501 383 FEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS------ 456 (962)
Q Consensus 383 ~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~------ 456 (962)
|||++|+....+....+.|+++.++.++.+++.|+..||+.|++||||||+|+|||..|++||+|||+|..+..
T Consensus 220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~ 299 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIES 299 (550)
T ss_pred EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhh
Confidence 99999765555556667799999999999999999999999999999999999999999999999999853211
Q ss_pred -----------------C-C-------------------------cccccCCccccChhhhccCCCCCchhHHHHHHHHH
Q psy501 457 -----------------R-P-------------------------YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFL 493 (962)
Q Consensus 457 -----------------~-~-------------------------~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL 493 (962)
. . ..+.+|||.|||||++.+. .|+..+|+||||||+
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k-gY~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 300 YRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK-GYGKECDWWSLGCIM 378 (550)
T ss_pred hcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC-CCCccccHHHHHHHH
Confidence 0 0 0123699999999999875 699999999999999
Q ss_pred HHHHcCCCCCCCcChhhhHHHHHhcc--ccccCCCCCCCCcHHHHHHHhccCCCCCCc---HHHHHh
Q psy501 494 FYSIDHVPPIQTTCLLAGTERLKSSY--ILLHTLPLYTYHVPPIQTTCLLAGTERLKS---SYILLH 555 (962)
Q Consensus 494 ~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~s~~l~~li~~Cl~~dperRPs---~~~Ll~ 555 (962)
|||+.|.+||.+..+.+...+|..-. +.+|.....+....++|..|+. +|++|-- ++++-.
T Consensus 379 yEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 379 YEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 99999999999999999999998766 4455555666778889999999 7777643 555443
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=297.50 Aligned_cols=205 Identities=28% Similarity=0.411 Sum_probs=179.0
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccchhHH------HHHHHHHHHHhcCCCCcccEEEEEEeC--CEEEEEEe
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEM------VVCFYRKSLKKLSHANLVKLKEVIREN--DTLYFVFE 384 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~------~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~LV~E 384 (962)
+...-++..+..+.||+++++.+..+++.|...-+.+ ...|||.+|.+++|||||.+-++.... +.+|||||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 3333344444555699999999999887665443322 479999999999999999999998643 47999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--Ccccc
Q psy501 385 YMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDY 462 (962)
Q Consensus 385 y~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~ 462 (962)
||+.+|...+..-..+|+..+++.++.|+++|++|||...|+||||||+|+|++..|.+||+|||+|+.+++. ..+..
T Consensus 158 ~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~l 237 (419)
T KOG0663|consen 158 YVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPL 237 (419)
T ss_pred HHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccCcce
Confidence 9999999999887788999999999999999999999999999999999999999999999999999998876 56777
Q ss_pred cCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHh
Q psy501 463 VSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKS 517 (962)
Q Consensus 463 ~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~ 517 (962)
+-|++|+|||++.|...|+++.|+||+|||+.||+++++.|.+....+...+|..
T Consensus 238 VVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ 292 (419)
T KOG0663|consen 238 VVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFK 292 (419)
T ss_pred EEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHH
Confidence 8899999999999999999999999999999999999999999888777776643
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=311.10 Aligned_cols=242 Identities=21% Similarity=0.235 Sum_probs=193.9
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEec
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEY 385 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey 385 (962)
+.....+..++.+.||.+.....++.++.|+... ....+.+|++++..++||||+++++++.+++..|+||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 3444455555566788888877666555544332 234578899999999999999999999999999999999
Q ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccC
Q psy501 386 MKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVS 464 (962)
Q Consensus 386 ~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~g 464 (962)
++| +|.+.+. ....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..... ......|
T Consensus 83 ~~g~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-~~~~~~g 160 (333)
T cd05600 83 VPGGDFRTLLN-NLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-YANSVVG 160 (333)
T ss_pred CCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-ccCCccc
Confidence 985 5655554 445689999999999999999999999999999999999999999999999999976544 3345679
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCC------CCCCCcHHHHHH
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLP------LYTYHVPPIQTT 538 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~------~~s~~l~~li~~ 538 (962)
|+.|+|||++.+. .++.++|||||||++|||++|..||.+.........+........... ..+..+..++..
T Consensus 161 t~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 239 (333)
T cd05600 161 SPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITK 239 (333)
T ss_pred CccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHH
Confidence 9999999999765 789999999999999999999999998877666555544322111111 336677889999
Q ss_pred HhccCCCCCCcHHHHHhhc
Q psy501 539 CLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 539 Cl~~dperRPs~~~Ll~~l 557 (962)
||..+|++||++.+++..-
T Consensus 240 ~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 240 LINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred HhhChhhhcCCHHHHHhCc
Confidence 9999999999988888653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=311.59 Aligned_cols=229 Identities=18% Similarity=0.209 Sum_probs=186.5
Q ss_pred cccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHH
Q psy501 324 TLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIR 395 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~ 395 (962)
.+.||.+.....++.++.|+... +...+.+|+.++++++||+|+++++++..++.+|+||||+.| +|.+.+.
T Consensus 8 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 87 (323)
T cd05571 8 FGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS 87 (323)
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHH
Confidence 34577777666665555443322 234577899999999999999999999999999999999985 5555554
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC--CCcccccCCccccChhh
Q psy501 396 DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAPEV 473 (962)
Q Consensus 396 ~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~--~~~~~~~gt~~Y~APE~ 473 (962)
. ...+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.... .......||+.|+|||+
T Consensus 88 ~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~ 166 (323)
T cd05571 88 R-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 166 (323)
T ss_pred H-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhh
Confidence 4 45699999999999999999999999999999999999999999999999999875422 23344579999999999
Q ss_pred hccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCC-----
Q psy501 474 LLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK----- 548 (962)
Q Consensus 474 l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRP----- 548 (962)
+.+ ..++.++|||||||++|||++|+.||.+.+.......+......+ ....+..+..++..||..+|++||
T Consensus 167 ~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~ 243 (323)
T cd05571 167 LED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLSPEAKSLLAGLLKKDPKQRLGGGPE 243 (323)
T ss_pred hcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCHHHHHHHHHHccCCHHHcCCCCCC
Confidence 965 478999999999999999999999998877766666665554333 245677889999999999999999
Q ss_pred cHHHHHhh
Q psy501 549 SSYILLHT 556 (962)
Q Consensus 549 s~~~Ll~~ 556 (962)
++.+++..
T Consensus 244 ~~~~ll~h 251 (323)
T cd05571 244 DAKEIMEH 251 (323)
T ss_pred CHHHHHcC
Confidence 67776654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=288.51 Aligned_cols=232 Identities=26% Similarity=0.373 Sum_probs=192.3
Q ss_pred cEEEEEecCCceEEEE-eccchh-----HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCC
Q psy501 326 PLYTCNLDQDNHILSR-HVSSRD-----EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDK 399 (962)
Q Consensus 326 ~Vy~~~~~~~~kvv~~-k~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~~ 399 (962)
.||++....+++.++. ++.-.+ .....||++.|+.++||||+.++++|...+.+.||+||++.+|...+.....
T Consensus 17 vVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~tdLe~vIkd~~i 96 (318)
T KOG0659|consen 17 VVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPTDLEVVIKDKNI 96 (318)
T ss_pred EEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccccHHHHhccccc
Confidence 3777777766665443 332221 3358999999999999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC--cccccCCccccChhhhccC
Q psy501 400 FLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--YTDYVSTRWYRAPEVLLHS 477 (962)
Q Consensus 400 ~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~--~~~~~gt~~Y~APE~l~~~ 477 (962)
.++..+++.++.++++||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+.+.. ....+-|.+|+|||.++|.
T Consensus 97 ~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGs 176 (318)
T KOG0659|consen 97 ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGS 176 (318)
T ss_pred ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccc
Confidence 99999999999999999999999999999999999999999999999999999987653 3334789999999999999
Q ss_pred CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc--c------------------------CCCCCCCC
Q psy501 478 TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL--H------------------------TLPLYTYH 531 (962)
Q Consensus 478 ~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~------------------------~~~~~s~~ 531 (962)
+.|+..+||||.||++.||+-|.+.|.+.+..+....|......+ . ..+..+..
T Consensus 177 r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d 256 (318)
T KOG0659|consen 177 RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSD 256 (318)
T ss_pred hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHH
Confidence 999999999999999999999999999988877766664321111 0 11112223
Q ss_pred cHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 532 VPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 532 l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.-+++..+|..+|.+|.++.+.++.-
T Consensus 257 ~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 257 ALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred HHHHHHhhhccCchhcccHHHHhcch
Confidence 45578889999999999977766643
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=310.98 Aligned_cols=240 Identities=17% Similarity=0.242 Sum_probs=195.5
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
..+.....++.++.+.||.+.....++.++.|.... ....+.+|+.++++++||||+++++++.+++..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 344455555556666788888877666555544322 2245889999999999999999999999999999999
Q ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccc
Q psy501 384 EYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDY 462 (962)
Q Consensus 384 Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 462 (962)
||+.| +|.+.+... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....... ...
T Consensus 98 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 175 (329)
T PTZ00263 98 EFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-FTL 175 (329)
T ss_pred cCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-cee
Confidence 99985 666666554 568999999999999999999999999999999999999999999999999998664432 345
Q ss_pred cCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhcc
Q psy501 463 VSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 542 (962)
Q Consensus 463 ~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~ 542 (962)
.||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+..+....+ ...+..+..++..||..
T Consensus 176 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~li~~~L~~ 252 (329)
T PTZ00263 176 CGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP--NWFDGRARDLVKGLLQT 252 (329)
T ss_pred cCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC--CCCCHHHHHHHHHHhhc
Confidence 78999999999965 4689999999999999999999999998887777777766644332 34667788999999999
Q ss_pred CCCCCCc-----HHHHHh
Q psy501 543 GTERLKS-----SYILLH 555 (962)
Q Consensus 543 dperRPs-----~~~Ll~ 555 (962)
+|.+|++ ..+++.
T Consensus 253 dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 253 DHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CHHHcCCCCCCCHHHHhc
Confidence 9999996 455553
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=301.72 Aligned_cols=238 Identities=25% Similarity=0.393 Sum_probs=187.5
Q ss_pred EEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCH
Q psy501 317 FSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENL 390 (962)
Q Consensus 317 ~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~L 390 (962)
..+..++.+.||.+....++..++.+... .....+.+|+.++++++||||+++++++..++..|+||||+++++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 86 (287)
T cd07848 7 GVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNM 86 (287)
T ss_pred EEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCH
Confidence 33344445557877776666554444322 123467899999999999999999999999999999999999988
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---CcccccCCcc
Q psy501 391 YQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYVSTRW 467 (962)
Q Consensus 391 l~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~gt~~ 467 (962)
++.+......+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++...... ......|++.
T Consensus 87 l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 166 (287)
T cd07848 87 LELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW 166 (287)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccc
Confidence 8887766667999999999999999999999999999999999999999999999999999876432 2234578999
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc-------------------ccC----
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL-------------------LHT---- 524 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------~~~---- 524 (962)
|+|||++.+. .++.++|||||||++|||++|++||.+.........+...... .+.
T Consensus 167 y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (287)
T cd07848 167 YRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHP 245 (287)
T ss_pred cCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCc
Confidence 9999999764 6899999999999999999999999876554433222211000 000
Q ss_pred -------CCCCCCCcHHHHHHHhccCCCCCCcHHHHHh
Q psy501 525 -------LPLYTYHVPPIQTTCLLAGTERLKSSYILLH 555 (962)
Q Consensus 525 -------~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~ 555 (962)
....+..+.++++.||..+|++||++.++++
T Consensus 246 ~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 246 QSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0123455788999999999999999888776
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=305.35 Aligned_cols=234 Identities=18% Similarity=0.239 Sum_probs=191.3
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CC
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-EN 389 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~ 389 (962)
.+..++.+.||.+.....++.++.|... .....+.+|+.++++++||||+++++++.++...++||||++ |+
T Consensus 8 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 87 (291)
T cd05612 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGE 87 (291)
T ss_pred eeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCC
Confidence 3444445568888777666555544432 123458899999999999999999999999999999999998 46
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCcccc
Q psy501 390 LYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYR 469 (962)
Q Consensus 390 Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~ 469 (962)
|.+++... +.+++..++.++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++...... .....|++.|+
T Consensus 88 L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~ 165 (291)
T cd05612 88 LFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-TWTLCGTPEYL 165 (291)
T ss_pred HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-cccccCChhhc
Confidence 76666554 56899999999999999999999999999999999999999999999999999766443 23457899999
Q ss_pred ChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCc
Q psy501 470 APEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 549 (962)
Q Consensus 470 APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs 549 (962)
|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..+....+ ...+..+.++++.||..+|.+|++
T Consensus 166 aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 166 APEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFP--RHLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred CHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCC--ccCCHHHHHHHHHHcCCCHHHccC
Confidence 9999865 4689999999999999999999999999887777777766644332 345677889999999999999995
Q ss_pred -----HHHHHhh
Q psy501 550 -----SYILLHT 556 (962)
Q Consensus 550 -----~~~Ll~~ 556 (962)
+.+++..
T Consensus 243 ~~~~~~~~~l~h 254 (291)
T cd05612 243 NMKNGADDVKNH 254 (291)
T ss_pred CccCCHHHHhcC
Confidence 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=315.88 Aligned_cols=240 Identities=18% Similarity=0.213 Sum_probs=198.1
Q ss_pred ecCCcc-cEEEEEecCCceEEEEeccchh-----HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHH
Q psy501 320 ILPHTL-PLYTCNLDQDNHILSRHVSSRD-----EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQL 393 (962)
Q Consensus 320 i~~~~~-~Vy~~~~~~~~kvv~~k~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~ 393 (962)
+++|.+ .||++....+.++++.++..-+ .+.+++|+.+|.++++|||.++|+.|..+..+|++||||.|+....
T Consensus 21 IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~ 100 (467)
T KOG0201|consen 21 IGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLD 100 (467)
T ss_pred ccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhh
Confidence 344444 4888888888888887775433 3568899999999999999999999999999999999999655555
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccCh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAP 471 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~AP 471 (962)
+...+..+++..+..++++++.||.|||.++.+|||||+.||++..+|.+||+|||.+..+... ....++||+.||||
T Consensus 101 lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAP 180 (467)
T KOG0201|consen 101 LLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAP 180 (467)
T ss_pred hhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccch
Confidence 5555566799999999999999999999999999999999999999999999999999877654 44678999999999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHH
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 551 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~ 551 (962)
|++.+ ..|+.|+||||||++++||.+|.+||....+.....-|-+. ..+.....++..+++++..||..+|+.||++.
T Consensus 181 EVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~-~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~ 258 (467)
T KOG0201|consen 181 EVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS-APPRLDGDFSPPFKEFVEACLDKNPEFRPSAK 258 (467)
T ss_pred hhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC-CCCccccccCHHHHHHHHHHhhcCcccCcCHH
Confidence 99984 58999999999999999999999999887773332222222 22222336777899999999999999999999
Q ss_pred HHHhhccccc
Q psy501 552 ILLHTLPLYT 561 (962)
Q Consensus 552 ~Ll~~l~~~~ 561 (962)
.|++.-....
T Consensus 259 ~LLKh~FIk~ 268 (467)
T KOG0201|consen 259 ELLKHKFIKR 268 (467)
T ss_pred HHhhhHHHHh
Confidence 9988664443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=301.50 Aligned_cols=210 Identities=16% Similarity=0.151 Sum_probs=176.9
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEe----CCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccc
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRE----NDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRH 423 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~----~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~ 423 (962)
..+.+|+.+|++++||||+++++++.+ ...+++||||++| +|.+.+.. ...+++...+.++.|++.||.|||+.
T Consensus 63 ~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~ 141 (283)
T PHA02988 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKY 141 (283)
T ss_pred HHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhc
Confidence 457799999999999999999999976 3578999999995 56665544 45689999999999999999999984
Q ss_pred -eeeeccCCCcccccccccceeeecccccccccCCCcccccCCccccChhhhccC-CCCCchhHHHHHHHHHHHHHcCCC
Q psy501 424 -GFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHS-TAYSAPIHLSRSQQFLFYSIDHVP 501 (962)
Q Consensus 424 -gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~t~ksDIwSLGvlL~elltG~~ 501 (962)
+++||||||+||+++.++.+||+|||++....... ....++..|+|||++.+. ..++.++|||||||++|||++|+.
T Consensus 142 ~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~ 220 (283)
T PHA02988 142 TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKI 220 (283)
T ss_pred CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCC
Confidence 99999999999999999999999999998654432 335688999999999652 468999999999999999999999
Q ss_pred CCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 502 PIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 502 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
||.+.........+......++....++..+..++..||..+|++||++.++++.|..+
T Consensus 221 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 221 PFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 99988776666666544444443446778899999999999999999999999987543
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=313.14 Aligned_cols=209 Identities=23% Similarity=0.370 Sum_probs=189.5
Q ss_pred hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCE-EEEEEecCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhccc
Q psy501 346 RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDT-LYFVFEYMKE-NLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHR 422 (962)
Q Consensus 346 ~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~-~~LV~Ey~~g-~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~ 422 (962)
........|+.++++++|||||.+++.|..++. ++|||+||+| ++.+.+.... ..|+++.++.|+.|++.|+.|||+
T Consensus 45 ~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~ 124 (426)
T KOG0589|consen 45 PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE 124 (426)
T ss_pred hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh
Confidence 345578999999999999999999999998887 9999999995 5666665544 679999999999999999999999
Q ss_pred ceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCC
Q psy501 423 HGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHV 500 (962)
Q Consensus 423 ~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~ 500 (962)
.+|+|||||+.||+++.++.|+|+|||+|+.+... ...+.+||+.||+||++.+ .+|+.|+|||||||++|||++-+
T Consensus 125 ~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk 203 (426)
T KOG0589|consen 125 NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLK 203 (426)
T ss_pred hhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcc
Confidence 99999999999999999999999999999998776 5667899999999999965 58999999999999999999999
Q ss_pred CCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 501 PPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 501 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
++|.+.+......+|..+. ..+....++..+..+++.|+..+|+.||++.+|+..
T Consensus 204 ~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 204 PAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 9999999999999998885 456667899999999999999999999999988875
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=299.64 Aligned_cols=228 Identities=18% Similarity=0.248 Sum_probs=196.4
Q ss_pred cEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhc
Q psy501 326 PLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDR 397 (962)
Q Consensus 326 ~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~ 397 (962)
+|.++.....++.++.+... .+...+.+|++||..|+||||+.+|++|+..+.+.|||||.. |.|++++..+
T Consensus 68 KVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer 147 (668)
T KOG0611|consen 68 KVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISER 147 (668)
T ss_pred ceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHh
Confidence 35555444444444443322 233468999999999999999999999999999999999997 7899998877
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCccccChhhhcc
Q psy501 398 DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPEVLLH 476 (962)
Q Consensus 398 ~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~APE~l~~ 476 (962)
+ .+++.+.+.+++||..|+.|+|..++||||||.+|||+|.++.+||+|||++..+... ....++|++.|.+||++.|
T Consensus 148 ~-~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG 226 (668)
T KOG0611|consen 148 G-SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNG 226 (668)
T ss_pred c-cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCC
Confidence 5 4999999999999999999999999999999999999999999999999999877665 5677899999999999977
Q ss_pred CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 477 STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 477 ~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
...-++.+|-|||||+||-|+.|..||++.+.......|..+....|. -|....-+|+.+|..+|+||.+.+++...
T Consensus 227 ~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 227 TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE---TPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC---CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 655678999999999999999999999999999999999998776653 34455779999999999999999999887
Q ss_pred c
Q psy501 557 L 557 (962)
Q Consensus 557 l 557 (962)
+
T Consensus 304 W 304 (668)
T KOG0611|consen 304 W 304 (668)
T ss_pred h
Confidence 6
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=303.75 Aligned_cols=241 Identities=18% Similarity=0.219 Sum_probs=187.1
Q ss_pred eEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-
Q psy501 315 LKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE- 388 (962)
Q Consensus 315 ~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g- 388 (962)
....++.++.+.||.+.....+..++.+... .....+.+|+++|++++||||+++++++..++..++||||++|
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (331)
T cd06649 9 RISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 88 (331)
T ss_pred EEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCC
Confidence 3333444444557888777666655554432 2235689999999999999999999999999999999999986
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccc-eeeeccCCCcccccccccceeeecccccccccCCCcccccCCcc
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRH-GFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRW 467 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~-gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~ 467 (962)
+|.+.+.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++............|++.
T Consensus 89 ~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~g~~~ 167 (331)
T cd06649 89 SLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 167 (331)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccccCCCCcC
Confidence 55555544 45689999999999999999999986 69999999999999999999999999998765555555679999
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHH-------------------------------
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLK------------------------------- 516 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~------------------------------- 516 (962)
|+|||++.+. .++.++|||||||++|||++|+.||...........+.
T Consensus 168 y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (331)
T cd06649 168 YMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMD 246 (331)
T ss_pred cCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccc
Confidence 9999999754 68999999999999999999999997654432221111
Q ss_pred ---------------hccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 517 ---------------SSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 517 ---------------~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.........+.++..+..++..||..+|++||++.+|+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 247 SRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000001123455678899999999999999999988765
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=317.08 Aligned_cols=236 Identities=22% Similarity=0.260 Sum_probs=191.4
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEec
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEY 385 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey 385 (962)
+++.|..+.++....+++..+|+++.-....++ ..++.+....|.+|++... ||.++.++.+|++..++|+||||
T Consensus 375 vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il----~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 375 VLGRGSFGKVLLAELKGTNEYYAIKVLKKGDIL----QRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EeccCcCceEEEEEEcCCCcEEEEEEeecccee----ccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 344444444444444444444444432222221 2345677889999988885 99999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccccccc--CCCccccc
Q psy501 386 MKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR--SRPYTDYV 463 (962)
Q Consensus 386 ~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~--~~~~~~~~ 463 (962)
+.|+.+. ...+...|++..+..++..|+.||.|||++||+|||||.+|||+|.+|.+||+|||+++..- .....+.+
T Consensus 451 ~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfC 529 (694)
T KOG0694|consen 451 VAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFC 529 (694)
T ss_pred cCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCcccccc
Confidence 9976632 23334669999999999999999999999999999999999999999999999999998643 34677789
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccC
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
||+.|||||++.+ ..|+.++|.|||||+||||+.|+.||.+.+..+....|....+..| ...+.....|++..|..+
T Consensus 530 GTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP--~~ls~ea~~il~~ll~k~ 606 (694)
T KOG0694|consen 530 GTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYP--RFLSKEAIAIMRRLLRKN 606 (694)
T ss_pred CChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC--CcccHHHHHHHHHHhccC
Confidence 9999999999976 4799999999999999999999999999999999999998866655 466777888999999999
Q ss_pred CCCCCcH
Q psy501 544 TERLKSS 550 (962)
Q Consensus 544 perRPs~ 550 (962)
|++|--+
T Consensus 607 p~kRLG~ 613 (694)
T KOG0694|consen 607 PEKRLGS 613 (694)
T ss_pred cccccCC
Confidence 9999643
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=297.91 Aligned_cols=243 Identities=19% Similarity=0.224 Sum_probs=205.2
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccchhH-------HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDE-------MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~-------~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
.......++.|..+.||.|.........+.|+..++. .+++.|.+||+.++||.++.+|..|+.++..|+|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 3333344455556679999998888887777765542 358889999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC------
Q psy501 385 YMKENLYQLIRDR--DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS------ 456 (962)
Q Consensus 385 y~~g~Ll~~l~~~--~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~------ 456 (962)
||+|+-+..++++ ++.|++..++.++..++.||+|||..|||+|||||+||||.++|.+.|+||.++.....
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~ 237 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVK 237 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeec
Confidence 9996555555433 46899999999999999999999999999999999999999999999999998753210
Q ss_pred -----------------------------C-----------------------CcccccCCccccChhhhccCCCCCchh
Q psy501 457 -----------------------------R-----------------------PYTDYVSTRWYRAPEVLLHSTAYSAPI 484 (962)
Q Consensus 457 -----------------------------~-----------------------~~~~~~gt~~Y~APE~l~~~~~~t~ks 484 (962)
. ....++||-.|.|||++.|. ..+.++
T Consensus 238 s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~-GHgsAV 316 (459)
T KOG0610|consen 238 SSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE-GHGSAV 316 (459)
T ss_pred cCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC-CCCchh
Confidence 0 01124688999999999764 789999
Q ss_pred HHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCc----HHHHHh
Q psy501 485 HLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS----SYILLH 555 (962)
Q Consensus 485 DIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs----~~~Ll~ 555 (962)
|+|+|||+||||+.|..||.+.+..+....|......++..+..+...++||+..|.+||.+|-. +.++-+
T Consensus 317 DWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 317 DWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred hHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 99999999999999999999999999999999999999988888899999999999999999976 555544
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=318.05 Aligned_cols=245 Identities=20% Similarity=0.222 Sum_probs=188.5
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeC--------CEEEEEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIREN--------DTLYFVF 383 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--------~~~~LV~ 383 (962)
.+..+..++.|+.+.||.+.....++.++.+....+.....+|+.+|+.++||||+++++++... ..+++||
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvm 146 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM 146 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEE
Confidence 34444455555556688887766655555444444444567899999999999999999987432 2577999
Q ss_pred ecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc-ceeeecccccccccCC-C
Q psy501 384 EYMKENLYQLIRD---RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE-LVKIADFGLAREIRSR-P 458 (962)
Q Consensus 384 Ey~~g~Ll~~l~~---~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g-~vKL~DFGla~~~~~~-~ 458 (962)
||+++++.+.+.. ....+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||+|+.+... .
T Consensus 147 E~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~ 226 (440)
T PTZ00036 147 EFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR 226 (440)
T ss_pred ecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCC
Confidence 9999988777643 346799999999999999999999999999999999999998665 7999999999866443 3
Q ss_pred cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc-----------------c
Q psy501 459 YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI-----------------L 521 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------~ 521 (962)
.....||+.|+|||++.+...++.++|||||||++|||++|.+||.+.........+..... .
T Consensus 227 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~ 306 (440)
T PTZ00036 227 SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIK 306 (440)
T ss_pred cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhccc
Confidence 34567899999999998766799999999999999999999999998765544443332110 0
Q ss_pred ccC----------CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 522 LHT----------LPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 522 ~~~----------~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.+. ....+.....++..||..+|++||++.+++..
T Consensus 307 ~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 307 FPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 010 11234567789999999999999998887764
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=308.05 Aligned_cols=240 Identities=18% Similarity=0.231 Sum_probs=192.0
Q ss_pred ceeeEEEEecCCcccEEEEEecCCc-eEEEEeccc-------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDN-HILSRHVSS-------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~-kvv~~k~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
.+.....++.++.+.||.+...... ..++.+... .....+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 3444444445555568888654433 333333221 22345788999999999999999999999999999999
Q ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccc
Q psy501 384 EYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDY 462 (962)
Q Consensus 384 Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 462 (962)
||+.| +|.+.+.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++...... ....
T Consensus 111 Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-~~~~ 188 (340)
T PTZ00426 111 EFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-TYTL 188 (340)
T ss_pred eCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-ccee
Confidence 99975 56666554 456999999999999999999999999999999999999999999999999999866433 3346
Q ss_pred cCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhcc
Q psy501 463 VSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 542 (962)
Q Consensus 463 ~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~ 542 (962)
.||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.........+..+....+ +..+.....+++.||..
T Consensus 189 ~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~li~~~l~~ 265 (340)
T PTZ00426 189 CGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP--KFLDNNCKHLMKKLLSH 265 (340)
T ss_pred cCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHccc
Confidence 79999999999965 4689999999999999999999999999887777777776644333 45566788999999999
Q ss_pred CCCCCC-----cHHHHHhh
Q psy501 543 GTERLK-----SSYILLHT 556 (962)
Q Consensus 543 dperRP-----s~~~Ll~~ 556 (962)
+|++|+ ++++++..
T Consensus 266 dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 266 DLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CHHHcCCCCCCCHHHHHcC
Confidence 999995 77777654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=306.91 Aligned_cols=244 Identities=20% Similarity=0.237 Sum_probs=182.1
Q ss_pred eeeEEEEecCCcccEEEEEec-----CCceEEEEecc-----chhHHHHHHHHHHHHhc-CCCCcccEEEEEEeC-CEEE
Q psy501 313 ERLKFSYILPHTLPLYTCNLD-----QDNHILSRHVS-----SRDEMVVCFYRKSLKKL-SHANLVKLKEVIREN-DTLY 380 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~-----~~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~-~~~~ 380 (962)
+.....++.++.+.||.+... ...+.++.|.. ......+.+|+.+|+++ +||||+++++++... +.++
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (338)
T cd05102 9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLM 88 (338)
T ss_pred ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceE
Confidence 334444444455557777531 11122222221 22345688999999999 899999999998754 4689
Q ss_pred EEEecCC-CCHHHHHHhcC-------------------------------------------------------------
Q psy501 381 FVFEYMK-ENLYQLIRDRD------------------------------------------------------------- 398 (962)
Q Consensus 381 LV~Ey~~-g~Ll~~l~~~~------------------------------------------------------------- 398 (962)
+||||++ |+|.+++....
T Consensus 89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (338)
T cd05102 89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK 168 (338)
T ss_pred EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence 9999998 57777665421
Q ss_pred CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhh
Q psy501 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVL 474 (962)
Q Consensus 399 ~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l 474 (962)
..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++...... .....++..|+|||++
T Consensus 169 ~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 248 (338)
T cd05102 169 SPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248 (338)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHh
Confidence 247888999999999999999999999999999999999999999999999997654321 1223456789999999
Q ss_pred ccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhH-HHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHH
Q psy501 475 LHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGT-ERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 552 (962)
Q Consensus 475 ~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~ 552 (962)
.+ ..++.++|||||||++|||++ |..||.+....... ..+..+ .........+..+..++..||..+|+.||++.+
T Consensus 249 ~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 326 (338)
T cd05102 249 FD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG-TRMRAPENATPEIYRIMLACWQGDPKERPTFSA 326 (338)
T ss_pred hc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 65 468999999999999999997 99999876543332 222222 222223455667889999999999999999999
Q ss_pred HHhhcc
Q psy501 553 LLHTLP 558 (962)
Q Consensus 553 Ll~~l~ 558 (962)
+++.|.
T Consensus 327 l~~~l~ 332 (338)
T cd05102 327 LVEILG 332 (338)
T ss_pred HHHHHH
Confidence 998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=322.53 Aligned_cols=245 Identities=20% Similarity=0.237 Sum_probs=199.8
Q ss_pred eeeEEEEecCCccc-EEEEEecCC-ceEEEEeccchhH---HHHHHHHHHHHhcC-CCCcccEEEE-EEe---C---CEE
Q psy501 313 ERLKFSYILPHTLP-LYTCNLDQD-NHILSRHVSSRDE---MVVCFYRKSLKKLS-HANLVKLKEV-IRE---N---DTL 379 (962)
Q Consensus 313 ~~~~~~~i~~~~~~-Vy~~~~~~~-~kvv~~k~~~~~~---~~~~~Ei~iL~~L~-HpnIv~l~~~-~~~---~---~~~ 379 (962)
.-.+..++..|+|. ||.+..... .+++.++....++ ..+.+||++|++|+ |+|||.++|. ... . -.+
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 33444566666665 999998887 5555444433343 46999999999997 9999999994 321 1 257
Q ss_pred EEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccce--eeeccCCCcccccccccceeeeccccccccc
Q psy501 380 YFVFEYMK-ENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHG--FFHRDMKPENLLCMGTELVKIADFGLAREIR 455 (962)
Q Consensus 380 ~LV~Ey~~-g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~g--IvHrDLkp~NILl~~~g~vKL~DFGla~~~~ 455 (962)
+|.||||. |+|.+++..+. ..|++.++++|+.|+++|+.+||... |+|||||-+||||+.+|..||||||.|...-
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 89999999 69999997542 34999999999999999999999998 9999999999999999999999999996432
Q ss_pred CCC-----------cccccCCccccChhhhc--cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc
Q psy501 456 SRP-----------YTDYVSTRWYRAPEVLL--HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL 522 (962)
Q Consensus 456 ~~~-----------~~~~~gt~~Y~APE~l~--~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 522 (962)
... .-....|+.|+|||++- .+.+.+.|+|||||||+||-|+....||++.. ...|..+.+.+
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg----~laIlng~Y~~ 273 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG----KLAILNGNYSF 273 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----ceeEEeccccC
Confidence 221 11235689999999983 45578999999999999999999999998763 35677888889
Q ss_pred cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 523 HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 523 ~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
|..+.++..+..||+.||+.+|++||.+.++++.+....
T Consensus 274 P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 274 PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 988999999999999999999999999998888765544
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=304.54 Aligned_cols=228 Identities=17% Similarity=0.229 Sum_probs=184.8
Q ss_pred cccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHH
Q psy501 324 TLPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIR 395 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~ 395 (962)
.+.||.+.....++.++.|... .....+.+|+.++++++||||+++++++.+++..++||||++| +|.+.+.
T Consensus 6 ~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 85 (312)
T cd05585 6 FGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQ 85 (312)
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHH
Confidence 3457777766665555444332 2234578899999999999999999999999999999999985 6666665
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhh
Q psy501 396 DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEV 473 (962)
Q Consensus 396 ~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~ 473 (962)
. ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...... ......||+.|+|||+
T Consensus 86 ~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~ 164 (312)
T cd05585 86 R-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPEL 164 (312)
T ss_pred h-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHH
Confidence 4 456999999999999999999999999999999999999999999999999999754322 3334579999999999
Q ss_pred hccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCc---H
Q psy501 474 LLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS---S 550 (962)
Q Consensus 474 l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs---~ 550 (962)
+.+ ..++.++|||||||++|||++|+.||.+.........+....... ....+..+..++..||..+|++||+ +
T Consensus 165 ~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 165 LLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRF--PDGFDRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred HcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCC--CCcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 975 478999999999999999999999999887776666665553332 2456778889999999999999974 4
Q ss_pred HHHHh
Q psy501 551 YILLH 555 (962)
Q Consensus 551 ~~Ll~ 555 (962)
.+++.
T Consensus 242 ~e~l~ 246 (312)
T cd05585 242 QEIKN 246 (312)
T ss_pred HHHHc
Confidence 44443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=309.21 Aligned_cols=241 Identities=21% Similarity=0.271 Sum_probs=197.0
Q ss_pred eeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecC
Q psy501 314 RLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 314 ~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
.....+..++.+.||.+....+++.++.|+... ....+..|++++..++||+|+++++++.+++..|+||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (350)
T cd05573 4 EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM 83 (350)
T ss_pred eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCC
Confidence 344445555566688888776666655554332 2345888999999999999999999999999999999999
Q ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC-------
Q psy501 387 KE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP------- 458 (962)
Q Consensus 387 ~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~------- 458 (962)
+| +|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 162 (350)
T cd05573 84 PGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162 (350)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccc
Confidence 74 676666654 569999999999999999999999999999999999999999999999999997654332
Q ss_pred ------------------------cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHH
Q psy501 459 ------------------------YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTER 514 (962)
Q Consensus 459 ------------------------~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~ 514 (962)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 241 (350)
T cd05573 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNK 241 (350)
T ss_pred ccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHH
Confidence 2345789999999999764 789999999999999999999999998887766666
Q ss_pred HHh--ccccccCCCCCCCCcHHHHHHHhccCCCCCCc-HHHHHhhc
Q psy501 515 LKS--SYILLHTLPLYTYHVPPIQTTCLLAGTERLKS-SYILLHTL 557 (962)
Q Consensus 515 i~~--~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs-~~~Ll~~l 557 (962)
+.. .....+....++..+..++..|+. +|++||+ +.+++..-
T Consensus 242 i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 242 IINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 665 334444444567888999999997 8999999 88888754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-32 Score=302.22 Aligned_cols=241 Identities=23% Similarity=0.303 Sum_probs=182.2
Q ss_pred EEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeC-----CEEEEEEe
Q psy501 316 KFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIREN-----DTLYFVFE 384 (962)
Q Consensus 316 ~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~-----~~~~LV~E 384 (962)
...+..++.+.||.+.....+..++.|... .....+.+|++++++++||||+++++++... ..+|+|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e 84 (338)
T cd07859 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 84 (338)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence 334444445557777766555444433221 2234588999999999999999999998543 35899999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-----Cc
Q psy501 385 YMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-----PY 459 (962)
Q Consensus 385 y~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-----~~ 459 (962)
|++++|.+.+... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 85 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 163 (338)
T cd07859 85 LMESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 163 (338)
T ss_pred cCCCCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccc
Confidence 9999988877654 45899999999999999999999999999999999999999999999999999754322 12
Q ss_pred ccccCCccccChhhhccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhc--------------------
Q psy501 460 TDYVSTRWYRAPEVLLHS-TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSS-------------------- 518 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~-~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~-------------------- 518 (962)
....|++.|+|||++.+. ..++.++|||||||++|||++|++||.+.........+...
T Consensus 164 ~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 243 (338)
T cd07859 164 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRY 243 (338)
T ss_pred cCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHH
Confidence 345789999999998542 46899999999999999999999999876543221111000
Q ss_pred ------cc---cccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 519 ------YI---LLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 519 ------~~---~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.. .....+..+..+..++..||..+|++||++.++++.-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp 291 (338)
T cd07859 244 LSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291 (338)
T ss_pred HHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence 00 0011234455678899999999999999988888743
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=304.70 Aligned_cols=230 Identities=19% Similarity=0.213 Sum_probs=184.4
Q ss_pred cccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHH
Q psy501 324 TLPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIR 395 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~ 395 (962)
.+.||.+.....++.++.|... .+...+.+|++++++++||+|+++++++...+..|+||||++| +|...+.
T Consensus 8 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~ 87 (323)
T cd05595 8 FGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS 87 (323)
T ss_pred CEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHH
Confidence 3457777666555544444322 1233567899999999999999999999999999999999985 5554444
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhh
Q psy501 396 DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEV 473 (962)
Q Consensus 396 ~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~ 473 (962)
....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... ......||+.|+|||+
T Consensus 88 -~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~ 166 (323)
T cd05595 88 -RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 166 (323)
T ss_pred -HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCccc
Confidence 4456999999999999999999999999999999999999999999999999998753222 2334578999999999
Q ss_pred hccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCC-----
Q psy501 474 LLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK----- 548 (962)
Q Consensus 474 l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRP----- 548 (962)
+.+. .++.++|||||||++|||++|+.||...........+.......+ ..++..+..++..||..+|++|+
T Consensus 167 ~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~ 243 (323)
T cd05595 167 LEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPS 243 (323)
T ss_pred ccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHccCCHHHhCCCCCC
Confidence 9654 689999999999999999999999988777666666554443332 45677889999999999999998
Q ss_pred cHHHHHhhc
Q psy501 549 SSYILLHTL 557 (962)
Q Consensus 549 s~~~Ll~~l 557 (962)
++.+++..-
T Consensus 244 ~~~~~l~h~ 252 (323)
T cd05595 244 DAKEVMEHR 252 (323)
T ss_pred CHHHHHcCC
Confidence 677666543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=305.36 Aligned_cols=229 Identities=19% Similarity=0.233 Sum_probs=184.3
Q ss_pred cccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHH
Q psy501 324 TLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIR 395 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~ 395 (962)
.+.||.+.....++.++.|+... +...+.+|+.+++.++||+|+++++++..++.+|+||||++| +|...+.
T Consensus 8 ~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~ 87 (328)
T cd05593 8 FGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLS 87 (328)
T ss_pred CEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHH
Confidence 34477776665555544443322 234678899999999999999999999999999999999985 5555554
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhh
Q psy501 396 DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEV 473 (962)
Q Consensus 396 ~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~ 473 (962)
....+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++...... ......||+.|+|||+
T Consensus 88 -~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~ 166 (328)
T cd05593 88 -RERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEV 166 (328)
T ss_pred -hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhh
Confidence 4456999999999999999999999999999999999999999999999999998754322 2334579999999999
Q ss_pred hccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCC-----
Q psy501 474 LLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK----- 548 (962)
Q Consensus 474 l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRP----- 548 (962)
+.+. .++.++|||||||++|+|++|+.||.+.........+....... ....+..+..++..||..+|++|+
T Consensus 167 ~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~ 243 (328)
T cd05593 167 LEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKF--PRTLSADAKSLLSGLLIKDPNKRLGGGPD 243 (328)
T ss_pred hcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccC--CCCCCHHHHHHHHHHcCCCHHHcCCCCCC
Confidence 9654 68999999999999999999999998877666555554443322 245677888999999999999997
Q ss_pred cHHHHHhh
Q psy501 549 SSYILLHT 556 (962)
Q Consensus 549 s~~~Ll~~ 556 (962)
++.+++..
T Consensus 244 ~~~~il~h 251 (328)
T cd05593 244 DAKEIMRH 251 (328)
T ss_pred CHHHHhcC
Confidence 67777654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=293.52 Aligned_cols=252 Identities=27% Similarity=0.397 Sum_probs=193.3
Q ss_pred ecCCccc-EEEEEecCCceEEE-Eecc-----chhHHHHHHHHHHHHhcCCCCcccEEEEEEe-----CCEEEEEEecCC
Q psy501 320 ILPHTLP-LYTCNLDQDNHILS-RHVS-----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRE-----NDTLYFVFEYMK 387 (962)
Q Consensus 320 i~~~~~~-Vy~~~~~~~~kvv~-~k~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-----~~~~~LV~Ey~~ 387 (962)
++.|.++ |..+....+++.++ +|+. ..+..+..||+++|+.++|+||+.+++++.. -..+|+|+|+|+
T Consensus 30 iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe 109 (359)
T KOG0660|consen 30 IGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME 109 (359)
T ss_pred ccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHh
Confidence 3444333 55555555554444 3332 2234578999999999999999999999965 346999999998
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccccccc----CCCccccc
Q psy501 388 ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR----SRPYTDYV 463 (962)
Q Consensus 388 g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~----~~~~~~~~ 463 (962)
.+|...+... ..++++.+..++.|+++||.|+|+.+|+||||||+|++++.+..+||||||+|+... ....+..+
T Consensus 110 tDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYV 188 (359)
T KOG0660|consen 110 TDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYV 188 (359)
T ss_pred hHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhcce
Confidence 8888777664 449999999999999999999999999999999999999999999999999999885 44667889
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc--------------------cc
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL--------------------LH 523 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------------~~ 523 (962)
.|.+|+|||++.....|+.+.||||+|||+.||++|++.|.+.+.......|...-.. .+
T Consensus 189 aTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp 268 (359)
T KOG0660|consen 189 ATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLP 268 (359)
T ss_pred eeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCC
Confidence 9999999999998889999999999999999999999999986655444333211110 01
Q ss_pred ---------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccccCCCCcchhhh
Q psy501 524 ---------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCL 572 (962)
Q Consensus 524 ---------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~~~~~~~~~~~ 572 (962)
..|..+....+++..+|..||.+|.|+++-+..--...++.|.-.+.|.
T Consensus 269 ~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~ 326 (359)
T KOG0660|consen 269 QIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQ 326 (359)
T ss_pred CCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCC
Confidence 1112233445588899999999999966555443355667765555443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=295.84 Aligned_cols=236 Identities=18% Similarity=0.167 Sum_probs=182.8
Q ss_pred EecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CH
Q psy501 319 YILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NL 390 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~L 390 (962)
++.++.+.||.+....+++.++.+.... ....+.+|++++++++|++|+++++++.+++..++||||++| +|
T Consensus 8 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L 87 (285)
T cd05631 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDL 87 (285)
T ss_pred EecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcH
Confidence 3334445588887766665555443221 123477899999999999999999999999999999999985 56
Q ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCccc
Q psy501 391 YQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWY 468 (962)
Q Consensus 391 l~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y 468 (962)
...+... ...+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++...... ......|+..|
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y 167 (285)
T cd05631 88 KFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGY 167 (285)
T ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCc
Confidence 5555433 346899999999999999999999999999999999999999999999999999875433 33445789999
Q ss_pred cChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcc--ccccCCCCCCCCcHHHHHHHhccCCCC
Q psy501 469 RAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSY--ILLHTLPLYTYHVPPIQTTCLLAGTER 546 (962)
Q Consensus 469 ~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~s~~l~~li~~Cl~~dper 546 (962)
+|||++.+ ..++.++|||||||++|||++|+.||.+.........+.... ........++..+..+++.||..+|++
T Consensus 168 ~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~ 246 (285)
T cd05631 168 MAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKE 246 (285)
T ss_pred cCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHH
Confidence 99999975 478999999999999999999999998765432222221111 112223356778889999999999999
Q ss_pred CCc-----HHHHHh
Q psy501 547 LKS-----SYILLH 555 (962)
Q Consensus 547 RPs-----~~~Ll~ 555 (962)
||+ +.++++
T Consensus 247 R~~~~~~~~~~~~~ 260 (285)
T cd05631 247 RLGCRGNGAAGVKQ 260 (285)
T ss_pred hcCCCCCCHHHHhc
Confidence 996 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=305.22 Aligned_cols=238 Identities=16% Similarity=0.195 Sum_probs=183.0
Q ss_pred EEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-
Q psy501 317 FSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE- 388 (962)
Q Consensus 317 ~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g- 388 (962)
..++.++.+.||.+.....++.++.|+... ....+.+|+.++.+++||+|+++++.+.++..+|+||||++|
T Consensus 7 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (363)
T cd05628 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGG 86 (363)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCC
Confidence 334444555688887777666665555432 123578899999999999999999999999999999999985
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC----------
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---------- 458 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---------- 458 (962)
+|.+.+.. .+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 165 (363)
T cd05628 87 DMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNH 165 (363)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccc
Confidence 56666554 4569999999999999999999999999999999999999999999999999987543210
Q ss_pred ---------------------------cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh
Q psy501 459 ---------------------------YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG 511 (962)
Q Consensus 459 ---------------------------~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~ 511 (962)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~ 244 (363)
T cd05628 166 SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244 (363)
T ss_pred cccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 123579999999999975 4689999999999999999999999998887777
Q ss_pred HHHHHhcc--ccccCCCCCCCCcHHHHHHHhc--cCCCCCCcHHHHHhh
Q psy501 512 TERLKSSY--ILLHTLPLYTYHVPPIQTTCLL--AGTERLKSSYILLHT 556 (962)
Q Consensus 512 ~~~i~~~~--~~~~~~~~~s~~l~~li~~Cl~--~dperRPs~~~Ll~~ 556 (962)
...+.... ...+.....+....+++..++. .++..||++.+++..
T Consensus 245 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 245 YKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 66666432 2233222345556666665333 233456887777764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=297.55 Aligned_cols=245 Identities=24% Similarity=0.338 Sum_probs=192.1
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
+.....++.++.+.||.+........++.+... .....+.+|+.++++++||||+++++++..++..++||||++
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 333344444455568888776655544443322 123357789999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCC
Q psy501 388 ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVST 465 (962)
Q Consensus 388 g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt 465 (962)
+++.+.+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... ......++
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 167 (309)
T cd07872 88 KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVT 167 (309)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccccccccc
Confidence 9999988877777899999999999999999999999999999999999999999999999999765432 23345678
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc-------------------cc----
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI-------------------LL---- 522 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~-------------------~~---- 522 (962)
+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+..... ..
T Consensus 168 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (309)
T cd07872 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYK 247 (309)
T ss_pred ccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccC
Confidence 9999999997766789999999999999999999999988765444333321100 00
Q ss_pred -----cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 523 -----HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 523 -----~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
...+..+....+++..||..+|++||++.+++..-
T Consensus 248 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 248 PQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred CCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 01123455677899999999999999988887744
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PF09766 FimP: Fms-interacting protein; InterPro: IPR019163 This entry represents Thoc5 which is one of the subunits of the THO complex, which additionally contains: HPR1, Thoc2, Thoc6 and Thoc7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=307.45 Aligned_cols=145 Identities=48% Similarity=0.730 Sum_probs=142.5
Q ss_pred HhhhhhHHHHHHHHHHHHHHHHHhhhhhhhHHHHhhHHHHHHhhHHHHHHHccCccCCCCCCCCChhhhhhcCCCCCCCC
Q psy501 818 LLKKLNRLEKYRLKNARETLQAKKSKVDSFNLQLQNLKYEIFHLKKEVVKCLQFKSKDEDIDLVDEETFFKDAPESISRP 897 (962)
Q Consensus 818 ~LK~lnr~ak~~~k~~R~~t~~ar~evD~l~lqLQnL~yE~~hL~kEi~~c~~f~s~~~~i~lv~~eef~~~~p~~~~~~ 897 (962)
.||+++|.+...++..|+.++++|++||..|+|||||+||++||++||++|++|+|+|++|+|||+|||++.||++++++
T Consensus 2 ~Lk~~nR~~~~~~~~~k~~t~e~k~~vD~~~LqLqNl~YE~~hL~kEI~~C~~F~s~~~~i~Lv~~eEF~~~ap~~~~~~ 81 (355)
T PF09766_consen 2 ALKQLNRAAQFRIKKAKDETAEAKQEVDALHLQLQNLLYEKSHLQKEIKKCLDFKSKYEDIELVPVEEFYAKAPEEISDP 81 (355)
T ss_pred ChHHHHHHHHHHHHHHHHHHHHHHhhhhHHHHHHhHHHHHHHHHHHHHHHHhccCCCCCCCcCccHHHHHHhChhhcccc
Confidence 58999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCChhHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhchHHHHHHHHhhhC
Q psy501 898 EVTKEDPHQLKLARLEWELKQRKELADECSLVERENESVAANINKKRGQLDNLAPLLKQLLSFLR 962 (962)
Q Consensus 898 ~~~~~d~h~lml~rl~~El~~R~~l~~~~~~l~~~k~~l~~~~~~~~~~l~~l~~~l~~~~~~~~ 962 (962)
+.+.+|+|++|||||+|||+|||+|++++++|+++|++|+++|++|+++|++|+++|++|+++++
T Consensus 82 ~~~~~~~H~lml~RL~~EL~~Rk~L~~~~~el~~~k~~l~~~~~~k~~~L~~l~~~L~~l~~a~~ 146 (355)
T PF09766_consen 82 ELTEDDEHQLMLARLEFELEQRKRLEEQLKELEQRKKKLQQENKKKKKFLDSLPPQLKSLKKAAK 146 (355)
T ss_pred ccCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999873
|
The evolutionarily conserved multisubunit THO complex, which is recruited to actively transcribed genes is required for the efficient expression of genes that have internal tandem repeats. It is suggested that the THO complex functions to rectify aberrant structures that arise during transcription [, ] and is required for cell proliferation and for proper export of heat-shock mRNAs under heat stress []. This entry also identifies the crucial 144 N-terminal residues of the FmiP protein, which is essential for the binding of the protein to the cytoplasmic domain of activated Fms-molecules in M-CSF induced haematopoietic differentiation of macrophages. The C terminus contains a putative nuclear localisation sequence and a leucine zipper which suggest further, as yet unknown, nuclear functions. The level of FMIP expression might form a threshold that determines whether cells differentiate into macrophages or into granulocytes []. |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=279.57 Aligned_cols=230 Identities=18% Similarity=0.240 Sum_probs=206.3
Q ss_pred CcccEEEEEecCCceEEEEeccchhH-------HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHH
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSSRDE-------MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLI 394 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~~~~-------~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l 394 (962)
..+.||.++.+....+++.|+..+.+ .++.+|++|-+.|+||||+++|++|.+....|+++||.. |.++..+
T Consensus 34 kFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L 113 (281)
T KOG0580|consen 34 KFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDL 113 (281)
T ss_pred ccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHH
Confidence 33469999988888888887765543 469999999999999999999999999999999999997 7888888
Q ss_pred Hhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccccChhh
Q psy501 395 RDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEV 473 (962)
Q Consensus 395 ~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~ 473 (962)
... ...|++...+.++.|++.||.|+|.++|+||||||+|+|++..|.+||+|||.+...........+||..|.|||+
T Consensus 114 ~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEm 193 (281)
T KOG0580|consen 114 QEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKRKTLCGTLDYLPPEM 193 (281)
T ss_pred HhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCCceeeecccccCCHhh
Confidence 744 3569999999999999999999999999999999999999999999999999998877777888999999999999
Q ss_pred hccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHH
Q psy501 474 LLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 553 (962)
Q Consensus 474 l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~L 553 (962)
..+ ..++..+|+|++|++.||++.|.+||......+.+++|......+| +..+....++|..|+..+|..|.+..++
T Consensus 194 v~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p--~~is~~a~dlI~~ll~~~p~~r~~l~~v 270 (281)
T KOG0580|consen 194 VEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP--STISGGAADLISRLLVKNPIERLALTEV 270 (281)
T ss_pred cCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC--cccChhHHHHHHHHhccCccccccHHHH
Confidence 965 5799999999999999999999999999998899999999887777 7788899999999999999988885555
Q ss_pred Hh
Q psy501 554 LH 555 (962)
Q Consensus 554 l~ 555 (962)
+.
T Consensus 271 ~~ 272 (281)
T KOG0580|consen 271 MD 272 (281)
T ss_pred hh
Confidence 44
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=300.64 Aligned_cols=228 Identities=18% Similarity=0.204 Sum_probs=182.8
Q ss_pred CcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCCC-CHHHH
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKE-NLYQL 393 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~ 393 (962)
+.+.||.+.....++.++.|.... +......|..++..+ +||+|+++++++.+++.+|+||||+.| +|...
T Consensus 7 ~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~ 86 (316)
T cd05620 7 SFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFH 86 (316)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHH
Confidence 344577777776665555444322 234567788888765 899999999999999999999999985 56665
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccccccc--CCCcccccCCccccCh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR--SRPYTDYVSTRWYRAP 471 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~--~~~~~~~~gt~~Y~AP 471 (962)
+.. ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.... ........||+.|+||
T Consensus 87 i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aP 165 (316)
T cd05620 87 IQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAP 165 (316)
T ss_pred HHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCH
Confidence 554 4568999999999999999999999999999999999999999999999999987432 2234456789999999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHH
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 551 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~ 551 (962)
|++.+. .++.++|||||||++|||++|+.||.+.........+....... ....+..+..++..||..+|++|+++.
T Consensus 166 E~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dP~~R~~~~ 242 (316)
T cd05620 166 EILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHY--PRWITKESKDILEKLFERDPTRRLGVV 242 (316)
T ss_pred HHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--CCCCCHHHHHHHHHHccCCHHHcCCCh
Confidence 999754 78999999999999999999999999887766666665443222 235667788999999999999999964
Q ss_pred -HHH
Q psy501 552 -ILL 554 (962)
Q Consensus 552 -~Ll 554 (962)
+++
T Consensus 243 ~~~~ 246 (316)
T cd05620 243 GNIR 246 (316)
T ss_pred HHHH
Confidence 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=308.96 Aligned_cols=239 Identities=17% Similarity=0.210 Sum_probs=184.2
Q ss_pred EEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-
Q psy501 316 KFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK- 387 (962)
Q Consensus 316 ~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~- 387 (962)
...++.++.+.||.+.....++.++.|.... ....+.+|++++++++||||+++++++.++..+|+||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g 85 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG 85 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence 3344445555688887776666655554322 22457889999999999999999999999999999999997
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---------
Q psy501 388 ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--------- 458 (962)
Q Consensus 388 g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~--------- 458 (962)
|+|.+.+.. ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.+....
T Consensus 86 g~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 164 (377)
T cd05629 86 GDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL 164 (377)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccc
Confidence 566666654 4568999999999999999999999999999999999999999999999999986321100
Q ss_pred ----------------------------------------cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc
Q psy501 459 ----------------------------------------YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID 498 (962)
Q Consensus 459 ----------------------------------------~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt 498 (962)
....+||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt 243 (377)
T cd05629 165 QGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMFECLI 243 (377)
T ss_pred cccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchhhhhhhc
Confidence 012468999999999965 468999999999999999999
Q ss_pred CCCCCCCcChhhhHHHHHhcc--ccccCCCCCCCCcHHHHHHHhccCCCC--CCcHHHHHhh
Q psy501 499 HVPPIQTTCLLAGTERLKSSY--ILLHTLPLYTYHVPPIQTTCLLAGTER--LKSSYILLHT 556 (962)
Q Consensus 499 G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~s~~l~~li~~Cl~~dper--RPs~~~Ll~~ 556 (962)
|.+||.+.........+.... ...+.....+..+.+++..|+..+++| |+++.+++..
T Consensus 244 G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 244 GWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSH 305 (377)
T ss_pred CCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcC
Confidence 999998877666555554322 222222245667788999999855555 5687766654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=299.60 Aligned_cols=229 Identities=19% Similarity=0.235 Sum_probs=180.8
Q ss_pred CcccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCCC-CHHHH
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKE-NLYQL 393 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~ 393 (962)
+.+.||.+....+++.++.|... .+......|..++..+ +||+|+++++++..++..|+||||++| +|...
T Consensus 7 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~ 86 (316)
T cd05592 7 SFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFH 86 (316)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHH
Confidence 34457777776666555444332 1233456677777654 799999999999999999999999985 55555
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC--CCcccccCCccccCh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAP 471 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~--~~~~~~~gt~~Y~AP 471 (962)
+.. ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..... .......||+.|+||
T Consensus 87 ~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aP 165 (316)
T cd05592 87 IQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAP 165 (316)
T ss_pred HHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCH
Confidence 544 45699999999999999999999999999999999999999999999999999975432 233445789999999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHH
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 551 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~ 551 (962)
|++.+. .++.++|||||||++|||++|+.||.+.........+..... .....++..+..++..||..+|++||+..
T Consensus 166 E~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~ll~~~l~~~P~~R~~~~ 242 (316)
T cd05592 166 EILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP--HFPRWISKEAKDCLSKLFERDPTKRLGVD 242 (316)
T ss_pred HHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHccCCHHHcCCCh
Confidence 999754 689999999999999999999999998877666665554422 22245667788999999999999999854
Q ss_pred -HHHh
Q psy501 552 -ILLH 555 (962)
Q Consensus 552 -~Ll~ 555 (962)
++++
T Consensus 243 ~~l~~ 247 (316)
T cd05592 243 GDIRQ 247 (316)
T ss_pred HHHHc
Confidence 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=300.62 Aligned_cols=224 Identities=19% Similarity=0.254 Sum_probs=182.4
Q ss_pred CcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCCC-CHHHH
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKE-NLYQL 393 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~ 393 (962)
+.+.||.+....+++.++.|.... ....+..|+.++..+ +||+|+++++++.+.+.+|+||||++| +|...
T Consensus 7 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~ 86 (320)
T cd05590 7 SFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFH 86 (320)
T ss_pred CCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHH
Confidence 334577777766665555444322 234567888888877 699999999999999999999999985 55555
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC--CCcccccCCccccCh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAP 471 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~--~~~~~~~gt~~Y~AP 471 (962)
+.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..... .......||+.|+||
T Consensus 87 i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aP 165 (320)
T cd05590 87 IQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAP 165 (320)
T ss_pred HHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCH
Confidence 544 45699999999999999999999999999999999999999999999999999875422 233445789999999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcH
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 550 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~ 550 (962)
|++.+ ..++.++|||||||++|||++|+.||.+.........+.......+ ...+..+..+++.||..+|++|+++
T Consensus 166 E~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 166 EILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP--TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 99965 4689999999999999999999999998887777777766543332 4567778899999999999999986
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=297.45 Aligned_cols=238 Identities=25% Similarity=0.384 Sum_probs=189.1
Q ss_pred EEecCCcc-cEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-----EEEEEEecCCCCHH
Q psy501 318 SYILPHTL-PLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIREND-----TLYFVFEYMKENLY 391 (962)
Q Consensus 318 ~~i~~~~~-~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~-----~~~LV~Ey~~g~Ll 391 (962)
.+++.|.+ .||.+......+.++.|..-.+...-.+|+++|+.++|||||++..+|.... ...+||||++.+|.
T Consensus 30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~ 109 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLY 109 (364)
T ss_pred EEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchHHHH
Confidence 34444444 4899888777655555444444445688999999999999999999986422 45689999999999
Q ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc-cceeeecccccccccCC-CcccccCCc
Q psy501 392 QLIRD---RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT-ELVKIADFGLAREIRSR-PYTDYVSTR 466 (962)
Q Consensus 392 ~~l~~---~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~-g~vKL~DFGla~~~~~~-~~~~~~gt~ 466 (962)
+.+.. .+..++...++-+..||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|+.+... +..++..|.
T Consensus 110 ~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSR 189 (364)
T KOG0658|consen 110 RVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSR 189 (364)
T ss_pred HHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEec
Confidence 88874 24568999999999999999999999999999999999999976 89999999999987654 567788999
Q ss_pred cccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-----------------c------
Q psy501 467 WYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL-----------------H------ 523 (962)
Q Consensus 467 ~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----------------~------ 523 (962)
.|+|||.+.|...|+.+.||||.|||+.||+-|++.|.+.+..+....|......+ +
T Consensus 190 yYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~ 269 (364)
T KOG0658|consen 190 YYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHP 269 (364)
T ss_pred cccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCccccccc
Confidence 99999999999999999999999999999999999999977666554443221111 1
Q ss_pred ----CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHh
Q psy501 524 ----TLPLYTYHVPPIQTTCLLAGTERLKSSYILLH 555 (962)
Q Consensus 524 ----~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~ 555 (962)
.....+.+.-+++..+|..+|.+|.++.+++.
T Consensus 270 ~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 270 WHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11123445566899999999999998555444
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-31 Score=313.12 Aligned_cols=242 Identities=18% Similarity=0.234 Sum_probs=194.4
Q ss_pred eeeEEEEecCCcccEEEEEecCC--ceEEEEeccch---hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQD--NHILSRHVSSR---DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~--~kvv~~k~~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
+.....++.++.+.||.+..... .++++++.... ....+.+|+.+|+.++||||+++++++..++..||||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 44455555566667898876554 33444433222 23457889999999999999999999999999999999998
Q ss_pred -CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----Cc
Q psy501 388 -ENLYQLIRD---RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PY 459 (962)
Q Consensus 388 -g~Ll~~l~~---~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~ 459 (962)
|+|.+.+.. ...++++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++...... ..
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~ 228 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccc
Confidence 567666543 2456899999999999999999999999999999999999999999999999999876443 23
Q ss_pred ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHH
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTC 539 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~C 539 (962)
...+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+..+... +....++..+..++..|
T Consensus 229 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~ 306 (478)
T PTZ00267 229 SSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-PFPCPVSSGMKALLDPL 306 (478)
T ss_pred cccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCccCCHHHHHHHHHH
Confidence 34569999999999865 47899999999999999999999999887776666666555332 22235667789999999
Q ss_pred hccCCCCCCcHHHHHhh
Q psy501 540 LLAGTERLKSSYILLHT 556 (962)
Q Consensus 540 l~~dperRPs~~~Ll~~ 556 (962)
|..+|+.||++.++++.
T Consensus 307 L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 307 LSKNPALRPTTQQLLHT 323 (478)
T ss_pred hccChhhCcCHHHHHhC
Confidence 99999999998888764
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=305.94 Aligned_cols=243 Identities=16% Similarity=0.167 Sum_probs=189.3
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCH
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENL 390 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~L 390 (962)
+.|.....++.++.+.||.|.....++.++.|... ...+.+|+++|++++||||++++++|..+...++|||++.+++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~~L 169 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDL 169 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCCCCH
Confidence 44555555555666669999888877777666533 3357899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC---CCcccccCCcc
Q psy501 391 YQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS---RPYTDYVSTRW 467 (962)
Q Consensus 391 l~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~---~~~~~~~gt~~ 467 (962)
...+... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+|..... .......||+.
T Consensus 170 ~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~ 248 (391)
T PHA03212 170 YCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIA 248 (391)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccC
Confidence 8887665 4589999999999999999999999999999999999999999999999999965332 23334579999
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh-------hhHHHHHh-----------------------
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL-------AGTERLKS----------------------- 517 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~-------~~~~~i~~----------------------- 517 (962)
|+|||++.+ ..++.++|||||||++|||++|..||...... .....+..
T Consensus 249 y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~ 327 (391)
T PHA03212 249 TNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIG 327 (391)
T ss_pred CCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHH
Confidence 999999965 47899999999999999999999887543210 00000000
Q ss_pred ---cccccc-C------CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 518 ---SYILLH-T------LPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 518 ---~~~~~~-~------~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.....+ . ....+..+..++..||..+|++||++.+++..-
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 328 LAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred HHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 000000 0 012344677899999999999999999888744
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=322.10 Aligned_cols=218 Identities=24% Similarity=0.328 Sum_probs=193.4
Q ss_pred EEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC---------C----CCCHHH
Q psy501 340 SRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD---------K----FLPESI 405 (962)
Q Consensus 340 ~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~---------~----~ls~~~ 405 (962)
+.+.......+|+||+++|..|+|||||+++|+|.+++.+|+|+|||. |+|.++++... . +++..+
T Consensus 525 Kd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q 604 (774)
T KOG1026|consen 525 KDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQ 604 (774)
T ss_pred cccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHH
Confidence 333333456689999999999999999999999999999999999998 99999997642 2 388999
Q ss_pred HHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCccc----ccCCccccChhhhccCCCCC
Q psy501 406 IRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD----YVSTRWYRAPEVLLHSTAYS 481 (962)
Q Consensus 406 i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~----~~gt~~Y~APE~l~~~~~~t 481 (962)
.+.|+.|||.|+.||-++.+|||||..+|+||.+...|||+|||+++...+..... ..-..+|||||.++-+ .++
T Consensus 605 ~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFT 683 (774)
T KOG1026|consen 605 FLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFT 683 (774)
T ss_pred HHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-ccc
Confidence 99999999999999999999999999999999999999999999999876653332 2335779999999865 799
Q ss_pred chhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 482 APIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 482 ~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
.+||||||||+|||+++ |+.||.+....+..+.+..+.+ .+-+..+|..+..|+..||...|.+||++.+|-..|..
T Consensus 684 teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 684 TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 99999999999999998 9999999999999999999988 67777999999999999999999999999999887643
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=303.05 Aligned_cols=230 Identities=18% Similarity=0.198 Sum_probs=183.4
Q ss_pred cccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHh
Q psy501 324 TLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRD 396 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~ 396 (962)
.+.||.+.....++.++.|+... ....+..|+++++.++||+|+++++++..++..|+||||++|+.+.....
T Consensus 8 ~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~ 87 (325)
T cd05594 8 FGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS 87 (325)
T ss_pred CEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHH
Confidence 33467666655555544443322 23456789999999999999999999999999999999998644444444
Q ss_pred cCCCCCHHHHHHHHHHHHHHHhhccc-ceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhh
Q psy501 397 RDKFLPESIIRNMMYQVLQGLAFMHR-HGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEV 473 (962)
Q Consensus 397 ~~~~ls~~~i~~i~~qI~~aL~yLH~-~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~ 473 (962)
....+++..++.++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++...... ......||+.|+|||+
T Consensus 88 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~ 167 (325)
T cd05594 88 RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 167 (325)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHH
Confidence 44569999999999999999999997 79999999999999999999999999998754322 3334579999999999
Q ss_pred hccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCC-----
Q psy501 474 LLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK----- 548 (962)
Q Consensus 474 l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRP----- 548 (962)
+.+. .++.++|||||||++|||++|+.||.+.........+.......+ ..++..+..++..||..+|++|+
T Consensus 168 ~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~ 244 (325)
T cd05594 168 LEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP--RTLSPEAKSLLSGLLKKDPKQRLGGGPD 244 (325)
T ss_pred HccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHhhcCHHHhCCCCCC
Confidence 9654 689999999999999999999999988777666666555433332 45677788999999999999996
Q ss_pred cHHHHHhh
Q psy501 549 SSYILLHT 556 (962)
Q Consensus 549 s~~~Ll~~ 556 (962)
++.++++.
T Consensus 245 ~~~~il~h 252 (325)
T cd05594 245 DAKEIMQH 252 (325)
T ss_pred CHHHHhcC
Confidence 77777654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=304.67 Aligned_cols=238 Identities=18% Similarity=0.219 Sum_probs=185.7
Q ss_pred EEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC
Q psy501 316 KFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE 388 (962)
Q Consensus 316 ~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g 388 (962)
...++.++.+.||.+.....++.++.|.... ....+.+|+++|+.++||+|+++++++.++..+|+||||+.|
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG 85 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence 3344445555688888877766665554432 123478899999999999999999999999999999999985
Q ss_pred -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---------
Q psy501 389 -NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--------- 458 (962)
Q Consensus 389 -~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~--------- 458 (962)
+|.+.+.. ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++..+....
T Consensus 86 g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 164 (364)
T cd05599 86 GDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164 (364)
T ss_pred cHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccccccc
Confidence 55555544 4569999999999999999999999999999999999999999999999999986543210
Q ss_pred -------------------------------cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcC
Q psy501 459 -------------------------------YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTC 507 (962)
Q Consensus 459 -------------------------------~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~ 507 (962)
....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~Pf~~~~ 243 (364)
T cd05599 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPPFCSDN 243 (364)
T ss_pred ccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCCCCCCCC
Confidence 012468999999999865 478999999999999999999999999887
Q ss_pred hhhhHHHHHhcccc--ccCCCCCCCCcHHHHHHHhccCCCCCCc---HHHHHhh
Q psy501 508 LLAGTERLKSSYIL--LHTLPLYTYHVPPIQTTCLLAGTERLKS---SYILLHT 556 (962)
Q Consensus 508 ~~~~~~~i~~~~~~--~~~~~~~s~~l~~li~~Cl~~dperRPs---~~~Ll~~ 556 (962)
.......+...... .+.....+.....++..|+. +|.+|++ +.+++..
T Consensus 244 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 244 PQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred HHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 76666665543222 22222456677889998887 6777775 7666654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=300.39 Aligned_cols=204 Identities=19% Similarity=0.301 Sum_probs=172.9
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeee
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFH 427 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvH 427 (962)
..+..|+.+|++++||||+++++++..++..|+||||+.| +|.+.+.. .+.+++..+..++.||+.||.|||+.||+|
T Consensus 45 ~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 123 (323)
T cd05584 45 AHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIY 123 (323)
T ss_pred HHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 3567899999999999999999999999999999999986 56555544 456899999999999999999999999999
Q ss_pred ccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q psy501 428 RDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQT 505 (962)
Q Consensus 428 rDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~ 505 (962)
|||||+||+++.++.+||+|||++...... ......|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+
T Consensus 124 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 124 RDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred CCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 999999999999999999999998754322 2334578999999999965 4688999999999999999999999998
Q ss_pred cChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCC-----cHHHHHhh
Q psy501 506 TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK-----SSYILLHT 556 (962)
Q Consensus 506 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRP-----s~~~Ll~~ 556 (962)
.........+..+... ..+..+..+..++..||..+|++|| ++.+++..
T Consensus 203 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 203 ENRKKTIDKILKGKLN--LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 8877766666655432 2345677889999999999999999 67766654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=306.41 Aligned_cols=244 Identities=19% Similarity=0.226 Sum_probs=195.6
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
.+.....++.++.+.||.+.....++.++.|.... ....+.+|+.+++.++||+|+++++++.++...|+|||
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME 123 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence 44444455555556688888777776665554332 22347789999999999999999999999999999999
Q ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---Ccc
Q psy501 385 YMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PYT 460 (962)
Q Consensus 385 y~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~ 460 (962)
|++| +|.+.+.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...... ...
T Consensus 124 y~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~ 201 (370)
T cd05596 124 YMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201 (370)
T ss_pred CCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCC
Confidence 9985 56665543 34899999999999999999999999999999999999999999999999999766433 223
Q ss_pred cccCCccccChhhhccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcc--ccccCCCCCCCCcHHH
Q psy501 461 DYVSTRWYRAPEVLLHS---TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSY--ILLHTLPLYTYHVPPI 535 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~---~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~s~~l~~l 535 (962)
...||+.|+|||++.+. ..++.++|||||||++|||++|++||.+.........+.... ...+....++..+..+
T Consensus 202 ~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 281 (370)
T cd05596 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDL 281 (370)
T ss_pred CCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHH
Confidence 45799999999998653 247899999999999999999999999988777777775543 2333334567788899
Q ss_pred HHHHhccCCCC--CCcHHHHHhhc
Q psy501 536 QTTCLLAGTER--LKSSYILLHTL 557 (962)
Q Consensus 536 i~~Cl~~dper--RPs~~~Ll~~l 557 (962)
+..||..+|++ |+++.+++..-
T Consensus 282 i~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 282 ICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred HHHHccChhhccCCCCHHHHhcCc
Confidence 99999999998 99988887653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=302.92 Aligned_cols=241 Identities=20% Similarity=0.212 Sum_probs=193.5
Q ss_pred eEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 315 LKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 315 ~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
....+..++.+.||.+.....++.++.+.... ....+.+|+.+++.++||+|+++++++.+++..|+||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (330)
T cd05601 5 VKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQP 84 (330)
T ss_pred EEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCC
Confidence 34444445555688887776666555544332 23458889999999999999999999999999999999997
Q ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---ccccc
Q psy501 388 -ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---YTDYV 463 (962)
Q Consensus 388 -g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~ 463 (962)
|+|.+++......+++..+..++.||+.||.|||+.+|+||||||+||+++.++.+||+|||++....... .....
T Consensus 85 ~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 164 (330)
T cd05601 85 GGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV 164 (330)
T ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeeccc
Confidence 57777776665679999999999999999999999999999999999999999999999999998765432 22346
Q ss_pred CCccccChhhhcc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcc--ccccCCCCCCCCcHHHH
Q psy501 464 STRWYRAPEVLLH-----STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSY--ILLHTLPLYTYHVPPIQ 536 (962)
Q Consensus 464 gt~~Y~APE~l~~-----~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~s~~l~~li 536 (962)
||+.|+|||++.. ...++.++|||||||++|||++|+.||...........+.... ...+..+..+..+..++
T Consensus 165 gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 244 (330)
T cd05601 165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLI 244 (330)
T ss_pred CCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHH
Confidence 8999999999863 3467899999999999999999999998877766666655432 22333445667788899
Q ss_pred HHHhccCCCCCCcHHHHHhh
Q psy501 537 TTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 537 ~~Cl~~dperRPs~~~Ll~~ 556 (962)
..||. +|.+||++.+++..
T Consensus 245 ~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 245 QSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHcc-ChhhCCCHHHHhCC
Confidence 99997 99999998887754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=300.19 Aligned_cols=229 Identities=21% Similarity=0.278 Sum_probs=185.3
Q ss_pred cccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHH
Q psy501 324 TLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLI 394 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l 394 (962)
.+.||.+.....+..++.|+... ....+..|.+++..+ +||+|+++++++.+++.+|+||||++| +|...+
T Consensus 8 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l 87 (321)
T cd05591 8 FGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQI 87 (321)
T ss_pred CeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHH
Confidence 34577777666555544443222 223467888888876 799999999999999999999999985 555555
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChh
Q psy501 395 RDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPE 472 (962)
Q Consensus 395 ~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE 472 (962)
.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... ......||+.|+|||
T Consensus 88 ~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE 166 (321)
T cd05591 88 QR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166 (321)
T ss_pred HH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHH
Confidence 44 456899999999999999999999999999999999999999999999999998754322 334457899999999
Q ss_pred hhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCC----
Q psy501 473 VLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK---- 548 (962)
Q Consensus 473 ~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRP---- 548 (962)
++.+ ..++.++|||||||++|||++|+.||.+.........+..+....+ ...+..+..++..||..+|++|+
T Consensus 167 ~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~ll~~~L~~dp~~R~~~~~ 243 (321)
T cd05591 167 ILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP--VWLSKEAVSILKAFMTKNPNKRLGCVA 243 (321)
T ss_pred HHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHhccCHHHcCCCCC
Confidence 9865 4789999999999999999999999999887777777766644333 35677788999999999999999
Q ss_pred ---cHHHHHhh
Q psy501 549 ---SSYILLHT 556 (962)
Q Consensus 549 ---s~~~Ll~~ 556 (962)
++.+++..
T Consensus 244 ~~~~~~~~~~h 254 (321)
T cd05591 244 SQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHhcC
Confidence 66766654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=297.91 Aligned_cols=233 Identities=18% Similarity=0.202 Sum_probs=182.3
Q ss_pred ecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHH---HhcCCCCcccEEEEEEeCCEEEEEEecCCCC
Q psy501 320 ILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSL---KKLSHANLVKLKEVIRENDTLYFVFEYMKEN 389 (962)
Q Consensus 320 i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL---~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~ 389 (962)
+.++.+.||.+.....++.++.|.... ....+.+|++++ +.++||||+++++++.+++..|+||||++|+
T Consensus 8 g~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 87 (324)
T cd05589 8 GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG 87 (324)
T ss_pred eecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCC
Confidence 334444577777666555544444321 223566676665 4667999999999999999999999999864
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCcc
Q psy501 390 LYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRW 467 (962)
Q Consensus 390 Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~ 467 (962)
.+...... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++...... ......|++.
T Consensus 88 ~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~ 166 (324)
T cd05589 88 DLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPE 166 (324)
T ss_pred cHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCcc
Confidence 44333332 45999999999999999999999999999999999999999999999999998754322 3344678999
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCC
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERL 547 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperR 547 (962)
|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+.......+ ...+..+..++..||..+|.+|
T Consensus 167 y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R 243 (324)
T cd05589 167 FLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP--RFLSREAISIMRRLLRRNPERR 243 (324)
T ss_pred ccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHHhhcCHhHc
Confidence 999999965 4689999999999999999999999998877766666665543332 4567778899999999999999
Q ss_pred C-----cHHHHHhh
Q psy501 548 K-----SSYILLHT 556 (962)
Q Consensus 548 P-----s~~~Ll~~ 556 (962)
| ++.++++.
T Consensus 244 ~~~~~~~~~~l~~~ 257 (324)
T cd05589 244 LGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCCCCCHHHHhhC
Confidence 9 46666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=284.02 Aligned_cols=247 Identities=19% Similarity=0.296 Sum_probs=200.5
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc---hhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEE
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS---RDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~---~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
++.|....+...+.+.+++-|.++...... ....++ .-.+.-.+|+.||+++ .||+|+.+.++|+.+..+++|+
T Consensus 25 lgrgvss~vrRci~k~t~~e~a~kii~~~a--t~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVF 102 (411)
T KOG0599|consen 25 LGRGVSSVVRRCIHKETGKEFAVKIIDVTA--TTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVF 102 (411)
T ss_pred hcccchhhhhhhhhcccccceeEEEEEecc--cccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhh
Confidence 334444444555555555555544221110 111111 1234678899999999 5999999999999999999999
Q ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-Cccc
Q psy501 384 EYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTD 461 (962)
Q Consensus 384 Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~ 461 (962)
|.|+ |.|++++.+. -.++++...++++|+++|+.|||..+||||||||+|||++++..+||+|||.|+.+... ....
T Consensus 103 dl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLre 181 (411)
T KOG0599|consen 103 DLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRE 181 (411)
T ss_pred hhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCchhHHH
Confidence 9998 8899988765 45999999999999999999999999999999999999999999999999999988765 6677
Q ss_pred ccCCccccChhhhc-----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC--CCCCCCCcHH
Q psy501 462 YVSTRWYRAPEVLL-----HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT--LPLYTYHVPP 534 (962)
Q Consensus 462 ~~gt~~Y~APE~l~-----~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l~~ 534 (962)
.+||++|.|||.+. +...|+..+|+||+||++|.|+.|.+||...........|..+...+.. +..++....+
T Consensus 182 lCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~Kd 261 (411)
T KOG0599|consen 182 LCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKD 261 (411)
T ss_pred hcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHH
Confidence 89999999999884 3456999999999999999999999999999888888889988877654 4467788999
Q ss_pred HHHHHhccCCCCCCcHHHHH-hhc
Q psy501 535 IQTTCLLAGTERLKSSYILL-HTL 557 (962)
Q Consensus 535 li~~Cl~~dperRPs~~~Ll-~~l 557 (962)
+|..||+.||..|-++++.+ |++
T Consensus 262 LIsrlLqVdp~~Ritake~LaHpf 285 (411)
T KOG0599|consen 262 LISRLLQVDPTKRITAKEALAHPF 285 (411)
T ss_pred HHHHHHeeCchhcccHHHHhcChH
Confidence 99999999999999966544 543
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=284.20 Aligned_cols=236 Identities=22% Similarity=0.294 Sum_probs=189.3
Q ss_pred ecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHh
Q psy501 320 ILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRD 396 (962)
Q Consensus 320 i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~ 396 (962)
..++.+.||.+.......++.+.+.. .....+.+|+.+|++++||+|+++++++..+...++||||++ |+|.+.+..
T Consensus 13 g~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~ 92 (256)
T cd05114 13 GSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQ 92 (256)
T ss_pred cCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHh
Confidence 33344457777665554444443322 234568899999999999999999999999999999999998 577777765
Q ss_pred cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCc---ccccCCccccChhh
Q psy501 397 RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY---TDYVSTRWYRAPEV 473 (962)
Q Consensus 397 ~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~---~~~~gt~~Y~APE~ 473 (962)
....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ ....++..|+|||+
T Consensus 93 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~ 172 (256)
T cd05114 93 RQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEV 172 (256)
T ss_pred CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhh
Confidence 555689999999999999999999999999999999999999999999999999876543321 22234567999999
Q ss_pred hccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHH
Q psy501 474 LLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 552 (962)
Q Consensus 474 l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~ 552 (962)
+.+ ..++.++||||||+++|||++ |+.||...........+..+... ......+..+..++..||..+|++||++.+
T Consensus 173 ~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~c~~~~p~~Rps~~~ 250 (256)
T cd05114 173 FNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL-YRPKLASMTVYEVMYSCWHEKPEGRPTFAE 250 (256)
T ss_pred ccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHHccCCcccCcCHHH
Confidence 865 468999999999999999999 99999988777776766655322 222345566888999999999999999999
Q ss_pred HHhhc
Q psy501 553 LLHTL 557 (962)
Q Consensus 553 Ll~~l 557 (962)
+++.|
T Consensus 251 l~~~l 255 (256)
T cd05114 251 LLRAI 255 (256)
T ss_pred HHHhh
Confidence 98865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=308.14 Aligned_cols=232 Identities=23% Similarity=0.287 Sum_probs=201.9
Q ss_pred cccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHh
Q psy501 324 TLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRD 396 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~ 396 (962)
.+.||.+....+..+|+.+..+- .-..+.+|++.|.+++|||++.+.++|..+...|+|||||-|+-.+.+.-
T Consensus 39 FGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClGSAsDlleV 118 (948)
T KOG0577|consen 39 FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDLLEV 118 (948)
T ss_pred cceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhccHHHHHHH
Confidence 34588888777777766554321 22469999999999999999999999999999999999999999999988
Q ss_pred cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccccChhhhc-
Q psy501 397 RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLL- 475 (962)
Q Consensus 397 ~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~- 475 (962)
..+++.+.++..|+.+.+.||+|||+.+.+|||||..|||+++.|.|||+|||.|.... +..+++||++|||||++.
T Consensus 119 hkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--PAnsFvGTPywMAPEVILA 196 (948)
T KOG0577|consen 119 HKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA--PANSFVGTPYWMAPEVILA 196 (948)
T ss_pred HhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC--chhcccCCccccchhHhee
Confidence 88899999999999999999999999999999999999999999999999999997654 456789999999999995
Q ss_pred -cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHH
Q psy501 476 -HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILL 554 (962)
Q Consensus 476 -~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll 554 (962)
....|+-++||||||++..||.-.++|+...+-......|.+...+.-..+..+..+..++..||+..|+.||+++.|+
T Consensus 197 MDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 197 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred ccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 4447999999999999999999999999988887777777766554444556777889999999999999999988888
Q ss_pred hhc
Q psy501 555 HTL 557 (962)
Q Consensus 555 ~~l 557 (962)
..-
T Consensus 277 ~H~ 279 (948)
T KOG0577|consen 277 KHR 279 (948)
T ss_pred hcc
Confidence 755
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=298.07 Aligned_cols=243 Identities=17% Similarity=0.195 Sum_probs=185.3
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
+.....++.++.+.||.+.....+..++.+... .....+.+|++++++++||||++++++|.+++..++||||+.
T Consensus 7 y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (333)
T cd06650 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (333)
T ss_pred hheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCC
Confidence 334444444445567887776666555544322 223568899999999999999999999999999999999998
Q ss_pred C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccc-eeeeccCCCcccccccccceeeecccccccccCCCcccccCC
Q psy501 388 E-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRH-GFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST 465 (962)
Q Consensus 388 g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~-gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt 465 (962)
| +|.+++.. .+.+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++............|+
T Consensus 87 ~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 165 (333)
T cd06650 87 GGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 165 (333)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccCCCC
Confidence 5 66666654 45689999999999999999999975 799999999999999999999999999976655444556789
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHH------------------------------
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERL------------------------------ 515 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i------------------------------ 515 (962)
..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+
T Consensus 166 ~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (333)
T cd06650 166 RSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPD 244 (333)
T ss_pred ccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhccc
Confidence 99999999965 46899999999999999999999999765432221110
Q ss_pred --------------HhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 516 --------------KSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 516 --------------~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
............++..+..++..||..+|++||++.+++..-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~ 300 (333)
T cd06650 245 SRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA 300 (333)
T ss_pred ccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence 000000000112344567899999999999999988887654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=296.73 Aligned_cols=228 Identities=20% Similarity=0.250 Sum_probs=181.8
Q ss_pred CcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCCC-CHHHH
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKE-NLYQL 393 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~ 393 (962)
+.+.||.+......+.++.|.... .......|..++..+ +||+|+++++++.+++.+++||||++| +|...
T Consensus 7 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~ 86 (316)
T cd05619 7 SFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFH 86 (316)
T ss_pred CCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHH
Confidence 344577777766665554443322 234567788888764 899999999999999999999999985 66666
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccccccc--CCCcccccCCccccCh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR--SRPYTDYVSTRWYRAP 471 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~--~~~~~~~~gt~~Y~AP 471 (962)
+.. ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.... ........||..|+||
T Consensus 87 l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aP 165 (316)
T cd05619 87 IQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAP 165 (316)
T ss_pred HHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCH
Confidence 554 3568999999999999999999999999999999999999999999999999987532 2233446789999999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHH
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 551 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~ 551 (962)
|++.+ ..++.++|||||||++|||++|+.||.+.........+....... ....+..+..++..||..+|++||++.
T Consensus 166 E~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~ 242 (316)
T cd05619 166 EILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCY--PRWLTREAKDILVKLFVREPERRLGVK 242 (316)
T ss_pred HHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--CccCCHHHHHHHHHHhccCHhhcCCCh
Confidence 99965 468999999999999999999999999887766666655443222 234666788999999999999999976
Q ss_pred -HHH
Q psy501 552 -ILL 554 (962)
Q Consensus 552 -~Ll 554 (962)
+++
T Consensus 243 ~~l~ 246 (316)
T cd05619 243 GDIR 246 (316)
T ss_pred HHHH
Confidence 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=304.10 Aligned_cols=245 Identities=20% Similarity=0.220 Sum_probs=195.8
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
..+.....++.++.+.||.+....+.+.++.++... ....+.+|+.+++.++||+|+++++++.++...|+||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 455555555555566688888887777766655432 2335778999999999999999999999999999999
Q ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---Cc
Q psy501 384 EYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PY 459 (962)
Q Consensus 384 Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~ 459 (962)
||++| +|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 123 Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~ 200 (371)
T cd05622 123 EYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 200 (371)
T ss_pred cCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccc
Confidence 99985 56665543 34899999999999999999999999999999999999999999999999999876433 22
Q ss_pred ccccCCccccChhhhccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcc--ccccCCCCCCCCcHH
Q psy501 460 TDYVSTRWYRAPEVLLHST---AYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSY--ILLHTLPLYTYHVPP 534 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~---~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~s~~l~~ 534 (962)
....||+.|+|||++.+.. .++.++|||||||++|||++|+.||.+.+.......+.... ..++..+.++.....
T Consensus 201 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 280 (371)
T cd05622 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 280 (371)
T ss_pred cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHH
Confidence 3457999999999996432 37899999999999999999999999988777777766533 233434466778889
Q ss_pred HHHHHhccCCCC--CCcHHHHHhhc
Q psy501 535 IQTTCLLAGTER--LKSSYILLHTL 557 (962)
Q Consensus 535 li~~Cl~~dper--RPs~~~Ll~~l 557 (962)
++..|+..++.| |+++.+++...
T Consensus 281 li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 281 LICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHHHHcCChhhhcCCCCHHHHhcCc
Confidence 999999866655 77888877755
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=287.39 Aligned_cols=208 Identities=16% Similarity=0.221 Sum_probs=174.2
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceee
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFF 426 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIv 426 (962)
...+.+|+.++++++||||+++++++..++..++||||+++ +|.+++......+++..++.++.|++.||+|||+.|++
T Consensus 50 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~ii 129 (266)
T cd05064 50 RRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYV 129 (266)
T ss_pred HHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 34688999999999999999999999999999999999986 45555555556799999999999999999999999999
Q ss_pred eccCCCcccccccccceeeecccccccccCCC---cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCC
Q psy501 427 HRDMKPENLLCMGTELVKIADFGLAREIRSRP---YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPP 502 (962)
Q Consensus 427 HrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~P 502 (962)
||||||+||+++.++.++++|||.+....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |+.|
T Consensus 130 H~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p 208 (266)
T cd05064 130 HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERP 208 (266)
T ss_pred eccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCC
Confidence 99999999999999999999999876543221 112234578999999865 478999999999999999775 9999
Q ss_pred CCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 503 IQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 503 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
|.+.........+..+. ..+..+.++..+..++..||..+|+.||++.+|.+.+
T Consensus 209 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l 262 (266)
T cd05064 209 YWDMSGQDVIKAVEDGF-RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262 (266)
T ss_pred cCcCCHHHHHHHHHCCC-CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHH
Confidence 99887766666665543 2344456777888999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=297.61 Aligned_cols=230 Identities=20% Similarity=0.261 Sum_probs=184.9
Q ss_pred CcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCCC-CHHHH
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKE-NLYQL 393 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~ 393 (962)
+.+.||.+....+++.++.|.... ....+.+|+++++.+ +||+|+++++++.+.+.+|+||||+.| +|...
T Consensus 7 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 86 (318)
T cd05570 7 SFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFH 86 (318)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHH
Confidence 344577777666555544443322 234577888999888 699999999999999999999999985 55555
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC--CCcccccCCccccCh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAP 471 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~--~~~~~~~gt~~Y~AP 471 (962)
+.. ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++..... .......|++.|+||
T Consensus 87 ~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aP 165 (318)
T cd05570 87 IQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAP 165 (318)
T ss_pred HHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCH
Confidence 544 45699999999999999999999999999999999999999999999999999865322 233345689999999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcH-
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS- 550 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~- 550 (962)
|++.+ ..++.++|||||||++|+|++|+.||.+.........+.......+ ...+..+..++..||..+|.+||++
T Consensus 166 E~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~~l~~dP~~R~s~~ 242 (318)
T cd05570 166 EILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP--RWLSKEAKSILKSFLTKNPEKRLGCL 242 (318)
T ss_pred HHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC--CcCCHHHHHHHHHHccCCHHHcCCCC
Confidence 99975 4789999999999999999999999998877666666655543332 3567778899999999999999998
Q ss_pred ----HHHHhh
Q psy501 551 ----YILLHT 556 (962)
Q Consensus 551 ----~~Ll~~ 556 (962)
.++++.
T Consensus 243 ~~~~~~ll~~ 252 (318)
T cd05570 243 PTGEQDIKGH 252 (318)
T ss_pred CCCHHHHhcC
Confidence 777654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=304.46 Aligned_cols=239 Identities=20% Similarity=0.249 Sum_probs=183.4
Q ss_pred EEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-
Q psy501 317 FSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE- 388 (962)
Q Consensus 317 ~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g- 388 (962)
..++.++.+.||++....+++.++.|+... ....+.+|++++++++||+|+++++++.+++.+|+||||++|
T Consensus 7 ~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg 86 (381)
T cd05626 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG 86 (381)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence 334444455688887777666655554322 234578999999999999999999999999999999999985
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-----------
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----------- 457 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----------- 457 (962)
+|.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..+...
T Consensus 87 ~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~ 165 (381)
T cd05626 87 DMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSH 165 (381)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccccccc
Confidence 56666554 456899999999999999999999999999999999999999999999999997533100
Q ss_pred --------------------------------------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcC
Q psy501 458 --------------------------------------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDH 499 (962)
Q Consensus 458 --------------------------------------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG 499 (962)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il~elltG 244 (381)
T cd05626 166 IRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILFEMLVG 244 (381)
T ss_pred ccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhHHHHHHhC
Confidence 0123469999999999965 4689999999999999999999
Q ss_pred CCCCCCcChhhhHHHHHhc--cccccCCCCCCCCcHHHHHH--HhccCCCCCCcHHHHHhhc
Q psy501 500 VPPIQTTCLLAGTERLKSS--YILLHTLPLYTYHVPPIQTT--CLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 500 ~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~s~~l~~li~~--Cl~~dperRPs~~~Ll~~l 557 (962)
+.||...........+... ....+....++.....++.. |+..++..|+++.+++..-
T Consensus 245 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp 306 (381)
T cd05626 245 QPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP 306 (381)
T ss_pred CCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence 9999887765555555432 22233333456667777777 4444555599988877643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=326.97 Aligned_cols=259 Identities=18% Similarity=0.214 Sum_probs=207.8
Q ss_pred EEecCCccc-EEEEEecCCce------EEEEec----cchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecC
Q psy501 318 SYILPHTLP-LYTCNLDQDNH------ILSRHV----SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 318 ~~i~~~~~~-Vy~~~~~~~~k------vv~~k~----~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
.++++|.|+ ||.+......- ++.+.+ ...+..+|.+|..+|++++|||||+++|++.+.+..+|++|||
T Consensus 698 ~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM 777 (1025)
T KOG1095|consen 698 RVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYM 777 (1025)
T ss_pred eeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhc
Confidence 445555554 88885543221 222222 2334568999999999999999999999999999999999999
Q ss_pred C-CCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCc
Q psy501 387 K-ENLYQLIRDR------DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY 459 (962)
Q Consensus 387 ~-g~Ll~~l~~~------~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~ 459 (962)
+ |+|+.+++.. ...++..+++.++.|||+|+.||+++++|||||..+|+|++....|||+|||+|+.+.....
T Consensus 778 ~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~y 857 (1025)
T KOG1095|consen 778 EGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDY 857 (1025)
T ss_pred ccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchh
Confidence 8 7899999887 56799999999999999999999999999999999999999999999999999996655433
Q ss_pred cccc----CCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHH
Q psy501 460 TDYV----STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPP 534 (962)
Q Consensus 460 ~~~~----gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 534 (962)
.... -...|||||.+.. ..++.|+|||||||+|||++| |..||.+....+.......+- +.+.++.+|..+.+
T Consensus 858 yr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P~~CP~~ly~ 935 (1025)
T KOG1095|consen 858 YRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPPSYCPEKLYQ 935 (1025)
T ss_pred eeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCCCCCChHHHH
Confidence 3222 2357999999986 479999999999999999999 999999988888777554443 55666889999999
Q ss_pred HHHHHhccCCCCCCcHHHHHhhccccccCCCCcchhhhcccccc
Q psy501 535 IQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTER 578 (962)
Q Consensus 535 li~~Cl~~dperRPs~~~Ll~~l~~~~~~~~~~~~~~~l~g~~~ 578 (962)
++..||..+|+.||++..|++.++......-+-.-.+..+..+.
T Consensus 936 lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~~~a~~~~ 979 (1025)
T KOG1095|consen 936 LMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGPLPADYES 979 (1025)
T ss_pred HHHHHccCChhhCccHHHHHhhhhhhhhhhccCcccccccccCc
Confidence 99999999999999999999977655444333333444444333
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=304.64 Aligned_cols=244 Identities=19% Similarity=0.203 Sum_probs=193.7
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
+.+.....++.++.+.||.+....+.+.++.|+... +...+.+|+.+++.++||+|+++++++.++..+|+||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 445555555555666688888877776666554332 2345788999999999999999999999999999999
Q ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---c
Q psy501 384 EYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---Y 459 (962)
Q Consensus 384 Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---~ 459 (962)
||++ |+|.+.+... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|....... .
T Consensus 123 Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~ 200 (370)
T cd05621 123 EYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC 200 (370)
T ss_pred cCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceec
Confidence 9998 4666666433 48999999999999999999999999999999999999999999999999998764332 2
Q ss_pred ccccCCccccChhhhccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc--cccCCCCCCCCcHH
Q psy501 460 TDYVSTRWYRAPEVLLHST---AYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI--LLHTLPLYTYHVPP 534 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~---~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~s~~l~~ 534 (962)
....||+.|+|||++.+.. .++.++|||||||++|||++|+.||.+.........+..... ..+.....+.....
T Consensus 201 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~ 280 (370)
T cd05621 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKN 280 (370)
T ss_pred ccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHH
Confidence 3457999999999996432 378999999999999999999999998887766666665332 22322345667788
Q ss_pred HHHHHhccCCCC--CCcHHHHHhh
Q psy501 535 IQTTCLLAGTER--LKSSYILLHT 556 (962)
Q Consensus 535 li~~Cl~~dper--RPs~~~Ll~~ 556 (962)
++..|+..++.+ |+++.++++.
T Consensus 281 li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 281 LICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHHccCchhccCCCCHHHHhcC
Confidence 999999877765 8888877764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=305.77 Aligned_cols=240 Identities=20% Similarity=0.243 Sum_probs=185.5
Q ss_pred eeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecC
Q psy501 314 RLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 314 ~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
.....++.++.+.||.+.....++.++.|+... ....+.+|+++|++++||+|+++++.+.+++.+|+||||+
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (376)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCC
Confidence 344445555556688888777776666655432 2345788999999999999999999999999999999999
Q ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--------
Q psy501 387 KE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-------- 457 (962)
Q Consensus 387 ~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-------- 457 (962)
+| +|.+.+.. .+.+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+|..+...
T Consensus 84 ~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~ 162 (376)
T cd05598 84 PGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQK 162 (376)
T ss_pred CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccc
Confidence 85 56666654 456899999999999999999999999999999999999999999999999997532100
Q ss_pred -------------------------------------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCC
Q psy501 458 -------------------------------------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHV 500 (962)
Q Consensus 458 -------------------------------------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~ 500 (962)
......||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyell~G~ 241 (376)
T cd05598 163 GDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQ 241 (376)
T ss_pred ccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeehhhCC
Confidence 0113468999999999965 47899999999999999999999
Q ss_pred CCCCCcChhhhHHHHHhccc--cccCCCCCCCCcHHHHHHHhccCCCCCC---cHHHHHhh
Q psy501 501 PPIQTTCLLAGTERLKSSYI--LLHTLPLYTYHVPPIQTTCLLAGTERLK---SSYILLHT 556 (962)
Q Consensus 501 ~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~s~~l~~li~~Cl~~dperRP---s~~~Ll~~ 556 (962)
.||.+.........+..... ..+.....+.....++..|+ .+|++|+ ++.+++..
T Consensus 242 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 242 PPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99998876665555543222 22222345556677777765 5888898 76776654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=289.86 Aligned_cols=236 Identities=25% Similarity=0.372 Sum_probs=180.1
Q ss_pred EecCCcccEEEEEecC-CceEEEEeccc------hhHHHHHHHHHHHHhc---CCCCcccEEEEEE-----eCCEEEEEE
Q psy501 319 YILPHTLPLYTCNLDQ-DNHILSRHVSS------RDEMVVCFYRKSLKKL---SHANLVKLKEVIR-----ENDTLYFVF 383 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~-~~kvv~~k~~~------~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~-----~~~~~~LV~ 383 (962)
+..++.+.||.+.... .++.++.|... .......+|+.+++.+ +||||+++++++. ....+++||
T Consensus 9 lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~ 88 (290)
T cd07862 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF 88 (290)
T ss_pred eccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEE
Confidence 3334445577776532 23333322211 1223466788877766 6999999999985 245689999
Q ss_pred ecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-Cccc
Q psy501 384 EYMKENLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTD 461 (962)
Q Consensus 384 Ey~~g~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~ 461 (962)
||+++++.+++... ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...... ....
T Consensus 89 e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 168 (290)
T cd07862 89 EHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 168 (290)
T ss_pred ccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCccccc
Confidence 99999998888654 345899999999999999999999999999999999999999999999999999765443 3344
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-------------------
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL------------------- 522 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------------- 522 (962)
..|++.|+|||++.+ ..++.++|||||||++|||++|++||.+.........+......+
T Consensus 169 ~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (290)
T cd07862 169 VVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSK 247 (290)
T ss_pred ccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCC
Confidence 578999999999965 468999999999999999999999999877665555554321100
Q ss_pred ------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHh
Q psy501 523 ------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLH 555 (962)
Q Consensus 523 ------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~ 555 (962)
...+..+..+.+++..||..+|++||++.+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 248 SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 001234556678999999999999999888775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=298.06 Aligned_cols=224 Identities=21% Similarity=0.317 Sum_probs=180.0
Q ss_pred CcccEEEEEecCCceEEEEeccch-------hHHHHHHHHH-HHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHH
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRK-SLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQL 393 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~ 393 (962)
+.+.||.+....+++.++.|.... ....+..|.. +++.++||||+++++++.+++..|+||||+.| +|...
T Consensus 7 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 86 (323)
T cd05575 7 SFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFH 86 (323)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHH
Confidence 344578887766666555444322 1223445544 46789999999999999999999999999985 55555
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC--CCcccccCCccccCh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAP 471 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~--~~~~~~~gt~~Y~AP 471 (962)
+.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..... .......||+.|+||
T Consensus 87 l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aP 165 (323)
T cd05575 87 LQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAP 165 (323)
T ss_pred HHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcCh
Confidence 544 45699999999999999999999999999999999999999999999999999875322 233445789999999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcH
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 550 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~ 550 (962)
|++.+ ..++.++|||||||++|||++|..||...........+...... ..+..+..+..++..||..+|.+||++
T Consensus 166 E~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~ 241 (323)
T cd05575 166 EVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR--LKPNISVSARHLLEGLLQKDRTKRLGA 241 (323)
T ss_pred hhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHhhcCHHhCCCC
Confidence 99965 46899999999999999999999999988776666666655333 234567788999999999999999986
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=289.36 Aligned_cols=245 Identities=24% Similarity=0.312 Sum_probs=191.4
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
+.....+..++.+.||.+......+.++.+... .....+.+|+.++++++||||+++++++..++..++||||++
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 344444444555568888776655544443322 123457889999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCC
Q psy501 388 ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVST 465 (962)
Q Consensus 388 g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt 465 (962)
+++...+......+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... ......++
T Consensus 88 ~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 167 (301)
T cd07873 88 KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVT 167 (301)
T ss_pred cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccccccee
Confidence 9999988877677999999999999999999999999999999999999999999999999999764332 22334678
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc-------------------cc---
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL-------------------LH--- 523 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------~~--- 523 (962)
+.|+|||++.+...++.++|||||||++|||++|++||.+.+.......+...... .+
T Consensus 168 ~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (301)
T cd07873 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYR 247 (301)
T ss_pred ecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccc
Confidence 89999999877667899999999999999999999999877654333322211000 00
Q ss_pred ------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 524 ------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 524 ------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..+..+..+.+++..||..+|.+||++.++++.-
T Consensus 248 ~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~ 287 (301)
T cd07873 248 ADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287 (301)
T ss_pred cccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0112344567899999999999999988888644
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=292.05 Aligned_cols=209 Identities=20% Similarity=0.221 Sum_probs=168.3
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC------------------CCCCHHHHHH
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD------------------KFLPESIIRN 408 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~------------------~~ls~~~i~~ 408 (962)
...+.+|+++|++++||||+++++++.+.+..++||||+. |+|.+++.... ..+++..++.
T Consensus 63 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (304)
T cd05096 63 RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLH 142 (304)
T ss_pred HHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHH
Confidence 3468899999999999999999999999999999999997 57777664421 2467889999
Q ss_pred HHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchh
Q psy501 409 MMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPI 484 (962)
Q Consensus 409 i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ks 484 (962)
++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....... .....++..|+|||++.+. .++.++
T Consensus 143 i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~ 221 (304)
T cd05096 143 VALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTAS 221 (304)
T ss_pred HHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchh
Confidence 99999999999999999999999999999999999999999997654332 2223457789999998654 689999
Q ss_pred HHHHHHHHHHHHHc--CCCCCCCcChhhhHHHHHhc------cccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 485 HLSRSQQFLFYSID--HVPPIQTTCLLAGTERLKSS------YILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 485 DIwSLGvlL~ellt--G~~Pf~~~~~~~~~~~i~~~------~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
|||||||++|||++ |..||...........+... .......+.++..+..++..||..+|++||++.++.+.
T Consensus 222 Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~ 301 (304)
T cd05096 222 DVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAF 301 (304)
T ss_pred hhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 99999999999986 67888876554443332211 11122234566778899999999999999999999775
Q ss_pred c
Q psy501 557 L 557 (962)
Q Consensus 557 l 557 (962)
|
T Consensus 302 l 302 (304)
T cd05096 302 L 302 (304)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=306.17 Aligned_cols=248 Identities=19% Similarity=0.193 Sum_probs=197.1
Q ss_pred eeEEEEecCCccc-EEEEEecCCceEEE-Eeccchh---HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC
Q psy501 314 RLKFSYILPHTLP-LYTCNLDQDNHILS-RHVSSRD---EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE 388 (962)
Q Consensus 314 ~~~~~~i~~~~~~-Vy~~~~~~~~kvv~-~k~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g 388 (962)
.....++++|+++ ||++++..+...++ +.+..++ ..-+..|+.+-++|+|.|||+++|.+.+++++-|.||-++|
T Consensus 577 ~~ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 577 SNERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred CCceEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence 3344556666655 88888777665444 4443333 23488999999999999999999999999999999999985
Q ss_pred -CHHHHHHhcCCCC--CHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccc-cccceeeecccccccccC--CCcccc
Q psy501 389 -NLYQLIRDRDKFL--PESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM-GTELVKIADFGLAREIRS--RPYTDY 462 (962)
Q Consensus 389 -~Ll~~l~~~~~~l--s~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~-~~g~vKL~DFGla~~~~~--~~~~~~ 462 (962)
+|.+.++..=+++ .+.++-.+.+||++||.|||+..|||||||.+||||. ..|.+||+|||.++++.. +....+
T Consensus 657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 5666666655677 8899999999999999999999999999999999995 678999999999988764 355668
Q ss_pred cCCccccChhhhc-cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh-HHHHHhccccccCCCCCCCCcHHHHHHHh
Q psy501 463 VSTRWYRAPEVLL-HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG-TERLKSSYILLHTLPLYTYHVPPIQTTCL 540 (962)
Q Consensus 463 ~gt~~Y~APE~l~-~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~s~~l~~li~~Cl 540 (962)
.||+.|||||++- |...|+.++|||||||++.||.||++||........ +-++..-...++.+...+...+.+|..|+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 8999999999995 445699999999999999999999999987654443 33333222333333355566778999999
Q ss_pred ccCCCCCCcHHHHHhhccccc
Q psy501 541 LAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 541 ~~dperRPs~~~Ll~~l~~~~ 561 (962)
..+|..||++.+|++.-..+.
T Consensus 817 epd~~~R~sA~~LL~DpFlq~ 837 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQDPFLQH 837 (1226)
T ss_pred CCCcccCccHHHhccCccccc
Confidence 999999999999998654443
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=295.49 Aligned_cols=229 Identities=18% Similarity=0.216 Sum_probs=183.2
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcCCC-CcccEEEEEEeCCEEEEEEecCCC-
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLSHA-NLVKLKEVIRENDTLYFVFEYMKE- 388 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~Hp-nIv~l~~~~~~~~~~~LV~Ey~~g- 388 (962)
.++.++.+.||.+......+.++.|+.. .+...+..|++++..+.|+ +|+++++++.+.+.+|+||||++|
T Consensus 7 ~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 86 (324)
T cd05587 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 86 (324)
T ss_pred EEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCC
Confidence 3344445568888777666655544432 2234578899999999765 688899999999999999999985
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccccccc--CCCcccccCCc
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR--SRPYTDYVSTR 466 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~--~~~~~~~~gt~ 466 (962)
+|.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.... ........||+
T Consensus 87 ~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 165 (324)
T cd05587 87 DLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTP 165 (324)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCc
Confidence 56555544 4568999999999999999999999999999999999999999999999999986532 22334457899
Q ss_pred cccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCC
Q psy501 467 WYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTER 546 (962)
Q Consensus 467 ~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dper 546 (962)
.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+....... ....+..+..++..||..+|.+
T Consensus 166 ~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~li~~~l~~~P~~ 242 (324)
T cd05587 166 DYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY--PKSLSKEAVSICKGLLTKHPAK 242 (324)
T ss_pred cccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCHHHHHHHHHHhhcCHHH
Confidence 9999999975 468999999999999999999999999887777766666554332 2356667788999999999999
Q ss_pred CCcH
Q psy501 547 LKSS 550 (962)
Q Consensus 547 RPs~ 550 (962)
|++.
T Consensus 243 R~~~ 246 (324)
T cd05587 243 RLGC 246 (324)
T ss_pred cCCC
Confidence 9974
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=285.87 Aligned_cols=238 Identities=26% Similarity=0.376 Sum_probs=184.4
Q ss_pred EecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHH
Q psy501 319 YILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQ 392 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~ 392 (962)
+..++.+.||.+.....+..++.+... .....+.+|+.++++++||||+++++++.++...|+||||+.+++.+
T Consensus 8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~ 87 (285)
T cd07861 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKK 87 (285)
T ss_pred ecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCCCCHHH
Confidence 333444557777665544444333221 12346889999999999999999999999999999999999998888
Q ss_pred HHHhcC--CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccc
Q psy501 393 LIRDRD--KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWY 468 (962)
Q Consensus 393 ~l~~~~--~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y 468 (962)
.+.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ......+++.|
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y 167 (285)
T cd07861 88 YLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWY 167 (285)
T ss_pred HHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccc
Confidence 876532 56899999999999999999999999999999999999999999999999999765433 22334668899
Q ss_pred cChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc---------------------------c
Q psy501 469 RAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI---------------------------L 521 (962)
Q Consensus 469 ~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~---------------------------~ 521 (962)
+|||++.+...++.++|||||||++|+|++|++||.+.........+..... .
T Consensus 168 ~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (285)
T cd07861 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSL 247 (285)
T ss_pred cChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchh
Confidence 9999987766689999999999999999999999987655433322211100 0
Q ss_pred ccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 522 LHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 522 ~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
......++..+.+++..||..+|++||++.+++..
T Consensus 248 ~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 248 RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00112345566789999999999999999888764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=283.11 Aligned_cols=207 Identities=19% Similarity=0.293 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeee
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFH 427 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvH 427 (962)
..+.+|++++++++||||+++++++.++...++|+||++| ++.+.+.. .+.+++..+..++.|++.||.|||+.|++|
T Consensus 49 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H 127 (263)
T cd06625 49 NALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVH 127 (263)
T ss_pred HHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 3588899999999999999999999999999999999985 55555544 456899999999999999999999999999
Q ss_pred ccCCCcccccccccceeeecccccccccCCC-----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCC
Q psy501 428 RDMKPENLLCMGTELVKIADFGLAREIRSRP-----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPP 502 (962)
Q Consensus 428 rDLkp~NILl~~~g~vKL~DFGla~~~~~~~-----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~P 502 (962)
+||+|+||+++.++.++|+|||++....... .....++..|+|||++.+. .++.++|||||||++|||++|+.|
T Consensus 128 ~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p 206 (263)
T cd06625 128 RDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPP 206 (263)
T ss_pred CCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999987654321 1334678899999999764 589999999999999999999999
Q ss_pred CCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 503 IQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 503 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
|...........+.............+..+..++..||..+|++||++.+++...
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 207 WAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred ccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 9877665555554444333333446677888999999999999999999888754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=303.44 Aligned_cols=236 Identities=20% Similarity=0.269 Sum_probs=181.1
Q ss_pred EEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-
Q psy501 317 FSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE- 388 (962)
Q Consensus 317 ~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g- 388 (962)
..++.++.+.||++.....++.++.|.... ....+.+|++++++++||+|+++++.+.+++.+|+|||||+|
T Consensus 7 ~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (382)
T cd05625 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 86 (382)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCC
Confidence 334444455688888777776655554332 234588899999999999999999999999999999999985
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-----------
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----------- 457 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----------- 457 (962)
+|.+.+... +.+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..+...
T Consensus 87 ~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~ 165 (382)
T cd05625 87 DMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDH 165 (382)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccc
Confidence 666666544 56899999999999999999999999999999999999999999999999997532100
Q ss_pred --------------------------------------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcC
Q psy501 458 --------------------------------------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDH 499 (962)
Q Consensus 458 --------------------------------------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG 499 (962)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil~elltG 244 (382)
T cd05625 166 VRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVG 244 (382)
T ss_pred cccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHHHHHHHhC
Confidence 0112468999999999965 4789999999999999999999
Q ss_pred CCCCCCcChhhhHHHHHhccc--cccCCCCCCCCcHHHHHHHhccCCCCCCc---HHHHHh
Q psy501 500 VPPIQTTCLLAGTERLKSSYI--LLHTLPLYTYHVPPIQTTCLLAGTERLKS---SYILLH 555 (962)
Q Consensus 500 ~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~s~~l~~li~~Cl~~dperRPs---~~~Ll~ 555 (962)
++||.+.........+..... ..+.....+.....++..++ .+|++|++ +.+++.
T Consensus 245 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 245 QPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred CCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 999998877666655554322 22222345555666665544 48888885 655554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-33 Score=282.37 Aligned_cols=240 Identities=26% Similarity=0.379 Sum_probs=198.9
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE 388 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g 388 (962)
+.|.+..++..+.+.++..|.++... .+++...+.+.+.+|++|-+.|+||||+++.+.+.+.+..|||+|++.|
T Consensus 20 gkG~FSvVrRc~~~~tg~~fa~kiin-----~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G 94 (355)
T KOG0033|consen 20 GKGAFSVVRRCVHKTTGLEFAAKIIN-----TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 94 (355)
T ss_pred ccCchHHHHHHHhccchHHHHHHHhh-----hhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccc
Confidence 34444444444444444444444322 3445556788899999999999999999999999999999999999985
Q ss_pred -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc---cceeeecccccccccCC-Cccccc
Q psy501 389 -NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT---ELVKIADFGLAREIRSR-PYTDYV 463 (962)
Q Consensus 389 -~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~---g~vKL~DFGla~~~~~~-~~~~~~ 463 (962)
++...+..+ ..+++..+-.+++||++||.|+|..||||||+||.|+++... .-+||+|||+|..+... ......
T Consensus 95 ~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~ 173 (355)
T KOG0033|consen 95 GELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFA 173 (355)
T ss_pred hHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcccccccc
Confidence 566666554 458999999999999999999999999999999999999543 36999999999887744 566789
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC--CCCCCCCcHHHHHHHhc
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT--LPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l~~li~~Cl~ 541 (962)
||+.|||||++.. .+|+..+|||+.||+||-|+.|.+||.+.+.....+.|..+....+. ++..++..+.+++.+|.
T Consensus 174 GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~ 252 (355)
T KOG0033|consen 174 GTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLT 252 (355)
T ss_pred CCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhc
Confidence 9999999999965 48999999999999999999999999999999999999998876654 56778889999999999
Q ss_pred cCCCCCCcHH-HHHh
Q psy501 542 AGTERLKSSY-ILLH 555 (962)
Q Consensus 542 ~dperRPs~~-~Ll~ 555 (962)
.||.+|-++. +|.|
T Consensus 253 ~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 253 VNPKKRITADEALKH 267 (355)
T ss_pred cChhhhccHHHHhCC
Confidence 9999999855 4555
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=282.40 Aligned_cols=238 Identities=23% Similarity=0.269 Sum_probs=188.2
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHH
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLI 394 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l 394 (962)
.++.++.+.||.+.......++.+.+.. .....+.+|+.++++++||||+++++++......++||||+. |+|.+++
T Consensus 11 ~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i 90 (256)
T cd05113 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL 90 (256)
T ss_pred EecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHH
Confidence 3333444557777655443333333322 224568999999999999999999999998889999999997 5677777
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcc---cccCCccccCh
Q psy501 395 RDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT---DYVSTRWYRAP 471 (962)
Q Consensus 395 ~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~---~~~gt~~Y~AP 471 (962)
......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+......... ...++..|+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~p 170 (256)
T cd05113 91 REHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170 (256)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCH
Confidence 665557899999999999999999999999999999999999999999999999998765443222 22345679999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcH
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 550 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~ 550 (962)
|.+.+. .++.++|||||||++|+|++ |..||...........+..+.. .......+..+..++..||..+|++||++
T Consensus 171 e~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 248 (256)
T cd05113 171 EVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR-LYRPHLASEKVYAIMYSCWHEKAEERPTF 248 (256)
T ss_pred HHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence 999654 68999999999999999998 9999988776666566655432 22233456778899999999999999999
Q ss_pred HHHHhhc
Q psy501 551 YILLHTL 557 (962)
Q Consensus 551 ~~Ll~~l 557 (962)
.+|+..+
T Consensus 249 ~~ll~~~ 255 (256)
T cd05113 249 QQLLSSI 255 (256)
T ss_pred HHHHHhh
Confidence 9998765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=297.27 Aligned_cols=245 Identities=23% Similarity=0.236 Sum_probs=187.7
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-----
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIREND----- 377 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----- 377 (962)
..+.|.....++.++.+.||.+.....++.++.|... .....+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3455666666666666679999877666554444322 22346789999999999999999999986443
Q ss_pred -EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC
Q psy501 378 -TLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS 456 (962)
Q Consensus 378 -~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~ 456 (962)
..|+||||+++++...+.. .+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 5799999999998887643 388999999999999999999999999999999999999999999999999976543
Q ss_pred C-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhc-----------------
Q psy501 457 R-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSS----------------- 518 (962)
Q Consensus 457 ~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~----------------- 518 (962)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 176 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (359)
T cd07876 176 NFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254 (359)
T ss_pred CccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 3 3344678999999999965 47899999999999999999999999876543222111100
Q ss_pred -----ccccc------------------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 519 -----YILLH------------------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 519 -----~~~~~------------------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
....+ .....+..+..++..||..+|++||++.+++..-
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00000 0001234567899999999999999988887754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=298.94 Aligned_cols=248 Identities=19% Similarity=0.197 Sum_probs=186.9
Q ss_pred cCceeeEEEEecCCcccEEEEEecC--CceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQ--DNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~--~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
.+.+.....+..++.+.||.|.... ..+.++.+.... .....+|+++|++++||||+++++++......|+|||++.
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~-~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 169 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTG-GKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccc-cccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC
Confidence 3455555555555566688886433 223333333222 2346789999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----Cccccc
Q psy501 388 ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PYTDYV 463 (962)
Q Consensus 388 g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~~~~ 463 (962)
+++.+++. ....+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...... ......
T Consensus 170 ~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~ 248 (392)
T PHA03207 170 CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248 (392)
T ss_pred CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccc
Confidence 99999884 3456999999999999999999999999999999999999999999999999999765443 223457
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh---HHHHHhcc---------------------
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG---TERLKSSY--------------------- 519 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~---~~~i~~~~--------------------- 519 (962)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+...... ...+....
T Consensus 249 gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (392)
T PHA03207 249 GTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQ 327 (392)
T ss_pred cccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHh
Confidence 8999999999965 4689999999999999999999999977543211 11111000
Q ss_pred ----ccc-cCC------CCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 520 ----ILL-HTL------PLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 520 ----~~~-~~~------~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
... ... ..++..+..++..||..+|++||++.+++..- |+.
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p-~f~ 379 (392)
T PHA03207 328 YAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP-LFT 379 (392)
T ss_pred hcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc-hhh
Confidence 000 000 12345667789999999999999988877653 443
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=297.01 Aligned_cols=224 Identities=21% Similarity=0.313 Sum_probs=178.6
Q ss_pred cccEEEEEecCCceEEEEeccch-------hHHHHHHHHH-HHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHH
Q psy501 324 TLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRK-SLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLI 394 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l 394 (962)
.+.||.+......+.++.++... ....+..|.. +++.++||||+++++++..++..|+||||+.| +|.+.+
T Consensus 8 fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 87 (325)
T cd05602 8 FGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL 87 (325)
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHH
Confidence 34577777766665554444322 1223444443 56788999999999999999999999999986 555555
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC--CCcccccCCccccChh
Q psy501 395 RDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAPE 472 (962)
Q Consensus 395 ~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~--~~~~~~~gt~~Y~APE 472 (962)
. ....+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..... .......||+.|+|||
T Consensus 88 ~-~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE 166 (325)
T cd05602 88 Q-RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPE 166 (325)
T ss_pred H-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHH
Confidence 4 445689999999999999999999999999999999999999999999999999875432 2334467999999999
Q ss_pred hhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHH
Q psy501 473 VLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 551 (962)
Q Consensus 473 ~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~ 551 (962)
++.+ ..++.++|||||||++|+|++|.+||.+.........+..... ...+..+..+..++..||..+|.+|+++.
T Consensus 167 ~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (325)
T cd05602 167 VLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAK 242 (325)
T ss_pred HHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc--CCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 9975 4789999999999999999999999998877666666655432 23356777889999999999999999865
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=280.17 Aligned_cols=236 Identities=20% Similarity=0.288 Sum_probs=190.2
Q ss_pred EecCCcccEEEEEecCCceEEEEecc------chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHH
Q psy501 319 YILPHTLPLYTCNLDQDNHILSRHVS------SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLY 391 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~~~kvv~~k~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll 391 (962)
+..++.+.+|.+.....++.++.+.. ......+.+|++++++++||||+++++++.+++..++||||++ ++|.
T Consensus 8 l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 87 (256)
T cd08529 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLH 87 (256)
T ss_pred ecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHH
Confidence 33444456788776655554443321 2345578899999999999999999999999999999999997 5677
Q ss_pred HHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccc
Q psy501 392 QLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWY 468 (962)
Q Consensus 392 ~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y 468 (962)
+.+... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ......+++.|
T Consensus 88 ~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y 167 (256)
T cd08529 88 KLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYY 167 (256)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccc
Confidence 766654 457899999999999999999999999999999999999999999999999998866543 22334678899
Q ss_pred cChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCC
Q psy501 469 RAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK 548 (962)
Q Consensus 469 ~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRP 548 (962)
+|||++.+. .++.++|||||||++|+|++|+.||...........+..+... +....++..+..++..||..+|++||
T Consensus 168 ~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp 245 (256)
T cd08529 168 LSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP-PVSQMYSQQLAQLIDQCLTKDYRQRP 245 (256)
T ss_pred cCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCccccCHHHHHHHHHHccCCcccCc
Confidence 999999654 6889999999999999999999999887765555555444322 22225667789999999999999999
Q ss_pred cHHHHHhh
Q psy501 549 SSYILLHT 556 (962)
Q Consensus 549 s~~~Ll~~ 556 (962)
++.++++.
T Consensus 246 ~~~~ll~~ 253 (256)
T cd08529 246 DTFQLLRN 253 (256)
T ss_pred CHHHHhhC
Confidence 99988874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=296.64 Aligned_cols=209 Identities=21% Similarity=0.331 Sum_probs=189.5
Q ss_pred hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhccccee
Q psy501 347 DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGF 425 (962)
Q Consensus 347 ~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gI 425 (962)
....+..|++.|+-++|||||++|++......+|||+|+-+ |+|++++..+...++++...+++.||+.|+.|+|+..+
T Consensus 60 st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHV 139 (864)
T KOG4717|consen 60 STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHV 139 (864)
T ss_pred hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhh
Confidence 34579999999999999999999999999999999999998 59999999998889999999999999999999999999
Q ss_pred eeccCCCccccc-ccccceeeecccccccccCC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q psy501 426 FHRDMKPENLLC-MGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPI 503 (962)
Q Consensus 426 vHrDLkp~NILl-~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf 503 (962)
|||||||+||++ ..-|-+||.|||++..+... .....+|++.|.|||++.|.....+++||||||||||-|+.|++||
T Consensus 140 VHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PF 219 (864)
T KOG4717|consen 140 VHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPF 219 (864)
T ss_pred hcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcc
Confidence 999999999977 46789999999999777654 6778899999999999999876678999999999999999999999
Q ss_pred CCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 504 QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 504 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+..+..+..-.|....+..| ...+...+++|..+|+.||.+|.+.+++..+-
T Consensus 220 qeANDSETLTmImDCKYtvP--shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~ 271 (864)
T KOG4717|consen 220 QEANDSETLTMIMDCKYTVP--SHVSKECRDLIQSMLVRDPKKRASLEEIVSTS 271 (864)
T ss_pred ccccchhhhhhhhcccccCc--hhhhHHHHHHHHHHHhcCchhhccHHHHhccc
Confidence 99998888888887766554 56777889999999999999999988877654
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=285.29 Aligned_cols=244 Identities=20% Similarity=0.222 Sum_probs=187.3
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE 388 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g 388 (962)
+.....+..++.+.||.+.....++.++.++.. .....+.+|+.++++++||+|+++++++..++..++||||+++
T Consensus 11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~ 90 (267)
T cd06646 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGG 90 (267)
T ss_pred cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCC
Confidence 333444444455568888776655554444322 2334678899999999999999999999999999999999985
Q ss_pred -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCC
Q psy501 389 -NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVST 465 (962)
Q Consensus 389 -~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt 465 (962)
+|.+.+.. ...+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++...... ......++
T Consensus 91 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 169 (267)
T cd06646 91 GSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGT 169 (267)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccC
Confidence 55555544 456899999999999999999999999999999999999999999999999999866433 22345688
Q ss_pred ccccChhhhcc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCC---CCCCCCcHHHHHHHh
Q psy501 466 RWYRAPEVLLH--STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTL---PLYTYHVPPIQTTCL 540 (962)
Q Consensus 466 ~~Y~APE~l~~--~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~s~~l~~li~~Cl 540 (962)
..|+|||.+.+ ...++.++|||||||++|||++|+.||...........+.......+.. ..++..+..++..||
T Consensus 170 ~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 249 (267)
T cd06646 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISL 249 (267)
T ss_pred ccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHh
Confidence 89999998852 3347889999999999999999999997655433322222222222211 234567888999999
Q ss_pred ccCCCCCCcHHHHHhhc
Q psy501 541 LAGTERLKSSYILLHTL 557 (962)
Q Consensus 541 ~~dperRPs~~~Ll~~l 557 (962)
..+|++||++.+++..+
T Consensus 250 ~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 250 TKNPKKRPTAERLLTHL 266 (267)
T ss_pred hCChhhCcCHHHHhcCC
Confidence 99999999999988755
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=300.17 Aligned_cols=235 Identities=22% Similarity=0.285 Sum_probs=182.5
Q ss_pred CCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-----EEEEEEecCCCCH
Q psy501 322 PHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIREND-----TLYFVFEYMKENL 390 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~-----~~~LV~Ey~~g~L 390 (962)
++.+.||.+....+++.++.|... .....+.+|+++|+.++||||+++++++.... ..|+||||+.+++
T Consensus 11 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l 90 (372)
T cd07853 11 GAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDL 90 (372)
T ss_pred CCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccccCH
Confidence 344456776655444443333221 12346889999999999999999999998776 7999999999988
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---CcccccCCcc
Q psy501 391 YQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYVSTRW 467 (962)
Q Consensus 391 l~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~gt~~ 467 (962)
...+... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++...... ......++..
T Consensus 91 ~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~ 169 (372)
T cd07853 91 HKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY 169 (372)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCC
Confidence 8877654 46999999999999999999999999999999999999999999999999999765432 2234467899
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhc-----------------------ccccc-
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSS-----------------------YILLH- 523 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~-----------------------~~~~~- 523 (962)
|+|||++.+...++.++|||||||++|||++|+.||.+.........+... ....+
T Consensus 170 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (372)
T cd07853 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPS 249 (372)
T ss_pred cCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCc
Confidence 999999987667899999999999999999999999887655443333211 00000
Q ss_pred ------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 524 ------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 524 ------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.....+.....++..||..+|++||++.+++..-
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 250 LPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred hHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 1112345567899999999999999988777643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=297.88 Aligned_cols=197 Identities=18% Similarity=0.290 Sum_probs=169.3
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeee
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFH 427 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvH 427 (962)
..+..|+++|++++||||+++++++.+++..|+||||+. |+|.+.+.. ...+++..++.++.||+.||.|||+.||+|
T Consensus 43 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H 121 (318)
T cd05582 43 VRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIY 121 (318)
T ss_pred HHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 457789999999999999999999999999999999998 566666644 456899999999999999999999999999
Q ss_pred ccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q psy501 428 RDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQT 505 (962)
Q Consensus 428 rDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~ 505 (962)
|||||+||+++.++.+||+|||++...... ......|++.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 122 ~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~ 200 (318)
T cd05582 122 RDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQG 200 (318)
T ss_pred CCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCC
Confidence 999999999999999999999998765433 2334578999999999965 4688999999999999999999999998
Q ss_pred cChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCc
Q psy501 506 TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 549 (962)
Q Consensus 506 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs 549 (962)
.........+....... ....+..+..+++.||..+|++||+
T Consensus 201 ~~~~~~~~~i~~~~~~~--p~~~~~~~~~li~~~l~~~P~~R~~ 242 (318)
T cd05582 201 KDRKETMTMILKAKLGM--PQFLSPEAQSLLRALFKRNPANRLG 242 (318)
T ss_pred CCHHHHHHHHHcCCCCC--CCCCCHHHHHHHHHHhhcCHhHcCC
Confidence 87766666665543322 2456777889999999999999998
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=282.41 Aligned_cols=238 Identities=20% Similarity=0.229 Sum_probs=190.6
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccchh---HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHH
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSSRD---EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQL 393 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~ 393 (962)
.+..++.+.||.+......+.++.+....+ ...+.+|++++++++||+|+++++++..+..+++||||++ ++|.+.
T Consensus 13 ~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 92 (263)
T cd05052 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 92 (263)
T ss_pred ecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHH
Confidence 334444556888776665555554443322 3468899999999999999999999999999999999997 567777
Q ss_pred HHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcc---cccCCcccc
Q psy501 394 IRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT---DYVSTRWYR 469 (962)
Q Consensus 394 l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~---~~~gt~~Y~ 469 (962)
+.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||.+......... ...++..|+
T Consensus 93 ~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~ 172 (263)
T cd05052 93 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 172 (263)
T ss_pred HHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccC
Confidence 65533 45899999999999999999999999999999999999999999999999999876543221 223356799
Q ss_pred ChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCC
Q psy501 470 APEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK 548 (962)
Q Consensus 470 APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRP 548 (962)
|||.+.+ ..++.++|||||||++|||++ |..||.+.........+... .........+..+..++..||..+|++||
T Consensus 173 aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 250 (263)
T cd05052 173 APESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-YRMERPEGCPPKVYELMRACWQWNPSDRP 250 (263)
T ss_pred CHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHHccCCcccCC
Confidence 9998865 468999999999999999998 99999887766655555543 23333456677889999999999999999
Q ss_pred cHHHHHhhc
Q psy501 549 SSYILLHTL 557 (962)
Q Consensus 549 s~~~Ll~~l 557 (962)
++.++++.|
T Consensus 251 ~~~~l~~~l 259 (263)
T cd05052 251 SFAEIHQAF 259 (263)
T ss_pred CHHHHHHHH
Confidence 999998865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=296.23 Aligned_cols=205 Identities=17% Similarity=0.220 Sum_probs=167.3
Q ss_pred HHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceee
Q psy501 349 MVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFF 426 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIv 426 (962)
..+..|+.++++++ ||+|+++++++..++.+++||||++| +|.+.+... ..+++..++.++.||+.||.|||+.||+
T Consensus 49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iv 127 (332)
T cd05614 49 EHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIV 127 (332)
T ss_pred HHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcE
Confidence 35788999999994 99999999999999999999999985 676666554 4589999999999999999999999999
Q ss_pred eccCCCcccccccccceeeecccccccccCC---CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q psy501 427 HRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPI 503 (962)
Q Consensus 427 HrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf 503 (962)
||||||+|||++.++.+||+|||++...... ......||+.|+|||++.+...++.++|||||||++|||++|+.||
T Consensus 128 HrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf 207 (332)
T cd05614 128 YRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207 (332)
T ss_pred ecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCC
Confidence 9999999999999999999999999765332 2234578999999999976556889999999999999999999999
Q ss_pred CCcChhh----hHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCC-----cHHHHHhh
Q psy501 504 QTTCLLA----GTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK-----SSYILLHT 556 (962)
Q Consensus 504 ~~~~~~~----~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRP-----s~~~Ll~~ 556 (962)
....... ....+... ..+..+..+..+..++..||..+|++|| ++++++..
T Consensus 208 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 208 TLEGERNTQSEVSRRILKC--DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 7543222 22222222 1222345667788999999999999999 66666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=283.95 Aligned_cols=237 Identities=27% Similarity=0.425 Sum_probs=185.7
Q ss_pred ecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHH
Q psy501 320 ILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQL 393 (962)
Q Consensus 320 i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~ 393 (962)
..++.+.||++.....++.++.+... .....+.+|++++++++||||+++++++..+...++||||+++++++.
T Consensus 10 ~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 89 (286)
T cd07847 10 GEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNE 89 (286)
T ss_pred cccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHH
Confidence 33344457777665544443333211 122457899999999999999999999999999999999999988888
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC--cccccCCccccCh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--YTDYVSTRWYRAP 471 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~--~~~~~gt~~Y~AP 471 (962)
+......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .....++..|+||
T Consensus 90 ~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aP 169 (286)
T cd07847 90 LEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAP 169 (286)
T ss_pred HHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCH
Confidence 77666679999999999999999999999999999999999999999999999999998765432 2344678899999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc-------------------ccc---------
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI-------------------LLH--------- 523 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~-------------------~~~--------- 523 (962)
|++.+...++.++|||||||++|+|++|++||.+.........+..... ..+
T Consensus 170 E~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (286)
T cd07847 170 ELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLE 249 (286)
T ss_pred HHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHH
Confidence 9987766689999999999999999999999987765444333321100 000
Q ss_pred -CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 524 -TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 524 -~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
..+..+..+.+++..||..+|++||++.+++..
T Consensus 250 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 250 SKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred HHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 012345567789999999999999998887763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=305.21 Aligned_cols=237 Identities=19% Similarity=0.261 Sum_probs=194.7
Q ss_pred cccEEEEEecCCceEEEEec----cchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHH-HHhcC
Q psy501 324 TLPLYTCNLDQDNHILSRHV----SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQL-IRDRD 398 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~----~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~-l~~~~ 398 (962)
.++||++..+..+..++.++ +..+.+.+.-||+||..++||+||++++.|..++.+||+.|||+|+-.+. +..-+
T Consensus 45 FGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~ 124 (1187)
T KOG0579|consen 45 FGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELG 124 (1187)
T ss_pred chhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhc
Confidence 34577776665544433333 22334578899999999999999999999999999999999999775554 45557
Q ss_pred CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhhhc-
Q psy501 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEVLL- 475 (962)
Q Consensus 399 ~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~l~- 475 (962)
..+.+.++..+++|++.||.|||+.+|+|||||..|||++-+|.++|+|||.+...... ....+.||++|||||+.+
T Consensus 125 r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmC 204 (1187)
T KOG0579|consen 125 RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMC 204 (1187)
T ss_pred cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheee
Confidence 78999999999999999999999999999999999999999999999999998765443 566789999999999986
Q ss_pred ---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc-CCCCCCCCcHHHHHHHhccCCCCCCcHH
Q psy501 476 ---HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH-TLPLYTYHVPPIQTTCLLAGTERLKSSY 551 (962)
Q Consensus 476 ---~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~s~~l~~li~~Cl~~dperRPs~~ 551 (962)
.+.+|++++||||||++|.||.-+.+|-...++.-..-+|.....+.- .+...+..+.++++.||..+|+.||++.
T Consensus 205 ET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aa 284 (1187)
T KOG0579|consen 205 ETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAA 284 (1187)
T ss_pred ccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHH
Confidence 456899999999999999999999999998888777777765543322 2336677899999999999999999987
Q ss_pred HHHhhccccc
Q psy501 552 ILLHTLPLYT 561 (962)
Q Consensus 552 ~Ll~~l~~~~ 561 (962)
+|++.- |..
T Consensus 285 qll~Hp-fv~ 293 (1187)
T KOG0579|consen 285 QLLKHP-FVQ 293 (1187)
T ss_pred HHhhCc-ccc
Confidence 777643 443
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=303.89 Aligned_cols=254 Identities=16% Similarity=0.133 Sum_probs=204.7
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEec---cchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHV---SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~---~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
+..+....+..++.|.-+.||++.+..+..|-...+ .....+.|..|+.+|++-+|.||+-++|++..+.. .||+.
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred cCHHHhhccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 334444555566666666799998876654433332 22345679999999999999999999999998877 99999
Q ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccc----cCCCc
Q psy501 385 YMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI----RSRPY 459 (962)
Q Consensus 385 y~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~----~~~~~ 459 (962)
+|+| +|+.++......|...+.+.|++||++|+.|||.++|+|||||..||++.+++.|||+|||++..- .....
T Consensus 468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~ 547 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQL 547 (678)
T ss_pred hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecccccc
Confidence 9997 688888877778999999999999999999999999999999999999999999999999998542 22345
Q ss_pred ccccCCccccChhhhcc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCC---CCCCCCcHH
Q psy501 460 TDYVSTRWYRAPEVLLH--STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTL---PLYTYHVPP 534 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~--~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~s~~l~~ 534 (962)
....|...|||||++.. ..+|+..+||||||||+|||++|..||......+....+-.|...+... ..++..+..
T Consensus 548 ~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~ 627 (678)
T KOG0193|consen 548 EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKR 627 (678)
T ss_pred CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHH
Confidence 55678899999999963 3469999999999999999999999999777766666666664444332 245567888
Q ss_pred HHHHHhccCCCCCCcHHHHHhhcccccc
Q psy501 535 IQTTCLLAGTERLKSSYILLHTLPLYTY 562 (962)
Q Consensus 535 li~~Cl~~dperRPs~~~Ll~~l~~~~~ 562 (962)
|...||..+++.||...+|+..+.....
T Consensus 628 Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 628 LLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred HHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 9999999999999999988886644443
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=294.13 Aligned_cols=228 Identities=17% Similarity=0.200 Sum_probs=183.0
Q ss_pred EecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCC-CC
Q psy501 319 YILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMK-EN 389 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~ 389 (962)
++.++.+.||++.....++.++.|+... .......|..++..+ .||+|+++++++.+.+.+++||||++ |+
T Consensus 8 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~ 87 (323)
T cd05616 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD 87 (323)
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCC
Confidence 3344445577777766665555443322 223467788888877 58999999999999999999999998 46
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC--CCcccccCCcc
Q psy501 390 LYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRW 467 (962)
Q Consensus 390 Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~--~~~~~~~gt~~ 467 (962)
|...+.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..... .......||+.
T Consensus 88 L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 166 (323)
T cd05616 88 LMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD 166 (323)
T ss_pred HHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChh
Confidence 6666544 35699999999999999999999999999999999999999999999999999975432 23344678999
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCC
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERL 547 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperR 547 (962)
|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+.......+ ...+..+..++..|+..+|++|
T Consensus 167 y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~l~~~p~~R 243 (323)
T cd05616 167 YIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--KSMSKEAVAICKGLMTKHPGKR 243 (323)
T ss_pred hcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--CcCCHHHHHHHHHHcccCHHhc
Confidence 999999965 4789999999999999999999999998887777777666544333 3566778889999999999999
Q ss_pred CcH
Q psy501 548 KSS 550 (962)
Q Consensus 548 Ps~ 550 (962)
++.
T Consensus 244 ~~~ 246 (323)
T cd05616 244 LGC 246 (323)
T ss_pred CCC
Confidence 974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=297.49 Aligned_cols=252 Identities=19% Similarity=0.209 Sum_probs=194.0
Q ss_pred EEecCceeeE-EEEecCCcccEEEEEecCCceEEEEeccch-----hHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCEE
Q psy501 307 CLLAGTERLK-FSYILPHTLPLYTCNLDQDNHILSRHVSSR-----DEMVVCFYRKSLKKLS-HANLVKLKEVIRENDTL 379 (962)
Q Consensus 307 ~l~~g~~~~~-~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-----~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~ 379 (962)
+.+.|..... ..++.||...||++...+..-.+.+++... ....+..|+..|.+|+ |.+|+++|||-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3444443333 344455566699998776665555544322 2345999999999996 99999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--
Q psy501 380 YFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-- 457 (962)
Q Consensus 380 ~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-- 457 (962)
|||||+-+.+|.+.+.+.....+.-.++.++.||+.|+.++|.+||||.||||.|+|+-. |.+||+|||.|..+..+
T Consensus 436 YmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred EEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 999999999999999887766665688999999999999999999999999999999854 89999999999888765
Q ss_pred --CcccccCCccccChhhhccC----------CCCCchhHHHHHHHHHHHHHcCCCCCCCcC-hhhhHHHHHhccc--cc
Q psy501 458 --PYTDYVSTRWYRAPEVLLHS----------TAYSAPIHLSRSQQFLFYSIDHVPPIQTTC-LLAGTERLKSSYI--LL 522 (962)
Q Consensus 458 --~~~~~~gt~~Y~APE~l~~~----------~~~t~ksDIwSLGvlL~elltG~~Pf~~~~-~~~~~~~i~~~~~--~~ 522 (962)
.....+||+.|||||.+... -..+.++||||||||||+|+.|++||.... .......|..-.. .+
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ief 594 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEF 594 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccc
Confidence 34456999999999999621 126789999999999999999999997754 3344444443322 22
Q ss_pred cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 523 HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 523 ~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
+..+... .+..+++.||..||.+||++.+||+.-...
T Consensus 595 p~~~~~~-~li~~mK~CL~rdPkkR~si~eLLqhpFl~ 631 (677)
T KOG0596|consen 595 PDIPEND-ELIDVMKCCLARDPKKRWSIPELLQHPFLQ 631 (677)
T ss_pred cCCCCch-HHHHHHHHHHhcCcccCCCcHHHhcCcccc
Confidence 3222222 278899999999999999988777654333
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=295.85 Aligned_cols=224 Identities=22% Similarity=0.300 Sum_probs=178.3
Q ss_pred CcccEEEEEecCCceEEEEeccch-------hHHHHHHHHH-HHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHH
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRK-SLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQL 393 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~ 393 (962)
+.+.||.+.....++.++.|+... ....+..|.. +++.++||||+++++++.+.+..|+||||++| +|...
T Consensus 7 ~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 86 (321)
T cd05603 7 SFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFH 86 (321)
T ss_pred CCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHH
Confidence 344578877766665554444321 1223455554 67889999999999999999999999999985 55555
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC--CCcccccCCccccCh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAP 471 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~--~~~~~~~gt~~Y~AP 471 (962)
+. ....+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..... .......||+.|+||
T Consensus 87 l~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aP 165 (321)
T cd05603 87 LQ-RERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAP 165 (321)
T ss_pred HH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCH
Confidence 54 445689999999999999999999999999999999999999999999999999875322 233445789999999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcH
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 550 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~ 550 (962)
|++.+ ..++.++|||||||++|||++|..||.+.+.......+....... .+..+..+..++..||..+|.+|+++
T Consensus 166 E~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~ 241 (321)
T cd05603 166 EVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQL--PGGKTVAACDLLVGLLHKDQRRRLGA 241 (321)
T ss_pred HHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCHHHHHHHHHHccCCHhhcCCC
Confidence 99865 468999999999999999999999999887766666665553322 24566678889999999999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=288.16 Aligned_cols=231 Identities=19% Similarity=0.239 Sum_probs=178.5
Q ss_pred cccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHH
Q psy501 324 TLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIR 395 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~ 395 (962)
.+.||.+....+++.++.+.... ....+..|++++++++||+|+++++++..+...++||||++| +|...+.
T Consensus 6 ~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~ 85 (280)
T cd05608 6 FGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIY 85 (280)
T ss_pred ceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHH
Confidence 34577777666555444433222 123467899999999999999999999999999999999985 5555543
Q ss_pred h---cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccC
Q psy501 396 D---RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRA 470 (962)
Q Consensus 396 ~---~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~A 470 (962)
. ....+++..++.++.||+.||.|||+.+|+||||||+||+++.++.++|+|||++...... ......|++.|+|
T Consensus 86 ~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~a 165 (280)
T cd05608 86 NVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMA 165 (280)
T ss_pred hccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccC
Confidence 2 3356899999999999999999999999999999999999999999999999999765443 2334578999999
Q ss_pred hhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc--cccCCCCCCCCcHHHHHHHhccCCCCCC
Q psy501 471 PEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI--LLHTLPLYTYHVPPIQTTCLLAGTERLK 548 (962)
Q Consensus 471 PE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~s~~l~~li~~Cl~~dperRP 548 (962)
||++.+. .++.++|||||||++|||++|+.||...........+..... .....+.++..+..++..||..+|++||
T Consensus 166 PE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 244 (280)
T cd05608 166 PELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRL 244 (280)
T ss_pred HHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhc
Confidence 9999764 789999999999999999999999987543322222221111 1122235677788999999999999999
Q ss_pred -----cHHHHHh
Q psy501 549 -----SSYILLH 555 (962)
Q Consensus 549 -----s~~~Ll~ 555 (962)
++.+++.
T Consensus 245 ~~~~~~~~~~l~ 256 (280)
T cd05608 245 GFRDGNCDGLRT 256 (280)
T ss_pred CCCCCCHHHHhc
Confidence 5666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=286.53 Aligned_cols=208 Identities=21% Similarity=0.251 Sum_probs=176.7
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC---------------CCCCHHHHHHHHH
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD---------------KFLPESIIRNMMY 411 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~---------------~~ls~~~i~~i~~ 411 (962)
...+.+|+.++++++||+|+++++++...+..|++|||++ |+|.+++.... ..+++..++.++.
T Consensus 52 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 131 (283)
T cd05048 52 QQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131 (283)
T ss_pred HHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHH
Confidence 3468899999999999999999999999999999999998 57777775431 4588999999999
Q ss_pred HHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----CcccccCCccccChhhhccCCCCCchhHHH
Q psy501 412 QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLS 487 (962)
Q Consensus 412 qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIw 487 (962)
|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... ......+++.|+|||.+.+. .++.++|||
T Consensus 132 ~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~ 210 (283)
T cd05048 132 QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIW 210 (283)
T ss_pred HHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHH
Confidence 9999999999999999999999999999999999999999765332 12234567889999998654 689999999
Q ss_pred HHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 488 RSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 488 SLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
||||++|||++ |..||.+.........+..... .+....++..+..++..||..+|..||++.++++.|
T Consensus 211 slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l 280 (283)
T cd05048 211 SFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL-LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280 (283)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 99999999998 9999998877666666655432 333456788899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=287.47 Aligned_cols=235 Identities=25% Similarity=0.364 Sum_probs=182.3
Q ss_pred CCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHH
Q psy501 322 PHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIR 395 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~ 395 (962)
++.+.||.+.....++.++.+... .....+.+|++++++++||||+++++++.+....++|+||+++++.+.+.
T Consensus 11 g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~ 90 (284)
T cd07839 11 GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFD 90 (284)
T ss_pred cCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCCCHHHHHH
Confidence 334457777666555444433221 11235778999999999999999999999999999999999999999887
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhh
Q psy501 396 DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEV 473 (962)
Q Consensus 396 ~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~ 473 (962)
.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ......++..|+|||+
T Consensus 91 ~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~ 170 (284)
T cd07839 91 SCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDV 170 (284)
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHH
Confidence 76677999999999999999999999999999999999999999999999999999765433 2334567889999999
Q ss_pred hccCCCCCchhHHHHHHHHHHHHHcCCCCCCC-cChhhhHHHHHhcc-----------------cc----------ccCC
Q psy501 474 LLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQT-TCLLAGTERLKSSY-----------------IL----------LHTL 525 (962)
Q Consensus 474 l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~-~~~~~~~~~i~~~~-----------------~~----------~~~~ 525 (962)
+.+...++.++|||||||++|+|++|..||.. .+.......+.... .. ....
T Consensus 171 ~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (284)
T cd07839 171 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVV 250 (284)
T ss_pred HhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhc
Confidence 97766689999999999999999999888643 33222222221100 00 0111
Q ss_pred CCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 526 PLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 526 ~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
+..+....+++..||..+|.+||++.+++..
T Consensus 251 ~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 251 PKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 2345567789999999999999998888764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=295.12 Aligned_cols=223 Identities=19% Similarity=0.266 Sum_probs=174.7
Q ss_pred CcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCCC-CHHHH
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKE-NLYQL 393 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~ 393 (962)
+.+.||.+.....++.++.|+... ....+.+|+.+++++ +||+|+++++++.++..+|+||||++| +|...
T Consensus 7 ~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 86 (329)
T cd05588 7 SYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFH 86 (329)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHH
Confidence 344577777666665555444332 123478899999998 699999999999999999999999985 56555
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccccccc--CCCcccccCCccccCh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR--SRPYTDYVSTRWYRAP 471 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~--~~~~~~~~gt~~Y~AP 471 (962)
+.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.... ........||+.|+||
T Consensus 87 ~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aP 165 (329)
T cd05588 87 MQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAP 165 (329)
T ss_pred HHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCH
Confidence 544 4569999999999999999999999999999999999999999999999999987532 2233446789999999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh---------hhHHHHHhccccccCCCCCCCCcHHHHHHHhcc
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL---------AGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 542 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~---------~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~ 542 (962)
|++.+ ..++.++|||||||++|+|++|+.||...... .....+...... .+...+..+..+++.||..
T Consensus 166 E~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~li~~~L~~ 242 (329)
T cd05588 166 EILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKASSVLKGFLNK 242 (329)
T ss_pred HHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHhcc
Confidence 99976 46899999999999999999999999642211 112223333222 2235566778899999999
Q ss_pred CCCCCCc
Q psy501 543 GTERLKS 549 (962)
Q Consensus 543 dperRPs 549 (962)
+|.+|++
T Consensus 243 dP~~R~~ 249 (329)
T cd05588 243 DPKERLG 249 (329)
T ss_pred CHHHcCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=281.52 Aligned_cols=232 Identities=23% Similarity=0.266 Sum_probs=185.6
Q ss_pred cccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCC
Q psy501 324 TLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKF 400 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~~~ 400 (962)
.+.||.+.......++.+.... .....+.+|++++++++||+|+++++++...+..++||||++ ++|.+++......
T Consensus 17 ~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 96 (256)
T cd05059 17 FGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK 96 (256)
T ss_pred CceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccC
Confidence 3446666654433333333222 123467889999999999999999999999999999999997 5687777765667
Q ss_pred CCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCccc---ccCCccccChhhhccC
Q psy501 401 LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD---YVSTRWYRAPEVLLHS 477 (962)
Q Consensus 401 ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~---~~gt~~Y~APE~l~~~ 477 (962)
+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||.++......... ..++..|+|||.+.+
T Consensus 97 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~- 175 (256)
T cd05059 97 LGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY- 175 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhcc-
Confidence 8999999999999999999999999999999999999999999999999997654432221 223457999999875
Q ss_pred CCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 478 TAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 478 ~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
..++.++|||||||++|||++ |..||...........+... ...+....++..+..++..||..+|++||++.+++..
T Consensus 176 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 176 SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 468999999999999999999 89999887766665555544 2333345678889999999999999999999999885
Q ss_pred c
Q psy501 557 L 557 (962)
Q Consensus 557 l 557 (962)
+
T Consensus 255 l 255 (256)
T cd05059 255 L 255 (256)
T ss_pred h
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=293.15 Aligned_cols=243 Identities=15% Similarity=0.205 Sum_probs=189.3
Q ss_pred eEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 315 LKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 315 ~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
....++.++.+.||.+.....++.++.|+... ....+.+|+.++..++||+|+++++++.+++.+|+||||+.
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (331)
T cd05597 5 ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYV 84 (331)
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCC
Confidence 33344444455678887776666655554332 23357889999999999999999999999999999999997
Q ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---ccccc
Q psy501 388 -ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---YTDYV 463 (962)
Q Consensus 388 -g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~ 463 (962)
|+|.+++......+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... .....
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 164 (331)
T cd05597 85 GGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV 164 (331)
T ss_pred CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcccccee
Confidence 57777776656679999999999999999999999999999999999999999999999999987654332 22346
Q ss_pred CCccccChhhhcc----CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc---cCCCCCCCCcHHHH
Q psy501 464 STRWYRAPEVLLH----STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL---HTLPLYTYHVPPIQ 536 (962)
Q Consensus 464 gt~~Y~APE~l~~----~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~s~~l~~li 536 (962)
||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.........+....... +..+..+..+..++
T Consensus 165 gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li 244 (331)
T cd05597 165 GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLI 244 (331)
T ss_pred ccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHH
Confidence 8999999999863 2357889999999999999999999999877666655554432222 22234566788899
Q ss_pred HHHhccCCCC--CCcHHHHHhhc
Q psy501 537 TTCLLAGTER--LKSSYILLHTL 557 (962)
Q Consensus 537 ~~Cl~~dper--RPs~~~Ll~~l 557 (962)
..|+..++++ |+++.+++..-
T Consensus 245 ~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 245 RRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred HHHccCcccccCCCCHHHHhcCC
Confidence 9988765555 77877777654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-33 Score=288.55 Aligned_cols=240 Identities=19% Similarity=0.249 Sum_probs=194.3
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
+++|+|+.+++.+.+..+.|...+ +.-...+...+.+|+.++.+++.|+||++||.|.....+|||||||+
T Consensus 41 LGEGSYGSV~KAIH~EsG~v~AIK---------~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 41 LGEGSYGSVHKAIHRESGHVLAIK---------KVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred hcCCcchHHHHHHHhccCcEEEEE---------ecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 455666655555555555444433 11234566789999999999999999999999998899999999998
Q ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccC
Q psy501 388 -ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVS 464 (962)
Q Consensus 388 -g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~g 464 (962)
|+..+.++.+.++++++++..+++..+.||+|||...-+|||||..|||+..+|.+||+|||.|..+... ......|
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIG 191 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIG 191 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCcccc
Confidence 8999999999999999999999999999999999999999999999999999999999999999877654 5566799
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcc-ccccCCCCCCCCcHHHHHHHhccC
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSY-ILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
|+.|||||++.. -.|+.++||||||++..||.-|++||.+..+.-....|-... ..+..+...+..+.++++.||...
T Consensus 192 TPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~ 270 (502)
T KOG0574|consen 192 TPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKK 270 (502)
T ss_pred CcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCC
Confidence 999999999965 479999999999999999999999998876543322221110 011111244567888999999999
Q ss_pred CCCCCcHHHHHhhc
Q psy501 544 TERLKSSYILLHTL 557 (962)
Q Consensus 544 perRPs~~~Ll~~l 557 (962)
|+.|.++-.|++.-
T Consensus 271 PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 271 PEERKTALRLCEHT 284 (502)
T ss_pred HHHHHHHHHHhhhh
Confidence 99999988777644
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=279.92 Aligned_cols=233 Identities=20% Similarity=0.270 Sum_probs=185.3
Q ss_pred CcccEEEEEecCCceEEEEecc-----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHh
Q psy501 323 HTLPLYTCNLDQDNHILSRHVS-----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRD 396 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~ 396 (962)
+.+.||.+.....++.++.+.. ......+.+|++++++++||||+++++++......++||||++| +|.+++..
T Consensus 7 ~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 86 (252)
T cd05084 7 NFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT 86 (252)
T ss_pred cCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHh
Confidence 3345777776655555444432 22245689999999999999999999999999999999999975 67767666
Q ss_pred cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCccc----ccCCccccChh
Q psy501 397 RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD----YVSTRWYRAPE 472 (962)
Q Consensus 397 ~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~----~~gt~~Y~APE 472 (962)
....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+.......... ...+..|+|||
T Consensus 87 ~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 166 (252)
T cd05084 87 EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE 166 (252)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCch
Confidence 55678999999999999999999999999999999999999999999999999987654321111 12245699999
Q ss_pred hhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHH
Q psy501 473 VLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 551 (962)
Q Consensus 473 ~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~ 551 (962)
.+.++ .++.++|||||||++|||++ |..||...........+... ...+....++..+..++..||..+|++||++.
T Consensus 167 ~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 244 (252)
T cd05084 167 ALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-VRLPCPELCPDAVYRLMERCWEYDPGQRPSFS 244 (252)
T ss_pred hhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-CCCCCcccCCHHHHHHHHHHcCCChhhCcCHH
Confidence 98654 68999999999999999997 99999876665554544433 22333345677888899999999999999999
Q ss_pred HHHhhc
Q psy501 552 ILLHTL 557 (962)
Q Consensus 552 ~Ll~~l 557 (962)
++++.|
T Consensus 245 ~~~~~l 250 (252)
T cd05084 245 TVHQEL 250 (252)
T ss_pred HHHHHH
Confidence 998865
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=279.65 Aligned_cols=244 Identities=20% Similarity=0.248 Sum_probs=193.9
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-EN 389 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~ 389 (962)
+.....+..++.+.||.+.......++.+.+.. .....+.+|+.++++++||||+++++++..++..++||||++ ++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05068 8 IQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGS 87 (261)
T ss_pred eeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCc
Confidence 344444455555568887765554444443322 234568899999999999999999999999999999999995 67
Q ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccC---C
Q psy501 390 LYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVS---T 465 (962)
Q Consensus 390 Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~g---t 465 (962)
|.+.+.... ..+++..+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++............+ +
T Consensus 88 L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 167 (261)
T cd05068 88 LLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP 167 (261)
T ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCc
Confidence 877776543 468999999999999999999999999999999999999999999999999998765432222222 4
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCC
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGT 544 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dp 544 (962)
..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.........+.... ..+..+..+..+..++..||..+|
T Consensus 168 ~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P 245 (261)
T cd05068 168 IKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY-RMPCPPGCPKELYDIMLDCWKEDP 245 (261)
T ss_pred eeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCcCCHHHHHHHHHHhhcCc
Confidence 57999998865 468999999999999999999 999998877666655554442 233345667788999999999999
Q ss_pred CCCCcHHHHHhhcc
Q psy501 545 ERLKSSYILLHTLP 558 (962)
Q Consensus 545 erRPs~~~Ll~~l~ 558 (962)
+.||++.+|+..|.
T Consensus 246 ~~Rp~~~~l~~~l~ 259 (261)
T cd05068 246 DDRPTFETLQWKLE 259 (261)
T ss_pred ccCCCHHHHHHHHh
Confidence 99999999998763
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=299.39 Aligned_cols=230 Identities=18% Similarity=0.238 Sum_probs=178.7
Q ss_pred EEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-
Q psy501 317 FSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE- 388 (962)
Q Consensus 317 ~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g- 388 (962)
..++.++.+.||.+.....++.++.++... ....+..|+.++.+++||+|+++++.+.+++.+|+||||++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (360)
T cd05627 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGG 86 (360)
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCc
Confidence 334444455688887776666655554322 234578899999999999999999999999999999999985
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC----------
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---------- 458 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---------- 458 (962)
+|.+.+.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++.......
T Consensus 87 ~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~ 165 (360)
T cd05627 87 DMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 165 (360)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccccccccc
Confidence 56665554 4569999999999999999999999999999999999999999999999999986542210
Q ss_pred ---------------------------cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh
Q psy501 459 ---------------------------YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG 511 (962)
Q Consensus 459 ---------------------------~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~ 511 (962)
....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~ 244 (360)
T cd05627 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244 (360)
T ss_pred CCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCCCCCHHHH
Confidence 113478999999999965 4789999999999999999999999998887776
Q ss_pred HHHHHhcc--ccccCCCCCCCCcHHHHHHHhccCCCCCCc
Q psy501 512 TERLKSSY--ILLHTLPLYTYHVPPIQTTCLLAGTERLKS 549 (962)
Q Consensus 512 ~~~i~~~~--~~~~~~~~~s~~l~~li~~Cl~~dperRPs 549 (962)
...+.... ...+.....+.....++..++. +|+.|++
T Consensus 245 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~ 283 (360)
T cd05627 245 YRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIG 283 (360)
T ss_pred HHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCC
Confidence 66665432 2222222345566667766554 7787774
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=297.58 Aligned_cols=235 Identities=24% Similarity=0.324 Sum_probs=199.3
Q ss_pred cccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEecCC-CCHHHHH
Q psy501 324 TLPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMK-ENLYQLI 394 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l 394 (962)
.+.||.|....+++.++.|+.. .+...+.+|+.+|+++. ||||+.++++|++...+++|||+|. |.|++.+
T Consensus 48 Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i 127 (382)
T KOG0032|consen 48 FGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRI 127 (382)
T ss_pred ceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHH
Confidence 3346667666655443333322 13468999999999998 9999999999999999999999998 6788888
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc----cceeeecccccccccCC-CcccccCCcccc
Q psy501 395 RDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT----ELVKIADFGLAREIRSR-PYTDYVSTRWYR 469 (962)
Q Consensus 395 ~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~----g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~ 469 (962)
... . +++..+..++.|++.|+.|||+.||+||||||+|+|+... +.+|++|||+|...... .....+||+.|+
T Consensus 128 ~~~-~-~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~ 205 (382)
T KOG0032|consen 128 VKK-H-YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYV 205 (382)
T ss_pred HHc-c-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCcccc
Confidence 776 3 9999999999999999999999999999999999999643 47999999999887753 566789999999
Q ss_pred ChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCC--CCCCCCcHHHHHHHhccCCCCC
Q psy501 470 APEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTL--PLYTYHVPPIQTTCLLAGTERL 547 (962)
Q Consensus 470 APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~l~~li~~Cl~~dperR 547 (962)
|||++.. ..|+..+||||+||++|.|++|.+||.+.........+..+...+... +..+....++++.++..+|.+|
T Consensus 206 APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R 284 (382)
T KOG0032|consen 206 APEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKR 284 (382)
T ss_pred CchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccC
Confidence 9999964 579999999999999999999999999999888888998887765544 4566788999999999999999
Q ss_pred CcHHHHHhhcccccc
Q psy501 548 KSSYILLHTLPLYTY 562 (962)
Q Consensus 548 Ps~~~Ll~~l~~~~~ 562 (962)
+++.+.++. ||...
T Consensus 285 ~ta~~~L~H-pWi~~ 298 (382)
T KOG0032|consen 285 LTAAQALQH-PWIKS 298 (382)
T ss_pred CCHHHHhcC-ccccC
Confidence 998888875 67554
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=286.98 Aligned_cols=239 Identities=18% Similarity=0.165 Sum_probs=184.9
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-C
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-N 389 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~ 389 (962)
.+..++.+.||++....+.+.++.+.... ....+.+|+.+++.++||+|+++++.+.+++..++||||++| +
T Consensus 7 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 86 (285)
T cd05605 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGD 86 (285)
T ss_pred EEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCc
Confidence 33444445588887766555554443221 123467899999999999999999999999999999999985 5
Q ss_pred HHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCcc
Q psy501 390 LYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRW 467 (962)
Q Consensus 390 Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~ 467 (962)
|.+.+... ...+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||++...... ......|++.
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 166 (285)
T cd05605 87 LKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVG 166 (285)
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccccCCCC
Confidence 66555443 346999999999999999999999999999999999999999999999999999765433 2234578999
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc--cccCCCCCCCCcHHHHHHHhccCCC
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI--LLHTLPLYTYHVPPIQTTCLLAGTE 545 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~s~~l~~li~~Cl~~dpe 545 (962)
|+|||++.+ ..++.++||||+||++|||++|+.||.+.........+..... .....+.++..+..++..||..+|+
T Consensus 167 y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 245 (285)
T cd05605 167 YMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPG 245 (285)
T ss_pred ccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHH
Confidence 999999965 4689999999999999999999999987654333222222111 1112235677788999999999999
Q ss_pred CCC-----cHHHHHhhc
Q psy501 546 RLK-----SSYILLHTL 557 (962)
Q Consensus 546 rRP-----s~~~Ll~~l 557 (962)
+|| ++.++++.-
T Consensus 246 ~R~~~~~~~~~~l~~~~ 262 (285)
T cd05605 246 FRLGCRGEGAEEVKAHP 262 (285)
T ss_pred HhcCCCCCCHHHHhcCc
Confidence 999 777776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=280.38 Aligned_cols=243 Identities=19% Similarity=0.262 Sum_probs=195.2
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-EN 389 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~ 389 (962)
+.....++.++.+.||.+......+++.+.... .....+.+|+.++++++||+|+++++++.+++..++||||+. |+
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87 (261)
T ss_pred eEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence 334444555556668888766555555554432 234578899999999999999999999999999999999997 57
Q ss_pred HHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---cccccCC
Q psy501 390 LYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---YTDYVST 465 (962)
Q Consensus 390 Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~gt 465 (962)
|.+++... ...+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+....... .....++
T Consensus 88 L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 167 (261)
T cd05072 88 LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 167 (261)
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccc
Confidence 77777543 3568999999999999999999999999999999999999999999999999998765432 1223456
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCC
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGT 544 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dp 544 (962)
..|+|||++.+. .++.++|||||||++|+|++ |..||...........+.... ..+....++..+..++..||..+|
T Consensus 168 ~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p 245 (261)
T cd05072 168 IKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY-RMPRMENCPDELYDIMKTCWKEKA 245 (261)
T ss_pred eecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHccCCc
Confidence 779999998654 68899999999999999998 999998877666666655443 334445677788999999999999
Q ss_pred CCCCcHHHHHhhc
Q psy501 545 ERLKSSYILLHTL 557 (962)
Q Consensus 545 erRPs~~~Ll~~l 557 (962)
++||++.++...|
T Consensus 246 ~~Rp~~~~i~~~l 258 (261)
T cd05072 246 EERPTFDYLQSVL 258 (261)
T ss_pred ccCcCHHHHHHHH
Confidence 9999999998866
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=301.96 Aligned_cols=210 Identities=20% Similarity=0.253 Sum_probs=170.6
Q ss_pred HHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC---------------------------
Q psy501 348 EMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD--------------------------- 398 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~--------------------------- 398 (962)
...+.+|+++|+.+ +||||+++++++.+++..++|||||+ |+|.+++....
T Consensus 82 ~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (375)
T cd05104 82 REALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMS 161 (375)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhccc
Confidence 45688999999999 89999999999999999999999998 67777775421
Q ss_pred -----------------------------------------------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCC
Q psy501 399 -----------------------------------------------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMK 431 (962)
Q Consensus 399 -----------------------------------------------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLk 431 (962)
..+++..++.++.||+.||.|||+.||+|||||
T Consensus 162 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 241 (375)
T cd05104 162 CDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLA 241 (375)
T ss_pred chhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCc
Confidence 247888999999999999999999999999999
Q ss_pred CcccccccccceeeecccccccccCCCc----ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCc
Q psy501 432 PENLLCMGTELVKIADFGLAREIRSRPY----TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTT 506 (962)
Q Consensus 432 p~NILl~~~g~vKL~DFGla~~~~~~~~----~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~ 506 (962)
|+||+++.++.+||+|||++........ ....++..|+|||++.+. .++.++|||||||++|||++ |..||...
T Consensus 242 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 242 ARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred hhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999999976644321 122345679999999654 78999999999999999998 89999876
Q ss_pred ChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 507 CLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 507 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
.......+..............+..+..++..||..+|++||++.++++.+.
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~ 372 (375)
T cd05104 321 PVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372 (375)
T ss_pred CchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 5443333333322222223345667889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=302.21 Aligned_cols=243 Identities=18% Similarity=0.195 Sum_probs=188.0
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHH
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLY 391 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll 391 (962)
.+.....+..++.+.||++........++.|... ...+.+|+++|++|+||||+++++++..++..++|||++.+++.
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~~~L~ 247 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLY 247 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccCCCHH
Confidence 3444444444455569999888776665555322 23467899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----CcccccCCcc
Q psy501 392 QLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PYTDYVSTRW 467 (962)
Q Consensus 392 ~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~~~~gt~~ 467 (962)
.++......+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||+++..... ......||..
T Consensus 248 ~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~ 327 (461)
T PHA03211 248 TYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327 (461)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcC
Confidence 998876667999999999999999999999999999999999999999999999999999765432 1223568999
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcC--------hhhhHHHHHhccccccCC--------------
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTC--------LLAGTERLKSSYILLHTL-------------- 525 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~--------~~~~~~~i~~~~~~~~~~-------------- 525 (962)
|+|||++.+. .++.++|||||||+||||++|..|+.... .......+..........
T Consensus 328 Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~ 406 (461)
T PHA03211 328 TNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRH 406 (461)
T ss_pred CcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHh
Confidence 9999999764 68999999999999999999876553321 112222222221111000
Q ss_pred ------------------CCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 526 ------------------PLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 526 ------------------~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
...+..+..++..||..||.+||++.++++.-
T Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp 456 (461)
T PHA03211 407 RAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP 456 (461)
T ss_pred hhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence 02234667899999999999999999888753
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=297.78 Aligned_cols=230 Identities=19% Similarity=0.236 Sum_probs=183.3
Q ss_pred cccEEEEEecCCceEEEEeccchh-------HHHHHHHHHHHHhc---CCCCcccEEEEEEeCCEEEEEEecCCC-CHHH
Q psy501 324 TLPLYTCNLDQDNHILSRHVSSRD-------EMVVCFYRKSLKKL---SHANLVKLKEVIRENDTLYFVFEYMKE-NLYQ 392 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~~~-------~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~ 392 (962)
.+.||.+.....++.++.|+.... ......|..++..+ .||+|+++++++.++..+|+||||+.| +|..
T Consensus 6 ~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~ 85 (330)
T cd05586 6 FGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFW 85 (330)
T ss_pred ceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHH
Confidence 345777777666665555543321 12355677777665 699999999999999999999999985 5655
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccC
Q psy501 393 LIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRA 470 (962)
Q Consensus 393 ~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~A 470 (962)
.+.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...... ......||+.|+|
T Consensus 86 ~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~a 164 (330)
T cd05586 86 HLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLA 164 (330)
T ss_pred HHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccC
Confidence 5544 456999999999999999999999999999999999999999999999999998754322 3344679999999
Q ss_pred hhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCC--
Q psy501 471 PEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK-- 548 (962)
Q Consensus 471 PE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRP-- 548 (962)
||++.+...++.++|||||||++|+|++|+.||.+.........+..+....+. ...+.....+++.||..+|.+||
T Consensus 165 PE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK-NVLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred HHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC-ccCCHHHHHHHHHHcCCCHHHCCCC
Confidence 999977666899999999999999999999999988777766666665444332 24567788899999999999998
Q ss_pred --cHHHHHh
Q psy501 549 --SSYILLH 555 (962)
Q Consensus 549 --s~~~Ll~ 555 (962)
++.+++.
T Consensus 244 ~~~~~~ll~ 252 (330)
T cd05586 244 HRDAVELKE 252 (330)
T ss_pred CCCHHHHhc
Confidence 4555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=295.87 Aligned_cols=225 Identities=22% Similarity=0.318 Sum_probs=179.1
Q ss_pred CcccEEEEEecCCceEEEEeccch-------hHHHHHHHHH-HHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHH
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRK-SLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQL 393 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~ 393 (962)
+.+.||.+....+++.++.|+... ....+..|.. +++.++||||+++++++..++..|+||||+.| +|...
T Consensus 7 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 86 (325)
T cd05604 7 SFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFH 86 (325)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHH
Confidence 344577777666665555444322 2234555554 46778999999999999999999999999986 55555
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC--CCcccccCCccccCh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAP 471 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~--~~~~~~~gt~~Y~AP 471 (962)
+. ....+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..... .......|++.|+||
T Consensus 87 l~-~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aP 165 (325)
T cd05604 87 LQ-RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAP 165 (325)
T ss_pred HH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCH
Confidence 44 455699999999999999999999999999999999999999999999999999875322 233446799999999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHH
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 551 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~ 551 (962)
|++.+ ..++.++|||||||++|||++|..||...+.......+....... .+..+..+..++..|+..+|.+||+..
T Consensus 166 E~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 166 EVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVL--RPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred HHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccC--CCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 99965 468999999999999999999999999887766666665543322 245666778899999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=295.47 Aligned_cols=245 Identities=22% Similarity=0.244 Sum_probs=186.9
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeC------
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIREN------ 376 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------ 376 (962)
..+.+.....++.++.+.||.+......+.++.+... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3455555555666666668888776655554444322 1234678899999999999999999998643
Q ss_pred CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC
Q psy501 377 DTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS 456 (962)
Q Consensus 377 ~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~ 456 (962)
...|+||||+++++.+.+.. .+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred ceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 35799999999998887754 388999999999999999999999999999999999999999999999999986654
Q ss_pred C-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc---------------
Q psy501 457 R-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI--------------- 520 (962)
Q Consensus 457 ~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~--------------- 520 (962)
. ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (355)
T cd07874 172 SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_pred ccccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence 3 3344678999999999965 4689999999999999999999999987654333222111000
Q ss_pred -------c-----cc-------------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 521 -------L-----LH-------------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 521 -------~-----~~-------------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
. .+ .....+..+.+++..||..+|++||++.++++.-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 0 00 0001123457899999999999999998888753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=285.46 Aligned_cols=236 Identities=22% Similarity=0.294 Sum_probs=183.9
Q ss_pred ecCCcccEEEEEec----CCc-eEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CC
Q psy501 320 ILPHTLPLYTCNLD----QDN-HILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-EN 389 (962)
Q Consensus 320 i~~~~~~Vy~~~~~----~~~-kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~ 389 (962)
+.|..+.||.+... ... .++.+.+.. .+...+.+|++.+++++||||+++++++...+..++||||++ |+
T Consensus 8 g~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~ 87 (259)
T PF07714_consen 8 GEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGS 87 (259)
T ss_dssp EEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEB
T ss_pred ccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccccccc
Confidence 33344457777666 112 233333322 234679999999999999999999999998888999999998 68
Q ss_pred HHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----CcccccC
Q psy501 390 LYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PYTDYVS 464 (962)
Q Consensus 390 Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~~~~g 464 (962)
|.+++... ...+++..++.|+.||+.||.|||+.+++|+||+++||+++.++.+||+|||++...... .......
T Consensus 88 L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~ 167 (259)
T PF07714_consen 88 LDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQL 167 (259)
T ss_dssp HHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSES
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 88888876 567999999999999999999999999999999999999999999999999999876322 1223356
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccC
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
...|+|||.+.+. .++.++||||||+++|||++ |+.||...........+..+.. .+....++..+..++..||..+
T Consensus 168 ~~~~~aPE~~~~~-~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~C~~~~ 245 (259)
T PF07714_consen 168 PLRYLAPEVLKDG-EYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-LPIPDNCPKDIYSLIQQCWSHD 245 (259)
T ss_dssp GGGGS-HHHHHHS-EESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE-TTSBTTSBHHHHHHHHHHT-SS
T ss_pred ccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc-ceeccchhHHHHHHHHHHcCCC
Confidence 6789999999764 58999999999999999999 7899998877776777755533 3344567888999999999999
Q ss_pred CCCCCcHHHHHhhc
Q psy501 544 TERLKSSYILLHTL 557 (962)
Q Consensus 544 perRPs~~~Ll~~l 557 (962)
|++||++.++++.|
T Consensus 246 p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 246 PEKRPSFQEILQEL 259 (259)
T ss_dssp GGGS--HHHHHHHH
T ss_pred hhhCcCHHHHHhcC
Confidence 99999999998754
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=303.63 Aligned_cols=200 Identities=25% Similarity=0.393 Sum_probs=176.3
Q ss_pred eEEEEecCCccc-EEEEEecCCceEEEEeccchhH---HHHHHHHHHHHhcC-C-----CCcccEEEEEEeCCEEEEEEe
Q psy501 315 LKFSYILPHTLP-LYTCNLDQDNHILSRHVSSRDE---MVVCFYRKSLKKLS-H-----ANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 315 ~~~~~i~~~~~~-Vy~~~~~~~~kvv~~k~~~~~~---~~~~~Ei~iL~~L~-H-----pnIv~l~~~~~~~~~~~LV~E 384 (962)
.+..++++|+++ |.+|.+..+++.|+.|+..... .+...|+.+|..|+ | -|+|+++++|...+++|||+|
T Consensus 189 ~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfE 268 (586)
T KOG0667|consen 189 EVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFE 268 (586)
T ss_pred EEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeeh
Confidence 445678888877 9999999999988888876654 36788999999996 4 379999999999999999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc--ceeeecccccccccCCCccc
Q psy501 385 YMKENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLAREIRSRPYTD 461 (962)
Q Consensus 385 y~~g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g--~vKL~DFGla~~~~~~~~~~ 461 (962)
.+.-+|.+++.... ..|+...++.++.||+.||.+||+.||||+||||+|||+.+.+ .|||+|||.|+....... .
T Consensus 269 LL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-t 347 (586)
T KOG0667|consen 269 LLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-T 347 (586)
T ss_pred hhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcce-e
Confidence 99999999998764 5699999999999999999999999999999999999997544 799999999998766655 7
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHH
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLK 516 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~ 516 (962)
++.+..|+|||++.|. +|+.+.||||||||++||++|.+.|.+.+..+....|.
T Consensus 348 YiQSRfYRAPEVILGl-pY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~ 401 (586)
T KOG0667|consen 348 YIQSRFYRAPEVILGL-PYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARII 401 (586)
T ss_pred eeeccccccchhhccC-CCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHH
Confidence 8899999999999985 89999999999999999999999999987777666554
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=294.03 Aligned_cols=244 Identities=22% Similarity=0.232 Sum_probs=188.5
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeC------
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIREN------ 376 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------ 376 (962)
..+.+.....++.++.+.||.+......+.++.|... .....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3455566656666666668888776666554444322 2234678899999999999999999988543
Q ss_pred CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC
Q psy501 377 DTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS 456 (962)
Q Consensus 377 ~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~ 456 (962)
...|+||||+++++...+.. .+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 35799999999998887754 378999999999999999999999999999999999999999999999999986654
Q ss_pred C-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-------------
Q psy501 457 R-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL------------- 522 (962)
Q Consensus 457 ~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------- 522 (962)
. ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (364)
T cd07875 179 SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257 (364)
T ss_pred CCcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence 3 2344578999999999976 478999999999999999999999998876554443332210000
Q ss_pred ------cC---------------------CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 523 ------HT---------------------LPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 523 ------~~---------------------~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
+. ....+..+.+++..||..+|++||++.++++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00112345689999999999999999988875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=289.63 Aligned_cols=242 Identities=15% Similarity=0.171 Sum_probs=188.4
Q ss_pred eeEEEEecCCcccEEEEEecCCce-----EEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 314 RLKFSYILPHTLPLYTCNLDQDNH-----ILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 314 ~~~~~~i~~~~~~Vy~~~~~~~~k-----vv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
.....++.++.+.||++.....+. ++.+.+. ......+.+|+.+++.++||||+++++++..+ ..++|+|
T Consensus 10 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e 88 (316)
T cd05108 10 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ 88 (316)
T ss_pred eeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeeee
Confidence 333344444455678776543332 2223221 12345688999999999999999999999765 4678999
Q ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCc----
Q psy501 385 YMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY---- 459 (962)
Q Consensus 385 y~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~---- 459 (962)
|+. |++.+.+......+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 89 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 168 (316)
T cd05108 89 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA 168 (316)
T ss_pred cCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcceec
Confidence 987 678888887666789999999999999999999999999999999999999999999999999987654321
Q ss_pred ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHH
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTT 538 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~ 538 (962)
....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.........+ ......+..+.++..+..++..
T Consensus 169 ~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~ 246 (316)
T cd05108 169 EGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVYMIMVK 246 (316)
T ss_pred cCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hCCCCCCCCCCCCHHHHHHHHH
Confidence 22234667999999965 468999999999999999998 99999887655444333 3333445556777888999999
Q ss_pred HhccCCCCCCcHHHHHhhcc
Q psy501 539 CLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 539 Cl~~dperRPs~~~Ll~~l~ 558 (962)
||..+|+.||++.+++..+.
T Consensus 247 cl~~~p~~Rps~~~l~~~l~ 266 (316)
T cd05108 247 CWMIDADSRPKFRELIIEFS 266 (316)
T ss_pred HccCChhhCcCHHHHHHHHH
Confidence 99999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=301.17 Aligned_cols=209 Identities=19% Similarity=0.229 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC---------------------------
Q psy501 348 EMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD--------------------------- 398 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~--------------------------- 398 (962)
...+.+|+++++.+ +||||+++++++..++..++|||||+ |+|.+++....
T Consensus 85 ~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (374)
T cd05106 85 REALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEK 164 (374)
T ss_pred HHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhc
Confidence 34688999999999 89999999999999999999999998 67777764321
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccc
Q psy501 399 ------------------------------------------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLL 436 (962)
Q Consensus 399 ------------------------------------------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NIL 436 (962)
.++++..++.++.||+.||.|||++||+||||||+||+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil 244 (374)
T cd05106 165 KYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVL 244 (374)
T ss_pred ccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEE
Confidence 24788999999999999999999999999999999999
Q ss_pred cccccceeeecccccccccCCCc----ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhh
Q psy501 437 CMGTELVKIADFGLAREIRSRPY----TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAG 511 (962)
Q Consensus 437 l~~~g~vKL~DFGla~~~~~~~~----~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~ 511 (962)
++.++.+||+|||++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||........
T Consensus 245 ~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~ 323 (374)
T cd05106 245 LTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK 323 (374)
T ss_pred EeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHH
Confidence 99999999999999976543321 12234567999999965 468999999999999999997 9999987655444
Q ss_pred HHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 512 TERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 512 ~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.................+..+..++..||..+|+.||++.++++.|
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l 369 (374)
T cd05106 324 FYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLI 369 (374)
T ss_pred HHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 4344333333333345577889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=294.56 Aligned_cols=224 Identities=19% Similarity=0.271 Sum_probs=172.9
Q ss_pred CcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCCC-CHHHH
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKE-NLYQL 393 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~ 393 (962)
+.+.||.+.....++.++.++... ....+..|+.++.++ +||+|+++++++.+++..++||||++| +|...
T Consensus 7 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~ 86 (329)
T cd05618 7 SYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 86 (329)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHH
Confidence 334577776666555544443221 223577888888877 799999999999999999999999985 55555
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC--CCcccccCCccccCh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAP 471 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~--~~~~~~~gt~~Y~AP 471 (962)
+. ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... .......||+.|+||
T Consensus 87 ~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aP 165 (329)
T cd05618 87 MQ-RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 165 (329)
T ss_pred HH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCH
Confidence 44 445699999999999999999999999999999999999999999999999999875322 233446789999999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcCh---------hhhHHHHHhccccccCCCCCCCCcHHHHHHHhcc
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCL---------LAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 542 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~---------~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~ 542 (962)
|++.+ ..++.++|||||||++|||++|+.||..... ......+...... .+...+..+..++..||..
T Consensus 166 E~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~p~~~~~~~~~ll~~~L~~ 242 (329)
T cd05618 166 EILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSFLNK 242 (329)
T ss_pred HHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHhcC
Confidence 99975 4689999999999999999999999963211 1112223232222 2235566778899999999
Q ss_pred CCCCCCcH
Q psy501 543 GTERLKSS 550 (962)
Q Consensus 543 dperRPs~ 550 (962)
+|++|+++
T Consensus 243 dP~~R~~~ 250 (329)
T cd05618 243 DPKERLGC 250 (329)
T ss_pred CHHHcCCC
Confidence 99999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=284.61 Aligned_cols=245 Identities=19% Similarity=0.201 Sum_probs=190.6
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE 388 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g 388 (962)
+.....+..++.+.||.+......+.++.+... .....+.+|+.+++.++||||+++++.+..++..++||||++|
T Consensus 14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (292)
T cd06644 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG 93 (292)
T ss_pred hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence 344444455555668888877766655544432 2234678899999999999999999999999999999999996
Q ss_pred C-HHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCC
Q psy501 389 N-LYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVST 465 (962)
Q Consensus 389 ~-Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt 465 (962)
+ +...+......+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+...... ......++
T Consensus 94 ~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 173 (292)
T cd06644 94 GAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGT 173 (292)
T ss_pred CcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccceecCC
Confidence 5 44455555567999999999999999999999999999999999999999999999999998754332 22345678
Q ss_pred ccccChhhhcc----CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc-cccCCCCCCCCcHHHHHHHh
Q psy501 466 RWYRAPEVLLH----STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI-LLHTLPLYTYHVPPIQTTCL 540 (962)
Q Consensus 466 ~~Y~APE~l~~----~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~l~~li~~Cl 540 (962)
..|+|||++.+ ...++.++|||||||++|||++|.+||...........+..... .......++..+..++..||
T Consensus 174 ~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 253 (292)
T cd06644 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTAL 253 (292)
T ss_pred ccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHh
Confidence 89999999852 33578899999999999999999999987765554444433321 11222345567788999999
Q ss_pred ccCCCCCCcHHHHHhhc
Q psy501 541 LAGTERLKSSYILLHTL 557 (962)
Q Consensus 541 ~~dperRPs~~~Ll~~l 557 (962)
..+|++||+..+++..-
T Consensus 254 ~~~p~~Rp~~~~il~~~ 270 (292)
T cd06644 254 DKHPETRPSAAQLLEHP 270 (292)
T ss_pred cCCcccCcCHHHHhcCc
Confidence 99999999998888754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=278.53 Aligned_cols=241 Identities=20% Similarity=0.239 Sum_probs=188.4
Q ss_pred eEEEEecCCcccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-C
Q psy501 315 LKFSYILPHTLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-N 389 (962)
Q Consensus 315 ~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~ 389 (962)
....+..++.+.||.+......+.++.+... .....+.+|++++++++||+|+++++++.+++.+|++|||++| +
T Consensus 7 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~ 86 (262)
T cd06613 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGS 86 (262)
T ss_pred EEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCc
Confidence 3334444455567877766555444443322 1345689999999999999999999999999999999999996 5
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCcc
Q psy501 390 LYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRW 467 (962)
Q Consensus 390 Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~ 467 (962)
+.+.+......+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+...... ......++..
T Consensus 87 l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 166 (262)
T cd06613 87 LQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPY 166 (262)
T ss_pred HHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCcc
Confidence 55555554467999999999999999999999999999999999999999999999999998765443 2334567889
Q ss_pred ccChhhhccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC---CCCCCCCcHHHHHHHhcc
Q psy501 468 YRAPEVLLHS--TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT---LPLYTYHVPPIQTTCLLA 542 (962)
Q Consensus 468 Y~APE~l~~~--~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~s~~l~~li~~Cl~~ 542 (962)
|+|||.+.+. ..++.++|||||||++|+|++|++||.+.........+.......+. .+.++..+..++..||..
T Consensus 167 y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 246 (262)
T cd06613 167 WMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTK 246 (262)
T ss_pred ccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCC
Confidence 9999998643 26788999999999999999999999887655554444433222211 223455678999999999
Q ss_pred CCCCCCcHHHHHh
Q psy501 543 GTERLKSSYILLH 555 (962)
Q Consensus 543 dperRPs~~~Ll~ 555 (962)
+|..||++.+++.
T Consensus 247 ~p~~Rpt~~~il~ 259 (262)
T cd06613 247 DPKKRPTATKLLQ 259 (262)
T ss_pred ChhhCCCHHHHhc
Confidence 9999999988775
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=277.56 Aligned_cols=236 Identities=21% Similarity=0.252 Sum_probs=189.0
Q ss_pred EecCCcccEEEEEecCCceEEEEecc-----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHH
Q psy501 319 YILPHTLPLYTCNLDQDNHILSRHVS-----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQ 392 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~ 392 (962)
+..++.+.||.+......+.++.+.. ......+..|+.+++.++||||+++++.+.+++.+++||||++ |++.+
T Consensus 8 lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 87 (255)
T cd08219 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQ 87 (255)
T ss_pred eeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHH
Confidence 33344445777766554444333321 2234568889999999999999999999999999999999998 57777
Q ss_pred HHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCcccc
Q psy501 393 LIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYR 469 (962)
Q Consensus 393 ~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~ 469 (962)
.+... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... ......+++.|+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 167 (255)
T cd08219 88 KIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYV 167 (255)
T ss_pred HHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCcccc
Confidence 76543 456899999999999999999999999999999999999999999999999999766443 223456888999
Q ss_pred ChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCc
Q psy501 470 APEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 549 (962)
Q Consensus 470 APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs 549 (962)
|||++.+ ..++.++|+||||+++|+|++|..||...........+..+... +....++..+..++..||..+|++||+
T Consensus 168 aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~ 245 (255)
T cd08219 168 PPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-PLPSHYSYELRSLIKQMFKRNPRSRPS 245 (255)
T ss_pred CHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-CCCcccCHHHHHHHHHHHhCCcccCCC
Confidence 9999865 46899999999999999999999999987766666666554332 223456667888999999999999999
Q ss_pred HHHHHhh
Q psy501 550 SYILLHT 556 (962)
Q Consensus 550 ~~~Ll~~ 556 (962)
+.+++..
T Consensus 246 ~~~il~~ 252 (255)
T cd08219 246 ATTILSR 252 (255)
T ss_pred HHHHhhc
Confidence 9988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=285.27 Aligned_cols=228 Identities=19% Similarity=0.224 Sum_probs=175.9
Q ss_pred ccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHh
Q psy501 325 LPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRD 396 (962)
Q Consensus 325 ~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~ 396 (962)
+.||.+.....++.++.+.... ....+..|++++++++||||+++++++.++...++||||++| +|...+..
T Consensus 7 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~ 86 (277)
T cd05607 7 GEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYN 86 (277)
T ss_pred eEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHh
Confidence 3466666555554444333221 123456799999999999999999999999999999999985 56555544
Q ss_pred c-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCccccChhhh
Q psy501 397 R-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPEVL 474 (962)
Q Consensus 397 ~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~APE~l 474 (962)
. ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...... ......|+..|+|||++
T Consensus 87 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 166 (277)
T cd05607 87 VGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEIL 166 (277)
T ss_pred ccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHH
Confidence 3 245899999999999999999999999999999999999999999999999999766543 22345789999999999
Q ss_pred ccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh----HHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcH
Q psy501 475 LHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG----TERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 550 (962)
Q Consensus 475 ~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~ 550 (962)
.+. .++.++|||||||++|||++|+.||........ ........... ....++..+.+++..||..+|++||++
T Consensus 167 ~~~-~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~ 244 (277)
T cd05607 167 KEE-PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLFLAKKPEDRLGS 244 (277)
T ss_pred ccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHHHHHHhccCHhhCCCC
Confidence 765 599999999999999999999999976433222 22222222111 123567788999999999999999998
Q ss_pred HHHH
Q psy501 551 YILL 554 (962)
Q Consensus 551 ~~Ll 554 (962)
++++
T Consensus 245 ~~~~ 248 (277)
T cd05607 245 REKN 248 (277)
T ss_pred ccch
Confidence 5544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=283.12 Aligned_cols=235 Identities=19% Similarity=0.261 Sum_probs=185.2
Q ss_pred CcccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCC-HHHHHHhc
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDR 397 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~-Ll~~l~~~ 397 (962)
+.+.||++........++.+... .....+.+|+++++.++||||+++++++..++..++||||++++ +...+...
T Consensus 17 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~ 96 (282)
T cd06643 17 AFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL 96 (282)
T ss_pred CCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhc
Confidence 33456777666655554444322 23346788999999999999999999999999999999999865 44445554
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhhhc
Q psy501 398 DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEVLL 475 (962)
Q Consensus 398 ~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~l~ 475 (962)
..++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ......++..|+|||++.
T Consensus 97 ~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 176 (282)
T cd06643 97 ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 176 (282)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhcc
Confidence 567999999999999999999999999999999999999999999999999998765332 233456889999999984
Q ss_pred ----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc-ccCCCCCCCCcHHHHHHHhccCCCCCCcH
Q psy501 476 ----HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL-LHTLPLYTYHVPPIQTTCLLAGTERLKSS 550 (962)
Q Consensus 476 ----~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~s~~l~~li~~Cl~~dperRPs~ 550 (962)
....++.++|||||||++|||++|++||...........+...... ......++..+..++..||..+|+.||++
T Consensus 177 ~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 256 (282)
T cd06643 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTT 256 (282)
T ss_pred ccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCH
Confidence 2345788999999999999999999999887765555555443221 12223466788999999999999999998
Q ss_pred HHHHhhc
Q psy501 551 YILLHTL 557 (962)
Q Consensus 551 ~~Ll~~l 557 (962)
.+++..-
T Consensus 257 ~~il~~~ 263 (282)
T cd06643 257 TQLLQHP 263 (282)
T ss_pred HHHhcCC
Confidence 8877644
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=283.22 Aligned_cols=238 Identities=26% Similarity=0.358 Sum_probs=182.3
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhc---CCCCcccEEEEEEe-----CCEEEEEE
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKL---SHANLVKLKEVIRE-----NDTLYFVF 383 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~-----~~~~~LV~ 383 (962)
.++.++.+.||.+....+++.++.|.... ......+|+.+++.+ +||||+++++++.. ....++||
T Consensus 7 ~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~ 86 (288)
T cd07863 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVF 86 (288)
T ss_pred EEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEE
Confidence 34444455688887776665554443221 123466788777766 69999999999864 34689999
Q ss_pred ecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-Cccc
Q psy501 384 EYMKENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTD 461 (962)
Q Consensus 384 Ey~~g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~ 461 (962)
||+++++.+.+.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...... ....
T Consensus 87 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 166 (288)
T cd07863 87 EHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP 166 (288)
T ss_pred cccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCcccCCC
Confidence 999999888876543 45899999999999999999999999999999999999999999999999999866543 3344
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-------------------
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL------------------- 522 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------------- 522 (962)
..++..|+|||++.+. .++.++|||||||++|+|++|++||.+........++.......
T Consensus 167 ~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (288)
T cd07863 167 VVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPR 245 (288)
T ss_pred ccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCC
Confidence 5788999999999754 68999999999999999999999998776655444443211000
Q ss_pred ------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 523 ------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 523 ------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
...+..+..+.+++..||..+|++||++.+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 246 GPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0112344556789999999999999998887763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=295.62 Aligned_cols=242 Identities=16% Similarity=0.182 Sum_probs=186.8
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHH
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLY 391 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll 391 (962)
.+.....+..++.+.||.+........++.|+.... ....|+.++++++||||+++++++..+...++|||++.|++.
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~ 144 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLY 144 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCCcHH
Confidence 455555555566667999988877776666654332 346799999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCccccC
Q psy501 392 QLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRA 470 (962)
Q Consensus 392 ~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~A 470 (962)
+++......+++..++.++.||+.||.|||+.||+||||||+||+++..+.+||+|||++...... ......||..|+|
T Consensus 145 ~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~a 224 (357)
T PHA03209 145 TYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNA 224 (357)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccccccccC
Confidence 999887778999999999999999999999999999999999999999999999999999754332 3344678999999
Q ss_pred hhhhccCCCCCchhHHHHHHHHHHHHHcCCC-CCCCcChhh---------hHHHHHh-ccccccCC--------------
Q psy501 471 PEVLLHSTAYSAPIHLSRSQQFLFYSIDHVP-PIQTTCLLA---------GTERLKS-SYILLHTL-------------- 525 (962)
Q Consensus 471 PE~l~~~~~~t~ksDIwSLGvlL~elltG~~-Pf~~~~~~~---------~~~~i~~-~~~~~~~~-------------- 525 (962)
||++.+. .++.++|||||||++|||+++.. +|....... ....+.. ....+...
T Consensus 225 PE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (357)
T PHA03209 225 PEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIE 303 (357)
T ss_pred CeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHh
Confidence 9999764 68999999999999999998544 444321110 0000000 00000000
Q ss_pred -----------------CCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 526 -----------------PLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 526 -----------------~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
...+.....++..||..+|.+||++.+++..
T Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 304 YASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred hcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 1234455669999999999999998887764
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=278.83 Aligned_cols=240 Identities=18% Similarity=0.285 Sum_probs=184.6
Q ss_pred EEecCCcccEEEEEecCCceEEEEecc-------chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-C
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVS-------SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-N 389 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~-------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~ 389 (962)
.+..++.+.||.+.....++.++.+.. ......+.+|+++++.++||+|+++++++.+.+..++||||+++ +
T Consensus 9 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 88 (267)
T cd08228 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGD 88 (267)
T ss_pred eeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCc
Confidence 333444455787776555444433321 12234578899999999999999999999999999999999995 5
Q ss_pred HHHHHHh---cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC--cccccC
Q psy501 390 LYQLIRD---RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--YTDYVS 464 (962)
Q Consensus 390 Ll~~l~~---~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~--~~~~~g 464 (962)
|.+.+.. ....+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+....... .....+
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 168 (267)
T cd08228 89 LSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168 (267)
T ss_pred HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCC
Confidence 6555532 33458999999999999999999999999999999999999999999999999988765432 223468
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcCh--hhhHHHHHhccccccCCCCCCCCcHHHHHHHhcc
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCL--LAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 542 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~ 542 (962)
++.|+|||.+.+. .++.++||||||+++|||++|+.||..... ......+............++..+.+++..||..
T Consensus 169 ~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 247 (267)
T cd08228 169 TPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYP 247 (267)
T ss_pred CccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCC
Confidence 8899999998654 688999999999999999999999976533 2333333332211111224566788999999999
Q ss_pred CCCCCCcHHHHHhhcc
Q psy501 543 GTERLKSSYILLHTLP 558 (962)
Q Consensus 543 dperRPs~~~Ll~~l~ 558 (962)
+|++||++.++++.+.
T Consensus 248 ~p~~Rp~~~~vl~~~~ 263 (267)
T cd08228 248 DPDQRPDIGYVHQIAK 263 (267)
T ss_pred CcccCcCHHHHHHHHH
Confidence 9999999999998663
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=296.08 Aligned_cols=238 Identities=20% Similarity=0.218 Sum_probs=180.9
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHH
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQ 392 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~ 392 (962)
.++.++.+.||.+.....++.++.|... .....+.+|+++++.++|+||+++++++..++.+++||||+.|+.+.
T Consensus 81 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 160 (353)
T PLN00034 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE 160 (353)
T ss_pred hccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccc
Confidence 3444455568888776655554444321 12346889999999999999999999999999999999999965442
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccC
Q psy501 393 LIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRA 470 (962)
Q Consensus 393 ~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~A 470 (962)
. ....++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..+... ......||..|+|
T Consensus 161 ~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~a 236 (353)
T PLN00034 161 G----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMS 236 (353)
T ss_pred c----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccC
Confidence 2 223578888999999999999999999999999999999999999999999999876433 2344678999999
Q ss_pred hhhhcc----CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhH---HHHHhccccccCCCCCCCCcHHHHHHHhccC
Q psy501 471 PEVLLH----STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGT---ERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 471 PE~l~~----~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~---~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
||++.. +...+.++|||||||++|||++|+.||......... ..+... ........++..+..++..||..+
T Consensus 237 PE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~ 315 (353)
T PLN00034 237 PERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS-QPPEAPATASREFRHFISCCLQRE 315 (353)
T ss_pred ccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc-CCCCCCCccCHHHHHHHHHHccCC
Confidence 998742 223457999999999999999999999743322211 111111 112223456677899999999999
Q ss_pred CCCCCcHHHHHhhccccc
Q psy501 544 TERLKSSYILLHTLPLYT 561 (962)
Q Consensus 544 perRPs~~~Ll~~l~~~~ 561 (962)
|++||++.+++..- |+.
T Consensus 316 P~~Rpt~~ell~hp-~~~ 332 (353)
T PLN00034 316 PAKRWSAMQLLQHP-FIL 332 (353)
T ss_pred hhhCcCHHHHhcCc-ccc
Confidence 99999988887744 443
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=277.81 Aligned_cols=208 Identities=16% Similarity=0.230 Sum_probs=172.9
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceee
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFF 426 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIv 426 (962)
...+..|+.+++.++||+|+++++++. +...++||||+++ +|.+++.. ...+++..+..++.|++.||.|||+.|++
T Consensus 40 ~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~ 117 (257)
T cd05116 40 KDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFV 117 (257)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 346889999999999999999999886 4567899999985 56666544 45689999999999999999999999999
Q ss_pred eccCCCcccccccccceeeecccccccccCCCc-----ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CC
Q psy501 427 HRDMKPENLLCMGTELVKIADFGLAREIRSRPY-----TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HV 500 (962)
Q Consensus 427 HrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~-----~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~ 500 (962)
||||||+||+++.++.++|+|||.+........ ....++..|+|||.+.+ ..++.++|||||||++|||++ |.
T Consensus 118 H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~ 196 (257)
T cd05116 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQ 196 (257)
T ss_pred ecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999976644321 12234578999998854 468899999999999999998 99
Q ss_pred CCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 501 PPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 501 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
.||...........+..+.. .+..+..+..+.+++..||..+|++||+...+.+.|..
T Consensus 197 ~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 197 KPYKGMKGNEVTQMIESGER-MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 99988777666666665432 33345677888999999999999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=289.62 Aligned_cols=227 Identities=18% Similarity=0.227 Sum_probs=181.9
Q ss_pred ecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEecCCC-CH
Q psy501 320 ILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMKE-NL 390 (962)
Q Consensus 320 i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey~~g-~L 390 (962)
+.++.+.||.+....+++.++.|+... ....+..|+.++..+. |++|+++++++.+.+.+|+||||++| +|
T Consensus 9 g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L 88 (323)
T cd05615 9 GKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL 88 (323)
T ss_pred EecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcH
Confidence 334444588887776666555554332 2235778888998886 57788999999999999999999985 56
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccc
Q psy501 391 YQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWY 468 (962)
Q Consensus 391 l~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y 468 (962)
...+.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... ......||+.|
T Consensus 89 ~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y 167 (323)
T cd05615 89 MYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDY 167 (323)
T ss_pred HHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccc
Confidence 555544 456999999999999999999999999999999999999999999999999998754322 23345689999
Q ss_pred cChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCC
Q psy501 469 RAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK 548 (962)
Q Consensus 469 ~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRP 548 (962)
+|||++.+ ..++.++|||||||++|||++|+.||.+.........+.......+ ...+.....++..||..+|.+|+
T Consensus 168 ~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~li~~~l~~~p~~R~ 244 (323)
T cd05615 168 IAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP--KSLSKEAVSICKGLMTKHPSKRL 244 (323)
T ss_pred cCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--ccCCHHHHHHHHHHcccCHhhCC
Confidence 99999965 4689999999999999999999999998877766666665543322 35666778899999999999999
Q ss_pred cH
Q psy501 549 SS 550 (962)
Q Consensus 549 s~ 550 (962)
+.
T Consensus 245 ~~ 246 (323)
T cd05615 245 GC 246 (323)
T ss_pred CC
Confidence 73
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=280.60 Aligned_cols=236 Identities=19% Similarity=0.291 Sum_probs=183.5
Q ss_pred cCCcccEEEEEecCCceEEEEecc---chhHHHHHHHHHHHHhc-CCCCcccEEEEEEeC------CEEEEEEecCCC-C
Q psy501 321 LPHTLPLYTCNLDQDNHILSRHVS---SRDEMVVCFYRKSLKKL-SHANLVKLKEVIREN------DTLYFVFEYMKE-N 389 (962)
Q Consensus 321 ~~~~~~Vy~~~~~~~~kvv~~k~~---~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~------~~~~LV~Ey~~g-~ 389 (962)
.++.+.||.+........++.+.. ......+..|+.+++++ +||||+++++++... ...|+||||+++ +
T Consensus 16 ~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~ 95 (272)
T cd06637 16 NGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGS 95 (272)
T ss_pred ecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCc
Confidence 334445777766655555444442 23345688999999999 699999999999753 468999999985 6
Q ss_pred HHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCc
Q psy501 390 LYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTR 466 (962)
Q Consensus 390 Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~ 466 (962)
+.+.+... ...+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++...... ......|+.
T Consensus 96 L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~ 175 (272)
T cd06637 96 VTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 175 (272)
T ss_pred HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccc
Confidence 77666653 346899999999999999999999999999999999999999999999999999765432 333457889
Q ss_pred cccChhhhcc----CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhcc
Q psy501 467 WYRAPEVLLH----STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 542 (962)
Q Consensus 467 ~Y~APE~l~~----~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~ 542 (962)
.|+|||++.+ ...++.++|||||||++|||++|+.||...........+............++..+.+++..||..
T Consensus 176 ~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 255 (272)
T cd06637 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVK 255 (272)
T ss_pred cccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCC
Confidence 9999999853 235788999999999999999999999876655444443333222222335667888999999999
Q ss_pred CCCCCCcHHHHHhh
Q psy501 543 GTERLKSSYILLHT 556 (962)
Q Consensus 543 dperRPs~~~Ll~~ 556 (962)
+|.+||++.+++..
T Consensus 256 ~p~~Rpt~~~il~~ 269 (272)
T cd06637 256 NHSQRPTTEQLMKH 269 (272)
T ss_pred ChhhCCCHHHHhhC
Confidence 99999998887763
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=279.78 Aligned_cols=238 Identities=21% Similarity=0.246 Sum_probs=192.4
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccch---hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHH
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSSR---DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQL 393 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~ 393 (962)
.+..++.+.||.+.......++.+.+... ....+..|+.+++.++||+|+++++++.++...++||||++ |+|.++
T Consensus 13 ~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 92 (261)
T cd05148 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAF 92 (261)
T ss_pred hhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHH
Confidence 34445555688887766444444333222 23568899999999999999999999999999999999998 478777
Q ss_pred HHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC--cccccCCccccC
Q psy501 394 IRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--YTDYVSTRWYRA 470 (962)
Q Consensus 394 l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~--~~~~~gt~~Y~A 470 (962)
+... +..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+....... .....++..|+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~ 172 (261)
T cd05148 93 LRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTA 172 (261)
T ss_pred HhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecC
Confidence 7653 3568999999999999999999999999999999999999999999999999997664431 223345678999
Q ss_pred hhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCc
Q psy501 471 PEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 549 (962)
Q Consensus 471 PE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs 549 (962)
||.+.+ ..++.++|||||||++|+|++ |+.||...........+..+ ...+.....+..+..++..||..+|++||+
T Consensus 173 PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt 250 (261)
T cd05148 173 PEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPCPAKCPQEIYKIMLECWAAEPEDRPS 250 (261)
T ss_pred HHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC-CcCCCCCCCCHHHHHHHHHHcCCCchhCcC
Confidence 999865 468999999999999999998 89999887766666655544 333444577788999999999999999999
Q ss_pred HHHHHhhc
Q psy501 550 SYILLHTL 557 (962)
Q Consensus 550 ~~~Ll~~l 557 (962)
+.+|++.|
T Consensus 251 ~~~l~~~L 258 (261)
T cd05148 251 FKALREEL 258 (261)
T ss_pred HHHHHHHH
Confidence 99999866
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=291.79 Aligned_cols=224 Identities=18% Similarity=0.261 Sum_probs=174.7
Q ss_pred CcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCCC-CHHHH
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKE-NLYQL 393 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~ 393 (962)
+.+.||.+......+.++.++... ....+.+|+.++.++ +||+|+++++++.+.+.+|+||||++| +|...
T Consensus 7 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 86 (327)
T cd05617 7 SYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFH 86 (327)
T ss_pred CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHH
Confidence 334577777766666555444332 223478899999888 599999999999999999999999985 55555
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC--CCcccccCCccccCh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAP 471 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~--~~~~~~~gt~~Y~AP 471 (962)
+.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... .......||+.|+||
T Consensus 87 ~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aP 165 (327)
T cd05617 87 MQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAP 165 (327)
T ss_pred HHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCH
Confidence 543 45699999999999999999999999999999999999999999999999999875322 233446799999999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcCh-------hhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCC
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCL-------LAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGT 544 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dp 544 (962)
|++.+ ..++.++|||||||++|||++|+.||..... ......+.... ...+...+.....++..||..+|
T Consensus 166 E~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP 242 (327)
T cd05617 166 EILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--IRIPRFLSVKASHVLKGFLNKDP 242 (327)
T ss_pred HHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHhccCH
Confidence 99965 4789999999999999999999999964221 11222222221 12223456678889999999999
Q ss_pred CCCCcH
Q psy501 545 ERLKSS 550 (962)
Q Consensus 545 erRPs~ 550 (962)
++|+++
T Consensus 243 ~~R~~~ 248 (327)
T cd05617 243 KERLGC 248 (327)
T ss_pred HHcCCC
Confidence 999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=280.42 Aligned_cols=239 Identities=25% Similarity=0.354 Sum_probs=187.4
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHH
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLY 391 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll 391 (962)
.+..++.+.||++.....++.++.+... .....+.+|+.++++++||+|+++++++..+...++||||+.++|.
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~L~ 86 (286)
T cd07832 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLS 86 (286)
T ss_pred ecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecccCCCHH
Confidence 3344444557777765544433333221 2235688999999999999999999999999999999999977888
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---cccccCCccc
Q psy501 392 QLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---YTDYVSTRWY 468 (962)
Q Consensus 392 ~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~gt~~Y 468 (962)
+.+......+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... .....++..|
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y 166 (286)
T cd07832 87 EVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWY 166 (286)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccc
Confidence 8887766779999999999999999999999999999999999999999999999999998765442 3445788999
Q ss_pred cChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc-------------------c-------
Q psy501 469 RAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL-------------------L------- 522 (962)
Q Consensus 469 ~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------~------- 522 (962)
+|||.+.+...++.++|||||||++|||++|.+||.+.........+...... .
T Consensus 167 ~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (286)
T cd07832 167 RAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIP 246 (286)
T ss_pred cCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcch
Confidence 99999877666799999999999999999999999776554433332221000 0
Q ss_pred --cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 523 --HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 523 --~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
...+..+..+..++..||..+|++||++.+++..
T Consensus 247 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 247 LEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0112345567789999999999999998887764
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=284.58 Aligned_cols=236 Identities=19% Similarity=0.228 Sum_probs=182.2
Q ss_pred ecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHH
Q psy501 320 ILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQL 393 (962)
Q Consensus 320 i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~ 393 (962)
..++.+.||.+.....++.++.+... .....+.+|++++++++||||+++++++.+++.+++||||++| +|.++
T Consensus 10 g~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~ 89 (308)
T cd06615 10 GAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 89 (308)
T ss_pred cCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHH
Confidence 33344457777666655555544322 1234588999999999999999999999999999999999985 56666
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhccc-ceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccccChh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHR-HGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPE 472 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~-~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE 472 (962)
+.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++............++..|+|||
T Consensus 90 l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE 168 (308)
T cd06615 90 LKK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE 168 (308)
T ss_pred HHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccccCCCCcCccChh
Confidence 554 3668999999999999999999997 58999999999999999999999999998766554455567899999999
Q ss_pred hhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc--------------------------------
Q psy501 473 VLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI-------------------------------- 520 (962)
Q Consensus 473 ~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~-------------------------------- 520 (962)
++.+ ..++.++|||||||++|+|++|+.||...........+.....
T Consensus 169 ~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (308)
T cd06615 169 RLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIV 247 (308)
T ss_pred HhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHh
Confidence 9865 4688999999999999999999999976543222211111000
Q ss_pred --cccCCC--CCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 521 --LLHTLP--LYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 521 --~~~~~~--~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..+..+ .++..+..++..||..+|++||++.+++...
T Consensus 248 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 248 NEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 001111 2445677899999999999999999888765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=278.63 Aligned_cols=233 Identities=21% Similarity=0.256 Sum_probs=180.2
Q ss_pred CcccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhc
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDR 397 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~ 397 (962)
+.+.||.+.....++.++.+... .....+.+|+.+++.++||+|+++++++..++..++||||+++ +|.+.+..
T Consensus 21 ~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~- 99 (267)
T cd06645 21 TYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV- 99 (267)
T ss_pred CCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHh-
Confidence 33446666655555544444322 2234578899999999999999999999999999999999985 56555544
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhhhc
Q psy501 398 DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEVLL 475 (962)
Q Consensus 398 ~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~l~ 475 (962)
.+.+++.+++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... ......|+..|+|||++.
T Consensus 100 ~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 179 (267)
T cd06645 100 TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA 179 (267)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhc
Confidence 456999999999999999999999999999999999999999999999999998765432 233457899999999974
Q ss_pred --cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCC---CCCCCCcHHHHHHHhccCCCCCCcH
Q psy501 476 --HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTL---PLYTYHVPPIQTTCLLAGTERLKSS 550 (962)
Q Consensus 476 --~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~s~~l~~li~~Cl~~dperRPs~ 550 (962)
....++.++|||||||++|+|++|..||...................+.. ..++..+..++..||..+|++||++
T Consensus 180 ~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 259 (267)
T cd06645 180 VERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTA 259 (267)
T ss_pred cccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCH
Confidence 23358899999999999999999999997655433333332222222211 1345567889999999999999999
Q ss_pred HHHHhh
Q psy501 551 YILLHT 556 (962)
Q Consensus 551 ~~Ll~~ 556 (962)
.+|++.
T Consensus 260 ~~ll~~ 265 (267)
T cd06645 260 EKLLQH 265 (267)
T ss_pred HHHhcC
Confidence 888763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=288.50 Aligned_cols=184 Identities=27% Similarity=0.509 Sum_probs=147.1
Q ss_pred CcccEEEEEecC--CceEEEEe-ccc-hhHHHHHHHHHHHHhcCCCCcccEEEEEEe--CCEEEEEEecCCCCHHHHHHh
Q psy501 323 HTLPLYTCNLDQ--DNHILSRH-VSS-RDEMVVCFYRKSLKKLSHANLVKLKEVIRE--NDTLYFVFEYMKENLYQLIRD 396 (962)
Q Consensus 323 ~~~~Vy~~~~~~--~~kvv~~k-~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~LV~Ey~~g~Ll~~l~~ 396 (962)
+.+.||.+.... ..+.++.+ +.. .....+.+|+.+|++++||||+++++++.. +...|+||||+++++.+.+..
T Consensus 13 ~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~ 92 (317)
T cd07868 13 TYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKF 92 (317)
T ss_pred CCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCCHHHHHHh
Confidence 334577776432 22333332 221 223457899999999999999999999854 457899999999998887753
Q ss_pred c--------CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccc----ccccceeeecccccccccCC-----Cc
Q psy501 397 R--------DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLC----MGTELVKIADFGLAREIRSR-----PY 459 (962)
Q Consensus 397 ~--------~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl----~~~g~vKL~DFGla~~~~~~-----~~ 459 (962)
. ...+++..++.++.||+.||.|||+.||+||||||+||++ +..+.+||+|||+|+..... ..
T Consensus 93 ~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~ 172 (317)
T cd07868 93 HRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172 (317)
T ss_pred cccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCcccccc
Confidence 2 1358999999999999999999999999999999999999 45678999999999876433 22
Q ss_pred ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCc
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTT 506 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~ 506 (962)
....+|+.|+|||++.+...++.++|||||||++|||++|++||...
T Consensus 173 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 34578999999999987667899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=290.46 Aligned_cols=239 Identities=15% Similarity=0.215 Sum_probs=188.6
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CC
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-EN 389 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~ 389 (962)
.++.++.+.||.+......+.++.++... ....+..|+.++..++||+|+++++++.+++.+|+||||+. |+
T Consensus 8 ~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~ 87 (332)
T cd05623 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGD 87 (332)
T ss_pred EEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCc
Confidence 33444444578887776666655554332 12347889999999999999999999999999999999997 67
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---CcccccCCc
Q psy501 390 LYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYVSTR 466 (962)
Q Consensus 390 Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~gt~ 466 (962)
|.+++......+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... ......||+
T Consensus 88 L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~ 167 (332)
T cd05623 88 LLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 167 (332)
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCc
Confidence 77777765667999999999999999999999999999999999999999999999999998765332 222357899
Q ss_pred cccChhhhcc----CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC---CCCCCCCcHHHHHHH
Q psy501 467 WYRAPEVLLH----STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT---LPLYTYHVPPIQTTC 539 (962)
Q Consensus 467 ~Y~APE~l~~----~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~s~~l~~li~~C 539 (962)
.|+|||++.+ ...++.++|||||||++|||++|+.||...........+.......+. ....+....++++.|
T Consensus 168 ~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~l 247 (332)
T cd05623 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRL 247 (332)
T ss_pred cccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHH
Confidence 9999999862 345889999999999999999999999988877777776654332221 224566788899998
Q ss_pred hccCCCC--CCcHHHHHhh
Q psy501 540 LLAGTER--LKSSYILLHT 556 (962)
Q Consensus 540 l~~dper--RPs~~~Ll~~ 556 (962)
+..++++ |+++.++++.
T Consensus 248 l~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 248 ICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccChhhhcCCCCHHHHhCC
Confidence 8776666 5677776665
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=278.97 Aligned_cols=234 Identities=31% Similarity=0.497 Sum_probs=183.7
Q ss_pred CCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcC-CCCcccEEEEEEeC--CEEEEEEecCCCCHHHH
Q psy501 322 PHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLS-HANLVKLKEVIREN--DTLYFVFEYMKENLYQL 393 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~--~~~~LV~Ey~~g~Ll~~ 393 (962)
++.+.||.+......+.++.+... .+.....+|+.+++++. ||||+++++++.++ +..++||||++|++++.
T Consensus 10 g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~ 89 (282)
T cd07831 10 GTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYEL 89 (282)
T ss_pred cccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCccHHHH
Confidence 334457777665555444433322 22234567999999995 99999999999987 88999999999999999
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCccccChh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPE 472 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~APE 472 (962)
+......+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.+||+|||.+...... ......++..|+|||
T Consensus 90 l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE 168 (282)
T cd07831 90 IKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPE 168 (282)
T ss_pred HHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCCCCCcccCChh
Confidence 8876667999999999999999999999999999999999999999 99999999999876443 233456788999999
Q ss_pred hhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc------------------c---------cCC
Q psy501 473 VLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL------------------L---------HTL 525 (962)
Q Consensus 473 ~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------~---------~~~ 525 (962)
++.++..++.++|||||||++|||++|.+||.+.+.......+...... . ...
T Consensus 169 ~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (282)
T cd07831 169 CLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLL 248 (282)
T ss_pred HhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHc
Confidence 8766556889999999999999999999999877654443333211000 0 011
Q ss_pred CCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 526 PLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 526 ~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
+..+..+..++..||..+|++||++.+++..
T Consensus 249 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 249 PNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 2456778889999999999999998888764
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=286.92 Aligned_cols=187 Identities=27% Similarity=0.496 Sum_probs=148.4
Q ss_pred ecCCcccEEEEEecC--Cce-EEEEeccch-hHHHHHHHHHHHHhcCCCCcccEEEEEEe--CCEEEEEEecCCCCHHHH
Q psy501 320 ILPHTLPLYTCNLDQ--DNH-ILSRHVSSR-DEMVVCFYRKSLKKLSHANLVKLKEVIRE--NDTLYFVFEYMKENLYQL 393 (962)
Q Consensus 320 i~~~~~~Vy~~~~~~--~~k-vv~~k~~~~-~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~LV~Ey~~g~Ll~~ 393 (962)
+.++.+.||++.... ..+ ++.+.+... ....+.+|+++|++++||||+++++++.. +...++||||+++++.+.
T Consensus 10 G~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~ 89 (317)
T cd07867 10 GRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHI 89 (317)
T ss_pred ccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCcHHHH
Confidence 334444577776543 223 333333222 23457899999999999999999999853 567899999999998887
Q ss_pred HHhc--------CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccc----ccccceeeecccccccccCC----
Q psy501 394 IRDR--------DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLC----MGTELVKIADFGLAREIRSR---- 457 (962)
Q Consensus 394 l~~~--------~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl----~~~g~vKL~DFGla~~~~~~---- 457 (962)
+... ...+++..++.++.||+.||.|||+.+|+||||||+||++ +..+.+||+|||+++.....
T Consensus 90 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~ 169 (317)
T cd07867 90 IKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169 (317)
T ss_pred HHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccc
Confidence 7532 1358899999999999999999999999999999999999 45678999999999866443
Q ss_pred -CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCc
Q psy501 458 -PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTT 506 (962)
Q Consensus 458 -~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~ 506 (962)
......+|+.|+|||++.+...++.++|||||||++|||+||++||...
T Consensus 170 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 2234567899999999977667899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=282.62 Aligned_cols=265 Identities=20% Similarity=0.230 Sum_probs=195.1
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE 388 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g 388 (962)
+.....+..++.+.||.+.....++.++.+... .....+.+|+.+++.++||||+++++++..+...++|+||+.|
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 334444444555567777655544443333211 2345688999999999999999999999999999999999986
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCc
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTR 466 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~ 466 (962)
+.+..+... ..+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ......++.
T Consensus 101 ~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 179 (296)
T cd06655 101 GSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 179 (296)
T ss_pred CcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCc
Confidence 544444433 35899999999999999999999999999999999999999999999999998765443 223346888
Q ss_pred cccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc-cccCCCCCCCCcHHHHHHHhccCCC
Q psy501 467 WYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI-LLHTLPLYTYHVPPIQTTCLLAGTE 545 (962)
Q Consensus 467 ~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~l~~li~~Cl~~dpe 545 (962)
.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+..... .......++..+..++..||..+|+
T Consensus 180 ~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 258 (296)
T cd06655 180 YWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVE 258 (296)
T ss_pred cccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChh
Confidence 9999999865 4688999999999999999999999988776554444433221 1122234566788899999999999
Q ss_pred CCCcHHHHHhhccccccCC-CCcchhhhcccccccc
Q psy501 546 RLKSSYILLHTLPLYTYHV-PPIQTTCLLAGTERLK 580 (962)
Q Consensus 546 rRPs~~~Ll~~l~~~~~~~-~~~~~~~~l~g~~~l~ 580 (962)
+||++.++++.- |+.... -...+...++..|.++
T Consensus 259 ~Rpt~~~il~~~-~~~~~~~~~~~~~~~~~~~~~~~ 293 (296)
T cd06655 259 KRGSAKELLQHP-FLKLAKPLSSLTPLILAAKEAMK 293 (296)
T ss_pred hCCCHHHHhhCh-HhhhccccccCCccccchhhhhh
Confidence 999988777644 433222 2333344444444433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=282.67 Aligned_cols=237 Identities=20% Similarity=0.266 Sum_probs=188.0
Q ss_pred cCCcccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHH
Q psy501 321 LPHTLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIR 395 (962)
Q Consensus 321 ~~~~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~ 395 (962)
.++.+.||.+......+.++.+... .....+.+|++++++++||+|+++++++..+...|+||||++| ++.+.+.
T Consensus 15 ~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 94 (280)
T cd06611 15 DGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIML 94 (280)
T ss_pred CCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHH
Confidence 3344457777665554444444322 2334688999999999999999999999999999999999986 5666666
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhh
Q psy501 396 DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEV 473 (962)
Q Consensus 396 ~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~ 473 (962)
..+..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+...... ......++..|+|||+
T Consensus 95 ~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~ 174 (280)
T cd06611 95 ELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV 174 (280)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHH
Confidence 65667999999999999999999999999999999999999999999999999998765432 2233468899999999
Q ss_pred hcc----CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc-ccCCCCCCCCcHHHHHHHhccCCCCCC
Q psy501 474 LLH----STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL-LHTLPLYTYHVPPIQTTCLLAGTERLK 548 (962)
Q Consensus 474 l~~----~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~s~~l~~li~~Cl~~dperRP 548 (962)
+.. ...++.++|||||||++|+|++|++||...........+..+... ......++..+..++..||..+|+.||
T Consensus 175 ~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 254 (280)
T cd06611 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP 254 (280)
T ss_pred HhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCc
Confidence 852 235788999999999999999999999887766555555444222 122235667888999999999999999
Q ss_pred cHHHHHhhc
Q psy501 549 SSYILLHTL 557 (962)
Q Consensus 549 s~~~Ll~~l 557 (962)
++.++++.-
T Consensus 255 s~~~il~~~ 263 (280)
T cd06611 255 TAAELLKHP 263 (280)
T ss_pred CHHHHhcCh
Confidence 988888754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=288.44 Aligned_cols=243 Identities=15% Similarity=0.193 Sum_probs=188.9
Q ss_pred eEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 315 LKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 315 ~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
....++.++.+.||.++.....+.++.|.... ....+..|+.++..++|++|+++++++.+++..|+||||+.
T Consensus 5 i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~ 84 (331)
T cd05624 5 IIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYV 84 (331)
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 33344444455688888777776665554332 22347789999999999999999999999999999999997
Q ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---ccccc
Q psy501 388 -ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---YTDYV 463 (962)
Q Consensus 388 -g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~ 463 (962)
|+|.+++......+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++....... .....
T Consensus 85 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 164 (331)
T cd05624 85 GGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV 164 (331)
T ss_pred CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeecccc
Confidence 56777776655679999999999999999999999999999999999999999999999999997664432 22356
Q ss_pred CCccccChhhhccC----CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC---CCCCCCCcHHHH
Q psy501 464 STRWYRAPEVLLHS----TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT---LPLYTYHVPPIQ 536 (962)
Q Consensus 464 gt~~Y~APE~l~~~----~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~s~~l~~li 536 (962)
|++.|+|||++.+. ..++.++|||||||++|||++|+.||...........+.......+. ....+.....++
T Consensus 165 gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li 244 (331)
T cd05624 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLI 244 (331)
T ss_pred CCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHH
Confidence 89999999998642 35788999999999999999999999988776666666544322221 223456778889
Q ss_pred HHHhccCCCC--CCcHHHHHhhc
Q psy501 537 TTCLLAGTER--LKSSYILLHTL 557 (962)
Q Consensus 537 ~~Cl~~dper--RPs~~~Ll~~l 557 (962)
..|+..++.+ |+++.+++..-
T Consensus 245 ~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 245 QRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred HHHccCchhhcCCCCHHHHhcCC
Confidence 9998876655 35667666543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=291.74 Aligned_cols=239 Identities=21% Similarity=0.208 Sum_probs=184.2
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccchh---HHHHHHHHHHHHhcCCCCcccEEEEEEeCC-EEEEEEecCC-CCHHH
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSSRD---EMVVCFYRKSLKKLSHANLVKLKEVIREND-TLYFVFEYMK-ENLYQ 392 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~-~~~LV~Ey~~-g~Ll~ 392 (962)
.++.++.+.||++.......++.++..... ..++..|+++|.+++|||+|+++|||.+++ ..+||+||++ |+|.+
T Consensus 82 ~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d 161 (361)
T KOG1187|consen 82 LIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLED 161 (361)
T ss_pred ceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHH
Confidence 344444556888888776545444443322 456999999999999999999999999988 5999999998 89999
Q ss_pred HHHhcCC-CCCHHHHHHHHHHHHHHHhhcccce---eeeccCCCcccccccccceeeecccccccccC-CCcc-cc-cCC
Q psy501 393 LIRDRDK-FLPESIIRNMMYQVLQGLAFMHRHG---FFHRDMKPENLLCMGTELVKIADFGLAREIRS-RPYT-DY-VST 465 (962)
Q Consensus 393 ~l~~~~~-~ls~~~i~~i~~qI~~aL~yLH~~g---IvHrDLkp~NILl~~~g~vKL~DFGla~~~~~-~~~~-~~-~gt 465 (962)
++..... +++|..+.+|+.++|+||+|||... |+||||||+|||+|++..+||+|||+|+.... .... .. .||
T Consensus 162 ~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt 241 (361)
T KOG1187|consen 162 HLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGT 241 (361)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCC
Confidence 9887766 8999999999999999999999864 99999999999999999999999999976654 3222 22 799
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcC---hhhh----HHHHHhcc---ccccCC--CCCCC--C
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTC---LLAG----TERLKSSY---ILLHTL--PLYTY--H 531 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~---~~~~----~~~i~~~~---~~~~~~--~~~s~--~ 531 (962)
.+|+|||++..+ ..+.|+|||||||+|.||+||+.|.+... .... ...+..+. +..+.+ ..++. .
T Consensus 242 ~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~ 320 (361)
T KOG1187|consen 242 FGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKE 320 (361)
T ss_pred CccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHH
Confidence 999999999763 68999999999999999999998887532 1111 11222221 122222 12221 1
Q ss_pred ---cHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 532 ---VPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 532 ---l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+..+...|+..+|+.||+..++++.+
T Consensus 321 ~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 321 VKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred HHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 33356779999999999988887766
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=280.77 Aligned_cols=229 Identities=16% Similarity=0.188 Sum_probs=179.1
Q ss_pred cccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcC
Q psy501 324 TLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~ 398 (962)
.+.||.+......+.++.+... .....+.+|++++++++||+|+++++++..++..++||||++++.+...
T Consensus 14 ~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~---- 89 (279)
T cd06619 14 GGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY---- 89 (279)
T ss_pred CeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh----
Confidence 3446777655555544444322 2234688999999999999999999999999999999999997655443
Q ss_pred CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccccChhhhccCC
Q psy501 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHST 478 (962)
Q Consensus 399 ~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~~ 478 (962)
..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++............++..|+|||++.+.
T Consensus 90 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 168 (279)
T cd06619 90 RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGE- 168 (279)
T ss_pred hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCCCChhhcCceeecCC-
Confidence 2478999999999999999999999999999999999999999999999999987665555566889999999999754
Q ss_pred CCCchhHHHHHHHHHHHHHcCCCCCCCcChhh-------hHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHH
Q psy501 479 AYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLA-------GTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 551 (962)
Q Consensus 479 ~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~ 551 (962)
.++.++|||||||++|+|++|+.||....... ....+.............+..+..++..||..+|+.||++.
T Consensus 169 ~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~ 248 (279)
T cd06619 169 QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPE 248 (279)
T ss_pred CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHH
Confidence 68999999999999999999999997533211 11111111111111223556678899999999999999999
Q ss_pred HHHhhc
Q psy501 552 ILLHTL 557 (962)
Q Consensus 552 ~Ll~~l 557 (962)
+++..-
T Consensus 249 eil~~~ 254 (279)
T cd06619 249 NLMDHP 254 (279)
T ss_pred HHhcCc
Confidence 888754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=280.32 Aligned_cols=244 Identities=26% Similarity=0.352 Sum_probs=185.6
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccch-----hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-----DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
+.....+..++.+.||++.....++.++.|.... ....+.+|++++++++||+|+++++++.++...++||||++
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 3344444445555688887765555544443221 12346789999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCC
Q psy501 388 ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVST 465 (962)
Q Consensus 388 g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt 465 (962)
++|.+.+......+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+...... ......++
T Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 166 (291)
T cd07844 87 TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVT 166 (291)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccccccc
Confidence 9999888776667899999999999999999999999999999999999999999999999998754322 22233567
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcCh-hhhHHHHHhcc-------------------------
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCL-LAGTERLKSSY------------------------- 519 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~-~~~~~~i~~~~------------------------- 519 (962)
..|+|||++.+...++.++|||||||++|+|++|+.||.+... ......+....
T Consensus 167 ~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (291)
T cd07844 167 LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFY 246 (291)
T ss_pred cccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccccccc
Confidence 8899999987766789999999999999999999999976552 11111111000
Q ss_pred ---ccccCCCCCC--CCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 520 ---ILLHTLPLYT--YHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 520 ---~~~~~~~~~s--~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
......+..+ .....++..||..+|++||++.+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 247 PPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred CChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000011122 455689999999999999998887763
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=277.02 Aligned_cols=242 Identities=24% Similarity=0.338 Sum_probs=189.8
Q ss_pred eeEEEEecCCcccEEEEEecCCceEEEEecc-chhHH-----HHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 314 RLKFSYILPHTLPLYTCNLDQDNHILSRHVS-SRDEM-----VVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 314 ~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~-~~~~~-----~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
..+..++.|+.+.||++......+.++.|.. ..+.. ...+|+.++++++||+|+++++++.+....++|||+++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 3445556666677999988888754444332 22211 23459999999999999999999999999999999999
Q ss_pred C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccc--cCCCcccccC
Q psy501 388 E-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI--RSRPYTDYVS 464 (962)
Q Consensus 388 g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~--~~~~~~~~~g 464 (962)
+ +|.+.+. ....+++..++.++.||+.||.+||+.+++|+||||+||+++.++.++|+|||.+... .........+
T Consensus 82 ~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 160 (260)
T PF00069_consen 82 GGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVG 160 (260)
T ss_dssp TEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSS
T ss_pred ccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 7 7777776 3355899999999999999999999999999999999999999999999999999753 2334455678
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh---HHHHHhccccccCCC--CCCCCcHHHHHHH
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG---TERLKSSYILLHTLP--LYTYHVPPIQTTC 539 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~---~~~i~~~~~~~~~~~--~~s~~l~~li~~C 539 (962)
+..|+|||++.....++.++||||||+++|+|++|..||........ ............... ..+..+..++..|
T Consensus 161 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 240 (260)
T PF00069_consen 161 TPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKM 240 (260)
T ss_dssp SGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHH
Confidence 99999999987345799999999999999999999999998733222 222222222221111 1125788899999
Q ss_pred hccCCCCCCcHHHHHhh
Q psy501 540 LLAGTERLKSSYILLHT 556 (962)
Q Consensus 540 l~~dperRPs~~~Ll~~ 556 (962)
|..+|++||++.++++.
T Consensus 241 l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 241 LSKDPEQRPSAEELLKH 257 (260)
T ss_dssp SSSSGGGSTTHHHHHTS
T ss_pred ccCChhHCcCHHHHhcC
Confidence 99999999999988874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=273.73 Aligned_cols=208 Identities=24% Similarity=0.322 Sum_probs=179.5
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHh
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDR--------DKFLPESIIRNMMYQVLQGLA 418 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~--------~~~ls~~~i~~i~~qI~~aL~ 418 (962)
...+.+|+++++.++|++|+++++++..+...++||||++ ++|.+.+... ...+++..++.++.|++.||.
T Consensus 40 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~ 119 (262)
T cd00192 40 RKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119 (262)
T ss_pred HHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 4578999999999999999999999999999999999996 6777777665 467999999999999999999
Q ss_pred hcccceeeeccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHHHHH
Q psy501 419 FMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLF 494 (962)
Q Consensus 419 yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ 494 (962)
|||+.+++|+||+|+||+++.++.++|+|||.+....... .....++..|+|||.+.+. .++.++|||||||++|
T Consensus 120 ~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ 198 (262)
T cd00192 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLW 198 (262)
T ss_pred HHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHH
Confidence 9999999999999999999999999999999998765532 3345678899999998664 7899999999999999
Q ss_pred HHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 495 YSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 495 ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+|++ |..||...........+..+. ........+..+..++..||..+|+.||++.++++.|
T Consensus 199 ~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 199 EIFTLGATPYPGLSNEEVLEYLRKGY-RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 9999 699999887766666665532 2333456678899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=281.78 Aligned_cols=208 Identities=18% Similarity=0.228 Sum_probs=171.3
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeee
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFH 427 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvH 427 (962)
..+..|+.+++++.||||+++++++.. ...++|+||++ |+|.+++......+++..++.++.||+.||.|||+.+++|
T Consensus 54 ~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH 132 (279)
T cd05111 54 QEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVH 132 (279)
T ss_pred HHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 457778889999999999999998754 45788999997 7888888776677999999999999999999999999999
Q ss_pred ccCCCcccccccccceeeecccccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCC
Q psy501 428 RDMKPENLLCMGTELVKIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPP 502 (962)
Q Consensus 428 rDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~P 502 (962)
+||||+||+++.++.+||+|||.++..... ......++..|+|||.+.+. .++.++|||||||++|||++ |..|
T Consensus 133 ~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p 211 (279)
T cd05111 133 RNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEP 211 (279)
T ss_pred cccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999765432 12234566789999999654 68999999999999999998 9999
Q ss_pred CCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 503 IQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 503 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
|.+.........+..+. ..+....++..+..++..||..+|++||++.++++.|..
T Consensus 212 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 212 YAGMRPHEVPDLLEKGE-RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred CCCCCHHHHHHHHHCCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 98876655444444332 223233455667789999999999999999999997744
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=275.15 Aligned_cols=243 Identities=20% Similarity=0.262 Sum_probs=190.3
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccch--hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR--DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-EN 389 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~--~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~ 389 (962)
+.....+..++.+.||.+......+++.+..... ....+.+|++++++++||+++++++++. .+..++||||+. |+
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 86 (260)
T cd05069 8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGS 86 (260)
T ss_pred eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCC
Confidence 3344444455555688887766655544433322 2356889999999999999999999885 456889999998 57
Q ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCc---ccccCC
Q psy501 390 LYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY---TDYVST 465 (962)
Q Consensus 390 Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~---~~~~gt 465 (962)
|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+........ ....++
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 166 (260)
T cd05069 87 LLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP 166 (260)
T ss_pred HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccc
Confidence 888876543 4589999999999999999999999999999999999999999999999999976543321 223456
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCC
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGT 544 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dp 544 (962)
..|+|||.+.+. .++.++|||||||++|||++ |..||.+.........+... ...+.....+..+..++..||..+|
T Consensus 167 ~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p 244 (260)
T cd05069 167 IKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YRMPCPQGCPESLHELMKLCWKKDP 244 (260)
T ss_pred hhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHHHHHHHHHHccCCc
Confidence 789999988654 68999999999999999999 99999887666555555443 2223334567788999999999999
Q ss_pred CCCCcHHHHHhhcc
Q psy501 545 ERLKSSYILLHTLP 558 (962)
Q Consensus 545 erRPs~~~Ll~~l~ 558 (962)
++||++..+++.+.
T Consensus 245 ~~Rp~~~~i~~~l~ 258 (260)
T cd05069 245 DERPTFEYIQSFLE 258 (260)
T ss_pred ccCcCHHHHHHHHh
Confidence 99999999988663
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=271.90 Aligned_cols=246 Identities=17% Similarity=0.198 Sum_probs=195.0
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEe-c--cc-hhHHHHHHHHHHHHhcCCCCcccEEEEEEe-----CCEEEEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRH-V--SS-RDEMVVCFYRKSLKKLSHANLVKLKEVIRE-----NDTLYFV 382 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k-~--~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-----~~~~~LV 382 (962)
.|.....+..||..-||.++...+.+.++.| + .. ++.+...+|++..++++||||++++++... ....||+
T Consensus 22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll 101 (302)
T KOG2345|consen 22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLL 101 (302)
T ss_pred eEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEE
Confidence 4444444444444447887755555543322 1 22 456679999999999999999999998743 3459999
Q ss_pred EecCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHhhcccce--eeeccCCCcccccccccceeeecccccccccC
Q psy501 383 FEYMK-ENLYQLIRDR---DKFLPESIIRNMMYQVLQGLAFMHRHG--FFHRDMKPENLLCMGTELVKIADFGLAREIRS 456 (962)
Q Consensus 383 ~Ey~~-g~Ll~~l~~~---~~~ls~~~i~~i~~qI~~aL~yLH~~g--IvHrDLkp~NILl~~~g~vKL~DFGla~~~~~ 456 (962)
++|.. |++++.+... +..+++.+++.|+.+|++||.+||+.. +.||||||.||++++++.++|.|||.+....-
T Consensus 102 ~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i 181 (302)
T KOG2345|consen 102 LPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPI 181 (302)
T ss_pred eehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccce
Confidence 99987 8899988653 457999999999999999999999999 99999999999999999999999999976532
Q ss_pred C-----------CcccccCCccccChhhhcc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh--hhHHHHHhcccc
Q psy501 457 R-----------PYTDYVSTRWYRAPEVLLH--STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL--AGTERLKSSYIL 521 (962)
Q Consensus 457 ~-----------~~~~~~gt~~Y~APE~l~~--~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~--~~~~~i~~~~~~ 521 (962)
. .......|..|+|||++.- ....+.++|||||||+||+|+.|..||+..-.. .....+..+.+.
T Consensus 182 ~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s 261 (302)
T KOG2345|consen 182 QIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQIS 261 (302)
T ss_pred EeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccc
Confidence 1 2333467899999999852 224688999999999999999999999764332 223455667777
Q ss_pred ccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 522 LHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 522 ~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+|..+.++..+..+++.|++.||..||+..+|+..+
T Consensus 262 ~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~ 297 (302)
T KOG2345|consen 262 IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKL 297 (302)
T ss_pred cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 888888999999999999999999999999888754
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=276.63 Aligned_cols=245 Identities=21% Similarity=0.284 Sum_probs=192.2
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK- 387 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~- 387 (962)
+.+....++..++.+.||.+......+++.+.... .....+.+|++++++++||+|+++++++.. ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCC
Confidence 34555555555666678888776665554444432 224568999999999999999999998754 56899999998
Q ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCc---cccc
Q psy501 388 ENLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY---TDYV 463 (962)
Q Consensus 388 g~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~---~~~~ 463 (962)
|++.+++... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~ 164 (262)
T cd05071 85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 164 (262)
T ss_pred CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCc
Confidence 5777777653 34589999999999999999999999999999999999999999999999999976643322 2234
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhcc
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 542 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~ 542 (962)
++..|+|||+..+. .++.++|||||||++|||++ |..||.+.........+.... ..+..+..+..+..++..||..
T Consensus 165 ~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~ 242 (262)
T cd05071 165 FPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPCPPECPESLHDLMCQCWRK 242 (262)
T ss_pred ccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-CCCCccccCHHHHHHHHHHccC
Confidence 56779999988654 68999999999999999999 899998876655555554432 2233345677888999999999
Q ss_pred CCCCCCcHHHHHhhcc
Q psy501 543 GTERLKSSYILLHTLP 558 (962)
Q Consensus 543 dperRPs~~~Ll~~l~ 558 (962)
+|+.||++.++++.+.
T Consensus 243 ~p~~Rp~~~~~~~~l~ 258 (262)
T cd05071 243 EPEERPTFEYLQAFLE 258 (262)
T ss_pred CcccCCCHHHHHHHHH
Confidence 9999999999888663
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=281.55 Aligned_cols=210 Identities=21% Similarity=0.274 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC---------------CCCCHHHHHHHHHH
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD---------------KFLPESIIRNMMYQ 412 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~---------------~~ls~~~i~~i~~q 412 (962)
..+.+|++++++++||||+++++++..+...++||||++ ++|.+++.... ..+++..++.++.|
T Consensus 52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 131 (291)
T cd05094 52 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131 (291)
T ss_pred HHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHH
Confidence 468899999999999999999999999999999999997 56777765432 34889999999999
Q ss_pred HHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHH
Q psy501 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSR 488 (962)
Q Consensus 413 I~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwS 488 (962)
|+.||.|||++|++||||||+||+++.++.++|+|||++....... .....++..|+|||.+.+ ..++.++||||
T Consensus 132 i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s 210 (291)
T cd05094 132 IASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWS 210 (291)
T ss_pred HHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHH
Confidence 9999999999999999999999999999999999999997654432 223456788999999865 46899999999
Q ss_pred HHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 489 SQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 489 LGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
|||++|||++ |..||...........+..+... ......+..+..++..||..+|++||++.++++.+...
T Consensus 211 lG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 211 FGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 9999999999 99999887766655555544332 22335567788999999999999999999999977443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=280.17 Aligned_cols=208 Identities=20% Similarity=0.247 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC-------------CCCCHHHHHHHHHHH
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD-------------KFLPESIIRNMMYQV 413 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~-------------~~ls~~~i~~i~~qI 413 (962)
...+.+|+++|+.++||+|+++++++..+...++||||++ |+|.+++...+ ..+++..+..++.|+
T Consensus 52 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i 131 (280)
T cd05049 52 RKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131 (280)
T ss_pred HHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHH
Confidence 4578999999999999999999999999999999999998 56777665432 347899999999999
Q ss_pred HHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHH
Q psy501 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRS 489 (962)
Q Consensus 414 ~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSL 489 (962)
+.||.|||+.|++|+||||+||+++.++.++|+|||++....... .....+++.|+|||++.+. .++.++|||||
T Consensus 132 ~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~sl 210 (280)
T cd05049 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSF 210 (280)
T ss_pred HHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHH
Confidence 999999999999999999999999999999999999997653321 2233456789999999764 68999999999
Q ss_pred HHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 490 QQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 490 GvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
||++|||++ |..||...........+..+.... ....++..+..++..||..+|+.||++.+++..+
T Consensus 211 G~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l 278 (280)
T cd05049 211 GVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278 (280)
T ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 999999998 999998877766666666554332 2346677889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=282.69 Aligned_cols=209 Identities=21% Similarity=0.212 Sum_probs=172.0
Q ss_pred HHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC---------------CCCCHHHHHHHH
Q psy501 348 EMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD---------------KFLPESIIRNMM 410 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~---------------~~ls~~~i~~i~ 410 (962)
...+.+|+.+++++ +||+|+++++++...+..++||||++ |+|.+.+.... ..+++..++.++
T Consensus 46 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 125 (297)
T cd05089 46 HRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125 (297)
T ss_pred HHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHH
Confidence 34688999999999 79999999999999999999999998 67777775432 358899999999
Q ss_pred HHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCccccChhhhccCCCCCchhHHHHH
Q psy501 411 YQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRS 489 (962)
Q Consensus 411 ~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSL 489 (962)
.|++.||+|||+.|++||||||+||+++.++.+||+|||++...... .......+..|+|||++.+ ..++.++|||||
T Consensus 126 ~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSl 204 (297)
T cd05089 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSF 204 (297)
T ss_pred HHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHH
Confidence 99999999999999999999999999999999999999998643322 1111223457999999865 468999999999
Q ss_pred HHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 490 QQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 490 GvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
||++|||++ |..||.+.........+..+. .......++..+..++..||..+|.+||++.++++.+.
T Consensus 205 G~il~el~t~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 273 (297)
T cd05089 205 GVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLS 273 (297)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 999999997 999998887766666555442 22223456778889999999999999999999987663
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=273.52 Aligned_cols=234 Identities=21% Similarity=0.250 Sum_probs=183.1
Q ss_pred cCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEE-eCCEEEEEEecCC-CCHHHHHHhcC
Q psy501 321 LPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIR-ENDTLYFVFEYMK-ENLYQLIRDRD 398 (962)
Q Consensus 321 ~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~-~~~~~~LV~Ey~~-g~Ll~~l~~~~ 398 (962)
.++.+.||.+.......+++..........+.+|+.++++++||+++++++++. .+...++||||++ |+|.+++....
T Consensus 16 ~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 95 (256)
T cd05082 16 KGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 95 (256)
T ss_pred ccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcC
Confidence 333445666655433322222222233456889999999999999999999764 5567899999998 57877776544
Q ss_pred -CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccccChhhhccC
Q psy501 399 -KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHS 477 (962)
Q Consensus 399 -~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~ 477 (962)
..+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++....... ....++..|+|||++.+
T Consensus 96 ~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~y~aPE~~~~- 173 (256)
T cd05082 96 RSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALRE- 173 (256)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-CCCccceeecCHHHHcc-
Confidence 358999999999999999999999999999999999999999999999999987654332 22344667999999865
Q ss_pred CCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 478 TAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 478 ~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
..++.++|||||||++|+|++ |+.||...........+..+. .....+.++..+..++..||..+|++||++.+++..
T Consensus 174 ~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 252 (256)
T cd05082 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQ 252 (256)
T ss_pred CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 468999999999999999997 999998877666655555442 223334667788899999999999999999999876
Q ss_pred c
Q psy501 557 L 557 (962)
Q Consensus 557 l 557 (962)
|
T Consensus 253 l 253 (256)
T cd05082 253 L 253 (256)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=272.61 Aligned_cols=230 Identities=18% Similarity=0.292 Sum_probs=187.0
Q ss_pred cEEEEEecCCceEEEEec------cchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhc-
Q psy501 326 PLYTCNLDQDNHILSRHV------SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDR- 397 (962)
Q Consensus 326 ~Vy~~~~~~~~kvv~~k~------~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~- 397 (962)
.+|.++....+..++.+. .......+.+|++++++++|+||+++++++.+.+..++||||++ |+|.+.+...
T Consensus 15 ~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~ 94 (256)
T cd08221 15 EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQK 94 (256)
T ss_pred eEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhcc
Confidence 355555544444333322 12333468899999999999999999999999999999999998 5777777654
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC--cccccCCccccChhhhc
Q psy501 398 DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--YTDYVSTRWYRAPEVLL 475 (962)
Q Consensus 398 ~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~--~~~~~gt~~Y~APE~l~ 475 (962)
...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+....... .....+++.|+|||++.
T Consensus 95 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~ 174 (256)
T cd08221 95 GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQ 174 (256)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcC
Confidence 4568999999999999999999999999999999999999999999999999997654432 33456889999999986
Q ss_pred cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHh
Q psy501 476 HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLH 555 (962)
Q Consensus 476 ~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~ 555 (962)
+. .++.++|||||||++|||++|..||...........+..+.... ..+.++..+..++..||..+|++||++.+++.
T Consensus 175 ~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 175 GV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-VVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred CC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-CccccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 54 58899999999999999999999998877776666666553332 23456777889999999999999999999887
Q ss_pred hc
Q psy501 556 TL 557 (962)
Q Consensus 556 ~l 557 (962)
.+
T Consensus 253 ~~ 254 (256)
T cd08221 253 QP 254 (256)
T ss_pred Cc
Confidence 54
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=300.17 Aligned_cols=236 Identities=19% Similarity=0.260 Sum_probs=192.2
Q ss_pred EEecCCccc-EEEEEecCCceEEEEe------c--cchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC--EEEEEEecC
Q psy501 318 SYILPHTLP-LYTCNLDQDNHILSRH------V--SSRDEMVVCFYRKSLKKLSHANLVKLKEVIREND--TLYFVFEYM 386 (962)
Q Consensus 318 ~~i~~~~~~-Vy~~~~~~~~kvv~~k------~--~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~--~~~LV~Ey~ 386 (962)
.++++|.++ ||++-+...+.-++.. + .+.+.+++..|+.+|+.|+||||+++|++|.+.. .+-+|+|.+
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 445555555 8888766665544421 1 2233468999999999999999999999998765 488999999
Q ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccce--eeeccCCCccccccc-ccceeeecccccccccCCCcccc
Q psy501 387 K-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHG--FFHRDMKPENLLCMG-TELVKIADFGLAREIRSRPYTDY 462 (962)
Q Consensus 387 ~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~g--IvHrDLkp~NILl~~-~g~vKL~DFGla~~~~~~~~~~~ 462 (962)
. |+|..++.+. +.++.+.++.|++||++||.|||++. |+|||||.+||+|+. .|.|||+|+|+|...........
T Consensus 126 TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aksv 204 (632)
T KOG0584|consen 126 TSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKSV 204 (632)
T ss_pred cCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccccee
Confidence 8 5666665554 55899999999999999999999986 999999999999974 58999999999998888877778
Q ss_pred cCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCc-ChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhc
Q psy501 463 VSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTT-CLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 463 ~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~ 541 (962)
+|||.|||||++. ..|+..+||||||++++||+|+.+||..- ...+.++++..|..+......-...++.||..|+.
T Consensus 205 IGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~ 282 (632)
T KOG0584|consen 205 IGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLA 282 (632)
T ss_pred ccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhc
Confidence 9999999999995 46999999999999999999999999874 56666777777744433333445688999999999
Q ss_pred cCCCCCCcHHHHHhhc
Q psy501 542 AGTERLKSSYILLHTL 557 (962)
Q Consensus 542 ~dperRPs~~~Ll~~l 557 (962)
. .+.|+++.+||..-
T Consensus 283 ~-~~~R~sa~eLL~d~ 297 (632)
T KOG0584|consen 283 T-KSERLSAKELLKDP 297 (632)
T ss_pred C-chhccCHHHHhhCh
Confidence 9 88889888887643
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=277.40 Aligned_cols=204 Identities=14% Similarity=0.176 Sum_probs=164.3
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCH-HHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeee
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENL-YQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFH 427 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~L-l~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvH 427 (962)
..+..|+.+++.++||||+++++++..+...++||||++++. ..++......+++..++.++.||+.||+|||+.+|+|
T Consensus 49 ~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 128 (262)
T cd05077 49 LAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVH 128 (262)
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeEC
Confidence 357888999999999999999999999889999999999654 4444444567999999999999999999999999999
Q ss_pred ccCCCcccccccccc-------eeeecccccccccCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHH-cC
Q psy501 428 RDMKPENLLCMGTEL-------VKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSI-DH 499 (962)
Q Consensus 428 rDLkp~NILl~~~g~-------vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ell-tG 499 (962)
|||||+||+++.++. ++++|||.+...... ....++..|+|||.+.+...++.++|||||||++|||+ +|
T Consensus 129 ~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~ 206 (262)
T cd05077 129 GNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR--QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNG 206 (262)
T ss_pred CCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc--ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 999999999987664 899999998655332 23467889999999875567899999999999999998 58
Q ss_pred CCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 500 VPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 500 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..||.......... ...... ......+..+..++..||..+|++||+..+|+..+
T Consensus 207 ~~p~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 207 EIPLKDKTLAEKER-FYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCCCCCcchhHHHH-HHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 99987765433322 222211 11222345677899999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=271.77 Aligned_cols=232 Identities=19% Similarity=0.263 Sum_probs=184.3
Q ss_pred cccEEEEEecCCceEEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC
Q psy501 324 TLPLYTCNLDQDNHILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD 398 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~ 398 (962)
.+.||.+.......++.+... ......+.+|++++++++||||+++++++...+..++||||++ +++.+.+....
T Consensus 8 ~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 87 (250)
T cd05085 8 FGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK 87 (250)
T ss_pred CceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcC
Confidence 345777765443333333322 1223468899999999999999999999999999999999997 56777776655
Q ss_pred CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCc---ccccCCccccChhhhc
Q psy501 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY---TDYVSTRWYRAPEVLL 475 (962)
Q Consensus 399 ~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~---~~~~gt~~Y~APE~l~ 475 (962)
..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ ....++..|+|||++.
T Consensus 88 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 167 (250)
T cd05085 88 DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALN 167 (250)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhc
Confidence 6689999999999999999999999999999999999999999999999999875433211 1223456799999986
Q ss_pred cCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHH
Q psy501 476 HSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILL 554 (962)
Q Consensus 476 ~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll 554 (962)
+ ..++.++|||||||++|+|++ |..||.+.........+.... ........+..+..++..||..+|+.||+..++.
T Consensus 168 ~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~ 245 (250)
T cd05085 168 Y-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY-RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQ 245 (250)
T ss_pred c-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 5 468999999999999999998 999998877666666555442 2233345677888999999999999999999998
Q ss_pred hhc
Q psy501 555 HTL 557 (962)
Q Consensus 555 ~~l 557 (962)
+.+
T Consensus 246 ~~l 248 (250)
T cd05085 246 KEL 248 (250)
T ss_pred HHh
Confidence 865
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=283.99 Aligned_cols=240 Identities=22% Similarity=0.268 Sum_probs=188.3
Q ss_pred CcccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHH
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIR 395 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~ 395 (962)
+.+.||.+.....++.++.+... .....+.+|+++++.++||||+++++++.+++..++||||+.|++.+.+.
T Consensus 27 ~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g~l~~~~~ 106 (307)
T cd06607 27 SFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILE 106 (307)
T ss_pred CCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCCCHHHHHH
Confidence 33456666655444443333211 12245889999999999999999999999999999999999999988887
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccccChhhhc
Q psy501 396 DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLL 475 (962)
Q Consensus 396 ~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~ 475 (962)
.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ....++..|+|||++.
T Consensus 107 ~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--~~~~~~~~y~aPE~~~ 184 (307)
T cd06607 107 VHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--NSFVGTPYWMAPEVIL 184 (307)
T ss_pred HcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--CCccCCccccCceeee
Confidence 66667999999999999999999999999999999999999999999999999998754332 3456788999999884
Q ss_pred c--CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHH
Q psy501 476 H--STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 553 (962)
Q Consensus 476 ~--~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~L 553 (962)
+ ...++.++||||||+++|||++|+.||...........+............++..+..++..||..+|++||++.++
T Consensus 185 ~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 264 (307)
T cd06607 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEEL 264 (307)
T ss_pred ccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 2 34588999999999999999999999988766555444433322111122355678899999999999999999888
Q ss_pred HhhccccccCCC
Q psy501 554 LHTLPLYTYHVP 565 (962)
Q Consensus 554 l~~l~~~~~~~~ 565 (962)
+... |+....+
T Consensus 265 l~~~-~~~~~~~ 275 (307)
T cd06607 265 LKHR-FVLRERP 275 (307)
T ss_pred hcCh-hhcccCC
Confidence 8754 5544433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=312.32 Aligned_cols=246 Identities=18% Similarity=0.238 Sum_probs=190.1
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEe--CCEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRE--NDTLYF 381 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~L 381 (962)
.+.|.+...+..++.+.||.+........++.+... .....+..|+.+|++|+||||++++++|.+ ...+||
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 345566556666666679999887777665554422 234568899999999999999999999854 457999
Q ss_pred EEecCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHhhcccc-------eeeeccCCCccccccc-----------
Q psy501 382 VFEYMK-ENLYQLIRDR---DKFLPESIIRNMMYQVLQGLAFMHRH-------GFFHRDMKPENLLCMG----------- 439 (962)
Q Consensus 382 V~Ey~~-g~Ll~~l~~~---~~~ls~~~i~~i~~qI~~aL~yLH~~-------gIvHrDLkp~NILl~~----------- 439 (962)
||||++ |+|.+.+... ...+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 999998 5777776542 35699999999999999999999985 4999999999999964
Q ss_pred ------ccceeeecccccccccCC-CcccccCCccccChhhhccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh
Q psy501 440 ------TELVKIADFGLAREIRSR-PYTDYVSTRWYRAPEVLLHS-TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG 511 (962)
Q Consensus 440 ------~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~APE~l~~~-~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~ 511 (962)
.+.+||+|||++..+... ......||+.|+|||++.+. ..++.++||||||||||||++|..||........
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~q 251 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ 251 (1021)
T ss_pred ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHH
Confidence 235899999999876443 23345789999999998643 3588999999999999999999999987654433
Q ss_pred HHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 512 TERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 512 ~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
......... ....+.++..+..|+..||..+|++||++.+++..
T Consensus 252 li~~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 252 LISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHHHHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 332222211 11223456778999999999999999999888863
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=281.57 Aligned_cols=235 Identities=27% Similarity=0.367 Sum_probs=184.7
Q ss_pred CCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CEEEEEEecCCCCHHHH
Q psy501 322 PHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIREN--DTLYFVFEYMKENLYQL 393 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~LV~Ey~~g~Ll~~ 393 (962)
++.+.||.+.....++.++.+... .....+.+|+.++++++||||+++++++..+ ...|+||||++++|.+.
T Consensus 16 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~ 95 (293)
T cd07843 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSL 95 (293)
T ss_pred CCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCcCHHHH
Confidence 334456776665544443332221 1123467899999999999999999999877 89999999999988888
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccCh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAP 471 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~AP 471 (962)
+......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... ......++..|+||
T Consensus 96 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aP 175 (293)
T cd07843 96 METMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAP 175 (293)
T ss_pred HHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCc
Confidence 8776667999999999999999999999999999999999999999999999999999876543 23345678889999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc----------------------------cc
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL----------------------------LH 523 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~----------------------------~~ 523 (962)
|.+.+...++.++|||||||++|+|++|.+||.+........++...... ..
T Consensus 176 E~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (293)
T cd07843 176 ELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRK 255 (293)
T ss_pred hhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhc
Confidence 99877656789999999999999999999999887665544443221100 01
Q ss_pred CCCC--CCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 524 TLPL--YTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 524 ~~~~--~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
..+. .+..+.+++..||..+|++||++.++++.
T Consensus 256 ~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 256 KFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111 35567889999999999999999888874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-29 Score=292.65 Aligned_cols=248 Identities=16% Similarity=0.143 Sum_probs=185.6
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccch---hHHHHHHHHHHHHhcCC------CCcccEEEEEEeC-CEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR---DEMVVCFYRKSLKKLSH------ANLVKLKEVIREN-DTL 379 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~---~~~~~~~Ei~iL~~L~H------pnIv~l~~~~~~~-~~~ 379 (962)
.+.+.....++.++.+.||++.....++.++.|+... .......|+.+++.++| ++++.++++|..+ .++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 3556666666666666799998877777666655432 23346678888887754 4588899998754 579
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhccc-ceeeeccCCCccccccccc----------------c
Q psy501 380 YFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHR-HGFFHRDMKPENLLCMGTE----------------L 442 (962)
Q Consensus 380 ~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~-~gIvHrDLkp~NILl~~~g----------------~ 442 (962)
|+|||++.+++++++... +.+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .
T Consensus 208 ~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~ 286 (467)
T PTZ00284 208 CIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286 (467)
T ss_pred EEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence 999999999999888765 469999999999999999999997 5999999999999998765 4
Q ss_pred eeeecccccccccCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc
Q psy501 443 VKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL 522 (962)
Q Consensus 443 vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 522 (962)
+||+|||.+.... ......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.........+......+
T Consensus 287 vkl~DfG~~~~~~-~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~ 364 (467)
T PTZ00284 287 VRICDLGGCCDER-HSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364 (467)
T ss_pred EEECCCCccccCc-cccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence 9999999886432 233456899999999999764 79999999999999999999999998766543332222110000
Q ss_pred c-------------------------CCC---------------CCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 523 H-------------------------TLP---------------LYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 523 ~-------------------------~~~---------------~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
+ ..+ ..+..+.+|+..||..||++||++.++++. +|+.
T Consensus 365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H-p~~~ 442 (467)
T PTZ00284 365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH-PYVL 442 (467)
T ss_pred CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC-cccc
Confidence 0 000 011234579999999999999998888764 3444
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=274.66 Aligned_cols=208 Identities=19% Similarity=0.196 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhccccee
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGF 425 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gI 425 (962)
...+.+|+.++++++||||+++++++.+ ...++||||++ |+|.+.+.... ..+++..++.++.|++.||.|||+.|+
T Consensus 40 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i 118 (257)
T cd05040 40 MDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118 (257)
T ss_pred HHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCc
Confidence 3468899999999999999999999988 88999999997 67888777655 568999999999999999999999999
Q ss_pred eeccCCCcccccccccceeeecccccccccCC-----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-C
Q psy501 426 FHRDMKPENLLCMGTELVKIADFGLAREIRSR-----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-H 499 (962)
Q Consensus 426 vHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G 499 (962)
+|+||+|+||+++.++.+||+|||++...... ......++..|+|||.+.+ ..++.++|||||||++|||++ |
T Consensus 119 ~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g 197 (257)
T cd05040 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYG 197 (257)
T ss_pred cccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCC
Confidence 99999999999999999999999999876442 1112356778999999865 468999999999999999998 9
Q ss_pred CCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 500 VPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 500 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+.||...........+.............+..+..++..||..+|++||++.++++.+
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 255 (257)
T cd05040 198 EEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHh
Confidence 9999877666655555543333333345667888999999999999999999999866
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=278.97 Aligned_cols=236 Identities=19% Similarity=0.189 Sum_probs=183.4
Q ss_pred ecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHH
Q psy501 320 ILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLY 391 (962)
Q Consensus 320 i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll 391 (962)
+.++.+.||.+.....++.++.+.... ....+.+|+++|++++|++|+.+++.+..++..|+||||+.| ++.
T Consensus 9 g~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 88 (285)
T cd05632 9 GKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLK 88 (285)
T ss_pred ecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHH
Confidence 334444588887776666555544321 123477899999999999999999999999999999999985 565
Q ss_pred HHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCcccc
Q psy501 392 QLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYR 469 (962)
Q Consensus 392 ~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~ 469 (962)
..+... ...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...... ......|+..|+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~ 168 (285)
T cd05632 89 FHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYM 168 (285)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCCCCCcCcc
Confidence 555443 346999999999999999999999999999999999999999999999999998765432 233457899999
Q ss_pred ChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc--cccCCCCCCCCcHHHHHHHhccCCCCC
Q psy501 470 APEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI--LLHTLPLYTYHVPPIQTTCLLAGTERL 547 (962)
Q Consensus 470 APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~s~~l~~li~~Cl~~dperR 547 (962)
|||++.+ ..++.++|||||||++|+|++|..||.+.........+..... .....+.++..+..++..||..+|++|
T Consensus 169 aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 247 (285)
T cd05632 169 APEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQR 247 (285)
T ss_pred ChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHc
Confidence 9999965 4689999999999999999999999987655433332222111 112223566678889999999999999
Q ss_pred Cc-----HHHHHhh
Q psy501 548 KS-----SYILLHT 556 (962)
Q Consensus 548 Ps-----~~~Ll~~ 556 (962)
|+ +.++++.
T Consensus 248 ~~~~~~~~~~l~~~ 261 (285)
T cd05632 248 LGCQEEGAGEVKRH 261 (285)
T ss_pred CCCcccChHHHHcC
Confidence 99 5555553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=290.86 Aligned_cols=234 Identities=22% Similarity=0.322 Sum_probs=179.2
Q ss_pred cCCcccEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeC------CEEEEEEecCCC
Q psy501 321 LPHTLPLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIREN------DTLYFVFEYMKE 388 (962)
Q Consensus 321 ~~~~~~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------~~~~LV~Ey~~g 388 (962)
.++.+.||.+....+++.++.|.... ....+.+|+++|++++||||+++++++... ...|++++++++
T Consensus 25 ~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~ 104 (343)
T cd07878 25 SGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGA 104 (343)
T ss_pred cCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecCCC
Confidence 33444577777665555444433221 234577899999999999999999988643 357999999988
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccc
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWY 468 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y 468 (962)
++.+.+.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... .....||+.|
T Consensus 105 ~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~t~~y 181 (343)
T cd07878 105 DLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-MTGYVATRWY 181 (343)
T ss_pred CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC-cCCccccccc
Confidence 88776643 35999999999999999999999999999999999999999999999999999865443 3446789999
Q ss_pred cChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc--------------------ccCC---
Q psy501 469 RAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL--------------------LHTL--- 525 (962)
Q Consensus 469 ~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------------~~~~--- 525 (962)
+|||++.+...++.++|||||||++|+|++|+.||.+.........+...... .+..
T Consensus 182 ~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (343)
T cd07878 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQ 261 (343)
T ss_pred cCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccch
Confidence 99999977667899999999999999999999999876554433333211000 0000
Q ss_pred ------CCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 526 ------PLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 526 ------~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
...+..+.+++..||..+|++||++.+++..-
T Consensus 262 ~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 262 DLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred hHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 11223456789999999999999988877653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=277.22 Aligned_cols=240 Identities=26% Similarity=0.333 Sum_probs=188.2
Q ss_pred EEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHH
Q psy501 317 FSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLY 391 (962)
Q Consensus 317 ~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll 391 (962)
..+..++.+.||++....++..++.+... .....+.+|+.++++++||||+++++++.+++..++||||+++++.
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~ 85 (284)
T cd07836 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLK 85 (284)
T ss_pred eeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCccHH
Confidence 34444455568888776655554444322 1234677899999999999999999999999999999999999998
Q ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCcc
Q psy501 392 QLIRDRD--KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRW 467 (962)
Q Consensus 392 ~~l~~~~--~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~ 467 (962)
+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++...... ......++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 165 (284)
T cd07836 86 KYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLW 165 (284)
T ss_pred HHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccccccccc
Confidence 8886654 56899999999999999999999999999999999999999999999999999765432 2233467889
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-------------------------
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL------------------------- 522 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------------------- 522 (962)
|+|||++.+...++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 166 y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (284)
T cd07836 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQD 245 (284)
T ss_pred ccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHH
Confidence 9999998776668999999999999999999999998776544433332110000
Q ss_pred --cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 523 --HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 523 --~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
...+..+..+..++..|+..+|++||+..++++.
T Consensus 246 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 246 LQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0012345667789999999999999998887763
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=296.63 Aligned_cols=245 Identities=19% Similarity=0.185 Sum_probs=185.0
Q ss_pred ceeeEEEEecCCcccEEEEEecCC------ceEEEEecc----chhHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQD------NHILSRHVS----SRDEMVVCFYRKSLKKLS-HANLVKLKEVIRENDTLY 380 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~------~kvv~~k~~----~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~ 380 (962)
.+..+..++.++.+.||.+..... .+++.+.+. ....+.+.+|+++|+++. ||||+++++++.+.+..|
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence 333444444444555777764321 123333332 122456889999999996 999999999999999999
Q ss_pred EEEecCC-CCHHHHHHhc--------------------------------------------------------------
Q psy501 381 FVFEYMK-ENLYQLIRDR-------------------------------------------------------------- 397 (962)
Q Consensus 381 LV~Ey~~-g~Ll~~l~~~-------------------------------------------------------------- 397 (962)
+|||||+ |+|.+++...
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 9999998 5777666432
Q ss_pred ---------------------------------CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccccee
Q psy501 398 ---------------------------------DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVK 444 (962)
Q Consensus 398 ---------------------------------~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vK 444 (962)
...+++..++.++.||+.||.|||+.+|+|+||||+||+++.++.+|
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~k 277 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVK 277 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEE
Confidence 12478888999999999999999999999999999999999999999
Q ss_pred eecccccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhcc
Q psy501 445 IADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSY 519 (962)
Q Consensus 445 L~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~ 519 (962)
|+|||++...... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||................
T Consensus 278 L~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~ 356 (400)
T cd05105 278 ICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG 356 (400)
T ss_pred EEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcC
Confidence 9999999765432 1223356778999999865 468999999999999999997 999998754433333222232
Q ss_pred ccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 520 ILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 520 ~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
...+.....+..+..++..||..+|+.||++.+|.+.+
T Consensus 357 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 357 YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 33333445677788999999999999999999888866
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=302.33 Aligned_cols=245 Identities=21% Similarity=0.230 Sum_probs=196.4
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEecc------chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC------
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS------SRDEMVVCFYRKSLKKLSHANLVKLKEVIREND------ 377 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 377 (962)
.+.|.....++.++.+.||.+.....++.++.|.. ..+...+.+|+.++..++|++|+++++.+....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 34666666666666667999987766665555542 223446889999999999999999988875332
Q ss_pred --EEEEEEecCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccc
Q psy501 378 --TLYFVFEYMK-ENLYQLIRDR---DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLA 451 (962)
Q Consensus 378 --~~~LV~Ey~~-g~Ll~~l~~~---~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla 451 (962)
.+++||||+. |+|.+.+... ...+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 3789999998 5777777543 356999999999999999999999999999999999999999999999999999
Q ss_pred ccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCC
Q psy501 452 REIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPL 527 (962)
Q Consensus 452 ~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 527 (962)
+..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+..+... +..+.
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~ 268 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD-PLPPS 268 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC-CCCCC
Confidence 765432 2334578999999999965 46899999999999999999999999988776666655544332 33456
Q ss_pred CCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 528 YTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 528 ~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
++..+..++..||..+|++||++.+++..
T Consensus 269 ~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 269 ISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 77788999999999999999998888764
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=277.01 Aligned_cols=244 Identities=28% Similarity=0.424 Sum_probs=192.2
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
+.....+..++.+.||.+....+++.++.+.... ....+.+|++++++++||||+++++++..++..++||||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 3344444445555688887766665555443221 2346889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---Cccccc
Q psy501 387 KENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYV 463 (962)
Q Consensus 387 ~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~ 463 (962)
++++++.+......+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||.+...... ......
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~ 162 (288)
T cd07833 83 ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV 162 (288)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcc
Confidence 99888887776667999999999999999999999999999999999999999999999999998776543 233456
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc---------------------cc
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI---------------------LL 522 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~---------------------~~ 522 (962)
++..|+|||++.+...++.++||||||+++|+|++|++||.+.........+..... ..
T Consensus 163 ~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07833 163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPE 242 (288)
T ss_pred cccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCC
Confidence 788999999997755789999999999999999999999987655433332221000 00
Q ss_pred ---------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 523 ---------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 523 ---------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.....++..+..+++.||..+|++||++.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 243 PSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0011236678899999999999999998888763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=277.87 Aligned_cols=233 Identities=20% Similarity=0.248 Sum_probs=185.5
Q ss_pred cCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHH
Q psy501 321 LPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLI 394 (962)
Q Consensus 321 ~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l 394 (962)
.++.+.||++.....+..++.+... .....+.+|++++++++||||+++++++.++...++|+||+++ ++.+.+
T Consensus 11 ~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~ 90 (274)
T cd06609 11 KGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL 90 (274)
T ss_pred CCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHH
Confidence 3444457777665555444443322 2234688999999999999999999999999999999999985 666666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChh
Q psy501 395 RDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPE 472 (962)
Q Consensus 395 ~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE 472 (962)
... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||
T Consensus 91 ~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE 168 (274)
T cd06609 91 KPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPE 168 (274)
T ss_pred hhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChh
Confidence 543 6899999999999999999999999999999999999999999999999999876543 233456788999999
Q ss_pred hhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHH
Q psy501 473 VLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 552 (962)
Q Consensus 473 ~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~ 552 (962)
.+.+. .++.++|||||||++|+|++|..||...........+............++..+.+++..||..+|++||++.+
T Consensus 169 ~~~~~-~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~ 247 (274)
T cd06609 169 VIKQS-GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKE 247 (274)
T ss_pred hhccC-CCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHH
Confidence 99764 58999999999999999999999998766544444444332211111126777899999999999999999888
Q ss_pred HHhh
Q psy501 553 LLHT 556 (962)
Q Consensus 553 Ll~~ 556 (962)
++..
T Consensus 248 il~~ 251 (274)
T cd06609 248 LLKH 251 (274)
T ss_pred HhhC
Confidence 8774
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=281.96 Aligned_cols=248 Identities=25% Similarity=0.328 Sum_probs=189.8
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CEEEEEEe
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIREN--DTLYFVFE 384 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~LV~E 384 (962)
+.....+..++.+.||.+.....+..++.|.... ....+.+|+.++++++||+|+++++++... +..++|||
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence 3333344444455677777665554444333221 122467899999999999999999999755 56899999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--Ccccc
Q psy501 385 YMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDY 462 (962)
Q Consensus 385 y~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~ 462 (962)
|+.+++.+.+......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus 89 ~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 168 (309)
T cd07845 89 YCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK 168 (309)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcc
Confidence 9999988888776667999999999999999999999999999999999999999999999999999876543 22333
Q ss_pred cCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc-------------------cc
Q psy501 463 VSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL-------------------LH 523 (962)
Q Consensus 463 ~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------~~ 523 (962)
.++..|+|||.+.+...++.++|||||||++|||++|++||.+.+.......+...... .+
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (309)
T cd07845 169 VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLP 248 (309)
T ss_pred cccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccccccc
Confidence 45788999999977667899999999999999999999999887766555444331100 00
Q ss_pred C---------CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 524 T---------LPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 524 ~---------~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
. .+..+....+++..||..+|++||++.+++..- |+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~-~f~ 294 (309)
T cd07845 249 KQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS-YFK 294 (309)
T ss_pred CCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh-hhc
Confidence 0 012345567799999999999999998888754 443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=275.83 Aligned_cols=205 Identities=20% Similarity=0.318 Sum_probs=170.2
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeee
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFH 427 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvH 427 (962)
..+.+|+.++++++||+|+++++++.+.+..++||||++| +|.+++.. .+.+++..+..++.|++.||.|||+.|++|
T Consensus 51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH 129 (267)
T cd06628 51 DALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIH 129 (267)
T ss_pred HHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCccc
Confidence 4588999999999999999999999999999999999986 55555544 456899999999999999999999999999
Q ss_pred ccCCCcccccccccceeeecccccccccCC--------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcC
Q psy501 428 RDMKPENLLCMGTELVKIADFGLAREIRSR--------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDH 499 (962)
Q Consensus 428 rDLkp~NILl~~~g~vKL~DFGla~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG 499 (962)
+||+|+||+++.++.++|+|||.+...... ......|+..|+|||.+.+. .++.++|||||||++|+|++|
T Consensus 130 ~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g 208 (267)
T cd06628 130 RDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTG 208 (267)
T ss_pred ccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhC
Confidence 999999999999999999999998766522 11223578899999998654 688999999999999999999
Q ss_pred CCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 500 VPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 500 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
+.||...........+... .........+..+..++..||..+|.+||++.++++.
T Consensus 209 ~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 209 KHPFPDCTQLQAIFKIGEN-ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CCCCCCccHHHHHHHHhcc-CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 9999876655444443332 1222234567778899999999999999999888774
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=280.02 Aligned_cols=240 Identities=29% Similarity=0.446 Sum_probs=187.2
Q ss_pred EEEecCCcccEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCH
Q psy501 317 FSYILPHTLPLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENL 390 (962)
Q Consensus 317 ~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~L 390 (962)
..+..++.+.||.+.....++.++.+.... ....+.+|+++++.++||||+++++++..+...++||||+++++
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 86 (286)
T cd07846 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTV 86 (286)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccH
Confidence 334444445578877765555444433211 23457889999999999999999999999999999999999888
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccc
Q psy501 391 YQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWY 468 (962)
Q Consensus 391 l~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y 468 (962)
+..+......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ......++..|
T Consensus 87 l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y 166 (286)
T cd07846 87 LDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWY 166 (286)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeec
Confidence 7777666566999999999999999999999999999999999999999999999999998765433 22335678899
Q ss_pred cChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc-------------------cc-------
Q psy501 469 RAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI-------------------LL------- 522 (962)
Q Consensus 469 ~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~-------------------~~------- 522 (962)
+|||++.+...++.++|||||||++|||++|++||...........+..... ..
T Consensus 167 ~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (286)
T cd07846 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIE 246 (286)
T ss_pred cCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcc
Confidence 9999997665688999999999999999999999987654333222221000 00
Q ss_pred ---cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 523 ---HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 523 ---~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
...+..+..+..++..||..+|++||++.++++.
T Consensus 247 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 247 PLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0123455668889999999999999999888764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=279.49 Aligned_cols=210 Identities=21% Similarity=0.264 Sum_probs=175.9
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC------------CCCCHHHHHHHHHHHH
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD------------KFLPESIIRNMMYQVL 414 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~------------~~ls~~~i~~i~~qI~ 414 (962)
...+.+|++++++++||+|+++++++..++..++||||++ ++|.+++.... ..+++..++.++.|++
T Consensus 51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~ 130 (288)
T cd05093 51 RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130 (288)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHH
Confidence 4468999999999999999999999999999999999998 56777665432 2489999999999999
Q ss_pred HHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHH
Q psy501 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQ 490 (962)
Q Consensus 415 ~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLG 490 (962)
.||+|||+.|++||||||+||+++.++.++|+|||.+....... .....++..|+|||++.+ ..++.++||||||
T Consensus 131 ~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG 209 (288)
T cd05093 131 AGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLG 209 (288)
T ss_pred HHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHH
Confidence 99999999999999999999999999999999999997654332 122345678999999865 4689999999999
Q ss_pred HHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 491 QFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 491 vlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
|++|+|++ |.+||...........+..+... ......+..+..++..||..+|.+||++.++...+..
T Consensus 210 ~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~ 278 (288)
T cd05093 210 VVLWEIFTYGKQPWYQLSNNEVIECITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQN 278 (288)
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 99999998 99999888776666666655432 2233566788999999999999999999999886633
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=273.85 Aligned_cols=234 Identities=21% Similarity=0.289 Sum_probs=184.6
Q ss_pred CCcccEEEEEecCCceEEEEeccch--hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcC
Q psy501 322 PHTLPLYTCNLDQDNHILSRHVSSR--DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRD 398 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~k~~~~--~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~ 398 (962)
++.+.+|.+......+.++.+.... ....+.+|++++++++||+|+++++++.++...|+++||+++ +|.+.+....
T Consensus 14 g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~ 93 (256)
T cd06612 14 GSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN 93 (256)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCc
Confidence 3344577776665444433333222 256799999999999999999999999999999999999985 6666666556
Q ss_pred CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhhhcc
Q psy501 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEVLLH 476 (962)
Q Consensus 399 ~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~l~~ 476 (962)
..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... ......++..|+|||++.+
T Consensus 94 ~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 173 (256)
T cd06612 94 KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE 173 (256)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhc
Confidence 67999999999999999999999999999999999999999999999999999876543 2233457889999999865
Q ss_pred CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc-ccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHh
Q psy501 477 STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL-LHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLH 555 (962)
Q Consensus 477 ~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~ 555 (962)
. .++.++|||||||++|+|++|+.||...........+...... ....+.++..+..++..||..+|++||++.+++.
T Consensus 174 ~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 174 I-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred C-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 4 7899999999999999999999999876554443333221111 1112245567888999999999999999998887
Q ss_pred h
Q psy501 556 T 556 (962)
Q Consensus 556 ~ 556 (962)
.
T Consensus 253 ~ 253 (256)
T cd06612 253 H 253 (256)
T ss_pred C
Confidence 4
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=272.61 Aligned_cols=234 Identities=23% Similarity=0.284 Sum_probs=183.5
Q ss_pred CCcccEEEEEecCCceEEEEeccc---------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHH
Q psy501 322 PHTLPLYTCNLDQDNHILSRHVSS---------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLY 391 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~k~~~---------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll 391 (962)
++.+.||.+........++.+... .....+.+|+.+++.++||+|+++++++.++...++|+||++| ++.
T Consensus 11 g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (258)
T cd06632 11 GSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLA 90 (258)
T ss_pred cCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHH
Confidence 344456776655333333222211 1234688999999999999999999999999999999999986 565
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC-cccccCCccccC
Q psy501 392 QLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP-YTDYVSTRWYRA 470 (962)
Q Consensus 392 ~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~~gt~~Y~A 470 (962)
+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+....... .....++..|+|
T Consensus 91 ~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~ 169 (258)
T cd06632 91 KLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMA 169 (258)
T ss_pred HHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccccCCCcceeC
Confidence 55544 4568999999999999999999999999999999999999999999999999987654432 344568899999
Q ss_pred hhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcH
Q psy501 471 PEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 550 (962)
Q Consensus 471 PE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~ 550 (962)
||.+.....++.++|+|||||++|+|++|+.||...........+..........+.++..+..++..||..+|++||++
T Consensus 170 pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 249 (258)
T cd06632 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTA 249 (258)
T ss_pred HHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCH
Confidence 99986543489999999999999999999999987765444444443222222334566778889999999999999998
Q ss_pred HHHHhh
Q psy501 551 YILLHT 556 (962)
Q Consensus 551 ~~Ll~~ 556 (962)
.+++..
T Consensus 250 ~~~l~~ 255 (258)
T cd06632 250 AELLEH 255 (258)
T ss_pred HHHhcC
Confidence 888764
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=279.38 Aligned_cols=236 Identities=27% Similarity=0.376 Sum_probs=182.9
Q ss_pred cCCcccEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHH
Q psy501 321 LPHTLPLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLI 394 (962)
Q Consensus 321 ~~~~~~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l 394 (962)
.++.+.||.+.....++.++.+.... ....+.+|++++++++||||+++++++.+++..++||||+.+++...+
T Consensus 10 ~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~ 89 (284)
T cd07860 10 EGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFM 89 (284)
T ss_pred CCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccccCHHHHH
Confidence 34445577776655444443332221 124688999999999999999999999999999999999998888877
Q ss_pred Hhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccCh
Q psy501 395 RDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAP 471 (962)
Q Consensus 395 ~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~AP 471 (962)
... ...+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++...... ......++..|+||
T Consensus 90 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aP 169 (284)
T cd07860 90 DASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 169 (284)
T ss_pred HhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCC
Confidence 653 356899999999999999999999999999999999999999999999999998765433 22334568889999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc---------------------------cC
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL---------------------------HT 524 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------------~~ 524 (962)
|++.+...++.++|||||||++|+|+||+.||.+........++....... ..
T Consensus 170 E~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (284)
T cd07860 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKV 249 (284)
T ss_pred eEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHH
Confidence 998776567899999999999999999999998766544433322110000 00
Q ss_pred CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 525 LPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 525 ~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.+..+..+..++..||..+|++||++.+++..
T Consensus 250 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 250 VPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred cccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 12344556779999999999999998887764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=275.90 Aligned_cols=209 Identities=15% Similarity=0.198 Sum_probs=172.9
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceee
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFF 426 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIv 426 (962)
...+.+|+.++++++||+|+++++++. ....++||||++ |+|.+.+......+++..++.++.|++.||.|||++|++
T Consensus 39 ~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 117 (257)
T cd05115 39 RDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117 (257)
T ss_pred HHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCee
Confidence 346889999999999999999999886 457899999998 567777665566799999999999999999999999999
Q ss_pred eccCCCcccccccccceeeecccccccccCCCc-----ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CC
Q psy501 427 HRDMKPENLLCMGTELVKIADFGLAREIRSRPY-----TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HV 500 (962)
Q Consensus 427 HrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~-----~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~ 500 (962)
|+||||+||+++.++.+||+|||++........ ....++..|+|||.+.+ ..++.++|||||||++|||++ |.
T Consensus 118 H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~ 196 (257)
T cd05115 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQ 196 (257)
T ss_pred ecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCC
Confidence 999999999999999999999999976543311 11223568999999865 468999999999999999996 99
Q ss_pred CCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 501 PPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 501 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
.||...........+..+. .....+..+..+..++..||..+|++||+..++.+.+..
T Consensus 197 ~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 197 KPYKKMKGPEVMSFIEQGK-RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCcCcCCHHHHHHHHHCCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 9998877666655555543 233345667788899999999999999999999887743
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=272.45 Aligned_cols=244 Identities=20% Similarity=0.242 Sum_probs=192.5
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-EN 389 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~ 389 (962)
+.....+..++.+.||.+.......++.+.+.. .....+.+|+.++++++||+|+++++++..+...++||||++ ++
T Consensus 8 ~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 87 (261)
T cd05034 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS 87 (261)
T ss_pred eeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCC
Confidence 333444444555568887765544444443332 234578999999999999999999999999899999999998 46
Q ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---cccccCC
Q psy501 390 LYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---YTDYVST 465 (962)
Q Consensus 390 Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~gt 465 (962)
|.+.+.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+....... .....++
T Consensus 88 L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 167 (261)
T cd05034 88 LLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP 167 (261)
T ss_pred HHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCC
Confidence 777776543 468999999999999999999999999999999999999999999999999997665321 1222345
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCC
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGT 544 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dp 544 (962)
..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.........+.... ..+.....+..+..++..||..+|
T Consensus 168 ~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p 245 (261)
T cd05034 168 IKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY-RMPRPPNCPEELYDLMLQCWDKDP 245 (261)
T ss_pred ccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcccCc
Confidence 67999999975 468999999999999999998 999998877666555555442 223334557788999999999999
Q ss_pred CCCCcHHHHHhhcc
Q psy501 545 ERLKSSYILLHTLP 558 (962)
Q Consensus 545 erRPs~~~Ll~~l~ 558 (962)
++||++.++.+.|.
T Consensus 246 ~~Rp~~~~l~~~l~ 259 (261)
T cd05034 246 EERPTFEYLQSFLE 259 (261)
T ss_pred ccCCCHHHHHHHHh
Confidence 99999999988663
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=276.49 Aligned_cols=237 Identities=19% Similarity=0.197 Sum_probs=184.1
Q ss_pred EecCCcccEEEEEecC-----CceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-
Q psy501 319 YILPHTLPLYTCNLDQ-----DNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK- 387 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~-----~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~- 387 (962)
+..++.+.||.+.... ....++.+... .....+.+|+.++++++||||+++++++.+.+..++||||+.
T Consensus 14 lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 93 (277)
T cd05036 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAG 93 (277)
T ss_pred CCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCC
Confidence 3334445688877654 34444444322 123468899999999999999999999998889999999997
Q ss_pred CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc---ceeeecccccccccCCC
Q psy501 388 ENLYQLIRDRD------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIRSRP 458 (962)
Q Consensus 388 g~Ll~~l~~~~------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g---~vKL~DFGla~~~~~~~ 458 (962)
++|.+++.... ..+++..++.++.||+.||.|||+.+++|+||||+||+++..+ .+||+|||+++......
T Consensus 94 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~ 173 (277)
T cd05036 94 GDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRAS 173 (277)
T ss_pred CCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCcc
Confidence 56777765542 2589999999999999999999999999999999999998655 59999999998663321
Q ss_pred c----ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcH
Q psy501 459 Y----TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVP 533 (962)
Q Consensus 459 ~----~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 533 (962)
. .....+..|+|||++.+. .++.++|||||||++|||++ |..||.+.........+... ......+.++..+.
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 251 (277)
T cd05036 174 YYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GRLDPPKGCPGPVY 251 (277)
T ss_pred ceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHH
Confidence 1 122335679999999754 69999999999999999997 99999887665554444332 22233345667788
Q ss_pred HHHHHHhccCCCCCCcHHHHHhhc
Q psy501 534 PIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 534 ~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.++..||..+|+.||++.++++.|
T Consensus 252 ~~i~~cl~~~p~~Rps~~~vl~~l 275 (277)
T cd05036 252 RIMTDCWQHTPEDRPNFATILERI 275 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHHHHh
Confidence 899999999999999999999866
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=276.19 Aligned_cols=208 Identities=16% Similarity=0.273 Sum_probs=175.5
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceee
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFF 426 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIv 426 (962)
...+.+|+.++++++||||+++++++..++..|+||||++| +|.+++......+++.+++.++.|++.||.|||+.+++
T Consensus 49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~ 128 (267)
T cd05066 49 RRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYV 128 (267)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 45689999999999999999999999999999999999984 67777766666789999999999999999999999999
Q ss_pred eccCCCcccccccccceeeecccccccccCCCc-----ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CC
Q psy501 427 HRDMKPENLLCMGTELVKIADFGLAREIRSRPY-----TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HV 500 (962)
Q Consensus 427 HrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~-----~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~ 500 (962)
|+||||+||+++.++.++|+|||++........ ....++..|+|||.+.+ ..++.++|||||||++||+++ |.
T Consensus 129 h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~ 207 (267)
T cd05066 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGE 207 (267)
T ss_pred ehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCC
Confidence 999999999999999999999999986644321 11223567999999965 368999999999999999886 99
Q ss_pred CCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 501 PPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 501 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.||...........+..+. ..+.....+..+..++..||..+|++||++.++++.|
T Consensus 208 ~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 263 (267)
T cd05066 208 RPYWEMSNQDVIKAIEEGY-RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263 (267)
T ss_pred CCcccCCHHHHHHHHhCCC-cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHH
Confidence 9998877665555555542 3344445677889999999999999999999998866
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=278.72 Aligned_cols=236 Identities=20% Similarity=0.293 Sum_probs=190.3
Q ss_pred EEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-
Q psy501 316 KFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK- 387 (962)
Q Consensus 316 ~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~- 387 (962)
...+..++.+.||.+......+.++.+.... ....+.+|++++++++||||+++++++.++...++||||++
T Consensus 6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (290)
T cd05580 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG 85 (290)
T ss_pred EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCC
Confidence 3344444555688777766555555444322 23458889999999999999999999999999999999996
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCcc
Q psy501 388 ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRW 467 (962)
Q Consensus 388 g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~ 467 (962)
++|.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...... .....+++.
T Consensus 86 ~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~ 163 (290)
T cd05580 86 GELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-TYTLCGTPE 163 (290)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-CCCCCCCcc
Confidence 6777766554 56999999999999999999999999999999999999999999999999999876554 344578899
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCC
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERL 547 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperR 547 (962)
|+|||.+.+. .++.++||||||+++|+|++|+.||...........+..+... .....+..+..++..||..+|.+|
T Consensus 164 y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~R 240 (290)
T cd05580 164 YLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVR--FPSFFSPDAKDLIRNLLQVDLTKR 240 (290)
T ss_pred ccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcc--CCccCCHHHHHHHHHHccCCHHHc
Confidence 9999998654 6889999999999999999999999887765555555544332 234557788899999999999999
Q ss_pred C-----cHHHHHhh
Q psy501 548 K-----SSYILLHT 556 (962)
Q Consensus 548 P-----s~~~Ll~~ 556 (962)
+ ++++|+..
T Consensus 241 ~~~~~~~~~~l~~~ 254 (290)
T cd05580 241 LGNLKNGVNDIKNH 254 (290)
T ss_pred cCcccCCHHHHHcC
Confidence 8 66676653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=277.47 Aligned_cols=244 Identities=27% Similarity=0.337 Sum_probs=185.5
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecC
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
.+.....+..++.+.||.+.....+..++.|... .....+.+|+.+++.++|+||+++++++..++..|+||||+
T Consensus 6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07870 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85 (291)
T ss_pred eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence 3444444555555668888766555544444322 11235788999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccC
Q psy501 387 KENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVS 464 (962)
Q Consensus 387 ~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~g 464 (962)
.+++++.+......+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++...... ......+
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 165 (291)
T cd07870 86 HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV 165 (291)
T ss_pred cCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccc
Confidence 99999888766666889999999999999999999999999999999999999999999999998754332 2233457
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh-HHHHHhcc---------------------ccc
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG-TERLKSSY---------------------ILL 522 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~-~~~i~~~~---------------------~~~ 522 (962)
++.|+|||++.+...++.++|||||||++|+|++|..||.+...... ...+.... ...
T Consensus 166 ~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (291)
T cd07870 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLP 245 (291)
T ss_pred cccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccc
Confidence 88999999987655688999999999999999999999986543211 11110000 000
Q ss_pred cCC---------CCCCCCcHHHHHHHhccCCCCCCcHHHHHh
Q psy501 523 HTL---------PLYTYHVPPIQTTCLLAGTERLKSSYILLH 555 (962)
Q Consensus 523 ~~~---------~~~s~~l~~li~~Cl~~dperRPs~~~Ll~ 555 (962)
... -..+..+.+++..|+..+|.+||++.+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 246 CKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 011345677999999999999999887765
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=274.37 Aligned_cols=205 Identities=22% Similarity=0.332 Sum_probs=169.8
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeee
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFH 427 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvH 427 (962)
..+.+|++++++++|+||+++++++.++...++||||++| +|.+.+.. ...+++..+..++.|++.||.|||+.+++|
T Consensus 47 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 125 (265)
T cd06631 47 EKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125 (265)
T ss_pred HHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 4588999999999999999999999999999999999986 55555544 456899999999999999999999999999
Q ss_pred ccCCCcccccccccceeeecccccccccC--------CCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcC
Q psy501 428 RDMKPENLLCMGTELVKIADFGLAREIRS--------RPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDH 499 (962)
Q Consensus 428 rDLkp~NILl~~~g~vKL~DFGla~~~~~--------~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG 499 (962)
+||+|+||+++.++.++|+|||.+..... .......++..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 126 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g 204 (265)
T cd06631 126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATG 204 (265)
T ss_pred CCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999876432 12233468889999999865 4688999999999999999999
Q ss_pred CCCCCCcChhhhHHHHHhcc-ccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHh
Q psy501 500 VPPIQTTCLLAGTERLKSSY-ILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLH 555 (962)
Q Consensus 500 ~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~ 555 (962)
..||...........+.... ........++..+..++..||..+|++||++.+++.
T Consensus 205 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 205 KPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 99998766554444443332 222333456777889999999999999999888776
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=274.59 Aligned_cols=239 Identities=21% Similarity=0.250 Sum_probs=188.2
Q ss_pred EEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHH
Q psy501 317 FSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQL 393 (962)
Q Consensus 317 ~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~ 393 (962)
..+..++.+.||.+.......++.+.+.. .....+.+|+.++++++||+++++++++. ....++||||++ ++|.+.
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~ 90 (260)
T cd05070 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDF 90 (260)
T ss_pred heeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHH
Confidence 34444555568888766555555554432 23456899999999999999999999885 456889999998 577777
Q ss_pred HHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCc---ccccCCcccc
Q psy501 394 IRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY---TDYVSTRWYR 469 (962)
Q Consensus 394 l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~---~~~~gt~~Y~ 469 (962)
+... ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+........ ....++..|+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~ 170 (260)
T cd05070 91 LKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT 170 (260)
T ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCcccc
Confidence 6553 34589999999999999999999999999999999999999999999999999976644321 1223456799
Q ss_pred ChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCC
Q psy501 470 APEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK 548 (962)
Q Consensus 470 APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRP 548 (962)
|||.+.+ ..++.++||||||+++|+|++ |.+||.+.........+... ...+.....+..+..++..||..+|++||
T Consensus 171 aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 248 (260)
T cd05070 171 APEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMPCPQDCPISLHELMLQCWKKDPEERP 248 (260)
T ss_pred ChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHHHcccCcccCc
Confidence 9999865 468999999999999999999 99999887766665655543 22233345677888999999999999999
Q ss_pred cHHHHHhhcc
Q psy501 549 SSYILLHTLP 558 (962)
Q Consensus 549 s~~~Ll~~l~ 558 (962)
++..|...|.
T Consensus 249 t~~~l~~~l~ 258 (260)
T cd05070 249 TFEYLQSFLE 258 (260)
T ss_pred CHHHHHHHHh
Confidence 9999887653
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=275.10 Aligned_cols=239 Identities=14% Similarity=0.211 Sum_probs=188.6
Q ss_pred EEEecCCcccEEEEEecCC---ceEEEEecc-----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC
Q psy501 317 FSYILPHTLPLYTCNLDQD---NHILSRHVS-----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE 388 (962)
Q Consensus 317 ~~~i~~~~~~Vy~~~~~~~---~kvv~~k~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g 388 (962)
..+..++.+.||.+..... ...++.+.. ......+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 10 ~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 89 (266)
T cd05033 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMEN 89 (266)
T ss_pred eEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCC
Confidence 3334444455777765432 122222221 12234688899999999999999999999999999999999985
Q ss_pred -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--C--ccccc
Q psy501 389 -NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--P--YTDYV 463 (962)
Q Consensus 389 -~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~--~~~~~ 463 (962)
+|.+++......+++..++.++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++...... . .....
T Consensus 90 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 169 (266)
T cd05033 90 GSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGK 169 (266)
T ss_pred CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCC
Confidence 777777666667999999999999999999999999999999999999999999999999999876421 1 11223
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhcc
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 542 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~ 542 (962)
++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+.... ..+.....+..+..++..||..
T Consensus 170 ~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~ 247 (266)
T cd05033 170 IPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-RLPPPMDCPSALYQLMLDCWQK 247 (266)
T ss_pred CCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCC
Confidence 4577999999865 468999999999999999998 999998777666666555442 2233446678889999999999
Q ss_pred CCCCCCcHHHHHhhc
Q psy501 543 GTERLKSSYILLHTL 557 (962)
Q Consensus 543 dperRPs~~~Ll~~l 557 (962)
+|++||++.++++.+
T Consensus 248 ~p~~Rp~~~ei~~~l 262 (266)
T cd05033 248 DRNERPTFSQIVSTL 262 (266)
T ss_pred CcccCcCHHHHHHHH
Confidence 999999999998866
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=282.21 Aligned_cols=209 Identities=21% Similarity=0.276 Sum_probs=172.6
Q ss_pred HHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccce
Q psy501 348 EMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHG 424 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~g 424 (962)
...+.+|+.+++++ +||||+++++++...+..++||||+. |+|.+++.... ..+++.++..++.|++.||.|||+.+
T Consensus 82 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ 161 (302)
T cd05055 82 REALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161 (302)
T ss_pred HHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34688999999999 79999999999999999999999998 57777775533 34899999999999999999999999
Q ss_pred eeeccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-C
Q psy501 425 FFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-H 499 (962)
Q Consensus 425 IvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G 499 (962)
++|+||||+||+++.++.++|+|||++....... .....++..|+|||.+.+. .++.++|||||||++|||++ |
T Consensus 162 ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g 240 (302)
T cd05055 162 CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLG 240 (302)
T ss_pred eehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999997654332 1123456789999998664 68999999999999999998 9
Q ss_pred CCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 500 VPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 500 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..||.........................+..+..++..||..+|+.||++.+++..+
T Consensus 241 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l 298 (302)
T cd05055 241 SNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298 (302)
T ss_pred CCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 9999877655444333333222333345567788999999999999999999999866
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=278.24 Aligned_cols=207 Identities=20% Similarity=0.265 Sum_probs=172.4
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhc----------------CCCCCHHHHHHHHH
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDR----------------DKFLPESIIRNMMY 411 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~----------------~~~ls~~~i~~i~~ 411 (962)
..+.+|++++++++||||+++++++..+...|+||||++ |+|.+++... ...+++..+..++.
T Consensus 52 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 131 (283)
T cd05090 52 GEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131 (283)
T ss_pred HHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHH
Confidence 468899999999999999999999999999999999998 5677766432 12478899999999
Q ss_pred HHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----CcccccCCccccChhhhccCCCCCchhHHH
Q psy501 412 QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLS 487 (962)
Q Consensus 412 qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIw 487 (962)
|++.||.|||+.|++|+||||+||+++.++.+||+|||++...... ......++..|+|||++.+. .++.++|||
T Consensus 132 ~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~ 210 (283)
T cd05090 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIW 210 (283)
T ss_pred HHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhH
Confidence 9999999999999999999999999999999999999999765432 12233456779999998654 689999999
Q ss_pred HHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 488 RSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 488 SLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
||||++|||++ |..||.+.........+..... .+....++..+..++..||..+|++||++.++++.+
T Consensus 211 slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 211 SFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL-LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 99999999998 9999988766555555544432 333445677888999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=276.75 Aligned_cols=238 Identities=17% Similarity=0.177 Sum_probs=185.3
Q ss_pred EecCCcccEEEEEecCCceE----EEEec-----cchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-C
Q psy501 319 YILPHTLPLYTCNLDQDNHI----LSRHV-----SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-E 388 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~~~kv----v~~k~-----~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g 388 (962)
+..++.+.||++.....+.. ++.|. .......+.+|+.+++.+.||||+++++++... ..++++||++ |
T Consensus 15 lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g 93 (279)
T cd05109 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYG 93 (279)
T ss_pred cCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCC
Confidence 33344445777765433321 22222 222345688999999999999999999998754 4678999997 6
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCc----ccccC
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY----TDYVS 464 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~----~~~~g 464 (962)
++.+.+......+++..++.++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++....... ....+
T Consensus 94 ~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~ 173 (279)
T cd05109 94 CLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV 173 (279)
T ss_pred CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCcc
Confidence 88888776666799999999999999999999999999999999999999999999999999987643321 12234
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccC
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
+..|+|||.+.+. .++.++|||||||++|||++ |..||...........+..+. ..+..+.++..+..++..||..+
T Consensus 174 ~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~d 251 (279)
T cd05109 174 PIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE-RLPQPPICTIDVYMIMVKCWMID 251 (279)
T ss_pred chhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-cCCCCccCCHHHHHHHHHHcCCC
Confidence 6779999998654 68999999999999999998 999998776555554444432 23334556777888999999999
Q ss_pred CCCCCcHHHHHhhccc
Q psy501 544 TERLKSSYILLHTLPL 559 (962)
Q Consensus 544 perRPs~~~Ll~~l~~ 559 (962)
|+.||++.++++.+..
T Consensus 252 p~~Rp~~~~l~~~l~~ 267 (279)
T cd05109 252 SECRPRFRELVDEFSR 267 (279)
T ss_pred hhhCcCHHHHHHHHHH
Confidence 9999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=280.48 Aligned_cols=242 Identities=21% Similarity=0.261 Sum_probs=186.9
Q ss_pred eeEEEEecCCcccEEEEEecCCc-----eEEEEecc-----chhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEE
Q psy501 314 RLKFSYILPHTLPLYTCNLDQDN-----HILSRHVS-----SRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 314 ~~~~~~i~~~~~~Vy~~~~~~~~-----kvv~~k~~-----~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV 382 (962)
.....++.++.+.||.+...... ..++.+.. ......+.+|+++++++ +||||+++++++..++.+++|
T Consensus 15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li 94 (293)
T cd05053 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVV 94 (293)
T ss_pred EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEE
Confidence 33333344445557777654321 23333322 12234588999999999 799999999999999999999
Q ss_pred EecCC-CCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeee
Q psy501 383 FEYMK-ENLYQLIRDR---------------DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIA 446 (962)
Q Consensus 383 ~Ey~~-g~Ll~~l~~~---------------~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~ 446 (962)
|||+. |+|..++... ...+++..++.++.|++.||.|||+.+|+|+||||+||+++.++.+||+
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~ 174 (293)
T cd05053 95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIA 174 (293)
T ss_pred EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeC
Confidence 99997 5677776532 3468999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhcccc
Q psy501 447 DFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYIL 521 (962)
Q Consensus 447 DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~ 521 (962)
|||.++...... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.........+.... .
T Consensus 175 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~ 252 (293)
T cd05053 175 DFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGY-R 252 (293)
T ss_pred ccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-c
Confidence 999998665432 122234567999999865 468999999999999999997 999998877666655554442 2
Q ss_pred ccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 522 LHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 522 ~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.......+..+..++..||..+|+.||++.++++.+
T Consensus 253 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 253 MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 233345566788899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=272.66 Aligned_cols=244 Identities=20% Similarity=0.293 Sum_probs=188.9
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEecc-------chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEec
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVS-------SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEY 385 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~-------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey 385 (962)
+.....+..++.+.||.+....+++.++.+.. ......+.+|++++++++|++|+++++++..++..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 33444444455556788777655544433321 12245688999999999999999999999999999999999
Q ss_pred CCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--Cc
Q psy501 386 MKE-NLYQLIRD---RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PY 459 (962)
Q Consensus 386 ~~g-~Ll~~l~~---~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~ 459 (962)
++| +|...+.. ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 163 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCccc
Confidence 984 67766643 2355899999999999999999999999999999999999999999999999998765443 22
Q ss_pred ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcCh--hhhHHHHHhccccccCCCCCCCCcHHHHH
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCL--LAGTERLKSSYILLHTLPLYTYHVPPIQT 537 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~s~~l~~li~ 537 (962)
....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ......+..+.......+.++..+..++.
T Consensus 164 ~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 242 (267)
T cd08224 164 HSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVS 242 (267)
T ss_pred ceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHH
Confidence 33568889999999865 4689999999999999999999999966542 22233333332222212256668889999
Q ss_pred HHhccCCCCCCcHHHHHhhc
Q psy501 538 TCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 538 ~Cl~~dperRPs~~~Ll~~l 557 (962)
.||..+|+.||++.+|++.+
T Consensus 243 ~cl~~~p~~Rp~~~~il~~~ 262 (267)
T cd08224 243 RCINPDPEKRPDISYVLQVA 262 (267)
T ss_pred HHcCCCcccCCCHHHHHHHH
Confidence 99999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-29 Score=270.24 Aligned_cols=238 Identities=18% Similarity=0.266 Sum_probs=187.0
Q ss_pred EEEecCCcccEEEEEecCCceEEEEecc------chhHHHHHHHHHHHHhcCCCCcccEEEEEEe-CCEEEEEEecCC-C
Q psy501 317 FSYILPHTLPLYTCNLDQDNHILSRHVS------SRDEMVVCFYRKSLKKLSHANLVKLKEVIRE-NDTLYFVFEYMK-E 388 (962)
Q Consensus 317 ~~~i~~~~~~Vy~~~~~~~~kvv~~k~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-~~~~~LV~Ey~~-g 388 (962)
..+..++.+.||.+......+.++.+.. ......+.+|++++++++||+++++++.+.. +..+++||||++ +
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (257)
T cd08223 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGG 85 (257)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCC
Confidence 3344445556888776655544333221 1223468889999999999999999998864 456899999998 5
Q ss_pred CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCC
Q psy501 389 NLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVST 465 (962)
Q Consensus 389 ~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt 465 (962)
++.+.+... ...+++.+++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...... ......++
T Consensus 86 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 165 (257)
T cd08223 86 DLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGT 165 (257)
T ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCC
Confidence 677776653 346899999999999999999999999999999999999999999999999999766432 23345688
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCC
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTE 545 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dpe 545 (962)
+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+..+.. .......+..+.+++..||..+|+
T Consensus 166 ~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~ 243 (257)
T cd08223 166 PYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPMPKDYSPELGELIATMLSKRPE 243 (257)
T ss_pred cCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCccccCHHHHHHHHHHhccCcc
Confidence 999999998654 688999999999999999999999987766555555544432 222345667788999999999999
Q ss_pred CCCcHHHHHhh
Q psy501 546 RLKSSYILLHT 556 (962)
Q Consensus 546 rRPs~~~Ll~~ 556 (962)
+||++.+++..
T Consensus 244 ~Rp~~~~~l~~ 254 (257)
T cd08223 244 KRPSVKSILRQ 254 (257)
T ss_pred cCCCHHHHhcC
Confidence 99998888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG2216|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=264.69 Aligned_cols=170 Identities=41% Similarity=0.591 Sum_probs=155.4
Q ss_pred HHHHHHHhhccCCCCCcchhhhhhhhhhhhhhHHHhhhhhHHHHHHHHHHHHHHHHHhhhhhhhHHHHhhHHHHHHhhHH
Q psy501 784 AIHLMESMLAYNPSKRPTAQQSLSIKREVSLSFVLLKKLNRLEKYRLKNARETLQAKKSKVDSFNLQLQNLKYEIFHLKK 863 (962)
Q Consensus 784 a~DLL~kmL~~dP~kR~sa~~~L~~~~e~s~lf~~LK~lnr~ak~~~k~~R~~t~~ar~evD~l~lqLQnL~yE~~hL~k 863 (962)
++..|+.|-.-.| +-+...+....|..+++.||....+.+.+|..+++++++||..|+|||||.||+.|+++
T Consensus 26 ~ia~ikeak~rg~--------~~e~~~q~~~~fv~Lr~aNR~~~~q~~~~r~~t~e~k~~vD~~~LQLqnl~yev~Hlkk 97 (303)
T KOG2216|consen 26 AIAGIKEAKSRGP--------IEENRIQTMSKFVLLRHANRLLHAQLKKARKETEEAKNKVDAKHLQLQNLLYEVQHLKK 97 (303)
T ss_pred HHHHHHHHHHcCC--------cchhhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHhCCCCHhhhhHHHHHHHHHHHHH
Confidence 4455555555455 11233455678999999999999999999999999999999999999999999999999
Q ss_pred HHHHHccCccCCCCCCCCChhhhhhcCCCCCCCCCCCCCChhHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q psy501 864 EVVKCLQFKSKDEDIDLVDEETFFKDAPESISRPEVTKEDPHQLKLARLEWELKQRKELADECSLVERENESVAANINKK 943 (962)
Q Consensus 864 Ei~~c~~f~s~~~~i~lv~~eef~~~~p~~~~~~~~~~~d~h~lml~rl~~El~~R~~l~~~~~~l~~~k~~l~~~~~~~ 943 (962)
||.+|++|+|+|++|+|||.|||+..+|+.+.+.+.+.+++|++|||||+|||+|||+|..+++||+++|++|+++|+.|
T Consensus 98 eI~~c~~fks~~~el~Lvs~eEf~kEaP~i~a~ae~sssn~H~q~larL~~ElkQRk~L~~~~~eLl~~K~~Ll~di~~k 177 (303)
T KOG2216|consen 98 EIKRCLDFKSKYTELELVSEEEFNKEAPEIIADAEESSSNPHKQMLARLDFELKQRKELSKLYQELLSRKAALLSDIKAK 177 (303)
T ss_pred HHHHHHHhhccCcccccccHHHHhhhCCcchhhhHhhcCCcHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999998888899999999999999999999999999999999999999999999
Q ss_pred HhhhhchHHHHHHHHhhh
Q psy501 944 RGQLDNLAPLLKQLLSFL 961 (962)
Q Consensus 944 ~~~l~~l~~~l~~~~~~~ 961 (962)
+++|.+|+|+|++|.+++
T Consensus 178 ~~~l~sl~p~L~tl~kas 195 (303)
T KOG2216|consen 178 KNRLQSLDPKLQTLLKAS 195 (303)
T ss_pred HHHHhccCHHHHHHHHhh
Confidence 999999999999999885
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=274.79 Aligned_cols=244 Identities=13% Similarity=0.196 Sum_probs=191.3
Q ss_pred ceeeEEEEecCCcccEEEEEecCCce---EEEEecc-----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNH---ILSRHVS-----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~k---vv~~k~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
++.....+..++.+.||.+.....++ .++.+.. ......+..|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 34445555555566688887655442 2333222 223457899999999999999999999999999999999
Q ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCc---
Q psy501 384 EYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY--- 459 (962)
Q Consensus 384 Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~--- 459 (962)
||+++ +|.+++....+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 164 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 164 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccc
Confidence 99985 66666666566789999999999999999999999999999999999999999999999999876543211
Q ss_pred -cccc---CCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHH
Q psy501 460 -TDYV---STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPP 534 (962)
Q Consensus 460 -~~~~---gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 534 (962)
.... .+..|+|||.+.+ ..++.++|||||||++|||++ |..||...........+... ...+..+.++..+..
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~ 242 (269)
T cd05065 165 YTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-YRLPPPMDCPTALHQ 242 (269)
T ss_pred cccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCCCcccCCHHHHH
Confidence 1111 2357999999865 468999999999999999886 99999887766665655443 333444566778889
Q ss_pred HHHHHhccCCCCCCcHHHHHhhc
Q psy501 535 IQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 535 li~~Cl~~dperRPs~~~Ll~~l 557 (962)
++..||..+|+.||+..+++..|
T Consensus 243 li~~~l~~~p~~Rp~~~~i~~~l 265 (269)
T cd05065 243 LMLDCWQKDRNARPKFGQIVSTL 265 (269)
T ss_pred HHHHHcCCChhhCcCHHHHHHHH
Confidence 99999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=274.53 Aligned_cols=244 Identities=19% Similarity=0.274 Sum_probs=185.4
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccc---hhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCC------EEEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS---RDEMVVCFYRKSLKKL-SHANLVKLKEVIREND------TLYF 381 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~---~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~------~~~L 381 (962)
.+.....+..++.+.+|.+........++.+... .....+.+|+.+++++ .||||+++++++.... .+++
T Consensus 7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~l 86 (275)
T cd06608 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWL 86 (275)
T ss_pred heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEE
Confidence 4444444555555668888776555444443322 2345689999999999 6999999999997543 5899
Q ss_pred EEecCCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC
Q psy501 382 VFEYMKE-NLYQLIRDR---DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR 457 (962)
Q Consensus 382 V~Ey~~g-~Ll~~l~~~---~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~ 457 (962)
||||+++ +|.+.+... +..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 166 (275)
T cd06608 87 VMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST 166 (275)
T ss_pred EEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence 9999996 555555432 457999999999999999999999999999999999999999999999999998765432
Q ss_pred --CcccccCCccccChhhhcc----CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-cCCCCCCC
Q psy501 458 --PYTDYVSTRWYRAPEVLLH----STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL-HTLPLYTY 530 (962)
Q Consensus 458 --~~~~~~gt~~Y~APE~l~~----~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~s~ 530 (962)
......++..|+|||++.. ...++.++|||||||++|+|++|..||...........+....... .....++.
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (275)
T cd06608 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSK 246 (275)
T ss_pred hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCH
Confidence 2334568899999998853 2347789999999999999999999998765544444443332211 11122556
Q ss_pred CcHHHHHHHhccCCCCCCcHHHHHh
Q psy501 531 HVPPIQTTCLLAGTERLKSSYILLH 555 (962)
Q Consensus 531 ~l~~li~~Cl~~dperRPs~~~Ll~ 555 (962)
.+..++..||..+|++||++.+++.
T Consensus 247 ~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 247 KFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHHHHHHHHhhcChhhCcCHHHHhc
Confidence 7889999999999999999988876
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=276.70 Aligned_cols=233 Identities=20% Similarity=0.283 Sum_probs=184.1
Q ss_pred cCCcccEEEEEecCCceEEEEecc-----chhHHHHHHHHHHHHhcC---CCCcccEEEEEEeCCEEEEEEecCCC-CHH
Q psy501 321 LPHTLPLYTCNLDQDNHILSRHVS-----SRDEMVVCFYRKSLKKLS---HANLVKLKEVIRENDTLYFVFEYMKE-NLY 391 (962)
Q Consensus 321 ~~~~~~Vy~~~~~~~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll 391 (962)
.++.+.||.+.....++.++.+.. ......+.+|+.++++++ ||+++++++++..+...|+||||++| +|.
T Consensus 11 ~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (277)
T cd06917 11 RGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVR 90 (277)
T ss_pred ccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHH
Confidence 334445777776555555444432 233456889999999996 99999999999999999999999986 555
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCcccc
Q psy501 392 QLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYR 469 (962)
Q Consensus 392 ~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~ 469 (962)
+.+.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... ......|+..|+
T Consensus 91 ~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~ 168 (277)
T cd06917 91 TLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWM 168 (277)
T ss_pred HHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCccee
Confidence 55433 36899999999999999999999999999999999999999999999999999776543 233346888999
Q ss_pred ChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCC--CCCCCcHHHHHHHhccCCCCC
Q psy501 470 APEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLP--LYTYHVPPIQTTCLLAGTERL 547 (962)
Q Consensus 470 APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~s~~l~~li~~Cl~~dperR 547 (962)
|||.+.++..++.++|+|||||++|+|++|..||.+.........+... ..+..+ .++..+..++..||..+|++|
T Consensus 169 aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 246 (277)
T cd06917 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLREFVAACLDEEPKER 246 (277)
T ss_pred CHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCHHHHHHHHHHcCCCcccC
Confidence 9999876667899999999999999999999999877654444333222 112222 256678889999999999999
Q ss_pred CcHHHHHhhc
Q psy501 548 KSSYILLHTL 557 (962)
Q Consensus 548 Ps~~~Ll~~l 557 (962)
|++.+++..-
T Consensus 247 ~~~~~il~~~ 256 (277)
T cd06917 247 LSAEELLKSK 256 (277)
T ss_pred cCHHHHhhCh
Confidence 9998887743
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=278.12 Aligned_cols=207 Identities=16% Similarity=0.188 Sum_probs=169.7
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHh
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD---------KFLPESIIRNMMYQVLQGLA 418 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~---------~~ls~~~i~~i~~qI~~aL~ 418 (962)
..+.+|+.+++.++||||+++++++..+...++||||++ |+|.+++.... ..+++..+..++.|++.||.
T Consensus 54 ~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 133 (277)
T cd05062 54 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133 (277)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 457899999999999999999999999999999999998 56776665422 23578889999999999999
Q ss_pred hcccceeeeccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHHHHH
Q psy501 419 FMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLF 494 (962)
Q Consensus 419 yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ 494 (962)
|||+.|++|+||||+||+++.++.++|+|||++....... .....++..|+|||.+.+ ..++.++|||||||++|
T Consensus 134 ~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ 212 (277)
T cd05062 134 YLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLW 212 (277)
T ss_pred HHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHH
Confidence 9999999999999999999999999999999987654321 112345678999999865 46899999999999999
Q ss_pred HHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 495 YSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 495 ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
||++ |..||.+.........+..... .......+..+..++..||..+|++||++.+++..+
T Consensus 213 el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 275 (277)
T cd05062 213 EIATLAEQPYQGMSNEQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275 (277)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence 9999 7999988766555544444322 222335566788899999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=278.59 Aligned_cols=238 Identities=24% Similarity=0.356 Sum_probs=183.4
Q ss_pred ecCCcccEEEEEecCCceEEEEeccc-h--------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCH
Q psy501 320 ILPHTLPLYTCNLDQDNHILSRHVSS-R--------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENL 390 (962)
Q Consensus 320 i~~~~~~Vy~~~~~~~~kvv~~k~~~-~--------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~L 390 (962)
..++.+.||.+.....++.++.+... . ....+..|++++++++||+|+++++++.++...++||||+.|+|
T Consensus 9 g~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~L 88 (298)
T cd07841 9 GEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMETDL 88 (298)
T ss_pred eeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEcccCCCH
Confidence 33444457777665444333332211 1 12346789999999999999999999999999999999997788
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccc
Q psy501 391 YQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWY 468 (962)
Q Consensus 391 l~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y 468 (962)
.+.+......+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ......++..|
T Consensus 89 ~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y 168 (298)
T cd07841 89 EKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWY 168 (298)
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceee
Confidence 8877665547999999999999999999999999999999999999999999999999999876543 22334567889
Q ss_pred cChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-----------------c--------
Q psy501 469 RAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL-----------------H-------- 523 (962)
Q Consensus 469 ~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----------------~-------- 523 (962)
+|||.+.+...++.++|||||||++|||++|.+||.+........++......+ .
T Consensus 169 ~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
T cd07841 169 RAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLK 248 (298)
T ss_pred eCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchh
Confidence 999998766678999999999999999999999998766554443332211000 0
Q ss_pred -CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 524 -TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 524 -~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.....+..+..++..||..+|++||++.+++..-
T Consensus 249 ~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~ 283 (298)
T cd07841 249 QIFPAASDDALDLLQRLLTLNPNKRITARQALEHP 283 (298)
T ss_pred hhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCc
Confidence 0012234566789999999999999999888854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=269.56 Aligned_cols=265 Identities=16% Similarity=0.200 Sum_probs=208.7
Q ss_pred ecCCcccEEEEEecCCceEEEEeccch-----hHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCCCCHHHH
Q psy501 320 ILPHTLPLYTCNLDQDNHILSRHVSSR-----DEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKENLYQL 393 (962)
Q Consensus 320 i~~~~~~Vy~~~~~~~~kvv~~k~~~~-----~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~ 393 (962)
+.+..+.|++++....+++++.|-..+ +..++...++++.+. ++|+||+.+|+|..+..++|.||.|.-.+...
T Consensus 101 GsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~C~ekL 180 (391)
T KOG0983|consen 101 GSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMSTCAEKL 180 (391)
T ss_pred cCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHHHHHHH
Confidence 445556699999999888877765433 223566666666555 49999999999999999999999998766666
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhccc-ceeeeccCCCcccccccccceeeecccccccccC-CCcccccCCccccCh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHR-HGFFHRDMKPENLLCMGTELVKIADFGLAREIRS-RPYTDYVSTRWYRAP 471 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~-~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~-~~~~~~~gt~~Y~AP 471 (962)
+..-.++++|..+-++...++.||.||-+ ++|+|||+||+|||+|..|.+||||||++-++-. ...+...|.+.||||
T Consensus 181 lkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaP 260 (391)
T KOG0983|consen 181 LKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAP 260 (391)
T ss_pred HHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccccccCCccccCc
Confidence 66667789999999999999999999986 4799999999999999999999999999976654 456667899999999
Q ss_pred hhhcc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCcCh-hhhHHHHHhccc-cccCCCCCCCCcHHHHHHHhccCCCCC
Q psy501 472 EVLLH--STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCL-LAGTERLKSSYI-LLHTLPLYTYHVPPIQTTCLLAGTERL 547 (962)
Q Consensus 472 E~l~~--~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~-~~~~~~i~~~~~-~~~~~~~~s~~l~~li~~Cl~~dperR 547 (962)
|.+.- ...|+.++||||||++|+||.||+.||.+-.. .+...++..... ..+....++..+.++...||..|+.+|
T Consensus 261 ERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~R 340 (391)
T KOG0983|consen 261 ERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKR 340 (391)
T ss_pred cccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccC
Confidence 99852 34689999999999999999999999998433 333344444322 222222578889999999999999999
Q ss_pred CcHHHHHhhccccccCCCCcchhhhccccccccccce
Q psy501 548 KSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 584 (962)
Q Consensus 548 Ps~~~Ll~~l~~~~~~~~~~~~~~~l~g~~~l~ssy~ 584 (962)
|-...|++.-....++....+-+.+...+....+++.
T Consensus 341 P~Y~~Ll~h~Fi~~ye~a~~dVa~WF~dV~~~~~~~~ 377 (391)
T KOG0983|consen 341 PKYNKLLEHPFIKRYETAEVDVASWFKDVMAKTESPR 377 (391)
T ss_pred cchHHHhcCcceeecchhhccHHHHHHHHHhcccccc
Confidence 9988888776566666666666666666666665554
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=273.34 Aligned_cols=237 Identities=15% Similarity=0.207 Sum_probs=185.7
Q ss_pred EecCCcccEEEEEecCCce---EEEEecc-----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-C
Q psy501 319 YILPHTLPLYTCNLDQDNH---ILSRHVS-----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-N 389 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~~~k---vv~~k~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~ 389 (962)
+..++.+.||.+....... .++.+.. ......+..|++++++++||||+++++++.+.+..++||||+++ +
T Consensus 13 lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (268)
T cd05063 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGA 92 (268)
T ss_pred ecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCC
Confidence 3334444577776543321 2222221 22245688999999999999999999999999999999999985 6
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCccc-----ccC
Q psy501 390 LYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD-----YVS 464 (962)
Q Consensus 390 Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~-----~~g 464 (962)
|.+++....+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......... ...
T Consensus 93 L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 172 (268)
T cd05063 93 LDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172 (268)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCc
Confidence 666666656679999999999999999999999999999999999999999999999999997664332111 123
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccC
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
+..|+|||++.+. .++.++|||||||++|||++ |..||...........+... ...+.....+..+..++..||..+
T Consensus 173 ~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~li~~c~~~~ 250 (268)
T cd05063 173 PIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLPAPMDCPSAVYQLMLQCWQQD 250 (268)
T ss_pred CceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCC
Confidence 4569999998654 68999999999999999997 99999887766666666544 233333456677889999999999
Q ss_pred CCCCCcHHHHHhhc
Q psy501 544 TERLKSSYILLHTL 557 (962)
Q Consensus 544 perRPs~~~Ll~~l 557 (962)
|+.||+..++++.+
T Consensus 251 p~~Rp~~~~i~~~l 264 (268)
T cd05063 251 RARRPRFVDIVNLL 264 (268)
T ss_pred cccCcCHHHHHHHH
Confidence 99999999998866
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=276.40 Aligned_cols=208 Identities=21% Similarity=0.250 Sum_probs=173.9
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC--------------CCCCHHHHHHHHHH
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD--------------KFLPESIIRNMMYQ 412 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~--------------~~ls~~~i~~i~~q 412 (962)
...+.+|+++++.++||||+++++++.+++..++||||++ |+|.+++.... ..+++..++.++.|
T Consensus 51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 130 (280)
T cd05092 51 RQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130 (280)
T ss_pred HHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHH
Confidence 4578999999999999999999999999999999999998 56777765432 24889999999999
Q ss_pred HHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHH
Q psy501 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSR 488 (962)
Q Consensus 413 I~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwS 488 (962)
++.||.|||+.|++|+||||+||++++++.++|+|||++....... .....+++.|+|||.+.+. .++.++||||
T Consensus 131 i~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s 209 (280)
T cd05092 131 IASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWS 209 (280)
T ss_pred HHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHH
Confidence 9999999999999999999999999999999999999997554321 1223346789999998654 6899999999
Q ss_pred HHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 489 SQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 489 LGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
|||++|||++ |.+||...........+..+.. ......++..+..++..||..+|+.||++.+|++.+
T Consensus 210 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l 278 (280)
T cd05092 210 FGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE-LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278 (280)
T ss_pred HHHHHHHHHcCCCCCCccCCHHHHHHHHHcCcc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 9999999998 9999987766665555554422 223345677788999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=276.03 Aligned_cols=235 Identities=19% Similarity=0.295 Sum_probs=181.6
Q ss_pred CcccEEEEEecCCceEEEEecc-------chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHH
Q psy501 323 HTLPLYTCNLDQDNHILSRHVS-------SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLI 394 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~-------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l 394 (962)
+.+.||.+....+++.++.+.. ......+.+|+.+++.++||||+++++++..++..++||||+.| +|.+.+
T Consensus 14 ~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~ 93 (267)
T cd08229 14 QFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMI 93 (267)
T ss_pred CCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHH
Confidence 3445777765544443333321 12234688999999999999999999999999999999999985 666655
Q ss_pred Hh---cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCcccc
Q psy501 395 RD---RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYR 469 (962)
Q Consensus 395 ~~---~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~ 469 (962)
.. ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ......++..|+
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 173 (267)
T cd08229 94 KHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173 (267)
T ss_pred HHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCcc
Confidence 43 2356899999999999999999999999999999999999999999999999998765433 223356888999
Q ss_pred ChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh--hhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCC
Q psy501 470 APEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL--AGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERL 547 (962)
Q Consensus 470 APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperR 547 (962)
|||++.+ ..++.++||||||+++|+|++|..||.+.... .....+............++..+..++..||..+|++|
T Consensus 174 ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 252 (267)
T cd08229 174 SPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252 (267)
T ss_pred CHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccC
Confidence 9999965 46889999999999999999999999765432 22223322221111122456678899999999999999
Q ss_pred CcHHHHHhhcc
Q psy501 548 KSSYILLHTLP 558 (962)
Q Consensus 548 Ps~~~Ll~~l~ 558 (962)
|++..+++.+.
T Consensus 253 pt~~~i~~~~~ 263 (267)
T cd08229 253 PDITYVYDVAK 263 (267)
T ss_pred CCHHHHHHHHh
Confidence 99998888663
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=280.50 Aligned_cols=246 Identities=20% Similarity=0.216 Sum_probs=189.6
Q ss_pred CceeeEEEEecCCcccEEEEEecCC--------ceEEEEecc----chhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCC
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQD--------NHILSRHVS----SRDEMVVCFYRKSLKKL-SHANLVKLKEVIREND 377 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~--------~kvv~~k~~----~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 377 (962)
+.+.....++.++.+.||.+..... ..++.+... ......+.+|+++++.+ +||+|+++++++..++
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 4455555555555566887764321 122222222 12234688899999999 7999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc
Q psy501 378 TLYFVFEYMK-ENLYQLIRDRD---------------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE 441 (962)
Q Consensus 378 ~~~LV~Ey~~-g~Ll~~l~~~~---------------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g 441 (962)
..|+||||++ |+|.+++.... ..+++.+++.++.|++.||+|||+.|++||||||+||+++.++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 177 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 177 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence 9999999998 57877776532 2488999999999999999999999999999999999999999
Q ss_pred ceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHH
Q psy501 442 LVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLK 516 (962)
Q Consensus 442 ~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~ 516 (962)
.++|+|||.+....... .....+++.|+|||++.+. .++.++|||||||++|||++ |..||.+.........+.
T Consensus 178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~ 256 (307)
T cd05098 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 256 (307)
T ss_pred cEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 99999999987654321 1112345689999999654 68999999999999999998 899998877655555554
Q ss_pred hccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 517 SSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 517 ~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
... ........+..+..++..||..+|+.||++.++++.+.
T Consensus 257 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~ 297 (307)
T cd05098 257 EGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297 (307)
T ss_pred cCC-CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 443 22333456678888999999999999999999988773
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=280.60 Aligned_cols=244 Identities=19% Similarity=0.218 Sum_probs=189.0
Q ss_pred ceeeEEEEecCCcccEEEEEecC-------CceEEEEecc-----chhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQ-------DNHILSRHVS-----SRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDT 378 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~-------~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 378 (962)
.+.....+..++.+.||.+.... ....++.+.. ......+.+|+.+++.+ +||||+++++++.....
T Consensus 16 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (304)
T cd05101 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 95 (304)
T ss_pred HeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCc
Confidence 33444444455555677775321 1122333322 22335688999999999 89999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccc
Q psy501 379 LYFVFEYMK-ENLYQLIRDRD---------------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL 442 (962)
Q Consensus 379 ~~LV~Ey~~-g~Ll~~l~~~~---------------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~ 442 (962)
.++||||+. |+|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~ 175 (304)
T cd05101 96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV 175 (304)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCc
Confidence 999999998 57777775531 34788899999999999999999999999999999999999999
Q ss_pred eeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHh
Q psy501 443 VKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKS 517 (962)
Q Consensus 443 vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~ 517 (962)
+||+|||.++...... .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 176 ~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 254 (304)
T cd05101 176 MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 254 (304)
T ss_pred EEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 9999999998664321 222345678999999965 468999999999999999998 8899988777666666654
Q ss_pred ccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 518 SYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 518 ~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.. .......++..+..++..||..+|++||++.++++.|
T Consensus 255 ~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 255 GH-RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred CC-cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 43 2222345667788899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=275.89 Aligned_cols=208 Identities=17% Similarity=0.196 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHH
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD---------KFLPESIIRNMMYQVLQGL 417 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~---------~~ls~~~i~~i~~qI~~aL 417 (962)
...+.+|+.+++.++||+|+++++++..+...++||||++ |+|.+++.... ..+++..++.++.|++.||
T Consensus 53 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 132 (277)
T cd05032 53 RIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132 (277)
T ss_pred HHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHH
Confidence 3467899999999999999999999999999999999997 57777765422 2468889999999999999
Q ss_pred hhcccceeeeccCCCcccccccccceeeecccccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHH
Q psy501 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFL 493 (962)
Q Consensus 418 ~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL 493 (962)
.|||+.+++|+||+|+||+++.++.+||+|||+++..... ......++..|+|||.+.+. .++.++|||||||++
T Consensus 133 ~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il 211 (277)
T cd05032 133 AYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVL 211 (277)
T ss_pred HHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHH
Confidence 9999999999999999999999999999999998765433 12234567889999998654 689999999999999
Q ss_pred HHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 494 FYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 494 ~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
|||++ |..||.+.........+..+. .......++..+..++..||..+|++||++.+++..|
T Consensus 212 ~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 275 (277)
T cd05032 212 WEMATLAEQPYQGLSNEEVLKFVIDGG-HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275 (277)
T ss_pred HHhhccCCCCCccCCHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence 99998 999998877666666555332 2333345677888999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=272.29 Aligned_cols=243 Identities=20% Similarity=0.244 Sum_probs=191.5
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccch--hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-C
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR--DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-E 388 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~--~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g 388 (962)
.+.....++.++.+.||.+......+++.+.+... ....+.+|+.++++++||+|+++++++. ++..++||||+. |
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~ 85 (260)
T cd05067 7 TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENG 85 (260)
T ss_pred HceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCC
Confidence 34444455555566688887665555544444322 2457899999999999999999999875 456899999997 5
Q ss_pred CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---cccccC
Q psy501 389 NLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---YTDYVS 464 (962)
Q Consensus 389 ~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~g 464 (962)
++.+.+... +..+++.++..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... .....+
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 165 (260)
T cd05067 86 SLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF 165 (260)
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcc
Confidence 777776543 3468999999999999999999999999999999999999999999999999997665322 122345
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccC
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
+..|+|||++.+ ..++.++||||||+++|||++ |++||.+.........+.... ..+.....+..+..++..||..+
T Consensus 166 ~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~ 243 (260)
T cd05067 166 PIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY-RMPRPDNCPEELYELMRLCWKEK 243 (260)
T ss_pred cccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHccCC
Confidence 678999999865 468899999999999999999 999998877665555554442 23333456678999999999999
Q ss_pred CCCCCcHHHHHhhc
Q psy501 544 TERLKSSYILLHTL 557 (962)
Q Consensus 544 perRPs~~~Ll~~l 557 (962)
|++||++..++..|
T Consensus 244 p~~Rp~~~~l~~~l 257 (260)
T cd05067 244 PEERPTFEYLRSVL 257 (260)
T ss_pred hhhCCCHHHHHHHh
Confidence 99999999998866
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=270.98 Aligned_cols=239 Identities=18% Similarity=0.216 Sum_probs=187.9
Q ss_pred EEEEecCCcccEEEEEecCCceEEEEeccch-hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHH
Q psy501 316 KFSYILPHTLPLYTCNLDQDNHILSRHVSSR-DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQL 393 (962)
Q Consensus 316 ~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~ 393 (962)
...+..++.+.||.+.......+++...... ....+.+|+.++++++|++|+++++++.+....++||||++ ++|.++
T Consensus 11 ~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~ 90 (256)
T cd05039 11 GATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDY 90 (256)
T ss_pred eeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHH
Confidence 3334444445577776553322222222222 24568899999999999999999999998899999999998 577777
Q ss_pred HHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccccChh
Q psy501 394 IRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPE 472 (962)
Q Consensus 394 l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE 472 (962)
+.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ ....+..|+|||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~ape 169 (256)
T cd05039 91 LRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-SGKLPVKWTAPE 169 (256)
T ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc-cCCCcccccCch
Confidence 76544 3689999999999999999999999999999999999999999999999999987643322 334566799999
Q ss_pred hhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHH
Q psy501 473 VLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 551 (962)
Q Consensus 473 ~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~ 551 (962)
.+.+. .++.++|||||||++|||++ |..||...........+.... .......++..+..++..||..+|++||++.
T Consensus 170 ~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 247 (256)
T cd05039 170 ALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-RMEAPEGCPPEVYKVMKDCWELDPAKRPTFK 247 (256)
T ss_pred hhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CCCCccCCCHHHHHHHHHHhccChhhCcCHH
Confidence 98654 68899999999999999997 999998877666555554432 2223345677888999999999999999999
Q ss_pred HHHhhc
Q psy501 552 ILLHTL 557 (962)
Q Consensus 552 ~Ll~~l 557 (962)
+++..|
T Consensus 248 ~l~~~l 253 (256)
T cd05039 248 QLREQL 253 (256)
T ss_pred HHHHHH
Confidence 998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=278.31 Aligned_cols=242 Identities=20% Similarity=0.242 Sum_probs=185.3
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
.+.....+..++.+.||.+........++.+... .....+.+|+.+++.++||||+++++.+..+...|+||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 3334444444555568887765544443333221 223568899999999999999999999999999999999998
Q ss_pred C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccC
Q psy501 388 E-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVS 464 (962)
Q Consensus 388 g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~g 464 (962)
| +|.+++.. ..+++.++..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+...... ......+
T Consensus 101 ~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 178 (296)
T cd06654 101 GGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 178 (296)
T ss_pred CCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccC
Confidence 5 56665543 35899999999999999999999999999999999999999999999999998765433 2233578
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcc-ccccCCCCCCCCcHHHHHHHhccC
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSY-ILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.... ...+.....+..+..++..||..+
T Consensus 179 ~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (296)
T cd06654 179 TPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257 (296)
T ss_pred CccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCC
Confidence 899999999865 468899999999999999999999998766533322222211 111222345566788999999999
Q ss_pred CCCCCcHHHHHhh
Q psy501 544 TERLKSSYILLHT 556 (962)
Q Consensus 544 perRPs~~~Ll~~ 556 (962)
|++||++.+++..
T Consensus 258 p~~Rpt~~eil~~ 270 (296)
T cd06654 258 VEKRGSAKELLQH 270 (296)
T ss_pred cccCcCHHHHhhC
Confidence 9999999988873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=271.10 Aligned_cols=240 Identities=21% Similarity=0.245 Sum_probs=185.9
Q ss_pred eeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHH
Q psy501 314 RLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQ 392 (962)
Q Consensus 314 ~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~ 392 (962)
.....+..++.+.||.+.......+++..........+.+|+.++++++||+|+++++++..+ ..++||||+. |+|.+
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~ 87 (254)
T cd05083 9 TLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVN 87 (254)
T ss_pred eeeeeeccCCCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHH
Confidence 333344444445577765433332223222222345688999999999999999999998765 4799999998 57877
Q ss_pred HHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccccCh
Q psy501 393 LIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAP 471 (962)
Q Consensus 393 ~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~AP 471 (962)
.+.... ..+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+...... ......+..|+||
T Consensus 88 ~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~y~~p 166 (254)
T cd05083 88 FLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-VDNSKLPVKWTAP 166 (254)
T ss_pred HHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-CCCCCCCceecCH
Confidence 776543 35899999999999999999999999999999999999999999999999998754332 2223445679999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcH
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 550 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~ 550 (962)
|.+.+. .++.++|+|||||++|||++ |++||...........+..+. .......++..+..++..||..+|+.||++
T Consensus 167 e~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 244 (254)
T cd05083 167 EALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY-RMEPPEGCPADVYVLMTSCWETEPKKRPSF 244 (254)
T ss_pred HHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC-CCCCCCcCCHHHHHHHHHHcCCChhhCcCH
Confidence 998654 68999999999999999997 999998877766655555442 223334567778899999999999999999
Q ss_pred HHHHhhc
Q psy501 551 YILLHTL 557 (962)
Q Consensus 551 ~~Ll~~l 557 (962)
.+|++.+
T Consensus 245 ~~l~~~l 251 (254)
T cd05083 245 HKLREKL 251 (254)
T ss_pred HHHHHHH
Confidence 9999866
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=276.76 Aligned_cols=207 Identities=19% Similarity=0.240 Sum_probs=173.0
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhc---------------CCCCCHHHHHHHHHH
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDR---------------DKFLPESIIRNMMYQ 412 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~---------------~~~ls~~~i~~i~~q 412 (962)
..+.+|+.++++++||+|+++++++.+....++++||+. +++..++... ...+++..++.++.|
T Consensus 53 ~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~q 132 (283)
T cd05091 53 EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132 (283)
T ss_pred HHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHH
Confidence 458889999999999999999999999999999999998 4566665421 234888999999999
Q ss_pred HHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHH
Q psy501 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSR 488 (962)
Q Consensus 413 I~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwS 488 (962)
++.||.|||+.|++||||||+||++++++.+||+|||+++...... .....+++.|+|||.+.++ .++.++||||
T Consensus 133 l~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s 211 (283)
T cd05091 133 IAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWS 211 (283)
T ss_pred HHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHH
Confidence 9999999999999999999999999999999999999987654321 2233456789999998654 5899999999
Q ss_pred HHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 489 SQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 489 LGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
|||++|||++ |..||.+.........+...... +....++..+..++..||..+|++||++.+++..+
T Consensus 212 lG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l 280 (283)
T cd05091 212 YGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280 (283)
T ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence 9999999998 89999887776666666555332 22346777889999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=276.01 Aligned_cols=241 Identities=27% Similarity=0.358 Sum_probs=185.7
Q ss_pred EEEEecCCcccEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCE-----EEEEE
Q psy501 316 KFSYILPHTLPLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLS-HANLVKLKEVIRENDT-----LYFVF 383 (962)
Q Consensus 316 ~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~-----~~LV~ 383 (962)
...+..++.+.||++....+++.++.+.... ....+.+|+.+++++. ||+|+++++++..... .|+||
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~ 85 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence 3334444555688887766665554443221 1245788999999995 6999999999987655 89999
Q ss_pred ecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc-ccceeeecccccccccCC-
Q psy501 384 EYMKENLYQLIRDR----DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG-TELVKIADFGLAREIRSR- 457 (962)
Q Consensus 384 Ey~~g~Ll~~l~~~----~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~-~g~vKL~DFGla~~~~~~- 457 (962)
||+++++.+++... ...+++..++.++.||+.||.|||+.|++||||+|+||+++. ++.++|+|||.+......
T Consensus 86 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~ 165 (295)
T cd07837 86 EYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV 165 (295)
T ss_pred eccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCc
Confidence 99999988887653 245899999999999999999999999999999999999998 889999999999765432
Q ss_pred -CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc---------------
Q psy501 458 -PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL--------------- 521 (962)
Q Consensus 458 -~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------- 521 (962)
......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.........+......
T Consensus 166 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T cd07837 166 KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDW 245 (295)
T ss_pred cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccch
Confidence 2233456788999999877667899999999999999999999999887655544333221000
Q ss_pred -----------ccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 522 -----------LHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 522 -----------~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
....+..+..+..++..||..+|.+||++.+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 246 HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00113456677889999999999999998887764
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=279.93 Aligned_cols=236 Identities=19% Similarity=0.267 Sum_probs=187.9
Q ss_pred ecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHH
Q psy501 320 ILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLY 391 (962)
Q Consensus 320 i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll 391 (962)
..++.+.||.+.....++.++.+.... ....+..|+++++.++||+|+++++.+.++...|+||||+.| +|.
T Consensus 10 g~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (316)
T cd05574 10 GKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89 (316)
T ss_pred cCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHH
Confidence 334445577777666555444333221 234588999999999999999999999999999999999985 676
Q ss_pred HHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC------------
Q psy501 392 QLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP------------ 458 (962)
Q Consensus 392 ~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~------------ 458 (962)
+.+... ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 90 ~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 169 (316)
T cd05574 90 RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169 (316)
T ss_pred HHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccc
Confidence 666543 3569999999999999999999999999999999999999999999999999986543210
Q ss_pred -------------------cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcc
Q psy501 459 -------------------YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSY 519 (962)
Q Consensus 459 -------------------~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~ 519 (962)
.....|+..|+|||++.+. .++.++|||||||++|+|++|..||.+.........+....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~ 248 (316)
T cd05574 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKE 248 (316)
T ss_pred cccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCC
Confidence 1123578889999999654 68999999999999999999999998877666666555544
Q ss_pred ccccCCCCCCCCcHHHHHHHhccCCCCCCc----HHHHHhh
Q psy501 520 ILLHTLPLYTYHVPPIQTTCLLAGTERLKS----SYILLHT 556 (962)
Q Consensus 520 ~~~~~~~~~s~~l~~li~~Cl~~dperRPs----~~~Ll~~ 556 (962)
...+.....+..+..++..||..+|++||+ +++++..
T Consensus 249 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 249 VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 444433346778999999999999999999 7777774
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=276.24 Aligned_cols=235 Identities=15% Similarity=0.215 Sum_probs=181.0
Q ss_pred cccEEEEEecCCceEEEEecc-----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcC
Q psy501 324 TLPLYTCNLDQDNHILSRHVS-----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~ 398 (962)
.+.||.+.....++.++.++. ......+.+|+++++.++||+|+++++++.....+++||||++++.+..+....
T Consensus 18 ~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 97 (284)
T cd06620 18 GGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKG 97 (284)
T ss_pred CeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhc
Confidence 344666665554444443321 223456889999999999999999999999999999999999965554444445
Q ss_pred CCCCHHHHHHHHHHHHHHHhhccc-ceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccccChhhhccC
Q psy501 399 KFLPESIIRNMMYQVLQGLAFMHR-HGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHS 477 (962)
Q Consensus 399 ~~ls~~~i~~i~~qI~~aL~yLH~-~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~ 477 (962)
+.+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++............|+..|+|||++.+.
T Consensus 98 ~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~ 177 (284)
T cd06620 98 GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGG 177 (284)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCccccCcccCCHHHHccC
Confidence 679999999999999999999997 6899999999999999999999999999876544444456789999999998654
Q ss_pred CCCCchhHHHHHHHHHHHHHcCCCCCCCcChh-----------hhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCC
Q psy501 478 TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL-----------AGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTER 546 (962)
Q Consensus 478 ~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~-----------~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dper 546 (962)
.++.++|||||||++|+|++|..||...... .....+............++..+..++..||..+|+.
T Consensus 178 -~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 256 (284)
T cd06620 178 -KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTE 256 (284)
T ss_pred -CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCccc
Confidence 7889999999999999999999999865432 1111222111111111125556788999999999999
Q ss_pred CCcHHHHHhhccc
Q psy501 547 LKSSYILLHTLPL 559 (962)
Q Consensus 547 RPs~~~Ll~~l~~ 559 (962)
||++.+++....+
T Consensus 257 Rpt~~e~~~~~~~ 269 (284)
T cd06620 257 RPTPQQLCAMPPF 269 (284)
T ss_pred CcCHHHHhcCccc
Confidence 9999999986544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-29 Score=272.63 Aligned_cols=205 Identities=21% Similarity=0.318 Sum_probs=164.2
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEe--CCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhccccee
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRE--NDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGF 425 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gI 425 (962)
..+.+|+.++++++||||+++++++.+ +..+++++||+++ +|.+.+... ..+++..++.++.|++.||.|||+.++
T Consensus 49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i 127 (266)
T cd06651 49 SALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMI 127 (266)
T ss_pred HHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 468889999999999999999999875 3678999999985 566666543 458999999999999999999999999
Q ss_pred eeccCCCcccccccccceeeecccccccccCC-----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCC
Q psy501 426 FHRDMKPENLLCMGTELVKIADFGLAREIRSR-----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHV 500 (962)
Q Consensus 426 vHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~ 500 (962)
+|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+ ..++.++|||||||++|||++|+
T Consensus 128 ~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~ 206 (266)
T cd06651 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEK 206 (266)
T ss_pred eeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCC
Confidence 99999999999999999999999998765321 1223457889999999965 46899999999999999999999
Q ss_pred CCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 501 PPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 501 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.||...........+......+......+..+..++ .||..+|++||++.+++..
T Consensus 207 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 207 PPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 999877554444433332222222224455667777 5888899999998888763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=306.93 Aligned_cols=177 Identities=27% Similarity=0.392 Sum_probs=141.9
Q ss_pred CEEEEEEecCCCCHHHHHHhcCCCC-CHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccccccc
Q psy501 377 DTLYFVFEYMKENLYQLIRDRDKFL-PESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR 455 (962)
Q Consensus 377 ~~~~LV~Ey~~g~Ll~~l~~~~~~l-s~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~ 455 (962)
..+||-||||+.+++..+....... .....|+++++|++||.|+|+.|||||||||.||+++.++.|||+|||+|....
T Consensus 669 ~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~ 748 (1351)
T KOG1035|consen 669 LILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLK 748 (1351)
T ss_pred eEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhh
Confidence 3588999999999999888876644 578899999999999999999999999999999999999999999999998721
Q ss_pred --------------------CCCcccccCCccccChhhhccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCc-ChhhhH
Q psy501 456 --------------------SRPYTDYVSTRWYRAPEVLLHST--AYSAPIHLSRSQQFLFYSIDHVPPIQTT-CLLAGT 512 (962)
Q Consensus 456 --------------------~~~~~~~~gt~~Y~APE~l~~~~--~~t~ksDIwSLGvlL~elltG~~Pf~~~-~~~~~~ 512 (962)
....+..+||..|+|||++.+.. .|+.|+|+|||||||+||+. ||... ......
T Consensus 749 ~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL 825 (1351)
T KOG1035|consen 749 ENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASIL 825 (1351)
T ss_pred hhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHH
Confidence 01345568999999999997655 59999999999999999985 57654 334445
Q ss_pred HHHHhcccccc---CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 513 ERLKSSYILLH---TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 513 ~~i~~~~~~~~---~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..++.+.+..+ ..+.++ .-..+|+.++..||.+||++.+|+..-
T Consensus 826 ~~LR~g~iP~~~~f~~~~~~-~e~slI~~Ll~hdP~kRPtA~eLL~s~ 872 (1351)
T KOG1035|consen 826 TNLRKGSIPEPADFFDPEHP-EEASLIRWLLSHDPSKRPTATELLNSE 872 (1351)
T ss_pred HhcccCCCCCCcccccccch-HHHHHHHHHhcCCCccCCCHHHHhhcc
Confidence 56665544444 112222 234588899999999999999998855
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=275.00 Aligned_cols=238 Identities=27% Similarity=0.370 Sum_probs=187.5
Q ss_pred EecCCcccEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CEEEEEEecCCCCH
Q psy501 319 YILPHTLPLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIREN--DTLYFVFEYMKENL 390 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~LV~Ey~~g~L 390 (962)
+..++.+.||++.....++.++.+.... ....+.+|++++++++||+++++++++... +..++||||+++++
T Consensus 7 l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~l 86 (287)
T cd07840 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDL 86 (287)
T ss_pred eccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccccH
Confidence 3344455678877666554444333221 234578899999999999999999999887 89999999999998
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---cccccCCcc
Q psy501 391 YQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---YTDYVSTRW 467 (962)
Q Consensus 391 l~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~gt~~ 467 (962)
.+.+......+++..++.++.||+.||.|||+.|++|+||+|+||++++++.++|+|||.+....... .....++..
T Consensus 87 ~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 166 (287)
T cd07840 87 TGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW 166 (287)
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccc
Confidence 88887765679999999999999999999999999999999999999999999999999998765442 334466888
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc------------------------
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH------------------------ 523 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------------ 523 (962)
|+|||.+.+...++.++||||||+++|||++|+.||...........+......+.
T Consensus 167 y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (287)
T cd07840 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKR 246 (287)
T ss_pred cCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchh
Confidence 99999887666789999999999999999999999988776554444432111000
Q ss_pred ----CCCC-CCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 524 ----TLPL-YTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 524 ----~~~~-~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.... ++..+..++..||..+|++||++.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 247 RLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred HHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0001 24556678999999999999999888764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=276.89 Aligned_cols=231 Identities=19% Similarity=0.204 Sum_probs=178.2
Q ss_pred cccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHH
Q psy501 324 TLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIR 395 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~ 395 (962)
.+.||.+.....++.++.+.... ....+..|+.++++++|++|+.+++.+.+++..|+||||+.| +|.+.+.
T Consensus 13 ~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~ 92 (285)
T cd05630 13 FGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY 92 (285)
T ss_pred CeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHH
Confidence 33477776666555544433221 123467899999999999999999999999999999999985 5666654
Q ss_pred hc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCccccChhh
Q psy501 396 DR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPEV 473 (962)
Q Consensus 396 ~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~APE~ 473 (962)
.. ...+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||++...... ......|+..|+|||+
T Consensus 93 ~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~ 172 (285)
T cd05630 93 HMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 172 (285)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCCCCCccccChHH
Confidence 33 245899999999999999999999999999999999999999999999999998765433 2234578999999999
Q ss_pred hccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh---HHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCc-
Q psy501 474 LLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG---TERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS- 549 (962)
Q Consensus 474 l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs- 549 (962)
+.+. .++.++|||||||++|+|++|+.||........ ....... ........++..+..++..||..+|++||+
T Consensus 173 ~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~ 250 (285)
T cd05630 173 VKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEKFSPDARSLCKMLLCKDPKERLGC 250 (285)
T ss_pred HcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcCccCCHHHHHHHHHHhhcCHHHccCC
Confidence 9654 689999999999999999999999987543211 1111111 111122356667888999999999999998
Q ss_pred ----HHHHHhh
Q psy501 550 ----SYILLHT 556 (962)
Q Consensus 550 ----~~~Ll~~ 556 (962)
+.++++.
T Consensus 251 ~~~~~~~~~~h 261 (285)
T cd05630 251 QGGGAREVKEH 261 (285)
T ss_pred CCCchHHHHcC
Confidence 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=273.69 Aligned_cols=208 Identities=17% Similarity=0.191 Sum_probs=164.5
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHhhcccc
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD----KFLPESIIRNMMYQVLQGLAFMHRH 423 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~----~~ls~~~i~~i~~qI~~aL~yLH~~ 423 (962)
..+.+|+.+++.++||||+++++.+.++...++||||++ |+|.+++.... ..+++..+..++.||+.||.|||+.
T Consensus 40 ~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 119 (269)
T cd05042 40 LLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119 (269)
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc
Confidence 457889999999999999999999999999999999998 57777775543 2346788899999999999999999
Q ss_pred eeeeccCCCcccccccccceeeecccccccccCC----CcccccCCccccChhhhcc------CCCCCchhHHHHHHHHH
Q psy501 424 GFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLH------STAYSAPIHLSRSQQFL 493 (962)
Q Consensus 424 gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~------~~~~t~ksDIwSLGvlL 493 (962)
+|+||||||+||+++.++.+||+|||++...... ......++..|+|||++.. ...++.++|||||||++
T Consensus 120 ~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l 199 (269)
T cd05042 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTM 199 (269)
T ss_pred CEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHH
Confidence 9999999999999999999999999998654322 1222345677999999743 23578899999999999
Q ss_pred HHHHc-CCCCCCCcChhhhHHHHHhccc-cccC---CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 494 FYSID-HVPPIQTTCLLAGTERLKSSYI-LLHT---LPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 494 ~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~~~~---~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
|||++ |..||................. ..+. ...++..+..++..||. +|++||+++++++.+
T Consensus 200 ~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-dp~~Rpt~~~v~~~l 267 (269)
T cd05042 200 WELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELL 267 (269)
T ss_pred HHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHhc-CcccccCHHHHHHHh
Confidence 99999 8899987765544443333222 2111 12445566778999995 999999999998865
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=278.66 Aligned_cols=209 Identities=22% Similarity=0.223 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC----------CCCCHHHHHHHHHHHHHH
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD----------KFLPESIIRNMMYQVLQG 416 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~----------~~ls~~~i~~i~~qI~~a 416 (962)
...+.+|++++++++||||+++++++..++..++|||++. ++|.+++.... ..+++..++.++.|++.|
T Consensus 63 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a 142 (296)
T cd05051 63 REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASG 142 (296)
T ss_pred HHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHH
Confidence 4568899999999999999999999999999999999998 56766665433 268999999999999999
Q ss_pred HhhcccceeeeccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHHH
Q psy501 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQF 492 (962)
Q Consensus 417 L~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvl 492 (962)
|.|||+.|++|+||||+||+++.++.++|+|||.+....... .....++..|+|||.+.+. .++.++|||||||+
T Consensus 143 l~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~ 221 (296)
T cd05051 143 MRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVT 221 (296)
T ss_pred HHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHH
Confidence 999999999999999999999999999999999997654331 2233456789999998654 68999999999999
Q ss_pred HHHHHc--CCCCCCCcChhhhHHHHHhc------cccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 493 LFYSID--HVPPIQTTCLLAGTERLKSS------YILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 493 L~ellt--G~~Pf~~~~~~~~~~~i~~~------~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+|||++ |..||...........+... ....+..+.++..+..++..||..+|++||++.+|++.|
T Consensus 222 l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L 294 (296)
T cd05051 222 LWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294 (296)
T ss_pred HHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence 999998 78899776555444443322 111222334566789999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=274.71 Aligned_cols=233 Identities=20% Similarity=0.281 Sum_probs=183.6
Q ss_pred CCcccEEEEEecCCceEEEEecc-----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHH
Q psy501 322 PHTLPLYTCNLDQDNHILSRHVS-----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIR 395 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~ 395 (962)
++.+.||.+......+.++.+.. ......+.+|++++++++||||+++++.+..+...++|+||++ ++|.+.+.
T Consensus 12 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 91 (265)
T cd06605 12 GNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILK 91 (265)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHH
Confidence 34445777776655554444332 2234568899999999999999999999999999999999999 56776666
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHhhccc-ceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccccChhhh
Q psy501 396 DRDKFLPESIIRNMMYQVLQGLAFMHR-HGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVL 474 (962)
Q Consensus 396 ~~~~~ls~~~i~~i~~qI~~aL~yLH~-~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l 474 (962)
.....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+............++..|+|||.+
T Consensus 92 ~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~ 171 (265)
T cd06605 92 EVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERI 171 (265)
T ss_pred HccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcccCChhccCHHHH
Confidence 554679999999999999999999999 9999999999999999999999999999876654433336788999999999
Q ss_pred ccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcC-----hhhhHHHHHhccccccCCC--CCCCCcHHHHHHHhccCCCCC
Q psy501 475 LHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTC-----LLAGTERLKSSYILLHTLP--LYTYHVPPIQTTCLLAGTERL 547 (962)
Q Consensus 475 ~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~--~~s~~l~~li~~Cl~~dperR 547 (962)
.+. .++.++|||||||++|+|++|+.||.... .......+.... .+..+ .++..+..++..||..+|++|
T Consensus 172 ~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R 248 (265)
T cd06605 172 QGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP--PPRLPSGKFSPDFQDFVNLCLIKDPRER 248 (265)
T ss_pred cCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC--CCCCChhhcCHHHHHHHHHHcCCCchhC
Confidence 664 78999999999999999999999997652 222222222221 11122 156678899999999999999
Q ss_pred CcHHHHHhhc
Q psy501 548 KSSYILLHTL 557 (962)
Q Consensus 548 Ps~~~Ll~~l 557 (962)
|++.+++..-
T Consensus 249 pt~~~ll~~~ 258 (265)
T cd06605 249 PSYKELLEHP 258 (265)
T ss_pred cCHHHHhhCc
Confidence 9988887653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-29 Score=271.12 Aligned_cols=236 Identities=19% Similarity=0.241 Sum_probs=179.2
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccc---------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CEEEEEEecC
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSS---------RDEMVVCFYRKSLKKLSHANLVKLKEVIREN--DTLYFVFEYM 386 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~---------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~LV~Ey~ 386 (962)
.+..++.+.||.+....+++.++.+... .....+.+|+.++++++||+|+++++++.++ ..+++||||+
T Consensus 9 ~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~ 88 (265)
T cd06652 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHM 88 (265)
T ss_pred EEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEec
Confidence 3334444557777665555444433211 1224678899999999999999999998763 5688999999
Q ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-----Ccc
Q psy501 387 KE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-----PYT 460 (962)
Q Consensus 387 ~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-----~~~ 460 (962)
+| +|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 89 ~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 167 (265)
T cd06652 89 PGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK 167 (265)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccc
Confidence 85 566665543 45899999999999999999999999999999999999999999999999999765421 223
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHh
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCL 540 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl 540 (962)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+..........+..+..+..++..||
T Consensus 168 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 246 (265)
T cd06652 168 SVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIF 246 (265)
T ss_pred cCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHh
Confidence 3468889999999965 468999999999999999999999998765554444433322222222344556777888998
Q ss_pred ccCCCCCCcHHHHHhh
Q psy501 541 LAGTERLKSSYILLHT 556 (962)
Q Consensus 541 ~~dperRPs~~~Ll~~ 556 (962)
. +|+.||++.+++..
T Consensus 247 ~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 247 V-EAKLRPSADELLRH 261 (265)
T ss_pred c-ChhhCCCHHHHhcC
Confidence 5 89999999888864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=271.34 Aligned_cols=207 Identities=21% Similarity=0.243 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceee
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFF 426 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIv 426 (962)
...+.+|+.+++.+.||+|+++++++. ....++||||+. |+|.+++.... .+++..++.++.|++.||.|||..+++
T Consensus 40 ~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~ 117 (257)
T cd05060 40 KKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFV 117 (257)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCee
Confidence 446889999999999999999999876 456899999997 57777776544 689999999999999999999999999
Q ss_pred eccCCCcccccccccceeeecccccccccCCCc-----ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CC
Q psy501 427 HRDMKPENLLCMGTELVKIADFGLAREIRSRPY-----TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HV 500 (962)
Q Consensus 427 HrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~-----~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~ 500 (962)
|+||||+||+++.++.+||+|||.+........ ....++..|+|||.+.+ ..++.++|||||||++|+|++ |.
T Consensus 118 H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~ 196 (257)
T cd05060 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGA 196 (257)
T ss_pred ccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999986643321 11123467999999865 468999999999999999998 99
Q ss_pred CCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 501 PPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 501 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
+||...........+.... ..+....++..+.+++..||..+|++||++.+|++.+.
T Consensus 197 ~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~ 253 (257)
T cd05060 197 KPYGEMKGAEVIAMLESGE-RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253 (257)
T ss_pred CCcccCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 9998877655555554443 23334566778889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-29 Score=272.27 Aligned_cols=233 Identities=17% Similarity=0.207 Sum_probs=180.0
Q ss_pred CcccEEEEEecCCce--EEEEec------cchhHHHHHHHHHHHHhcCCCCcccEEEEEEeC------CEEEEEEecCC-
Q psy501 323 HTLPLYTCNLDQDNH--ILSRHV------SSRDEMVVCFYRKSLKKLSHANLVKLKEVIREN------DTLYFVFEYMK- 387 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~k--vv~~k~------~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------~~~~LV~Ey~~- 387 (962)
+.+.||.+....... .++.+. .......+.+|+.+++.++||||+++++++... ...++||||+.
T Consensus 11 ~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~ 90 (272)
T cd05075 11 EFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKH 90 (272)
T ss_pred cCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCC
Confidence 344567766554432 122221 122345688899999999999999999987432 25789999998
Q ss_pred CCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC----
Q psy501 388 ENLYQLIRD-----RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---- 458 (962)
Q Consensus 388 g~Ll~~l~~-----~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---- 458 (962)
|++.+.+.. ....+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++.......
T Consensus 91 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 170 (272)
T cd05075 91 GDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ 170 (272)
T ss_pred CcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceec
Confidence 566666532 22458999999999999999999999999999999999999999999999999998764432
Q ss_pred cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHH
Q psy501 459 YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQT 537 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~ 537 (962)
.....+++.|+|||.+.+ ..++.++|||||||++|||++ |+.||.+.........+..+.. .+..+.++..+..++.
T Consensus 171 ~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 248 (272)
T cd05075 171 GRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR-LKQPPDCLDGLYSLMS 248 (272)
T ss_pred CCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHHHHHHH
Confidence 112245678999999865 468999999999999999999 8999988766665555555432 2334466677889999
Q ss_pred HHhccCCCCCCcHHHHHhhc
Q psy501 538 TCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 538 ~Cl~~dperRPs~~~Ll~~l 557 (962)
.||..+|++||++.+|++.+
T Consensus 249 ~~l~~~p~~Rps~~~l~~~l 268 (272)
T cd05075 249 SCWLLNPKDRPSFETLRCEL 268 (272)
T ss_pred HHcCCCcccCcCHHHHHHHH
Confidence 99999999999999999866
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-29 Score=276.81 Aligned_cols=245 Identities=24% Similarity=0.323 Sum_probs=185.8
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCC--------
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIREND-------- 377 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~-------- 377 (962)
.+.....+..++.+.||.+....+++.++.+.... ....+.+|+.++++++||+|+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 44444455555556688887766665554443211 1234678999999999999999999986543
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC
Q psy501 378 TLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR 457 (962)
Q Consensus 378 ~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~ 457 (962)
..++||||+++++.+.+......+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+......
T Consensus 93 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 172 (310)
T cd07865 93 SFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLS 172 (310)
T ss_pred eEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCC
Confidence 46999999999998888776667999999999999999999999999999999999999999999999999999765432
Q ss_pred C------cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--C-----
Q psy501 458 P------YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--T----- 524 (962)
Q Consensus 458 ~------~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~----- 524 (962)
. .....++..|+|||.+.+...++.++||||||+++|||++|.+||.+.........+.......+ .
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (310)
T cd07865 173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD 252 (310)
T ss_pred cccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 1 12345778899999987766688999999999999999999999987765433332222110000 0
Q ss_pred -----------------------CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 525 -----------------------LPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 525 -----------------------~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
....+....+++..||..+|++||++.+++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 253 KLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred chhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00112344579999999999999998888753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-29 Score=279.93 Aligned_cols=233 Identities=22% Similarity=0.280 Sum_probs=187.1
Q ss_pred ccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhc
Q psy501 325 LPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDR 397 (962)
Q Consensus 325 ~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~ 397 (962)
+.||.+.....+..++.+... .....+.+|++++++++||+++++++++.++...++||||+.|++.+.+...
T Consensus 39 ~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~ 118 (317)
T cd06635 39 GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH 118 (317)
T ss_pred eEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCCCHHHHHHHh
Confidence 346666554444433333221 1234688899999999999999999999999999999999999998888776
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccccChhhhcc-
Q psy501 398 DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLH- 476 (962)
Q Consensus 398 ~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~- 476 (962)
...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .....++..|+|||++.+
T Consensus 119 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~ 196 (317)
T cd06635 119 KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--ANSFVGTPYWMAPEVILAM 196 (317)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--cccccCCccccChhhhhcC
Confidence 67799999999999999999999999999999999999999999999999999865432 234568889999999742
Q ss_pred -CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHh
Q psy501 477 -STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLH 555 (962)
Q Consensus 477 -~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~ 555 (962)
...++.++|||||||++|||++|+.||...........+............++..+..++..||..+|++||++.++++
T Consensus 197 ~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 276 (317)
T cd06635 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276 (317)
T ss_pred CCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHh
Confidence 3358899999999999999999999998876655555555443333333455667889999999999999999998888
Q ss_pred hccc
Q psy501 556 TLPL 559 (962)
Q Consensus 556 ~l~~ 559 (962)
....
T Consensus 277 ~~~~ 280 (317)
T cd06635 277 HMFV 280 (317)
T ss_pred Chhh
Confidence 6633
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=281.16 Aligned_cols=237 Identities=20% Similarity=0.215 Sum_probs=181.3
Q ss_pred EecCCcccEEEEEecCCce--EEE-Eecc----chhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCC-CC
Q psy501 319 YILPHTLPLYTCNLDQDNH--ILS-RHVS----SRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMK-EN 389 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~~~k--vv~-~k~~----~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~ 389 (962)
++.++.+.||.+.....+. .++ +... ......+.+|++++.++ +||||+++++++..++..|+||||++ |+
T Consensus 15 lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 94 (303)
T cd05088 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 94 (303)
T ss_pred ecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCc
Confidence 3334444577776544332 112 2211 12234688899999999 89999999999999999999999998 57
Q ss_pred HHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccc
Q psy501 390 LYQLIRDRD---------------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI 454 (962)
Q Consensus 390 Ll~~l~~~~---------------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~ 454 (962)
|.+++.... ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++...
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 174 (303)
T cd05088 95 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ 174 (303)
T ss_pred HHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCccc
Confidence 777775432 35889999999999999999999999999999999999999999999999998643
Q ss_pred cCC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCc
Q psy501 455 RSR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHV 532 (962)
Q Consensus 455 ~~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 532 (962)
... ......++..|+|||.+.+ ..++.++|||||||++|||+| |..||.+.........+.... ........+..+
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 252 (303)
T cd05088 175 EVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEKPLNCDDEV 252 (303)
T ss_pred chhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC-cCCCCCCCCHHH
Confidence 221 1111234567999998855 468999999999999999998 999998776655555443331 122223456678
Q ss_pred HHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 533 PPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 533 ~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..++..||..+|+.||++.+++..+
T Consensus 253 ~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 253 YDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHH
Confidence 8899999999999999999988866
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-29 Score=274.08 Aligned_cols=239 Identities=25% Similarity=0.362 Sum_probs=184.5
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHH
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLY 391 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll 391 (962)
.+..++.+.||++.....++.++.+... .....+.+|++++++++||||+++++++.++...|+||||+++++.
T Consensus 9 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~ 88 (294)
T PLN00009 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLK 88 (294)
T ss_pred EecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccccHH
Confidence 3344445568888776555544443322 1124578899999999999999999999999999999999999988
Q ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc-ccceeeecccccccccCC--CcccccCCcc
Q psy501 392 QLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG-TELVKIADFGLAREIRSR--PYTDYVSTRW 467 (962)
Q Consensus 392 ~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~-~g~vKL~DFGla~~~~~~--~~~~~~gt~~ 467 (962)
+.+.... ..+++..++.++.||+.||.|||+.+++|+||+|+||+++. ++.+||+|||++...... ......+++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 168 (294)
T PLN00009 89 KHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLW 168 (294)
T ss_pred HHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeec
Confidence 8876543 33688999999999999999999999999999999999985 457999999999765432 2233467889
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-------------------------
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL------------------------- 522 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------------------- 522 (962)
|+|||++.+...++.++|||||||++|+|+||.+||..........++......+
T Consensus 169 y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (294)
T PLN00009 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKD 248 (294)
T ss_pred ccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCC
Confidence 9999998776678999999999999999999999998765544443332110000
Q ss_pred --cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 523 --HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 523 --~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
...+..+..+..++..|+..+|++||++.+++..
T Consensus 249 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 249 LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred HHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0113455667789999999999999998887764
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-29 Score=267.95 Aligned_cols=236 Identities=22% Similarity=0.292 Sum_probs=185.5
Q ss_pred ecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHh
Q psy501 320 ILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRD 396 (962)
Q Consensus 320 i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~ 396 (962)
..++.+.||.+.......++.+.+.. .....+.+|++++++++||+++++++++......++||||+.| +|.+++..
T Consensus 13 g~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~ 92 (256)
T cd05112 13 GSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRA 92 (256)
T ss_pred cCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHh
Confidence 33444457777655433333333222 2245688999999999999999999999999999999999985 66666666
Q ss_pred cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcc---cccCCccccChhh
Q psy501 397 RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT---DYVSTRWYRAPEV 473 (962)
Q Consensus 397 ~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~---~~~gt~~Y~APE~ 473 (962)
....++++.++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+......... ...++..|+|||.
T Consensus 93 ~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~ 172 (256)
T cd05112 93 QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEV 172 (256)
T ss_pred CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhH
Confidence 5567899999999999999999999999999999999999999999999999998765443221 2234568999999
Q ss_pred hccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHH
Q psy501 474 LLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 552 (962)
Q Consensus 474 l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~ 552 (962)
+.+. .++.++|||||||++|||++ |..||...........+..+.. .......+..+..++..||..+|+.||++.+
T Consensus 173 ~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 250 (256)
T cd05112 173 FSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR-LYKPRLASQSVYELMQHCWKERPEDRPSFSL 250 (256)
T ss_pred hccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC-CCCCCCCCHHHHHHHHHHcccChhhCCCHHH
Confidence 8654 68999999999999999998 9999988776655555544322 1222345677889999999999999999999
Q ss_pred HHhhc
Q psy501 553 LLHTL 557 (962)
Q Consensus 553 Ll~~l 557 (962)
+++.+
T Consensus 251 ~l~~l 255 (256)
T cd05112 251 LLHQL 255 (256)
T ss_pred HHHhh
Confidence 98754
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=281.94 Aligned_cols=232 Identities=15% Similarity=0.138 Sum_probs=175.8
Q ss_pred cEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhc-
Q psy501 326 PLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDR- 397 (962)
Q Consensus 326 ~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~- 397 (962)
.||.+....+++.++.+.... ....+.+|+++++.++||||+++++++..++..++||||++ |++.+.+...
T Consensus 15 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~ 94 (327)
T cd08227 15 TVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF 94 (327)
T ss_pred EEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhc
Confidence 567777766666555444322 23457889999999999999999999999999999999998 4666666543
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---------CcccccCCccc
Q psy501 398 DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---------PYTDYVSTRWY 468 (962)
Q Consensus 398 ~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---------~~~~~~gt~~Y 468 (962)
...+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++++||+.+...... ......++..|
T Consensus 95 ~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 174 (327)
T cd08227 95 MDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPW 174 (327)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecc
Confidence 345899999999999999999999999999999999999999999999999875433211 11123467789
Q ss_pred cChhhhccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-------------------------
Q psy501 469 RAPEVLLHS-TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL------------------------- 522 (962)
Q Consensus 469 ~APE~l~~~-~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------------------- 522 (962)
+|||++.+. ..++.++|||||||++|||++|+.||..............+....
T Consensus 175 ~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T cd08227 175 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGL 254 (327)
T ss_pred cChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCC
Confidence 999999753 358999999999999999999999998654433222222111100
Q ss_pred -------------------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 523 -------------------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 523 -------------------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+....++..+..++..||..+|++||++.++++.-
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 255 GESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred CcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 00001233566899999999999999999888754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-29 Score=274.03 Aligned_cols=245 Identities=16% Similarity=0.181 Sum_probs=190.8
Q ss_pred eeeEEEEecCCcccEEEEEecCCce----EEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNH----ILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~k----vv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
+.....+..++.+.||.+.....+. .++.+... .....+.+|+.++++++||||+++++++.. ...++||
T Consensus 9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 87 (279)
T cd05057 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT 87 (279)
T ss_pred cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence 3334444444555677776543322 22222211 223568899999999999999999999987 7889999
Q ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCc---
Q psy501 384 EYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY--- 459 (962)
Q Consensus 384 Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~--- 459 (962)
||+. |+|.+.+......+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||.++.......
T Consensus 88 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 167 (279)
T cd05057 88 QLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH 167 (279)
T ss_pred ecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCccccee
Confidence 9997 678888777666799999999999999999999999999999999999999999999999999986653311
Q ss_pred -ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHH
Q psy501 460 -TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQT 537 (962)
Q Consensus 460 -~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~ 537 (962)
....++..|+|||.+.. ..++.++|||||||++|||++ |+.||.+.........+..+. ..+..+.++..+..++.
T Consensus 168 ~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 245 (279)
T cd05057 168 AEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RLPQPPICTIDVYMVLV 245 (279)
T ss_pred cCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-CCCCCCCCCHHHHHHHH
Confidence 11223567999998864 468999999999999999998 999999887666665555442 23334456677888999
Q ss_pred HHhccCCCCCCcHHHHHhhcccc
Q psy501 538 TCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 538 ~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
.||..+|..||++.+++..+...
T Consensus 246 ~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 246 KCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred HHcCCChhhCCCHHHHHHHHHHH
Confidence 99999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=277.84 Aligned_cols=208 Identities=18% Similarity=0.243 Sum_probs=172.4
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhc-----------------------CCCCCH
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDR-----------------------DKFLPE 403 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~-----------------------~~~ls~ 403 (962)
...+.+|+.+++.++||||+++++.+..++..++||||+. |+|.+++... ...+++
T Consensus 47 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 126 (290)
T cd05045 47 LRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126 (290)
T ss_pred HHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCH
Confidence 3468899999999999999999999999999999999998 5666665431 134789
Q ss_pred HHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhhccCCC
Q psy501 404 SIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTA 479 (962)
Q Consensus 404 ~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~ 479 (962)
..++.++.|++.||.|||+.+++||||||+||++++++.++|+|||+++...... .....++..|+|||.+.+ ..
T Consensus 127 ~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~ 205 (290)
T cd05045 127 GDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HI 205 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CC
Confidence 9999999999999999999999999999999999999999999999997653321 122345678999999865 46
Q ss_pred CCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 480 YSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 480 ~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
++.++|||||||++|||++ |..||.+.........+... ...+....++..+..++..||..+|++||+..+++..|
T Consensus 206 ~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l 283 (290)
T cd05045 206 YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTG-YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283 (290)
T ss_pred cchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 8999999999999999998 99999887766555544433 23333445677888999999999999999999998866
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-29 Score=278.12 Aligned_cols=213 Identities=23% Similarity=0.311 Sum_probs=177.7
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeec
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHR 428 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHr 428 (962)
..+.+|+++++.++||+++++++++..+...++||||+.|++.+.+......+++..++.++.|++.||.|||+.+++|+
T Consensus 60 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~ 139 (308)
T cd06634 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139 (308)
T ss_pred HHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 45778999999999999999999999999999999999999888887666779999999999999999999999999999
Q ss_pred cCCCcccccccccceeeecccccccccCCCcccccCCccccChhhhcc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCc
Q psy501 429 DMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLH--STAYSAPIHLSRSQQFLFYSIDHVPPIQTT 506 (962)
Q Consensus 429 DLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~t~ksDIwSLGvlL~elltG~~Pf~~~ 506 (962)
||+|+||+++.++.++|+|||++...... ....++..|+|||.+.+ ...++.++|||||||++|+|++|..||...
T Consensus 140 dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 140 DVKAGNILLSEPGLVKLGDFGSASIMAPA--NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred CCCHHhEEECCCCcEEECCcccceeecCc--ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999998765432 34567889999999852 235788999999999999999999999876
Q ss_pred ChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccccC
Q psy501 507 CLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYH 563 (962)
Q Consensus 507 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~~ 563 (962)
........+............++..+..++..||..+|+.||++.++++........
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 218 NAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred cHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 554444444433332222345667788999999999999999999988875333333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=274.25 Aligned_cols=204 Identities=16% Similarity=0.136 Sum_probs=166.1
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeee
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFH 427 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvH 427 (962)
..+..|+.+++.++||||+++++++..+...++||||+++ +|..++......+++..++.++.||+.||.|||++||+|
T Consensus 44 ~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH 123 (258)
T cd05078 44 ESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTH 123 (258)
T ss_pred HHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 4578899999999999999999999998999999999985 666776665567899999999999999999999999999
Q ss_pred ccCCCcccccccccc--------eeeecccccccccCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcC
Q psy501 428 RDMKPENLLCMGTEL--------VKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDH 499 (962)
Q Consensus 428 rDLkp~NILl~~~g~--------vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG 499 (962)
|||||+||+++.++. ++++|||.+...... ....++..|+|||++.+...++.++|||||||++|||++|
T Consensus 124 ~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g 201 (258)
T cd05078 124 GNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK--EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201 (258)
T ss_pred CCCccceEEEecccccccCCCceEEecccccccccCCc--hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcC
Confidence 999999999987764 699999998655432 2346788999999997655689999999999999999998
Q ss_pred -CCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 500 -VPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 500 -~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.+||.......... ...... ...+..+..+..++..||..+|+.||++.++++.|
T Consensus 202 ~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 202 GDKPLSALDSQKKLQ-FYEDRH--QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred CCCChhhccHHHHHH-HHHccc--cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 56766554443322 222211 11223445678899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=278.58 Aligned_cols=246 Identities=19% Similarity=0.240 Sum_probs=186.3
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
.+.....+..++.+.||.+.....+..++.+... ...+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (297)
T cd06656 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 99 (297)
T ss_pred hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence 3344444444555567777765444443333221 234568889999999999999999999999999999999998
Q ss_pred C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccC
Q psy501 388 E-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVS 464 (962)
Q Consensus 388 g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~g 464 (962)
| ++.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... ......+
T Consensus 100 ~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 177 (297)
T cd06656 100 GGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 177 (297)
T ss_pred CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccC
Confidence 5 55555543 34899999999999999999999999999999999999999999999999998765433 2233568
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhc-cccccCCCCCCCCcHHHHHHHhccC
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSS-YILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+... ..........+..+..++..||..+
T Consensus 178 ~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 256 (297)
T cd06656 178 TPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMD 256 (297)
T ss_pred CccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCC
Confidence 889999999965 46889999999999999999999999876543332222211 1111122344556778999999999
Q ss_pred CCCCCcHHHHHhhccccc
Q psy501 544 TERLKSSYILLHTLPLYT 561 (962)
Q Consensus 544 perRPs~~~Ll~~l~~~~ 561 (962)
|++||++.++++.- |+.
T Consensus 257 p~~Rps~~~il~~~-~~~ 273 (297)
T cd06656 257 VDRRGSAKELLQHP-FLK 273 (297)
T ss_pred hhhCcCHHHHhcCc-hhc
Confidence 99999999888854 443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=275.91 Aligned_cols=245 Identities=19% Similarity=0.249 Sum_probs=186.5
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccch---hHHHHHHHHHHHHhc-CCCCcccEEEEEEe------CCEEEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR---DEMVVCFYRKSLKKL-SHANLVKLKEVIRE------NDTLYF 381 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~---~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~------~~~~~L 381 (962)
.+.....+..++.+.||.+......+.++.++... ....+..|+.+++++ +||||+++++++.. ....|+
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 96 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL 96 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence 33333344444455678777766666555554332 334688899999999 69999999999853 467899
Q ss_pred EEecCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--
Q psy501 382 VFEYMKE-NLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-- 457 (962)
Q Consensus 382 V~Ey~~g-~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-- 457 (962)
||||+++ ++.+.+... ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~ 176 (282)
T cd06636 97 VMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176 (282)
T ss_pred EEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc
Confidence 9999985 666666543 345889999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccCCccccChhhhcc----CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcH
Q psy501 458 PYTDYVSTRWYRAPEVLLH----STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVP 533 (962)
Q Consensus 458 ~~~~~~gt~~Y~APE~l~~----~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 533 (962)
......|+..|+|||.+.. ...++.++|||||||++|||++|..||...........+............++..+.
T Consensus 177 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (282)
T cd06636 177 RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFI 256 (282)
T ss_pred CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHH
Confidence 2334568899999998852 235788999999999999999999999876554444333332222222234677888
Q ss_pred HHHHHHhccCCCCCCcHHHHHhh
Q psy501 534 PIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 534 ~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.++..||..+|++||++.+|+..
T Consensus 257 ~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 257 DFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred HHHHHHhCCChhhCcCHHHHhcC
Confidence 99999999999999999888763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=273.70 Aligned_cols=239 Identities=14% Similarity=0.162 Sum_probs=180.3
Q ss_pred EecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHH-HHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHH
Q psy501 319 YILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKS-LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQ 392 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~i-L~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~ 392 (962)
+..++.+.||++....+++.++.+... .....+..|+.+ ++.++||||+++++++..++..|+||||++|++.+
T Consensus 9 ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~l~~ 88 (283)
T cd06617 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDK 88 (283)
T ss_pred ecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhcccHHH
Confidence 333444457777666555554443321 223456666665 56678999999999999999999999999998877
Q ss_pred HHHh---cCCCCCHHHHHHHHHHHHHHHhhcccc-eeeeccCCCcccccccccceeeecccccccccCCC-cccccCCcc
Q psy501 393 LIRD---RDKFLPESIIRNMMYQVLQGLAFMHRH-GFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP-YTDYVSTRW 467 (962)
Q Consensus 393 ~l~~---~~~~ls~~~i~~i~~qI~~aL~yLH~~-gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~~gt~~ 467 (962)
.+.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||.+....... .....++..
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 168 (283)
T cd06617 89 FYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP 168 (283)
T ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccCCcc
Confidence 7654 335689999999999999999999997 99999999999999999999999999998664432 233568889
Q ss_pred ccChhhhccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCcC-hhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccC
Q psy501 468 YRAPEVLLHS---TAYSAPIHLSRSQQFLFYSIDHVPPIQTTC-LLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 468 Y~APE~l~~~---~~~t~ksDIwSLGvlL~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
|+|||.+.+. ..++.++|+|||||++|+|++|+.||.... .......+............++..+..++..||..+
T Consensus 169 y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 248 (283)
T cd06617 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKN 248 (283)
T ss_pred ccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCC
Confidence 9999988542 347889999999999999999999997532 222222222221111112246677889999999999
Q ss_pred CCCCCcHHHHHhhc
Q psy501 544 TERLKSSYILLHTL 557 (962)
Q Consensus 544 perRPs~~~Ll~~l 557 (962)
|++||+..++++.-
T Consensus 249 p~~Rp~~~~il~~~ 262 (283)
T cd06617 249 YKERPNYPELLQHP 262 (283)
T ss_pred hhhCcCHHHHhcCc
Confidence 99999999888643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=269.61 Aligned_cols=244 Identities=18% Similarity=0.264 Sum_probs=193.9
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccch--hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR--DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK- 387 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~--~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~- 387 (962)
+++.....+..++.+.||.+......+++.+..... ....+.+|++++++++|++|+++++++.+ ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAK 84 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCC
Confidence 445555555556666788887665555555444332 23568899999999999999999999987 77899999997
Q ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---ccccc
Q psy501 388 ENLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---YTDYV 463 (962)
Q Consensus 388 g~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~ 463 (962)
|++.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++..+.++|+|||.+....... .....
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 164 (260)
T cd05073 85 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK 164 (260)
T ss_pred CcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCc
Confidence 5788877653 3457889999999999999999999999999999999999999999999999997654322 12234
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhcc
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 542 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~ 542 (962)
++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+..+. ..+..+..+..+..++..||..
T Consensus 165 ~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~ 242 (260)
T cd05073 165 FPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-RMPRPENCPEELYNIMMRCWKN 242 (260)
T ss_pred ccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-CCCCcccCCHHHHHHHHHHccc
Confidence 4567999999865 468999999999999999998 999998877666666555543 2333456677788999999999
Q ss_pred CCCCCCcHHHHHhhc
Q psy501 543 GTERLKSSYILLHTL 557 (962)
Q Consensus 543 dperRPs~~~Ll~~l 557 (962)
+|++||+...++..|
T Consensus 243 ~p~~Rp~~~~l~~~L 257 (260)
T cd05073 243 RPEERPTFEYIQSVL 257 (260)
T ss_pred CcccCcCHHHHHHHH
Confidence 999999999888765
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=279.88 Aligned_cols=209 Identities=21% Similarity=0.278 Sum_probs=172.8
Q ss_pred HHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC---------------CCCCHHHHHHHH
Q psy501 348 EMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD---------------KFLPESIIRNMM 410 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~---------------~~ls~~~i~~i~ 410 (962)
...+..|+++++++ +||||+++++++..++..++||||++ |+|.+++.... ..+++..+..++
T Consensus 61 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 140 (314)
T cd05099 61 LADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCA 140 (314)
T ss_pred HHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHH
Confidence 34688999999999 69999999999999999999999998 57777775431 358899999999
Q ss_pred HHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHH
Q psy501 411 YQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHL 486 (962)
Q Consensus 411 ~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDI 486 (962)
.|++.||.|||+.|++|+||||+||+++.++.+||+|||.++...... .....++..|+|||++.+ ..++.++||
T Consensus 141 ~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di 219 (314)
T cd05099 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDV 219 (314)
T ss_pred HHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchh
Confidence 999999999999999999999999999999999999999997654321 112234467999999865 468999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 487 SRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 487 wSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
|||||++|+|++ |..||.+.........+.... .......++..+..++..||..+|+.||++.++++.+.
T Consensus 220 wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 291 (314)
T cd05099 220 WSFGILMWEIFTLGGSPYPGIPVEELFKLLREGH-RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291 (314)
T ss_pred hHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 999999999999 899998877666655555442 22223455667889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=268.45 Aligned_cols=233 Identities=21% Similarity=0.281 Sum_probs=184.9
Q ss_pred CcccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhc
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDR 397 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~ 397 (962)
+.+.||.+.......++.+.... .....+..|++++++++||+|+++++++.+....++||||++ +++.+++...
T Consensus 7 ~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~ 86 (251)
T cd05041 7 NFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKK 86 (251)
T ss_pred CCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhc
Confidence 34457777765533333332221 134568899999999999999999999999999999999997 5677777665
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCc----ccccCCccccChhh
Q psy501 398 DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY----TDYVSTRWYRAPEV 473 (962)
Q Consensus 398 ~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~----~~~~gt~~Y~APE~ 473 (962)
...+++..+..++.+++.||.|||+.+++||||+|+||+++.++.++|+|||.+........ .....+..|+|||.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~ 166 (251)
T cd05041 87 KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEA 166 (251)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHh
Confidence 56789999999999999999999999999999999999999999999999999976543211 11233567999999
Q ss_pred hccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHH
Q psy501 474 LLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 552 (962)
Q Consensus 474 l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~ 552 (962)
+.+. .++.++|||||||++|||++ |..||...........+.... ..+.....+..+..++..||..+|++||++.+
T Consensus 167 ~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e 244 (251)
T cd05041 167 LNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSE 244 (251)
T ss_pred hccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CCCCCccCCHHHHHHHHHHhccChhhCcCHHH
Confidence 8654 68999999999999999999 899998877655555554432 22223355678888999999999999999999
Q ss_pred HHhhc
Q psy501 553 LLHTL 557 (962)
Q Consensus 553 Ll~~l 557 (962)
++..|
T Consensus 245 ll~~l 249 (251)
T cd05041 245 IYNEL 249 (251)
T ss_pred HHHHh
Confidence 99866
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=293.73 Aligned_cols=213 Identities=18% Similarity=0.224 Sum_probs=187.1
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceee
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFF 426 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIv 426 (962)
...+.+|++++++++|||||++||+......++||||+|. |+|.+++...++.++..+...++.+.+.||+|||+++++
T Consensus 205 ~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~I 284 (474)
T KOG0194|consen 205 IKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCI 284 (474)
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCc
Confidence 4579999999999999999999999999999999999998 578888888777799999999999999999999999999
Q ss_pred eccCCCcccccccccceeeecccccccccCCCcc--cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCC
Q psy501 427 HRDMKPENLLCMGTELVKIADFGLAREIRSRPYT--DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPI 503 (962)
Q Consensus 427 HrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~--~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf 503 (962)
||||-.+|+|++.++.+||+|||+++........ ...-...|+|||.+..+ .|+.++|||||||++||+++ |..||
T Consensus 285 HRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py 363 (474)
T KOG0194|consen 285 HRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPY 363 (474)
T ss_pred chhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCC
Confidence 9999999999999999999999998765422111 11345779999999765 89999999999999999999 89999
Q ss_pred CCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 504 QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 504 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
.+....+...++.......+.....|..+..++..||..+|+.||+...+.+.+....
T Consensus 364 ~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 364 PGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred CCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 9999999999996666666666677888889999999999999999998888775443
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=273.38 Aligned_cols=208 Identities=19% Similarity=0.242 Sum_probs=175.4
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHhh
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD--------KFLPESIIRNMMYQVLQGLAF 419 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~--------~~ls~~~i~~i~~qI~~aL~y 419 (962)
..+.+|++++++++||+|+++++++.+....|+||||++ |+|.+++.... ..+++..+..++.|++.||.|
T Consensus 53 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~ 132 (275)
T cd05046 53 SEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132 (275)
T ss_pred HHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 468999999999999999999999999899999999998 56766665433 158999999999999999999
Q ss_pred cccceeeeccCCCcccccccccceeeecccccccccCC---CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHH
Q psy501 420 MHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYS 496 (962)
Q Consensus 420 LH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~el 496 (962)
||+.+|+|+||||+||+++.++.++|+|||++...... ......++..|+|||.+.+. .++.++||||||+++|+|
T Consensus 133 LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l 211 (275)
T cd05046 133 LSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEV 211 (275)
T ss_pred hhhcCcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHH
Confidence 99999999999999999999999999999998654332 22334556779999998654 578999999999999999
Q ss_pred Hc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 497 ID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 497 lt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
++ |..||...........+..+....+....++..+..++..||..+|++||++.+++..+
T Consensus 212 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l 273 (275)
T cd05046 212 FTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273 (275)
T ss_pred HhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 98 88999877666666666555544444556777889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=272.78 Aligned_cols=245 Identities=21% Similarity=0.260 Sum_probs=184.3
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc---hhHHHHHHHHHHHHhc-CCCCcccEEEEEE-----eCCEEEEEE
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS---RDEMVVCFYRKSLKKL-SHANLVKLKEVIR-----ENDTLYFVF 383 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~---~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~-----~~~~~~LV~ 383 (962)
+.....+..++.+.||++......+.++.++.. .....+.+|+.+++.+ +||||+++++++. .+...++||
T Consensus 20 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 99 (286)
T cd06638 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVL 99 (286)
T ss_pred eeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEE
Confidence 333344444445567887776655554444322 2235678899999999 6999999999884 346799999
Q ss_pred ecCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--
Q psy501 384 EYMKE-NLYQLIRD---RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-- 457 (962)
Q Consensus 384 Ey~~g-~Ll~~l~~---~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-- 457 (962)
||++| +|.+.+.. ....+++..++.++.|++.||.|||+.+++||||||+||+++.++.++|+|||++......
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 179 (286)
T cd06638 100 ELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179 (286)
T ss_pred eecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCCC
Confidence 99985 55555432 3356899999999999999999999999999999999999999999999999999765432
Q ss_pred CcccccCCccccChhhhcc----CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc-ccCCCCCCCCc
Q psy501 458 PYTDYVSTRWYRAPEVLLH----STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL-LHTLPLYTYHV 532 (962)
Q Consensus 458 ~~~~~~gt~~Y~APE~l~~----~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~s~~l 532 (962)
......|++.|+|||++.. ...++.++|||||||++|||++|+.||...........+...... ......++..+
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (286)
T cd06638 180 RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEF 259 (286)
T ss_pred ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHH
Confidence 2234568899999998853 234788999999999999999999999876554443333222111 11122345568
Q ss_pred HHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 533 PPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 533 ~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..++..||..+|++||++.++++..
T Consensus 260 ~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 260 NDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred HHHHHHHccCCcccCCCHHHHhhcc
Confidence 8899999999999999999988765
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=276.78 Aligned_cols=233 Identities=19% Similarity=0.251 Sum_probs=179.8
Q ss_pred cccEEEEEecCCceEEEEec-----cchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCC-HHHHHHhc
Q psy501 324 TLPLYTCNLDQDNHILSRHV-----SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDR 397 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~-----~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~-Ll~~l~~~ 397 (962)
.+.||.+.....++.++.+. .......+.+|++++++++||||+++++.+..++..++||||++|. +..++...
T Consensus 14 ~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~ 93 (286)
T cd06622 14 YGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGG 93 (286)
T ss_pred CeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhc
Confidence 33456665554444333332 2222356889999999999999999999999999999999999964 54444432
Q ss_pred --CCCCCHHHHHHHHHHHHHHHhhccc-ceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccccChhhh
Q psy501 398 --DKFLPESIIRNMMYQVLQGLAFMHR-HGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVL 474 (962)
Q Consensus 398 --~~~ls~~~i~~i~~qI~~aL~yLH~-~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l 474 (962)
...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+............++..|+|||.+
T Consensus 94 ~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~ 173 (286)
T cd06622 94 VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERI 173 (286)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccccCCCccCccCcchh
Confidence 2368999999999999999999996 5999999999999999999999999999977655544455688899999998
Q ss_pred ccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHH---HhccccccCCCCCCCCcHHHHHHHhccCCCC
Q psy501 475 LHST-----AYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERL---KSSYILLHTLPLYTYHVPPIQTTCLLAGTER 546 (962)
Q Consensus 475 ~~~~-----~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i---~~~~~~~~~~~~~s~~l~~li~~Cl~~dper 546 (962)
.+.. .++.++|||||||++|+|++|+.||...........+ ... ......+.++..+..++..||..+|++
T Consensus 174 ~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~ 252 (286)
T cd06622 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNR 252 (286)
T ss_pred cCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhc-CCCCCCcccCHHHHHHHHHHcccCccc
Confidence 5432 3588999999999999999999999765443332222 222 112223456778889999999999999
Q ss_pred CCcHHHHHhhc
Q psy501 547 LKSSYILLHTL 557 (962)
Q Consensus 547 RPs~~~Ll~~l 557 (962)
||++.+++..-
T Consensus 253 Rp~~~~l~~~~ 263 (286)
T cd06622 253 RPTYAQLLEHP 263 (286)
T ss_pred CCCHHHHhcCh
Confidence 99999888754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=273.42 Aligned_cols=232 Identities=21% Similarity=0.227 Sum_probs=179.3
Q ss_pred cccEEEEEecCCceE--EEEe-cc----chhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHH
Q psy501 324 TLPLYTCNLDQDNHI--LSRH-VS----SRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLI 394 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kv--v~~k-~~----~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l 394 (962)
.+.||.+....++.. ++.+ .. ......+.+|++++.++ +||||+++++++...+..++||||++ |+|.+++
T Consensus 8 ~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i 87 (270)
T cd05047 8 FGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 87 (270)
T ss_pred CceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHH
Confidence 345777766554321 2222 21 22334688999999999 79999999999999999999999998 6777777
Q ss_pred HhcC---------------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-C
Q psy501 395 RDRD---------------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-P 458 (962)
Q Consensus 395 ~~~~---------------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~ 458 (962)
.... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++...... .
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~ 167 (270)
T cd05047 88 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 167 (270)
T ss_pred HhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhhh
Confidence 5432 24789999999999999999999999999999999999999999999999998633221 1
Q ss_pred cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHH
Q psy501 459 YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQT 537 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~ 537 (962)
......+..|+|||++.+ ..++.++|||||||++|||++ |..||.+.........+.... ........+..+..++.
T Consensus 168 ~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~ 245 (270)
T cd05047 168 KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEKPLNCDDEVYDLMR 245 (270)
T ss_pred ccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-CCCCCCcCCHHHHHHHH
Confidence 111233567999999854 468999999999999999997 999998876655555554432 12222345567788999
Q ss_pred HHhccCCCCCCcHHHHHhhc
Q psy501 538 TCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 538 ~Cl~~dperRPs~~~Ll~~l 557 (962)
.||..+|..||++.+++..|
T Consensus 246 ~~l~~~p~~Rps~~~il~~l 265 (270)
T cd05047 246 QCWREKPYERPSFAQILVSL 265 (270)
T ss_pred HHcccChhhCCCHHHHHHHH
Confidence 99999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=281.95 Aligned_cols=207 Identities=24% Similarity=0.339 Sum_probs=170.9
Q ss_pred HHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeecc
Q psy501 350 VVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRD 429 (962)
Q Consensus 350 ~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrD 429 (962)
.+.+|++++++++||||+++++++..++..++||||+.|++.+.+... ..+++..+..++.|++.||.|||+.|++|+|
T Consensus 66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~d 144 (335)
T PTZ00024 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRD 144 (335)
T ss_pred hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccccCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 477899999999999999999999999999999999999988887654 4589999999999999999999999999999
Q ss_pred CCCcccccccccceeeecccccccccC----------------CCcccccCCccccChhhhccCCCCCchhHHHHHHHHH
Q psy501 430 MKPENLLCMGTELVKIADFGLAREIRS----------------RPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFL 493 (962)
Q Consensus 430 Lkp~NILl~~~g~vKL~DFGla~~~~~----------------~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL 493 (962)
|+|+||+++.++.++|+|||.+..... .......++..|+|||.+.+...++.++|||||||++
T Consensus 145 l~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l 224 (335)
T PTZ00024 145 LSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIF 224 (335)
T ss_pred ccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHH
Confidence 999999999999999999999976541 1122235678899999997766689999999999999
Q ss_pred HHHHcCCCCCCCcChhhhHHHHHhcccccc--------------------------CCCCCCCCcHHHHHHHhccCCCCC
Q psy501 494 FYSIDHVPPIQTTCLLAGTERLKSSYILLH--------------------------TLPLYTYHVPPIQTTCLLAGTERL 547 (962)
Q Consensus 494 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~s~~l~~li~~Cl~~dperR 547 (962)
|+|++|.+||.+.........+......+. ..+..+..+..++..||..+|++|
T Consensus 225 ~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 304 (335)
T PTZ00024 225 AELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLER 304 (335)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhc
Confidence 999999999988776554444332111000 012335567789999999999999
Q ss_pred CcHHHHHhhc
Q psy501 548 KSSYILLHTL 557 (962)
Q Consensus 548 Ps~~~Ll~~l 557 (962)
|++.+++...
T Consensus 305 ~s~~~~l~~~ 314 (335)
T PTZ00024 305 ISAKEALKHE 314 (335)
T ss_pred cCHHHHhcCc
Confidence 9988888744
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=268.97 Aligned_cols=204 Identities=17% Similarity=0.165 Sum_probs=164.7
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceee
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFF 426 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIv 426 (962)
...+.+|+.++++++||+|+++++++.. ...++||||+++ +|.+++......+++..+..++.||+.||.|||+.||+
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~ 123 (259)
T cd05037 45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLV 123 (259)
T ss_pred HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 4578899999999999999999999987 778999999985 56666655554799999999999999999999999999
Q ss_pred eccCCCccccccccc-------ceeeecccccccccCCCcccccCCccccChhhhccC-CCCCchhHHHHHHHHHHHHHc
Q psy501 427 HRDMKPENLLCMGTE-------LVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHS-TAYSAPIHLSRSQQFLFYSID 498 (962)
Q Consensus 427 HrDLkp~NILl~~~g-------~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~t~ksDIwSLGvlL~ellt 498 (962)
|+||||+||+++.++ .++|+|||++..... .....++..|+|||++.+. ..++.++|||||||++|+|++
T Consensus 124 H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~ 201 (259)
T cd05037 124 HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICS 201 (259)
T ss_pred cccCccceEEEecCccccCCceeEEeCCCCccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHh
Confidence 999999999999887 799999999976544 2234567789999998654 368999999999999999999
Q ss_pred -CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 499 -HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 499 -G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
|..||............... ...+ ......+..++..||..+|++||++.++++.|
T Consensus 202 ~~~~p~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 202 NGEEPLSTLSSSEKERFYQDQ-HRLP--MPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCCCCcccCCchhHHHHHhcC-CCCC--CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 68888776533222222211 1111 11225777899999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=284.60 Aligned_cols=210 Identities=23% Similarity=0.274 Sum_probs=166.9
Q ss_pred HHHHHHHHHHHHhc-CCCCcccEEEEEEe-CCEEEEEEecCCC-CHHHHHHhcC--------------------------
Q psy501 348 EMVVCFYRKSLKKL-SHANLVKLKEVIRE-NDTLYFVFEYMKE-NLYQLIRDRD-------------------------- 398 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~-~~~~~LV~Ey~~g-~Ll~~l~~~~-------------------------- 398 (962)
...+.+|+.+++++ +||||+++++++.. +..++++|||++| +|.+.+....
T Consensus 54 ~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (337)
T cd05054 54 YKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL 133 (337)
T ss_pred HHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhcccccccccccccccccccccccccccc
Confidence 34578899999999 79999999998864 4578899999985 6666654321
Q ss_pred ----------------------------------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccccee
Q psy501 399 ----------------------------------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVK 444 (962)
Q Consensus 399 ----------------------------------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vK 444 (962)
..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vk 213 (337)
T cd05054 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVK 213 (337)
T ss_pred ccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEE
Confidence 2588999999999999999999999999999999999999999999
Q ss_pred eecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhcc
Q psy501 445 IADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSY 519 (962)
Q Consensus 445 L~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~ 519 (962)
|+|||++..+.... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+..............
T Consensus 214 L~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~ 292 (337)
T cd05054 214 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG 292 (337)
T ss_pred EeccccchhcccCcchhhccCCCCCccccCcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc
Confidence 99999998764321 222345678999999966 479999999999999999998 999998754433322222222
Q ss_pred ccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 520 ILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 520 ~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
.........+..+..++..||..+|+.||++.++++.+.
T Consensus 293 ~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~ 331 (337)
T cd05054 293 TRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILG 331 (337)
T ss_pred CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 222223345667888999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=271.69 Aligned_cols=208 Identities=16% Similarity=0.159 Sum_probs=163.0
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHhhcccc
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD----KFLPESIIRNMMYQVLQGLAFMHRH 423 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~----~~ls~~~i~~i~~qI~~aL~yLH~~ 423 (962)
..+.+|+.++++++||||+++++++.+....++||||++ |+|.+++.... ..+++..+..++.|++.||.|||+.
T Consensus 40 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~ 119 (269)
T cd05087 40 MKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119 (269)
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 468889999999999999999999999889999999998 56767765422 2467778889999999999999999
Q ss_pred eeeeccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhhccC------CCCCchhHHHHHHHHH
Q psy501 424 GFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHS------TAYSAPIHLSRSQQFL 493 (962)
Q Consensus 424 gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~------~~~t~ksDIwSLGvlL 493 (962)
+++|+||||+||+++.++.++|+|||.+....... .....++..|+|||++.+. ..++.++|||||||++
T Consensus 120 ~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l 199 (269)
T cd05087 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTI 199 (269)
T ss_pred CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHH
Confidence 99999999999999999999999999987543321 1234567889999998532 1357899999999999
Q ss_pred HHHHc-CCCCCCCcChhhhHHHHHhc-cccccCC---CCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 494 FYSID-HVPPIQTTCLLAGTERLKSS-YILLHTL---PLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 494 ~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~---~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
|||++ |+.||............... ....+.. ...+..+..++..|| .+|++||++.+|...|
T Consensus 200 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 200 WELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred HHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 99996 99999876554433322222 1111111 134455677999999 5799999999998755
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=301.12 Aligned_cols=207 Identities=19% Similarity=0.194 Sum_probs=160.6
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHhhcccc
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD----KFLPESIIRNMMYQVLQGLAFMHRH 423 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~----~~ls~~~i~~i~~qI~~aL~yLH~~ 423 (962)
...+.+|+.+|++++||||+++++++...+..|+|+|++.++++.++.... .......++.++.||+.||.|||++
T Consensus 207 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~ 286 (501)
T PHA03210 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK 286 (501)
T ss_pred HHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 346889999999999999999999999999999999999999988876432 2234677888999999999999999
Q ss_pred eeeeccCCCcccccccccceeeecccccccccCC---CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCC
Q psy501 424 GFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHV 500 (962)
Q Consensus 424 gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~ 500 (962)
||+||||||+|||++.++.+||+|||++..+... ......||..|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 287 gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~ 365 (501)
T PHA03210 287 KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHD 365 (501)
T ss_pred CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCC
Confidence 9999999999999999999999999999876543 2234579999999999976 46999999999999999999987
Q ss_pred CC-CCCcC--hhhhHHHHHhc-cccccCC-----------------------------CCCCCCcHHHHHHHhccCCCCC
Q psy501 501 PP-IQTTC--LLAGTERLKSS-YILLHTL-----------------------------PLYTYHVPPIQTTCLLAGTERL 547 (962)
Q Consensus 501 ~P-f~~~~--~~~~~~~i~~~-~~~~~~~-----------------------------~~~s~~l~~li~~Cl~~dperR 547 (962)
.+ |.... ......++... ....... ...+..+..++..||..||.+|
T Consensus 366 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~R 445 (501)
T PHA03210 366 FCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLR 445 (501)
T ss_pred CCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccC
Confidence 54 43322 11111111110 0000000 0123345556889999999999
Q ss_pred CcHHHHHh
Q psy501 548 KSSYILLH 555 (962)
Q Consensus 548 Ps~~~Ll~ 555 (962)
|++.+++.
T Consensus 446 psa~elL~ 453 (501)
T PHA03210 446 PGAAELLA 453 (501)
T ss_pred cCHHHHhh
Confidence 99988876
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=276.23 Aligned_cols=237 Identities=25% Similarity=0.372 Sum_probs=179.5
Q ss_pred ecCCcccEEEEEecC--CceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CEEEEEEecCCC
Q psy501 320 ILPHTLPLYTCNLDQ--DNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIREN--DTLYFVFEYMKE 388 (962)
Q Consensus 320 i~~~~~~Vy~~~~~~--~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~LV~Ey~~g 388 (962)
..++.+.||.+.... .+..++.+.... ....+.+|+.++++++||||+++++++.+. ..+++||||+++
T Consensus 9 g~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 88 (316)
T cd07842 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH 88 (316)
T ss_pred ccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc
Confidence 334444577776655 344444333222 124678899999999999999999999988 889999999999
Q ss_pred CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc----ccceeeecccccccccCCC--
Q psy501 389 NLYQLIRDR----DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG----TELVKIADFGLAREIRSRP-- 458 (962)
Q Consensus 389 ~Ll~~l~~~----~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~----~g~vKL~DFGla~~~~~~~-- 458 (962)
++.+.+... ...+++..++.++.|++.||.|||+.+|+||||||+||+++. ++.+||+|||++.......
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 168 (316)
T cd07842 89 DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168 (316)
T ss_pred CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCccc
Confidence 888776533 236899999999999999999999999999999999999999 8999999999998654331
Q ss_pred ---cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhh---------hHHHHHhc--------
Q psy501 459 ---YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLA---------GTERLKSS-------- 518 (962)
Q Consensus 459 ---~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~---------~~~~i~~~-------- 518 (962)
.....++..|+|||++.+...++.++|||||||++|+|++|++||.+..... ....+...
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 248 (316)
T cd07842 169 LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKD 248 (316)
T ss_pred ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhH
Confidence 2234678889999998776678999999999999999999999998654332 00000000
Q ss_pred ---------------cccccCCC------------CCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 519 ---------------YILLHTLP------------LYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 519 ---------------~~~~~~~~------------~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.......+ ..+..+..++..||..+|++||++.+++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 249 WPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000111 334456779999999999999999888753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=288.74 Aligned_cols=213 Identities=18% Similarity=0.248 Sum_probs=186.8
Q ss_pred chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccc
Q psy501 345 SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRH 423 (962)
Q Consensus 345 ~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~ 423 (962)
..+.+.+..|..+|+.++||||++++|+|.+ ...|||||+++ |.|.+++......++...+..++.||+.||.|||+.
T Consensus 432 ~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk 510 (974)
T KOG4257|consen 432 PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK 510 (974)
T ss_pred hhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh
Confidence 3456789999999999999999999999975 57899999998 889999998888899999999999999999999999
Q ss_pred eeeeccCCCcccccccccceeeecccccccccCCC---cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-C
Q psy501 424 GFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-H 499 (962)
Q Consensus 424 gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G 499 (962)
++|||||..+|||+.....+||+|||+++.+.... .+...-..-|||||.+.- ..++.+||||.|||++||+++ |
T Consensus 511 rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lG 589 (974)
T KOG4257|consen 511 RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLG 589 (974)
T ss_pred chhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhc
Confidence 99999999999999999999999999999887652 222233456999999953 579999999999999999997 9
Q ss_pred CCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 500 VPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 500 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
..||.+....+....+..|. +.|.++.+|..+..++..||..+|.+||.+.+|...+...
T Consensus 590 vkPfqgvkNsDVI~~iEnGe-RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 590 VKPFQGVKNSDVIGHIENGE-RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred CCccccccccceEEEecCCC-CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 99999988777777777774 4566789999999999999999999999988888776443
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=273.56 Aligned_cols=208 Identities=21% Similarity=0.252 Sum_probs=173.2
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC---------------------CCCCHHH
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD---------------------KFLPESI 405 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~---------------------~~ls~~~ 405 (962)
...+.+|+.+++++.||+|+++++++.++...++||||++ |+|.+++.... ..+++..
T Consensus 52 ~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 131 (288)
T cd05050 52 QADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131 (288)
T ss_pred HHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHH
Confidence 3468889999999999999999999999999999999998 57777775321 2478889
Q ss_pred HHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhhccCCCCC
Q psy501 406 IRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYS 481 (962)
Q Consensus 406 i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t 481 (962)
++.++.|++.||.|||+.+++||||+|+||+++.++.++|+|||.+....... ......+..|+|||.+.+. .++
T Consensus 132 ~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~ 210 (288)
T cd05050 132 QLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYT 210 (288)
T ss_pred HHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCC
Confidence 99999999999999999999999999999999999999999999987653321 2223446679999998654 689
Q ss_pred chhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 482 APIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 482 ~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.++|||||||++|||++ |..||.+.........+..+... +..+..+..+..++..||..+|+.||++.++++.|
T Consensus 211 ~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l 286 (288)
T cd05050 211 TESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286 (288)
T ss_pred chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 99999999999999997 88999887776666666555432 22345667788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=276.61 Aligned_cols=237 Identities=23% Similarity=0.286 Sum_probs=189.1
Q ss_pred CCcccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHH
Q psy501 322 PHTLPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLI 394 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l 394 (962)
++.+.||.+.....++.++.+... .....+.+|+++++.++||+++++++++.++...|+||||+.|++.+.+
T Consensus 32 g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l 111 (313)
T cd06633 32 GSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLL 111 (313)
T ss_pred CCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCCCHHHHH
Confidence 334457777665555544433321 1223578899999999999999999999999999999999999999988
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccccChhhh
Q psy501 395 RDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVL 474 (962)
Q Consensus 395 ~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l 474 (962)
......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.... ......|+..|+|||++
T Consensus 112 ~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~--~~~~~~~~~~y~aPE~~ 189 (313)
T cd06633 112 EVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--PANSFVGTPYWMAPEVI 189 (313)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC--CCCCccccccccChhhc
Confidence 7777779999999999999999999999999999999999999999999999999986432 23345788999999998
Q ss_pred cc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHH
Q psy501 475 LH--STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 552 (962)
Q Consensus 475 ~~--~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~ 552 (962)
.. ...++.++|||||||++|+|++|.+||...........+..........+.++..+..++..||..+|++||++.+
T Consensus 190 ~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~ 269 (313)
T cd06633 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAE 269 (313)
T ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 42 3458889999999999999999999998876655555554433322223345566888999999999999999888
Q ss_pred HHhhccccc
Q psy501 553 LLHTLPLYT 561 (962)
Q Consensus 553 Ll~~l~~~~ 561 (962)
++..- |+.
T Consensus 270 ~l~~~-~~~ 277 (313)
T cd06633 270 LLRHD-FVR 277 (313)
T ss_pred HhcCc-ccC
Confidence 88643 443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=271.36 Aligned_cols=239 Identities=18% Similarity=0.214 Sum_probs=186.5
Q ss_pred EEecCCcccEEEEEecC-----CceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEe-CCEEEEEEecCC
Q psy501 318 SYILPHTLPLYTCNLDQ-----DNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRE-NDTLYFVFEYMK 387 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~-----~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-~~~~~LV~Ey~~ 387 (962)
.+..++.+.||.+.... ...++.+.+.. .....+.+|+.++++++||||+++++++.. +...++++||++
T Consensus 13 ~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~ 92 (280)
T cd05043 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMN 92 (280)
T ss_pred eecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCC
Confidence 33344445588877655 33333333322 224568899999999999999999998765 567899999998
Q ss_pred -CCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC-
Q psy501 388 -ENLYQLIRDRD-------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP- 458 (962)
Q Consensus 388 -g~Ll~~l~~~~-------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~- 458 (962)
|++.+++.... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||+++.+....
T Consensus 93 ~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~ 172 (280)
T cd05043 93 WGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY 172 (280)
T ss_pred CCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCce
Confidence 67777765432 458999999999999999999999999999999999999999999999999997654321
Q ss_pred ---cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHH
Q psy501 459 ---YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPP 534 (962)
Q Consensus 459 ---~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 534 (962)
.....++..|+|||++.+ ..++.++|||||||++|||++ |+.||...........+..+. .......++..+..
T Consensus 173 ~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 250 (280)
T cd05043 173 HCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-RLAQPINCPDELFA 250 (280)
T ss_pred EEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-CCCCCCcCCHHHHH
Confidence 122345678999999965 468999999999999999999 999998877666555555442 22333456777889
Q ss_pred HHHHHhccCCCCCCcHHHHHhhcc
Q psy501 535 IQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 535 li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
++..||..+|+.||++.++++.|.
T Consensus 251 li~~~l~~~p~~Rps~~~~~~~l~ 274 (280)
T cd05043 251 VMACCWALDPEERPSFSQLVQCLT 274 (280)
T ss_pred HHHHHcCCChhhCCCHHHHHHHHH
Confidence 999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=273.95 Aligned_cols=235 Identities=27% Similarity=0.402 Sum_probs=182.8
Q ss_pred CCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHH
Q psy501 322 PHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIR 395 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~ 395 (962)
++.+.||++.....++.++.+... .....+.+|++++++++||+++++++++.++...++||||+++++.+.+.
T Consensus 10 g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~~~l~~~~~ 89 (283)
T cd07835 10 GTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMD 89 (283)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccCcCHHHHHh
Confidence 334457777655444444433322 11245788999999999999999999999999999999999988888876
Q ss_pred hcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChh
Q psy501 396 DRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPE 472 (962)
Q Consensus 396 ~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE 472 (962)
... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||
T Consensus 90 ~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE 169 (283)
T cd07835 90 SSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 169 (283)
T ss_pred hCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCc
Confidence 644 46899999999999999999999999999999999999999999999999999765432 223345688899999
Q ss_pred hhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc---------------------------ccCC
Q psy501 473 VLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL---------------------------LHTL 525 (962)
Q Consensus 473 ~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------------~~~~ 525 (962)
++.+...++.++|||||||++|+|++|++||..........++...... ....
T Consensus 170 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (283)
T cd07835 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVV 249 (283)
T ss_pred eeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhc
Confidence 8876656789999999999999999999999876654433332211000 0012
Q ss_pred CCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 526 PLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 526 ~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
+.++..+..++..||..+|++||+..+++..
T Consensus 250 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 250 PNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 3445567789999999999999999888764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=263.27 Aligned_cols=238 Identities=21% Similarity=0.291 Sum_probs=188.0
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccch----hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHH
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSSR----DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQ 392 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~ 392 (962)
.+..++.+.+|.+.....++.++.+.... ....+.+|++++++++||+|+++++++..+...++++||++ ++|.+
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 86 (253)
T cd05122 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKD 86 (253)
T ss_pred eeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHH
Confidence 33344455688887765554433333221 34578999999999999999999999999999999999999 56666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC-cccccCCccccCh
Q psy501 393 LIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP-YTDYVSTRWYRAP 471 (962)
Q Consensus 393 ~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~-~~~~~gt~~Y~AP 471 (962)
.+......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .....++..|+||
T Consensus 87 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~P 166 (253)
T cd05122 87 LLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAP 166 (253)
T ss_pred HHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceecCCcccCH
Confidence 666554679999999999999999999999999999999999999999999999999998765543 3456788999999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc-cccCCCCCCCCcHHHHHHHhccCCCCCCcH
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI-LLHTLPLYTYHVPPIQTTCLLAGTERLKSS 550 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~l~~li~~Cl~~dperRPs~ 550 (962)
|.+.+. .++.++||||||+++|+|++|+.||................. ..+....++..+..++..||..+|++||++
T Consensus 167 E~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~ 245 (253)
T cd05122 167 EVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTA 245 (253)
T ss_pred HHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCH
Confidence 999654 588999999999999999999999987754444433332211 111112236678899999999999999999
Q ss_pred HHHHhh
Q psy501 551 YILLHT 556 (962)
Q Consensus 551 ~~Ll~~ 556 (962)
.+++..
T Consensus 246 ~~~l~~ 251 (253)
T cd05122 246 EQLLKH 251 (253)
T ss_pred HHHhcC
Confidence 887763
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=269.94 Aligned_cols=239 Identities=18% Similarity=0.182 Sum_probs=185.9
Q ss_pred EEecCCcccEEEEEecCC---ce-EEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-C
Q psy501 318 SYILPHTLPLYTCNLDQD---NH-ILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-E 388 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~---~k-vv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g 388 (962)
.+..++.+.||.+..... .. ++.+... ....+.+.+|+.++++++||||+++++++.+ ...++||||++ |
T Consensus 13 ~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 91 (270)
T cd05056 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLG 91 (270)
T ss_pred eeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCC
Confidence 333444455777765432 22 2222222 1234468899999999999999999999875 45789999998 5
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---cccccCC
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---YTDYVST 465 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~gt 465 (962)
+|.+++......+++..++.++.|++.||.|||+.|++|+||+|+||+++..+.++|+|||++....... .....++
T Consensus 92 ~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 171 (270)
T cd05056 92 ELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP 171 (270)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCcc
Confidence 7777776655568999999999999999999999999999999999999999999999999997654431 1122345
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCC
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGT 544 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dp 544 (962)
..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.........+..+.. .+..+.++..+..++..||..+|
T Consensus 172 ~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P 249 (270)
T cd05056 172 IKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER-LPMPPNCPPTLYSLMTKCWAYDP 249 (270)
T ss_pred ccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCCh
Confidence 67999998854 468999999999999999996 9999988776665555554432 23345677889999999999999
Q ss_pred CCCCcHHHHHhhccc
Q psy501 545 ERLKSSYILLHTLPL 559 (962)
Q Consensus 545 erRPs~~~Ll~~l~~ 559 (962)
++||++.+++..+..
T Consensus 250 ~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 250 SKRPRFTELKAQLSD 264 (270)
T ss_pred hhCcCHHHHHHHHHH
Confidence 999999998887643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=269.75 Aligned_cols=229 Identities=20% Similarity=0.300 Sum_probs=182.7
Q ss_pred ccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHh
Q psy501 325 LPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRD 396 (962)
Q Consensus 325 ~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~ 396 (962)
+.||.+......+.++.+... .....+.+|+.+++.++||+|+++++.+.++...++||||++| +|.+.+..
T Consensus 7 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 86 (262)
T cd05572 7 GRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD 86 (262)
T ss_pred eEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhh
Confidence 356777665544443333321 2235689999999999999999999999999999999999984 66666654
Q ss_pred cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCccccChhhhc
Q psy501 397 RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPEVLL 475 (962)
Q Consensus 397 ~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~APE~l~ 475 (962)
. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.
T Consensus 87 ~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~ 165 (262)
T cd05572 87 R-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIIL 165 (262)
T ss_pred c-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccChhHhc
Confidence 3 45899999999999999999999999999999999999999999999999999876544 233356788999999986
Q ss_pred cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcC--hhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCc----
Q psy501 476 HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTC--LLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS---- 549 (962)
Q Consensus 476 ~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs---- 549 (962)
+ ..++.++|+||||+++|+|++|..||.... .......+..+..........+..+..++..||..+|++||+
T Consensus 166 ~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~ 244 (262)
T cd05572 166 N-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKG 244 (262)
T ss_pred C-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCccc
Confidence 5 468999999999999999999999998776 444444444322333333445678899999999999999999
Q ss_pred -HHHHHh
Q psy501 550 -SYILLH 555 (962)
Q Consensus 550 -~~~Ll~ 555 (962)
++++++
T Consensus 245 ~~~~l~~ 251 (262)
T cd05572 245 GIKDIKK 251 (262)
T ss_pred CHHHHhc
Confidence 777766
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=270.33 Aligned_cols=209 Identities=18% Similarity=0.178 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCE------EEEEEecCC-CCHHHHHHhc-----CCCCCHHHHHHHHHHHHH
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDT------LYFVFEYMK-ENLYQLIRDR-----DKFLPESIIRNMMYQVLQ 415 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~------~~LV~Ey~~-g~Ll~~l~~~-----~~~ls~~~i~~i~~qI~~ 415 (962)
...+.+|+++++.++||+|+++++++..... .++||||++ |++...+... ...+++..++.++.|++.
T Consensus 45 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~ 124 (273)
T cd05035 45 IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124 (273)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHH
Confidence 3468999999999999999999998865443 799999998 5666665332 235899999999999999
Q ss_pred HHhhcccceeeeccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHH
Q psy501 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQ 491 (962)
Q Consensus 416 aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGv 491 (962)
||.|||+.+++||||||+||++++++.+||+|||+++...... .....++..|+|||.+.+ ..++.++|||||||
T Consensus 125 aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~ 203 (273)
T cd05035 125 GMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGV 203 (273)
T ss_pred HHHHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHH
Confidence 9999999999999999999999999999999999998664332 112234678999999854 47899999999999
Q ss_pred HHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 492 FLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 492 lL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
++|||++ |.+||.+.........+..+. .......++..+..++..||..+|++||++.++++.|.
T Consensus 204 il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~ 270 (273)
T cd05035 204 TMWEIATRGQTPYPGVENHEIYDYLRHGN-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270 (273)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9999999 999998877666655555442 23334466778889999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=268.55 Aligned_cols=240 Identities=21% Similarity=0.243 Sum_probs=186.0
Q ss_pred EEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-C
Q psy501 316 KFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-N 389 (962)
Q Consensus 316 ~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~ 389 (962)
...+..++.+.||.+........++.+... .....+.+|+++++.++||+|+++++.+..+...++|||+++| +
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS 85 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCc
Confidence 334444445567777655544444333321 2345689999999999999999999999999999999999985 5
Q ss_pred HHHHHHhc--CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC------ccc
Q psy501 390 LYQLIRDR--DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP------YTD 461 (962)
Q Consensus 390 Ll~~l~~~--~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~------~~~ 461 (962)
+.+.+... ...+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||++....... ...
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 165 (267)
T cd06610 86 LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT 165 (267)
T ss_pred HHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccccccc
Confidence 66665443 2468999999999999999999999999999999999999999999999999987665431 123
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc-ccCC---CCCCCCcHHHHH
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL-LHTL---PLYTYHVPPIQT 537 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~---~~~s~~l~~li~ 537 (962)
..++..|+|||++.....++.++|+|||||++|+|++|+.||.................. .... ..++..+..++.
T Consensus 166 ~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 245 (267)
T cd06610 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMIS 245 (267)
T ss_pred ccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHH
Confidence 468889999999976557899999999999999999999999877655444444333111 1111 134556788999
Q ss_pred HHhccCCCCCCcHHHHHh
Q psy501 538 TCLLAGTERLKSSYILLH 555 (962)
Q Consensus 538 ~Cl~~dperRPs~~~Ll~ 555 (962)
.||..+|++||++.+|+.
T Consensus 246 ~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 246 LCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHcCCChhhCcCHHHHhh
Confidence 999999999999888876
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=276.71 Aligned_cols=230 Identities=18% Similarity=0.276 Sum_probs=180.1
Q ss_pred cEEEEEecCCceEEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCC
Q psy501 326 PLYTCNLDQDNHILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFL 401 (962)
Q Consensus 326 ~Vy~~~~~~~~kvv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~~~l 401 (962)
.||.+.....++.++.+.. ......+.+|+.+++.++||||+++++++..++..++||||++++.+..+... ..+
T Consensus 36 ~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~ 114 (297)
T cd06659 36 IVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-TRL 114 (297)
T ss_pred eEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh-cCC
Confidence 4566655443333322221 12344688999999999999999999999999999999999986544444433 458
Q ss_pred CHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhhhccCCC
Q psy501 402 PESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEVLLHSTA 479 (962)
Q Consensus 402 s~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~l~~~~~ 479 (962)
++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ......++..|+|||++.+. .
T Consensus 115 ~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~ 193 (297)
T cd06659 115 NEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRT-P 193 (297)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccC-C
Confidence 99999999999999999999999999999999999999999999999998755433 23345688999999999654 6
Q ss_pred CCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 480 YSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL-HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 480 ~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
++.++|||||||++|||++|+.||...........+....... ......+..+..++..||..+|++||++.+++..-
T Consensus 194 ~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 194 YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 8999999999999999999999998776655555444332111 11234566778899999999999999999888743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=279.64 Aligned_cols=245 Identities=25% Similarity=0.331 Sum_probs=185.7
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeC-----CEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIREN-----DTLY 380 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~-----~~~~ 380 (962)
+.+.....+..++.+.||.+....+++.++.+... .....+.+|+.++++++||||+++++++... ...+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 34444445555555668888766655554444322 1234578899999999999999999987644 3589
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---
Q psy501 381 FVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--- 457 (962)
Q Consensus 381 LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--- 457 (962)
+|+||+++++...+.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 85 lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 85 IVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162 (336)
T ss_pred EEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence 9999999988877754 35899999999999999999999999999999999999999999999999998765432
Q ss_pred --CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcc----------------
Q psy501 458 --PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSY---------------- 519 (962)
Q Consensus 458 --~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~---------------- 519 (962)
......|+..|+|||.+.+...++.++|||||||++|+|++|++||.+.........+....
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (336)
T cd07849 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRA 242 (336)
T ss_pred cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhh
Confidence 11234678899999998665678999999999999999999999997754332221111000
Q ss_pred ---c----cc------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 520 ---I----LL------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 520 ---~----~~------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
. .. ...+..+..+..++..||..+|++||++.+++..-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp 293 (336)
T cd07849 243 RNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293 (336)
T ss_pred hhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 0 00 01134466678899999999999999988877753
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=281.01 Aligned_cols=246 Identities=20% Similarity=0.211 Sum_probs=188.2
Q ss_pred ceeeEEEEecCCcccEEEEEecCC-------ceEEEEeccc-----hhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQD-------NHILSRHVSS-----RDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDT 378 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~-------~kvv~~k~~~-----~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 378 (962)
.+.++..++.++.+.||.+..... ...++.+... .....+.+|+.+++++ +||||+++++++..++.
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 92 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence 344444444455555777754221 1122332221 2234688999999999 79999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccc
Q psy501 379 LYFVFEYMK-ENLYQLIRDR---------------DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL 442 (962)
Q Consensus 379 ~~LV~Ey~~-g~Ll~~l~~~---------------~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~ 442 (962)
.++||||++ |+|.+++... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.
T Consensus 93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~ 172 (334)
T cd05100 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV 172 (334)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc
Confidence 999999998 5777776542 134788899999999999999999999999999999999999999
Q ss_pred eeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHh
Q psy501 443 VKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKS 517 (962)
Q Consensus 443 vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~ 517 (962)
+||+|||+++...... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.........+..
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 251 (334)
T cd05100 173 MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251 (334)
T ss_pred EEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 9999999997654321 122234567999999965 468999999999999999998 8999988776666655544
Q ss_pred ccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 518 SYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 518 ~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
.. .......++..+..++..||..+|+.||++.++++.+..
T Consensus 252 ~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~ 292 (334)
T cd05100 252 GH-RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDR 292 (334)
T ss_pred CC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 32 222234556678889999999999999999999997743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=277.02 Aligned_cols=236 Identities=17% Similarity=0.285 Sum_probs=182.0
Q ss_pred cEEEEEecCCceEEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCC
Q psy501 326 PLYTCNLDQDNHILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFL 401 (962)
Q Consensus 326 ~Vy~~~~~~~~kvv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~~~l 401 (962)
.||.+......+.++.+.. ......+.+|+.++++++||||+++++.+..++..++||||++|+.+..+... ..+
T Consensus 37 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l 115 (292)
T cd06658 37 IVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRM 115 (292)
T ss_pred EEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc-CCC
Confidence 3555554444433333221 12344688999999999999999999999999999999999987555444433 358
Q ss_pred CHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhhhccCCC
Q psy501 402 PESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEVLLHSTA 479 (962)
Q Consensus 402 s~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~l~~~~~ 479 (962)
++..++.++.||+.||.|||+.+++||||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+ ..
T Consensus 116 ~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~ 194 (292)
T cd06658 116 NEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISR-LP 194 (292)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHcc-CC
Confidence 99999999999999999999999999999999999999999999999998755332 2234568899999999865 46
Q ss_pred CCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc-cccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 480 YSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI-LLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 480 ~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
++.++|||||||++|||++|+.||...........+..... ........+..+..++..||..+|.+||+++++++. +
T Consensus 195 ~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~-~ 273 (292)
T cd06658 195 YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH-P 273 (292)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC-h
Confidence 89999999999999999999999988766555444433211 111222455668889999999999999999888874 3
Q ss_pred ccccCC
Q psy501 559 LYTYHV 564 (962)
Q Consensus 559 ~~~~~~ 564 (962)
|+....
T Consensus 274 ~~~~~~ 279 (292)
T cd06658 274 FLKLAG 279 (292)
T ss_pred hhhccC
Confidence 544433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=271.80 Aligned_cols=204 Identities=16% Similarity=0.172 Sum_probs=164.2
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeee
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFH 427 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~-Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvH 427 (962)
..+.+|+.++++++||||+++++++.++...++||||++++ |...+....+.+++..+..++.|++.||.|||+.+|+|
T Consensus 61 ~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH 140 (274)
T cd05076 61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVH 140 (274)
T ss_pred HHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccC
Confidence 35778899999999999999999999999999999999965 54455444567899999999999999999999999999
Q ss_pred ccCCCccccccccc-------ceeeecccccccccCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHH-cC
Q psy501 428 RDMKPENLLCMGTE-------LVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSI-DH 499 (962)
Q Consensus 428 rDLkp~NILl~~~g-------~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ell-tG 499 (962)
|||||+||+++..+ .++++|||.+...... ....++..|+|||.+.+...++.++|||||||++|||+ +|
T Consensus 141 ~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g 218 (274)
T cd05076 141 GNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDG 218 (274)
T ss_pred CCCCcccEEEeccCcccCccceeeecCCccccccccc--cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999997644 4899999998644322 23457788999999876567899999999999999995 79
Q ss_pred CCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 500 VPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 500 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+.||............... ... ....+..+..++..||..+|++||++.++++.|
T Consensus 219 ~~p~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 219 EVPLKERTPSEKERFYEKK-HRL--PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred CCCccccChHHHHHHHHhc-cCC--CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 9999876554433222221 111 122344678899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=266.07 Aligned_cols=233 Identities=19% Similarity=0.281 Sum_probs=186.2
Q ss_pred CCcccEEEEEecCCceEEEEec------cchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHH
Q psy501 322 PHTLPLYTCNLDQDNHILSRHV------SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLI 394 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~k~------~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l 394 (962)
++.+.+|.+.....++.++.+. .......+.+|+.++++++||+|+++++++.+.+..++||||+. +++.+.+
T Consensus 11 g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 90 (256)
T cd08218 11 GSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKI 90 (256)
T ss_pred CCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHH
Confidence 3344566666555544433332 12234468999999999999999999999999999999999997 5777777
Q ss_pred HhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccCh
Q psy501 395 RDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAP 471 (962)
Q Consensus 395 ~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~AP 471 (962)
.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... ......|++.|+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p 170 (256)
T cd08218 91 NAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSP 170 (256)
T ss_pred HhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCH
Confidence 6543 35899999999999999999999999999999999999999999999999999766443 22234678899999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHH
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 551 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~ 551 (962)
|++.+. .++.++|+|||||++|+|++|+.||...........+..+... +....++..+..++..||..+|++||++.
T Consensus 171 e~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 248 (256)
T cd08218 171 EICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP-PVSSHYSYDLRNLVSQLFKRNPRDRPSVN 248 (256)
T ss_pred HHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC-CCcccCCHHHHHHHHHHhhCChhhCcCHH
Confidence 998654 6889999999999999999999999887766666555544322 22335566788999999999999999988
Q ss_pred HHHhh
Q psy501 552 ILLHT 556 (962)
Q Consensus 552 ~Ll~~ 556 (962)
++++.
T Consensus 249 ~vl~~ 253 (256)
T cd08218 249 SILEK 253 (256)
T ss_pred HHhhC
Confidence 88764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=271.67 Aligned_cols=246 Identities=21% Similarity=0.257 Sum_probs=187.5
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc---hhHHHHHHHHHHHHhc-CCCCcccEEEEEEeC-----CEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS---RDEMVVCFYRKSLKKL-SHANLVKLKEVIREN-----DTLYF 381 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~---~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~-----~~~~L 381 (962)
+.+.....+..++.+.||.+......+.++.+... .....+.+|+.+++++ +|||++++++++... +..++
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l 101 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence 34444444555555668888776666655544432 2235678899999999 799999999998653 46899
Q ss_pred EEecCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC
Q psy501 382 VFEYMKE-NLYQLIRD---RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR 457 (962)
Q Consensus 382 V~Ey~~g-~Ll~~l~~---~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~ 457 (962)
||||++| +|.+.+.. ....+++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||.+......
T Consensus 102 v~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 181 (291)
T cd06639 102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181 (291)
T ss_pred EEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccc
Confidence 9999985 56555532 3456899999999999999999999999999999999999999999999999998765433
Q ss_pred --CcccccCCccccChhhhccCC----CCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc-ccCCCCCCC
Q psy501 458 --PYTDYVSTRWYRAPEVLLHST----AYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL-LHTLPLYTY 530 (962)
Q Consensus 458 --~~~~~~gt~~Y~APE~l~~~~----~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~s~ 530 (962)
......++..|+|||++.... .++.++|||||||++|||++|++||...........+...... .......+.
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (291)
T cd06639 182 RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCR 261 (291)
T ss_pred cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCH
Confidence 223356788999999985432 3688999999999999999999999887665554444333221 111223445
Q ss_pred CcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 531 HVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 531 ~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.+..++..||..+|+.||++.++++.
T Consensus 262 ~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 262 SFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 67889999999999999998888774
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=284.72 Aligned_cols=239 Identities=19% Similarity=0.240 Sum_probs=202.6
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccc---hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHH
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSS---RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQL 393 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~---~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~ 393 (962)
+++++-.+.||.+-++.-.-.++.+... -+.++|..|+.+|+.++|||+|+++++|...-.+|||+|||. |.|+++
T Consensus 274 KLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdY 353 (1157)
T KOG4278|consen 274 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDY 353 (1157)
T ss_pred ccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHH
Confidence 3344444558888776655555544433 345689999999999999999999999999999999999997 999999
Q ss_pred HHhcCC-CCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccC---Ccccc
Q psy501 394 IRDRDK-FLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVS---TRWYR 469 (962)
Q Consensus 394 l~~~~~-~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~g---t~~Y~ 469 (962)
++.+.. .++.-.++.++.||..|+.||..++++||||..+|+|+.++..+|++|||+++.+..+..+...| ..-|.
T Consensus 354 LRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWT 433 (1157)
T KOG4278|consen 354 LRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 433 (1157)
T ss_pred HHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCccccc
Confidence 988753 46777888999999999999999999999999999999999999999999999998876665555 45699
Q ss_pred ChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCC
Q psy501 470 APEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK 548 (962)
Q Consensus 470 APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRP 548 (962)
|||.+.- ..++.|+|||+|||+|||+.| |..||.+.+..+.+.-+..++. ...+..||..+..|++.||.+.|.+||
T Consensus 434 APEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR-M~~PeGCPpkVYeLMraCW~WsPsDRP 511 (1157)
T KOG4278|consen 434 APESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR-MDGPEGCPPKVYELMRACWNWSPSDRP 511 (1157)
T ss_pred Ccccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc-ccCCCCCCHHHHHHHHHHhcCCcccCc
Confidence 9999864 368999999999999999998 9999999999888887777744 444568899999999999999999999
Q ss_pred cHHHHHhhcc
Q psy501 549 SSYILLHTLP 558 (962)
Q Consensus 549 s~~~Ll~~l~ 558 (962)
++.++-+.|.
T Consensus 512 sFaeiHqafE 521 (1157)
T KOG4278|consen 512 SFAEIHQAFE 521 (1157)
T ss_pred cHHHHHHHHH
Confidence 9998877663
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=271.30 Aligned_cols=209 Identities=20% Similarity=0.282 Sum_probs=172.4
Q ss_pred hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHhh
Q psy501 347 DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDR------DKFLPESIIRNMMYQVLQGLAF 419 (962)
Q Consensus 347 ~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~------~~~ls~~~i~~i~~qI~~aL~y 419 (962)
....+.+|+.+++.++||+|+++++++..+...++||||++ ++|.+++... ...+++..+..++.|++.||.|
T Consensus 42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 121 (269)
T cd05044 42 EKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121 (269)
T ss_pred hHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHH
Confidence 34568899999999999999999999999999999999998 5777777542 2347889999999999999999
Q ss_pred cccceeeeccCCCccccccccc-----ceeeecccccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHH
Q psy501 420 MHRHGFFHRDMKPENLLCMGTE-----LVKIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQ 490 (962)
Q Consensus 420 LH~~gIvHrDLkp~NILl~~~g-----~vKL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLG 490 (962)
||+.+++|+||+|+||+++.++ .++|+|||++...... ......++..|+|||++.+. .++.++||||||
T Consensus 122 lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG 200 (269)
T cd05044 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFG 200 (269)
T ss_pred HHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHH
Confidence 9999999999999999999877 8999999999765432 12223456789999999764 689999999999
Q ss_pred HHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 491 QFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 491 vlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
|++|||++ |..||...........+.... ........+..+..++..||..+|++||++.++++.+
T Consensus 201 ~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 267 (269)
T cd05044 201 VLMWEILTLGQQPYPALNNQEVLQHVTAGG-RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267 (269)
T ss_pred HHHHHHHHcCCCCCcccCHHHHHHHHhcCC-ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 99999998 999998776655555444332 2233345677788999999999999999999998865
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=276.73 Aligned_cols=209 Identities=22% Similarity=0.259 Sum_probs=168.4
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcC-----------CCCCHHHHHHHHHHHHH
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRD-----------KFLPESIIRNMMYQVLQ 415 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~-----------~~ls~~~i~~i~~qI~~ 415 (962)
...+.+|++++++++||+|+++++++..+...++||||+++ +|.+++.... ..+++..++.++.|++.
T Consensus 61 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~ 140 (295)
T cd05097 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIAS 140 (295)
T ss_pred HHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHH
Confidence 34688999999999999999999999999999999999984 6666664322 23688999999999999
Q ss_pred HHhhcccceeeeccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHH
Q psy501 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQ 491 (962)
Q Consensus 416 aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGv 491 (962)
||.|||+.|++|+||||+||+++.++.+||+|||++....... .....++..|+|||++.++ .++.++|||||||
T Consensus 141 al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~ 219 (295)
T cd05097 141 GMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGV 219 (295)
T ss_pred HHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHH
Confidence 9999999999999999999999999999999999997654332 1223446789999998754 6899999999999
Q ss_pred HHHHHHc--CCCCCCCcChhhhHHHHHh------ccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 492 FLFYSID--HVPPIQTTCLLAGTERLKS------SYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 492 lL~ellt--G~~Pf~~~~~~~~~~~i~~------~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
++|+|++ |..||...........+.. ........+..+..+.+++..||..+|++||+..++++.|
T Consensus 220 ~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 293 (295)
T cd05097 220 TLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293 (295)
T ss_pred HHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 9999988 6789887655443333221 1111222345667788999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=274.74 Aligned_cols=239 Identities=26% Similarity=0.369 Sum_probs=185.1
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC----------EEEE
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIREND----------TLYF 381 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----------~~~L 381 (962)
.+..++.+.||.+.....++.++.+... .....+.+|++++++++||||+++++++.+.. .+++
T Consensus 14 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~l 93 (302)
T cd07864 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYL 93 (302)
T ss_pred eecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEE
Confidence 3333444457777665544444333321 12245778999999999999999999987654 7999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---
Q psy501 382 VFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--- 458 (962)
Q Consensus 382 V~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~--- 458 (962)
|+||+++++...+......+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||.+.......
T Consensus 94 v~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 173 (302)
T cd07864 94 VFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173 (302)
T ss_pred EEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccc
Confidence 99999999988887766679999999999999999999999999999999999999999999999999997664332
Q ss_pred cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc----------------
Q psy501 459 YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL---------------- 522 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------- 522 (962)
.....++..|+|||.+.+...++.++|||||||++|+|++|++||...........+.......
T Consensus 174 ~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T cd07864 174 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNT 253 (302)
T ss_pred cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccc
Confidence 2223557789999998765567899999999999999999999998766555444433321100
Q ss_pred ------------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 523 ------------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 523 ------------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
......+..+..++..||..+|++||++.++++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 254 MKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred cccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0112345677889999999999999999888764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=271.61 Aligned_cols=229 Identities=18% Similarity=0.301 Sum_probs=181.4
Q ss_pred ccEEEEEecCCceEEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCC
Q psy501 325 LPLYTCNLDQDNHILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDK 399 (962)
Q Consensus 325 ~~Vy~~~~~~~~kvv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~~ 399 (962)
+.||.+.....+..++.+.. ......+.+|+.+++.+.||+|+++++++..++..++|+||+.| +|.+.+.. .
T Consensus 33 g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~ 110 (285)
T cd06648 33 GIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--T 110 (285)
T ss_pred eEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--C
Confidence 34666655444433333221 12234578999999999999999999999999999999999985 56555554 4
Q ss_pred CCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhhhccC
Q psy501 400 FLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEVLLHS 477 (962)
Q Consensus 400 ~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~l~~~ 477 (962)
.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+...... ......|+..|+|||.+.+.
T Consensus 111 ~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 190 (285)
T cd06648 111 RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL 190 (285)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCC
Confidence 5899999999999999999999999999999999999999999999999988755433 22334688999999998654
Q ss_pred CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc-CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 478 TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH-TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 478 ~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.++.++|||||||++|+|++|+.||...........+........ .....+..+..++..||..+|++||++.+++..
T Consensus 191 -~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 191 -PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred -CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 689999999999999999999999988776666655554422111 122366778899999999999999999888874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=273.60 Aligned_cols=228 Identities=19% Similarity=0.208 Sum_probs=179.0
Q ss_pred ecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHH
Q psy501 320 ILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLY 391 (962)
Q Consensus 320 i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll 391 (962)
..++.+.||.+......+.++.+.... ....+.+|+++++.++||||+++++.+..++..++||||++| +|.
T Consensus 10 ~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~ 89 (305)
T cd05609 10 SNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCA 89 (305)
T ss_pred ecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHH
Confidence 334444577777666554444433221 233577899999999999999999999999999999999986 555
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--------------
Q psy501 392 QLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-------------- 457 (962)
Q Consensus 392 ~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-------------- 457 (962)
+.+.. .+.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++.....
T Consensus 90 ~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 168 (305)
T cd05609 90 TLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168 (305)
T ss_pred HHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccch
Confidence 55544 456899999999999999999999999999999999999999999999999998632110
Q ss_pred ---CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCC-CCCCCCcH
Q psy501 458 ---PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTL-PLYTYHVP 533 (962)
Q Consensus 458 ---~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~s~~l~ 533 (962)
......++..|+|||.+.+ ..++.++|||||||++|||++|..||.+.........+.......+.. +.++..+.
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (305)
T cd05609 169 REFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQ 247 (305)
T ss_pred hhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHH
Confidence 1112356788999999865 468999999999999999999999998877666666655554333322 24567789
Q ss_pred HHHHHHhccCCCCCCc
Q psy501 534 PIQTTCLLAGTERLKS 549 (962)
Q Consensus 534 ~li~~Cl~~dperRPs 549 (962)
.++..||..+|++||+
T Consensus 248 ~li~~~l~~~P~~R~~ 263 (305)
T cd05609 248 DLISRLLRQNPLERLG 263 (305)
T ss_pred HHHHHHhccChhhccC
Confidence 9999999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=264.17 Aligned_cols=233 Identities=21% Similarity=0.268 Sum_probs=183.9
Q ss_pred CCcccEEEEEecCCceEEEEec------cchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHH
Q psy501 322 PHTLPLYTCNLDQDNHILSRHV------SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLI 394 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~k~------~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l 394 (962)
++.+.+|.+........++.+. .......+.+|+++|++++||+|+++++.+..++..++||||++| +|.+.+
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 90 (256)
T cd08220 11 GAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYI 90 (256)
T ss_pred cCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHH
Confidence 3334566665544444333322 122345688999999999999999999999999999999999985 677777
Q ss_pred Hhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc-cceeeecccccccccCC-CcccccCCccccCh
Q psy501 395 RDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT-ELVKIADFGLAREIRSR-PYTDYVSTRWYRAP 471 (962)
Q Consensus 395 ~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~-g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~AP 471 (962)
... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||.+...... ......++..|+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aP 170 (256)
T cd08220 91 QKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISP 170 (256)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCc
Confidence 654 3458999999999999999999999999999999999999855 46899999999876543 22335688899999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHH
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 551 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~ 551 (962)
|.+.+ ..++.++||||||+++|+|++|+.||...........+..... .+.....+..+..++..||..+|++||++.
T Consensus 171 E~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 248 (256)
T cd08220 171 ELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-APISDRYSPDLRQLILSMLNLDPSKRPQLS 248 (256)
T ss_pred hhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-CCCCCCcCHHHHHHHHHHccCChhhCCCHH
Confidence 99965 4688999999999999999999999988776665555544322 222335677889999999999999999988
Q ss_pred HHHhh
Q psy501 552 ILLHT 556 (962)
Q Consensus 552 ~Ll~~ 556 (962)
+++..
T Consensus 249 ~ll~~ 253 (256)
T cd08220 249 QIMAQ 253 (256)
T ss_pred HHhhC
Confidence 87763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=273.03 Aligned_cols=231 Identities=19% Similarity=0.248 Sum_probs=172.2
Q ss_pred ccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHH---hcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHH
Q psy501 325 LPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLK---KLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQL 393 (962)
Q Consensus 325 ~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~---~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~ 393 (962)
+.||.+.....++.++.+... .......+|..+++ ...||+|+.+++++..++..++||||++| +|.+.
T Consensus 8 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 87 (279)
T cd05633 8 GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYH 87 (279)
T ss_pred eEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHH
Confidence 346666655544443333221 11222344444333 34799999999999999999999999985 55555
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccccChhh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEV 473 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~ 473 (962)
+. ..+.+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++............|+..|+|||.
T Consensus 88 i~-~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~ 166 (279)
T cd05633 88 LS-QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV 166 (279)
T ss_pred HH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCCcCccCHHH
Confidence 44 44569999999999999999999999999999999999999999999999999997665444444578999999999
Q ss_pred hccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhc--cccccCCCCCCCCcHHHHHHHhccCCCCCC---
Q psy501 474 LLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSS--YILLHTLPLYTYHVPPIQTTCLLAGTERLK--- 548 (962)
Q Consensus 474 l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~s~~l~~li~~Cl~~dperRP--- 548 (962)
+.++..++.++|||||||++|+|++|..||......... .+... .......+.++..+..++..||..+|++||
T Consensus 167 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 245 (279)
T cd05633 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCL 245 (279)
T ss_pred hcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCC
Confidence 865556899999999999999999999999764332211 11111 111222345677888999999999999999
Q ss_pred --cHHHHHhhc
Q psy501 549 --SSYILLHTL 557 (962)
Q Consensus 549 --s~~~Ll~~l 557 (962)
+++++++.-
T Consensus 246 ~~~~~~~~~h~ 256 (279)
T cd05633 246 GRGAQEVKEHV 256 (279)
T ss_pred CCCHHHHHhCc
Confidence 577776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=274.58 Aligned_cols=209 Identities=20% Similarity=0.233 Sum_probs=168.9
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC----------CCCCHHHHHHHHHHHHHH
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD----------KFLPESIIRNMMYQVLQG 416 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~----------~~ls~~~i~~i~~qI~~a 416 (962)
...+.+|+.+++.++||+|+++++++..++..++||||++ |+|.+++.... ..+++..++.++.|++.|
T Consensus 63 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a 142 (296)
T cd05095 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASG 142 (296)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHH
Confidence 3468899999999999999999999999999999999998 57777765432 247788999999999999
Q ss_pred HhhcccceeeeccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHHH
Q psy501 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQF 492 (962)
Q Consensus 417 L~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvl 492 (962)
|.|||+.|++|+||||+||+++.++.++|+|||++..+.... .....++..|+|||+..++ .++.++|||||||+
T Consensus 143 l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~ 221 (296)
T cd05095 143 MKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVT 221 (296)
T ss_pred HHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHH
Confidence 999999999999999999999999999999999997654332 1223345789999988664 68999999999999
Q ss_pred HHHHHc--CCCCCCCcChhhhHHHHHh------ccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 493 LFYSID--HVPPIQTTCLLAGTERLKS------SYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 493 L~ellt--G~~Pf~~~~~~~~~~~i~~------~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+|||++ |..||.............. .....+..+.++..+..++..||..+|+.||++.++.+.|
T Consensus 222 l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 294 (296)
T cd05095 222 LWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294 (296)
T ss_pred HHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 999998 7899977655443332211 1111233345667788999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=269.14 Aligned_cols=229 Identities=21% Similarity=0.274 Sum_probs=184.3
Q ss_pred ccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHh
Q psy501 325 LPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRD 396 (962)
Q Consensus 325 ~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~ 396 (962)
+.||.+.....++.++.+... .....+.+|++++++++||||+++++.+..+...|+||||++| +|.+.+..
T Consensus 7 ~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 86 (265)
T cd05579 7 GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN 86 (265)
T ss_pred eEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHH
Confidence 457777666544444443322 1234688999999999999999999999999999999999985 66666554
Q ss_pred cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----------CcccccCCc
Q psy501 397 RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----------PYTDYVSTR 466 (962)
Q Consensus 397 ~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----------~~~~~~gt~ 466 (962)
. ..+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++...... ......++.
T Consensus 87 ~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (265)
T cd05579 87 V-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165 (265)
T ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCc
Confidence 4 46899999999999999999999999999999999999999999999999998754333 223346788
Q ss_pred cccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCC
Q psy501 467 WYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTER 546 (962)
Q Consensus 467 ~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dper 546 (962)
.|+|||...+. .++.++||||||+++|+|++|..||...........+..+....+.....+..+..++..||..+|++
T Consensus 166 ~~~~Pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 244 (265)
T cd05579 166 DYIAPEVILGQ-GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEK 244 (265)
T ss_pred cccCHHHhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhh
Confidence 89999998664 58899999999999999999999998887776666666544443333334778899999999999999
Q ss_pred CCcH---HHHHh
Q psy501 547 LKSS---YILLH 555 (962)
Q Consensus 547 RPs~---~~Ll~ 555 (962)
||++ .+++.
T Consensus 245 Rpt~~~~~~~l~ 256 (265)
T cd05579 245 RLGAKSIEEIKN 256 (265)
T ss_pred cCCCccHHHHhc
Confidence 9998 66555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=270.12 Aligned_cols=208 Identities=21% Similarity=0.253 Sum_probs=166.9
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeee
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFH 427 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvH 427 (962)
...+.+|+.++++++||+|+++++++.+++..++||||+.|..+..+.....++++..++.++.|++.||.|||+.|++|
T Consensus 47 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H 126 (268)
T cd06630 47 VEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126 (268)
T ss_pred HHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 34688999999999999999999999999999999999996444444444457899999999999999999999999999
Q ss_pred ccCCCccccccccc-ceeeecccccccccCC------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCC
Q psy501 428 RDMKPENLLCMGTE-LVKIADFGLAREIRSR------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHV 500 (962)
Q Consensus 428 rDLkp~NILl~~~g-~vKL~DFGla~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~ 500 (962)
+||+|+||+++.++ .++|+|||.+...... ......++..|+|||.+.+ ..++.++|||||||++|+|++|.
T Consensus 127 ~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~ 205 (268)
T cd06630 127 RDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAK 205 (268)
T ss_pred CCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCC
Confidence 99999999998776 6999999999766543 1123467889999999865 46899999999999999999999
Q ss_pred CCCCCcChhhhHHHHH---hccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 501 PPIQTTCLLAGTERLK---SSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 501 ~Pf~~~~~~~~~~~i~---~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.||...........+. .........+..+..+..++..||..+|+.||++.+|+..
T Consensus 206 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 206 PPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 9997654332222221 1212222223456677889999999999999998888763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=265.51 Aligned_cols=234 Identities=21% Similarity=0.264 Sum_probs=185.7
Q ss_pred ecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHH
Q psy501 320 ILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQL 393 (962)
Q Consensus 320 i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~ 393 (962)
..++.+.+|.+.....++.++.+... .....+.+|+.++.+++||+|+++++++..+...++||||++ ++|.+.
T Consensus 10 ~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 89 (264)
T cd06623 10 GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADL 89 (264)
T ss_pred eecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHH
Confidence 33445567777766544444333322 224578999999999999999999999999999999999999 566666
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhccc-ceeeeccCCCcccccccccceeeecccccccccCCCc--ccccCCccccC
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHR-HGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY--TDYVSTRWYRA 470 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~-~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~--~~~~gt~~Y~A 470 (962)
+... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+........ ....++..|+|
T Consensus 90 l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~ 168 (264)
T cd06623 90 LKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMS 168 (264)
T ss_pred HHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccC
Confidence 5544 669999999999999999999999 9999999999999999999999999999987654422 24567889999
Q ss_pred hhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcC---hhhhHHHHHhccccccCCCC-CCCCcHHHHHHHhccCCCC
Q psy501 471 PEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTC---LLAGTERLKSSYILLHTLPL-YTYHVPPIQTTCLLAGTER 546 (962)
Q Consensus 471 PE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~-~s~~l~~li~~Cl~~dper 546 (962)
||.+.+. .++.++|+||||+++|+|++|+.||.... .......+... ........ ++..+..++..||..+|+.
T Consensus 169 pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~ 246 (264)
T cd06623 169 PERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG-PPPSLPAEEFSPEFRDFISACLQKDPKK 246 (264)
T ss_pred HhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC-CCCCCCcccCCHHHHHHHHHHccCChhh
Confidence 9998654 78999999999999999999999998774 33333333322 22222223 6778999999999999999
Q ss_pred CCcHHHHHhh
Q psy501 547 LKSSYILLHT 556 (962)
Q Consensus 547 RPs~~~Ll~~ 556 (962)
||++.++++.
T Consensus 247 R~~~~~ll~~ 256 (264)
T cd06623 247 RPSAAELLQH 256 (264)
T ss_pred CCCHHHHHhC
Confidence 9999988874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=266.97 Aligned_cols=208 Identities=21% Similarity=0.216 Sum_probs=168.5
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEE-eCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhccccee
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIR-ENDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGF 425 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~-~~~~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gI 425 (962)
...+.+|+.+++.++||||+++++++. .++..++||||+. |+|.+++......+++..+..++.|++.||.|||+.++
T Consensus 40 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 119 (262)
T cd05058 40 VEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF 119 (262)
T ss_pred HHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 346788999999999999999999775 4556899999998 67777776655567888899999999999999999999
Q ss_pred eeccCCCcccccccccceeeecccccccccCC------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-
Q psy501 426 FHRDMKPENLLCMGTELVKIADFGLAREIRSR------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID- 498 (962)
Q Consensus 426 vHrDLkp~NILl~~~g~vKL~DFGla~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt- 498 (962)
+||||||+||+++.++.+||+|||+++..... ......++..|+|||.+.+ ..++.++|||||||++|||++
T Consensus 120 ~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~ 198 (262)
T cd05058 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTR 198 (262)
T ss_pred cccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcC
Confidence 99999999999999999999999999755332 1123345678999999865 468999999999999999999
Q ss_pred CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 499 HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 499 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
|.+||...........+..+.. .......+..+..++..||..+|++||++.+++..+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l 256 (262)
T cd05058 199 GAPPYPDVDSFDITVYLLQGRR-LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRI 256 (262)
T ss_pred CCCCCCCCCHHHHHHHHhcCCC-CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 5777877666555554444322 222234566788899999999999999999998866
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=269.58 Aligned_cols=210 Identities=16% Similarity=0.205 Sum_probs=165.7
Q ss_pred hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHhhccc
Q psy501 347 DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD---KFLPESIIRNMMYQVLQGLAFMHR 422 (962)
Q Consensus 347 ~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~---~~ls~~~i~~i~~qI~~aL~yLH~ 422 (962)
....+.+|+.+++.++||||+++++.+.+....|+||||++ |+|.+++.... ..+++..++.++.||+.||.|||+
T Consensus 38 ~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~ 117 (268)
T cd05086 38 EQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK 117 (268)
T ss_pred HHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH
Confidence 34578999999999999999999999999999999999998 57777776532 346777888999999999999999
Q ss_pred ceeeeccCCCcccccccccceeeecccccccccCC----CcccccCCccccChhhhcc------CCCCCchhHHHHHHHH
Q psy501 423 HGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLH------STAYSAPIHLSRSQQF 492 (962)
Q Consensus 423 ~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~------~~~~t~ksDIwSLGvl 492 (962)
.+++|+||||+||+++.++.++|+|||++...... ......++..|+|||++.. ...++.++|||||||+
T Consensus 118 ~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~ 197 (268)
T cd05086 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVT 197 (268)
T ss_pred CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHH
Confidence 99999999999999999999999999998643221 2234567889999998842 1245789999999999
Q ss_pred HHHHHc-CCCCCCCcChhhhHHHHHhccc-c---ccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 493 LFYSID-HVPPIQTTCLLAGTERLKSSYI-L---LHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 493 L~ellt-G~~Pf~~~~~~~~~~~i~~~~~-~---~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+|||++ |..||...........+..... . +.....++..+..++..|| .+|+.||++.++++.|
T Consensus 198 l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 198 LWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 999997 6789977665554444332221 1 1112245566778999999 5699999999998765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=267.80 Aligned_cols=233 Identities=21% Similarity=0.207 Sum_probs=177.2
Q ss_pred cccEEEEEecCCceEEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC
Q psy501 324 TLPLYTCNLDQDNHILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD 398 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~ 398 (962)
.+.||.+....+...++.+.. ......+.+|+.++++++||||+++++++..++..++|+||++ ++|.+.+....
T Consensus 21 ~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 100 (268)
T cd06624 21 YGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKW 100 (268)
T ss_pred ceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhc
Confidence 345777765555443333322 1234568999999999999999999999999999999999998 46777666554
Q ss_pred CCC--CHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc-ccceeeecccccccccCC--CcccccCCccccChhh
Q psy501 399 KFL--PESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG-TELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEV 473 (962)
Q Consensus 399 ~~l--s~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~-~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~ 473 (962)
..+ ++..+..++.|++.||.|||+.||+|+||+|+||+++. .+.++|+|||.+...... ......++..|+|||+
T Consensus 101 ~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~ 180 (268)
T cd06624 101 GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEV 180 (268)
T ss_pred ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhh
Confidence 455 88899999999999999999999999999999999976 679999999998765432 2233467889999999
Q ss_pred hccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhH-HHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHH
Q psy501 474 LLHS-TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGT-ERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 551 (962)
Q Consensus 474 l~~~-~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~ 551 (962)
+.+. ..++.++||||||+++|+|++|+.||......... ................+..+..++..||..+|++||++.
T Consensus 181 ~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 260 (268)
T cd06624 181 IDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAH 260 (268)
T ss_pred hccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHH
Confidence 8543 24789999999999999999999999765432221 111111111122234556778899999999999999988
Q ss_pred HHHhh
Q psy501 552 ILLHT 556 (962)
Q Consensus 552 ~Ll~~ 556 (962)
+++..
T Consensus 261 ~ll~~ 265 (268)
T cd06624 261 DLLQD 265 (268)
T ss_pred HHHhC
Confidence 87764
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=272.96 Aligned_cols=235 Identities=34% Similarity=0.510 Sum_probs=185.7
Q ss_pred CCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHH
Q psy501 322 PHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIR 395 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~ 395 (962)
++.+.||.+.....++.++.+... .....+.+|++++++++||+|+++++++..+...++|+||+++++.+.+.
T Consensus 10 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~l~ 89 (283)
T cd05118 10 GTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIK 89 (283)
T ss_pred CCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCCCHHHHHH
Confidence 334456776655444433333211 12346888999999999999999999999999999999999999999888
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC--cccccCCccccChhh
Q psy501 396 DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--YTDYVSTRWYRAPEV 473 (962)
Q Consensus 396 ~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~--~~~~~gt~~Y~APE~ 473 (962)
.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+....... .....++..|+|||.
T Consensus 90 ~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~ 169 (283)
T cd05118 90 DRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPEL 169 (283)
T ss_pred hhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHH
Confidence 766779999999999999999999999999999999999999999999999999997665432 233567888999999
Q ss_pred hccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc----------------------------cCC
Q psy501 474 LLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL----------------------------HTL 525 (962)
Q Consensus 474 l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------------------------~~~ 525 (962)
+.+...++.++|||||||++|+|++|+.||...+.......+....... ...
T Consensus 170 ~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (283)
T cd05118 170 LLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLF 249 (283)
T ss_pred HhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhh
Confidence 9765578999999999999999999999998776554443332210000 011
Q ss_pred CCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 526 PLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 526 ~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
+..+..+..++..||..+|.+||++.+++..
T Consensus 250 ~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 250 PNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 2345567789999999999999998887763
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=264.97 Aligned_cols=234 Identities=22% Similarity=0.272 Sum_probs=186.6
Q ss_pred CCcccEEEEEecCCc----eEEEEeccch-----hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHH
Q psy501 322 PHTLPLYTCNLDQDN----HILSRHVSSR-----DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLY 391 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~----kvv~~k~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll 391 (962)
++.+.||.+...... ..++.|.... ....+..|+++++.++||+|+++++++.+.+..+++|||++| ++.
T Consensus 10 g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~ 89 (258)
T smart00219 10 GAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLL 89 (258)
T ss_pred CCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHH
Confidence 334457777665533 3333322221 345789999999999999999999999999999999999985 677
Q ss_pred HHHHhcCCC-CCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcc---cccCCcc
Q psy501 392 QLIRDRDKF-LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT---DYVSTRW 467 (962)
Q Consensus 392 ~~l~~~~~~-ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~---~~~gt~~ 467 (962)
+.+...... +++..+..++.|++.||++||+.+++|+||+|+||+++.++.++|+|||.+......... ...++..
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 169 (258)
T smart00219 90 DYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIR 169 (258)
T ss_pred HHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCccc
Confidence 666554433 899999999999999999999999999999999999999999999999999766543111 2236788
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCC
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTER 546 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dper 546 (962)
|+|||.+.+ ..++.++|||||||++|+|++ |.+||...........+..... .......+..+..++..||..+|++
T Consensus 170 y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~ 247 (258)
T smart00219 170 WMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR-LPKPENCPPEIYKLMLQCWAEDPED 247 (258)
T ss_pred ccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-CCCCCcCCHHHHHHHHHHCcCChhh
Confidence 999999854 578999999999999999998 8999988776666666655533 2334456778888999999999999
Q ss_pred CCcHHHHHhhc
Q psy501 547 LKSSYILLHTL 557 (962)
Q Consensus 547 RPs~~~Ll~~l 557 (962)
||++.++++.|
T Consensus 248 Rpt~~~ll~~l 258 (258)
T smart00219 248 RPTFSELVEIL 258 (258)
T ss_pred CcCHHHHHhhC
Confidence 99999998743
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=275.34 Aligned_cols=207 Identities=17% Similarity=0.213 Sum_probs=171.1
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeee
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFH 427 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvH 427 (962)
..+.+|+.++++++||||+++++++..+ ..++++||++ |++.+.+......+++..++.++.|++.||.|||+.+|+|
T Consensus 54 ~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH 132 (303)
T cd05110 54 VEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVH 132 (303)
T ss_pred HHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeec
Confidence 3578999999999999999999998754 4678999998 6788887776667899999999999999999999999999
Q ss_pred ccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCC
Q psy501 428 RDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPP 502 (962)
Q Consensus 428 rDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~P 502 (962)
+||||+||+++.++.+||+|||++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..|
T Consensus 133 ~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p 211 (303)
T cd05110 133 RDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKP 211 (303)
T ss_pred cccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998664331 122345678999999865 468999999999999999997 9999
Q ss_pred CCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 503 IQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 503 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
|.+.........+..+ ...+..+.++..+..++..||..+|+.||++.++++.+.
T Consensus 212 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~ 266 (303)
T cd05110 212 YDGIPTREIPDLLEKG-ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFS 266 (303)
T ss_pred CCCCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9876554443333332 333444556777888999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=281.10 Aligned_cols=243 Identities=23% Similarity=0.251 Sum_probs=186.1
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeC------C
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIREN------D 377 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------~ 377 (962)
.+.+.....+..++.+.||.+.....++.++.|... .....+.+|+.++++++||||++++++|... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 445555555555555668888877666655554432 1234577899999999999999999998643 3
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC
Q psy501 378 TLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR 457 (962)
Q Consensus 378 ~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~ 457 (962)
..|+||||+.+++.+.+... +++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 95 DVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred cEEEEEeccCCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 57999999999988877543 899999999999999999999999999999999999999999999999999876543
Q ss_pred -CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc--------------
Q psy501 458 -PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL-------------- 522 (962)
Q Consensus 458 -~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------------- 522 (962)
......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+......+
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T cd07850 172 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN 250 (353)
T ss_pred CCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence 2234567889999999976 478999999999999999999999998765433322221110000
Q ss_pred ----------------------cC-----CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 523 ----------------------HT-----LPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 523 ----------------------~~-----~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
+. ....+....+++..||..+|++||++.+++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 00123345789999999999999998888764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=265.82 Aligned_cols=235 Identities=20% Similarity=0.255 Sum_probs=177.4
Q ss_pred cCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHH
Q psy501 321 LPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLI 394 (962)
Q Consensus 321 ~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l 394 (962)
.++.+.+|.+......+.++.+... .....+..|+.++++++||+|+++++++...+..++|+||+++..+..+
T Consensus 10 ~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 89 (264)
T cd06626 10 GGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEEL 89 (264)
T ss_pred cCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHH
Confidence 3334456666655444333322211 2345789999999999999999999999999999999999985444444
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC------cccccCCccc
Q psy501 395 RDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP------YTDYVSTRWY 468 (962)
Q Consensus 395 ~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~------~~~~~gt~~Y 468 (962)
......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+....... .....++..|
T Consensus 90 ~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
T cd06626 90 LEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAY 169 (264)
T ss_pred HhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCc
Confidence 4444568999999999999999999999999999999999999999999999999997764431 1124678899
Q ss_pred cChhhhccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhH-HHHHhc-cccccCCCCCCCCcHHHHHHHhccCC
Q psy501 469 RAPEVLLHST--AYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGT-ERLKSS-YILLHTLPLYTYHVPPIQTTCLLAGT 544 (962)
Q Consensus 469 ~APE~l~~~~--~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~-~~i~~~-~~~~~~~~~~s~~l~~li~~Cl~~dp 544 (962)
+|||++.+.. .++.++||||||+++|+|++|+.||......... ..+... ....+.....+..+..++..||..+|
T Consensus 170 ~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 249 (264)
T cd06626 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDP 249 (264)
T ss_pred cChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCc
Confidence 9999996542 3789999999999999999999999765432222 222221 11112122336677889999999999
Q ss_pred CCCCcHHHHHh
Q psy501 545 ERLKSSYILLH 555 (962)
Q Consensus 545 erRPs~~~Ll~ 555 (962)
++||++.+++.
T Consensus 250 ~~R~~~~~i~~ 260 (264)
T cd06626 250 KKRPTASELLQ 260 (264)
T ss_pred ccCCCHHHHhc
Confidence 99999888765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=271.40 Aligned_cols=232 Identities=18% Similarity=0.228 Sum_probs=182.0
Q ss_pred CCcccEEEEEecCCceEEEEecc-----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHH
Q psy501 322 PHTLPLYTCNLDQDNHILSRHVS-----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIR 395 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~ 395 (962)
++.+.||.+........++.+.. ......+.+|+.+++++.||+|+++++++.++...++||||++| +|.+.+.
T Consensus 15 g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~ 94 (277)
T cd06640 15 GSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR 94 (277)
T ss_pred CCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHh
Confidence 33345677766554444333332 22345688999999999999999999999999999999999985 6666554
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhh
Q psy501 396 DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEV 473 (962)
Q Consensus 396 ~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~ 473 (962)
. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... ......++..|+|||+
T Consensus 95 ~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~ 172 (277)
T cd06640 95 A--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172 (277)
T ss_pred c--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhH
Confidence 3 45899999999999999999999999999999999999999999999999999765443 2233467888999999
Q ss_pred hccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHH
Q psy501 474 LLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 553 (962)
Q Consensus 474 l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~L 553 (962)
+.+. .++.++|+|||||++|||++|..||...........+.... .......++..+..++..||..+|+.||++.++
T Consensus 173 ~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 250 (277)
T cd06640 173 IQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKEL 250 (277)
T ss_pred hccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC-CCCCchhhhHHHHHHHHHHcccCcccCcCHHHH
Confidence 8654 68999999999999999999999998766544443332221 122223456677889999999999999999888
Q ss_pred Hhhc
Q psy501 554 LHTL 557 (962)
Q Consensus 554 l~~l 557 (962)
+..-
T Consensus 251 l~~~ 254 (277)
T cd06640 251 LKHK 254 (277)
T ss_pred HhCh
Confidence 7754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=270.77 Aligned_cols=199 Identities=19% Similarity=0.219 Sum_probs=161.9
Q ss_pred HHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccc
Q psy501 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENL 435 (962)
Q Consensus 356 ~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NI 435 (962)
..++...||+|+++++++..++..++||||+.|+.+.......+.+++..++.++.|++.||.|||+.+++|+||+|+||
T Consensus 49 ~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~ni 128 (278)
T cd05606 49 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANI 128 (278)
T ss_pred HHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHE
Confidence 34445579999999999999999999999998654444444456799999999999999999999999999999999999
Q ss_pred ccccccceeeecccccccccCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh---hhH
Q psy501 436 LCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL---AGT 512 (962)
Q Consensus 436 Ll~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~---~~~ 512 (962)
+++.++.++|+|||++............|+..|+|||++.++..++.++||||+||++|||++|+.||...... ...
T Consensus 129 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~ 208 (278)
T cd05606 129 LLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 208 (278)
T ss_pred EECCCCCEEEccCcCccccCccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH
Confidence 99999999999999997665544445678999999999976556899999999999999999999999876322 211
Q ss_pred HHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCC-----cHHHHHhh
Q psy501 513 ERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK-----SSYILLHT 556 (962)
Q Consensus 513 ~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRP-----s~~~Ll~~ 556 (962)
...... ........+..+..++..||..+|.+|| ++.+++..
T Consensus 209 ~~~~~~--~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 209 RMTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHhhcc--CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 112111 1222335677889999999999999999 88888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=269.85 Aligned_cols=236 Identities=17% Similarity=0.206 Sum_probs=185.4
Q ss_pred EEEecCCcccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-
Q psy501 317 FSYILPHTLPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE- 388 (962)
Q Consensus 317 ~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g- 388 (962)
..+..++.+.||.+.....++.++.+... .....+.+|++++++++||||+++++++.++...++|+||+.|
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (258)
T cd05578 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGG 85 (258)
T ss_pred EEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCC
Confidence 33444455568888776555555544332 2245688999999999999999999999999999999999986
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCcc
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRW 467 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~ 467 (962)
+|...+... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+...... ......++..
T Consensus 86 ~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 164 (258)
T cd05578 86 DLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPG 164 (258)
T ss_pred CHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccCCChh
Confidence 555555443 57999999999999999999999999999999999999999999999999998766543 3344568889
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh--hhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCC
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL--AGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTE 545 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dpe 545 (962)
|+|||.+.+. .++.++|+||||+++|+|++|..||...... ......... ......+..+..+..++..||..+|.
T Consensus 165 y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~ 242 (258)
T cd05578 165 YMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAIDAINKLLERDPQ 242 (258)
T ss_pred hcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHHHHHHHHccCChh
Confidence 9999998654 5899999999999999999999999876642 221111111 22233345677888999999999999
Q ss_pred CCCcH--HHHHh
Q psy501 546 RLKSS--YILLH 555 (962)
Q Consensus 546 rRPs~--~~Ll~ 555 (962)
+||+. .+++.
T Consensus 243 ~R~~~~~~~l~~ 254 (258)
T cd05578 243 KRLGDNLKDLKN 254 (258)
T ss_pred HcCCccHHHHhc
Confidence 99999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=264.27 Aligned_cols=233 Identities=25% Similarity=0.368 Sum_probs=184.8
Q ss_pred CCcccEEEEEecCCceEEEEec------cchhHHHHHHHHHHHHhcCCCCcccEEEEEEe--CCEEEEEEecCC-CCHHH
Q psy501 322 PHTLPLYTCNLDQDNHILSRHV------SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRE--NDTLYFVFEYMK-ENLYQ 392 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~k~------~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~LV~Ey~~-g~Ll~ 392 (962)
++.+.||.+.....+..++.+. .......+..|++++++++||+|+++++++.. +...+++|||++ ++|.+
T Consensus 11 g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~ 90 (265)
T cd08217 11 GSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQ 90 (265)
T ss_pred CCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHH
Confidence 3444566666555444433332 12234568889999999999999999998854 457899999998 46766
Q ss_pred HHHhc---CCCCCHHHHHHHHHHHHHHHhhcc-----cceeeeccCCCcccccccccceeeecccccccccCCC--cccc
Q psy501 393 LIRDR---DKFLPESIIRNMMYQVLQGLAFMH-----RHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--YTDY 462 (962)
Q Consensus 393 ~l~~~---~~~ls~~~i~~i~~qI~~aL~yLH-----~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~--~~~~ 462 (962)
.+... ...+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 91 ~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 170 (265)
T cd08217 91 LIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY 170 (265)
T ss_pred HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCccccccc
Confidence 66543 457999999999999999999999 8999999999999999999999999999998765443 3445
Q ss_pred cCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhcc
Q psy501 463 VSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 542 (962)
Q Consensus 463 ~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~ 542 (962)
.++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+..+.. ......++..+..++..||..
T Consensus 171 ~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~l~~ 248 (265)
T cd08217 171 VGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF-RRIPYRYSSELNEVIKSMLNV 248 (265)
T ss_pred ccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC-CCCccccCHHHHHHHHHHccC
Confidence 789999999999654 588999999999999999999999998775555555554432 223346677888999999999
Q ss_pred CCCCCCcHHHHHhh
Q psy501 543 GTERLKSSYILLHT 556 (962)
Q Consensus 543 dperRPs~~~Ll~~ 556 (962)
+|+.||++.++++.
T Consensus 249 ~p~~Rp~~~~il~~ 262 (265)
T cd08217 249 DPDKRPSTEELLQL 262 (265)
T ss_pred CcccCCCHHHHhhC
Confidence 99999999888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=291.98 Aligned_cols=235 Identities=19% Similarity=0.256 Sum_probs=197.1
Q ss_pred ecCCcc-cEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCH
Q psy501 320 ILPHTL-PLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENL 390 (962)
Q Consensus 320 i~~~~~-~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~L 390 (962)
+++|+| .|..++.+.+.++++.|+..+ +...|..|.++|..-..+-|+.++..|+++.++|+||||++ |+|
T Consensus 83 IGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDl 162 (1317)
T KOG0612|consen 83 IGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDL 162 (1317)
T ss_pred hcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchH
Confidence 344444 488888888888888776554 23458899999999999999999999999999999999998 577
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---CcccccCCcc
Q psy501 391 YQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYVSTRW 467 (962)
Q Consensus 391 l~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~gt~~ 467 (962)
+..+...+ +++++.++.++..|+.||.-||+.|+|||||||+|||+|..|++||+|||.|-.+..+ .....+|||.
T Consensus 163 ltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPD 241 (1317)
T KOG0612|consen 163 LTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPD 241 (1317)
T ss_pred HHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCC
Confidence 77777666 7999999999999999999999999999999999999999999999999999888754 3445689999
Q ss_pred ccChhhhc---cC-CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhc--cccccCCCCCCCCcHHHHHHHhc
Q psy501 468 YRAPEVLL---HS-TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSS--YILLHTLPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 468 Y~APE~l~---~~-~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~s~~l~~li~~Cl~ 541 (962)
|.|||++. ++ ..|+..+|.||+||++|||+.|..||...+....+.+|... .+.+|.....|.....||...+.
T Consensus 242 YISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~ 321 (1317)
T KOG0612|consen 242 YISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC 321 (1317)
T ss_pred ccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc
Confidence 99999995 22 46999999999999999999999999999999999999876 45555445678888899988777
Q ss_pred cCCCCCC--cHHHHHh
Q psy501 542 AGTERLK--SSYILLH 555 (962)
Q Consensus 542 ~dperRP--s~~~Ll~ 555 (962)
..+.|.- ..+++-.
T Consensus 322 ~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 322 DREVRLGRNGIEDIKN 337 (1317)
T ss_pred ChhhhcccccHHHHHh
Confidence 6665544 2555543
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=272.62 Aligned_cols=242 Identities=16% Similarity=0.141 Sum_probs=177.4
Q ss_pred CceeeEEEEecCCcccEEEEEecCC---ceEEEEeccchhHH---------------HHHHHHHHHHhcCCCCcccEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQD---NHILSRHVSSRDEM---------------VVCFYRKSLKKLSHANLVKLKEV 372 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~---~kvv~~k~~~~~~~---------------~~~~Ei~iL~~L~HpnIv~l~~~ 372 (962)
+.+.....++.++.+.||++..... .+.++.+....+.. ....+...+..+.|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4555555555566666888876655 33333333221111 11223344556789999999998
Q ss_pred EEeCC----EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecc
Q psy501 373 IREND----TLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADF 448 (962)
Q Consensus 373 ~~~~~----~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DF 448 (962)
+.... ..++++|++.+++.+.+... ..+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeEecCCceEEEEEEehhccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 75443 45788998887776665443 34688999999999999999999999999999999999999999999999
Q ss_pred cccccccCC---------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhh-hH------
Q psy501 449 GLAREIRSR---------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLA-GT------ 512 (962)
Q Consensus 449 Gla~~~~~~---------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~-~~------ 512 (962)
|+|+.+... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..... ..
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~ 249 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCD 249 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHH
Confidence 999765321 1223469999999999865 468999999999999999999999998763221 11
Q ss_pred --HHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 513 --ERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 513 --~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..+..+.. ..+..+..+.+++..||..+|++||+..+|.+.+
T Consensus 250 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 250 FIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11222211 2345567788999999999999999999998854
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=270.99 Aligned_cols=229 Identities=18% Similarity=0.244 Sum_probs=178.4
Q ss_pred ccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcC
Q psy501 325 LPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRD 398 (962)
Q Consensus 325 ~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~ 398 (962)
+.||.+.....+..++.+... .....+.+|++++++++||+|+++++++..+...++||||++| ++.+.+..
T Consensus 18 ~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-- 95 (277)
T cd06642 18 GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-- 95 (277)
T ss_pred eeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc--
Confidence 346666554444433333322 2234688999999999999999999999999999999999985 55555433
Q ss_pred CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC--cccccCCccccChhhhcc
Q psy501 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--YTDYVSTRWYRAPEVLLH 476 (962)
Q Consensus 399 ~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~--~~~~~gt~~Y~APE~l~~ 476 (962)
..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+
T Consensus 96 ~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 175 (277)
T cd06642 96 GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175 (277)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCc
Confidence 458999999999999999999999999999999999999999999999999997665432 223467889999999865
Q ss_pred CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 477 STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 477 ~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
. .++.++|||||||++|||++|+.||...........+.... ........+..+..++..||..+|++||++.++++.
T Consensus 176 ~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 176 S-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred C-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC-CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 4 68999999999999999999999998665444433332221 111223455678889999999999999998888864
Q ss_pred c
Q psy501 557 L 557 (962)
Q Consensus 557 l 557 (962)
-
T Consensus 254 ~ 254 (277)
T cd06642 254 K 254 (277)
T ss_pred H
Confidence 3
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=265.17 Aligned_cols=235 Identities=19% Similarity=0.250 Sum_probs=179.3
Q ss_pred EEecCCcccEEEEEecCCceEEEEecc---------chhHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CEEEEEEecC
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVS---------SRDEMVVCFYRKSLKKLSHANLVKLKEVIREN--DTLYFVFEYM 386 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~---------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~LV~Ey~ 386 (962)
.+..++.+.||.+.....++.++.+.. ......+.+|++++++++||+|+++++++.+. ..+++||||+
T Consensus 9 ~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~ 88 (264)
T cd06653 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYM 88 (264)
T ss_pred eEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeC
Confidence 333344445777765554444443321 12234688999999999999999999998764 5689999999
Q ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-----Ccc
Q psy501 387 KE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-----PYT 460 (962)
Q Consensus 387 ~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-----~~~ 460 (962)
+| +|.+.+... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 89 ~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 167 (264)
T cd06653 89 PGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK 167 (264)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCcccc
Confidence 85 566666543 45899999999999999999999999999999999999999999999999999765431 222
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHh
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCL 540 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl 540 (962)
...++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..........+..+..+..++..||
T Consensus 168 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l 246 (264)
T cd06653 168 SVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIF 246 (264)
T ss_pred ccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHh
Confidence 3468889999999966 468899999999999999999999998765555444443332222233456667888999999
Q ss_pred ccCCCCCCcHHHHHh
Q psy501 541 LAGTERLKSSYILLH 555 (962)
Q Consensus 541 ~~dperRPs~~~Ll~ 555 (962)
.. +.+||++..++.
T Consensus 247 ~~-~~~r~~~~~~~~ 260 (264)
T cd06653 247 VE-EKRRPTAEFLLR 260 (264)
T ss_pred cC-cccCccHHHHhc
Confidence 95 699999776664
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=272.63 Aligned_cols=247 Identities=24% Similarity=0.296 Sum_probs=188.7
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeC-------
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIREN------- 376 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------- 376 (962)
.+.+.....+..++.+.||.+.....+..++.+... .....+.+|++++++++||+|+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 345556666666666678888776555443333221 1123578899999999999999999987543
Q ss_pred -CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccccccc
Q psy501 377 -DTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR 455 (962)
Q Consensus 377 -~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~ 455 (962)
..+++||||+.+++...+......+++..++.++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 3579999999999988887766679999999999999999999999999999999999999999999999999997654
Q ss_pred CCC-------------cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc
Q psy501 456 SRP-------------YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL 522 (962)
Q Consensus 456 ~~~-------------~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 522 (962)
... .....+++.|+|||.+.+...++.++|||||||++|||++|++||.+.........+.......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 321 1223567889999998776678999999999999999999999998776655444332211000
Q ss_pred c----------------------------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 523 H----------------------------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 523 ~----------------------------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
. .....+..+..++..||..+|++||++.+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0 001223456689999999999999998887763
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=270.19 Aligned_cols=207 Identities=23% Similarity=0.231 Sum_probs=163.3
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEe--CCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccce
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRE--NDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHG 424 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~g 424 (962)
...+.+|+++|++++||||+++++++.. ....++||||+.+ +|.+++.. ..+++..++.++.|++.||.|||+.+
T Consensus 50 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~ 127 (283)
T cd05080 50 TSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQH 127 (283)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4567899999999999999999998865 3468999999985 56665544 24899999999999999999999999
Q ss_pred eeeccCCCcccccccccceeeecccccccccCCC-----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcC
Q psy501 425 FFHRDMKPENLLCMGTELVKIADFGLAREIRSRP-----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDH 499 (962)
Q Consensus 425 IvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~-----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG 499 (962)
++|+||||+||+++.++.++|+|||++....... .....++..|+|||.+.+. .++.++|||||||++|||++|
T Consensus 128 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg 206 (283)
T cd05080 128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTH 206 (283)
T ss_pred eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhC
Confidence 9999999999999999999999999998664331 1223456679999998654 689999999999999999999
Q ss_pred CCCCCCcChhhh--------------HHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 500 VPPIQTTCLLAG--------------TERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 500 ~~Pf~~~~~~~~--------------~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..||........ ...........+....++..+..++..||..+|+.||++.++++.+
T Consensus 207 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l 278 (283)
T cd05080 207 CDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278 (283)
T ss_pred CCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 999865332100 0001111111222345567888899999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=266.30 Aligned_cols=206 Identities=22% Similarity=0.315 Sum_probs=167.8
Q ss_pred HHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeec
Q psy501 350 VVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHR 428 (962)
Q Consensus 350 ~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHr 428 (962)
.+..|+.++++++||+|+++++++..+...++||||++| +|.+.+... ..+++..+..++.|++.||.|||+.+++|+
T Consensus 54 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~ 132 (272)
T cd06629 54 ALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHR 132 (272)
T ss_pred HHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeec
Confidence 578899999999999999999999999999999999985 566665554 568999999999999999999999999999
Q ss_pred cCCCcccccccccceeeecccccccccCC----CcccccCCccccChhhhccCC-CCCchhHHHHHHHHHHHHHcCCCCC
Q psy501 429 DMKPENLLCMGTELVKIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHST-AYSAPIHLSRSQQFLFYSIDHVPPI 503 (962)
Q Consensus 429 DLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~-~~t~ksDIwSLGvlL~elltG~~Pf 503 (962)
||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+.. .++.++|+||||+++|+|++|..||
T Consensus 133 dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 212 (272)
T cd06629 133 DLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW 212 (272)
T ss_pred CCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999765432 123346788999999986543 4789999999999999999999999
Q ss_pred CCcChhhhHHHHHhcccccc----CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 504 QTTCLLAGTERLKSSYILLH----TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 504 ~~~~~~~~~~~i~~~~~~~~----~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
...........+........ ..+.++..+..++..||..+|+.||++.+++..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 213 SDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 76554433333322211111 123456678889999999999999998887764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=301.95 Aligned_cols=247 Identities=17% Similarity=0.116 Sum_probs=185.6
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
|.+.....++.++.+.||.+.....++.++.|.... ....+.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 345555566666667799988776555544443221 2346889999999999999999999999999999999
Q ss_pred ecCCC-CHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccc
Q psy501 384 EYMKE-NLYQLIRDR----------DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR 452 (962)
Q Consensus 384 Ey~~g-~Ll~~l~~~----------~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~ 452 (962)
||++| +|.+.+... ...++...++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 99985 566655431 1235677889999999999999999999999999999999999999999999997
Q ss_pred cccCC--------------------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhH
Q psy501 453 EIRSR--------------------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGT 512 (962)
Q Consensus 453 ~~~~~--------------------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~ 512 (962)
..... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||.........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 65211 11124689999999998764 6899999999999999999999999875433222
Q ss_pred HHHHhc-cccccCCCCCCCCcHHHHHHHhccCCCCCCc-HHHHHhhcc
Q psy501 513 ERLKSS-YILLHTLPLYTYHVPPIQTTCLLAGTERLKS-SYILLHTLP 558 (962)
Q Consensus 513 ~~i~~~-~~~~~~~~~~s~~l~~li~~Cl~~dperRPs-~~~Ll~~l~ 558 (962)
...... ..........+..+..++..||..+|++|++ .+++.+.+.
T Consensus 241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le 288 (932)
T PRK13184 241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLE 288 (932)
T ss_pred hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 211111 0011111245566788999999999999965 666766553
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=280.16 Aligned_cols=237 Identities=24% Similarity=0.352 Sum_probs=180.1
Q ss_pred ecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEE----eCCEEEEEEecCCCC
Q psy501 320 ILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIR----ENDTLYFVFEYMKEN 389 (962)
Q Consensus 320 i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~----~~~~~~LV~Ey~~g~ 389 (962)
..++.+.||.+.....++.++.+... .....+.+|+.+|++++||+|+++++++. .....++||||+.|+
T Consensus 14 g~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~ 93 (334)
T cd07855 14 GSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESD 93 (334)
T ss_pred ecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhhhh
Confidence 33344456776665545444433321 12345778999999999999999999885 345789999999998
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC------ccccc
Q psy501 390 LYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP------YTDYV 463 (962)
Q Consensus 390 Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~------~~~~~ 463 (962)
+.+.+... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++....... .....
T Consensus 94 l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 172 (334)
T cd07855 94 LHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172 (334)
T ss_pred HHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCccccccc
Confidence 87777554 459999999999999999999999999999999999999999999999999997654321 12346
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhc-----------------------cc
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSS-----------------------YI 520 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~-----------------------~~ 520 (962)
++..|+|||.+.+...++.++|||||||++|||++|++||.+.........+... ..
T Consensus 173 ~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 252 (334)
T cd07855 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLP 252 (334)
T ss_pred ccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcc
Confidence 8889999999876556899999999999999999999999876543322211110 00
Q ss_pred cccC------CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 521 LLHT------LPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 521 ~~~~------~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.... .+..+..+..++..||..+|++||++.+++..-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 253 RKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred cCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 0000 133566788899999999999999988877754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=278.29 Aligned_cols=245 Identities=22% Similarity=0.287 Sum_probs=184.2
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEecc-c---hhHHHHHHHHHHHHhcCCCCcccEEEEEEeC----------
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS-S---RDEMVVCFYRKSLKKLSHANLVKLKEVIREN---------- 376 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~-~---~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~---------- 376 (962)
+.+.....++.++.+.||.+.....++.++.+.. . .....+.+|++++++++||+|+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 3444544555555566888877666554443332 1 2234588899999999999999999877543
Q ss_pred ----CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc-ccceeeeccccc
Q psy501 377 ----DTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG-TELVKIADFGLA 451 (962)
Q Consensus 377 ----~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~-~g~vKL~DFGla 451 (962)
...|+||||+++++.+.+.. ..+++..++.++.||+.||.|||+.|++||||||+||+++. ++.++|+|||.+
T Consensus 85 ~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~ 162 (342)
T cd07854 85 LTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162 (342)
T ss_pred ccccceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccc
Confidence 35799999999988777653 35899999999999999999999999999999999999974 557899999999
Q ss_pred ccccCC-----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc-----
Q psy501 452 REIRSR-----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL----- 521 (962)
Q Consensus 452 ~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~----- 521 (962)
...... ......++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.........+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07854 163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242 (342)
T ss_pred eecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 765332 1122357889999998876667889999999999999999999999876554443333221100
Q ss_pred -----------------c------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 522 -----------------L------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 522 -----------------~------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
. ...+..+..+..++..||..+|++||++.+++..-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~ 301 (342)
T cd07854 243 RNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHP 301 (342)
T ss_pred hhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCC
Confidence 0 01123455567799999999999999988888754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=295.58 Aligned_cols=245 Identities=15% Similarity=0.226 Sum_probs=205.9
Q ss_pred EEecCCcccEEEEEecCCce---EEEEec-----cchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-C
Q psy501 318 SYILPHTLPLYTCNLDQDNH---ILSRHV-----SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-E 388 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~k---vv~~k~-----~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g 388 (962)
+++.+..+.|+.++++.-++ .++.|. .++....|..|+.||-+++||||+++.|+......++||+|||+ |
T Consensus 636 VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENG 715 (996)
T KOG0196|consen 636 VIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENG 715 (996)
T ss_pred EEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCC
Confidence 33333344477776654442 122222 34456679999999999999999999999999999999999998 8
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCc---ccccC-
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY---TDYVS- 464 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~---~~~~g- 464 (962)
+|..+++.+++.|+..++..+++.|+.|+.||-+.++|||||..+|||++.+-.+|++|||+++.+.++.. +...|
T Consensus 716 sLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGK 795 (996)
T KOG0196|consen 716 SLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGK 795 (996)
T ss_pred cHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCc
Confidence 89999999999999999999999999999999999999999999999999999999999999998865532 12222
Q ss_pred -CccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhcc
Q psy501 465 -TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 542 (962)
Q Consensus 465 -t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~ 542 (962)
...|.|||.+.. ..++.+|||||+|+++||.++ |+.||.+.+..+..+.|..+... |.+..+|..+.+|+..||+.
T Consensus 796 IPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRL-PpPmDCP~aL~qLMldCWqk 873 (996)
T KOG0196|consen 796 IPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRL-PPPMDCPAALYQLMLDCWQK 873 (996)
T ss_pred cceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCC-CCCCCCcHHHHHHHHHHHHH
Confidence 356999999975 479999999999999999887 99999999999999999988554 44668999999999999999
Q ss_pred CCCCCCcHHHHHhhccccccCC
Q psy501 543 GTERLKSSYILLHTLPLYTYHV 564 (962)
Q Consensus 543 dperRPs~~~Ll~~l~~~~~~~ 564 (962)
|-.+||.+.+|+..|..+-..+
T Consensus 874 dR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 874 DRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred HhhcCCCHHHHHHHHHHHhcCc
Confidence 9999999999999886654443
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=271.14 Aligned_cols=207 Identities=17% Similarity=0.199 Sum_probs=169.2
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHh
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD---------KFLPESIIRNMMYQVLQGLA 418 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~---------~~ls~~~i~~i~~qI~~aL~ 418 (962)
..+.+|+.+++.++||+|+++++++.++...++||||++ |+|.+++.... ..++...+..++.|++.||.
T Consensus 54 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 133 (288)
T cd05061 54 IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133 (288)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHH
Confidence 457889999999999999999999999999999999998 67777775421 23567788999999999999
Q ss_pred hcccceeeeccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHHHHH
Q psy501 419 FMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLF 494 (962)
Q Consensus 419 yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ 494 (962)
|||+.+++||||||+||+++.++.++|+|||+++...... .....++..|+|||.+.+. .++.++|||||||++|
T Consensus 134 ~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~ 212 (288)
T cd05061 134 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLW 212 (288)
T ss_pred HHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHH
Confidence 9999999999999999999999999999999987654321 1222446779999998654 6899999999999999
Q ss_pred HHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 495 YSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 495 ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
||++ |..||.+.........+..+.. .......+..+..++..||..+|++||++.++++.+
T Consensus 213 el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l 275 (288)
T cd05061 213 EITSLAEQPYQGLSNEQVLKFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275 (288)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9998 7999988766555554443322 222234466788999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=265.25 Aligned_cols=208 Identities=23% Similarity=0.377 Sum_probs=173.6
Q ss_pred HHHHHHHHHHHh-cCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHH---hcCCCCCHHHHHHHHHHHHHHHhhccc-
Q psy501 349 MVVCFYRKSLKK-LSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIR---DRDKFLPESIIRNMMYQVLQGLAFMHR- 422 (962)
Q Consensus 349 ~~~~~Ei~iL~~-L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~---~~~~~ls~~~i~~i~~qI~~aL~yLH~- 422 (962)
..+..|+.++.+ ++||||+++++++..++..++||||++| ++.+.+. .....+++..++.++.|++.||.|||+
T Consensus 53 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 132 (269)
T cd08528 53 GDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE 132 (269)
T ss_pred HHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC
Confidence 457788888875 7999999999999999999999999985 5655553 334569999999999999999999996
Q ss_pred ceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCC
Q psy501 423 HGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVP 501 (962)
Q Consensus 423 ~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~ 501 (962)
.+++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+. .++.++||||||+++|+|++|++
T Consensus 133 ~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~ 211 (269)
T cd08528 133 KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQP 211 (269)
T ss_pred CceeecCCCHHHEEECCCCcEEEecccceeecccccccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCC
Confidence 78999999999999999999999999999765544 33445788999999999764 58999999999999999999999
Q ss_pred CCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 502 PIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 502 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
||...........+......+.....++..+..++..||..+|++||++.++...+
T Consensus 212 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~ 267 (269)
T cd08528 212 PFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267 (269)
T ss_pred cccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence 99887766666555554433322335677889999999999999999999887754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=295.12 Aligned_cols=187 Identities=19% Similarity=0.255 Sum_probs=149.9
Q ss_pred HHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeee
Q psy501 350 VVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFH 427 (962)
Q Consensus 350 ~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvH 427 (962)
....|..++..++ ||.++++...++.+...++++++..| .+...+.. ...+.+.....+...++.|++++|+.+++|
T Consensus 42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiy 120 (612)
T KOG0603|consen 42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAY 120 (612)
T ss_pred ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHH
Confidence 3456778888887 99999999999999999999999986 55554443 455888889999999999999999999999
Q ss_pred ccCCCcccccccccceeeecccccccccCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcC
Q psy501 428 RDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTC 507 (962)
Q Consensus 428 rDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~ 507 (962)
||+|++||+++.+|.+++.|||.++..-..... +||..|||||++. ....++|.||||++++||+||-.||.+
T Consensus 121 rd~k~enilld~~Ghi~~tdfglske~v~~~~~--cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~-- 193 (612)
T KOG0603|consen 121 RDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG-- 193 (612)
T ss_pred hcccccceeecccCccccCCchhhhHhHhhhhc--ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch--
Confidence 999999999999999999999999876554433 8999999999996 468899999999999999999999988
Q ss_pred hhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCC
Q psy501 508 LLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK 548 (962)
Q Consensus 508 ~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRP 548 (962)
+....|....... +...+...+.++...+..+|..|-
T Consensus 194 --~~~~~Il~~~~~~--p~~l~~~a~~~~~~l~~r~p~nrL 230 (612)
T KOG0603|consen 194 --DTMKRILKAELEM--PRELSAEARSLFRQLFKRNPENRL 230 (612)
T ss_pred --HHHHHHhhhccCC--chhhhHHHHHHHHHHHhhCHHHHh
Confidence 4444454432222 234444555566666666665553
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=277.69 Aligned_cols=239 Identities=24% Similarity=0.339 Sum_probs=187.6
Q ss_pred EEecCCcccEEEEEecCCceEEEEecc------chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-----EEEEEEecC
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVS------SRDEMVVCFYRKSLKKLSHANLVKLKEVIREND-----TLYFVFEYM 386 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~-----~~~LV~Ey~ 386 (962)
.+..++.+.||.+.....++.++.+.. ......+.+|+.++++++||+|+++++++.... .+|+||||+
T Consensus 7 ~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 86 (330)
T cd07834 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM 86 (330)
T ss_pred eecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecch
Confidence 334444555777776654444443322 122346889999999999999999999998765 789999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC-----ccc
Q psy501 387 KENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP-----YTD 461 (962)
Q Consensus 387 ~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~-----~~~ 461 (962)
++++.+.+.... .+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||.+....... ...
T Consensus 87 ~~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~ 165 (330)
T cd07834 87 ETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165 (330)
T ss_pred hhhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccc
Confidence 988887776543 79999999999999999999999999999999999999999999999999998765442 334
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc------------------
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH------------------ 523 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------ 523 (962)
..++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.........+......+.
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (330)
T cd07834 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKS 245 (330)
T ss_pred cccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhh
Confidence 56788999999997755789999999999999999999999988776554444333211100
Q ss_pred -----------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 524 -----------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 524 -----------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..+..+..+..++..||..+|++||++.+++..-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 246 LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 0122455667899999999999999988887654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=269.27 Aligned_cols=230 Identities=22% Similarity=0.259 Sum_probs=179.3
Q ss_pred ccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHh
Q psy501 325 LPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRD 396 (962)
Q Consensus 325 ~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~ 396 (962)
+.||.|.....++.++.+... .....+..|+++|++++||+|+++++++...+..|+||||++| +|.+.+..
T Consensus 7 g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 86 (277)
T cd05577 7 GEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYN 86 (277)
T ss_pred eeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHH
Confidence 356666655555444433321 1233467899999999999999999999999999999999985 66666655
Q ss_pred cC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCccccChhhh
Q psy501 397 RD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPEVL 474 (962)
Q Consensus 397 ~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~APE~l 474 (962)
.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||++
T Consensus 87 ~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~ 166 (277)
T cd05577 87 VGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVL 166 (277)
T ss_pred cCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHh
Confidence 43 36999999999999999999999999999999999999999999999999998765432 23345678899999998
Q ss_pred ccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc--cccCCCCCCCCcHHHHHHHhccCCCCCC----
Q psy501 475 LHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI--LLHTLPLYTYHVPPIQTTCLLAGTERLK---- 548 (962)
Q Consensus 475 ~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~s~~l~~li~~Cl~~dperRP---- 548 (962)
.+. .++.++|||||||++|+|++|+.||...........+..... .....+.++..+..++..||..+|++||
T Consensus 167 ~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 167 QGE-VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred cCC-CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 764 589999999999999999999999987654322222222211 1222345677889999999999999999
Q ss_pred -cHHHHHh
Q psy501 549 -SSYILLH 555 (962)
Q Consensus 549 -s~~~Ll~ 555 (962)
++.+|+.
T Consensus 246 ~~~~~ll~ 253 (277)
T cd05577 246 GSADEVRE 253 (277)
T ss_pred ccHHHHHh
Confidence 7776765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=262.38 Aligned_cols=236 Identities=19% Similarity=0.272 Sum_probs=186.5
Q ss_pred EecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHH
Q psy501 319 YILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLY 391 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll 391 (962)
+..++.+.||++.....+..++.+... .+...+.+|+.++++++||+|+++++.+..+...++|+||++ ++|.
T Consensus 8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 87 (257)
T cd08225 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLM 87 (257)
T ss_pred ecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHH
Confidence 333444557777766555444433322 234568899999999999999999999999999999999997 4777
Q ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc-ceeeecccccccccCCC--cccccCCcc
Q psy501 392 QLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE-LVKIADFGLAREIRSRP--YTDYVSTRW 467 (962)
Q Consensus 392 ~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g-~vKL~DFGla~~~~~~~--~~~~~gt~~ 467 (962)
+.+.... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||.+....... .....|++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 167 (257)
T cd08225 88 KRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPY 167 (257)
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCcc
Confidence 7665533 3589999999999999999999999999999999999998876 56999999997665432 223468889
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCC
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERL 547 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperR 547 (962)
|+|||++.+. .++.++|+|||||++|||++|..||...........+..... .+..+..+..+..++..||..+|++|
T Consensus 168 ~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R 245 (257)
T cd08225 168 YLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF-APISPNFSRDLRSLISQLFKVSPRDR 245 (257)
T ss_pred ccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC-CCCCCCCCHHHHHHHHHHhccChhhC
Confidence 9999988654 688999999999999999999999987766555554444322 23344567788999999999999999
Q ss_pred CcHHHHHhh
Q psy501 548 KSSYILLHT 556 (962)
Q Consensus 548 Ps~~~Ll~~ 556 (962)
|++.+++..
T Consensus 246 pt~~~ll~~ 254 (257)
T cd08225 246 PSITSILKR 254 (257)
T ss_pred cCHHHHhhC
Confidence 999888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=284.85 Aligned_cols=208 Identities=21% Similarity=0.253 Sum_probs=169.9
Q ss_pred HHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC----------------------------
Q psy501 349 MVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD---------------------------- 398 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~---------------------------- 398 (962)
..+.+|+++|.++. ||||+++++++...+..++||||+. |+|.+++....
T Consensus 85 ~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (401)
T cd05107 85 QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQR 164 (401)
T ss_pred HHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccccc
Confidence 36889999999997 9999999999999999999999998 67777775321
Q ss_pred ---------------------------------------------------------------------CCCCHHHHHHH
Q psy501 399 ---------------------------------------------------------------------KFLPESIIRNM 409 (962)
Q Consensus 399 ---------------------------------------------------------------------~~ls~~~i~~i 409 (962)
..+++..++.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 244 (401)
T cd05107 165 KSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGF 244 (401)
T ss_pred ccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHH
Confidence 23677888999
Q ss_pred HHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----CcccccCCccccChhhhccCCCCCchhH
Q psy501 410 MYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIH 485 (962)
Q Consensus 410 ~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksD 485 (962)
+.||+.||.|||+.+++||||||+||+++.++.+||+|||+++..... ......++..|+|||.+.+ ..++.++|
T Consensus 245 ~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D 323 (401)
T cd05107 245 SYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSD 323 (401)
T ss_pred HHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhH
Confidence 999999999999999999999999999999999999999999765322 1223456788999999965 46899999
Q ss_pred HHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 486 LSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 486 IwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
||||||++|||++ |..||........................++..+..++..||..+|+.||++.+|++.|
T Consensus 324 vwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 396 (401)
T cd05107 324 VWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396 (401)
T ss_pred HHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9999999999998 89999876544433333222222333345677888999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=265.92 Aligned_cols=233 Identities=18% Similarity=0.225 Sum_probs=182.9
Q ss_pred ecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHH
Q psy501 320 ILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQL 393 (962)
Q Consensus 320 i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~ 393 (962)
..++.+.||.+......+.++.+... .....+.+|+.++++++||+|+++++++..+...++||||+++ ++.+.
T Consensus 13 g~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~ 92 (277)
T cd06641 13 GKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL 92 (277)
T ss_pred eecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHH
Confidence 33444457777655544444443322 1234688999999999999999999999999999999999986 55555
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccCh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAP 471 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~AP 471 (962)
+.. ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++...... ......++..|+||
T Consensus 93 i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~P 170 (277)
T cd06641 93 LEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170 (277)
T ss_pred Hhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccCh
Confidence 443 35899999999999999999999999999999999999999999999999998765443 22234678899999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHH
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 551 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~ 551 (962)
|.+.+ ..++.++|+|||||++|+|++|..||...........+.... .......++..+.+++..||..+|+.||++.
T Consensus 171 E~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~ 248 (277)
T cd06641 171 EVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTAK 248 (277)
T ss_pred hhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC-CCCCCcccCHHHHHHHHHHccCChhhCcCHH
Confidence 99865 467899999999999999999999998766554444443321 1222335667788999999999999999988
Q ss_pred HHHhh
Q psy501 552 ILLHT 556 (962)
Q Consensus 552 ~Ll~~ 556 (962)
+++..
T Consensus 249 ~~l~~ 253 (277)
T cd06641 249 ELLKH 253 (277)
T ss_pred HHHhC
Confidence 88875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=259.20 Aligned_cols=237 Identities=22% Similarity=0.287 Sum_probs=186.8
Q ss_pred EEecCCcccEEEEEecCCceEEEEecc-c-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CEEEEEEecCC-C
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVS-S-----RDEMVVCFYRKSLKKLSHANLVKLKEVIREN--DTLYFVFEYMK-E 388 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~-~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~LV~Ey~~-g 388 (962)
.+..++.+.+|.+.....++.+..+.. . .....+.+|++++++++||+|+++++.+... ...++|+||++ +
T Consensus 7 ~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 86 (260)
T cd06606 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGG 86 (260)
T ss_pred EeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCC
Confidence 344445556888877654544333322 1 2245789999999999999999999999988 89999999996 5
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC----cccccC
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVS 464 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~g 464 (962)
++.+.+... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+....... .....+
T Consensus 87 ~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 165 (260)
T cd06606 87 SLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165 (260)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCC
Confidence 566655544 479999999999999999999999999999999999999999999999999998776543 345678
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcC-hhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccC
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTC-LLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
+..|+|||.+.+. .++.++||||||+++|+|++|..||.... .......+.............+..+..++..|+..+
T Consensus 166 ~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~ 244 (260)
T cd06606 166 TPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRD 244 (260)
T ss_pred CccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCC
Confidence 8999999998654 58999999999999999999999998776 222223332212222333455778899999999999
Q ss_pred CCCCCcHHHHHhh
Q psy501 544 TERLKSSYILLHT 556 (962)
Q Consensus 544 perRPs~~~Ll~~ 556 (962)
|++||+..+++..
T Consensus 245 p~~Rp~~~~ll~~ 257 (260)
T cd06606 245 PKKRPTADELLQH 257 (260)
T ss_pred hhhCCCHHHHhhC
Confidence 9999998887763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=269.08 Aligned_cols=233 Identities=16% Similarity=0.202 Sum_probs=176.6
Q ss_pred ccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEecCCCCHHHHHH---
Q psy501 325 LPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMKENLYQLIR--- 395 (962)
Q Consensus 325 ~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~--- 395 (962)
+.||.+.....+..++.+... .....+.+|+.++.++. ||||+++++++..++..+++|||+.+++.+...
T Consensus 18 g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~~l~~l~~~~~ 97 (288)
T cd06616 18 GTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVY 97 (288)
T ss_pred eEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccCCHHHHHHHHH
Confidence 346666555544444333221 23446889999999996 999999999999999999999999876655432
Q ss_pred -hcCCCCCHHHHHHHHHHHHHHHhhccc-ceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCccccChh
Q psy501 396 -DRDKFLPESIIRNMMYQVLQGLAFMHR-HGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPE 472 (962)
Q Consensus 396 -~~~~~ls~~~i~~i~~qI~~aL~yLH~-~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~APE 472 (962)
.....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++...... ......++..|+|||
T Consensus 98 ~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE 177 (288)
T cd06616 98 EVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 177 (288)
T ss_pred HhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHH
Confidence 223569999999999999999999997 49999999999999999999999999999765433 233446889999999
Q ss_pred hhccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCcChh-hhHHHHHhccc-ccc--CCCCCCCCcHHHHHHHhccCCCC
Q psy501 473 VLLHS--TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL-AGTERLKSSYI-LLH--TLPLYTYHVPPIQTTCLLAGTER 546 (962)
Q Consensus 473 ~l~~~--~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~-~~~~~i~~~~~-~~~--~~~~~s~~l~~li~~Cl~~dper 546 (962)
++.+. ..++.++|||||||++|+|++|+.||...... .....+..+.. ..+ ....++..+..++..||..+|++
T Consensus 178 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 257 (288)
T cd06616 178 RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESK 257 (288)
T ss_pred HhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhh
Confidence 99765 36899999999999999999999999765421 11122211111 111 11135566788999999999999
Q ss_pred CCcHHHHHhhc
Q psy501 547 LKSSYILLHTL 557 (962)
Q Consensus 547 RPs~~~Ll~~l 557 (962)
||++.+++..-
T Consensus 258 Rpt~~~i~~~~ 268 (288)
T cd06616 258 RPKYKELLEHP 268 (288)
T ss_pred CcCHHHHhcCh
Confidence 99998887754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=266.47 Aligned_cols=237 Identities=18% Similarity=0.247 Sum_probs=181.2
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEe--CCEEEEEEecCCC-C
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRE--NDTLYFVFEYMKE-N 389 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~LV~Ey~~g-~ 389 (962)
.+..++.+.||.+......+.++.+... .....+.+|++++++++||||+++++++.+ .+.+++||||++| +
T Consensus 8 ~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~ 87 (287)
T cd06621 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGS 87 (287)
T ss_pred EeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCC
Confidence 3444445568888876665555544432 124568999999999999999999999864 3478999999985 5
Q ss_pred HHHHHH---hcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCc
Q psy501 390 LYQLIR---DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTR 466 (962)
Q Consensus 390 Ll~~l~---~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~ 466 (962)
|.+.+. .....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++............++.
T Consensus 88 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 167 (287)
T cd06621 88 LDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTS 167 (287)
T ss_pred HHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccccccccCCc
Confidence 655443 23456899999999999999999999999999999999999999999999999998766544444556788
Q ss_pred cccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcCh-----hhhHHHHHhccccccCCC-------CCCCCcHH
Q psy501 467 WYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCL-----LAGTERLKSSYILLHTLP-------LYTYHVPP 534 (962)
Q Consensus 467 ~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~-----~~~~~~i~~~~~~~~~~~-------~~s~~l~~ 534 (962)
.|+|||.+.+ ..++.++|||||||++|+|++|..||..... ......+.... .+..+ ..+..+..
T Consensus 168 ~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 244 (287)
T cd06621 168 FYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP--NPELKDEPGNGIKWSEEFKD 244 (287)
T ss_pred cccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC--chhhccCCCCCCchHHHHHH
Confidence 9999999865 4689999999999999999999999987622 22222222211 11111 12345678
Q ss_pred HHHHHhccCCCCCCcHHHHHhhc
Q psy501 535 IQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 535 li~~Cl~~dperRPs~~~Ll~~l 557 (962)
++..||..+|+.||++.+++..-
T Consensus 245 li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 245 FIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred HHHHHcCCCcccCCCHHHHHhCc
Confidence 99999999999999988877754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=259.53 Aligned_cols=236 Identities=23% Similarity=0.309 Sum_probs=189.6
Q ss_pred EecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHH
Q psy501 319 YILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLY 391 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll 391 (962)
+..++.+.||.+....++..++.+... .....+.+|++++++++||+++++++.+..+...++|+|+++| +|.
T Consensus 8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 87 (258)
T cd08215 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLS 87 (258)
T ss_pred eccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHH
Confidence 334444567777766544443333322 2345688999999999999999999999999999999999985 677
Q ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCc
Q psy501 392 QLIRDR---DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTR 466 (962)
Q Consensus 392 ~~l~~~---~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~ 466 (962)
+.+... ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...... ......+++
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 167 (258)
T cd08215 88 QKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTP 167 (258)
T ss_pred HHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcceecceeeee
Confidence 777654 367999999999999999999999999999999999999999999999999999766544 233356888
Q ss_pred cccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCC
Q psy501 467 WYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTER 546 (962)
Q Consensus 467 ~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dper 546 (962)
.|+|||.+.+ ..++.++|+||+|+++|+|++|..||................ ..+....++..+..++..||..+|++
T Consensus 168 ~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~ 245 (258)
T cd08215 168 YYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-YPPIPSQYSSELRNLVSSLLQKDPEE 245 (258)
T ss_pred cccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhh
Confidence 9999998865 468899999999999999999999998877665555554432 22223366778889999999999999
Q ss_pred CCcHHHHHhh
Q psy501 547 LKSSYILLHT 556 (962)
Q Consensus 547 RPs~~~Ll~~ 556 (962)
||++.+++..
T Consensus 246 Rp~~~~ll~~ 255 (258)
T cd08215 246 RPSIAQILQS 255 (258)
T ss_pred CcCHHHHhcC
Confidence 9999888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=313.92 Aligned_cols=237 Identities=22% Similarity=0.267 Sum_probs=190.2
Q ss_pred ecCCcc-cEEEEEecCCceEEEEeccch---h---HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHH
Q psy501 320 ILPHTL-PLYTCNLDQDNHILSRHVSSR---D---EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQ 392 (962)
Q Consensus 320 i~~~~~-~Vy~~~~~~~~kvv~~k~~~~---~---~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~ 392 (962)
+++|.+ .||.+....++..++.+.... + ...+.+|..+|..|+|||+|++||+-.+.+..+|.||||.|+.+.
T Consensus 1243 Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa 1322 (1509)
T KOG4645|consen 1243 IGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLA 1322 (1509)
T ss_pred cCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHH
Confidence 334444 488887777777665543221 1 234889999999999999999999999999999999999977777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC------CcccccCCc
Q psy501 393 LIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR------PYTDYVSTR 466 (962)
Q Consensus 393 ~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~------~~~~~~gt~ 466 (962)
.+...+...++.....+..|++.|+.|||+.|||||||||.||+++..|.+|++|||.|..+... ......||+
T Consensus 1323 ~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~ 1402 (1509)
T KOG4645|consen 1323 SLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTP 1402 (1509)
T ss_pred HHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCc
Confidence 77777777888889999999999999999999999999999999999999999999999887654 234568999
Q ss_pred cccChhhhccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCcChh-hhHHHHHhccccccCCCCCCCCcHHHHHHHhccC
Q psy501 467 WYRAPEVLLHST--AYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL-AGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 467 ~Y~APE~l~~~~--~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
.|||||++.+.. ...-++||||||||+.||+||+.||...+.. +.+.++..+ ..++.+...+..-.+++..||..|
T Consensus 1403 ~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g-h~Pq~P~~ls~~g~dFle~Cl~~d 1481 (1509)
T KOG4645|consen 1403 MYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG-HKPQIPERLSSEGRDFLEHCLEQD 1481 (1509)
T ss_pred hhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc-CCCCCchhhhHhHHHHHHHHHhcC
Confidence 999999998643 4667999999999999999999999876544 444444444 334444457777888999999999
Q ss_pred CCCCCcH-HHHHhhc
Q psy501 544 TERLKSS-YILLHTL 557 (962)
Q Consensus 544 perRPs~-~~Ll~~l 557 (962)
|.+|=++ +.+-|.+
T Consensus 1482 P~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1482 PKMRWTASQLLEHAF 1496 (1509)
T ss_pred chhhhHHHHHHHhhc
Confidence 9999776 3444433
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=262.31 Aligned_cols=234 Identities=22% Similarity=0.341 Sum_probs=186.7
Q ss_pred cCCcccEEEEEecCCceEEEEecc------chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHH
Q psy501 321 LPHTLPLYTCNLDQDNHILSRHVS------SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQL 393 (962)
Q Consensus 321 ~~~~~~Vy~~~~~~~~kvv~~k~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~ 393 (962)
.++.+.+|.+.....++.++.+.. ..+...+.+|++++++++||+|+++++++.++...++||||++| +|.+.
T Consensus 10 ~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~ 89 (256)
T cd08530 10 KGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKA 89 (256)
T ss_pred CCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHH
Confidence 334445777765555444333321 12234678899999999999999999999999999999999975 66666
Q ss_pred HHhc---CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccccC
Q psy501 394 IRDR---DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRA 470 (962)
Q Consensus 394 l~~~---~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~A 470 (962)
+... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++............++..|+|
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~ 169 (256)
T cd08530 90 ISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMA 169 (256)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCcccccCCccccC
Confidence 5442 3568999999999999999999999999999999999999999999999999998776554444568889999
Q ss_pred hhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcH
Q psy501 471 PEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 550 (962)
Q Consensus 471 PE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~ 550 (962)
||.+.+ ..++.++|+||||+++|+|++|+.||...........+..... .+....++..+..++..||..+|++||++
T Consensus 170 Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 247 (256)
T cd08530 170 PEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY-PPIPPIYSQDLQNFIRSMLQVKPKLRPNC 247 (256)
T ss_pred HHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCchhhCHHHHHHHHHHcCCCcccCCCH
Confidence 999965 4688999999999999999999999988776555555444322 22223566778999999999999999999
Q ss_pred HHHHhh
Q psy501 551 YILLHT 556 (962)
Q Consensus 551 ~~Ll~~ 556 (962)
.+++..
T Consensus 248 ~~~l~~ 253 (256)
T cd08530 248 DKILAS 253 (256)
T ss_pred HHHhcC
Confidence 888764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=268.59 Aligned_cols=208 Identities=19% Similarity=0.256 Sum_probs=165.3
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeC--CEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccce
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIREN--DTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHG 424 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~g 424 (962)
...+.+|+.++++++||||+++++++... ...++||||++ ++|.+++......+++..++.++.|++.||+|||+.|
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g 129 (284)
T cd05079 50 IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129 (284)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34689999999999999999999999765 57899999997 5666666555556899999999999999999999999
Q ss_pred eeeccCCCcccccccccceeeecccccccccCCC-----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcC
Q psy501 425 FFHRDMKPENLLCMGTELVKIADFGLAREIRSRP-----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDH 499 (962)
Q Consensus 425 IvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~-----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG 499 (962)
++||||||+||+++.++.++|+|||++..+.... .....++..|+|||++.+. .++.++|||||||++|||+++
T Consensus 130 i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~ 208 (284)
T cd05079 130 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTY 208 (284)
T ss_pred eeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcC
Confidence 9999999999999999999999999998664331 1234567789999998654 689999999999999999998
Q ss_pred CCCCCCcCh---------------hhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 500 VPPIQTTCL---------------LAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 500 ~~Pf~~~~~---------------~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..|+..... ......+..+ ...+....++..+..++..||..+|++||++.+++..+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 280 (284)
T cd05079 209 CDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG-KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF 280 (284)
T ss_pred CCCCccccchhhhhcccccccccHHHHHHHHHcC-ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 776532110 0011111111 12223345677888999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=259.46 Aligned_cols=234 Identities=25% Similarity=0.315 Sum_probs=184.4
Q ss_pred ecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHH
Q psy501 320 ILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQ 392 (962)
Q Consensus 320 i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~ 392 (962)
..++.+.+|.+......+.++.+... .....+.+|++++++++||+++++++++.++...++||||+++ +|.+
T Consensus 9 ~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 88 (254)
T cd06627 9 GRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQ 88 (254)
T ss_pred cccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHH
Confidence 33344456766655444333322211 2335689999999999999999999999999999999999986 5555
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCc--ccccCCccccC
Q psy501 393 LIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY--TDYVSTRWYRA 470 (962)
Q Consensus 393 ~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~--~~~~gt~~Y~A 470 (962)
.+... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........ ....++..|+|
T Consensus 89 ~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~ 167 (254)
T cd06627 89 IIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMA 167 (254)
T ss_pred HHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcC
Confidence 55443 6699999999999999999999999999999999999999999999999999987655432 34568889999
Q ss_pred hhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcH
Q psy501 471 PEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 550 (962)
Q Consensus 471 PE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~ 550 (962)
||...+. .++.++||||||+++|+|++|..||................ .....+..+..+..++..||..+|++||++
T Consensus 168 pe~~~~~-~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 245 (254)
T cd06627 168 PEVIEMS-GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQCFQKDPNLRPTA 245 (254)
T ss_pred HhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC-CCCCCCCCCHHHHHHHHHHHhCChhhCcCH
Confidence 9998654 58899999999999999999999998766544444443221 122234566788899999999999999999
Q ss_pred HHHHhh
Q psy501 551 YILLHT 556 (962)
Q Consensus 551 ~~Ll~~ 556 (962)
.+++..
T Consensus 246 ~~~l~~ 251 (254)
T cd06627 246 KQLLKH 251 (254)
T ss_pred HHHhcC
Confidence 888763
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=270.17 Aligned_cols=245 Identities=17% Similarity=0.198 Sum_probs=185.2
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEecC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
+.....+..+..+.||.+.....++.++.+... .....+.+|+.++.++. ||+|+++++++.++...|+||||+
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 333444444455567887776545444443322 12334667777776665 999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhccc-ceeeeccCCCcccccccccceeeecccccccccCC-CcccccC
Q psy501 387 KENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHR-HGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVS 464 (962)
Q Consensus 387 ~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~-~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~g 464 (962)
.+.+.+.+......+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.++|+|||++..+... ......+
T Consensus 97 ~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 176 (296)
T cd06618 97 STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAG 176 (296)
T ss_pred CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcccCCCC
Confidence 988877776656679999999999999999999997 59999999999999999999999999999765433 2233457
Q ss_pred CccccChhhhccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCcCh-hhhHHHHHhccc-cccCCCCCCCCcHHHHHHH
Q psy501 465 TRWYRAPEVLLHS---TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCL-LAGTERLKSSYI-LLHTLPLYTYHVPPIQTTC 539 (962)
Q Consensus 465 t~~Y~APE~l~~~---~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~-~~~~~~i~~~~~-~~~~~~~~s~~l~~li~~C 539 (962)
+..|+|||.+.+. ..++.++||||||+++|+|++|+.||..... ......+..... ..+....++..+..++..|
T Consensus 177 ~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 256 (296)
T cd06618 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLC 256 (296)
T ss_pred CccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHH
Confidence 8899999998643 2478899999999999999999999976433 222233322221 1111123566788999999
Q ss_pred hccCCCCCCcHHHHHhhc
Q psy501 540 LLAGTERLKSSYILLHTL 557 (962)
Q Consensus 540 l~~dperRPs~~~Ll~~l 557 (962)
|..+|+.||++.+++...
T Consensus 257 l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 257 LTKDHRKRPKYRELLQHP 274 (296)
T ss_pred ccCChhhCCCHHHHhcCh
Confidence 999999999998888764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=265.66 Aligned_cols=209 Identities=21% Similarity=0.205 Sum_probs=165.1
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEe--CCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccce
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRE--NDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHG 424 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~g 424 (962)
...+.+|++++++++||||+++++++.. ...+++||||++ |+|.+++......+++..++.++.|++.||.|||+.|
T Consensus 49 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~ 128 (284)
T cd05081 49 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128 (284)
T ss_pred HHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3468899999999999999999998753 346899999997 5777777665566899999999999999999999999
Q ss_pred eeeccCCCcccccccccceeeecccccccccCCCc-----ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcC
Q psy501 425 FFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY-----TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDH 499 (962)
Q Consensus 425 IvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~-----~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG 499 (962)
++|+||||+||+++.++.++|+|||++........ ....++..|+|||++.+. .++.++|||||||++|||++|
T Consensus 129 i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~ 207 (284)
T cd05081 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTY 207 (284)
T ss_pred ceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhc
Confidence 99999999999999999999999999986644321 112234569999999654 689999999999999999998
Q ss_pred CCCCCCcChhhh---------------HHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 500 VPPIQTTCLLAG---------------TERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 500 ~~Pf~~~~~~~~---------------~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..|+........ ...+.......+....++..+..++..||..+|+.||++.+++..+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05081 208 SDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280 (284)
T ss_pred CCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 877654322110 0111112222333345667789999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=277.18 Aligned_cols=234 Identities=21% Similarity=0.251 Sum_probs=190.4
Q ss_pred eeeEEEEecCCccc-EEEEEecCCceEEEEeccchh-------HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 313 ERLKFSYILPHTLP-LYTCNLDQDNHILSRHVSSRD-------EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 313 ~~~~~~~i~~~~~~-Vy~~~~~~~~kvv~~k~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
....+.++++|+++ |+.|....++|.++.+...+. +.....|..+|+++..+.||.+-.+|++.+.+|+||.
T Consensus 186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLt 265 (591)
T KOG0986|consen 186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLT 265 (591)
T ss_pred ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEE
Confidence 34455566665555 999999999988765543332 3458899999999999999999999999999999999
Q ss_pred cCCCC-HHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-Cccc
Q psy501 385 YMKEN-LYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTD 461 (962)
Q Consensus 385 y~~g~-Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~ 461 (962)
.|.|+ |.-++...+ ..|++..++.++.+|+.||.+||+.+||+||+||+|||+|+.|.++|+|+|+|..+... ....
T Consensus 266 lMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~ 345 (591)
T KOG0986|consen 266 LMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRG 345 (591)
T ss_pred eecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCcccc
Confidence 99865 444444333 46999999999999999999999999999999999999999999999999999988765 4555
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHH----HhccccccCCCCCCCCcHHHHH
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERL----KSSYILLHTLPLYTYHVPPIQT 537 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i----~~~~~~~~~~~~~s~~l~~li~ 537 (962)
.+||.+|||||++.++. |+...|.|||||+||||+.|+.||...........+ .......+ ..++.....|.+
T Consensus 346 rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~--~kFS~eakslc~ 422 (591)
T KOG0986|consen 346 RVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS--DKFSEEAKSLCE 422 (591)
T ss_pred ccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc--cccCHHHHHHHH
Confidence 69999999999998764 999999999999999999999999875544333333 22322222 577778888999
Q ss_pred HHhccCCCCCCc
Q psy501 538 TCLLAGTERLKS 549 (962)
Q Consensus 538 ~Cl~~dperRPs 549 (962)
..|..+|++|--
T Consensus 423 ~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 423 GLLTKDPEKRLG 434 (591)
T ss_pred HHHccCHHHhcc
Confidence 999999998853
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=267.55 Aligned_cols=234 Identities=22% Similarity=0.307 Sum_probs=185.2
Q ss_pred CcccEEEEEecCCceEEEEeccc-h--hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSS-R--DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD 398 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~-~--~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~ 398 (962)
+.+.||.+........++.+... . ....+.+|++++++++|+||+++++++..+...|+|+||++ ++|.+.+....
T Consensus 31 ~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 110 (286)
T cd06614 31 ASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF 110 (286)
T ss_pred CCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc
Confidence 34456776665433333333222 1 24568899999999999999999999999999999999999 57777776654
Q ss_pred CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhhhcc
Q psy501 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEVLLH 476 (962)
Q Consensus 399 ~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~l~~ 476 (962)
..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+
T Consensus 111 ~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 190 (286)
T cd06614 111 VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR 190 (286)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcC
Confidence 47999999999999999999999999999999999999999999999999998755433 2233457889999999865
Q ss_pred CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHh
Q psy501 477 STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL-HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLH 555 (962)
Q Consensus 477 ~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~ 555 (962)
..++.++|+|||||++|+|++|+.||...........+....... .....++..+..++..||..+|..||++.+++.
T Consensus 191 -~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 191 -KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 468999999999999999999999998876665555444332211 112236677899999999999999999998887
Q ss_pred hc
Q psy501 556 TL 557 (962)
Q Consensus 556 ~l 557 (962)
..
T Consensus 270 ~~ 271 (286)
T cd06614 270 HP 271 (286)
T ss_pred Ch
Confidence 44
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=268.56 Aligned_cols=238 Identities=44% Similarity=0.649 Sum_probs=186.2
Q ss_pred EecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEecCCCCHHH
Q psy501 319 YILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMKENLYQ 392 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~ 392 (962)
+..++.+.||.+......+.++.+... .+.....+|+..+++++ ||+|+++++++..++..++||||+.|++.+
T Consensus 7 ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~ 86 (283)
T cd07830 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQ 86 (283)
T ss_pred eccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecCCCCHHH
Confidence 344445568888776655544433321 12334567999999999 999999999999999999999999999998
Q ss_pred HHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCccccC
Q psy501 393 LIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRA 470 (962)
Q Consensus 393 ~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~A 470 (962)
.+.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... ......++..|+|
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~a 166 (283)
T cd07830 87 LMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRA 166 (283)
T ss_pred HHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCCcccccC
Confidence 887654 46899999999999999999999999999999999999999999999999999866543 3344568889999
Q ss_pred hhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc----------------------------c
Q psy501 471 PEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL----------------------------L 522 (962)
Q Consensus 471 PE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~----------------------------~ 522 (962)
||++.+...++.++|+||||+++|||++|++||...........+...... .
T Consensus 167 PE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (283)
T cd07830 167 PEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLH 246 (283)
T ss_pred ceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHH
Confidence 999876667899999999999999999999999876554433322211000 0
Q ss_pred cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 523 HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 523 ~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
...+..+..+..++..||..+|++||++.+++..
T Consensus 247 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 247 QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0011224567789999999999999999888764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=276.23 Aligned_cols=232 Identities=30% Similarity=0.420 Sum_probs=178.2
Q ss_pred CcccEEEEEecCCceEEEEe-cc-----chhHHHHHHHHHHHHhc-CCCCcccEEEEEEe--CCEEEEEEecCCCCHHHH
Q psy501 323 HTLPLYTCNLDQDNHILSRH-VS-----SRDEMVVCFYRKSLKKL-SHANLVKLKEVIRE--NDTLYFVFEYMKENLYQL 393 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k-~~-----~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~--~~~~~LV~Ey~~g~Ll~~ 393 (962)
+.+.||.+.....++.++.+ +. ......+.+|+.+++++ +||||+++++++.. +...|+||||++++|...
T Consensus 19 ~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~ 98 (337)
T cd07852 19 AYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAV 98 (337)
T ss_pred CCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccccCHHHH
Confidence 33446666655444333322 21 12234577899999999 99999999999864 346899999999988887
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-------CcccccCCc
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-------PYTDYVSTR 466 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-------~~~~~~gt~ 466 (962)
+... .+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||.+...... ......|+.
T Consensus 99 ~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~ 176 (337)
T cd07852 99 IRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176 (337)
T ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccc
Confidence 7654 6889999999999999999999999999999999999999999999999999765432 222346788
Q ss_pred cccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc-------------------------
Q psy501 467 WYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL------------------------- 521 (962)
Q Consensus 467 ~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------------- 521 (962)
.|+|||.+.+...++.++|||||||++|+|++|+.||.+........++......
T Consensus 177 ~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (337)
T cd07852 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRP 256 (337)
T ss_pred cccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhccccc
Confidence 9999999876667889999999999999999999999876554433332211100
Q ss_pred ----ccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 522 ----LHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 522 ----~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
....+..+..+..++..||..+|+.||++.+++..
T Consensus 257 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 257 RKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred ccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 01112346667889999999999999998888874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=274.40 Aligned_cols=237 Identities=24% Similarity=0.368 Sum_probs=181.3
Q ss_pred ecCCcccEEEEEecCCceEEEEecc------chhHHHHHHHHHHHHhcCCCCcccEEEEEEeC-----CEEEEEEecCCC
Q psy501 320 ILPHTLPLYTCNLDQDNHILSRHVS------SRDEMVVCFYRKSLKKLSHANLVKLKEVIREN-----DTLYFVFEYMKE 388 (962)
Q Consensus 320 i~~~~~~Vy~~~~~~~~kvv~~k~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~-----~~~~LV~Ey~~g 388 (962)
..++.+.||.+.....++.++.+.. ......+.+|+.+++.++||||+++++++... ...|+|+||+++
T Consensus 14 g~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~ 93 (337)
T cd07858 14 GRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDT 93 (337)
T ss_pred ccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCCC
Confidence 3334445777776655554443322 12234577899999999999999999988643 358999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCc
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTR 466 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~ 466 (962)
++.+.+... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++...... ......++.
T Consensus 94 ~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~ 172 (337)
T cd07858 94 DLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR 172 (337)
T ss_pred CHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCccccccccccc
Confidence 988877654 56999999999999999999999999999999999999999999999999999765433 223446788
Q ss_pred cccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcc----------------------c----
Q psy501 467 WYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSY----------------------I---- 520 (962)
Q Consensus 467 ~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~----------------------~---- 520 (962)
.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+.... .
T Consensus 173 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (337)
T cd07858 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTP 252 (337)
T ss_pred CccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCccc
Confidence 99999998765568999999999999999999999998754322221111000 0
Q ss_pred ---cccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 521 ---LLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 521 ---~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.....+..+..+..++..||..+|++||++.+++..-
T Consensus 253 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~ 292 (337)
T cd07858 253 RQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292 (337)
T ss_pred ccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCc
Confidence 0011234566678899999999999999988888653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=276.00 Aligned_cols=210 Identities=22% Similarity=0.268 Sum_probs=164.2
Q ss_pred HHHHHHHHHHHHhc-CCCCcccEEEEEEe-CCEEEEEEecCC-CCHHHHHHhcC--------------------------
Q psy501 348 EMVVCFYRKSLKKL-SHANLVKLKEVIRE-NDTLYFVFEYMK-ENLYQLIRDRD-------------------------- 398 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~-~~~~~LV~Ey~~-g~Ll~~l~~~~-------------------------- 398 (962)
...+.+|+.+|.++ +||||+++++++.. +...++||||++ |+|.+++....
T Consensus 54 ~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (343)
T cd05103 54 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISED 133 (343)
T ss_pred HHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhh
Confidence 34688999999999 68999999998865 456899999998 56776665321
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccc
Q psy501 399 ----------------------------------------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM 438 (962)
Q Consensus 399 ----------------------------------------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~ 438 (962)
..+++..+..++.|++.||.|||+.||+||||||+||+++
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 213 (343)
T cd05103 134 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 213 (343)
T ss_pred hhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc
Confidence 2367888899999999999999999999999999999999
Q ss_pred cccceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHH
Q psy501 439 GTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTE 513 (962)
Q Consensus 439 ~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~ 513 (962)
.++.+||+|||++....... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||..........
T Consensus 214 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 292 (343)
T cd05103 214 ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 292 (343)
T ss_pred CCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHH
Confidence 99999999999997653321 122334567999999865 468999999999999999997 999998754332222
Q ss_pred HHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 514 RLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 514 ~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
.........+.....+..+..++..||..+|+.||++.+|++.+.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~ 337 (343)
T cd05103 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 337 (343)
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 222221222222345566788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=271.28 Aligned_cols=211 Identities=18% Similarity=0.206 Sum_probs=164.3
Q ss_pred hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccce
Q psy501 347 DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHG 424 (962)
Q Consensus 347 ~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~g 424 (962)
....+.+|++++++++||||+++++++.+++..+++|||+++ ++.+.+... ...+++..+..++.|++.||.|||+.+
T Consensus 42 ~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ 121 (314)
T cd08216 42 DLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121 (314)
T ss_pred HHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345799999999999999999999999999999999999985 565665543 345899999999999999999999999
Q ss_pred eeeccCCCcccccccccceeeecccccccccCC---------CcccccCCccccChhhhccC-CCCCchhHHHHHHHHHH
Q psy501 425 FFHRDMKPENLLCMGTELVKIADFGLAREIRSR---------PYTDYVSTRWYRAPEVLLHS-TAYSAPIHLSRSQQFLF 494 (962)
Q Consensus 425 IvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---------~~~~~~gt~~Y~APE~l~~~-~~~t~ksDIwSLGvlL~ 494 (962)
|+|+||||+||+++.++.++|+|||.+...... ......++..|+|||++.+. ..++.++|||||||++|
T Consensus 122 ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~ 201 (314)
T cd08216 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITAC 201 (314)
T ss_pred eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHH
Confidence 999999999999999999999999998654321 11223567789999998653 35889999999999999
Q ss_pred HHHcCCCCCCCcChhhhHHHHHhccccc--------------------------------cCCCCCCCCcHHHHHHHhcc
Q psy501 495 YSIDHVPPIQTTCLLAGTERLKSSYILL--------------------------------HTLPLYTYHVPPIQTTCLLA 542 (962)
Q Consensus 495 elltG~~Pf~~~~~~~~~~~i~~~~~~~--------------------------------~~~~~~s~~l~~li~~Cl~~ 542 (962)
||++|+.||..............+.... .....++..+..++..||..
T Consensus 202 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 281 (314)
T cd08216 202 ELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQR 281 (314)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhc
Confidence 9999999998755433221111110000 00001112355689999999
Q ss_pred CCCCCCcHHHHHhhc
Q psy501 543 GTERLKSSYILLHTL 557 (962)
Q Consensus 543 dperRPs~~~Ll~~l 557 (962)
+|++||++.+++..-
T Consensus 282 ~P~~Rpt~~~ll~~p 296 (314)
T cd08216 282 DPESRPSASQLLNHS 296 (314)
T ss_pred CCCcCcCHHHHhcCc
Confidence 999999999888754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=261.21 Aligned_cols=229 Identities=22% Similarity=0.247 Sum_probs=175.2
Q ss_pred cccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHH-HhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHH
Q psy501 324 TLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSL-KKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLI 394 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL-~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l 394 (962)
.+.||.+.....++.++.+.... ....+..|..++ ...+|||++++++++..++..|+||||++| +|.+.+
T Consensus 9 ~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 88 (260)
T cd05611 9 FGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLI 88 (260)
T ss_pred CeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHH
Confidence 33567776655544444433221 112344454444 445899999999999999999999999986 555544
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccccChhhh
Q psy501 395 RDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVL 474 (962)
Q Consensus 395 ~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l 474 (962)
.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..... .....++..|+|||.+
T Consensus 89 -~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~y~~pe~~ 165 (260)
T cd05611 89 -KTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--NKKFVGTPDYLAPETI 165 (260)
T ss_pred -HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc--cccCCCCcCccChhhh
Confidence 4445689999999999999999999999999999999999999999999999999875433 2334678899999998
Q ss_pred ccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--CCCCCCCCcHHHHHHHhccCCCCCCcH--
Q psy501 475 LHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--TLPLYTYHVPPIQTTCLLAGTERLKSS-- 550 (962)
Q Consensus 475 ~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l~~li~~Cl~~dperRPs~-- 550 (962)
.+. .++.++||||||+++|+|++|..||...........+.......+ ....++..+..++..||..+|++||++
T Consensus 166 ~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 244 (260)
T cd05611 166 LGV-GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANG 244 (260)
T ss_pred cCC-CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCc
Confidence 765 489999999999999999999999988776665555544433222 223567788999999999999999965
Q ss_pred -HHHHhh
Q psy501 551 -YILLHT 556 (962)
Q Consensus 551 -~~Ll~~ 556 (962)
+++++.
T Consensus 245 ~~~~l~~ 251 (260)
T cd05611 245 YQEIKSH 251 (260)
T ss_pred HHHHHcC
Confidence 455443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=274.95 Aligned_cols=244 Identities=20% Similarity=0.273 Sum_probs=188.8
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCE------
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDT------ 378 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~------ 378 (962)
+.+.....+..++.+.||.+....++..++.+... .....+.+|+.++++++||+|+++++++..++.
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 34444444445555668888777665554444322 123457789999999999999999998876554
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC
Q psy501 379 LYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP 458 (962)
Q Consensus 379 ~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~ 458 (962)
.++|+||++++|.+.+.. ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 95 ~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 95 VYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171 (343)
T ss_pred EEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence 899999998888887765 35899999999999999999999999999999999999999999999999999765433
Q ss_pred cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc----------------
Q psy501 459 YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL---------------- 522 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------- 522 (962)
.....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.........+.......
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 251 (343)
T cd07851 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNY 251 (343)
T ss_pred ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHH
Confidence 3445678899999998765578899999999999999999999998766554444332211000
Q ss_pred -------------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 523 -------------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 523 -------------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
...+..+..+.+++..||..+|++||++.+++..-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~ 299 (343)
T cd07851 252 IQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299 (343)
T ss_pred HHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCC
Confidence 00123456677899999999999999998887754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=265.74 Aligned_cols=234 Identities=29% Similarity=0.404 Sum_probs=184.9
Q ss_pred CcccEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHh
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRD 396 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~ 396 (962)
+.+.||.+.....++.++.+.... ....+..|+.++++++||+|+++++++.+.+..++||||+++++.+.+..
T Consensus 11 ~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~i~~ 90 (282)
T cd07829 11 TYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDK 90 (282)
T ss_pred CcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCcCHHHHHHh
Confidence 334577776665444444333221 23457889999999999999999999999999999999999999888887
Q ss_pred cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhhh
Q psy501 397 RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEVL 474 (962)
Q Consensus 397 ~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~l 474 (962)
....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+
T Consensus 91 ~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~ 170 (282)
T cd07829 91 RPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEIL 170 (282)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHh
Confidence 6556999999999999999999999999999999999999999999999999999766443 22334567789999999
Q ss_pred ccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc------------------cc---------cCCCC
Q psy501 475 LHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI------------------LL---------HTLPL 527 (962)
Q Consensus 475 ~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~------------------~~---------~~~~~ 527 (962)
.+...++.++|||||||++|||++|.+||..........++..... .. ...+.
T Consensus 171 ~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (282)
T cd07829 171 LGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPR 250 (282)
T ss_pred cCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhccc
Confidence 7665789999999999999999999999988765544433322100 00 11123
Q ss_pred CCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 528 YTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 528 ~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.+..+..++..||..+|++||++.+++..
T Consensus 251 ~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 251 LDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 35567889999999999999998887763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-28 Score=265.71 Aligned_cols=237 Identities=17% Similarity=0.279 Sum_probs=183.3
Q ss_pred ccEEEEEecCCceEEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCC
Q psy501 325 LPLYTCNLDQDNHILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKF 400 (962)
Q Consensus 325 ~~Vy~~~~~~~~kvv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~~~ 400 (962)
+.||.+.....+..++.+.. ......+.+|+.+++.++||+|+++++.+..++..++||||++++.+..+... ..
T Consensus 34 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~ 112 (292)
T cd06657 34 GIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TR 112 (292)
T ss_pred eEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc-CC
Confidence 34666655444443333221 12344688999999999999999999999999999999999986544444433 35
Q ss_pred CCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhhhccCC
Q psy501 401 LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEVLLHST 478 (962)
Q Consensus 401 ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~l~~~~ 478 (962)
+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+ .
T Consensus 113 ~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~ 191 (292)
T cd06657 113 MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-L 191 (292)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcC-C
Confidence 899999999999999999999999999999999999999999999999998765433 2233568889999998854 4
Q ss_pred CCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcc-ccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 479 AYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSY-ILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 479 ~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.++.++|+|||||++|+|++|..||.+.........+.... .........+..+..++..||..+|.+||++.+++..
T Consensus 192 ~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~- 270 (292)
T cd06657 192 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH- 270 (292)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC-
Confidence 68899999999999999999999998776655444443321 1222334556678889999999999999998888774
Q ss_pred cccccCC
Q psy501 558 PLYTYHV 564 (962)
Q Consensus 558 ~~~~~~~ 564 (962)
+|+....
T Consensus 271 ~~~~~~~ 277 (292)
T cd06657 271 PFLAKAG 277 (292)
T ss_pred hHHhccC
Confidence 3544443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-28 Score=270.65 Aligned_cols=248 Identities=24% Similarity=0.326 Sum_probs=182.3
Q ss_pred CcccEEEEEecCC--ceEEEEeccch------hHHHHHHHHHHHHhc-CCCCcccEEEEEEeC----CEEEEEEecCCCC
Q psy501 323 HTLPLYTCNLDQD--NHILSRHVSSR------DEMVVCFYRKSLKKL-SHANLVKLKEVIREN----DTLYFVFEYMKEN 389 (962)
Q Consensus 323 ~~~~Vy~~~~~~~--~kvv~~k~~~~------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~----~~~~LV~Ey~~g~ 389 (962)
+.+.||.+..... ++.++.+.... ....+.+|+.+++++ .||||+++++.+... ...++++|+++++
T Consensus 12 ~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~~~ 91 (332)
T cd07857 12 AYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEAD 91 (332)
T ss_pred CCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecccCC
Confidence 3344666665544 33333332211 134578899999999 599999999976432 4688999999998
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC------Cccccc
Q psy501 390 LYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR------PYTDYV 463 (962)
Q Consensus 390 Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~------~~~~~~ 463 (962)
|...+... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||.+...... ......
T Consensus 92 L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 170 (332)
T cd07857 92 LHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170 (332)
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcc
Confidence 88887654 46899999999999999999999999999999999999999999999999999765432 123346
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc-----------------------
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI----------------------- 520 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~----------------------- 520 (962)
|+..|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+.....
T Consensus 171 g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (332)
T cd07857 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLP 250 (332)
T ss_pred cCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhcc
Confidence 889999999987656789999999999999999999999987654332222111100
Q ss_pred ------cccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccccCCCCcchhh
Q psy501 521 ------LLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTC 571 (962)
Q Consensus 521 ------~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~~~~~~~~~~ 571 (962)
.....+..+..+..++..||..+|+.||++.+++..-.....+.|.-.+.|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~ 307 (332)
T cd07857 251 NIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVC 307 (332)
T ss_pred ccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccc
Confidence 001112345567889999999999999998888775433333433333333
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=265.20 Aligned_cols=209 Identities=22% Similarity=0.247 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEe--CCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccce
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRE--NDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHG 424 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~g 424 (962)
...+.+|+++++.+.||+|+++++++.. +...++||||++ +++.+++......+++..++.++.|++.||.|||+.|
T Consensus 50 ~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~ 129 (284)
T cd05038 50 RSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129 (284)
T ss_pred HHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4578999999999999999999999877 567999999997 5787777766556999999999999999999999999
Q ss_pred eeeccCCCcccccccccceeeecccccccccCCCc-----ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcC
Q psy501 425 FFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY-----TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDH 499 (962)
Q Consensus 425 IvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~-----~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG 499 (962)
++|+||+|+||+++.++.++|+|||.+........ ....++..|+|||.+.+. .++.++|||||||++|||++|
T Consensus 130 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg 208 (284)
T cd05038 130 YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTY 208 (284)
T ss_pred eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeecc
Confidence 99999999999999999999999999987653211 122345669999998654 689999999999999999999
Q ss_pred CCCCCCcChhh--------------hHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 500 VPPIQTTCLLA--------------GTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 500 ~~Pf~~~~~~~--------------~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..||....... ............+....++..+..++..||..+|+.||++.++++.+
T Consensus 209 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05038 209 GDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280 (284)
T ss_pred CCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 99987542211 11112222223333345667788999999999999999999998866
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=269.69 Aligned_cols=252 Identities=23% Similarity=0.287 Sum_probs=190.1
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEecc------chhHHHHHHHHHHHHhcCCCCcccEEEEEEe-CCEEEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS------SRDEMVVCFYRKSLKKLSHANLVKLKEVIRE-NDTLYFVF 383 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-~~~~~LV~ 383 (962)
+.+.....+..++.+.||.+.....++.++.|.. ......+.+|++++++++||||++++++|.. +...++||
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~ 89 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT 89 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence 3444454555555666888887766655554432 1123567889999999999999999999875 56789999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCccccc
Q psy501 384 EYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYV 463 (962)
Q Consensus 384 Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 463 (962)
||+++++...+.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus 90 e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-~~~~~ 166 (328)
T cd07856 90 ELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-MTGYV 166 (328)
T ss_pred ehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC-cCCCc
Confidence 9998887776653 34889999999999999999999999999999999999999999999999998754332 23456
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhc-----------------------cc
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSS-----------------------YI 520 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~-----------------------~~ 520 (962)
++..|+|||.+.+...++.++|||||||++|+|++|++||...........+... ..
T Consensus 167 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (328)
T cd07856 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLP 246 (328)
T ss_pred ccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhcc
Confidence 7889999999876567899999999999999999999999876543222111100 00
Q ss_pred -cc-----cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccccCCC
Q psy501 521 -LL-----HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVP 565 (962)
Q Consensus 521 -~~-----~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~~~~ 565 (962)
.. ...+..+..+..++..||..+|++||++.+++..-.+...+.|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 247 KREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred ccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 00 0112456678889999999999999998888876534334444
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=278.18 Aligned_cols=237 Identities=21% Similarity=0.239 Sum_probs=194.7
Q ss_pred ecCCcc-cEEEEEecCCceEEEEeccchh----HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHH
Q psy501 320 ILPHTL-PLYTCNLDQDNHILSRHVSSRD----EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQL 393 (962)
Q Consensus 320 i~~~~~-~Vy~~~~~~~~kvv~~k~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~ 393 (962)
++.|.+ .|..|......+++.+.....+ ...+.+|+++|.+|+||||++++++|..++.+|+|+||++ |+|-++
T Consensus 546 iGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqF 625 (807)
T KOG1094|consen 546 IGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQF 625 (807)
T ss_pred hcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHH
Confidence 334444 4999998887777776665443 3579999999999999999999999999999999999998 889998
Q ss_pred HHhcCCCC-CHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCccc----ccCCccc
Q psy501 394 IRDRDKFL-PESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD----YVSTRWY 468 (962)
Q Consensus 394 l~~~~~~l-s~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~----~~gt~~Y 468 (962)
+..+..+. .-....+|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++.+.+..... .+-...|
T Consensus 626 l~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRw 705 (807)
T KOG1094|consen 626 LSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRW 705 (807)
T ss_pred HHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeee
Confidence 88775433 556677899999999999999999999999999999999999999999999776553332 3446789
Q ss_pred cChhhhccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCcChhhhHHHHHhc------cccccCCCCCCCCcHHHHHHHh
Q psy501 469 RAPEVLLHSTAYSAPIHLSRSQQFLFYSID--HVPPIQTTCLLAGTERLKSS------YILLHTLPLYTYHVPPIQTTCL 540 (962)
Q Consensus 469 ~APE~l~~~~~~t~ksDIwSLGvlL~ellt--G~~Pf~~~~~~~~~~~i~~~------~~~~~~~~~~s~~l~~li~~Cl 540 (962)
||||.+.-+ .++.++|+|+||+++||+++ .+.||......+........ ..-+..++.++..+.+++..||
T Consensus 706 mawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw 784 (807)
T KOG1094|consen 706 MAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCW 784 (807)
T ss_pred hhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHh
Confidence 999999765 69999999999999999986 78899887766665544322 1123445678888999999999
Q ss_pred ccCCCCCCcHHHHHhhc
Q psy501 541 LAGTERLKSSYILLHTL 557 (962)
Q Consensus 541 ~~dperRPs~~~Ll~~l 557 (962)
..+.++||+++.|...|
T Consensus 785 ~~es~~RPsFe~lh~~l 801 (807)
T KOG1094|consen 785 RRESEQRPSFEQLHLFL 801 (807)
T ss_pred chhhhcCCCHHHHHHHH
Confidence 99999999999876654
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=267.54 Aligned_cols=242 Identities=20% Similarity=0.248 Sum_probs=182.5
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE 388 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g 388 (962)
+.....+..++.+.||++......+.++.+... .....+.+|+.++++++||+|+++++++..++..|+|+||++|
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 100 (293)
T cd06647 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG 100 (293)
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCC
Confidence 333334444445557777655444433333221 2234688899999999999999999999999999999999985
Q ss_pred -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCC
Q psy501 389 -NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVST 465 (962)
Q Consensus 389 -~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt 465 (962)
++.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ......++
T Consensus 101 ~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~ 178 (293)
T cd06647 101 GSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178 (293)
T ss_pred CcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCC
Confidence 56665543 24789999999999999999999999999999999999999999999999998755433 22334688
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhc-cccccCCCCCCCCcHHHHHHHhccCC
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSS-YILLHTLPLYTYHVPPIQTTCLLAGT 544 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~l~~li~~Cl~~dp 544 (962)
+.|+|||.+.+. .++.++|||||||++|+|++|+.||...........+... ..........+..+..++..||..+|
T Consensus 179 ~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 257 (293)
T cd06647 179 PYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 257 (293)
T ss_pred hhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCCh
Confidence 889999998654 6889999999999999999999999876543332222111 11111122334567889999999999
Q ss_pred CCCCcHHHHHhhc
Q psy501 545 ERLKSSYILLHTL 557 (962)
Q Consensus 545 erRPs~~~Ll~~l 557 (962)
+.||++.+++..-
T Consensus 258 ~~Rp~~~~il~h~ 270 (293)
T cd06647 258 EKRGSAKELLQHP 270 (293)
T ss_pred hhCcCHHHHhcCH
Confidence 9999988887754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=284.27 Aligned_cols=209 Identities=19% Similarity=0.230 Sum_probs=184.0
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHhhccccee
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRD-RDKFLPESIIRNMMYQVLQGLAFMHRHGF 425 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~-~~~~ls~~~i~~i~~qI~~aL~yLH~~gI 425 (962)
-..|.+|+.+|.+|+|||++++||+..+ ....+|||+++ |+|++.+.. ....|-...+..++.||+.|+.||.++++
T Consensus 155 mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrl 233 (1039)
T KOG0199|consen 155 MDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRL 233 (1039)
T ss_pred HHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhh
Confidence 3469999999999999999999999987 67889999998 889999887 45678899999999999999999999999
Q ss_pred eeccCCCcccccccccceeeecccccccccCC-Ccc----cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-C
Q psy501 426 FHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYT----DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-H 499 (962)
Q Consensus 426 vHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~----~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G 499 (962)
|||||..+|+++.....|||+|||+.+.+... ... ...-...|+|||.+... .++.++|||+|||++|||+| |
T Consensus 234 vHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyG 312 (1039)
T KOG0199|consen 234 VHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYG 312 (1039)
T ss_pred hhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccC
Confidence 99999999999999999999999999987654 111 12335669999999764 79999999999999999998 8
Q ss_pred CCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 500 VPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 500 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
+.||.+.......+.|..+ ...+..+.++..+..+++.||...|++||++.+|.+.+..
T Consensus 313 EePW~G~~g~qIL~~iD~~-erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 313 EEPWVGCRGIQILKNIDAG-ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred CCCCCCCCHHHHHHhcccc-ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 9999999999999999844 5666778899999999999999999999999998765543
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=261.96 Aligned_cols=236 Identities=27% Similarity=0.357 Sum_probs=179.3
Q ss_pred ecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhc---CCCCcccEEEEEEeCCE-----EEEEEec
Q psy501 320 ILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKL---SHANLVKLKEVIRENDT-----LYFVFEY 385 (962)
Q Consensus 320 i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~~~~-----~~LV~Ey 385 (962)
..++.+.||.+.....++.++.+... .....+.+|+.+++++ .||+|+++++++..... .+++|||
T Consensus 8 ~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~ 87 (287)
T cd07838 8 GEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEH 87 (287)
T ss_pred cccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehh
Confidence 33444557777766544443333321 1123466788877766 59999999999987766 9999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-Cccccc
Q psy501 386 MKENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYV 463 (962)
Q Consensus 386 ~~g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~ 463 (962)
+.+++.+.+.... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+...... ......
T Consensus 88 ~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 167 (287)
T cd07838 88 VDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVV 167 (287)
T ss_pred cccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCccccccc
Confidence 9998888776643 36899999999999999999999999999999999999999999999999999776443 223345
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc----------------cC---
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL----------------HT--- 524 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------------~~--- 524 (962)
++..|+|||++.+. .++.++|||||||++|+|++|.+||.+........++....... +.
T Consensus 168 ~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (287)
T cd07838 168 VTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTP 246 (287)
T ss_pred ccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccc
Confidence 78889999999764 68999999999999999999999998877655544443211100 00
Q ss_pred ------CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 525 ------LPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 525 ------~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.+..+..+..++..||..+|++||++.+++..
T Consensus 247 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 247 RSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 01123445678999999999999998887753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=262.35 Aligned_cols=235 Identities=21% Similarity=0.302 Sum_probs=186.8
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEecCC-C
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMK-E 388 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey~~-g 388 (962)
.+..++.+.||.+.....++.++.++.. .....+.+|+++++++. ||||+++++++..++..++|||++. +
T Consensus 8 ~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (280)
T cd05581 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNG 87 (280)
T ss_pred eecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCC
Confidence 3444445567777766555554444332 22346888999999998 9999999999999999999999995 6
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC----------
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---------- 458 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---------- 458 (962)
+|.+.+... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 88 ~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 166 (280)
T cd05581 88 ELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166 (280)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCc
Confidence 777766654 469999999999999999999999999999999999999999999999999987654332
Q ss_pred ------------cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCC
Q psy501 459 ------------YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLP 526 (962)
Q Consensus 459 ------------~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 526 (962)
.....++..|+|||++.+ ..++.++||||||+++|+|++|+.||...........+..... ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~ 243 (280)
T cd05581 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY--SFPP 243 (280)
T ss_pred cccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC--CCCC
Confidence 122356788999998865 3688999999999999999999999998776555555543322 2224
Q ss_pred CCCCCcHHHHHHHhccCCCCCCcH----HHHHhh
Q psy501 527 LYTYHVPPIQTTCLLAGTERLKSS----YILLHT 556 (962)
Q Consensus 527 ~~s~~l~~li~~Cl~~dperRPs~----~~Ll~~ 556 (962)
..+..+..++..||..+|++||++ .+++..
T Consensus 244 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 244 NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 567788999999999999999999 776653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-29 Score=262.53 Aligned_cols=251 Identities=19% Similarity=0.221 Sum_probs=198.0
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeee
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFH 427 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~-Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvH 427 (962)
..-..|-++|...+||.+..+...|+..+++|+||||..|+ |+-++. +...|+++..+.+...|+.||.|||+.+||+
T Consensus 213 AHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLHs~~ivY 291 (516)
T KOG0690|consen 213 AHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLS-RERVFSEDRTRFYGAEIVSALGYLHSRNIVY 291 (516)
T ss_pred hhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehh-hhhcccchhhhhhhHHHHHHhhhhhhCCeee
Confidence 34677889999999999999999999999999999999864 554444 4566999999999999999999999999999
Q ss_pred ccCCCcccccccccceeeeccccccccc--CCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q psy501 428 RDMKPENLLCMGTELVKIADFGLAREIR--SRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQT 505 (962)
Q Consensus 428 rDLkp~NILl~~~g~vKL~DFGla~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~ 505 (962)
||||.+|.++|.+|.+||+|||+++.-- .......+||+.|+|||++.. ..|+.++|.|.+||++|||+.|+.||..
T Consensus 292 RDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 292 RDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred eechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccc
Confidence 9999999999999999999999997532 336677899999999999954 5899999999999999999999999999
Q ss_pred cChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCC----c-HHHHHhhccccc--------cCCC-Ccchhh
Q psy501 506 TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK----S-SYILLHTLPLYT--------YHVP-PIQTTC 571 (962)
Q Consensus 506 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRP----s-~~~Ll~~l~~~~--------~~~~-~~~~~~ 571 (962)
.+......-|....+.+| ...+.....++.-.|..+|.+|- . +.++...-.+.. .+++ |..+
T Consensus 371 ~dh~kLFeLIl~ed~kFP--r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKP-- 446 (516)
T KOG0690|consen 371 KDHEKLFELILMEDLKFP--RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKP-- 446 (516)
T ss_pred cchhHHHHHHHhhhccCC--ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCC--
Confidence 988888888877777666 56677778899999999999993 3 555444332222 2222 3332
Q ss_pred hccccccccccceeecccccccccCCCccccccccc
Q psy501 572 LLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 607 (962)
Q Consensus 572 ~l~g~~~l~ssy~~~~~lpl~~~~~~~~~~~~~~~~ 607 (962)
.-+.....+|.--.....+---.||.+...|--+
T Consensus 447 --qVtSetDTryFD~EFT~q~v~lTPP~r~~~~~~~ 480 (516)
T KOG0690|consen 447 --QVTSETDTRYFDEEFTSQPVTLTPPDRYGSTVDE 480 (516)
T ss_pred --CcccccchhhhhhhhhcceeEecCCCCCCcccch
Confidence 2222334567666666555556677777665433
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=271.40 Aligned_cols=235 Identities=23% Similarity=0.310 Sum_probs=177.2
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeC------CEEEEEEec
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIREN------DTLYFVFEY 385 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------~~~~LV~Ey 385 (962)
.+..++.+.||.+....+++.++.+... .....+.+|+.++++++||||+++++++... ..+++|+||
T Consensus 22 ~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~ 101 (342)
T cd07879 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPY 101 (342)
T ss_pred EeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecc
Confidence 3333444457777655444433333221 1123578999999999999999999998754 346999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCC
Q psy501 386 MKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST 465 (962)
Q Consensus 386 ~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt 465 (962)
+.+++.... +..+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++..... ......++
T Consensus 102 ~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-~~~~~~~~ 177 (342)
T cd07879 102 MQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-EMTGYVVT 177 (342)
T ss_pred cccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-CCCCceee
Confidence 988766554 23589999999999999999999999999999999999999999999999999876433 23345678
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc-----------------------cc
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI-----------------------LL 522 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------------~~ 522 (962)
..|+|||.+.+...++.++|||||||++|||++|+.||.+.........+..... ..
T Consensus 178 ~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (342)
T cd07879 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKY 257 (342)
T ss_pred ecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCc
Confidence 8999999987655689999999999999999999999988665443333222100 00
Q ss_pred c------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 523 H------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 523 ~------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
+ ..+..+..+..++..||..+|++||++.+++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 258 PRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred ccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 012344557789999999999999998887754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=257.55 Aligned_cols=227 Identities=22% Similarity=0.312 Sum_probs=181.9
Q ss_pred ccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHh
Q psy501 325 LPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRD 396 (962)
Q Consensus 325 ~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~ 396 (962)
+.+|.+......+.++.+.... ....+..|++++++++||+|+++++.+..+...++||||++ ++|.+++..
T Consensus 7 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~ 86 (250)
T cd05123 7 GKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSK 86 (250)
T ss_pred eEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHh
Confidence 3466666554444333332211 23468899999999999999999999999999999999995 677777665
Q ss_pred cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhhh
Q psy501 397 RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEVL 474 (962)
Q Consensus 397 ~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~l 474 (962)
. ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+
T Consensus 87 ~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~ 165 (250)
T cd05123 87 E-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL 165 (250)
T ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHh
Confidence 4 45899999999999999999999999999999999999999999999999999776543 34455788899999998
Q ss_pred ccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcH---H
Q psy501 475 LHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS---Y 551 (962)
Q Consensus 475 ~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~---~ 551 (962)
.+. ..+.++|+||||+++|+|++|..||...+.......+.... .+.....+..+..+++.||..+|++||++ .
T Consensus 166 ~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~ 242 (250)
T cd05123 166 LGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP--LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAE 242 (250)
T ss_pred CCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHH
Confidence 654 57899999999999999999999998777655555554432 23334557788999999999999999998 5
Q ss_pred HHHh
Q psy501 552 ILLH 555 (962)
Q Consensus 552 ~Ll~ 555 (962)
+++.
T Consensus 243 ~l~~ 246 (250)
T cd05123 243 EIKA 246 (250)
T ss_pred HHHh
Confidence 5554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=268.96 Aligned_cols=243 Identities=24% Similarity=0.284 Sum_probs=183.8
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC------EE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIREND------TL 379 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------~~ 379 (962)
.+.....++.++.+.||.+.....++.++.+... .....+.+|+++|++++||||+++++++..+. .+
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 3444444555555567777666555544443321 11235789999999999999999999997543 46
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCc
Q psy501 380 YFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY 459 (962)
Q Consensus 380 ~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~ 459 (962)
++||||+++++...+.. ..+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++...... .
T Consensus 96 ~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-~ 172 (343)
T cd07880 96 YLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-M 172 (343)
T ss_pred EEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC-c
Confidence 89999998777766653 45899999999999999999999999999999999999999999999999999765432 2
Q ss_pred ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-----------------
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL----------------- 522 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------------- 522 (962)
....+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.........+.......
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (343)
T cd07880 173 TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYV 252 (343)
T ss_pred cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHH
Confidence 334678899999999765568899999999999999999999998765543333322211000
Q ss_pred ------------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 523 ------------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 523 ------------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
...+..+..+..++..|+..+|++||++.+++..-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~ 299 (343)
T cd07880 253 KKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP 299 (343)
T ss_pred HhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 01123445577899999999999999988877543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-29 Score=260.27 Aligned_cols=247 Identities=18% Similarity=0.224 Sum_probs=197.1
Q ss_pred ceeeEE-EEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhc-CCCCcccEEEEEEe----CCEEEEEEec
Q psy501 312 TERLKF-SYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKL-SHANLVKLKEVIRE----NDTLYFVFEY 385 (962)
Q Consensus 312 ~~~~~~-~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~----~~~~~LV~Ey 385 (962)
+|.... +++.+..++|..|-.+.+....+.|+..+ ....++|+++--.. .|||||.++++|+. ...+.+|||.
T Consensus 62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hheehhhhhccccCCceEEEEeccchhhhHHHHHhc-CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 344433 34445566788887777766666555333 33478898886665 59999999999964 3568899999
Q ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc---cceeeecccccccccC-CCc
Q psy501 386 MK-ENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT---ELVKIADFGLAREIRS-RPY 459 (962)
Q Consensus 386 ~~-g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~---g~vKL~DFGla~~~~~-~~~ 459 (962)
++ |.|++.+..++ ..|++.++..|++||+.|+.|||+.+|.||||||+|+|.... ..+||+|||+|+.... ...
T Consensus 141 meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L 220 (400)
T KOG0604|consen 141 MEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDL 220 (400)
T ss_pred ccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccc
Confidence 98 56888887765 579999999999999999999999999999999999999654 4799999999987653 356
Q ss_pred ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcCh----hhhHHHHHhccccccCCC--CCCCCcH
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCL----LAGTERLKSSYILLHTLP--LYTYHVP 533 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~--~~s~~l~ 533 (962)
.+.+.|+.|.|||++ |...|+..+|+||+||++|-|+.|.+||....- .....+|..+...+|... ..+....
T Consensus 221 ~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aK 299 (400)
T KOG0604|consen 221 MTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAK 299 (400)
T ss_pred cCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHH
Confidence 667889999999999 556799999999999999999999999986432 334578888888777654 5567888
Q ss_pred HHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 534 PIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 534 ~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
++|+..|..+|..|-+..+++..- |..
T Consensus 300 dlIR~LLkt~PteRlTI~~~m~hp-wi~ 326 (400)
T KOG0604|consen 300 DLIRKLLKTEPTERLTIEEVMDHP-WIN 326 (400)
T ss_pred HHHHHHhcCCchhheeHHHhhcCc-hhc
Confidence 999999999999999988777643 443
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=276.15 Aligned_cols=232 Identities=18% Similarity=0.252 Sum_probs=197.9
Q ss_pred CcccEEEEEecCCceEEEEeccchh------HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHH
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSSRD------EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIR 395 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~ 395 (962)
....|..+....++.-++.|+..+. ...+.+|+++|+.|.|||||+++.+.+....+|+||||+. |.+.+++.
T Consensus 68 ~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~ 147 (596)
T KOG0586|consen 68 NFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLV 147 (596)
T ss_pred eeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHH
Confidence 3334777766666655555443321 2348999999999999999999999999999999999997 67888877
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCccccChhhh
Q psy501 396 DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPEVL 474 (962)
Q Consensus 396 ~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~APE~l 474 (962)
..+. +.+..+..++.|+.+|++|||+++|||||||++||+++.+..+||+|||++..+... .....+|++.|.|||++
T Consensus 148 ~~gr-~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~ 226 (596)
T KOG0586|consen 148 KHGR-MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELF 226 (596)
T ss_pred hccc-chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccccCCCCCccChHhh
Confidence 7654 677999999999999999999999999999999999999999999999999988755 56678999999999999
Q ss_pred ccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHH
Q psy501 475 LHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILL 554 (962)
Q Consensus 475 ~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll 554 (962)
.+....++.+|+||+|++||-|+.|.+||++........+...+.+.++. ..+.+...+++..+..+|.+|++..++.
T Consensus 227 ~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~--~ms~dce~lLrk~lvl~Pskr~~~dqim 304 (596)
T KOG0586|consen 227 NGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF--YMSCDCEDLLRKFLVLNPSKRGPCDQIM 304 (596)
T ss_pred cCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc--eeechhHHHHHHhhccCccccCCHHHhh
Confidence 98877889999999999999999999999999888888877777666652 3455678899999999999999999888
Q ss_pred hhc
Q psy501 555 HTL 557 (962)
Q Consensus 555 ~~l 557 (962)
...
T Consensus 305 ~~~ 307 (596)
T KOG0586|consen 305 KDR 307 (596)
T ss_pred hhc
Confidence 765
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=296.81 Aligned_cols=181 Identities=20% Similarity=0.274 Sum_probs=144.9
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccchh-------HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD-------EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
.|.....++.++.+.||.+.....++.++.|+.... ...+..|+.+++.++||+|+++++++.....+|+|||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 344444555555566899888766665555543321 2568899999999999999999999999999999999
Q ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--Cccc
Q psy501 385 YMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTD 461 (962)
Q Consensus 385 y~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~ 461 (962)
|+.| +|.+++.. .+.+++..++.++.||+.||.|||..+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 85 y~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~~~~~ 163 (669)
T cd05610 85 YLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMD 163 (669)
T ss_pred CCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCcccccc
Confidence 9975 66666544 456899999999999999999999999999999999999999999999999999866433 3445
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHH
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFL 493 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL 493 (962)
..+|+.|++||......+-...+++|++|+-.
T Consensus 164 ~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~~ 195 (669)
T cd05610 164 ILTTPSMAKPKNDYSRTPGQVLSLISSLGFNT 195 (669)
T ss_pred cccCccccCccccccCCCCceeeeeeecCcCC
Confidence 68899999999876555556678889988543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=268.94 Aligned_cols=232 Identities=15% Similarity=0.200 Sum_probs=174.0
Q ss_pred cEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhc-
Q psy501 326 PLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDR- 397 (962)
Q Consensus 326 ~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~- 397 (962)
.||.+.....++.++.++.. ...+.+.+|+.+++.++||||++++++|..++..++||||+.+ ++.+.+...
T Consensus 15 ~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~ 94 (328)
T cd08226 15 SVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYF 94 (328)
T ss_pred eEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhc
Confidence 47777766555555444422 1234688999999999999999999999999999999999985 666666543
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---------cccccCCccc
Q psy501 398 DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---------YTDYVSTRWY 468 (962)
Q Consensus 398 ~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---------~~~~~gt~~Y 468 (962)
...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++++||+.+....... .....++..|
T Consensus 95 ~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 174 (328)
T cd08226 95 PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPW 174 (328)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCc
Confidence 2358999999999999999999999999999999999999999999999998654322110 0112345679
Q ss_pred cChhhhccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc--------------------------
Q psy501 469 RAPEVLLHS-TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL-------------------------- 521 (962)
Q Consensus 469 ~APE~l~~~-~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------------- 521 (962)
+|||++.+. ..++.++|||||||++|||++|++||.+................
T Consensus 175 ~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (328)
T cd08226 175 LSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGI 254 (328)
T ss_pred cChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhccc
Confidence 999999754 34789999999999999999999999876544333222211100
Q ss_pred -------------------ccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 522 -------------------LHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 522 -------------------~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.+....++..+..+++.||..+|++||++.++++.-
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 255 GESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred ccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 000112334567899999999999999999887644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=260.36 Aligned_cols=233 Identities=23% Similarity=0.338 Sum_probs=188.5
Q ss_pred CCcccEEEEEecCCceEEEEeccch----hHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHH
Q psy501 322 PHTLPLYTCNLDQDNHILSRHVSSR----DEMVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIR 395 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~k~~~~----~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~ 395 (962)
+....|..|....+++.++.|+..+ ...++.+|++++.+++ |+||+.++++|+++..+|||||-+. |.++.++.
T Consensus 89 GAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~ 168 (463)
T KOG0607|consen 89 GAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQ 168 (463)
T ss_pred ccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHH
Confidence 3344577787776666655555433 4568999999999996 9999999999999999999999997 57888877
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc---ceeeecccccccccC---------CCccccc
Q psy501 396 DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIRS---------RPYTDYV 463 (962)
Q Consensus 396 ~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g---~vKL~DFGla~~~~~---------~~~~~~~ 463 (962)
.+ ..|++.++.+++++|+.||.|||.+||.||||||+|||..+.. -+|||||.++.-+.- +...+.+
T Consensus 169 ~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPv 247 (463)
T KOG0607|consen 169 KR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPV 247 (463)
T ss_pred Hh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcc
Confidence 65 4599999999999999999999999999999999999996554 589999988764421 2344567
Q ss_pred CCccccChhhhc----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCc---------------ChhhhHHHHHhccccccC
Q psy501 464 STRWYRAPEVLL----HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTT---------------CLLAGTERLKSSYILLHT 524 (962)
Q Consensus 464 gt~~Y~APE~l~----~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~---------------~~~~~~~~i~~~~~~~~~ 524 (962)
|+..|||||+.. ....|+.++|.||||||||-|++|.+||.+. +.......|..+...+|.
T Consensus 248 GSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPd 327 (463)
T KOG0607|consen 248 GSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPD 327 (463)
T ss_pred cchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCCh
Confidence 889999999873 2346999999999999999999999999873 334456677788777765
Q ss_pred CC--CCCCCcHHHHHHHhccCCCCCCcHHHHHh
Q psy501 525 LP--LYTYHVPPIQTTCLLAGTERLKSSYILLH 555 (962)
Q Consensus 525 ~~--~~s~~l~~li~~Cl~~dperRPs~~~Ll~ 555 (962)
-. ..+..-.+++...+..++..|-++..++.
T Consensus 328 kdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 328 KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 44 55667788999999999999988766555
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=258.24 Aligned_cols=227 Identities=15% Similarity=0.211 Sum_probs=169.6
Q ss_pred cccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCC
Q psy501 324 TLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKFL 401 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~~~l 401 (962)
.+.||.+........++.+....... ...|+.....+ +||+|+++++.+..++..|+||||++ |+|.+.+... ..+
T Consensus 29 ~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~l 106 (267)
T PHA03390 29 FGKVSVLKHKPTQKLFVQKIIKAKNF-NAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE-GKL 106 (267)
T ss_pred ceEEEEEEEcCCCcEEEEEEEehhhc-chhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc-CCC
Confidence 33466666555555444444322111 01133333223 69999999999999999999999997 5777776654 479
Q ss_pred CHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc-ceeeecccccccccCCCcccccCCccccChhhhccCCCC
Q psy501 402 PESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE-LVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAY 480 (962)
Q Consensus 402 s~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g-~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~~~~ 480 (962)
++..++.++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||.+...... ....++..|+|||++.+ ..+
T Consensus 107 ~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~ 183 (267)
T PHA03390 107 SEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--SCYDGTLDYFSPEKIKG-HNY 183 (267)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--ccCCCCCcccChhhhcC-CCC
Confidence 9999999999999999999999999999999999999988 9999999998765433 23468899999999965 468
Q ss_pred CchhHHHHHHHHHHHHHcCCCCCCCcChhhhH-HHHH-hccccccCCCCCCCCcHHHHHHHhccCCCCCCc-HHHHHh
Q psy501 481 SAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGT-ERLK-SSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS-SYILLH 555 (962)
Q Consensus 481 t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~-~~i~-~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs-~~~Ll~ 555 (962)
+.++|||||||++|+|++|+.||......... .... ......+..+..+..+..++..||..+|++||+ .+++++
T Consensus 184 ~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 184 DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 99999999999999999999999855432211 1111 111222333467778899999999999999996 477664
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=266.77 Aligned_cols=242 Identities=21% Similarity=0.267 Sum_probs=180.8
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeC------CEEE
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIREN------DTLY 380 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------~~~~ 380 (962)
+.....+..++.+.||.+.....++.++.+.... ....+.+|+.++++++||||+++++++... ...+
T Consensus 19 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (345)
T cd07877 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 98 (345)
T ss_pred eEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEE
Confidence 3333344444455678777655555444433211 234577899999999999999999998643 3478
Q ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcc
Q psy501 381 FVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT 460 (962)
Q Consensus 381 LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~ 460 (962)
++++++.+++.+.+.. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..... ...
T Consensus 99 lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~-~~~ 175 (345)
T cd07877 99 LVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-EMT 175 (345)
T ss_pred EEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc-ccc
Confidence 9999998888766643 3489999999999999999999999999999999999999999999999999876533 333
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc--------------------
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI-------------------- 520 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~-------------------- 520 (962)
...++..|+|||.+.+...++.++|||||||++|+|++|++||...........+.....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (345)
T cd07877 176 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 255 (345)
T ss_pred ccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHH
Confidence 457788999999987655688999999999999999999999976554333222211100
Q ss_pred ---cccC------CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 521 ---LLHT------LPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 521 ---~~~~------~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..+. ....+..+.+++..|+..+|++||++.+++..-
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 256 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0000 012345577899999999999999988777654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=256.53 Aligned_cols=208 Identities=19% Similarity=0.180 Sum_probs=167.1
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCC------EEEEEEecCC-CCHHHHHHhc-----CCCCCHHHHHHHHHHHHH
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIREND------TLYFVFEYMK-ENLYQLIRDR-----DKFLPESIIRNMMYQVLQ 415 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------~~~LV~Ey~~-g~Ll~~l~~~-----~~~ls~~~i~~i~~qI~~ 415 (962)
.+.+.+|++++++++||+|+++++++.... ..++++||+. |++..++... ...+++..++.++.|++.
T Consensus 45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 124 (273)
T cd05074 45 IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124 (273)
T ss_pred HHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Confidence 446889999999999999999999986532 3478899997 5666555322 124789999999999999
Q ss_pred HHhhcccceeeeccCCCcccccccccceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHH
Q psy501 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQ 491 (962)
Q Consensus 416 aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGv 491 (962)
||+|||+.||+|+||||+||+++.++.+||+|||.++...... .....+++.|++||.+.+ ..++.++|||||||
T Consensus 125 ~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~ 203 (273)
T cd05074 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGV 203 (273)
T ss_pred HHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHH
Confidence 9999999999999999999999999999999999998654321 222345678999999865 46889999999999
Q ss_pred HHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 492 FLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 492 lL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
++|||++ |++||.+.........+..... ....+..+..+..++..||..+|+.||++.+++..+
T Consensus 204 il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l 269 (273)
T cd05074 204 TMWEIMTRGQTPYAGVENSEIYNYLIKGNR-LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269 (273)
T ss_pred HHHHHhhCCCCCCCCCCHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999999 8999988776555555544322 222345667788899999999999999999998866
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=258.19 Aligned_cols=207 Identities=15% Similarity=0.223 Sum_probs=163.7
Q ss_pred HHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceee
Q psy501 349 MVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFF 426 (962)
Q Consensus 349 ~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIv 426 (962)
+.+.+|+.+++++ +||+|+++++++..+...++||||++| +|.+++... ..+++..+..++.|++.||.|||+.|++
T Consensus 49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~ 127 (290)
T cd05613 49 EHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGII 127 (290)
T ss_pred HHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 4578899999999 599999999999999999999999985 676666554 5689999999999999999999999999
Q ss_pred eccCCCcccccccccceeeecccccccccCC---CcccccCCccccChhhhccC-CCCCchhHHHHHHHHHHHHHcCCCC
Q psy501 427 HRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYVSTRWYRAPEVLLHS-TAYSAPIHLSRSQQFLFYSIDHVPP 502 (962)
Q Consensus 427 HrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~gt~~Y~APE~l~~~-~~~t~ksDIwSLGvlL~elltG~~P 502 (962)
||||+|+||+++.++.++|+|||++...... ......|+..|+|||.+.+. ..++.++||||||+++|+|++|..|
T Consensus 128 H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p 207 (290)
T cd05613 128 YRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207 (290)
T ss_pred ccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999765432 22235688999999998653 2477899999999999999999999
Q ss_pred CCCcChhhhHHHHHhcc--ccccCCCCCCCCcHHHHHHHhccCCCCCC-----cHHHHHhh
Q psy501 503 IQTTCLLAGTERLKSSY--ILLHTLPLYTYHVPPIQTTCLLAGTERLK-----SSYILLHT 556 (962)
Q Consensus 503 f~~~~~~~~~~~i~~~~--~~~~~~~~~s~~l~~li~~Cl~~dperRP-----s~~~Ll~~ 556 (962)
|...........+.... ...+....++..+..++..||..+|+.|| +..+++..
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 208 FTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 97543322222221111 11122234566778899999999999997 55665553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=255.24 Aligned_cols=158 Identities=32% Similarity=0.613 Sum_probs=143.6
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEe-CCEEEEEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHhhcccc
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRE-NDTLYFVFEYMKENLYQLIRDR----DKFLPESIIRNMMYQVLQGLAFMHRH 423 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~-~~~~~LV~Ey~~g~Ll~~l~~~----~~~ls~~~i~~i~~qI~~aL~yLH~~ 423 (962)
....||+.+++.++||||+.+..+|.. +..+|+++||.+.+|++.+.-+ ...++...++.++.||+.|+.|||+.
T Consensus 72 ~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N 151 (438)
T KOG0666|consen 72 MSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN 151 (438)
T ss_pred HHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh
Confidence 358999999999999999999999976 8899999999999999988643 35699999999999999999999999
Q ss_pred eeeeccCCCcccccccc----cceeeecccccccccCC-----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHH
Q psy501 424 GFFHRDMKPENLLCMGT----ELVKIADFGLAREIRSR-----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLF 494 (962)
Q Consensus 424 gIvHrDLkp~NILl~~~----g~vKL~DFGla~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ 494 (962)
-|+||||||.||++..+ |.|||+|||+++.+... .....+-|.+|+|||++.|...|+.+.||||+|||+.
T Consensus 152 WvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfa 231 (438)
T KOG0666|consen 152 WVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFA 231 (438)
T ss_pred heeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHH
Confidence 99999999999999877 89999999999988765 3344567899999999999999999999999999999
Q ss_pred HHHcCCCCCCCc
Q psy501 495 YSIDHVPPIQTT 506 (962)
Q Consensus 495 elltG~~Pf~~~ 506 (962)
||+|-++.|.+.
T Consensus 232 ElLtl~PlF~g~ 243 (438)
T KOG0666|consen 232 ELLTLEPLFKGR 243 (438)
T ss_pred HHHccCccccch
Confidence 999999999764
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=254.85 Aligned_cols=206 Identities=23% Similarity=0.335 Sum_probs=168.3
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHhhcccc
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRD---RDKFLPESIIRNMMYQVLQGLAFMHRH 423 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~---~~~~ls~~~i~~i~~qI~~aL~yLH~~ 423 (962)
...+..|+.++++++||||+++++++.+....++||||+++ ++.+.+.. ....+++..++.++.|++.||.|||+.
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 125 (260)
T cd08222 46 TVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125 (260)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc
Confidence 44577899999999999999999999999999999999985 55555542 345699999999999999999999999
Q ss_pred eeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCC
Q psy501 424 GFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVP 501 (962)
Q Consensus 424 gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~ 501 (962)
|++|+||+|+||+++. +.++|+|||.+...... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..
T Consensus 126 ~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~ 203 (260)
T cd08222 126 RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAH 203 (260)
T ss_pred CccccCCChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999975 57999999998765433 2233567889999998854 468889999999999999999999
Q ss_pred CCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 502 PIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 502 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
||.+.........+..+. .......++..+..++..||..+|++||++.++++.
T Consensus 204 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 204 AFEGQNFLSVVLRIVEGP-TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCCccHHHHHHHHHcCC-CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 998776655555544332 112223566678889999999999999998888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=234.37 Aligned_cols=193 Identities=29% Similarity=0.449 Sum_probs=171.8
Q ss_pred ccEEEEEecCCceEEEEeccchh------HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcC
Q psy501 325 LPLYTCNLDQDNHILSRHVSSRD------EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398 (962)
Q Consensus 325 ~~Vy~~~~~~~~kvv~~k~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~ 398 (962)
+.||+++...+..+++.+...-+ .....+|+-+|+.++|.|||+++++...+..+-+|+|||+.+|..++.+..
T Consensus 16 gtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdqdlkkyfdsln 95 (292)
T KOG0662|consen 16 GTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSLN 95 (292)
T ss_pred eeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhHHHHHHHHhcC
Confidence 34777777777777766553322 246899999999999999999999999999999999999999999999988
Q ss_pred CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhhhcc
Q psy501 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEVLLH 476 (962)
Q Consensus 399 ~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~l~~ 476 (962)
+.++.+.++.++.|+++||.|+|++++.|||+||.|.+|..+|.+||+|||+++.++-+ .....+-|++|++|.++.|
T Consensus 96 g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfg 175 (292)
T KOG0662|consen 96 GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175 (292)
T ss_pred CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeee
Confidence 89999999999999999999999999999999999999999999999999999988765 4455678999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHh
Q psy501 477 STAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKS 517 (962)
Q Consensus 477 ~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~ 517 (962)
.+-|+...|+||.||++.|+.. |++.|.+.+..+...+|..
T Consensus 176 akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~ 217 (292)
T KOG0662|consen 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_pred eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHH
Confidence 9999999999999999999996 8999999888877777643
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=276.17 Aligned_cols=226 Identities=16% Similarity=0.183 Sum_probs=181.3
Q ss_pred cEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCCCC-HHHHHHhcCCCCCH
Q psy501 326 PLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKFLPE 403 (962)
Q Consensus 326 ~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~g~-Ll~~l~~~~~~ls~ 403 (962)
.+-.|....+.+....++.++......+|+.++... .||||+++.+.+.++.+.|+|||.+.|. +++.+.... .++
T Consensus 337 ~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~-~~~- 414 (612)
T KOG0603|consen 337 AVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKP-EFC- 414 (612)
T ss_pred ceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcc-hhH-
Confidence 366666666666655555555555678888777766 6999999999999999999999999864 555555443 233
Q ss_pred HHHHHHHHHHHHHHhhcccceeeeccCCCccccc-ccccceeeecccccccccCCCcccccCCccccChhhhccCCCCCc
Q psy501 404 SIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLC-MGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSA 482 (962)
Q Consensus 404 ~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl-~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ 482 (962)
..+..|+++|+.|+.|||++|+|||||||+|||+ +..|.++|+|||.++..... ....+-|..|.|||++. ...|+.
T Consensus 415 ~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-~~tp~~t~~y~APEvl~-~~~yt~ 492 (612)
T KOG0603|consen 415 SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-CDTPALTLQYVAPEVLA-IQEYTE 492 (612)
T ss_pred HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-hcccchhhcccChhhhc-cCCCCc
Confidence 7788899999999999999999999999999999 58899999999999876655 33456788999999997 468999
Q ss_pred hhHHHHHHHHHHHHHcCCCCCCCcChh-hhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 483 PIHLSRSQQFLFYSIDHVPPIQTTCLL-AGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 483 ksDIwSLGvlL~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
++||||||++||+|++|+.||...... +...++..+. .....|...++++..||+.+|.+|+++.++...- |+
T Consensus 493 acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~----~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~-w~ 566 (612)
T KOG0603|consen 493 ACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK----FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP-WF 566 (612)
T ss_pred chhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc----cccccCHHHHHHHHHhccCChhhCcChhhhccCc-ch
Confidence 999999999999999999999876554 3344443332 2256788889999999999999999988776654 44
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=252.56 Aligned_cols=218 Identities=14% Similarity=0.135 Sum_probs=168.8
Q ss_pred CcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCC
Q psy501 323 HTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFL 401 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~~~l 401 (962)
..+.||.+....+++.++.|..... ....+|...+....||||+++++++.+....++||||++| +|.+.+... ..+
T Consensus 5 ~~~~v~~~~~~~~~~~~~~K~i~~~-~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l 82 (237)
T cd05576 5 VIDKVLLVMDTRTQQTFILKGLRKS-SEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-LNI 82 (237)
T ss_pred ccceEEEEEEccCCcEEEEEeecch-hhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh-cCC
Confidence 3445788777766665554443322 2345566666667899999999999999999999999985 677776554 458
Q ss_pred CHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccccChhhhccCCCCC
Q psy501 402 PESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYS 481 (962)
Q Consensus 402 s~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t 481 (962)
++..+..++.|++.||.|||+.|++||||||+||+++.++.++++|||.+...... .....++..|+|||.+.+ ..++
T Consensus 83 ~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~ 160 (237)
T cd05576 83 PEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-CDGEAVENMYCAPEVGGI-SEET 160 (237)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-cccCCcCccccCCcccCC-CCCC
Confidence 99999999999999999999999999999999999999999999999988665443 233456778999998854 4688
Q ss_pred chhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcH
Q psy501 482 APIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 550 (962)
Q Consensus 482 ~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~ 550 (962)
.++||||+||++|||++|+.||....... .........+.++..+..++..||..+|++|+++
T Consensus 161 ~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 161 EACDWWSLGAILFELLTGKTLVECHPSGI------NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred chhhHHHHHHHHHHHHHCcchhhcCchhc------ccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 99999999999999999999886432211 1111112224566678889999999999999984
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=254.40 Aligned_cols=201 Identities=19% Similarity=0.249 Sum_probs=161.6
Q ss_pred HHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceee
Q psy501 349 MVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFF 426 (962)
Q Consensus 349 ~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIv 426 (962)
..+..|+.++.++ +||+|+++++.+..+...++||||++| +|.+.+... ..+++..++.++.|++.||.|||+.+++
T Consensus 49 ~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~ 127 (288)
T cd05583 49 EHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGII 127 (288)
T ss_pred HHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 3578899999999 599999999999999999999999985 666666543 4689999999999999999999999999
Q ss_pred eccCCCcccccccccceeeecccccccccCCC---cccccCCccccChhhhccCC-CCCchhHHHHHHHHHHHHHcCCCC
Q psy501 427 HRDMKPENLLCMGTELVKIADFGLAREIRSRP---YTDYVSTRWYRAPEVLLHST-AYSAPIHLSRSQQFLFYSIDHVPP 502 (962)
Q Consensus 427 HrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~gt~~Y~APE~l~~~~-~~t~ksDIwSLGvlL~elltG~~P 502 (962)
|+||+|+||+++.++.++|+|||++..+.... .....++..|+|||.+.+.. ..+.++||||||+++|||++|..|
T Consensus 128 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p 207 (288)
T cd05583 128 YRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207 (288)
T ss_pred ccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999987654332 22345788999999986542 368899999999999999999999
Q ss_pred CCCcChhhh----HHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHH
Q psy501 503 IQTTCLLAG----TERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 552 (962)
Q Consensus 503 f~~~~~~~~----~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~ 552 (962)
|........ ...+... ..+....++..+..++..||..+|++||++..
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~ 259 (288)
T cd05583 208 FTVDGEQNSQSEISRRILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANG 259 (288)
T ss_pred cccCcccchHHHHHHHHHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcch
Confidence 965332211 1222222 12223456677889999999999999998543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-28 Score=255.20 Aligned_cols=212 Identities=18% Similarity=0.240 Sum_probs=171.9
Q ss_pred chhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHhh
Q psy501 345 SRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKENLYQLIR----DRDKFLPESIIRNMMYQVLQGLAF 419 (962)
Q Consensus 345 ~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~----~~~~~ls~~~i~~i~~qI~~aL~y 419 (962)
..+..++..|.++..+- ++|+||++||..-.++..||.||+|+-++..++. .....++|..+-.|....+.||.|
T Consensus 103 ~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~y 182 (361)
T KOG1006|consen 103 EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDY 182 (361)
T ss_pred hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHH
Confidence 34566788898876555 6999999999999999999999999977665543 234569999999999999999999
Q ss_pred ccc-ceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCccccChhhhccCC-CCCchhHHHHHHHHHHHH
Q psy501 420 MHR-HGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPEVLLHST-AYSAPIHLSRSQQFLFYS 496 (962)
Q Consensus 420 LH~-~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~APE~l~~~~-~~t~ksDIwSLGvlL~el 496 (962)
|-. ..|+|||+||+|||++..|.+||||||.+-.+... ..+...|...|||||.+.... .|+.+|||||||++|||+
T Consensus 183 LK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~Ev 262 (361)
T KOG1006|consen 183 LKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEV 262 (361)
T ss_pred HHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeee
Confidence 985 58999999999999999999999999999776554 445568999999999996443 499999999999999999
Q ss_pred HcCCCCCCCcCh-hhhHHHHHhccccccCCC----CCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 497 IDHVPPIQTTCL-LAGTERLKSSYILLHTLP----LYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 497 ltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~----~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.||..||..-+. .+....+..+..+.-..+ .++..+..++..|+.++...||....|...
T Consensus 263 AtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 263 ATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 999999988544 333444555543332222 356677889999999999999998887763
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-28 Score=268.82 Aligned_cols=212 Identities=22% Similarity=0.317 Sum_probs=181.5
Q ss_pred cchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhccc
Q psy501 344 SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHR 422 (962)
Q Consensus 344 ~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~ 422 (962)
..+..+.+..|..||.+++.|.||++|-.|.++.++|++||-|- |.++..++.++ .|++.+...++..+++|++|||+
T Consensus 460 dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~ 538 (732)
T KOG0614|consen 460 DTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHR 538 (732)
T ss_pred chhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHh
Confidence 34556679999999999999999999999999999999999986 67888887765 59999999999999999999999
Q ss_pred ceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCC
Q psy501 423 HGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVP 501 (962)
Q Consensus 423 ~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~ 501 (962)
+|||+|||||+|.+++.+|-+||.|||+|+.+.+. ....++||+.|.|||++... ..+.++|.||||+++|||++|.+
T Consensus 539 k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnK-GHD~avDyWaLGIli~ELL~G~p 617 (732)
T KOG0614|consen 539 KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNK-GHDRAVDYWALGILIYELLTGSP 617 (732)
T ss_pred cCceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhcc-CcchhhHHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999999998766 66778999999999999864 78999999999999999999999
Q ss_pred CCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHH-HhccCCCCCC----cHHHHHhhc
Q psy501 502 PIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTT-CLLAGTERLK----SSYILLHTL 557 (962)
Q Consensus 502 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~-Cl~~dperRP----s~~~Ll~~l 557 (962)
||.+.++...+..|..+.-....+...+.....+++. |-..+.+|.- ...++-+..
T Consensus 618 PFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 618 PFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred CCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 9999999999999988865555445566665666666 5544444433 266666655
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=241.60 Aligned_cols=229 Identities=28% Similarity=0.418 Sum_probs=183.6
Q ss_pred ccEEEEEecCCceEEEEeccc-hh----HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcC
Q psy501 325 LPLYTCNLDQDNHILSRHVSS-RD----EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRD 398 (962)
Q Consensus 325 ~~Vy~~~~~~~~kvv~~k~~~-~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~ 398 (962)
+.||.+.....++.++.+... .. ...+.+|++.+++++|++|+++++++..+...++++|++++ ++.+.+....
T Consensus 3 g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~ 82 (244)
T smart00220 3 GKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG 82 (244)
T ss_pred eEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc
Confidence 356777666534333333322 11 46789999999999999999999999999999999999997 7777665543
Q ss_pred CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCccccChhhhccC
Q psy501 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPEVLLHS 477 (962)
Q Consensus 399 ~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~APE~l~~~ 477 (962)
.+++..++.++.+++.++.+||+.+++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+
T Consensus 83 -~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~- 160 (244)
T smart00220 83 -RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLG- 160 (244)
T ss_pred -CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHcc-
Confidence 3899999999999999999999999999999999999999999999999999876554 4455678889999999864
Q ss_pred CCCCchhHHHHHHHHHHHHHcCCCCCCC-cChhhhHHHHHhccccccCCCC-CCCCcHHHHHHHhccCCCCCCcHHHHHh
Q psy501 478 TAYSAPIHLSRSQQFLFYSIDHVPPIQT-TCLLAGTERLKSSYILLHTLPL-YTYHVPPIQTTCLLAGTERLKSSYILLH 555 (962)
Q Consensus 478 ~~~t~ksDIwSLGvlL~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~-~s~~l~~li~~Cl~~dperRPs~~~Ll~ 555 (962)
..++.++||||||+++|+|++|..||.. .........+............ ++..+..++..||..+|+.||++.++++
T Consensus 161 ~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 161 KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 4678899999999999999999999987 4444444444433332222111 6777889999999999999999998886
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=264.23 Aligned_cols=226 Identities=22% Similarity=0.334 Sum_probs=188.3
Q ss_pred EEEEEecCCceEEE------EeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhc-CC
Q psy501 327 LYTCNLDQDNHILS------RHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDR-DK 399 (962)
Q Consensus 327 Vy~~~~~~~~kvv~------~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~-~~ 399 (962)
||.++...+++-++ .++..+.+..++.|+.||.++.||.||.+...|++.+.+++|||-+.|+.++.+.+. .+
T Consensus 580 VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkg 659 (888)
T KOG4236|consen 580 VYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKG 659 (888)
T ss_pred eecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcc
Confidence 55554444443333 344556678899999999999999999999999999999999999999999988765 46
Q ss_pred CCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc---cceeeecccccccccCC-CcccccCCccccChhhhc
Q psy501 400 FLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT---ELVKIADFGLAREIRSR-PYTDYVSTRWYRAPEVLL 475 (962)
Q Consensus 400 ~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~---g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~APE~l~ 475 (962)
.+++.....++.||+.||.|||-++|||+||||+|||+... ..+||||||.|+.++.. .....+||+.|+|||++.
T Consensus 660 RL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLr 739 (888)
T KOG4236|consen 660 RLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLR 739 (888)
T ss_pred cchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHh
Confidence 89999999999999999999999999999999999999654 37999999999998765 556679999999999997
Q ss_pred cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCC--CCCcHHHHHHHhccCCCCCCcHH-H
Q psy501 476 HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLY--TYHVPPIQTTCLLAGTERLKSSY-I 552 (962)
Q Consensus 476 ~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~--s~~l~~li~~Cl~~dperRPs~~-~ 552 (962)
. +.|...-|+||.||++|--++|..||.... +....|.......|..|+. +....++|...|+..-++|-+.. .
T Consensus 740 n-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 740 N-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred h-ccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 5 579999999999999999999999997654 4556777777777766644 45667789999999999998854 4
Q ss_pred HHh
Q psy501 553 LLH 555 (962)
Q Consensus 553 Ll~ 555 (962)
|-|
T Consensus 817 lsh 819 (888)
T KOG4236|consen 817 LSH 819 (888)
T ss_pred ccc
Confidence 444
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=273.65 Aligned_cols=191 Identities=24% Similarity=0.326 Sum_probs=158.0
Q ss_pred EEEecCCcccEEEEEecCCceEEEEecc-----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC------EEEEEEec
Q psy501 317 FSYILPHTLPLYTCNLDQDNHILSRHVS-----SRDEMVVCFYRKSLKKLSHANLVKLKEVIREND------TLYFVFEY 385 (962)
Q Consensus 317 ~~~i~~~~~~Vy~~~~~~~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------~~~LV~Ey 385 (962)
...+.|+.+.||+.+.+.++..++.|.. .+..+...+|+++|++|+|||||+++++-++.. ...+||||
T Consensus 19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEy 98 (732)
T KOG4250|consen 19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEY 98 (732)
T ss_pred hhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEee
Confidence 3344455556888887766666555443 345678999999999999999999999976543 56899999
Q ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccc--ccc--ceeeecccccccccCC-
Q psy501 386 MK-ENLYQLIRDRD--KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM--GTE--LVKIADFGLAREIRSR- 457 (962)
Q Consensus 386 ~~-g~Ll~~l~~~~--~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~--~~g--~vKL~DFGla~~~~~~- 457 (962)
|. |+|...+.+.. ..+++.+++.++.+++.||.|||++||+||||||.||++- .+| ..||+|||.|+.+...
T Consensus 99 C~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s 178 (732)
T KOG4250|consen 99 CSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS 178 (732)
T ss_pred cCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC
Confidence 98 56777776543 4599999999999999999999999999999999999983 334 5799999999988765
Q ss_pred CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcC
Q psy501 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTC 507 (962)
Q Consensus 458 ~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~ 507 (962)
...+.+||+.|.+||++.....|+..+|.|||||++|+++||..||....
T Consensus 179 ~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 179 LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 66778999999999999755689999999999999999999999997643
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=279.73 Aligned_cols=213 Identities=21% Similarity=0.302 Sum_probs=180.3
Q ss_pred chhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC---------------CCCCHHHHH
Q psy501 345 SRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD---------------KFLPESIIR 407 (962)
Q Consensus 345 ~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~---------------~~ls~~~i~ 407 (962)
..+...+..|+++|+.+ +||||+.+++++..++.+++|+||+. |+|+++++... ..++..+++
T Consensus 342 ~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLl 421 (609)
T KOG0200|consen 342 SSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLL 421 (609)
T ss_pred cHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHH
Confidence 34567899999999999 59999999999999999999999998 89999998776 348999999
Q ss_pred HHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCccc---ccC--CccccChhhhccCCCCCc
Q psy501 408 NMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD---YVS--TRWYRAPEVLLHSTAYSA 482 (962)
Q Consensus 408 ~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~---~~g--t~~Y~APE~l~~~~~~t~ 482 (962)
.++.||+.|++||++..+|||||..+|||+..+..+||+|||+|+......... ..+ ...|||||.+.. ..|+.
T Consensus 422 sfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~ 500 (609)
T KOG0200|consen 422 SFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTS 500 (609)
T ss_pred HHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-Ccccc
Confidence 999999999999999999999999999999999999999999998665442222 222 334999999976 68999
Q ss_pred hhHHHHHHHHHHHHHc-CCCCCCCcC-hhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 483 PIHLSRSQQFLFYSID-HVPPIQTTC-LLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 483 ksDIwSLGvlL~ellt-G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
++||||||++||||+| |..||.+.. .......+..|... ..+..++..+..+++.||..+|++||++.++.+.+..
T Consensus 501 kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~-~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 501 KSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRM-EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred cchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 9999999999999998 999999855 44445566666443 3344568888899999999999999999998886643
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=254.45 Aligned_cols=235 Identities=19% Similarity=0.214 Sum_probs=184.5
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEec
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEY 385 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey 385 (962)
+++.|+.+.+...-.+++-..|+++.-.... .+...+.+--..|-++|.-. +-|.+++++.+|++-+.+|+||||
T Consensus 356 VlGKGSFGKVlLaerkgtdELyAiKiLkKDV----iiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEy 431 (683)
T KOG0696|consen 356 VLGKGSFGKVLLAERKGTDELYAIKILKKDV----IIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEY 431 (683)
T ss_pred EeccCccceeeeecccCcchhhhhhhhccce----eeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEE
Confidence 4444444444444444444455554322211 12234445566777788776 578999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccc--cCCCccccc
Q psy501 386 MKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI--RSRPYTDYV 463 (962)
Q Consensus 386 ~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~--~~~~~~~~~ 463 (962)
+.|+.+-+..++-+.|.+..+..++..|+-||-+||++||++||||.+||+++.+|.+||+|||+++.- ........+
T Consensus 432 vnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFC 511 (683)
T KOG0696|consen 432 VNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFC 511 (683)
T ss_pred ecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcceeeec
Confidence 986555454455566999999999999999999999999999999999999999999999999999753 333566789
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccC
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
||+.|+|||++.- .+|+.++|.||+||+||||+.|++||++.+.......|.......| ...+.....+.+..+...
T Consensus 512 GTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP--KslSkEAv~ickg~ltK~ 588 (683)
T KOG0696|consen 512 GTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP--KSLSKEAVAICKGLLTKH 588 (683)
T ss_pred CCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc--ccccHHHHHHHHHHhhcC
Confidence 9999999999964 5899999999999999999999999999999999998887765554 455666677888889999
Q ss_pred CCCCC
Q psy501 544 TERLK 548 (962)
Q Consensus 544 perRP 548 (962)
|.+|-
T Consensus 589 P~kRL 593 (683)
T KOG0696|consen 589 PGKRL 593 (683)
T ss_pred Ccccc
Confidence 98883
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=272.39 Aligned_cols=243 Identities=17% Similarity=0.193 Sum_probs=201.4
Q ss_pred EEEecCCcccEEEEEecCCceEEEE---------eccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 317 FSYILPHTLPLYTCNLDQDNHILSR---------HVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 317 ~~~i~~~~~~Vy~~~~~~~~kvv~~---------k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
++++.+..+.||++.+...++-++. .-..+....+..|+-+|.+|+|||++++++++..+. +.||++|++
T Consensus 702 kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP 780 (1177)
T KOG1025|consen 702 KVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMP 780 (1177)
T ss_pred ceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcc
Confidence 3344444445777755544432221 222334567999999999999999999999998765 889999999
Q ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC--ccc--c
Q psy501 388 -ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--YTD--Y 462 (962)
Q Consensus 388 -g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~--~~~--~ 462 (962)
|.|+++++.....+..+..+.|..||++|+.|||++++|||||-.+|||+.....+||.|||+++.+..+. ... .
T Consensus 781 ~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~g 860 (1177)
T KOG1025|consen 781 LGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGG 860 (1177)
T ss_pred cchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccccccccc
Confidence 88999999988889999999999999999999999999999999999999999999999999999876552 121 2
Q ss_pred cCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhc
Q psy501 463 VSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 463 ~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~ 541 (962)
.-.+.|||-|.+.. ..|+.++|||||||++||++| |..||++....+...-+..+.. .+.+|.++.++..++..||.
T Consensus 861 K~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-LsqPpiCtiDVy~~mvkCwm 938 (1177)
T KOG1025|consen 861 KVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQPPICTIDVYMVMVKCWM 938 (1177)
T ss_pred ccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCCCCCccHHHHHHHHHHhc
Confidence 23456999998864 579999999999999999998 9999999998888887877765 77788999999999999999
Q ss_pred cCCCCCCcHHHHHhhcccccc
Q psy501 542 AGTERLKSSYILLHTLPLYTY 562 (962)
Q Consensus 542 ~dperRPs~~~Ll~~l~~~~~ 562 (962)
.|+.+||.+++|...|.....
T Consensus 939 id~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 939 IDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred cCcccCccHHHHHHHHHHHhc
Confidence 999999999999987754443
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=261.65 Aligned_cols=288 Identities=20% Similarity=0.259 Sum_probs=210.6
Q ss_pred CCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHHH
Q psy501 322 PHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQL 393 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~ 393 (962)
+..+.|-.+...++..+++.|...+ ....+..|.+||..-+.+-||++|..|++++.+|+||||++| ++...
T Consensus 640 GAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSL 719 (1034)
T KOG0608|consen 640 GAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSL 719 (1034)
T ss_pred cccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHH
Confidence 3344477776666666665544332 223588899999999999999999999999999999999985 56666
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----------------
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---------------- 457 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---------------- 457 (962)
+.+. +.|.|+.++.++..+..|+++.|..|++||||||+|||||.+|.+||+|||+|.-+...
T Consensus 720 LIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDS 798 (1034)
T KOG0608|consen 720 LIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDS 798 (1034)
T ss_pred HHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCcccccc
Confidence 6554 56999999999999999999999999999999999999999999999999999643100
Q ss_pred ----------------------------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh
Q psy501 458 ----------------------------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL 509 (962)
Q Consensus 458 ----------------------------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~ 509 (962)
.....+||+.|+|||++.. ..|+..+|.||.|||||||+.|++||....+.
T Consensus 799 mep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 799 MEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEMLVGQPPFLADTPG 877 (1034)
T ss_pred CCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHHhhCCCCccCCCCC
Confidence 0012368999999999975 47999999999999999999999999988877
Q ss_pred hhHHHHHhc--cccccCCCCCC-CCcHHHHHHHhccCCCCCCcHHHHHhhccccccCCCCcchhhhccccccccccceee
Q psy501 510 AGTERLKSS--YILLHTLPLYT-YHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILL 586 (962)
Q Consensus 510 ~~~~~i~~~--~~~~~~~~~~s-~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~~~~~~~~~~~l~g~~~l~ssy~~~ 586 (962)
....++..= .+.++.....+ +.+..|++.|...+..--..-.+-++.-+|+.- +. .+.-.+.+..|+=.
T Consensus 878 ~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkg----ID----fsslRkq~ApYIP~ 949 (1034)
T KOG0608|consen 878 ETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKG----ID----FSSLRKQRAPYIPR 949 (1034)
T ss_pred cceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccc----cc----hHhhhhccCCcCcc
Confidence 776655432 22233333344 345556666766554433334443333333321 11 11223344568777
Q ss_pred cccccccccCCCcccccccccccccccceeEeec
Q psy501 587 HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 620 (962)
Q Consensus 587 ~~lpl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (962)
.+-|-.|-.|-|++-.-+-++..- |++-|-.|+
T Consensus 950 ItHptDTSNFdpvdpeklwnddse-s~~~~~~~n 982 (1034)
T KOG0608|consen 950 ITHPTDTSNFDPVDPEKLWNDDSE-SPNVRDTLN 982 (1034)
T ss_pred ccCCCccccCCcCCcccccccccc-CCCcccccc
Confidence 777888889999999888888777 776665554
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-28 Score=247.29 Aligned_cols=240 Identities=25% Similarity=0.385 Sum_probs=187.2
Q ss_pred EEecCCccc-EEEEEecCCceEEEE--eccchh----HHHHHHHHHHHHhcCCCCcccEEEEEEe--------CCEEEEE
Q psy501 318 SYILPHTLP-LYTCNLDQDNHILSR--HVSSRD----EMVVCFYRKSLKKLSHANLVKLKEVIRE--------NDTLYFV 382 (962)
Q Consensus 318 ~~i~~~~~~-Vy~~~~~~~~kvv~~--k~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--------~~~~~LV 382 (962)
..++.|++. ||+++...+++.++. .+.+.+ .....+|+++|..|+|+|++.+++.|.. ...+|+|
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 344455555 888887777665433 223222 2358999999999999999999888742 2358999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-----
Q psy501 383 FEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----- 457 (962)
Q Consensus 383 ~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----- 457 (962)
|++|+.+|.-.+......|+..++.+++.++..||.|+|+..|+|||+||+|+||+.+|.+||+|||+++.+...
T Consensus 103 f~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~k 182 (376)
T KOG0669|consen 103 FDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVK 182 (376)
T ss_pred HHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCC
Confidence 999999999998887778999999999999999999999999999999999999999999999999999877544
Q ss_pred -CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhc--cccccCCCCC------
Q psy501 458 -PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSS--YILLHTLPLY------ 528 (962)
Q Consensus 458 -~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~------ 528 (962)
..+..+-|++|++||.+.|.+.|+++.|||..||++.||.||.+.|++.........|... .+....+|..
T Consensus 183 prytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~ 262 (376)
T KOG0669|consen 183 PRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLY 262 (376)
T ss_pred CCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHH
Confidence 2344556999999999999999999999999999999999999999987766555544322 1111111110
Q ss_pred -------------------------CCCcHHHHHHHhccCCCCCCcHHHHH-hhc
Q psy501 529 -------------------------TYHVPPIQTTCLLAGTERLKSSYILL-HTL 557 (962)
Q Consensus 529 -------------------------s~~l~~li~~Cl~~dperRPs~~~Ll-~~l 557 (962)
+....+++...+..||.+|+.+.+.+ |.+
T Consensus 263 ~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 263 QSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred HhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 11233478889999999999865544 544
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-28 Score=274.64 Aligned_cols=380 Identities=19% Similarity=0.155 Sum_probs=260.9
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE 388 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g 388 (962)
+....++..+..+.||+++.+...+.++.++. ..+...++.|+-+++..+||||+.+++.+.....+|++||||+|
T Consensus 17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgg 96 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGG 96 (829)
T ss_pred hhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCC
Confidence 34444555555667999988888776554442 23445689999999999999999999999999999999999997
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCc
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTR 466 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~ 466 (962)
+.++.+-.-.+++++.++..+++..++||+|||+.|-+|||||-.||++++.|.+|++|||.+..+... ...++.||+
T Consensus 97 gslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtp 176 (829)
T KOG0576|consen 97 GSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTP 176 (829)
T ss_pred CcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCc
Confidence 666666555678999999999999999999999999999999999999999999999999999877654 666789999
Q ss_pred cccChhhhc--cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCC---CCCCCCcHHHHHHHhc
Q psy501 467 WYRAPEVLL--HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTL---PLYTYHVPPIQTTCLL 541 (962)
Q Consensus 467 ~Y~APE~l~--~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~s~~l~~li~~Cl~ 541 (962)
.|||||+.. ....|...+|||++|++..|+---++|.....+.....-....-..++.+ ...+..+-.+++.|+.
T Consensus 177 ywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~alt 256 (829)
T KOG0576|consen 177 YWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALT 256 (829)
T ss_pred cccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhc
Confidence 999999874 22358999999999999999988888876665554444333333333333 2556678889999999
Q ss_pred cCCCCCCcHHHHHhhccccccCCCCcchhhhccccccccccceeecccccccccCCCcccccccccccccccceeEeecc
Q psy501 542 AGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 621 (962)
Q Consensus 542 ~dperRPs~~~Ll~~l~~~~~~~~~~~~~~~l~g~~~l~ssy~~~~~lpl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (962)
.+|.+||+++.++. -++.+..++.+-...+|-....-...+..+. ..+--.=-|.-|+.
T Consensus 257 knpKkRptaeklL~-h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~--------------------d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 257 KNPKKRPTAEKLLQ-HPFVSQTLSRRLAIELLDKVNNPNPVVRYLE--------------------DYDGEDYLWIPMRI 315 (829)
T ss_pred CCCccCCChhhhee-ceeeccchhhHHHHHHHHHccCCCCcccccc--------------------cCCcccccchhhhh
Confidence 99999999877766 4444444333222233322111111111111 11111111222222
Q ss_pred cccccccCCcceeecccccccccceeee-eeecceEEE----ecCCceeEEeeccccccceeeEEE--EEEeeeeeecCC
Q psy501 622 PLYTYHVPPIQTTCLLAGTERLKSSYIL-LHTLPLYTY----HVPPIQTTCLLAGTERLKSSYILL--HTLPLYTYHVPP 694 (962)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 694 (962)
---+|||++--+.--.+ .+..+.-+.+ ..+-||-+. +|.|- ||+. +.+++.++++++
T Consensus 316 ~s~~rs~~~~~~~se~~-~~~~~~~~~~r~et~~l~~l~~~~~~~~d---------------~~l~s~~~~~~~~~~v~~ 379 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIA-LEQYQFAYPLRKETRPLAELHSSYKVHRD---------------NILGSEEEVKLLDFAVPP 379 (829)
T ss_pred hcCCccccccCChhhHh-hhhhhhhhhhhhhcccccccccccccCcc---------------cccccccccccccccCCc
Confidence 22224555433221110 1112222222 234444332 23332 4444 889999999998
Q ss_pred C-ce---eeeccCCCcccccceeeecCCCCCCCCCceeeee
Q psy501 695 I-QT---TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTC 731 (962)
Q Consensus 695 ~-~~---~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGC 731 (962)
. .. ..+..||+.|++|+++--+ .|+.+.|.||.|.
T Consensus 380 ~L~~~~~~~t~~~~~~~~~pev~~~~--~~~~~p~~~~~~~ 418 (829)
T KOG0576|consen 380 QLTRTMKPRTAIGTPEPLAPEVIQEN--TIDGCPDSGSLAV 418 (829)
T ss_pred ccCcccccccCCCCCCCCCchhhccc--ccccCCCccCCCc
Confidence 8 22 3445899999999988765 3899999999997
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=269.73 Aligned_cols=231 Identities=21% Similarity=0.336 Sum_probs=177.3
Q ss_pred cEEEEEecCCceEEEEec---cchhHHHHHHHHHHHHhc-CCCCcccEEEEEE-----eCCEEEEEEecCCCCHH-HHHH
Q psy501 326 PLYTCNLDQDNHILSRHV---SSRDEMVVCFYRKSLKKL-SHANLVKLKEVIR-----ENDTLYFVFEYMKENLY-QLIR 395 (962)
Q Consensus 326 ~Vy~~~~~~~~kvv~~k~---~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~-----~~~~~~LV~Ey~~g~Ll-~~l~ 395 (962)
.||+++....+..++.++ .....+.++.|.++|+.. .|||++.+|++|. .++.+|||||||.|+.. +.+.
T Consensus 34 kv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVK 113 (953)
T KOG0587|consen 34 KVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVK 113 (953)
T ss_pred eEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHh
Confidence 355555444444444333 223355688899999988 5999999999995 35789999999985444 4433
Q ss_pred h-cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChh
Q psy501 396 D-RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPE 472 (962)
Q Consensus 396 ~-~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE 472 (962)
. .+..+.|..+..|++.++.||.+||...++|||||-.|||++.+|.|||+|||++..+.+. .....+||+.|||||
T Consensus 114 n~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPE 193 (953)
T KOG0587|consen 114 NTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPE 193 (953)
T ss_pred hhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccce
Confidence 2 2567999999999999999999999999999999999999999999999999999887665 566679999999999
Q ss_pred hhccC----CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhc-cccccCCCCCCCCcHHHHHHHhccCCCCC
Q psy501 473 VLLHS----TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSS-YILLHTLPLYTYHVPPIQTTCLLAGTERL 547 (962)
Q Consensus 473 ~l~~~----~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~s~~l~~li~~Cl~~dperR 547 (962)
++... ..|+..+|+||||++..||..|.+|+.+..+.-..-.|-.. ......+...+..+-++|..||..+-++|
T Consensus 194 Viac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~R 273 (953)
T KOG0587|consen 194 VIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQR 273 (953)
T ss_pred eeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccC
Confidence 99643 34778999999999999999999999877654443332211 00111112334567779999999999999
Q ss_pred CcHHHHHhh
Q psy501 548 KSSYILLHT 556 (962)
Q Consensus 548 Ps~~~Ll~~ 556 (962)
|+..+|++.
T Consensus 274 P~~~~ll~h 282 (953)
T KOG0587|consen 274 PSTEELLKH 282 (953)
T ss_pred cchhhhccC
Confidence 997777654
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-26 Score=228.70 Aligned_cols=192 Identities=17% Similarity=0.233 Sum_probs=153.9
Q ss_pred EEEEEecCCceEEEEec-----cchhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCCCCHHHHH---Hhc
Q psy501 327 LYTCNLDQDNHILSRHV-----SSRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKENLYQLI---RDR 397 (962)
Q Consensus 327 Vy~~~~~~~~kvv~~k~-----~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l---~~~ 397 (962)
|-+.+....+.+++.|. ..+...++.+|+++..+. .+|++|.+||.+...+.+||.||.|+-++..+. ...
T Consensus 62 vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~tSldkfy~~v~~~ 141 (282)
T KOG0984|consen 62 VEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDTSLDKFYRKVLKK 141 (282)
T ss_pred hhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhhhHHHHHHHHHhc
Confidence 44444445555544332 344556788899876655 799999999999999999999999998776655 456
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhcccc-eeeeccCCCcccccccccceeeecccccccccCCCccc-ccCCccccChhhhc
Q psy501 398 DKFLPESIIRNMMYQVLQGLAFMHRH-GFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD-YVSTRWYRAPEVLL 475 (962)
Q Consensus 398 ~~~ls~~~i~~i~~qI~~aL~yLH~~-gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~-~~gt~~Y~APE~l~ 475 (962)
++.++|..+-+|+..+..||.|||++ .++|||+||+|||++.+|.+|+||||.+-.+.++...+ ..|...|||||.+.
T Consensus 142 g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~ 221 (282)
T KOG0984|consen 142 GGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERIN 221 (282)
T ss_pred CCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcC
Confidence 78899999999999999999999976 79999999999999999999999999998877664433 68899999999985
Q ss_pred c---CCCCCchhHHHHHHHHHHHHHcCCCCCCCc-ChhhhHHHHHhc
Q psy501 476 H---STAYSAPIHLSRSQQFLFYSIDHVPPIQTT-CLLAGTERLKSS 518 (962)
Q Consensus 476 ~---~~~~t~ksDIwSLGvlL~elltG~~Pf~~~-~~~~~~~~i~~~ 518 (962)
. ...|+-++||||||+++.||.+++.||+.- .+.+....+...
T Consensus 222 ~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 222 PELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred cccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 2 336899999999999999999999999864 344444444433
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=252.92 Aligned_cols=236 Identities=19% Similarity=0.314 Sum_probs=189.6
Q ss_pred ecCCccc-EEEEEecCCceEEEEeccch-----h------HHHHHHHHHHHHhcCCCCcccEEEEEE-eCCEEEEEEecC
Q psy501 320 ILPHTLP-LYTCNLDQDNHILSRHVSSR-----D------EMVVCFYRKSLKKLSHANLVKLKEVIR-ENDTLYFVFEYM 386 (962)
Q Consensus 320 i~~~~~~-Vy~~~~~~~~kvv~~k~~~~-----~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~-~~~~~~LV~Ey~ 386 (962)
+++|+|. ||++-+....+.++.++... + .....+|.+|-+.|+||.||++|++|. +.+.+|-|+|||
T Consensus 471 LGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYc 550 (775)
T KOG1151|consen 471 LGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYC 550 (775)
T ss_pred hccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeec
Confidence 3444444 77776555555555554321 1 124889999999999999999999996 556799999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccce--eeeccCCCcccccc---cccceeeecccccccccCCC---
Q psy501 387 KENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHG--FFHRDMKPENLLCM---GTELVKIADFGLAREIRSRP--- 458 (962)
Q Consensus 387 ~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~g--IvHrDLkp~NILl~---~~g~vKL~DFGla~~~~~~~--- 458 (962)
+|..++++....+.+++++++.|+.||+.||.||.+.. |+|-||||.|||+- .-|.+||+|||+++.+..+.
T Consensus 551 eGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~ 630 (775)
T KOG1151|consen 551 EGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNS 630 (775)
T ss_pred CCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCc
Confidence 99888888888888999999999999999999999875 99999999999994 45689999999999886542
Q ss_pred ------cccccCCccccChhhhccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCcChh----hhHHHHHhccccccCC
Q psy501 459 ------YTDYVSTRWYRAPEVLLHS---TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL----AGTERLKSSYILLHTL 525 (962)
Q Consensus 459 ------~~~~~gt~~Y~APE~l~~~---~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~ 525 (962)
.....||.+|++||.+.-+ ...+.++||||+|||+|.++.|+.||...... .....+....+.+|..
T Consensus 631 vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~K 710 (775)
T KOG1151|consen 631 VDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPK 710 (775)
T ss_pred ccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCC
Confidence 2345799999999998633 34788999999999999999999999865322 2222344556677878
Q ss_pred CCCCCCcHHHHHHHhccCCCCCCcHHHHHh
Q psy501 526 PLYTYHVPPIQTTCLLAGTERLKSSYILLH 555 (962)
Q Consensus 526 ~~~s~~l~~li~~Cl~~dperRPs~~~Ll~ 555 (962)
|..+.....+|+.||...-+.|-...+|..
T Consensus 711 PvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 711 PVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred CccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 888889999999999999999998777665
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=287.28 Aligned_cols=233 Identities=16% Similarity=0.173 Sum_probs=170.5
Q ss_pred EecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhc
Q psy501 319 YILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDR 397 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~ 397 (962)
++.++.+.||++.....++.++.|...........|++++++++||||+++++++.+++..++||||++ |+|.+.+.
T Consensus 698 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-- 775 (968)
T PLN00113 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-- 775 (968)
T ss_pred EccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh--
Confidence 344455569999886666655555443333334567899999999999999999999999999999998 56666653
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhcc---cceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccccChhhh
Q psy501 398 DKFLPESIIRNMMYQVLQGLAFMH---RHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVL 474 (962)
Q Consensus 398 ~~~ls~~~i~~i~~qI~~aL~yLH---~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l 474 (962)
.+++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+...... ....++..|+|||++
T Consensus 776 --~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--~~~~~t~~y~aPE~~ 850 (968)
T PLN00113 776 --NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--TKCFISSAYVAPETR 850 (968)
T ss_pred --cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--CCccccccccCcccc
Confidence 2789999999999999999999 6699999999999999988887765 6655433222 234678999999998
Q ss_pred ccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhh--hHHHHHh----cc---ccccCC-CCCC------CCcHHHHHH
Q psy501 475 LHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLA--GTERLKS----SY---ILLHTL-PLYT------YHVPPIQTT 538 (962)
Q Consensus 475 ~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~--~~~~i~~----~~---~~~~~~-~~~s------~~l~~li~~ 538 (962)
.+ ..++.++|||||||++|||+||+.||....... ....... .. ...+.. +..+ ..+..++..
T Consensus 851 ~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 929 (968)
T PLN00113 851 ET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALH 929 (968)
T ss_pred cC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHh
Confidence 65 469999999999999999999999996432111 1100000 00 000111 0111 123457788
Q ss_pred HhccCCCCCCcHHHHHhhccc
Q psy501 539 CLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 539 Cl~~dperRPs~~~Ll~~l~~ 559 (962)
||..+|++||++.++++.+..
T Consensus 930 Cl~~~P~~RPt~~evl~~L~~ 950 (968)
T PLN00113 930 CTATDPTARPCANDVLKTLES 950 (968)
T ss_pred hCcCCchhCcCHHHHHHHHHH
Confidence 999999999999999998744
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=246.73 Aligned_cols=147 Identities=24% Similarity=0.366 Sum_probs=120.9
Q ss_pred CCCCccccCCCceEEec-----CceeeEEEEecCCcccEEEEEecCCceEEEEeccchhH---HHHHHHHHHHHhcC---
Q psy501 294 DGDTTWFPTGHTTCLLA-----GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDE---MVVCFYRKSLKKLS--- 362 (962)
Q Consensus 294 ~~~~~~~~~g~~~~l~~-----g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~---~~~~~Ei~iL~~L~--- 362 (962)
+....|..+|++.+.+. |.|.+..+++.+...+||.|.+.+..+.++.|+....+ +....||++|++++
T Consensus 56 E~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~D 135 (590)
T KOG1290|consen 56 EDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGD 135 (590)
T ss_pred cChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcC
Confidence 44555677777766433 56666667777777779999999999998888876653 46899999999994
Q ss_pred --C---CCcccEEEEEEe----CCEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhccc-ceeeeccCC
Q psy501 363 --H---ANLVKLKEVIRE----NDTLYFVFEYMKENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHR-HGFFHRDMK 431 (962)
Q Consensus 363 --H---pnIv~l~~~~~~----~~~~~LV~Ey~~g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~-~gIvHrDLk 431 (962)
| .+||++++.|.. +.++|+|+|+++..|+..+.... +.++...++.|++||+.||.|||. +||+|.|||
T Consensus 136 p~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlK 215 (590)
T KOG1290|consen 136 PNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLK 215 (590)
T ss_pred CCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCC
Confidence 3 369999999964 56899999999999999997754 569999999999999999999996 589999999
Q ss_pred Ccccccccc
Q psy501 432 PENLLCMGT 440 (962)
Q Consensus 432 p~NILl~~~ 440 (962)
|+|||+...
T Consensus 216 PENvLl~~~ 224 (590)
T KOG1290|consen 216 PENVLLCST 224 (590)
T ss_pred cceeeeecc
Confidence 999998654
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=266.01 Aligned_cols=284 Identities=17% Similarity=0.177 Sum_probs=200.1
Q ss_pred cEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhc--CCC-C
Q psy501 326 PLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDR--DKF-L 401 (962)
Q Consensus 326 ~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~--~~~-l 401 (962)
.||++.... +.++++.+.......+.+|+..|+.-+ |||||++|+.-.+....||..|.|.++|.+++... +.. .
T Consensus 525 ~Vf~G~ye~-R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~dlie~~~~d~~~~ 603 (903)
T KOG1027|consen 525 VVFRGVYEG-REVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQDLIESSGLDVEMQ 603 (903)
T ss_pred EEEEEeeCC-ceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHHHHHhccccchhhc
Confidence 377776543 344445555555667999999999985 99999999999999999999999999999999874 111 1
Q ss_pred CHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc---c--cceeeecccccccccCC-----CcccccCCccccCh
Q psy501 402 PESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG---T--ELVKIADFGLAREIRSR-----PYTDYVSTRWYRAP 471 (962)
Q Consensus 402 s~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~---~--g~vKL~DFGla~~~~~~-----~~~~~~gt~~Y~AP 471 (962)
.....+.++.|++.||+|||+.+||||||||.||||+. + .+++|+|||+|+.+... ......||.+|+||
T Consensus 604 ~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~AP 683 (903)
T KOG1027|consen 604 SDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAP 683 (903)
T ss_pred ccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCH
Confidence 11456788999999999999999999999999999976 3 37999999999988654 23446799999999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCcChhhhHHHHHhccccccCCC-CCCCCcHHHHHHHhccCCCCCCc
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDH-VPPIQTTCLLAGTERLKSSYILLHTLP-LYTYHVPPIQTTCLLAGTERLKS 549 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~s~~l~~li~~Cl~~dperRPs 549 (962)
|++... .-+.++|||||||++|+.++| ..||...-. -...|..+......+. .......++|..++..+|..||+
T Consensus 684 E~L~~~-~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPs 760 (903)
T KOG1027|consen 684 EQLRED-RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPS 760 (903)
T ss_pred HHHhcc-ccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCC
Confidence 999765 457799999999999999995 999965432 2233444433222221 11115678999999999999999
Q ss_pred HHH-HHhhccccccC-CCCcchhhhccccccccccceeecccccccccCCCcccccccccccccccceeEeecccccccc
Q psy501 550 SYI-LLHTLPLYTYH-VPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYH 627 (962)
Q Consensus 550 ~~~-Ll~~l~~~~~~-~~~~~~~~~l~g~~~l~ssy~~~~~lpl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (962)
+.+ |.|+|.|-.-+ +..... .-.++.+-+.+-|..=-+.|-||.+--..+.|.-|.=+-||-|
T Consensus 761 a~~VL~HPlFW~~ekrL~Fl~d---------------vSDRvE~e~r~~~s~lL~~le~~~~~vv~~~W~~kl~~~~~~~ 825 (903)
T KOG1027|consen 761 ATDVLNHPLFWDSEKRLSFLRD---------------VSDRVEKENRDSPSELLRALEAGARVVVSGDWTEKLDKTFMDN 825 (903)
T ss_pred HHHHhCCCccCChHHHHHHHHh---------------hhhhhhhhhccCchHHHHhhccCCceEecCchhhhhCHHHHHH
Confidence 665 55777663321 111100 0011223333333333344556666556777777766666554
Q ss_pred c
Q psy501 628 V 628 (962)
Q Consensus 628 ~ 628 (962)
.
T Consensus 826 l 826 (903)
T KOG1027|consen 826 L 826 (903)
T ss_pred H
Confidence 3
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-26 Score=237.10 Aligned_cols=152 Identities=26% Similarity=0.351 Sum_probs=130.7
Q ss_pred cccccccccceeeeeeecceEEEecCCceeEEeeccccccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCccc
Q psy501 636 LLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLK 708 (962)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~ 708 (962)
+|-|.+-+-+-|++ -|-||..|+++ |.+|++|||+... ....+.-+.++||
T Consensus 110 ~LkGl~y~H~~~Il----------------------HRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWY 167 (318)
T KOG0659|consen 110 TLKGLAYCHSKWIL----------------------HRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWY 167 (318)
T ss_pred HHHHHHHHHhhhhh----------------------cccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeec
Confidence 46677777777765 37899999999 9999999998765 3444444679999
Q ss_pred ccceeeecCCCCCCCCCceeeeeEee----------cCCchhHHHHHHHhcCCCchhhhcccccc----cCCCcccCCcc
Q psy501 709 SSYILLHTLPLYTYHVPPIQTTCLLA----------GTERLKSSYILLHTLPLYTCYTLASNMNF----KFPQFRRVPFT 774 (962)
Q Consensus 709 ~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G~~~~~ql~~I~~~lG~p~~~~~~~~~~~----~~~~~~~~~l~ 774 (962)
|+||||+|++.|+..|||||+|||+| |.+++|||..||.+||+|.++.|+..... .+...+..++.
T Consensus 168 RAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~ 247 (318)
T KOG0659|consen 168 RAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLN 247 (318)
T ss_pred cChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccc
Confidence 99999999999999999999999999 99999999999999999999998775443 24456677778
Q ss_pred ccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 775 SIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 775 ~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
.+|+.++++++|||.+||+|||.+|++|.|+|+..
T Consensus 248 ~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 248 NLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred cccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 89999999999999999999999999999999744
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=236.07 Aligned_cols=240 Identities=20% Similarity=0.255 Sum_probs=184.8
Q ss_pred EEecCCcc-cEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhc--CCCCcccEEEEEEeCC----EEEEEEecCC-CC
Q psy501 318 SYILPHTL-PLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKL--SHANLVKLKEVIREND----TLYFVFEYMK-EN 389 (962)
Q Consensus 318 ~~i~~~~~-~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L--~HpnIv~l~~~~~~~~----~~~LV~Ey~~-g~ 389 (962)
..+++|.+ .||++.+.. ..++++.++++++....+|.+|...+ +|+||+.+++.-..+. .+|||++|.+ |+
T Consensus 217 e~IGkGRyGEVwrG~wrG-e~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GS 295 (513)
T KOG2052|consen 217 EIIGKGRFGEVWRGRWRG-EDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGS 295 (513)
T ss_pred EEecCccccceeeccccC-CceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCc
Confidence 34455544 499999855 45566667788888899999998865 8999999999865433 5899999998 99
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccc--------eeeeccCCCcccccccccceeeecccccccccCC----
Q psy501 390 LYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRH--------GFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---- 457 (962)
Q Consensus 390 Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~--------gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---- 457 (962)
|++++.. ..++....++++..++.||+|||.. .|.|||||+.|||+..+|.+.|+|+|+|....+.
T Consensus 296 L~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~i 373 (513)
T KOG2052|consen 296 LYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTI 373 (513)
T ss_pred HHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcc
Confidence 9999987 3589999999999999999999953 4999999999999999999999999999776543
Q ss_pred --CcccccCCccccChhhhccCCC---C--CchhHHHHHHHHHHHHHc----------CCCCCCCc----ChhhhHHHHH
Q psy501 458 --PYTDYVSTRWYRAPEVLLHSTA---Y--SAPIHLSRSQQFLFYSID----------HVPPIQTT----CLLAGTERLK 516 (962)
Q Consensus 458 --~~~~~~gt~~Y~APE~l~~~~~---~--t~ksDIwSLGvlL~ellt----------G~~Pf~~~----~~~~~~~~i~ 516 (962)
.....+||..|||||++-..-. + -..+||||||.|+||+.- -++||.+. ...+.+.++.
T Consensus 374 di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVV 453 (513)
T KOG2052|consen 374 DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVV 453 (513)
T ss_pred cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcce
Confidence 4456799999999999953211 1 147899999999999983 24788763 3334445554
Q ss_pred hccccccCCCCC--CC----CcHHHHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 517 SSYILLHTLPLY--TY----HVPPIQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 517 ~~~~~~~~~~~~--s~----~l~~li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
......|.+|.. +. .+-.+++.||..+|.-|-++-.+-+++...
T Consensus 454 Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 454 CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 444444444421 11 344578999999999999988888877443
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=230.56 Aligned_cols=233 Identities=18% Similarity=0.232 Sum_probs=179.5
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccchh-------HHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD-------EMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~-------~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
+...-.+++.+...+|..++.+.+..+++.++..++ -.-++.|-.+..+. +||.+|-++.+|++...+++|.
T Consensus 251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 333333343344445777777777777666554332 23478888888887 5999999999999999999999
Q ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccccccc--CCCcc
Q psy501 384 EYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR--SRPYT 460 (962)
Q Consensus 384 Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~--~~~~~ 460 (962)
||+.| +|.-++.+ ...++++.++.+...|+.||.|||++||++||||.+|+|++..|.+||+|+|+++.-- .+...
T Consensus 331 eyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~ts 409 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTS 409 (593)
T ss_pred EEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcccc
Confidence 99985 55555544 4569999999999999999999999999999999999999999999999999997542 23566
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCc---Chhh-----hHHHHHhccccccCCCCCCCCc
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTT---CLLA-----GTERLKSSYILLHTLPLYTYHV 532 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~---~~~~-----~~~~i~~~~~~~~~~~~~s~~l 532 (962)
.++||+.|.|||++.|. .|+..+|.|+|||+++||+.|+.||+-. ++.. ..+-|...++.+| ...+...
T Consensus 410 tfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip--rslsvka 486 (593)
T KOG0695|consen 410 TFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP--RSLSVKA 486 (593)
T ss_pred cccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc--ceeehhh
Confidence 78999999999999764 7999999999999999999999999742 1111 1233333433333 3445555
Q ss_pred HHHHHHHhccCCCCCC
Q psy501 533 PPIQTTCLLAGTERLK 548 (962)
Q Consensus 533 ~~li~~Cl~~dperRP 548 (962)
..+++.-|..||..|-
T Consensus 487 s~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 487 SHVLKGFLNKDPKERL 502 (593)
T ss_pred HHHHHHhhcCCcHHhc
Confidence 6688899999998874
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-25 Score=241.81 Aligned_cols=186 Identities=25% Similarity=0.380 Sum_probs=155.3
Q ss_pred ecCCcc-cEEEEEecCCceEEEEeccch---hHHHHHHHHHHHHhcC--CCC----cccEEEEEEeCCEEEEEEecCCCC
Q psy501 320 ILPHTL-PLYTCNLDQDNHILSRHVSSR---DEMVVCFYRKSLKKLS--HAN----LVKLKEVIRENDTLYFVFEYMKEN 389 (962)
Q Consensus 320 i~~~~~-~Vy~~~~~~~~kvv~~k~~~~---~~~~~~~Ei~iL~~L~--Hpn----Iv~l~~~~~~~~~~~LV~Ey~~g~ 389 (962)
.+.|++ .|..|.+......++.++... -.+...-|+++|.++. .|+ ++.+.++|.-.++.|||+|.++-+
T Consensus 97 lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfellG~S 176 (415)
T KOG0671|consen 97 LGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELLGLS 176 (415)
T ss_pred hcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEeccChh
Confidence 344444 488888777766666665433 3457888999999994 233 788889999999999999999999
Q ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc--------------------ccceeeecc
Q psy501 390 LYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG--------------------TELVKIADF 448 (962)
Q Consensus 390 Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~--------------------~g~vKL~DF 448 (962)
+.+++.... .+|+...+..++.|++.++++||+.+++|.||||+||++.+ ...|+|+||
T Consensus 177 ~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDF 256 (415)
T KOG0671|consen 177 TFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDF 256 (415)
T ss_pred HHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEec
Confidence 999998754 67999999999999999999999999999999999999942 224899999
Q ss_pred cccccccCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcC
Q psy501 449 GLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTC 507 (962)
Q Consensus 449 Gla~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~ 507 (962)
|.|....... ...+.|..|+|||++++ -+++.++||||+||||+|++||...|++-+
T Consensus 257 GsAtf~~e~h-s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 257 GSATFDHEHH-STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred CCcceeccCc-ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCC
Confidence 9998654443 55788999999999987 589999999999999999999999998765
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=241.08 Aligned_cols=238 Identities=17% Similarity=0.207 Sum_probs=177.8
Q ss_pred cCCcc-cEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhc--CCCCcccEEEEEEeCC----EEEEEEecCC-CCHHH
Q psy501 321 LPHTL-PLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKL--SHANLVKLKEVIREND----TLYFVFEYMK-ENLYQ 392 (962)
Q Consensus 321 ~~~~~-~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L--~HpnIv~l~~~~~~~~----~~~LV~Ey~~-g~Ll~ 392 (962)
++|.+ .||++.... ..|+++.+...+...+..|.+|.+-. +|+||++++++-..+. .++||++|.+ |+|.+
T Consensus 219 ~~Grfg~V~KaqL~~-~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~d 297 (534)
T KOG3653|consen 219 GRGRFGCVWKAQLDN-RLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCD 297 (534)
T ss_pred hcCccceeehhhccC-ceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHH
Confidence 33433 488888765 44445555566677788888887754 7999999999986655 7999999998 89999
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHhhcccc---------eeeeccCCCcccccccccceeeecccccccccCC----Cc
Q psy501 393 LIRDRDKFLPESIIRNMMYQVLQGLAFMHRH---------GFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PY 459 (962)
Q Consensus 393 ~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~---------gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~ 459 (962)
++...- +++....+++..|++||+|||+. .|+|||||+.||||..++++.|+|||+|..+... ..
T Consensus 298 yL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~ 375 (534)
T KOG3653|consen 298 YLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDT 375 (534)
T ss_pred HHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcch
Confidence 988754 89999999999999999999963 5999999999999999999999999999877543 34
Q ss_pred ccccCCccccChhhhccCCCCC-----chhHHHHHHHHHHHHHcCCC------------CCCC----cChhhhHHHHHhc
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYS-----APIHLSRSQQFLFYSIDHVP------------PIQT----TCLLAGTERLKSS 518 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t-----~ksDIwSLGvlL~elltG~~------------Pf~~----~~~~~~~~~i~~~ 518 (962)
...+||.+|||||++.|...+. .+.||||+|.|||||++.-. ||.. ....+.++...-.
T Consensus 376 ~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~ 455 (534)
T KOG3653|consen 376 HGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVR 455 (534)
T ss_pred hhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHh
Confidence 4478999999999998765444 47899999999999997432 3331 1111222222222
Q ss_pred cccccCCCC------CCCCcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 519 YILLHTLPL------YTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 519 ~~~~~~~~~------~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
....|.++. ....+.+.+..||..|++-|-|+..+.+.+....
T Consensus 456 kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 456 KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 222232221 1124566789999999999999888877664433
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.8e-25 Score=245.52 Aligned_cols=187 Identities=24% Similarity=0.321 Sum_probs=162.0
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccchhHH------------HHHHHHHHHHhcC---CCCcccEEEEEEeCCEEEEE
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSSRDEM------------VVCFYRKSLKKLS---HANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~------------~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~LV 382 (962)
..+.|..+.|+.|..+...+.+..|...+++- .+--|+.||..|+ |+||++++++|++++.+||+
T Consensus 568 ~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~ 647 (772)
T KOG1152|consen 568 PLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLE 647 (772)
T ss_pred eccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEE
Confidence 34444555688887777776665554433321 3667999999997 99999999999999999999
Q ss_pred EecCC-C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcc
Q psy501 383 FEYMK-E-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT 460 (962)
Q Consensus 383 ~Ey~~-g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~ 460 (962)
||... | +|++++..+ ..++|.+...|++|++.|+++||+.||||||||-+|+.++.+|.+||+|||.|....+.+..
T Consensus 648 te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ksgpfd 726 (772)
T KOG1152|consen 648 TEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPFD 726 (772)
T ss_pred ecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhcCCCcc
Confidence 99886 4 677777665 45999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQT 505 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~ 505 (962)
.+.||..|.|||++.|....+..-|||+||++||.++..+.||..
T Consensus 727 ~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 727 VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999999999998877788999999999999999999999964
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-26 Score=241.56 Aligned_cols=151 Identities=21% Similarity=0.260 Sum_probs=130.8
Q ss_pred cccccccccceeeeeeecceEEEecCCceeEEeeccccccceeeEEE---EEEeeeeeecCCC-ce---eeeccCCCccc
Q psy501 636 LLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILL---HTLPLYTYHVPPI-QT---TCLLAGTERLK 708 (962)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~-~~---~~~~~gt~~~~ 708 (962)
||.|.+-+-+-|||- |-||.||+|+ |.+|++|||++.. +. ..|..+-|.||
T Consensus 186 lL~glk~lH~~wilH----------------------RDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWY 243 (419)
T KOG0663|consen 186 LLRGLKHLHDNWILH----------------------RDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWY 243 (419)
T ss_pred HHHHHHHHhhceeEe----------------------cccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeee
Confidence 689999999999873 7899999999 9999999999876 22 24445558999
Q ss_pred ccceeeecCCCCCCCCCceeeeeEee----------cCCchhHHHHHHHhcCCCchhhhcccccc------cCCCcccCC
Q psy501 709 SSYILLHTLPLYTYHVPPIQTTCLLA----------GTERLKSSYILLHTLPLYTCYTLASNMNF------KFPQFRRVP 772 (962)
Q Consensus 709 ~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G~~~~~ql~~I~~~lG~p~~~~~~~~~~~------~~~~~~~~~ 772 (962)
|||+||||++.|+++|||||+|||++ |++|+||+.+||.+||+|+...|+.+... .++..+...
T Consensus 244 RaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~ 323 (419)
T KOG0663|consen 244 RAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNN 323 (419)
T ss_pred cCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchh
Confidence 99999999999999999999999999 99999999999999999999988775543 345555667
Q ss_pred ccccCCCC--CHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 773 FTSIIPHA--SPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 773 l~~~~p~~--s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
++..|+.. ++.+.|||.+||.|||.+|+||.++|.+
T Consensus 324 lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 324 LRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 77778754 5999999999999999999999999964
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-24 Score=229.57 Aligned_cols=216 Identities=19% Similarity=0.169 Sum_probs=182.1
Q ss_pred cchhHHHHHHHHHHHHhcCCCCcccEEEEEEe-CCEEEEEEecCC-CCHHHHHHhcC-------CCCCHHHHHHHHHHHH
Q psy501 344 SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRE-NDTLYFVFEYMK-ENLYQLIRDRD-------KFLPESIIRNMMYQVL 414 (962)
Q Consensus 344 ~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-~~~~~LV~Ey~~-g~Ll~~l~~~~-------~~ls~~~i~~i~~qI~ 414 (962)
+..+...+..|.-.|..+.|||+..+.+++.+ ....++++++.. |.|..++.... ..++-.++..++.|++
T Consensus 327 S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla 406 (563)
T KOG1024|consen 327 SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLA 406 (563)
T ss_pred cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHH
Confidence 33444567888888889999999999999864 456788889887 88888887332 3477788899999999
Q ss_pred HHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcc----cccCCccccChhhhccCCCCCchhHHHHHH
Q psy501 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT----DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQ 490 (962)
Q Consensus 415 ~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~----~~~gt~~Y~APE~l~~~~~~t~ksDIwSLG 490 (962)
.|++|||++|+||.||..+|.+|++.-.+||+|=.+++.+-..... ..-....|||||.+... .|+.++|+||||
T Consensus 407 ~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfG 485 (563)
T KOG1024|consen 407 MAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFG 485 (563)
T ss_pred HHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHH
Confidence 9999999999999999999999999999999999999876544221 12345679999999764 799999999999
Q ss_pred HHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 491 QFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 491 vlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
|+||||+| |+.||.+.++.+....+..|... ..+-.+|..+-.++..||...|+.||+.++|.+.|..+.
T Consensus 486 VllWELmtlg~~PyaeIDPfEm~~ylkdGyRl-aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 486 VLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL-AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred HHHHHHHhcCCCCccccCHHHHHHHHhcccee-cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 99999998 99999999999998888888554 445588999999999999999999999999999886553
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-25 Score=242.06 Aligned_cols=138 Identities=28% Similarity=0.356 Sum_probs=122.5
Q ss_pred cccccceeeEEE---EEEeeeeeecCCCce------eeeccCCCcccccceeeecCCCCCCCCCceeeeeEee-------
Q psy501 671 GTERLKSSYILL---HTLPLYTYHVPPIQT------TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA------- 734 (962)
Q Consensus 671 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~------~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~------- 734 (962)
+-|-||.+||++ |.+|++|||++.... ..|-.+.|+|||+|+|++....|+.+|||||+|||||
T Consensus 147 iHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkp 226 (359)
T KOG0660|consen 147 IHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKP 226 (359)
T ss_pred cccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCC
Confidence 458999999999 999999999988742 1244778999999999999999999999999999999
Q ss_pred ---cCCchhHHHHHHHhcCCCchhhhcccc-------cccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhh
Q psy501 735 ---GTERLKSSYILLHTLPLYTCYTLASNM-------NFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQ 804 (962)
Q Consensus 735 ---G~~~~~ql~~I~~~lG~p~~~~~~~~~-------~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~ 804 (962)
|++..+||..|+.++|+|+.+.+.... ....+..++.+|..+||+++++|+|||++||++||.+|+||+|
T Consensus 227 lFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~e 306 (359)
T KOG0660|consen 227 LFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEE 306 (359)
T ss_pred CCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHH
Confidence 999999999999999999988754432 1247788899999999999999999999999999999999999
Q ss_pred hhhh
Q psy501 805 SLSI 808 (962)
Q Consensus 805 ~L~~ 808 (962)
+|.+
T Consensus 307 AL~h 310 (359)
T KOG0660|consen 307 ALAH 310 (359)
T ss_pred HhcC
Confidence 9953
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-25 Score=233.29 Aligned_cols=193 Identities=24% Similarity=0.395 Sum_probs=162.6
Q ss_pred CCcccEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-----EEEEEEecCCCCH
Q psy501 322 PHTLPLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIREND-----TLYFVFEYMKENL 390 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~-----~~~LV~Ey~~g~L 390 (962)
+..+.||.+.+..+++.++.+.... .-..+.+|+++|..++|.|++..++..+-.+ .+|+|+|++..+|
T Consensus 64 GAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQSDL 143 (449)
T KOG0664|consen 64 GAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQSDL 143 (449)
T ss_pred cceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHhhh
Confidence 3344688888877777665544332 2346899999999999999999999886543 3678999998888
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---CcccccCCcc
Q psy501 391 YQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYVSTRW 467 (962)
Q Consensus 391 l~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~gt~~ 467 (962)
...+.+. ..++.+.++-++.||++||+|||+.+|.||||||.|.|++.+..+||||||+++....+ .++..+-|..
T Consensus 144 HKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQY 222 (449)
T KOG0664|consen 144 HKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQY 222 (449)
T ss_pred hheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHH
Confidence 8777664 56999999999999999999999999999999999999999999999999999876544 4455677899
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHH
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERL 515 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i 515 (962)
|+|||+++|...|+.+.||||.||++.|++..+..|....+.+..+-|
T Consensus 223 YRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lI 270 (449)
T KOG0664|consen 223 YRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMI 270 (449)
T ss_pred hccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHH
Confidence 999999999999999999999999999999999999988776665544
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-25 Score=244.82 Aligned_cols=137 Identities=28% Similarity=0.437 Sum_probs=126.9
Q ss_pred cccceeeEEE---EEEeeeeeecCCC---ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------cC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI---QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------GT 736 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G~ 736 (962)
|-||.-||++ -++||+|||++.. +..+|-+++|||||+|||||.++.|+.+|||||+|||+| |.
T Consensus 134 RDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~ 213 (538)
T KOG0661|consen 134 RDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA 213 (538)
T ss_pred ccCChhheEecccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC
Confidence 7789999998 5899999999987 777888999999999999999999999999999999998 99
Q ss_pred CchhHHHHHHHhcCCCchhhh------cccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 737 ERLKSSYILLHTLPLYTCYTL------ASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 737 ~~~~ql~~I~~~lG~p~~~~~------~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
+|+|||++|.++||+|..+.+ +..+.+++|+.++.++..++|.+++++.+||.+||.|||.+||||+++|+..
T Consensus 214 sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 214 SEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred cHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 999999999999999998775 4467778999999999999999999999999999999999999999999643
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=241.19 Aligned_cols=196 Identities=21% Similarity=0.287 Sum_probs=165.8
Q ss_pred eeEEEEecCCccc-EEEEEecCCceEEEEeccchh---HHHHHHHHHHHHhcC------CCCcccEEEEEEeCCEEEEEE
Q psy501 314 RLKFSYILPHTLP-LYTCNLDQDNHILSRHVSSRD---EMVVCFYRKSLKKLS------HANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 314 ~~~~~~i~~~~~~-Vy~~~~~~~~kvv~~k~~~~~---~~~~~~Ei~iL~~L~------HpnIv~l~~~~~~~~~~~LV~ 383 (962)
+.+..+.++|.|. |..|.....+..++.++.... ...-.+|++||++|. --|+++++-.|...+++|||+
T Consensus 434 Y~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVF 513 (752)
T KOG0670|consen 434 YEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVF 513 (752)
T ss_pred eEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEe
Confidence 3444555666665 888877776666666665443 345789999999995 348999999999999999999
Q ss_pred ecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc-ceeeecccccccccCCCcc
Q psy501 384 EYMKENLYQLIRDRD--KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE-LVKIADFGLAREIRSRPYT 460 (962)
Q Consensus 384 Ey~~g~Ll~~l~~~~--~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g-~vKL~DFGla~~~~~~~~~ 460 (962)
|-+.-.|-+.+..-+ -.|....+..++.|++.||..|-.+||+|.||||+|||+.+.. .+||||||.|........+
T Consensus 514 E~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneit 593 (752)
T KOG0670|consen 514 EPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEIT 593 (752)
T ss_pred hhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccccccc
Confidence 999998888887654 3578899999999999999999999999999999999998654 7899999999988888888
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhh
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLA 510 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~ 510 (962)
.+.-+..|+|||++.| .+|+...|+||.||+||||.||+..|.+.....
T Consensus 594 PYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ 642 (752)
T KOG0670|consen 594 PYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ 642 (752)
T ss_pred HHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHH
Confidence 8888899999999987 489999999999999999999999999865433
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=249.77 Aligned_cols=247 Identities=17% Similarity=0.191 Sum_probs=152.2
Q ss_pred ceeeEEEEecCCcccEEEEEecCC----ce-EEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEE------EEeCCEEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQD----NH-ILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEV------IRENDTLY 380 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~----~k-vv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~------~~~~~~~~ 380 (962)
.+.....++.++.+.||++....+ .. ++.+++..........+ +.++...+..+..++.. ...+...+
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~-e~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMN-ERVRRACPNSCADFVYGFLEPVSSKKEDEYW 211 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHH-HHHHhhchhhHHHHHHhhhcccccccCCceE
Confidence 344444555555566888877665 33 33343322221111111 11222222333322222 23556799
Q ss_pred EEEecCC-CCHHHHHHhcCCC-------------------CCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc-
Q psy501 381 FVFEYMK-ENLYQLIRDRDKF-------------------LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG- 439 (962)
Q Consensus 381 LV~Ey~~-g~Ll~~l~~~~~~-------------------ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~- 439 (962)
+|+||++ ++|.+.+...... .....+..++.||+.||.|||+.+|+||||||+|||++.
T Consensus 212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~ 291 (566)
T PLN03225 212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEG 291 (566)
T ss_pred EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCC
Confidence 9999998 4666666543211 123456789999999999999999999999999999985
Q ss_pred ccceeeecccccccccCC---CcccccCCccccChhhhccCC---------------------CCCchhHHHHHHHHHHH
Q psy501 440 TELVKIADFGLAREIRSR---PYTDYVSTRWYRAPEVLLHST---------------------AYSAPIHLSRSQQFLFY 495 (962)
Q Consensus 440 ~g~vKL~DFGla~~~~~~---~~~~~~gt~~Y~APE~l~~~~---------------------~~t~ksDIwSLGvlL~e 495 (962)
++.+||+|||+|+.+... ......+++.|+|||.+.... .++.++|||||||+|||
T Consensus 292 ~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~e 371 (566)
T PLN03225 292 SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 371 (566)
T ss_pred CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHH
Confidence 579999999999765432 334567899999999764221 23456799999999999
Q ss_pred HHcCCCCCCCcChhhhHHHHHhcccc--------ccC-CC----------CCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 496 SIDHVPPIQTTCLLAGTERLKSSYIL--------LHT-LP----------LYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 496 lltG~~Pf~~~~~~~~~~~i~~~~~~--------~~~-~~----------~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
|+++..|+..... .....+...... .+. .+ ..+....+|+..||..||++||++.++++.
T Consensus 372 l~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 372 MAFPNLRSDSNLI-QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHhCcCCCchHHH-HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 9998776543211 111111110000 000 00 001112379999999999999998888775
Q ss_pred ccccc
Q psy501 557 LPLYT 561 (962)
Q Consensus 557 l~~~~ 561 (962)
||+.
T Consensus 451 -pff~ 454 (566)
T PLN03225 451 -PYFD 454 (566)
T ss_pred -cCcC
Confidence 4543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=208.68 Aligned_cols=200 Identities=30% Similarity=0.439 Sum_probs=166.5
Q ss_pred cccEEEEEecCCceEEEEec-cchh----HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhc
Q psy501 324 TLPLYTCNLDQDNHILSRHV-SSRD----EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDR 397 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~-~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~ 397 (962)
.+.+|.+.....++.+..|. .... ...+.+|++.++.++|++|+++++++......++++|+++ +++.+.+...
T Consensus 6 ~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~ 85 (215)
T cd00180 6 FGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKEN 85 (215)
T ss_pred ceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhc
Confidence 34577777765333333333 2222 3579999999999999999999999999999999999999 5677766654
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc-ccceeeecccccccccCCC--cccccCCccccChhhh
Q psy501 398 DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG-TELVKIADFGLAREIRSRP--YTDYVSTRWYRAPEVL 474 (962)
Q Consensus 398 ~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~-~g~vKL~DFGla~~~~~~~--~~~~~gt~~Y~APE~l 474 (962)
...++...++.++.+++.+|.+||+.|++|+||+|.||+++. .+.++|+|||.+....... .....+...|++||.+
T Consensus 86 ~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 165 (215)
T cd00180 86 EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVL 165 (215)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHh
Confidence 356899999999999999999999999999999999999999 8999999999998765543 4456678899999998
Q ss_pred ccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHH
Q psy501 475 LHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILL 554 (962)
Q Consensus 475 ~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll 554 (962)
.....++.++|+|++|+++++| ..+..++..|+..+|+.||+..+++
T Consensus 166 ~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~ 212 (215)
T cd00180 166 LGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEKRPSAKEIL 212 (215)
T ss_pred cccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcccCcCHHHHh
Confidence 6543688999999999999999 4567789999999999999999887
Q ss_pred hh
Q psy501 555 HT 556 (962)
Q Consensus 555 ~~ 556 (962)
..
T Consensus 213 ~~ 214 (215)
T cd00180 213 EH 214 (215)
T ss_pred hC
Confidence 64
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.8e-24 Score=224.81 Aligned_cols=204 Identities=27% Similarity=0.356 Sum_probs=166.5
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeC------CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhccc
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIREN------DTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHR 422 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~ 422 (962)
....+|..++..+.|+||++++.+|.-. ...|+|||+++.++...+... ++-+.+..++.|++.|++|||+
T Consensus 60 kra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~~e---lDH~tis~i~yq~~~~ik~lhs 136 (369)
T KOG0665|consen 60 KRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVILME---LDHETISYILYQMLCGIKHLHS 136 (369)
T ss_pred hhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHHHh---cchHHHHHHHHHHHHHHHHHHh
Confidence 4688999999999999999999999643 357999999999998887743 6788999999999999999999
Q ss_pred ceeeeccCCCcccccccccceeeecccccccccCC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCC
Q psy501 423 HGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVP 501 (962)
Q Consensus 423 ~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~ 501 (962)
.||+||||||+||++..++.+||.|||+|+..... ..+..+.+..|+|||++.+- .|...+||||+||++.||++|..
T Consensus 137 ~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~-~~ke~vdiwSvGci~gEli~~~V 215 (369)
T KOG0665|consen 137 AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELILGTV 215 (369)
T ss_pred cceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheecc-CCcccchhhhhhhHHHHHhhceE
Confidence 99999999999999999999999999999887766 67778999999999999875 59999999999999999999999
Q ss_pred CCCCcChhhhHHHHHhccc-------------------------------cccCC---------CCCCCCcHHHHHHHhc
Q psy501 502 PIQTTCLLAGTERLKSSYI-------------------------------LLHTL---------PLYTYHVPPIQTTCLL 541 (962)
Q Consensus 502 Pf~~~~~~~~~~~i~~~~~-------------------------------~~~~~---------~~~s~~l~~li~~Cl~ 541 (962)
.|.+.+..+...++...-. .++.. +.-....+++...+|.
T Consensus 216 lf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLv 295 (369)
T KOG0665|consen 216 LFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLV 295 (369)
T ss_pred EecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhc
Confidence 9988655444332221100 00000 0111235668888999
Q ss_pred cCCCCCCcHHHHHhh
Q psy501 542 AGTERLKSSYILLHT 556 (962)
Q Consensus 542 ~dperRPs~~~Ll~~ 556 (962)
.+|++|-++.+++..
T Consensus 296 i~pe~Risv~daL~H 310 (369)
T KOG0665|consen 296 IDPEKRISVDDALRH 310 (369)
T ss_pred cChhhcccHHHHhcC
Confidence 999999998776653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=210.92 Aligned_cols=201 Identities=28% Similarity=0.382 Sum_probs=160.1
Q ss_pred EecCCcccEEEEEecCCceEEEEeccch-----hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHH
Q psy501 319 YILPHTLPLYTCNLDQDNHILSRHVSSR-----DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQ 392 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~ 392 (962)
+..++.+.+|.+......+.++.+.... ....+.+|++.+++++|++++++++++......++++|++++ +|.+
T Consensus 7 i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 86 (225)
T smart00221 7 LGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFD 86 (225)
T ss_pred eecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHH
Confidence 3344455677777665343333333221 456789999999999999999999999998999999999997 7777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---CcccccCCcccc
Q psy501 393 LIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYVSTRWYR 469 (962)
Q Consensus 393 ~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~gt~~Y~ 469 (962)
.+......+++..++.++.+++.++.+||+.+++|+||+|.||+++..+.++|+|||.+...... ......++..|+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~ 166 (225)
T smart00221 87 YLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYL 166 (225)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcC
Confidence 66654433899999999999999999999999999999999999999999999999999876543 234456788899
Q ss_pred ChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCC-cC-hhhhHHHHHhcc
Q psy501 470 APEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQT-TC-LLAGTERLKSSY 519 (962)
Q Consensus 470 APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~-~~-~~~~~~~i~~~~ 519 (962)
+||.+.+...++.++|+||||+++++|++|+.||.. .. .....+.+..+.
T Consensus 167 ~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 167 APEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred CHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 999884445678899999999999999999999977 33 335556666553
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-24 Score=226.52 Aligned_cols=140 Identities=19% Similarity=0.216 Sum_probs=121.5
Q ss_pred ccccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 672 TERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 672 ~~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
-|.||.-||++ |++||||||++.. +..+|-++.|||||+||||+|.+.||++|||||+|||++
T Consensus 124 HRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P 203 (396)
T KOG0593|consen 124 HRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP 203 (396)
T ss_pred cccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCC
Confidence 47899999999 9999999999765 556777889999999999999999999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhc---cc---ccccCCCcc-cCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLA---SN---MNFKFPQFR-RVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~---~~---~~~~~~~~~-~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
|.+++|||+.|...||...++... .. ...++|..+ +.+++..+|+++.-++||+++||.+||.+|++.+++|.
T Consensus 204 G~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 204 GRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 999999999999999997776632 22 222455543 67899999999999999999999999999999999997
Q ss_pred hhhh
Q psy501 808 IKRE 811 (962)
Q Consensus 808 ~~~e 811 (962)
+...
T Consensus 284 H~yF 287 (396)
T KOG0593|consen 284 HPYF 287 (396)
T ss_pred ChHH
Confidence 5543
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-24 Score=241.43 Aligned_cols=136 Identities=19% Similarity=0.164 Sum_probs=115.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
|-||++|||+ |++||+|||+... ....|.++-|+||||||||||++.|+++|||||+||||+
T Consensus 242 RDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~ 321 (560)
T KOG0600|consen 242 RDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ 321 (560)
T ss_pred ccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC
Confidence 7899999999 9999999999873 233566777899999999999999999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcc--cccc---cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLAS--NMNF---KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~--~~~~---~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
|.+|++||.+|++++|.|+.+.|+. .+.+ +........+++.|..+++.+++||.+||.+||.+|.||.++|..
T Consensus 322 G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 322 GRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 9999999999999999999988772 2211 111112455777788999999999999999999999999999953
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.4e-24 Score=264.93 Aligned_cols=195 Identities=16% Similarity=0.143 Sum_probs=143.2
Q ss_pred HhcCC-CCcccEEEEE-------EeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccC
Q psy501 359 KKLSH-ANLVKLKEVI-------RENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDM 430 (962)
Q Consensus 359 ~~L~H-pnIv~l~~~~-------~~~~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDL 430 (962)
+.+.| +||++++++| ..+..++++||+++++|.+.+......+++..++.++.||+.||.|||++||+||||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 34556 6888888887 233467888999999999999766667999999999999999999999999999999
Q ss_pred CCccccccc-------------------ccceeeecccccccccCC------------------CcccccCCccccChhh
Q psy501 431 KPENLLCMG-------------------TELVKIADFGLAREIRSR------------------PYTDYVSTRWYRAPEV 473 (962)
Q Consensus 431 kp~NILl~~-------------------~g~vKL~DFGla~~~~~~------------------~~~~~~gt~~Y~APE~ 473 (962)
||+||||+. ++.+|++|||+++..... ......||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999954 345667777776532110 0011357888999999
Q ss_pred hccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHH
Q psy501 474 LLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 553 (962)
Q Consensus 474 l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~L 553 (962)
+.+. .++.++|||||||+||||++|.+|+..... ....+..... ++...........++..||..+|.+||++.++
T Consensus 187 ~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 187 DNGS-SSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVL-PPQILLNWPKEASFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred hccC-CCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhc-ChhhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence 8764 689999999999999999999998764322 1222222211 11111112234467778999999999998888
Q ss_pred Hhhc
Q psy501 554 LHTL 557 (962)
Q Consensus 554 l~~l 557 (962)
++.-
T Consensus 263 l~h~ 266 (793)
T PLN00181 263 LQSE 266 (793)
T ss_pred hhch
Confidence 7643
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-24 Score=232.48 Aligned_cols=168 Identities=22% Similarity=0.325 Sum_probs=141.3
Q ss_pred ccccceeeeeeecceEEEecCCceeEEeec-----c--ccccceeeEEE----EEEeeeeeecCCC---ceeeeccCCCc
Q psy501 641 ERLKSSYILLHTLPLYTYHVPPIQTTCLLA-----G--TERLKSSYILL----HTLPLYTYHVPPI---QTTCLLAGTER 706 (962)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~--~~~~~~~~~~~----~~~~~~~~~~~~~---~~~~~~~gt~~ 706 (962)
+.||||-+..+-+|++++|.=-.|+..-++ | -|-||.+|||. |.+||+|||=+.. +.....+=-.|
T Consensus 110 ~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSR 189 (364)
T KOG0658|consen 110 RVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSR 189 (364)
T ss_pred HHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEec
Confidence 578999999999999999999888754332 1 36679999999 9999999996543 11111112269
Q ss_pred ccccceeeecCCCCCCCCCceeeeeEee----------cCCchhHHHHHHHhcCCCchhhhcc----cccccCCCcccCC
Q psy501 707 LKSSYILLHTLPLYTYHVPPIQTTCLLA----------GTERLKSSYILLHTLPLYTCYTLAS----NMNFKFPQFRRVP 772 (962)
Q Consensus 707 ~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G~~~~~ql~~I~~~lG~p~~~~~~~----~~~~~~~~~~~~~ 772 (962)
|||||||++|++.|+.+|||||+|||+| |++..+||..|++++|+|+.+++.. ....+++..++.+
T Consensus 190 yYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~ 269 (364)
T KOG0658|consen 190 YYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHP 269 (364)
T ss_pred cccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCccccccc
Confidence 9999999999999999999999999999 9999999999999999999998543 3455688888889
Q ss_pred ccc-cCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 773 FTS-IIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 773 l~~-~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
|.+ +++..+++++|||.++|+|+|.+|.+|.++|..
T Consensus 270 ~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 270 WHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred ceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 877 456799999999999999999999999999973
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=205.61 Aligned_cols=158 Identities=20% Similarity=0.198 Sum_probs=124.6
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCcc
Q psy501 388 ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRW 467 (962)
Q Consensus 388 g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~ 467 (962)
|+|.+.+...+..+++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||.+....... ..|++.
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---~~g~~~ 69 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---SRVDPY 69 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc---CCCccc
Confidence 6788888776777999999999999999999999998 999999999999999 99987654432 368899
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh-HHHHHhcccccc-----CCCCCCC--CcHHHHHHH
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG-TERLKSSYILLH-----TLPLYTY--HVPPIQTTC 539 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~-~~~i~~~~~~~~-----~~~~~s~--~l~~li~~C 539 (962)
|+|||++.+. .++.++|||||||++|||++|+.||........ ...+........ .....+. .+..++..|
T Consensus 70 y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c 148 (176)
T smart00750 70 FMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVC 148 (176)
T ss_pred ccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHH
Confidence 9999999764 689999999999999999999999976544322 222222211110 0111222 578899999
Q ss_pred hccCCCCCCcHHHHHhhc
Q psy501 540 LLAGTERLKSSYILLHTL 557 (962)
Q Consensus 540 l~~dperRPs~~~Ll~~l 557 (962)
|..+|++||++.+++...
T Consensus 149 l~~~p~~Rp~~~~ll~~~ 166 (176)
T smart00750 149 ASRLPQRREAANHYLAHC 166 (176)
T ss_pred HhcccccccCHHHHHHHH
Confidence 999999999988888765
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=206.45 Aligned_cols=185 Identities=21% Similarity=0.360 Sum_probs=153.1
Q ss_pred EEecCCcccEEEEE-ecCCceEEEEeccchhHHHHHHHHHHHHhcC-CCCcccEEEEEEeC--CEEEEEEecCCCCHHHH
Q psy501 318 SYILPHTLPLYTCN-LDQDNHILSRHVSSRDEMVVCFYRKSLKKLS-HANLVKLKEVIREN--DTLYFVFEYMKENLYQL 393 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~-~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~--~~~~LV~Ey~~g~Ll~~ 393 (962)
+++.|....||.+. .....|++.+.+.+-....+.+|+.||..|. ||||+.+++...++ ....+|+||+....+..
T Consensus 45 k~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ 124 (338)
T KOG0668|consen 45 KVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQ 124 (338)
T ss_pred HHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHH
Confidence 33333344577764 4455667777777777788999999999997 99999999999765 45789999998755555
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc-ceeeecccccccccCC-CcccccCCccccCh
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE-LVKIADFGLAREIRSR-PYTDYVSTRWYRAP 471 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g-~vKL~DFGla~~~~~~-~~~~~~gt~~Y~AP 471 (962)
+-. .++...+..++.+++.||.|+|+.||.|||+||.|++|+... .++|+|+|+|.+.... .....+.+..|.-|
T Consensus 125 ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGP 201 (338)
T KOG0668|consen 125 LYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 201 (338)
T ss_pred Hhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCc
Confidence 443 378889999999999999999999999999999999998654 7999999999987665 45556778889999
Q ss_pred hhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q psy501 472 EVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQT 505 (962)
Q Consensus 472 E~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~ 505 (962)
|++..-..|+..-|+|||||+|..|++.+.||..
T Consensus 202 ELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 202 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred hheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 9999888899999999999999999999888754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-21 Score=227.20 Aligned_cols=205 Identities=20% Similarity=0.210 Sum_probs=143.7
Q ss_pred HHHHHHHHHhcCCCCc-----ccEEEEEEe--------CCEEEEEEecCC-CCHHHHHHhcC------------------
Q psy501 351 VCFYRKSLKKLSHANL-----VKLKEVIRE--------NDTLYFVFEYMK-ENLYQLIRDRD------------------ 398 (962)
Q Consensus 351 ~~~Ei~iL~~L~HpnI-----v~l~~~~~~--------~~~~~LV~Ey~~-g~Ll~~l~~~~------------------ 398 (962)
...|+.++.+++|.++ ++++++|.. .+..|+||||++ |+|.+.+....
T Consensus 219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~ 298 (507)
T PLN03224 219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP 298 (507)
T ss_pred hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence 3457777778876554 677777643 356899999998 56666654321
Q ss_pred -----CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC-cc--cccCCccccC
Q psy501 399 -----KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP-YT--DYVSTRWYRA 470 (962)
Q Consensus 399 -----~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~-~~--~~~gt~~Y~A 470 (962)
..+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++....... .. ...+++.|+|
T Consensus 299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred hhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 124667889999999999999999999999999999999999999999999997654321 11 1234789999
Q ss_pred hhhhccCCC-------------------C--CchhHHHHHHHHHHHHHcCCC-CCCCcChhhhH-----------HHHHh
Q psy501 471 PEVLLHSTA-------------------Y--SAPIHLSRSQQFLFYSIDHVP-PIQTTCLLAGT-----------ERLKS 517 (962)
Q Consensus 471 PE~l~~~~~-------------------~--t~ksDIwSLGvlL~elltG~~-Pf~~~~~~~~~-----------~~i~~ 517 (962)
||.+..... + ..+.||||+||++|+|++|.. ||......... .....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 999853211 1 234799999999999999975 77643221111 11112
Q ss_pred ccccccCCCCCCCCcHHHHHHHhccCC---CCCCcHHHHHh
Q psy501 518 SYILLHTLPLYTYHVPPIQTTCLLAGT---ERLKSSYILLH 555 (962)
Q Consensus 518 ~~~~~~~~~~~s~~l~~li~~Cl~~dp---erRPs~~~Ll~ 555 (962)
....+...+..+....+++..++..+| .+|+|+.+.+.
T Consensus 459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 222333344556677889999998765 67888655444
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.5e-22 Score=216.87 Aligned_cols=114 Identities=27% Similarity=0.458 Sum_probs=95.9
Q ss_pred eEEEEec-cchhHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHH
Q psy501 337 HILSRHV-SSRDEMVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVL 414 (962)
Q Consensus 337 kvv~~k~-~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~ 414 (962)
+++.+.+ .......+..|+++|..+. +.||+++.+++...+..++||||++..-...+... ++...+..+++.++
T Consensus 66 ~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll 142 (418)
T KOG1167|consen 66 YVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLL 142 (418)
T ss_pred eEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHH
Confidence 3433443 3344667999999999995 99999999999999999999999996555555443 77899999999999
Q ss_pred HHHhhcccceeeeccCCCccccccc-ccceeeeccccccc
Q psy501 415 QGLAFMHRHGFFHRDMKPENLLCMG-TELVKIADFGLARE 453 (962)
Q Consensus 415 ~aL~yLH~~gIvHrDLkp~NILl~~-~g~vKL~DFGla~~ 453 (962)
.||.++|..|||||||||+|++.+. .+.-.|+|||+|..
T Consensus 143 ~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 143 KALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred HHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 9999999999999999999999974 46788999999854
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-22 Score=242.85 Aligned_cols=441 Identities=17% Similarity=0.151 Sum_probs=268.2
Q ss_pred HHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHhhcc-ccee
Q psy501 350 VVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDK-FLPESIIRNMMYQVLQGLAFMH-RHGF 425 (962)
Q Consensus 350 ~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~~-~ls~~~i~~i~~qI~~aL~yLH-~~gI 425 (962)
....|..+-+.+. |+|++.+++...+....++++++..| ++...+..... ..+......++.|+..++.|+| ..++
T Consensus 66 ~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~ 145 (601)
T KOG0590|consen 66 HIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGV 145 (601)
T ss_pred hcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccccc
Confidence 3555777777776 99999999999999999999999875 55555523332 5788888999999999999999 9999
Q ss_pred eeccCCCccccccccc-ceeeecccccccccC-C----CcccccC-CccccChhhhccCCCCCchhHHHHHHHHHHHHHc
Q psy501 426 FHRDMKPENLLCMGTE-LVKIADFGLAREIRS-R----PYTDYVS-TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID 498 (962)
Q Consensus 426 vHrDLkp~NILl~~~g-~vKL~DFGla~~~~~-~----~~~~~~g-t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt 498 (962)
.|+||+|+|.+++..+ .+++.|||+|..+.. . .....+| ++.|+|||...+........|+||.|+++.-|++
T Consensus 146 ~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~ 225 (601)
T KOG0590|consen 146 THRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLT 225 (601)
T ss_pred ccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccccccccccccc
Confidence 9999999999999999 999999999987655 2 3334578 9999999999875567889999999999999999
Q ss_pred CCCCCCCcChhhhHHHHHhc---cccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcccccc-CCCCcc------
Q psy501 499 HVPPIQTTCLLAGTERLKSS---YILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTY-HVPPIQ------ 568 (962)
Q Consensus 499 G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~-~~~~~~------ 568 (962)
|..||...........-... ......+...+.....+...++..+|+.|.+.+++... +|... ......
T Consensus 226 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d-~~~~~~~~~~~~~n~~~~ 304 (601)
T KOG0590|consen 226 GELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD-NWLSSKRNGFSKSNPCAD 304 (601)
T ss_pred CCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhcccccccccc-cccccccccccccccccc
Confidence 99999876554432111111 11122233444455567777888899999987765432 34333 111000
Q ss_pred ----------------hhhhccccccccccceeecccccccccCCCcccccccccccc-----cccceeEeecccccc--
Q psy501 569 ----------------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTER-----LKSSYILLHTLPLYT-- 625 (962)
Q Consensus 569 ----------------~~~~l~g~~~l~ssy~~~~~lpl~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~-- 625 (962)
....+.|.....+.++.....++..++.+-.=.....+.+++ +-+.+..-++|..+.
T Consensus 305 ~~~~~~~~~~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~ 384 (601)
T KOG0590|consen 305 SLTIAKSPIGFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNII 384 (601)
T ss_pred ccccccCccccccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchh
Confidence 011111222222344455555665554432111100222222 222223333333322
Q ss_pred ------cccCCccee-ecccc------cc-----cccceeeeeeecceEEEecCCceeEEeeccccccceeeEEE---EE
Q psy501 626 ------YHVPPIQTT-CLLAG------TE-----RLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILL---HT 684 (962)
Q Consensus 626 ------~~~~~~~~~-~~~~~------~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 684 (962)
++-+-+... ++..+ +. .+.-.+-+.|+++=|-| .. -|.-.-|.+|..||++ |+
T Consensus 385 e~l~~~~~~~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y----~h--~~GiahrdlK~enll~~~~g~ 458 (601)
T KOG0590|consen 385 ETLDIVQEIDGILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKY----LH--SMGLAHRDLKLENLLVTENGI 458 (601)
T ss_pred hhHHHHhhcccchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHH----HH--hcCceeccCccccEEEecCCc
Confidence 222222222 22222 00 01111112222211111 00 1223467789999999 89
Q ss_pred EeeeeeecCCC-ceee--------eccCCCcccccceeeecCCCCC-CCCCceeeeeEeecCCchhHHHHHHHhcCCCc-
Q psy501 685 LPLYTYHVPPI-QTTC--------LLAGTERLKSSYILLHTLPLYT-YHVPPIQTTCLLAGTERLKSSYILLHTLPLYT- 753 (962)
Q Consensus 685 ~~~~~~~~~~~-~~~~--------~~~gt~~~~~~~~lLlg~~~Y~-~~vDIWSlGCIl~G~~~~~ql~~I~~~lG~p~- 753 (962)
+|++|||.+.. .... -.+|+..|++||++-. ..|+ ..+||||+|+|+. ..++|..+
T Consensus 459 lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~--~~ydpr~vDiwS~~ii~~-----------~m~~~~~~W 525 (601)
T KOG0590|consen 459 LKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTG--KEYDPRAVDVWSCGIIYI-----------CMILGRFPW 525 (601)
T ss_pred eEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccc--cccCcchhhhhhccceEE-----------EEecCCCcc
Confidence 99999999876 2111 1299999999777664 3488 5899999999996 12233211
Q ss_pred hhhhccccc---ccCCCc--ccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh-hhh
Q psy501 754 CYTLASNMN---FKFPQF--RRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS-IKR 810 (962)
Q Consensus 754 ~~~~~~~~~---~~~~~~--~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~-~~~ 810 (962)
..-...... .....+ .......+...+....+.+|.+||++||.+|++++++|+ +|.
T Consensus 526 k~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~ 588 (601)
T KOG0590|consen 526 KVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWI 588 (601)
T ss_pred ccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHh
Confidence 110000000 000000 000111122345668899999999999999999999996 443
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.6e-21 Score=188.70 Aligned_cols=137 Identities=19% Similarity=0.295 Sum_probs=116.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-cee--e-eccCCCcccccceeeecCCCCCCCCCceeeeeEee-----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-QTT--C-LLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-~~~--~-~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------- 734 (962)
|.||.+|.++ |.+||.|||++.+ +.. | +--.-+.|||||-+++|++.|++++||||+||||+
T Consensus 125 rdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 125 RDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred ccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 6789999999 9999999998876 222 2 22345799999999999999999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcccccc---c-CCCcc-cCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNF---K-FPQFR-RVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~---~-~~~~~-~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
|.+-.||+.+|+.++|+|+.+.|+..... + +|.++ ..+|.+++|+++..+.|||+++|..+|.+|++|+++|+..
T Consensus 205 g~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp 284 (292)
T KOG0662|consen 205 GNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP 284 (292)
T ss_pred CCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence 88889999999999999999988775432 1 33333 3579999999999999999999999999999999999754
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-20 Score=196.73 Aligned_cols=218 Identities=19% Similarity=0.246 Sum_probs=151.5
Q ss_pred EEEEEecCCceEEEEeccchh---HHHHHHHHHHHHhc-CCCCcccEEEE-EEeCCEEEEEEecCC-CCHHHHHHhcCCC
Q psy501 327 LYTCNLDQDNHILSRHVSSRD---EMVVCFYRKSLKKL-SHANLVKLKEV-IRENDTLYFVFEYMK-ENLYQLIRDRDKF 400 (962)
Q Consensus 327 Vy~~~~~~~~kvv~~k~~~~~---~~~~~~Ei~iL~~L-~HpnIv~l~~~-~~~~~~~~LV~Ey~~-g~Ll~~l~~~~~~ 400 (962)
+-.|........++.+...+. ...+.+|..---.| .|.||+.-|++ |++.+.+++++||++ |+|.+-+... .
T Consensus 40 IlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~--G 117 (378)
T KOG1345|consen 40 ILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA--G 117 (378)
T ss_pred EEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcc--c
Confidence 344555555555555444443 34678887665556 48999998876 677889999999999 7887776654 3
Q ss_pred CCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccc--cccceeeecccccccccCCCcccccCCccccChhhhc---
Q psy501 401 LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM--GTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLL--- 475 (962)
Q Consensus 401 ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~--~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~--- 475 (962)
+.+.....++.|+++|+.|+|++++||||||.+||||- +..++||||||.++..+.... ....+..|.+||+..
T Consensus 118 igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~-~~~~~~~y~~pe~~~~~~ 196 (378)
T KOG1345|consen 118 IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK-YLEYVNNYHAPELCDTVV 196 (378)
T ss_pred ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh-hhhhhcccCCcHHHhhcc
Confidence 78999999999999999999999999999999999994 344899999999976544321 123467799999774
Q ss_pred -cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh----HHHHHhccc--cccCCCCCCCCcHHHHHHHhccCCCCC
Q psy501 476 -HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG----TERLKSSYI--LLHTLPLYTYHVPPIQTTCLLAGTERL 547 (962)
Q Consensus 476 -~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~----~~~i~~~~~--~~~~~~~~s~~l~~li~~Cl~~dperR 547 (962)
+.....+.+|||.||+++|.++||.+||+....... ..+-..... .+.....++.....+.+.-+..++++|
T Consensus 197 ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 197 NEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred ccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 222357889999999999999999999985432221 111111111 111111233333335556777788887
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.5e-21 Score=201.61 Aligned_cols=152 Identities=22% Similarity=0.282 Sum_probs=116.4
Q ss_pred cccccccccceeeeeeecceEEEecCCceeEEeeccccccceeeEEE-------EEEeeeeeecCCC-----ceeeec--
Q psy501 636 LLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILL-------HTLPLYTYHVPPI-----QTTCLL-- 701 (962)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~-----~~~~~~-- 701 (962)
+|.|..-|-+-|+|- |.||.+||++ |.||++|+|++.. ++.++.
T Consensus 141 il~Gv~YLH~NWvlH----------------------RDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~ 198 (438)
T KOG0666|consen 141 ILDGVHYLHSNWVLH----------------------RDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDP 198 (438)
T ss_pred HHhhhHHHhhhheee----------------------ccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCc
Confidence 456777777788762 6789999988 7899999999866 444443
Q ss_pred cCCCcccccceeeecCCCCCCCCCceeeeeEee----------cC---------CchhHHHHHHHhcCCCchhhhccccc
Q psy501 702 AGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------GT---------ERLKSSYILLHTLPLYTCYTLASNMN 762 (962)
Q Consensus 702 ~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G~---------~~~~ql~~I~~~lG~p~~~~~~~~~~ 762 (962)
++-|-|||+||||||+++|+++|||||+||||+ |. -..+|+.+|+++||+|+.+.|+....
T Consensus 199 VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk 278 (438)
T KOG0666|consen 199 VVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKK 278 (438)
T ss_pred eEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhh
Confidence 566789999999999999999999999999999 21 14589999999999999998776544
Q ss_pred cc--------CC--CcccCCcccc---CCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 763 FK--------FP--QFRRVPFTSI---IPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 763 ~~--------~~--~~~~~~l~~~---~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
+. |+ .+-..+|... ...-++.+.|||.+||++||.||+||+++|+..
T Consensus 279 ~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 279 MPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred CcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 21 11 1111222222 223467799999999999999999999999744
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.7e-18 Score=192.08 Aligned_cols=245 Identities=19% Similarity=0.181 Sum_probs=185.5
Q ss_pred ceeeEEEEecCCcccEEEEEecCCc-eEEEEeccchh----HHHHHHHHHHHHhcCC----CCcccEEEEE-EeCCEEEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDN-HILSRHVSSRD----EMVVCFYRKSLKKLSH----ANLVKLKEVI-RENDTLYF 381 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~-kvv~~k~~~~~----~~~~~~Ei~iL~~L~H----pnIv~l~~~~-~~~~~~~L 381 (962)
.+.....++.|+.+.||.+...... +.++.++.... ...+..|+.++..+.. +++..+++.+ ..+...|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 4556666666666779999877664 33333332221 1268889999999973 6999999999 57888999
Q ss_pred EEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc-----cceeeeccccccccc
Q psy501 382 VFEYMKENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT-----ELVKIADFGLAREIR 455 (962)
Q Consensus 382 V~Ey~~g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~-----g~vKL~DFGla~~~~ 455 (962)
||+.++.+|.+...... +.|+..++..++.|++.+|.+||+.|++||||||+|+++... ..+.|.|||+|+...
T Consensus 99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~ 178 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFK 178 (322)
T ss_pred EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcccc
Confidence 99999999999886554 789999999999999999999999999999999999999765 368999999998322
Q ss_pred --CC---------C-cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc
Q psy501 456 --SR---------P-YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH 523 (962)
Q Consensus 456 --~~---------~-~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~ 523 (962)
.. . .....||..|+++.+..+ ...+.+.|+||++.++.|++.|..||....................
T Consensus 179 ~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~ 257 (322)
T KOG1164|consen 179 YVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLL 257 (322)
T ss_pred ccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhc
Confidence 11 1 223459999999999876 4789999999999999999999999987664433333332222221
Q ss_pred C---CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 524 T---LPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 524 ~---~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
. ....+..+..+...+-..+...+|....+...+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l 294 (322)
T KOG1164|consen 258 TDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELL 294 (322)
T ss_pred cccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHH
Confidence 1 223445666777777778999999887777654
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-18 Score=177.71 Aligned_cols=252 Identities=16% Similarity=0.157 Sum_probs=204.2
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh--HHHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEE
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD--EMVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~--~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~ 383 (962)
.+..|.+.+..+++.+.-+.+|.+.....+..++.++.+.. ..++..|..+.+.|+ ...|..+..++.+..+-.+||
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 56778888888888887788999988888887777775554 457999999999997 578999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc---cceeeecccccccccCC---
Q psy501 384 EYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT---ELVKIADFGLAREIRSR--- 457 (962)
Q Consensus 384 Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~---g~vKL~DFGla~~~~~~--- 457 (962)
|+++.+|.+.+.-+...|+.++++-++.|++.-++|+|.++++||||||+|+|+.-. ..+.|+|||+|+...+.
T Consensus 91 dLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 91 DLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred eccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 999999999888888889999999999999999999999999999999999999643 36889999999876443
Q ss_pred ------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh---HHHHHhcccccc---CC
Q psy501 458 ------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG---TERLKSSYILLH---TL 525 (962)
Q Consensus 458 ------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~---~~~i~~~~~~~~---~~ 525 (962)
......||..|.+-....+. ..+.+.|+-|+|.+|.+.--|..||++...... .++|.......+ .-
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~-eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC 249 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGI-EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLC 249 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhh-hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHh
Confidence 33445799999998887653 578899999999999999999999998654433 344433322222 12
Q ss_pred CCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 526 PLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 526 ~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
..+|.++...+.-|-...-+.-|...-|-+.|..
T Consensus 250 ~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 250 KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 3667778888999999999999986666655543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.4e-17 Score=175.84 Aligned_cols=208 Identities=25% Similarity=0.282 Sum_probs=163.9
Q ss_pred HHHHHHHHHHHHhcCCC-CcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHhhcccc
Q psy501 348 EMVVCFYRKSLKKLSHA-NLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDK---FLPESIIRNMMYQVLQGLAFMHRH 423 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~Hp-nIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~~---~ls~~~i~~i~~qI~~aL~yLH~~ 423 (962)
...+.+|+.+++.+.|+ +++++++.+......+++++++.|..+..+..... .++......++.|++.++.++|+.
T Consensus 41 ~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~ 120 (384)
T COG0515 41 VERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120 (384)
T ss_pred HHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 55699999999999988 79999999988888899999999654444433332 689999999999999999999999
Q ss_pred eeeeccCCCccccccccc-ceeeecccccccccCC--------CcccccCCccccChhhhccC--CCCCchhHHHHHHHH
Q psy501 424 GFFHRDMKPENLLCMGTE-LVKIADFGLAREIRSR--------PYTDYVSTRWYRAPEVLLHS--TAYSAPIHLSRSQQF 492 (962)
Q Consensus 424 gIvHrDLkp~NILl~~~g-~vKL~DFGla~~~~~~--------~~~~~~gt~~Y~APE~l~~~--~~~t~ksDIwSLGvl 492 (962)
+++|||+||+||+++..+ .++++|||.+...... ......|+..|+|||.+.+. ..++...|+||+|++
T Consensus 121 ~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~ 200 (384)
T COG0515 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGIT 200 (384)
T ss_pred CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHH
Confidence 999999999999999988 7999999999755443 23567899999999999763 478899999999999
Q ss_pred HHHHHcCCCCCCCcCh----hhhHHHHHhcccc-ccCCCCCC------CCcHHHHHHHhccCCCCCCcHHHHHh
Q psy501 493 LFYSIDHVPPIQTTCL----LAGTERLKSSYIL-LHTLPLYT------YHVPPIQTTCLLAGTERLKSSYILLH 555 (962)
Q Consensus 493 L~elltG~~Pf~~~~~----~~~~~~i~~~~~~-~~~~~~~s------~~l~~li~~Cl~~dperRPs~~~Ll~ 555 (962)
++++++|..||..... ......+...... ........ .....++..|+..+|..|.+......
T Consensus 201 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 201 LYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred HHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 9999999999877763 2333333333221 11111111 25677899999999999988665554
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-17 Score=177.19 Aligned_cols=245 Identities=14% Similarity=0.098 Sum_probs=189.2
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccchh--HHHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEecCCC
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD--EMVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMKE 388 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~--~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey~~g 388 (962)
.++++.+++.+..+..+.++..-....++.|+.+.. ..++..|.+..+.|. .+.|..+|.+..++.+-.||+|+++.
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLLGP 108 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLLGP 108 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhhCc
Confidence 455555555444445777777777777888876654 457999999999995 79999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc-----ceeeecccccccccCC------
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE-----LVKIADFGLAREIRSR------ 457 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g-----~vKL~DFGla~~~~~~------ 457 (962)
+|.+.+.-++..|+.+++..++.|++.-++++|++.+|+|||||+|+||...+ .+.|+|||+|+...+.
T Consensus 109 SLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHI 188 (449)
T KOG1165|consen 109 SLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHI 188 (449)
T ss_pred CHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccC
Confidence 99999999999999999999999999999999999999999999999997544 5889999999876543
Q ss_pred ---CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh---HHHHHhccccccC---CCCC
Q psy501 458 ---PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG---TERLKSSYILLHT---LPLY 528 (962)
Q Consensus 458 ---~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~---~~~i~~~~~~~~~---~~~~ 528 (962)
...+..||..||+-...+|. ..+.+.|+=|||-++.+.+-|..||++..-... +++|-......+. ...+
T Consensus 189 PYrE~KSLsGTARYMSINTHlGr-EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~ 267 (449)
T KOG1165|consen 189 PYREHKSLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGF 267 (449)
T ss_pred ccccccccccceeeeEeeccccc-hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcC
Confidence 34556899999999888774 689999999999999999999999998654433 3333222111110 1134
Q ss_pred CCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 529 TYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 529 s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
|..+..-+.-....+-+.-|...-|...|
T Consensus 268 P~efa~Yl~yvR~L~F~E~PDYdylr~Lf 296 (449)
T KOG1165|consen 268 PEEFATYLRYVRRLDFFETPDYDYLRKLF 296 (449)
T ss_pred HHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 44444455556666667777765544433
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.6e-18 Score=177.46 Aligned_cols=136 Identities=16% Similarity=0.173 Sum_probs=107.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-c-------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee-------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-Q-------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-~-------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~------- 734 (962)
|.+|.+|.++ |+++|.|||...+ . ..+|-.+-+.||||+|+|||.+.|++++|||.+|||++
T Consensus 148 RDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrsp 227 (376)
T KOG0669|consen 148 RDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSP 227 (376)
T ss_pred hcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCc
Confidence 7889999999 9999999999844 2 22333344789999999999999999999999999998
Q ss_pred ---cCCchhHHHHHHHhcCCCchhhhccccccc------CCCcccC---CccccCC--CCCHHHHHHHHHhhccCCCCCc
Q psy501 735 ---GTERLKSSYILLHTLPLYTCYTLASNMNFK------FPQFRRV---PFTSIIP--HASPDAIHLMESMLAYNPSKRP 800 (962)
Q Consensus 735 ---G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~------~~~~~~~---~l~~~~p--~~s~~a~DLL~kmL~~dP~kR~ 800 (962)
|.++..|+..|-.++|..+++.|+...... .++.+.. .+++... .-+++|.|||.+||.+||.||+
T Consensus 228 imqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~ 307 (376)
T KOG0669|consen 228 IMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRI 307 (376)
T ss_pred cccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCc
Confidence 899999999999999999988877644321 1111111 1111111 1377999999999999999999
Q ss_pred chhhhhhh
Q psy501 801 TAQQSLSI 808 (962)
Q Consensus 801 sa~~~L~~ 808 (962)
.|+++|.+
T Consensus 308 ~ad~alnh 315 (376)
T KOG0669|consen 308 DADQALNH 315 (376)
T ss_pred chHhhhch
Confidence 99999964
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-18 Score=199.75 Aligned_cols=134 Identities=21% Similarity=0.262 Sum_probs=103.1
Q ss_pred ccceeeEEE-----EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------cC
Q psy501 674 RLKSSYILL-----HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------GT 736 (962)
Q Consensus 674 ~~~~~~~~~-----~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G~ 736 (962)
-||.-||+| +.||+.|||-+-- +..| ..-.-||||+||++||. .|+.+|||||||||+| |.
T Consensus 314 DLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-tYiQSRfYRAPEVILGl-pY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 314 DLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-TYIQSRFYRAPEVILGL-PYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred cCChhheeeccCCcCceeEEecccccccCCcce-eeeeccccccchhhccC-CCCCccceeehhhhHHhHhcCccccCCC
Confidence 479999999 7899999998765 6666 45567999999999995 5999999999999999 99
Q ss_pred CchhHHHHHHHhcCCCchhhhcccccc-----c---CCC-----------------------------c-ccCCccccCC
Q psy501 737 ERLKSSYILLHTLPLYTCYTLASNMNF-----K---FPQ-----------------------------F-RRVPFTSIIP 778 (962)
Q Consensus 737 ~~~~ql~~I~~~lG~p~~~~~~~~~~~-----~---~~~-----------------------------~-~~~~l~~~~p 778 (962)
+|.|||..|++++|.|+..++...... + ++. . ...+|+...+
T Consensus 392 ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~ 471 (586)
T KOG0667|consen 392 NEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLP 471 (586)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcc
Confidence 999999999999999998874221100 0 000 0 1122333333
Q ss_pred CCC-HHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 779 HAS-PDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 779 ~~s-~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
..+ ..++|||++||.|||.+|+|+.++|.+.
T Consensus 472 ~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hp 503 (586)
T KOG0667|consen 472 KADDKLFIDFLKRCLEWDPAERITPAQALNHP 503 (586)
T ss_pred cccHHHHHHHHHHHhccCchhcCCHHHHhcCc
Confidence 233 3579999999999999999999999744
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.4e-18 Score=208.81 Aligned_cols=206 Identities=22% Similarity=0.230 Sum_probs=164.3
Q ss_pred HHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccC
Q psy501 351 VCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDM 430 (962)
Q Consensus 351 ~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDL 430 (962)
+..|+-+-..+.||+++..+..+.+.....-+||||+++|+..+... ..+...++..++.|++.|+.|+|+.||.|||+
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrdl 446 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPYDLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDL 446 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccHHHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccC
Confidence 55677777788999998887777665555555999999777777664 45899999999999999999999999999999
Q ss_pred CCcccccccccceeeecccccccccCC------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q psy501 431 KPENLLCMGTELVKIADFGLAREIRSR------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQ 504 (962)
Q Consensus 431 kp~NILl~~~g~vKL~DFGla~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~ 504 (962)
|++|+++...|.+||+|||.+..+.-. .....+|+..|+|||++.+...-....||||.|++++.|++|+.||.
T Consensus 447 K~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk 526 (601)
T KOG0590|consen 447 KLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWK 526 (601)
T ss_pred ccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccc
Confidence 999999999999999999999766432 34567899999999999876555678999999999999999999998
Q ss_pred CcChhhhH--HHHHhccc-----cccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 505 TTCLLAGT--ERLKSSYI-----LLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 505 ~~~~~~~~--~~i~~~~~-----~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.....+.. ........ ..+.+...+...+.++..+|+.+|.+|-+++++++.-
T Consensus 527 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~ 586 (601)
T KOG0590|consen 527 VAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDE 586 (601)
T ss_pred cccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhCh
Confidence 75544332 11111111 1112235566778899999999999999999998855
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.8e-17 Score=178.94 Aligned_cols=188 Identities=19% Similarity=0.223 Sum_probs=145.6
Q ss_pred CCCCcccEEEEEEe---------------------------CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHH
Q psy501 362 SHANLVKLKEVIRE---------------------------NDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVL 414 (962)
Q Consensus 362 ~HpnIv~l~~~~~~---------------------------~~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~ 414 (962)
+|||||++..+|.+ +..+|+||.-++.+|..++..+. .+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~--~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH--RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC--CchHHHHHHHHHHH
Confidence 69999999888853 23589999999999999998765 57778888999999
Q ss_pred HHHhhcccceeeeccCCCcccccc--ccc--ceeeecccccccccCC--------CcccccCCccccChhhhccCCC---
Q psy501 415 QGLAFMHRHGFFHRDMKPENLLCM--GTE--LVKIADFGLAREIRSR--------PYTDYVSTRWYRAPEVLLHSTA--- 479 (962)
Q Consensus 415 ~aL~yLH~~gIvHrDLkp~NILl~--~~g--~vKL~DFGla~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~--- 479 (962)
+|+.|||++||.|||+|++|||+. +++ .+.|+|||++-.-... ......|....||||+...-..
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999994 443 5789999998533221 2334467778999998853211
Q ss_pred --CCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHH
Q psy501 480 --YSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 551 (962)
Q Consensus 480 --~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~ 551 (962)
--.++|.|+.|.+.||+++...||..........+-.+..-.+.....++...++++...|+.+|.+|++..
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 125899999999999999999999885443333222333334455557788899999999999999999844
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-17 Score=173.02 Aligned_cols=229 Identities=13% Similarity=0.175 Sum_probs=177.8
Q ss_pred CCcccEEEEEecCCceEEEE----eccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHh
Q psy501 322 PHTLPLYTCNLDQDNHILSR----HVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRD 396 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~----k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~ 396 (962)
...+..|++++.....+++. .+..+....+..|.-.|+-+.||||+.+++.|..+..+.++..|++ |+|+..+..
T Consensus 201 ~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe 280 (448)
T KOG0195|consen 201 SHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHE 280 (448)
T ss_pred CCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhc
Confidence 34556677766554433222 2223334458888888999999999999999999999999999999 888888876
Q ss_pred cC-CCCCHHHHHHHHHHHHHHHhhcccce--eeeccCCCcccccccccceeee--cccccccccCCCcccccCCccccCh
Q psy501 397 RD-KFLPESIIRNMMYQVLQGLAFMHRHG--FFHRDMKPENLLCMGTELVKIA--DFGLAREIRSRPYTDYVSTRWYRAP 471 (962)
Q Consensus 397 ~~-~~ls~~~i~~i~~qI~~aL~yLH~~g--IvHrDLkp~NILl~~~g~vKL~--DFGla~~~~~~~~~~~~gt~~Y~AP 471 (962)
.. -..+..++.+++.++++|++|||+.. |.---|.+..+++|++-+++|. |--++. ......-.+.||||
T Consensus 281 ~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf-----qe~gr~y~pawmsp 355 (448)
T KOG0195|consen 281 QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-----QEVGRAYSPAWMSP 355 (448)
T ss_pred CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-----eccccccCcccCCH
Confidence 54 34677889999999999999999975 3344688999999998877654 322221 11223456889999
Q ss_pred hhhccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCc
Q psy501 472 EVLLHSTA--YSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 549 (962)
Q Consensus 472 E~l~~~~~--~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs 549 (962)
|.+..... --.++|+|||+++|||+.|.+.||.+.++.+.-.++.-.-+....+|..+..+..++..|+..||.+||.
T Consensus 356 ealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpk 435 (448)
T KOG0195|consen 356 EALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPK 435 (448)
T ss_pred HHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCC
Confidence 99975432 2358999999999999999999999988888777887777888888999999999999999999999998
Q ss_pred HHHHHh
Q psy501 550 SYILLH 555 (962)
Q Consensus 550 ~~~Ll~ 555 (962)
+..++-
T Consensus 436 fdmivp 441 (448)
T KOG0195|consen 436 FDMIVP 441 (448)
T ss_pred cceehh
Confidence 765544
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.9e-17 Score=181.76 Aligned_cols=123 Identities=20% Similarity=0.242 Sum_probs=89.8
Q ss_pred ccccceeeEEE------EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCC-CCCceeeeeEeecCCchh
Q psy501 672 TERLKSSYILL------HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTY-HVPPIQTTCLLAGTERLK 740 (962)
Q Consensus 672 ~~~~~~~~~~~------~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~-~vDIWSlGCIl~G~~~~~ 740 (962)
-|-||..|||+ |.+|+.|||++.. +-+-|.||||.|.|||+|.-+...|.+ +|||||+|||+|
T Consensus 299 HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLf------ 372 (475)
T KOG0615|consen 299 HRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLF------ 372 (475)
T ss_pred cccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEE------
Confidence 47899999999 9999999999876 455566999999999999876665554 999999999998
Q ss_pred HHHHHHHhcCCCchhhhcc-------cccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh-hhh
Q psy501 741 SSYILLHTLPLYTCYTLAS-------NMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS-IKR 810 (962)
Q Consensus 741 ql~~I~~~lG~p~~~~~~~-------~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~-~~~ 810 (962)
+.+.|.||=.+-.. ....+++ +.+..| ..+|.+++|||++||+.||++|+|++++|+ +|.
T Consensus 373 -----vcLsG~pPFS~~~~~~sl~eQI~~G~y~-f~p~~w----~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 373 -----VCLSGYPPFSEEYTDPSLKEQILKGRYA-FGPLQW----DRISEEALDLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred -----EEeccCCCcccccCCccHHHHHhcCccc-ccChhh----hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence 22333333110000 0000111 122233 378999999999999999999999999997 454
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.7e-16 Score=178.34 Aligned_cols=158 Identities=17% Similarity=0.099 Sum_probs=114.2
Q ss_pred EecCceeeEEEEecCCcccEEEEEecC-CceEEEEec-cc--------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQ-DNHILSRHV-SS--------RDEMVVCFYRKSLKKLSHANLVKLKEVIREND 377 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~-~~kvv~~k~-~~--------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 377 (962)
.+.+.|.....++.++.+.||++.... .+.+++.|. .. .....+.+|+++|++++|+++++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 345556666666666666788887654 334333322 11 124468999999999999999853332 24
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccC-CCcccccccccceeeecccccccccC
Q psy501 378 TLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDM-KPENLLCMGTELVKIADFGLAREIRS 456 (962)
Q Consensus 378 ~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDL-kp~NILl~~~g~vKL~DFGla~~~~~ 456 (962)
..|+||||++|..+..... .. ...++.|++.||.|||+.||+|||| ||+||+++.++.++|+|||+|+.+..
T Consensus 92 ~~~LVmE~~~G~~L~~~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred CcEEEEEccCCCCHHHhCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 5799999999765543211 11 1467899999999999999999999 99999999999999999999986643
Q ss_pred CC----------cccccCCccccChhhhc
Q psy501 457 RP----------YTDYVSTRWYRAPEVLL 475 (962)
Q Consensus 457 ~~----------~~~~~gt~~Y~APE~l~ 475 (962)
.. .....++..|+|||.+.
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 31 13346778899999885
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.2e-17 Score=183.90 Aligned_cols=121 Identities=14% Similarity=0.099 Sum_probs=89.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
|-|||.||+| |.|||+|||+++. ....|++|||+||+||++-. +.||++|||||||.|+.
T Consensus 393 rDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtr--k~YG~KVDIWSLGIMaI---------- 460 (550)
T KOG0578|consen 393 RDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTR--KPYGPKVDIWSLGIMAI---------- 460 (550)
T ss_pred eccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhh--cccCccccchhhhhHHH----------
Confidence 6789999999 9999999999987 35667899999999999987 55999999999999983
Q ss_pred HHHhcCCCchhh---hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 745 LLHTLPLYTCYT---LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 745 I~~~lG~p~~~~---~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
..+-|-||--. +...+. .+......+. .-..+|++++|||.+||+.||.+|++|.++|++.
T Consensus 461 -EMveGEPPYlnE~PlrAlyL--Ia~ng~P~lk-~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 461 -EMVEGEPPYLNENPLRALYL--IATNGTPKLK-NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred -HHhcCCCCccCCChHHHHHH--HhhcCCCCcC-CccccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence 33345554211 000000 0000000110 0136899999999999999999999999999854
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.3e-16 Score=169.89 Aligned_cols=98 Identities=20% Similarity=0.274 Sum_probs=84.7
Q ss_pred cccccccccCCeeEEEEeeeeccCCCCCCCCCCCEEEEE-Eecccc-ChhhhhhhHHHHHHhccCCCC-eeeeeeeeeCC
Q psy501 4 SRFDRGNCNGQGLIVPKSKEEDRIGGKPAVPNGPSISIK-MKRKYY-SWEEAMNLREVKSLKKLSHAN-LVKLKEVILDP 80 (962)
Q Consensus 4 ~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~tg~~VAiK-i~~~~~-~~~~~~~lREi~~L~~l~HpN-IV~l~dv~~~~ 80 (962)
..|+...++|+|+||.||+++.+ .+|+.||+| |+..++ +|+|.+++|||.+|+.|+|+| ||.|.||+...
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~-------~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~ 83 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSK-------RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTS 83 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEe-------cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence 45888999999999999999999 699999999 887654 799999999999999999999 99999999873
Q ss_pred CCcEEEEEcCcchhhhhhHHhhhcccccccc
Q psy501 81 PLHAYFQVGGPTTRVTSLKREAASEHISARS 111 (962)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (962)
+. ..+.|.++.|++.++.-+..|+....
T Consensus 84 -~~--~~~~~~l~lvfe~~d~DL~~ymd~~~ 111 (323)
T KOG0594|consen 84 -NN--HRGIGKLYLVFEFLDRDLKKYMDSLP 111 (323)
T ss_pred -cc--ccccceEEEEEEeecccHHHHHHhcc
Confidence 22 55667788888988888888887654
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.8e-17 Score=173.15 Aligned_cols=136 Identities=18% Similarity=0.267 Sum_probs=107.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-ce--eeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------cC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-QT--TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------GT 736 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-~~--~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G~ 736 (962)
|-||.+||.+ |++|+.|||.... ++ ..|...-+||||.||+++|.+ |...|||||+|||++ |+
T Consensus 142 RdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 142 RDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred cccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCc
Confidence 4799999999 9999999999988 22 345566689999999999977 999999999999998 99
Q ss_pred CchhHHHHHHHhcCCCchhhhcccc------cccCCCcccCCccccCCC------------CCHHHHHHHHHhhccCCCC
Q psy501 737 ERLKSSYILLHTLPLYTCYTLASNM------NFKFPQFRRVPFTSIIPH------------ASPDAIHLMESMLAYNPSK 798 (962)
Q Consensus 737 ~~~~ql~~I~~~lG~p~~~~~~~~~------~~~~~~~~~~~l~~~~p~------------~s~~a~DLL~kmL~~dP~k 798 (962)
+-+||..+|.+.+|+|.+..+.+.. ....++....++.+.||. -+..|.|||.+||..||++
T Consensus 221 d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~ 300 (369)
T KOG0665|consen 221 DHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEK 300 (369)
T ss_pred hHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhh
Confidence 9999999999999999987643311 112233323344444432 2346899999999999999
Q ss_pred Ccchhhhhhhh
Q psy501 799 RPTAQQSLSIK 809 (962)
Q Consensus 799 R~sa~~~L~~~ 809 (962)
|.|++++|.+.
T Consensus 301 Risv~daL~HP 311 (369)
T KOG0665|consen 301 RISVDDALRHP 311 (369)
T ss_pred cccHHHHhcCC
Confidence 99999999744
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.63 E-value=6.3e-17 Score=168.57 Aligned_cols=136 Identities=14% Similarity=0.220 Sum_probs=102.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
|.||.-|.+. |++|++|||+... ..-.|.-+-+-|||.||||.|++.|+.+|||||+||||+
T Consensus 180 RDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ 259 (449)
T KOG0664|consen 180 RDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ 259 (449)
T ss_pred ccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence 6788888888 9999999999876 111222333678899999999999999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhccccc----ccC-CCcccCCccccCC-----CCCHHHHHHHHHhhccCCCCCcchhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMN----FKF-PQFRRVPFTSIIP-----HASPDAIHLMESMLAYNPSKRPTAQQ 804 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~----~~~-~~~~~~~l~~~~p-----~~s~~a~DLL~kmL~~dP~kR~sa~~ 804 (962)
..+.++|+..|.++||+|+.+.+...-. ..+ ...+..++..++. ....++++++.+||.+||.+|++.++
T Consensus 260 Aq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~ 339 (449)
T KOG0664|consen 260 AAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEE 339 (449)
T ss_pred ccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhh
Confidence 6789999999999999999887532110 000 1112222222222 23457999999999999999999999
Q ss_pred hhhh
Q psy501 805 SLSI 808 (962)
Q Consensus 805 ~L~~ 808 (962)
+|..
T Consensus 340 A~~~ 343 (449)
T KOG0664|consen 340 ALQH 343 (449)
T ss_pred hccc
Confidence 9853
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.3e-15 Score=155.66 Aligned_cols=170 Identities=14% Similarity=0.022 Sum_probs=122.4
Q ss_pred cEEEEEecCCceEEEEeccchhH-------HHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhc
Q psy501 326 PLYTCNLDQDNHILSRHVSSRDE-------MVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDR 397 (962)
Q Consensus 326 ~Vy~~~~~~~~kvv~~k~~~~~~-------~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~ 397 (962)
.|+.+.. .+.+++...+..... ..+.+|+++|++|. |+++++++++ +..+++|||+.|..+.....
T Consensus 17 ~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~- 90 (218)
T PRK12274 17 RILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPP- 90 (218)
T ss_pred eEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhh-
Confidence 3554444 455555444433322 24789999999995 5889999886 34689999999865533221
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhcccceeeeccC-CCcccccccccceeeecccccccccCCCc---------------cc
Q psy501 398 DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDM-KPENLLCMGTELVKIADFGLAREIRSRPY---------------TD 461 (962)
Q Consensus 398 ~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDL-kp~NILl~~~g~vKL~DFGla~~~~~~~~---------------~~ 461 (962)
.. ...++.|++.+|.++|+.||+|||| ||+||+++.+|.++|+|||+|........ .-
T Consensus 91 -----~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~ 164 (218)
T PRK12274 91 -----RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHK 164 (218)
T ss_pred -----hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHH
Confidence 11 2457889999999999999999999 79999999999999999999985443221 01
Q ss_pred ccCCccccChhhhccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCcC
Q psy501 462 YVSTRWYRAPEVLLHSTAYS-APIHLSRSQQFLFYSIDHVPPIQTTC 507 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t-~ksDIwSLGvlL~elltG~~Pf~~~~ 507 (962)
...++.|++|+...--...+ ...+.++.|+-+|.++|+..|+.+..
T Consensus 165 ~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 165 RMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 12467788887653222233 56788999999999999999886654
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.8e-16 Score=177.42 Aligned_cols=201 Identities=18% Similarity=0.256 Sum_probs=157.7
Q ss_pred HHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhccccee-eeccCCCccc
Q psy501 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGF-FHRDMKPENL 435 (962)
Q Consensus 358 L~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gI-vHrDLkp~NI 435 (962)
|+.+.|.|+.+++|.+.++...++|.+||. |+|.+.+......+++--...++++|+.||.|||..-| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 467899999999999999999999999998 88999888877778999999999999999999998765 9999999999
Q ss_pred ccccccceeeecccccccccC----CCcccccCCccccChhhhccCC--C----CCchhHHHHHHHHHHHHHcCCCCCCC
Q psy501 436 LCMGTELVKIADFGLAREIRS----RPYTDYVSTRWYRAPEVLLHST--A----YSAPIHLSRSQQFLFYSIDHVPPIQT 505 (962)
Q Consensus 436 Ll~~~g~vKL~DFGla~~~~~----~~~~~~~gt~~Y~APE~l~~~~--~----~t~ksDIwSLGvlL~elltG~~Pf~~ 505 (962)
+++....+||+|||+...... ...........|.|||.+.+.. . .+.+.||||||++++|+++.+.||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999876642 1122223446699999997531 1 46789999999999999999999987
Q ss_pred cChh----hhHHHHHhccc--cccCCC---CCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 506 TCLL----AGTERLKSSYI--LLHTLP---LYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 506 ~~~~----~~~~~i~~~~~--~~~~~~---~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
.... .....+..+.. ..|... ..+..+..+++.||..+|+.||+...+-..+.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~ 222 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLL 222 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence 4322 23334443111 111111 22335677899999999999999888776553
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=7.4e-16 Score=163.53 Aligned_cols=169 Identities=12% Similarity=0.132 Sum_probs=120.6
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEeccch---hHH---------HHHHHHHHHHhcCCCCcccEEEEEEe
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR---DEM---------VVCFYRKSLKKLSHANLVKLKEVIRE 375 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~---~~~---------~~~~Ei~iL~~L~HpnIv~l~~~~~~ 375 (962)
++.|.+........++.+.||.+... ..+++.+.+.+. .+. .+.+|++.+.++.||+|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~-~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTD-YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecC-CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 34667777777776666678887664 334433333211 111 15799999999999999999998764
Q ss_pred C--------CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeec
Q psy501 376 N--------DTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIAD 447 (962)
Q Consensus 376 ~--------~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~D 447 (962)
. +..+|||||++|..+..+. .+++ ....+++.+|..+|+.|++|||++|+||+++.+| ++|+|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 3 3589999999985443332 1333 2456999999999999999999999999999988 99999
Q ss_pred ccccccccCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHH
Q psy501 448 FGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSI 497 (962)
Q Consensus 448 FGla~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ell 497 (962)
||.+......... +.+.-...|..++||||||+++....
T Consensus 178 fg~~~~~~e~~a~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 9988654322211 11222345778999999999987554
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.60 E-value=3e-16 Score=188.48 Aligned_cols=229 Identities=16% Similarity=0.175 Sum_probs=162.8
Q ss_pred ccEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcC
Q psy501 325 LPLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398 (962)
Q Consensus 325 ~~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~ 398 (962)
.++.+++...+..+++..+... ...+..+|++ ...++|||++++.-+...+...|||-+|...+|++.+..+.
T Consensus 37 lKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkhnLyDRlSTRP 115 (1431)
T KOG1240|consen 37 LKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKHNLYDRLSTRP 115 (1431)
T ss_pred hhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhhhhhhhhccch
Confidence 3455555554443333333222 2234445555 56668999999999888888899999999999999987653
Q ss_pred CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccccccc--CC---Cc----ccccCCcccc
Q psy501 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR--SR---PY----TDYVSTRWYR 469 (962)
Q Consensus 399 ~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~--~~---~~----~~~~gt~~Y~ 469 (962)
.+..-+.+.|+.|++.||.-+|..||+|||||.+||||+.-..+.|+||..-+... .+ .. .+...-..|.
T Consensus 116 -FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYi 194 (1431)
T KOG1240|consen 116 -FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYI 194 (1431)
T ss_pred -HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeec
Confidence 47788889999999999999999999999999999999999999999998765331 11 11 1122335699
Q ss_pred ChhhhccCC---------C-CCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHH
Q psy501 470 APEVLLHST---------A-YSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTT 538 (962)
Q Consensus 470 APE~l~~~~---------~-~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~ 538 (962)
|||.+.... + .+++.||||+||+++||++ |++||.-.... .+..-.........-...+..++.++..
T Consensus 195 APERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~-aYr~~~~~~~e~~Le~Ied~~~Rnlil~ 273 (1431)
T KOG1240|consen 195 APERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL-AYRSGNADDPEQLLEKIEDVSLRNLILS 273 (1431)
T ss_pred ChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH-hHhccCccCHHHHHHhCcCccHHHHHHH
Confidence 999986411 2 5789999999999999998 78888532211 1111100000000011223478889999
Q ss_pred HhccCCCCCCcHHHHHhh
Q psy501 539 CLLAGTERLKSSYILLHT 556 (962)
Q Consensus 539 Cl~~dperRPs~~~Ll~~ 556 (962)
+++.+|+.|-++++.++.
T Consensus 274 Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 274 MIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHccCchhccCHHHHHHh
Confidence 999999999999999986
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=99.57 E-value=7.3e-16 Score=177.02 Aligned_cols=117 Identities=20% Similarity=0.283 Sum_probs=88.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
|-||=.||+| =.||++|||++.. ..-.|+||||.|.|||++. + +.++..|||||+|||+|
T Consensus 142 RDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~-k-~gHsfEvDiWSlGcvmY---------- 209 (592)
T KOG0575|consen 142 RDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLN-K-SGHSFEVDIWSLGCVMY---------- 209 (592)
T ss_pred cccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhc-c-CCCCCchhhhhhhhHHH----------
Confidence 7789999999 4899999999766 3456779999999999988 3 55899999999999998
Q ss_pred HHHhcCCCchhh--hccccc-ccCCCcccCCccccC-CCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 745 LLHTLPLYTCYT--LASNMN-FKFPQFRRVPFTSII-PHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 745 I~~~lG~p~~~~--~~~~~~-~~~~~~~~~~l~~~~-p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
.-++|.||=+. +...+. .+...+ .+ ..+|.+|+|||.+||+.||.+|||++++|...
T Consensus 210 -tLL~G~PPFetk~vkety~~Ik~~~Y-------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 210 -TLLVGRPPFETKTVKETYNKIKLNEY-------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred -hhhhCCCCcccchHHHHHHHHHhcCc-------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 23567666332 111111 001111 11 26899999999999999999999999999643
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.57 E-value=6e-14 Score=172.75 Aligned_cols=140 Identities=13% Similarity=0.036 Sum_probs=101.9
Q ss_pred Hhhcccc-eeeeccCCCc-ccccccccceeeecccccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHH
Q psy501 417 LAFMHRH-GFFHRDMKPE-NLLCMGTELVKIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQ 490 (962)
Q Consensus 417 L~yLH~~-gIvHrDLkp~-NILl~~~g~vKL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLG 490 (962)
..+.|.. .--|++..|. |++++..+..++.|||.++..... ......||+.|+|||++.+. .++.++||||||
T Consensus 489 ~~~~~~~~~~~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~-~~~~~~DiwSlG 567 (669)
T cd05610 489 SQSGSYPAITPTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGK-PHGPAVDWWALG 567 (669)
T ss_pred cccCCCcccCCCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCC-CCCcHHHHHHHH
Confidence 3444443 2234555566 566666777888999998765332 23345899999999999764 699999999999
Q ss_pred HHHHHHHcCCCCCCCcChhhhHHHHHhccccccCC-CCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 491 QFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTL-PLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 491 vlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
|+||||++|++||.+.........+.......+.. ..++..+..++..||..+|++||++.+++..-
T Consensus 568 ~il~ElltG~~pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~~dP~~R~ta~e~l~h~ 635 (669)
T cd05610 568 VCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635 (669)
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhHCcCHHHHHhCH
Confidence 99999999999999887776666665443332221 23445567789999999999999988887753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.5e-15 Score=157.94 Aligned_cols=111 Identities=22% Similarity=0.296 Sum_probs=82.3
Q ss_pred ccccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee---------
Q psy501 672 TERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA--------- 734 (962)
Q Consensus 672 ~~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~--------- 734 (962)
-|.||.+||+| |+|||+|||++.. +.+.+.+|||+|||||.|-- ..|+.+.||||+||++|
T Consensus 151 HRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~--~~Y~~kSDiWslGCllyEMcaL~~PF 228 (375)
T KOG0591|consen 151 HRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHE--SGYNFKSDIWSLGCLLYEMCALQSPF 228 (375)
T ss_pred eccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhc--CCCCcchhHHHHHHHHHHHHhcCCCc
Confidence 37899999999 9999999999876 55566799999999998864 46999999999999997
Q ss_pred -cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhh
Q psy501 735 -GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSL 806 (962)
Q Consensus 735 -G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L 806 (962)
|.+-.+.-.+|.. ..+++. |- ...|.+...|+.-|+..||.+||+.-..+
T Consensus 229 ~g~n~~~L~~KI~q---------------gd~~~~---p~----~~YS~~l~~li~~ci~vd~~~RP~t~~~v 279 (375)
T KOG0591|consen 229 YGDNLLSLCKKIEQ---------------GDYPPL---PD----EHYSTDLRELINMCIAVDPEQRPDTVPYV 279 (375)
T ss_pred ccccHHHHHHHHHc---------------CCCCCC---cH----HHhhhHHHHHHHHHccCCcccCCCcchHH
Confidence 2211111111111 012211 11 15788999999999999999999865554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.8e-14 Score=157.28 Aligned_cols=222 Identities=14% Similarity=0.084 Sum_probs=135.1
Q ss_pred EecCCcccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcC----------CCCcccEEEEEEe------
Q psy501 319 YILPHTLPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLS----------HANLVKLKEVIRE------ 375 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~----------HpnIv~l~~~~~~------ 375 (962)
+..++...||.+....++..++.++.. .+.+.+.+|.-....+. |-.++-.++...-
T Consensus 20 i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~ 99 (288)
T PF14531_consen 20 IGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPF 99 (288)
T ss_dssp EEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SE
T ss_pred cccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcc
Confidence 334445558888877766655543321 12334555554444432 2233333333321
Q ss_pred ---C---CE-----EEEEEecCCCCHHHHHH---hcCCC---CCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccc
Q psy501 376 ---N---DT-----LYFVFEYMKENLYQLIR---DRDKF---LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM 438 (962)
Q Consensus 376 ---~---~~-----~~LV~Ey~~g~Ll~~l~---~~~~~---ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~ 438 (962)
. .. .+++|+-+.++|...+. ..... +.......+..|+++.+++||..|+||+||+|+|++++
T Consensus 100 ~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~ 179 (288)
T PF14531_consen 100 FERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLD 179 (288)
T ss_dssp EEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-
T ss_pred eecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEc
Confidence 1 12 36788989888877653 22221 22334455668999999999999999999999999999
Q ss_pred cccceeeecccccccccCCCcccccCCccccChhhhccC-------CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh
Q psy501 439 GTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHS-------TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG 511 (962)
Q Consensus 439 ~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~-------~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~ 511 (962)
.+|.+.|+||+.....+..... ...+..|.|||..... ..++.+.|.|+||+++|.|..|..||........
T Consensus 180 ~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~ 258 (288)
T PF14531_consen 180 QDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEAD 258 (288)
T ss_dssp TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGST
T ss_pred CCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccc
Confidence 9999999999988765544322 3455789999977432 2478999999999999999999999987655443
Q ss_pred HHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCC
Q psy501 512 TERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERL 547 (962)
Q Consensus 512 ~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperR 547 (962)
... .+..-...|..++.+|...|..+|++|
T Consensus 259 ~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 259 PEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 332 111122566778889999999999887
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.4e-15 Score=154.06 Aligned_cols=103 Identities=21% Similarity=0.255 Sum_probs=76.7
Q ss_pred EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------cCCchhHHHHHHHh
Q psy501 683 HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------GTERLKSSYILLHT 748 (962)
Q Consensus 683 ~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G~~~~~ql~~I~~~ 748 (962)
.-|||++||+.-. ++.|-.+|||.||+||++-- ..|+.++||||+|+|+| |++.-+....|.
T Consensus 150 A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~-- 225 (355)
T KOG0033|consen 150 AAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK-- 225 (355)
T ss_pred CceeecccceEEEeCCccccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh--
Confidence 4689999998644 66777799999999998764 45999999999999997 111111111221
Q ss_pred cCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 749 LPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 749 lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
...+++. +.-| ++++++|+||+.+||..||+||+||.|+|.
T Consensus 226 ---------~g~yd~~-----~~~w----~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 226 ---------AGAYDYP-----SPEW----DTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ---------ccccCCC-----Cccc----CcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1122222 2223 689999999999999999999999999997
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=8.2e-15 Score=152.49 Aligned_cols=101 Identities=23% Similarity=0.274 Sum_probs=80.4
Q ss_pred HHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhc-ccceeeecc
Q psy501 351 VCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFM-HRHGFFHRD 429 (962)
Q Consensus 351 ~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yL-H~~gIvHrD 429 (962)
..+|++++.++.++++.....+.... .+|||||++|+.+.........+++..+..++.|++.+|.++ |+.||+|||
T Consensus 66 ~~~E~~~l~~l~~~~v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrD 143 (190)
T cd05147 66 AEKEMRNLKRLVTAGIPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHAD 143 (190)
T ss_pred HHHHHHHHHHHHHCCCCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 34599999999888775444333222 389999999764433322345689999999999999999999 799999999
Q ss_pred CCCcccccccccceeeecccccccc
Q psy501 430 MKPENLLCMGTELVKIADFGLAREI 454 (962)
Q Consensus 430 Lkp~NILl~~~g~vKL~DFGla~~~ 454 (962)
|||+||+++ ++.++|+|||+|...
T Consensus 144 lkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 144 LSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCHHHEEEE-CCcEEEEEccccccC
Confidence 999999998 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.4e-15 Score=178.41 Aligned_cols=135 Identities=23% Similarity=0.374 Sum_probs=107.0
Q ss_pred cccceeeEEE----EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL----HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~----~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
|-||++||++ +.++|+|||++.. ....+.+||+.|++||.++ |...|+.++||||+|||++
T Consensus 194 rDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlGvil~elltG~~pf~ 272 (440)
T PTZ00036 194 RDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELML-GATNYTTHIDLWSLGCIIAEMILGYPIFS 272 (440)
T ss_pred CCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhc-CCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 6789999999 4799999998854 2333457888888888765 5567999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcc----cccccCCCcccCCccccCC-CCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLAS----NMNFKFPQFRRVPFTSIIP-HASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~----~~~~~~~~~~~~~l~~~~p-~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
|.+..+++..|..++|+|+.+.+.. +....++...+..+...+| ..+++++|||++||++||.+|+|+.++|.+
T Consensus 273 ~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 273 GQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 5677899999999999998776432 2223345555556666666 478899999999999999999999999974
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.9e-15 Score=166.18 Aligned_cols=121 Identities=19% Similarity=0.165 Sum_probs=93.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-----eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-----TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-----~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
|.||.+||++ |.|||+||||++.- ...|.+|||.|||||+|.. ..|+.++||||||...
T Consensus 135 rDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITa----------- 201 (467)
T KOG0201|consen 135 RDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITA----------- 201 (467)
T ss_pred ccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhcc--ccccchhhhhhhhHHH-----------
Confidence 5679999999 99999999998872 2244599999999999993 5699999999999887
Q ss_pred HHHhcCCCchhhhcc-cccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 745 LLHTLPLYTCYTLAS-NMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 745 I~~~lG~p~~~~~~~-~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
|.-.-|.||-..+.. ...+-.|.-.+..+. ...|+.+++|+..||..||..||+|.++|+.+
T Consensus 202 iEla~GePP~s~~hPmrvlflIpk~~PP~L~---~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~ 264 (467)
T KOG0201|consen 202 IELAKGEPPHSKLHPMRVLFLIPKSAPPRLD---GDFSPPFKEFVEACLDKNPEFRPSAKELLKHK 264 (467)
T ss_pred HHHhcCCCCCcccCcceEEEeccCCCCCccc---cccCHHHHHHHHHHhhcCcccCcCHHHHhhhH
Confidence 344567776444322 222224444444444 36799999999999999999999999999744
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.8e-15 Score=165.31 Aligned_cols=135 Identities=23% Similarity=0.298 Sum_probs=104.6
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-----eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-----TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-----~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
+.||..||++ +.++|.|||++... .....+||+.|++||.+. +...|+.++||||+||+++
T Consensus 127 ~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~~l~~l~~g~~pf~ 205 (288)
T cd07871 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL-GSTEYSTPIDMWGVGCILYEMATGRPMFP 205 (288)
T ss_pred CCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhc-CCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 5789999999 78999999987541 122336788888888765 5567999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcccccc------cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNF------KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~------~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.+..+.+..++..+|.|+.+.++..... .++.+...++....+.++++++|||++||++||.+|+|++|+|++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 206 GSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred CCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 45667888899999999988776553221 233333444444556789999999999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.8e-14 Score=145.99 Aligned_cols=102 Identities=20% Similarity=0.203 Sum_probs=83.0
Q ss_pred HHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHhhccc-ceeeec
Q psy501 351 VCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHR-HGFFHR 428 (962)
Q Consensus 351 ~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~-Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~-~gIvHr 428 (962)
..+|.+.+.++.|+++.....+.... .++||||++|. +...... ...++...+..++.|++.++.++|. .||+||
T Consensus 66 ~~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHr 142 (190)
T cd05145 66 AEKEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHG 142 (190)
T ss_pred HHHHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 46899999999999876555444333 48999999975 3333222 3457889999999999999999999 999999
Q ss_pred cCCCcccccccccceeeecccccccccC
Q psy501 429 DMKPENLLCMGTELVKIADFGLAREIRS 456 (962)
Q Consensus 429 DLkp~NILl~~~g~vKL~DFGla~~~~~ 456 (962)
||||+||+++ ++.++|+|||+|.....
T Consensus 143 DlkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 143 DLSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCChhhEEEE-CCCEEEEEcccceecCC
Confidence 9999999998 78999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.51 E-value=5e-15 Score=162.76 Aligned_cols=134 Identities=20% Similarity=0.273 Sum_probs=106.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------c
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------G 735 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G 735 (962)
+.||.+||++ |.++|.|||++.. ......+||+.|++||.+.. ..|+.++||||+||+++ +
T Consensus 134 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~ 211 (290)
T cd07862 134 RDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRG 211 (290)
T ss_pred CCCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCC
Confidence 4689999999 7899999998754 22334478999999998753 45899999999999998 5
Q ss_pred CCchhHHHHHHHhcCCCchhhhcccccc---cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 736 TERLKSSYILLHTLPLYTCYTLASNMNF---KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 736 ~~~~~ql~~I~~~lG~p~~~~~~~~~~~---~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++.+++..|++.+|.|..+.++..... .+...+..+++.+.+.+++++.|||.+||++||++|||+.++|+.
T Consensus 212 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 212 SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 6678899999999998877665443222 123334456666778899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.9e-14 Score=155.88 Aligned_cols=126 Identities=13% Similarity=0.185 Sum_probs=87.0
Q ss_pred EEEeeeeeecCCCceee-eccCCCcccccceeeecCCCCCCCCCceeeeeEee----------cCCchhHHHHHHHhcCC
Q psy501 683 HTLPLYTYHVPPIQTTC-LLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------GTERLKSSYILLHTLPL 751 (962)
Q Consensus 683 ~~~~~~~~~~~~~~~~~-~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G~~~~~ql~~I~~~lG~ 751 (962)
..+++-|||=..-.... +..++|+=||+|||+||-+ |+.++||||+||||+ +.++.++|+++..+||+
T Consensus 249 ~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp 327 (415)
T KOG0671|consen 249 TAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGP 327 (415)
T ss_pred cceEEEecCCcceeccCcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCC
Confidence 35667777765441111 2245677777777777865 999999999999998 67788999999999999
Q ss_pred Cchhhhccccccc-----CCCc--------------ccCCccccCCCCCH---HHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 752 YTCYTLASNMNFK-----FPQF--------------RRVPFTSIIPHASP---DAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 752 p~~~~~~~~~~~~-----~~~~--------------~~~~l~~~~p~~s~---~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
+|..++.+....+ .-.| ...++.......++ +.+|||++||.|||++|+|+.|+|+..
T Consensus 328 ~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 328 IPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHP 407 (415)
T ss_pred CcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCH
Confidence 8877754431110 0011 12333333333344 467999999999999999999999843
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.4e-14 Score=169.50 Aligned_cols=134 Identities=22% Similarity=0.255 Sum_probs=114.3
Q ss_pred HHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-----------------CcccccCCccccChhhhcc
Q psy501 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-----------------PYTDYVSTRWYRAPEVLLH 476 (962)
Q Consensus 414 ~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-----------------~~~~~~gt~~Y~APE~l~~ 476 (962)
+.+++|||+.||+|||+||+|.+|+.-|.+|+.|||+++...-. .....+||+.|+|||++..
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr 232 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR 232 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh
Confidence 78999999999999999999999999999999999998743110 2334589999999999965
Q ss_pred CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCC-CCCCCCcHHHHHHHhccCCCCCC
Q psy501 477 STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTL-PLYTYHVPPIQTTCLLAGTERLK 548 (962)
Q Consensus 477 ~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~s~~l~~li~~Cl~~dperRP 548 (962)
..|+..+|+|++|+++||.+-|..||.+..+.+.........+..+.- ..++.+.++++...|..+|..|-
T Consensus 233 -qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 233 -QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred -hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 479999999999999999999999999999888887777776665543 35566788899999999998885
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.3e-14 Score=162.00 Aligned_cols=135 Identities=16% Similarity=0.208 Sum_probs=95.8
Q ss_pred cccceeeEEE-------EEEeeeeeecCCC--------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee---
Q psy501 673 ERLKSSYILL-------HTLPLYTYHVPPI--------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA--- 734 (962)
Q Consensus 673 ~~~~~~~~~~-------~~~~~~~~~~~~~--------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~--- 734 (962)
+-||..||++ +.++|.|||++.. ......+||+.|++||+++ |...|+.++||||+|||++
T Consensus 132 rDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~ 210 (317)
T cd07868 132 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL-GARHYTKAIDIWAIGCIFAELL 210 (317)
T ss_pred CCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHc-CCCCcCchhhHHHHHHHHHHHH
Confidence 5789999998 5799999998753 1223347888888877765 5567999999999999998
Q ss_pred -cCC---------------chhHHHHHHHhcCCCchhhhccccccc--------C--CCcccCCc----cccCCCCCHHH
Q psy501 735 -GTE---------------RLKSSYILLHTLPLYTCYTLASNMNFK--------F--PQFRRVPF----TSIIPHASPDA 784 (962)
Q Consensus 735 -G~~---------------~~~ql~~I~~~lG~p~~~~~~~~~~~~--------~--~~~~~~~l----~~~~p~~s~~a 784 (962)
|.. ..+++..++.++|.|....+....... + .......+ +......++++
T Consensus 211 ~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (317)
T cd07868 211 TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKA 290 (317)
T ss_pred hCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHH
Confidence 322 247889999999998876654422110 0 00000111 11112356789
Q ss_pred HHHHHHhhccCCCCCcchhhhhhh
Q psy501 785 IHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 785 ~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+|||++||++||.+|+|++++|++
T Consensus 291 ~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 291 FHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHHHHHHhccCcccCCCHHHHhcC
Confidence 999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.48 E-value=2e-14 Score=163.36 Aligned_cols=164 Identities=23% Similarity=0.323 Sum_probs=126.3
Q ss_pred EEEEEEecCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccc
Q psy501 378 TLYFVFEYMK-ENLYQLIRDR--DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI 454 (962)
Q Consensus 378 ~~~LV~Ey~~-g~Ll~~l~~~--~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~ 454 (962)
+++|.|++|. ++|.+++..+ ...-+....+.++.|++.|++| +|.+|+|+||.||++..+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 5889999998 5677777533 2446788899999999999999 99999999999999999999999999998765
Q ss_pred cCC--------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCC
Q psy501 455 RSR--------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTL 525 (962)
Q Consensus 455 ~~~--------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 525 (962)
... ..+...||..||+||.+.+ ..|+.++||||||++|+|++. -..+|. .......++.+.+.+...
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g~ip~~~~ 482 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDGIIPPEFL 482 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcCCCChHHh
Confidence 433 3455689999999999976 479999999999999999997 222222 222334455554433333
Q ss_pred CCCCCCcHHHHHHHhccCCCCCCc
Q psy501 526 PLYTYHVPPIQTTCLLAGTERLKS 549 (962)
Q Consensus 526 ~~~s~~l~~li~~Cl~~dperRPs 549 (962)
..+|.. ..+....+...|+.||+
T Consensus 483 ~d~p~e-~~ll~~lls~~p~~RP~ 505 (516)
T KOG1033|consen 483 QDYPEE-YTLLQQLLSPSPEERPS 505 (516)
T ss_pred hcCcHH-HHHHHHhcCCCcccCch
Confidence 344433 45778889999999994
|
|
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.3e-14 Score=162.31 Aligned_cols=120 Identities=22% Similarity=0.266 Sum_probs=85.3
Q ss_pred ccceeeEEE--EEEeeeeeecCCC---ceee----eccCCCcccccceeeecCCC---------CCCCCCceeeeeEee-
Q psy501 674 RLKSSYILL--HTLPLYTYHVPPI---QTTC----LLAGTERLKSSYILLHTLPL---------YTYHVPPIQTTCLLA- 734 (962)
Q Consensus 674 ~~~~~~~~~--~~~~~~~~~~~~~---~~~~----~~~gt~~~~~~~~lLlg~~~---------Y~~~vDIWSlGCIl~- 734 (962)
-||.+|.++ |.+||-|||++-. .++. +.|||+.||+||.+.-.... -+.+.||||||||+|
T Consensus 485 DLKPANFLlVkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYq 564 (677)
T KOG0596|consen 485 DLKPANFLLVKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQ 564 (677)
T ss_pred CCCcccEEEEeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHH
Confidence 469999999 9999999999876 2222 33999999999998654332 458899999999998
Q ss_pred ---cCCchhHHH-HHHHh--cCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 ---GTERLKSSY-ILLHT--LPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 ---G~~~~~ql~-~I~~~--lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
|+..+.++. .|.++ +-.|.- ...||.. |. ..+++|+++.||.+||+||++..++|+.
T Consensus 565 MvYgktPf~~~~n~~aKl~aI~~P~~-------~Iefp~~---------~~-~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 565 MVYGKTPFGQIINQIAKLHAITDPNH-------EIEFPDI---------PE-NDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHhcCCchHHHHHHHHHHHhhcCCCc-------cccccCC---------CC-chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 777766654 22222 111211 0113222 11 1139999999999999999999999985
Q ss_pred hh
Q psy501 809 KR 810 (962)
Q Consensus 809 ~~ 810 (962)
..
T Consensus 628 pF 629 (677)
T KOG0596|consen 628 PF 629 (677)
T ss_pred cc
Confidence 43
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=99.47 E-value=2e-14 Score=157.17 Aligned_cols=121 Identities=17% Similarity=0.155 Sum_probs=86.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCC---ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI---QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILL 746 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I~ 746 (962)
|-||.+|||+ |-|||+||||+.. ..+.|-+||-.|||||-+-.+ .|+.++||||+|..+. .
T Consensus 203 RDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsll-----------E 269 (364)
T KOG0581|consen 203 RDIKPSNLLVNSKGEVKICDFGVSGILVNSIANTFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLL-----------E 269 (364)
T ss_pred ccCCHHHeeeccCCCEEeccccccHHhhhhhcccccccccccChhhhcCC--cCCcccceecccHHHH-----------H
Confidence 7899999999 9999999999988 555666999999999999864 5999999999999884 2
Q ss_pred HhcCCCchh-------hhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 747 HTLPLYTCY-------TLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 747 ~~lG~p~~~-------~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
..+|.+|-- .+......-. .-++..+.+ ..+|+++.+|+.+||+.||.+|++++|+|++.
T Consensus 270 ~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~--~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 270 LAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPE--GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred HhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCc--ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 233421100 0000000000 001111110 13799999999999999999999999999743
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.5e-14 Score=151.34 Aligned_cols=122 Identities=20% Similarity=0.275 Sum_probs=89.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeee----cCCCCCCCCCceeeeeEee----cCC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLH----TLPLYTYHVPPIQTTCLLA----GTE 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLl----g~~~Y~~~vDIWSlGCIl~----G~~ 737 (962)
|.||.-||++ ..++|.|||++-. ....-+||||.|.+||+|-. +...|+..||+||||+|+| |..
T Consensus 147 RDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcp 226 (411)
T KOG0599|consen 147 RDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCP 226 (411)
T ss_pred cccChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCC
Confidence 6789999999 8999999998543 44444599999999999854 3567999999999999997 444
Q ss_pred chhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 738 RLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 738 ~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.+-+-.+++.+- -.+...+.+.-|. | .++|.+++|||.++|+.||.+|+|++++|.+
T Consensus 227 PFwHRkQmlMLR-----~ImeGkyqF~spe-----W----adis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 227 PFWHRKQMLMLR-----MIMEGKYQFRSPE-----W----ADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred chhHHHHHHHHH-----HHHhcccccCCcc-----h----hhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 333322222110 0012223322333 3 4789999999999999999999999999963
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.3e-13 Score=169.65 Aligned_cols=196 Identities=14% Similarity=0.168 Sum_probs=148.8
Q ss_pred CCceEEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc-hhHHHHHHHHHHHHhcC---CCCcccEEEEEEeCCE
Q psy501 303 GHTTCLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-RDEMVVCFYRKSLKKLS---HANLVKLKEVIRENDT 378 (962)
Q Consensus 303 g~~~~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~ 378 (962)
+....++.-.+.+...++.++.+.||.+.... ++.++.|+.. ...-++.-=.+++.+|+ -+.|+.+..++.-.+.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 33434444456666667777777899998887 5555555432 22222222234455555 3566777777777777
Q ss_pred EEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc-------ccceeeecccc
Q psy501 379 LYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG-------TELVKIADFGL 450 (962)
Q Consensus 379 ~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~-------~g~vKL~DFGl 450 (962)
.++|+||.+ |+|++.+. ..+.+++..+..++.|++..+++||..+|||+||||+|++|.. ...++|+|||.
T Consensus 769 S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred ceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 889999998 88888887 4566999999999999999999999999999999999999942 23589999999
Q ss_pred cccccC---C-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCC
Q psy501 451 AREIRS---R-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVP 501 (962)
Q Consensus 451 a~~~~~---~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~ 501 (962)
|..+.- . .....++|-.+-++|+..| .+|++.+|.|.|+.+++-|++|+.
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence 975532 2 4556688999999999965 589999999999999999999954
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=99.45 E-value=2e-14 Score=160.67 Aligned_cols=120 Identities=20% Similarity=0.221 Sum_probs=90.1
Q ss_pred ceeEEeeccccccceeeEEE----EEEeeeeeecC----CCceeeeccCCCcccccceeeecCCCCC-CCCCceeeeeEe
Q psy501 663 IQTTCLLAGTERLKSSYILL----HTLPLYTYHVP----PIQTTCLLAGTERLKSSYILLHTLPLYT-YHVPPIQTTCLL 733 (962)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~----~~~~~~~~~gt~~~~~~~~lLlg~~~Y~-~~vDIWSlGCIl 733 (962)
||+-+. -|.||.-|+.+ |.|||.|||++ |++...|.||+..|-+||||| |.. |+ ++|||||+|||+
T Consensus 135 HqLHVV---HRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILL-GDs-YDAPAVDiWSLGVIL 209 (864)
T KOG4717|consen 135 HQLHVV---HRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILL-GDS-YDAPAVDIWSLGVIL 209 (864)
T ss_pred hhhhhh---cccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhh-cCc-cCCcchhhhHHHHHH
Confidence 554433 47899999877 99999999987 457788889999998888776 543 77 899999999999
Q ss_pred ecCCchhHHHHHHHhcCCCchhhh------cccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 734 AGTERLKSSYILLHTLPLYTCYTL------ASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 734 ~G~~~~~ql~~I~~~lG~p~~~~~------~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
| +-++|.||-... ...++.++... .++|.+++|||..||+.||+||.+.+++.+
T Consensus 210 y-----------MLVCGq~PFqeANDSETLTmImDCKYtvP---------shvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 210 Y-----------MLVCGQPPFQEANDSETLTMIMDCKYTVP---------SHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred H-----------HHHhCCCccccccchhhhhhhhcccccCc---------hhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 7 235666653221 11222222111 368999999999999999999999999974
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.5e-14 Score=155.77 Aligned_cols=134 Identities=21% Similarity=0.303 Sum_probs=102.9
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc----eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------c
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ----TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------G 735 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~----~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G 735 (962)
+.||.+||++ +.++|.|||++... ......||+.|++||.+. + ..|+.++||||+||+++ +
T Consensus 132 ~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~~DiwslG~~l~~l~~g~~~f~~ 209 (288)
T cd07863 132 RDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLL-Q-STYATPVDMWSVGCIFAEMFRRKPLFCG 209 (288)
T ss_pred CCCCHHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHhh-C-CCCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence 5689999999 78999999987652 122347888998888765 3 35899999999999988 4
Q ss_pred CCchhHHHHHHHhcCCCchhhhcccccc---cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 736 TERLKSSYILLHTLPLYTCYTLASNMNF---KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 736 ~~~~~ql~~I~~~lG~p~~~~~~~~~~~---~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.+..+++.+++..+|.|....++..... .+......++....+.+++++.|||.+||++||++|||+.++|..
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 210 NSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 4566788899999888876655443221 122333445566667889999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=6e-13 Score=140.45 Aligned_cols=102 Identities=14% Similarity=0.227 Sum_probs=81.0
Q ss_pred hHHHHHHHHHHHHhc-----CCCCcccEEEEEEeCC---E-EEEEEecCC---CCHHHHHHhcCCCCCHHHHHHHHHHHH
Q psy501 347 DEMVVCFYRKSLKKL-----SHANLVKLKEVIREND---T-LYFVFEYMK---ENLYQLIRDRDKFLPESIIRNMMYQVL 414 (962)
Q Consensus 347 ~~~~~~~Ei~iL~~L-----~HpnIv~l~~~~~~~~---~-~~LV~Ey~~---g~Ll~~l~~~~~~ls~~~i~~i~~qI~ 414 (962)
....+.+|+++++++ .||||++++++++++. . +.+||||++ |+|.+++... .+++. ..++.|++
T Consensus 39 ~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L 114 (210)
T PRK10345 39 GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLL 114 (210)
T ss_pred hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHH
Confidence 345699999999999 5799999999998863 4 347899954 5777777542 36666 36688888
Q ss_pred HHH-hhcccceeeeccCCCccccccc----ccceeeec-ccccc
Q psy501 415 QGL-AFMHRHGFFHRDMKPENLLCMG----TELVKIAD-FGLAR 452 (962)
Q Consensus 415 ~aL-~yLH~~gIvHrDLkp~NILl~~----~g~vKL~D-FGla~ 452 (962)
.++ +|||+.+|+||||||+||+++. .+.++|+| ||...
T Consensus 115 ~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~ 158 (210)
T PRK10345 115 KKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGEST 158 (210)
T ss_pred HHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCcc
Confidence 887 9999999999999999999974 33799999 55443
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.7e-14 Score=146.28 Aligned_cols=137 Identities=20% Similarity=0.362 Sum_probs=106.3
Q ss_pred cccceeeEEE----EEEeeeeeecCCC---ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee-----------
Q psy501 673 ERLKSSYILL----HTLPLYTYHVPPI---QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------- 734 (962)
Q Consensus 673 ~~~~~~~~~~----~~~~~~~~~~~~~---~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------- 734 (962)
|.+|..|..+ --+.|-|+|++.- +..+.+.+.-+|.--|+||...+.|+++.||||+||+||
T Consensus 156 RDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 156 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred ccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 4556666666 4677888888643 566666666788888899999999999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhccccccc--------CCCcccCCccccCCC-----CCHHHHHHHHHhhccCCCCCcc
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNFK--------FPQFRRVPFTSIIPH-----ASPDAIHLMESMLAYNPSKRPT 801 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~--------~~~~~~~~l~~~~p~-----~s~~a~DLL~kmL~~dP~kR~s 801 (962)
|.+..|||.+|.++||+.........+... .....+.+|..+++. .+|+|+|||.++|.||...|+|
T Consensus 236 G~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT 315 (338)
T KOG0668|consen 236 GHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT 315 (338)
T ss_pred CCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc
Confidence 999999999999999996543322211111 123346778777652 5799999999999999999999
Q ss_pred hhhhhhhh
Q psy501 802 AQQSLSIK 809 (962)
Q Consensus 802 a~~~L~~~ 809 (962)
|.|++.+.
T Consensus 316 akEam~Hp 323 (338)
T KOG0668|consen 316 AKEAMAHP 323 (338)
T ss_pred hHHHhcCc
Confidence 99999744
|
|
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=99.43 E-value=9.7e-14 Score=157.97 Aligned_cols=118 Identities=23% Similarity=0.263 Sum_probs=87.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeec---CCCCCCCCCceeeeeEee-------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHT---LPLYTYHVPPIQTTCLLA------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg---~~~Y~~~vDIWSlGCIl~------- 734 (962)
|.||.-||++ |+++|.||||++. +..-+-.|||+||+||++... .+.||+++||||+|+.|.
T Consensus 154 RDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEP 233 (1187)
T KOG0579|consen 154 RDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEP 233 (1187)
T ss_pred hhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCC
Confidence 6789999999 9999999999998 333344999999999998654 678999999999999884
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCC-CCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIP-HASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p-~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
...++..+.-++++- ...+..| +-| +.+..+.|||++||..||..||+|.++|.+.
T Consensus 234 PHhelnpMRVllKia-----------------KSePPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 234 PHHELNPMRVLLKIA-----------------KSEPPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred CccccchHHHHHHHh-----------------hcCCCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 222333332222221 1111111 012 4688999999999999999999999999854
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.42 E-value=6e-14 Score=158.64 Aligned_cols=135 Identities=20% Similarity=0.282 Sum_probs=102.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------cCC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------GTE 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G~~ 737 (962)
+-||++||++ |.++|.|||+... ......+||+.|++||++. +...|+.++||||+|||++ +.+
T Consensus 142 rdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 142 RDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220 (343)
T ss_pred ccCChhhEEECCCCCEEEcCCccceecCCCcCCccccccccCchHhc-CCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 6689999999 7899999999765 2333447888888888765 5457999999999999998 345
Q ss_pred chhHHHHHHHhcCCCchhhhcccccc-------cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 738 RLKSSYILLHTLPLYTCYTLASNMNF-------KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 738 ~~~ql~~I~~~lG~p~~~~~~~~~~~-------~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
..+++..+....|.++.+........ ..+..+...+...+...++.++|||.+||++||.+|||+.++|..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 221 YIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 56788888888888876543221110 122333344555566788999999999999999999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.4e-14 Score=167.05 Aligned_cols=134 Identities=16% Similarity=0.151 Sum_probs=93.7
Q ss_pred cccceeeEEEE-------------------EEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeee
Q psy501 673 ERLKSSYILLH-------------------TLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTC 731 (962)
Q Consensus 673 ~~~~~~~~~~~-------------------~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGC 731 (962)
|-||..||++. .+||.|||.... ......+||+.|++||++. | ..|+.++||||+||
T Consensus 256 rDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~-~-~~~~~~~DiwSlGv 333 (467)
T PTZ00284 256 TDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVL-G-LGWMYSTDMWSMGC 333 (467)
T ss_pred CCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccccccccCCccccCcHHhh-c-CCCCcHHHHHHHHH
Confidence 46788888882 499999997644 2334558999999999876 4 35999999999999
Q ss_pred Eee----------cCCchhHHHHHHHhcCCCchhhhccccc------c----c-CCCcccCCccccC-----C--CCCHH
Q psy501 732 LLA----------GTERLKSSYILLHTLPLYTCYTLASNMN------F----K-FPQFRRVPFTSII-----P--HASPD 783 (962)
Q Consensus 732 Il~----------G~~~~~ql~~I~~~lG~p~~~~~~~~~~------~----~-~~~~~~~~l~~~~-----p--~~s~~ 783 (962)
|+| +.+..+++..|...+|.++......... + . .+...+..+..+. . ..++.
T Consensus 334 il~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (467)
T PTZ00284 334 IIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDL 413 (467)
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHH
Confidence 998 5667889999999999887553211000 0 0 0001111111000 0 12567
Q ss_pred HHHHHHHhhccCCCCCcchhhhhhh
Q psy501 784 AIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 784 a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
++|||.+||++||++|+|++|+|++
T Consensus 414 ~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 414 LCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHHHHHHhCCcChhhCCCHHHHhcC
Confidence 8899999999999999999999974
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.3e-14 Score=158.16 Aligned_cols=136 Identities=23% Similarity=0.332 Sum_probs=103.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCCce--------eeeccCCCcccccceeeecCCCCCCCCCceeeeeEee-------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQT--------TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~--------~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~------- 734 (962)
+.||++||++ |.++|.|||++.... ....+||+.|++||++......|+.++||||+||+++
T Consensus 127 ~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~ 206 (338)
T cd07859 127 RDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206 (338)
T ss_pred CCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCC
Confidence 5789999999 889999999875411 1223788999999876543357999999999999998
Q ss_pred ---cCCchhHHHHHHHhcCCCchhhhcccccc-------cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhh
Q psy501 735 ---GTERLKSSYILLHTLPLYTCYTLASNMNF-------KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQ 804 (962)
Q Consensus 735 ---G~~~~~ql~~I~~~lG~p~~~~~~~~~~~-------~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~ 804 (962)
+.+..+++..+.+.+|.|+.......... ......+.++...++..++++.|||.+||+.||++||++++
T Consensus 207 pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e 286 (338)
T cd07859 207 LFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286 (338)
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHH
Confidence 45667788889999999887654332111 01122234455566788999999999999999999999999
Q ss_pred hhhh
Q psy501 805 SLSI 808 (962)
Q Consensus 805 ~L~~ 808 (962)
+|+.
T Consensus 287 ~l~h 290 (338)
T cd07859 287 ALAD 290 (338)
T ss_pred HhcC
Confidence 9974
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.4e-13 Score=154.57 Aligned_cols=331 Identities=17% Similarity=0.127 Sum_probs=228.7
Q ss_pred HHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH----HHhhcccce
Q psy501 350 VVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ----GLAFMHRHG 424 (962)
Q Consensus 350 ~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~----aL~yLH~~g 424 (962)
.-.+|+...+.++ |++.++.+..++.++..++-+|+|+.++..+.......++...++..+.+... ||.++|..+
T Consensus 163 ~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~ 242 (524)
T KOG0601|consen 163 RKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN 242 (524)
T ss_pred cccchhhcccccCccccccccCcccccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc
Confidence 4566777777775 99999999999999999999999999999999888777999999999999999 999999999
Q ss_pred eeeccCCCcccccccc-cceeeecccccccccCCCcc-------cccCCccccChhhhccCCCCCchhHHHHHHHHHHHH
Q psy501 425 FFHRDMKPENLLCMGT-ELVKIADFGLAREIRSRPYT-------DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYS 496 (962)
Q Consensus 425 IvHrDLkp~NILl~~~-g~vKL~DFGla~~~~~~~~~-------~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~el 496 (962)
++|-|++|+||++..+ ...+++|||+...+...... ...|...|++||+..+ -++.++||||+|.+..+.
T Consensus 243 ~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~ 320 (524)
T KOG0601|consen 243 IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEA 320 (524)
T ss_pred ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhh
Confidence 9999999999999998 78999999999887665321 1256778999999965 589999999999999999
Q ss_pred HcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccccCCCCcchhhhcccc
Q psy501 497 IDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGT 576 (962)
Q Consensus 497 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~~~~~~~~~~~l~g~ 576 (962)
.+|..++...... .-..+..+.+........+..++..+..++..++-.|++++++...-
T Consensus 321 ~l~~~~~~~g~~~-~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~------------------- 380 (524)
T KOG0601|consen 321 ILGSHLPSVGKNS-SWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALN------------------- 380 (524)
T ss_pred HhhcccccCCCCC-CccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccc-------------------
Confidence 9987766543111 11122233222222223344555577777777777777766655421
Q ss_pred ccccccceeecccccccccCCCcccccccccccccccceeEeecccccccccCCcceeecccccccccceeeeeeecceE
Q psy501 577 ERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLY 656 (962)
Q Consensus 577 ~~l~ssy~~~~~lpl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (962)
+++
T Consensus 381 -------------------------------------------~i~---------------------------------- 383 (524)
T KOG0601|consen 381 -------------------------------------------VIH---------------------------------- 383 (524)
T ss_pred -------------------------------------------ccc----------------------------------
Confidence 111
Q ss_pred EEecCCceeEEeeccccccceeeEEE----EEEeeeeeecCCCceeee--ccCCCcccc-cceeeecCCCCCCCCCceee
Q psy501 657 TYHVPPIQTTCLLAGTERLKSSYILL----HTLPLYTYHVPPIQTTCL--LAGTERLKS-SYILLHTLPLYTYHVPPIQT 729 (962)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~--~~gt~~~~~-~~~lLlg~~~Y~~~vDIWSl 729 (962)
-|+.=-..+|.+||++ +.-+++|+|+...-+... ..++.++|+ +|+++ ....+..++|+.|+
T Consensus 384 ----------s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~~~~~~r~~p~~~~~~-e~~~~~~~~~~~sl 452 (524)
T KOG0601|consen 384 ----------SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGVFHHIDRLYPIAEILL-EDYPHLSKADIFSL 452 (524)
T ss_pred ----------chhhhcccccccceeeccchhhhhccccccccccceecccccccccccccchhhc-cccccccccccccc
Confidence 1111123467788887 457889999886522221 145667775 55554 66778899999999
Q ss_pred eeEeecCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 730 TCLLAGTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 730 GCIl~G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
|.-+. . ...|.+-.+....+....-... ...+....++..+++.|...|+..|+++.+...
T Consensus 453 ~~~~~--------e---~~~~~~ls~~~~~~~~i~~~~~------p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 453 GLSVD--------E---AITGSPLSESGVQSLTIRSGDT------PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred ccccc--------c---cccCcccCcccccceeeecccc------cCCCchHHhhhhhhhhhcCCccccchhhhhhcc
Confidence 97663 0 1111111110000000000000 011344467889999999999999999988654
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=99.41 E-value=9.2e-14 Score=153.72 Aligned_cols=120 Identities=16% Similarity=0.145 Sum_probs=81.8
Q ss_pred cccceeeEEE----EEEeeeeeecCCCce--------eeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchh
Q psy501 673 ERLKSSYILL----HTLPLYTYHVPPIQT--------TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK 740 (962)
Q Consensus 673 ~~~~~~~~~~----~~~~~~~~~~~~~~~--------~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ 740 (962)
+-||++||++ |.+||.|||++.... .....||+.||+||++.-|. .-++++||||+||++.
T Consensus 141 ~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~-~~~~~sDiWSlGCtVv------ 213 (313)
T KOG0198|consen 141 CDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGE-VARRESDIWSLGCTVV------ 213 (313)
T ss_pred cCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCC-cCCccchhhhcCCEEE------
Confidence 4679999999 699999999877522 33569999999999999642 1235999999999996
Q ss_pred HHHHHHHhc-CC-Cchhh---hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 741 SSYILLHTL-PL-YTCYT---LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 741 ql~~I~~~l-G~-p~~~~---~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
+++ |. |+.+. ........... ....+-+.+|+++.|||.+||.+||.+||||+++|.+.
T Consensus 214 ------EM~Tg~~PW~~~~~~~~~~~~ig~~~----~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 214 ------EMLTGKPPWSEFFEEAEALLLIGRED----SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ------eccCCCCcchhhcchHHHHHHHhccC----CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 111 11 11110 00000000000 01112246899999999999999999999999999744
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.8e-12 Score=155.45 Aligned_cols=198 Identities=18% Similarity=0.101 Sum_probs=130.1
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEE----EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccc
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLY----FVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRH 423 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~----LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~ 423 (962)
....+.|...+.++.|+|++.++.+.......- +..++|.+.-...+...-..++..+.+.+..++..||.++|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 344677888899999999999999875543322 3345666543334444445689999999999999999999998
Q ss_pred eeeeccCCCc---ccccccccceeee--cccccccccCCC-cccccCCccccChhhhccCC-CCCchhHHHHHHHHHHHH
Q psy501 424 GFFHRDMKPE---NLLCMGTELVKIA--DFGLAREIRSRP-YTDYVSTRWYRAPEVLLHST-AYSAPIHLSRSQQFLFYS 496 (962)
Q Consensus 424 gIvHrDLkp~---NILl~~~g~vKL~--DFGla~~~~~~~-~~~~~gt~~Y~APE~l~~~~-~~t~ksDIwSLGvlL~el 496 (962)
...|.-+..+ .--.+..+.+.++ ||+.+....... ......+..+.+||...... ......|+|++|..+..+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 7666666555 4444566666666 898887765542 22234456677888774321 123346999999999999
Q ss_pred HcCCCCCCCcChhhhHHHHHhccccccCCCCCC-CCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 497 IDHVPPIQTTCLLAGTERLKSSYILLHTLPLYT-YHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 497 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s-~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..|..+-.-.. ... ...+... .........|+..++++|.++.+++...
T Consensus 386 ~~~~~i~~~~~---~~~---------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 386 SQGEDISEKSA---VPV---------SLLDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhcCccccccc---chh---------hhhccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 98855421111 011 1111111 1445567789999999999877776544
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.40 E-value=7.9e-14 Score=154.79 Aligned_cols=136 Identities=18% Similarity=0.163 Sum_probs=96.9
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cC----
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GT---- 736 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~---- 736 (962)
+-||.+||++ |.++|.|||++.. ......+||+.|++||++. +...|+.++||||+||+++ |.
T Consensus 127 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~ 205 (303)
T cd07869 127 RDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL-GSTEYSTCLDMWGVGCIFVEMIQGVAAFP 205 (303)
T ss_pred CCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHc-CCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 5789999999 7899999998653 1223347888888888765 5567999999999999998 43
Q ss_pred ---CchhHHHHHHHhcCCCchhhhccccccc------CCCcccCCccccCC--CCCHHHHHHHHHhhccCCCCCcchhhh
Q psy501 737 ---ERLKSSYILLHTLPLYTCYTLASNMNFK------FPQFRRVPFTSIIP--HASPDAIHLMESMLAYNPSKRPTAQQS 805 (962)
Q Consensus 737 ---~~~~ql~~I~~~lG~p~~~~~~~~~~~~------~~~~~~~~l~~~~p--~~s~~a~DLL~kmL~~dP~kR~sa~~~ 805 (962)
+..+++..++..+|.|....++...... +....+..+...++ ..++++.|||++||++||++|+|+.++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~ 285 (303)
T cd07869 206 GMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAA 285 (303)
T ss_pred CCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHH
Confidence 3347788888888888766544322110 11111222222222 246789999999999999999999999
Q ss_pred hhhh
Q psy501 806 LSIK 809 (962)
Q Consensus 806 L~~~ 809 (962)
|++.
T Consensus 286 l~h~ 289 (303)
T cd07869 286 LSHE 289 (303)
T ss_pred hcCc
Confidence 9744
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.8e-14 Score=154.23 Aligned_cols=113 Identities=22% Similarity=0.235 Sum_probs=81.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
|-||..||+| |-++|+|||++.. .++.+.|||+.|||||+++.. .|+.+||.||+||++| .
T Consensus 149 RDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillY---------e 217 (357)
T KOG0598|consen 149 RDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLY---------E 217 (357)
T ss_pred ccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcC--CCCcccchHhHHHHHH---------H
Confidence 7889999999 9999999999985 567778999999999999864 5999999999999996 2
Q ss_pred HHHhcCCCchhhhcccccccCCCcccCCccccCCC-CCHHHHHHHHHhhccCCCCCcc
Q psy501 745 LLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPH-ASPDAIHLMESMLAYNPSKRPT 801 (962)
Q Consensus 745 I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~-~s~~a~DLL~kmL~~dP~kR~s 801 (962)
++....++..+........ ....+ +. ..|. +|++++|||++||+.||.+|..
T Consensus 218 ML~G~pPF~~~~~~~~~~~-I~~~k---~~-~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 218 MLTGKPPFYAEDVKKMYDK-ILKGK---LP-LPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred HhhCCCCCcCccHHHHHHH-HhcCc---CC-CCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 2222222222221111100 00000 00 1134 8999999999999999999985
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=99.39 E-value=9.8e-14 Score=160.17 Aligned_cols=113 Identities=19% Similarity=0.292 Sum_probs=85.7
Q ss_pred ccccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cC----
Q psy501 672 TERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GT---- 736 (962)
Q Consensus 672 ~~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~---- 736 (962)
-|.||.-|++| +.+|++|||.+.. ....|.||+|.|.+||||. |.++-|.+.||||||+||| |.
T Consensus 135 HRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~-G~pYdG~~sDVWSCGVILfALLtG~LPFd 213 (786)
T KOG0588|consen 135 HRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVS-GRPYDGRPSDVWSCGVILFALLTGKLPFD 213 (786)
T ss_pred eccCCchhhhhhcccCEeeeccceeecccCCccccccCCCcccCCchhhc-CCCCCCCccccchhHHHHHHHHhCCCCCC
Confidence 47899999999 7899999999877 5667779999999999988 5455568999999999997 22
Q ss_pred -CchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 737 -ERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 737 -~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.+.+|-.-++ ...|..| .+++++|.|||.+||+.||.+|+|.++++++
T Consensus 214 DdNir~LLlKV~------------~G~f~MP-----------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 214 DDNIRVLLLKVQ------------RGVFEMP-----------SNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CccHHHHHHHHH------------cCcccCC-----------CcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 22222211100 0011111 3689999999999999999999999999963
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.38 E-value=9.7e-14 Score=154.54 Aligned_cols=135 Identities=19% Similarity=0.312 Sum_probs=102.6
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-----eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-----TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-----~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
+-||++||++ +.++|.|||++... .....+||+.|++||.+. +...|+.++||||+||+++
T Consensus 128 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~tg~~pf~ 206 (309)
T cd07872 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL-GSSEYSTQIDMWGVGCIFFEMASGRPLFP 206 (309)
T ss_pred CCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 5689999999 78999999987541 122336788888777665 5567999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhccccc------ccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMN------FKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~------~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.+..+.+..++..+|.|....++.... +.++...+.++....+.++++++|||.+||.+||.+|+|+.++|+.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 207 GSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 3455678888999999988776544321 1233333444444557789999999999999999999999999973
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.6e-13 Score=155.81 Aligned_cols=111 Identities=23% Similarity=0.259 Sum_probs=86.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
|-||.+|||+ +.|+|+|||++.. +.+++++|||.|+.||+|-- ..|+.|.||||+||++|
T Consensus 130 RDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d--~pYn~KSDiWsLGC~~yEm~~lk~aF~ 207 (426)
T KOG0589|consen 130 RDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSD--IPYNEKSDIWSLGCCLYEMCTLKPAFK 207 (426)
T ss_pred ccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCC--CCCCccCcchhhcchHHHHHhcccccC
Confidence 7889999999 7779999999877 37778899999999998763 56999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.+....+.+|+..+.. |+. ...+.+..-|++.||..+|..||+|.++|..
T Consensus 208 a~~m~~Li~ki~~~~~~--------------------Plp---~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 208 ASNMSELILKINRGLYS--------------------PLP---SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccchHHHHHHHhhccCC--------------------CCC---ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 22222222233222111 111 3568899999999999999999999999963
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.7e-13 Score=150.35 Aligned_cols=135 Identities=17% Similarity=0.234 Sum_probs=96.8
Q ss_pred ccceeeEEE----EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------cCC
Q psy501 674 RLKSSYILL----HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------GTE 737 (962)
Q Consensus 674 ~~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G~~ 737 (962)
-||..|||. -++||||||-+-. ...-|++---++||+|+|+||- .|++++|+||+||.|| |.+
T Consensus 561 DIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~-~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 561 DIKPDNILVNESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGL-PYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred ccCccceEeccCcceeeeccCccccccccccccHHHHHHhccCcceeecC-cccCCccceeeceeeEEeeccceecCCCC
Confidence 359999999 7999999997544 2222222223789999999995 5999999999999998 889
Q ss_pred chhHHHHHHHhcCCCchhhhcccc--cc------c-----------------CCCccc-CCccccC---CCCC-------
Q psy501 738 RLKSSYILLHTLPLYTCYTLASNM--NF------K-----------------FPQFRR-VPFTSII---PHAS------- 781 (962)
Q Consensus 738 ~~~ql~~I~~~lG~p~~~~~~~~~--~~------~-----------------~~~~~~-~~l~~~~---p~~s------- 781 (962)
.-++|...+++-|.+|..++..-. .. . .+..+| ..|...+ +.++
T Consensus 640 NN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~ 719 (752)
T KOG0670|consen 640 NNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIV 719 (752)
T ss_pred cHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHH
Confidence 999999999999999988753310 00 0 011111 2222111 1122
Q ss_pred HHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 782 PDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 782 ~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
..+.|||.+||.+||.||.|..++|.+.
T Consensus 720 ~~~rdLLdkml~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 720 QQLRDLLDKMLILDPEKRITVNQALKHP 747 (752)
T ss_pred HHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence 2478999999999999999999999754
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.5e-13 Score=154.82 Aligned_cols=134 Identities=19% Similarity=0.281 Sum_probs=96.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc----eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------c
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ----TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------G 735 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~----~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G 735 (962)
+.||.+||++ |.++|.|||++... ......||+.|++||.+. | ..|+.++||||+||+++ +
T Consensus 147 rDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~-~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 147 RDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL-G-MGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred CCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhcc-C-CCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 5689999999 89999999997542 122337888999888775 3 45899999999999998 5
Q ss_pred CCchhHHHHHHHhcCCCchhhhccccc------ccCCCcccCCccccC------------CCCCHHHHHHHHHhhccCCC
Q psy501 736 TERLKSSYILLHTLPLYTCYTLASNMN------FKFPQFRRVPFTSII------------PHASPDAIHLMESMLAYNPS 797 (962)
Q Consensus 736 ~~~~~ql~~I~~~lG~p~~~~~~~~~~------~~~~~~~~~~l~~~~------------p~~s~~a~DLL~kmL~~dP~ 797 (962)
.+..+++..+.+.+|+|+.+.+..... ...+..+...+.+.+ ...++++.|||.+||++||+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 304 (359)
T cd07876 225 TDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPD 304 (359)
T ss_pred CCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcc
Confidence 566788888999999987654221100 011111112222222 12467899999999999999
Q ss_pred CCcchhhhhhh
Q psy501 798 KRPTAQQSLSI 808 (962)
Q Consensus 798 kR~sa~~~L~~ 808 (962)
+|||+.++|.+
T Consensus 305 ~R~t~~e~l~h 315 (359)
T cd07876 305 KRISVDEALRH 315 (359)
T ss_pred cCCCHHHHhcC
Confidence 99999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.9e-13 Score=156.59 Aligned_cols=134 Identities=19% Similarity=0.301 Sum_probs=98.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCCce------eeeccCCCcccccceeeecCCCCCCCCCceeeeeEee---------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQT------TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA--------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~------~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~--------- 734 (962)
+-||.+||++ |.++|.|||++.... .....||+.|++||.+. |...|+.++||||+|||++
T Consensus 127 ~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~pf 205 (372)
T cd07853 127 RDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILM-GSRHYTSAVDIWSVGCIFAELLGRRILF 205 (372)
T ss_pred CCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHc-CCCCCCcHHHHHhHHHHHHHHHcCCCCC
Confidence 6799999999 889999999875421 12236777777776554 6667999999999999998
Q ss_pred -cCCchhHHHHHHHhcCCCchhhhcccccc------cCCCcccCCcc---ccCCCCCHHHHHHHHHhhccCCCCCcchhh
Q psy501 735 -GTERLKSSYILLHTLPLYTCYTLASNMNF------KFPQFRRVPFT---SIIPHASPDAIHLMESMLAYNPSKRPTAQQ 804 (962)
Q Consensus 735 -G~~~~~ql~~I~~~lG~p~~~~~~~~~~~------~~~~~~~~~l~---~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~ 804 (962)
+.+..+++..|.+.+|.|+.+.+...... ..+. .+..+. .+.+..++++.|||.+||++||.+|||+.+
T Consensus 206 ~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e 284 (372)
T cd07853 206 QAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPH-KPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAAD 284 (372)
T ss_pred CCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCC-CCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHH
Confidence 55678899999999999987654321100 0111 111111 122456889999999999999999999999
Q ss_pred hhhh
Q psy501 805 SLSI 808 (962)
Q Consensus 805 ~L~~ 808 (962)
+|..
T Consensus 285 ~l~h 288 (372)
T cd07853 285 ALAH 288 (372)
T ss_pred HhcC
Confidence 9974
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.35 E-value=4e-13 Score=147.48 Aligned_cols=134 Identities=19% Similarity=0.297 Sum_probs=95.5
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee---------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA--------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~--------- 734 (962)
+.||..||++ +.++|.|||++..- .....+||+.|++||.+. + ..|+.++||||+||+++
T Consensus 124 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~~DiwslGvil~el~~g~~pf 201 (287)
T cd07848 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL-G-APYGKAVDMWSVGCILGELSDGQPLF 201 (287)
T ss_pred CCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHc-C-CCCCCchhHHhHHHHHHHHHhCCCCC
Confidence 5789999999 78999999987541 112347899999988775 4 34899999999999998
Q ss_pred -cCCchhHHHHHHHhcCCCchhhhccccc---c---cCCCcc-cCCc-cccCCCCCHHHHHHHHHhhccCCCCCcchhhh
Q psy501 735 -GTERLKSSYILLHTLPLYTCYTLASNMN---F---KFPQFR-RVPF-TSIIPHASPDAIHLMESMLAYNPSKRPTAQQS 805 (962)
Q Consensus 735 -G~~~~~ql~~I~~~lG~p~~~~~~~~~~---~---~~~~~~-~~~l-~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~ 805 (962)
+.+..+++..+....|+.+...+..... + .++... ...+ ....+.+|+++.|||++||++||++|+|++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~ 281 (287)
T cd07848 202 PGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQC 281 (287)
T ss_pred CCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 4456678888888888876554322111 0 011110 1111 11123578899999999999999999999999
Q ss_pred hhh
Q psy501 806 LSI 808 (962)
Q Consensus 806 L~~ 808 (962)
|++
T Consensus 282 l~h 284 (287)
T cd07848 282 LNH 284 (287)
T ss_pred hcC
Confidence 974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.4e-13 Score=155.90 Aligned_cols=120 Identities=19% Similarity=0.161 Sum_probs=87.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCCceeeec-----cCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQTTCLL-----AGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~-----~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
|.+|.+||++ |.+|++|||+.....+-++ .|||.||+||.+- | ..|+..+|+||+|||+|
T Consensus 124 rd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~-e-~pyd~~sDlWslGcilY---------- 191 (808)
T KOG0597|consen 124 RDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVE-E-QPYDHTSDLWSLGCILY---------- 191 (808)
T ss_pred ccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHc-C-CCccchhhHHHHHHHHH----------
Confidence 7899999999 9999999999988544444 9999999999877 3 56999999999999998
Q ss_pred HHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 745 LLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 745 I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
....|.||=..-.-....+.....+..|. +.+|++++.||+.+|..||.+|++..++|.+
T Consensus 192 -E~~~G~PPF~a~si~~Lv~~I~~d~v~~p---~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 192 -ELYVGQPPFYARSITQLVKSILKDPVKPP---STASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -HHhcCCCCchHHHHHHHHHHHhcCCCCCc---ccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 12345554211000000000000111121 3789999999999999999999999999953
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.34 E-value=4e-13 Score=153.43 Aligned_cols=134 Identities=19% Similarity=0.251 Sum_probs=96.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCCcee----eeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------c
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQTT----CLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------G 735 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~~----~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G 735 (962)
+-||..||++ |.++|.|||++..... ....||..|++||.+. + ..|+.++||||+||+++ +
T Consensus 150 ~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~-~-~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 150 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-G-MGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred CCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHh-C-CCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 5789999999 8899999999865221 2337888888888765 4 45999999999999998 5
Q ss_pred CCchhHHHHHHHhcCCCchhhhcccccc------cCCCcccCCccccC------------CCCCHHHHHHHHHhhccCCC
Q psy501 736 TERLKSSYILLHTLPLYTCYTLASNMNF------KFPQFRRVPFTSII------------PHASPDAIHLMESMLAYNPS 797 (962)
Q Consensus 736 ~~~~~ql~~I~~~lG~p~~~~~~~~~~~------~~~~~~~~~l~~~~------------p~~s~~a~DLL~kmL~~dP~ 797 (962)
.+..+.+..++..+|.|..+.+...... ..+......+...+ ...+++++|||.+||++||.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 307 (364)
T cd07875 228 TDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307 (364)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcc
Confidence 6677888889999998876543221100 01111111111111 12356899999999999999
Q ss_pred CCcchhhhhhh
Q psy501 798 KRPTAQQSLSI 808 (962)
Q Consensus 798 kR~sa~~~L~~ 808 (962)
+|||++++|..
T Consensus 308 ~R~t~~e~L~h 318 (364)
T cd07875 308 KRISVDEALQH 318 (364)
T ss_pred cCCCHHHHhcC
Confidence 99999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.6e-13 Score=142.98 Aligned_cols=120 Identities=14% Similarity=0.123 Sum_probs=87.7
Q ss_pred cccccceeeEEE------EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchh
Q psy501 671 GTERLKSSYILL------HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK 740 (962)
Q Consensus 671 ~~~~~~~~~~~~------~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ 740 (962)
.-|.||.-|+|. +.+||+|||+... +...|.|=||+|++||++ |-.+||..+||||+|||+|
T Consensus 183 AHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevl--g~eKydkscdmwSlgVimY------ 254 (400)
T KOG0604|consen 183 AHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVL--GPEKYDKSCDMWSLGVIMY------ 254 (400)
T ss_pred hhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHh--CchhcCCCCCccchhHHHH------
Confidence 457889999988 8999999999877 446677999988888653 5567999999999999997
Q ss_pred HHHHHHHhcCCCchhhhcc---cccc------cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 741 SSYILLHTLPLYTCYTLAS---NMNF------KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 741 ql~~I~~~lG~p~~~~~~~---~~~~------~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
+-++|-||=..... .+.. ..-.++..-| ..+|.+++|||++||..+|.+|.|.++.++
T Consensus 255 -----IlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 255 -----ILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW----SCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred -----HhhcCCCcccccCCccCChhHHhHhhccCccCCChhH----hHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 23456655322111 0000 0011222233 257999999999999999999999999996
|
|
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.1e-12 Score=146.84 Aligned_cols=115 Identities=18% Similarity=0.185 Sum_probs=87.6
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-ceeeeccCCCcccccceeeec-CCCCCCCCCceeeeeEee----------cCC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-QTTCLLAGTERLKSSYILLHT-LPLYTYHVPPIQTTCLLA----------GTE 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-~~~~~~~gt~~~~~~~~lLlg-~~~Y~~~vDIWSlGCIl~----------G~~ 737 (962)
|.||.-||+| |.|||+|||-..+ ..+.+-+|||+||+||+||-- .+.||-+|||||+|+... ..+
T Consensus 150 RDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN 229 (948)
T KOG0577|consen 150 RDIKAGNILLSEPGLVKLADFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 229 (948)
T ss_pred hhccccceEecCCCeeeeccccchhhcCchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch
Confidence 6789999999 9999999998777 667777999999999998755 668999999999997652 122
Q ss_pred chhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 738 RLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 738 ~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
.+..|+.|. +..+..|. -+..|..++.|+.+||+.=|..|||++++|.+.
T Consensus 230 AMSALYHIA--------------------QNesPtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 230 AMSALYHIA--------------------QNESPTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred HHHHHHHHH--------------------hcCCCCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 222222222 11122221 135688999999999999999999999999754
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.6e-13 Score=149.16 Aligned_cols=135 Identities=15% Similarity=0.197 Sum_probs=94.6
Q ss_pred cccceeeEEE-------EEEeeeeeecCCCc--------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee---
Q psy501 673 ERLKSSYILL-------HTLPLYTYHVPPIQ--------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA--- 734 (962)
Q Consensus 673 ~~~~~~~~~~-------~~~~~~~~~~~~~~--------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~--- 734 (962)
+.||++||++ +.++|.|||++..- .....+||+.|++||.+. +...|+.++||||+|||++
T Consensus 132 ~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlG~il~el~ 210 (317)
T cd07867 132 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL-GARHYTKAIDIWAIGCIFAELL 210 (317)
T ss_pred CCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhc-CCCccCcHHHHHhHHHHHHHHH
Confidence 6689999998 57999999987531 122347888888888765 5567999999999999998
Q ss_pred -cCC---------------chhHHHHHHHhcCCCchhhhccccccc-CC---------CcccCCc----cccCCCCCHHH
Q psy501 735 -GTE---------------RLKSSYILLHTLPLYTCYTLASNMNFK-FP---------QFRRVPF----TSIIPHASPDA 784 (962)
Q Consensus 735 -G~~---------------~~~ql~~I~~~lG~p~~~~~~~~~~~~-~~---------~~~~~~l----~~~~p~~s~~a 784 (962)
|.. ..+++..++..+|.|..+.+....... ++ ......+ +..-...+..+
T Consensus 211 tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (317)
T cd07867 211 TSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKV 290 (317)
T ss_pred hCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHH
Confidence 321 246788899999988766654322110 00 0000011 11112356789
Q ss_pred HHHHHHhhccCCCCCcchhhhhhh
Q psy501 785 IHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 785 ~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+|||.+||+.||.+|||++|+|..
T Consensus 291 ~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 291 FLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHHHHHhccCcccccCHHHHhcC
Confidence 999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.6e-13 Score=156.88 Aligned_cols=134 Identities=16% Similarity=0.106 Sum_probs=93.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCC------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cC---
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GT--- 736 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~--- 736 (962)
|-||.+||++ |.++|.|||++.. ......+||+.|++||.+.. ..|+.++||||+|||++ |.
T Consensus 206 rDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 206 RDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred CCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 6789999999 8899999998742 12234589999999887653 45999999999999998 43
Q ss_pred ----------CchhHHHHHHHhcCCCchhhhccc-------c-c----ccCCCcccCCccccCCCCCHHHHHHHHHhhcc
Q psy501 737 ----------ERLKSSYILLHTLPLYTCYTLASN-------M-N----FKFPQFRRVPFTSIIPHASPDAIHLMESMLAY 794 (962)
Q Consensus 737 ----------~~~~ql~~I~~~lG~p~~~~~~~~-------~-~----~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~ 794 (962)
....++..|+..+|+++.+..... . . ..........|... ..++.++.+||.+||++
T Consensus 284 ~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~Li~~mL~~ 362 (391)
T PHA03212 284 FEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNL-YELPIDLEYLICKMLAF 362 (391)
T ss_pred CCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHH-hhhhhhHHHHHHHHhcC
Confidence 234688889998998764421000 0 0 00000011112211 23567899999999999
Q ss_pred CCCCCcchhhhhhhh
Q psy501 795 NPSKRPTAQQSLSIK 809 (962)
Q Consensus 795 dP~kR~sa~~~L~~~ 809 (962)
||.+||||.++|...
T Consensus 363 dP~~Rpta~elL~hp 377 (391)
T PHA03212 363 DAHHRPSAEALLDFA 377 (391)
T ss_pred ChhhCCCHHHHhcCh
Confidence 999999999999743
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.8e-12 Score=159.51 Aligned_cols=119 Identities=19% Similarity=0.213 Sum_probs=79.7
Q ss_pred cccceeeEEEE--------------------EEeeeeeecCCCc----eeeeccCCCcccccceeeecCCCCCCCCCcee
Q psy501 673 ERLKSSYILLH--------------------TLPLYTYHVPPIQ----TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQ 728 (962)
Q Consensus 673 ~~~~~~~~~~~--------------------~~~~~~~~~~~~~----~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWS 728 (962)
+-||++||++. .++|.|||++... .....+||+.|++||+++.....|+.++||||
T Consensus 149 RDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWS 228 (1021)
T PTZ00266 149 RDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWA 228 (1021)
T ss_pred ccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHH
Confidence 46777777773 3899999987652 22345799999999988766667999999999
Q ss_pred eeeEeecCCchhHHHHHHHhcCCCchhh---hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhh
Q psy501 729 TTCLLAGTERLKSSYILLHTLPLYTCYT---LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQS 805 (962)
Q Consensus 729 lGCIl~G~~~~~ql~~I~~~lG~p~~~~---~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~ 805 (962)
||||++ .++ .|.+|-.. ...... .....+..+ ++..++++.|||.+||.+||.+||++.++
T Consensus 229 LG~ILY---------ELL--TGk~PF~~~~~~~qli~-~lk~~p~lp----i~~~S~eL~dLI~~~L~~dPeeRPSa~Ql 292 (1021)
T PTZ00266 229 LGCIIY---------ELC--SGKTPFHKANNFSQLIS-ELKRGPDLP----IKGKSKELNILIKNLLNLSAKERPSALQC 292 (1021)
T ss_pred HHHHHH---------HHH--HCCCCCCcCCcHHHHHH-HHhcCCCCC----cCCCCHHHHHHHHHHhcCChhHCcCHHHH
Confidence 999997 111 12222100 000000 000000011 13568899999999999999999999999
Q ss_pred hh
Q psy501 806 LS 807 (962)
Q Consensus 806 L~ 807 (962)
|.
T Consensus 293 L~ 294 (1021)
T PTZ00266 293 LG 294 (1021)
T ss_pred hc
Confidence 94
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.6e-13 Score=151.27 Aligned_cols=124 Identities=21% Similarity=0.222 Sum_probs=90.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----cee--------------eeccCCCcccccceeeecCCCCCCCCCceeeee
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTT--------------CLLAGTERLKSSYILLHTLPLYTYHVPPIQTTC 731 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~--------------~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGC 731 (962)
|-||.-|||| |-++|.|||-... +.. ++-+||..|++||.|.-+. -++.+|||++||
T Consensus 198 RDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~--~~~~sDiWAlGC 275 (604)
T KOG0592|consen 198 RDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP--AGPSSDLWALGC 275 (604)
T ss_pred ccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC--CCcccchHHHHH
Confidence 7889999999 9999999996433 111 4459999999999877654 578899999999
Q ss_pred Eee----------cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcc
Q psy501 732 LLA----------GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPT 801 (962)
Q Consensus 732 Il~----------G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~s 801 (962)
|+| |.+|.-.+.+|+++ .+.|+ ++.++++.||++|+|+.||+.|++
T Consensus 276 ilyQmlaG~PPFra~NeyliFqkI~~l-------------~y~fp-----------~~fp~~a~dLv~KLLv~dp~~Rlt 331 (604)
T KOG0592|consen 276 ILYQMLAGQPPFRAANEYLIFQKIQAL-------------DYEFP-----------EGFPEDARDLIKKLLVRDPSDRLT 331 (604)
T ss_pred HHHHHhcCCCCCccccHHHHHHHHHHh-------------cccCC-----------CCCCHHHHHHHHHHHccCcccccc
Confidence 997 33444444444332 11121 466799999999999999999999
Q ss_pred hhhhhhhhhhhhhhHHHhhhh
Q psy501 802 AQQSLSIKREVSLSFVLLKKL 822 (962)
Q Consensus 802 a~~~L~~~~e~s~lf~~LK~l 822 (962)
++++-++.-.....+..+++.
T Consensus 332 ~~qIk~HpFF~~Vdw~nlw~~ 352 (604)
T KOG0592|consen 332 SQQIKAHPFFEGVDWENLWQQ 352 (604)
T ss_pred HHHHhhCcccccCChhhhhhc
Confidence 999876655444444444443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.32 E-value=7.5e-12 Score=131.57 Aligned_cols=124 Identities=15% Similarity=0.230 Sum_probs=95.0
Q ss_pred cccEEEEEecCCceEEEEeccch----------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCC-HHH
Q psy501 324 TLPLYTCNLDQDNHILSRHVSSR----------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQ 392 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~~----------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~-Ll~ 392 (962)
.+.||.+.......+++...... ....+.+|++++..+.|++|.....++.+....++||||++|. +.+
T Consensus 9 ~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~ 88 (211)
T PRK14879 9 EAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKD 88 (211)
T ss_pred eEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHH
Confidence 44577776644444444322211 1235788999999999999888777777777889999999874 554
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccccc
Q psy501 393 LIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE 453 (962)
Q Consensus 393 ~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~ 453 (962)
.+.. .. . ....++.+++.+|.++|+.+++|+|++|+||+++ .+.++|+|||.+..
T Consensus 89 ~~~~-~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 89 LINS-NG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred HHHh-cc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 4433 21 2 7889999999999999999999999999999999 78899999999865
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.2e-13 Score=142.53 Aligned_cols=105 Identities=22% Similarity=0.200 Sum_probs=80.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLH 747 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I~~ 747 (962)
|-||.-||++ |-+|+.|||++.. +.++|+||||.|++||+|.. +.|+.+||-||+|+++| . .
T Consensus 168 RDLKPENiLlD~~G~iKitDFGFAK~v~~rT~TlCGTPeYLAPEii~s--k~ynkavDWWalGVLIY---------E--M 234 (355)
T KOG0616|consen 168 RDLKPENLLLDQNGHIKITDFGFAKRVSGRTWTLCGTPEYLAPEIIQS--KGYNKAVDWWALGVLIY---------E--M 234 (355)
T ss_pred ccCChHHeeeccCCcEEEEeccceEEecCcEEEecCCccccChHHhhc--CCCCcchhHHHHHHHHH---------H--H
Confidence 6789999999 9999999999877 88999999999999999986 56999999999999997 1 1
Q ss_pred hcCCCchhhhcc--------cccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcc
Q psy501 748 TLPLYTCYTLAS--------NMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPT 801 (962)
Q Consensus 748 ~lG~p~~~~~~~--------~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~s 801 (962)
+.|-||=..... ....+|| +..+++++|||++||+.|-.+|..
T Consensus 235 laG~pPF~~~~~~~iY~KI~~~~v~fP-----------~~fs~~~kdLl~~LL~vD~t~R~g 285 (355)
T KOG0616|consen 235 LAGYPPFYDDNPIQIYEKILEGKVKFP-----------SYFSSDAKDLLKKLLQVDLTKRFG 285 (355)
T ss_pred HcCCCCCcCCChHHHHHHHHhCcccCC-----------cccCHHHHHHHHHHHhhhhHhhhc
Confidence 223332110000 0001122 357999999999999999999953
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=99.31 E-value=8.3e-13 Score=147.64 Aligned_cols=112 Identities=18% Similarity=0.191 Sum_probs=84.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc----------eeeeccCCCcccccceeeecC-CCC-CCCCCceeeeeEee---
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ----------TTCLLAGTERLKSSYILLHTL-PLY-TYHVPPIQTTCLLA--- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~----------~~~~~~gt~~~~~~~~lLlg~-~~Y-~~~vDIWSlGCIl~--- 734 (962)
|-||.+|+|+ |.|||.||||+-.. ....-+|||.++|||.|+.|. ..| +.++||||+||.||
T Consensus 234 RDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCll 313 (576)
T KOG0585|consen 234 RDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLL 313 (576)
T ss_pred cccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhh
Confidence 7899999999 99999999998632 111239999999999999976 333 48999999999987
Q ss_pred -------cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhh
Q psy501 735 -------GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSL 806 (962)
Q Consensus 735 -------G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L 806 (962)
+..+++...+|... ...||.. |.+.++++|||++||+.||.+|++..++-
T Consensus 314 fG~~PF~~~~~~~l~~KIvn~-------------pL~fP~~---------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik 370 (576)
T KOG0585|consen 314 FGQLPFFDDFELELFDKIVND-------------PLEFPEN---------PEINEDLKDLIKRLLEKDPEQRITLPDIK 370 (576)
T ss_pred hccCCcccchHHHHHHHHhcC-------------cccCCCc---------ccccHHHHHHHHHHhhcChhheeehhhhe
Confidence 33444444444321 0112222 46789999999999999999999999976
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.1e-12 Score=145.81 Aligned_cols=126 Identities=20% Similarity=0.193 Sum_probs=87.4
Q ss_pred ccccceeeEEE---EEEeeeeeecCCC--------cee-eeccCCCcccccceeeecCCCCCCCCCceeeeeEee----c
Q psy501 672 TERLKSSYILL---HTLPLYTYHVPPI--------QTT-CLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----G 735 (962)
Q Consensus 672 ~~~~~~~~~~~---~~~~~~~~~~~~~--------~~~-~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G 735 (962)
-|.+|..|||+ |.|+|.|||+.+- ... .+.+||++||+||++.-.-..|+.|+||||+|.... |
T Consensus 149 HRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G 228 (516)
T KOG0582|consen 149 HRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHG 228 (516)
T ss_pred ecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcC
Confidence 37899999999 9999999999764 111 445999999999998766677999999999998865 3
Q ss_pred CC---chhHHHHHHH-hcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 736 TE---RLKSSYILLH-TLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 736 ~~---~~~ql~~I~~-~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
.- .+..+...+. +-|.||.-. ... ++. +.....+..+..++..||+.||+|||||.++|++.
T Consensus 229 ~aPf~k~pPmkvLl~tLqn~pp~~~---t~~--~~~-------d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 229 HAPFSKYPPMKVLLLTLQNDPPTLL---TSG--LDK-------DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred CCCcccCChHHHHHHHhcCCCCCcc---ccc--CCh-------HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 32 2222222222 223332110 000 000 00123566899999999999999999999999754
|
|
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.1e-12 Score=160.68 Aligned_cols=118 Identities=18% Similarity=0.186 Sum_probs=87.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--cee-------eeccCCCcccccceeeecC-CCCCCCCCceeeeeEee----c
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--QTT-------CLLAGTERLKSSYILLHTL-PLYTYHVPPIQTTCLLA----G 735 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--~~~-------~~~~gt~~~~~~~~lLlg~-~~Y~~~vDIWSlGCIl~----G 735 (962)
|-+|++||+| |.+|++|||.++. ..+ +.+.||+.||+||++.... +.-+-+.||||+|||+. |
T Consensus 1358 RDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tG 1437 (1509)
T KOG4645|consen 1358 RDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATG 1437 (1509)
T ss_pred cCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecC
Confidence 6679999999 9999999998876 222 3349999999999998765 45668999999999986 3
Q ss_pred C---CchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 736 T---ERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 736 ~---~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
+ .++|.=+.|+--+|.- ..|+.| ..+|+++.|||.+||+-||++|.++.|+|+..
T Consensus 1438 krPW~~~dne~aIMy~V~~g-----------h~Pq~P--------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1438 KRPWAELDNEWAIMYHVAAG-----------HKPQIP--------ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred CCchhhccchhHHHhHHhcc-----------CCCCCc--------hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 3 2333333333222110 122221 24899999999999999999999999999754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.29 E-value=6.1e-12 Score=135.49 Aligned_cols=102 Identities=19% Similarity=0.160 Sum_probs=79.3
Q ss_pred HHHHHHHHHHhcCCC--CcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccce-ee
Q psy501 350 VVCFYRKSLKKLSHA--NLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHG-FF 426 (962)
Q Consensus 350 ~~~~Ei~iL~~L~Hp--nIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~g-Iv 426 (962)
.+.+|+++++++.+. .++++++. . ..++||||++|..+.........+....+..++.|++.+|.+||+.| ++
T Consensus 96 ~~~~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~ii 171 (237)
T smart00090 96 WAEKEFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELV 171 (237)
T ss_pred HHHHHHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEE
Confidence 367899999999753 34455543 2 34899999998544333222344667778899999999999999999 99
Q ss_pred eccCCCcccccccccceeeecccccccccC
Q psy501 427 HRDMKPENLLCMGTELVKIADFGLAREIRS 456 (962)
Q Consensus 427 HrDLkp~NILl~~~g~vKL~DFGla~~~~~ 456 (962)
|+||||+||+++ ++.++|+|||.+.....
T Consensus 172 H~Dikp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 172 HGDLSEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred eCCCChhhEEEE-CCCEEEEEChhhhccCC
Confidence 999999999999 78999999999875433
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.29 E-value=9e-13 Score=144.29 Aligned_cols=135 Identities=18% Similarity=0.293 Sum_probs=98.5
Q ss_pred cccceeeEEE---EEEeeeeeecCCCce-----eeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQT-----TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~-----~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
+.||++||++ +.++|.|||++.... .....||..|++||.+ .|...|+.++||||+|||++
T Consensus 123 ~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 123 RDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL-FGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred CCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHH-hCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 5689999999 789999999876411 1123567777777765 46567899999999999987
Q ss_pred -cCCchhHHHHHHHhcCCCchhhhccccc---cc-CCCc-ccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 -GTERLKSSYILLHTLPLYTCYTLASNMN---FK-FPQF-RRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 -G~~~~~ql~~I~~~lG~p~~~~~~~~~~---~~-~~~~-~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.+..+++..|+..+|.+....++.... +. ++.. ....|.+..+.+++++.|||++||..||.+|||++++|..
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 202 PGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 3345678888888888877655433211 10 1111 1234455667889999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.3e-12 Score=145.30 Aligned_cols=120 Identities=21% Similarity=0.216 Sum_probs=87.3
Q ss_pred cccceeeEEE-------EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL-------HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~-------~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
|.||..|+++ +.+++.|||++.. ......|||+.|++||++.. ..|+.++||||+|||+|
T Consensus 159 rDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~--~~y~~~~DiWS~Gvi~y------- 229 (382)
T KOG0032|consen 159 RDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG--RPYGDEVDVWSIGVILY------- 229 (382)
T ss_pred ccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcC--CCCCcccchhHHHHHHH-------
Confidence 6789999998 4699999999876 36777799999999998874 45999999999999997
Q ss_pred HHHHHHhcCCCchhhhcccc-----cccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh-hh
Q psy501 742 SYILLHTLPLYTCYTLASNM-----NFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS-IK 809 (962)
Q Consensus 742 l~~I~~~lG~p~~~~~~~~~-----~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~-~~ 809 (962)
.+ +.|.||-....... ...-..+...+| +.+|..|+||+++||..||.+|+||.++|+ +|
T Consensus 230 --iL--L~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w----~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 230 --IL--LSGVPPFWGETEFEIFLAILRGDFDFTSEPW----DDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred --HH--hhCCCCCcCCChhHHHHHHHcCCCCCCCCCc----cccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 11 22222211100000 000012233344 688999999999999999999999999997 44
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.4e-12 Score=148.23 Aligned_cols=134 Identities=17% Similarity=0.231 Sum_probs=94.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCCce----eeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------c
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQT----TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------G 735 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~----~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G 735 (962)
+-||..||++ |.++|.|||++.... ....+||+.|++||.+. | ..|+.++||||+|||++ |
T Consensus 143 rDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~-~-~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 143 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-G-MGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred CCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHc-C-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 5789999999 889999999986521 12337888998888764 4 45999999999999998 5
Q ss_pred CCchhHHHHHHHhcCCCchhhhcccccc------cCCCcccCCc-----------c-ccCCCCCHHHHHHHHHhhccCCC
Q psy501 736 TERLKSSYILLHTLPLYTCYTLASNMNF------KFPQFRRVPF-----------T-SIIPHASPDAIHLMESMLAYNPS 797 (962)
Q Consensus 736 ~~~~~ql~~I~~~lG~p~~~~~~~~~~~------~~~~~~~~~l-----------~-~~~p~~s~~a~DLL~kmL~~dP~ 797 (962)
.+..+++..++..+|.|..+.+...... ..+......+ . ...+..+.+++|||.+||++||+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 300 (355)
T cd07874 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300 (355)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCch
Confidence 5667788888888888765543221100 0000000000 0 01123466889999999999999
Q ss_pred CCcchhhhhhh
Q psy501 798 KRPTAQQSLSI 808 (962)
Q Consensus 798 kR~sa~~~L~~ 808 (962)
+|||+.++|+.
T Consensus 301 ~Rps~~ell~h 311 (355)
T cd07874 301 KRISVDEALQH 311 (355)
T ss_pred hcCCHHHHhcC
Confidence 99999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.6e-12 Score=144.13 Aligned_cols=135 Identities=19% Similarity=0.278 Sum_probs=98.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-----eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-----TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-----~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
+-||++||++ +.++|.|||++... ......+|+.|++||.+. +...|+.++||||+||+++
T Consensus 128 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~~Dv~slG~~l~el~tg~~~f~ 206 (301)
T cd07873 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILL-GSTDYSTQIDMWGVGCIFYEMSTGRPLFP 206 (301)
T ss_pred CCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHh-CCCCCccHHHHHHHHHHHHHHHhCCCCCC
Confidence 4689999999 78999999987542 112235677787777655 5567899999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhccccc------ccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMN------FKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~------~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.+..+++..+...++.|....++.... +.++......+....+.+++++.|||.+||++||.+|||++++|..
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 207 GSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred CCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 3455678888888999887665443221 1122222222233335789999999999999999999999999973
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.6e-11 Score=127.91 Aligned_cols=98 Identities=15% Similarity=0.229 Sum_probs=78.8
Q ss_pred HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeec
Q psy501 349 MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHR 428 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHr 428 (962)
..+.+|++++..+.|+++.....++......++||||++|..+..+...... .++.+++.+|.+||+.|++|+
T Consensus 42 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~ 114 (199)
T TIGR03724 42 ERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHG 114 (199)
T ss_pred HHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecC
Confidence 4577899999999988766655555666677899999986544333322211 789999999999999999999
Q ss_pred cCCCcccccccccceeeecccccccc
Q psy501 429 DMKPENLLCMGTELVKIADFGLAREI 454 (962)
Q Consensus 429 DLkp~NILl~~~g~vKL~DFGla~~~ 454 (962)
|++|+||+++ ++.++++|||.+...
T Consensus 115 Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 115 DLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999999999 789999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.2e-12 Score=139.77 Aligned_cols=135 Identities=24% Similarity=0.414 Sum_probs=103.6
Q ss_pred cccceeeEEE---EEEeeeeeecCCCce------eeeccCCCcccccceeeecCCCCCCCCCceeeeeEee---------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQT------TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA--------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~------~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~--------- 734 (962)
+.||..||++ +.++|.|||+..... .....||.+|++||.+. +.+.++.++||||+||+++
T Consensus 123 ~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~~l~~l~tg~~~~ 201 (286)
T cd07832 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY-GARKYDPGVDLWAVGCIFAELLNGSPLF 201 (286)
T ss_pred CCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeee-ccccCCchhHHHHHHHHHHHHHcCCcCc
Confidence 4689999999 789999999876521 22347888888888765 5566899999999999998
Q ss_pred -cCCchhHHHHHHHhcCCCchhhhccccc------ccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 735 -GTERLKSSYILLHTLPLYTCYTLASNMN------FKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 735 -G~~~~~ql~~I~~~lG~p~~~~~~~~~~------~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
+.++..++..+...+|.|....++.... ..++.....++.+.++..+.++.|||++||..||.+||+++++|.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 202 PGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 4566788888899999887655443222 123333445566677888899999999999999999999999987
Q ss_pred h
Q psy501 808 I 808 (962)
Q Consensus 808 ~ 808 (962)
.
T Consensus 282 h 282 (286)
T cd07832 282 H 282 (286)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.3e-11 Score=146.43 Aligned_cols=124 Identities=15% Similarity=0.176 Sum_probs=94.8
Q ss_pred cCCcccEEEEEecCCceEEEEeccc----------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-C
Q psy501 321 LPHTLPLYTCNLDQDNHILSRHVSS----------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-N 389 (962)
Q Consensus 321 ~~~~~~Vy~~~~~~~~kvv~~k~~~----------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~ 389 (962)
.++.+.||++.......+++++... .....+.+|+++++.++|++++..+.++.++...++||||++| +
T Consensus 343 ~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~ 422 (535)
T PRK09605 343 KGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKD 422 (535)
T ss_pred cCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCc
Confidence 3344457776655444443332211 1124588999999999999999888887777778999999986 4
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccc
Q psy501 390 LYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI 454 (962)
Q Consensus 390 Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~ 454 (962)
|.+.+. ....++.+++.+|.+||+.|++||||||+||++ .++.++|+|||+++..
T Consensus 423 L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 423 LKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred HHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 544443 356789999999999999999999999999999 6788999999999753
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.1e-12 Score=146.26 Aligned_cols=112 Identities=24% Similarity=0.273 Sum_probs=81.9
Q ss_pred cccceeeEEE----EEEeeeeeecCCCc-----eeeeccCCCcccccceeeecCCCCC-CCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL----HTLPLYTYHVPPIQ-----TTCLLAGTERLKSSYILLHTLPLYT-YHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~----~~~~~~~~~~~~~~-----~~~~~~gt~~~~~~~~lLlg~~~Y~-~~vDIWSlGCIl~G~~~~~ql 742 (962)
|-||.-||++ +.+||.|||++... ...+.|||++|++||++..... |+ .++||||||+|+|
T Consensus 144 RDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~-Y~g~~aDvWS~GViLy-------- 214 (370)
T KOG0583|consen 144 RDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGT-YSGKAADVWSLGVILY-------- 214 (370)
T ss_pred CCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCC-cCCchhhhhhhHHHHH--------
Confidence 6679999999 68999999999853 4555699999999999886433 65 8999999999997
Q ss_pred HHHHHhcCCCchhh--hcc------cccccCCCcccCCccccCCCC-CHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYT--LAS------NMNFKFPQFRRVPFTSIIPHA-SPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~--~~~------~~~~~~~~~~~~~l~~~~p~~-s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
..+.|..|=.+ .+. ...+.+|. .+ |+++.+|+.+||+.||.+|+++.+++.
T Consensus 215 ---~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~-----------~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 215 ---VLLCGRLPFDDSNVPNLYRKIRKGEFKIPS-----------YLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ---HHHhCCCCCCCccHHHHHHHHhcCCccCCC-----------CcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 11222211110 000 00111111 23 999999999999999999999999996
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.4e-12 Score=140.80 Aligned_cols=135 Identities=21% Similarity=0.329 Sum_probs=96.9
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-----eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-----TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-----~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
+.||++||++ |.++|.|||++... ......||+.|++||.+. +...|+.++||||+||+++
T Consensus 125 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~il~~l~tg~~~~~ 203 (285)
T cd07861 125 RDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLL-GSPRYSTPVDIWSIGTIFAEMATKKPLFH 203 (285)
T ss_pred cCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhc-CCCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 4689999999 88999999986531 111225678888887764 4456899999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcccccc-----cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNF-----KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~-----~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+..+.+.+..++..+|.+....++..... .++.+....+....+.+++++.|||++||..||.+|||+.++|+.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 204 GDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred CCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 44566777778888887765544332211 122222222333345689999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.23 E-value=4.9e-11 Score=128.72 Aligned_cols=99 Identities=19% Similarity=0.181 Sum_probs=78.8
Q ss_pred HHHHHHHHHHHhcCCCCc--ccEEEEEEeC-C---EEEEEEecCCC--CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhc
Q psy501 349 MVVCFYRKSLKKLSHANL--VKLKEVIREN-D---TLYFVFEYMKE--NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFM 420 (962)
Q Consensus 349 ~~~~~Ei~iL~~L~HpnI--v~l~~~~~~~-~---~~~LV~Ey~~g--~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yL 420 (962)
..+.+|++++.+|.|++| +..+++.... . ..++|||+++| ++.+.+.. ..+++.. +.+++.+|.+|
T Consensus 85 ~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~l 158 (239)
T PRK01723 85 TRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARF 158 (239)
T ss_pred hHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHH
Confidence 468899999999998774 6777765432 2 23599999996 55555433 3455543 56899999999
Q ss_pred ccceeeeccCCCcccccccccceeeeccccccc
Q psy501 421 HRHGFFHRDMKPENLLCMGTELVKIADFGLARE 453 (962)
Q Consensus 421 H~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~ 453 (962)
|+.||+|+||||+|||++.++.++|+|||.+..
T Consensus 159 H~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 159 HDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 999999999999999999888999999999865
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 962 | ||||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-24 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-24 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-24 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-24 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-24 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-24 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-24 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-24 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-24 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-24 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-24 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-24 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-24 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-24 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-24 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-24 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-24 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-24 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-24 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-24 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-24 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-24 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-23 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-23 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-23 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-23 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-23 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-23 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-23 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-23 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-23 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-23 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-23 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-23 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-23 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-23 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-23 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-23 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-23 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-22 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-22 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-21 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-21 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-21 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-21 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-21 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-20 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-20 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-20 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-20 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-19 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-19 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-19 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-19 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-19 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-19 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-19 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-19 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-19 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-18 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-18 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-18 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-18 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-18 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-18 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-18 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-18 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-18 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-18 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-18 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-18 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-18 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-18 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-18 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-18 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-18 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-18 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-18 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-18 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-18 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-18 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-18 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-18 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-17 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-17 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-17 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-17 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-17 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-17 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-17 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-17 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-17 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-17 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-17 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-17 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-17 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-17 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-17 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-17 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-17 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-17 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-17 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-17 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-17 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-17 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-17 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-17 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-17 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-17 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-17 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-17 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-17 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-17 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-17 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-17 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-17 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-17 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-17 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-17 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-17 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-17 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-17 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-17 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-17 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-17 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-17 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-17 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-17 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-17 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-17 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-17 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-17 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-17 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-17 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-17 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-17 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-17 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-17 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-17 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-17 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-17 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-17 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-17 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-17 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-16 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-16 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-16 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-16 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-16 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-16 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-16 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-16 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-16 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-16 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-16 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-16 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-16 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-16 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-16 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-15 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-15 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-15 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-15 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-13 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-11 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-11 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-11 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-09 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 7e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-09 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 8e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 8e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-08 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-08 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 8e-08 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 8e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-08 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 9e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-07 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-07 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-07 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-07 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-07 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-07 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-07 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-07 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-07 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-07 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-07 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-07 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-07 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-07 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 7e-07 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 7e-07 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 7e-07 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 7e-07 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 7e-07 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 7e-07 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 7e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-07 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 7e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-07 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 7e-07 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-07 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 8e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-06 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-06 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-05 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-05 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-05 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-05 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-05 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-05 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-05 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-05 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-05 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-05 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-05 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-05 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-05 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-05 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-05 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-05 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-05 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-05 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-05 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-05 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-05 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-05 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-05 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-04 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-04 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-04 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-04 |
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 5e-63
Identities = 52/131 (39%), Positives = 78/131 (59%), Gaps = 2/131 (1%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
+ LK+L H NLV L EV R L+ VFEY + + + +PE +++++ +Q LQ
Sbjct: 54 RMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQ 113
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAPEV 473
+ F H+H HRD+KPEN+L ++K+ DFG AR + Y D V+TRWYR+PE+
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173
Query: 474 LLHSTAYSAPI 484
L+ T Y P+
Sbjct: 174 LVGDTQYGPPV 184
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 5e-10
Identities = 13/59 (22%), Positives = 26/59 (44%), Gaps = 1/59 (1%)
Query: 748 TLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSL 806
+++ S + P+ P P+ S A+ L++ L +P++R T +Q L
Sbjct: 226 HQQVFSTNQYFSGVKIPDPE-DMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 13/37 (35%), Positives = 19/37 (51%), Gaps = 1/37 (2%)
Query: 41 IKMKRKYYSWEEAMNLREVKSLKKLSHANLVKLKEVI 77
+ + + LRE++ LK+L H NLV L EV
Sbjct: 36 FLES-EDDPVIKKIALREIRMLKQLKHPNLVNLLEVF 71
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 9e-60
Identities = 49/131 (37%), Positives = 75/131 (57%), Gaps = 2/131 (1%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
K LK+L H NLV L EV ++ Y VFE++ + + L +++ ++Q++
Sbjct: 76 KLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIIN 135
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAPEV 473
G+ F H H HRD+KPEN+L + +VK+ DFG AR + + Y D V+TRWYRAPE+
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195
Query: 474 LLHSTAYSAPI 484
L+ Y +
Sbjct: 196 LVGDVKYGKAV 206
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 13/53 (24%), Positives = 19/53 (35%), Gaps = 1/53 (1%)
Query: 755 YTLASNMNFKFPQFR-RVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSL 806
+ P+ + R P P S I L + L +P KRP + L
Sbjct: 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 2e-04
Identities = 13/37 (35%), Positives = 18/37 (48%), Gaps = 1/37 (2%)
Query: 41 IKMKRKYYSWEEAMNLREVKSLKKLSHANLVKLKEVI 77
+ + +RE+K LK+L H NLV L EV
Sbjct: 58 FLES-DDDKMVKKIAMREIKLLKQLRHENLVNLLEVC 93
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 3e-49
Identities = 48/140 (34%), Positives = 79/140 (56%), Gaps = 11/140 (7%)
Query: 356 KSLKKLSHANLVKLKEVIRENDT------LYFVFEYMKENLYQLIRDRDK---FLPESII 406
+ ++ + H N+V LK N L V EY+ E +Y+ R K +P +I
Sbjct: 84 QIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLI 143
Query: 407 RNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG-TELVKIADFGLAREIRS-RPYTDYVS 464
+ MYQ+L+ LA++H G HRD+KP+NLL + ++K+ DFG A+ + + P Y+
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC 203
Query: 465 TRWYRAPEVLLHSTAYSAPI 484
+R+YRAPE++ +T Y+ I
Sbjct: 204 SRYYRAPELIFGATNYTTNI 223
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 22/52 (42%), Positives = 29/52 (55%), Gaps = 1/52 (1%)
Query: 757 LASNMNFKFPQFRRVPFTSII-PHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
+ M KFPQ R PF+ + P PDAI L+ +L Y PS R TA ++L
Sbjct: 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 6e-49
Identities = 55/131 (41%), Positives = 78/131 (59%), Gaps = 2/131 (1%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
LK+L H+N+VKL +VI L VFE++ ++L +L+ + L ++ + Q+L
Sbjct: 52 SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE--IRSRPYTDYVSTRWYRAPEV 473
G+A+ H HRD+KP+NLL +KIADFGLAR I R YT + T WYRAP+V
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
Query: 474 LLHSTAYSAPI 484
L+ S YS I
Sbjct: 172 LMGSKKYSTTI 182
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 59.4 bits (145), Expect = 1e-09
Identities = 16/60 (26%), Positives = 27/60 (45%), Gaps = 9/60 (15%)
Query: 748 TLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
LP Y + F + +P+ S + I L+ ML +P++R TA+Q+L
Sbjct: 230 ELPKY---------DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-48
Identities = 55/131 (41%), Positives = 80/131 (61%), Gaps = 2/131 (1%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
LK L HAN+V L ++I +L VFEY+ ++L Q + D + ++ ++Q+L+
Sbjct: 52 SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLR 111
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE--IRSRPYTDYVSTRWYRAPEV 473
GLA+ HR HRD+KP+NLL +K+ADFGLAR I ++ Y + V T WYR P++
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDI 171
Query: 474 LLHSTAYSAPI 484
LL ST YS I
Sbjct: 172 LLGSTDYSTQI 182
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 6e-10
Identities = 9/46 (19%), Positives = 20/46 (43%)
Query: 762 NFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
+ +P++R S P D L+ +L + R +A+ ++
Sbjct: 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 2e-48
Identities = 57/131 (43%), Positives = 82/131 (62%), Gaps = 2/131 (1%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
LK+L H N+V L +VI L VFE+M+++L +++ + L +S I+ +YQ+L+
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE--IRSRPYTDYVSTRWYRAPEV 473
G+A H+H HRD+KP+NLL +K+ADFGLAR I R YT V T WYRAP+V
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190
Query: 474 LLHSTAYSAPI 484
L+ S YS +
Sbjct: 191 LMGSKKYSTSV 201
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 3e-10
Identities = 18/60 (30%), Positives = 33/60 (55%), Gaps = 8/60 (13%)
Query: 748 TLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
LPL+ F F + P++SIIP + I L+ +ML ++P+KR +A+ +++
Sbjct: 249 ELPLWK--------QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-48
Identities = 50/131 (38%), Positives = 76/131 (58%), Gaps = 2/131 (1%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
LK+L H N+V+L +V+ + L VFE+ ++L + + L I+++ ++Q+L+
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE--IRSRPYTDYVSTRWYRAPEV 473
GL F H HRD+KP+NLL +K+A+FGLAR I R Y+ V T WYR P+V
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 474 LLHSTAYSAPI 484
L + YS I
Sbjct: 173 LFGAKLYSTSI 183
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 54.4 bits (132), Expect = 6e-08
Identities = 9/45 (20%), Positives = 24/45 (53%), Gaps = 1/45 (2%)
Query: 764 KFPQF-RRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
+P + +++P + L++++L NP +R +A+++L
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-48
Identities = 46/140 (32%), Positives = 81/140 (57%), Gaps = 11/140 (7%)
Query: 356 KSLKKLSHANLVKLKEVIRENDT------LYFVFEYMKENLYQLIRDRDK---FLPESII 406
+ ++KL H N+V+L+ + L V +Y+ E +Y++ R + LP +
Sbjct: 99 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 158
Query: 407 RNMMYQVLQGLAFMHRHGFFHRDMKPENLLC-MGTELVKIADFGLAREIRS-RPYTDYVS 464
+ MYQ+ + LA++H G HRD+KP+NLL T ++K+ DFG A+++ P Y+
Sbjct: 159 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 465 TRWYRAPEVLLHSTAYSAPI 484
+R+YRAPE++ +T Y++ I
Sbjct: 219 SRYYRAPELIFGATDYTSSI 238
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 17/51 (33%), Positives = 27/51 (52%), Gaps = 1/51 (1%)
Query: 758 ASNMNFKFPQFRRVPFTSII-PHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
+ FKFPQ + P+T + P P+AI L +L Y P+ R T ++ +
Sbjct: 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 9e-48
Identities = 52/131 (39%), Positives = 77/131 (58%), Gaps = 2/131 (1%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
K L++LSH N++ L + + VF++M+ +L +I+D L S I+ M LQ
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE--IRSRPYTDYVSTRWYRAPEV 473
GL ++H+H HRD+KP NLL ++K+ADFGLA+ +R YT V TRWYRAPE+
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183
Query: 474 LLHSTAYSAPI 484
L + Y +
Sbjct: 184 LFGARMYGVGV 194
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 14/42 (33%), Positives = 21/42 (50%)
Query: 765 FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSL 806
F F +P I A D + L++ + +NP R TA Q+L
Sbjct: 249 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 8e-10
Identities = 17/60 (28%), Positives = 31/60 (51%), Gaps = 9/60 (15%)
Query: 748 TLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
++P Y FP++ R F+ ++P D L+ ML Y+P+KR +A+ +L+
Sbjct: 233 SMPDY---------KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 283
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-46
Identities = 53/136 (38%), Positives = 79/136 (58%), Gaps = 7/136 (5%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDR-----DKFLPESIIRNMM 410
+K+L H N+V+L +VI + L VFE+M +L + + R + L ++++
Sbjct: 55 SLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE--IRSRPYTDYVSTRWY 468
+Q+LQGLAF H + HRD+KP+NLL +K+ DFGLAR I ++ V T WY
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWY 174
Query: 469 RAPEVLLHSTAYSAPI 484
RAP+VL+ S YS I
Sbjct: 175 RAPDVLMGSRTYSTSI 190
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 12/65 (18%), Positives = 21/65 (32%), Gaps = 14/65 (21%)
Query: 748 TLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHA-----SPDAIHLMESMLAYNPSKRPTA 802
LP Y N Q ++ + + + +L NP R +A
Sbjct: 238 KLPKY---------NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288
Query: 803 QQSLS 807
+Q+L
Sbjct: 289 KQALH 293
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 6e-46
Identities = 53/136 (38%), Positives = 81/136 (59%), Gaps = 8/136 (5%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
LK+L H N+++LK VI N L+ +FEY + +L + + D++ + +I++ +YQ++
Sbjct: 85 SLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYM-DKNPDVSMRVIKSFLYQLIN 143
Query: 416 GLAFMHRHGFFHRDMKPENLL-----CMGTELVKIADFGLARE--IRSRPYTDYVSTRWY 468
G+ F H HRD+KP+NLL T ++KI DFGLAR I R +T + T WY
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWY 203
Query: 469 RAPEVLLHSTAYSAPI 484
R PE+LL S YS +
Sbjct: 204 RPPEILLGSRHYSTSV 219
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 3e-07
Identities = 12/44 (27%), Positives = 23/44 (52%), Gaps = 1/44 (2%)
Query: 765 FPQFRRVPFTSIIPHA-SPDAIHLMESMLAYNPSKRPTAQQSLS 807
FP+FR ++ + + L+ +ML +P KR +A+ +L
Sbjct: 275 FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-43
Identities = 54/136 (39%), Positives = 77/136 (56%), Gaps = 8/136 (5%)
Query: 356 KSLKKLSHANLVKLKEVIRENDT-----LYFVFEYMKENLYQLIRDR-DKFLPESIIRNM 409
+ L+ H N+V+L +V + T + VFE++ ++L + LP I+++
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 410 MYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS-RPYTDYVSTRWY 468
M Q L+GL F+H + HRD+KPEN+L VK+ADFGLAR T V T WY
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY 185
Query: 469 RAPEVLLHSTAYSAPI 484
RAPEVLL ST Y+ P+
Sbjct: 186 RAPEVLLQST-YATPV 200
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 14/46 (30%), Positives = 21/46 (45%)
Query: 762 NFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
FP P S++P L+ ML +NP KR +A ++L
Sbjct: 251 RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 8e-43
Identities = 52/136 (38%), Positives = 79/136 (58%), Gaps = 8/136 (5%)
Query: 356 KSLKKLSHANLVKLKEVI-----RENDTLYFVFEYMKENLYQLIRD-RDKFLPESIIRNM 409
+ L+ H N+V+L +V L VFE++ ++L + + +P I++M
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125
Query: 410 MYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS-RPYTDYVSTRWY 468
M+Q+L+GL F+H H HRD+KP+N+L + +K+ADFGLAR T V T WY
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 185
Query: 469 RAPEVLLHSTAYSAPI 484
RAPEVLL S+ Y+ P+
Sbjct: 186 RAPEVLLQSS-YATPV 200
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-09
Identities = 11/46 (23%), Positives = 17/46 (36%)
Query: 762 NFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
F P + L+ L +NP+KR +A +LS
Sbjct: 251 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-42
Identities = 51/143 (35%), Positives = 75/143 (52%), Gaps = 14/143 (9%)
Query: 356 KSLKKLSHANLVKLKEVIREN--------DTLYFVFEYMKENLYQLIRDRDKFLPESIIR 407
K L+ L H N+V L E+ R ++Y VF++ + +L L+ + S I+
Sbjct: 68 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 127
Query: 408 NMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI------RSRPYTD 461
+M +L GL ++HR+ HRDMK N+L ++K+ADFGLAR + YT+
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187
Query: 462 YVSTRWYRAPEVLLHSTAYSAPI 484
V T WYR PE+LL Y PI
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPI 210
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 9/60 (15%), Positives = 23/60 (38%), Gaps = 10/60 (16%)
Query: 749 LPLYTCYTLASNMNFKFPQFRRVPFTSIIPH--ASPDAIHLMESMLAYNPSKRPTAQQSL 806
LY + + ++ + P A+ L++ +L +P++R + +L
Sbjct: 259 YELYE--------KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-41
Identities = 49/146 (33%), Positives = 83/146 (56%), Gaps = 19/146 (13%)
Query: 358 LKKLSHANLVKLKEVIRE--NDTLYFVFEYMKENLYQLIR--------DRDKFLPESIIR 407
L++L H N++ L++V + ++ +F+Y + +L+ +I+ + LP +++
Sbjct: 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 408 NMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE----LVKIADFGLAREIRS--RPYTD 461
+++YQ+L G+ ++H + HRD+KP N+L MG VKIAD G AR S +P D
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191
Query: 462 Y---VSTRWYRAPEVLLHSTAYSAPI 484
V T WYRAPE+LL + Y+ I
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAI 217
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 11/62 (17%), Positives = 23/62 (37%)
Query: 746 LHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQS 805
+ +P ++ N A HL++ +L +P KR T++Q+
Sbjct: 272 IKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331
Query: 806 LS 807
+
Sbjct: 332 MQ 333
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-38
Identities = 45/139 (32%), Positives = 70/139 (50%), Gaps = 8/139 (5%)
Query: 354 YR--KSLKKLSHANLVKLKEVIR-----ENDTLYFVFEYMKENLYQLIRDRDKFLPESII 406
R + L H N++ L+++ LY V E M+ +L Q+I D+ + I
Sbjct: 77 LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHI 136
Query: 407 RNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY-TDYVST 465
+ MY +L GL +H G HRD+ P N+L + I DF LARE + T YV+
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH 196
Query: 466 RWYRAPEVLLHSTAYSAPI 484
RWYRAPE+++ ++ +
Sbjct: 197 RWYRAPELVMQFKGFTKLV 215
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 13/43 (30%), Positives = 24/43 (55%)
Query: 765 FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
+T+++P A P A+ L+ ML +NP +R + +Q+L
Sbjct: 274 LSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-38
Identities = 38/143 (26%), Positives = 72/143 (50%), Gaps = 14/143 (9%)
Query: 356 KSLKKLSHANLVKLKEVIRENDT-------LYFVFEYMKENLYQLIRDRDKF---LPESI 405
+ L L H N+V+L+ L V EY+ + L++ R+ + P +
Sbjct: 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPIL 130
Query: 406 IRNMMYQVLQGLAFMHR--HGFFHRDMKPENLLC-MGTELVKIADFGLAREI-RSRPYTD 461
I+ ++Q+++ + +H HRD+KP N+L +K+ DFG A+++ S P
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 462 YVSTRWYRAPEVLLHSTAYSAPI 484
Y+ +R+YRAPE++ + Y+ +
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAV 213
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 9/52 (17%), Positives = 22/52 (42%), Gaps = 4/52 (7%)
Query: 760 NMNFKFPQFRRVP----FTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
+ + + +P F+ + +A L+ ++L Y P +R ++L
Sbjct: 263 HTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 53/143 (37%), Positives = 81/143 (56%), Gaps = 14/143 (9%)
Query: 354 YR--KSLKKLSHANLVKLKEVIR-----ENDTLYFVFEYMKENLYQLIRDRDKFLPESII 406
R K L + H N++ + ++IR + +Y V + M+ +LY+L++ + L I
Sbjct: 73 LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHI 130
Query: 407 RNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY-----TD 461
+YQ+L+GL ++H HRD+KP NLL T +KI DFGLAR T+
Sbjct: 131 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 462 YVSTRWYRAPEVLLHSTAYSAPI 484
YV+TRWYRAPE++L+S Y+ I
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSI 213
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 17/50 (34%), Positives = 28/50 (56%)
Query: 758 ASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
A N P +VP+ + P+A A+ L++ ML +NP KR +Q+L+
Sbjct: 264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-35
Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 35/161 (21%)
Query: 358 LKKLSHANLVKLKEVIR-----ENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQ 412
L +L+H ++VK+ +++ + D LY V E + +L R L E I+ ++Y
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVY-LTELHIKTLLYN 164
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI------------------ 454
+L G+ ++H G HRD+KP N L VK+ DFGLAR +
Sbjct: 165 LLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 455 -----------RSRPYTDYVSTRWYRAPEVLLHSTAYSAPI 484
R T +V TRWYRAPE++L Y+ I
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI 265
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 18/50 (36%), Positives = 26/50 (52%)
Query: 758 ASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
A FP+ P +S DAIHL++ ML +NP+KR T + L+
Sbjct: 347 AKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-35
Identities = 48/150 (32%), Positives = 75/150 (50%), Gaps = 21/150 (14%)
Query: 354 YR--KSLKKLSHANLVKLKEVIR-----ENDTLYFVFEYMKENLYQLIRDRDKFLPESII 406
R K LK H N++ + + R + +Y + E M+ +L+++I + L + I
Sbjct: 57 LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM--LSDDHI 114
Query: 407 RNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY------- 459
+ +YQ L+ + +H HRD+KP NLL +K+ DFGLAR I
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 460 -----TDYVSTRWYRAPEVLLHSTAYSAPI 484
++V+TRWYRAPEV+L S YS +
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAM 204
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 7e-11
Identities = 15/50 (30%), Positives = 26/50 (52%)
Query: 758 ASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
A P + P + P +P I L++ ML ++P+KR TA+++L
Sbjct: 256 AREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-35
Identities = 50/139 (35%), Positives = 73/139 (52%), Gaps = 12/139 (8%)
Query: 354 YR--KSLKKLSHANLVKLKEVIR------ENDTLYFVFEYMKENLYQLIRDRDKFLPESI 405
YR LK + H N++ L +V Y V +M+ +L +++ + E
Sbjct: 71 YRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEEK 127
Query: 406 IRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST 465
I+ ++YQ+L+GL ++H G HRD+KP NL +KI DFGLAR T YV T
Sbjct: 128 IQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA-DAEMTGYVVT 186
Query: 466 RWYRAPEVLLHSTAYSAPI 484
RWYRAPEV+L Y+ +
Sbjct: 187 RWYRAPEVILSWMHYNQTV 205
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 21/50 (42%), Positives = 27/50 (54%)
Query: 758 ASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
A + PQ R FT + P ASP A L+E ML + KR TA Q+L+
Sbjct: 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-35
Identities = 48/139 (34%), Positives = 78/139 (56%), Gaps = 11/139 (7%)
Query: 354 YR--KSLKKLSHANLVKLKEVIR------ENDTLYFVFEYMKENLYQLIRDRDKFLPESI 405
YR + LK + H N++ L +V E + +Y V M +L +++ + L +
Sbjct: 76 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDH 133
Query: 406 IRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST 465
++ ++YQ+L+GL ++H HRD+KP NL +KI DFGLAR + T YV+T
Sbjct: 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT-ADEMTGYVAT 192
Query: 466 RWYRAPEVLLHSTAYSAPI 484
RWYRAPE++L+ Y+ +
Sbjct: 193 RWYRAPEIMLNWMHYNQTV 211
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 17/50 (34%), Positives = 27/50 (54%)
Query: 758 ASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
A N Q ++ F ++ A+P A+ L+E ML + KR TA Q+L+
Sbjct: 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 9e-35
Identities = 54/139 (38%), Positives = 80/139 (57%), Gaps = 11/139 (7%)
Query: 354 YR--KSLKKLSHANLVKLKEVIRENDT------LYFVFEYMKENLYQLIRDRDKFLPESI 405
YR + LK + H N++ L +V ++T Y V +M +L +L++ L E
Sbjct: 72 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDR 129
Query: 406 IRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST 465
I+ ++YQ+L+GL ++H G HRD+KP NL +KI DFGLAR+ S T YV T
Sbjct: 130 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-MTGYVVT 188
Query: 466 RWYRAPEVLLHSTAYSAPI 484
RWYRAPEV+L+ Y+ +
Sbjct: 189 RWYRAPEVILNWMRYTQTV 207
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 18/50 (36%), Positives = 30/50 (60%)
Query: 758 ASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
A N P+ + F SI+ +ASP A++L+E ML + +R TA ++L+
Sbjct: 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 32/157 (20%)
Query: 354 YR--KSLKKLSHANLVKLKEVIR--------------ENDTLYFVFEYMKENLYQLIRDR 397
R K +++L H N+VK+ E++ E +++Y V EYM+ +L ++
Sbjct: 56 LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG 115
Query: 398 DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLL-----CMGTELVKIADFGLAR 452
L E R MYQ+L+GL ++H HRD+KP NL + +KI DFGLAR
Sbjct: 116 P--LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV----LKIGDFGLAR 169
Query: 453 EIRSRPY-----TDYVSTRWYRAPEVLLHSTAYSAPI 484
+ ++ + T+WYR+P +LL Y+ I
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAI 206
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 13/42 (30%), Positives = 24/42 (57%)
Query: 766 PQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
P T ++P S +A+ +E +L ++P R TA+++LS
Sbjct: 264 MTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-34
Identities = 43/170 (25%), Positives = 78/170 (45%), Gaps = 43/170 (25%)
Query: 358 LKKLSHANLVKLKEVIRENDT--------------------------------------L 379
+K L H N++KL + L
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 380 YFVFEYMKENLYQLIRDRDKF---LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLL 436
+ EY+ + L+++++ + +P ++I +YQ+ + + F+H G HRD+KP+NLL
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL 173
Query: 437 C-MGTELVKIADFGLAREI-RSRPYTDYVSTRWYRAPEVLLHSTAYSAPI 484
+K+ DFG A+++ S P Y+ +R+YRAPE++L +T Y+ I
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSI 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 13/49 (26%), Positives = 24/49 (48%), Gaps = 1/49 (2%)
Query: 760 NMNFKFPQFRRVPFTSIIPHASP-DAIHLMESMLAYNPSKRPTAQQSLS 807
+FP + + I+P +P AI L+E +L Y P R ++++
Sbjct: 273 YTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 37/135 (27%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 356 KSLKKLS-HANLVKLKEVIR--ENDTLYFVFEY-MKENLYQLIRDRDKFLPESIIRNMMY 411
K L+ L N++ L ++++ + T VFE+ + QL + L + IR MY
Sbjct: 82 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMY 137
Query: 412 QVLQGLAFMHRHGFFHRDMKPENLLC-MGTELVKIADFGLAR-EIRSRPYTDYVSTRWYR 469
++L+ L + H G HRD+KP N++ +++ D+GLA + Y V++R+++
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 197
Query: 470 APEVLLHSTAYSAPI 484
PE+L+ Y +
Sbjct: 198 GPELLVDYQMYDYSL 212
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 11/57 (19%), Positives = 24/57 (42%), Gaps = 5/57 (8%)
Query: 756 TLASNMNFKFPQFRRVPFTSIIPH-----ASPDAIHLMESMLAYNPSKRPTAQQSLS 807
L N + R + + SP+A+ ++ +L Y+ R TA++++
Sbjct: 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-33
Identities = 57/159 (35%), Positives = 84/159 (52%), Gaps = 30/159 (18%)
Query: 354 YR--KSLKKLS-HANLVKLKEVIR--ENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRN 408
+R L +LS H N+V L V+R + +Y VF+YM+ +L+ +IR L +
Sbjct: 56 FREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANI--LEPVHKQY 113
Query: 409 MMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY--------- 459
++YQ+++ + ++H G HRDMKP N+L VK+ADFGL+R +
Sbjct: 114 VVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 460 --------------TDYVSTRWYRAPEVLLHSTAYSAPI 484
TDYV+TRWYRAPE+LL ST Y+ I
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI 212
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 10/62 (16%), Positives = 27/62 (43%)
Query: 746 LHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQS 805
+ +L ++ + + + + +A+ L++ +L +NP+KR +A +
Sbjct: 267 IESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDA 326
Query: 806 LS 807
L
Sbjct: 327 LK 328
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-32
Identities = 49/140 (35%), Positives = 72/140 (51%), Gaps = 13/140 (9%)
Query: 354 YR--KSLKKLSHANLVKLKEVIRENDT------LYFVFEYMKENLYQLIRDRDKFLPESI 405
YR +K ++H N++ L V + +Y V E M NL Q+I+ L
Sbjct: 72 YRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHER 128
Query: 406 IRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY-TDYVS 464
+ ++YQ+L G+ +H G HRD+KP N++ +KI DFGLAR + T YV
Sbjct: 129 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 188
Query: 465 TRWYRAPEVLLHSTAYSAPI 484
TR+YRAPEV+L Y +
Sbjct: 189 TRYYRAPEVIL-GMGYKENV 207
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 11/62 (17%), Positives = 20/62 (32%), Gaps = 12/62 (19%)
Query: 758 ASNMNFKFPQFRRVPFTSIIPHA------------SPDAIHLMESMLAYNPSKRPTAQQS 805
P++ F + P + A L+ ML + SKR + ++
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316
Query: 806 LS 807
L
Sbjct: 317 LQ 318
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-32
Identities = 51/162 (31%), Positives = 72/162 (44%), Gaps = 32/162 (19%)
Query: 354 YR--KSLKKLSHANLVKLKEVIR-----ENDTLYFVFEYMKENLYQLIRDRDKFLPESII 406
R L +L +++L ++I + D LY V E +L +L + L E I
Sbjct: 73 LREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIF-LTEEHI 131
Query: 407 RNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY------- 459
+ ++Y +L G F+H G HRD+KP N L VK+ DFGLAR I S
Sbjct: 132 KTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 460 -----------------TDYVSTRWYRAPEVLLHSTAYSAPI 484
T +V TRWYRAPE++L Y+ I
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI 233
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 18/50 (36%), Positives = 25/50 (50%)
Query: 758 ASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
FP + + P S D I+L+ESML +NP+KR T Q+L
Sbjct: 312 VIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD 361
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-32
Identities = 50/140 (35%), Positives = 72/140 (51%), Gaps = 13/140 (9%)
Query: 354 YR--KSLKKLSHANLVKLKEVIR------ENDTLYFVFEYMKENLYQLIRDRDKFLPESI 405
YR +K ++H N++ L V E +Y V E M NL Q+I+ L
Sbjct: 109 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHER 165
Query: 406 IRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY-TDYVS 464
+ ++YQ+L G+ +H G HRD+KP N++ +KI DFGLAR + T YV
Sbjct: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 225
Query: 465 TRWYRAPEVLLHSTAYSAPI 484
TR+YRAPEV+L Y +
Sbjct: 226 TRYYRAPEVIL-GMGYKENV 244
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 12/62 (19%), Positives = 23/62 (37%), Gaps = 12/62 (19%)
Query: 758 ASNMNFKFPQFRRVPFTSIIPHA------------SPDAIHLMESMLAYNPSKRPTAQQS 805
N P++ + F + P + + A L+ ML +P+KR + +
Sbjct: 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353
Query: 806 LS 807
L
Sbjct: 354 LQ 355
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 35/124 (28%), Positives = 61/124 (49%), Gaps = 6/124 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
L H N++ L E + L +FE++ + +++ I L E I + ++QV +
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLD-IFERINTSAFELNEREIVSYVHQVCE 113
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLAREIR-SRPYTDYVSTRWYRAPE 472
L F+H H H D++PEN++ +KI +FG AR+++ + + Y APE
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173
Query: 473 VLLH 476
V H
Sbjct: 174 VHQH 177
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 48/133 (36%), Positives = 75/133 (56%), Gaps = 9/133 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
+KL H N+V+L + I+E Y VF+ + E L++ I R+ + E+ + + Q+L+
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE-LFEDIVAREFY-SEADASHCIQQILE 116
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIR-SRPYTDYVSTRWYRAP 471
+A+ H +G HR++KPENLL VK+ADFGLA E+ S + + T Y +P
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 176
Query: 472 EVLLHSTAYSAPI 484
EVL YS P+
Sbjct: 177 EVLKKD-PYSKPV 188
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 28/124 (22%), Positives = 61/124 (49%), Gaps = 9/124 (7%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
L+++ H N++ L ++ + + E + E L+ + +++ E + Q+L
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGE-LFDFLAEKESL-TEDEATQFLKQILD 119
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTE----LVKIADFGLAREIR-SRPYTDYVSTRWYRA 470
G+ ++H H D+KPEN++ + +K+ DFG+A +I + + T + A
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 179
Query: 471 PEVL 474
PE++
Sbjct: 180 PEIV 183
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 47/123 (38%), Positives = 69/123 (56%), Gaps = 8/123 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
LKKL H N++KL E++ ++ + Y V E E L+ I R +F E ++ QV
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE-LFDEIIKRKRF-SEHDAARIIKQVFS 132
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIR-SRPYTDYVSTRWYRAP 471
G+ +MH+H HRD+KPEN+L E +KI DFGL+ + + D + T +Y AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
Query: 472 EVL 474
EVL
Sbjct: 193 EVL 195
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 6e-29
Identities = 37/122 (30%), Positives = 61/122 (50%), Gaps = 6/122 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
+ +L H L+ L + + + + E++ E L+ I D + E+ + N M Q +
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE-LFDRIAAEDYKMSEAEVINYMRQACE 160
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLAREIR-SRPYTDYVSTRWYRAPE 472
GL MH H H D+KPEN++C + VKI DFGLA ++ +T + APE
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE 220
Query: 473 VL 474
++
Sbjct: 221 IV 222
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 24/137 (17%), Positives = 50/137 (36%), Gaps = 24/137 (17%)
Query: 768 FRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS---IKREVSLSFVLLKKLNR 824
F F+S+ SP+A ++++L P KR T +L +K + S +R
Sbjct: 269 FDEDAFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS------NLTSR 318
Query: 825 LEKYRLKNARETLQAKKSKVDSFNLQLQNLKYEIFHLKKEVVKCLQFKSKDEDIDLVDEE 884
+ R R+ ++ K + + + + + K + ++ + D
Sbjct: 319 IPSSRYNKIRQKIKEKYADWPAPQPAIGRIA----NFSS------LRKHRPQEYQIYDSY 368
Query: 885 TFFKD-APESISRPEVT 900
K+ P RP +
Sbjct: 369 FDRKEAVPRFKLRPSLI 385
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 40/123 (32%), Positives = 63/123 (51%), Gaps = 8/123 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
+K L H N+++L E +N +Y V E E L++ + + F ES +M VL
Sbjct: 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGE-LFERVVHKRVF-RESDAARIMKDVLS 117
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIR-SRPYTDYVSTRWYRAP 471
+A+ H+ HRD+KPEN L + +K+ DFGLA + + V T +Y +P
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177
Query: 472 EVL 474
+VL
Sbjct: 178 QVL 180
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 9e-29
Identities = 31/124 (25%), Positives = 61/124 (49%), Gaps = 9/124 (7%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
L+++ H N++ L +V + + E + E L+ + ++ E + + Q+L
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGE-LFDFLAQKESL-SEEEATSFIKQILD 126
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTE----LVKIADFGLAREIR-SRPYTDYVSTRWYRA 470
G+ ++H H D+KPEN++ + +K+ DFGLA EI + + T + A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 471 PEVL 474
PE++
Sbjct: 187 PEIV 190
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 4e-04
Identities = 15/77 (19%), Positives = 27/77 (35%), Gaps = 8/77 (10%)
Query: 768 FRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS----IKREVSLSFVLLKKLN 823
F F+ S A + +L KR T Q++L + + V + +
Sbjct: 237 FDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVV 292
Query: 824 RLEKYRLKNARETLQAK 840
LE +R + R +
Sbjct: 293 NLENFRKQYVRRRWKLS 309
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 48/133 (36%), Positives = 75/133 (56%), Gaps = 9/133 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
+KL H N+V+L + I+E Y VF+ + E L++ I R+ + E+ + + Q+L+
Sbjct: 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE-LFEDIVAREFY-SEADASHCIQQILE 139
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIR-SRPYTDYVSTRWYRAP 471
+A+ H +G HR++KPENLL VK+ADFGLA E+ S + + T Y +P
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 199
Query: 472 EVLLHSTAYSAPI 484
EVL YS P+
Sbjct: 200 EVLKKD-PYSKPV 211
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 27/92 (29%), Positives = 43/92 (46%), Gaps = 8/92 (8%)
Query: 778 PHASPDAIHLMESMLAYNPSKRPTAQQSLS----IKREVSLSFVLLKK-LNRLEKYRLKN 832
+P+A L++SML NP KR TA Q+L RE S + + ++ L+K+ N
Sbjct: 255 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKF---N 311
Query: 833 ARETLQAKKSKVDSFNLQLQNLKYEIFHLKKE 864
AR L+ L NL + + K++
Sbjct: 312 ARRKLKGAILTTMIATRNLSNLGRNLLNKKEQ 343
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 45/144 (31%), Positives = 72/144 (50%), Gaps = 14/144 (9%)
Query: 346 RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPE 403
+E+ V LKK+ H N+V L+++ Y V + + E L+ I +R + E
Sbjct: 54 ENEIAV------LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGE-LFDRILERGVY-TE 105
Query: 404 SIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIRSRPYT 460
++ QVL + ++H +G HRD+KPENLL + E + I DFGL++ ++ +
Sbjct: 106 KDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165
Query: 461 DYVSTRWYRAPEVLLHSTAYSAPI 484
T Y APEVL YS +
Sbjct: 166 TACGTPGYVAPEVLAQ-KPYSKAV 188
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 40/125 (32%), Positives = 65/125 (52%), Gaps = 7/125 (5%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKFLPESIIRNMMYQVLQG 416
LKKL+H ++K+K + + Y V E M+ L+ + + E+ + YQ+L
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRL-KEATCKLYFYQMLLA 126
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIR-SRPYTDYVSTRWYRAPE 472
+ ++H +G HRD+KPEN+L E L+KI DFG ++ + + T Y APE
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186
Query: 473 VLLHS 477
VL+
Sbjct: 187 VLVSV 191
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 42/122 (34%), Positives = 65/122 (53%), Gaps = 7/122 (5%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKFLPESIIRNMMYQVLQG 416
LKKL+H ++K+K + + Y V E M+ L+ + K L E+ + YQ+L
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLA 251
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIR-SRPYTDYVSTRWYRAPE 472
+ ++H +G HRD+KPEN+L E L+KI DFG ++ + + T Y APE
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 311
Query: 473 VL 474
VL
Sbjct: 312 VL 313
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 42/122 (34%), Positives = 63/122 (51%), Gaps = 6/122 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
+ +L HANL++L + + + V EY+ E L+ I D L E M Q+ +
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE-LFDRIIDESYNLTELDTILFMKQICE 198
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLAREIRSR-PYTDYVSTRWYRAPE 472
G+ MH+ H D+KPEN+LC+ + +KI DFGLAR + R T + APE
Sbjct: 199 GIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPE 258
Query: 473 VL 474
V+
Sbjct: 259 VV 260
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 36/121 (29%), Positives = 64/121 (52%), Gaps = 6/121 (4%)
Query: 358 LKKLS-HANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVL 414
L+K+S H N+++LK+ N + VF+ MK E L+ + ++ E R +M +L
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE-LFDYLTEKVTL-SEKETRKIMRALL 134
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS-RPYTDYVSTRWYRAPEV 473
+ + +H+ HRD+KPEN+L +K+ DFG + ++ + T Y APE+
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 474 L 474
+
Sbjct: 195 I 195
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 33/124 (26%), Positives = 61/124 (49%), Gaps = 9/124 (7%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
LK++ H N++ L EV + + E + E L+ + +++ E + Q+L
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGE-LFDFLAEKESL-TEEEATEFLKQILN 125
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTE----LVKIADFGLAREIR-SRPYTDYVSTRWYRA 470
G+ ++H H D+KPEN++ + +KI DFGLA +I + + T + A
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 471 PEVL 474
PE++
Sbjct: 186 PEIV 189
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 16/71 (22%), Positives = 29/71 (40%), Gaps = 11/71 (15%)
Query: 768 FRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS---IKREVSLSFVLLKK--- 821
F F++ S A + +L +P KR T Q SL IK + + + K
Sbjct: 236 FEDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAV 291
Query: 822 -LNRLEKYRLK 831
+ + +K+ +
Sbjct: 292 NMEKFKKFAAR 302
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 45/126 (35%), Positives = 63/126 (50%), Gaps = 10/126 (7%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDR---DKFLPESIIRNMMYQ 412
LK L H N++K+ EV + +Y V E + E L + I K L E + +M Q
Sbjct: 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE-LLERIVSAQARGKALSEGYVAELMKQ 132
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIRS-RPYTDYVSTRWY 468
++ LA+ H H+D+KPEN+L T +KI DFGLA +S T+ T Y
Sbjct: 133 MMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALY 192
Query: 469 RAPEVL 474
APEV
Sbjct: 193 MAPEVF 198
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 31/124 (25%), Positives = 61/124 (49%), Gaps = 9/124 (7%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
L+++ H N++ L +V + + E + E L+ + ++ E + + Q+L
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGE-LFDFLAQKESL-SEEEATSFIKQILD 126
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTE----LVKIADFGLAREIRSR-PYTDYVSTRWYRA 470
G+ ++H H D+KPEN++ + +K+ DFGLA EI + + T + A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 471 PEVL 474
PE++
Sbjct: 187 PEIV 190
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 9e-05
Identities = 24/124 (19%), Positives = 43/124 (34%), Gaps = 20/124 (16%)
Query: 768 FRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS----IKREVSLSFVLLKKLN 823
F F+ S A + +L KR T Q++L + + V + +
Sbjct: 237 FDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVV 292
Query: 824 RLEKYRLKNARETLQAKKSKVDSFNLQLQNLKYEIFHLKKEVVKCLQFK-SKDEDIDLVD 882
LE ++ + R + S V N HL + ++K + + S+D D
Sbjct: 293 NLENFKKQYVRRRWKLSFSIVSLCN-----------HLTRSLMKKVHLRTSEDLRNCESD 341
Query: 883 EETF 886
E
Sbjct: 342 TEEN 345
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-28
Identities = 48/156 (30%), Positives = 81/156 (51%), Gaps = 14/156 (8%)
Query: 338 ILSRHVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQL 393
I ++ +S+RD + R + + L H N+V+L + I E Y +F+ + E L++
Sbjct: 44 INTKKLSARDHQKL--EREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE-LFED 100
Query: 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGL 450
I R+ + E+ + + Q+L+ + H+ G HR++KPENLL VK+ADFGL
Sbjct: 101 IVAREYY-SEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGL 159
Query: 451 AREIRS--RPYTDYVSTRWYRAPEVLLHSTAYSAPI 484
A E+ + + + T Y +PEVL Y P+
Sbjct: 160 AIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPV 194
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 32/135 (23%), Positives = 56/135 (41%), Gaps = 22/135 (16%)
Query: 778 PHASPDAIHLMESMLAYNPSKRPTAQQSLS----IKREVSLSFVLLKK-LNRLEKYRLKN 832
+P+A L+ ML NPSKR TA ++L R S + ++ ++ L+K+ N
Sbjct: 238 DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKF---N 294
Query: 833 ARETLQAKKSKVDSFNLQLQNLKYEIFHLKKEVVKCLQFKSKDEDIDLVDEETFFKDAPE 892
AR L K + + L +N + K + + + D E++ K
Sbjct: 295 ARRKL---KGAILTVMLATRNFSVRKQEIIKV-----TEQLIEAISN-GDFESYTK---- 341
Query: 893 SISRPEVTKEDPHQL 907
+ P +T +P L
Sbjct: 342 -MCDPGMTAFEPEAL 355
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 35/122 (28%), Positives = 52/122 (42%), Gaps = 2/122 (1%)
Query: 355 RKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQV 413
S +K+ H V+L++ E LY E +L Q LPE+ + +
Sbjct: 107 VGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDT 166
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD-YVSTRWYRAPE 472
L LA +H G H D+KP N+ K+ DFGL E+ + + Y APE
Sbjct: 167 LLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE 226
Query: 473 VL 474
+L
Sbjct: 227 LL 228
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-28
Identities = 31/121 (25%), Positives = 66/121 (54%), Gaps = 6/121 (4%)
Query: 358 LKKLS-HANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVL 414
L++++ H +++ L + + ++ VF+ M+ E L+ + ++ E R++M +L
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE-LFDYLTEKVAL-SEKETRSIMRSLL 210
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR-SRPYTDYVSTRWYRAPEV 473
+ ++F+H + HRD+KPEN+L ++++DFG + + + T Y APE+
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270
Query: 474 L 474
L
Sbjct: 271 L 271
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 31/124 (25%), Positives = 62/124 (50%), Gaps = 7/124 (5%)
Query: 358 LKKLSHA-NLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVL 414
L+ ++ L EV + + EY E + + + + E+ + ++ Q+L
Sbjct: 82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL 141
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIR-SRPYTDYVSTRWYRA 470
+G+ ++H++ H D+KP+N+L +KI DFG++R+I + + + T Y A
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLA 201
Query: 471 PEVL 474
PE+L
Sbjct: 202 PEIL 205
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 6e-04
Identities = 16/76 (21%), Positives = 34/76 (44%), Gaps = 7/76 (9%)
Query: 768 FRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS---IKREVSLSFVLLKKLNR 824
+ F+S+ S A ++S+L NP KRPTA+ LS +++ + ++ +
Sbjct: 252 YSEETFSSV----SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSS 307
Query: 825 LEKYRLKNARETLQAK 840
+ + + R +
Sbjct: 308 SSQTQDHSVRSSEDKT 323
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 45/122 (36%), Positives = 64/122 (52%), Gaps = 6/122 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQG 416
LK+L H N++KL E + Y V E L+ I R +F E ++ QVL G
Sbjct: 80 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF-SEVDAARIIRQVLSG 138
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIR-SRPYTDYVSTRWYRAPE 472
+ +MH++ HRD+KPENLL ++I DFGL+ S+ D + T +Y APE
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198
Query: 473 VL 474
VL
Sbjct: 199 VL 200
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 28/166 (16%), Positives = 48/166 (28%), Gaps = 24/166 (14%)
Query: 766 PQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS---IKREVSLSFVLLKKL 822
F + + S A L+ ML Y PS R +A+ +L I+ +
Sbjct: 244 YTFELPQWKKV----SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPS 299
Query: 823 NRLEKYRLK--NARETLQAKKSKVDSFNLQLQNLKYEIFHLKKEVVKCLQFKSKDEDID- 879
++ + L L Q+ E L F D++ D
Sbjct: 300 LDNAILNIRQFQGTQKLAQAALLYMGSKLTSQD---ETKELTA------IFHKMDKNGDG 350
Query: 880 -LVDEETFFKDAPESISRPEVTKEDPHQLKLARLEWELKQRKELAD 924
L E + + + R + E E+ Q + D
Sbjct: 351 QLDRAE--LIEGYKELMRMKGQDASMLDASAV--EHEVDQVLDAVD 392
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 47/123 (38%), Positives = 69/123 (56%), Gaps = 8/123 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
LKKL H N++KL E++ ++ + Y V E E L+ I R +F E ++ QV
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE-LFDEIIKRKRF-SEHDAARIIKQVFS 132
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIR-SRPYTDYVSTRWYRAP 471
G+ +MH+H HRD+KPEN+L E +KI DFGL+ + + D + T +Y AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
Query: 472 EVL 474
EVL
Sbjct: 193 EVL 195
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 32/169 (18%), Positives = 61/169 (36%), Gaps = 26/169 (15%)
Query: 766 PQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS---IKREVSLSFVLLKK- 821
F + +I S DA L+ ML ++PS R TA Q L I++ S + +
Sbjct: 239 YAFDLPQWRTI----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLP 294
Query: 822 -----LNRLEKYRLKNARETLQAKKSKVDSFNLQLQNLKYEIFHLKKEVVKCLQFKSKDE 876
+ + ++ A + L + L + E L + F+ D
Sbjct: 295 SLESAMTNIRQF---QAEKKLAQAALLYMASKLTTLD---ETKQLTE------IFRKLDT 342
Query: 877 DID-LVDEETFFKDAPESISRPEVTKEDPHQLKLARLEWELKQRKELAD 924
+ D ++D + + E + V Q + + +E ++ L D
Sbjct: 343 NNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLD 391
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-27
Identities = 29/128 (22%), Positives = 52/128 (40%), Gaps = 11/128 (8%)
Query: 358 LKKLS-HANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQG 416
L++ H N+++ ++ Y E L + + +D ++ Q G
Sbjct: 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSG 130
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTEL-----VKIADFGLAREIRSRPY-----TDYVSTR 466
LA +H HRD+KP N+L I+DFGL +++ + + T
Sbjct: 131 LAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 467 WYRAPEVL 474
+ APE+L
Sbjct: 191 GWIAPEML 198
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 23/97 (23%), Positives = 35/97 (36%), Gaps = 6/97 (6%)
Query: 772 PFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS----IKREVSLSFVLLKKLNRLEK 827
H A L+E M+A +P KRP+A+ L E L F +R+EK
Sbjct: 248 DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQF-FQDVSDRIEK 306
Query: 828 YRLKNA-RETLQAKKSKVDSFNLQLQNLKYEIFHLKK 863
L + L+ V + + L+K
Sbjct: 307 ESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRK 343
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 47/122 (38%), Positives = 65/122 (53%), Gaps = 6/122 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQG 416
LK L H N++KL + + Y V E K L+ I R KF E ++ QVL G
Sbjct: 90 LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF-NEVDAAVIIKQVLSG 148
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIR-SRPYTDYVSTRWYRAPE 472
+ ++H+H HRD+KPENLL E L+KI DFGL+ + + + T +Y APE
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE 208
Query: 473 VL 474
VL
Sbjct: 209 VL 210
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 29/152 (19%), Positives = 51/152 (33%), Gaps = 38/152 (25%)
Query: 743 YILLHTLPLYTCYT--------LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAY 794
+ILL P + T F P+++ V S A L++ ML +
Sbjct: 228 FILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV---------SEGAKDLIKQMLQF 278
Query: 795 NPSKRPTAQQSLS--------IKREVSLSFVLLKK-LNRLEKYRLKNARETLQAKKSKVD 845
+ +R +AQQ+L K+E + L + + K+ + L
Sbjct: 279 DSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKF---QNSQKLAQAALLYM 335
Query: 846 SFNLQLQNLKYEIFHLKKEVVKCLQFKSKDED 877
+ L Q E L F+ D++
Sbjct: 336 ASKLTSQE---ETKELTD------IFRHIDKN 358
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 40/135 (29%), Positives = 65/135 (48%), Gaps = 11/135 (8%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
L+ H N++ LK+V + +Y V E MK E L I + F E +++ + +
Sbjct: 70 LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE-LLDKILRQKFF-SEREASAVLFTITK 127
Query: 416 GLAFMHRHGFFHRDMKPENLLCM----GTELVKIADFGLAREIRS--RPYTDYVSTRWYR 469
+ ++H G HRD+KP N+L + E ++I DFG A+++R+ T +
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFV 187
Query: 470 APEVLLHSTAYSAPI 484
APEVL Y A
Sbjct: 188 APEVLER-QGYDAAC 201
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 26/123 (21%), Positives = 56/123 (45%), Gaps = 8/123 (6%)
Query: 358 LKKLSHANL--VKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
L KL + ++L + + +Y V E +L ++ + ++ +L+
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI-DPWERKSYWKNMLE 138
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTR----WYRAP 471
+ +H+HG H D+KP N L + ++K+ DFG+A +++ + ++ Y P
Sbjct: 139 AVHTIHQHGIVHSDLKPANFL-IVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 472 EVL 474
E +
Sbjct: 198 EAI 200
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 10/127 (7%)
Query: 358 LKKLSHANLVKLKEVI--RENDTLYFVFEYMKE-NLYQLIRDRDK--FLPESIIRNMMYQ 412
LKKL+H N+VKL + + E+ +LY ++ + LPES ++
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTE----LVKIADFGLAREIR-SRPYTDYVSTRW 467
V+ G+ + +G HR++KP N++ + E + K+ DFG ARE+ + T
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180
Query: 468 YRAPEVL 474
Y P++
Sbjct: 181 YLHPDMY 187
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 40/137 (29%), Positives = 62/137 (45%), Gaps = 12/137 (8%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDK---FLPESIIRNMMYQ 412
L H ++V+L E + LY VFE+M + L I R E++ + M Q
Sbjct: 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGAD-LCFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIR--SRPYTDYVSTRW 467
+L+ L + H + HRD+KP +L E VK+ FG+A ++ V T
Sbjct: 139 ILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPH 198
Query: 468 YRAPEVLLHSTAYSAPI 484
+ APEV+ Y P+
Sbjct: 199 FMAPEVVKRE-PYGKPV 214
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 5e-27
Identities = 34/122 (27%), Positives = 58/122 (47%), Gaps = 6/122 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
+ L H LV L + +++ + ++E+M E L++ + D + E M QV +
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE-LFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLAREIR-SRPYTDYVSTRWYRAPE 472
GL MH + + H D+KPEN++ +K+ DFGL + + T + APE
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE 326
Query: 473 VL 474
V
Sbjct: 327 VA 328
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 14/91 (15%), Positives = 31/91 (34%), Gaps = 12/91 (13%)
Query: 768 FRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS---IKREVSLSFVLLKKLNR 824
F+ I S D + +L +P+ R T Q+L + + + ++
Sbjct: 375 MDDSAFSGI----SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG-----RDSQ 425
Query: 825 LEKYRLKNARETLQAKKSKVDSFNLQLQNLK 855
+ R R++++ K L +
Sbjct: 426 IPSSRYTKIRDSIKTKYDAWPEPLPPLGRIS 456
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 44/135 (32%), Positives = 64/135 (47%), Gaps = 11/135 (8%)
Query: 358 LKKLS-HANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVL 414
LK H N+VKL EV + + V E + E L++ I+ + F E+ +M +++
Sbjct: 59 LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE-LFERIKKKKHF-SETEASYIMRKLV 116
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIR--SRPYTDYVSTRWYR 469
++ MH G HRD+KPENLL +KI DFG AR ++P T Y
Sbjct: 117 SAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYA 176
Query: 470 APEVLLHSTAYSAPI 484
APE+L Y
Sbjct: 177 APELLNQ-NGYDESC 190
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 29/124 (23%), Positives = 49/124 (39%), Gaps = 6/124 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
L+K H N++ L V ++ + +LY + + + ++ Q +G
Sbjct: 74 LRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTR--WYR--APE 472
+ ++H HRD+K N+ VKI DFGLA E + APE
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 473 VLLH 476
V+
Sbjct: 193 VIRM 196
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 40/153 (26%), Positives = 58/153 (37%), Gaps = 30/153 (19%)
Query: 358 LKKLSHANLVKLKEVIREND-------------TLYFVFEYM-KENLYQLIRDRDKFLPE 403
L L+H +V+ E TL+ EY LY LI +
Sbjct: 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 404 SIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY---- 459
+ Q+L+ L+++H G HRD+KP N+ + VKI DFGLA+ +
Sbjct: 116 DEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 460 ------------TDYVSTRWYRAPEVLLHSTAY 480
T + T Y A EVL + Y
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY 208
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 46/122 (37%), Positives = 67/122 (54%), Gaps = 6/122 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQG 416
LK L H N++KL +V + Y V E+ + L++ I +R KF E N+M Q+L G
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF-DECDAANIMKQILSG 158
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIR-SRPYTDYVSTRWYRAPE 472
+ ++H+H HRD+KPEN+L +KI DFGL+ D + T +Y APE
Sbjct: 159 ICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPE 218
Query: 473 VL 474
VL
Sbjct: 219 VL 220
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 23/117 (19%), Positives = 42/117 (35%), Gaps = 18/117 (15%)
Query: 766 PQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS---IKREVSLSFVLLKKL 822
F + +I S +A L++ ML Y+ +KR TA+++L+ IK+ + +K
Sbjct: 264 YYFDFNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKT 319
Query: 823 NRLEKYRLK--NARETLQAKKSKVDSFNLQLQNLKYEIFHLKKEVVKCLQFKSKDED 877
++ + L L E L FK D++
Sbjct: 320 LCGALSNMRKFEGSQKLAQAAILFIGSKL---TTLEERKELTD------IFKKLDKN 367
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 34/136 (25%), Positives = 57/136 (41%), Gaps = 17/136 (12%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
++ L H N++K V+ ++ L F+ EY+K L +I+ D P S + + G
Sbjct: 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASG 120
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYR------- 469
+A++H HRD+ N L + V +ADFGLAR + +
Sbjct: 121 MAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 470 ---------APEVLLH 476
APE++
Sbjct: 181 TVVGNPYWMAPEMING 196
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 44/133 (33%), Positives = 69/133 (51%), Gaps = 9/133 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
L +LSH N++KLKE+ + V E + E L+ I ++ + E + + Q+L+
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGE-LFDRIVEKGYY-SERDAADAVKQILE 159
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIR-SRPYTDYVSTRWYRAP 471
+A++H +G HRD+KPENLL +KIADFGL++ + T Y AP
Sbjct: 160 AVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAP 219
Query: 472 EVLLHSTAYSAPI 484
E+ L AY +
Sbjct: 220 EI-LRGCAYGPEV 231
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 38/131 (29%), Positives = 62/131 (47%), Gaps = 7/131 (5%)
Query: 358 LKKLSHA--NLVKLKEVIRENDTLYFVFEYMKEN--LYQLIRDRDKFLPESIIRNMMYQV 413
LKK+S +++L + D+ + E + L+ I +R L E + R+ +QV
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 158
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTEL-VKIADFGLAREIRSRPYTDYVSTRWYRAPE 472
L+ + H G HRD+K EN+L +K+ DFG ++ YTD+ TR Y PE
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 218
Query: 473 VLLHSTAYSAP 483
+ + Y
Sbjct: 219 WIRYH-RYHGR 228
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-26
Identities = 35/127 (27%), Positives = 60/127 (47%), Gaps = 10/127 (7%)
Query: 358 LKKLSHANLVKLKEVI--RENDTLYFVFEYMKE-NLYQLI--RDRDKFLPESIIRNMMYQ 412
LKKL+H N+VKL + + E+ +LY ++ LPES ++
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTE----LVKIADFGLAREIR-SRPYTDYVSTRW 467
V+ G+ + +G HR++KP N++ + E + K+ DFG ARE+ + T
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180
Query: 468 YRAPEVL 474
Y P++
Sbjct: 181 YLHPDMY 187
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 27/123 (21%), Positives = 58/123 (47%), Gaps = 8/123 (6%)
Query: 358 LKKLSHANL--VKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
L KL + ++L + + +Y V E +L ++ + K + ++ +L+
Sbjct: 61 LNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLE 119
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTR----WYRAP 471
+ +H+HG H D+KP N L + ++K+ DFG+A +++ + ++ Y P
Sbjct: 120 AVHTIHQHGIVHSDLKPANFL-IVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 472 EVL 474
E +
Sbjct: 179 EAI 181
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 10/79 (12%), Positives = 23/79 (29%), Gaps = 3/79 (3%)
Query: 778 PHASPDAIHLMESMLAYNPSKRPTAQQSLS---IKREVSLSFVLLKKLNRLEKYRLKNAR 834
D +++ L +P +R + + L+ ++ + + K KY L
Sbjct: 244 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLV 303
Query: 835 ETLQAKKSKVDSFNLQLQN 853
+ L
Sbjct: 304 GLNSPNSILKAAKTLYEHY 322
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 37/124 (29%), Positives = 61/124 (49%), Gaps = 8/124 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLI---RDRDKFLPESIIRNMMYQV 413
LK+L+H N++K E++ L V E +L ++I + + + +PE + Q+
Sbjct: 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS---RPYTDYVSTRWYRA 470
L MH HRD+KP N+ T +VK+ D GL R S ++ V T +Y +
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMS 204
Query: 471 PEVL 474
PE +
Sbjct: 205 PERI 208
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 12/128 (9%)
Query: 358 LKKLS-HANLVKLKEV----IRENDTLYFVFEYMK--ENLYQLIRDR-DKFLPESIIRNM 409
+ S ++V + +V L + E M+ E L+ I++R D+ E +
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGE-LFSRIQERGDQAFTEREAAEI 133
Query: 410 MYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIRSRPYTDYVSTR 466
M + + F+H H HRD+KPENLL E ++K+ DFG A+E T
Sbjct: 134 MRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTP 193
Query: 467 WYRAPEVL 474
+Y APEVL
Sbjct: 194 YYVAPEVL 201
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 33/123 (26%), Positives = 58/123 (47%), Gaps = 8/123 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDK-FLPESIIRNMMYQVLQ 415
L + H N+V+ +E EN +LY V +Y + +L++ I + E I + Q+
Sbjct: 77 LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL 136
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTR----WYRAP 471
L +H HRD+K +N+ V++ DFG+AR + S + +Y +P
Sbjct: 137 ALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--VELARACIGTPYYLSP 194
Query: 472 EVL 474
E+
Sbjct: 195 EIC 197
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 35/128 (27%), Positives = 52/128 (40%), Gaps = 5/128 (3%)
Query: 359 KKLSHANLVKLKEVIRENDTLYFVFEYMKEN--LYQLIRDRDKFLPESIIRNMMYQVLQG 416
H +++L + + V E L+ I ++ L E R QV+
Sbjct: 93 AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-LGEGPSRCFFGQVVAA 151
Query: 417 LAFMHRHGFFHRDMKPENLLC-MGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLL 475
+ H G HRD+K EN+L + K+ DFG + PYTD+ TR Y PE +
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWIS 211
Query: 476 HSTAYSAP 483
Y A
Sbjct: 212 RH-QYHAL 218
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 26/123 (21%), Positives = 56/123 (45%), Gaps = 8/123 (6%)
Query: 358 LKKLSHANL--VKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
L KL + ++L + + +Y V E +L ++ + ++ +L+
Sbjct: 108 LNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI-DPWERKSYWKNMLE 166
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTR----WYRAP 471
+ +H+HG H D+KP N L + ++K+ DFG+A +++ + ++ Y P
Sbjct: 167 AVHTIHQHGIVHSDLKPANFL-IVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 472 EVL 474
E +
Sbjct: 226 EAI 228
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 10/79 (12%), Positives = 23/79 (29%), Gaps = 3/79 (3%)
Query: 778 PHASPDAIHLMESMLAYNPSKRPTAQQSLS---IKREVSLSFVLLKKLNRLEKYRLKNAR 834
D +++ L +P +R + + L+ ++ + + K KY L
Sbjct: 291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLV 350
Query: 835 ETLQAKKSKVDSFNLQLQN 853
+ L
Sbjct: 351 GLNSPNSILKAAKTLYEHY 369
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 36/136 (26%), Positives = 62/136 (45%), Gaps = 15/136 (11%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
L H N++ L+ V + L V E+ + L +++ + +P I+ N Q+ +G
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARG 117
Query: 417 LAFMHRHGFF---HRDMKPENLL--------CMGTELVKIADFGLAREIRSRPYTDYVST 465
+ ++H HRD+K N+L + +++KI DFGLARE
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGA 177
Query: 466 RWYRAPEVLLHSTAYS 481
+ APEV+ S +S
Sbjct: 178 YAWMAPEVIRASM-FS 192
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 30/142 (21%), Positives = 55/142 (38%), Gaps = 9/142 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
++ H N+V L + K LY ++RD L + R + ++++G
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDY-----VSTRWYR-- 469
+ ++H G H+D+K +N+ V I DFGL + W
Sbjct: 143 MGYLHAKGILHKDLKSKNVF-YDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201
Query: 470 APEVLLHSTAYSAPIHLSRSQQ 491
APE++ + + L S+
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKH 223
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 44/132 (33%), Positives = 58/132 (43%), Gaps = 17/132 (12%)
Query: 358 LKKLS-HANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVL 414
L + H N+++L E E D Y VFE M+ + I R F E ++ V
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS-ILSHIHKRRHF-NELEASVVVQDVA 121
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIRSRPYTDYVSTRW---- 467
L F+H G HRD+KPEN+LC VKI DF L I+ +ST
Sbjct: 122 SALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 468 -----YRAPEVL 474
Y APEV+
Sbjct: 182 CGSAEYMAPEVV 193
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 35/126 (27%), Positives = 67/126 (53%), Gaps = 15/126 (11%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKFLPESIIRNMMYQVLQG 416
+L H ++++L +++ +Y V E + + +++R K E+ R+ M+Q++ G
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG 124
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR---SRPYT-----DYVSTRWY 468
+ ++H HG HRD+ NLL +KIADFGLA +++ + YT +Y+
Sbjct: 125 MLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI----- 179
Query: 469 RAPEVL 474
+PE+
Sbjct: 180 -SPEIA 184
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 29/136 (21%), Positives = 49/136 (36%), Gaps = 19/136 (13%)
Query: 358 LKKLSHANLVKLKEVIRE----NDTLYFVFEYMKE-NLYQLIRDR---DKFLPESIIRNM 409
+ +H N+++L + + + K L+ I FL E I +
Sbjct: 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL 139
Query: 410 MYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD-------- 461
+ + +GL +H G+ HRD+KP N+L + D G +
Sbjct: 140 LLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 462 ---YVSTRWYRAPEVL 474
T YRAPE+
Sbjct: 200 WAAQRCTISYRAPELF 215
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 35/128 (27%), Positives = 57/128 (44%), Gaps = 11/128 (8%)
Query: 358 LKKLS-HANLVKLKEV----IRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMM 410
+ S ++V++ +V L V E + E ++ D+ E +M
Sbjct: 108 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 167
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIRS-RPYTDYVSTR 466
+ + + ++H HRD+KPENLL ++K+ DFG A+E S T T
Sbjct: 168 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 227
Query: 467 WYRAPEVL 474
+Y APEVL
Sbjct: 228 YYVAPEVL 235
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 16/89 (17%), Positives = 34/89 (38%), Gaps = 9/89 (10%)
Query: 778 PHASPDAIHLMESMLAYNPSKRPTAQQSLS---IKREVSLSFVLLKKLNRLEKYRLKNAR 834
S + L+ ++L P++R T + ++ I + + L+ + R
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP---QTPLHTSRVLKEDKER 348
Query: 835 ETLQAKKSKVDSFNLQLQNLKYEIFHLKK 863
+ K ++ S L + YE +KK
Sbjct: 349 --WEDVKEEMTSA-LATMRVDYEQIKIKK 374
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 36/158 (22%), Positives = 63/158 (39%), Gaps = 26/158 (16%)
Query: 358 LKKLS-HANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKF------LPESIIRNMM 410
L + H N+++ + LY E NL L+ ++ E +++
Sbjct: 62 LTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL-------------VKIADFGLAREIR-- 455
Q+ G+A +H HRD+KP+N+L + + I+DFGL +++
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 456 ----SRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRS 489
+ T +RAPE+L S L+RS
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS 219
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 26/106 (24%), Positives = 40/106 (37%), Gaps = 14/106 (13%)
Query: 743 YILLHT--LPLYTCYTLASNM---NFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPS 797
Y +L P Y+ SN+ F + + + +A L+ M+ ++P
Sbjct: 230 YYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHD----RSLIAEATDLISQMIDHDPL 285
Query: 798 KRPTAQQSLS----IKREVSLSFVLLKKLNRLEKYRLKNARETLQA 839
KRPTA + L + L F LLK +RLE L
Sbjct: 286 KRPTAMKVLRHPLFWPKSKKLEF-LLKVSDRLEIENRDPPSALLMK 330
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 36/136 (26%), Positives = 58/136 (42%), Gaps = 19/136 (13%)
Query: 358 LKKLSHANLVKLKEVIREND----------------TLYFVFEYM-KENLYQLIRDR-DK 399
L KL H N+V D L+ E+ K L Q I R +
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 400 FLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS-RP 458
L + + + Q+ +G+ ++H +RD+KP N+ + T+ VKI DFGL +++
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177
Query: 459 YTDYVSTRWYRAPEVL 474
T T Y +PE +
Sbjct: 178 RTRSKGTLRYMSPEQI 193
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-24
Identities = 44/136 (32%), Positives = 68/136 (50%), Gaps = 11/136 (8%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYF------VFEYMKENLYQLIRD-RDKFLPESIIRNMM 410
L+ L + VI + F FE + NLY+LI+ + + ++R
Sbjct: 147 LEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFA 206
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLLCM--GTELVKIADFGLAREIRSRPYTDYVSTRWY 468
+ +LQ L +H++ H D+KPEN+L G +K+ DFG + R YT Y+ +R+Y
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT-YIQSRFY 265
Query: 469 RAPEVLLHSTAYSAPI 484
RAPEV+L Y PI
Sbjct: 266 RAPEVILG-ARYGMPI 280
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-24
Identities = 39/130 (30%), Positives = 62/130 (47%), Gaps = 13/130 (10%)
Query: 358 LKKLSHANLVKLKEVIRE------NDTLYFVFEYMKE-NLYQLI--RDRDKFLPESIIRN 408
+KKL+H N+V +EV ND EY + +L + + + L E IR
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 409 MMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIRSRPYTD-YVS 464
++ + L ++H + HRD+KPEN++ + KI D G A+E+ +V
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG 185
Query: 465 TRWYRAPEVL 474
T Y APE+L
Sbjct: 186 TLQYLAPELL 195
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 42/123 (34%), Positives = 61/123 (49%), Gaps = 8/123 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
K L+H N+VK RE + Y EY E L+ I +PE + +Q++
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE-LFDRIEPDIG-MPEPDAQRFFHQLMA 116
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTR----WYRAP 471
G+ ++H G HRD+KPENLL + +KI+DFGLA R ++ Y AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 472 EVL 474
E+L
Sbjct: 177 ELL 179
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 43/134 (32%), Positives = 62/134 (46%), Gaps = 25/134 (18%)
Query: 358 LKKLSHANLVKLKEVIR--ENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQV 413
LKKL H N+VKL EV+ D LY VFE + + L E R +
Sbjct: 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---LSEDQARFYFQDL 146
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEV 473
++G+ ++H HRD+KP NLL +KIADFG++ E ++ +
Sbjct: 147 IKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE--------------FKGSDA 192
Query: 474 LLHST----AYSAP 483
LL +T A+ AP
Sbjct: 193 LLSNTVGTPAFMAP 206
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 38/126 (30%), Positives = 59/126 (46%), Gaps = 16/126 (12%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKFLPESIIRNMMYQVLQG 416
+ L+H ++V +ND ++ V E + L +L + R L E R + Q++ G
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA-LTEPEARYYLRQIVLG 127
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR---SRPYT-----DYVSTRWY 468
++HR+ HRD+K NL VKI DFGLA ++ R +Y+
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI----- 182
Query: 469 RAPEVL 474
APEVL
Sbjct: 183 -APEVL 187
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 34/124 (27%), Positives = 55/124 (44%), Gaps = 14/124 (11%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
L H N+++L + +Y + EY +Y+ ++ KF E + ++
Sbjct: 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANA 121
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS-RPYT-----DYVSTRWYRA 470
L++ H HRD+KPENLL +KIADFG + S R DY+
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------P 175
Query: 471 PEVL 474
PE++
Sbjct: 176 PEMI 179
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-23
Identities = 41/165 (24%), Positives = 61/165 (36%), Gaps = 48/165 (29%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDR------------------- 397
+KKL H N+ +L EV + + V E +L +
Sbjct: 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 398 --------------------DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLC 437
D E +I N+M Q+ L ++H G HRD+KPEN L
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201
Query: 438 MGTE--LVKIADFGLAREIRS------RPYTDYVSTRWYRAPEVL 474
+ +K+ DFGL++E T T ++ APEVL
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL 246
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 42/123 (34%), Positives = 61/123 (49%), Gaps = 8/123 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
K L+H N+VK RE + Y EY E L+ I +PE + +Q++
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE-LFDRIEPDIG-MPEPDAQRFFHQLMA 116
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTR----WYRAP 471
G+ ++H G HRD+KPENLL + +KI+DFGLA R ++ Y AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 472 EVL 474
E+L
Sbjct: 177 ELL 179
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 27/135 (20%), Positives = 60/135 (44%), Gaps = 9/135 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDRDKF-------LPESIIRNM 409
+ + + + + +I D +Y ++EYM +++ + +P +I+ +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 410 MYQVLQGLAFMHRH-GFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWY 468
+ VL +++H HRD+KP N+L VK++DFG + + + T +
Sbjct: 157 IKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEF 216
Query: 469 RAPEVLLHSTAYSAP 483
PE + ++Y+
Sbjct: 217 MPPEFFSNESSYNGA 231
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 30/120 (25%), Positives = 54/120 (45%), Gaps = 4/120 (3%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE--NLYQLIRDRDKFLPESIIRNMMYQVLQ 415
L ++ HAN++K+ ++ V E +L+ I + L E + + Q++
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQLVS 141
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD-YVSTRWYRAPEVL 474
+ ++ HRD+K EN++ +K+ DFG A + + T Y APEVL
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVL 201
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 39/126 (30%), Positives = 60/126 (47%), Gaps = 16/126 (12%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKFLPESIIRNMMYQVLQG 416
+ L+H ++V +ND ++ V E + L +L + R K L E R + Q++ G
Sbjct: 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLG 153
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI---RSRPYT-----DYVSTRWY 468
++HR+ HRD+K NL VKI DFGLA ++ R +Y+
Sbjct: 154 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI----- 208
Query: 469 RAPEVL 474
APEVL
Sbjct: 209 -APEVL 213
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 34/124 (27%), Positives = 55/124 (44%), Gaps = 14/124 (11%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
L H N++++ + +Y + E+ LY+ ++ +F E M ++
Sbjct: 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF-DEQRSATFMEELADA 126
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS-RPYT-----DYVSTRWYRA 470
L + H HRD+KPENLL +KIADFG + S R T DY+
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------P 180
Query: 471 PEVL 474
PE++
Sbjct: 181 PEMI 184
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-23
Identities = 35/134 (26%), Positives = 62/134 (46%), Gaps = 9/134 (6%)
Query: 358 LKKLSHANLVKLKEVIR--ENDTLYFVFEYMKENLYQLIRDR--DKFLPESIIRNMMYQV 413
L++L H N+++L +V+ E +Y V EY + +++ D +K P Q+
Sbjct: 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEML-DSVPEKRFPVCQAHGYFCQL 118
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTR----WYR 469
+ GL ++H G H+D+KP NLL +KI+ G+A + D T ++
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 470 APEVLLHSTAYSAP 483
PE+ +S
Sbjct: 179 PPEIANGLDTFSGF 192
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 9/128 (7%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRD--KFLPESIIRNMMYQVL 414
+K+L H N+V + + L V EY+ +LY+L+ + L E +M Y V
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 415 QGLAFMHRHG--FFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST---RWYR 469
+G+ ++H HR++K NLL VK+ DFGL+R S + + W
Sbjct: 148 KGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEW-M 206
Query: 470 APEVLLHS 477
APEVL
Sbjct: 207 APEVLRDE 214
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 16/151 (10%)
Query: 337 HILSRHVS--------SRDEMVVC-FYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEY 385
IL+ V+ E + F R + +LSH N+V + +V E+D Y V EY
Sbjct: 33 TILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY 92
Query: 386 MK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVK 444
++ L + I ++ I Q+L G+ H HRD+KP+N+L + +K
Sbjct: 93 IEGPTLSEYIESHGPLSVDTAIN-FTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLK 151
Query: 445 IADFGLAREIRSRPYTD---YVSTRWYRAPE 472
I DFG+A+ + T + T Y +PE
Sbjct: 152 IFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 43/130 (33%), Positives = 65/130 (50%), Gaps = 13/130 (10%)
Query: 358 LKKLSHANLVKLKEVI--RENDTLYFVFEYMKE-NLYQLIRD---RDKFLPESIIRNMMY 411
L++L H N+V+ + I R N TLY V EY + +L +I ++L E + +M
Sbjct: 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 412 QVLQGLAFMHRHGFF-----HRDMKPENLLCMGTELVKIADFGLAREIRSRPY--TDYVS 464
Q+ L HR HRD+KP N+ G + VK+ DFGLAR + +V
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178
Query: 465 TRWYRAPEVL 474
T +Y +PE +
Sbjct: 179 TPYYMSPEQM 188
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 27/112 (24%), Positives = 48/112 (42%), Gaps = 10/112 (8%)
Query: 358 LKKLS-HANLVKLKEV----IRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMM 410
+ S ++V++ +V L V E + E ++ D+ E +M
Sbjct: 64 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIRSRPY 459
+ + + ++H HRD+KPENLL ++K+ DFG A+E Y
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKY 175
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 34/126 (26%), Positives = 59/126 (46%), Gaps = 8/126 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+ + H N+++L+ V+ V EYM+ +L +R D + M+ V G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST------RWYRA 470
+ ++ G+ HRD+ N+L + K++DFGL+R + P Y +T RW A
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-A 222
Query: 471 PEVLLH 476
PE +
Sbjct: 223 PEAIAF 228
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 46/143 (32%), Positives = 72/143 (50%), Gaps = 10/143 (6%)
Query: 338 ILSRHVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIR 395
+SR + + +M + R LK L H +++KL +VI + V EY L+ I
Sbjct: 41 FISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIV 100
Query: 396 DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR 455
++ + + E R Q++ + + HRH HRD+KPENLL VKIADFGL+ +
Sbjct: 101 EKKR-MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159
Query: 456 SRPYTDYVSTR----WYRAPEVL 474
+++ T Y APEV+
Sbjct: 160 D---GNFLKTSCGSPNYAAPEVI 179
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 46/145 (31%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 338 ILSRHVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQL 393
IL+R ++V R ++LK H +++KL +VI + V EY+ E L+
Sbjct: 43 ILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGE-LFDY 101
Query: 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE 453
I + + E R + Q+L + + HRH HRD+KPEN+L KIADFGL+
Sbjct: 102 ICKHGR-VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 160
Query: 454 IRSRPYTDYVSTR----WYRAPEVL 474
+ +++ T Y APEV+
Sbjct: 161 MSDG---EFLRTSCGSPNYAAPEVI 182
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 5e-22
Identities = 31/126 (24%), Positives = 61/126 (48%), Gaps = 8/126 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+ + H N+++L+ V+ ++ + V EYM+ +L +R D + M+ + G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST------RWYRA 470
+ ++ G+ HRD+ N+L + K++DFGL R + P Y + RW +
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT-S 218
Query: 471 PEVLLH 476
PE + +
Sbjct: 219 PEAIAY 224
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-22
Identities = 35/140 (25%), Positives = 54/140 (38%), Gaps = 18/140 (12%)
Query: 344 SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKEN--LYQLIRDRDKFL 401
+E+V LS +V L +RE + E + E L QLI+
Sbjct: 96 FRVEELVA------CAGLSSPRIVPLYGAVREGPWVNIFMELL-EGGSLGQLIKQMGCL- 147
Query: 402 PESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT-ELVKIADFGLAREIRSRPYT 460
PE + Q L+GL ++H H D+K +N+L + DFG A ++
Sbjct: 148 PEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207
Query: 461 DYVSTR-------WYRAPEV 473
+ T + APEV
Sbjct: 208 KSLLTGDYIPGTETHMAPEV 227
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 32/126 (25%), Positives = 64/126 (50%), Gaps = 8/126 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+ + SH N+++L+ VI + + + EYM+ L + +R++D + M+ + G
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST------RWYRA 470
+ ++ + HRD+ N+L + K++DFGL+R + P Y ++ RW A
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT-A 218
Query: 471 PEVLLH 476
PE + +
Sbjct: 219 PEAISY 224
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 37/124 (29%), Positives = 59/124 (47%), Gaps = 9/124 (7%)
Query: 358 LKKLSHANLVKL----KEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQ 412
LK L H N+V+ + ++ + V E M L ++ R K + ++R+ Q
Sbjct: 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQ 137
Query: 413 VLQGLAFMHRHGFF--HRDMKPENLLCMGTE-LVKIADFGLAREIRSRPYTDYVSTRWYR 469
+L+GL F+H HRD+K +N+ G VKI D GLA R+ + T +
Sbjct: 138 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFM 197
Query: 470 APEV 473
APE+
Sbjct: 198 APEM 201
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 6e-22
Identities = 44/125 (35%), Positives = 60/125 (48%), Gaps = 6/125 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+ KLSH LVK V + +Y V EY+ L +R K L S + M Y V +G
Sbjct: 57 MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST----RWYRAPE 472
+AF+ H F HRD+ N L VK++DFG+ R + Y V T +W APE
Sbjct: 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS-APE 175
Query: 473 VLLHS 477
V +
Sbjct: 176 VFHYF 180
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 7e-22
Identities = 37/148 (25%), Positives = 61/148 (41%), Gaps = 29/148 (19%)
Query: 356 KSLKKLSHANLVKLKEVIREND------------TLYFVFEYM-KENLYQLIRDRD--KF 400
K+L KL H +V+ E + LY + KENL + R +
Sbjct: 55 KALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE 114
Query: 401 LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS---- 456
S+ ++ Q+ + + F+H G HRD+KP N+ ++VK+ DFGL +
Sbjct: 115 RERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 457 ----------RPYTDYVSTRWYRAPEVL 474
+T V T+ Y +PE +
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQI 202
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 7e-22
Identities = 36/125 (28%), Positives = 58/125 (46%), Gaps = 6/125 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+ KLSH LV+L V E + V E+M+ L +R + + M V +G
Sbjct: 57 MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST----RWYRAPE 472
+A++ HRD+ N L +++K++DFG+ R + YT T +W +PE
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA-SPE 175
Query: 473 VLLHS 477
V S
Sbjct: 176 VFSFS 180
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 9e-22
Identities = 43/122 (35%), Positives = 61/122 (50%), Gaps = 7/122 (5%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+ L H N+V+ KEVI L + EY LY+ I + + E R Q+L G
Sbjct: 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR-FSEDEARFFFQQLLSG 128
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTEL--VKIADFGLAREIR--SRPYTDYVSTRWYRAPE 472
+++ H HRD+K EN L G+ +KI DFG ++ S+P + V T Y APE
Sbjct: 129 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPE 187
Query: 473 VL 474
VL
Sbjct: 188 VL 189
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 39/120 (32%), Positives = 59/120 (49%), Gaps = 3/120 (2%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+K L+H N+VKL EVI TLY + EY ++ + + + E R+ Q++
Sbjct: 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSA 126
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD-YVSTRWYRAPEVLL 475
+ + H+ HRD+K ENLL +KIADFG + E D + Y APE+
Sbjct: 127 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQ 186
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-21
Identities = 33/125 (26%), Positives = 55/125 (44%), Gaps = 7/125 (5%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
LK+ SH N+V+L V + +Y V E ++ + +R L + M+ G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST-----RWYRAP 471
+ ++ HRD+ N L ++KI+DFG++RE Y +W AP
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-AP 284
Query: 472 EVLLH 476
E L +
Sbjct: 285 EALNY 289
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 38/134 (28%), Positives = 61/134 (45%), Gaps = 9/134 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLP--ESIIRNMMYQVL 414
K L H N+V+ EN + E + +L L+R + L E I Q+L
Sbjct: 73 HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTE-LVKIADFGLAR---EIRSRPYTDYVSTRWYRA 470
+GL ++H + HRD+K +N+L ++KI+DFG ++ I T + T Y A
Sbjct: 133 EGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMA 191
Query: 471 PEVLLHS-TAYSAP 483
PE++ Y
Sbjct: 192 PEIIDKGPRGYGKA 205
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 41/138 (29%), Positives = 65/138 (47%), Gaps = 13/138 (9%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYF------VFEYMKENLYQLIRDRDKF-LPESIIRNMM 410
L+ ++ + ++ F VFE + NLY L+R+ + + ++ R
Sbjct: 104 LELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFA 163
Query: 411 YQVLQGLAFMHRH--GFFHRDMKPEN-LLC-MGTELVKIADFGLAREIRSRPYTDYVSTR 466
Q+ L F+ H D+KPEN LLC +KI DFG + ++ R Y Y+ +R
Sbjct: 164 QQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ-YIQSR 222
Query: 467 WYRAPEVLLHSTAYSAPI 484
+YR+PEVLL Y I
Sbjct: 223 FYRSPEVLLG-MPYDLAI 239
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 96.7 bits (240), Expect = 2e-21
Identities = 20/150 (13%), Positives = 42/150 (28%), Gaps = 7/150 (4%)
Query: 337 HILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRD 396
R +++ +++ + + + +L L
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST 180
Query: 397 RDKF------LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGL 450
D + + Q+++ A + G H P+NL M + + D
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 451 AREIRSRPYTDYVSTRWYRAPEVLLHSTAY 480
++ +R Y E L STA
Sbjct: 241 LWKVGTRGPA-SSVPVTYAPREFLNASTAT 269
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 95.8 bits (238), Expect = 2e-21
Identities = 22/142 (15%), Positives = 50/142 (35%), Gaps = 20/142 (14%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDR----DKFLPESIIRNM 409
+ LK +K + V E L I +K +P+ ++ +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 410 MYQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL-----------VKIADFGLAREIRSRP 458
++L + +H H D+KP+N + L + + D G + +++ P
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 459 YTDYVSTRW----YRAPEVLLH 476
+ + ++ E+L +
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSN 259
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 37/125 (29%), Positives = 59/125 (47%), Gaps = 6/125 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+ LSH LV+L V + ++ + EYM L +R+ + M V +
Sbjct: 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 132
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST----RWYRAPE 472
+ ++ F HRD+ N L +VK++DFGL+R + YT V + RW PE
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS-PPE 191
Query: 473 VLLHS 477
VL++S
Sbjct: 192 VLMYS 196
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-21
Identities = 41/111 (36%), Positives = 57/111 (51%), Gaps = 10/111 (9%)
Query: 382 VFEYMKENLYQLIRD-RDKFLPESIIRNMMYQVLQGLAFMHRH-GFFHRDMKPENLL--- 436
VFE + ENL LI+ + +P ++ + Q+L GL +MHR G H D+KPEN+L
Sbjct: 108 VFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 167
Query: 437 ---CMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPI 484
+KIAD G A YT+ + TR YR+PEVLL +
Sbjct: 168 VDSPENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLL-GAPWGCGA 216
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 31/148 (20%), Positives = 56/148 (37%), Gaps = 26/148 (17%)
Query: 358 LKKLS-HANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDK---FLPESIIRNMMYQ 412
L H+++V+ E+D + EY +L I + + + E+ +++++ Q
Sbjct: 64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 413 VLQGLAFMHRHGFFHRDMKPENLL-------------------CMGTELVKIADFGLARE 453
V +GL ++H H D+KP N+ + KI D G
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 454 IRSRPYTDYVSTRWYRAPEVLLHSTAYS 481
I S P + A EVL + +
Sbjct: 184 I-SSPQV-EEGDSRFLANEVLQENYTHL 209
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 30/117 (25%), Positives = 52/117 (44%), Gaps = 5/117 (4%)
Query: 360 KLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLA 418
+L ++V + + + LY + +L ++R + P + ++ Q+ L
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA-IVRQIGSALD 148
Query: 419 FMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT---DYVSTRWYRAPE 472
H G HRD+KPEN+L + + DFG+A T + V T +Y APE
Sbjct: 149 AAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE 205
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 37/126 (29%), Positives = 63/126 (50%), Gaps = 7/126 (5%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRD-KFLPESIIRNMMYQVLQ 415
+K++ H NLV+L V Y + E+M NL +R+ + + + ++ M Q+
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST----RWYRAP 471
+ ++ + F HRD+ N L LVK+ADFGL+R + YT + +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT-AP 181
Query: 472 EVLLHS 477
E L ++
Sbjct: 182 ESLAYN 187
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 29/133 (21%), Positives = 58/133 (43%), Gaps = 12/133 (9%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+ L+H N+VKL ++ V E++ +LY + D+ + S+ +M + G
Sbjct: 77 MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 417 LAFMHRHGFF--HRDMKPENLL-----CMGTELVKIADFGLAREIRSRPYTDYVSTRWYR 469
+ +M HRD++ N+ K+ADFGL+++ + + +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-SVHSVSGLLGNFQWM 193
Query: 470 APEVLLH-STAYS 481
APE + +Y+
Sbjct: 194 APETIGAEEESYT 206
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 2e-20
Identities = 37/171 (21%), Positives = 61/171 (35%), Gaps = 18/171 (10%)
Query: 328 YTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM- 386
+D S + + S N V + LY +
Sbjct: 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCR 144
Query: 387 KENLYQLIRDR--DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVK 444
KENL + R + + ++ Q+ + + F+H G HRD+KP N+ ++VK
Sbjct: 145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVK 204
Query: 445 IADFGLAREI--------------RSRPYTDYVSTRWYRAPEVLLHSTAYS 481
+ DFGL + +T V T+ Y +PE +H YS
Sbjct: 205 VGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ-IHGNNYS 254
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 38/127 (29%), Positives = 63/127 (49%), Gaps = 10/127 (7%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDK--FLPESIIRNMMYQVL 414
L +++H N+VKL + V EY + +LY ++ + + + + Q
Sbjct: 55 LSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 415 QGLAFMHRH---GFFHRDMKPEN-LLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRA 470
QG+A++H HRD+KP N LL G ++KI DFG A +I++ T+ + + A
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-MTNNKGSAAWMA 171
Query: 471 PEVLLHS 477
PEV S
Sbjct: 172 PEVFEGS 178
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 35/132 (26%), Positives = 56/132 (42%), Gaps = 17/132 (12%)
Query: 337 HILSRHVS--------SRDEMVVC-FYR--KSLKKLSHANLVKL----KEVIRENDTLYF 381
R V+ +RD F R ++ L+H +V + + Y
Sbjct: 34 LRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 93
Query: 382 VFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT 440
V EY+ L ++ P+ I ++ Q L F H++G HRD+KP N++ T
Sbjct: 94 VMEYVDGVTLRDIVHTEGPMTPKRAIE-VIADACQALNFSHQNGIIHRDVKPANIMISAT 152
Query: 441 ELVKIADFGLAR 452
VK+ DFG+AR
Sbjct: 153 NAVKVMDFGIAR 164
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 40/153 (26%), Positives = 65/153 (42%), Gaps = 28/153 (18%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYF------VFEYMKENLYQLIRDRDKF-LPESIIRNMM 410
L+ L+ + ++ + VFE + + Y I++ IR M
Sbjct: 65 LEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMA 124
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL-------------------VKIADFGLA 451
YQ+ + + F+H + H D+KPEN+L + ++ +K+ DFG A
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 452 REIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPI 484
T VSTR YRAPEV+L + +S P
Sbjct: 185 TYDDEHHST-LVSTRHYRAPEVIL-ALGWSQPC 215
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-20
Identities = 39/153 (25%), Positives = 66/153 (43%), Gaps = 28/153 (18%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYF------VFEYMKENLYQLIRDRDKF-LPESIIRNMM 410
LKK+ + + +D F FE + +N ++ +++ + P +R+M
Sbjct: 70 LKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMA 129
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLL-------------------CMGTELVKIADFGLA 451
YQ+ L F+H + H D+KPEN+L + +++ADFG A
Sbjct: 130 YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 452 REIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPI 484
T V+TR YR PEV+L ++ P
Sbjct: 190 TFDHEHHTT-IVATRHYRPPEVIL-ELGWAQPC 220
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 7e-20
Identities = 48/146 (32%), Positives = 74/146 (50%), Gaps = 15/146 (10%)
Query: 338 ILSRHVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQL 393
IL+R ++V R ++LK H +++KL +VI ++ V EY+ E L+
Sbjct: 48 ILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGE-LFDY 106
Query: 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE 453
I + L E R + Q+L G+ + HRH HRD+KPEN+L KIADFGL+
Sbjct: 107 ICKNGR-LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165
Query: 454 IRSRPYTDYVSTRW-----YRAPEVL 474
+ +++ T Y APEV+
Sbjct: 166 MSD---GEFLRT-SCGSPNYAAPEVI 187
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 22/133 (16%), Positives = 49/133 (36%), Gaps = 11/133 (8%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+ KLSH +LV V D V E++K +L ++ + + Q+
Sbjct: 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA 125
Query: 417 LAFMHRHGFFHRDM--------KPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWY 468
+ F+ + H ++ + E+ +K++D G++ + + W
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL-QERIPWV 184
Query: 469 RAPEVLLHSTAYS 481
PE + + +
Sbjct: 185 -PPECIENPKNLN 196
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 9e-20
Identities = 23/132 (17%), Positives = 49/132 (37%), Gaps = 10/132 (7%)
Query: 358 LKKLSHANLVKLKEVIREND--TLYFVFEYMKENLYQLIRD------RDKFLPESIIRNM 409
+K +++++ R+ + +F++ M+ NL K L +
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211
Query: 410 MYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYR 469
QV++ LA +H +G H ++P +++ V + F R +R +
Sbjct: 212 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGARVVSSVSRGFE 269
Query: 470 APEVLLHSTAYS 481
PE+ S
Sbjct: 270 PPELEARRATIS 281
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 39/123 (31%), Positives = 60/123 (48%), Gaps = 4/123 (3%)
Query: 358 LKKLSHANLVKLKEVI-RENDTLYFVFEYMKE-NLYQLIRDRD-KFLPESIIRNMMYQVL 414
+ +L H+NLV+L VI E LY V EYM + +L +R R L + V
Sbjct: 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 127
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVL 474
+ + ++ + F HRD+ N+L + K++DFGL +E S T + +W APE L
Sbjct: 128 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT-APEAL 186
Query: 475 LHS 477
Sbjct: 187 REK 189
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 27/126 (21%), Positives = 55/126 (43%), Gaps = 10/126 (7%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+ + + ++ +L + T+ + + M L +R+ + + N Q+ +G
Sbjct: 71 MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST------RWYRA 470
+ ++ HRD+ N+L + VKI DFGLA+ + + Y + +W A
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-YHAEGGKVPIKWM-A 187
Query: 471 PEVLLH 476
E +LH
Sbjct: 188 LESILH 193
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 35/135 (25%), Positives = 55/135 (40%), Gaps = 12/135 (8%)
Query: 358 LKKLSHANLVKLKEVIRENDT--LYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVL 414
LK L H N+VK K V L + EY+ +L ++ + + + Q+
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST-------RW 467
+G+ ++ + HRD+ N+L VKI DFGL + + + W
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF-FKVKEPGESPIFW 183
Query: 468 YRAPEVLLHSTAYSA 482
Y APE L S A
Sbjct: 184 Y-APESLTESKFSVA 197
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 36/144 (25%), Positives = 57/144 (39%), Gaps = 27/144 (18%)
Query: 358 LKKLS-HANLVKL-------KEVIRENDTLYFVFEYMKEN--LYQLIRDRDK-FLPESII 406
+KKLS H N+V+ KE + + + + + L + + L +
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV 138
Query: 407 RNMMYQVLQGLAFMHRHG--FFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVS 464
+ YQ + + MHR HRD+K ENLL +K+ DFG A I P + +
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 465 TRW--------------YRAPEVL 474
R YR PE++
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEII 222
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 1e-19
Identities = 34/157 (21%), Positives = 67/157 (42%), Gaps = 27/157 (17%)
Query: 335 DNHILSRHV------SSRDEMVVC-FYR--KSLKKLSHANLVKLKEVIREND-----TLY 380
D ++ R V S D + L ++ H ++V++ + D Y
Sbjct: 101 DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY 160
Query: 381 FVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG 439
V EY+ ++L + + LP + + ++L L+++H G + D+KPEN++ +
Sbjct: 161 IVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIM-LT 216
Query: 440 TELVKIADFGLAREIRSRPYTDY---VSTRWYRAPEV 473
E +K+ D G I + T ++APE+
Sbjct: 217 EEQLKLIDLGAVSRI-----NSFGYLYGTPGFQAPEI 248
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 36/127 (28%), Positives = 51/127 (40%), Gaps = 11/127 (8%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+ L H NL++L V+ + V E +L +R + QV +G
Sbjct: 75 MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST-------RWYR 469
+ ++ F HRD+ NLL +LVKI DFGL R + YV W
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND-DHYVMQEHRKVPFAWC- 191
Query: 470 APEVLLH 476
APE L
Sbjct: 192 APESLKT 198
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 33/127 (25%), Positives = 58/127 (45%), Gaps = 13/127 (10%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+++ H ++VKL VI E + ++ + E L ++ R L + + YQ+
Sbjct: 70 MRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST-------RWYR 469
LA++ F HRD+ N+L + VK+ DFGL+R + + Y +W
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKLPIKWM- 184
Query: 470 APEVLLH 476
APE +
Sbjct: 185 APESINF 191
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 41/127 (32%), Positives = 67/127 (52%), Gaps = 8/127 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRD-KFLPESIIRNMMYQVLQ 415
+K+L H LV+L V+ + + +Y + EYM+ +L ++ L + + +M Q+ +
Sbjct: 62 MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST----RWYRAP 471
G+AF+ + HRD++ N+L T KIADFGLAR I YT +W AP
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT-AP 179
Query: 472 EVLLHST 478
E + + T
Sbjct: 180 EAINYGT 186
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 4e-19
Identities = 36/127 (28%), Positives = 63/127 (49%), Gaps = 7/127 (5%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDK-FLPESIIRNMMYQVLQ 415
+K++ H NLV+L V Y + E+M NL +R+ ++ + ++ M Q+
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST----RWYRAP 471
+ ++ + F HR++ N L LVK+ADFGL+R + YT + +W AP
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT-AP 388
Query: 472 EVLLHST 478
E L ++
Sbjct: 389 ESLAYNK 395
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 35/134 (26%), Positives = 58/134 (43%), Gaps = 10/134 (7%)
Query: 358 LKKLSHANLVKLKEVIRENDT--LYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVL 414
L+ L H N+VK K + E+ + + E++ +L + + + Q+
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC 136
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST------RWY 468
+G+ ++ + HRD+ N+L VKI DFGL + I + V WY
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY 196
Query: 469 RAPEVLLHSTAYSA 482
APE L+ S Y A
Sbjct: 197 -APECLMQSKFYIA 209
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 19/127 (14%), Positives = 46/127 (36%), Gaps = 11/127 (8%)
Query: 358 LKKLSHANLVKLKEVIRE--NDTLYFVFEYMKE-NLYQLIRD-RDKFLPESIIRNMMYQV 413
L+ SH N++ + + + +M +LY ++ + + + +S +
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 414 LQGLAFMHRHGFF--HRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST-RWYRA 470
+G+AF+H + +++ +I+ + +S + W A
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS---PGRMYAPAWV-A 176
Query: 471 PEVLLHS 477
PE L
Sbjct: 177 PEALQKK 183
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 31/127 (24%), Positives = 62/127 (48%), Gaps = 11/127 (8%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+ +L + +V+L V + + L V E L++ + + + +P S + +++QV G
Sbjct: 64 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 122
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST-------RWYR 469
+ ++ F HRD+ N+L + KI+DFGL++ + + Y + +WY
Sbjct: 123 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTARSAGKWPLKWY- 180
Query: 470 APEVLLH 476
APE +
Sbjct: 181 APECINF 187
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-19
Identities = 39/122 (31%), Positives = 60/122 (49%), Gaps = 4/122 (3%)
Query: 358 LKKLSHANLVKLKEVI-RENDTLYFVFEYMKE-NLYQLIRDRD-KFLPESIIRNMMYQVL 414
+ +L H+NLV+L VI E LY V EYM + +L +R R L + V
Sbjct: 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 299
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVL 474
+ + ++ + F HRD+ N+L + K++DFGL +E S T + +W APE L
Sbjct: 300 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT-APEAL 358
Query: 475 LH 476
Sbjct: 359 RE 360
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 30/126 (23%), Positives = 63/126 (50%), Gaps = 10/126 (7%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+++L + +V++ + E ++ V E + L + ++ ++II +++QV G
Sbjct: 72 MQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII-ELVHQVSMG 129
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST------RWYRA 470
+ ++ F HRD+ N+L + KI+DFGL++ +R+ T +WY A
Sbjct: 130 MKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-A 188
Query: 471 PEVLLH 476
PE + +
Sbjct: 189 PECINY 194
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 36/135 (26%), Positives = 55/135 (40%), Gaps = 12/135 (8%)
Query: 358 LKKLSHANLVKLKEVIRENDT--LYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVL 414
LK L H N+VK K V L + EY+ +L ++ + + + Q+
Sbjct: 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 155
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST-------RW 467
+G+ ++ + HRD+ N+L VKI DFGL + + Y W
Sbjct: 156 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY-YKVKEPGESPIFW 214
Query: 468 YRAPEVLLHSTAYSA 482
Y APE L S A
Sbjct: 215 Y-APESLTESKFSVA 228
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 32/127 (25%), Positives = 53/127 (41%), Gaps = 13/127 (10%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+K L H ++VKL +I E + + + E L + L + Q+ +
Sbjct: 67 MKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST-------RWYR 469
+A++ HRD+ N+L E VK+ DFGL+R I DY +W
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED---EDYYKASVTRLPIKWM- 181
Query: 470 APEVLLH 476
+PE +
Sbjct: 182 SPESINF 188
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 9e-19
Identities = 29/129 (22%), Positives = 53/129 (41%), Gaps = 28/129 (21%)
Query: 382 VFEYMKENLYQLIRDRDKF-LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLL---- 436
+FE + +LY++I + I+ ++L+ L ++ + H D+KPEN+L
Sbjct: 114 IFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDP 173
Query: 437 ---------------------CMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLL 475
+ +K+ DFG A + ++TR YRAPEV+L
Sbjct: 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGS-IINTRQYRAPEVIL 232
Query: 476 HSTAYSAPI 484
+ +
Sbjct: 233 -NLGWDVSS 240
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 29/129 (22%), Positives = 56/129 (43%), Gaps = 12/129 (9%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+ L HA++V+L + +L V +Y+ +L +R L ++ N Q+ +G
Sbjct: 69 IGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST-------RWYR 469
+ ++ HG HR++ N+L V++ADFG+A + + +W
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK--QLLYSEAKTPIKWM- 184
Query: 470 APEVLLHST 478
A E +
Sbjct: 185 ALESIHFGK 193
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-18
Identities = 39/127 (30%), Positives = 66/127 (51%), Gaps = 8/127 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDRD-KFLPESIIRNMMYQVLQ 415
+K L H LVKL V+ + + +Y + E+M K +L ++ + P + + Q+ +
Sbjct: 237 MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 295
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST----RWYRAP 471
G+AF+ + + HRD++ N+L + + KIADFGLAR I YT +W AP
Sbjct: 296 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT-AP 354
Query: 472 EVLLHST 478
E + +
Sbjct: 355 EAINFGS 361
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 37/135 (27%), Positives = 53/135 (39%), Gaps = 12/135 (8%)
Query: 358 LKKLSHANLVKLKEVIRENDT--LYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVL 414
LK L +VK + V L V EY+ L ++ L S + Q+
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST-------RW 467
+G+ ++ HRD+ N+L VKIADFGLA+ + YV W
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY-YVVREPGQSPIFW 196
Query: 468 YRAPEVLLHSTAYSA 482
Y APE L +
Sbjct: 197 Y-APESLSDNIFSRQ 210
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 41/121 (33%), Positives = 60/121 (49%), Gaps = 2/121 (1%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
L+KL H N ++ + T + V EY + L+ K L E I + + LQGL
Sbjct: 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHS 477
A++H H HRD+K N+L LVK+ DFG A + +V T ++ APEV+L
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--NSFVGTPYWMAPEVILAM 225
Query: 478 T 478
Sbjct: 226 D 226
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-18
Identities = 44/127 (34%), Positives = 67/127 (52%), Gaps = 8/127 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDRD-KFLPESIIRNMMYQVLQ 415
+KKL H LV+L V+ E + +Y V EYM K +L ++ K+L + +M Q+
Sbjct: 233 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST----RWYRAP 471
G+A++ R + HRD++ N+L + K+ADFGLAR I YT +W AP
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-AP 350
Query: 472 EVLLHST 478
E L+
Sbjct: 351 EAALYGR 357
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 27/126 (21%), Positives = 55/126 (43%), Gaps = 10/126 (7%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+ + + ++ +L + T+ + + M L +R+ + + N Q+ +G
Sbjct: 71 MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST------RWYRA 470
+ ++ HRD+ N+L + VKI DFGLA+ + + Y + +W A
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-YHAEGGKVPIKWM-A 187
Query: 471 PEVLLH 476
E +LH
Sbjct: 188 LESILH 193
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 4e-18
Identities = 23/148 (15%), Positives = 49/148 (33%), Gaps = 13/148 (8%)
Query: 338 ILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIREND-----TLYFVFEYMKENLYQ 392
+L + + V + + K+ V + + +F++ M+ NL
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193
Query: 393 LIR------DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIA 446
K L + QV++ LA +H +G H ++P +++ V +
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 253
Query: 447 DFGLAREIRSRPYTDYVSTRWYRAPEVL 474
F + + R + PE
Sbjct: 254 GFEHLVRDGASAVSP--IGRGFAPPETT 279
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 37/130 (28%), Positives = 58/130 (44%), Gaps = 14/130 (10%)
Query: 358 LKKLSHANLVKLKEV-IRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQ 415
++ L+H N++ L + + + + YM +L Q IR + + + QV +
Sbjct: 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVAR 135
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLAREIRSRPYTDYVST-------R 466
G+ ++ F HRD+ N CM E VK+ADFGLAR+I R Y +
Sbjct: 136 GMEYLAEQKFVHRDLAARN--CMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK 193
Query: 467 WYRAPEVLLH 476
W A E L
Sbjct: 194 WT-ALESLQT 202
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 29/120 (24%), Positives = 52/120 (43%), Gaps = 2/120 (1%)
Query: 357 SLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQG 416
LK +V+ N ++ E M +L + +PE I+ M +++
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 417 LAFMH-RHGFFHRDMKPENLLCMGTELVKIADFGLARE-IRSRPYTDYVSTRWYRAPEVL 474
L ++ +HG HRD+KP N+L +K+ DFG++ + + Y APE +
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERI 196
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 27/122 (22%), Positives = 53/122 (43%), Gaps = 5/122 (4%)
Query: 357 SLKKLSHANLVKLKEVIRENDTLYFVFEYM---KENLYQLIRDRDKFLPESIIRNMMYQV 413
S++ + V + ++ E M + Y+ + D+ + +PE I+ + +
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 414 LQGLAFMH-RHGFFHRDMKPENLLCMGTELVKIADFGLARE-IRSRPYTDYVSTRWYRAP 471
++ L +H + HRD+KP N+L VK+ DFG++ + + Y AP
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAP 178
Query: 472 EV 473
E
Sbjct: 179 ER 180
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 9e-18
Identities = 44/127 (34%), Positives = 67/127 (52%), Gaps = 8/127 (6%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDRD-KFLPESIIRNMMYQVLQ 415
+KKL H LV+L V+ E + +Y V EYM K +L ++ K+L + +M Q+
Sbjct: 316 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 374
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST----RWYRAP 471
G+A++ R + HRD++ N+L + K+ADFGLAR I YT +W AP
Sbjct: 375 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-AP 433
Query: 472 EVLLHST 478
E L+
Sbjct: 434 EAALYGR 440
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 37/123 (30%), Positives = 65/123 (52%), Gaps = 5/123 (4%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQ 412
++ L+ ++ LVKL+ ++N LY V EY+ E ++ +R +F E R Q
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE-MFSHLRRIGRF-SEPHARFYAAQ 149
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPE 472
++ ++H +RD+KPENLL +++ DFG A+ ++ R +T T APE
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-LCGTPEALAPE 208
Query: 473 VLL 475
++L
Sbjct: 209 IIL 211
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 33/130 (25%), Positives = 64/130 (49%), Gaps = 5/130 (3%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
L H +VKL + L+ + E+ + ++ + D+ L E I+ + Q+L+
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLA---REIRSRPYTDYVSTRWYRAPEV 473
L F+H HRD+K N+L +++ADFG++ + + + ++ T ++ APEV
Sbjct: 130 LNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEV 188
Query: 474 LLHSTAYSAP 483
++ T P
Sbjct: 189 VMCETMKDTP 198
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 4e-17
Identities = 26/128 (20%), Positives = 50/128 (39%), Gaps = 11/128 (8%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDR-DKFLPESIIRNMMYQVLQ 415
K +H N+V + ++ L+ V +M + LI + E I ++ VL+
Sbjct: 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLA---------REIRSRPYTDYVSTR 466
L ++H G+ HR +K ++L V ++ + + V
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 467 WYRAPEVL 474
+ +PEVL
Sbjct: 200 PWLSPEVL 207
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 39/136 (28%), Positives = 60/136 (44%), Gaps = 16/136 (11%)
Query: 358 LKKLSHANLVKLKEVIRENDT--LYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVL 414
L+ L H +++K K + L V EY+ +L + L + + Q+
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQ--LLLFAQQIC 144
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDY--VST------R 466
+G+A++H + HRD+ N+L LVKI DFGLA+ + +Y V
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH--EYYRVREDGDSPVF 202
Query: 467 WYRAPEVLLHSTAYSA 482
WY APE L Y A
Sbjct: 203 WY-APECLKEYKFYYA 217
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 41/144 (28%), Positives = 63/144 (43%), Gaps = 30/144 (20%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDR---------------DKFL 401
L L H ++VK V + D L VFEYMK +L + +R L
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 402 PESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLAREIRSRPY 459
S + ++ Q+ G+ ++ F HRD+ N C+ LVKI DFG++R++ S Y
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRN--CLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 460 TDYVST-------RWYRAPEVLLH 476
Y RW PE +++
Sbjct: 189 --YRVGGHTMLPIRWM-PPESIMY 209
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 7e-17
Identities = 34/128 (26%), Positives = 55/128 (42%), Gaps = 10/128 (7%)
Query: 358 LKKLSHANLVKLKEVIRENDT-LYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQ 415
+K SH N++ L + ++ V YMK +L IR+ + QV +
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 203
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST-------RWY 468
G+ F+ F HRD+ N + VK+ADFGLAR++ + + + +W
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 469 RAPEVLLH 476
A E L
Sbjct: 264 -ALESLQT 270
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 8e-17
Identities = 32/127 (25%), Positives = 57/127 (44%), Gaps = 13/127 (10%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+++ H ++VKL VI + ++ + E L ++ R L + + YQ+
Sbjct: 445 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST-------RWYR 469
LA++ F HRD+ N+L + VK+ DFGL+R + + Y +W
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKLPIKWM- 559
Query: 470 APEVLLH 476
APE +
Sbjct: 560 APESINF 566
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 9e-17
Identities = 33/124 (26%), Positives = 54/124 (43%), Gaps = 3/124 (2%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQ 412
++ L+K++ +V L D L V M + + + PE+ +
Sbjct: 235 KQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE 294
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD-YVSTRWYRAP 471
+ GL +HR +RD+KPEN+L ++I+D GLA + V T Y AP
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAP 354
Query: 472 EVLL 475
EV+
Sbjct: 355 EVVK 358
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 9e-17
Identities = 30/127 (23%), Positives = 62/127 (48%), Gaps = 11/127 (8%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+ +L + +V+L V + + L V E L++ + + + +P S + +++QV G
Sbjct: 390 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 448
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST-------RWYR 469
+ ++ F HR++ N+L + KI+DFGL++ + + Y + +WY
Sbjct: 449 MKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTARSAGKWPLKWY- 506
Query: 470 APEVLLH 476
APE +
Sbjct: 507 APECINF 513
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 36/120 (30%), Positives = 63/120 (52%), Gaps = 5/120 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+++ ++VK +N L+ V EY ++ +IR R+K L E I ++ L+G
Sbjct: 78 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKG 137
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI---RSRPYTDYVSTRWYRAPEV 473
L ++H HRD+K N+L K+ADFG+A ++ ++ T + T ++ APEV
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFWMAPEV 196
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 38/130 (29%), Positives = 60/130 (46%), Gaps = 14/130 (10%)
Query: 358 LKKLSHANLVKLKEVIREND-TLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQ 415
+K SH N++ L + ++ + V YMK +L IR+ + QV +
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 139
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLAREIRSR-PYTDYVST------R 466
G+ ++ F HRD+ N CM E VK+ADFGLAR++ + Y+ + T +
Sbjct: 140 GMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197
Query: 467 WYRAPEVLLH 476
W A E L
Sbjct: 198 WM-ALESLQT 206
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 8/127 (6%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQ 412
R + +L H VKL ++++ LYF Y K E L + + F E+ R +
Sbjct: 81 RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SF-DETCTRFYTAE 138
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD----YVSTRWY 468
++ L ++H G HRD+KPEN+L ++I DFG A+ + +V T Y
Sbjct: 139 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198
Query: 469 RAPEVLL 475
+PE+L
Sbjct: 199 VSPELLT 205
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 32/137 (23%), Positives = 51/137 (37%), Gaps = 21/137 (15%)
Query: 357 SLKKLSHANLVKL----KEVIRENDTLYFVFEYM-KENLYQLIRDRDKFLPESIIRNMMY 411
L H N++ + L+ V +Y +L+ + + + +
Sbjct: 89 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLAL 146
Query: 412 QVLQGLAFMH--------RHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYV 463
GLA +H + HRD+K +N+L IAD GLA S T +
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 206
Query: 464 S------TRWYRAPEVL 474
+ T+ Y APEVL
Sbjct: 207 APNHRVGTKRYMAPEVL 223
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 34/152 (22%), Positives = 53/152 (34%), Gaps = 21/152 (13%)
Query: 357 SLKKLSHANLVKL----KEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMY 411
+ L H N++ + L+ + Y + +LY ++ L ++
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVL 112
Query: 412 QVLQGLAFMHRHGFF--------HRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYV 463
+ GLA +H F HRD+K +N+L IAD GLA V
Sbjct: 113 SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV 172
Query: 464 S------TRWYRAPEVLLHSTAYSAPIHLSRS 489
T+ Y APEVL + R
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRV 204
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 32/137 (23%), Positives = 52/137 (37%), Gaps = 21/137 (15%)
Query: 357 SLKKLSHANLVKL----KEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMY 411
+ H N++ + LY + +Y + +LY ++ L + + Y
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAY 141
Query: 412 QVLQGLAFMHRHGFF--------HRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYV 463
+ GL +H F HRD+K +N+L IAD GLA + S +
Sbjct: 142 SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDI 201
Query: 464 S------TRWYRAPEVL 474
T+ Y PEVL
Sbjct: 202 PPNTRVGTKRYMPPEVL 218
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 35/139 (25%), Positives = 61/139 (43%), Gaps = 17/139 (12%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--------ENLYQLIRDRDKFLPESIIRNM 409
+ + H N+V D L+ V + + +++ + L ES I +
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 410 MYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTR--- 466
+ +VL+GL ++H++G HRD+K N+L V+IADFG++ + + R
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 467 -----WYRAPEVLLHSTAY 480
W APEV+ Y
Sbjct: 187 VGTPCWM-APEVMEQVRGY 204
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-16
Identities = 37/145 (25%), Positives = 69/145 (47%), Gaps = 8/145 (5%)
Query: 338 ILSRHVSSRDEMVVCFY--RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQL 393
I+++ + V CF R L + +L ++ + LY V EY + L L
Sbjct: 93 IMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL 152
Query: 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE 453
+ ++ P + R + +++ + +HR G+ HRD+KP+N+L +++ADFG +
Sbjct: 153 SKFGERI-PAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211
Query: 454 IRSRPYTD---YVSTRWYRAPEVLL 475
+R+ V T Y +PE+L
Sbjct: 212 LRADGTVRSLVAVGTPDYLSPEILQ 236
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 7e-16
Identities = 35/146 (23%), Positives = 67/146 (45%), Gaps = 10/146 (6%)
Query: 338 ILSRHVSSRDEMVVCFY--RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQL 393
IL++ + CF R L + L ++++ LY V +Y + L L
Sbjct: 106 ILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL 165
Query: 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE 453
+ D+ PE + R + +++ + +H+ + HRD+KP+N+L +++ADFG +
Sbjct: 166 SKFEDRL-PEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224
Query: 454 IRS----RPYTDYVSTRWYRAPEVLL 475
+ + V T Y +PE+L
Sbjct: 225 LMEDGTVQSSV-AVGTPDYISPEILQ 249
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 8e-16
Identities = 37/129 (28%), Positives = 59/129 (45%), Gaps = 10/129 (7%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYM-----KENLYQLIRDRDKFLPESIIRNM 409
+K L K+ +V L L V M + ++Y + D F E
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF-QEPRAIFY 294
Query: 410 MYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI---RSRPYTDYVSTR 466
Q++ GL +H+ +RD+KPEN+L V+I+D GLA E+ +++ Y T
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTP 353
Query: 467 WYRAPEVLL 475
+ APE+LL
Sbjct: 354 GFMAPELLL 362
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 9e-16
Identities = 35/130 (26%), Positives = 65/130 (50%), Gaps = 19/130 (14%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMY- 411
R L ++H ++++ ++ ++ + +Y++ E L+ L+R +F P + + Y
Sbjct: 57 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGE-LFSLLRKSQRF-PNPVAK--FYA 112
Query: 412 -QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT-----DYVST 465
+V L ++H +RD+KPEN+L +KI DFG A+ + YT DY+
Sbjct: 113 AEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYI-- 170
Query: 466 RWYRAPEVLL 475
APEV+
Sbjct: 171 ----APEVVS 176
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 34/130 (26%), Positives = 62/130 (47%), Gaps = 12/130 (9%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK----ENLYQLIRDRDKFLPESIIRNMMYQV 413
L + + +V + + E+M + + + + +PE I+ + V
Sbjct: 85 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAV 140
Query: 414 LQGLAFMH-RHGFFHRDMKPENLLCMGTELVKIADFGLARE-IRSRPYTDYVSTRWYRAP 471
++GL ++ +H HRD+KP N+L +K+ DFG++ + I S + +V TR Y +P
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSP 199
Query: 472 EVLLHSTAYS 481
E L T YS
Sbjct: 200 ER-LQGTHYS 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 18/128 (14%), Positives = 40/128 (31%), Gaps = 8/128 (6%)
Query: 337 HILSRHVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQL 393
+ D+++ L ++ + ++ +V+ V E+++ +L ++
Sbjct: 62 TFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEV 121
Query: 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE 453
P IR M + HR G P + V +A +
Sbjct: 122 ADTS--PSPVGAIR-AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPD 178
Query: 454 IRSRPYTD 461
+ P D
Sbjct: 179 --ANPQDD 184
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 42/144 (29%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 338 ILSRHVSSRDEMVVCFY--RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLI 394
+LS+ + F+ R + + +V+L +++ LY V EYM +L L+
Sbjct: 101 LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 160
Query: 395 RDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI 454
+ D +PE R +V+ L +H GF HRD+KP+N+L + +K+ADFG ++
Sbjct: 161 SNYD--VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218
Query: 455 RSRPYTD---YVSTRWYRAPEVLL 475
V T Y +PEVL
Sbjct: 219 NKEGMVRCDTAVGTPDYISPEVLK 242
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 39/132 (29%), Positives = 59/132 (44%), Gaps = 7/132 (5%)
Query: 355 RKSLKKLSHAN---LVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNM 409
R L +S + +V + D L F+ + M + Y L + F E+ +R
Sbjct: 240 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VF-SEADMRFY 297
Query: 410 MYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYR 469
+++ GL MH +RD+KP N+L V+I+D GLA + + V T Y
Sbjct: 298 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYM 357
Query: 470 APEVLLHSTAYS 481
APEVL AY
Sbjct: 358 APEVLQKGVAYD 369
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 32/136 (23%), Positives = 55/136 (40%), Gaps = 20/136 (14%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDR------DKFLPESIIRNMM 410
+ K +H N+V+ V ++ + + E M +L +R+ L + ++
Sbjct: 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLL--CMGTEL-VKIADFGLAREIRSRPYTDYVST-- 465
+ G ++ + F HRD+ N L C G KI DFG+AR+I Y Y
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY--YRKGGC 204
Query: 466 -----RWYRAPEVLLH 476
+W PE +
Sbjct: 205 AMLPVKWM-PPEAFME 219
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 39/143 (27%), Positives = 59/143 (41%), Gaps = 29/143 (20%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRN-------- 408
L L H ++V+ V E L VFEYM+ +L + +R
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 409 ------MMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLAREIRSRPYT 460
+ QV G+ ++ F HRD+ N C+ + +VKI DFG++R+I S Y
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRN--CLVGQGLVVKIGDFGMSRDIYSTDY- 213
Query: 461 DYVST-------RWYRAPEVLLH 476
Y RW PE +L+
Sbjct: 214 -YRVGGRTMLPIRWM-PPESILY 234
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 27/124 (21%), Positives = 51/124 (41%), Gaps = 6/124 (4%)
Query: 357 SLKKLSHANLVKLKEVIRENDTLYFVFEYMK---ENLY-QLIRDRDKFLPESIIRNMMYQ 412
++ +V+ + + E M + Y + D +PE I+ +
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 413 VLQGLAFMHR-HGFFHRDMKPENLLCMGTELVKIADFGLARE-IRSRPYTDYVSTRWYRA 470
++ L + HRD+KP N+L + +K+ DFG++ + + S T R Y A
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMA 193
Query: 471 PEVL 474
PE +
Sbjct: 194 PERI 197
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 34/142 (23%), Positives = 60/142 (42%), Gaps = 26/142 (18%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDR---------------DKFL 401
+L H N+V L V+ ++ L +F Y +L++ + R L
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 402 PESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD 461
+++ Q+ G+ ++ H H+D+ N+L VKI+D GL RE+ + Y
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY-- 183
Query: 462 YVST-------RWYRAPEVLLH 476
Y RW APE +++
Sbjct: 184 YKLLGNSLLPIRWM-APEAIMY 204
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 34/138 (24%), Positives = 59/138 (42%), Gaps = 24/138 (17%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRN-------- 408
+K+ + ++V+L V+ + + E M +L +R + + +
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 409 -MMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLAREIRSRPYTDYVST 465
M ++ G+A+++ + F HRD+ N CM E VKI DFG+ R+I Y Y
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARN--CMVAEDFTVKIGDFGMTRDIYETDY--YRKG 197
Query: 466 -------RWYRAPEVLLH 476
RW +PE L
Sbjct: 198 GKGLLPVRWM-SPESLKD 214
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 32/136 (23%), Positives = 55/136 (40%), Gaps = 20/136 (14%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDR------DKFLPESIIRNMM 410
+ K +H N+V+ V ++ + + E M +L +R+ L + ++
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLL--CMGTEL-VKIADFGLAREIRSRPYTDYVST-- 465
+ G ++ + F HRD+ N L C G KI DFG+AR+I Y Y
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY--YRKGGC 245
Query: 466 -----RWYRAPEVLLH 476
+W PE +
Sbjct: 246 AMLPVKWM-PPEAFME 260
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-15
Identities = 29/125 (23%), Positives = 58/125 (46%), Gaps = 5/125 (4%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQ 412
+ ++ L H LV L ++ + ++ V + + + Y L ++ F E ++ + +
Sbjct: 66 LQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV-HF-KEETVKLFICE 123
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVS-TRWYRAP 471
++ L ++ HRDMKP+N+L V I DF +A + ++ T+ Y AP
Sbjct: 124 LVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAP 183
Query: 472 EVLLH 476
E+
Sbjct: 184 EMFSS 188
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 33/139 (23%), Positives = 57/139 (41%), Gaps = 25/139 (17%)
Query: 358 LKKLSHANLVKL-----KEVIRENDTLYFVFEYMKE-NLYQLIRDR-----DKFLPESII 406
+K SH N+++L + + + +MK +L+ + K +P +
Sbjct: 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149
Query: 407 RNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLAREIRSRPYTDYVS 464
M + G+ ++ F HRD+ N CM + V +ADFGL+++I S Y Y
Sbjct: 150 LKFMVDIALGMEYLSNRNFLHRDLAARN--CMLRDDMTVCVADFGLSKKIYSGDY--YRQ 205
Query: 465 T-------RWYRAPEVLLH 476
+W A E L
Sbjct: 206 GRIAKMPVKWI-AIESLAD 223
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 35/120 (29%), Positives = 61/120 (50%), Gaps = 7/120 (5%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
+++ + N+V + D L+ V EY+ +L ++ + + E I + + LQ
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQA 128
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI---RSRPYTDYVSTRWYRAPEV 473
L F+H + HRD+K +N+L VK+ DFG +I +S+ T V T ++ APEV
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEV 187
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 34/124 (27%), Positives = 63/124 (50%), Gaps = 7/124 (5%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
L + + K ++ L+ + EY+ + L+ L E+ I ++ ++L+G
Sbjct: 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKG 131
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI---RSRPYTDYVSTRWYRAPEV 473
L ++H HRD+K N+L VK+ADFG+A ++ + + T +V T ++ APEV
Sbjct: 132 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEV 190
Query: 474 LLHS 477
+ S
Sbjct: 191 IKQS 194
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 34/140 (24%), Positives = 53/140 (37%), Gaps = 26/140 (18%)
Query: 358 LKKLSHANLVKL------KEVIRENDTLYFVFEYMKE-NLYQLIRDR-----DKFLPESI 405
+K+ H ++ KL + +MK +L+ + LP
Sbjct: 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138
Query: 406 IRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLAREIRSRPYTDYV 463
+ M + G+ ++ F HRD+ N CM E V +ADFGL+R+I S Y Y
Sbjct: 139 LVRFMVDIACGMEYLSSRNFIHRDLAARN--CMLAEDMTVCVADFGLSRKIYSGDY--YR 194
Query: 464 ST-------RWYRAPEVLLH 476
+W A E L
Sbjct: 195 QGCASKLPVKWL-ALESLAD 213
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 34/146 (23%), Positives = 61/146 (41%), Gaps = 21/146 (14%)
Query: 357 SLKKLSHANLVKL----KEVIRENDTLYFVFEYM-KENLYQLIRDRDKFLPESIIRNMMY 411
SL + H N+++ K + L+ + + K +L ++ + + + ++
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAE 128
Query: 412 QVLQGLAFMHRHGFF----------HRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD 461
+ +GLA++H HRD+K +N+L IADFGLA + +
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 462 Y----VSTRWYRAPEVLLHSTAYSAP 483
V TR Y APEVL + +
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRD 214
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 17/140 (12%)
Query: 358 LKKLS-HANLVKL------KEVIRENDTLYFVFEYMK----ENLYQLIRDRDKFLPESII 406
LKK S H N+ K +D L+ V E+ +L + + L E I
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWI 131
Query: 407 RNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI---RSRPYTDYV 463
+ ++L+GL+ +H+H HRD+K +N+L VK+ DFG++ ++ R T ++
Sbjct: 132 AYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FI 190
Query: 464 STRWYRAPEVLLHSTAYSAP 483
T ++ APEV+ A
Sbjct: 191 GTPYWMAPEVIACDENPDAT 210
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 35/141 (24%), Positives = 53/141 (37%), Gaps = 25/141 (17%)
Query: 358 LKKL-SHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRN------- 408
+ L H N+V L + + EY +L +R + + L
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 409 ------MMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDY 462
QV QG+AF+ HRD+ N+L + KI DFGLAR+I + Y
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN--Y 220
Query: 463 VST-------RWYRAPEVLLH 476
+ +W APE +
Sbjct: 221 IVKGNARLPVKWM-APESIFD 240
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 33/121 (27%), Positives = 62/121 (51%), Gaps = 7/121 (5%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQG 416
++ H N+V++ + + L+ + E+++ L ++ L E I + VLQ
Sbjct: 96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQA 153
Query: 417 LAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI---RSRPYTDYVSTRWYRAPEV 473
LA++H G HRD+K +++L VK++DFG +I + + V T ++ APEV
Sbjct: 154 LAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEV 212
Query: 474 L 474
+
Sbjct: 213 I 213
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 29/143 (20%), Positives = 48/143 (33%), Gaps = 27/143 (18%)
Query: 357 SLKKLSHANLVKL-----KEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMM 410
+ + H N+ + + V EY +L + + +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLA 117
Query: 411 YQVLQGLAFMH---------RHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD 461
+ V +GLA++H + HRD+ N+L I+DFGL+ +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 462 Y----------VSTRWYRAPEVL 474
V T Y APEVL
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVL 200
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 40/152 (26%), Positives = 61/152 (40%), Gaps = 38/152 (25%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDR------------------- 397
+ + + N+VKL V + +FEYM +L + +R
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 398 ----DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLA 451
L + + QV G+A++ F HRD+ N C+ E +VKIADFGL+
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN--CLVGENMVVKIADFGLS 221
Query: 452 REIRSRPYTDYVST-------RWYRAPEVLLH 476
R I S Y Y + RW PE + +
Sbjct: 222 RNIYSADY--YKADGNDAIPIRWM-PPESIFY 250
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 33/152 (21%), Positives = 59/152 (38%), Gaps = 38/152 (25%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK------------------------ENLYQL 393
LK+++H +++KL ++ L + EY K N L
Sbjct: 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLA 451
++ L + + +Q+ QG+ ++ HRD+ N + E +KI+DFGL+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN--ILVAEGRKMKISDFGLS 197
Query: 452 REIRSRPYTDYVST-------RWYRAPEVLLH 476
R++ YV +W A E L
Sbjct: 198 RDVYEEDS--YVKRSQGRIPVKWM-AIESLFD 226
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 9e-13
Identities = 38/152 (25%), Positives = 59/152 (38%), Gaps = 31/152 (20%)
Query: 358 LKKL-SHANLVKLKEVIRENDTLYFVFEYMK------------------ENLYQLIRDRD 398
L L +H N+V L + EY + ++ D +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP 458
L + + YQV +G+AF+ HRD+ N+L + KI DFGLAR+I++
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 459 YTDYVST-------RWYRAPEVLLHS--TAYS 481
YV +W APE + + T S
Sbjct: 200 N--YVVKGNARLPVKWM-APESIFNCVYTFES 228
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-13
Identities = 38/143 (26%), Positives = 60/143 (41%), Gaps = 27/143 (18%)
Query: 358 LKKL-SHANLVKLKEVIRENDTLYFVFEYMK----------------ENLYQLIRDRDKF 400
+K + H N++ L ++ LY + EY E Y + ++
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 401 LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT 460
L + + YQV +G+ ++ HRD+ N+L ++KIADFGLAR+I Y
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY- 246
Query: 461 DYVST-------RWYRAPEVLLH 476
Y T +W APE L
Sbjct: 247 -YKKTTNGRLPVKWM-APEALFD 267
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 41/125 (32%), Positives = 58/125 (46%), Gaps = 6/125 (4%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQ 412
+ L+ H L LK + +D L FV EY E + L R+R F E R +
Sbjct: 56 SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VF-TEERARFYGAE 113
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE-IRSRPYTD-YVSTRWYRA 470
++ L ++H +RD+K ENL+ +KI DFGL +E I + T Y A
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173
Query: 471 PEVLL 475
PEVL
Sbjct: 174 PEVLE 178
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 38/145 (26%), Positives = 63/145 (43%), Gaps = 31/145 (21%)
Query: 358 LKKL-SHANLVKLKEVIRENDTLYFVFEYMK----------------ENLYQLIRDRDKF 400
+K + H N++ L ++ LY + EY E Y + R ++
Sbjct: 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 401 LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLAREIRSRP 458
+ + + YQ+ +G+ ++ HRD+ N + TE ++KIADFGLAR+I +
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN--VLVTENNVMKIADFGLARDINNID 211
Query: 459 YTDYVST-------RWYRAPEVLLH 476
Y Y T +W APE L
Sbjct: 212 Y--YKKTTNGRLPVKWM-APEALFD 233
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 40/155 (25%), Positives = 59/155 (38%), Gaps = 53/155 (34%)
Query: 381 FVFEYMKENLYQLIRD-RDKFLPESIIRNMMYQVLQGLAFMHRH-GFFHRDMKPENLLCM 438
VFE + +L + I + LP ++ ++ QVLQGL ++H H D+KPEN+L
Sbjct: 122 MVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS 181
Query: 439 GTE-------------------------------------------------LVKIADFG 449
E VKIAD G
Sbjct: 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLG 241
Query: 450 LAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPI 484
A + +T+ + TR YR+ EVL+ S Y+ P
Sbjct: 242 NAC-WVHKHFTEDIQTRQYRSLEVLIGS-GYNTPA 274
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 36/146 (24%), Positives = 53/146 (36%), Gaps = 32/146 (21%)
Query: 358 LKKL-SHANLVKLKEV-IRENDTLYFVFEYMK----------------ENLYQLIRDRDK 399
L + H N+V L + L + E+ K
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 400 FLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLAREIRSR 457
FL + +QV +G+ F+ HRD+ N + +E +VKI DFGLAR+I
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN--ILLSEKNVVKICDFGLARDIYKD 201
Query: 458 PYTDYVST-------RWYRAPEVLLH 476
P YV +W APE +
Sbjct: 202 PD--YVRKGDARLPLKWM-APETIFD 224
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 38/145 (26%), Positives = 63/145 (43%), Gaps = 31/145 (21%)
Query: 358 LKKL-SHANLVKLKEVIRENDTLYFVFEYMK----------------ENLYQLIRDRDKF 400
+K + H N++ L ++ LY + EY E Y + R ++
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 401 LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLAREIRSRP 458
+ + + YQ+ +G+ ++ HRD+ N + TE ++KIADFGLAR+I +
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN--VLVTENNVMKIADFGLARDINNID 257
Query: 459 YTDYVST-------RWYRAPEVLLH 476
Y Y T +W APE L
Sbjct: 258 Y--YKKTTNGRLPVKWM-APEALFD 279
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 41/126 (32%), Positives = 59/126 (46%), Gaps = 7/126 (5%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQ 412
+ L+ H L LK + +D L FV EY E + L R+R F E R +
Sbjct: 199 NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VF-SEDRARFYGAE 256
Query: 413 VLQGLAFMH-RHGFFHRDMKPENLLCMGTELVKIADFGLARE-IRSRPYTD-YVSTRWYR 469
++ L ++H +RD+K ENL+ +KI DFGL +E I+ + T Y
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYL 316
Query: 470 APEVLL 475
APEVL
Sbjct: 317 APEVLE 322
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 5e-12
Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 6/125 (4%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQ 412
R L+++ H +V L + LY + EY+ E QL R+ F E + +
Sbjct: 72 RNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG-IF-MEDTACFYLAE 129
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE-IRSRPYTD-YVSTRWYRA 470
+ L +H+ G +RD+KPEN++ VK+ DFGL +E I T + T Y A
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189
Query: 471 PEVLL 475
PE+L+
Sbjct: 190 PEILM 194
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 1e-11
Identities = 34/125 (27%), Positives = 63/125 (50%), Gaps = 6/125 (4%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQ 412
R L +++H +VKL + LY + ++++ + +L ++ F E ++ + +
Sbjct: 77 RDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MF-TEEDVKFYLAE 134
Query: 413 VLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE-IRSRPYTD-YVSTRWYRA 470
+ L +H G +RD+KPEN+L +K+ DFGL++E I + T Y A
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194
Query: 471 PEVLL 475
PEV+
Sbjct: 195 PEVVN 199
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 30/146 (20%), Positives = 62/146 (42%), Gaps = 18/146 (12%)
Query: 342 HVSSRDEMVVCFY--RKSLKKLSHAN-LVKLKEVIRENDTLYFVFEYMK--ENLYQLIRD 396
+ + + R+ L+ + + LV L + L+ + +Y+ E L +
Sbjct: 94 TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR 153
Query: 397 RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS 456
+F E ++ + +++ L +H+ G +RD+K EN+L V + DFGL++E
Sbjct: 154 E-RF-TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE--- 208
Query: 457 RPYTDYVSTRW-------YRAPEVLL 475
D + Y AP+++
Sbjct: 209 -FVADETERAYDFCGTIEYMAPDIVR 233
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 35/118 (29%), Positives = 59/118 (50%), Gaps = 6/118 (5%)
Query: 362 SHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAF 419
+H LV L + L+FV EY+ + ++ + R R K PE R ++ L +
Sbjct: 68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KL-PEEHARFYSAEISLALNY 125
Query: 420 MHRHGFFHRDMKPENLLCMGTELVKIADFGLARE-IRSRPYTD-YVSTRWYRAPEVLL 475
+H G +RD+K +N+L +K+ D+G+ +E +R T + T Y APE+L
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 183
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 5e-11
Identities = 33/119 (27%), Positives = 55/119 (46%), Gaps = 8/119 (6%)
Query: 362 SHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAF 419
L +L + D LYFV EY+ + +Y + + +F E ++ GL F
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RF-KEPHAVFYAAEIAIGLFF 457
Query: 420 MHRHGFFHRDMKPENLLCMGTELVKIADFGLARE---IRSRPYTDYVSTRWYRAPEVLL 475
+ G +RD+K +N++ +KIADFG+ +E T + T Y APE++
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIA 515
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 44/159 (27%), Positives = 62/159 (38%), Gaps = 40/159 (25%)
Query: 358 LKKL-SHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIR-------- 407
+ +L SH N+V L + +Y +FEY +L +R + + E I
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 408 --------------NMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLA 451
YQV +G+ F+ HRD+ N + T +VKI DFGLA
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN--VLVTHGKVVKICDFGLA 219
Query: 452 REIRSRPYTDYVST-------RWYRAPEVLLHS--TAYS 481
R+I S YV +W APE L T S
Sbjct: 220 RDIMSDSN--YVVRGNARLPVKWM-APESLFEGIYTIKS 255
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-11
Identities = 44/125 (35%), Positives = 60/125 (48%), Gaps = 12/125 (9%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMY--QV 413
LK + H LV L + D LYFV +Y+ E Y L R+R F E R Y ++
Sbjct: 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER-CF-LEP--RARFYAAEI 148
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE---IRSRPYTDYVSTRWYRA 470
L ++H +RD+KPEN+L + + DFGL +E S T + T Y A
Sbjct: 149 ASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLA 207
Query: 471 PEVLL 475
PEVL
Sbjct: 208 PEVLH 212
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 7e-11
Identities = 35/118 (29%), Positives = 62/118 (52%), Gaps = 6/118 (5%)
Query: 362 SHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAF 419
+H L +L + D L+FV E++ + ++ + + R +F E+ R +++ L F
Sbjct: 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RF-DEARARFYAAEIISALMF 139
Query: 420 MHRHGFFHRDMKPENLLCMGTELVKIADFGLARE-IRSRPYTD-YVSTRWYRAPEVLL 475
+H G +RD+K +N+L K+ADFG+ +E I + T + T Y APE+L
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQ 197
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 9e-11
Identities = 34/118 (28%), Positives = 56/118 (47%), Gaps = 6/118 (5%)
Query: 362 SHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAF 419
L +L + D LYFV EY+ + +Y + + +F E ++ GL F
Sbjct: 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RF-KEPHAVFYAAEIAIGLFF 136
Query: 420 MHRHGFFHRDMKPENLLCMGTELVKIADFGLARE-IRSRPYTD-YVSTRWYRAPEVLL 475
+ G +RD+K +N++ +KIADFG+ +E I T + T Y APE++
Sbjct: 137 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 194
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 35/118 (29%), Positives = 59/118 (50%), Gaps = 6/118 (5%)
Query: 362 SHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAF 419
+H LV L + L+FV EY+ + ++ + R R K PE R ++ L +
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KL-PEEHARFYSAEISLALNY 168
Query: 420 MHRHGFFHRDMKPENLLCMGTELVKIADFGLARE-IRSRPYTD-YVSTRWYRAPEVLL 475
+H G +RD+K +N+L +K+ D+G+ +E +R T + T Y APE+L
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 226
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-10
Identities = 36/122 (29%), Positives = 59/122 (48%), Gaps = 6/122 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
H L + + + L+FV EY+ + +Y + KF S +++
Sbjct: 72 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KF-DLSRATFYAAEIIL 129
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE-IRSRPYTD-YVSTRWYRAPEV 473
GL F+H G +RD+K +N+L +KIADFG+ +E + T+ + T Y APE+
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 189
Query: 474 LL 475
LL
Sbjct: 190 LL 191
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 35/145 (24%), Positives = 53/145 (36%), Gaps = 32/145 (22%)
Query: 358 LKKL-SHANLVKLKEVIRENDTLYFVFEYMK----------------ENLYQLIRDRDKF 400
L KL H N++ L LY EY + + +
Sbjct: 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 401 LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT 460
L + + V +G+ ++ + F HRD+ N+L + KIADFGL+R
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG------Q 192
Query: 461 D-YVST-------RWYRAPEVLLHS 477
+ YV RW A E L +S
Sbjct: 193 EVYVKKTMGRLPVRWM-AIESLNYS 216
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 4e-10
Identities = 39/128 (30%), Positives = 56/128 (43%), Gaps = 19/128 (14%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDRDKFLPES------IIRNMM 410
+ K H NLV+L + D L V+ YM +L + D P S I +
Sbjct: 84 MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQG-- 141
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLLCMGTELV-KIADFGLAREIRSRPYTDYVSTRW-- 467
G+ F+H + HRD+K N+L + KI+DFGLAR T +++R
Sbjct: 142 --AANGINFLHENHHIHRDIKSANIL-LDEAFTAKISDFGLARASEKFAQT-VMTSRIVG 197
Query: 468 ---YRAPE 472
Y APE
Sbjct: 198 TTAYMAPE 205
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 39/148 (26%), Positives = 59/148 (39%), Gaps = 24/148 (16%)
Query: 356 KSLKKLSHANLV-KLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVL 414
K K + + ++ E D V E + +L L + + + Q++
Sbjct: 56 KIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMI 115
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTE----LVKIADFGLAREIRS------RPYTDYVS 464
+ ++H F HRD+KP+N L MG LV I DFGLA++ R PY + +
Sbjct: 116 SRIEYIHSKNFIHRDVKPDNFL-MGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 174
Query: 465 TRWYRAPEVLLHSTAYSAPI--HLSRSQ 490
L TA A I HL Q
Sbjct: 175 ----------LTGTARYASINTHLGIEQ 192
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 19/85 (22%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 374 RENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPE 433
+ + V E + +L ++ F ++++ + ++L L ++H + + H D+K
Sbjct: 122 KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQ-LGIRMLDVLEYIHENEYVHGDIKAA 180
Query: 434 NLLCMGTE---LVKIADFGLAREIR 455
NLL +G + V +AD+GL+
Sbjct: 181 NLL-LGYKNPDQVYLADYGLSYRYC 204
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 31/106 (29%), Positives = 42/106 (39%), Gaps = 12/106 (11%)
Query: 385 YMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVK 444
E FL + +QV +G+ F+ HRD+ N+L +VK
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 233
Query: 445 IADFGLAREIRSRPYTDYVST-------RWYRAPEVLLHS--TAYS 481
I DFGLAR+I P YV +W APE + T S
Sbjct: 234 ICDFGLARDIYKDPD--YVRKGDARLPLKWM-APETIFDRVYTIQS 276
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 17/79 (21%), Positives = 35/79 (44%), Gaps = 4/79 (5%)
Query: 380 YFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG 439
+ + + +L ++ K + + ++L L ++H H + H D+K NLL +
Sbjct: 128 FMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLL-LN 186
Query: 440 TE---LVKIADFGLAREIR 455
+ V + D+GLA
Sbjct: 187 YKNPDQVYLVDYGLAYRYC 205
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 21/88 (23%), Positives = 37/88 (42%), Gaps = 7/88 (7%)
Query: 374 RENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPE 433
V E + +L L D+ + + Q++ + ++H +RD+KPE
Sbjct: 75 PCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPE 134
Query: 434 NLLCMGTE------LVKIADFGLAREIR 455
N L +G ++ I DF LA+E
Sbjct: 135 NFL-IGRPGNKTQQVIHIIDFALAKEYI 161
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 21/119 (17%), Positives = 45/119 (37%), Gaps = 17/119 (14%)
Query: 353 FYRKSLKKLSHANLVKLKEV------------IRENDTLYFVFEYMKENLYQLIRDRD-K 399
F++++ K L KL + ++ + V + +L +
Sbjct: 95 FFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKH 154
Query: 400 FLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIR 455
L E + + ++L L F+H + + H ++ EN+ + E V +A +G A
Sbjct: 155 VLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF-VDPEDQSQVTLAGYGFAFRYC 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 18/88 (20%), Positives = 37/88 (42%), Gaps = 7/88 (7%)
Query: 374 RENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPE 433
+E V + + +L L+ + + Q+L + +H +RD+KP+
Sbjct: 76 QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPD 135
Query: 434 NLLCMGTE------LVKIADFGLAREIR 455
N L +G ++ + DFG+ + R
Sbjct: 136 NFL-IGRPNSKNANMIYVVDFGMVKFYR 162
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.0 bits (139), Expect = 6e-09
Identities = 22/109 (20%), Positives = 39/109 (35%), Gaps = 2/109 (1%)
Query: 373 IRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMH-RHGFFHRDMK 431
++D L+ V E+ L + R K + +++++Q+ LA F HRD+
Sbjct: 131 FFKDDQLFIVLEFE-FGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLH 189
Query: 432 PENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAY 480
N+L T L K+ + VS Y +
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVV 238
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 8e-09
Identities = 33/138 (23%), Positives = 55/138 (39%), Gaps = 38/138 (27%)
Query: 358 LKKLSHANLVKLKEVI---RENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQV 413
L H +LV L I E + + +++YM+ NL + + D
Sbjct: 89 LSFCRHPHLVSL---IGFCDERNEMILIYKYMENGNLKRHLYGSDL----------PTMS 135
Query: 414 L-------------QGLAFMHRHGFFHRDMKPENLLCMGTELV-KIADFGLAREIRSRPY 459
+ +GL ++H HRD+K N+L + V KI DFG++++
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINIL-LDENFVPKITDFGISKKGTELDQ 194
Query: 460 TDYVSTRW-----YRAPE 472
T ++ST Y PE
Sbjct: 195 T-HLSTVVKGTLGYIDPE 211
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 36/129 (27%), Positives = 56/129 (43%), Gaps = 28/129 (21%)
Query: 363 HANLVKLKEVIRENDTLYFVFEYMKEN--LYQLIRDRDKFLPE-------SIIRNMMYQV 413
H NL++L+ V+ YM N + +R+R + P I
Sbjct: 86 HRNLLRLRGFCMTPTERLLVYPYM-ANGSVASCLRERPESQPPLDWPKRQRIALG----S 140
Query: 414 LQGLAFMHRHG---FFHRDMKPENLLCMGTEL-VKIADFGLAREIRSRPYTD-YVSTRW- 467
+GLA++H H HRD+K N+L + E + DFGLA+ + Y D +V+T
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANIL-LDEEFEAVVGDFGLAKLM---DYKDTHVTTAVR 196
Query: 468 ----YRAPE 472
+ APE
Sbjct: 197 GTIGHIAPE 205
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 38/148 (25%), Positives = 59/148 (39%), Gaps = 24/148 (16%)
Query: 356 KSLKKLSHANLV-KLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVL 414
K + L + ++ E D V + + +L L + L + + Q++
Sbjct: 54 KIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTE----LVKIADFGLAREIRS------RPYTDYVS 464
+ F+H F HRD+KP+N L MG V I DFGLA++ R PY + +
Sbjct: 114 NRVEFVHSKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
Query: 465 TRWYRAPEVLLHSTAYSAPI--HLSRSQ 490
L TA A + HL Q
Sbjct: 173 ----------LTGTARYASVNTHLGIEQ 190
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 1e-07
Identities = 109/681 (16%), Positives = 203/681 (29%), Gaps = 198/681 (29%)
Query: 312 TERLKFSY--ILPHTLPLYTCNLD----QD-----------NHIL-SRHVSSR------- 346
T ++ Y IL + N D QD +HI+ S+ S
Sbjct: 11 TGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWT 70
Query: 347 -----DEMVVCFYRKSLKKLSHANLV-KLKEVIRENDTLYFVFEYMKENLYQLIRDRDKF 400
+EMV F + L+ ++ L+ +K R+ + ++ ++ LY D F
Sbjct: 71 LLSKQEEMVQKFVEEVLRI-NYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY---NDNQVF 126
Query: 401 LPESIIRNMMYQVLQ-GLAFMHRHGFFHRDMKPENLLC---MG----TELVKIA--DFGL 450
++ R Y L+ L +++P + + T + + +
Sbjct: 127 AKYNVSRLQPYLKLRQAL----------LELRPAKNVLIDGVLGSGKTWVALDVCLSYKV 176
Query: 451 AREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLA 510
++ + + +++ + +PE +L Q L Y ID P + +
Sbjct: 177 QCKMDFKIF--WLNLKNCNSPETVL------------EMLQKLLYQID--PNWTSRSDHS 220
Query: 511 GTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQT- 569
+L+ I L CLL +LL+ +
Sbjct: 221 SNIKLRIHSIQAELRRLLKSKPYE---NCLL----------VLLNV-----QNAKAWNAF 262
Query: 570 --TC--LLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK--SSYILL--HTL 621
+C LL T R K + T H+ + L E Y+ L
Sbjct: 263 NLSCKILL--TTRFKQ--VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDL 318
Query: 622 PLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTY-HVPPIQTTCL--LAGTERLKSS 678
P P + ++A E ++ + I + L L E +
Sbjct: 319 PREVLTTNP-RRLSIIA--ESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAE-YRKM 374
Query: 679 YILLHTLPLYTYHVP-PIQTTCLL-AGTERLKSSYIL--LHTLPL-------YTYHVPPI 727
+ L P P L+ + ++ LH L T +P I
Sbjct: 375 FDRLSVFP---PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSI 431
Query: 728 QTTCLLAGTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVP------FTSIIPHAS 781
L E + LH + Y N+ F +P F S I H
Sbjct: 432 YLE-LKVKLENEYA----LHRS-IVDHY----NIPKTFDSDDLIPPYLDQYFYSHIGH-- 479
Query: 782 PDAIHLMESMLAYNPSKRPTAQQSLSIKREVSLSFVLLKK------------------LN 823
HL + +++ R V L F L++ L
Sbjct: 480 ----HLKNIEHP----------ERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQ 525
Query: 824 RLEKYRLKNARETLQAKKSKVDSFNLQLQNLKYE--IFHLKKEVVKCLQFKSKDEDIDLV 881
+L+ Y+ + + + KYE + + + K + + DL+
Sbjct: 526 QLKFYK----------------PY-ICDNDPKYERLVNAILDFLPKIEENLICSKYTDLL 568
Query: 882 ------DEETFFKDAPESISR 896
++E F++A + + R
Sbjct: 569 RIALMAEDEAIFEEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 8e-06
Identities = 90/585 (15%), Positives = 160/585 (27%), Gaps = 160/585 (27%)
Query: 218 PNNISQNANNTQNNPNNSHYN--PNNIQNNPNNFSQNNISQNNTNNTQINKTTQYNPPPY 275
+ Q N Y + I+ S Q ++ N
Sbjct: 75 QEEMVQKFVEEVLRIN---YKFLMSPIKTEQRQPSMMTRMYI----EQRDRLYNDNQVFA 127
Query: 276 PININKENTPAWLTNSATDGDTTWFPTGHTTCLLAGTERLK-FSYILPH--------TLP 326
N+++ L LL L+ +L +
Sbjct: 128 KYNVSRLQPYLKLRQ----------------ALL----ELRPAKNVLIDGVLGSGKTWVA 167
Query: 327 LYTCN-----LDQDNHI--LS-RHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDT 378
L C D I L+ ++ +S + ++ + L+KL + +
Sbjct: 168 LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVL-----EMLQKLLYQIDPNWTSRSDHSSN 222
Query: 379 LYFVFEYMKENLYQLIRDRDKFLPES--IIRNMMY-QVLQGLAFMHRHGFFHRDMKPENL 435
+ ++ L +L++ + ++ N+ + AF NL
Sbjct: 223 IKLRIHSIQAELRRLLKSKP--YENCLLVLLNVQNAKAWN--AF--------------NL 264
Query: 436 LC---MGTELVKIADFGLAR-------EIRSRPYTD---------YVSTRWYRAP-EVLL 475
C + T ++ DF A + S T Y+ R P EVL
Sbjct: 265 SCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLT 324
Query: 476 HSTAYSAPIHLS-----------RSQQFLFYSIDHVPPIQTTCL--LAGTERLKSSYILL 522
+ P LS + + D + I + L L E + + L
Sbjct: 325 TN-----PRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAE-YRKMFDRL 378
Query: 523 HTLPLYTYHVP-PIQTTCLL-AGTERLKSSYIL--LHTLPL-------YTYHVPPIQTTC 571
P P L+ + ++ LH L T +P I
Sbjct: 379 SVFP---PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLE- 434
Query: 572 LLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPI 631
L E + LH + Y++P +T Y H +H
Sbjct: 435 LKVKLENEYA----LHRSIVDHYNIP--KTFDSDDLIPPYLDQYFYSH----IGHH---- 480
Query: 632 QTTCLLAGTERLKSSYILLHTLPL-YTYHVPPIQTTCLLAGTERLKSSYIL--LHTLPLY 688
L E + L + L + + ++ T S IL L L Y
Sbjct: 481 -----LKNIEHPE-RMTLFRMVFLDFRF----LEQKIRHDSTAWNASGSILNTLQQLKFY 530
Query: 689 TYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLL 733
++ ERL ++ +L LP ++ + T LL
Sbjct: 531 KPYICDNDPK-----YERLVNA--ILDFLPKIEENLICSKYTDLL 568
|
| >3sqr_A Laccase; multicopper oxidase, glycosylation, oxidoreductase; HET: NAG BMA MAN; 1.67A {Botrytis aclada} Length = 580 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 26/163 (15%), Positives = 55/163 (33%), Gaps = 16/163 (9%)
Query: 136 YDILLSNPANSMLANNSMVSTNNAVYVNQNPHNNNPNISQYNNPNNYDPTTSQNNNISQY 195
YD+++ AN+ N + N N I +Y++ + +PT+
Sbjct: 311 YDVIVE--ANAAADNYWIRGNWGTTCSTNNEAANATGILRYDSSSIANPTSVGTT----- 363
Query: 196 MPNNTSQNNNNTQYNPNSSQNMPNNISQNANNTQNNPNNSHYNPNNI--QNNPNNFSQNN 253
P T ++ P+ + ++ + + N + N+ + ++ +
Sbjct: 364 -PRGTCEDEPVASLVPHLALDVGGYSLVDEQVSSAFTNYFTWTINSSSLLLDWSSPTTLK 422
Query: 254 ISQNNTNNTQINKTTQYNP-PPYPININKENTPAWLTNSATDG 295
I N T T+YN N N+E + + G
Sbjct: 423 IFNNETIF-----PTEYNVVALEQTNANEEWVVYVIEDLTGFG 460
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 1e-04
Identities = 10/58 (17%), Positives = 21/58 (36%), Gaps = 11/58 (18%)
Query: 894 ISRPEVTKEDPHQLKLARLEWELKQRKELA--DECSLVERENESVAANINKKRGQLDN 949
I++ + ++P ++ +W +QRK L D K + L+
Sbjct: 74 IAQADRLTQEPESIR----KWREEQRKRLQELD-----AASKVMEQEWREKAKKDLEE 122
|
| >1ru4_A Pectate lyase, PEL9A; parallel beta-helix; 1.60A {Erwinia chrysanthemi} SCOP: b.80.1.9 Length = 400 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 25/200 (12%), Positives = 57/200 (28%), Gaps = 21/200 (10%)
Query: 106 HISARSIYPTVKNTLTLNVLPQPVTLYSHDYDILLSNPANSMLANNSMVSTNNAVYVNQN 165
I+ Y TV N+ +YD + N +
Sbjct: 155 EINNGGSYNTVINSDAYR-----------NYDPKKNGSMADGFGPKQKQGPGNRFVGCRA 203
Query: 166 PHNNNPNISQYNNPNN--YDPTTSQNNNISQYMPNNTSQNNNNTQ---YNPNSSQNMPNN 220
N++ +++P + + + N I+ + + + N N + + + +
Sbjct: 204 WENSDDGFDLFDSPQKVVIENSWAFRNGINYWNDSAFAGNGNGFKLGGNQAVGNHRITRS 263
Query: 221 ISQNANNT----QNNPNNSHYNPNNIQNNPNNFSQNNISQNNTNNTQINKTTQYNPPPYP 276
++ + NN N N N+ + Q+ + N +
Sbjct: 264 VAFGNVSKGFDQNNNAGGVTVINNTSYKNGINYGFGSNVQSGQKHYFRNNVSLSASVTVS 323
Query: 277 ININKENTPAWLTNSATDGD 296
K N+ +A+ D
Sbjct: 324 NADAKSNS-WDTGPAASASD 342
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 32/140 (22%), Positives = 58/140 (41%), Gaps = 6/140 (4%)
Query: 818 LLKKLNRLEKYRLKNARETLQAKKSKVDSFNLQLQNLKYEIFHLKKEVVKCLQFKSKDED 877
L ++L E R K E K+ + ++ + L KE K L+ + D
Sbjct: 960 LEEQLEEEEAARQKLQLE-KVTADGKIKKMEDDILIMEDQNNKLTKER-KLLEERVSDLT 1017
Query: 878 IDLVDEETFFKDAPESISRPEVTKEDPHQLKLARLEWELKQRKELADECSLVERENESVA 937
+L +EE K+ + ++ E + L+ RL+ E K R+EL +E E+ +
Sbjct: 1018 TNLAEEEEKAKNLTKLKNKHESMISE---LE-VRLKKEEKSRQELEKIKRKLEGESSDLH 1073
Query: 938 ANINKKRGQLDNLAPLLKQL 957
I + + Q+ L L +
Sbjct: 1074 EQIAELQAQIAELKAQLAKK 1093
|
| >2q9o_A Laccase-1; multicopper oxidase, 2-OXOH oxidoreductase; HET: OHI NAG MAN GOL; 1.30A {Melanocarpus albomyces} SCOP: b.6.1.3 b.6.1.3 b.6.1.3 PDB: 3fu7_A* 3fu8_A* 3fu7_B* 1gw0_A* 2ih9_A* 2ih8_A* 3fu9_A* 3qpk_A* 3dkh_A* 3pps_A* Length = 559 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 6e-04
Identities = 20/156 (12%), Positives = 38/156 (24%), Gaps = 9/156 (5%)
Query: 136 YDILLSNPANSMLANNSMVSTNNAVYVNQNPHNNNPNIS---QYNNPNNYDPTTSQNNNI 192
YD+++ A+ N + NP+ + Y PT +
Sbjct: 273 YDVVID--ASRAPDNYWFNV--TFGGQAACGGSLNPHPAAIFHYAGAPGGLPTDEGTPPV 328
Query: 193 SQYMPNNTSQNNNNTQYNPNSSQNMPNNISQNANNTQNNPNNSHYNPNNIQNN--PNNFS 250
+ + P +S + + + N N
Sbjct: 329 DHQCLDTLDVRPVVPRSVPVNSFVKRPDNTLPVALDLTGTPLFVWKVNGSDINVDWGKPI 388
Query: 251 QNNISQNNTNNTQINKTTQYNPPPYPININKENTPA 286
+ I NT+ + Q + EN P
Sbjct: 389 IDYILTGNTSYPVSDNIVQVDAVDQWTYWLIENDPE 424
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 962 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.98 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.98 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.98 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.98 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.98 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.98 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.98 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.98 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.98 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.98 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.98 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.98 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.98 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.98 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.98 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.98 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.98 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.98 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.98 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.98 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.95 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.81 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.78 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.76 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.68 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.65 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.65 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.64 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.64 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.62 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.62 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.62 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.62 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.61 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.61 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.6 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.6 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.59 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.58 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.58 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.58 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.57 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.57 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.57 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.56 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.54 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.53 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.52 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.51 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.51 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.5 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.5 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.49 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.49 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.47 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.47 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.45 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.45 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.44 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.44 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.44 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.44 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.43 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.43 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.42 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.42 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.41 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.4 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.4 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.4 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.4 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.4 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.38 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.37 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.36 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.36 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.36 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.35 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.35 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.34 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.33 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.32 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.31 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.31 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.29 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.29 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.28 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.28 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.28 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.26 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.25 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.25 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.25 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.25 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.25 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.25 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.25 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.24 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.24 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.23 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.23 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.22 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.22 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.21 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.21 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.21 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.21 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.21 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.2 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.2 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.2 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.2 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.2 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.19 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.19 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.19 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.19 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.19 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.18 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.18 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.18 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.18 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.17 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.17 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.17 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.17 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.17 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.17 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.17 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.16 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.16 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.16 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.15 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.15 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.14 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.14 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.14 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.14 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.14 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.14 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.13 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.13 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.13 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.13 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.13 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.12 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.12 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.11 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.11 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.11 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.1 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.1 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.1 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.1 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.09 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.09 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.09 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.09 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.09 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.09 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.08 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.08 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.08 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.08 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.08 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.08 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.07 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.06 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.06 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.06 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.05 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.05 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.05 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.05 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.05 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.05 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.05 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.04 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.04 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.04 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.03 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.03 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.03 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.03 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.03 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.02 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.02 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.02 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.02 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.02 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.02 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.01 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.01 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.01 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.01 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.01 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.01 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.01 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 98.99 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 98.99 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 98.99 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 98.99 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 98.98 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 98.98 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 98.98 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 98.98 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 98.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 98.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 98.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 98.96 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 98.96 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 98.96 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 98.96 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 98.96 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 98.95 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 98.95 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 98.95 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 98.95 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 98.95 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 98.94 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 98.94 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 98.93 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 98.93 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 98.93 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 98.93 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 98.92 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 98.92 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 98.92 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 98.92 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 98.92 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 98.92 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 98.92 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 98.91 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 98.91 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 98.91 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 98.91 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 98.9 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 98.9 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 98.9 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 98.9 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 98.9 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 98.89 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 98.88 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 98.88 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 98.88 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 98.87 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 98.87 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 98.87 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 98.86 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 98.86 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 98.86 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 98.86 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 98.85 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 98.85 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 98.85 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 98.84 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 98.82 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 98.82 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 98.82 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 98.81 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 98.81 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.81 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=388.73 Aligned_cols=251 Identities=20% Similarity=0.261 Sum_probs=202.0
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
|.|.....++.|+.+.||.+....+++.++.|+.. .....+.+|+++|++++|||||++++++.+++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 56777767766667779999888777766655432 12346899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-Ccccc
Q psy501 384 EYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTDY 462 (962)
Q Consensus 384 Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~~ 462 (962)
|||+|+|++.+... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... .....
T Consensus 93 Ey~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 171 (275)
T 3hyh_A 93 EYAGNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS 171 (275)
T ss_dssp ECCCEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred eCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCe
Confidence 99999999998775 45999999999999999999999999999999999999999999999999999876543 44557
Q ss_pred cCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhcc
Q psy501 463 VSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 542 (962)
Q Consensus 463 ~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~ 542 (962)
+||+.|||||++.+...++.++|||||||++|||++|++||.+.+.......+..+....+ ...+..+.+++..||..
T Consensus 172 ~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~L~~ 249 (275)
T 3hyh_A 172 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP--KFLSPGAAGLIKRMLIV 249 (275)
T ss_dssp ---CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--TTSCHHHHHHHHHHSCS
T ss_pred eECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHccC
Confidence 8999999999998765567899999999999999999999999888888888877754443 45777889999999999
Q ss_pred CCCCCCcHHHHHhhccccccCCC
Q psy501 543 GTERLKSSYILLHTLPLYTYHVP 565 (962)
Q Consensus 543 dperRPs~~~Ll~~l~~~~~~~~ 565 (962)
||++||++.++++. +|+....|
T Consensus 250 dP~~R~s~~eil~h-pw~k~~~p 271 (275)
T 3hyh_A 250 NPLNRISIHEIMQD-DWFKVDLP 271 (275)
T ss_dssp SGGGSCCHHHHHHC-HHHHTTCC
T ss_pred ChhHCcCHHHHHcC-cccccCCC
Confidence 99999998888774 46654443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=392.79 Aligned_cols=250 Identities=18% Similarity=0.280 Sum_probs=207.0
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE 388 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g 388 (962)
+.....++.|+.+.||++....+++.++.|... ...+.+.+|+++|++++|||||+++++|.+++.+|||||||+|
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 444445555666669999988877776665532 2344689999999999999999999999999999999999985
Q ss_pred -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCC
Q psy501 389 -NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVST 465 (962)
Q Consensus 389 -~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt 465 (962)
+|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+... .....+||
T Consensus 156 g~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT 233 (346)
T 4fih_A 156 GALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 233 (346)
T ss_dssp EEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSC
T ss_pred CcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccC
Confidence 56665543 35999999999999999999999999999999999999999999999999999877543 45567999
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc-cccCCCCCCCCcHHHHHHHhccCC
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI-LLHTLPLYTYHVPPIQTTCLLAGT 544 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~l~~li~~Cl~~dp 544 (962)
+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+.......+..... ..+..+.++..+.+++..||..||
T Consensus 234 p~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP 312 (346)
T 4fih_A 234 PYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDP 312 (346)
T ss_dssp GGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSST
T ss_pred cCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCCh
Confidence 99999999965 5799999999999999999999999999888887777766532 222334567788999999999999
Q ss_pred CCCCcHHHHHhhccccccCCCC
Q psy501 545 ERLKSSYILLHTLPLYTYHVPP 566 (962)
Q Consensus 545 erRPs~~~Ll~~l~~~~~~~~~ 566 (962)
++||++.++++. +|+....++
T Consensus 313 ~~R~ta~e~l~H-p~~~~~~~p 333 (346)
T 4fih_A 313 AQRATAAELLKH-PFLAKAGPP 333 (346)
T ss_dssp TTSCCHHHHTTC-GGGGGCCCG
T ss_pred hHCcCHHHHhcC-HhhcCCCCC
Confidence 999999888764 466655443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=387.75 Aligned_cols=238 Identities=18% Similarity=0.234 Sum_probs=206.3
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
+|.....++.|+.+.||.|....+++.++.|+... ....+.+|+++|++++|||||+++++|++++.+|||||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46666666666677799999888887777665432 23568999999999999999999999999999999999
Q ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----Cc
Q psy501 385 YMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PY 459 (962)
Q Consensus 385 y~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~ 459 (962)
||+ |+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+... ..
T Consensus 113 y~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~ 191 (311)
T 4aw0_A 113 YAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191 (311)
T ss_dssp CCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCB
T ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccc
Confidence 998 4788877665 46999999999999999999999999999999999999999999999999999876533 34
Q ss_pred ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHH
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTC 539 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~C 539 (962)
...+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+......++..+.+.++ ..++....+++..|
T Consensus 192 ~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p--~~~s~~~~dli~~l 268 (311)
T 4aw0_A 192 NSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP--EKFFPKARDLVEKL 268 (311)
T ss_dssp CCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--TTCCHHHHHHHHHH
T ss_pred cCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--cccCHHHHHHHHHH
Confidence 55789999999999976 4799999999999999999999999999998888888888765544 46777888999999
Q ss_pred hccCCCCCCcHHHH
Q psy501 540 LLAGTERLKSSYIL 553 (962)
Q Consensus 540 l~~dperRPs~~~L 553 (962)
|..||++||++.++
T Consensus 269 L~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 269 LVLDATKRLGCEEM 282 (311)
T ss_dssp SCSSGGGSTTSGGG
T ss_pred ccCCHhHCcChHHH
Confidence 99999999997764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=393.31 Aligned_cols=247 Identities=17% Similarity=0.226 Sum_probs=204.7
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEec
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEY 385 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey 385 (962)
.|.....++.|+.+.||++....+++.++.|+.. .+.+.+.+|+++|++|+|||||+++++|++++.+||||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4455555555556669999988777766655432 2345799999999999999999999999999999999999
Q ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--Cccc
Q psy501 386 MK-ENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTD 461 (962)
Q Consensus 386 ~~-g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~ 461 (962)
|+ |+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... ....
T Consensus 105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 184 (350)
T 4b9d_A 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA 184 (350)
T ss_dssp CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHH
T ss_pred CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccc
Confidence 98 58888886543 46899999999999999999999999999999999999999999999999999876543 2345
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhc
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~ 541 (962)
.+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+......++..+... +....++..+.+++..||.
T Consensus 185 ~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-~~~~~~s~~~~~li~~~L~ 262 (350)
T 4b9d_A 185 CIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSLHYSYDLRSLVSQLFK 262 (350)
T ss_dssp HHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTC
T ss_pred cCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHcc
Confidence 689999999999976 47999999999999999999999999999888888888776543 3345677788999999999
Q ss_pred cCCCCCCcHHHHHhhccccc
Q psy501 542 AGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 542 ~dperRPs~~~Ll~~l~~~~ 561 (962)
.||++||++.++++. +|+.
T Consensus 263 ~dP~~R~s~~e~l~h-p~~~ 281 (350)
T 4b9d_A 263 RNPRDRPSVNSILEK-GFIA 281 (350)
T ss_dssp SSGGGSCCHHHHHTS-HHHH
T ss_pred CChhHCcCHHHHhcC-HHhh
Confidence 999999999988764 3444
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=380.03 Aligned_cols=239 Identities=20% Similarity=0.210 Sum_probs=193.9
Q ss_pred eEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEe----CCEEEEEEe
Q psy501 315 LKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRE----NDTLYFVFE 384 (962)
Q Consensus 315 ~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~----~~~~~LV~E 384 (962)
+...++.|+.+.||++....++..++.|... .....+.+|+++|++|+|||||+++++|.+ +..+|||||
T Consensus 30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE 109 (290)
T 3fpq_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence 3444555666669999888777665544322 234568999999999999999999999975 346899999
Q ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccce--eeeccCCCccccccc-ccceeeecccccccccCCCcc
Q psy501 385 YMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHG--FFHRDMKPENLLCMG-TELVKIADFGLAREIRSRPYT 460 (962)
Q Consensus 385 y~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~g--IvHrDLkp~NILl~~-~g~vKL~DFGla~~~~~~~~~ 460 (962)
||+ |+|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++. +|.+||+|||+|+........
T Consensus 110 y~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~~~ 188 (290)
T 3fpq_A 110 LMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK 188 (290)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBE
T ss_pred CCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCccC
Confidence 998 5677776654 56999999999999999999999998 999999999999974 789999999999876666667
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh-hhHHHHHhccccccCCCCCCCCcHHHHHHH
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL-AGTERLKSSYILLHTLPLYTYHVPPIQTTC 539 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~~l~~li~~C 539 (962)
..+||+.|||||++.+ .|+.++|||||||+||||+||++||.+.... .....+..+..........+..+..++..|
T Consensus 189 ~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~ 266 (290)
T 3fpq_A 189 AVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC 266 (290)
T ss_dssp ESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHH
T ss_pred CcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHH
Confidence 7899999999999864 5999999999999999999999999875443 344455444333333345566788999999
Q ss_pred hccCCCCCCcHHHHHhh
Q psy501 540 LLAGTERLKSSYILLHT 556 (962)
Q Consensus 540 l~~dperRPs~~~Ll~~ 556 (962)
|..+|++||++.++++.
T Consensus 267 L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 267 IRQNKDERYSIKDLLNH 283 (290)
T ss_dssp SCSSGGGSCCHHHHHTS
T ss_pred ccCChhHCcCHHHHhcC
Confidence 99999999998888764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=395.05 Aligned_cols=251 Identities=18% Similarity=0.276 Sum_probs=208.4
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
.|.....++.|+.+.||.|....+++.++.|... ...+.+.+|+.+|++++|||||+++++|.+++.+|||||||+
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~ 231 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 231 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCC
Confidence 3445555666666679999888877766655432 234568999999999999999999999999999999999998
Q ss_pred C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccC
Q psy501 388 E-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVS 464 (962)
Q Consensus 388 g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~g 464 (962)
| +|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+... .....+|
T Consensus 232 gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~G 309 (423)
T 4fie_A 232 GGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 309 (423)
T ss_dssp TEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEE
T ss_pred CCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccccccc
Confidence 5 56665543 34999999999999999999999999999999999999999999999999999877543 4556789
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc-cccCCCCCCCCcHHHHHHHhccC
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI-LLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
|+.|||||++.+ ..|+.++|||||||++|||++|++||.+.........+..... .......++..+.+|+..||..|
T Consensus 310 Tp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~d 388 (423)
T 4fie_A 310 TPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 388 (423)
T ss_dssp CTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSS
T ss_pred CcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCC
Confidence 999999999965 4799999999999999999999999999888888777766532 23334466778899999999999
Q ss_pred CCCCCcHHHHHhhccccccCCCC
Q psy501 544 TERLKSSYILLHTLPLYTYHVPP 566 (962)
Q Consensus 544 perRPs~~~Ll~~l~~~~~~~~~ 566 (962)
|++||++.++++. +|+....++
T Consensus 389 P~~R~ta~ell~H-p~~~~~~~p 410 (423)
T 4fie_A 389 PAQRATAAELLKH-PFLAKAGPP 410 (423)
T ss_dssp TTTSCCHHHHTTC-GGGGGCCCG
T ss_pred hhHCcCHHHHhcC-HHhcCCCCC
Confidence 9999999988874 466555443
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=382.34 Aligned_cols=249 Identities=17% Similarity=0.168 Sum_probs=190.7
Q ss_pred EEEEecCCcccEEEEEecCCceEEEEecc---chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHH
Q psy501 316 KFSYILPHTLPLYTCNLDQDNHILSRHVS---SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLY 391 (962)
Q Consensus 316 ~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~---~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll 391 (962)
...++.|+.+.||++....+..+.+.+.. ....+.+.+|+++|++++|||||++++++.+ +.+|||||||+ |+|.
T Consensus 41 ~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~ 119 (307)
T 3omv_A 41 STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLY 119 (307)
T ss_dssp EEECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHH
T ss_pred eeEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHH
Confidence 33444444555888876543211111211 2234579999999999999999999998764 56899999998 6888
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----CcccccCCcc
Q psy501 392 QLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PYTDYVSTRW 467 (962)
Q Consensus 392 ~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~~~~gt~~ 467 (962)
+++......+++.++..|+.||+.||+|||+++||||||||+|||++.++.+||+|||+|+..... .....+||+.
T Consensus 120 ~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ 199 (307)
T 3omv_A 120 KHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL 199 (307)
T ss_dssp HHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTT
T ss_pred HHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCC
Confidence 888777778999999999999999999999999999999999999999999999999999865432 3345689999
Q ss_pred ccChhhhccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC----CCCCCCCcHHHHHHHhc
Q psy501 468 YRAPEVLLHS--TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT----LPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 468 Y~APE~l~~~--~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~s~~l~~li~~Cl~ 541 (962)
|||||++.+. ..|+.++|||||||+||||+||+.||.+.........+.......+. .+.++..+..++..||.
T Consensus 200 ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~ 279 (307)
T 3omv_A 200 WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVK 279 (307)
T ss_dssp SCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTC
T ss_pred ccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcC
Confidence 9999999643 35899999999999999999999999886655444433333222222 23556678889999999
Q ss_pred cCCCCCCcHHHHHhhccccccCCC
Q psy501 542 AGTERLKSSYILLHTLPLYTYHVP 565 (962)
Q Consensus 542 ~dperRPs~~~Ll~~l~~~~~~~~ 565 (962)
.+|++||++.+++..+..+.-.+|
T Consensus 280 ~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 280 KVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp SSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred CCHhHCcCHHHHHHHHHHHhccCC
Confidence 999999999999887755444444
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=389.58 Aligned_cols=243 Identities=17% Similarity=0.111 Sum_probs=201.9
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHH
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLY 391 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll 391 (962)
+....+++.|+.+.||++....+++.++.|....+. ...+|+.+|++++|||||+++++|.+++.+|||||||+ |+|.
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~ 138 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHH
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHH
Confidence 334445555666669999988877776666544332 24579999999999999999999999999999999998 5777
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc-ceeeecccccccccCCC-------ccccc
Q psy501 392 QLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE-LVKIADFGLAREIRSRP-------YTDYV 463 (962)
Q Consensus 392 ~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g-~vKL~DFGla~~~~~~~-------~~~~~ 463 (962)
+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+.+.... ....+
T Consensus 139 ~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~ 217 (336)
T 4g3f_A 139 QLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217 (336)
T ss_dssp HHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCC
T ss_pred HHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccc
Confidence 777654 4699999999999999999999999999999999999999988 69999999998765431 22357
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc-CCCCCCCCcHHHHHHHhcc
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH-TLPLYTYHVPPIQTTCLLA 542 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~s~~l~~li~~Cl~~ 542 (962)
||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.........+........ ..+.++..+..++..||..
T Consensus 218 GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~ 296 (336)
T 4g3f_A 218 GTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRK 296 (336)
T ss_dssp CCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCS
T ss_pred cCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccC
Confidence 9999999999976 4799999999999999999999999999888777777877655443 3456778889999999999
Q ss_pred CCCCCCcHHHHHhhcc
Q psy501 543 GTERLKSSYILLHTLP 558 (962)
Q Consensus 543 dperRPs~~~Ll~~l~ 558 (962)
||++||++.+|++.+.
T Consensus 297 dP~~R~sa~el~~~l~ 312 (336)
T 4g3f_A 297 EPVHRASAMELRRKVG 312 (336)
T ss_dssp SGGGSCCHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHHH
Confidence 9999999999987653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=379.78 Aligned_cols=244 Identities=20% Similarity=0.228 Sum_probs=199.4
Q ss_pred eeEEEEecCCcccEEEEEecC-----CceEEEEec-c---chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 314 RLKFSYILPHTLPLYTCNLDQ-----DNHILSRHV-S---SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 314 ~~~~~~i~~~~~~Vy~~~~~~-----~~kvv~~k~-~---~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
.+...++.|+.+.||++.... ++..++.|. . ......+.+|+++|++++|||||++++++.+++.+|||||
T Consensus 16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 95 (299)
T 4asz_A 16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE 95 (299)
T ss_dssp EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 344455555566699987542 233333333 2 2234579999999999999999999999999999999999
Q ss_pred cCC-CCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccc
Q psy501 385 YMK-ENLYQLIRDR------------DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLA 451 (962)
Q Consensus 385 y~~-g~Ll~~l~~~------------~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla 451 (962)
||+ |+|.+++... ...+++.+++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|
T Consensus 96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla 175 (299)
T 4asz_A 96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS 175 (299)
T ss_dssp CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCH
T ss_pred cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccc
Confidence 998 6888888653 246999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCC
Q psy501 452 REIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLP 526 (962)
Q Consensus 452 ~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 526 (962)
+...... .....||+.|||||++.+. .|+.++|||||||+||||+| |+.||.+.+..+....+..+.. ++.+.
T Consensus 176 ~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~-~~~p~ 253 (299)
T 4asz_A 176 RDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV-LQRPR 253 (299)
T ss_dssp HHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC-CCCCT
T ss_pred eecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-CCCCc
Confidence 8664432 2234689999999999764 79999999999999999999 9999999888888888877643 33345
Q ss_pred CCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 527 LYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 527 ~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
.+|..+..++..||..+|++||++.++...|..
T Consensus 254 ~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 254 TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 678889999999999999999999999776643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=380.64 Aligned_cols=248 Identities=19% Similarity=0.207 Sum_probs=196.1
Q ss_pred eeEEEEecCCcccEEEEEecC-----CceEEEEec-cc---hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 314 RLKFSYILPHTLPLYTCNLDQ-----DNHILSRHV-SS---RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 314 ~~~~~~i~~~~~~Vy~~~~~~-----~~kvv~~k~-~~---~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
.....++.|+.+.||++.... ++..++.|. .. ...+.+.+|+++|++++|||||+++++|.+++.+|||||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 334455555666688887542 233344333 22 234579999999999999999999999999999999999
Q ss_pred cCC-CCHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccc
Q psy501 385 YMK-ENLYQLIRDR--------------DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFG 449 (962)
Q Consensus 385 y~~-g~Ll~~l~~~--------------~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFG 449 (962)
||+ |+|.+++... ..++++.+++.|+.||+.||.|||+++||||||||+|||++.++.+||+|||
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFG 203 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFG 203 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccc
Confidence 998 6788777643 2469999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccC
Q psy501 450 LAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHT 524 (962)
Q Consensus 450 la~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~ 524 (962)
+|+..... ......||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.........+..+. .++.
T Consensus 204 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~-~~~~ 281 (329)
T 4aoj_A 204 MSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR-ELER 281 (329)
T ss_dssp ----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC-CCCC
T ss_pred cceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCC
Confidence 99876433 2334679999999999976 479999999999999999999 999999988888777777664 3344
Q ss_pred CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccccC
Q psy501 525 LPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYH 563 (962)
Q Consensus 525 ~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~~ 563 (962)
+..++..+..|+..||..+|++||++.+|++.|......
T Consensus 282 p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 282 PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 456788899999999999999999999999877554433
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=378.30 Aligned_cols=244 Identities=17% Similarity=0.182 Sum_probs=200.6
Q ss_pred eeeEEEEecCCcccEEEEEecC-----CceEEEEecc-c----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQ-----DNHILSRHVS-S----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~-----~~kvv~~k~~-~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
..+...++.|+.+.||++.+.. ..+.++.|.. . ...+.+.+|+.+|++++|||||+++|++.+++.++||
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 3444455555566688887532 2333433332 1 2346799999999999999999999999999999999
Q ss_pred EecCC-CCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeee
Q psy501 383 FEYMK-ENLYQLIRDR---------------DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIA 446 (962)
Q Consensus 383 ~Ey~~-g~Ll~~l~~~---------------~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~ 446 (962)
||||+ |+|.+++... ...+++..++.++.||+.||.|||+++||||||||+|||+++++.+||+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~ 187 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKIS 187 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEEC
Confidence 99998 6888888643 2458999999999999999999999999999999999999999999999
Q ss_pred cccccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhcccc
Q psy501 447 DFGLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYIL 521 (962)
Q Consensus 447 DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~ 521 (962)
|||+|+..... ......||+.|||||++.++ .|+.++|||||||+||||+| |..||.+.........+..+..
T Consensus 188 DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~- 265 (308)
T 4gt4_A 188 DLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV- 265 (308)
T ss_dssp CSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCC-
T ss_pred CcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-
Confidence 99999866432 33456799999999999765 79999999999999999998 8999999988888877776643
Q ss_pred ccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 522 LHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 522 ~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
.+.++.+|..+..++..||..+|++||++.+|+..|.
T Consensus 266 ~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~ 302 (308)
T 4gt4_A 266 LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302 (308)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 3445577888899999999999999999999988763
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=378.06 Aligned_cols=234 Identities=17% Similarity=0.234 Sum_probs=186.9
Q ss_pred eeeEEEEecCCcccEEEEEec---CCceEEEEecc------chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 313 ERLKFSYILPHTLPLYTCNLD---QDNHILSRHVS------SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~---~~~kvv~~k~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
|.....++.|+.+.||.++.. ..++.++.|+. ..+...+.+|+++|++++|||||+++++|++++.+||||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 444444444445557777653 23334433332 122346889999999999999999999999999999999
Q ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--Ccc
Q psy501 384 EYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYT 460 (962)
Q Consensus 384 Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~ 460 (962)
|||+ |+|.+.+... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... ...
T Consensus 106 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 184 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 184 (304)
T ss_dssp CCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCC
T ss_pred EcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCcccc
Confidence 9998 5777777665 46999999999999999999999999999999999999999999999999999865432 445
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHh
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCL 540 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl 540 (962)
..+||+.|||||++.+ ..|+.++|||||||+||||+||++||.+.+.......+......++ ...+..+.+++..||
T Consensus 185 ~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~L 261 (304)
T 3ubd_A 185 SFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP--QFLSPEAQSLLRMLF 261 (304)
T ss_dssp SCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHT
T ss_pred ccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC--CcCCHHHHHHHHHHc
Confidence 6789999999999976 4799999999999999999999999999998888888887755443 467788899999999
Q ss_pred ccCCCCCCcH
Q psy501 541 LAGTERLKSS 550 (962)
Q Consensus 541 ~~dperRPs~ 550 (962)
..||++||++
T Consensus 262 ~~dP~~R~ta 271 (304)
T 3ubd_A 262 KRNPANRLGA 271 (304)
T ss_dssp CSSGGGSTTC
T ss_pred ccCHHHCCCC
Confidence 9999999984
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=378.23 Aligned_cols=249 Identities=22% Similarity=0.293 Sum_probs=203.2
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEe------CCE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRE------NDT 378 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~------~~~ 378 (962)
..|.....++.|+.+.||+|....+++.++.|+.. .....+.+|+++|++|+|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 35666666666667779999988888777666532 223468899999999999999999999864 367
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-
Q psy501 379 LYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457 (962)
Q Consensus 379 ~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~- 457 (962)
+|||||||+|+|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus 134 ~~ivmE~~~g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp EEEEEECCSEEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred EEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence 9999999999998888664 56999999999999999999999999999999999999999999999999999876432
Q ss_pred -----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC--------
Q psy501 458 -----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT-------- 524 (962)
Q Consensus 458 -----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 524 (962)
.....+||+.|||||++.+...++.++||||+||++|||++|++||.+.+.......|......++.
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~ 292 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 292 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC----
T ss_pred cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhh
Confidence 3455789999999999988767899999999999999999999999998887777666543222110
Q ss_pred ---------------------CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 525 ---------------------LPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 525 ---------------------~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
.+..+....+|+..||..||++|||+.++++.- |+.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp-~f~ 349 (398)
T 4b99_A 293 ERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP-FLA 349 (398)
T ss_dssp -CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG-GGT
T ss_pred hhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH-hhC
Confidence 122344567799999999999999988877643 444
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=370.89 Aligned_cols=246 Identities=19% Similarity=0.198 Sum_probs=195.6
Q ss_pred ceeeEEEEecCCcccEEEEEecCC-----ceEEEEecc-c----hhHHHHHHHHHHHHhcCC-CCcccEEEEEEe-CCEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQD-----NHILSRHVS-S----RDEMVVCFYRKSLKKLSH-ANLVKLKEVIRE-NDTL 379 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~-----~kvv~~k~~-~----~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~-~~~~ 379 (962)
.+.+...++.|+.+.||++..... .+.++.|.. . .+...+.+|+++|+++.| ||||+++++|.+ ++.+
T Consensus 65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~ 144 (353)
T 4ase_A 65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 144 (353)
T ss_dssp GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEE
Confidence 444555556666666888875543 234444332 1 234568999999999975 899999999976 4578
Q ss_pred EEEEecCC-CCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccce
Q psy501 380 YFVFEYMK-ENLYQLIRDR---------------DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELV 443 (962)
Q Consensus 380 ~LV~Ey~~-g~Ll~~l~~~---------------~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~v 443 (962)
|||||||+ |+|.+++... ...+++..++.++.||+.||+|||+++||||||||+|||++.++.+
T Consensus 145 ~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~v 224 (353)
T 4ase_A 145 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 224 (353)
T ss_dssp EEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCE
Confidence 99999998 6788887653 2358999999999999999999999999999999999999999999
Q ss_pred eeecccccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhc
Q psy501 444 KIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSS 518 (962)
Q Consensus 444 KL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~ 518 (962)
||+|||+|+.+... ......||+.|||||++.+. .|+.++|||||||+||||+| |+.||.+.............
T Consensus 225 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~ 303 (353)
T 4ase_A 225 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 303 (353)
T ss_dssp EECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH
T ss_pred EECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHc
Confidence 99999999876543 22345789999999999764 79999999999999999998 99999987654444333333
Q ss_pred cccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 519 YILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 519 ~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
...++.++.++..+..++..||..+|++||++.+|++.|.
T Consensus 304 g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~ 343 (353)
T 4ase_A 304 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 343 (353)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 3344445567888999999999999999999999998763
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=358.20 Aligned_cols=240 Identities=19% Similarity=0.218 Sum_probs=174.1
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC----------
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIREND---------- 377 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---------- 377 (962)
+.....++.|+.+.||.+....+++.++.|... ...+.+.+|+++|++|+|||||+++++|.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 344445555555668888887766655544321 23356899999999999999999999997543
Q ss_pred --EEEEEEecCC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccc
Q psy501 378 --TLYFVFEYMK-ENLYQLIRDRDK--FLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR 452 (962)
Q Consensus 378 --~~~LV~Ey~~-g~Ll~~l~~~~~--~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~ 452 (962)
.+|||||||+ |+|.+.+..... ..++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~ 166 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT 166 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC-
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccce
Confidence 4799999998 567777765432 34567789999999999999999999999999999999999999999999998
Q ss_pred cccCCC--------------cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh-hhHHHHHh
Q psy501 453 EIRSRP--------------YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL-AGTERLKS 517 (962)
Q Consensus 453 ~~~~~~--------------~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~-~~~~~i~~ 517 (962)
.+.... ....+||+.|||||++.+ ..|+.++|||||||++|||++ ||.+.... .....+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~ 242 (299)
T 4g31_A 167 AMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRN 242 (299)
T ss_dssp -------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHT
T ss_pred ecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhc
Confidence 765431 233579999999999976 479999999999999999996 78654322 22222322
Q ss_pred ccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 518 SYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 518 ~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
... ++..+..+.....++..||..+|++||++.++++.-
T Consensus 243 ~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~ 281 (299)
T 4g31_A 243 LKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENA 281 (299)
T ss_dssp TCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 211 111122233456799999999999999999888743
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=348.48 Aligned_cols=244 Identities=19% Similarity=0.165 Sum_probs=177.8
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHH--HHHHHHHhcCCCCcccEEEEEEeCC----EEEEEEec
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVC--FYRKSLKKLSHANLVKLKEVIREND----TLYFVFEY 385 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~--~Ei~iL~~L~HpnIv~l~~~~~~~~----~~~LV~Ey 385 (962)
++.....++.|+.+.||++... ...++.+.+...+...+. .|+..+.+++|||||++++++.+++ .+||||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 3444555666666679999874 334444444444444444 4555567889999999999997653 68999999
Q ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccc--------eeeeccCCCcccccccccceeeecccccccccC
Q psy501 386 MK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRH--------GFFHRDMKPENLLCMGTELVKIADFGLAREIRS 456 (962)
Q Consensus 386 ~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~--------gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~ 456 (962)
|+ |+|.+++... .++++.+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 83 HEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 98 6777777653 489999999999999999999987 899999999999999999999999999987654
Q ss_pred CC------cccccCCccccChhhhccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCcCh---------------hh
Q psy501 457 RP------YTDYVSTRWYRAPEVLLHST-----AYSAPIHLSRSQQFLFYSIDHVPPIQTTCL---------------LA 510 (962)
Q Consensus 457 ~~------~~~~~gt~~Y~APE~l~~~~-----~~t~ksDIwSLGvlL~elltG~~Pf~~~~~---------------~~ 510 (962)
.. ....+||+.|||||++.+.. .++.++|||||||+||||+||.+||..... ..
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 32 22357999999999996532 367899999999999999999877643211 11
Q ss_pred hHHHHHhccccccCCCCC-C-----CCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 511 GTERLKSSYILLHTLPLY-T-----YHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 511 ~~~~i~~~~~~~~~~~~~-s-----~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
....+..... .+..|.. . ..+..++..||..+|++|||+.++++.|..
T Consensus 241 ~~~~~~~~~~-rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 241 MRKVVCEQKL-RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp HHHHHTTSCC-CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhcccC-CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 1112222211 2222211 1 135678999999999999999999987743
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=375.58 Aligned_cols=237 Identities=18% Similarity=0.196 Sum_probs=196.6
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh-------HHHHHHH---HHHHHhcCCCCcccEEEEEEeCCEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD-------EMVVCFY---RKSLKKLSHANLVKLKEVIRENDTL 379 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~-------~~~~~~E---i~iL~~L~HpnIv~l~~~~~~~~~~ 379 (962)
..++.....++.|+.+.||.|....+++.++.|+.... ...+.+| +.+++.++|||||+++++|++++.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 45666666666677777999999888888777764322 2234444 5666778999999999999999999
Q ss_pred EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC
Q psy501 380 YFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP 458 (962)
Q Consensus 380 ~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~ 458 (962)
|||||||. |+|.+++... +.|++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+....
T Consensus 268 ylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~ 346 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 346 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence 99999998 5777777655 569999999999999999999999999999999999999999999999999999887777
Q ss_pred cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh---hhHHHHHhccccccCCCCCCCCcHHH
Q psy501 459 YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL---AGTERLKSSYILLHTLPLYTYHVPPI 535 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~s~~l~~l 535 (962)
....+||+.|||||++.++..|+.++|||||||+||||++|++||.+.... .....+....... +..++....+|
T Consensus 347 ~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~--p~~~S~~a~dL 424 (689)
T 3v5w_A 347 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL--PDSFSPELRSL 424 (689)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCC--CTTSCHHHHHH
T ss_pred CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCC--CccCCHHHHHH
Confidence 777899999999999976667999999999999999999999999875432 2333444443322 34677788999
Q ss_pred HHHHhccCCCCCCc
Q psy501 536 QTTCLLAGTERLKS 549 (962)
Q Consensus 536 i~~Cl~~dperRPs 549 (962)
+..||..||.+|++
T Consensus 425 I~~lL~~dP~~Rl~ 438 (689)
T 3v5w_A 425 LEGLLQRDVNRRLG 438 (689)
T ss_dssp HHHHTCSCGGGCTT
T ss_pred HHHHccCCHhHCCC
Confidence 99999999999997
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=351.36 Aligned_cols=243 Identities=16% Similarity=0.215 Sum_probs=184.7
Q ss_pred cCceeeEEEEecCCcccEEEEEec---CCceEEEEe-c-cchhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLD---QDNHILSRH-V-SSRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~---~~~kvv~~k-~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
.+.|.....++.|+.+.||.|... ...+.++.| + .......+.+|+++|+.+ .||||++++++|.+++++|+||
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 345666666666666779998753 233433333 3 233456789999999999 6999999999999999999999
Q ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc-cceeeecccccccccCC----
Q psy501 384 EYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT-ELVKIADFGLAREIRSR---- 457 (962)
Q Consensus 384 Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~-g~vKL~DFGla~~~~~~---- 457 (962)
|||+ |+|.+.+. .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 100 E~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~ 175 (361)
T 4f9c_A 100 PYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIEL 175 (361)
T ss_dssp ECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGG
T ss_pred eCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccc
Confidence 9998 56777662 48999999999999999999999999999999999999876 79999999999754322
Q ss_pred --------------------------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcC-hhh
Q psy501 458 --------------------------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTC-LLA 510 (962)
Q Consensus 458 --------------------------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~-~~~ 510 (962)
.....+||+.|||||++.+...|+.++||||+||++|||++|++||.... ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~ 255 (361)
T 4f9c_A 176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLT 255 (361)
T ss_dssp GGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHH
Confidence 12345799999999999877679999999999999999999999996543 222
Q ss_pred hHHHHHhc--------------------------------------cc--------------cccCCCCCCCCcHHHHHH
Q psy501 511 GTERLKSS--------------------------------------YI--------------LLHTLPLYTYHVPPIQTT 538 (962)
Q Consensus 511 ~~~~i~~~--------------------------------------~~--------------~~~~~~~~s~~l~~li~~ 538 (962)
....|... .. .....+..+....+++..
T Consensus 256 ~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~ 335 (361)
T 4f9c_A 256 ALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDK 335 (361)
T ss_dssp HHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHH
T ss_pred HHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHH
Confidence 22222110 00 001112344556789999
Q ss_pred HhccCCCCCCcHHHHHhh
Q psy501 539 CLLAGTERLKSSYILLHT 556 (962)
Q Consensus 539 Cl~~dperRPs~~~Ll~~ 556 (962)
||..||++|+|++++++.
T Consensus 336 lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 336 LLDLNPASRITAEEALLH 353 (361)
T ss_dssp HTCSCTTTSCCHHHHHTS
T ss_pred HCcCChhHCcCHHHHhcC
Confidence 999999999998877763
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=372.90 Aligned_cols=248 Identities=18% Similarity=0.225 Sum_probs=208.7
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
.|.+...++.|+.+.||+|....+++.++.|+. ..+...+.+|+++|++|+|||||+++++|.+++.+|||||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 455555555555666888888877776655542 2334578999999999999999999999999999999999998
Q ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc--cceeeecccccccccCC-Cccccc
Q psy501 388 -ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT--ELVKIADFGLAREIRSR-PYTDYV 463 (962)
Q Consensus 388 -g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~--g~vKL~DFGla~~~~~~-~~~~~~ 463 (962)
|+|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.+... .....+
T Consensus 238 gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~ 317 (573)
T 3uto_A 238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 317 (573)
T ss_dssp CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEEC
T ss_pred CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeE
Confidence 58888887766779999999999999999999999999999999999999854 79999999999987654 345568
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--CCCCCCCCcHHHHHHHhc
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--TLPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l~~li~~Cl~ 541 (962)
||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.........+......++ ..+..+....+|+..||.
T Consensus 318 GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~ 396 (573)
T 3uto_A 318 GTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL 396 (573)
T ss_dssp SSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSC
T ss_pred ECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcc
Confidence 9999999999976 5799999999999999999999999999998888888877655443 234567778899999999
Q ss_pred cCCCCCCcHHHHHhhccccc
Q psy501 542 AGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 542 ~dperRPs~~~Ll~~l~~~~ 561 (962)
.||++||++.++++. +|+.
T Consensus 397 ~dp~~R~t~~e~l~H-pw~~ 415 (573)
T 3uto_A 397 ADPNTRMTIHQALEH-PWLT 415 (573)
T ss_dssp SSGGGSCCHHHHHHS-TTTS
T ss_pred CChhHCcCHHHHhcC-cCcC
Confidence 999999998887764 3544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=334.31 Aligned_cols=247 Identities=19% Similarity=0.234 Sum_probs=208.9
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
.|.|.....++.++.+.||.+....+++.++.|+.. .....+.+|+++|++++||||+++++++.+++..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 567777777777777789999887666665555432 23446889999999999999999999999999999999
Q ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-Cccc
Q psy501 384 EYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTD 461 (962)
Q Consensus 384 Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~ 461 (962)
||++ |+|.+.+... +.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... ....
T Consensus 94 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 172 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172 (328)
T ss_dssp CCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGT
T ss_pred ECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcccc
Confidence 9997 5777777665 45999999999999999999999999999999999999999999999999999876543 4456
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhc
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~ 541 (962)
.+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+..+....+ ...+..+..+++.||.
T Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~L~ 250 (328)
T 3fe3_A 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP--FYMSTDCENLLKRFLV 250 (328)
T ss_dssp TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHCC
T ss_pred ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHHCC
Confidence 78999999999998765556899999999999999999999999988888888877754433 3567778899999999
Q ss_pred cCCCCCCcHHHHHhhcccc
Q psy501 542 AGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 542 ~dperRPs~~~Ll~~l~~~ 560 (962)
.+|.+||++.++++.- |+
T Consensus 251 ~dP~~R~t~~eil~h~-~~ 268 (328)
T 3fe3_A 251 LNPIKRGTLEQIMKDR-WI 268 (328)
T ss_dssp SSTTTSCCHHHHTTCT-TT
T ss_pred CChhHCcCHHHHhcCH-hh
Confidence 9999999999888753 44
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=322.62 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=201.1
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEec
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEY 385 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey 385 (962)
.|.....++.++.+.||.+....+++.++.|... .....+.+|+.++++++||||+++++++.+++..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 3455556666677779999887776655544322 1235688999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--Cccccc
Q psy501 386 MKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYV 463 (962)
Q Consensus 386 ~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~ 463 (962)
++|++++.+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...... ......
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 162 (292)
T 3o0g_A 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV 162 (292)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCC
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCc
Confidence 999999999887788999999999999999999999999999999999999999999999999999876543 344567
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCC-CCCcChhhhHHHHHhcccccc-------------------
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPP-IQTTCLLAGTERLKSSYILLH------------------- 523 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~P-f~~~~~~~~~~~i~~~~~~~~------------------- 523 (962)
||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.........+......+.
T Consensus 163 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (292)
T 3o0g_A 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242 (292)
T ss_dssp SCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCC
T ss_pred cccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccc
Confidence 899999999998766689999999999999999988777 555554444444433211110
Q ss_pred --------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccccCCC
Q psy501 524 --------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVP 565 (962)
Q Consensus 524 --------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~~~~ 565 (962)
..+..+..+..++..||..+|++||++.++++. +|+...+|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h-p~f~~~~p 291 (292)
T 3o0g_A 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH-PYFSDFCP 291 (292)
T ss_dssp CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS-GGGTTC--
T ss_pred cCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC-cccccCCC
Confidence 111234456789999999999999999888874 46554433
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=325.15 Aligned_cols=252 Identities=25% Similarity=0.324 Sum_probs=203.4
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCCceEEEEeccch-----hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-----DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
+.+.|.....++.++.+.||.+.......++.+.+... ....+.+|++++++++||||+++++++.++...++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 45667777777777777899998866544444443221 1346889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--Cccc
Q psy501 384 EYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTD 461 (962)
Q Consensus 384 Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~ 461 (962)
||++|++.+.+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... ....
T Consensus 99 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 178 (311)
T 3niz_A 99 EFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178 (311)
T ss_dssp ECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---C
T ss_pred cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccC
Confidence 99999999999887778999999999999999999999999999999999999999999999999999876533 3445
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc------------------
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH------------------ 523 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------ 523 (962)
..||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.........+......+.
T Consensus 179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (311)
T 3niz_A 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258 (311)
T ss_dssp CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCC
T ss_pred CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhccc
Confidence 67899999999998766799999999999999999999999998776666555543211111
Q ss_pred ----------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 524 ----------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 524 ----------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
..+.++..+.+++..||..+|++||++.++++.- |+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp-~f~ 305 (311)
T 3niz_A 259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP-YFK 305 (311)
T ss_dssp CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSG-GGT
T ss_pred ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCc-ccc
Confidence 0122344566899999999999999999888743 443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=322.72 Aligned_cols=248 Identities=19% Similarity=0.238 Sum_probs=200.1
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
.|.....++.++.+.||.+.....++.++.|.. ......+.+|+.++++++||||+++++++..++..|+||||++
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 444455555566667888887666665554432 2235678999999999999999999999999999999999997
Q ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccC
Q psy501 388 -ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVS 464 (962)
Q Consensus 388 -g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~g 464 (962)
|+|.+.+... .+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...... ......|
T Consensus 101 ~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 178 (297)
T 3fxz_A 101 GGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 178 (297)
T ss_dssp TCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCS
T ss_pred CCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccC
Confidence 5666666543 4899999999999999999999999999999999999999999999999999876543 3445689
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc-cccCCCCCCCCcHHHHHHHhccC
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI-LLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+..... ........+..+..++..||..+
T Consensus 179 t~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 257 (297)
T 3fxz_A 179 TPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 257 (297)
T ss_dssp CGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSS
T ss_pred CcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCC
Confidence 9999999999764 789999999999999999999999998877666555543322 22233456677889999999999
Q ss_pred CCCCCcHHHHHhhccccccC
Q psy501 544 TERLKSSYILLHTLPLYTYH 563 (962)
Q Consensus 544 perRPs~~~Ll~~l~~~~~~ 563 (962)
|++||++.++++.- |+...
T Consensus 258 p~~Rps~~ell~h~-~~~~~ 276 (297)
T 3fxz_A 258 VEKRGSAKELLQHQ-FLKIA 276 (297)
T ss_dssp TTTSCCHHHHTTCG-GGGGC
T ss_pred hhHCcCHHHHhhCh-hhccc
Confidence 99999998888753 55443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=320.93 Aligned_cols=245 Identities=24% Similarity=0.277 Sum_probs=194.5
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccch-----hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecC
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-----DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
.|.....++.++.+.||.+.......++.+.+... ....+.+|++++++++||||+++++++.+++..++||||+
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence 34455555666666799998754555544443221 2356889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccC
Q psy501 387 KENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVS 464 (962)
Q Consensus 387 ~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~g 464 (962)
+|++.+.+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... ......|
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 162 (288)
T 1ob3_A 83 DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV 162 (288)
T ss_dssp SEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------C
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccc
Confidence 99999998877778999999999999999999999999999999999999999999999999999876533 3344578
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc---------------------
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--------------------- 523 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------- 523 (962)
|+.|+|||++.+...++.++|||||||++|||++|++||.+.........+........
T Consensus 163 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T 1ob3_A 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242 (288)
T ss_dssp CCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCC
T ss_pred cccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccccccc
Confidence 99999999997766789999999999999999999999998776665555433211000
Q ss_pred ------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 524 ------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 524 ------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.....+..+..++..||..+|++||++.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 011234455689999999999999998888874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=323.64 Aligned_cols=249 Identities=24% Similarity=0.273 Sum_probs=202.1
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh------------------------------HHHHHHHHH
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD------------------------------EMVVCFYRK 356 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~------------------------------~~~~~~Ei~ 356 (962)
.+..+.+.....++.++.+.||.+....+++.++.|+.... ...+.+|++
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 34456777777777777777999988777766555543221 235889999
Q ss_pred HHHhcCCCCcccEEEEEEe--CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcc
Q psy501 357 SLKKLSHANLVKLKEVIRE--NDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPEN 434 (962)
Q Consensus 357 iL~~L~HpnIv~l~~~~~~--~~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~N 434 (962)
+|++++||||+++++++.+ +...++||||++++.+..+.. ...+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 9999999999999999986 568999999998543333322 3469999999999999999999999999999999999
Q ss_pred cccccccceeeecccccccccCC--CcccccCCccccChhhhccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCcChhh
Q psy501 435 LLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEVLLHSTA--YSAPIHLSRSQQFLFYSIDHVPPIQTTCLLA 510 (962)
Q Consensus 435 ILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~l~~~~~--~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~ 510 (962)
|+++.++.+||+|||++...... ......||+.|+|||++.+... ++.++|||||||++|+|++|+.||.+.....
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 247 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence 99999999999999999876543 2345679999999999975432 4789999999999999999999999887777
Q ss_pred hHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 511 GTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 511 ~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
....+.......+..+.++..+..++..||..+|++||++.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 7777776666666566778889999999999999999999888763
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=333.98 Aligned_cols=251 Identities=20% Similarity=0.251 Sum_probs=208.2
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh-------HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD-------EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
.|.|.....++.|+.+.||.+....+++.++.|+.... ...+.+|+.+++.++||||+++++++.+++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46777777777777888999998777766666554322 24689999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-Cccc
Q psy501 383 FEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTD 461 (962)
Q Consensus 383 ~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~ 461 (962)
|||++|++++.+.... .+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... ....
T Consensus 88 ~E~~~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~ 166 (336)
T 3h4j_B 88 IEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT 166 (336)
T ss_dssp ECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCC
T ss_pred EECCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccccc
Confidence 9999999999887764 5999999999999999999999999999999999999999999999999999876544 3455
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhc
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~ 541 (962)
.+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+..+... .+...+..+..++..||.
T Consensus 167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L~ 244 (336)
T 3h4j_B 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYV--MPDFLSPGAQSLIRRMIV 244 (336)
T ss_dssp CTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCC--CCTTSCHHHHHHHHTTSC
T ss_pred ccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC--CcccCCHHHHHHHHHHcC
Confidence 689999999999976544588999999999999999999999887655544444333222 224566778899999999
Q ss_pred cCCCCCCcHHHHHhhccccccCC
Q psy501 542 AGTERLKSSYILLHTLPLYTYHV 564 (962)
Q Consensus 542 ~dperRPs~~~Ll~~l~~~~~~~ 564 (962)
.+|.+||++.++++. +|+....
T Consensus 245 ~dP~~Rpt~~eil~h-p~~~~~~ 266 (336)
T 3h4j_B 245 ADPMQRITIQEIRRD-PWFNVNL 266 (336)
T ss_dssp SSGGGSCCHHHHTTC-HHHHTTC
T ss_pred CChhHCcCHHHHHhC-hhhccCC
Confidence 999999999988875 4655443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=327.31 Aligned_cols=243 Identities=17% Similarity=0.168 Sum_probs=202.7
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
+.+.....++.++.+.||.+....+++.++.|+... ....+.+|+.+|++++||+|+++++++.+.+.+|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 345555566666667799998887777666665432 2346889999999999999999999999999999999
Q ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC--CCcc
Q psy501 384 EYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYT 460 (962)
Q Consensus 384 Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~--~~~~ 460 (962)
||++| +|...+... ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++.... ....
T Consensus 85 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~ 163 (337)
T 1o6l_A 85 EYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163 (337)
T ss_dssp ECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBC
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCccc
Confidence 99985 666666554 5699999999999999999999999999999999999999999999999999986432 2445
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHh
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCL 540 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl 540 (962)
..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+.......+ ...+..+..++..||
T Consensus 164 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~lL 240 (337)
T 1o6l_A 164 TFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKSLLAGLL 240 (337)
T ss_dssp CCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHT
T ss_pred ccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHh
Confidence 5789999999999965 4789999999999999999999999999888777777766644433 456778899999999
Q ss_pred ccCCCCCC-----cHHHHHhhc
Q psy501 541 LAGTERLK-----SSYILLHTL 557 (962)
Q Consensus 541 ~~dperRP-----s~~~Ll~~l 557 (962)
..+|++|| ++.++++.-
T Consensus 241 ~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 241 KKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSG
T ss_pred hcCHHHhcCCCCCCHHHHHcCC
Confidence 99999998 777776643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=325.86 Aligned_cols=249 Identities=17% Similarity=0.228 Sum_probs=207.7
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEecc---chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS---SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~---~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
+.|.....++.++.+.||.|....+++.++.+.. ..+...+.+|+.+|+.++||||+++++++.+.+.+++|||||+
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 4556666666667777999988877766555443 2344568999999999999999999999999999999999998
Q ss_pred C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc--ccceeeecccccccccCC-Cccccc
Q psy501 388 E-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG--TELVKIADFGLAREIRSR-PYTDYV 463 (962)
Q Consensus 388 g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~--~g~vKL~DFGla~~~~~~-~~~~~~ 463 (962)
| +|.+.+......+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++...... ......
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 164 (321)
T 1tki_A 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEE
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcccccc
Confidence 5 788888766667999999999999999999999999999999999999987 789999999999876544 334567
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC--CCCCCCCcHHHHHHHhc
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT--LPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l~~li~~Cl~ 541 (962)
||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.........+......++. .+..+..+..++..||.
T Consensus 165 gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 243 (321)
T 1tki_A 165 TAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLV 243 (321)
T ss_dssp SCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSC
T ss_pred CChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcC
Confidence 99999999999654 6899999999999999999999999998887777777766544332 23567788899999999
Q ss_pred cCCCCCCcHHHHHhhccccc
Q psy501 542 AGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 542 ~dperRPs~~~Ll~~l~~~~ 561 (962)
.+|++||++.++++.- |+.
T Consensus 244 ~dp~~Rpt~~e~l~hp-~~~ 262 (321)
T 1tki_A 244 KERKSRMTASEALQHP-WLK 262 (321)
T ss_dssp SSGGGSCCHHHHHHSH-HHH
T ss_pred CChhHCcCHHHHhcCh-hhc
Confidence 9999999988877743 443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=329.33 Aligned_cols=244 Identities=15% Similarity=0.221 Sum_probs=201.8
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccch----------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR----------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLY 380 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~----------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 380 (962)
+.|.....++.|+.+.||.|....+++.++.|+... ....+.+|+.+|++++||||+++++++.++..++
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 445555566666666788888777666555443221 2467899999999999999999999999999999
Q ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc----ceeeeccccccccc
Q psy501 381 FVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE----LVKIADFGLAREIR 455 (962)
Q Consensus 381 LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g----~vKL~DFGla~~~~ 455 (962)
+||||++ |+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++....
T Consensus 92 lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 92 LILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 9999997 567776654 45699999999999999999999999999999999999998777 79999999998765
Q ss_pred CC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC--CCCCCCCc
Q psy501 456 SR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT--LPLYTYHV 532 (962)
Q Consensus 456 ~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l 532 (962)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+......++. .+..+..+
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 249 (361)
T 2yab_A 171 DGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA 249 (361)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred CCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence 54 3455689999999999965 47999999999999999999999999998887777777766443321 24566778
Q ss_pred HHHHHHHhccCCCCCCcHHHHHhh
Q psy501 533 PPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 533 ~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
..++..||..+|++||++.+++..
T Consensus 250 ~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 250 KDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHCCCChhHCcCHHHHhcC
Confidence 899999999999999998888874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=327.18 Aligned_cols=250 Identities=21% Similarity=0.244 Sum_probs=206.8
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEec
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEY 385 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey 385 (962)
+.....++.++.+.||.+....+++.++.|... .....+.+|+++|++++||||+++++++.+++..++||||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence 444455555666679999877666655554422 1124688999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCC
Q psy501 386 MKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST 465 (962)
Q Consensus 386 ~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt 465 (962)
+.|++.+.+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..... .....||
T Consensus 136 ~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--~~~~~gt 213 (348)
T 1u5q_A 136 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANSFVGT 213 (348)
T ss_dssp CSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--BCCCCSC
T ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--CCcccCC
Confidence 99999999887777899999999999999999999999999999999999999999999999999976543 3346799
Q ss_pred ccccChhhhcc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccC
Q psy501 466 RWYRAPEVLLH--STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 466 ~~Y~APE~l~~--~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.........+............++..+..++..||..+
T Consensus 214 ~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 293 (348)
T 1u5q_A 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI 293 (348)
T ss_dssp GGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred cceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 99999999853 3468999999999999999999999999887766666666554433334466777889999999999
Q ss_pred CCCCCcHHHHHhhccccccCCC
Q psy501 544 TERLKSSYILLHTLPLYTYHVP 565 (962)
Q Consensus 544 perRPs~~~Ll~~l~~~~~~~~ 565 (962)
|++||++.++++.. |+....+
T Consensus 294 P~~Rps~~~ll~h~-~~~~~~~ 314 (348)
T 1u5q_A 294 PQDRPTSEVLLKHR-FVLRERP 314 (348)
T ss_dssp GGGSCCHHHHTTCH-HHHSCCC
T ss_pred hhhCcCHHHHhhCh-hhhccCC
Confidence 99999999988764 5444433
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=331.38 Aligned_cols=240 Identities=18% Similarity=0.207 Sum_probs=198.2
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCE
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKL-SHANLVKLKEVIRENDT 378 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 378 (962)
.+..+.+.....++.++.+.||.+....+++.++.|+... ....+.+|+.+|+.+ +||+|+++++++.+++.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 3445667777777777777899999888777766665433 234588999999998 69999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC
Q psy501 379 LYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR 457 (962)
Q Consensus 379 ~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~ 457 (962)
+|+||||++| +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 9999999985 676666554 55999999999999999999999999999999999999999999999999999854322
Q ss_pred --CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHH
Q psy501 458 --PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPI 535 (962)
Q Consensus 458 --~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~l 535 (962)
.....+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+.......+.......+ ...+..+..+
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~l 254 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP--TWLHEDATGI 254 (353)
T ss_dssp --------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHHHH
T ss_pred CccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHH
Confidence 44556899999999999754 689999999999999999999999999988888888887755444 4577788999
Q ss_pred HHHHhccCCCCCCcH
Q psy501 536 QTTCLLAGTERLKSS 550 (962)
Q Consensus 536 i~~Cl~~dperRPs~ 550 (962)
++.||..+|++||++
T Consensus 255 i~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 255 LKSFMTKNPTMRLGS 269 (353)
T ss_dssp HHHHTCSSGGGSTTS
T ss_pred HHHHhhhCHHHccCC
Confidence 999999999999987
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=319.28 Aligned_cols=253 Identities=19% Similarity=0.187 Sum_probs=202.6
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
+..+.+..+..++.++.+.||.+....+++.++.|.. ......+.+|++++++++||||+++++++.+++..++||
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 4456667777777777777999988776666555432 233457899999999999999999999999999999999
Q ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCc---
Q psy501 384 EYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY--- 459 (962)
Q Consensus 384 Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~--- 459 (962)
||++| +|.+.+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 99985 78888777677899999999999999999999999999999999999999999999999999987643311
Q ss_pred -------------ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHH-HHhccccccCC
Q psy501 460 -------------TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTER-LKSSYILLHTL 525 (962)
Q Consensus 460 -------------~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~-i~~~~~~~~~~ 525 (962)
....||+.|+|||++.+ ..++.++|||||||++|||++|..||........... ...........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCC
T ss_pred ccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCC
Confidence 14579999999999965 4789999999999999999999999976432221100 01111112234
Q ss_pred CCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 526 PLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 526 ~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
+.++..+..++..||..+|++||++.++++.|..+.
T Consensus 246 ~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 246 PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 577889999999999999999999999998775443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=322.81 Aligned_cols=247 Identities=26% Similarity=0.319 Sum_probs=191.7
Q ss_pred eeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC
Q psy501 314 RLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE 388 (962)
Q Consensus 314 ~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g 388 (962)
.....++.++.+.||.+....+++.++.|... .....+.+|++++++++||||+++++++.+++..++||||++|
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 87 (317)
T 2pmi_A 8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN 87 (317)
T ss_dssp -----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCCC
T ss_pred eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecCC
Confidence 33334444445568888776666554444322 2235688999999999999999999999999999999999999
Q ss_pred CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--Cccc
Q psy501 389 NLYQLIRDRD-----KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTD 461 (962)
Q Consensus 389 ~Ll~~l~~~~-----~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~ 461 (962)
+|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... ....
T Consensus 88 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (317)
T 2pmi_A 88 DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167 (317)
T ss_dssp BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCC
T ss_pred CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCC
Confidence 9998886542 45899999999999999999999999999999999999999999999999999876533 3445
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-------------------
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL------------------- 522 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------------- 522 (962)
..||+.|+|||++.+...++.++|||||||++|||++|+.||.+.........+......+
T Consensus 168 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (317)
T 2pmi_A 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQ 247 (317)
T ss_dssp CCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCC
T ss_pred CcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccc
Confidence 6789999999999876678999999999999999999999999887766555553321100
Q ss_pred -------------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 523 -------------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 523 -------------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
......+..+..++..||..+|++||++.++++.- |+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp-~f~ 298 (317)
T 2pmi_A 248 QRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP-WFA 298 (317)
T ss_dssp CCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG-GGG
T ss_pred cccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCCh-hhh
Confidence 01113445677899999999999999998888743 443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=323.18 Aligned_cols=251 Identities=14% Similarity=0.068 Sum_probs=202.9
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccch--hHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEE
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR--DEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~--~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
.+..+.+.....++.++.+.||.+....+++.++.|+... ....+.+|+++++++ +||+|+++++++..++..++||
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 3445566666666666667799999877777666655432 234588999999999 8999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccc-----eeeecccccccccCCC
Q psy501 384 EYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL-----VKIADFGLAREIRSRP 458 (962)
Q Consensus 384 Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~-----vKL~DFGla~~~~~~~ 458 (962)
||+.|+|.+.+......+++..++.++.||+.||.|||+.||+||||||+||+++.++. +||+|||++.......
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 85 ELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred EeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99988899988876678999999999999999999999999999999999999998887 9999999998764432
Q ss_pred ---------cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh---hhHHHHHhcccccc---
Q psy501 459 ---------YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL---AGTERLKSSYILLH--- 523 (962)
Q Consensus 459 ---------~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~--- 523 (962)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.... .....+.......+
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 243 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV 243 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred CCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH
Confidence 245689999999999976 47899999999999999999999999885433 22333332222111
Q ss_pred CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 524 TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 524 ~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
....+| .+..++..||..+|..||++.+|.+.|..
T Consensus 244 ~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 244 LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 112345 88899999999999999999998887743
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=311.47 Aligned_cols=246 Identities=20% Similarity=0.241 Sum_probs=205.6
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE 388 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g 388 (962)
..+.....++.++.+.||.+......+++.+.+.. .....+.+|++++++++||||+++++++.+++..++||||++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 35555666666677779999887666665554433 2356799999999999999999999999999999999999985
Q ss_pred -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---CcccccC
Q psy501 389 -NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYVS 464 (962)
Q Consensus 389 -~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~g 464 (962)
+|.+.+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...... ......+
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 169 (269)
T 4hcu_A 90 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF 169 (269)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTC
T ss_pred CcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCccc
Confidence 777777776777999999999999999999999999999999999999999999999999999866443 3334456
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccC
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
++.|+|||++.+. .++.++|||||||++|+|++ |+.||...........+.... ........+..+..++..||..+
T Consensus 170 ~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~ 247 (269)
T 4hcu_A 170 PVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLYKPRLASTHVYQIMNHCWRER 247 (269)
T ss_dssp CGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCCTTSCHHHHHHHHHHTCSS
T ss_pred ccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-cCCCCCcCCHHHHHHHHHHccCC
Confidence 7889999999754 69999999999999999999 999999988877777766552 23333456777889999999999
Q ss_pred CCCCCcHHHHHhhcc
Q psy501 544 TERLKSSYILLHTLP 558 (962)
Q Consensus 544 perRPs~~~Ll~~l~ 558 (962)
|++||++.++++.+.
T Consensus 248 p~~Rps~~~ll~~l~ 262 (269)
T 4hcu_A 248 PEDRPAFSRLLRQLA 262 (269)
T ss_dssp GGGSCCHHHHHHHHH
T ss_pred cccCcCHHHHHHHHH
Confidence 999999999998764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=316.95 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=199.1
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEeccch---------hHHHHHHHHHHHHhcC---CCCcccEEEEEEe
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR---------DEMVVCFYRKSLKKLS---HANLVKLKEVIRE 375 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~---------~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~ 375 (962)
+..+.|.....++.++.+.||.+.....++.++.|.... ....+.+|+.++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 345667777777777777899999877776655554321 1245778888877775 9999999999987
Q ss_pred CC-----EEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccc
Q psy501 376 ND-----TLYFVFEYMKENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFG 449 (962)
Q Consensus 376 ~~-----~~~LV~Ey~~g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFG 449 (962)
.. ..++||||++|+|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred cCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 65 589999999999999887754 349999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC----
Q psy501 450 LAREIRSR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT---- 524 (962)
Q Consensus 450 la~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---- 524 (962)
++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.........+......++.
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred cccccCCCcccCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 99876543 44556899999999999764 6899999999999999999999999998877776666543221111
Q ss_pred ---------------------CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 525 ---------------------LPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 525 ---------------------~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.+..+..+..++..||..+|++||++.++++.-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~ 298 (308)
T 3g33_A 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298 (308)
T ss_dssp SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence 123445567899999999999999988887743
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=329.75 Aligned_cols=243 Identities=14% Similarity=0.193 Sum_probs=197.3
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
.+.+.....++.|+.+.||.+....+++.++.|+... ....+.+|+++|++++||||++++++|.+.+.+|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 4566666666667777799999888887777665432 235688999999999999999999999999999999
Q ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-Ccc
Q psy501 383 FEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYT 460 (962)
Q Consensus 383 ~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~ 460 (962)
|||+.| +|...+. ....+++..++.++.||+.||.|||+.||+||||||+||+++.+|.+||+|||++...... ...
T Consensus 94 ~e~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 172 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQ-QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT 172 (384)
T ss_dssp ECCCTTEEHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBC
T ss_pred EecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCcee
Confidence 999986 5555554 4566999999999999999999999999999999999999999999999999999876543 455
Q ss_pred cccCCccccChhhhcc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhh---hHHHHHhccccccCCCCCCCCcHHH
Q psy501 461 DYVSTRWYRAPEVLLH--STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLA---GTERLKSSYILLHTLPLYTYHVPPI 535 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~--~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~s~~l~~l 535 (962)
..+||+.|+|||++.+ +..++.++|||||||++|||++|+.||....... ....+.... ......++..+..+
T Consensus 173 ~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~p~~~s~~~~~l 250 (384)
T 4fr4_A 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYPSAWSQEMVSL 250 (384)
T ss_dssp CCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--CCCCTTSCHHHHHH
T ss_pred ccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--cCCCCcCCHHHHHH
Confidence 6789999999999964 3358999999999999999999999998543332 223333332 22234667788899
Q ss_pred HHHHhccCCCCCCc-HHHHHh
Q psy501 536 QTTCLLAGTERLKS-SYILLH 555 (962)
Q Consensus 536 i~~Cl~~dperRPs-~~~Ll~ 555 (962)
+..||..+|++||+ +.++++
T Consensus 251 i~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 251 LKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHhcCCHhHhcccHHHHHc
Confidence 99999999999998 565554
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=319.40 Aligned_cols=241 Identities=15% Similarity=0.251 Sum_probs=202.4
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
..+.....++.++.+.||.+....+++.++.|+... ....+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 345555566666667799998887777666665432 2346789999999999999999999999999999999
Q ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccc
Q psy501 384 EYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDY 462 (962)
Q Consensus 384 Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 462 (962)
||++| +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++...... ....
T Consensus 86 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-~~~~ 163 (318)
T 1fot_A 86 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-TYTL 163 (318)
T ss_dssp CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-BCCC
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-cccc
Confidence 99985 67766655 456999999999999999999999999999999999999999999999999999875443 3456
Q ss_pred cCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhcc
Q psy501 463 VSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 542 (962)
Q Consensus 463 ~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~ 542 (962)
+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+.......+ +.++..+..++..||..
T Consensus 164 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~li~~lL~~ 240 (318)
T 1fot_A 164 CGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFNEDVKDLLSRLITR 240 (318)
T ss_dssp CSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHTCS
T ss_pred cCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHHhcc
Confidence 89999999999965 4789999999999999999999999999888777777777654433 56777889999999999
Q ss_pred CCCCCC-----cHHHHHhh
Q psy501 543 GTERLK-----SSYILLHT 556 (962)
Q Consensus 543 dperRP-----s~~~Ll~~ 556 (962)
+|++|| ++.+++..
T Consensus 241 dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 241 DLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CTTTCTTSSTTTTHHHHTS
T ss_pred CHHHcCCCcCCCHHHHhcC
Confidence 999999 76666653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=320.63 Aligned_cols=245 Identities=15% Similarity=0.209 Sum_probs=199.4
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccch----------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR----------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLY 380 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~----------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 380 (962)
+.|.....++.++.+.||.+....+++.++.|+... ....+.+|+.+|++++||||+++++++.++...+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 345555555556666789888877666555443221 2467999999999999999999999999999999
Q ss_pred EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc----ceeeeccccccccc
Q psy501 381 FVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE----LVKIADFGLAREIR 455 (962)
Q Consensus 381 LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g----~vKL~DFGla~~~~ 455 (962)
+||||++| +|.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++....
T Consensus 91 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999975 67666654 45699999999999999999999999999999999999998877 79999999998765
Q ss_pred CC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC--CCCCCCCc
Q psy501 456 SR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT--LPLYTYHV 532 (962)
Q Consensus 456 ~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l 532 (962)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.......+. .+..+..+
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (326)
T 2y0a_A 170 FGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 248 (326)
T ss_dssp TTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred CCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHH
Confidence 33 4455689999999999965 47999999999999999999999999988777666666554332221 23566678
Q ss_pred HHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 533 PPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 533 ~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..++..||..+|++||++.++++.-
T Consensus 249 ~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 249 KDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred HHHHHHHccCChhhCCCHHHHhcCC
Confidence 8899999999999999988888743
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=317.54 Aligned_cols=250 Identities=18% Similarity=0.177 Sum_probs=199.8
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEecc-------chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEE
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS-------SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLY 380 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~-------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 380 (962)
++.+.|.....++.++.+.||.+.....++.++.|.. ......+.+|+.++++++||||+++++++.+++..|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 3456777777777777888999988776665554432 112346899999999999999999999999999999
Q ss_pred EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--
Q psy501 381 FVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-- 457 (962)
Q Consensus 381 LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-- 457 (962)
+||||++| +|.+++... +.+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 88 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999985 677766554 46999999999999999999999999999999999999999999999999999876543
Q ss_pred -CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc---cCCCCCCCCcH
Q psy501 458 -PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL---HTLPLYTYHVP 533 (962)
Q Consensus 458 -~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~s~~l~ 533 (962)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+................. ...+.++..+.
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245 (294)
T ss_dssp --------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred cccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence 23345789999999999764 68999999999999999999999999887766554444332221 12345677888
Q ss_pred HHHHHHhccCCCCCC-cHHHHHhhccc
Q psy501 534 PIQTTCLLAGTERLK-SSYILLHTLPL 559 (962)
Q Consensus 534 ~li~~Cl~~dperRP-s~~~Ll~~l~~ 559 (962)
.++..||..+|++|| +++++.+.|..
T Consensus 246 ~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 246 NVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 999999999999998 68888887743
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=324.01 Aligned_cols=254 Identities=15% Similarity=0.183 Sum_probs=206.6
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCce----EEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCE
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDNH----ILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDT 378 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~k----vv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 378 (962)
.+..+.+.....++.++.+.||.+.....+. ++.+.+. ......+.+|+.+|++++||||+++++++.+++.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 3445677777777777778899998764332 3333332 2234568999999999999999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC
Q psy501 379 LYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR 457 (962)
Q Consensus 379 ~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~ 457 (962)
.++||||++| +|.+++......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 9999999975 788887766677999999999999999999999999999999999999999999999999999876543
Q ss_pred -----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCC
Q psy501 458 -----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYH 531 (962)
Q Consensus 458 -----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 531 (962)
......+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.........+..+ ...+....++..
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 282 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPAPMGCPHA 282 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHH
T ss_pred ccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CCCCCCCCcCHH
Confidence 12223457789999999754 68999999999999999999 99999998877777766655 333444567778
Q ss_pred cHHHHHHHhccCCCCCCcHHHHHhhcccccc
Q psy501 532 VPPIQTTCLLAGTERLKSSYILLHTLPLYTY 562 (962)
Q Consensus 532 l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~ 562 (962)
+..++..||..+|++||++.++++.|.....
T Consensus 283 l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 283 LHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8999999999999999999999998755443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=321.70 Aligned_cols=251 Identities=19% Similarity=0.180 Sum_probs=195.4
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
+..+.+.....++.++.+.||.+.......+++.... ......+.+|+++|++++||||+++++++.++...++||
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 3445666677777777778999976543322332211 122346889999999999999999999999999999999
Q ss_pred ecCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHhhcccce--eeeccCCCcccccccccceeeecccccccccCC-
Q psy501 384 EYMKE-NLYQLIRDRD--KFLPESIIRNMMYQVLQGLAFMHRHG--FFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457 (962)
Q Consensus 384 Ey~~g-~Ll~~l~~~~--~~ls~~~i~~i~~qI~~aL~yLH~~g--IvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~- 457 (962)
||++| +|.+.+.... ..+++..++.++.||+.||.|||+.| |+||||||+||+++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 99985 7777766543 23899999999999999999999999 999999999999999999999999999765443
Q ss_pred -CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHH
Q psy501 458 -PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQ 536 (962)
Q Consensus 458 -~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li 536 (962)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+............++..+..++
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 272 (309)
T 3p86_A 194 LSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAII 272 (309)
T ss_dssp --------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred cccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHH
Confidence 2345679999999999976 46899999999999999999999999988877776666555444555567778889999
Q ss_pred HHHhccCCCCCCcHHHHHhhccc
Q psy501 537 TTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 537 ~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
..||..+|++||++.++++.|..
T Consensus 273 ~~~l~~dP~~Rps~~~ll~~L~~ 295 (309)
T 3p86_A 273 EGCWTNEPWKRPSFATIMDLLRP 295 (309)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHHHHH
Confidence 99999999999999999887643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=314.88 Aligned_cols=247 Identities=26% Similarity=0.391 Sum_probs=194.9
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEecc-ch-----hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS-SR-----DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~-~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
+.+.....++.++.+.||.+....+++.++.|.. .. ....+.+|++++++++||||+++++++.+++..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 3455666666677777999988776665544432 11 13457899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--Ccccc
Q psy501 385 YMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDY 462 (962)
Q Consensus 385 y~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~ 462 (962)
|++|+++..+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...... .....
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 162 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE 162 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCC
Confidence 9998887777776677999999999999999999999999999999999999999999999999999876533 33456
Q ss_pred cCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc-------------------cc
Q psy501 463 VSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL-------------------LH 523 (962)
Q Consensus 463 ~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------~~ 523 (962)
.||+.|+|||++.+...++.++|||||||++|+|++|++||.+.........+...... .+
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (311)
T 4agu_A 163 VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIP 242 (311)
T ss_dssp ---GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCC
T ss_pred cCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCC
Confidence 78999999999987667899999999999999999999999987766554444321100 00
Q ss_pred ----------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 524 ----------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 524 ----------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..+..+..+..++..||..+|++||++.++++.-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 286 (311)
T 4agu_A 243 DPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286 (311)
T ss_dssp CCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred CccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence 0123445577899999999999999999888753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=331.43 Aligned_cols=246 Identities=20% Similarity=0.213 Sum_probs=206.5
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh-------HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD-------EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
.+.+.....++.|+.+.||.+....+++.++.|+.... ...+.+|+.+++.++||||++++++|.++..+|+|
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 34566666667777777999998888877776664432 22478999999999999999999999999999999
Q ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---
Q psy501 383 FEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--- 458 (962)
Q Consensus 383 ~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~--- 458 (962)
|||++ |+|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.......
T Consensus 148 ~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 225 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225 (410)
T ss_dssp ECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEE
T ss_pred EeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccc
Confidence 99997 567776654 358999999999999999999999999999999999999999999999999998765542
Q ss_pred cccccCCccccChhhhccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcc--ccccCCCCCCCCcH
Q psy501 459 YTDYVSTRWYRAPEVLLHSTA---YSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSY--ILLHTLPLYTYHVP 533 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~~~~---~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~s~~l~ 533 (962)
....+||+.|+|||++.+... ++.++|||||||++|||++|++||.+.+.......+.... ...+..+.++..+.
T Consensus 226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 305 (410)
T 3v8s_A 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 305 (410)
T ss_dssp CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHH
T ss_pred ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHH
Confidence 345689999999999975422 7899999999999999999999999998888888887653 34444456788899
Q ss_pred HHHHHHhccCCCC--CCcHHHHHhhc
Q psy501 534 PIQTTCLLAGTER--LKSSYILLHTL 557 (962)
Q Consensus 534 ~li~~Cl~~dper--RPs~~~Ll~~l 557 (962)
.++..||..+|.+ ||++.+++..-
T Consensus 306 ~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 306 NLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp HHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred HHHHHHccChhhhCCCCCHHHHhcCc
Confidence 9999999999999 99988887654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=319.86 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=202.3
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEe--------
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRE-------- 375 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-------- 375 (962)
.+.|.....++.++.+.||.+....+++.++.|... .....+.+|+.+|++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 355666666666666779999987766655554321 123467899999999999999999999987
Q ss_pred CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccccccc
Q psy501 376 NDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR 455 (962)
Q Consensus 376 ~~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~ 455 (962)
++..++||||++|++...+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 45789999999999999998877789999999999999999999999999999999999999999999999999998664
Q ss_pred CC------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC--CCC
Q psy501 456 SR------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT--LPL 527 (962)
Q Consensus 456 ~~------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~ 527 (962)
.. ......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.........+.......+. .+.
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 255 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 22 3344578999999999987667899999999999999999999999998776666555443222211 111
Q ss_pred C----------------------------CCCcHHHHHHHhccCCCCCCcHHHHHhhcccccc
Q psy501 528 Y----------------------------TYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTY 562 (962)
Q Consensus 528 ~----------------------------s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~ 562 (962)
. +..+..++..||..||++||++.++++.- |+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp-~f~~ 317 (351)
T 3mi9_A 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD-FFWS 317 (351)
T ss_dssp GGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG-GGGS
T ss_pred cccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC-CcCC
Confidence 1 23366899999999999999988888754 5443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=320.69 Aligned_cols=248 Identities=24% Similarity=0.296 Sum_probs=195.5
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
..+.|.....++.++.+.||.+.....++.++.|.... ....+.+|+.+|++++||||+++++++.+++..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 35567777777777778899998887777666555321 123577999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccc-----cccceeeecccccccccCC
Q psy501 383 FEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM-----GTELVKIADFGLAREIRSR 457 (962)
Q Consensus 383 ~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~-----~~g~vKL~DFGla~~~~~~ 457 (962)
|||++|+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++ ..+.+||+|||++......
T Consensus 112 ~e~~~~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 112 FEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp EECCSEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred EecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 9999999998887654 599999999999999999999999999999999999994 4556999999999876533
Q ss_pred --CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCC---------
Q psy501 458 --PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLP--------- 526 (962)
Q Consensus 458 --~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 526 (962)
......||+.|+|||++.+...++.++|||||||++|||++|++||.+.........+......+....
T Consensus 191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (329)
T 3gbz_A 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD 270 (329)
T ss_dssp ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhh
Confidence 344557899999999998766789999999999999999999999998877766665544321111100
Q ss_pred -------------------CCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 527 -------------------LYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 527 -------------------~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..+..+..++..||..+|++||++.++++.-
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 0344556899999999999999998888744
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=325.90 Aligned_cols=244 Identities=24% Similarity=0.341 Sum_probs=202.2
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
+.|.....++.++.+.||.|....+++.++.|+.. .+...+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 34566666666666779999887766655554432 234568899999999999999999999999999999999
Q ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc---ceeeecccccccccCC-Cc
Q psy501 385 YMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIRSR-PY 459 (962)
Q Consensus 385 y~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g---~vKL~DFGla~~~~~~-~~ 459 (962)
|+.| +|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++...... ..
T Consensus 109 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~ 187 (362)
T 2bdw_A 109 LVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187 (362)
T ss_dssp CCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence 9985 677766554 5699999999999999999999999999999999999998654 5999999999876544 34
Q ss_pred ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCC--CCCCCCcHHHHH
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTL--PLYTYHVPPIQT 537 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~l~~li~ 537 (962)
....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+..+....+.. +..+..+..++.
T Consensus 188 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 266 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 266 (362)
T ss_dssp CCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHH
T ss_pred ccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 45689999999999965 479999999999999999999999999988877777777765544332 345677889999
Q ss_pred HHhccCCCCCCcHHHHHhh
Q psy501 538 TCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 538 ~Cl~~dperRPs~~~Ll~~ 556 (962)
.||..+|++||++.++++.
T Consensus 267 ~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 267 SMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHSCSSGGGSCCHHHHTTS
T ss_pred HHcCCChhhCcCHHHHhcC
Confidence 9999999999998887764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=323.06 Aligned_cols=249 Identities=20% Similarity=0.189 Sum_probs=198.3
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccch-----hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEec
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-----DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEY 385 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey 385 (962)
+.+.....++.++.+.||.+.....++.++.|+... ....+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 456666666667777799998876666655554321 234588999999999999999999999999999999999
Q ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----Ccc
Q psy501 386 MKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PYT 460 (962)
Q Consensus 386 ~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~ 460 (962)
++| +|.+.+. ....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... ...
T Consensus 87 ~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 165 (323)
T 3tki_A 87 CSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (323)
T ss_dssp CTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred CCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence 986 5655554 3456999999999999999999999999999999999999999999999999999765432 234
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh-HHHHHhccccccCCCCCCCCcHHHHHHH
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG-TERLKSSYILLHTLPLYTYHVPPIQTTC 539 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~s~~l~~li~~C 539 (962)
...||+.|+|||++.+...++.++|||||||++|+|++|+.||........ ................++..+..++..|
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (323)
T 3tki_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245 (323)
T ss_dssp SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHH
T ss_pred CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHH
Confidence 568999999999998765568899999999999999999999987655432 2333333333333345677788899999
Q ss_pred hccCCCCCCcHHHHHhhccccc
Q psy501 540 LLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 540 l~~dperRPs~~~Ll~~l~~~~ 561 (962)
|..+|++||++.++++.- |+.
T Consensus 246 L~~dP~~R~t~~eil~h~-~~~ 266 (323)
T 3tki_A 246 LVENPSARITIPDIKKDR-WYN 266 (323)
T ss_dssp SCSSTTTSCCHHHHTTCT-TTT
T ss_pred ccCChhhCcCHHHHhhCh-hhc
Confidence 999999999999888754 544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=323.22 Aligned_cols=242 Identities=17% Similarity=0.228 Sum_probs=205.3
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
.+.+.....++.++.+.||.+....+++.++.|+... ....+.+|+++|++++||+|+++++++.++..+|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 4566666666667777799999887777666665432 234688999999999999999999999999999999
Q ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCccc
Q psy501 383 FEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD 461 (962)
Q Consensus 383 ~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 461 (962)
|||++ |+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++...... ...
T Consensus 120 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-~~~ 197 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TWT 197 (350)
T ss_dssp EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-BCC
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-ccc
Confidence 99997 5777777654 45999999999999999999999999999999999999999999999999999876543 345
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhc
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~ 541 (962)
.+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.........+..+....+ ..++..+..++..||.
T Consensus 198 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~li~~lL~ 274 (350)
T 1rdq_E 198 LCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP--SHFSSDLKDLLRNLLQ 274 (350)
T ss_dssp CEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTCCHHHHHHHHHHSC
T ss_pred ccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHhh
Confidence 689999999999975 4789999999999999999999999999888888888877754433 4677888999999999
Q ss_pred cCCCCCCc-----HHHHHhh
Q psy501 542 AGTERLKS-----SYILLHT 556 (962)
Q Consensus 542 ~dperRPs-----~~~Ll~~ 556 (962)
.+|++||+ +.+++..
T Consensus 275 ~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 275 VDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp SCTTTCTTSSTTTTHHHHTS
T ss_pred cCHHhccCCccCCHHHHHhC
Confidence 99999997 6666653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=310.82 Aligned_cols=247 Identities=19% Similarity=0.209 Sum_probs=201.9
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
.+.+.....++.++.+.||.+.....+..++.|+... ....+.+|+.++++++||||+++++++.+++..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 3456666667777777899998888776666554322 134688999999999999999999999999999999
Q ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCccc
Q psy501 383 FEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD 461 (962)
Q Consensus 383 ~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 461 (962)
|||++| +|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..........
T Consensus 88 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 166 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD 166 (279)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcccccc
Confidence 999985 666666554 459999999999999999999999999999999999999999999999999997766665666
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhc
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~ 541 (962)
..|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....... ....+..+..++..||.
T Consensus 167 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~ 243 (279)
T 3fdn_A 167 LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF--PDFVTEGARDLISRLLK 243 (279)
T ss_dssp -CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC--CTTSCHHHHHHHHHHCC
T ss_pred cCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCC--CCcCCHHHHHHHHHHhc
Confidence 789999999999965 478999999999999999999999999888777777666554333 24567778899999999
Q ss_pred cCCCCCCcHHHHHhhccccc
Q psy501 542 AGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 542 ~dperRPs~~~Ll~~l~~~~ 561 (962)
.+|++||++.++++.- |+.
T Consensus 244 ~~p~~Rps~~e~l~h~-~~~ 262 (279)
T 3fdn_A 244 HNPSQRPMLREVLEHP-WIT 262 (279)
T ss_dssp SSGGGSCCHHHHHHCH-HHH
T ss_pred cChhhCCCHHHHhhCc-ccc
Confidence 9999999988888754 544
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=322.72 Aligned_cols=250 Identities=25% Similarity=0.331 Sum_probs=201.1
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccchh---------HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD---------EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYF 381 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~---------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~L 381 (962)
+.|.....++.++.+.||.+....+++.++.|..... ...+.+|++++++++||||+++++++.+++..++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 4455555566666667888887766655554443211 1357899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--Cc
Q psy501 382 VFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PY 459 (962)
Q Consensus 382 V~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~ 459 (962)
||||++|++...+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...... ..
T Consensus 90 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 169 (346)
T 1ua2_A 90 VFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 169 (346)
T ss_dssp EEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred EEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccC
Confidence 9999999999988877777999999999999999999999999999999999999999999999999999876443 34
Q ss_pred ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC---------------
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT--------------- 524 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--------------- 524 (962)
....||+.|+|||++.+...++.++|||||||++|||++|.+||.+.........+......+..
T Consensus 170 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T 1ua2_A 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 249 (346)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred CcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccc
Confidence 45678999999999977667899999999999999999999999998877666665443211110
Q ss_pred -----------CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 525 -----------LPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 525 -----------~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
.+..+..+..++..||..+|++||++.++++.- |+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~-~f~ 296 (346)
T 1ua2_A 250 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK-YFS 296 (346)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG-GGT
T ss_pred cccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh-hhh
Confidence 022344577899999999999999999888755 444
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=309.67 Aligned_cols=249 Identities=21% Similarity=0.225 Sum_probs=205.6
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
.+.+.....++.++.+.||.+.......++.+.+.. .....+.+|++++++++||||+++++++.++...++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 345566666666777779999877665555554433 235678999999999999999999999999999999999997
Q ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCc---cccc
Q psy501 388 -ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY---TDYV 463 (962)
Q Consensus 388 -g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~---~~~~ 463 (962)
|+|.+.+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........ ....
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 166 (268)
T 3sxs_A 87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK 166 (268)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCC
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCC
Confidence 568888877666799999999999999999999999999999999999999999999999999987655432 2344
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhcc
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 542 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~ 542 (962)
+++.|+|||++.+. .++.++|||||||++|+|++ |..||...........+..+.. .......+..+..++..||..
T Consensus 167 ~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~ 244 (268)
T 3sxs_A 167 FPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR-LYRPHLASDTIYQIMYSCWHE 244 (268)
T ss_dssp CCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-CCCCTTSCHHHHHHHHHTTCS
T ss_pred cCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC-CCCCCcChHHHHHHHHHHcCC
Confidence 56779999999754 68999999999999999999 9999998887777666665532 222345667788999999999
Q ss_pred CCCCCCcHHHHHhhcccc
Q psy501 543 GTERLKSSYILLHTLPLY 560 (962)
Q Consensus 543 dperRPs~~~Ll~~l~~~ 560 (962)
+|++||++.++++.+..+
T Consensus 245 ~p~~Rps~~~ll~~L~~l 262 (268)
T 3sxs_A 245 LPEKRPTFQQLLSSIEPL 262 (268)
T ss_dssp SGGGSCCHHHHHHHHGGG
T ss_pred ChhhCcCHHHHHHHHHHh
Confidence 999999999999977443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=319.45 Aligned_cols=246 Identities=25% Similarity=0.322 Sum_probs=195.7
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccchhH-----HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecC
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDE-----MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~-----~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
.|.....++.|+.+.||.+....+++.++.|...... ..+.+|+++|++++||||+++++++.+++..++||||+
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 4555556666667779999887766665555432221 13557999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccC
Q psy501 387 KENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVS 464 (962)
Q Consensus 387 ~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~g 464 (962)
+|++.+.+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... ......|
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 162 (324)
T 3mtl_A 83 DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV 162 (324)
T ss_dssp SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------------
T ss_pred ccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccC
Confidence 99999999888778999999999999999999999999999999999999999999999999999765433 3344578
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc---------------------
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--------------------- 523 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------- 523 (962)
|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.........+......+.
T Consensus 163 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (324)
T 3mtl_A 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKY 242 (324)
T ss_dssp CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCC
T ss_pred cccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccc
Confidence 99999999998766799999999999999999999999999877666555543211111
Q ss_pred -------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 524 -------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 524 -------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..+.++..+..++..||..+|++||++.++++.-
T Consensus 243 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 283 (324)
T 3mtl_A 243 RAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283 (324)
T ss_dssp CCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred cchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence 1123445567899999999999999988888754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=311.71 Aligned_cols=252 Identities=13% Similarity=0.058 Sum_probs=205.7
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEe
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
+..+.+.....+..++.+.||.+.....++.++.|+.. .....+.+|+.+++++ +|++++++++++.++...++|||
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 45667777777777778889999977766665555432 2334689999999999 79999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccc-----eeeecccccccccCC--
Q psy501 385 YMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL-----VKIADFGLAREIRSR-- 457 (962)
Q Consensus 385 y~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~-----vKL~DFGla~~~~~~-- 457 (962)
|+.++|.+.+......+++..++.++.||+.||.|||+.||+||||||+||+++.++. +||+|||++......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 166 (298)
T 1csn_A 87 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166 (298)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred ecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence 9988999998877777999999999999999999999999999999999999987775 999999999876543
Q ss_pred -------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcCh---hhhHHHHHhcccc---ccC
Q psy501 458 -------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCL---LAGTERLKSSYIL---LHT 524 (962)
Q Consensus 458 -------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~---~~~~~~i~~~~~~---~~~ 524 (962)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+... ......+...... ...
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
T 1csn_A 167 KQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 245 (298)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred cccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH
Confidence 1244579999999999965 4689999999999999999999999988533 2222333222111 112
Q ss_pred CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 525 LPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 525 ~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
.+.++..+..++..||..+|++||++.+|++.|...
T Consensus 246 ~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 246 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 236777889999999999999999999999877543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=332.22 Aligned_cols=245 Identities=22% Similarity=0.295 Sum_probs=202.4
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEecc------chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS------SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
+.|.....++.|+.+.||.|....+++.++.++. ..+...+.+|++++++++||||+++++++.+++..|+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 3455555666666667888887776665554332 2234568999999999999999999999999999999999
Q ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccc---cccceeeecccccccccCC--C
Q psy501 385 YMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM---GTELVKIADFGLAREIRSR--P 458 (962)
Q Consensus 385 y~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~---~~g~vKL~DFGla~~~~~~--~ 458 (962)
||.| +|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+|||++...... .
T Consensus 91 ~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~ 169 (444)
T 3soa_A 91 LVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169 (444)
T ss_dssp CCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred eCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence 9985 777777665 5599999999999999999999999999999999999998 4578999999999876544 3
Q ss_pred cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCC--CCCCCCcHHHH
Q psy501 459 YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTL--PLYTYHVPPIQ 536 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~l~~li 536 (962)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+..+....+.. +..+..+..++
T Consensus 170 ~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 248 (444)
T 3soa_A 170 WFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI 248 (444)
T ss_dssp CCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred eecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence 345689999999999965 479999999999999999999999999988888888887776554432 46677889999
Q ss_pred HHHhccCCCCCCcHHHHHhhc
Q psy501 537 TTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 537 ~~Cl~~dperRPs~~~Ll~~l 557 (962)
..||..+|++||++.++++.-
T Consensus 249 ~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 249 NKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp HHHSCSSTTTSCCHHHHHHSC
T ss_pred HHHcCCChhHCCCHHHHhcCc
Confidence 999999999999988877643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=327.26 Aligned_cols=245 Identities=27% Similarity=0.352 Sum_probs=190.9
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEecc------chhHHHHHHHHHHHHhcC-CCCcccEEEEEEeCC--EEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS------SRDEMVVCFYRKSLKKLS-HANLVKLKEVIREND--TLYF 381 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~------~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~--~~~L 381 (962)
+.|.....++.|+.+.||.+....+++.++.|.. ..+...+.+|+.+|+++. ||||+++++++..++ .+|+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 4455555555666667999987777665555432 233456889999999997 999999999998544 7999
Q ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC-----
Q psy501 382 VFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS----- 456 (962)
Q Consensus 382 V~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~----- 456 (962)
|||||+|+|...+.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+....
T Consensus 89 v~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 166 (388)
T 3oz6_A 89 VFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166 (388)
T ss_dssp EEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCC
T ss_pred EecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccc
Confidence 999999999888876 3589999999999999999999999999999999999999999999999999976532
Q ss_pred ------------------CCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhc
Q psy501 457 ------------------RPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSS 518 (962)
Q Consensus 457 ------------------~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~ 518 (962)
......+||+.|+|||++.+...++.++|||||||++|||++|++||.+.+.......+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 246 (388)
T 3oz6_A 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246 (388)
T ss_dssp CCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 12334589999999999987668999999999999999999999999988776665555421
Q ss_pred cccc---------------------------------------------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHH
Q psy501 519 YILL---------------------------------------------HTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 553 (962)
Q Consensus 519 ~~~~---------------------------------------------~~~~~~s~~l~~li~~Cl~~dperRPs~~~L 553 (962)
...+ ......+..+.+++..||..+|++||++.++
T Consensus 247 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~ 326 (388)
T 3oz6_A 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDA 326 (388)
T ss_dssp HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHH
Confidence 1100 0111445567889999999999999998888
Q ss_pred Hhhc
Q psy501 554 LHTL 557 (962)
Q Consensus 554 l~~l 557 (962)
++.-
T Consensus 327 l~Hp 330 (388)
T 3oz6_A 327 LKHP 330 (388)
T ss_dssp TTST
T ss_pred hCCH
Confidence 7643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=323.03 Aligned_cols=247 Identities=21% Similarity=0.257 Sum_probs=199.9
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEeccch---------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCE
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR---------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDT 378 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~---------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 378 (962)
...+.|.....++.++.+.||.+....+++.++.|+... ....+.+|+.++++++||||+++++++.+++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 345566777777777777899998887777666554321 34578999999999999999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccc---eeeeccccc
Q psy501 379 LYFVFEYMK-ENLYQLIRDR---DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL---VKIADFGLA 451 (962)
Q Consensus 379 ~~LV~Ey~~-g~Ll~~l~~~---~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~---vKL~DFGla 451 (962)
+|+|||||+ |+|.+.+... +..+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999998 5776666543 345899999999999999999999999999999999999987654 999999999
Q ss_pred ccccCC--CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--CCCC
Q psy501 452 REIRSR--PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--TLPL 527 (962)
Q Consensus 452 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~ 527 (962)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... .....+..+..... ..+.
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCCCCHHHHTT
T ss_pred eEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCCCCcccccc
Confidence 876554 2345689999999999965 4689999999999999999999999988543 33344444332221 1245
Q ss_pred CCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 528 YTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 528 ~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.+..+..++..||..+|++||++.++++.
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 67788899999999999999998888764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=332.58 Aligned_cols=247 Identities=15% Similarity=0.190 Sum_probs=205.1
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccchhH-------HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDE-------MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~-------~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
..+.....++.|+.+.||.+....+++.++.|+..... ..+.+|+.++..++||+|++++++|.+++.+|+||
T Consensus 74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~ 153 (437)
T 4aw2_A 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM 153 (437)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence 45556666666677779999998888877766654321 23889999999999999999999999999999999
Q ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---c
Q psy501 384 EYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---Y 459 (962)
Q Consensus 384 Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---~ 459 (962)
|||+ |+|.+++......+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+...... .
T Consensus 154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 233 (437)
T 4aw2_A 154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 233 (437)
T ss_dssp CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccc
Confidence 9997 67888887756779999999999999999999999999999999999999999999999999997665432 2
Q ss_pred ccccCCccccChhhhc----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc--cccC-CCCCCCCc
Q psy501 460 TDYVSTRWYRAPEVLL----HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI--LLHT-LPLYTYHV 532 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~----~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~-~~~~s~~l 532 (962)
...+||+.|+|||++. +...++.++|||||||++|||++|++||.+.+.......+..... ..+. .+..+...
T Consensus 234 ~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~ 313 (437)
T 4aw2_A 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENA 313 (437)
T ss_dssp CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHH
T ss_pred ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHH
Confidence 3468999999999996 244689999999999999999999999999888888777765432 2222 23467788
Q ss_pred HHHHHHHhccCCCC--CCcHHHHHhhc
Q psy501 533 PPIQTTCLLAGTER--LKSSYILLHTL 557 (962)
Q Consensus 533 ~~li~~Cl~~dper--RPs~~~Ll~~l 557 (962)
.++++.||..+|++ ||++.++++.-
T Consensus 314 ~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 314 KDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp HHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred HHHHHHHhcccccccCCCCHHHHhCCC
Confidence 89999999999998 99987776643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=334.01 Aligned_cols=251 Identities=20% Similarity=0.245 Sum_probs=210.3
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh-------HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEE
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD-------EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLY 380 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 380 (962)
+..|.|.....++.|+.+.||.+....+++.++.|+.... ...+.+|+.+|+.++||||+++++++.+++.+|
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3457788877777777788999998877766665554322 346899999999999999999999999999999
Q ss_pred EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-C
Q psy501 381 FVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-P 458 (962)
Q Consensus 381 LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~ 458 (962)
+||||++| +|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... .
T Consensus 93 lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 93 MVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 99999975 66666654 456999999999999999999999999999999999999999999999999999876543 3
Q ss_pred cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHH
Q psy501 459 YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTT 538 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~ 538 (962)
....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+..+.... ....+..+..++..
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~Li~~ 249 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT--PQYLNPSVISLLKH 249 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCC--CTTCCHHHHHHHHH
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCC--CccCCHHHHHHHHH
Confidence 4556899999999999876445889999999999999999999999988877777777664332 24567778899999
Q ss_pred HhccCCCCCCcHHHHHhhcccccc
Q psy501 539 CLLAGTERLKSSYILLHTLPLYTY 562 (962)
Q Consensus 539 Cl~~dperRPs~~~Ll~~l~~~~~ 562 (962)
||..+|++||++.++++. +|+..
T Consensus 250 ~L~~dP~~Rpt~~eil~h-p~~~~ 272 (476)
T 2y94_A 250 MLQVDPMKRATIKDIREH-EWFKQ 272 (476)
T ss_dssp HTCSSTTTSCCHHHHHTC-HHHHT
T ss_pred HcCCCchhCcCHHHHHhC-HHhhh
Confidence 999999999999988874 35443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=324.38 Aligned_cols=242 Identities=17% Similarity=0.211 Sum_probs=202.9
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEE
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLY 380 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~ 380 (962)
..+.+.....++.|+.+.||.+....+++.++.|.... ....+..|..+++.+ +||+|+++++++.+++.+|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 34566666666667777799999888777766665433 234688899999987 8999999999999999999
Q ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccccccc--CC
Q psy501 381 FVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR--SR 457 (962)
Q Consensus 381 LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~--~~ 457 (962)
+||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++... ..
T Consensus 95 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 173 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173 (345)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence 9999997 5777776654 459999999999999999999999999999999999999999999999999998643 23
Q ss_pred CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHH
Q psy501 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQT 537 (962)
Q Consensus 458 ~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~ 537 (962)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+.......+ ...+..+..++.
T Consensus 174 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~ 250 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP--RWLEKEAKDLLV 250 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHHHHHH
T ss_pred cccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC--cccCHHHHHHHH
Confidence 4556789999999999976 4789999999999999999999999999888877777776644333 456778889999
Q ss_pred HHhccCCCCCCcHH-HHH
Q psy501 538 TCLLAGTERLKSSY-ILL 554 (962)
Q Consensus 538 ~Cl~~dperRPs~~-~Ll 554 (962)
.||..+|++||++. +++
T Consensus 251 ~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 251 KLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHSCSSGGGSBTTBSCGG
T ss_pred HHhcCCHhHcCCChHHHH
Confidence 99999999999975 444
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=322.51 Aligned_cols=245 Identities=16% Similarity=0.167 Sum_probs=203.7
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEE
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTL 379 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 379 (962)
+..+.+.....++.|+.+.||.+....+++.++.|+... ....+..|..+|..+ +||+|+++++++.+.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 334566666666667777799999888777766665432 235688999999988 799999999999999999
Q ss_pred EEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC--
Q psy501 380 YFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS-- 456 (962)
Q Consensus 380 ~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~-- 456 (962)
|+||||++| +|.+++... +.+++..++.++.||+.||.|||+.||+||||||+||+++.+|.+||+|||+|.....
T Consensus 97 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 999999985 777776654 4599999999999999999999999999999999999999999999999999986432
Q ss_pred CCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHH
Q psy501 457 RPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQ 536 (962)
Q Consensus 457 ~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li 536 (962)
......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+.......+.......+ ...+..+..++
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li 252 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--KSMSKEAVAIC 252 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHHHHH
T ss_pred cccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCHHHHHHH
Confidence 24456789999999999965 4789999999999999999999999999888888888877654443 46677888999
Q ss_pred HHHhccCCCCCCc-----HHHHHhh
Q psy501 537 TTCLLAGTERLKS-----SYILLHT 556 (962)
Q Consensus 537 ~~Cl~~dperRPs-----~~~Ll~~ 556 (962)
..||..+|++||+ +.+++..
T Consensus 253 ~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 253 KGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999994 4565553
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=324.20 Aligned_cols=252 Identities=20% Similarity=0.167 Sum_probs=190.7
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccch---hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecC
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR---DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
.+.|.....++.|+.+.||.+....+++.++.|.... ....+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 4456666666666667799999887777666554332 2456899999999999999999999999999999999999
Q ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccc--eeeecccccccccCC-Ccccc
Q psy501 387 K-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL--VKIADFGLAREIRSR-PYTDY 462 (962)
Q Consensus 387 ~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~--vKL~DFGla~~~~~~-~~~~~ 462 (962)
+ |+|.+.+... +.+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++..... .....
T Consensus 99 ~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 177 (361)
T 3uc3_A 99 SGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 177 (361)
T ss_dssp CSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------------
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCC
Confidence 7 5777776554 45999999999999999999999999999999999999987765 999999999754322 34456
Q ss_pred cCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhh----hHHHHHhccccccCCCCCCCCcHHHHHH
Q psy501 463 VSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLA----GTERLKSSYILLHTLPLYTYHVPPIQTT 538 (962)
Q Consensus 463 ~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~s~~l~~li~~ 538 (962)
.||+.|+|||++.+....+.++|||||||++|+|++|+.||.+..... ....+.......+.....+..+..++..
T Consensus 178 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 257 (361)
T 3uc3_A 178 VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISR 257 (361)
T ss_dssp ---CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHH
T ss_pred cCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHH
Confidence 799999999999876444555999999999999999999998754432 2333444444444444567778899999
Q ss_pred HhccCCCCCCcHHHHHhhccccccC
Q psy501 539 CLLAGTERLKSSYILLHTLPLYTYH 563 (962)
Q Consensus 539 Cl~~dperRPs~~~Ll~~l~~~~~~ 563 (962)
||..+|++||++.+++.. +|+...
T Consensus 258 ~L~~dP~~Rps~~ell~h-p~f~~~ 281 (361)
T 3uc3_A 258 IFVADPATRISIPEIKTH-SWFLKN 281 (361)
T ss_dssp HSCSCTTTSCCHHHHHTS-HHHHTT
T ss_pred HccCChhHCcCHHHHHhC-cchhcC
Confidence 999999999999888875 355443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=320.30 Aligned_cols=237 Identities=18% Similarity=0.233 Sum_probs=191.5
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYF 381 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~L 381 (962)
.+.+.....++.++.+.||.+....+++.++.|+... ....+.+|+.+++++ +||||+++++++.+++.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 3455666666666667799998887777666555332 234588999999998 89999999999999999999
Q ss_pred EEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC--CC
Q psy501 382 VFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RP 458 (962)
Q Consensus 382 V~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~--~~ 458 (962)
||||++| +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++.... ..
T Consensus 88 v~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~ 166 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166 (345)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCC
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCc
Confidence 9999985 677666554 4699999999999999999999999999999999999999999999999999986432 24
Q ss_pred cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCc---------ChhhhHHHHHhccccccCCCCCC
Q psy501 459 YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTT---------CLLAGTERLKSSYILLHTLPLYT 529 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~~s 529 (962)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ........+....... ....+
T Consensus 167 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~--p~~~s 243 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI--PRSLS 243 (345)
T ss_dssp BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCC--CTTSC
T ss_pred ccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCC--CCCCC
Confidence 455689999999999976 47899999999999999999999999752 2222333444443332 24567
Q ss_pred CCcHHHHHHHhccCCCCCCcH
Q psy501 530 YHVPPIQTTCLLAGTERLKSS 550 (962)
Q Consensus 530 ~~l~~li~~Cl~~dperRPs~ 550 (962)
..+..++..||..+|++||++
T Consensus 244 ~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 244 VKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHHHHHHhcCCHhHCCCC
Confidence 778899999999999999984
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=315.24 Aligned_cols=242 Identities=18% Similarity=0.172 Sum_probs=195.0
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV 382 (962)
.+.+.....++.++.+.||++....+++.++.|... .+......|+..+.++ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 456666667777777889999988766665555421 2233456666666665 899999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-Cccc
Q psy501 383 FEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTD 461 (962)
Q Consensus 383 ~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~ 461 (962)
|||++|+|.+.+......+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||++...... ....
T Consensus 136 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 215 (311)
T 3p1a_A 136 TELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV 215 (311)
T ss_dssp EECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------C
T ss_pred EeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcc
Confidence 999999999999888778999999999999999999999999999999999999999999999999999876544 3344
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhc
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~ 541 (962)
..||+.|+|||++.+ .++.++|||||||++|||++|..||.+... ...+..........+..+..+..++..||.
T Consensus 216 ~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 290 (311)
T 3p1a_A 216 QEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMMLE 290 (311)
T ss_dssp CCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHHSC
T ss_pred cCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHHcC
Confidence 579999999999865 589999999999999999999776655432 233333333333334677788999999999
Q ss_pred cCCCCCCcHHHHHhh
Q psy501 542 AGTERLKSSYILLHT 556 (962)
Q Consensus 542 ~dperRPs~~~Ll~~ 556 (962)
.+|++||++.++++.
T Consensus 291 ~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 291 PDPKLRATAEALLAL 305 (311)
T ss_dssp SSTTTSCCHHHHHTS
T ss_pred CChhhCcCHHHHHhC
Confidence 999999999988874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=308.51 Aligned_cols=244 Identities=17% Similarity=0.210 Sum_probs=205.8
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
.+.+.....++.++.+.||.+.....++.++.|.... ....+.+|++++++++||||+++++++.+++..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 3556666667777777899999887776665554322 135689999999999999999999999999999999
Q ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCccc
Q psy501 383 FEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD 461 (962)
Q Consensus 383 ~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~ 461 (962)
|||++| +|.+.+... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++..........
T Consensus 93 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 171 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT 171 (284)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBCC
T ss_pred EEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccccccc
Confidence 999985 777777665 459999999999999999999999999999999999999999999999999998766655566
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhc
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~ 541 (962)
..|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....... .+..+..+..++..||.
T Consensus 172 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~ 248 (284)
T 2vgo_A 172 MCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF--PPFLSDGSKDLISKLLR 248 (284)
T ss_dssp CCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC--CTTSCHHHHHHHHHHSC
T ss_pred ccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCC--CCcCCHHHHHHHHHHhh
Confidence 789999999999975 468999999999999999999999999887777666666554332 35667788899999999
Q ss_pred cCCCCCCcHHHHHhhc
Q psy501 542 AGTERLKSSYILLHTL 557 (962)
Q Consensus 542 ~dperRPs~~~Ll~~l 557 (962)
.+|++||++.+++..-
T Consensus 249 ~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 249 YHPPQRLPLKGVMEHP 264 (284)
T ss_dssp SSGGGSCCHHHHHTCH
T ss_pred cCHhhCCCHHHHhhCH
Confidence 9999999998888753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=309.60 Aligned_cols=245 Identities=19% Similarity=0.222 Sum_probs=202.3
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEec
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEY 385 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey 385 (962)
.+.+.....++.++.+.||.+........++.+.. ..+...+.+|++++++++||||+++++++.++...++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 34555666666667777999988777654443332 23456799999999999999999999999999999999999
Q ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccc---ccccceeeecccccccccCC-Ccc
Q psy501 386 MKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLC---MGTELVKIADFGLAREIRSR-PYT 460 (962)
Q Consensus 386 ~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl---~~~g~vKL~DFGla~~~~~~-~~~ 460 (962)
++| +|.+.+... ..+++..++.++.|++.||.|||+.||+||||||+||++ +.++.++|+|||++...... ...
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~ 166 (277)
T 3f3z_A 88 CTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 166 (277)
T ss_dssp CCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBC
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchh
Confidence 985 676766654 459999999999999999999999999999999999999 77889999999999876544 445
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCC--CCCCCCcHHHHHH
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTL--PLYTYHVPPIQTT 538 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~l~~li~~ 538 (962)
...||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........+..+....+.. ..++..+..++..
T Consensus 167 ~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (277)
T 3f3z_A 167 TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244 (277)
T ss_dssp CCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHH
T ss_pred ccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHH
Confidence 5679999999999865 48999999999999999999999999988877777777664443321 2567788899999
Q ss_pred HhccCCCCCCcHHHHHhhc
Q psy501 539 CLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 539 Cl~~dperRPs~~~Ll~~l 557 (962)
||..+|++||++.++++.-
T Consensus 245 ~l~~dp~~R~s~~~~l~h~ 263 (277)
T 3f3z_A 245 LLTKSPKQRITSLQALEHE 263 (277)
T ss_dssp HTCSSTTTSCCHHHHTTSH
T ss_pred HccCChhhCcCHHHHhcCH
Confidence 9999999999988887643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.17 Aligned_cols=246 Identities=24% Similarity=0.337 Sum_probs=203.6
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
.+.+.....+..++.+.||.+.....++.++.|+.. .....+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 345666666667777789999887766655554432 22356889999999999999999999999999999999
Q ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccc---eeeecccccccccCC-C
Q psy501 384 EYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL---VKIADFGLAREIRSR-P 458 (962)
Q Consensus 384 Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~---vKL~DFGla~~~~~~-~ 458 (962)
||++| ++.+.+... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++. +||+|||.+...... .
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 99985 676776655 45999999999999999999999999999999999999986655 999999999776544 3
Q ss_pred cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC--CCCCCCCcHHHH
Q psy501 459 YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT--LPLYTYHVPPIQ 536 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l~~li 536 (962)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..+....+. ...++..+..++
T Consensus 164 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242 (284)
T ss_dssp CCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred ccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHH
Confidence 345689999999999965 46899999999999999999999999998887777777666544332 235677788999
Q ss_pred HHHhccCCCCCCcHHHHHhhc
Q psy501 537 TTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 537 ~~Cl~~dperRPs~~~Ll~~l 557 (962)
..||..+|++||++.++++.-
T Consensus 243 ~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 243 DSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp HHHSCSSTTTSCCHHHHTTSH
T ss_pred HHHcccChhhCCCHHHHhcCc
Confidence 999999999999999888743
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=326.90 Aligned_cols=246 Identities=18% Similarity=0.224 Sum_probs=204.8
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecC
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
+.+.....++.++.+.||.|....+++.++.++.. .+...+.+|+++|++++||||+++++++.++...++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 45566666666667779999888777766655533 23457899999999999999999999999999999999999
Q ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc--ccceeeecccccccccCC-Ccccc
Q psy501 387 K-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG--TELVKIADFGLAREIRSR-PYTDY 462 (962)
Q Consensus 387 ~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~--~g~vKL~DFGla~~~~~~-~~~~~ 462 (962)
+ |+|.+.+......+++..++.++.||+.||.|||+.||+||||||+||+++. .+.+||+|||++...... .....
T Consensus 131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 210 (387)
T 1kob_A 131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT 210 (387)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEE
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeee
Confidence 8 5777777666667999999999999999999999999999999999999974 467999999999876544 33445
Q ss_pred cCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--CCCCCCCCcHHHHHHHh
Q psy501 463 VSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--TLPLYTYHVPPIQTTCL 540 (962)
Q Consensus 463 ~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l~~li~~Cl 540 (962)
.||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.........+.......+ .....+..+..++..||
T Consensus 211 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 289 (387)
T 1kob_A 211 TATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 289 (387)
T ss_dssp CSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTS
T ss_pred ccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHc
Confidence 79999999999965 4789999999999999999999999999887777776666543332 22356677889999999
Q ss_pred ccCCCCCCcHHHHHhhc
Q psy501 541 LAGTERLKSSYILLHTL 557 (962)
Q Consensus 541 ~~dperRPs~~~Ll~~l 557 (962)
..+|++||++.++++.-
T Consensus 290 ~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 290 QKEPRKRLTVHDALEHP 306 (387)
T ss_dssp CSSGGGSCCHHHHHTST
T ss_pred CCChhHCcCHHHHhhCc
Confidence 99999999999888754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=308.04 Aligned_cols=245 Identities=21% Similarity=0.239 Sum_probs=189.0
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEecc------chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS------SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
+.+.....++.++.+.||.+.......+++.... ......+.+|+++++.++||||+++++++.+++..++|||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 4555556666666677888886533222222111 1123568899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccce---eeeccCCCccccccc--------ccceeeeccccccc
Q psy501 385 YMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHG---FFHRDMKPENLLCMG--------TELVKIADFGLARE 453 (962)
Q Consensus 385 y~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~g---IvHrDLkp~NILl~~--------~g~vKL~DFGla~~ 453 (962)
|++|+.+..+.. ...+++..++.++.|++.||.|||+.| |+||||||+||+++. ++.+||+|||++..
T Consensus 87 ~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~ 165 (271)
T 3dtc_A 87 FARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165 (271)
T ss_dssp CCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred cCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence 998654444443 346999999999999999999999999 899999999999986 67899999999987
Q ss_pred ccCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcH
Q psy501 454 IRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVP 533 (962)
Q Consensus 454 ~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 533 (962)
..........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+.......+....++..+.
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (271)
T 3dtc_A 166 WHRTTKMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFA 244 (271)
T ss_dssp ----------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHH
T ss_pred cccccccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHH
Confidence 766655567899999999999764 6899999999999999999999999998877777766666655565667788899
Q ss_pred HHHHHHhccCCCCCCcHHHHHhhc
Q psy501 534 PIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 534 ~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.++..||..+|++||++.++++.|
T Consensus 245 ~li~~~l~~~p~~Rps~~e~l~~L 268 (271)
T 3dtc_A 245 KLMEDCWNPDPHSRPSFTNILDQL 268 (271)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhcCCcccCcCHHHHHHHH
Confidence 999999999999999999999866
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=313.63 Aligned_cols=237 Identities=19% Similarity=0.266 Sum_probs=192.8
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHHH
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQ 392 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~ 392 (962)
.++.++.+.||.+.....++.++.|+.. .....+.+|+.++++++||||+++++++..++..++||||++| +|.+
T Consensus 52 ~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~ 131 (321)
T 2c30_A 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD 131 (321)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHH
T ss_pred EeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHH
Confidence 3444555568888877655555444322 2345689999999999999999999999999999999999986 5555
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccC
Q psy501 393 LIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRA 470 (962)
Q Consensus 393 ~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~A 470 (962)
.+ .. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...... ......||+.|+|
T Consensus 132 ~l-~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~a 209 (321)
T 2c30_A 132 IV-SQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMA 209 (321)
T ss_dssp HH-TT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCC
T ss_pred HH-Hh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccC
Confidence 44 33 45999999999999999999999999999999999999999999999999999876543 3445689999999
Q ss_pred hhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-cCCCCCCCCcHHHHHHHhccCCCCCCc
Q psy501 471 PEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL-HTLPLYTYHVPPIQTTCLLAGTERLKS 549 (962)
Q Consensus 471 PE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~s~~l~~li~~Cl~~dperRPs 549 (962)
||++.+ ..++.++|||||||++|||++|+.||.+.........+....... ......+..+..++..||..+|++||+
T Consensus 210 PE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 288 (321)
T 2c30_A 210 PEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT 288 (321)
T ss_dssp HHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcC
Confidence 999965 478999999999999999999999999887776666665542211 112245666888999999999999999
Q ss_pred HHHHHhhc
Q psy501 550 SYILLHTL 557 (962)
Q Consensus 550 ~~~Ll~~l 557 (962)
+.++++.-
T Consensus 289 ~~ell~hp 296 (321)
T 2c30_A 289 AQELLDHP 296 (321)
T ss_dssp HHHHHTSG
T ss_pred HHHHhcCh
Confidence 99988754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=309.96 Aligned_cols=245 Identities=18% Similarity=0.218 Sum_probs=200.2
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccch--hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-C
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR--DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-E 388 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~--~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g 388 (962)
.+.....++.++.+.||.+.......++.+.+... ....+.+|++++++++||||+++++++.+++..++||||++ |
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 104 (283)
T ss_dssp GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTC
T ss_pred HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCC
Confidence 44444444555555689998776555555544332 45678999999999999999999999999999999999997 5
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---CcccccCC
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYVST 465 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~gt 465 (962)
+|.+++......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...... ......+|
T Consensus 105 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 184 (283)
T 3gen_A 105 CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP 184 (283)
T ss_dssp BHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSC
T ss_pred cHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccC
Confidence 788887765567999999999999999999999999999999999999999999999999999866443 23334567
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCC
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGT 544 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dp 544 (962)
+.|+|||++.+. .++.++|||||||++|+|++ |+.||...........+..+. ........+..+..++..||..+|
T Consensus 185 ~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p 262 (283)
T 3gen_A 185 VRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-RLYRPHLASEKVYTIMYSCWHEKA 262 (283)
T ss_dssp GGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSG
T ss_pred cccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc-CCCCCCcCCHHHHHHHHHHccCCh
Confidence 889999999764 68999999999999999998 999999988777777666552 233334567778899999999999
Q ss_pred CCCCcHHHHHhhcc
Q psy501 545 ERLKSSYILLHTLP 558 (962)
Q Consensus 545 erRPs~~~Ll~~l~ 558 (962)
++||++.++++.+.
T Consensus 263 ~~Rps~~~ll~~L~ 276 (283)
T 3gen_A 263 DERPTFKILLSNIL 276 (283)
T ss_dssp GGSCCHHHHHHHHH
T ss_pred hHCcCHHHHHHHHH
Confidence 99999999998763
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=325.88 Aligned_cols=248 Identities=21% Similarity=0.262 Sum_probs=199.4
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEe--------------
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRE-------------- 375 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-------------- 375 (962)
.+.+.....++.|+.+.||.+....+++.++.|....+.....+|+++|+.++||||++++++|..
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 85 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD 85 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence 456666667777777779999887777766666555555556789999999999999999999944
Q ss_pred ------------------------CCEEEEEEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHhhcccceeeec
Q psy501 376 ------------------------NDTLYFVFEYMKENLYQLIR---DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHR 428 (962)
Q Consensus 376 ------------------------~~~~~LV~Ey~~g~Ll~~l~---~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHr 428 (962)
...+++||||++|+|.+.+. .....+++..++.++.||+.||.|||+.||+||
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~ 165 (383)
T 3eb0_A 86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHR 165 (383)
T ss_dssp ------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECS
T ss_pred cccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccC
Confidence 33489999999998776664 345679999999999999999999999999999
Q ss_pred cCCCcccccc-cccceeeecccccccccCC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCc
Q psy501 429 DMKPENLLCM-GTELVKIADFGLAREIRSR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTT 506 (962)
Q Consensus 429 DLkp~NILl~-~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~ 506 (962)
||||+||+++ .++.+||+|||+|...... ......+|+.|+|||++.+...++.++|||||||++|||++|++||.+.
T Consensus 166 Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 245 (383)
T 3eb0_A 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGE 245 (383)
T ss_dssp CCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCC
Confidence 9999999997 6889999999999876443 4455688999999999987667999999999999999999999999988
Q ss_pred ChhhhHHHHHhcccc-----------------cc----------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 507 CLLAGTERLKSSYIL-----------------LH----------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 507 ~~~~~~~~i~~~~~~-----------------~~----------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
........+...... .+ .....+..+..++..||..+|++||++.++++.-
T Consensus 246 ~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (383)
T 3eb0_A 246 TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHP 323 (383)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCH
Confidence 776665555431110 00 1123455578899999999999999988887643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=324.83 Aligned_cols=246 Identities=19% Similarity=0.221 Sum_probs=198.5
Q ss_pred CceeeEEEEecCCcccEEEEEecC-------CceEEEEeccc-----hhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCC
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQ-------DNHILSRHVSS-----RDEMVVCFYRKSLKKL-SHANLVKLKEVIREND 377 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~-------~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 377 (962)
+.+.....++.++.+.||.+.... ....++.|... .....+.+|+.+|+++ +||||+++++++.+++
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 445555555555566699987532 22233333322 2335689999999999 8999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc
Q psy501 378 TLYFVFEYMKE-NLYQLIRDRD---------------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE 441 (962)
Q Consensus 378 ~~~LV~Ey~~g-~Ll~~l~~~~---------------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g 441 (962)
.+|+||||++| +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN 240 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC
Confidence 99999999984 7888876543 3589999999999999999999999999999999999999999
Q ss_pred ceeeecccccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHH
Q psy501 442 LVKIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLK 516 (962)
Q Consensus 442 ~vKL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~ 516 (962)
.+||+|||+++..... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.........+.
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~ 319 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 319 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence 9999999999866543 2233466789999999976 479999999999999999999 999999887777666665
Q ss_pred hccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 517 SSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 517 ~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
.+. .......++..+..++..||..+|++||++.++++.|.
T Consensus 320 ~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 360 (370)
T 2psq_A 320 EGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360 (370)
T ss_dssp TTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 553 23334567778899999999999999999999998774
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=322.96 Aligned_cols=248 Identities=15% Similarity=0.125 Sum_probs=192.9
Q ss_pred cCceeeEEEEecC--CcccEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEE
Q psy501 310 AGTERLKFSYILP--HTLPLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYF 381 (962)
Q Consensus 310 ~g~~~~~~~~i~~--~~~~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~L 381 (962)
.+.|.....++.+ +.+.||.+....+++.++.|.... ....+.+|+.++++++||||+++++++.+++.+|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3455555555555 566799999887776655554322 23568889999999999999999999999999999
Q ss_pred EEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--
Q psy501 382 VFEYMK-ENLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-- 457 (962)
Q Consensus 382 V~Ey~~-g~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-- 457 (962)
||||++ |+|.+.+... ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||.+......
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence 999998 5677776554 256999999999999999999999999999999999999999999999999998654221
Q ss_pred -------CcccccCCccccChhhhccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc--------
Q psy501 458 -------PYTDYVSTRWYRAPEVLLHS-TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL-------- 521 (962)
Q Consensus 458 -------~~~~~~gt~~Y~APE~l~~~-~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~-------- 521 (962)
......||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.........+..+...
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (389)
T 3gni_B 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263 (389)
T ss_dssp ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------
T ss_pred cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccc
Confidence 22234789999999999763 46899999999999999999999999886655544433322111
Q ss_pred ------------------------------------ccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 522 ------------------------------------LHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 522 ------------------------------------~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.+....++..+..++..||..+|++||++.++++.-
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp ------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 011223455677899999999999999998888653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=325.22 Aligned_cols=238 Identities=18% Similarity=0.222 Sum_probs=193.4
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh-------HHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEE
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD-------EMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLY 380 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~-------~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~ 380 (962)
....+.....++.++.+.||.+....+++.++.|+.... ...+.+|+.+|+++ +||||++++++|.+++.+|
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 345666666677777777999998888877666554322 23588999999887 8999999999999999999
Q ss_pred EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccccccc--CC
Q psy501 381 FVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR--SR 457 (962)
Q Consensus 381 LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~--~~ 457 (962)
+||||++| +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+... ..
T Consensus 130 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 208 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208 (396)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence 99999985 666666554 569999999999999999999999999999999999999999999999999998532 23
Q ss_pred CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcC---------hhhhHHHHHhccccccCCCCC
Q psy501 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTC---------LLAGTERLKSSYILLHTLPLY 528 (962)
Q Consensus 458 ~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~---------~~~~~~~i~~~~~~~~~~~~~ 528 (962)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.... .......+....... +..+
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~--p~~~ 285 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI--PRSL 285 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC--CTTS
T ss_pred ccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC--CCcC
Confidence 4556789999999999976 479999999999999999999999996432 122334444443333 2456
Q ss_pred CCCcHHHHHHHhccCCCCCCcH
Q psy501 529 TYHVPPIQTTCLLAGTERLKSS 550 (962)
Q Consensus 529 s~~l~~li~~Cl~~dperRPs~ 550 (962)
+..+..+++.||..+|++||++
T Consensus 286 s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 286 SVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CHHHHHHHHHHTCSCTTTSTTC
T ss_pred CHHHHHHHHHHhcCCHhHcCCC
Confidence 7778899999999999999984
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.97 Aligned_cols=251 Identities=14% Similarity=0.182 Sum_probs=186.6
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccch-----hH-HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-----DE-MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-----~~-~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
.+.+.....++.++.+.||.+.....++.++.|.... .. ..+..+...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 4556666677777777899998877776655554321 12 23444555578889999999999999999999999
Q ss_pred ecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHhhcccc-eeeeccCCCcccccccccceeeecccccccccCC-C
Q psy501 384 EYMKENLYQLIRD---RDKFLPESIIRNMMYQVLQGLAFMHRH-GFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-P 458 (962)
Q Consensus 384 Ey~~g~Ll~~l~~---~~~~ls~~~i~~i~~qI~~aL~yLH~~-gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~ 458 (962)
||++|++.+.+.. ....+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++...... .
T Consensus 86 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 165 (290)
T 3fme_A 86 ELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA 165 (290)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred ehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccccc
Confidence 9999988776644 456799999999999999999999998 9999999999999999999999999999876544 3
Q ss_pred cccccCCccccChhhh---ccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcC-hhhhHHHHHhccccccCCCCCCCCcHH
Q psy501 459 YTDYVSTRWYRAPEVL---LHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTC-LLAGTERLKSSYILLHTLPLYTYHVPP 534 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l---~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~s~~l~~ 534 (962)
.....||+.|+|||++ .....++.++|||||||++|+|++|+.||.... ....................++..+..
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (290)
T 3fme_A 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD 245 (290)
T ss_dssp ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHH
T ss_pred ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHH
Confidence 3345799999999997 344568999999999999999999999998633 333333333332222223456777889
Q ss_pred HHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 535 IQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 535 li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
++..||..+|++||++.++++.- |+.
T Consensus 246 li~~~l~~~p~~Rpt~~e~l~hp-~f~ 271 (290)
T 3fme_A 246 FTSQCLKKNSKERPTYPELMQHP-FFT 271 (290)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTSH-HHH
T ss_pred HHHHHhhcChhhCcCHHHHHhCc-ccc
Confidence 99999999999999998887743 443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=316.95 Aligned_cols=242 Identities=18% Similarity=0.248 Sum_probs=188.0
Q ss_pred CceeeEEEEecCCcccEEEEEec---CCceEEEEeccc--------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLD---QDNHILSRHVSS--------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTL 379 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~---~~~kvv~~k~~~--------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 379 (962)
..+.....++.++.+.||.+... ..++.++.|+.. .....+.+|+.+|++++||||+++++++.+++.+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 45555555666666678888764 344444443322 1234578899999999999999999999999999
Q ss_pred EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-
Q psy501 380 YFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457 (962)
Q Consensus 380 ~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~- 457 (962)
|+||||++ |+|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 175 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG 175 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-------
T ss_pred EEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC
Confidence 99999998 5677666554 45899999999999999999999999999999999999999999999999999754332
Q ss_pred -CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHH
Q psy501 458 -PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQ 536 (962)
Q Consensus 458 -~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li 536 (962)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+....... .+..+..+..++
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~--p~~~~~~~~~li 252 (327)
T 3a62_A 176 TVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL--PPYLTQEARDLL 252 (327)
T ss_dssp ---CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--CTTSCHHHHHHH
T ss_pred ccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC--CCCCCHHHHHHH
Confidence 33456799999999999654 68999999999999999999999999988877777776654433 356677889999
Q ss_pred HHHhccCCCCCC-----cHHHHHhh
Q psy501 537 TTCLLAGTERLK-----SSYILLHT 556 (962)
Q Consensus 537 ~~Cl~~dperRP-----s~~~Ll~~ 556 (962)
..||..+|++|| ++.++++.
T Consensus 253 ~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 253 KKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHhcCHhhccCCCCCCHHHHHcC
Confidence 999999999998 66665553
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.60 Aligned_cols=245 Identities=20% Similarity=0.228 Sum_probs=202.8
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccch--hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-C
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR--DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-E 388 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~--~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g 388 (962)
.+.....+..++.+.||.+.......++.+.+... ....+.+|++++++++||||+++++++.+++..++||||++ |
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG 88 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence 44555555556666799998776555555544332 35679999999999999999999999999999999999997 5
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---CcccccCC
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYVST 465 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~gt 465 (962)
+|.+++......+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++...... ......++
T Consensus 89 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 168 (267)
T 3t9t_A 89 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 168 (267)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCC
T ss_pred cHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccccccccccc
Confidence 788888776677999999999999999999999999999999999999999999999999999866433 23344677
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCC
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGT 544 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dp 544 (962)
..|+|||++.+. .++.++|||||||++|+|++ |+.||...........+..+.. .......+..+..++..||..+|
T Consensus 169 ~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p 246 (267)
T 3t9t_A 169 VKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-LYKPRLASTHVYQIMNHCWRERP 246 (267)
T ss_dssp GGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CCCCTTSCHHHHHHHHHHTCSSG
T ss_pred ccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc-CCCCccCcHHHHHHHHHHccCCh
Confidence 889999999754 68999999999999999999 8999998877777666665532 22334567778899999999999
Q ss_pred CCCCcHHHHHhhcc
Q psy501 545 ERLKSSYILLHTLP 558 (962)
Q Consensus 545 erRPs~~~Ll~~l~ 558 (962)
++||++.+++..|.
T Consensus 247 ~~Rps~~~ll~~L~ 260 (267)
T 3t9t_A 247 EDRPAFSRLLRQLA 260 (267)
T ss_dssp GGSCCHHHHHHHHH
T ss_pred hhCcCHHHHHHHHH
Confidence 99999999998764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=314.16 Aligned_cols=246 Identities=15% Similarity=0.220 Sum_probs=201.5
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccch----------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR----------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTL 379 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~----------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 379 (962)
.+.+.....++.++.+.||.+....+++.++.|+... ....+.+|+.++++++||||+++++++.++...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 3455666666666777799998877666554443221 246789999999999999999999999999999
Q ss_pred EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc----ceeeecccccccc
Q psy501 380 YFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE----LVKIADFGLAREI 454 (962)
Q Consensus 380 ~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g----~vKL~DFGla~~~ 454 (962)
++||||++ ++|.+.+.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++ .+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 99999997 467766654 45699999999999999999999999999999999999999887 7999999999876
Q ss_pred cCC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC--CCCCCCC
Q psy501 455 RSR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT--LPLYTYH 531 (962)
Q Consensus 455 ~~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~ 531 (962)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.......+. .+..+..
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred CccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHH
Confidence 544 3445679999999999965 47899999999999999999999999988777776666654332221 1356677
Q ss_pred cHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 532 VPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 532 l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+..++..||..+|++||++.+++..-
T Consensus 249 ~~~li~~~l~~dp~~Rps~~e~l~hp 274 (321)
T 2a2a_A 249 AKDFIRKLLVKETRKRLTIQEALRHP 274 (321)
T ss_dssp HHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 88999999999999999988888743
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=320.12 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=185.7
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecC
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
..+.+.....++.++.+.||.+.....++.++.|+.. .+...+.+|+++|++++||||+++++++.++...++||||+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 3455666666777777789999988776655554433 23456889999999999999999999999999999999999
Q ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc---ccceeeecccccccccCC-Cccc
Q psy501 387 K-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG---TELVKIADFGLAREIRSR-PYTD 461 (962)
Q Consensus 387 ~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~---~g~vKL~DFGla~~~~~~-~~~~ 461 (962)
+ |+|.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++...... ....
T Consensus 131 ~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 209 (349)
T 2w4o_A 131 TGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT 209 (349)
T ss_dssp CSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccccc
Confidence 8 467676654 456999999999999999999999999999999999999975 789999999999876543 3345
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhh-hHHHHHhccccc--cCCCCCCCCcHHHHHH
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLA-GTERLKSSYILL--HTLPLYTYHVPPIQTT 538 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~-~~~~i~~~~~~~--~~~~~~s~~l~~li~~ 538 (962)
..||+.|+|||++.+. .++.++|||||||++|||++|..||.+..... ....+....... +..+..+..+..++..
T Consensus 210 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 288 (349)
T 2w4o_A 210 VCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRK 288 (349)
T ss_dssp ---CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHT
T ss_pred ccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHH
Confidence 6799999999999764 68999999999999999999999998765443 344444443322 2224566678889999
Q ss_pred HhccCCCCCCcHHHHHhhccccc
Q psy501 539 CLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 539 Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
||..+|++||++.++++.- |+.
T Consensus 289 ~L~~dP~~Rpt~~e~l~hp-~~~ 310 (349)
T 2w4o_A 289 LIVLDPKKRLTTFQALQHP-WVT 310 (349)
T ss_dssp TSCSSGGGSCCHHHHHHST-TTT
T ss_pred HccCChhhCcCHHHHhcCc-ccC
Confidence 9999999999988887743 443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.50 Aligned_cols=242 Identities=20% Similarity=0.243 Sum_probs=200.0
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
.+.....++.++.+.||.+.....++.++.++.. .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (294)
T 2rku_A 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95 (294)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence 4455555666666779999988777766655432 234568899999999999999999999999999999999
Q ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--Cccc
Q psy501 385 YMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTD 461 (962)
Q Consensus 385 y~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~ 461 (962)
|++| +|.+.+.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||.+...... ....
T Consensus 96 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (294)
T 2rku_A 96 LCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 174 (294)
T ss_dssp CCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccccc
Confidence 9985 66665544 356999999999999999999999999999999999999999999999999999876432 3444
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhc
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~ 541 (962)
..|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....... ....+..+..++..||.
T Consensus 175 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~ 251 (294)
T 2rku_A 175 LCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI--PKHINPVAASLIQKMLQ 251 (294)
T ss_dssp CCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC--CTTSCHHHHHHHHHHTC
T ss_pred ccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCC--ccccCHHHHHHHHHHcc
Confidence 678999999999965 468999999999999999999999999887776666665553332 24566778889999999
Q ss_pred cCCCCCCcHHHHHhhc
Q psy501 542 AGTERLKSSYILLHTL 557 (962)
Q Consensus 542 ~dperRPs~~~Ll~~l 557 (962)
.+|++||++.+++..-
T Consensus 252 ~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 252 TDPTARPTINELLNDE 267 (294)
T ss_dssp SSGGGSCCGGGGGGSH
T ss_pred cChhhCcCHHHHhhCh
Confidence 9999999988888754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=306.47 Aligned_cols=244 Identities=22% Similarity=0.239 Sum_probs=194.0
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEec
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEY 385 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey 385 (962)
+.+.....++.++.+.||.+.....++.++.+... .....+.+|+++|++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 45566666666777779999887766554444322 2346789999999999999999999999999999999999
Q ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccc---ccccceeeecccccccccCC-
Q psy501 386 MKE-NLYQLIRDR---DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLC---MGTELVKIADFGLAREIRSR- 457 (962)
Q Consensus 386 ~~g-~Ll~~l~~~---~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl---~~~g~vKL~DFGla~~~~~~- 457 (962)
++| +|.+.+... ...+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++......
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 985 787777542 4679999999999999999999999999999999999999 45578999999999876543
Q ss_pred CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC-CCCCCCCcHHHH
Q psy501 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT-LPLYTYHVPPIQ 536 (962)
Q Consensus 458 ~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~s~~l~~li 536 (962)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+......... ....+..+..++
T Consensus 182 ~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (285)
T 3is5_A 182 HSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLL 259 (285)
T ss_dssp -----CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHH
T ss_pred cCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHH
Confidence 3445678999999999853 5899999999999999999999999988777666655544333222 123566778899
Q ss_pred HHHhccCCCCCCcHHHHHhh
Q psy501 537 TTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 537 ~~Cl~~dperRPs~~~Ll~~ 556 (962)
..||..+|++||++.++++.
T Consensus 260 ~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 260 KQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHTCSCTTTSCCHHHHHTS
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999999999999988874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=315.75 Aligned_cols=251 Identities=14% Similarity=0.159 Sum_probs=199.9
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCce-----EEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDNH-----ILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIREND 377 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~k-----vv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 377 (962)
.+..+.+.....++.++.+.||++....+++ ++.+.+. ......+.+|+.++++++||||+++++++.++.
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 3445566666667777777799998654443 2333221 233457899999999999999999999998765
Q ss_pred EEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC
Q psy501 378 TLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS 456 (962)
Q Consensus 378 ~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~ 456 (962)
.++|+||+. |+|.+++......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+|+....
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 678888887 788888888777899999999999999999999999999999999999999999999999999987654
Q ss_pred C----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCC
Q psy501 457 R----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYH 531 (962)
Q Consensus 457 ~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 531 (962)
. ......+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.........+..+. ..+..+.++..
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 247 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQPPICTID 247 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTBCHH
T ss_pred CcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-CCCCCccCCHH
Confidence 3 22234567899999999764 79999999999999999999 999999887766666555443 33445567778
Q ss_pred cHHHHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 532 VPPIQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 532 l~~li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
+..++..||..+|++||++.+++..+...
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 88999999999999999999999877443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=311.08 Aligned_cols=249 Identities=17% Similarity=0.192 Sum_probs=201.0
Q ss_pred cCceeeEEEEecCCcccEEEEEe-----cCCceEEEEeccc-----hhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNL-----DQDNHILSRHVSS-----RDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDT 378 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~-----~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 378 (962)
.+.+.....++.++.+.||.+.. ....+.++.|... .....+.+|+.+++++ +||||+++++++.+++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 34566666666677777998874 2333444443322 2345789999999999 89999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc
Q psy501 379 LYFVFEYMKE-NLYQLIRDRDK-----------------FLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT 440 (962)
Q Consensus 379 ~~LV~Ey~~g-~Ll~~l~~~~~-----------------~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~ 440 (962)
.++||||++| +|.+++..... .+++..++.++.||+.||.|||+.||+||||||+||+++.+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCC
Confidence 9999999985 88888766432 48999999999999999999999999999999999999999
Q ss_pred cceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHH
Q psy501 441 ELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERL 515 (962)
Q Consensus 441 g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i 515 (962)
+.+||+|||++....... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+..........
T Consensus 182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 260 (313)
T 1t46_A 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260 (313)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred CCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHH
Confidence 999999999998765442 2234567889999999764 79999999999999999999 99999887665555544
Q ss_pred HhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 516 KSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 516 ~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
.............+..+..++..||..+|++||++.++++.+..
T Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 44444444455677788999999999999999999999987743
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=325.41 Aligned_cols=247 Identities=16% Similarity=0.175 Sum_probs=201.7
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh-------HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD-------EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
...+.....++.++.+.||.+....+++.++.|+.... ...+.+|+.++..++||+|++++++|.+++.+|+|
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 34556666666666677999998877777766654432 22478999999999999999999999999999999
Q ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---
Q psy501 383 FEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--- 458 (962)
Q Consensus 383 ~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~--- 458 (962)
|||++ |+|.+++...+..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|.......
T Consensus 140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~ 219 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219 (412)
T ss_dssp ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccc
Confidence 99996 68888887766679999999999999999999999999999999999999999999999999998765442
Q ss_pred cccccCCccccChhhhcc------CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcc--ccccC-CCCCC
Q psy501 459 YTDYVSTRWYRAPEVLLH------STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSY--ILLHT-LPLYT 529 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~------~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~-~~~~s 529 (962)
....+||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+......++.... ...+. ...++
T Consensus 220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s 299 (412)
T 2vd5_A 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVP 299 (412)
T ss_dssp CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCC
T ss_pred cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCC
Confidence 234589999999999973 3468999999999999999999999999988887777776533 22222 23577
Q ss_pred CCcHHHHHHHhccCCCCC---CcHHHHHhhc
Q psy501 530 YHVPPIQTTCLLAGTERL---KSSYILLHTL 557 (962)
Q Consensus 530 ~~l~~li~~Cl~~dperR---Ps~~~Ll~~l 557 (962)
.....+++.||. +|++| |++.+++..-
T Consensus 300 ~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 300 EEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp HHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred HHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 788999999999 77776 5777766543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=322.46 Aligned_cols=236 Identities=22% Similarity=0.275 Sum_probs=195.3
Q ss_pred ecCC-cccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHH
Q psy501 320 ILPH-TLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQL 393 (962)
Q Consensus 320 i~~~-~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~ 393 (962)
++.| .+.||.+.....++.++.|+.. .+...+.+|+++|++++||||+++++++.+++..++||||++ |+|.+.
T Consensus 97 lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~ 176 (373)
T 2x4f_A 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDR 176 (373)
T ss_dssp CC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHH
T ss_pred EecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHH
Confidence 4444 4459999887766655554432 345678999999999999999999999999999999999998 578888
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccc--ccccceeeecccccccccCC-CcccccCCccccC
Q psy501 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLC--MGTELVKIADFGLAREIRSR-PYTDYVSTRWYRA 470 (962)
Q Consensus 394 l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl--~~~g~vKL~DFGla~~~~~~-~~~~~~gt~~Y~A 470 (962)
+......+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++...... ......||+.|+|
T Consensus 177 l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~a 256 (373)
T 2x4f_A 177 IIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLA 256 (373)
T ss_dssp HHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCC
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeC
Confidence 87766679999999999999999999999999999999999999 56778999999999876544 3344579999999
Q ss_pred hhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--CCCCCCCCcHHHHHHHhccCCCCCC
Q psy501 471 PEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--TLPLYTYHVPPIQTTCLLAGTERLK 548 (962)
Q Consensus 471 PE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l~~li~~Cl~~dperRP 548 (962)
||++.+ ..++.++|||||||++|||++|+.||.+.........+.......+ ..+.++..+..++..||..+|++||
T Consensus 257 PE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp 335 (373)
T 2x4f_A 257 PEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRI 335 (373)
T ss_dssp HHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred hhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCC
Confidence 999865 4789999999999999999999999999887777777766543332 2245677889999999999999999
Q ss_pred cHHHHHhh
Q psy501 549 SSYILLHT 556 (962)
Q Consensus 549 s~~~Ll~~ 556 (962)
++.++++.
T Consensus 336 s~~e~l~h 343 (373)
T 2x4f_A 336 SASEALKH 343 (373)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 98888764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=326.41 Aligned_cols=245 Identities=19% Similarity=0.232 Sum_probs=200.7
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccch-----hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecC
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-----DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
.+.....++.++.+.||.+....+++.++.|.... ....+.+|+++|++++||||+++++++.+++..++||||+
T Consensus 115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 194 (377)
T 3cbl_A 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 194 (377)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcC
Confidence 44455555566666799998876666555554322 2235889999999999999999999999989999999999
Q ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcc----c
Q psy501 387 K-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT----D 461 (962)
Q Consensus 387 ~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~----~ 461 (962)
+ |+|.+++...+..+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++........ .
T Consensus 195 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~ 274 (377)
T 3cbl_A 195 QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL 274 (377)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSC
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCC
Confidence 7 6888888776667999999999999999999999999999999999999999999999999999865443211 1
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHh
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCL 540 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl 540 (962)
..+++.|+|||++.+. .++.++|||||||++|||++ |..||.+.........+..+. ..+....++..+..++..||
T Consensus 275 ~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl 352 (377)
T 3cbl_A 275 RQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-RLPCPELCPDAVFRLMEQCW 352 (377)
T ss_dssp CEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHT
T ss_pred CCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHc
Confidence 2346779999999754 68999999999999999998 999999887766666555543 33334567778889999999
Q ss_pred ccCCCCCCcHHHHHhhcc
Q psy501 541 LAGTERLKSSYILLHTLP 558 (962)
Q Consensus 541 ~~dperRPs~~~Ll~~l~ 558 (962)
..+|++||++.++++.|.
T Consensus 353 ~~dP~~Rps~~~i~~~L~ 370 (377)
T 3cbl_A 353 AYEPGQRPSFSTIYQELQ 370 (377)
T ss_dssp CSSGGGSCCHHHHHHHHH
T ss_pred CCCchhCcCHHHHHHHHH
Confidence 999999999999998764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.22 Aligned_cols=247 Identities=17% Similarity=0.162 Sum_probs=191.0
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCC---ceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEE
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQD---NHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLY 380 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~---~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 380 (962)
..+.+.....++.++.+.||.+..... ...++.+... .....+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 345666666777777777999877543 2334443322 22456899999999999999999999985 45789
Q ss_pred EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--
Q psy501 381 FVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-- 457 (962)
Q Consensus 381 LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-- 457 (962)
+||||++| +|.+++......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 99999985 788888776667999999999999999999999999999999999999999999999999999876543
Q ss_pred -CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHH
Q psy501 458 -PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPI 535 (962)
Q Consensus 458 -~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~l 535 (962)
......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+.........+..+.. .+..+.++..+..+
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~l 249 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-LPMPPNCPPTLYSL 249 (281)
T ss_dssp -------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-CCCCTTCCHHHHHH
T ss_pred cccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC-CCCCCCCCHHHHHH
Confidence 2233456788999999975 468999999999999999997 9999998877776666665532 33445677788999
Q ss_pred HHHHhccCCCCCCcHHHHHhhcc
Q psy501 536 QTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 536 i~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
+..||..+|++||++.++++.|.
T Consensus 250 i~~~l~~~p~~Rps~~~l~~~l~ 272 (281)
T 1mp8_A 250 MTKCWAYDPSRRPRFTELKAQLS 272 (281)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHHHH
Confidence 99999999999999999998764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=304.24 Aligned_cols=252 Identities=19% Similarity=0.235 Sum_probs=199.6
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh-------HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEE
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD-------EMVVCFYRKSLKKLSHANLVKLKEVIRENDTL 379 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 379 (962)
.+..+.+.....+..++.+.||.+....+++.++.|..... ...+.+|+.++++++||||+++++++.+++..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 34457777877777778888999998766665555543221 34688999999999999999999999999999
Q ss_pred EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-
Q psy501 380 YFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457 (962)
Q Consensus 380 ~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~- 457 (962)
++||||++ ++|.+.+... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999997 5777777655 45899999999999999999999999999999999999999999999999999876543
Q ss_pred CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHH
Q psy501 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQT 537 (962)
Q Consensus 458 ~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~ 537 (962)
......+++.|+|||++.+....+.++||||||+++|+|++|+.||...........+..+.... ....+..+..++.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~ 243 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI--PEYLNRSVATLLM 243 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--CTTSCHHHHHHHH
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccC--chhcCHHHHHHHH
Confidence 23445789999999999765445789999999999999999999999887777666666553322 2456677889999
Q ss_pred HHhccCCCCCCcHHHHHhhcccccc
Q psy501 538 TCLLAGTERLKSSYILLHTLPLYTY 562 (962)
Q Consensus 538 ~Cl~~dperRPs~~~Ll~~l~~~~~ 562 (962)
.||..+|++||++.++++. +|+..
T Consensus 244 ~~l~~~p~~Rps~~~~l~h-~~~~~ 267 (276)
T 2h6d_A 244 HMLQVDPLKRATIKDIREH-EWFKQ 267 (276)
T ss_dssp HHTCSSGGGSCCHHHHHHS-HHHHT
T ss_pred HHccCChhhCCCHHHHHhC-hhhcc
Confidence 9999999999999888874 34443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=308.51 Aligned_cols=250 Identities=16% Similarity=0.176 Sum_probs=200.1
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc--------hhHHHHHHHHHHHHhcCCCCcccEEEEEE--eCCEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--------RDEMVVCFYRKSLKKLSHANLVKLKEVIR--ENDTL 379 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~--~~~~~ 379 (962)
.+.|.....++.++.+.||.+.....++.++.|+.. .....+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 345555556666666778888877666655544432 22456899999999999999999999984 45678
Q ss_pred EEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-
Q psy501 380 YFVFEYMKENLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457 (962)
Q Consensus 380 ~LV~Ey~~g~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~- 457 (962)
++||||+++++.+.+... ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||.+......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 999999998888777653 456999999999999999999999999999999999999999999999999999876432
Q ss_pred ---CcccccCCccccChhhhccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcH
Q psy501 458 ---PYTDYVSTRWYRAPEVLLHST-AYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVP 533 (962)
Q Consensus 458 ---~~~~~~gt~~Y~APE~l~~~~-~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 533 (962)
......|++.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.........+..+.... .+.++..+.
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--~~~~~~~l~ 241 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI--PGDCGPPLS 241 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC--CSSSCHHHH
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCC--CCccCHHHH
Confidence 223457899999999996532 24789999999999999999999999988777777776654332 346677788
Q ss_pred HHHHHHhccCCCCCCcHHHHHhhcccccc
Q psy501 534 PIQTTCLLAGTERLKSSYILLHTLPLYTY 562 (962)
Q Consensus 534 ~li~~Cl~~dperRPs~~~Ll~~l~~~~~ 562 (962)
.++..||..+|++||++.++++.- |+..
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~~~-~~~~ 269 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQHS-WFRK 269 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSH-HHHS
T ss_pred HHHHHHccCChhhCCCHHHHhcCc-cccc
Confidence 999999999999999999888753 4443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.03 Aligned_cols=247 Identities=15% Similarity=0.187 Sum_probs=199.2
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEeccch-----hH------HHHHHHHHHHHhcCCCCcccEEEEEEeC
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-----DE------MVVCFYRKSLKKLSHANLVKLKEVIREN 376 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-----~~------~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 376 (962)
+..+.+.....+..++.+.||.+....+++.++.|.... .. ..+.+|++++++++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 334556666666666666799999877776655554311 11 5689999999999999999999999766
Q ss_pred CEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccce--eeeccCCCcccccccccc-----eeeecc
Q psy501 377 DTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHG--FFHRDMKPENLLCMGTEL-----VKIADF 448 (962)
Q Consensus 377 ~~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~g--IvHrDLkp~NILl~~~g~-----vKL~DF 448 (962)
. ++||||++ |+|.+.+......+++..++.++.|++.||.|||+.| |+||||||+||+++.++. +||+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 5 69999998 6888888877778999999999999999999999999 999999999999988776 999999
Q ss_pred cccccccCCCcccccCCccccChhhhcc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh--HHHHHhccccccCC
Q psy501 449 GLAREIRSRPYTDYVSTRWYRAPEVLLH-STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG--TERLKSSYILLHTL 525 (962)
Q Consensus 449 Gla~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~--~~~i~~~~~~~~~~ 525 (962)
|++..... ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||........ ...+..........
T Consensus 174 g~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T 4f0f_A 174 GLSQQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP 252 (287)
T ss_dssp TTCBCCSS-CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCC
T ss_pred Cccccccc-cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCC
Confidence 99975443 3445679999999999843 33578999999999999999999999987654433 33344444444445
Q ss_pred CCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 526 PLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 526 ~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..++..+..++..||..+|++||++.++++.|
T Consensus 253 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 284 (287)
T 4f0f_A 253 EDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284 (287)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 56777889999999999999999999999866
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=320.61 Aligned_cols=245 Identities=20% Similarity=0.295 Sum_probs=198.7
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCCC
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKE 388 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~g 388 (962)
.+.|.....++.|+.+.||.|....+++.++.|+.........+|++++.++ +||||+++++++.++...|+|||||+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g 100 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence 3455566666666667799999888887777766555545567899999988 799999999999999999999999985
Q ss_pred -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc----cceeeecccccccccCC--Cccc
Q psy501 389 -NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT----ELVKIADFGLAREIRSR--PYTD 461 (962)
Q Consensus 389 -~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~----g~vKL~DFGla~~~~~~--~~~~ 461 (962)
+|.+.+... +.+++..++.++.||+.||.|||+.||+||||||+||++... +.+||+|||++...... ....
T Consensus 101 g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 179 (342)
T 2qr7_A 101 GELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179 (342)
T ss_dssp CBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCC
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceec
Confidence 777777654 569999999999999999999999999999999999998432 35999999999876543 3445
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCc---ChhhhHHHHHhccccccC--CCCCCCCcHHHH
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTT---CLLAGTERLKSSYILLHT--LPLYTYHVPPIQ 536 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~---~~~~~~~~i~~~~~~~~~--~~~~s~~l~~li 536 (962)
.+||+.|+|||++.+. .++.++|||||||++|||++|..||.+. ........+..+....+. .+..+..+..++
T Consensus 180 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 258 (342)
T 2qr7_A 180 PCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLV 258 (342)
T ss_dssp SSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHH
T ss_pred cCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHH
Confidence 6889999999999653 5889999999999999999999999863 344445556555444332 245677788999
Q ss_pred HHHhccCCCCCCcHHHHHhh
Q psy501 537 TTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 537 ~~Cl~~dperRPs~~~Ll~~ 556 (962)
..||..+|++||++.++++.
T Consensus 259 ~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 259 SKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHTCSSTTTSCCHHHHTTS
T ss_pred HHHCCCChhHCcCHHHHhcC
Confidence 99999999999998887764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=309.43 Aligned_cols=246 Identities=20% Similarity=0.245 Sum_probs=202.5
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccch----hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEec
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR----DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEY 385 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey 385 (962)
.+.+.....++.++.+.||.+....+++.++.|.... ....+.+|+.++++++||||+++++++.+++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 3455566666666677799998876666555544322 234688999999999999999999999999999999999
Q ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccc---ccccceeeecccccccccCCCccc
Q psy501 386 MK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLC---MGTELVKIADFGLAREIRSRPYTD 461 (962)
Q Consensus 386 ~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl---~~~g~vKL~DFGla~~~~~~~~~~ 461 (962)
++ |+|.+.+... +.+++..++.++.|++.||.|||+.||+||||||+||++ +.++.+||+|||++..........
T Consensus 88 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (304)
T 2jam_A 88 VSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST 166 (304)
T ss_dssp CCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHH
T ss_pred CCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcccc
Confidence 98 5777777654 458999999999999999999999999999999999999 778899999999997665544555
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--CCCCCCCCcHHHHHHH
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--TLPLYTYHVPPIQTTC 539 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l~~li~~C 539 (962)
..|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..+....+ ..+..+..+..++..|
T Consensus 167 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (304)
T 2jam_A 167 ACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHL 245 (304)
T ss_dssp HHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHH
T ss_pred ccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHH
Confidence 679999999999965 4789999999999999999999999998887777777776654433 2245677788999999
Q ss_pred hccCCCCCCcHHHHHhhc
Q psy501 540 LLAGTERLKSSYILLHTL 557 (962)
Q Consensus 540 l~~dperRPs~~~Ll~~l 557 (962)
|..+|++||++.+++..-
T Consensus 246 l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 246 LEKDPNERYTCEKALSHP 263 (304)
T ss_dssp HCSSTTTSCCHHHHHTSH
T ss_pred cCCChhHCcCHHHHhcCc
Confidence 999999999998888743
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=316.46 Aligned_cols=249 Identities=17% Similarity=0.180 Sum_probs=193.4
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCC----
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIREND---- 377 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---- 377 (962)
+.+.|.....++.++.+.||.+.....++.++.|+... ....+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 45667777777777778899999877776665554322 1236889999999999999999999987543
Q ss_pred EEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC
Q psy501 378 TLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS 456 (962)
Q Consensus 378 ~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~ 456 (962)
..|+||||++| +|.+.+... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred ccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 45999999985 666666554 4699999999999999999999999999999999999999999999999999986643
Q ss_pred C-----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--CCCCCC
Q psy501 457 R-----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--TLPLYT 529 (962)
Q Consensus 457 ~-----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s 529 (962)
. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.................+ ..+.++
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 247 (311)
T ss_dssp -------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCC
T ss_pred cccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCC
Confidence 3 22335689999999999764 799999999999999999999999998877666555544433222 123567
Q ss_pred CCcHHHHHHHhccCCCCCCc-HHHHHhhccc
Q psy501 530 YHVPPIQTTCLLAGTERLKS-SYILLHTLPL 559 (962)
Q Consensus 530 ~~l~~li~~Cl~~dperRPs-~~~Ll~~l~~ 559 (962)
..+..++..||..+|++||+ +++|.+.+..
T Consensus 248 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 248 ADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 77889999999999999997 6666665533
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=316.46 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=194.3
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
+.+.....++.++.+.||.+.....++.++.|... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 44555555555666679999888766655544321 123457899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--Ccccc
Q psy501 385 YMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDY 462 (962)
Q Consensus 385 y~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~ 462 (962)
|++|+++..+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... .....
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 184 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE 184 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------C
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCC
Confidence 9999888888776677999999999999999999999999999999999999999999999999999766443 33456
Q ss_pred cCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc-------------------c-
Q psy501 463 VSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL-------------------L- 522 (962)
Q Consensus 463 ~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------~- 522 (962)
.||+.|+|||++.+...++.++|||||||++|+|++|++||.+.........+...... .
T Consensus 185 ~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (331)
T 4aaa_A 185 VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLP 264 (331)
T ss_dssp CCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCC
T ss_pred cCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCc
Confidence 78999999999987667899999999999999999999999987766554444321100 0
Q ss_pred ---------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 523 ---------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 523 ---------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
...+.++..+..++..||..+|++||++.++++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 265 EIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0112456667889999999999999998887774
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=316.68 Aligned_cols=250 Identities=21% Similarity=0.213 Sum_probs=199.7
Q ss_pred cCceeeEEEEecCCcccEEEEEec-----CCceEEEEecc-----chhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLD-----QDNHILSRHVS-----SRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDT 378 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~-----~~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 378 (962)
...+.....++.++.+.||.+... .....++.|.. ......+.+|+.+|+++ +||||+++++++..++.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 345556666666666778888752 23333333332 22345789999999999 89999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccc
Q psy501 379 LYFVFEYMK-ENLYQLIRDRDK----------------------FLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENL 435 (962)
Q Consensus 379 ~~LV~Ey~~-g~Ll~~l~~~~~----------------------~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NI 435 (962)
.++||||++ |+|.+++..... .+++..++.++.||+.||.|||+.||+||||||+||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 203 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 203 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 999999997 588888866532 379999999999999999999999999999999999
Q ss_pred ccccccceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhh
Q psy501 436 LCMGTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLA 510 (962)
Q Consensus 436 Ll~~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~ 510 (962)
+++.++.+||+|||++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.....
T Consensus 204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 282 (344)
T 1rjb_A 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282 (344)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH
Confidence 99999999999999998665432 2234567889999999764 69999999999999999998 999999877655
Q ss_pred hHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 511 GTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 511 ~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
..................+..+..++..||..+|.+||++.++++.+...
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 283 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 55555544444454556778899999999999999999999999977443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=306.98 Aligned_cols=243 Identities=18% Similarity=0.232 Sum_probs=176.7
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccchh-------HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD-------EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
.+.....+..++.+.||.+.....++.++.|..... ...+.+|+.++++++||||+++++++.+++..++|||
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 455555666666677999988766665555543322 2568999999999999999999999999999999999
Q ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--Cccc
Q psy501 385 YMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTD 461 (962)
Q Consensus 385 y~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~ 461 (962)
|++ ++|.+.+......+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++...... ....
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 171 (278)
T 3cok_A 92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT 171 (278)
T ss_dssp CCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--------
T ss_pred cCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCccee
Confidence 997 4777777766677999999999999999999999999999999999999999999999999999876532 3334
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhc
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~ 541 (962)
..||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..... .....++..+..++..||.
T Consensus 172 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~ 248 (278)
T 3cok_A 172 LCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY--EMPSFLSIEAKDLIHQLLR 248 (278)
T ss_dssp ---------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCC--CCCTTSCHHHHHHHHHHSC
T ss_pred ccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhccc--CCccccCHHHHHHHHHHcc
Confidence 578999999999865 4689999999999999999999999987665544443333222 2223566678899999999
Q ss_pred cCCCCCCcHHHHHhhc
Q psy501 542 AGTERLKSSYILLHTL 557 (962)
Q Consensus 542 ~dperRPs~~~Ll~~l 557 (962)
.+|++||++.+++..-
T Consensus 249 ~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 249 RNPADRLSLSSVLDHP 264 (278)
T ss_dssp SSGGGSCCHHHHTTST
T ss_pred cCHhhCCCHHHHhcCc
Confidence 9999999998888743
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=306.05 Aligned_cols=241 Identities=20% Similarity=0.207 Sum_probs=193.6
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEecc------chhHHHHHHHHHHHHhcCCCCcccEEEEEEe----CCEEEEE
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVS------SRDEMVVCFYRKSLKKLSHANLVKLKEVIRE----NDTLYFV 382 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~----~~~~~LV 382 (962)
+.....++.++.+.||.+........++.+.. ......+.+|+.++++++||||+++++++.. +..+++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 34444555566667999988777766554432 2234568999999999999999999999875 4568999
Q ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccce--eeeccCCCcccccc-cccceeeecccccccccCCC
Q psy501 383 FEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHG--FFHRDMKPENLLCM-GTELVKIADFGLAREIRSRP 458 (962)
Q Consensus 383 ~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~g--IvHrDLkp~NILl~-~~g~vKL~DFGla~~~~~~~ 458 (962)
|||++| +|.+++... ..+++..++.++.||+.||.|||+.+ |+|+||||+||+++ .++.+||+|||++.......
T Consensus 108 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 186 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred EEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc
Confidence 999975 777776554 45899999999999999999999999 99999999999997 78899999999998776666
Q ss_pred cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh-HHHHHhccccccCCCCCCCCcHHHHH
Q psy501 459 YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG-TERLKSSYILLHTLPLYTYHVPPIQT 537 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~s~~l~~li~ 537 (962)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||........ ...+..+..........+..+..++.
T Consensus 187 ~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 264 (290)
T 1t4h_A 187 AKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264 (290)
T ss_dssp BEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred cccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHH
Confidence 666789999999998864 489999999999999999999999988544433 33343333322333355567889999
Q ss_pred HHhccCCCCCCcHHHHHhh
Q psy501 538 TCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 538 ~Cl~~dperRPs~~~Ll~~ 556 (962)
.||..+|++||++.++++.
T Consensus 265 ~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 265 GCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHSCSSGGGSCCHHHHHTS
T ss_pred HHccCChhhCCCHHHHhhC
Confidence 9999999999999888874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=329.79 Aligned_cols=243 Identities=17% Similarity=0.165 Sum_probs=194.0
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
+.+.....++.|+.+.||.+.....++.++.|+... ....+.+|+.+|+.++||||+++++++.+++.+|+||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 445555566666666789988877777666655432 2245788999999999999999999999999999999
Q ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhccc-ceeeeccCCCcccccccccceeeecccccccccCC--Cc
Q psy501 384 EYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHR-HGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PY 459 (962)
Q Consensus 384 Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~-~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~ 459 (962)
||++| +|.+.+... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+|+..... ..
T Consensus 228 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 306 (446)
T 4ejn_A 228 EYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 306 (446)
T ss_dssp CCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred eeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCccc
Confidence 99985 666666544 569999999999999999999998 99999999999999999999999999999764332 44
Q ss_pred ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHH
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTC 539 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~C 539 (962)
...+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+.......+ ...+..+..++..|
T Consensus 307 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~li~~~ 383 (446)
T 4ejn_A 307 KTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP--RTLGPEAKSLLSGL 383 (446)
T ss_dssp CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHH
T ss_pred ccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC--ccCCHHHHHHHHHH
Confidence 55789999999999966 4799999999999999999999999999888777777766654433 45677889999999
Q ss_pred hccCCCCCC-----cHHHHHhhc
Q psy501 540 LLAGTERLK-----SSYILLHTL 557 (962)
Q Consensus 540 l~~dperRP-----s~~~Ll~~l 557 (962)
|..+|.+|| ++.++++.-
T Consensus 384 L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 384 LKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSG
T ss_pred cccCHHHhCCCCCCCHHHHHhCc
Confidence 999999999 888877643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=323.78 Aligned_cols=262 Identities=23% Similarity=0.295 Sum_probs=198.3
Q ss_pred CCceEEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeC
Q psy501 303 GHTTCLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIREN 376 (962)
Q Consensus 303 g~~~~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 376 (962)
+...+.+.+.|.....++.|+.+.||.+....+++.++.|... .....+.+|+.+|++++||||+++++++...
T Consensus 18 ~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 97 (432)
T 3n9x_A 18 GIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPD 97 (432)
T ss_dssp CGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred CCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 3344555677777777777778889999988877765555432 2345789999999999999999999999765
Q ss_pred -----CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccc
Q psy501 377 -----DTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLA 451 (962)
Q Consensus 377 -----~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla 451 (962)
..+|+||||++|+|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 98 DLLKFDELYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CTTTCCCEEEEEECCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CCCcCCeEEEEEecCCcCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 579999999999998888654 56999999999999999999999999999999999999999999999999999
Q ss_pred ccccCC------------------------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcC--------
Q psy501 452 REIRSR------------------------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDH-------- 499 (962)
Q Consensus 452 ~~~~~~------------------------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG-------- 499 (962)
+..... .....+||+.|+|||++.....++.++|||||||++|||++|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 256 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence 876432 135568999999999986666799999999999999999984
Q ss_pred ---CCCCCCcChh-----------------hhHHHH------------------------Hhccccc-----cCCCCCCC
Q psy501 500 ---VPPIQTTCLL-----------------AGTERL------------------------KSSYILL-----HTLPLYTY 530 (962)
Q Consensus 500 ---~~Pf~~~~~~-----------------~~~~~i------------------------~~~~~~~-----~~~~~~s~ 530 (962)
.++|.+.+.. .....+ ....... ...+..+.
T Consensus 257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 336 (432)
T 3n9x_A 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD 336 (432)
T ss_dssp GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence 4444443210 000000 0000000 01134566
Q ss_pred CcHHHHHHHhccCCCCCCcHHHHHhhccccccCCC
Q psy501 531 HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVP 565 (962)
Q Consensus 531 ~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~~~~ 565 (962)
.+.+++..||..+|++||++.++++.-.+..+..+
T Consensus 337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 337 DGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 77889999999999999998888875433334443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=314.20 Aligned_cols=250 Identities=16% Similarity=0.186 Sum_probs=189.7
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCC--CCcccEEEEEEeCCEEEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSH--ANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~H--pnIv~l~~~~~~~~~~~LV~ 383 (962)
+.|.....++.++.+.||.+.......++.+.+.. .....+.+|+.+|++++| |||+++++++.++...++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 34555555555556669999876544444443321 123568899999999986 99999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----Cc
Q psy501 384 EYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PY 459 (962)
Q Consensus 384 Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~ 459 (962)
|+..|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||++...... ..
T Consensus 89 e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~ 166 (343)
T 3dbq_A 89 ECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK 166 (343)
T ss_dssp CCCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---------
T ss_pred eCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccC
Confidence 98888999888765 4699999999999999999999999999999999999997 578999999999876543 22
Q ss_pred ccccCCccccChhhhcc----------CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh-hhHHHHHhccccccCCCCC
Q psy501 460 TDYVSTRWYRAPEVLLH----------STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL-AGTERLKSSYILLHTLPLY 528 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~----------~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~ 528 (962)
....||+.|+|||++.+ ...++.++|||||||++|||++|+.||...... .....+.............
T Consensus 167 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T 3dbq_A 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 246 (343)
T ss_dssp ---CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCS
T ss_pred CCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccC
Confidence 35679999999999864 246899999999999999999999999875332 2233333332233333344
Q ss_pred CCCcHHHHHHHhccCCCCCCcHHHHHhhccccccC
Q psy501 529 TYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYH 563 (962)
Q Consensus 529 s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~~ 563 (962)
+..+..++..||..+|++||++.+++..- |+...
T Consensus 247 ~~~l~~li~~~L~~dp~~Rpt~~e~l~hp-~~~~~ 280 (343)
T 3dbq_A 247 EKDLQDVLKCCLKRDPKQRISIPELLAHP-YVQIQ 280 (343)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSH-HHHSC
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHHhCc-ccccc
Confidence 55688899999999999999998888754 55543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=315.43 Aligned_cols=251 Identities=15% Similarity=0.162 Sum_probs=199.1
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCce-----EEEEec----cchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDNH-----ILSRHV----SSRDEMVVCFYRKSLKKLSHANLVKLKEVIREND 377 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~k-----vv~~k~----~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 377 (962)
.+..+.+.....++.++.+.||.+.....++ ++.+.+ .......+.+|+.++++++||||+++++++..+.
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 3445667777777777777799998655443 233322 2234567999999999999999999999998765
Q ss_pred EEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC
Q psy501 378 TLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS 456 (962)
Q Consensus 378 ~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~ 456 (962)
.++|+|++. |+|.+++......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 678888887 688888888777899999999999999999999999999999999999999999999999999987643
Q ss_pred C----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCC
Q psy501 457 R----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYH 531 (962)
Q Consensus 457 ~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 531 (962)
. ......+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.........+.... ..+..+.++..
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 247 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQPPICTID 247 (327)
T ss_dssp ----------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTBCHH
T ss_pred ccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCCCCccCCHH
Confidence 3 22334567889999999764 79999999999999999999 999999887776666555543 34445567778
Q ss_pred cHHHHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 532 VPPIQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 532 l~~li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
+..++..||..+|++||++.++++.|...
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 89999999999999999999999977543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=314.24 Aligned_cols=248 Identities=17% Similarity=0.166 Sum_probs=201.5
Q ss_pred cCceeeEEEEecCCcccEEEEEecC-----CceEEEEeccch-----hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQ-----DNHILSRHVSSR-----DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTL 379 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~-----~~kvv~~k~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 379 (962)
.+.+.....++.++.+.||.+.... ..+.++.|.... ....+.+|+.++++++||||+++++++.+++..
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 3456666666667777799998763 224444443221 245689999999999999999999999999999
Q ss_pred EEEEecCCC-CHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccc
Q psy501 380 YFVFEYMKE-NLYQLIRDRD-----------------------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENL 435 (962)
Q Consensus 380 ~LV~Ey~~g-~Ll~~l~~~~-----------------------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NI 435 (962)
++||||++| +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI 205 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 205 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceE
Confidence 999999985 7888776532 5699999999999999999999999999999999999
Q ss_pred ccccccceeeecccccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhh
Q psy501 436 LCMGTELVKIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLA 510 (962)
Q Consensus 436 Ll~~~g~vKL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~ 510 (962)
+++.++.+||+|||++...... ......+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.....
T Consensus 206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 284 (343)
T 1luf_A 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284 (343)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCcCCCCChHH
Confidence 9999999999999999765432 22345678899999999764 69999999999999999999 999999988777
Q ss_pred hHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 511 GTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 511 ~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
....+..+.. ......++..+..++..||..+|++||++.++++.|..
T Consensus 285 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~ 332 (343)
T 1luf_A 285 VIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 332 (343)
T ss_dssp HHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHH
Confidence 7776666543 23334667788999999999999999999999887743
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=318.54 Aligned_cols=248 Identities=19% Similarity=0.200 Sum_probs=196.9
Q ss_pred cCceeeEEEEecCCcccEEEEEe-----cCCceEEEEeccc-----hhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCC-
Q psy501 310 AGTERLKFSYILPHTLPLYTCNL-----DQDNHILSRHVSS-----RDEMVVCFYRKSLKKL-SHANLVKLKEVIREND- 377 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~-----~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~- 377 (962)
.+.+.....++.++.+.||.+.. ....+.++.|... .....+.+|+++++++ +||||+++++++.+.+
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 45566666666677777999973 3344544444432 2234689999999999 7999999999998754
Q ss_pred EEEEEEecCCC-CHHHHHHhcCC---------------------------------------------------------
Q psy501 378 TLYFVFEYMKE-NLYQLIRDRDK--------------------------------------------------------- 399 (962)
Q Consensus 378 ~~~LV~Ey~~g-~Ll~~l~~~~~--------------------------------------------------------- 399 (962)
..++||||++| +|.+++.....
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 48999999985 77777765422
Q ss_pred --------CCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----CcccccCCcc
Q psy501 400 --------FLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PYTDYVSTRW 467 (962)
Q Consensus 400 --------~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~~~~gt~~ 467 (962)
.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... ......||+.
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~ 260 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence 2899999999999999999999999999999999999999999999999999866433 2334567889
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCC
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTER 546 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dper 546 (962)
|+|||++.+ ..++.++|||||||++|||++ |..||.+......................++..+..++..||..+|++
T Consensus 261 y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 339 (359)
T 3vhe_A 261 WMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQ 339 (359)
T ss_dssp GCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred eEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence 999999976 479999999999999999998 999998876555444444443344444567778899999999999999
Q ss_pred CCcHHHHHhhcc
Q psy501 547 LKSSYILLHTLP 558 (962)
Q Consensus 547 RPs~~~Ll~~l~ 558 (962)
||++.++++.|.
T Consensus 340 Rps~~ell~~L~ 351 (359)
T 3vhe_A 340 RPTFSELVEHLG 351 (359)
T ss_dssp SCCHHHHHHHHH
T ss_pred CCCHHHHHHHHH
Confidence 999999998773
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=322.94 Aligned_cols=237 Identities=20% Similarity=0.273 Sum_probs=190.9
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHH-HHhcCCCCcccEEEEEEeCCEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKS-LKKLSHANLVKLKEVIRENDTLYF 381 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~i-L~~L~HpnIv~l~~~~~~~~~~~L 381 (962)
.+.+.....++.++.+.||.+....+++.++.|+... ....+.+|..+ ++.++||+|+++++++.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 4455666666666666799999888777666554322 22346677776 567899999999999999999999
Q ss_pred EEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC--CC
Q psy501 382 VFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RP 458 (962)
Q Consensus 382 V~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~--~~ 458 (962)
||||++| +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++.... ..
T Consensus 117 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~ 195 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST 195 (373)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCC
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCc
Confidence 9999985 666666554 4689999999999999999999999999999999999999999999999999986432 24
Q ss_pred cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHH
Q psy501 459 YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTT 538 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~ 538 (962)
....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+.......+.......+ +..+..+..++..
T Consensus 196 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~ 272 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK--PNITNSARHLLEG 272 (373)
T ss_dssp CCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC--SSSCHHHHHHHHH
T ss_pred cccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC--CCCCHHHHHHHHH
Confidence 556789999999999975 4799999999999999999999999999888888787777644333 5677788999999
Q ss_pred HhccCCCCCCcH
Q psy501 539 CLLAGTERLKSS 550 (962)
Q Consensus 539 Cl~~dperRPs~ 550 (962)
||..+|.+||++
T Consensus 273 lL~~dp~~R~~~ 284 (373)
T 2r5t_A 273 LLQKDRTKRLGA 284 (373)
T ss_dssp HTCSSGGGSTTT
T ss_pred HcccCHHhCCCC
Confidence 999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=304.80 Aligned_cols=252 Identities=17% Similarity=0.127 Sum_probs=200.8
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEE-EeCCEEEEEEe
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVI-RENDTLYFVFE 384 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~-~~~~~~~LV~E 384 (962)
...+.+.....+..++.+.||.+.....++.++.|+.. .....+.+|+.+++.++|++++..+..+ ..+...++|||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 34566777777777777789999987766665555422 2334689999999999988866665555 67788999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccc---ccccceeeecccccccccCCC---
Q psy501 385 YMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLC---MGTELVKIADFGLAREIRSRP--- 458 (962)
Q Consensus 385 y~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl---~~~g~vKL~DFGla~~~~~~~--- 458 (962)
|++++|.+.+......+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++.......
T Consensus 86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (296)
T 3uzp_A 86 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred ecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccc
Confidence 99889999888666779999999999999999999999999999999999999 478899999999998765432
Q ss_pred ------cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcCh---hhhHHHHHhcccccc---CCC
Q psy501 459 ------YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCL---LAGTERLKSSYILLH---TLP 526 (962)
Q Consensus 459 ------~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~---~~~ 526 (962)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... ......+.......+ ..+
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T 3uzp_A 166 HIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 244 (296)
T ss_dssp BCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTT
T ss_pred ccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHh
Confidence 2456799999999999764 689999999999999999999999987432 222333332222221 224
Q ss_pred CCCCCcHHHHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 527 LYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 527 ~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
.++..+..++..||..+|++||++.++++.|...
T Consensus 245 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 245 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 6777889999999999999999999999877543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=323.51 Aligned_cols=248 Identities=21% Similarity=0.284 Sum_probs=199.4
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC------EEEE
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIREND------TLYF 381 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------~~~L 381 (962)
...+.|.....++.|+.+.||.+......+++.+++... .....+|+++|+.++||||+++++++...+ .+++
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~-~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECC-TTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecC-cchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 345567777777777778899999888777666655432 233457999999999999999999996533 3889
Q ss_pred EEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccc-cccceeeecccccccccCC
Q psy501 382 VFEYMKENLYQLIRD---RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM-GTELVKIADFGLAREIRSR 457 (962)
Q Consensus 382 V~Ey~~g~Ll~~l~~---~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~-~~g~vKL~DFGla~~~~~~ 457 (962)
||||++++++..+.. ....+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+|||+|+.....
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 999999988776543 346799999999999999999999999999999999999998 7899999999999876433
Q ss_pred -CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc---------------
Q psy501 458 -PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL--------------- 521 (962)
Q Consensus 458 -~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------- 521 (962)
......||+.|+|||++.+...++.++|||||||++|||++|++||.+.+.......+......
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 275 (394)
T 4e7w_A 196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYME 275 (394)
T ss_dssp CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSS
T ss_pred CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence 4456788999999999987667999999999999999999999999988766555544332100
Q ss_pred --cc----------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 522 --LH----------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 522 --~~----------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.+ ..+..+..+..++..||..+|++||++.+++..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 276 HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 112355577889999999999999998887764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=315.08 Aligned_cols=248 Identities=19% Similarity=0.191 Sum_probs=201.7
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc---hhHHHHHHHHHHHHhcC-----CCCcccEEEEEEeCCE
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS---RDEMVVCFYRKSLKKLS-----HANLVKLKEVIRENDT 378 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~---~~~~~~~~Ei~iL~~L~-----HpnIv~l~~~~~~~~~ 378 (962)
.++.+.|.....++.++.+.||.+.....++.++.|+.. .....+..|+.+++.+. ||||+++++++...+.
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~ 110 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH 110 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence 456778888888888888889999988777766665543 23446788999999996 9999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc------------------
Q psy501 379 LYFVFEYMKENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG------------------ 439 (962)
Q Consensus 379 ~~LV~Ey~~g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~------------------ 439 (962)
.|+||||++++|.+.+.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 111 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 111 MCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp EEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred eEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence 99999999889999887654 45999999999999999999999999999999999999975
Q ss_pred -------ccceeeecccccccccCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhH
Q psy501 440 -------TELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGT 512 (962)
Q Consensus 440 -------~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~ 512 (962)
++.+||+|||+|..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.......
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 268 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTS-CCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccCCCCEEEEeccCceecCC-CCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHH
Confidence 78899999999986543 33456899999999999764 6999999999999999999999999987766555
Q ss_pred HHHHhccccccC-----------------------CC---------------------CCCCCcHHHHHHHhccCCCCCC
Q psy501 513 ERLKSSYILLHT-----------------------LP---------------------LYTYHVPPIQTTCLLAGTERLK 548 (962)
Q Consensus 513 ~~i~~~~~~~~~-----------------------~~---------------------~~s~~l~~li~~Cl~~dperRP 548 (962)
..+.......+. .+ ..+..+..++..||..+|++||
T Consensus 269 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 348 (360)
T 3llt_A 269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP 348 (360)
T ss_dssp HHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCC
Confidence 444332111110 00 0112344899999999999999
Q ss_pred cHHHHHhh
Q psy501 549 SSYILLHT 556 (962)
Q Consensus 549 s~~~Ll~~ 556 (962)
++.++++.
T Consensus 349 ta~elL~h 356 (360)
T 3llt_A 349 SPAELLKH 356 (360)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99888764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=325.44 Aligned_cols=246 Identities=21% Similarity=0.307 Sum_probs=194.2
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeC------CEEEEEEec
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIREN------DTLYFVFEY 385 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------~~~~LV~Ey 385 (962)
.|.....++.++.+.||.+.....++.++.|....+.....+|+++|++++||||++++++|... ..+++||||
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 45555566666667799999887666666555444444566899999999999999999998542 247799999
Q ss_pred CCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc-cceeeecccccccccCC-Ccc
Q psy501 386 MKENLYQLIR---DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT-ELVKIADFGLAREIRSR-PYT 460 (962)
Q Consensus 386 ~~g~Ll~~l~---~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~-g~vKL~DFGla~~~~~~-~~~ 460 (962)
+++++.+.+. .....+++..++.++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||+++..... ...
T Consensus 135 ~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~ 214 (420)
T 1j1b_A 135 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 214 (420)
T ss_dssp CCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCC
T ss_pred ccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCce
Confidence 9998777664 345679999999999999999999999999999999999999955 57899999999876433 445
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcc-----------------cccc
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSY-----------------ILLH 523 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~-----------------~~~~ 523 (962)
...||+.|+|||++.+...++.++|||||||++|||++|++||.+.........+.... ...+
T Consensus 215 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p 294 (420)
T 1j1b_A 215 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 294 (420)
T ss_dssp SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCC
T ss_pred eeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccC
Confidence 56899999999999776679999999999999999999999999877655544443210 0011
Q ss_pred C----------CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 524 T----------LPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 524 ~----------~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
. .+..+..+.+|+..||..+|++||++.+++..-
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 295 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp CCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 0 123355678899999999999999988877644
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=321.44 Aligned_cols=252 Identities=20% Similarity=0.212 Sum_probs=204.4
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCc-------e-EEEEeccc----hhHHHHHHHHHHHHhc-CCCCcccEEEEE
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDN-------H-ILSRHVSS----RDEMVVCFYRKSLKKL-SHANLVKLKEVI 373 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~-------k-vv~~k~~~----~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~ 373 (962)
.+..+.+.....++.++.+.||.+...... . ++.+.+.. .....+.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 344556666777777777789999854321 2 33333221 2235689999999999 899999999999
Q ss_pred EeCCEEEEEEecCCC-CHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccc
Q psy501 374 RENDTLYFVFEYMKE-NLYQLIRDRD---------------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLC 437 (962)
Q Consensus 374 ~~~~~~~LV~Ey~~g-~Ll~~l~~~~---------------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl 437 (962)
.+++..++||||++| +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||++
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 999999999999985 8888876643 359999999999999999999999999999999999999
Q ss_pred ccccceeeecccccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhH
Q psy501 438 MGTELVKIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGT 512 (962)
Q Consensus 438 ~~~g~vKL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~ 512 (962)
+.++.+||+|||++...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.......
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999876543 2334467788999999976 479999999999999999999 99999988877776
Q ss_pred HHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 513 ERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 513 ~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
..+..+. .......++..+..++..||..+|++||++.++++.|...
T Consensus 304 ~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 304 KLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp HHHHTTC-CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCC-CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 6665553 2333456777889999999999999999999999877443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=313.67 Aligned_cols=242 Identities=21% Similarity=0.253 Sum_probs=200.7
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
.|.....++.++.+.||.+.....++.++.++... ....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 121 (335)
T 2owb_A 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121 (335)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence 44555556666667799999888777666555322 34568999999999999999999999999999999999
Q ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--Cccc
Q psy501 385 YMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTD 461 (962)
Q Consensus 385 y~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~ 461 (962)
|++| +|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... ....
T Consensus 122 ~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (335)
T 2owb_A 122 LCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 200 (335)
T ss_dssp CCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred cCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccc
Confidence 9985 666655543 56999999999999999999999999999999999999999999999999999876432 3445
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhc
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~ 541 (962)
..|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....... ...++..+..++..||.
T Consensus 201 ~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~ 277 (335)
T 2owb_A 201 LCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI--PKHINPVAASLIQKMLQ 277 (335)
T ss_dssp CCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC--CTTSCHHHHHHHHHHTC
T ss_pred cCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCC--CccCCHHHHHHHHHHcc
Confidence 678999999999975 468999999999999999999999999887766666665554332 24566778889999999
Q ss_pred cCCCCCCcHHHHHhhc
Q psy501 542 AGTERLKSSYILLHTL 557 (962)
Q Consensus 542 ~dperRPs~~~Ll~~l 557 (962)
.+|++||++.+++..-
T Consensus 278 ~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 278 TDPTARPTINELLNDE 293 (335)
T ss_dssp SSGGGSCCGGGGGGSH
T ss_pred CChhHCcCHHHHhcCc
Confidence 9999999988888754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=316.44 Aligned_cols=246 Identities=24% Similarity=0.279 Sum_probs=193.3
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeC------
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIREN------ 376 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------ 376 (962)
+.+.|.....++.|+.+.||.+....+++.++.|... .....+.+|+++|++++||||+++++++..+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3455666555555666679999887766655554431 1234688999999999999999999999765
Q ss_pred CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC
Q psy501 377 DTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS 456 (962)
Q Consensus 377 ~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~ 456 (962)
..+|+||||++++|.+.+.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 103 TDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 34699999998888877765 3589999999999999999999999999999999999999999999999999987654
Q ss_pred CCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc--------------
Q psy501 457 RPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL-------------- 522 (962)
Q Consensus 457 ~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------------- 522 (962)
. .....+|+.|+|||++.+...++.++|||||||++|||++|++||.+.+.......+......+
T Consensus 181 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 259 (367)
T 1cm8_A 181 E-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259 (367)
T ss_dssp S-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred c-cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHH
Confidence 3 4456889999999999876679999999999999999999999999887665555443321110
Q ss_pred ---------------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 523 ---------------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 523 ---------------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
...+..+..+..++..||..||++||++.+++..-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp 309 (367)
T 1cm8_A 260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309 (367)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence 11234455678899999999999999988777644
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=317.75 Aligned_cols=241 Identities=17% Similarity=0.187 Sum_probs=193.2
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccch------------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR------------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDT 378 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~------------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 378 (962)
+.|.....++.++.+.||.+.....++.++.|+... ....+.+|+.+|++++||||+++++++.+++.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 345555555555566699998877777665554322 12347789999999999999999999999999
Q ss_pred EEEEEecCC-C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC
Q psy501 379 LYFVFEYMK-E-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS 456 (962)
Q Consensus 379 ~~LV~Ey~~-g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~ 456 (962)
.++||||+. | ++.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 999999986 4 66666654 45699999999999999999999999999999999999999999999999999987654
Q ss_pred C-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHH
Q psy501 457 R-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPI 535 (962)
Q Consensus 457 ~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~l 535 (962)
. ......||+.|+|||++.+...++.++|||||||++|+|++|..||...... ... .......++..+..+
T Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~--~~~~~~~~~~~l~~l 254 (335)
T 3dls_A 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VEA--AIHPPYLVSKELMSL 254 (335)
T ss_dssp TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TTT--CCCCSSCCCHHHHHH
T ss_pred CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hhh--ccCCCcccCHHHHHH
Confidence 4 3445679999999999987644589999999999999999999999764321 111 122233567788999
Q ss_pred HHHHhccCCCCCCcHHHHHhhccccc
Q psy501 536 QTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 536 i~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
+..||..+|++||++.++++.- |+.
T Consensus 255 i~~~L~~dP~~Rps~~ell~hp-~~~ 279 (335)
T 3dls_A 255 VSGLLQPVPERRTTLEKLVTDP-WVT 279 (335)
T ss_dssp HHHHTCSSGGGSCCHHHHHHCT-TTT
T ss_pred HHHHccCChhhCcCHHHHhcCc-ccc
Confidence 9999999999999988888753 443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-34 Score=321.90 Aligned_cols=248 Identities=17% Similarity=0.183 Sum_probs=198.7
Q ss_pred CceeeEEEEecCCcccEEEEEec-----CCceEEEEecc-----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLD-----QDNHILSRHVS-----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLY 380 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~-----~~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 380 (962)
..+.....++.|+.+.||.+... ...+.++.|.. ......+.+|+.++++++||||+++++++.++...+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 34455555555556669999843 23344444432 233456889999999999999999999999999999
Q ss_pred EEEecCC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc---ceeeecccc
Q psy501 381 FVFEYMK-ENLYQLIRDRD------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGL 450 (962)
Q Consensus 381 LV~Ey~~-g~Ll~~l~~~~------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g---~vKL~DFGl 450 (962)
+||||++ |+|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~ 230 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence 9999997 58888886643 4589999999999999999999999999999999999999655 599999999
Q ss_pred cccccC----CCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCC
Q psy501 451 AREIRS----RPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTL 525 (962)
Q Consensus 451 a~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 525 (962)
++.... .......+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.........+..+.. ....
T Consensus 231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~-~~~~ 308 (367)
T 3l9p_A 231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR-MDPP 308 (367)
T ss_dssp HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-CCCC
T ss_pred ccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCC
Confidence 975432 233345678999999999764 69999999999999999998 9999999887777776666532 2334
Q ss_pred CCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 526 PLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 526 ~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
..++..+..++..||..+|++||++.++++.+...
T Consensus 309 ~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 309 KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 46677788999999999999999999999987443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=308.69 Aligned_cols=248 Identities=17% Similarity=0.192 Sum_probs=194.3
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh-------HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD-------EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
.+.|.....+..++.+.||.+.....++.++.|+.... ...+.+|+.++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 35677777777777778999998877776666554321 25688999999999999999999999999999999
Q ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---C
Q psy501 383 FEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---P 458 (962)
Q Consensus 383 ~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~ 458 (962)
|||++| +|.+.+... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++...... .
T Consensus 113 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp EECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 999986 777766654 46999999999999999999999999999999999999999999999999999766543 2
Q ss_pred cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-cCCCCCCCCcHHHHH
Q psy501 459 YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL-HTLPLYTYHVPPIQT 537 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~s~~l~~li~ 537 (962)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+....... ...+.++..+..++.
T Consensus 192 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 270 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIA 270 (309)
T ss_dssp -----CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHH
T ss_pred ccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHH
Confidence 334578999999999965 478999999999999999999999999876654444444332222 233567888999999
Q ss_pred HHhccCCCCCC-cHHHHHhhccc
Q psy501 538 TCLLAGTERLK-SSYILLHTLPL 559 (962)
Q Consensus 538 ~Cl~~dperRP-s~~~Ll~~l~~ 559 (962)
.||..+|++|| ++++|++.|..
T Consensus 271 ~~l~~dP~~Rp~s~~~l~~~l~~ 293 (309)
T 2h34_A 271 RGMAKNPEDRYVTCGDLSAAAHA 293 (309)
T ss_dssp HHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HhccCCHHHHHHhHHHHHHHHHH
Confidence 99999999999 89999987743
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=315.62 Aligned_cols=251 Identities=21% Similarity=0.252 Sum_probs=200.7
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc---------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS---------RDEMVVCFYRKSLKKLSHANLVKLKEVIREND 377 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~---------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 377 (962)
.-+.+.+.....++.++.+.||.+......+.++.|+.. .....+.+|++++++++||||+++++++.+++
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 334566777777777777789999888877766655432 23457899999999999999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHH
Q psy501 378 TLYFVFEYMK-ENLYQLIRDR---------------------------------------DKFLPESIIRNMMYQVLQGL 417 (962)
Q Consensus 378 ~~~LV~Ey~~-g~Ll~~l~~~---------------------------------------~~~ls~~~i~~i~~qI~~aL 417 (962)
..++||||++ |+|.+.+... ...+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 9999999997 5666665310 11246788999999999999
Q ss_pred hhcccceeeeccCCCccccccccc--ceeeecccccccccCC------CcccccCCccccChhhhccC-CCCCchhHHHH
Q psy501 418 AFMHRHGFFHRDMKPENLLCMGTE--LVKIADFGLAREIRSR------PYTDYVSTRWYRAPEVLLHS-TAYSAPIHLSR 488 (962)
Q Consensus 418 ~yLH~~gIvHrDLkp~NILl~~~g--~vKL~DFGla~~~~~~------~~~~~~gt~~Y~APE~l~~~-~~~t~ksDIwS 488 (962)
.|||+.||+||||||+||+++.++ .+||+|||++..+... ......||+.|+|||++.+. ..++.++||||
T Consensus 182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 999999999999999999998776 8999999999865332 23456799999999999642 46899999999
Q ss_pred HHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC--CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 489 SQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT--LPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 489 LGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
|||++|||++|+.||.+.........+.......+. ...++..+..++..||..+|++||++.++++.-
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence 999999999999999998887777777665443332 224677889999999999999999988877643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=304.53 Aligned_cols=244 Identities=14% Similarity=0.239 Sum_probs=195.3
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccch----------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR----------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLY 380 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~----------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 380 (962)
+.+.....+..++.+.||.+.....++.++.|+... ....+.+|+.++++++||||+++++++.++...+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 345556666666677799998876665544443211 2567999999999999999999999999999999
Q ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc----ceeeeccccccccc
Q psy501 381 FVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE----LVKIADFGLAREIR 455 (962)
Q Consensus 381 LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g----~vKL~DFGla~~~~ 455 (962)
+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||.+....
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 9999997 5777776554 4599999999999999999999999999999999999998877 89999999998765
Q ss_pred CC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--CCCCCCCCc
Q psy501 456 SR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--TLPLYTYHV 532 (962)
Q Consensus 456 ~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l 532 (962)
.. ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.......+ ..+..+..+
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 242 (283)
T ss_dssp --------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHH
T ss_pred CCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHH
Confidence 43 3345578999999999965 4689999999999999999999999998877666666554433221 123556678
Q ss_pred HHHHHHHhccCCCCCCcHHHHHhh
Q psy501 533 PPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 533 ~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
..++..||..+|++||++.++++.
T Consensus 243 ~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 243 KDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHccCCHhHCcCHHHHHhC
Confidence 889999999999999998887764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=328.75 Aligned_cols=253 Identities=21% Similarity=0.300 Sum_probs=181.9
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEe-----CCEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRE-----NDTL 379 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-----~~~~ 379 (962)
+.+.....++.|+.+.||.+....+++.++.|... .+...+.+|+.+|++++||||+++++++.. ...+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 34444445555556669999877766665554322 234568899999999999999999999943 3579
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--
Q psy501 380 YFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-- 457 (962)
Q Consensus 380 ~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-- 457 (962)
|+||||++|+|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+.....
T Consensus 133 ~lv~e~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 211 (458)
T 3rp9_A 133 YVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211 (458)
T ss_dssp EEEECCCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTT
T ss_pred EEEEeccccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccc
Confidence 999999999998888654 56999999999999999999999999999999999999999999999999999876422
Q ss_pred ---------------------------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-----------C
Q psy501 458 ---------------------------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-----------H 499 (962)
Q Consensus 458 ---------------------------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-----------G 499 (962)
.....+||+.|+|||++.....++.++|||||||+||||++ |
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~ 291 (458)
T 3rp9_A 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291 (458)
T ss_dssp CCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGC
T ss_pred cccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccc
Confidence 23445789999999988666679999999999999999999 7
Q ss_pred CCCCCCcChh--------------------hhHHHHHhc-----------------------------cccccCCCCCCC
Q psy501 500 VPPIQTTCLL--------------------AGTERLKSS-----------------------------YILLHTLPLYTY 530 (962)
Q Consensus 500 ~~Pf~~~~~~--------------------~~~~~i~~~-----------------------------~~~~~~~~~~s~ 530 (962)
++||.+.... .....+... .......+..+.
T Consensus 292 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 371 (458)
T 3rp9_A 292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSA 371 (458)
T ss_dssp CCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCH
T ss_pred cccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCH
Confidence 7788665421 000111000 000111234456
Q ss_pred CcHHHHHHHhccCCCCCCcHHHHHhhccccccCC
Q psy501 531 HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHV 564 (962)
Q Consensus 531 ~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~~~ 564 (962)
.+.+|+..||..||++||++.++++.-.+.....
T Consensus 372 ~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 372 DAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred HHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 6788999999999999999888777543333433
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=313.88 Aligned_cols=247 Identities=16% Similarity=0.183 Sum_probs=197.4
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCce-----EEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNH-----ILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLY 380 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~k-----vv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 380 (962)
...+.....++.++.+.||++.....+. ++.+.+.. .....+.+|+.++++++||||+++++++. +...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 4455555566666666799987655443 33332221 12235788999999999999999999986 45688
Q ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--
Q psy501 381 FVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-- 457 (962)
Q Consensus 381 LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-- 457 (962)
+||||+. |+|.+.+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 9999998 6888888776667999999999999999999999999999999999999999999999999999876443
Q ss_pred --CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHH
Q psy501 458 --PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPP 534 (962)
Q Consensus 458 --~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 534 (962)
......++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.........+..+. .......++..+..
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 248 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE-RLAQPQICTIDVYM 248 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC-BCCCCTTBCTTTTH
T ss_pred cccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-CCCCCCcCcHHHHH
Confidence 23345678899999999764 69999999999999999999 999999887766666665543 33334567888999
Q ss_pred HHHHHhccCCCCCCcHHHHHhhccc
Q psy501 535 IQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 535 li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
++..||..+|++||++.+++..|..
T Consensus 249 li~~~l~~dp~~Rps~~el~~~l~~ 273 (325)
T 3kex_A 249 VMVKCWMIDENIRPTFKELANEFTR 273 (325)
T ss_dssp HHHHHTCSCTTTSCCHHHHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHH
Confidence 9999999999999999999997743
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=310.96 Aligned_cols=248 Identities=17% Similarity=0.192 Sum_probs=199.6
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCc------eEEEEeccc----hhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDN------HILSRHVSS----RDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDT 378 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~------kvv~~k~~~----~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 378 (962)
.+.+.....++.++.+.||.+.....+ +++.+.+.. .....+.+|+.+++++ +||||+++++++.+++.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 445666666666777779998865433 233333322 2345689999999999 89999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccccee
Q psy501 379 LYFVFEYMKE-NLYQLIRDR-------------DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVK 444 (962)
Q Consensus 379 ~~LV~Ey~~g-~Ll~~l~~~-------------~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vK 444 (962)
.++||||++| +|.+++... ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+|
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k 204 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAK 204 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEE
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEE
Confidence 9999999985 888877643 24589999999999999999999999999999999999999999999
Q ss_pred eecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhcc
Q psy501 445 IADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSY 519 (962)
Q Consensus 445 L~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~ 519 (962)
|+|||++....... .....+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.........+....
T Consensus 205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 283 (333)
T 2i1m_A 205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 283 (333)
T ss_dssp BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHT
T ss_pred ECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcC
Confidence 99999998664432 2234567889999999764 68999999999999999998 999998876655555555444
Q ss_pred ccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 520 ILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 520 ~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
.........+..+..++..||..+|.+||++.+++..|.
T Consensus 284 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 322 (333)
T 2i1m_A 284 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322 (333)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHH
Confidence 444445566778889999999999999999999988663
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=328.80 Aligned_cols=244 Identities=23% Similarity=0.311 Sum_probs=203.0
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEecc------chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS------SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
.+.|.....++.++.+.||.|....+++.++.|+. ..+...+.+|+++|++++||||+++++++.++..+|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 45566666666667777999998877766655543 234567899999999999999999999999999999999
Q ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccc---cccceeeecccccccccCC-C
Q psy501 384 EYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM---GTELVKIADFGLAREIRSR-P 458 (962)
Q Consensus 384 Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~---~~g~vKL~DFGla~~~~~~-~ 458 (962)
|||. |+|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+|||++...... .
T Consensus 101 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 179 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (486)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence 9998 4777777665 4599999999999999999999999999999999999995 4567999999999866544 3
Q ss_pred cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--CCCCCCCCcHHHH
Q psy501 459 YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--TLPLYTYHVPPIQ 536 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l~~li 536 (962)
.....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.........+..+....+ .....+..+..++
T Consensus 180 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 257 (486)
T 3mwu_A 180 MKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI 257 (486)
T ss_dssp --CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHH
T ss_pred cCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHH
Confidence 455689999999999965 489999999999999999999999999888888777777654433 2345677788999
Q ss_pred HHHhccCCCCCCcHHHHHhh
Q psy501 537 TTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 537 ~~Cl~~dperRPs~~~Ll~~ 556 (962)
..||..+|++||++.++++.
T Consensus 258 ~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 258 RKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHTCSSTTTSCCHHHHHHC
T ss_pred HHHcCCChhhCcCHHHHhcC
Confidence 99999999999998888874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=303.77 Aligned_cols=250 Identities=18% Similarity=0.133 Sum_probs=196.8
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEE-EeCCEEEEEEec
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVI-RENDTLYFVFEY 385 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~-~~~~~~~LV~Ey 385 (962)
..+.+.....+..++.+.||.+.....++.++.|+.. .....+.+|+++++.++|++++..+..+ ..+...++||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 3456677777777777789999987777666655422 2234589999999999988776666555 678889999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccc---ccccceeeecccccccccCCC----
Q psy501 386 MKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLC---MGTELVKIADFGLAREIRSRP---- 458 (962)
Q Consensus 386 ~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl---~~~g~vKL~DFGla~~~~~~~---- 458 (962)
+.|+|.+.+......+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++.......
T Consensus 87 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~ 166 (296)
T 4hgt_A 87 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166 (296)
T ss_dssp CCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCcc
Confidence 9889999888766779999999999999999999999999999999999999 788899999999998765431
Q ss_pred -----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh---hhHHHHHhcccccc---CCCC
Q psy501 459 -----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL---AGTERLKSSYILLH---TLPL 527 (962)
Q Consensus 459 -----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~---~~~~ 527 (962)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.... .....+.......+ ....
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T 4hgt_A 167 IPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 245 (296)
T ss_dssp CCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTT
T ss_pred CCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhcc
Confidence 2345789999999999764 6899999999999999999999999874332 22222222222221 1245
Q ss_pred CCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 528 YTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 528 ~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
++..+..++..||..+|++||++.++++.+..
T Consensus 246 ~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 246 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 67788999999999999999999999987744
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=302.95 Aligned_cols=246 Identities=20% Similarity=0.183 Sum_probs=196.0
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEec
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEY 385 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey 385 (962)
+.+.....++.++.+.||.+....+++.++.|... .....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 34555556666667779999887666655544422 2246789999999999999999999999999999999999
Q ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----Ccc
Q psy501 386 MKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PYT 460 (962)
Q Consensus 386 ~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~ 460 (962)
++| +|.+.+. ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+...... ...
T Consensus 87 ~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 165 (276)
T 2yex_A 87 CSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (276)
T ss_dssp CTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred cCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhccc
Confidence 986 6666554 3456999999999999999999999999999999999999999999999999999765432 234
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhh-hHHHHHhccccccCCCCCCCCcHHHHHHH
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLA-GTERLKSSYILLHTLPLYTYHVPPIQTTC 539 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~s~~l~~li~~C 539 (962)
...|++.|+|||++.+...++.++|||||||++|+|++|+.||....... ....+.......+..+..+..+..++..|
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (276)
T 2yex_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245 (276)
T ss_dssp CCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHH
T ss_pred CCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHH
Confidence 56789999999999765445789999999999999999999998765432 22333333222333345677788999999
Q ss_pred hccCCCCCCcHHHHHhhc
Q psy501 540 LLAGTERLKSSYILLHTL 557 (962)
Q Consensus 540 l~~dperRPs~~~Ll~~l 557 (962)
|..+|++||++.+++..-
T Consensus 246 l~~~p~~Rps~~~il~~~ 263 (276)
T 2yex_A 246 LVENPSARITIPDIKKDR 263 (276)
T ss_dssp SCSSTTTSCCHHHHTTCT
T ss_pred CCCCchhCCCHHHHhcCc
Confidence 999999999999888743
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=310.98 Aligned_cols=253 Identities=16% Similarity=0.159 Sum_probs=190.0
Q ss_pred CCceEEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC---
Q psy501 303 GHTTCLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIREND--- 377 (962)
Q Consensus 303 g~~~~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~--- 377 (962)
+....+..+.+.....++.++.+.||++.... ..++.+.+.. .......+|+.+|++++||||+++++++..+.
T Consensus 16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp CCCEEETTEEEEEEEEEECSTTCEEEEEEETT-EEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred ccccccchhhchhhheecccCceEEEEEEECC-CEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 33445555667777777777777799998763 3333333322 23345677899999999999999999998743
Q ss_pred -EEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccc----------eeeeccCCCcccccccccceee
Q psy501 378 -TLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRH----------GFFHRDMKPENLLCMGTELVKI 445 (962)
Q Consensus 378 -~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~----------gIvHrDLkp~NILl~~~g~vKL 445 (962)
.+++||||+++ +|.+++... .+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred ceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 47999999985 777777653 489999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCC----CcccccCCccccChhhhccC----CCCCchhHHHHHHHHHHHHHcCCCCCCCcChh--------
Q psy501 446 ADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHS----TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL-------- 509 (962)
Q Consensus 446 ~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~----~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~-------- 509 (962)
+|||+++..... ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+....
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999776543 23345789999999999763 24567889999999999999999999764321
Q ss_pred --------hhHHHHHhccccccCCC-CCCC-----CcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 510 --------AGTERLKSSYILLHTLP-LYTY-----HVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 510 --------~~~~~i~~~~~~~~~~~-~~s~-----~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
.....+.... ..+..+ ..+. .+..++..||..+|++||++.++++.|..
T Consensus 253 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKK-KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp HCSSCCHHHHHHHHTTSC-CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhccc-CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1111111111 111111 1111 27789999999999999999999987743
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=315.84 Aligned_cols=248 Identities=17% Similarity=0.200 Sum_probs=197.3
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
+..+.+.....++.++.+.||.+.....++.++.++.. .....+.+|+.++++++||||+++++++.+++..++|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 34556677777777777789999988777666655532 2245689999999999999999999999999999999
Q ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccc-eeeeccCCCcccccccccceeeecccccccccCCCcc
Q psy501 383 FEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRH-GFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT 460 (962)
Q Consensus 383 ~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~-gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~ 460 (962)
|||++| +|.+.+... ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++.........
T Consensus 110 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 188 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 188 (360)
T ss_dssp ECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred EECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccccc
Confidence 999985 777776654 4599999999999999999999996 9999999999999999999999999999766554555
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHH--------------------------
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTER-------------------------- 514 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~-------------------------- 514 (962)
...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........
T Consensus 189 ~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3eqc_A 189 SFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267 (360)
T ss_dssp --CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred CCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence 6689999999999976 4799999999999999999999999987654332211
Q ss_pred ----------------HHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 515 ----------------LKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 515 ----------------i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+............++..+..++..||..+|++||++.++++.-
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 1111111111123456788899999999999999998888754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=308.23 Aligned_cols=246 Identities=15% Similarity=0.160 Sum_probs=199.0
Q ss_pred CceeeEEEEecCCcccEEEEEec-----CCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLD-----QDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLY 380 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~-----~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 380 (962)
..+.....++.++.+.||.+... ...+.++.|... .....+.+|++++++++||||+++++++.+++..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 102 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL 102 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence 34555556666666679998763 222444444322 22356889999999999999999999999999999
Q ss_pred EEEecCC-CCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccc
Q psy501 381 FVFEYMK-ENLYQLIRDRD-----------------------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLL 436 (962)
Q Consensus 381 LV~Ey~~-g~Ll~~l~~~~-----------------------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NIL 436 (962)
+||||++ |+|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIl 182 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEE
Confidence 9999998 67877776532 23899999999999999999999999999999999999
Q ss_pred cccccceeeecccccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhh
Q psy501 437 CMGTELVKIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAG 511 (962)
Q Consensus 437 l~~~g~vKL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~ 511 (962)
++.++.+||+|||++...... ......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+......
T Consensus 183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999866443 2233456788999999976 468999999999999999999 9999998877766
Q ss_pred HHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 512 TERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 512 ~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
...+.... .......++..+..++..||..+|++||++.++++.|.
T Consensus 262 ~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~ 307 (314)
T 2ivs_A 262 FNLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307 (314)
T ss_dssp HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhhcCC-cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 66655543 33344567778899999999999999999999988764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=327.48 Aligned_cols=252 Identities=21% Similarity=0.247 Sum_probs=196.3
Q ss_pred ceEEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeC--
Q psy501 305 TTCLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIREN-- 376 (962)
Q Consensus 305 ~~~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~-- 376 (962)
..+...+.|.....++.|+.+.||.+.....++.++.|... .....+.+|+.+|+.++||||+++++++...
T Consensus 56 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 135 (464)
T 3ttj_A 56 STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 135 (464)
T ss_dssp CEEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred cceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCc
Confidence 34455677888888888888889999888777766555432 2245688999999999999999999999654
Q ss_pred ----CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccc
Q psy501 377 ----DTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR 452 (962)
Q Consensus 377 ----~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~ 452 (962)
..+|+||||+++++.+.+.. .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+
T Consensus 136 ~~~~~~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 136 LEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp TTTCCEEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred cccCCeEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 46899999999998887754 38999999999999999999999999999999999999999999999999998
Q ss_pred cccCC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--------
Q psy501 453 EIRSR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH-------- 523 (962)
Q Consensus 453 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------- 523 (962)
..... .....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+.......+......+.
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 213 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred ecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 76554 44557899999999999764 799999999999999999999999999876665555433211000
Q ss_pred --------CCCC---------C---------------CCCcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 524 --------TLPL---------Y---------------TYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 524 --------~~~~---------~---------------s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
..+. + +..+.+++..||..||++||++.++++.- |+.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp-~~~ 360 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP-YIN 360 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST-TTG
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh-hhh
Confidence 0000 0 12356799999999999999988888754 443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=315.58 Aligned_cols=249 Identities=24% Similarity=0.304 Sum_probs=201.0
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeC-----CEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIREN-----DTL 379 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~-----~~~ 379 (962)
.+.|.....++.|+.+.||.+.....++.++.|... .....+.+|+++|++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 346666667777777779999887777655554432 1235688999999999999999999999754 468
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--
Q psy501 380 YFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-- 457 (962)
Q Consensus 380 ~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-- 457 (962)
|+||||++|+|.+.+... .+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 106 ~iv~e~~~~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 183 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183 (364)
T ss_dssp EEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEcccCcCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence 999999999999888653 4999999999999999999999999999999999999999999999999999866433
Q ss_pred ---CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc-----------
Q psy501 458 ---PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH----------- 523 (962)
Q Consensus 458 ---~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~----------- 523 (962)
......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.........+......+.
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 263 (364)
T 3qyz_A 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263 (364)
T ss_dssp BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 234458999999999987776799999999999999999999999998877666555542111100
Q ss_pred ------------------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 524 ------------------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 524 ------------------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
..+..+..+..++..||..+|++||++.++++.- |+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp-~~~ 318 (364)
T 3qyz_A 264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP-YLE 318 (364)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG-GGT
T ss_pred HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc-chh
Confidence 1134556678899999999999999988888744 443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=324.40 Aligned_cols=245 Identities=20% Similarity=0.250 Sum_probs=197.7
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEec-cchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-EEEEEEecCC-
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHV-SSRDEMVVCFYRKSLKKLSHANLVKLKEVIREND-TLYFVFEYMK- 387 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~-~~~LV~Ey~~- 387 (962)
..+.....++.++.+.||.+..... .++.+.+ .......+.+|+++|++++||||+++++++.+.. ..++||||++
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~~~-~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~ 271 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYRGN-KVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTE-EEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred HHeEEEeeecCcCCeeEEEEEecCC-eEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence 3444555555566667888887643 3333333 2334567999999999999999999999987665 7999999998
Q ss_pred CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCc
Q psy501 388 ENLYQLIRDRDK-FLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTR 466 (962)
Q Consensus 388 g~Ll~~l~~~~~-~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~ 466 (962)
|+|.+++...+. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....++.
T Consensus 272 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~ 350 (450)
T 1k9a_A 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPV 350 (450)
T ss_dssp CBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-------CCCT
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-cCCCCCc
Confidence 588888876653 47999999999999999999999999999999999999999999999999998654332 2336788
Q ss_pred cccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCC
Q psy501 467 WYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTE 545 (962)
Q Consensus 467 ~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dpe 545 (962)
.|+|||++.+. .++.++|||||||++|||++ |+.||.+.........+..+. ..+....++..+..++..||..+|+
T Consensus 351 ~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~dp~ 428 (450)
T 1k9a_A 351 KWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KMDAPDGCPPAVYDVMKNCWHLDAA 428 (450)
T ss_dssp TTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred ceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCcCCHHHHHHHHHHcCCChh
Confidence 99999999764 79999999999999999998 999999887777777666653 3344457788899999999999999
Q ss_pred CCCcHHHHHhhccc
Q psy501 546 RLKSSYILLHTLPL 559 (962)
Q Consensus 546 rRPs~~~Ll~~l~~ 559 (962)
+||++.+++..|..
T Consensus 429 ~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 429 TRPTFLQLREQLEH 442 (450)
T ss_dssp GSCCHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHH
Confidence 99999999887643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=331.72 Aligned_cols=245 Identities=22% Similarity=0.276 Sum_probs=205.9
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEecc-------chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS-------SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~-------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
.+.|.....++.++.+.||.|.....++.++.|+. ......+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 45566666677777777999988877666555542 23456799999999999999999999999999999999
Q ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccc---ccccceeeecccccccccCC-
Q psy501 383 FEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLC---MGTELVKIADFGLAREIRSR- 457 (962)
Q Consensus 383 ~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl---~~~g~vKL~DFGla~~~~~~- 457 (962)
||||. |+|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++......
T Consensus 105 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 183 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183 (484)
T ss_dssp ECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence 99998 5677766654 569999999999999999999999999999999999999 46789999999999876544
Q ss_pred CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--CCCCCCCCcHHH
Q psy501 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--TLPLYTYHVPPI 535 (962)
Q Consensus 458 ~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l~~l 535 (962)
......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.........+..+....+ .....+..+..+
T Consensus 184 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 261 (484)
T 3nyv_A 184 KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261 (484)
T ss_dssp SHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHH
T ss_pred ccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHH
Confidence 3455689999999999965 589999999999999999999999999988888888877655433 224567788899
Q ss_pred HHHHhccCCCCCCcHHHHHhhc
Q psy501 536 QTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 536 i~~Cl~~dperRPs~~~Ll~~l 557 (962)
+..||..+|++||++.++++.-
T Consensus 262 i~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 262 IRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSH
T ss_pred HHHHCCCChhHCcCHHHHhhCh
Confidence 9999999999999988888743
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=329.33 Aligned_cols=247 Identities=21% Similarity=0.279 Sum_probs=204.0
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc-----------------hhHHHHHHHHHHHHhcCCCCcccEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----------------RDEMVVCFYRKSLKKLSHANLVKLKEV 372 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----------------~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 372 (962)
.+.|.....++.|+.+.||.|.....++.++.|+.. .....+.+|+.+|++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 345666666666667779999887766655444322 224568999999999999999999999
Q ss_pred EEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc---ceeeecc
Q psy501 373 IRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADF 448 (962)
Q Consensus 373 ~~~~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g---~vKL~DF 448 (962)
+.++..+|+|||||+| +|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999985 777777665 4599999999999999999999999999999999999998776 6999999
Q ss_pred cccccccCC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--CC
Q psy501 449 GLAREIRSR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--TL 525 (962)
Q Consensus 449 Gla~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~ 525 (962)
|++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.........+..+....+ ..
T Consensus 194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (504)
T 3q5i_A 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271 (504)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH
T ss_pred CCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence 999876554 4455689999999999864 589999999999999999999999999988888888877654332 22
Q ss_pred CCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 526 PLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 526 ~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
+..+..+..++..||..+|.+||++.+++..- |+
T Consensus 272 ~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~-~~ 305 (504)
T 3q5i_A 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSR-WI 305 (504)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH-HH
T ss_pred CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH-hh
Confidence 46677889999999999999999998888743 44
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-33 Score=303.31 Aligned_cols=247 Identities=19% Similarity=0.270 Sum_probs=203.7
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc-------------hhHHHHHHHHHHHHhcC-CCCcccEEEEEEe
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-------------RDEMVVCFYRKSLKKLS-HANLVKLKEVIRE 375 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-------------~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~ 375 (962)
.+.+.....+..++.+.||.+....+++.++.|+.. .....+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 456666666667777789999888777665555432 11346889999999996 9999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccc
Q psy501 376 NDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI 454 (962)
Q Consensus 376 ~~~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~ 454 (962)
+...++||||++ |+|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++...
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 999999999998 5777777654 46999999999999999999999999999999999999999999999999999876
Q ss_pred cCC-CcccccCCccccChhhhc-----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCC--C
Q psy501 455 RSR-PYTDYVSTRWYRAPEVLL-----HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTL--P 526 (962)
Q Consensus 455 ~~~-~~~~~~gt~~Y~APE~l~-----~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--~ 526 (962)
... ......+++.|+|||++. ....++.++|||||||++|+|++|..||...........+..+....+.. +
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (298)
T 1phk_A 175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 254 (298)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccccc
Confidence 543 344567899999999985 23468899999999999999999999999887777766666654443322 3
Q ss_pred CCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 527 LYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 527 ~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.++..+..++..||..+|++||++.++++.-
T Consensus 255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (298)
T 1phk_A 255 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285 (298)
T ss_dssp GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence 5667788999999999999999999888643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=308.74 Aligned_cols=248 Identities=20% Similarity=0.249 Sum_probs=192.8
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC--EEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIREND--TLYFV 382 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~--~~~LV 382 (962)
.+.|.....++.++.+.||.+....+++.++.|+.. .....+.+|+++|++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 455666666777777779999988766665555432 22456889999999999999999999998755 78999
Q ss_pred EecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccc----ccccceeeeccccccccc
Q psy501 383 FEYMK-ENLYQLIRDRD--KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLC----MGTELVKIADFGLAREIR 455 (962)
Q Consensus 383 ~Ey~~-g~Ll~~l~~~~--~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl----~~~g~vKL~DFGla~~~~ 455 (962)
|||++ |+|.+.+.... ..+++..++.++.||+.||.|||+.||+||||||+||++ +..+.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 99998 57777776543 339999999999999999999999999999999999999 778889999999998765
Q ss_pred CC-CcccccCCccccChhhhcc-------CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh----hhHHHHHhccccc-
Q psy501 456 SR-PYTDYVSTRWYRAPEVLLH-------STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL----AGTERLKSSYILL- 522 (962)
Q Consensus 456 ~~-~~~~~~gt~~Y~APE~l~~-------~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~----~~~~~i~~~~~~~- 522 (962)
.. ......||+.|+|||++.. ...++.++|||||||++|||++|+.||...... .....+..+....
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence 44 3445679999999999862 357899999999999999999999999753322 2233333321100
Q ss_pred ---------------cCCC-------CCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 523 ---------------HTLP-------LYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 523 ---------------~~~~-------~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
...+ ..+..+..++..||..||++||++.++++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 0001 1112456689999999999999999988755
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=305.60 Aligned_cols=244 Identities=12% Similarity=0.089 Sum_probs=192.6
Q ss_pred CceeeEEEEecCCcccEEEEEecCCc--------eEEEEecc---chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDN--------HILSRHVS---SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTL 379 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~--------kvv~~k~~---~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 379 (962)
..+.....++.++.+.||.+.....+ .++.+.+. ......+.+|+.++++++||||+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 34555555566666678888766543 23333322 23346789999999999999999999999999999
Q ss_pred EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccc--------eeeecccc
Q psy501 380 YFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL--------VKIADFGL 450 (962)
Q Consensus 380 ~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~--------vKL~DFGl 450 (962)
++||||++ |+|.+++......+++..++.++.||+.||.|||+.||+||||||+||+++.++. +||+|||+
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~ 167 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCS
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcc
Confidence 99999998 5888888776666999999999999999999999999999999999999988876 99999999
Q ss_pred cccccCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCcChhhhHHHHHhccccccCCCCCC
Q psy501 451 AREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDH-VPPIQTTCLLAGTERLKSSYILLHTLPLYT 529 (962)
Q Consensus 451 a~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 529 (962)
+...... ....+++.|+|||++.+...++.++|||||||++|||++| .+||............... .......+
T Consensus 168 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 242 (289)
T 4fvq_A 168 SITVLPK--DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR---HQLPAPKA 242 (289)
T ss_dssp CTTTSCH--HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT---CCCCCCSS
T ss_pred cccccCc--cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc---CCCCCCCC
Confidence 8654332 3345788999999997655799999999999999999995 5555555444333332222 22234567
Q ss_pred CCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 530 YHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 530 ~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
..+..++..||..+|++||++.++++.|..
T Consensus 243 ~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 272 (289)
T 4fvq_A 243 AELANLINNCMDYEPDHRPSFRAIIRDLNS 272 (289)
T ss_dssp CTTHHHHHHHSCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 889999999999999999999999997743
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=308.55 Aligned_cols=250 Identities=18% Similarity=0.168 Sum_probs=192.3
Q ss_pred ecCceeeEEEEecCCcccEEEEEe----cCCceEEEEec-cch---hHHHHHHHHHHHHhcCCCCcccEEEEEEe--CCE
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNL----DQDNHILSRHV-SSR---DEMVVCFYRKSLKKLSHANLVKLKEVIRE--NDT 378 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~----~~~~kvv~~k~-~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~ 378 (962)
..+.+.....++.++.+.||.+.. ...++.++.|. ... ....+.+|+++|++++||||+++++++.. ...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 345666666777777777999983 34444444443 222 23468899999999999999999999854 356
Q ss_pred EEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC
Q psy501 379 LYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR 457 (962)
Q Consensus 379 ~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~ 457 (962)
+++||||++ |+|.+.+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 899999997 5888888776667999999999999999999999999999999999999999999999999999876443
Q ss_pred -----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh---------------HHHHHh
Q psy501 458 -----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG---------------TERLKS 517 (962)
Q Consensus 458 -----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~---------------~~~i~~ 517 (962)
......++..|+|||++.+. .++.++|||||||++|||++|..||........ ......
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp --------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 22234567789999999764 689999999999999999999999875432110 111111
Q ss_pred ccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 518 SYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 518 ~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
.....+....++..+..++..||..+|++||++.++++.+..
T Consensus 247 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 247 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 222334445677788999999999999999999999987744
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=327.43 Aligned_cols=243 Identities=22% Similarity=0.284 Sum_probs=200.4
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEecc------chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS------SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
+.|.....++.|+.+.||.|.....+..++.|+. ......+.+|+.+|+.++||||+++++++.++...|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 3566666666666777999988776665554442 2234578999999999999999999999999999999999
Q ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc---cceeeecccccccccCC-Cc
Q psy501 385 YMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT---ELVKIADFGLAREIRSR-PY 459 (962)
Q Consensus 385 y~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~---g~vKL~DFGla~~~~~~-~~ 459 (962)
||.| +|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+||+++.. +.+||+|||+|...... ..
T Consensus 117 ~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~ 195 (494)
T 3lij_A 117 CYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195 (494)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence 9985 777777655 459999999999999999999999999999999999999764 45999999999876544 44
Q ss_pred ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC--CCCCCCCcHHHHH
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT--LPLYTYHVPPIQT 537 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l~~li~ 537 (962)
....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.........+..+....+. .+..+..+..++.
T Consensus 196 ~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 273 (494)
T 3lij_A 196 KERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK 273 (494)
T ss_dssp CCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHH
T ss_pred cccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHH
Confidence 55689999999999853 5899999999999999999999999998888888877776554432 2456777889999
Q ss_pred HHhccCCCCCCcHHHHHhh
Q psy501 538 TCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 538 ~Cl~~dperRPs~~~Ll~~ 556 (962)
.||..+|++||++.++++.
T Consensus 274 ~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 274 QMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHTCSSTTTSCCHHHHHTC
T ss_pred HHCCCChhhCccHHHHhcC
Confidence 9999999999999888874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=316.38 Aligned_cols=252 Identities=20% Similarity=0.282 Sum_probs=193.0
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccch--------------hHHHHHHHHHHHHhcCCCCcccEEEEEEe
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR--------------DEMVVCFYRKSLKKLSHANLVKLKEVIRE 375 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~--------------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 375 (962)
.+.+.....++.++.+.||.+.......++.+.+... ....+.+|+++|++++||||+++++++..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 3556666666666777788887766555544443211 12578999999999999999999999954
Q ss_pred -----CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccc
Q psy501 376 -----NDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGL 450 (962)
Q Consensus 376 -----~~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGl 450 (962)
...+|+||||++|++.+.+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+
T Consensus 101 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 180 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL 180 (362)
T ss_dssp CCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC
T ss_pred ccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCc
Confidence 347899999999999999988777899999999999999999999999999999999999999999999999999
Q ss_pred cccccCC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-------
Q psy501 451 AREIRSR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL------- 522 (962)
Q Consensus 451 a~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~------- 522 (962)
+...... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 260 (362)
T 3pg1_A 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260 (362)
T ss_dssp ---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhh
Confidence 9765433 34456789999999999775679999999999999999999999999887666555543321110
Q ss_pred -----------------------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcccccc
Q psy501 523 -----------------------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTY 562 (962)
Q Consensus 523 -----------------------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~ 562 (962)
...+..+..+..++..||..+|++||++.++++.- |+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp-~f~~ 322 (362)
T 3pg1_A 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP-YFES 322 (362)
T ss_dssp TSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG-GGTT
T ss_pred ccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc-hhhh
Confidence 01123345577899999999999999998888743 4443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=320.90 Aligned_cols=248 Identities=14% Similarity=0.211 Sum_probs=188.6
Q ss_pred CceeeEEEEecCCcccEEEEEec---CCce-EEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLD---QDNH-ILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~---~~~k-vv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
..+.....++.++.+.||.+... .... ++.+.+. ......+.+|+.+|++++||||+++++++.+++..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 34445555555666678888765 2222 3333322 22345689999999999999999999999999999999
Q ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---
Q psy501 383 FEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--- 458 (962)
Q Consensus 383 ~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~--- 458 (962)
|||++ |+|.+++......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 204 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccc
Confidence 99997 68888887766679999999999999999999999999999999999999999999999999998765431
Q ss_pred --cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHH
Q psy501 459 --YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPI 535 (962)
Q Consensus 459 --~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~l 535 (962)
.....+++.|+|||++.+. .++.++|||||||++|||++ |+.||.+.........+..+. ..+....++..+..+
T Consensus 205 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~l 282 (373)
T 2qol_A 205 YTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY-RLPPPMDCPAALYQL 282 (373)
T ss_dssp ---------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE-ECCCCTTCBHHHHHH
T ss_pred eeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCccccHHHHHH
Confidence 1122456789999999764 69999999999999999998 999999887777666665553 333345667788899
Q ss_pred HHHHhccCCCCCCcHHHHHhhcccc
Q psy501 536 QTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 536 i~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
+..||..+|++||++.++++.|...
T Consensus 283 i~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 283 MLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhCcChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999877443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=306.85 Aligned_cols=257 Identities=22% Similarity=0.294 Sum_probs=197.7
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEE--------
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIR-------- 374 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~-------- 374 (962)
..+.+.+.....++.++.+.||.+.....++.++.|... .....+.+|++++++++||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 445667777766666677779999988766655544322 23456889999999999999999999873
Q ss_pred ------eCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccc-cccceeeec
Q psy501 375 ------ENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM-GTELVKIAD 447 (962)
Q Consensus 375 ------~~~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~-~~g~vKL~D 447 (962)
+....++||||++|+|.+.+.. ..+++..++.++.|++.||.|||+.||+||||||+||+++ .++.+||+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ----CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 3468999999999998887754 4589999999999999999999999999999999999997 567999999
Q ss_pred ccccccccCC-----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc
Q psy501 448 FGLAREIRSR-----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL 522 (962)
Q Consensus 448 FGla~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 522 (962)
||++...... ......++..|+|||++.+...++.++|||||||++|||++|+.||.+.........+.......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999876432 23345678999999999776679999999999999999999999999887666555544321100
Q ss_pred ----------------------------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccccCCC
Q psy501 523 ----------------------------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVP 565 (962)
Q Consensus 523 ----------------------------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~~~~ 565 (962)
...+.++..+..++..||..+|++||++.++++.-.+..+.+|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 0123467778899999999999999999988875433333333
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-33 Score=301.60 Aligned_cols=246 Identities=16% Similarity=0.134 Sum_probs=195.5
Q ss_pred cCceeeEEEEecCCcccEEEEEecCC---ceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQD---NHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYF 381 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~---~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~L 381 (962)
.+.+.....++.++.+.||.+..... ...++.|... .....+.+|+.++++++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 34555666666666777999875432 2233333322 2345789999999999999999999998754 5689
Q ss_pred EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---
Q psy501 382 VFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--- 457 (962)
Q Consensus 382 V~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--- 457 (962)
||||++ ++|.+.+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 169 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence 999998 5788888777777999999999999999999999999999999999999999999999999999876543
Q ss_pred CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHH
Q psy501 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQ 536 (962)
Q Consensus 458 ~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li 536 (962)
......+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||...........+.... ..+....++..+..++
T Consensus 170 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 247 (281)
T 3cc6_A 170 KASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-RLPKPDLCPPVLYTLM 247 (281)
T ss_dssp ---CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC-CCCCCTTCCHHHHHHH
T ss_pred ccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC-CCCCCCCCCHHHHHHH
Confidence 2233456788999999965 468999999999999999998 999998776666655555442 2333456677789999
Q ss_pred HHHhccCCCCCCcHHHHHhhcc
Q psy501 537 TTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 537 ~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
..||..+|++||++.+++..|.
T Consensus 248 ~~~l~~~p~~Rps~~ell~~L~ 269 (281)
T 3cc6_A 248 TRCWDYDPSDRPRFTELVCSLS 269 (281)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHccCCchhCcCHHHHHHHHH
Confidence 9999999999999999998764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=315.94 Aligned_cols=253 Identities=13% Similarity=0.030 Sum_probs=187.7
Q ss_pred CceeeEEEEecCCcccEEEEEecC---CceEEEEeccchh---------------HHHHHHHHHHHHhcCCCCcccEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQ---DNHILSRHVSSRD---------------EMVVCFYRKSLKKLSHANLVKLKEV 372 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~---~~kvv~~k~~~~~---------------~~~~~~Ei~iL~~L~HpnIv~l~~~ 372 (962)
+.+.....++.++.+.||.+.... ....++.+..... ...+.+|+.+++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 445555555555566799998864 3333333322211 1236678888999999999999999
Q ss_pred EEe----CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc--ceeee
Q psy501 373 IRE----NDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE--LVKIA 446 (962)
Q Consensus 373 ~~~----~~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g--~vKL~ 446 (962)
+.. +...|+||||+.++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+
T Consensus 117 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~ 195 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA 195 (345)
T ss_dssp EEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred cccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence 987 77899999999667777765544 699999999999999999999999999999999999998877 99999
Q ss_pred cccccccccCC---------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh-HHHHH
Q psy501 447 DFGLAREIRSR---------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG-TERLK 516 (962)
Q Consensus 447 DFGla~~~~~~---------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~-~~~i~ 516 (962)
|||+++.+... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...... .....
T Consensus 196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 274 (345)
T 2v62_A 196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK 274 (345)
T ss_dssp CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHH
T ss_pred eCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHH
Confidence 99999765322 12445799999999999764 789999999999999999999999965322111 11111
Q ss_pred hc-ccccc-------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccccCCC
Q psy501 517 SS-YILLH-------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVP 565 (962)
Q Consensus 517 ~~-~~~~~-------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~~~~ 565 (962)
.. ....+ ....++..+..++..||..+|++||++.++++.|.......+
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 331 (345)
T 2v62_A 275 TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLG 331 (345)
T ss_dssp HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCC
T ss_pred HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCccc
Confidence 11 00011 111567788999999999999999999999998865544433
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=309.57 Aligned_cols=252 Identities=18% Similarity=0.155 Sum_probs=188.6
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCce----EEEEec-----cchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEE-
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNH----ILSRHV-----SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTL- 379 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~k----vv~~k~-----~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~- 379 (962)
.+.+.....++.++.+.||.+....... ++.+.+ .......+.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4455666666666677799887665542 333322 223346789999999999999999999999876654
Q ss_pred -----EEEEecCCC-CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecc
Q psy501 380 -----YFVFEYMKE-NLYQLIRDRD-----KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADF 448 (962)
Q Consensus 380 -----~LV~Ey~~g-~Ll~~l~~~~-----~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DF 448 (962)
++||||+.| +|.+.+.... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeec
Confidence 999999985 7777775432 25899999999999999999999999999999999999999999999999
Q ss_pred cccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhcccccc
Q psy501 449 GLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLH 523 (962)
Q Consensus 449 Gla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~ 523 (962)
|++...... ......+++.|+|||++.+. .++.++|||||||++|||++ |..||.+.........+..+. ...
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~ 259 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-RLK 259 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCC
T ss_pred cccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-CCC
Confidence 999866443 22234567889999999764 69999999999999999999 999999888777766665553 233
Q ss_pred CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccccC
Q psy501 524 TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYH 563 (962)
Q Consensus 524 ~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~~ 563 (962)
..+.++..+..++..||..+|++||++.++++.+.....+
T Consensus 260 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 260 QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 4456777889999999999999999988888877544333
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=315.96 Aligned_cols=246 Identities=16% Similarity=0.190 Sum_probs=189.9
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEecc-----chhHHHHHHHHHHHHhcC--CCCcccEEEEEEeCCEEEEEEec
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVS-----SRDEMVVCFYRKSLKKLS--HANLVKLKEVIRENDTLYFVFEY 385 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~~~~~LV~Ey 385 (962)
|.....++.++.+.||.+.......++.+.+. ......+.+|+.+|++++ ||||+++++++..++.+|+|||+
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~ 137 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 137 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEec
Confidence 55555555556666999987664434333331 122356899999999996 59999999999999999999997
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----Cccc
Q psy501 386 MKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PYTD 461 (962)
Q Consensus 386 ~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~~ 461 (962)
..++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||++...... ....
T Consensus 138 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~ 215 (390)
T 2zmd_A 138 GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS 215 (390)
T ss_dssp CSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CC
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCC
Confidence 778888888765 4689999999999999999999999999999999999995 589999999999876543 2345
Q ss_pred ccCCccccChhhhcc----------CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh-hhHHHHHhccccccCCCCCCC
Q psy501 462 YVSTRWYRAPEVLLH----------STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL-AGTERLKSSYILLHTLPLYTY 530 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~----------~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~ 530 (962)
.+||+.|+|||++.+ ...++.++|||||||++|||++|+.||...... .....+.............+.
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (390)
T 2zmd_A 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 295 (390)
T ss_dssp SCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCH
T ss_pred CCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchH
Confidence 679999999999964 135899999999999999999999999875432 333344433333333344556
Q ss_pred CcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 531 HVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 531 ~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
.+..++..||..+|++||++.++++.- |+.
T Consensus 296 ~~~~li~~~L~~dP~~Rps~~ell~hp-~~~ 325 (390)
T 2zmd_A 296 DLQDVLKCCLKRDPKQRISIPELLAHP-YVQ 325 (390)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSH-HHH
T ss_pred HHHHHHHHHcccChhhCCCHHHHhhCc-Ccc
Confidence 788999999999999999999888754 444
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=304.16 Aligned_cols=246 Identities=18% Similarity=0.202 Sum_probs=202.6
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc---hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS---RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~---~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
..+.....+..++.+.||.+......+.++.+... .....+.+|++++++++||||+++++++.++...++||||++
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 92 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 92 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCC
Confidence 34455555555666679999888766655544432 234678999999999999999999999999999999999998
Q ss_pred -CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---cccc
Q psy501 388 -ENLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---YTDY 462 (962)
Q Consensus 388 -g~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~ 462 (962)
|+|.+.+... ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++....... ....
T Consensus 93 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 172 (288)
T 3kfa_A 93 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 172 (288)
T ss_dssp TEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTE
T ss_pred CCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCC
Confidence 5788877663 3569999999999999999999999999999999999999999999999999998765442 2234
Q ss_pred cCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhc
Q psy501 463 VSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 463 ~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~ 541 (962)
.+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.........+... ........++..+..++..||.
T Consensus 173 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~ 250 (288)
T 3kfa_A 173 KFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPEGCPEKVYELMRACWQ 250 (288)
T ss_dssp EECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTC
T ss_pred ccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc-CCCCCCCCCCHHHHHHHHHHhC
Confidence 567789999999764 68999999999999999999 99999988777666655544 3334445677788999999999
Q ss_pred cCCCCCCcHHHHHhhcc
Q psy501 542 AGTERLKSSYILLHTLP 558 (962)
Q Consensus 542 ~dperRPs~~~Ll~~l~ 558 (962)
.+|++||++.++++.|.
T Consensus 251 ~dp~~Rps~~~~~~~l~ 267 (288)
T 3kfa_A 251 WNPSDRPSFAEIHQAFE 267 (288)
T ss_dssp SSGGGSCCHHHHHHHHH
T ss_pred CChhhCcCHHHHHHHHH
Confidence 99999999999988763
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=300.76 Aligned_cols=245 Identities=11% Similarity=0.138 Sum_probs=197.5
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CEEEEEEe
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIREN--DTLYFVFE 384 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~LV~E 384 (962)
+.+.....++.++.+.||.+.......+++.... ......+.+|+.++++++||||+++++++.+. ...++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 3455555566666667899887633333333221 12345689999999999999999999999876 78899999
Q ss_pred cCC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHhhcccce--eeeccCCCcccccccccceeeecccccccccCCCcc
Q psy501 385 YMK-ENLYQLIRDRDK-FLPESIIRNMMYQVLQGLAFMHRHG--FFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT 460 (962)
Q Consensus 385 y~~-g~Ll~~l~~~~~-~ls~~~i~~i~~qI~~aL~yLH~~g--IvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~ 460 (962)
|++ |+|.+.+..... .+++..++.++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++..... .
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~---~ 166 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS---P 166 (271)
T ss_dssp CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC---T
T ss_pred ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc---c
Confidence 998 588888776543 5899999999999999999999999 99999999999999999999998888754322 3
Q ss_pred cccCCccccChhhhccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHH
Q psy501 461 DYVSTRWYRAPEVLLHST--AYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTT 538 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~--~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~ 538 (962)
...||+.|+|||++.+.. .++.++|||||||++|||++|+.||.+.........+..........+.++..+..++..
T Consensus 167 ~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 246 (271)
T 3kmu_A 167 GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKI 246 (271)
T ss_dssp TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHH
T ss_pred CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 457899999999997532 234489999999999999999999998887777666666655555556778889999999
Q ss_pred HhccCCCCCCcHHHHHhhcc
Q psy501 539 CLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 539 Cl~~dperRPs~~~Ll~~l~ 558 (962)
||..+|++||++.++++.|.
T Consensus 247 ~l~~~p~~Rps~~~il~~L~ 266 (271)
T 3kmu_A 247 CMNEDPAKRPKFDMIVPILE 266 (271)
T ss_dssp HTCSSGGGSCCHHHHHHHHH
T ss_pred HcCCChhhCcCHHHHHHHHH
Confidence 99999999999999998763
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-33 Score=304.08 Aligned_cols=248 Identities=18% Similarity=0.196 Sum_probs=197.0
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEec
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEY 385 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey 385 (962)
.+.+.....++.++.+.||.+....+++.++.+... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 345555666666667779999988766665554432 2345788999999999999999999999999999999999
Q ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--Ccccc
Q psy501 386 MKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDY 462 (962)
Q Consensus 386 ~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~ 462 (962)
++| ++.+.+......+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++...... .....
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 177 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF 177 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC----
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccc
Confidence 985 566666665677999999999999999999999999999999999999999999999999997643221 23345
Q ss_pred cCCccccChhhhc----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-cCCCCCCCCcHHHHH
Q psy501 463 VSTRWYRAPEVLL----HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL-HTLPLYTYHVPPIQT 537 (962)
Q Consensus 463 ~gt~~Y~APE~l~----~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~s~~l~~li~ 537 (962)
.|++.|+|||++. ....++.++|||||||++|+|++|..||...........+....... .....++..+..++.
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 257 (302)
T 2j7t_A 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLK 257 (302)
T ss_dssp -CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred cCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHH
Confidence 7899999999984 34568999999999999999999999999887766655555443222 222355667889999
Q ss_pred HHhccCCCCCCcHHHHHhhc
Q psy501 538 TCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 538 ~Cl~~dperRPs~~~Ll~~l 557 (962)
.||..+|++||++.++++.-
T Consensus 258 ~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 258 IALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp HHSCSCTTTSCCHHHHTTST
T ss_pred HHcccChhhCCCHHHHhcCh
Confidence 99999999999999888753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=310.81 Aligned_cols=248 Identities=15% Similarity=0.221 Sum_probs=193.8
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCc-----eEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDN-----HILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLY 380 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~-----kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 380 (962)
...+.....++.++.+.||.+...... .++.+.+.. .....+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 344555555666666679988765432 133333221 23446889999999999999999999999999999
Q ss_pred EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC-
Q psy501 381 FVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP- 458 (962)
Q Consensus 381 LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~- 458 (962)
+||||++| +|.+++......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence 99999985 7888777766779999999999999999999999999999999999999999999999999998765431
Q ss_pred ----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcH
Q psy501 459 ----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVP 533 (962)
Q Consensus 459 ----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 533 (962)
.....+++.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.........+..+. ..+....++..+.
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 280 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-RLPTPMDCPSAIY 280 (333)
T ss_dssp --------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCCTTCBHHHH
T ss_pred cccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC-cCCCcccCCHHHH
Confidence 222345788999999965 478999999999999999999 999999887776666665542 2333456677888
Q ss_pred HHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 534 PIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 534 ~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
.++..||..+|++||++.+++..|..
T Consensus 281 ~li~~~l~~~p~~Rps~~~l~~~L~~ 306 (333)
T 1mqb_A 281 QLMMQCWQQERARRPKFADIVSILDK 306 (333)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 99999999999999999999887743
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=304.78 Aligned_cols=249 Identities=17% Similarity=0.202 Sum_probs=185.6
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEec--c---chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHV--S---SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~--~---~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
+..+.+.....++.++.+.||.+..... ++.+.+ . ......+.+|+.+|++++||||+++++++ .....++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~~--vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSSE--EEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcCc--eEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 4456677777777777778999876543 322222 1 22345689999999999999999999965 45668999
Q ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----
Q psy501 383 FEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---- 457 (962)
Q Consensus 383 ~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---- 457 (962)
|||++ ++|.+.+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 99998 5777777666677999999999999999999999999999999999999999999999999999765432
Q ss_pred CcccccCCccccChhhhc--cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC----CCCCCCC
Q psy501 458 PYTDYVSTRWYRAPEVLL--HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT----LPLYTYH 531 (962)
Q Consensus 458 ~~~~~~gt~~Y~APE~l~--~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~s~~ 531 (962)
......||+.|+|||++. ....++.++|||||||++|+|++|+.||.+.................+. ...++..
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHH
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHH
Confidence 334457899999999986 2346889999999999999999999999886554443333322222222 1245667
Q ss_pred cHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 532 VPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 532 l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
+..++..||..+|++||++.++++.+..
T Consensus 258 l~~li~~~l~~~p~~Rps~~ell~~L~~ 285 (289)
T 3og7_A 258 MKRLMAECLKKKRDERPSFPRILAEIEE 285 (289)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 8889999999999999999999987643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=316.95 Aligned_cols=248 Identities=14% Similarity=0.066 Sum_probs=186.8
Q ss_pred CceeeEEEEecCCcccEEEEEecCC-----ceEEEEeccchhHHHH---------------HHHHHHHHhcCCCCcccEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQD-----NHILSRHVSSRDEMVV---------------CFYRKSLKKLSHANLVKLK 370 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~-----~kvv~~k~~~~~~~~~---------------~~Ei~iL~~L~HpnIv~l~ 370 (962)
+.+.....++.++.+.||.+....+ .+.++.|+...+...+ ..|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 4555555555566666999987654 2333444333222223 3444556667899999999
Q ss_pred EEEEeC----CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccc--ccccee
Q psy501 371 EVIREN----DTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM--GTELVK 444 (962)
Q Consensus 371 ~~~~~~----~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~--~~g~vK 444 (962)
+++... ...|+||||+.|+|.+.+......+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~k 194 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVY 194 (364)
T ss_dssp EEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEE
T ss_pred eeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEE
Confidence 999764 46899999997788888877767899999999999999999999999999999999999999 889999
Q ss_pred eecccccccccCC---------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHH
Q psy501 445 IADFGLAREIRSR---------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERL 515 (962)
Q Consensus 445 L~DFGla~~~~~~---------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i 515 (962)
|+|||+++.+... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..........
T Consensus 195 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~ 273 (364)
T 3op5_A 195 LVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRD 273 (364)
T ss_dssp ECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHH
T ss_pred EEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHH
Confidence 9999999765432 12334599999999999764 6999999999999999999999999864332221111
Q ss_pred Hhccc--c-------ccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 516 KSSYI--L-------LHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 516 ~~~~~--~-------~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
..... . ......++..+..++..||..+|+.||++.+|++.|..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 274 SKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp HHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred HHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 11000 0 00114567788999999999999999999999887744
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=303.04 Aligned_cols=245 Identities=19% Similarity=0.247 Sum_probs=196.1
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE- 388 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g- 388 (962)
.+.....++.++.+.||.+....+++.++.|... .....+.+|+.++++++||||+++++++..++..++||||++|
T Consensus 30 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (314)
T 3com_A 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAG 109 (314)
T ss_dssp CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred hhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCC
Confidence 3444444444455569999887766655544432 3346789999999999999999999999999999999999985
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCc
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTR 466 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~ 466 (962)
+|.+.+......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+...... ......|++
T Consensus 110 ~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 189 (314)
T 3com_A 110 SVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTP 189 (314)
T ss_dssp EHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCG
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCC
Confidence 777777666677999999999999999999999999999999999999999999999999999776543 334457899
Q ss_pred cccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc-ccCCCCCCCCcHHHHHHHhccCCC
Q psy501 467 WYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL-LHTLPLYTYHVPPIQTTCLLAGTE 545 (962)
Q Consensus 467 ~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~s~~l~~li~~Cl~~dpe 545 (962)
.|+|||++.+. .++.++|||||||++|+|++|..||...........+...... ......++..+..++..||..+|+
T Consensus 190 ~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 268 (314)
T 3com_A 190 FWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPE 268 (314)
T ss_dssp GGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTT
T ss_pred CccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChh
Confidence 99999999654 6899999999999999999999999887765554444333211 112234566788999999999999
Q ss_pred CCCcHHHHHhhc
Q psy501 546 RLKSSYILLHTL 557 (962)
Q Consensus 546 rRPs~~~Ll~~l 557 (962)
+||++.+++..-
T Consensus 269 ~Rpt~~~ll~~~ 280 (314)
T 3com_A 269 QRATATQLLQHP 280 (314)
T ss_dssp TSCCHHHHTTSH
T ss_pred hCcCHHHHHhCH
Confidence 999999888743
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=312.57 Aligned_cols=245 Identities=18% Similarity=0.281 Sum_probs=199.8
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccch------------hHHHHHHHHHHHHhc-CCCCcccEEEEEEeCC
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR------------DEMVVCFYRKSLKKL-SHANLVKLKEVIREND 377 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~------------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 377 (962)
+.+.....++.++.+.||.+....+++.++.|+... ....+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 345555666666677799998876665555443211 134578999999999 7999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC
Q psy501 378 TLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS 456 (962)
Q Consensus 378 ~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~ 456 (962)
..++||||++| +|.+.+... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.+|.+||+|||++.....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999985 677766654 4599999999999999999999999999999999999999999999999999987654
Q ss_pred C-CcccccCCccccChhhhccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--CCCCC
Q psy501 457 R-PYTDYVSTRWYRAPEVLLHS-----TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--TLPLY 528 (962)
Q Consensus 457 ~-~~~~~~gt~~Y~APE~l~~~-----~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~ 528 (962)
. ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.........+..+..... .....
T Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 332 (365)
T 2y7j_A 253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR 332 (365)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSS
T ss_pred CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccC
Confidence 3 44556899999999998632 3588999999999999999999999998877766666665544322 12355
Q ss_pred CCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 529 TYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 529 s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
+..+..++..||..+|++||++.++++.
T Consensus 333 ~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 333 SSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 6678899999999999999998888764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=301.74 Aligned_cols=244 Identities=14% Similarity=0.155 Sum_probs=192.2
Q ss_pred CceeeEE-EEecCCcccEEEEEe--cCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEE
Q psy501 311 GTERLKF-SYILPHTLPLYTCNL--DQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYF 381 (962)
Q Consensus 311 g~~~~~~-~~i~~~~~~Vy~~~~--~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~L 381 (962)
..+.... .++.++.+.||.+.. ....+.++.|.... ....+.+|++++++++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 3444444 444455556888843 34444444433221 245689999999999999999999999 5667899
Q ss_pred EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC--
Q psy501 382 VFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP-- 458 (962)
Q Consensus 382 V~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~-- 458 (962)
||||++ |+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 95 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 999998 466666655 4569999999999999999999999999999999999999999999999999998765432
Q ss_pred ---cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHH
Q psy501 459 ---YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPP 534 (962)
Q Consensus 459 ---~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 534 (962)
.....+++.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.........+..+. .....+.++..+..
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 251 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGCPAGCPREMYD 251 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHHHHH
T ss_pred ccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHH
Confidence 2223467889999999654 68899999999999999999 999999887776666665543 23334567778999
Q ss_pred HHHHHhccCCCCCCcHHHHHhhcc
Q psy501 535 IQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 535 li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
++..||..+|++||++.+++..|.
T Consensus 252 li~~~l~~dp~~Rps~~~l~~~L~ 275 (291)
T 1xbb_A 252 LMNLCWTYDVENRPGFAAVELRLR 275 (291)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHHHH
Confidence 999999999999999999988763
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-33 Score=301.43 Aligned_cols=246 Identities=14% Similarity=0.171 Sum_probs=194.9
Q ss_pred CceeeEE-EEecCCcccEEEEEec--CCceEEEEecc-c----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 311 GTERLKF-SYILPHTLPLYTCNLD--QDNHILSRHVS-S----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 311 g~~~~~~-~~i~~~~~~Vy~~~~~--~~~kvv~~k~~-~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
+.+.... .++.++.+.||.+... .....++.|.. . .....+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3444444 3444455568888643 23333333332 1 2345689999999999999999999999 45668999
Q ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---
Q psy501 383 FEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--- 458 (962)
Q Consensus 383 ~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~--- 458 (962)
|||++| +|.+++......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 167 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 167 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCccee
Confidence 999985 7777776666779999999999999999999999999999999999999999999999999998765431
Q ss_pred --cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHH
Q psy501 459 --YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPI 535 (962)
Q Consensus 459 --~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~l 535 (962)
.....+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.........+..+. .....+.++..+..+
T Consensus 168 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~l 245 (287)
T 1u59_A 168 TARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPECPPELYAL 245 (287)
T ss_dssp CCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-CCCCCTTCCHHHHHH
T ss_pred eccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC-cCCCCCCcCHHHHHH
Confidence 223456789999999965 368999999999999999998 999999887766666665543 233345777888999
Q ss_pred HHHHhccCCCCCCcHHHHHhhccc
Q psy501 536 QTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 536 i~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
+..||..+|++||++.++++.+..
T Consensus 246 i~~~l~~~p~~Rps~~~l~~~l~~ 269 (287)
T 1u59_A 246 MSDCWIYKWEDRPDFLTVEQRMRA 269 (287)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHHHHH
Confidence 999999999999999999987743
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=320.13 Aligned_cols=244 Identities=18% Similarity=0.231 Sum_probs=187.5
Q ss_pred ceeeE-EEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHh-cCCCCcccEEEEEEe----CCEEEEEEec
Q psy501 312 TERLK-FSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKK-LSHANLVKLKEVIRE----NDTLYFVFEY 385 (962)
Q Consensus 312 ~~~~~-~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~-L~HpnIv~l~~~~~~----~~~~~LV~Ey 385 (962)
.+... ..++.|+.+.||.+....+++.++.|+... ...+.+|+.++.+ .+||||++++++|.. +..+|+||||
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~ 140 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEe
Confidence 34443 344555666799999887777666665443 3457889998754 489999999999976 5679999999
Q ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc---ccceeeecccccccccCC-Cc
Q psy501 386 MKE-NLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG---TELVKIADFGLAREIRSR-PY 459 (962)
Q Consensus 386 ~~g-~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~---~g~vKL~DFGla~~~~~~-~~ 459 (962)
|+| +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++..... ..
T Consensus 141 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~ 220 (400)
T 1nxk_A 141 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 220 (400)
T ss_dssp CCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----
T ss_pred CCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCcc
Confidence 985 7888877643 46999999999999999999999999999999999999987 788999999999876543 34
Q ss_pred ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhh----hHHHHHhccccccC--CCCCCCCcH
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLA----GTERLKSSYILLHT--LPLYTYHVP 533 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~----~~~~i~~~~~~~~~--~~~~s~~l~ 533 (962)
...+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..... ....+..+....+. ...++..+.
T Consensus 221 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 299 (400)
T 1nxk_A 221 TTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK 299 (400)
T ss_dssp ------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred ccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHH
Confidence 55688999999999865 479999999999999999999999998754332 33445444443332 245677788
Q ss_pred HHHHHHhccCCCCCCcHHHHHhhc
Q psy501 534 PIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 534 ~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.++..||..+|++||++.+++..-
T Consensus 300 ~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 300 MLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHCCCChhHCcCHHHHhcCc
Confidence 999999999999999988887654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-33 Score=307.23 Aligned_cols=249 Identities=18% Similarity=0.185 Sum_probs=180.9
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCCceEEEEecc----chhHHHHHHHHHHHHhcC-CCCcccEEEEEE--------e
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS----SRDEMVVCFYRKSLKKLS-HANLVKLKEVIR--------E 375 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~----~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~--------~ 375 (962)
....+.....+..++.+.||.+.....++.++.|.. ......+.+|+.+++++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 334556666666666677999998766665554432 223456899999999996 999999999994 3
Q ss_pred CCEEEEEEecCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHhhcccce--eeeccCCCcccccccccceeeeccccc
Q psy501 376 NDTLYFVFEYMKENLYQLIRD--RDKFLPESIIRNMMYQVLQGLAFMHRHG--FFHRDMKPENLLCMGTELVKIADFGLA 451 (962)
Q Consensus 376 ~~~~~LV~Ey~~g~Ll~~l~~--~~~~ls~~~i~~i~~qI~~aL~yLH~~g--IvHrDLkp~NILl~~~g~vKL~DFGla 451 (962)
...+++||||+.|+|.+.+.. ....+++..++.++.||+.||.|||+.| |+||||||+||+++.++.+||+|||++
T Consensus 106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 106 QAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp SEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred CceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 346899999999999998865 3456999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCc--------------ccccCCccccChhhhc--cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHH
Q psy501 452 REIRSRPY--------------TDYVSTRWYRAPEVLL--HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERL 515 (962)
Q Consensus 452 ~~~~~~~~--------------~~~~gt~~Y~APE~l~--~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i 515 (962)
........ ....||+.|+|||++. ....++.++|||||||++|+|++|+.||....... +
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~ 261 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----I 261 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----h
Confidence 87654311 1346899999999984 33468899999999999999999999997654432 2
Q ss_pred HhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 516 KSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 516 ~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
.......+.....+..+..++..||..+|++||++.++++.|....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp ----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2233334444566677899999999999999999999999875544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=308.96 Aligned_cols=247 Identities=19% Similarity=0.194 Sum_probs=194.8
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEE--EEecc-----chhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHIL--SRHVS-----SRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv--~~k~~-----~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV 382 (962)
+.+.....++.++.+.||.+....++..+ +.+.. ......+.+|+++++++ +||||+++++++.+++..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 44555555555555668888766554321 22221 22334689999999999 899999999999999999999
Q ss_pred EecCC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeee
Q psy501 383 FEYMK-ENLYQLIRDRD---------------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIA 446 (962)
Q Consensus 383 ~Ey~~-g~Ll~~l~~~~---------------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~ 446 (962)
|||++ |+|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEc
Confidence 99997 57888776543 469999999999999999999999999999999999999999999999
Q ss_pred cccccccccCC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccC
Q psy501 447 DFGLAREIRSR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHT 524 (962)
Q Consensus 447 DFGla~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~ 524 (962)
|||++...... ......+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+.........+..+. ....
T Consensus 185 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~-~~~~ 262 (327)
T 1fvr_A 185 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEK 262 (327)
T ss_dssp CTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-CCCC
T ss_pred ccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC-CCCC
Confidence 99999754322 2333456889999999965 468999999999999999998 999999888777666665542 2333
Q ss_pred CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 525 LPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 525 ~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
...++..+..++..||..+|++||++.++++.+..
T Consensus 263 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 263 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 44667788899999999999999999999987744
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-32 Score=316.36 Aligned_cols=254 Identities=19% Similarity=0.219 Sum_probs=201.0
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh---HHHHHHHHHHHHhc------CCCCcccEEEEEEeCCEE
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD---EMVVCFYRKSLKKL------SHANLVKLKEVIRENDTL 379 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~---~~~~~~Ei~iL~~L------~HpnIv~l~~~~~~~~~~ 379 (962)
..+.+.....++.++.+.||++.....++.++.|+...+ ...+.+|+++++.+ .|+||+++++++.....+
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 355677777777777778999988887776666554332 34678899988887 577999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccc--eeeecccccccccC
Q psy501 380 YFVFEYMKENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL--VKIADFGLAREIRS 456 (962)
Q Consensus 380 ~LV~Ey~~g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~--vKL~DFGla~~~~~ 456 (962)
|+||||++++|.+.+.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||+|.....
T Consensus 175 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 175 CMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp EEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred EEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 9999999999999987754 45999999999999999999999999999999999999999887 99999999976543
Q ss_pred CCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc-------------
Q psy501 457 RPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH------------- 523 (962)
Q Consensus 457 ~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------- 523 (962)
. .....||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.........+......++
T Consensus 255 ~-~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~ 332 (429)
T 3kvw_A 255 R-VYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNF 332 (429)
T ss_dssp C-CCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHH
T ss_pred c-ccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhc
Confidence 3 3456899999999999765 689999999999999999999999998876655544432211000
Q ss_pred ----C----------------------------------------CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 524 ----T----------------------------------------LPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 524 ----~----------------------------------------~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
. ....+..+.+++..||..||++||++.++++. +|
T Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~H-pw 411 (429)
T 3kvw_A 333 VSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRH-PW 411 (429)
T ss_dssp BCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTS-TT
T ss_pred cCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCC-hh
Confidence 0 00113345689999999999999998888874 46
Q ss_pred cccCCC
Q psy501 560 YTYHVP 565 (962)
Q Consensus 560 ~~~~~~ 565 (962)
+....+
T Consensus 412 ~~~~~~ 417 (429)
T 3kvw_A 412 LRRRLP 417 (429)
T ss_dssp TC----
T ss_pred hccCCC
Confidence 554443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=308.44 Aligned_cols=246 Identities=22% Similarity=0.280 Sum_probs=196.1
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeC-----CEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIREN-----DTL 379 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~-----~~~ 379 (962)
.+.+.....++.++.+.||.+....+++.++.|... .....+.+|++++++++||||+++++++..+ ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 456666667777777789999887766655554422 1234678999999999999999999998654 679
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--
Q psy501 380 YFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-- 457 (962)
Q Consensus 380 ~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-- 457 (962)
++||||++|+|.+.+.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 90 ~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 90 YIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp EEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 99999999999888876 35899999999999999999999999999999999999999999999999999876432
Q ss_pred ----------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-----
Q psy501 458 ----------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL----- 522 (962)
Q Consensus 458 ----------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~----- 522 (962)
......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.........+......+
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTT
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcc
Confidence 12234789999999998776679999999999999999999999999877554433332211000
Q ss_pred -------------------------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 523 -------------------------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 523 -------------------------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
...+..+..+..++..||..+|++||++.++++.-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp TTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 01134556677899999999999999999888754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=305.34 Aligned_cols=251 Identities=19% Similarity=0.268 Sum_probs=196.3
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEecc---chhHHHHHHHHHHHHhc-CCCCcccEEEEEEe------CCEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS---SRDEMVVCFYRKSLKKL-SHANLVKLKEVIRE------NDTL 379 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~---~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~------~~~~ 379 (962)
.+.+.....++.++.+.||.+.....++.++.|+. ......+.+|+.+++++ +||||+++++++.. ....
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 102 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 102 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceE
Confidence 45566666666677778999988766665555442 23456789999999999 79999999999987 5689
Q ss_pred EEEEecCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC
Q psy501 380 YFVFEYMKE-NLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR 457 (962)
Q Consensus 380 ~LV~Ey~~g-~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~ 457 (962)
++||||++| +|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++......
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 103 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp EEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred EEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 999999985 777777653 256999999999999999999999999999999999999999999999999999866433
Q ss_pred --CcccccCCccccChhhhcc----CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCC
Q psy501 458 --PYTDYVSTRWYRAPEVLLH----STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYH 531 (962)
Q Consensus 458 --~~~~~~gt~~Y~APE~l~~----~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 531 (962)
......|++.|+|||++.+ ...++.++|||||||++|+|++|..||.+.........+............++..
T Consensus 183 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (326)
T 2x7f_A 183 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKK 262 (326)
T ss_dssp --------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHH
T ss_pred ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCHH
Confidence 2344578999999999862 3468899999999999999999999998877666655555443333334466778
Q ss_pred cHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 532 VPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 532 l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
+..++..||..+|++||++.++++.- |+.
T Consensus 263 l~~li~~~l~~dp~~Rps~~~ll~hp-~~~ 291 (326)
T 2x7f_A 263 FQSFIESCLVKNHSQRPATEQLMKHP-FIR 291 (326)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHTSH-HHH
T ss_pred HHHHHHHHhccChhhCCCHHHHhhCh-HHh
Confidence 89999999999999999999888753 443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-33 Score=300.07 Aligned_cols=245 Identities=22% Similarity=0.303 Sum_probs=198.2
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEe--CCEEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRE--NDTLYFV 382 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~LV 382 (962)
+.+.....++.++.+.||.+....+++.++.+... .....+.+|+.++++++||||+++++++.+ +...++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 35555666666667779999887766655544422 234568999999999999999999998854 5789999
Q ss_pred EecCCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHhhcccce-----eeeccCCCcccccccccceeeeccccccc
Q psy501 383 FEYMKE-NLYQLIRDR---DKFLPESIIRNMMYQVLQGLAFMHRHG-----FFHRDMKPENLLCMGTELVKIADFGLARE 453 (962)
Q Consensus 383 ~Ey~~g-~Ll~~l~~~---~~~ls~~~i~~i~~qI~~aL~yLH~~g-----IvHrDLkp~NILl~~~g~vKL~DFGla~~ 453 (962)
|||++| +|.+.+... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||.+..
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 999985 787777543 345999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCC--cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCC
Q psy501 454 IRSRP--YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYH 531 (962)
Q Consensus 454 ~~~~~--~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 531 (962)
..... .....|++.|+|||++.+. .++.++|||||||++|+|++|+.||...........+..+... .....++..
T Consensus 166 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~~ 243 (279)
T 2w5a_A 166 LNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYRYSDE 243 (279)
T ss_dssp C---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-CCCTTSCHH
T ss_pred eccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc-cCCcccCHH
Confidence 65432 2335789999999999764 6899999999999999999999999988777666666665432 223466778
Q ss_pred cHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 532 VPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 532 l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+..++..||..+|++||++.++++.+
T Consensus 244 l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 244 LNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred HHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 89999999999999999999999866
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=324.26 Aligned_cols=246 Identities=18% Similarity=0.269 Sum_probs=200.6
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-C
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-E 388 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g 388 (962)
.+.....++.++.+.||.+......+++.+.+.. ...+.+.+|+++|++++||||+++++++. +...++||||+. |
T Consensus 189 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g 267 (454)
T 1qcf_A 189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKG 267 (454)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTC
T ss_pred HeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCC
Confidence 4444555555556668998887666655554432 34567999999999999999999999986 567899999997 5
Q ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---CcccccC
Q psy501 389 NLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYVS 464 (962)
Q Consensus 389 ~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~g 464 (962)
+|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++..... ......+
T Consensus 268 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 347 (454)
T 1qcf_A 268 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF 347 (454)
T ss_dssp BHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSS
T ss_pred cHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcc
Confidence 8888876542 35899999999999999999999999999999999999999999999999999876543 2233456
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccC
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
+..|+|||++.+. .++.++|||||||++|||++ |+.||.+.........+..+. ..+....++..+..++..||..+
T Consensus 348 ~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~cl~~d 425 (454)
T 1qcf_A 348 PIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-RMPRPENCPEELYNIMMRCWKNR 425 (454)
T ss_dssp CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-CCCCCTTSCHHHHHHHHHHTCSS
T ss_pred cccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHccCC
Confidence 7889999999754 69999999999999999999 999999888777776666553 33444567788899999999999
Q ss_pred CCCCCcHHHHHhhcccc
Q psy501 544 TERLKSSYILLHTLPLY 560 (962)
Q Consensus 544 perRPs~~~Ll~~l~~~ 560 (962)
|++||++.+|+..|..+
T Consensus 426 p~~RPt~~~i~~~L~~~ 442 (454)
T 1qcf_A 426 PEERPTFEYIQSVLDDF 442 (454)
T ss_dssp GGGSCCHHHHHHHHHTS
T ss_pred hhHCcCHHHHHHHHHHH
Confidence 99999999998877443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=311.81 Aligned_cols=236 Identities=23% Similarity=0.294 Sum_probs=170.8
Q ss_pred CcccEEEEEecCCceEEEEecc-chhHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCC
Q psy501 323 HTLPLYTCNLDQDNHILSRHVS-SRDEMVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDK 399 (962)
Q Consensus 323 ~~~~Vy~~~~~~~~kvv~~k~~-~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~~ 399 (962)
+.+.||.+....+++.++.|+. ......+.+|+.+++.+. ||||+++++++.++...|+||||++| +|.+.+... .
T Consensus 23 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~ 101 (325)
T 3kn6_A 23 SFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK-K 101 (325)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHC-S
T ss_pred CCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhc-C
Confidence 3445888887766665555443 344567899999999997 99999999999999999999999985 677776654 5
Q ss_pred CCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc---ceeeecccccccccCC--CcccccCCccccChhhh
Q psy501 400 FLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREIRSR--PYTDYVSTRWYRAPEVL 474 (962)
Q Consensus 400 ~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g---~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~l 474 (962)
.+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++...... ......||+.|+|||++
T Consensus 102 ~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~ 181 (325)
T 3kn6_A 102 HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181 (325)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------------------
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHh
Confidence 699999999999999999999999999999999999998766 8999999999865443 33456789999999999
Q ss_pred ccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcCh-------hhhHHHHHhccccccCC--CCCCCCcHHHHHHHhccCCC
Q psy501 475 LHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCL-------LAGTERLKSSYILLHTL--PLYTYHVPPIQTTCLLAGTE 545 (962)
Q Consensus 475 ~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~~--~~~s~~l~~li~~Cl~~dpe 545 (962)
.+ ..++.++|||||||++|+|++|+.||.+... ......+..+....+.. +..+..+..++..||..+|+
T Consensus 182 ~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 260 (325)
T 3kn6_A 182 NQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPN 260 (325)
T ss_dssp ---CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTT
T ss_pred cC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChh
Confidence 65 4799999999999999999999999987543 23344444443322211 24677788899999999999
Q ss_pred CCCcHHHHHhhccccc
Q psy501 546 RLKSSYILLHTLPLYT 561 (962)
Q Consensus 546 rRPs~~~Ll~~l~~~~ 561 (962)
+||++.+++..- |+.
T Consensus 261 ~Rpt~~ell~h~-w~~ 275 (325)
T 3kn6_A 261 KRLKMSGLRYNE-WLQ 275 (325)
T ss_dssp TCCCTTTSTTCG-GGC
T ss_pred HCCCHHHHhcCh-hhc
Confidence 999988877643 443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=312.25 Aligned_cols=246 Identities=22% Similarity=0.221 Sum_probs=188.8
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC---
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIREND--- 377 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~--- 377 (962)
+...+.|.....++.++.+.||.+.....++.++.|... .....+.+|+.+++.++||||+++++++...+
T Consensus 21 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 21 FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred cchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 445677778777877888889999887777665555432 22346889999999999999999999997654
Q ss_pred ---EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccc
Q psy501 378 ---TLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI 454 (962)
Q Consensus 378 ---~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~ 454 (962)
..|+||||++|++.+.+.. .+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 101 ~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 101 EFQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp TCCEEEEEEECCSEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred cccceEEEEEcCCCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 7899999999999888753 4899999999999999999999999999999999999999999999999999876
Q ss_pred cCC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-----------
Q psy501 455 RSR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL----------- 522 (962)
Q Consensus 455 ~~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------- 522 (962)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus 178 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 178 GTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp ------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred ccccccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 543 3445689999999999976 478999999999999999999999999887766555544321100
Q ss_pred --------cCCCC---------------------CCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 523 --------HTLPL---------------------YTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 523 --------~~~~~---------------------~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
+.... .+..+.+++..||..||++||++.++++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000 02245679999999999999998887764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=308.21 Aligned_cols=233 Identities=23% Similarity=0.317 Sum_probs=179.8
Q ss_pred cccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhc
Q psy501 324 TLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDR 397 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~ 397 (962)
.+.||.+....+++.++.|+.. .....+.+|+++|+++ +||||+++++++.+++..|+||||++ |+|.+.+...
T Consensus 26 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 105 (316)
T 2ac3_A 26 HARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR 105 (316)
T ss_dssp SEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH
T ss_pred eEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc
Confidence 3457777766555554444322 2356789999999995 79999999999999999999999998 5777777665
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccc---eeeecccccccccCC---------CcccccCC
Q psy501 398 DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL---VKIADFGLAREIRSR---------PYTDYVST 465 (962)
Q Consensus 398 ~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~---vKL~DFGla~~~~~~---------~~~~~~gt 465 (962)
..+++..++.++.||+.||.|||+.||+||||||+||+++.++. +||+|||++...... ......||
T Consensus 106 -~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt 184 (316)
T 2ac3_A 106 -RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184 (316)
T ss_dssp -SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCS
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCC
Confidence 45999999999999999999999999999999999999988775 999999998765321 22234699
Q ss_pred ccccChhhhcc----CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh---------------hhHHHHHhccccccC--
Q psy501 466 RWYRAPEVLLH----STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL---------------AGTERLKSSYILLHT-- 524 (962)
Q Consensus 466 ~~Y~APE~l~~----~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~---------------~~~~~i~~~~~~~~~-- 524 (962)
+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.... .....+..+....+.
T Consensus 185 ~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 264 (316)
T 2ac3_A 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKD 264 (316)
T ss_dssp GGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHH
T ss_pred cCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchh
Confidence 99999999864 124789999999999999999999999875421 223344444332221
Q ss_pred CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 525 LPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 525 ~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.+..+..+..++..||..+|++||++.++++.-
T Consensus 265 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 265 WAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred cccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 134566788999999999999999988888754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-32 Score=299.60 Aligned_cols=241 Identities=17% Similarity=0.196 Sum_probs=197.4
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
+.....++.++.+.||.+.....++.++.|+.. .....+.+|+.++++++||+|+++++++.++...++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 444555555666679999877666655554432 234679999999999999999999999999999999999998
Q ss_pred C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccC
Q psy501 388 E-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVS 464 (962)
Q Consensus 388 g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~g 464 (962)
| +|.+.+.. ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++...... ......|
T Consensus 104 ~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 181 (303)
T 3a7i_A 104 GGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVG 181 (303)
T ss_dssp TEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCS
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCccCC
Confidence 6 56665543 45999999999999999999999999999999999999999999999999999876543 3345678
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCC
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGT 544 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dp 544 (962)
++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... .......++..+..++..||..+|
T Consensus 182 ~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp 259 (303)
T 3a7i_A 182 TPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEP 259 (303)
T ss_dssp CGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCCCCSSCCHHHHHHHHHHCCSSG
T ss_pred CcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC-CCCCccccCHHHHHHHHHHcCCCh
Confidence 999999999965 468999999999999999999999998877666555554432 222234667778999999999999
Q ss_pred CCCCcHHHHHhhc
Q psy501 545 ERLKSSYILLHTL 557 (962)
Q Consensus 545 erRPs~~~Ll~~l 557 (962)
++||++.++++..
T Consensus 260 ~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 260 SFRPTAKELLKHK 272 (303)
T ss_dssp GGSCCHHHHTTCH
T ss_pred hhCcCHHHHhhCh
Confidence 9999999988754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=310.96 Aligned_cols=247 Identities=16% Similarity=0.240 Sum_probs=201.6
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchhH---------------------HHHHHHHHHHHhcCCCCcc
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDE---------------------MVVCFYRKSLKKLSHANLV 367 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~---------------------~~~~~Ei~iL~~L~HpnIv 367 (962)
..+.+.....++.++.+.||.+.. .++.++.|...... ..+.+|+.++++++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 356777777777777788999998 34443333322211 6799999999999999999
Q ss_pred cEEEEEEeCCEEEEEEecCCC-CHHHH------HHhc-CCCCCHHHHHHHHHHHHHHHhhccc-ceeeeccCCCcccccc
Q psy501 368 KLKEVIRENDTLYFVFEYMKE-NLYQL------IRDR-DKFLPESIIRNMMYQVLQGLAFMHR-HGFFHRDMKPENLLCM 438 (962)
Q Consensus 368 ~l~~~~~~~~~~~LV~Ey~~g-~Ll~~------l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~-~gIvHrDLkp~NILl~ 438 (962)
++++++.+++..++||||++| +|.++ +... ...+++..++.++.||+.||.|||+ .||+|+||+|+||+++
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 999999999999999999986 66665 3332 4679999999999999999999999 9999999999999999
Q ss_pred cccceeeecccccccccCCCcccccCCccccChhhhccCCCCCc-hhHHHHHHHHHHHHHcCCCCCCCcCh-hhhHHHHH
Q psy501 439 GTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSA-PIHLSRSQQFLFYSIDHVPPIQTTCL-LAGTERLK 516 (962)
Q Consensus 439 ~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t~-ksDIwSLGvlL~elltG~~Pf~~~~~-~~~~~~i~ 516 (962)
.++.+||+|||.+............|++.|+|||++.+...++. ++|||||||++|||++|..||..... ......+.
T Consensus 187 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~ 266 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266 (348)
T ss_dssp TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHT
T ss_pred CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence 99999999999998876665666789999999999976545666 99999999999999999999998766 55555555
Q ss_pred hccccccCC-----------------CCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 517 SSYILLHTL-----------------PLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 517 ~~~~~~~~~-----------------~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.+....+.. +.++..+..++..||..+|++||++.++++.-
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 267 TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 554433321 44666788899999999999999999888743
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-33 Score=301.42 Aligned_cols=247 Identities=18% Similarity=0.138 Sum_probs=196.5
Q ss_pred cCceeeEEEEecCCcccEEEEEecC-Cce--EEEEeccc-------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQ-DNH--ILSRHVSS-------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTL 379 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~-~~k--vv~~k~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 379 (962)
...+.....+..++.+.||.+.... ..+ .++.|... .....+.+|++++++++||||+++++++.++. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3455555555555556699997543 222 23333321 23456889999999999999999999998765 8
Q ss_pred EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC
Q psy501 380 YFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP 458 (962)
Q Consensus 380 ~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~ 458 (962)
++||||++ |+|.+.+......+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.......
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 89999998 68888887766679999999999999999999999999999999999999999999999999998765432
Q ss_pred -----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCc
Q psy501 459 -----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHV 532 (962)
Q Consensus 459 -----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 532 (962)
.....++..|+|||++.+. .++.++|||||||++|+|++ |+.||.+.........+.......+....++..+
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 254 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred cchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHH
Confidence 2234577889999999754 68999999999999999999 9999999888777777766655556566778889
Q ss_pred HHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 533 PPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 533 ~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
..++..||..+|++||++.++++.|.
T Consensus 255 ~~li~~~l~~~p~~Rps~~~l~~~l~ 280 (291)
T 1u46_A 255 YNVMVQCWAHKPEDRPTFVALRDFLL 280 (291)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHH
Confidence 99999999999999999999998663
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=301.57 Aligned_cols=246 Identities=17% Similarity=0.185 Sum_probs=192.4
Q ss_pred CceeeEEEEecCCcccEEEEEe----cCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeC--CEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNL----DQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIREN--DTL 379 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~----~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~ 379 (962)
..+.....++.++.+.||.+.. ...++.++.|... .....+.+|++++++++||||+++++++.+. ..+
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3445555566666667888873 3344444443322 2235789999999999999999999999876 668
Q ss_pred EEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-
Q psy501 380 YFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457 (962)
Q Consensus 380 ~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~- 457 (962)
++||||++| +|.+++......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 180 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCC
Confidence 999999975 888888777777999999999999999999999999999999999999999999999999999876543
Q ss_pred ----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcC--------------hhhhHHHHHhcc
Q psy501 458 ----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTC--------------LLAGTERLKSSY 519 (962)
Q Consensus 458 ----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~--------------~~~~~~~i~~~~ 519 (962)
......+|..|+|||++.+. .++.++|||||||++|+|++|..||.... ............
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (302)
T 4e5w_A 181 EYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259 (302)
T ss_dssp CEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred cceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence 23345678889999999764 68899999999999999999999864321 111111222222
Q ss_pred ccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 520 ILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 520 ~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
...+..+.++..+..++..||..+|++||++.++++.|
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 297 (302)
T 4e5w_A 260 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297 (302)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 23344456777889999999999999999999999866
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-32 Score=300.79 Aligned_cols=249 Identities=18% Similarity=0.269 Sum_probs=187.2
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEecc-------chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS-------SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~-------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
.+.+.....+..++.+.||.+....+++.++.|.. ......+.+|+.++++++||||+++++++..++..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 34566666666666777999987666655444432 12345688999999999999999999999999999999
Q ss_pred EecCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-
Q psy501 383 FEYMKE-NLYQLIRD---RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457 (962)
Q Consensus 383 ~Ey~~g-~Ll~~l~~---~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~- 457 (962)
|||++| +|.+.+.. ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 999986 77766643 3466999999999999999999999999999999999999999999999999999766543
Q ss_pred -CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcCh--hhhHHHHHhccccccCCCCCCCCcHH
Q psy501 458 -PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCL--LAGTERLKSSYILLHTLPLYTYHVPP 534 (962)
Q Consensus 458 -~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~s~~l~~ 534 (962)
......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ......+............++..+..
T Consensus 191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 269 (310)
T 2wqm_A 191 TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269 (310)
T ss_dssp --------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHH
T ss_pred ccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHH
Confidence 2334578999999999965 4789999999999999999999999976532 23334444443333223456777889
Q ss_pred HHHHHhccCCCCCCcHHHHHhhccc
Q psy501 535 IQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 535 li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
++..||..+|++||++.++++.+..
T Consensus 270 li~~~l~~dp~~Rps~~~il~~l~~ 294 (310)
T 2wqm_A 270 LVNMCINPDPEKRPDVTYVYDVAKR 294 (310)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHcCCChhhCCCHHHHHHHHHH
Confidence 9999999999999999999987743
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-33 Score=326.89 Aligned_cols=245 Identities=18% Similarity=0.199 Sum_probs=201.3
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc---hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-C
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS---RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-E 388 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~---~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g 388 (962)
+.....++.++.+.||.+........++.|... .....+.+|+.+|++++||||+++++++.++..+++||||++ |
T Consensus 222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g 301 (495)
T 1opk_A 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 301 (495)
T ss_dssp EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCC
Confidence 344444445555669999887755555444432 235679999999999999999999999999999999999998 6
Q ss_pred CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---cccccC
Q psy501 389 NLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---YTDYVS 464 (962)
Q Consensus 389 ~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~g 464 (962)
+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .....+
T Consensus 302 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 381 (495)
T 1opk_A 302 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 381 (495)
T ss_dssp BHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCC
T ss_pred CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcC
Confidence 888888764 3568999999999999999999999999999999999999999999999999998765442 223445
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccC
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
+..|+|||++.+. .++.++|||||||+||||++ |..||.+.........+..+ ........++..+..++..||..+
T Consensus 382 ~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~d 459 (495)
T 1opk_A 382 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPEGCPEKVYELMRACWQWN 459 (495)
T ss_dssp CGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCcC
Confidence 6789999999754 68999999999999999999 99999988776666655544 333444567788899999999999
Q ss_pred CCCCCcHHHHHhhccc
Q psy501 544 TERLKSSYILLHTLPL 559 (962)
Q Consensus 544 perRPs~~~Ll~~l~~ 559 (962)
|++||++.+|++.|..
T Consensus 460 P~~RPs~~el~~~L~~ 475 (495)
T 1opk_A 460 PSDRPSFAEIHQAFET 475 (495)
T ss_dssp GGGSCCHHHHHHHHHT
T ss_pred hhHCcCHHHHHHHHHH
Confidence 9999999999987743
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=300.53 Aligned_cols=242 Identities=19% Similarity=0.185 Sum_probs=191.5
Q ss_pred EEEecCCcccEEEEEecCCce---EEEEec-cc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEE-EEEEecCC
Q psy501 317 FSYILPHTLPLYTCNLDQDNH---ILSRHV-SS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTL-YFVFEYMK 387 (962)
Q Consensus 317 ~~~i~~~~~~Vy~~~~~~~~k---vv~~k~-~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~-~LV~Ey~~ 387 (962)
..++.|+.+.||.+....... .++.+. .. .....+.+|+.++++++||||+++++++.+.+.. ++||||+.
T Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~ 106 (298)
T 3pls_A 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMC 106 (298)
T ss_dssp EEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCT
T ss_pred ceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEeccc
Confidence 444555566688887543332 233332 21 2235688999999999999999999999766554 99999996
Q ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC------Ccc
Q psy501 388 -ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR------PYT 460 (962)
Q Consensus 388 -g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~------~~~ 460 (962)
|+|.+.+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...... ...
T Consensus 107 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 186 (298)
T 3pls_A 107 HGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186 (298)
T ss_dssp TCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSS
T ss_pred CCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCc
Confidence 6888888776777999999999999999999999999999999999999999999999999999765332 333
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHH
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTC 539 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~C 539 (962)
...+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||...........+.... ..+....++..+..++..|
T Consensus 187 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~ 264 (298)
T 3pls_A 187 HARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-RLPQPEYCPDSLYQVMQQC 264 (298)
T ss_dssp CTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC-CCCCCTTCCHHHHHHHHHH
T ss_pred CCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC-CCCCCccchHHHHHHHHHH
Confidence 4567889999999965 478999999999999999999 556666666655555555443 3344456777889999999
Q ss_pred hccCCCCCCcHHHHHhhcccc
Q psy501 540 LLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 540 l~~dperRPs~~~Ll~~l~~~ 560 (962)
|..+|++||++.++++.+...
T Consensus 265 l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 265 WEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp TCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCChhhCcCHHHHHHHHHHH
Confidence 999999999999999877443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=297.16 Aligned_cols=241 Identities=17% Similarity=0.186 Sum_probs=192.5
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
+.+.....+..++.+.||.+....+++.++.|... .....+.+|+.++.++ +||||+++++++.+++..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 44555556666667779999887666655554422 2455788999999999 8999999999999999999999
Q ss_pred ecCCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc-------------------
Q psy501 384 EYMKE-NLYQLIRDR---DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT------------------- 440 (962)
Q Consensus 384 Ey~~g-~Ll~~l~~~---~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~------------------- 440 (962)
||++| +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 99975 888877654 2569999999999999999999999999999999999999844
Q ss_pred cceeeecccccccccCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc
Q psy501 441 ELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI 520 (962)
Q Consensus 441 g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~ 520 (962)
..+||+|||.+....... ...||+.|+|||++.+...++.++|||||||++|+|++|.+|+..... ...+..+..
T Consensus 171 ~~~kl~Dfg~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~~~ 245 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSPQ--VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQGRL 245 (289)
T ss_dssp CCEEECCCTTCEETTCSC--CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHTTCC
T ss_pred eEEEEcccccccccCCcc--ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHcCCC
Confidence 379999999998765432 346899999999998765677899999999999999999988755432 233333322
Q ss_pred cccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 521 LLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 521 ~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
....+.++..+..++..||..+|++||++.++++.-
T Consensus 246 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 246 -PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp -CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred -CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 222346777889999999999999999999888754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=307.68 Aligned_cols=252 Identities=15% Similarity=0.165 Sum_probs=194.1
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEe----CCEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRE----NDTLYF 381 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~----~~~~~L 381 (962)
.+.+.....++.++.+.||.+.....++.++.|.. ......+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 34566666666666667999998766665555432 2334578999999999999999999999963 347899
Q ss_pred EEecCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC
Q psy501 382 VFEYMKE-NLYQLIRD---RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR 457 (962)
Q Consensus 382 V~Ey~~g-~Ll~~l~~---~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~ 457 (962)
||||+.+ +|.+.+.. ....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||.+......
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence 9999985 78777765 3567999999999999999999999999999999999999999999999999998765321
Q ss_pred -----------CcccccCCccccChhhhccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCcChhh-hHHHHHhcccccc
Q psy501 458 -----------PYTDYVSTRWYRAPEVLLHST--AYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLA-GTERLKSSYILLH 523 (962)
Q Consensus 458 -----------~~~~~~gt~~Y~APE~l~~~~--~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~ 523 (962)
......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||....... ............+
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 267 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIP 267 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CC
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCC
Confidence 112345799999999986532 26889999999999999999999996522111 1112222233444
Q ss_pred CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 524 TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 524 ~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
..+.++..+..++..||..+|.+||++.++++.|....
T Consensus 268 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 268 QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 45567778999999999999999999999999875443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=322.22 Aligned_cols=246 Identities=21% Similarity=0.276 Sum_probs=196.4
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-C
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-E 388 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g 388 (962)
.+.....++.++.+.||.+.......++.+.+.. ...+.+.+|+++|++++||||+++++++.+ +..++||||++ |
T Consensus 185 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~g 263 (452)
T 1fmk_A 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 263 (452)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred HceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCC
Confidence 4445555566666679999887766655554432 235679999999999999999999999876 67899999998 5
Q ss_pred CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---cccccC
Q psy501 389 NLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---YTDYVS 464 (962)
Q Consensus 389 ~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~~g 464 (962)
+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .....+
T Consensus 264 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 343 (452)
T 1fmk_A 264 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 343 (452)
T ss_dssp BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------C
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcc
Confidence 888887643 3568999999999999999999999999999999999999999999999999998765432 223456
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccC
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
+..|+|||++.+. .++.++|||||||++|||++ |+.||.+.........+..+. ..+..+.++..+..++..||..+
T Consensus 344 ~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~cl~~d 421 (452)
T 1fmk_A 344 PIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPCPPECPESLHDLMCQCWRKE 421 (452)
T ss_dssp CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTSCHHHHHHHHHHTCSS
T ss_pred cccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHccCC
Confidence 7889999999764 69999999999999999999 999999887777666666553 33444567778899999999999
Q ss_pred CCCCCcHHHHHhhcccc
Q psy501 544 TERLKSSYILLHTLPLY 560 (962)
Q Consensus 544 perRPs~~~Ll~~l~~~ 560 (962)
|++||++.+|+..|..+
T Consensus 422 P~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 422 PEERPTFEYLQAFLEDY 438 (452)
T ss_dssp GGGSCCHHHHHHHHHTT
T ss_pred hhhCcCHHHHHHHHHHH
Confidence 99999999998876443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=305.22 Aligned_cols=248 Identities=19% Similarity=0.205 Sum_probs=195.5
Q ss_pred cCceeeEEEEecCCcccEEEEEec-----CCceEEEEeccc-----hhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCC-
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLD-----QDNHILSRHVSS-----RDEMVVCFYRKSLKKL-SHANLVKLKEVIREND- 377 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~-----~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~- 377 (962)
.+.+.....++.++.+.||.+... ...+.++.|... .....+.+|+.+++++ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 456666666666777779998742 333444444322 2334688999999999 6999999999997654
Q ss_pred EEEEEEecCCC-CHHHHHHhcCC---------------CCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc
Q psy501 378 TLYFVFEYMKE-NLYQLIRDRDK---------------FLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE 441 (962)
Q Consensus 378 ~~~LV~Ey~~g-~Ll~~l~~~~~---------------~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g 441 (962)
.+++||||++| +|.+++..... .+++..++.++.||+.||.|||+.||+||||||+||+++.++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~ 185 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC
Confidence 58999999985 77777765433 289999999999999999999999999999999999999999
Q ss_pred ceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHH
Q psy501 442 LVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLK 516 (962)
Q Consensus 442 ~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~ 516 (962)
.+||+|||++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+...........
T Consensus 186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~ 264 (316)
T 2xir_A 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264 (316)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred CEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHh
Confidence 99999999998664432 2234578899999999764 68999999999999999998 999998876544433333
Q ss_pred hccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 517 SSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 517 ~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
............+..+..++..||..+|++||++.++++.|.
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 306 (316)
T 2xir_A 265 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 306 (316)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 332333334566778899999999999999999999998774
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=315.57 Aligned_cols=248 Identities=20% Similarity=0.243 Sum_probs=182.7
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeC----
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIREN---- 376 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~---- 376 (962)
....+.|.....++.|+.+.||.+.....++.++.|... .....+.+|+++|++++||||+++++++...
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 344566666666666666679999887777665555432 1245688999999999999999999999754
Q ss_pred --CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccc
Q psy501 377 --DTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI 454 (962)
Q Consensus 377 --~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~ 454 (962)
...|+|||+++++|.+.+.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 105 ~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 105 EFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp GCCCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred cCCeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 56899999998888777754 45999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc------------
Q psy501 455 RSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL------------ 522 (962)
Q Consensus 455 ~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------ 522 (962)
... .....||+.|+|||++.+...++.++|||||||++|||++|++||.+.+.......+......+
T Consensus 183 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 183 ADE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred ccc-CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 433 3456899999999999876679999999999999999999999999887665555443321100
Q ss_pred --------c---------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 523 --------H---------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 523 --------~---------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+ ..+..+..+.+++..||..+|++||++.+++..-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 0 0123345577899999999999999988877654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=309.05 Aligned_cols=247 Identities=17% Similarity=0.211 Sum_probs=187.4
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccch---hHHHHHHHHHHHHhcCCCCcccEEEEEEeCC-------EEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR---DEMVVCFYRKSLKKLSHANLVKLKEVIREND-------TLY 380 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~---~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~-------~~~ 380 (962)
+.+.....++.++.+.||.+....+++.++.|.... ......+|++.++.++||||+++++++...+ ..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 102 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN 102 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence 445555555556666799998876666554443222 2335677888889999999999999997533 389
Q ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHhhcc--cceeeeccCCCccccccc-ccceeeecccccccc
Q psy501 381 FVFEYMKENLYQLIRD---RDKFLPESIIRNMMYQVLQGLAFMH--RHGFFHRDMKPENLLCMG-TELVKIADFGLAREI 454 (962)
Q Consensus 381 LV~Ey~~g~Ll~~l~~---~~~~ls~~~i~~i~~qI~~aL~yLH--~~gIvHrDLkp~NILl~~-~g~vKL~DFGla~~~ 454 (962)
+||||++|++...+.. ....+++..++.++.|++.||.||| +.||+||||||+||+++. ++.+||+|||++...
T Consensus 103 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~ 182 (360)
T 3e3p_A 103 VVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182 (360)
T ss_dssp EEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCC
T ss_pred EEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceec
Confidence 9999999998776653 4567899999999999999999999 999999999999999996 899999999999876
Q ss_pred cCC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-----------
Q psy501 455 RSR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL----------- 522 (962)
Q Consensus 455 ~~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------- 522 (962)
... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3e3p_A 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPS 262 (360)
T ss_dssp CTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTT
T ss_pred CCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccc
Confidence 544 34456789999999999776668999999999999999999999999887766655554321100
Q ss_pred -------------------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 523 -------------------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 523 -------------------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
......+..+..++..||..+|++||++.++++.-
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 263 HTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp CCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred hhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 00111334577899999999999999988888754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=306.24 Aligned_cols=250 Identities=18% Similarity=0.214 Sum_probs=200.8
Q ss_pred EecCceeeEEEEecCCcccEEEEEecC-------CceEEEEeccc-----hhHHHHHHHHHHHHhc-CCCCcccEEEEEE
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQ-------DNHILSRHVSS-----RDEMVVCFYRKSLKKL-SHANLVKLKEVIR 374 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~-------~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 374 (962)
+..+.+.....++.++.+.||.+.... ....++.|... .....+.+|+++++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 334566666667767777799998642 22333333322 2235688999999999 8999999999999
Q ss_pred eCCEEEEEEecCCC-CHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccc
Q psy501 375 ENDTLYFVFEYMKE-NLYQLIRDRD---------------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM 438 (962)
Q Consensus 375 ~~~~~~LV~Ey~~g-~Ll~~l~~~~---------------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~ 438 (962)
+++..++||||++| +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence 99999999999985 7887776543 2489999999999999999999999999999999999999
Q ss_pred cccceeeecccccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHH
Q psy501 439 GTELVKIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTE 513 (962)
Q Consensus 439 ~~g~vKL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~ 513 (962)
.++.+||+|||++...... ......+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+........
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 9999999999999876543 22334567889999999764 68999999999999999999 999999887776666
Q ss_pred HHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 514 RLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 514 ~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
.+..+. .......++..+..++..||..+|++||++.+++..|..
T Consensus 271 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 315 (334)
T 2pvf_A 271 LLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315 (334)
T ss_dssp HHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhcCC-CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 655543 233345677788899999999999999999999987743
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-33 Score=300.29 Aligned_cols=245 Identities=20% Similarity=0.249 Sum_probs=190.5
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEec-cchhHHHHHHHHHHHHhcCCCCcccEEEEEEeC-CEEEEEEecCC
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHV-SSRDEMVVCFYRKSLKKLSHANLVKLKEVIREN-DTLYFVFEYMK 387 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~-~~~~LV~Ey~~ 387 (962)
.+.+.....+..++.+.||.+..... .++.+.+ .......+.+|++++++++||||+++++++.+. +..++||||++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGN-KVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTE-EEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hhhceEEeEEecCCCceEEEEEEcCC-EEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 45566666677777777999987533 3333333 233456789999999999999999999997544 47899999998
Q ss_pred C-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCC
Q psy501 388 E-NLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVST 465 (962)
Q Consensus 388 g-~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt 465 (962)
| +|.+.+.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++....... ....++
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~ 177 (278)
T 1byg_A 99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLP 177 (278)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------------CC
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc-cCCCcc
Confidence 5 7888776543 238999999999999999999999999999999999999999999999999997654432 234678
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCC
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGT 544 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dp 544 (962)
+.|+|||++.+ ..++.++|||||||++|+|++ |..||...........+..+. .......++..+..++..||..+|
T Consensus 178 ~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p 255 (278)
T 1byg_A 178 VKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-KMDAPDGCPPAVYEVMKNCWHLDA 255 (278)
T ss_dssp TTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-CCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred ccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCcccCCHHHHHHHHHHhcCCh
Confidence 89999999975 468999999999999999998 999999887766666665542 233345677788999999999999
Q ss_pred CCCCcHHHHHhhcc
Q psy501 545 ERLKSSYILLHTLP 558 (962)
Q Consensus 545 erRPs~~~Ll~~l~ 558 (962)
++||++.++++.|.
T Consensus 256 ~~Rps~~~l~~~L~ 269 (278)
T 1byg_A 256 AMRPSFLQLREQLE 269 (278)
T ss_dssp GGSCCHHHHHHHHH
T ss_pred hhCCCHHHHHHHHH
Confidence 99999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=302.88 Aligned_cols=251 Identities=17% Similarity=0.132 Sum_probs=191.7
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCC---ceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC--
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQD---NHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIREND-- 377 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~---~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~-- 377 (962)
..+.+.....++.++.+.||.+..... ...++.|... .....+.+|+.++++++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 344566666666666777999876542 2233333321 22356899999999999999999999997654
Q ss_pred ---EEEEEEecCC-CCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecc
Q psy501 378 ---TLYFVFEYMK-ENLYQLIRD-----RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADF 448 (962)
Q Consensus 378 ---~~~LV~Ey~~-g~Ll~~l~~-----~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DF 448 (962)
..++||||++ |+|.+++.. ....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 3599999998 477777643 2356999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhcccccc
Q psy501 449 GLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLH 523 (962)
Q Consensus 449 Gla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~ 523 (962)
|++...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+..+. ...
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~ 269 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-RLK 269 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCC
T ss_pred CcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-CCC
Confidence 999866433 2233456788999999975 479999999999999999999 999999887777666665553 233
Q ss_pred CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 524 TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 524 ~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
....++..+..++..||..+|++||++.+++..|....
T Consensus 270 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 270 QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 34566778889999999999999999999998775443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=298.34 Aligned_cols=244 Identities=19% Similarity=0.225 Sum_probs=196.0
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEe---------------
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRE--------------- 375 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--------------- 375 (962)
+.+.....+..++.+.||.+....+++.++.|........+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 44555556666666779999988666666655544444568899999999999999999999864
Q ss_pred -CCEEEEEEecCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccc
Q psy501 376 -NDTLYFVFEYMKE-NLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR 452 (962)
Q Consensus 376 -~~~~~LV~Ey~~g-~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~ 452 (962)
...+++||||++| +|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 170 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhhe
Confidence 4458999999995 788877654 3569999999999999999999999999999999999999999999999999998
Q ss_pred cccCC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCC
Q psy501 453 EIRSR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYH 531 (962)
Q Consensus 453 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 531 (962)
..... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.... .....+... ...+.++..
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~~----~~~~~~~~~ 243 (284)
T 2a19_B 171 SLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDG----IISDIFDKK 243 (284)
T ss_dssp ESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHTT----CCCTTSCHH
T ss_pred eccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhcc----cccccCCHH
Confidence 76544 3445679999999999976 468999999999999999999999885432 112222222 122456677
Q ss_pred cHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 532 VPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 532 l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
+..++..||..+|++||++.++++.+..+.
T Consensus 244 ~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 244 EKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 889999999999999999999999875443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=310.89 Aligned_cols=248 Identities=23% Similarity=0.292 Sum_probs=198.0
Q ss_pred eEEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEE
Q psy501 306 TCLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTL 379 (962)
Q Consensus 306 ~~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 379 (962)
..-+.+.+.....++.++.+.||.+.....++.++.|.... ....+.+|+.++++++||||+++++++...+..
T Consensus 37 ~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 116 (371)
T 4exu_A 37 AWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 116 (371)
T ss_dssp EEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSS
T ss_pred eecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCc
Confidence 34456777777777778888899999887777665554322 235688999999999999999999999876654
Q ss_pred ------EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccccc
Q psy501 380 ------YFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE 453 (962)
Q Consensus 380 ------~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~ 453 (962)
++||||+.|++.+.+. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 117 ~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 117 RNFYDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp TTCCCCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred ccceeEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 9999999998887763 3499999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-----------
Q psy501 454 IRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL----------- 522 (962)
Q Consensus 454 ~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------- 522 (962)
.... .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 194 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 194 ADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred cccC-cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence 5443 3456789999999999875679999999999999999999999999877665555443211100
Q ss_pred ------------------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 523 ------------------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 523 ------------------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
...+..+..+..++..||..+|++||++.+++..-
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 01134566788899999999999999988888754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=298.28 Aligned_cols=247 Identities=19% Similarity=0.226 Sum_probs=199.5
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
...+.....++.++.+.||.+.......++.+.+.. .....+.+|++++++++||||+++++++.+ +..++||||++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence 345556666666677779999877655555544432 245679999999999999999999999864 45899999997
Q ss_pred -CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---cccc
Q psy501 388 -ENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---YTDY 462 (962)
Q Consensus 388 -g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---~~~~ 462 (962)
|+|.+++.... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++....... ....
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 170 (279)
T 1qpc_A 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170 (279)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCC
Confidence 57777765432 258999999999999999999999999999999999999999999999999998765442 2334
Q ss_pred cCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhc
Q psy501 463 VSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 463 ~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~ 541 (962)
.++..|+|||++.+. .++.++|||||||++|||++ |+.||.+.........+..+. .......++..+..++..||.
T Consensus 171 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~ 248 (279)
T 1qpc_A 171 KFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-RMVRPDNCPEELYQLMRLCWK 248 (279)
T ss_dssp CCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTC
T ss_pred CCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc-CCCCcccccHHHHHHHHHHhc
Confidence 567889999999654 68999999999999999999 999999887776666665542 233345677788999999999
Q ss_pred cCCCCCCcHHHHHhhccc
Q psy501 542 AGTERLKSSYILLHTLPL 559 (962)
Q Consensus 542 ~dperRPs~~~Ll~~l~~ 559 (962)
.+|++||++.+++..+..
T Consensus 249 ~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 249 ERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp SSGGGSCCHHHHHHHHHH
T ss_pred cChhhCCCHHHHHHHHHH
Confidence 999999999999887743
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=305.10 Aligned_cols=248 Identities=15% Similarity=0.141 Sum_probs=199.6
Q ss_pred cCceeeEEEEecCCcccEEEEEecC-----CceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQ-----DNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTL 379 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~-----~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 379 (962)
.+.+.....++.++.+.||.+.... ..+.++.|... .....+.+|+.++++++||||+++++++.+++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 4556666666667777799887552 23333333322 2334688999999999999999999999999999
Q ss_pred EEEEecCC-CCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccc
Q psy501 380 YFVFEYMK-ENLYQLIRDRD---------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFG 449 (962)
Q Consensus 380 ~LV~Ey~~-g~Ll~~l~~~~---------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFG 449 (962)
++||||++ |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 183 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCc
Confidence 99999998 57887775432 457999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccC
Q psy501 450 LAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHT 524 (962)
Q Consensus 450 la~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~ 524 (962)
++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.........+..+.. ...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~ 261 (322)
T 1p4o_A 184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-LDK 261 (322)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-CCC
T ss_pred cccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc-CCC
Confidence 99765433 12234568889999999764 68999999999999999999 8999998877776666655432 233
Q ss_pred CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 525 LPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 525 ~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
...++..+..++..||..+|++||++.+++..+..
T Consensus 262 ~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~ 296 (322)
T 1p4o_A 262 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296 (322)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 45667778899999999999999999999987743
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-32 Score=296.80 Aligned_cols=246 Identities=19% Similarity=0.207 Sum_probs=186.2
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHh--cCCCCcccEEEEEEe----CCEEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKK--LSHANLVKLKEVIRE----NDTLYFVF 383 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~--L~HpnIv~l~~~~~~----~~~~~LV~ 383 (962)
.+.+.....++.++.+.||.+... ...++.+.+.......+.+|.+++.. ++||||+++++++.. ....++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEEC-CEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 456666667777777779999873 33444444555556667778888777 789999999999754 24689999
Q ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcc--------cceeeeccCCCcccccccccceeeecccccccc
Q psy501 384 EYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMH--------RHGFFHRDMKPENLLCMGTELVKIADFGLAREI 454 (962)
Q Consensus 384 Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH--------~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~ 454 (962)
||+++ +|.+++.. ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 86 e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 163 (301)
T 3q4u_A 86 HYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163 (301)
T ss_dssp CCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred hhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeec
Confidence 99985 77777743 45999999999999999999999 999999999999999999999999999999765
Q ss_pred cCCC------cccccCCccccChhhhccCC-----CCCchhHHHHHHHHHHHHHcC----------CCCCCCcChh----
Q psy501 455 RSRP------YTDYVSTRWYRAPEVLLHST-----AYSAPIHLSRSQQFLFYSIDH----------VPPIQTTCLL---- 509 (962)
Q Consensus 455 ~~~~------~~~~~gt~~Y~APE~l~~~~-----~~t~ksDIwSLGvlL~elltG----------~~Pf~~~~~~---- 509 (962)
.... .....||+.|+|||++.+.. .++.++|||||||++|||++| ..||......
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~ 243 (301)
T 3q4u_A 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243 (301)
T ss_dssp ETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred ccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcch
Confidence 4431 23347999999999997643 244799999999999999999 8898664322
Q ss_pred hhHHHHHhccccccCCCC------CCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 510 AGTERLKSSYILLHTLPL------YTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 510 ~~~~~i~~~~~~~~~~~~------~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
.............+..+. .+..+..++..||..+|++||++.++++.|.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 298 (301)
T 3q4u_A 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298 (301)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred hhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence 122222221111121111 1234778999999999999999999998763
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=306.38 Aligned_cols=253 Identities=18% Similarity=0.156 Sum_probs=198.7
Q ss_pred EEecCceeeEEEEecCCcccEEEEEe----cCCceEEEEecc-c---hhHHHHHHHHHHHHhcCCCCcccEEEEEE--eC
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNL----DQDNHILSRHVS-S---RDEMVVCFYRKSLKKLSHANLVKLKEVIR--EN 376 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~----~~~~kvv~~k~~-~---~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~--~~ 376 (962)
++-...+.....++.++.+.||.+.. ...++.++.|.. . .....+.+|++++++++||||+++++++. +.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 44455667777777777778999983 344444444332 2 22346899999999999999999999987 45
Q ss_pred CEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccccccc
Q psy501 377 DTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR 455 (962)
Q Consensus 377 ~~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~ 455 (962)
...++||||++ |+|.+.+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 67999999996 67888777655679999999999999999999999999999999999999999999999999998765
Q ss_pred CC-----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhh--------------hHHHHH
Q psy501 456 SR-----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLA--------------GTERLK 516 (962)
Q Consensus 456 ~~-----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~--------------~~~~i~ 516 (962)
.. ......+|..|+|||++.+. .++.++|||||||++|+|++|..||....... ......
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 43 22334678889999999764 68999999999999999999999997643321 111122
Q ss_pred hccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 517 SSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 517 ~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
......+..+.++..+..++..||..+|++||++.++++.|...
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22233444556777889999999999999999999998877443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=300.63 Aligned_cols=245 Identities=19% Similarity=0.184 Sum_probs=192.4
Q ss_pred eeeEEEEecCCcccEEEEEecCCc---eEEEEec-c----chhHHHHHHHHHHHHhcCCCCcccEEEEE-EeCCEEEEEE
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDN---HILSRHV-S----SRDEMVVCFYRKSLKKLSHANLVKLKEVI-RENDTLYFVF 383 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~---kvv~~k~-~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~-~~~~~~~LV~ 383 (962)
+.....++.++.+.||.+...... ..++.+. . ......+.+|+.++++++||||+++++++ ..++..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 444455555666678888754322 2233332 1 12335688999999999999999999986 4556789999
Q ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-----
Q psy501 384 EYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----- 457 (962)
Q Consensus 384 Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----- 457 (962)
||++| +|.+.+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~ 186 (298)
T 3f66_A 107 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 186 (298)
T ss_dssp ECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC
T ss_pred eCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhcc
Confidence 99985 888888776677999999999999999999999999999999999999999999999999999865432
Q ss_pred -CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHH
Q psy501 458 -PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPI 535 (962)
Q Consensus 458 -~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~l 535 (962)
......+|+.|+|||.+.+. .++.++|||||||++|+|++ |.+||.+.........+..+.. ......++..+..+
T Consensus 187 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l 264 (298)
T 3f66_A 187 HNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-LLQPEYCPDPLYEV 264 (298)
T ss_dssp -----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC-CCCCTTCCHHHHHH
T ss_pred ccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC-CCCCccCCHHHHHH
Confidence 23344677889999999764 68999999999999999999 6778887776666666655532 22234567778899
Q ss_pred HHHHhccCCCCCCcHHHHHhhccc
Q psy501 536 QTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 536 i~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
+..||..+|++||++.++++.+..
T Consensus 265 i~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 265 MLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHHHHH
Confidence 999999999999999999987743
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-32 Score=326.19 Aligned_cols=244 Identities=19% Similarity=0.172 Sum_probs=196.8
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
.+.+.....++.|+.+.||.+....+++.++.|.... ....+.+|+++|++++||||+++++++.+++.+|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 3445555556666666799998887777666655432 234588999999999999999999999999999999
Q ss_pred EecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-Cc
Q psy501 383 FEYMK-ENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PY 459 (962)
Q Consensus 383 ~Ey~~-g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~ 459 (962)
|||++ |+|.+.+.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|...... ..
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~ 342 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 342 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCE
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCccc
Confidence 99997 56777666543 35999999999999999999999999999999999999999999999999999876544 34
Q ss_pred ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh----hhHHHHHhccccccCCCCCCCCcHHH
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL----AGTERLKSSYILLHTLPLYTYHVPPI 535 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~s~~l~~l 535 (962)
...+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.... .....+..... .....++..+..+
T Consensus 343 ~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~--~~p~~~s~~~~dL 419 (576)
T 2acx_A 343 KGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE--EYSERFSPQARSL 419 (576)
T ss_dssp ECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC--CCCTTSCHHHHHH
T ss_pred cccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc--cCCccCCHHHHHH
Confidence 55689999999999976 46899999999999999999999999876432 22333333322 2224567788999
Q ss_pred HHHHhccCCCCCC-----cHHHHHhh
Q psy501 536 QTTCLLAGTERLK-----SSYILLHT 556 (962)
Q Consensus 536 i~~Cl~~dperRP-----s~~~Ll~~ 556 (962)
+..||..+|++|| ++.++++.
T Consensus 420 I~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 420 CSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 9999999999999 66776654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=313.72 Aligned_cols=247 Identities=21% Similarity=0.236 Sum_probs=194.6
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh---HHHHHHHHHHHHhcC--------CCCcccEEEEEE--
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD---EMVVCFYRKSLKKLS--------HANLVKLKEVIR-- 374 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~---~~~~~~Ei~iL~~L~--------HpnIv~l~~~~~-- 374 (962)
++.+.|.....++.++.+.||.+....+++.++.|+.... ...+.+|+.+|++++ ||+|+++++++.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 3467788888888888888999998887776666654432 356889999999995 788999999997
Q ss_pred --eCCEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccc-eeeeccCCCccccccccc---------
Q psy501 375 --ENDTLYFVFEYMKENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRH-GFFHRDMKPENLLCMGTE--------- 441 (962)
Q Consensus 375 --~~~~~~LV~Ey~~g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~-gIvHrDLkp~NILl~~~g--------- 441 (962)
.+..+|+||||++|++++.+.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 114 GVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp ETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred CCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence 456899999999999999887654 5699999999999999999999998 999999999999998775
Q ss_pred ----------------------------------------ceeeecccccccccCCCcccccCCccccChhhhccCCCCC
Q psy501 442 ----------------------------------------LVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYS 481 (962)
Q Consensus 442 ----------------------------------------~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t 481 (962)
.+||+|||++...... .....||+.|+|||++.+. .++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~ 271 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVLIGS-GYN 271 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHHHHTS-CCC
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-CccCCCCCcccCChhhcCC-CCC
Confidence 7999999999876543 3446799999999999764 699
Q ss_pred chhHHHHHHHHHHHHHcCCCCCCCcChhh------hHHHHHhcccccc---------------------CC---------
Q psy501 482 APIHLSRSQQFLFYSIDHVPPIQTTCLLA------GTERLKSSYILLH---------------------TL--------- 525 (962)
Q Consensus 482 ~ksDIwSLGvlL~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~---------------------~~--------- 525 (962)
.++|||||||++|||++|+.||.+..... ....+.......+ ..
T Consensus 272 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (397)
T 1wak_A 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF 351 (397)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHH
T ss_pred cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchh
Confidence 99999999999999999999998654221 1111111000000 00
Q ss_pred ----------CCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 526 ----------PLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 526 ----------~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
...+..+..++..||..+|++||++.++++.
T Consensus 352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 352 EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred HhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0011234579999999999999999988874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-33 Score=302.98 Aligned_cols=247 Identities=19% Similarity=0.216 Sum_probs=179.7
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccch-----hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEec
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-----DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEY 385 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-----~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey 385 (962)
+.+.....++.++.+.||.+.....++.++.|.... ....+.+|+.++++++||||+++++++..++..++||||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 445555555555556699988765555555544322 234688999999999999999999999999999999999
Q ss_pred CC-CCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC
Q psy501 386 MK-ENLYQLIRD-------RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR 457 (962)
Q Consensus 386 ~~-g~Ll~~l~~-------~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~ 457 (962)
++ |+|.+.+.. ....+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 174 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence 97 577777653 2456999999999999999999999999999999999999999999999999999765432
Q ss_pred -------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc--------
Q psy501 458 -------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL-------- 522 (962)
Q Consensus 458 -------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------- 522 (962)
......||+.|+|||++.+...++.++|||||||++|+|++|+.||...................
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (303)
T 2vwi_A 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDK 254 (303)
T ss_dssp -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----
T ss_pred CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccc
Confidence 12345789999999999754468999999999999999999999998876655544333322111
Q ss_pred cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 523 HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 523 ~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.....++..+..++..||..+|++||++.+++..-
T Consensus 255 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 255 EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 11234555678899999999999999999888753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=334.99 Aligned_cols=244 Identities=16% Similarity=0.168 Sum_probs=204.7
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEE
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTL 379 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 379 (962)
+..+.+.....++.++.+.||.+....+++.++.|+... ....+..|..+|..+ +||+|+++++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 345566666666666667799999988887766665432 234688899999988 699999999999999999
Q ss_pred EEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC--
Q psy501 380 YFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS-- 456 (962)
Q Consensus 380 ~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~-- 456 (962)
||||||++| +|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+....
T Consensus 418 ~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 999999985 677666654 4599999999999999999999999999999999999999999999999999986432
Q ss_pred CCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHH
Q psy501 457 RPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQ 536 (962)
Q Consensus 457 ~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li 536 (962)
......+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+.......+.......+ ...+..+..|+
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li 573 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--KSMSKEAVAIC 573 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC--TTSCHHHHHHH
T ss_pred cccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC--ccCCHHHHHHH
Confidence 34556789999999999965 4799999999999999999999999999988888888887755444 46777889999
Q ss_pred HHHhccCCCCCCcH-----HHHHh
Q psy501 537 TTCLLAGTERLKSS-----YILLH 555 (962)
Q Consensus 537 ~~Cl~~dperRPs~-----~~Ll~ 555 (962)
+.||..+|++|+++ .+++.
T Consensus 574 ~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 574 KGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHccCCHHHCCCCCCCcHHHHhc
Confidence 99999999999986 55554
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-32 Score=322.89 Aligned_cols=237 Identities=18% Similarity=0.190 Sum_probs=193.2
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh-------HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD-------EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
...+.....++.++.+.||.+....+++.++.|..... ...+.+|+++|++++||+|+++++++.+...+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 34455555566666667999998877776666554322 34688999999999999999999999999999999
Q ss_pred EecCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-
Q psy501 383 FEYMK-ENLYQLIRDR---DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457 (962)
Q Consensus 383 ~Ey~~-g~Ll~~l~~~---~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~- 457 (962)
|||++ |+|..++... ...+++..++.++.||+.||.|||+.||+||||||+||+++.+|.+||+|||++......
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 99998 5677766553 246999999999999999999999999999999999999999999999999999876544
Q ss_pred -CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcCh----hhhHHHHHhccccccCCCCCCCCc
Q psy501 458 -PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCL----LAGTERLKSSYILLHTLPLYTYHV 532 (962)
Q Consensus 458 -~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~s~~l 532 (962)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+... ......+....... .+.++..+
T Consensus 344 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~--p~~~s~~~ 420 (543)
T 3c4z_A 344 TKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY--PDKFSPAS 420 (543)
T ss_dssp CCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCC--CTTSCHHH
T ss_pred cccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCC--CcccCHHH
Confidence 2344589999999999976 4799999999999999999999999987532 33344444443222 25677788
Q ss_pred HHHHHHHhccCCCCCCc
Q psy501 533 PPIQTTCLLAGTERLKS 549 (962)
Q Consensus 533 ~~li~~Cl~~dperRPs 549 (962)
..++..||..+|++||+
T Consensus 421 ~~li~~lL~~dP~~R~~ 437 (543)
T 3c4z_A 421 KDFCEALLQKDPEKRLG 437 (543)
T ss_dssp HHHHHHHSCSSGGGSCC
T ss_pred HHHHHHhccCCHhHCCC
Confidence 99999999999999995
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=307.54 Aligned_cols=247 Identities=23% Similarity=0.291 Sum_probs=195.1
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCE--
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDT-- 378 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~-- 378 (962)
..+.+.+.....++.++.+.||.+.....++.++.|.... ....+.+|+.++++++||||+++++++.....
T Consensus 20 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 20 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred cccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 3455677777777777778899999887776655554321 23468899999999999999999999987653
Q ss_pred ----EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccc
Q psy501 379 ----LYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI 454 (962)
Q Consensus 379 ----~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~ 454 (962)
.|+||||++|+|.+.+. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 100 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 100 NFYDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp GCCCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred cceeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 59999999998876653 34899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc-------------
Q psy501 455 RSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL------------- 521 (962)
Q Consensus 455 ~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~------------- 521 (962)
... .....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.........+......
T Consensus 177 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 177 DAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred CCC-ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 433 344678999999999977567999999999999999999999999987765544443321100
Q ss_pred ----------------ccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 522 ----------------LHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 522 ----------------~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
....+..+..+..++..||..+|++||++.+++..-
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 011234556778899999999999999988887643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=303.89 Aligned_cols=242 Identities=17% Similarity=0.193 Sum_probs=182.2
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEecc-----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC---------
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVS-----SRDEMVVCFYRKSLKKLSHANLVKLKEVIREND--------- 377 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~--------- 377 (962)
.+.....++.++.+.||++....+++.++.|.. ......+.+|+++|++++||||++++++|.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 86 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence 445555566666667999988766665554442 223467999999999999999999999986543
Q ss_pred ------------------------------------------------EEEEEEecCCC-CHHHHHHhcC--CCCCHHHH
Q psy501 378 ------------------------------------------------TLYFVFEYMKE-NLYQLIRDRD--KFLPESII 406 (962)
Q Consensus 378 ------------------------------------------------~~~LV~Ey~~g-~Ll~~l~~~~--~~ls~~~i 406 (962)
..++|||||+| +|.+.+.... ...++..+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 166 (332)
T 3qd2_B 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166 (332)
T ss_dssp C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence 38999999985 6777666543 23566779
Q ss_pred HHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--------------CcccccCCccccChh
Q psy501 407 RNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--------------PYTDYVSTRWYRAPE 472 (962)
Q Consensus 407 ~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--------------~~~~~~gt~~Y~APE 472 (962)
+.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... ......||+.|+|||
T Consensus 167 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 246 (332)
T 3qd2_B 167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246 (332)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHH
T ss_pred HHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChH
Confidence 999999999999999999999999999999999999999999999876543 123357999999999
Q ss_pred hhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHH
Q psy501 473 VLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 552 (962)
Q Consensus 473 ~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~ 552 (962)
++.+. .++.++|||||||++|||++|..|+.... .....+..... +...+..+..+..++..||..+|++||++.+
T Consensus 247 ~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 322 (332)
T 3qd2_B 247 QIHGN-NYSHKVDIFSLGLILFELLYSFSTQMERV--RIITDVRNLKF-PLLFTQKYPQEHMMVQDMLSPSPTERPEATD 322 (332)
T ss_dssp HHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHHHH--HHHHHHHTTCC-CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHH
T ss_pred HhcCC-CCcchhhHHHHHHHHHHHHHcCCChhHHH--HHHHHhhccCC-CcccccCChhHHHHHHHHccCCCCcCCCHHH
Confidence 99764 78999999999999999999977753221 11222222211 1111223445677999999999999999888
Q ss_pred HHhhc
Q psy501 553 LLHTL 557 (962)
Q Consensus 553 Ll~~l 557 (962)
+++.-
T Consensus 323 ~l~~~ 327 (332)
T 3qd2_B 323 IIENA 327 (332)
T ss_dssp HHHST
T ss_pred Hhhch
Confidence 88743
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=321.32 Aligned_cols=237 Identities=15% Similarity=0.126 Sum_probs=181.7
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccc-------hhHHHHHHHH---HHHHhcCCCCcccEE-------EEEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYR---KSLKKLSHANLVKLK-------EVIR 374 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei---~iL~~L~HpnIv~l~-------~~~~ 374 (962)
.+.....++.++.+.||.+....+++.++.|+.. .....+.+|+ ++|++++||||++++ +++.
T Consensus 74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~ 153 (377)
T 3byv_A 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153 (377)
T ss_dssp EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence 3444555666666779999876655555444421 2346788999 455566899999998 7776
Q ss_pred eCCE-----------------EEEEEecCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHhhcccceeeeccCC
Q psy501 375 ENDT-----------------LYFVFEYMKENLYQLIRDRDK------FLPESIIRNMMYQVLQGLAFMHRHGFFHRDMK 431 (962)
Q Consensus 375 ~~~~-----------------~~LV~Ey~~g~Ll~~l~~~~~------~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLk 431 (962)
+++. .|+||||++|+|.+++..... .+++..++.++.||+.||.|||+.||+|||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDik 233 (377)
T 3byv_A 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 233 (377)
T ss_dssp CTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred ccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 6542 899999999999998876422 23348888999999999999999999999999
Q ss_pred CcccccccccceeeecccccccccCCCcccccCCccccChhhhccC----------CCCCchhHHHHHHHHHHHHHcCCC
Q psy501 432 PENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHS----------TAYSAPIHLSRSQQFLFYSIDHVP 501 (962)
Q Consensus 432 p~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~----------~~~t~ksDIwSLGvlL~elltG~~ 501 (962)
|+|||++.++.+||+|||+|+.... ......| +.|+|||++.+. ..++.++|||||||++|||++|+.
T Consensus 234 p~NIll~~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~ 311 (377)
T 3byv_A 234 PVDIVLDQRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311 (377)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred HHHEEEcCCCCEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCC
Confidence 9999999999999999999986433 3344567 999999999764 268999999999999999999999
Q ss_pred CCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 502 PIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 502 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
||.+.........+ ....+.++..+..++..||..+|++||++.++++.
T Consensus 312 Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 312 PITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp CC------CCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred CCcccccccchhhh------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99876544433322 22235677888999999999999999999988874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-32 Score=303.88 Aligned_cols=246 Identities=16% Similarity=0.232 Sum_probs=194.8
Q ss_pred CceeeE-EEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEE
Q psy501 311 GTERLK-FSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 311 g~~~~~-~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV 382 (962)
+.+... ..++.++.+.||.+....+++.++.|+.. .....+.+|+.+++++. ||+|+++++++.+++..++|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 344444 34444555669999887766665554432 22467899999999995 69999999999999999999
Q ss_pred EecCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc---ccceeeecccccccccCC
Q psy501 383 FEYMKE-NLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG---TELVKIADFGLAREIRSR 457 (962)
Q Consensus 383 ~Ey~~g-~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~---~g~vKL~DFGla~~~~~~ 457 (962)
|||+.| +|.+.+... ...+++..++.++.||+.||.|||+.||+||||||+||+++. .+.+||+|||++......
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 999985 666665432 356999999999999999999999999999999999999987 789999999999876544
Q ss_pred -CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--CCCCCCCCcHH
Q psy501 458 -PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--TLPLYTYHVPP 534 (962)
Q Consensus 458 -~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l~~ 534 (962)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.......+ ..+.++..+..
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 266 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATD 266 (327)
T ss_dssp ------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred cccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHH
Confidence 3345679999999999965 4789999999999999999999999999887777666665443332 23456667888
Q ss_pred HHHHHhccCCCCCCcHHHHHhhc
Q psy501 535 IQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 535 li~~Cl~~dperRPs~~~Ll~~l 557 (962)
++..||..+|++||++.++++.-
T Consensus 267 li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 267 FIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTCG
T ss_pred HHHHHcCCChhhCcCHHHHhCCH
Confidence 99999999999999999888754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-32 Score=301.11 Aligned_cols=248 Identities=19% Similarity=0.195 Sum_probs=195.5
Q ss_pred EecCceeeEEEEecCCcccEEEEEe-cCCceEEEEeccch---hHHHHHHHHHHHHhcCCC------CcccEEEEEEeCC
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNL-DQDNHILSRHVSSR---DEMVVCFYRKSLKKLSHA------NLVKLKEVIREND 377 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~-~~~~kvv~~k~~~~---~~~~~~~Ei~iL~~L~Hp------nIv~l~~~~~~~~ 377 (962)
++.+.+.....++.++.+.||.+.. ...++.++.|+... ....+.+|+++++.++|+ +++++++++..++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 3456777777777777778999987 44555555544332 245688999999998765 4999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc-----------------
Q psy501 378 TLYFVFEYMKENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG----------------- 439 (962)
Q Consensus 378 ~~~LV~Ey~~g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~----------------- 439 (962)
..++||||++++|.+.+.... ..+++..++.++.||+.||.|||+.||+||||||+||+++.
T Consensus 91 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 91 HICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 999999999999999887664 36899999999999999999999999999999999999987
Q ss_pred --ccceeeecccccccccCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHh
Q psy501 440 --TELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKS 517 (962)
Q Consensus 440 --~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~ 517 (962)
++.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+..
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 248 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEH-HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248 (339)
T ss_dssp ESCCCEEECCCSSCEETTSC-CCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHH
T ss_pred ccCCCceEeeCcccccCccc-cccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 567999999999765433 345678999999999975 4689999999999999999999999988766554433322
Q ss_pred ccccccC------------------------------------------CCCCCCCcHHHHHHHhccCCCCCCcHHHHHh
Q psy501 518 SYILLHT------------------------------------------LPLYTYHVPPIQTTCLLAGTERLKSSYILLH 555 (962)
Q Consensus 518 ~~~~~~~------------------------------------------~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~ 555 (962)
.....+. .+..+..+..++..||..+|++||++.++++
T Consensus 249 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 1111000 0011234568999999999999999998887
Q ss_pred hc
Q psy501 556 TL 557 (962)
Q Consensus 556 ~l 557 (962)
.-
T Consensus 329 hp 330 (339)
T 1z57_A 329 HP 330 (339)
T ss_dssp SG
T ss_pred CH
Confidence 53
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-32 Score=313.62 Aligned_cols=239 Identities=22% Similarity=0.345 Sum_probs=173.9
Q ss_pred CcccEEEEEec--CCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEe--CCEEEEEEecCCCCHHHHHHh
Q psy501 323 HTLPLYTCNLD--QDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIRE--NDTLYFVFEYMKENLYQLIRD 396 (962)
Q Consensus 323 ~~~~Vy~~~~~--~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~LV~Ey~~g~Ll~~l~~ 396 (962)
+.+.||.+... ...+.++.|... .....+.+|+.+|++++||||+++++++.. +..+|+||||++|+|.+.+..
T Consensus 33 ~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~ 112 (405)
T 3rgf_A 33 TYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKF 112 (405)
T ss_dssp ---EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSEEHHHHHHH
T ss_pred CCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCCCHHHHHHH
Confidence 34457888754 233333333322 224568899999999999999999999965 678999999999999888753
Q ss_pred c--------CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccc----ccccceeeecccccccccCC-----Cc
Q psy501 397 R--------DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLC----MGTELVKIADFGLAREIRSR-----PY 459 (962)
Q Consensus 397 ~--------~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl----~~~g~vKL~DFGla~~~~~~-----~~ 459 (962)
. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +..+.+||+|||+|+..... ..
T Consensus 113 ~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 192 (405)
T 3rgf_A 113 HRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192 (405)
T ss_dssp HHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC------------
T ss_pred hccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccC
Confidence 2 1249999999999999999999999999999999999999 67789999999999876542 23
Q ss_pred ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh---------hhHHHHHhcccccc-------
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL---------AGTERLKSSYILLH------- 523 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~---------~~~~~i~~~~~~~~------- 523 (962)
....||+.|+|||++.+...++.++|||||||++|||++|++||.+.... .....+......+.
T Consensus 193 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~ 272 (405)
T 3rgf_A 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDI 272 (405)
T ss_dssp ----CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGG
T ss_pred CCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchh
Confidence 44678999999999987667999999999999999999999999765431 11111111100000
Q ss_pred -----------------------------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcccccc
Q psy501 524 -----------------------------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTY 562 (962)
Q Consensus 524 -----------------------------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~ 562 (962)
.....+..+..|+..||..||++||++.++++.- |+..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp-~f~~ 339 (405)
T 3rgf_A 273 KKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP-YFLE 339 (405)
T ss_dssp GGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG-GGTS
T ss_pred hcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh-hhcc
Confidence 0011245667899999999999999998888754 5543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-32 Score=296.95 Aligned_cols=243 Identities=23% Similarity=0.311 Sum_probs=199.2
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
+.+.....+..++.+.||.+.....++.++.|+.. .....+.+|++++++++||||+++++++.+++..++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 45566666666677779999887666555444421 235678999999999999999999999999999999999
Q ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc---cceeeecccccccccCC-Cc
Q psy501 385 YMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT---ELVKIADFGLAREIRSR-PY 459 (962)
Q Consensus 385 y~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~---g~vKL~DFGla~~~~~~-~~ 459 (962)
|+. ++|.+.+... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.. +.+||+|||++...... ..
T Consensus 102 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~ 180 (287)
T 2wei_A 102 LYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (287)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence 997 5777777654 459999999999999999999999999999999999999754 46999999999866543 33
Q ss_pred ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--CCCCCCCCcHHHHH
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--TLPLYTYHVPPIQT 537 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l~~li~ 537 (962)
....+++.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+..+....+ ....++..+..++.
T Consensus 181 ~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 258 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258 (287)
T ss_dssp SCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHH
T ss_pred ccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHH
Confidence 44568899999999865 489999999999999999999999999887777777766544332 22456777889999
Q ss_pred HHhccCCCCCCcHHHHHhh
Q psy501 538 TCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 538 ~Cl~~dperRPs~~~Ll~~ 556 (962)
.||..+|++||++.+++..
T Consensus 259 ~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 259 KMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHTCSSGGGSCCHHHHHHS
T ss_pred HHcccChhhCcCHHHHhcC
Confidence 9999999999999888874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-32 Score=302.52 Aligned_cols=247 Identities=18% Similarity=0.216 Sum_probs=193.5
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEec-cchhHHHHHHHHHHHHhcC-CCCcccEEEEEEe--CCEEEEEE
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHV-SSRDEMVVCFYRKSLKKLS-HANLVKLKEVIRE--NDTLYFVF 383 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~-~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~--~~~~~LV~ 383 (962)
...+.+.....++.++.+.||.+.....++.++.|+ .......+.+|+.+|++++ ||||+++++++.+ ....++||
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 345667777777777788899998776666555444 4455677999999999997 9999999999987 66899999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc-ceeeecccccccccCC-Cccc
Q psy501 384 EYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE-LVKIADFGLAREIRSR-PYTD 461 (962)
Q Consensus 384 Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g-~vKL~DFGla~~~~~~-~~~~ 461 (962)
||+.++.+..+.. .+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++...... ....
T Consensus 113 e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 189 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 189 (330)
T ss_dssp ECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCS
T ss_pred eccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcccc
Confidence 9999654444443 289999999999999999999999999999999999999777 8999999999876543 4455
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh-hhHHHHHh-------------cccc------
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL-AGTERLKS-------------SYIL------ 521 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~-~~~~~i~~-------------~~~~------ 521 (962)
..++..|+|||++.+...++.++|||||||++|+|++|+.||...... .....+.. ....
T Consensus 190 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (330)
T 3nsz_A 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 269 (330)
T ss_dssp CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHH
T ss_pred ccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchh
Confidence 678999999999977667999999999999999999999999543221 11111111 0000
Q ss_pred ----------------ccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 522 ----------------LHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 522 ----------------~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.......+..+..++..||..+|++||++.++++.-
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp 321 (330)
T 3nsz_A 270 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321 (330)
T ss_dssp HHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSG
T ss_pred hhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCc
Confidence 000112566778899999999999999999888753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-32 Score=294.09 Aligned_cols=236 Identities=18% Similarity=0.182 Sum_probs=182.6
Q ss_pred CCcccEEEEEecCCceEEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHh
Q psy501 322 PHTLPLYTCNLDQDNHILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRD 396 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~ 396 (962)
++.+.||.+....+++.++.|.. ......+.+|+.++++++||||+++++++.+.+..++||||++ ++|.+.+..
T Consensus 33 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 112 (295)
T 2clq_A 33 GTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS 112 (295)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHH
T ss_pred cCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHh
Confidence 33445777776655554444332 2234568999999999999999999999999999999999997 577777765
Q ss_pred cC--CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc-ccceeeecccccccccCC--CcccccCCccccCh
Q psy501 397 RD--KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG-TELVKIADFGLAREIRSR--PYTDYVSTRWYRAP 471 (962)
Q Consensus 397 ~~--~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~-~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~AP 471 (962)
.. ..+++..++.++.|++.||.|||+.|++|+||||+||+++. ++.+||+|||++...... ......|++.|+||
T Consensus 113 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aP 192 (295)
T 2clq_A 113 KWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192 (295)
T ss_dssp TTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCH
T ss_pred hccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccCh
Confidence 43 34679999999999999999999999999999999999987 889999999999876542 23445789999999
Q ss_pred hhhccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh-HHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCc
Q psy501 472 EVLLHS-TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG-TERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 549 (962)
Q Consensus 472 E~l~~~-~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs 549 (962)
|++.+. ..++.++|||||||++|+|++|+.||........ ................++..+..++..||..+|++||+
T Consensus 193 E~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 272 (295)
T 2clq_A 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRAC 272 (295)
T ss_dssp HHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCC
T ss_pred hhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCC
Confidence 999654 2378999999999999999999999976543322 12221222222333466777889999999999999999
Q ss_pred HHHHHhhc
Q psy501 550 SYILLHTL 557 (962)
Q Consensus 550 ~~~Ll~~l 557 (962)
+.+++..-
T Consensus 273 ~~~ll~~~ 280 (295)
T 2clq_A 273 ANDLLVDE 280 (295)
T ss_dssp HHHHHTSG
T ss_pred HHHHhcCh
Confidence 98887653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=310.34 Aligned_cols=245 Identities=15% Similarity=0.195 Sum_probs=191.3
Q ss_pred cCceeeEEEEecCCcccEEEEEec---CCceEEEEeccc--------hhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCC
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLD---QDNHILSRHVSS--------RDEMVVCFYRKSLKKL-SHANLVKLKEVIREND 377 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~---~~~kvv~~k~~~--------~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 377 (962)
.+.+.....++.++.+.||.+... ..++.++.|+.. .....+.+|+++|+++ .||+|+++++++..+.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 356666666777777779999873 234444433321 2234578899999999 6999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC
Q psy501 378 TLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS 456 (962)
Q Consensus 378 ~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~ 456 (962)
..++||||++| +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 99999999985 777777654 4599999999999999999999999999999999999999999999999999986543
Q ss_pred C---CcccccCCccccChhhhccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh----HHHHHhccccccCCCCC
Q psy501 457 R---PYTDYVSTRWYRAPEVLLHS-TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG----TERLKSSYILLHTLPLY 528 (962)
Q Consensus 457 ~---~~~~~~gt~~Y~APE~l~~~-~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~ 528 (962)
. ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||........ ...+... ..+..+..
T Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 289 (355)
T 1vzo_A 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--EPPYPQEM 289 (355)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC--CCCCCTTS
T ss_pred CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc--CCCCCccc
Confidence 2 23345799999999999753 3578999999999999999999999976433222 2222222 12223456
Q ss_pred CCCcHHHHHHHhccCCCCCC-----cHHHHHhhc
Q psy501 529 TYHVPPIQTTCLLAGTERLK-----SSYILLHTL 557 (962)
Q Consensus 529 s~~l~~li~~Cl~~dperRP-----s~~~Ll~~l 557 (962)
+..+..++..||..+|++|| ++.++++..
T Consensus 290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 66778899999999999999 888888765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.4e-32 Score=307.94 Aligned_cols=244 Identities=12% Similarity=0.082 Sum_probs=188.2
Q ss_pred EecCceeeEEEEecCCcccEEEEE-----ecC-CceEEEEeccchhHHHHHHHHHHHHhcC---CCCcccEEEEEEeCCE
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCN-----LDQ-DNHILSRHVSSRDEMVVCFYRKSLKKLS---HANLVKLKEVIRENDT 378 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~-----~~~-~~kvv~~k~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~ 378 (962)
+....+.....++.|+.+.||++. ... ...++.+.........+.+|+++++.++ |++|+++++++..++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 344556666666667777799993 333 3344455555555667889999999987 9999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc-----------ccc
Q psy501 379 LYFVFEYMK-ENLYQLIRD----RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG-----------TEL 442 (962)
Q Consensus 379 ~~LV~Ey~~-g~Ll~~l~~----~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~-----------~g~ 442 (962)
.|+|||||+ |+|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTT
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCC
Confidence 999999998 678877764 3456999999999999999999999999999999999999998 899
Q ss_pred eeeecccccccccC----CCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhc
Q psy501 443 VKIADFGLAREIRS----RPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSS 518 (962)
Q Consensus 443 vKL~DFGla~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~ 518 (962)
+||+|||+|+.+.. ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||......... +.
T Consensus 222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~-- 296 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--PE-- 296 (365)
T ss_dssp EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--EC--
T ss_pred EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccHHHHHHHHHHHHhCCCccccCCCCcee--ec--
Confidence 99999999976532 234456799999999999764 6999999999999999999999999654331110 00
Q ss_pred cccccCCCCCCCCcHHHHHHHhccCCCCCC-cHHHHHhhcc
Q psy501 519 YILLHTLPLYTYHVPPIQTTCLLAGTERLK-SSYILLHTLP 558 (962)
Q Consensus 519 ~~~~~~~~~~s~~l~~li~~Cl~~dperRP-s~~~Ll~~l~ 558 (962)
...... ..+..+..++..|+..+|..|+ +..+|.+.+.
T Consensus 297 -~~~~~~-~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~ 335 (365)
T 3e7e_A 297 -GLFRRL-PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK 335 (365)
T ss_dssp -SCCTTC-SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred -hhcccc-CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence 001111 2244677899999999998885 5777766553
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=309.75 Aligned_cols=248 Identities=12% Similarity=0.097 Sum_probs=192.4
Q ss_pred CceeeEEEEecCCcccEEEEEecCC--------ceEEEEeccchhHHHHHHHHHHHHhcCCCCccc--------------
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQD--------NHILSRHVSSRDEMVVCFYRKSLKKLSHANLVK-------------- 368 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~--------~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~-------------- 368 (962)
+.+.....++.++.+.||.+....+ ++.++.|..... ..+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 4666666666677777999988762 344444433322 45889999999999999887
Q ss_pred -EEEEEEe-CCEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc--ce
Q psy501 369 -LKEVIRE-NDTLYFVFEYMKENLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE--LV 443 (962)
Q Consensus 369 -l~~~~~~-~~~~~LV~Ey~~g~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g--~v 443 (962)
+++++.. +...++||||+.|+|.+++... ...+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~ 200 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQV 200 (352)
T ss_dssp CCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEE
T ss_pred chhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceE
Confidence 6778876 7889999999977888888764 35699999999999999999999999999999999999999988 99
Q ss_pred eeecccccccccCC---------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcC-hhhhHH
Q psy501 444 KIADFGLAREIRSR---------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTC-LLAGTE 513 (962)
Q Consensus 444 KL~DFGla~~~~~~---------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~-~~~~~~ 513 (962)
||+|||++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ......
T Consensus 201 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 279 (352)
T 2jii_A 201 TLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIM 279 (352)
T ss_dssp EECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHH
Confidence 99999999765432 12334789999999999764 78999999999999999999999998764 222222
Q ss_pred HHHhccc-cccCC-------CCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 514 RLKSSYI-LLHTL-------PLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 514 ~i~~~~~-~~~~~-------~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
....... ..... ..++..+..++..||..+|++||++.++++.|...
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 280 KQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp HHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 2111111 11110 13567788999999999999999999999877443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=304.00 Aligned_cols=247 Identities=17% Similarity=0.184 Sum_probs=193.4
Q ss_pred CceeeEEEEecCCcccEEEEEe-----cCCceEEEEecc-----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNL-----DQDNHILSRHVS-----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLY 380 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~-----~~~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 380 (962)
+.+.....++.++.+.||.+.. ......++.|.. ......+.+|+.++++++||||+++++++.++...|
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 4455555555555667888873 233333333332 233457899999999999999999999999999999
Q ss_pred EEEecCC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc---cceeeecccc
Q psy501 381 FVFEYMK-ENLYQLIRDRD------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT---ELVKIADFGL 450 (962)
Q Consensus 381 LV~Ey~~-g~Ll~~l~~~~------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~---g~vKL~DFGl 450 (962)
+||||++ |+|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++.+ ..+||+|||+
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~ 189 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccc
Confidence 9999996 57888876643 358999999999999999999999999999999999999844 4699999999
Q ss_pred cccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCC
Q psy501 451 AREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTL 525 (962)
Q Consensus 451 a~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 525 (962)
+...... ......+++.|+|||++.+. .++.++|||||||++|+|++ |..||...........+..+.. ....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~~~ 267 (327)
T 2yfx_A 190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR-MDPP 267 (327)
T ss_dssp HHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-CCCC
T ss_pred ccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC-CCCC
Confidence 9765332 22345678899999999764 68999999999999999998 9999998877666666655432 2334
Q ss_pred CCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 526 PLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 526 ~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
..++..+..++..||..+|.+||++.++++.+..
T Consensus 268 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 268 KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 5667788899999999999999999999987743
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.98 E-value=8.3e-32 Score=298.57 Aligned_cols=246 Identities=25% Similarity=0.340 Sum_probs=193.7
Q ss_pred cCceeeEEEEecCCcccEEEEEec-CCceEEEEeccc------hhHHHHHHHHHHHHhc---CCCCcccEEEEEE-----
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLD-QDNHILSRHVSS------RDEMVVCFYRKSLKKL---SHANLVKLKEVIR----- 374 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~-~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~----- 374 (962)
.+.|.....++.++.+.||.+... ..++.++.|... .....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 355666666666677779999874 444444433221 1123567888887777 8999999999997
Q ss_pred eCCEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccccc
Q psy501 375 ENDTLYFVFEYMKENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE 453 (962)
Q Consensus 375 ~~~~~~LV~Ey~~g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~ 453 (962)
.....++||||++|+|.+.+.... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 90 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred CCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 456799999999999999887654 4599999999999999999999999999999999999999999999999999976
Q ss_pred ccCC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc----------
Q psy501 454 IRSR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL---------- 522 (962)
Q Consensus 454 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------- 522 (962)
.... ......|++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 170 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (326)
T 1blx_A 170 YSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248 (326)
T ss_dssp CCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred ccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccc
Confidence 6533 33456789999999999764 68999999999999999999999999887766655554321110
Q ss_pred ---------------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 523 ---------------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 523 ---------------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
...+.++..+..++..||..+|++||++.+++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0112345556789999999999999998888864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.3e-32 Score=302.24 Aligned_cols=251 Identities=19% Similarity=0.231 Sum_probs=197.5
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCc-eEEEEeccc---hhHHHHHHHHHHHHhcCCCC------cccEEEEEEeCC
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDN-HILSRHVSS---RDEMVVCFYRKSLKKLSHAN------LVKLKEVIREND 377 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~-kvv~~k~~~---~~~~~~~~Ei~iL~~L~Hpn------Iv~l~~~~~~~~ 377 (962)
.+.+.|.....++.++.+.||.+...... ..++.|+.. .....+.+|+.++++++|++ ++.+++++...+
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 34667777777777777889999876655 444444433 23456889999999997655 999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccc-------------------
Q psy501 378 TLYFVFEYMKENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLC------------------- 437 (962)
Q Consensus 378 ~~~LV~Ey~~g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl------------------- 437 (962)
..++||||+++++++.+.... ..+++..++.++.||+.||.|||+.||+||||||+||++
T Consensus 96 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 96 HMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred eEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 999999999999999887764 569999999999999999999999999999999999999
Q ss_pred ccccceeeecccccccccCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHh
Q psy501 438 MGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKS 517 (962)
Q Consensus 438 ~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~ 517 (962)
+.++.+||+|||++..... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.........+..
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 253 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHE-HHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253 (355)
T ss_dssp ESCCCEEECCCTTCEETTS-CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cCCCcEEEeecCccccccc-cccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 5678899999999976543 3345689999999999975 4789999999999999999999999998766544433322
Q ss_pred ccccccC------------------------------------------CCCCCCCcHHHHHHHhccCCCCCCcHHHHHh
Q psy501 518 SYILLHT------------------------------------------LPLYTYHVPPIQTTCLLAGTERLKSSYILLH 555 (962)
Q Consensus 518 ~~~~~~~------------------------------------------~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~ 555 (962)
.....+. ....+..+..++..||..+|++||++.++++
T Consensus 254 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 2111100 0001124558999999999999999988876
Q ss_pred hccccc
Q psy501 556 TLPLYT 561 (962)
Q Consensus 556 ~l~~~~ 561 (962)
.- |+.
T Consensus 334 hp-~f~ 338 (355)
T 2eu9_A 334 HP-FFA 338 (355)
T ss_dssp SG-GGG
T ss_pred Ch-hhc
Confidence 43 443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-32 Score=299.83 Aligned_cols=245 Identities=19% Similarity=0.255 Sum_probs=183.6
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEec-cchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-C
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHV-SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-N 389 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~ 389 (962)
.+.....++.++.+.||.+.... ..++.+.+ .......+.+|+++|++++||||+++++++.+ ..++||||++| +
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~ 85 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWRA-KDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGS 85 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEETT-EEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCB
T ss_pred HeeeeeEeecCCCceEEEEEECC-eeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCC
Confidence 44455555555666799988754 33333333 33345678999999999999999999998864 47899999984 7
Q ss_pred HHHHHHhcCC--CCCHHHHHHHHHHHHHHHhhccc---ceeeeccCCCcccccccccc-eeeecccccccccCCCccccc
Q psy501 390 LYQLIRDRDK--FLPESIIRNMMYQVLQGLAFMHR---HGFFHRDMKPENLLCMGTEL-VKIADFGLAREIRSRPYTDYV 463 (962)
Q Consensus 390 Ll~~l~~~~~--~ls~~~i~~i~~qI~~aL~yLH~---~gIvHrDLkp~NILl~~~g~-vKL~DFGla~~~~~~~~~~~~ 463 (962)
|.+.+..... .+++..++.++.|++.||.|||+ .||+||||||+||+++.++. +||+|||++...... .....
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 164 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-MTNNK 164 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-cccCC
Confidence 7777765432 47899999999999999999999 89999999999999998886 799999999765433 23456
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhh--hHHHHHhccccccCCCCCCCCcHHHHHHHhc
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLA--GTERLKSSYILLHTLPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~ 541 (962)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+..+ ...+....++..+..++..||.
T Consensus 165 gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~ 242 (307)
T 2eva_A 165 GSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG-TRPPLIKNLPKPIESLMTRCWS 242 (307)
T ss_dssp CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT-CCCCCBTTCCHHHHHHHHHHTC
T ss_pred CCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC-CCCCcccccCHHHHHHHHHHhc
Confidence 8999999999965 478999999999999999999999998643322 22222222 2233345667788899999999
Q ss_pred cCCCCCCcHHHHHhhcccccc
Q psy501 542 AGTERLKSSYILLHTLPLYTY 562 (962)
Q Consensus 542 ~dperRPs~~~Ll~~l~~~~~ 562 (962)
.+|++||++.++++.+.....
T Consensus 243 ~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 243 KDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp SSGGGSCCHHHHHHHHHHHGG
T ss_pred CChhhCcCHHHHHHHHHHHHH
Confidence 999999999999987754433
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-32 Score=301.75 Aligned_cols=245 Identities=21% Similarity=0.292 Sum_probs=190.7
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccch------------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR------------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDT 378 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~------------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 378 (962)
+.|.....++.++.+.||.+....+++.++.|+... ....+.+|+++|++++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 445556666666667799998877766555554321 1224789999999999999999999997665
Q ss_pred EEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccc---eeeecccccccc
Q psy501 379 LYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL---VKIADFGLAREI 454 (962)
Q Consensus 379 ~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~---vKL~DFGla~~~ 454 (962)
.++||||++| +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999985 67766654 456999999999999999999999999999999999999987664 999999999876
Q ss_pred cCC-CcccccCCccccChhhhc--cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh-hhHHHHHhccccc--cCCCCC
Q psy501 455 RSR-PYTDYVSTRWYRAPEVLL--HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL-AGTERLKSSYILL--HTLPLY 528 (962)
Q Consensus 455 ~~~-~~~~~~gt~~Y~APE~l~--~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~-~~~~~i~~~~~~~--~~~~~~ 528 (962)
... ......||+.|+|||++. +...++.++|||||||++|+|++|..||...... .....+..+.... ...+.+
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 247 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTS
T ss_pred ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhc
Confidence 544 223457899999999984 3456899999999999999999999999875443 2233333332211 112356
Q ss_pred CCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 529 TYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 529 s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+..+..++..||..+|++||++.++++.-
T Consensus 248 ~~~~~~li~~~l~~dP~~Rps~~~~l~h~ 276 (322)
T 2ycf_A 248 SEKALDLVKKLLVVDPKARFTTEEALRHP 276 (322)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred CHHHHHHHHHHcccCHhhCCCHHHHhhCc
Confidence 77788999999999999999998888743
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=311.83 Aligned_cols=243 Identities=19% Similarity=0.171 Sum_probs=185.4
Q ss_pred EEEEecCCcccEEEEEecCCc---eEEEEecc-----chhHHHHHHHHHHHHhcCCCCcccEEEEEE-eCCEEEEEEecC
Q psy501 316 KFSYILPHTLPLYTCNLDQDN---HILSRHVS-----SRDEMVVCFYRKSLKKLSHANLVKLKEVIR-ENDTLYFVFEYM 386 (962)
Q Consensus 316 ~~~~i~~~~~~Vy~~~~~~~~---kvv~~k~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~-~~~~~~LV~Ey~ 386 (962)
...++.++.+.||++...... ..++.|.. ......+.+|+.++++++||||+++++++. .++..++||||+
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~ 173 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence 334445555568888754321 22333322 123457899999999999999999999875 456789999999
Q ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC------Cc
Q psy501 387 K-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR------PY 459 (962)
Q Consensus 387 ~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~------~~ 459 (962)
+ |+|.+++......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 174 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~ 253 (373)
T 3c1x_A 174 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253 (373)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------
T ss_pred CCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccccccccc
Confidence 8 5888888776677999999999999999999999999999999999999999999999999999865432 12
Q ss_pred ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHH
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTT 538 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~ 538 (962)
....+++.|+|||++.+. .++.++|||||||++|||++ |.+||.+.........+..+.. ......++..+..++..
T Consensus 254 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~-~~~p~~~~~~l~~li~~ 331 (373)
T 3c1x_A 254 TGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-LLQPEYCPDPLYEVMLK 331 (373)
T ss_dssp ----CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC-CCCCTTCCHHHHHHHHH
T ss_pred CCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHH
Confidence 334567889999999764 78999999999999999999 7889988776666666655532 23334677788999999
Q ss_pred HhccCCCCCCcHHHHHhhcccc
Q psy501 539 CLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 539 Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
||..+|++||++.++++.|...
T Consensus 332 cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 332 CWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999877543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=8e-33 Score=305.81 Aligned_cols=237 Identities=16% Similarity=0.157 Sum_probs=187.2
Q ss_pred CCcccEEEEEecCCceEEEEecc-----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHH
Q psy501 322 PHTLPLYTCNLDQDNHILSRHVS-----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIR 395 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~ 395 (962)
++.+.||.+..... ++.+.+. ......+.+|+.++++++||||+++++++.++...++||||++ ++|.+.+.
T Consensus 44 G~~g~V~~~~~~~~--~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~ 121 (319)
T 2y4i_B 44 GRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR 121 (319)
T ss_dssp SSSSEEEEEEESSS--EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTT
T ss_pred CCceEEEEEEEcCe--EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHH
Confidence 33445777765443 2222221 1122457889999999999999999999999999999999998 56777776
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC-------CCcccccCCccc
Q psy501 396 DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS-------RPYTDYVSTRWY 468 (962)
Q Consensus 396 ~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~-------~~~~~~~gt~~Y 468 (962)
.....+++..++.++.||+.||.|||+.||+||||||+||+++ ++.+||+|||++..... .......|++.|
T Consensus 122 ~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y 200 (319)
T 2y4i_B 122 DAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200 (319)
T ss_dssp SSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGT
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccc
Confidence 6556799999999999999999999999999999999999998 68999999999875432 123334688999
Q ss_pred cChhhhcc--------CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHh
Q psy501 469 RAPEVLLH--------STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCL 540 (962)
Q Consensus 469 ~APE~l~~--------~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl 540 (962)
+|||++.+ ...++.++|||||||++|||++|+.||...........+..+.........++..+..++..||
T Consensus 201 ~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 280 (319)
T 2y4i_B 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCW 280 (319)
T ss_dssp SCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHH
T ss_pred cChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHh
Confidence 99999964 2357899999999999999999999999888777776666654444333467889999999999
Q ss_pred ccCCCCCCcHHHHHhhccccc
Q psy501 541 LAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 541 ~~dperRPs~~~Ll~~l~~~~ 561 (962)
..+|++||++.++++.+....
T Consensus 281 ~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 281 AFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp CSSTTTSCCHHHHHHHHTTC-
T ss_pred cCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999875543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.6e-33 Score=313.37 Aligned_cols=243 Identities=10% Similarity=0.025 Sum_probs=175.9
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhc--CCCCcccEE-------EEEEeC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKL--SHANLVKLK-------EVIREN 376 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L--~HpnIv~l~-------~~~~~~ 376 (962)
+.....++.++.+.||.+....+++.++.|+... ....+.+|+.+++.| +||||++++ +++..+
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 4445556666666799999877666555544322 234577885555444 699987755 555543
Q ss_pred -----------------CEEEEEEecCCCCHHHHHHhcCCCCCHHHH------HHHHHHHHHHHhhcccceeeeccCCCc
Q psy501 377 -----------------DTLYFVFEYMKENLYQLIRDRDKFLPESII------RNMMYQVLQGLAFMHRHGFFHRDMKPE 433 (962)
Q Consensus 377 -----------------~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i------~~i~~qI~~aL~yLH~~gIvHrDLkp~ 433 (962)
..+|+||||++|+|.+++...+..+++..+ +.++.||+.||+|||++||+||||||+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~ 223 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPD 223 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHH
Confidence 348999999999999999876555666666 788899999999999999999999999
Q ss_pred ccccccccceeeecccccccccCCCcccccCCccccChhhhccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhH
Q psy501 434 NLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHS-TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGT 512 (962)
Q Consensus 434 NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~ 512 (962)
|||++.++.+||+|||+|+....... ...+|+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.......
T Consensus 224 NIll~~~~~~kL~DFG~a~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~ 302 (371)
T 3q60_A 224 NLFIMPDGRLMLGDVSALWKVGTRGP-ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302 (371)
T ss_dssp GEEECTTSCEEECCGGGEEETTCEEE-GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT
T ss_pred HEEECCCCCEEEEecceeeecCCCcc-CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccccc
Confidence 99999999999999999987644322 45677999999999642 36899999999999999999999999886432211
Q ss_pred H-------HHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 513 E-------RLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 513 ~-------~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
. .........+..+..+..+..++..||..+|++||++.++++.
T Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0111122233334667788899999999999999998888763
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=3.5e-32 Score=324.44 Aligned_cols=246 Identities=20% Similarity=0.266 Sum_probs=201.2
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK- 387 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~- 387 (962)
..+.....++.++.+.||.+......+++.+.+.. ...+.+.+|+++|++++||||+++++++.+ +..||||||+.
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~ 345 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 345 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcC
Confidence 34455555666666679999887766655554432 235679999999999999999999999876 67899999998
Q ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---Cccccc
Q psy501 388 ENLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYV 463 (962)
Q Consensus 388 g~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~ 463 (962)
|+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 346 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 425 (535)
T 2h8h_A 346 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 425 (535)
T ss_dssp EEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTT
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCc
Confidence 5788887643 356899999999999999999999999999999999999999999999999999876533 223345
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhcc
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 542 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~ 542 (962)
++..|+|||++.+. .++.++|||||||+||||++ |+.||.+.........+..+. ..+....++..+..++..||..
T Consensus 426 ~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~cl~~ 503 (535)
T 2h8h_A 426 FPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPCPPECPESLHDLMCQCWRK 503 (535)
T ss_dssp SCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCS
T ss_pred CcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCC
Confidence 67889999999764 69999999999999999999 999999887777666666553 3334456777889999999999
Q ss_pred CCCCCCcHHHHHhhccc
Q psy501 543 GTERLKSSYILLHTLPL 559 (962)
Q Consensus 543 dperRPs~~~Ll~~l~~ 559 (962)
+|++||++.+|+..|..
T Consensus 504 dP~~RPt~~~l~~~L~~ 520 (535)
T 2h8h_A 504 EPEERPTFEYLQAFLED 520 (535)
T ss_dssp SGGGSCCHHHHHHHHHT
T ss_pred ChhHCcCHHHHHHHHHH
Confidence 99999999999887644
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-32 Score=314.80 Aligned_cols=245 Identities=21% Similarity=0.298 Sum_probs=184.2
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccchh------------HHHHHHHHHHHHhcCCCCcccEEEEEEeCCE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD------------EMVVCFYRKSLKKLSHANLVKLKEVIRENDT 378 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~------------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 378 (962)
+.+.....++.++.+.||.+....+.+.++.|+.... ...+.+|+.+|++++||||+++++++. ...
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCc
Confidence 4555666666666777999988777666655543221 124789999999999999999999985 456
Q ss_pred EEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc---ceeeecccccccc
Q psy501 379 LYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE---LVKIADFGLAREI 454 (962)
Q Consensus 379 ~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g---~vKL~DFGla~~~ 454 (962)
.++||||++| +|.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+||+++..+ .+||+|||+++..
T Consensus 214 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred eEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 8999999985 66665544 45699999999999999999999999999999999999997544 5999999999876
Q ss_pred cCC-CcccccCCccccChhhhcc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhh-hHHHHHhccccc--cCCCCC
Q psy501 455 RSR-PYTDYVSTRWYRAPEVLLH--STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLA-GTERLKSSYILL--HTLPLY 528 (962)
Q Consensus 455 ~~~-~~~~~~gt~~Y~APE~l~~--~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~-~~~~i~~~~~~~--~~~~~~ 528 (962)
... ......||+.|+|||++.+ ...++.++|||||||++|+|++|++||....... ....+..+.... ...+..
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 372 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 372 (419)
T ss_dssp C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTS
T ss_pred CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhccc
Confidence 544 3345689999999999853 3468899999999999999999999998754432 333444332221 112356
Q ss_pred CCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 529 TYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 529 s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+..+..++..||..+|++||++.++++.-
T Consensus 373 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 373 SEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 77788999999999999999988877643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=8e-32 Score=326.32 Aligned_cols=238 Identities=14% Similarity=0.179 Sum_probs=190.7
Q ss_pred EecCCcccEEEEEecC--CceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCH
Q psy501 319 YILPHTLPLYTCNLDQ--DNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENL 390 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~--~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~L 390 (962)
++.|+.+.||.+.... ....++.|... .....+.+|+++|++++||||+++++++.. +.+++||||++ |+|
T Consensus 344 LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L 422 (613)
T 2ozo_A 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPL 422 (613)
T ss_dssp EEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBH
T ss_pred EecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcH
Confidence 4444555688876542 23333333322 245679999999999999999999999976 56899999998 577
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC-----cccccCC
Q psy501 391 YQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP-----YTDYVST 465 (962)
Q Consensus 391 l~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~-----~~~~~gt 465 (962)
.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .....++
T Consensus 423 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~ 502 (613)
T 2ozo_A 423 HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502 (613)
T ss_dssp HHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------C
T ss_pred HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCc
Confidence 77777666779999999999999999999999999999999999999999999999999998764331 1223456
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCC
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGT 544 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dp 544 (962)
+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.........+..+. ..+..+.++..+..++..||..+|
T Consensus 503 ~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~dP 580 (613)
T 2ozo_A 503 LKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPECPPELYALMSDCWIYKW 580 (613)
T ss_dssp CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSST
T ss_pred cceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCCCCCcCCHHHHHHHHHHcCCCh
Confidence 889999999754 79999999999999999998 999999988777777776654 233445678889999999999999
Q ss_pred CCCCcHHHHHhhccc
Q psy501 545 ERLKSSYILLHTLPL 559 (962)
Q Consensus 545 erRPs~~~Ll~~l~~ 559 (962)
++||++.++++.|..
T Consensus 581 ~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 581 EDRPDFLTVEQRMRA 595 (613)
T ss_dssp TTSCCHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHH
Confidence 999999999887643
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.6e-33 Score=309.12 Aligned_cols=240 Identities=18% Similarity=0.156 Sum_probs=182.8
Q ss_pred EecCCcccEEEEEecCCceEEEEeccc---hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHH
Q psy501 319 YILPHTLPLYTCNLDQDNHILSRHVSS---RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLI 394 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~~~kvv~~k~~~---~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l 394 (962)
++.++.+.||.+.......++.+.... .....+.+|+.++++++||||+++++++.+++..++||||++ |+|.+.+
T Consensus 47 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 126 (321)
T 2qkw_B 47 IGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126 (321)
T ss_dssp SCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGS
T ss_pred eecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHH
Confidence 333444567887765444444443322 234578999999999999999999999999999999999998 4676666
Q ss_pred HhcC---CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----CcccccCCcc
Q psy501 395 RDRD---KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PYTDYVSTRW 467 (962)
Q Consensus 395 ~~~~---~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~~~~gt~~ 467 (962)
.... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...... ......||+.
T Consensus 127 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 206 (321)
T 2qkw_B 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLG 206 (321)
T ss_dssp SSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETT
T ss_pred hccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCcc
Confidence 4432 35899999999999999999999999999999999999999999999999999765432 2233468999
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHH-------HhccccccCCC--------CCCCCc
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERL-------KSSYILLHTLP--------LYTYHV 532 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i-------~~~~~~~~~~~--------~~s~~l 532 (962)
|+|||++.+. .++.++|||||||++|||++|+.||.+.......... ..+.......+ ..+..+
T Consensus 207 y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (321)
T 2qkw_B 207 YIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKF 285 (321)
T ss_dssp TCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHH
T ss_pred ccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHH
Confidence 9999999764 6899999999999999999999999875433221111 11111100001 112245
Q ss_pred HHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 533 PPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 533 ~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
..++..||..+|++||++.++++.+..
T Consensus 286 ~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 286 GDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 678999999999999999999987743
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-32 Score=302.91 Aligned_cols=242 Identities=19% Similarity=0.232 Sum_probs=198.3
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh----------HHHHHHHHHHHHhcC--CCCcccEEEEEE
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD----------EMVVCFYRKSLKKLS--HANLVKLKEVIR 374 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~----------~~~~~~Ei~iL~~L~--HpnIv~l~~~~~ 374 (962)
....+.+.....++.++.+.||.+....+++.++.|..... ...+.+|+.+++++. ||+|+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 44566677776666666677999988777766655543322 134778999999996 599999999999
Q ss_pred eCCEEEEEEecCC--CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccc-cccceeeeccccc
Q psy501 375 ENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM-GTELVKIADFGLA 451 (962)
Q Consensus 375 ~~~~~~LV~Ey~~--g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~-~~g~vKL~DFGla 451 (962)
.++..++|||++. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+|||++
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 9999999999997 6788877664 4589999999999999999999999999999999999998 7889999999999
Q ss_pred ccccCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCC
Q psy501 452 REIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYH 531 (962)
Q Consensus 452 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~ 531 (962)
............||+.|+|||++.+...++.++|||||||++|||++|+.||.... .+..... .....++..
T Consensus 198 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~--~~~~~~~~~ 269 (320)
T 3a99_A 198 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV--FFRQRVSSE 269 (320)
T ss_dssp EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCC--CCSSCCCHH
T ss_pred cccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccc--cccccCCHH
Confidence 88776666667899999999999776556789999999999999999999997642 1222222 223466778
Q ss_pred cHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 532 VPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 532 l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+..++..||..+|++||++.++++.-
T Consensus 270 ~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 270 CQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCH
Confidence 89999999999999999999988754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-31 Score=295.29 Aligned_cols=248 Identities=16% Similarity=0.179 Sum_probs=178.8
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccch-----hH-HHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-----DE-MVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-----~~-~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
.+.+.....+..++.+.||.+....+++.++.|.... .. ..+..+..+++.++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 3445555555555566799999876666555544321 11 23444455788889999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccc-eeeeccCCCcccccccccceeeecccccccccCC-Cccc
Q psy501 384 EYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRH-GFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-PYTD 461 (962)
Q Consensus 384 Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~-gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~~~~ 461 (962)
||+++.+..........+++..++.++.|++.||.|||+. ||+|+||||+||+++.++.+||+|||++...... ....
T Consensus 104 e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (318)
T 2dyl_A 104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDR 183 (318)
T ss_dssp CCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred eccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccc
Confidence 9996666555555566799999999999999999999995 9999999999999999999999999999766443 3344
Q ss_pred ccCCccccChhhhc----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcC-hhhhHHHHHhccc-cccCCCCCCCCcHHH
Q psy501 462 YVSTRWYRAPEVLL----HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTC-LLAGTERLKSSYI-LLHTLPLYTYHVPPI 535 (962)
Q Consensus 462 ~~gt~~Y~APE~l~----~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~-~~~~~~~i~~~~~-~~~~~~~~s~~l~~l 535 (962)
..+++.|+|||++. ....++.++|||||||++|+|++|+.||.... .......+..... ..+....++..+..+
T Consensus 184 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 263 (318)
T 2dyl_A 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSF 263 (318)
T ss_dssp ---CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHH
T ss_pred cCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHH
Confidence 57899999999995 23468899999999999999999999998743 3333334433322 222223567778999
Q ss_pred HHHHhccCCCCCCcHHHHHhhc
Q psy501 536 QTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 536 i~~Cl~~dperRPs~~~Ll~~l 557 (962)
+..||..+|.+||++.++++.-
T Consensus 264 i~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 264 VKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp HHHHTCSCTTTSCCHHHHTTSH
T ss_pred HHHHccCChhHCcCHHHHhhCH
Confidence 9999999999999999888754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.7e-33 Score=308.48 Aligned_cols=245 Identities=18% Similarity=0.147 Sum_probs=182.9
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccchh----HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD----EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE 388 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g 388 (962)
+.....++.++.+.||.+.......++.+.+.... ...+.+|++++++++||||+++++++.++...++||||++|
T Consensus 32 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 111 (326)
T 3uim_A 32 FSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 111 (326)
T ss_dssp SCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTT
T ss_pred cccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccC
Confidence 33333444455556777765544444444433221 22689999999999999999999999999999999999985
Q ss_pred -CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHhhcccc---eeeeccCCCcccccccccceeeecccccccccCC---C
Q psy501 389 -NLYQLIRDRD---KFLPESIIRNMMYQVLQGLAFMHRH---GFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---P 458 (962)
Q Consensus 389 -~Ll~~l~~~~---~~ls~~~i~~i~~qI~~aL~yLH~~---gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~ 458 (962)
+|.+.+.... ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++...... .
T Consensus 112 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (326)
T 3uim_A 112 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 191 (326)
T ss_dssp CBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCE
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccc
Confidence 7777776543 3599999999999999999999999 9999999999999999999999999999876433 2
Q ss_pred cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh----hhHHHHHhccccccCCC--------
Q psy501 459 YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL----AGTERLKSSYILLHTLP-------- 526 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~~-------- 526 (962)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... .................
T Consensus 192 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 3uim_A 192 TTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQ 270 (326)
T ss_dssp ECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCT
T ss_pred cccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhc
Confidence 3345699999999999764 6899999999999999999999999632111 11111111111110000
Q ss_pred -----CCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 527 -----LYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 527 -----~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
..+..+..++..||..+|++||++.++++.|.
T Consensus 271 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 271 GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 11124667889999999999999999999774
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-31 Score=296.47 Aligned_cols=246 Identities=17% Similarity=0.212 Sum_probs=184.3
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhc--CCCCcccEEEEEEeC----CEEEEEEe
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKL--SHANLVKLKEVIREN----DTLYFVFE 384 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L--~HpnIv~l~~~~~~~----~~~~LV~E 384 (962)
+.+.....++.++.+.||.+... ...++.+.+.........+|.+++..+ +||||+++++++... ...++|||
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 115 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD 115 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEEC
T ss_pred cceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEe
Confidence 45666666666777779999876 334444444444555566777777665 899999999999887 78999999
Q ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccc--------eeeeccCCCcccccccccceeeeccccccccc
Q psy501 385 YMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRH--------GFFHRDMKPENLLCMGTELVKIADFGLAREIR 455 (962)
Q Consensus 385 y~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~--------gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~ 455 (962)
|++| +|.+++... .+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++....
T Consensus 116 ~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 193 (337)
T 3mdy_A 116 YHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI 193 (337)
T ss_dssp CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeec
Confidence 9985 788777553 589999999999999999999998 99999999999999999999999999997664
Q ss_pred CCC------cccccCCccccChhhhccCCCCCc------hhHHHHHHHHHHHHHcC----------CCCCCCcChhh---
Q psy501 456 SRP------YTDYVSTRWYRAPEVLLHSTAYSA------PIHLSRSQQFLFYSIDH----------VPPIQTTCLLA--- 510 (962)
Q Consensus 456 ~~~------~~~~~gt~~Y~APE~l~~~~~~t~------ksDIwSLGvlL~elltG----------~~Pf~~~~~~~--- 510 (962)
... .....||+.|+|||++.+. .++. ++|||||||++|||++| ..||.......
T Consensus 194 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~ 272 (337)
T 3mdy_A 194 SDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272 (337)
T ss_dssp ---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCch
Confidence 432 2245799999999999754 3333 49999999999999999 77776542221
Q ss_pred -hHHHHHhccccccCCC------CCCCCcHHHHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 511 -GTERLKSSYILLHTLP------LYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 511 -~~~~i~~~~~~~~~~~------~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
............+..+ .++..+..++..||..+|++||++.++++.|...
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 1122211111111111 1223367799999999999999999999987543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-31 Score=295.24 Aligned_cols=248 Identities=16% Similarity=0.190 Sum_probs=188.1
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEecc-----chhHHHHHHHHHHHHhcC--CCCcccEEEEEEeCCEEEEEEe
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVS-----SRDEMVVCFYRKSLKKLS--HANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~~~~~LV~E 384 (962)
.+.....++.++.+.||.+.......++.+.+. ......+.+|++++++++ ||+|+++++++.++...++|||
T Consensus 29 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 108 (313)
T 3cek_A 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 108 (313)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe
Confidence 355555555556667999987654444444332 123456899999999997 5999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----Ccc
Q psy501 385 YMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PYT 460 (962)
Q Consensus 385 y~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~ 460 (962)
+..++|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+||++++ +.+||+|||++...... ...
T Consensus 109 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~ 186 (313)
T 3cek_A 109 CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKD 186 (313)
T ss_dssp CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-----------
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCcccccccc
Confidence 7778898888765 46899999999999999999999999999999999999964 89999999999876443 223
Q ss_pred cccCCccccChhhhcc----------CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh-hhHHHHHhccccccCCCCCC
Q psy501 461 DYVSTRWYRAPEVLLH----------STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL-AGTERLKSSYILLHTLPLYT 529 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~----------~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s 529 (962)
...|++.|+|||++.+ ...++.++|||||||++|+|++|+.||...... .....+.............+
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (313)
T 3cek_A 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 266 (313)
T ss_dssp ---CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSC
T ss_pred CCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccch
Confidence 4578999999999864 136889999999999999999999999875432 22333333322233334456
Q ss_pred CCcHHHHHHHhccCCCCCCcHHHHHhhcccccc
Q psy501 530 YHVPPIQTTCLLAGTERLKSSYILLHTLPLYTY 562 (962)
Q Consensus 530 ~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~ 562 (962)
..+..++..||..+|++||++.++++.- |+..
T Consensus 267 ~~l~~li~~~l~~dp~~Rps~~ell~h~-~~~~ 298 (313)
T 3cek_A 267 KDLQDVLKCCLKRDPKQRISIPELLAHP-YVQI 298 (313)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSH-HHHC
T ss_pred HHHHHHHHHHccCCcccCcCHHHHhcCc-cccC
Confidence 6788999999999999999999888754 4443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-31 Score=291.12 Aligned_cols=246 Identities=21% Similarity=0.222 Sum_probs=185.2
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc---hhHHHHHHHHHHHHhcCCCCcccEEEEEEe------------
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS---RDEMVVCFYRKSLKKLSHANLVKLKEVIRE------------ 375 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~---~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~------------ 375 (962)
+.+.....++.++.+.||.+....+++.++.|... .....+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 34555556666666779999877666655554433 234568899999999999999999999865
Q ss_pred -CCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccccc
Q psy501 376 -NDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE 453 (962)
Q Consensus 376 -~~~~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~ 453 (962)
....++||||++ |+|.+.+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 165 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSC
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhh
Confidence 357899999997 588888877666789999999999999999999999999999999999999999999999999976
Q ss_pred ccCC----------------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCc-ChhhhHHHHH
Q psy501 454 IRSR----------------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTT-CLLAGTERLK 516 (962)
Q Consensus 454 ~~~~----------------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~-~~~~~~~~i~ 516 (962)
.... ......|++.|+|||++.+...++.++|||||||++|+|++ ||... ........+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~ 242 (303)
T 1zy4_A 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLR 242 (303)
T ss_dssp TTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHH
T ss_pred cccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhcc
Confidence 5421 22345689999999999765578999999999999999998 55433 2223333333
Q ss_pred hccccccC--CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 517 SSYILLHT--LPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 517 ~~~~~~~~--~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
......+. ....+..+..++..||..+|++||++.++++.- |+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~-~~ 287 (303)
T 1zy4_A 243 SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG-WL 287 (303)
T ss_dssp STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS-CS
T ss_pred ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC-Cc
Confidence 33222221 122333468899999999999999998888753 44
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-32 Score=297.98 Aligned_cols=209 Identities=22% Similarity=0.231 Sum_probs=169.5
Q ss_pred HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHhhcccce
Q psy501 348 EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDR--DKFLPESIIRNMMYQVLQGLAFMHRHG 424 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~--~~~ls~~~i~~i~~qI~~aL~yLH~~g 424 (962)
...+.+|+.++++++||||+++++++.+++..++||||++ |+|.+.+... ...+++..++.++.||+.||.|||+.|
T Consensus 74 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 153 (307)
T 2nru_A 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 153 (307)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 4578999999999999999999999999999999999997 5777777543 356999999999999999999999999
Q ss_pred eeeccCCCcccccccccceeeecccccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCC
Q psy501 425 FFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHV 500 (962)
Q Consensus 425 IvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~ 500 (962)
|+||||||+||+++.++.+||+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|.
T Consensus 154 i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~ 231 (307)
T 2nru_A 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGL 231 (307)
T ss_dssp EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCC
T ss_pred eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCC
Confidence 999999999999999999999999999765443 1234578999999999865 4889999999999999999999
Q ss_pred CCCCCcChhhhHHHHHh----ccc-----cccCCC----CCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 501 PPIQTTCLLAGTERLKS----SYI-----LLHTLP----LYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 501 ~Pf~~~~~~~~~~~i~~----~~~-----~~~~~~----~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
+||...........+.. ... .....+ .++..+..++..||..+|.+||++.++++.|.
T Consensus 232 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~ 302 (307)
T 2nru_A 232 PAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302 (307)
T ss_dssp CSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 99987654332222211 100 001111 12234667999999999999999999998763
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-32 Score=299.10 Aligned_cols=243 Identities=19% Similarity=0.175 Sum_probs=188.7
Q ss_pred eeEEEEecCCcccEEEEEec----CCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEe--CCEEEEE
Q psy501 314 RLKFSYILPHTLPLYTCNLD----QDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRE--NDTLYFV 382 (962)
Q Consensus 314 ~~~~~~i~~~~~~Vy~~~~~----~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~LV 382 (962)
.....++.++.+.||.+... ..++.++.|+.. .....+.+|+++|++++||||+++++++.+ ...+++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 56666666667778777543 233444443322 224568999999999999999999999987 4689999
Q ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----
Q psy501 383 FEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---- 457 (962)
Q Consensus 383 ~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---- 457 (962)
|||+++ +|.+.+... .+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 114 ~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 191 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 191 (318)
T ss_dssp ECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEE
T ss_pred EecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccccc
Confidence 999985 676666543 3899999999999999999999999999999999999999999999999999876543
Q ss_pred -CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhh--------------hHHHHHhccccc
Q psy501 458 -PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLA--------------GTERLKSSYILL 522 (962)
Q Consensus 458 -~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~--------------~~~~i~~~~~~~ 522 (962)
......++..|+|||++.+. .++.++|||||||++|+|++|..||....... ............
T Consensus 192 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (318)
T 3lxp_A 192 RVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERL 270 (318)
T ss_dssp EC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCC
T ss_pred ccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCC
Confidence 22344678889999999764 68899999999999999999999997643211 111122222334
Q ss_pred cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 523 HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 523 ~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
+....++..+..++..||..+|++||++.++++.|..
T Consensus 271 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 271 PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 4445677788999999999999999999999987643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=314.63 Aligned_cols=248 Identities=20% Similarity=0.249 Sum_probs=191.2
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC--EEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIREND--TLYFV 382 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~--~~~LV 382 (962)
.+.|.....++.++.+.||.+....+++.++.|+.. .....+.+|+++|++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 445666667777777789999988777666555433 22456889999999999999999999998755 78999
Q ss_pred EecCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccc----ccccceeeeccccccccc
Q psy501 383 FEYMKE-NLYQLIRDRD--KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLC----MGTELVKIADFGLAREIR 455 (962)
Q Consensus 383 ~Ey~~g-~Ll~~l~~~~--~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl----~~~g~vKL~DFGla~~~~ 455 (962)
|||++| +|.+.+.... ..+++..++.++.||+.||.|||+.||+||||||+||++ +..+.+||+|||+++...
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 999984 6777665432 339999999999999999999999999999999999999 777889999999998765
Q ss_pred CC-CcccccCCccccChhhhccC-------CCCCchhHHHHHHHHHHHHHcCCCCCCCcCh----hhhHHHHHhcccccc
Q psy501 456 SR-PYTDYVSTRWYRAPEVLLHS-------TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCL----LAGTERLKSSYILLH 523 (962)
Q Consensus 456 ~~-~~~~~~gt~~Y~APE~l~~~-------~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~ 523 (962)
.. ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||..... ......+..+.....
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence 44 33456799999999998641 3578899999999999999999999975332 222333333221100
Q ss_pred ----------------CCC-------CCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 524 ----------------TLP-------LYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 524 ----------------~~~-------~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..+ ..+..+..++..||..||++||++.+++..+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l 304 (396)
T 4eut_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (396)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHH
Confidence 001 1112455789999999999999999887765
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=303.17 Aligned_cols=207 Identities=21% Similarity=0.300 Sum_probs=173.1
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh---HHHHHHHHHHHHhcC-CC-----CcccEEEEEEeCCEE
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD---EMVVCFYRKSLKKLS-HA-----NLVKLKEVIRENDTL 379 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~---~~~~~~Ei~iL~~L~-Hp-----nIv~l~~~~~~~~~~ 379 (962)
..+.+.....++.++.+.||++....+++.++.|+.... ...+.+|+.+++.+. |+ +|+++++++...+..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 356677777777777788999998877776666554332 346788999998885 55 499999999999999
Q ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcc--cceeeeccCCCcccccc--cccceeeecccccccc
Q psy501 380 YFVFEYMKENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMH--RHGFFHRDMKPENLLCM--GTELVKIADFGLAREI 454 (962)
Q Consensus 380 ~LV~Ey~~g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH--~~gIvHrDLkp~NILl~--~~g~vKL~DFGla~~~ 454 (962)
|+||||++|+|.+.+.... ..+++..++.++.|++.||.||| +.||+||||||+|||++ .++.+||+|||+|...
T Consensus 132 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 132 CLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp EEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 9999999999999987764 56999999999999999999999 57999999999999995 4778999999999876
Q ss_pred cCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHh
Q psy501 455 RSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKS 517 (962)
Q Consensus 455 ~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~ 517 (962)
... .....||+.|+|||++.+. .++.++|||||||++|||++|++||.+.........+..
T Consensus 212 ~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 272 (382)
T 2vx3_A 212 GQR-IYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272 (382)
T ss_dssp TCC-CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccc-cccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 543 3456899999999999764 699999999999999999999999998877666555543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=315.59 Aligned_cols=245 Identities=15% Similarity=0.126 Sum_probs=179.7
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCCCCHH
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKENLY 391 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll 391 (962)
+.....++.|+.+.||.........++.+.+.......+.+|+++|+++ +||||+++++++.++...|+|||||+|+|.
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g~L~ 105 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQ 105 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSEEHH
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCCCHH
Confidence 3444444444445556555445555555555444444578899999999 799999999999999999999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc---c--cceeeecccccccccCC-----Cccc
Q psy501 392 QLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG---T--ELVKIADFGLAREIRSR-----PYTD 461 (962)
Q Consensus 392 ~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~---~--g~vKL~DFGla~~~~~~-----~~~~ 461 (962)
+++......+++..++.++.||+.||.|||+.||+||||||+||+++. + ..+||+|||+|...... ....
T Consensus 106 ~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~ 185 (432)
T 3p23_A 106 EYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185 (432)
T ss_dssp HHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------
T ss_pred HHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccc
Confidence 999887766777788899999999999999999999999999999953 2 35789999999876532 2344
Q ss_pred ccCCccccChhhhcc--CCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccC-CCCCCCCcHHHHH
Q psy501 462 YVSTRWYRAPEVLLH--STAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHT-LPLYTYHVPPIQT 537 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~--~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~s~~l~~li~ 537 (962)
..||+.|+|||++.+ ...++.++|||||||++|||++ |..||...........+......... ....+..+..++.
T Consensus 186 ~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 265 (432)
T 3p23_A 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIE 265 (432)
T ss_dssp CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHH
T ss_pred cCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHH
Confidence 679999999999964 3457889999999999999999 99999665443332221111111000 0011223567999
Q ss_pred HHhccCCCCCCcHHHHHhhc
Q psy501 538 TCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 538 ~Cl~~dperRPs~~~Ll~~l 557 (962)
.||..+|++||++.++++.-
T Consensus 266 ~~L~~dP~~Rps~~evl~hp 285 (432)
T 3p23_A 266 KMIAMDPQKRPSAKHVLKHP 285 (432)
T ss_dssp HHSCSSGGGSCCHHHHHTST
T ss_pred HHHhCCHhhCCCHHHHHhCc
Confidence 99999999999988887643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=325.35 Aligned_cols=237 Identities=14% Similarity=0.156 Sum_probs=188.4
Q ss_pred EecCCcccEEEEEe--cCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-C
Q psy501 319 YILPHTLPLYTCNL--DQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-N 389 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~--~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~ 389 (962)
++.|+.+.||++.. ....+.++.|+... ....+.+|+++|++++||||+++++++.. +..++||||++| +
T Consensus 377 LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~ 455 (635)
T 4fl3_A 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGP 455 (635)
T ss_dssp EEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred eccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCC
Confidence 44455556888843 33334444433221 24679999999999999999999999975 458899999985 6
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-----CcccccC
Q psy501 390 LYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-----PYTDYVS 464 (962)
Q Consensus 390 Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-----~~~~~~g 464 (962)
|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+... ......+
T Consensus 456 L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~ 534 (635)
T 4fl3_A 456 LNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 534 (635)
T ss_dssp HHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------
T ss_pred HHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCC
Confidence 6666654 456999999999999999999999999999999999999999999999999999876543 1223356
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccC
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.........+..+. .......++..+..++..||..+
T Consensus 535 t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~d 612 (635)
T 4fl3_A 535 PVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGCPAGCPREMYDLMNLCWTYD 612 (635)
T ss_dssp CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSS
T ss_pred ceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCC
Confidence 788999999965 469999999999999999998 999999988877777666653 23334567788899999999999
Q ss_pred CCCCCcHHHHHhhccc
Q psy501 544 TERLKSSYILLHTLPL 559 (962)
Q Consensus 544 perRPs~~~Ll~~l~~ 559 (962)
|++||++.+|+..|..
T Consensus 613 P~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 613 VENRPGFAAVELRLRN 628 (635)
T ss_dssp TTTSCCHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHHHH
Confidence 9999999999887643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=314.62 Aligned_cols=249 Identities=18% Similarity=0.162 Sum_probs=197.1
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCC-CCcccEEEEEEeCCEEEEEEecC
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSH-ANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
.+.+.....++.++.+.||.+.....++.++.|+.. .....+.+|+++++.++| ++|..+..++..+...+|||||+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 445555555666666679999877666666655432 223458899999999986 56666777778889999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccc---ccccceeeecccccccccCCC-----
Q psy501 387 KENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLC---MGTELVKIADFGLAREIRSRP----- 458 (962)
Q Consensus 387 ~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl---~~~g~vKL~DFGla~~~~~~~----- 458 (962)
.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++......
T Consensus 86 g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (483)
T 3sv0_A 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (483)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccccc
Confidence 889999988767789999999999999999999999999999999999999 578899999999998765432
Q ss_pred ----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh---hhHHHHHhcccc---ccCCCCC
Q psy501 459 ----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL---AGTERLKSSYIL---LHTLPLY 528 (962)
Q Consensus 459 ----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~---~~~~~i~~~~~~---~~~~~~~ 528 (962)
.....||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.... .....+...... ......+
T Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (483)
T 3sv0_A 166 PYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGY 244 (483)
T ss_dssp CCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTS
T ss_pred ccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCC
Confidence 2256799999999999764 6999999999999999999999999875432 222222222111 1112466
Q ss_pred CCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 529 TYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 529 s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
+..+..++..||..+|++||++.+|++.|..
T Consensus 245 p~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 245 PTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred cHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 7788999999999999999999988887643
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=298.46 Aligned_cols=248 Identities=18% Similarity=0.180 Sum_probs=192.1
Q ss_pred cCceeeEEEEecCCcccEEEEEe----cCCceEEEEec-cc---hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC--EE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNL----DQDNHILSRHV-SS---RDEMVVCFYRKSLKKLSHANLVKLKEVIREND--TL 379 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~----~~~~kvv~~k~-~~---~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~--~~ 379 (962)
.+.+.....++.++.+.||.+.. ...++.++.|. .. .....+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 34555666666666677999984 33444444433 22 22456899999999999999999999986543 68
Q ss_pred EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC
Q psy501 380 YFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP 458 (962)
Q Consensus 380 ~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~ 458 (962)
++||||++ |+|.+.+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 99999997 58888887776779999999999999999999999999999999999999999999999999998765432
Q ss_pred -----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhh---------------hHHHHHhc
Q psy501 459 -----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLA---------------GTERLKSS 518 (962)
Q Consensus 459 -----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~---------------~~~~i~~~ 518 (962)
.....++..|+|||++.+. .++.++|||||||++|||++|..||....... ........
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 278 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred cccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhc
Confidence 2234567789999999764 68999999999999999999999986532110 00111111
Q ss_pred cccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 519 YILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 519 ~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
....+..+.++..+..++..||..+|++||++.+++..|.
T Consensus 279 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~ 318 (326)
T 2w1i_A 279 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318 (326)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1223344567778899999999999999999999998764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=309.21 Aligned_cols=237 Identities=17% Similarity=0.215 Sum_probs=174.8
Q ss_pred EEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHh
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRD 396 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~ 396 (962)
.++.|+.+.||.+.......++.+.+.......+.+|+.+|+++ +||||+++++++.+++..|+|||||+|+|.+.+..
T Consensus 22 ~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~gsL~~~l~~ 101 (434)
T 2rio_A 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVES 101 (434)
T ss_dssp EEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHT
T ss_pred eEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCCCCHHHHHhc
Confidence 34444445576655444444544444444456688999999987 89999999999999999999999999999988876
Q ss_pred cCCC------CCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc-------------ceeeecccccccccCC
Q psy501 397 RDKF------LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE-------------LVKIADFGLAREIRSR 457 (962)
Q Consensus 397 ~~~~------ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g-------------~vKL~DFGla~~~~~~ 457 (962)
.... .++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++......
T Consensus 102 ~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~ 181 (434)
T 2rio_A 102 KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181 (434)
T ss_dssp C------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC-
T ss_pred cCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCC
Confidence 4321 13345678999999999999999999999999999997543 8999999999876543
Q ss_pred C------cccccCCccccChhhhcc------CCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccC
Q psy501 458 P------YTDYVSTRWYRAPEVLLH------STAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHT 524 (962)
Q Consensus 458 ~------~~~~~gt~~Y~APE~l~~------~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~ 524 (962)
. .....||+.|+|||++.+ ...++.++|||||||++|||++ |..||.+..... ..+..+....+.
T Consensus 182 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~ 259 (434)
T 2rio_A 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDE 259 (434)
T ss_dssp -------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCC
T ss_pred CccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCccc
Confidence 2 234579999999999965 2468999999999999999999 999997654332 233333333222
Q ss_pred CCCC-----CCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 525 LPLY-----TYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 525 ~~~~-----s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.+.. +..+..++..||..+|++||++.++++.
T Consensus 260 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 260 MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 2211 2356789999999999999998887764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=298.82 Aligned_cols=242 Identities=20% Similarity=0.242 Sum_probs=189.3
Q ss_pred EEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh----------HHHHHHHHHHHHhc----CCCCcccEEEE
Q psy501 307 CLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD----------EMVVCFYRKSLKKL----SHANLVKLKEV 372 (962)
Q Consensus 307 ~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~----------~~~~~~Ei~iL~~L----~HpnIv~l~~~ 372 (962)
....+.|.....++.++.+.||.+.....++.++.|..... ...+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34456677777777777778999988777665555543221 22466799999999 89999999999
Q ss_pred EEeCCEEEEEEec-CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccc-cccceeeeccc
Q psy501 373 IRENDTLYFVFEY-MK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM-GTELVKIADFG 449 (962)
Q Consensus 373 ~~~~~~~~LV~Ey-~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~-~~g~vKL~DFG 449 (962)
+..++..++|||+ +. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+|||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 9999999999999 55 6777777664 4599999999999999999999999999999999999999 88999999999
Q ss_pred ccccccCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCC
Q psy501 450 LAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 529 (962)
Q Consensus 450 la~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 529 (962)
++............|+..|+|||++.+....+.++|||||||++|+|++|+.||..... +.... ......++
T Consensus 186 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~--~~~~~~~~ 257 (312)
T 2iwi_A 186 SGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAE--LHFPAHVS 257 (312)
T ss_dssp SCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTC--CCCCTTSC
T ss_pred hhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhhc--cCCcccCC
Confidence 99887776666778999999999997665456699999999999999999999976421 22222 22234567
Q ss_pred CCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 530 YHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 530 ~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..+..++..||..+|++||++.++++.-
T Consensus 258 ~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 258 PDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 7788999999999999999988888754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-32 Score=302.63 Aligned_cols=248 Identities=18% Similarity=0.237 Sum_probs=168.5
Q ss_pred ecCceeeEEE-EecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEe----CCEEEEEE
Q psy501 309 LAGTERLKFS-YILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRE----NDTLYFVF 383 (962)
Q Consensus 309 ~~g~~~~~~~-~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~----~~~~~LV~ 383 (962)
+.+.+..... ++.++.+.||.+....+++.++.|+..............++.+.||||+++++++.. +...++||
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 3455666444 455566679999988777776666655444444444455677799999999999976 45689999
Q ss_pred ecCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc---ccceeeecccccccccCCC
Q psy501 384 EYMKE-NLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG---TELVKIADFGLAREIRSRP 458 (962)
Q Consensus 384 Ey~~g-~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~---~g~vKL~DFGla~~~~~~~ 458 (962)
||++| +|.+.+.... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++.......
T Consensus 106 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~ 185 (336)
T 3fhr_A 106 ECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185 (336)
T ss_dssp ECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc
Confidence 99985 7888877654 46999999999999999999999999999999999999976 4459999999998776666
Q ss_pred cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhH----HHHHhccc--cccCCCCCCCCc
Q psy501 459 YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGT----ERLKSSYI--LLHTLPLYTYHV 532 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~----~~i~~~~~--~~~~~~~~s~~l 532 (962)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......... ..+..... ..+....++..+
T Consensus 186 ~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (336)
T 3fhr_A 186 LQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA 264 (336)
T ss_dssp -------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHH
T ss_pred cccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHH
Confidence 666788999999999854 46899999999999999999999999776543331 12222222 122224567778
Q ss_pred HHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 533 PPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 533 ~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..++..||..+|++||++.++++.-
T Consensus 265 ~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 265 KQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCc
Confidence 8999999999999999988887743
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=302.49 Aligned_cols=260 Identities=21% Similarity=0.225 Sum_probs=195.7
Q ss_pred cccCCCceEEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccch---hHHHHHHHHHHHHhcC-----------CC
Q psy501 299 WFPTGHTTCLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR---DEMVVCFYRKSLKKLS-----------HA 364 (962)
Q Consensus 299 ~~~~g~~~~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~---~~~~~~~Ei~iL~~L~-----------Hp 364 (962)
+.|.-.+..+..+.+.....++.++.+.||.+.....++.++.|+... ....+.+|+.+++++. ||
T Consensus 7 ~~p~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 86 (373)
T 1q8y_A 7 YHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86 (373)
T ss_dssp CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred ceeeecCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccc
Confidence 334434445556778888888878888899999877777666665442 2456889999999886 89
Q ss_pred CcccEEEEEEeCC----EEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccc-eeeeccCCCcccccc
Q psy501 365 NLVKLKEVIREND----TLYFVFEYMKENLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRH-GFFHRDMKPENLLCM 438 (962)
Q Consensus 365 nIv~l~~~~~~~~----~~~LV~Ey~~g~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~-gIvHrDLkp~NILl~ 438 (962)
||+++++++...+ .+++|||+++++|.+.+... ...+++..++.++.||+.||.|||++ ||+||||||+||+++
T Consensus 87 ~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~ 166 (373)
T 1q8y_A 87 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166 (373)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred hHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEe
Confidence 9999999997654 78999999988999988764 34599999999999999999999998 999999999999995
Q ss_pred ------cccceeeecccccccccCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh---
Q psy501 439 ------GTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL--- 509 (962)
Q Consensus 439 ------~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~--- 509 (962)
..+.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....
T Consensus 167 ~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 167 IVDSPENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccCCCcCcceEEEcccccccccCCC-CCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 3448999999999876543 3445789999999999764 6899999999999999999999999865421
Q ss_pred ---hhHHHHHhccccc----------------------------------------cCCCCCCCCcHHHHHHHhccCCCC
Q psy501 510 ---AGTERLKSSYILL----------------------------------------HTLPLYTYHVPPIQTTCLLAGTER 546 (962)
Q Consensus 510 ---~~~~~i~~~~~~~----------------------------------------~~~~~~s~~l~~li~~Cl~~dper 546 (962)
.....+....... ...+..+..+..++..||..+|++
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 1111111100000 000112234567899999999999
Q ss_pred CCcHHHHHhhccccc
Q psy501 547 LKSSYILLHTLPLYT 561 (962)
Q Consensus 547 RPs~~~Ll~~l~~~~ 561 (962)
||++.++++.- |+.
T Consensus 325 Rpt~~ell~hp-~f~ 338 (373)
T 1q8y_A 325 RADAGGLVNHP-WLK 338 (373)
T ss_dssp CBCHHHHHTCG-GGT
T ss_pred cCCHHHHhhCh-hhh
Confidence 99998888754 443
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-32 Score=299.14 Aligned_cols=247 Identities=13% Similarity=0.144 Sum_probs=169.3
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHH-HHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRK-SLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
+.+.....++.++.+.||.+....+++.++.|... .....+..|+. +++.++||||+++++++.+++..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 44444555555666678888877666555444321 22334566666 6777899999999999999999999999
Q ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHhhcccc-eeeeccCCCcccccccccceeeecccccccccCC-C
Q psy501 385 YMKENLYQLIRD----RDKFLPESIIRNMMYQVLQGLAFMHRH-GFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-P 458 (962)
Q Consensus 385 y~~g~Ll~~l~~----~~~~ls~~~i~~i~~qI~~aL~yLH~~-gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~ 458 (962)
|++|++.+.+.. ....+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++...... .
T Consensus 102 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 181 (327)
T 3aln_A 102 LMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181 (327)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred ecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc
Confidence 999988877753 246799999999999999999999999 9999999999999999999999999999876544 2
Q ss_pred cccccCCccccChhhhc---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh-hhHHHHHhcccc---ccCCCCCCCC
Q psy501 459 YTDYVSTRWYRAPEVLL---HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL-AGTERLKSSYIL---LHTLPLYTYH 531 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~---~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~-~~~~~i~~~~~~---~~~~~~~s~~ 531 (962)
.....||+.|+|||++. ....++.++|||||||++|+|++|+.||.+.... .....+..+... ......++..
T Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (327)
T 3aln_A 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPS 261 (327)
T ss_dssp ------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHH
T ss_pred cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHH
Confidence 33347899999999984 2346899999999999999999999999864322 111111111110 0111245667
Q ss_pred cHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 532 VPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 532 l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+..++..||..+|++||++.++++.-
T Consensus 262 l~~li~~~l~~dp~~Rps~~ell~hp 287 (327)
T 3aln_A 262 FINFVNLCLTKDESKRPKYKELLKHP 287 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred HHHHHHHHhhCChhhCcCHHHHHhCh
Confidence 88899999999999999999888753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-31 Score=292.79 Aligned_cols=247 Identities=19% Similarity=0.197 Sum_probs=190.2
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHh--cCCCCcccEEEEEEeCC----EEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKK--LSHANLVKLKEVIREND----TLYFVF 383 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~--L~HpnIv~l~~~~~~~~----~~~LV~ 383 (962)
.+.+.....+..++.+.||.+... ...++.+.+.......+.+|++++.. ++||||+++++++.... ..++||
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~ 119 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 119 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEE
T ss_pred cccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEE
Confidence 345666666666677779999874 34444555555566678899999988 78999999999998776 799999
Q ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcc--------cceeeeccCCCcccccccccceeeecccccccc
Q psy501 384 EYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMH--------RHGFFHRDMKPENLLCMGTELVKIADFGLAREI 454 (962)
Q Consensus 384 Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH--------~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~ 454 (962)
||+++ +|.+++... .+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 120 e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 197 (342)
T 1b6c_B 120 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197 (342)
T ss_dssp CCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEE
T ss_pred eecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceec
Confidence 99985 788877653 5899999999999999999999 899999999999999999999999999999776
Q ss_pred cCCC------cccccCCccccChhhhccCCC-----CCchhHHHHHHHHHHHHHcC----------CCCCCCcChh----
Q psy501 455 RSRP------YTDYVSTRWYRAPEVLLHSTA-----YSAPIHLSRSQQFLFYSIDH----------VPPIQTTCLL---- 509 (962)
Q Consensus 455 ~~~~------~~~~~gt~~Y~APE~l~~~~~-----~t~ksDIwSLGvlL~elltG----------~~Pf~~~~~~---- 509 (962)
.... .....||+.|+|||++.+... ++.++|||||||++|||++| ..||......
T Consensus 198 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~ 277 (342)
T 1b6c_B 198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277 (342)
T ss_dssp ETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccH
Confidence 5432 244579999999999975432 23789999999999999999 7898765321
Q ss_pred -hhHHHHHhccccccCCCC------CCCCcHHHHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 510 -AGTERLKSSYILLHTLPL------YTYHVPPIQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 510 -~~~~~i~~~~~~~~~~~~------~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
.....+..... .+..+. .+..+..++..||..+|++||++.++++.|..+
T Consensus 278 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 278 EEMRKVVCEQKL-RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp HHHHHHHTTSCC-CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh-CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 11222222211 111111 112466799999999999999999999877443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=321.50 Aligned_cols=246 Identities=17% Similarity=0.169 Sum_probs=196.7
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCc---eEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDN---HILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYF 381 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~---kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~L 381 (962)
.+.+.....++.|+.+.||.+...... ..++.+... ...+.+.+|+.++++++||||+++++++. ++..|+
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 345556666666666679998765422 233333321 12356899999999999999999999985 456899
Q ss_pred EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC--
Q psy501 382 VFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP-- 458 (962)
Q Consensus 382 V~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~-- 458 (962)
||||++ |+|.+++......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 547 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 547 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcce
Confidence 999998 67888887766679999999999999999999999999999999999999999999999999998765432
Q ss_pred -cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHH
Q psy501 459 -YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQ 536 (962)
Q Consensus 459 -~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li 536 (962)
.....+++.|+|||++.+. .++.++|||||||++|||++ |..||.+.........+..+.. .+..+.++..+..++
T Consensus 548 ~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~li 625 (656)
T 2j0j_A 548 KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-LPMPPNCPPTLYSLM 625 (656)
T ss_dssp ------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC-CCCCTTCCHHHHHHH
T ss_pred eccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-CCCCccccHHHHHHH
Confidence 2234567889999999754 79999999999999999997 9999998887777666665532 334456778889999
Q ss_pred HHHhccCCCCCCcHHHHHhhcc
Q psy501 537 TTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 537 ~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
..||..+|++||++.+++..|.
T Consensus 626 ~~~l~~dP~~RPs~~el~~~L~ 647 (656)
T 2j0j_A 626 TKCWAYDPSRRPRFTELKAQLS 647 (656)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHHHH
Confidence 9999999999999999988763
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=290.32 Aligned_cols=249 Identities=16% Similarity=0.146 Sum_probs=178.3
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHH--HHhcCCCCcccEEEEEEe-----CCEEEEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKS--LKKLSHANLVKLKEVIRE-----NDTLYFV 382 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~i--L~~L~HpnIv~l~~~~~~-----~~~~~LV 382 (962)
.+.+.....++.++.+.||.++... ..++.+.+.......+..|.++ +..++||||+++++.+.. ...+++|
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDE-RPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETT-EEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEECC-eEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 4556666666667777799987633 3333333333334445555555 445899999999987643 2367999
Q ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccc---------eeeeccCCCcccccccccceeeecccccc
Q psy501 383 FEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRH---------GFFHRDMKPENLLCMGTELVKIADFGLAR 452 (962)
Q Consensus 383 ~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~---------gIvHrDLkp~NILl~~~g~vKL~DFGla~ 452 (962)
|||++ |+|.+++.... +++..++.++.||+.||.|||+. ||+||||||+||+++.++.+||+|||++.
T Consensus 91 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~ 168 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168 (336)
T ss_dssp ECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCE
T ss_pred EecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecccee
Confidence 99997 57877776543 58999999999999999999999 99999999999999999999999999998
Q ss_pred cccCC----------CcccccCCccccChhhhccC------CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhh------
Q psy501 453 EIRSR----------PYTDYVSTRWYRAPEVLLHS------TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLA------ 510 (962)
Q Consensus 453 ~~~~~----------~~~~~~gt~~Y~APE~l~~~------~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~------ 510 (962)
..... ......||+.|+|||++.+. ..++.++|||||||++|||++|..||.......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~ 248 (336)
T 3g2f_A 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248 (336)
T ss_dssp ECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTT
T ss_pred ecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhh
Confidence 66432 22245799999999999752 246678999999999999999977664322110
Q ss_pred -----------hHHHHHhccccccCCC-CCCC------CcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 511 -----------GTERLKSSYILLHTLP-LYTY------HVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 511 -----------~~~~i~~~~~~~~~~~-~~s~------~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
............+..+ ..+. .+..++..||..+|++||++.++++.|....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 1111111111112111 1111 4788999999999999999999998775443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=274.72 Aligned_cols=225 Identities=16% Similarity=0.206 Sum_probs=170.9
Q ss_pred CceeeE-EEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHH-HhcCCCCcccEEEEEEe----CCEEEEEEe
Q psy501 311 GTERLK-FSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSL-KKLSHANLVKLKEVIRE----NDTLYFVFE 384 (962)
Q Consensus 311 g~~~~~-~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL-~~L~HpnIv~l~~~~~~----~~~~~LV~E 384 (962)
+.+... ..++.++.+.||.+.....++.++.|.... .....+|+.++ +.++||||+++++++.. +...++|||
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 95 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 95 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence 344444 334555566699998877777666665443 34578899988 55689999999999987 678999999
Q ss_pred cCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc---ccceeeecccccccccCCCc
Q psy501 385 YMKE-NLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG---TELVKIADFGLAREIRSRPY 459 (962)
Q Consensus 385 y~~g-~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~---~g~vKL~DFGla~~~~~~~~ 459 (962)
|++| +|.+.+.... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++....
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---- 171 (299)
T 3m2w_A 96 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---- 171 (299)
T ss_dssp CCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc----
Confidence 9985 8888887654 46999999999999999999999999999999999999998 7889999999986432
Q ss_pred ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHH----hcccccc--CCCCCCCCcH
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLK----SSYILLH--TLPLYTYHVP 533 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~----~~~~~~~--~~~~~s~~l~ 533 (962)
+..++.++|||||||++|||++|+.||.+.........+. ......+ ....++..+.
T Consensus 172 -----------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T 3m2w_A 172 -----------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK 234 (299)
T ss_dssp -----------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHH
T ss_pred -----------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHH
Confidence 1347889999999999999999999997754432211111 1111111 1134567788
Q ss_pred HHHHHHhccCCCCCCcHHHHHhhc
Q psy501 534 PIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 534 ~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.++..||..+|++||++.++++.-
T Consensus 235 ~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 235 MLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHHcccChhhCCCHHHHhcCh
Confidence 899999999999999988888744
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-29 Score=272.06 Aligned_cols=222 Identities=10% Similarity=0.032 Sum_probs=176.0
Q ss_pred EecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh-------HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEE
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD-------EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLY 380 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~-------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 380 (962)
++.|.|.....++.++.+.||.+.....++.++.|+.... ...+.+|+.++++++||||+++++++.+++..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 5567788887777777788999998876766665553321 256899999999999999999999999999999
Q ss_pred EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCc
Q psy501 381 FVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY 459 (962)
Q Consensus 381 LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~ 459 (962)
+||||++| +|.+.+. . + ....++..++.||+.||.|||+.||+||||||+||+++.+|.+||+++|.
T Consensus 108 lv~e~~~g~~L~~~l~-~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~--------- 175 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVAD-T-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT--------- 175 (286)
T ss_dssp EEEECCCEEEHHHHHT-T-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC---------
T ss_pred EEEEecCCCCHHHHHh-c-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc---------
Confidence 99999985 6666653 2 2 46667899999999999999999999999999999999999999985443
Q ss_pred ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHH---HHHhccccc--cCCCCCCCCcHH
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTE---RLKSSYILL--HTLPLYTYHVPP 534 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~---~i~~~~~~~--~~~~~~s~~l~~ 534 (962)
++ .++.++|||||||++|||++|+.||.+........ ......... ...+..+..+..
T Consensus 176 ---------~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (286)
T 3uqc_A 176 ---------MP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238 (286)
T ss_dssp ---------CT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred ---------cC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence 32 37899999999999999999999998865433210 111111111 112456777899
Q ss_pred HHHHHhccCCCCCCcHHHHHhhccc
Q psy501 535 IQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 535 li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
++..||..+|++| ++.++++.|..
T Consensus 239 li~~~l~~dP~~R-s~~el~~~L~~ 262 (286)
T 3uqc_A 239 VAARSVQGDGGIR-SASTLLNLMQQ 262 (286)
T ss_dssp HHHHHHCTTSSCC-CHHHHHHHHHH
T ss_pred HHHHHcccCCccC-CHHHHHHHHHH
Confidence 9999999999999 99999997744
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=309.26 Aligned_cols=234 Identities=16% Similarity=0.180 Sum_probs=182.0
Q ss_pred EecCceeeEEEEecCCcccEEEEEecC-CceEEEEe-ccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCE---
Q psy501 308 LLAGTERLKFSYILPHTLPLYTCNLDQ-DNHILSRH-VSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDT--- 378 (962)
Q Consensus 308 l~~g~~~~~~~~i~~~~~~Vy~~~~~~-~~kvv~~k-~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~--- 378 (962)
++.+.|.....++.++.+.||.+.... .++.++.| +.. .....+.+|+++|++++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 456788888888888888899998864 44444444 321 223468899999999999999999999987654
Q ss_pred --EEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccccccc
Q psy501 379 --LYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR 455 (962)
Q Consensus 379 --~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~ 455 (962)
.||||||++| +|.+.+.. .+++..++.++.||+.||.|||++||+||||||+||+++.+ .+||+|||++....
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred ceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 7999999986 45443332 59999999999999999999999999999999999999875 89999999998765
Q ss_pred CCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHH
Q psy501 456 SRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPI 535 (962)
Q Consensus 456 ~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~l 535 (962)
.. ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+........ .......+..+..+
T Consensus 233 ~~--~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~--------~~~~~~~~~~l~~l 300 (681)
T 2pzi_A 233 SF--GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE--------DDPVLKTYDSYGRL 300 (681)
T ss_dssp CC--SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCT--------TCHHHHHCHHHHHH
T ss_pred cC--CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccccccc--------cccccccCHHHHHH
Confidence 44 456799999999999764 5899999999999999999999987632211100 00000123456789
Q ss_pred HHHHhccCCCCCCc-HHHHHhhc
Q psy501 536 QTTCLLAGTERLKS-SYILLHTL 557 (962)
Q Consensus 536 i~~Cl~~dperRPs-~~~Ll~~l 557 (962)
+..||..+|++||+ .+++.+.+
T Consensus 301 i~~~l~~dP~~R~~~~~~l~~~l 323 (681)
T 2pzi_A 301 LRRAIDPDPRQRFTTAEEMSAQL 323 (681)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHH
T ss_pred HhhhccCChhhCCCHHHHHHHHH
Confidence 99999999999996 77777755
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=291.04 Aligned_cols=233 Identities=15% Similarity=0.107 Sum_probs=175.6
Q ss_pred EEEEecCCcccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcCC-CCc---------cc----------
Q psy501 316 KFSYILPHTLPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLSH-ANL---------VK---------- 368 (962)
Q Consensus 316 ~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~H-pnI---------v~---------- 368 (962)
+..++.|+.+.||++....+++.++.|+.. .....+.+|+.+++.+.| ++. +.
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 334555556669999987666665555433 123568899999999987 221 11
Q ss_pred --EEEEEEe-----CCEEEEEEecCCCCHHHHHH------hcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccc
Q psy501 369 --LKEVIRE-----NDTLYFVFEYMKENLYQLIR------DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENL 435 (962)
Q Consensus 369 --l~~~~~~-----~~~~~LV~Ey~~g~Ll~~l~------~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NI 435 (962)
+..++.. ...++++|+++.|+|.+.+. .....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NI 242 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 242 (413)
T ss_dssp --------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred CccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceE
Confidence 1111211 22478999999999888874 2234578889999999999999999999999999999999
Q ss_pred ccccccceeeecccccccccCCCcccccCCccccChhhhc---------cCCCCCchhHHHHHHHHHHHHHcCCCCCCCc
Q psy501 436 LCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLL---------HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTT 506 (962)
Q Consensus 436 Ll~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~---------~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~ 506 (962)
|++.++.+||+|||+++..... ....+| +.|+|||++. ....++.++|||||||++|||++|+.||.+.
T Consensus 243 Ll~~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~ 320 (413)
T 3dzo_A 243 VLDQRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320 (413)
T ss_dssp EECTTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTT
T ss_pred EEecCCeEEEEeccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999765544 444577 9999999994 3345888999999999999999999999876
Q ss_pred ChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 507 CLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 507 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
........+ ....+.++..+..++..||..+|++||++.++++.
T Consensus 321 ~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 321 AALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp GGGSCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred chhhhHHHH------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 654433322 22334667789999999999999999998887763
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-29 Score=304.40 Aligned_cols=244 Identities=20% Similarity=0.254 Sum_probs=180.0
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEecc-----chhHHHHHHHHHHHHhcCCCCcccEEEEEEe------CCEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVS-----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRE------NDTL 379 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~------~~~~ 379 (962)
|.|.....++.|+.+.||.+.....++.++.|.. ......+.+|++++++++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 4555555555566667888877666655555542 2234568999999999999999999999755 6678
Q ss_pred EEEEecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccc---eeeeccccccc
Q psy501 380 YFVFEYMK-ENLYQLIRDRD--KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL---VKIADFGLARE 453 (962)
Q Consensus 380 ~LV~Ey~~-g~Ll~~l~~~~--~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~---vKL~DFGla~~ 453 (962)
++||||++ |+|.+++.... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++. +||+|||.+..
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence 99999997 57777776543 26999999999999999999999999999999999999987664 89999999987
Q ss_pred ccCC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhH---------HHH-----Hhc
Q psy501 454 IRSR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGT---------ERL-----KSS 518 (962)
Q Consensus 454 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~---------~~i-----~~~ 518 (962)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....... ..+ ..+
T Consensus 174 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g 252 (676)
T 3qa8_A 174 LDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252 (676)
T ss_dssp TTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSS
T ss_pred cccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcc
Confidence 6554 3445689999999999965 47899999999999999999999999764322110 000 001
Q ss_pred cccccC----CC----CCCCCcHHHHHHHhccCCCCCCcHHHHHh
Q psy501 519 YILLHT----LP----LYTYHVPPIQTTCLLAGTERLKSSYILLH 555 (962)
Q Consensus 519 ~~~~~~----~~----~~s~~l~~li~~Cl~~dperRPs~~~Ll~ 555 (962)
...... .. .++..+..++..||..+|++||++.+++.
T Consensus 253 ~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~ 297 (676)
T 3qa8_A 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297 (676)
T ss_dssp SCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCC
T ss_pred ccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhc
Confidence 011100 00 12335677999999999999999876554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-29 Score=281.21 Aligned_cols=230 Identities=16% Similarity=0.081 Sum_probs=165.7
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccch------------hHHHHHHHHHHHHhcC---------CCCcccE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR------------DEMVVCFYRKSLKKLS---------HANLVKL 369 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~------------~~~~~~~Ei~iL~~L~---------HpnIv~l 369 (962)
+.+.....++.++.+.||.+... ++.++.|.... ....+.+|+.+|+.++ ||||+++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEET--TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEeC--CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 34445555555556668888763 23333332221 1267899999999886 8888888
Q ss_pred EEEEE------------------------------eCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHh
Q psy501 370 KEVIR------------------------------ENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLA 418 (962)
Q Consensus 370 ~~~~~------------------------------~~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~ 418 (962)
.+++. .++.+|+|||||+| ++++.+.. ..+++..++.++.||+.||.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 77753 26789999999974 47766644 45899999999999999999
Q ss_pred hcc-cceeeeccCCCccccccccc--------------------ceeeecccccccccCCCcccccCCccccChhhhccC
Q psy501 419 FMH-RHGFFHRDMKPENLLCMGTE--------------------LVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHS 477 (962)
Q Consensus 419 yLH-~~gIvHrDLkp~NILl~~~g--------------------~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~ 477 (962)
||| +.||+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|||++.+.
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~aPE~~~g~ 252 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDLFTGD 252 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTCSGGGCCC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecccChhhhcCC
Confidence 999 99999999999999999887 8999999999876543 34799999999999764
Q ss_pred CCCCchhHHHHHHHH-HHHHHcCCCCCCCcCh-hhhHHHHHhc-cccccC----CCCCCCCcHHHHHHHhccCCCCCCcH
Q psy501 478 TAYSAPIHLSRSQQF-LFYSIDHVPPIQTTCL-LAGTERLKSS-YILLHT----LPLYTYHVPPIQTTCLLAGTERLKSS 550 (962)
Q Consensus 478 ~~~t~ksDIwSLGvl-L~elltG~~Pf~~~~~-~~~~~~i~~~-~~~~~~----~~~~s~~l~~li~~Cl~~dperRPs~ 550 (962)
. +.++||||||++ .+++++|..||.+... ......+... ...... .+..+..+.+++..||..| ++
T Consensus 253 -~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa 325 (336)
T 2vuw_A 253 -G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SA 325 (336)
T ss_dssp -S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SH
T ss_pred -C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CH
Confidence 3 899999998777 7788899999954321 1111222211 111110 1124456778999999976 66
Q ss_pred HHHH
Q psy501 551 YILL 554 (962)
Q Consensus 551 ~~Ll 554 (962)
.+++
T Consensus 326 ~e~l 329 (336)
T 2vuw_A 326 TDLL 329 (336)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6666
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-26 Score=276.71 Aligned_cols=149 Identities=15% Similarity=0.157 Sum_probs=112.9
Q ss_pred HHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhccccee
Q psy501 348 EMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGF 425 (962)
Q Consensus 348 ~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gI 425 (962)
.+.+.+|+++|+++ .|+||+++++++++++.+||||||++| +|.+.+. ..+++++. .|+.||+.||+|+|++||
T Consensus 285 ~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~-~~~~l~~~---~I~~QIl~AL~ylH~~GI 360 (569)
T 4azs_A 285 KYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLA-AGEEIDRE---KILGSLLRSLAALEKQGF 360 (569)
T ss_dssp HHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHH-TTCCCCHH---HHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHH-hCCCCCHH---HHHHHHHHHHHHHHHCCc
Confidence 35699999999999 699999999999999999999999997 4555554 45667765 478999999999999999
Q ss_pred eeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCC
Q psy501 426 FHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPP 502 (962)
Q Consensus 426 vHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~P 502 (962)
|||||||+|||++.+|.+||+|||+|+..... .....+||+.|||||++.+. +..++|+||+|+++++|.+|..|
T Consensus 361 IHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 361 WHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp EESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred eeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC--CCCcccccccccchhhhccccch
Confidence 99999999999999999999999999876543 34556899999999999763 67789999999999888766444
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.5e-21 Score=220.96 Aligned_cols=135 Identities=20% Similarity=0.306 Sum_probs=113.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCC---------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI---------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA------ 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~---------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~------ 734 (962)
|-||..||++ |.+||+|||++.. ....+.|||+.|++||+++ |...|+.++||||+|||+|
T Consensus 182 RDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~-~~~~~~~~~DiWSlG~il~ell~G~ 260 (398)
T 4b99_A 182 RDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELML-SLHEYTQAIDLWSVGCIFGEMLARR 260 (398)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHT-TCSCCCTHHHHHHHHHHHHHHHHTS
T ss_pred CCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhc-CCCCCCChhheehhHHHHHHHHHCC
Confidence 7899999999 9999999999853 2344569999999998765 6677999999999999998
Q ss_pred ----cCCchhHHHHHHHhcCCCchhhhcccccc-------cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchh
Q psy501 735 ----GTERLKSSYILLHTLPLYTCYTLASNMNF-------KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQ 803 (962)
Q Consensus 735 ----G~~~~~ql~~I~~~lG~p~~~~~~~~~~~-------~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~ 803 (962)
|.++.+++..|+..+|+|+...+...... .++...+.+|+.+++.+|++++|||++||++||.+|+||+
T Consensus 261 ~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 340 (398)
T 4b99_A 261 QLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAA 340 (398)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHH
Confidence 78899999999999999987764332211 3556667889999999999999999999999999999999
Q ss_pred hhhhh
Q psy501 804 QSLSI 808 (962)
Q Consensus 804 ~~L~~ 808 (962)
|+|++
T Consensus 341 e~L~H 345 (398)
T 4b99_A 341 AALRH 345 (398)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99974
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=6e-20 Score=218.94 Aligned_cols=172 Identities=13% Similarity=0.107 Sum_probs=133.1
Q ss_pred CCcccEEEEEecCCceEEEEeccch----------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCH
Q psy501 322 PHTLPLYTCNLDQDNHILSRHVSSR----------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENL 390 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~~kvv~~k~~~~----------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~L 390 (962)
++.+.||++.......+++...... ....+.+|+++|++++||||+++..++...+..||||||++ |+|
T Consensus 347 G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL 426 (540)
T 3en9_A 347 GAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLA 426 (540)
T ss_dssp -CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEH
T ss_pred CCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCH
Confidence 3344588775544443444322211 12347999999999999999966666557777899999998 567
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---------ccc
Q psy501 391 YQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP---------YTD 461 (962)
Q Consensus 391 l~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~---------~~~ 461 (962)
.+++.. +..++.|++.||.|||++||+||||||+|||++. .+||+|||+|+...... ...
T Consensus 427 ~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~ 495 (540)
T 3en9_A 427 KDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKA 495 (540)
T ss_dssp HHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHH
T ss_pred HHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhh
Confidence 666544 5689999999999999999999999999999998 99999999998775531 135
Q ss_pred ccCCccccChhhhccC-CCCCchhHHHHHHHHHHHHHcCCCCCC
Q psy501 462 YVSTRWYRAPEVLLHS-TAYSAPIHLSRSQQFLFYSIDHVPPIQ 504 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~-~~~t~ksDIwSLGvlL~elltG~~Pf~ 504 (962)
..||+.|||||++.+. ..|+..+|+||.++-..+.+.++.+|.
T Consensus 496 ~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 496 VLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 6799999999999641 247888999999999999888877774
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=3.2e-20 Score=210.32 Aligned_cols=136 Identities=17% Similarity=0.199 Sum_probs=98.4
Q ss_pred cccceeeEEE----EEEeeeeeecCCC---------------------------------ceeeeccCCCcccccceeee
Q psy501 673 ERLKSSYILL----HTLPLYTYHVPPI---------------------------------QTTCLLAGTERLKSSYILLH 715 (962)
Q Consensus 673 ~~~~~~~~~~----~~~~~~~~~~~~~---------------------------------~~~~~~~gt~~~~~~~~lLl 715 (962)
|-||..||++ |.+||.|||++.. +...+.|||+.|+|||+++
T Consensus 141 RDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~- 219 (361)
T 4f9c_A 141 RDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLT- 219 (361)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHT-
T ss_pred CcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHc-
Confidence 6789999999 7899999999742 1234458999999988765
Q ss_pred cCCCCCCCCCceeeeeEee-----------cCCchhHHHHHHHhcCCCchhhhcccccc------c--------------
Q psy501 716 TLPLYTYHVPPIQTTCLLA-----------GTERLKSSYILLHTLPLYTCYTLASNMNF------K-------------- 764 (962)
Q Consensus 716 g~~~Y~~~vDIWSlGCIl~-----------G~~~~~ql~~I~~~lG~p~~~~~~~~~~~------~-------------- 764 (962)
|...|+.++||||+|||+| |.++.+|+..|+.++|+|+.......... .
T Consensus 220 ~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 299 (361)
T 4f9c_A 220 KCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLR 299 (361)
T ss_dssp TCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC
T ss_pred CCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhc
Confidence 6577999999999999999 67889999999999998765432211100 0
Q ss_pred -----CCCcc-----cCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 765 -----FPQFR-----RVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 765 -----~~~~~-----~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
.+... .....+.++.+|++|+|||++||++||++|+||+|+|++.
T Consensus 300 ~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp 354 (361)
T 4f9c_A 300 GMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHP 354 (361)
T ss_dssp ----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred cccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 00000 0001122356899999999999999999999999999843
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=4.1e-18 Score=191.34 Aligned_cols=113 Identities=21% Similarity=0.261 Sum_probs=86.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
|-||..||++ |.+||+|||++.. ....+.|||+.||+||++. ...|+.++||||+|||+|
T Consensus 194 RDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~--~~~y~~~~DiWSlGvilyeml~G~~PF~ 271 (346)
T 4fih_A 194 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS--RLPYGPEVDIWSLGIMVIEMVDGEPPYF 271 (346)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHT--TCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHC--CCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 7789999999 9999999999753 3455679999999999753 356999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.+..+.+..|..... +. ...+ +.+|++++|||++||+.||++|+|++|+|++
T Consensus 272 ~~~~~~~~~~i~~~~~---------------~~--~~~~----~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 272 NEPPLKAMKMIRDNLP---------------PR--LKNL----HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp TSCHHHHHHHHHHSSC---------------CC--CSCG----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CcCHHHHHHHHHcCCC---------------CC--CCcc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 3333344433332110 00 0111 3679999999999999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.2e-17 Score=192.23 Aligned_cols=113 Identities=21% Similarity=0.282 Sum_probs=86.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
|-||..|||+ |.+||+|||++.. ....+.|||+.|||||++. + ..|+.++||||+|||+|
T Consensus 271 RDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~-~-~~y~~~~DiWSlGvilyeml~G~~PF~ 348 (423)
T 4fie_A 271 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS-R-LPYGPEVDIWSLGIMVIEMVDGEPPYF 348 (423)
T ss_dssp CCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHT-T-CCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHC-C-CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 6779999999 9999999999753 3455679999999999764 3 56999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
|.+..+.+..|..... +.. ...+.+|++++|||++||+.||++|+|++|+|++
T Consensus 349 ~~~~~~~~~~i~~~~~---------------~~~------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 349 NEPPLKAMKMIRDNLP---------------PRL------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp TSCHHHHHHHHHHSCC---------------CCC------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CcCHHHHHHHHHcCCC---------------CCC------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 3333344433332110 000 0114689999999999999999999999999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.6e-17 Score=182.45 Aligned_cols=119 Identities=13% Similarity=0.145 Sum_probs=82.3
Q ss_pred cccceeeEEE----EEEeeeeeecCCC---ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHH
Q psy501 673 ERLKSSYILL----HTLPLYTYHVPPI---QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 745 (962)
Q Consensus 673 ~~~~~~~~~~----~~~~~~~~~~~~~---~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I 745 (962)
|-||++||++ |.+||+|||++.. ..+.+.|||+.|||||++ .+ .|+.++||||+|||+| .+
T Consensus 155 RDlKp~NILl~~~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~-~~--~y~~~~DiwSlGvily---------el 222 (290)
T 3fpq_A 155 RDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMY-EE--KYDESVDVYAFGMCML---------EM 222 (290)
T ss_dssp CCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGG-GT--CCCTHHHHHHHHHHHH---------HH
T ss_pred cccChhheeEECCCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHc-CC--CCCcHHHHHHHHHHHH---------HH
Confidence 7889999999 6899999999864 455667999999999965 33 5999999999999997 11
Q ss_pred HHhcCCCchhhh---cccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 746 LHTLPLYTCYTL---ASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 746 ~~~lG~p~~~~~---~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+ .|.+|-... ......-.....+..+. +.+++++.|||.+||+.||++|||++++|++
T Consensus 223 l--tg~~Pf~~~~~~~~~~~~i~~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 223 A--TSEYPYSECQNAAQIYRRVTSGVKPASFD---KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp H--HSSCTTTTCSSHHHHHHHHTTTCCCGGGG---GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred H--HCCCCCCCCCcHHHHHHHHHcCCCCCCCC---ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 122221000 00000000000011111 3568899999999999999999999999984
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.9e-17 Score=180.42 Aligned_cols=111 Identities=15% Similarity=0.113 Sum_probs=76.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cC-----
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GT----- 736 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~----- 736 (962)
|-||..||++ |.+||+|||++.. ....+.|||+.|+|||++. |..+|+.++||||+|||+| |.
T Consensus 136 RDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~-~~~y~~~~~DiwSlGvily~lltg~~PF~~ 214 (275)
T 3hyh_A 136 RDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214 (275)
T ss_dssp CCCCTTTEEECTTCCEEECCSSCC---------------CTTSCHHHHS-SSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhc-CCCCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence 6689999999 8999999999865 3445669999999999875 5555679999999999997 21
Q ss_pred -CchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 737 -ERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 737 -~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+..+.+..|.. . . .++. +.+|++++|||++||+.||++|||++|+|++
T Consensus 215 ~~~~~~~~~i~~-------------~---~-----~~~p---~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 215 ESIPVLFKNISN-------------G---V-----YTLP---KFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp SSHHHHHHHHHH-------------T---C-----CCCC---TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCHHHHHHHHHc-------------C---C-----CCCC---CCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11111111111 0 0 0111 3579999999999999999999999999973
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.64 E-value=4.3e-17 Score=189.92 Aligned_cols=136 Identities=20% Similarity=0.274 Sum_probs=106.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc--------------------------------eeeeccCCCcccccceeeecC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ--------------------------------TTCLLAGTERLKSSYILLHTL 717 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~--------------------------------~~~~~~gt~~~~~~~~lLlg~ 717 (962)
|-||.+||++ |.+||+|||++... ..+..+||+.|++||+++.+
T Consensus 180 rDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~- 258 (458)
T 3rp9_A 180 RDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ- 258 (458)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-
T ss_pred CCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-
Confidence 5689999999 89999999998541 23445889888888877644
Q ss_pred CCCCCCCCceeeeeEee----c-----------------C--------------------CchhHHHHHHHhcCCCchhh
Q psy501 718 PLYTYHVPPIQTTCLLA----G-----------------T--------------------ERLKSSYILLHTLPLYTCYT 756 (962)
Q Consensus 718 ~~Y~~~vDIWSlGCIl~----G-----------------~--------------------~~~~ql~~I~~~lG~p~~~~ 756 (962)
..|+.++||||+|||+| | . ...+|+..|++++|+|+.+.
T Consensus 259 ~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~ 338 (458)
T 3rp9_A 259 ENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEED 338 (458)
T ss_dssp CCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHH
T ss_pred CCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHH
Confidence 56999999999999988 2 1 13689999999999999887
Q ss_pred hccccc-------ccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 757 LASNMN-------FKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 757 ~~~~~~-------~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
+..... ..++......+.+.++.++++++|||++||++||.+|+|++++|++.
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp 398 (458)
T 3rp9_A 339 IEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHP 398 (458)
T ss_dssp HHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCH
Confidence 544322 12444456677788899999999999999999999999999999743
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=5e-17 Score=188.31 Aligned_cols=136 Identities=24% Similarity=0.297 Sum_probs=107.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc---------------------------eeeeccCCCcccccceeeecCCCCCC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ---------------------------TTCLLAGTERLKSSYILLHTLPLYTY 722 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~---------------------------~~~~~~gt~~~~~~~~lLlg~~~Y~~ 722 (962)
+-||.+||++ |.+||+|||++... ...+.+||+.|++||+++.+ ..|+.
T Consensus 153 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~ 231 (432)
T 3n9x_A 153 RDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTK 231 (432)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTC-SCCCT
T ss_pred CCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCc
Confidence 5689999999 89999999998641 12455898888888876644 67999
Q ss_pred CCCceeeeeEee----c-----------------CC-----------------chhHHHHHHHhcCCCchhhhcccccc-
Q psy501 723 HVPPIQTTCLLA----G-----------------TE-----------------RLKSSYILLHTLPLYTCYTLASNMNF- 763 (962)
Q Consensus 723 ~vDIWSlGCIl~----G-----------------~~-----------------~~~ql~~I~~~lG~p~~~~~~~~~~~- 763 (962)
++||||+|||++ | .+ ..+|+..|++++|+|+.+.+......
T Consensus 232 ~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~ 311 (432)
T 3n9x_A 232 SIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPE 311 (432)
T ss_dssp HHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred ccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHH
Confidence 999999999997 1 11 47899999999999998875442221
Q ss_pred ------cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 764 ------KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 764 ------~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
.++...+.++...++.++++++|||++||++||++|||++++|++.
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 363 (432)
T 3n9x_A 312 VIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHP 363 (432)
T ss_dssp HHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCG
T ss_pred HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCh
Confidence 2344456677778899999999999999999999999999999743
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.62 E-value=3.2e-17 Score=186.80 Aligned_cols=135 Identities=19% Similarity=0.270 Sum_probs=100.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--------------------------ceeeeccCCCcccccceeeecCCCCCCC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--------------------------QTTCLLAGTERLKSSYILLHTLPLYTYH 723 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--------------------------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~ 723 (962)
+-||.+||++ |.++|+|||++.. ......+||+.|++||+++ +...|+.+
T Consensus 133 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~ 211 (388)
T 3oz6_A 133 RDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL-GSTKYTKG 211 (388)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHT-TCCCCCTH
T ss_pred CCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhc-CCCCCCCh
Confidence 5689999999 8999999998742 1123348988888877665 65779999
Q ss_pred CCceeeeeEee----------cCCchhHHHHHHHhcCCCchhhhccccccc----------CCCcccCCccccCC-----
Q psy501 724 VPPIQTTCLLA----------GTERLKSSYILLHTLPLYTCYTLASNMNFK----------FPQFRRVPFTSIIP----- 778 (962)
Q Consensus 724 vDIWSlGCIl~----------G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~----------~~~~~~~~l~~~~p----- 778 (962)
+||||+|||++ |.+..+++..|+..+|.|+.+.+.....-. ........+...++
T Consensus 212 ~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (388)
T 3oz6_A 212 IDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNL 291 (388)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHH
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhh
Confidence 99999999998 778899999999999999887653321100 00001122222222
Q ss_pred --------CCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 779 --------HASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 779 --------~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++++++|||++||++||.+|||++++|++
T Consensus 292 ~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 292 LLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 679999999999999999999999999974
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.62 E-value=3.5e-17 Score=181.13 Aligned_cols=109 Identities=17% Similarity=0.240 Sum_probs=84.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee--------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA-------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~-------- 734 (962)
|-||..||++ |.+||+|||++.. ..+.+.|||+.|||||++. | ..|+.++||||+|||+|
T Consensus 156 RDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~-~-~~y~~~~DiWSlGvilyeml~G~~P 233 (311)
T 4aw0_A 156 RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT-E-KSACKSSDLWALGCIIYQLVAGLPP 233 (311)
T ss_dssp SCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHH-H-SCBCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHc-C-CCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 6789999999 8999999999853 2355679999999999875 4 45999999999999998
Q ss_pred --cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 735 --GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 735 --G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
|.+..+.+..|... .+.++ +.+|++++|||++||+.||++|+|++|++.
T Consensus 234 F~~~~~~~~~~~i~~~-------------~~~~p-----------~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 234 FRAGNEGLIFAKIIKL-------------EYDFP-----------EKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp SCCSSHHHHHHHHHHT-------------CCCCC-----------TTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred CCCCCHHHHHHHHHcC-------------CCCCC-----------cccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 23333333333321 00011 357999999999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.8e-17 Score=186.30 Aligned_cols=111 Identities=22% Similarity=0.259 Sum_probs=85.9
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
|-||..||++ |.+||+|||++.. ..+.+.|||+.||+||++. | ..|+.++||||+|||+|
T Consensus 149 RDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~-~-~~y~~~~DiwSlGvilyemltG~~PF~ 226 (350)
T 4b9d_A 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE-N-KPYNNKSDIWALGCVLYELCTLKHAFE 226 (350)
T ss_dssp TTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHT-T-CCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHC-C-CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 7899999999 8999999999875 1234569999999999765 4 56999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
|.+..+.+..|... .++.. -+.+|+++.|||.+||+.||++|||++|+|+.
T Consensus 227 ~~~~~~~~~~i~~~---------------~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 227 AGSMKNLVLKIISG---------------SFPPV--------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CSSHHHHHHHHHHT---------------CCCCC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CcCHHHHHHHHHcC---------------CCCCC--------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 33333333333321 01111 13679999999999999999999999999973
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.61 E-value=1.1e-16 Score=181.43 Aligned_cols=136 Identities=21% Similarity=0.300 Sum_probs=110.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------cCC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------GTE 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G~~ 737 (962)
+-||.+||++ |.++|+|||++.. ......+||+.|++||+++ +...|+.++||||+|||++ |.+
T Consensus 152 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 152 RDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHH-TTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCcCHHHEEEcCCCCEEEEeeecccccccccCcCcCCCCcCCHHHHh-CCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4689999999 8999999999865 2233347877777777655 5567999999999999998 677
Q ss_pred chhHHHHHHHhcCCCchhhhccccc-------ccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 738 RLKSSYILLHTLPLYTCYTLASNMN-------FKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 738 ~~~ql~~I~~~lG~p~~~~~~~~~~-------~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
..+++..|+..+|+|+.+.+..... ..++..+...|..+++.++++++|||.+||++||.+|||++++|++.
T Consensus 231 ~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp 309 (367)
T 1cm8_A 231 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309 (367)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence 8899999999999999876543221 12445556778888899999999999999999999999999999743
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=4.3e-16 Score=170.45 Aligned_cols=135 Identities=16% Similarity=0.118 Sum_probs=100.7
Q ss_pred EEEEecCCcccEEEEEecCCceEEEEeccc----------------------hhHHHHHHHHHHHHhcCCCCcccEEEEE
Q psy501 316 KFSYILPHTLPLYTCNLDQDNHILSRHVSS----------------------RDEMVVCFYRKSLKKLSHANLVKLKEVI 373 (962)
Q Consensus 316 ~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~----------------------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~ 373 (962)
+..++.++.+.||.+.. .+++.++.|... .....+.+|+.+|++++| +++.+++
T Consensus 95 ~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~ 170 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVY 170 (282)
T ss_dssp EEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEE
T ss_pred cCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEE
Confidence 34555556667999888 444444443322 123468899999999994 5665555
Q ss_pred EeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccc
Q psy501 374 RENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR 452 (962)
Q Consensus 374 ~~~~~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~ 452 (962)
.. +..|+||||++| +|.+ + .......++.|++.||.|||+.||+||||||+||+++ ++.+||+|||+|+
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l-------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-V-------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-C-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred ec-cceEEEEEecCCCcHHH-c-------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence 44 446999999986 5654 3 1233557999999999999999999999999999999 9999999999986
Q ss_pred cccCCCcccccCCccccChhhhc
Q psy501 453 EIRSRPYTDYVSTRWYRAPEVLL 475 (962)
Q Consensus 453 ~~~~~~~~~~~gt~~Y~APE~l~ 475 (962)
. +..++|||++.
T Consensus 241 ~-----------~~~~~a~e~l~ 252 (282)
T 1zar_A 241 E-----------VGEEGWREILE 252 (282)
T ss_dssp E-----------TTSTTHHHHHH
T ss_pred E-----------CCCCCHHHHHH
Confidence 3 34578999884
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=6.5e-17 Score=178.70 Aligned_cols=110 Identities=19% Similarity=0.224 Sum_probs=83.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
|-||..||++ |.+||+|||++.. ....+.|||+.|||||++. + ..|+.++||||+|||+|
T Consensus 150 RDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~-~-~~y~~~~DiwSlGvilyemltG~~PF~ 227 (304)
T 3ubd_A 150 RDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN-R-RGHTQSADWWSFGVLMFEMLTGTLPFQ 227 (304)
T ss_dssp SSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHH-T-SCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhc-c-CCCCCCCcccchHHHHHHHHhCCCCCC
Confidence 5679999999 8999999999853 3445679999999999865 3 56999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcch-----hhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTA-----QQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa-----~~~L~~ 808 (962)
|.+..+.+..|... . . .+ -+.+|+++.|||++||+.||++|+|| +|+|++
T Consensus 228 ~~~~~~~~~~i~~~--~-------------~-~~--------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 228 GKDRKETMTMILKA--K-------------L-GM--------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp CSSHHHHHHHHHHC--C-------------C-CC--------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred CcCHHHHHHHHHcC--C-------------C-CC--------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 33333333333321 0 0 00 03579999999999999999999996 577763
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.60 E-value=9.8e-17 Score=181.98 Aligned_cols=135 Identities=22% Similarity=0.310 Sum_probs=102.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------cCC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------GTE 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G~~ 737 (962)
+-||.+||++ |.++|+|||++.. ......+||+.|++||+++ +...|+.++||||+|||++ |.+
T Consensus 156 ~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 156 RDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp CCCCGGGEEECTTCCEEECC---------------CCCTTCCHHHHT-TCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCCCHhhEEECCCCCEEEeeccccccccccCCCcCcCcCccChHHHc-CCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5689999999 8999999999866 2233447888887777655 5567999999999999998 677
Q ss_pred chhHHHHHHHhcCCCchhhhcccccc-------cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 738 RLKSSYILLHTLPLYTCYTLASNMNF-------KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 738 ~~~ql~~I~~~lG~p~~~~~~~~~~~-------~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
..+++..|++.+|+|+.+.+...... ..+..+..++...++.++++++|||++||++||.+|||++++|+.
T Consensus 235 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 235 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 88999999999999988765443221 234455667788888999999999999999999999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=1.1e-16 Score=179.17 Aligned_cols=122 Identities=15% Similarity=0.122 Sum_probs=83.5
Q ss_pred cccceeeEEE---E-EEeeeeeecCCCc----------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCc
Q psy501 673 ERLKSSYILL---H-TLPLYTYHVPPIQ----------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTER 738 (962)
Q Consensus 673 ~~~~~~~~~~---~-~~~~~~~~~~~~~----------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~ 738 (962)
|-||+.||++ | .+||+|||++..- +..+.|||+.|||||++. | ..|+.++||||+|||+|
T Consensus 174 RDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~-~-~~y~~~~DiwSlGvily---- 247 (336)
T 4g3f_A 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM-G-KPCDAKVDIWSSCCMML---- 247 (336)
T ss_dssp SCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHT-T-CCCCTHHHHHHHHHHHH----
T ss_pred cccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHC-C-CCCCcHHHHHHHHHHHH----
Confidence 6789999999 5 4999999998531 122358999999999876 4 56999999999999997
Q ss_pred hhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 739 LKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 739 ~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.+ +.|.+|-...............+.++.++.+.+++++.|||.+||+.||.+|||+.|+++
T Consensus 248 -----em--ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~ 309 (336)
T 4g3f_A 248 -----HM--LNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRR 309 (336)
T ss_dssp -----HH--HHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----HH--HHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 11 124333110000000000000112233344678999999999999999999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=6.3e-17 Score=178.62 Aligned_cols=115 Identities=19% Similarity=0.244 Sum_probs=78.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----------------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeE
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----------------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCL 732 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----------------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCI 732 (962)
|-||++||++ |.+||+|||++.. ....+.|||+.|||||++. | ..|+.++||||+|||
T Consensus 142 RDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~-~-~~y~~~~DiwSlGvi 219 (299)
T 4g31_A 142 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH-G-NSYSHKVDIFSLGLI 219 (299)
T ss_dssp CCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHT-T-CCCCTHHHHHHHHHH
T ss_pred ccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHc-C-CCCCCHHHHHHHHHH
Confidence 7789999999 9999999999754 1123458999999999865 4 569999999999999
Q ss_pred ee-----cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 733 LA-----GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 733 l~-----G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
+| ...+.+....+..+ ....+| ..++..++++.|||++||+.||.+|||+.++|+
T Consensus 220 lyell~Pf~~~~~~~~~~~~~------------~~~~~p--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 220 LFELLYPFSTQMERVRTLTDV------------RNLKFP--------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHSCCSSHHHHHHHHHHH------------HTTCCC--------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHccCCCCccHHHHHHHHH------------hcCCCC--------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 97 11111111111111 000111 112345788999999999999999999999997
Q ss_pred hh
Q psy501 808 IK 809 (962)
Q Consensus 808 ~~ 809 (962)
..
T Consensus 280 h~ 281 (299)
T 4g31_A 280 NA 281 (299)
T ss_dssp SG
T ss_pred CH
Confidence 43
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.7e-16 Score=179.94 Aligned_cols=135 Identities=25% Similarity=0.423 Sum_probs=109.4
Q ss_pred cccceeeEEE----EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL----HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~----~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
+-||.+||++ |.++|+|||++.. ......+||+.|++||++ .|...|+.++||||+|||++
T Consensus 165 rDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 243 (394)
T 4e7w_A 165 RDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELI-FGATNYTTNIDIWSTGCVMAELMQGQPLFP 243 (394)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHH-TTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHH-cCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 5689999999 6799999998743 334445788887777765 46667999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcc----cccccCCCcccCCccccCC-CCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLAS----NMNFKFPQFRRVPFTSIIP-HASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~----~~~~~~~~~~~~~l~~~~p-~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
|.+..+++..|++.+|+|+.+.+.. .....++..++.+|...++ .++++++|||.+||++||.+|||+.++|++
T Consensus 244 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 244 GESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 6778899999999999999876432 2333456666677776665 489999999999999999999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.58 E-value=2.6e-16 Score=181.67 Aligned_cols=136 Identities=21% Similarity=0.366 Sum_probs=109.9
Q ss_pred cccceeeEEE----EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL----HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~----~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
+-||..||++ +.+||+|||++.. ......+||+.|++||++. |...|+.++||||+|||++
T Consensus 180 rDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlG~il~ell~G~~pf~ 258 (420)
T 1j1b_A 180 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF-GATDYTSSIDVWSAGCVLAELLLGQPIFP 258 (420)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHT-TCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHc-CCCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 5789999999 4689999999853 2333458888888887765 5567999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcc----cccccCCCcccCCccccCC-CCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLAS----NMNFKFPQFRRVPFTSIIP-HASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~----~~~~~~~~~~~~~l~~~~p-~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
|.+..+++..|+..+|+|+.+.+.. ...+.++..+..+|...++ .++++++|||++||++||.+|+++.++|++.
T Consensus 259 ~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 259 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 6678899999999999998776533 2334566666777777664 6899999999999999999999999999743
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=2.3e-16 Score=184.67 Aligned_cols=135 Identities=18% Similarity=0.274 Sum_probs=100.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc----eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------c
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ----TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------G 735 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~----~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G 735 (962)
|-||..||++ |.+||.|||++... .....+||+.|++||+++ + ..|+.++||||+|||++ |
T Consensus 188 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~DiwSlG~il~ell~g~~pF~g 265 (464)
T 3ttj_A 188 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-G-MGYKENVDIWSVGCIMGEMVRHKILFPG 265 (464)
T ss_dssp CCCCGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHT-T-CCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHc-C-CCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 5689999999 89999999998652 233458999888888775 4 36999999999999998 7
Q ss_pred CCchhHHHHHHHhcCCCchhhhccccc------ccCCCcccCCccccCCCC------------CHHHHHHHHHhhccCCC
Q psy501 736 TERLKSSYILLHTLPLYTCYTLASNMN------FKFPQFRRVPFTSIIPHA------------SPDAIHLMESMLAYNPS 797 (962)
Q Consensus 736 ~~~~~ql~~I~~~lG~p~~~~~~~~~~------~~~~~~~~~~l~~~~p~~------------s~~a~DLL~kmL~~dP~ 797 (962)
.+..+|+..|++.+|+|..+.+..... ...+......+...+|.. +++++|||++||++||+
T Consensus 266 ~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~ 345 (464)
T 3ttj_A 266 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 345 (464)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTT
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChh
Confidence 788999999999999998776543211 012222333344344332 67899999999999999
Q ss_pred CCcchhhhhhhh
Q psy501 798 KRPTAQQSLSIK 809 (962)
Q Consensus 798 kR~sa~~~L~~~ 809 (962)
+|||++++|++.
T Consensus 346 ~R~ta~e~L~Hp 357 (464)
T 3ttj_A 346 KRISVDDALQHP 357 (464)
T ss_dssp TSCCHHHHHTST
T ss_pred hCCCHHHHhcCh
Confidence 999999999743
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=4.6e-16 Score=172.20 Aligned_cols=125 Identities=12% Similarity=0.125 Sum_probs=83.8
Q ss_pred ccccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeec-CCCCCCCCCceeeeeEeecCCchh
Q psy501 672 TERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHT-LPLYTYHVPPIQTTCLLAGTERLK 740 (962)
Q Consensus 672 ~~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg-~~~Y~~~vDIWSlGCIl~G~~~~~ 740 (962)
-|-||++||++ +.+||+|||++.. ..+.+.+||+.|||||++... ...|+.++||||+|||+|
T Consensus 155 HRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~------ 228 (307)
T 3omv_A 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLY------ 228 (307)
T ss_dssp CSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHH------
T ss_pred CCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHH------
Confidence 37789999999 8999999999854 223456999999999998754 346999999999999997
Q ss_pred HHHHHHHhcCCCchhhhccc---ccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 741 SSYILLHTLPLYTCYTLASN---MNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 741 ql~~I~~~lG~p~~~~~~~~---~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. |.+|-...... ............+....+.+++++.+|+.+||+.||++|||+.++++
T Consensus 229 ---Ellt--g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 229 ---ELMT--GELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp ---HHHH--SSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred ---HHHH--CCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1211 22221100000 00000000011122233578899999999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=5.9e-16 Score=171.02 Aligned_cols=135 Identities=21% Similarity=0.325 Sum_probs=107.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
+-||..||++ |.++|.|||++.. ......+||+.|++||++. +...|+.++||||+||+++
T Consensus 143 ~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~ 221 (311)
T 3niz_A 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLM-GSKKYSTSVDIWSIGCIFAEMITGKPLFP 221 (311)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHT-TCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhc-CCCCCCchHHhHHHHHHHHHHHhCCCCCC
Confidence 5689999999 8999999998753 2233348888888888765 5567999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcccccc------cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNF------KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~------~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.++.+++..|+..+|.|....++..... .+......+|....+.++++++|||++||++||.+|||++++|++
T Consensus 222 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 222 GVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 56778899999999999887665443221 233344566777778899999999999999999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=5.2e-16 Score=170.56 Aligned_cols=134 Identities=22% Similarity=0.333 Sum_probs=109.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------c
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------G 735 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G 735 (962)
+-||++||++ +.++|.|||++.. ......+||+.|++||.+.. ..|+.++||||+|||++ +
T Consensus 144 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~ 221 (308)
T 3g33_A 144 RDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCG 221 (308)
T ss_dssp SCCCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred CCCCHHHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcC--CCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 4679999999 8999999999864 23344589999999998764 34899999999999998 6
Q ss_pred CCchhHHHHHHHhcCCCchhhhcccccc---cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 736 TERLKSSYILLHTLPLYTCYTLASNMNF---KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 736 ~~~~~ql~~I~~~lG~p~~~~~~~~~~~---~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++.+++..|+..+|.|+...++..... .++...+.++....+.+++++.+||.+||++||++|||+.++|++
T Consensus 222 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 222 NSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 6788999999999999887766553332 233344556666778899999999999999999999999999974
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1e-15 Score=166.61 Aligned_cols=135 Identities=18% Similarity=0.292 Sum_probs=103.9
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
+-||..||++ |.++|.|||++.. ......+||+.|++||++. +...|+.++||||+|||++
T Consensus 124 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~ 202 (288)
T 1ob3_A 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM-GSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (288)
T ss_dssp SCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHT-TCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchhee-CCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4679999999 8999999998643 2233447999999988775 5567999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcccccc-----cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNF-----KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~-----~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.++.+++..++..+|.++...++..... .+....+.+|+...+.++++++|||++||+.||++|||++++|+.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 203 GVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 55677889999999998876654432211 233344566777778899999999999999999999999999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.53 E-value=9.6e-16 Score=174.31 Aligned_cols=135 Identities=17% Similarity=0.327 Sum_probs=109.0
Q ss_pred cccceeeEEE----EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL----HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~----~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
+-||.+||++ |.++|+|||.+.. ......+||+.|++||.+. |...|+.++||||+|||++
T Consensus 165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~ 243 (383)
T 3eb0_A 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELML-GATEYTPSIDLWSIGCVFGELILGKPLFS 243 (383)
T ss_dssp SCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHT-TCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhc-CCCCCCcchhhhhHHHHHHHHHhCCCCCC
Confidence 4689999999 5799999998753 3334457888887777665 6667999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcc----cccccCCCcccCCccccCCC-CCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLAS----NMNFKFPQFRRVPFTSIIPH-ASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~----~~~~~~~~~~~~~l~~~~p~-~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
|.+..+++..|+..+|+|+.+.+.. .....++......|...++. ++++++|||.+||++||.+|||+.++|++
T Consensus 244 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 6788899999999999999876433 22334566666777777764 89999999999999999999999999983
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=2.1e-15 Score=164.39 Aligned_cols=136 Identities=18% Similarity=0.292 Sum_probs=104.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
+-||..||++ |.++|.|||++.. ......+||+.|++||++. +...|+.++||||+|||++
T Consensus 125 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF-GAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHT-TCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred CCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHc-CCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 4689999999 8999999999743 2233347888888887765 5566999999999999998
Q ss_pred -cCCchhHHHHHHHhcCCCchhhhcccccc----cCCCc-ccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 -GTERLKSSYILLHTLPLYTCYTLASNMNF----KFPQF-RRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 -G~~~~~ql~~I~~~lG~p~~~~~~~~~~~----~~~~~-~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.+..+++..++..+|.|+.+.+...... .++.. ....+....+.+++++.|||++||++||.+|||++++|++
T Consensus 204 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 204 PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 55677899999999999887765443221 11111 1233445567889999999999999999999999999974
Q ss_pred h
Q psy501 809 K 809 (962)
Q Consensus 809 ~ 809 (962)
.
T Consensus 284 p 284 (292)
T 3o0g_A 284 P 284 (292)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.6e-15 Score=168.48 Aligned_cols=135 Identities=19% Similarity=0.252 Sum_probs=102.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
+-||+.||++ |.++|.|||++.. ......+||+.|++||++. +...|+.++||||+|||++
T Consensus 124 ~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~ 202 (324)
T 3mtl_A 124 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILL-GSTDYSTQIDMWGVGCIFYEMATGRPLFP 202 (324)
T ss_dssp SSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhc-CCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4679999999 8999999998643 2233347888888887764 5567999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcccccc------cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNF------KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~------~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.+..+++..|...+|.|+...++..... .++......+....+.+++++.|||++||++||.+|||++++|+.
T Consensus 203 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 203 GSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 56778999999999999987765543221 233333344445567889999999999999999999999999973
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.51 E-value=2.3e-15 Score=169.91 Aligned_cols=135 Identities=26% Similarity=0.417 Sum_probs=109.5
Q ss_pred cccceeeEEE---EEEeeeeeecCCCce--------eeeccCCCcccccceeeecCCCCCCCCCceeeeeEee-------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQT--------TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~--------~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~------- 734 (962)
+-||+.||++ |.++|.|||++.... ....+||+.|++||+++ +...|+.++||||+|||++
T Consensus 152 ~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~ 230 (364)
T 3qyz_A 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNRP 230 (364)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHH-TBCSCSTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhc-CCCCCCcchhHHHHHHHHHHHHHCCC
Confidence 4689999999 899999999976411 23348999998888765 4466999999999999998
Q ss_pred ---cCCchhHHHHHHHhcCCCchhhhcccccc-------cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhh
Q psy501 735 ---GTERLKSSYILLHTLPLYTCYTLASNMNF-------KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQ 804 (962)
Q Consensus 735 ---G~~~~~ql~~I~~~lG~p~~~~~~~~~~~-------~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~ 804 (962)
+.+..+++..|...+|.|+.+.+...... ..+.....+|...++.+++++.|||++||++||.+|||+.+
T Consensus 231 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 310 (364)
T 3qyz_A 231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 310 (364)
T ss_dssp SSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 67788999999999999998765443221 23444456777788899999999999999999999999999
Q ss_pred hhhh
Q psy501 805 SLSI 808 (962)
Q Consensus 805 ~L~~ 808 (962)
+|+.
T Consensus 311 ~l~h 314 (364)
T 3qyz_A 311 ALAH 314 (364)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9973
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.50 E-value=1.2e-15 Score=183.00 Aligned_cols=114 Identities=18% Similarity=0.151 Sum_probs=87.0
Q ss_pred cccceeeEEE-----EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee---------
Q psy501 673 ERLKSSYILL-----HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA--------- 734 (962)
Q Consensus 673 ~~~~~~~~~~-----~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~--------- 734 (962)
|-||..||++ |.+||.|||++.. ....+.|||+.|+|||++. | ..|+.++||||+|||+|
T Consensus 279 RDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~-~-~~y~~~~DiWSlGvilyeml~G~~Pf 356 (573)
T 3uto_A 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE-G-KPVGYYTDMWSVGVLSYILLSGLSPF 356 (573)
T ss_dssp CCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHT-T-CCBCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred ccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhC-C-CCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 6789999999 7899999999753 5566679999999999765 4 56999999999999997
Q ss_pred -cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 -GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 -G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
|.+..+++..|...-.. ++ . ..++.+|++++|||++||++||.+|+|++|+|++
T Consensus 357 ~~~~~~~~~~~i~~~~~~-------------~~---~----~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 357 GGENDDETLRNVKSCDWN-------------MD---D----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CCSSHHHHHHHHHTTCCC-------------CC---S----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCcCHHHHHHHHHhCCCC-------------CC---c----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 23333333333321111 11 1 1225789999999999999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.50 E-value=3.2e-15 Score=167.54 Aligned_cols=135 Identities=24% Similarity=0.352 Sum_probs=107.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
+-||..||++ |.++|.|||++.. ......+||+.|++||.+. +...|+.++||||+|||++
T Consensus 136 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~~~~ 214 (346)
T 1ua2_A 136 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF-GARMYGVGVDMWAVGCILAELLLRVPFLP 214 (346)
T ss_dssp CCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHT-TCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhh-CCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 4689999999 8999999998754 2233458999998888765 5566999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcccccc----cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNF----KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~----~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
|.++.+++..|+..+|.|+.+.++..... .+...+..++..+++.+++++.|||++||++||.+|||++++|+.
T Consensus 215 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 215 GDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 66788899999999999887765443221 122333455666677889999999999999999999999999973
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.49 E-value=2.1e-15 Score=181.53 Aligned_cols=121 Identities=17% Similarity=0.133 Sum_probs=84.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCC---ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI---QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILL 746 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I~ 746 (962)
|-||..||++ |.+||+|||++.. ..+.+.|||+.|||||++.-| ..|+.++||||+|||+| .+
T Consensus 316 RDLKPeNILld~~G~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilY---------Em- 384 (689)
T 3v5w_A 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLF---------KL- 384 (689)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHH---------HH-
T ss_pred cCCchHHeEEeCCCCEEecccceeeecCCCCCCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHH---------HH-
Confidence 6679999999 9999999999854 556677999999999988654 56999999999999997 11
Q ss_pred HhcCCCchhh--hccccc-ccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcc-----hhhhhhh
Q psy501 747 HTLPLYTCYT--LASNMN-FKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPT-----AQQSLSI 808 (962)
Q Consensus 747 ~~lG~p~~~~--~~~~~~-~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~s-----a~~~L~~ 808 (962)
+.|.+|=.. ...... ..........+ -+.+|++++|||++||+.||.+|++ |++++++
T Consensus 385 -LtG~~PF~~~~~~~~~~i~~~i~~~~~~~---p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 385 -LRGHSPFRQHKTKDKHEIDRMTLTMAVEL---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp -HHSSCTTCGGGCCCHHHHHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred -HhCCCCCCCCChHHHHHHHHhhcCCCCCC---CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 123332110 000000 00000000001 1368999999999999999999998 6888864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=4e-15 Score=164.64 Aligned_cols=135 Identities=17% Similarity=0.205 Sum_probs=101.5
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
+-||..||++ |.++|.|||++.. ......+||+.|++||++. +...|+.++||||+|||++
T Consensus 132 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~pf~ 210 (317)
T 2pmi_A 132 RDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLM-GSRTYSTSIDIWSCGCILAEMITGKPLFP 210 (317)
T ss_dssp CCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 5689999999 8999999998753 2233458999999888765 5567999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhccccccc-----CCCcccCCcccc-----CCCCCHHHHHHHHHhhccCCCCCcchhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNFK-----FPQFRRVPFTSI-----IPHASPDAIHLMESMLAYNPSKRPTAQQ 804 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~-----~~~~~~~~l~~~-----~p~~s~~a~DLL~kmL~~dP~kR~sa~~ 804 (962)
+.++.+++..|++.+|.|+...++...... +....+..+.+. ...+++++.|||.+||++||.+|||+++
T Consensus 211 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 290 (317)
T 2pmi_A 211 GTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQ 290 (317)
T ss_dssp CSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHH
Confidence 567788999999999998776544322210 111111222111 1257899999999999999999999999
Q ss_pred hhhh
Q psy501 805 SLSI 808 (962)
Q Consensus 805 ~L~~ 808 (962)
+|+.
T Consensus 291 ~l~h 294 (317)
T 2pmi_A 291 ALHH 294 (317)
T ss_dssp HTTS
T ss_pred HhCC
Confidence 9974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=5e-15 Score=171.40 Aligned_cols=134 Identities=16% Similarity=0.237 Sum_probs=100.9
Q ss_pred cccceeeEEE---EE--EeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------c
Q psy501 673 ERLKSSYILL---HT--LPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------G 735 (962)
Q Consensus 673 ~~~~~~~~~~---~~--~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G 735 (962)
+-||+.||++ +. ++|.|||++.. ....+.+||+.|++||++.. ..|+.++||||+|||++ |
T Consensus 224 rDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 224 CDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILG--ARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp SCCSGGGEEESSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHT--BCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCHHHeEEccCCCcceEEeecccceecCCcccccCCCCCccChHHHhC--CCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 5689999999 44 99999999754 44455689999999888764 34999999999999998 6
Q ss_pred CCchhHHHHHHHhcCCCchhhhcccccc-------cCC---------------------------CcccCCccccCC-CC
Q psy501 736 TERLKSSYILLHTLPLYTCYTLASNMNF-------KFP---------------------------QFRRVPFTSIIP-HA 780 (962)
Q Consensus 736 ~~~~~ql~~I~~~lG~p~~~~~~~~~~~-------~~~---------------------------~~~~~~l~~~~p-~~ 780 (962)
.++.+++..|++.+|.|+...+...... .++ ......|...++ ..
T Consensus 302 ~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 381 (429)
T 3kvw_A 302 EDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCD 381 (429)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCC
T ss_pred CCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccc
Confidence 7888999999999999987753221110 000 001122333333 34
Q ss_pred CHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 781 SPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 781 s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+++++|||++||++||++|||++++|++
T Consensus 382 ~~~~~dli~~~L~~dP~~Rpta~e~L~H 409 (429)
T 3kvw_A 382 DPLFLDFLKQCLEWDPAVRMTPGQALRH 409 (429)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hHHHHHHHHHHCCCChhhCCCHHHHhCC
Confidence 7889999999999999999999999974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.47 E-value=9e-15 Score=165.67 Aligned_cols=135 Identities=24% Similarity=0.310 Sum_probs=104.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------cCC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------GTE 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G~~ 737 (962)
+-||..||++ |.++|.|||++.. ......+||+.|++||.+. +...|+.++||||+|||++ +.+
T Consensus 168 ~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 168 RDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVIL-SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp SCCCGGGEEECTTCCEEECSTTCC--------CTTCCCTTSCHHHHS-CCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCcCHHHeEECCCCCEEEEecCcccccccCcCCcccCccccCHHHhc-CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4689999999 8999999999876 3334458999988888765 4456999999999999998 667
Q ss_pred chhHHHHHHHhcCCCchhhhcccccc-------cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 738 RLKSSYILLHTLPLYTCYTLASNMNF-------KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 738 ~~~ql~~I~~~lG~p~~~~~~~~~~~-------~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
..+++..|+..+|.|+.+........ ..+..+...+...++.+++++.|||.+||++||.+|||+.++|+.
T Consensus 247 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 247 YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 88899999999999987654332111 133334455666678899999999999999999999999999973
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.45 E-value=9e-15 Score=163.94 Aligned_cols=135 Identities=16% Similarity=0.262 Sum_probs=104.6
Q ss_pred cccceeeEEE----EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL----HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~----~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
+-||.+||++ +.++|.|||++.. ......+||+.|++||.+. +...|+.++||||+|||++
T Consensus 155 ~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~Di~slG~il~ell~g~~pf~ 233 (360)
T 3e3p_A 155 RDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIF-GNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233 (360)
T ss_dssp SCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHT-TCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHc-CCCCCCcHHHHHHHHHHHHHHHhCCCCcC
Confidence 5689999999 5799999999854 2333458888888888764 5566999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcccc----cccCCCcccCCccccCCC----CCHHHHHHHHHhhccCCCCCcchhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNM----NFKFPQFRRVPFTSIIPH----ASPDAIHLMESMLAYNPSKRPTAQQSL 806 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~----~~~~~~~~~~~l~~~~p~----~s~~a~DLL~kmL~~dP~kR~sa~~~L 806 (962)
+.+..+++..+...+|.|+.+.+.... ...+......+|...++. .++++.|||.+||++||.+|||+.++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 313 (360)
T 3e3p_A 234 GDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313 (360)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHh
Confidence 567788999999999999877643321 112223334455555544 578999999999999999999999999
Q ss_pred hh
Q psy501 807 SI 808 (962)
Q Consensus 807 ~~ 808 (962)
++
T Consensus 314 ~h 315 (360)
T 3e3p_A 314 CH 315 (360)
T ss_dssp TS
T ss_pred cC
Confidence 63
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=3.4e-15 Score=171.09 Aligned_cols=136 Identities=15% Similarity=0.205 Sum_probs=95.9
Q ss_pred cccceeeEEE-------EEEeeeeeecCCC--------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee---
Q psy501 673 ERLKSSYILL-------HTLPLYTYHVPPI--------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA--- 734 (962)
Q Consensus 673 ~~~~~~~~~~-------~~~~~~~~~~~~~--------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~--- 734 (962)
+-||..||++ +.++|.|||++.. ......+||+.|++||++. +...|+.++||||+|||++
T Consensus 152 ~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwSlG~il~ell 230 (405)
T 3rgf_A 152 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL-GARHYTKAIDIWAIGCIFAELL 230 (405)
T ss_dssp CCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHT-TCCSCCHHHHHHHHHHHHHHHH
T ss_pred CCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhc-CCCcccchhhhHHHHHHHHHHH
Confidence 5689999999 7899999999864 2223458999988888765 5567999999999999998
Q ss_pred -cCC---------------chhHHHHHHHhcCCCchhhhccccccc--------C--CCcccCCc----cccCCCCCHHH
Q psy501 735 -GTE---------------RLKSSYILLHTLPLYTCYTLASNMNFK--------F--PQFRRVPF----TSIIPHASPDA 784 (962)
Q Consensus 735 -G~~---------------~~~ql~~I~~~lG~p~~~~~~~~~~~~--------~--~~~~~~~l----~~~~p~~s~~a 784 (962)
|.. ..+++..|+..+|.|+...+....... + ..+....+ .......++++
T Consensus 231 ~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (405)
T 3rgf_A 231 TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKA 310 (405)
T ss_dssp HSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHH
T ss_pred hCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHH
Confidence 332 248999999999999877654432210 0 00011111 11112457899
Q ss_pred HHHHHHhhccCCCCCcchhhhhhhh
Q psy501 785 IHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 785 ~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
+|||.+||++||.+|||++++|++.
T Consensus 311 ~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 311 FHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHHccCCcccCCCHHHHhcCh
Confidence 9999999999999999999999743
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.3e-14 Score=160.76 Aligned_cols=135 Identities=24% Similarity=0.310 Sum_probs=103.9
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------cCC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------GTE 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G~~ 737 (962)
+.||.+||++ |.++|.|||++.. ......+||+.|++||.+. +...|+.++||||+|||++ +.+
T Consensus 150 ~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 150 RDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVIL-SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp SSCCGGGEEECTTCCEEECSTTCTTC--------CCSBCCSCHHHHS-CCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred CCCCHHHEeECCCCcEEEeecccccCCCCCccccccCcCcCCHHHHh-CcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4689999999 8899999999876 2233448888888888765 4456999999999999998 567
Q ss_pred chhHHHHHHHhcCCCchhhhcccccc-------cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 738 RLKSSYILLHTLPLYTCYTLASNMNF-------KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 738 ~~~ql~~I~~~lG~p~~~~~~~~~~~-------~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
..+++..|...+|.|+.+........ ..+..+...+...++.+++++.|||.+||..||.+|||+.++|+.
T Consensus 229 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 229 YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 77899999999999887654332211 123333445666667899999999999999999999999999973
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.44 E-value=6.3e-15 Score=163.27 Aligned_cols=120 Identities=11% Similarity=0.022 Sum_probs=82.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
|-||++||++ +.+||+|||++.. ..+.+.+||++|||||.+..+ .|+.++||||+|||++
T Consensus 169 RDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~~s~ksDVwSfGvvl~-------- 238 (308)
T 4gt4_A 169 KDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLW-------- 238 (308)
T ss_dssp SCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHH--------
T ss_pred CCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC--CCCccchhhhHHHHHH--------
Confidence 6799999999 8999999999764 123345899999999988754 5999999999999996
Q ss_pred HHHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
+|+ ..|.+|-......... ........+. -+.+++++.+|+.+|+..||++|||+.++++
T Consensus 239 -El~-t~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~ 299 (308)
T 4gt4_A 239 -EVF-SYGLQPYCGYSNQDVVEMIRNRQVLPC---PDDCPAWVYALMIECWNEFPSRRPRFKDIHS 299 (308)
T ss_dssp -HHH-TTTCCTTTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHH-hCCCCCCCCCCHHHHHHHHHcCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 222 1233321110000000 0000000011 1367889999999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.1e-14 Score=162.82 Aligned_cols=120 Identities=13% Similarity=0.086 Sum_probs=77.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
|-||++||++ +.+||+|||++.. ....+.+||++||+||++.. ..|+.++||||+|||+|
T Consensus 182 RDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl~-------- 251 (329)
T 4aoj_A 182 RDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLW-------- 251 (329)
T ss_dssp SCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHHH--------
T ss_pred ccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC--CCCCccccccchHHHHH--------
Confidence 6799999999 8999999999864 12234589999999997653 46999999999999996
Q ss_pred HHHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
+|+ ..|.+|-......... ....-...+. -+.+++++.+|+.+||+.||++|||++++++
T Consensus 252 -Ell-t~G~~Pf~~~~~~~~~~~i~~g~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 252 -EIF-TYGKQPWYQLSNTEAIDCITQGRELER---PRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp -HHH-TTSCCTTCSSCHHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred -HHH-cCCCCCCCCCCHHHHHHHHHcCCCCCC---cccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 111 1233321110000000 0000000001 1357899999999999999999999999875
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.44 E-value=7.4e-15 Score=166.35 Aligned_cols=134 Identities=19% Similarity=0.270 Sum_probs=92.6
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc----eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------c
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ----TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------G 735 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~----~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G 735 (962)
+-||..||++ |.++|.|||++... .....+||+.|++||++.. ..|+.++||||+|||++ |
T Consensus 151 ~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~ 228 (371)
T 2xrw_A 151 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPG 228 (371)
T ss_dssp SCCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 5789999999 79999999998652 2234489999999988763 45999999999999998 6
Q ss_pred CCchhHHHHHHHhcCCCchhhhcccccc------cCCCcccCCccccCCC------------CCHHHHHHHHHhhccCCC
Q psy501 736 TERLKSSYILLHTLPLYTCYTLASNMNF------KFPQFRRVPFTSIIPH------------ASPDAIHLMESMLAYNPS 797 (962)
Q Consensus 736 ~~~~~ql~~I~~~lG~p~~~~~~~~~~~------~~~~~~~~~l~~~~p~------------~s~~a~DLL~kmL~~dP~ 797 (962)
.+..+++..|+..+|.|.++.+...... ..+.+....++..++. .+++++|||++||++||.
T Consensus 229 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 308 (371)
T 2xrw_A 229 TDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 308 (371)
T ss_dssp SSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGG
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChh
Confidence 6778899999999999877654332110 1122222233333322 156899999999999999
Q ss_pred CCcchhhhhhh
Q psy501 798 KRPTAQQSLSI 808 (962)
Q Consensus 798 kR~sa~~~L~~ 808 (962)
+|||++++|+.
T Consensus 309 ~R~t~~e~l~h 319 (371)
T 2xrw_A 309 KRISVDEALQH 319 (371)
T ss_dssp GSCCHHHHHHS
T ss_pred hCCCHHHHhCC
Confidence 99999999973
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=1e-14 Score=162.31 Aligned_cols=136 Identities=21% Similarity=0.316 Sum_probs=97.3
Q ss_pred cccceeeEEEE--------EEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee-----
Q psy501 673 ERLKSSYILLH--------TLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----- 734 (962)
Q Consensus 673 ~~~~~~~~~~~--------~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----- 734 (962)
+-||..||++. .++|.|||++.. ......+||+.|++||++. +...|+.++||||+|||++
T Consensus 156 ~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g 234 (329)
T 3gbz_A 156 RDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILL-GSRHYSTSVDIWSIACIWAEMLMK 234 (329)
T ss_dssp SCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhc-CCCCCCcHHHHHHHHHHHHHHHHC
Confidence 46799999992 399999998643 3334447888988888765 5567999999999999998
Q ss_pred -----cCCchhHHHHHHHhcCCCchhhhcccccc-----cCCCcccCCccccCC-CCCHHHHHHHHHhhccCCCCCcchh
Q psy501 735 -----GTERLKSSYILLHTLPLYTCYTLASNMNF-----KFPQFRRVPFTSIIP-HASPDAIHLMESMLAYNPSKRPTAQ 803 (962)
Q Consensus 735 -----G~~~~~ql~~I~~~lG~p~~~~~~~~~~~-----~~~~~~~~~l~~~~p-~~s~~a~DLL~kmL~~dP~kR~sa~ 803 (962)
+.++.+++..++..+|.|+...++..... .++......+...++ .++++++|||++||++||.+|||++
T Consensus 235 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 314 (329)
T 3gbz_A 235 TPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAK 314 (329)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHH
Confidence 66788999999999999887654432211 122222233332222 2789999999999999999999999
Q ss_pred hhhhhh
Q psy501 804 QSLSIK 809 (962)
Q Consensus 804 ~~L~~~ 809 (962)
++|+..
T Consensus 315 e~l~hp 320 (329)
T 3gbz_A 315 NALEHP 320 (329)
T ss_dssp HHHTSG
T ss_pred HHhCCc
Confidence 999743
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=8.6e-15 Score=165.15 Aligned_cols=120 Identities=15% Similarity=0.150 Sum_probs=82.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
|-||++||++ +.+||+|||++.. ..+.+.+||++|||||++.- ..|+.++||||+|||++
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l~-------- 278 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLW-------- 278 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHH--------
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc--CCCCCcccEeehHHHHH--------
Confidence 7789999999 8999999999864 12334589999999998864 45999999999999996
Q ss_pred HHHHHhcCCCchhhhcccccc-c-CCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNF-K-FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~-~-~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
+|+ .+|.+|-........+ . ...-...+. -+.+++++.+||.+||+.||++|||+.++++
T Consensus 279 -El~-t~G~~Pf~~~~~~~~~~~~i~~g~~~~~---p~~~~~~~~~li~~c~~~dP~~RPt~~eil~ 340 (353)
T 4ase_A 279 -EIF-SLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 340 (353)
T ss_dssp -HHT-TTSCCSSTTCCCSHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHH-hCCCCCCCCCCHHHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 111 1244331111000000 0 000000001 1357899999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=1.7e-14 Score=163.92 Aligned_cols=134 Identities=19% Similarity=0.259 Sum_probs=96.6
Q ss_pred cccceeeEEE-----EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------c
Q psy501 673 ERLKSSYILL-----HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------G 735 (962)
Q Consensus 673 ~~~~~~~~~~-----~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G 735 (962)
+-||+.||++ +.++|.|||++.. ......+||+.|++||++. + ..|+.++||||+|||++ +
T Consensus 183 rDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~-~-~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 183 CDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLL-G-MPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CCCSGGGEEESSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHT-T-CCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCcccEEEecCCCCcEEEEeccCceecccccccccCCccccChHHHc-C-CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 5789999999 5699999999855 3344558999998888775 3 35999999999999998 6
Q ss_pred CCchhHHHHHHHhcCCCchhhhcccccc-----cCC--------------Ccc---cCCccccCC-----------C---
Q psy501 736 TERLKSSYILLHTLPLYTCYTLASNMNF-----KFP--------------QFR---RVPFTSIIP-----------H--- 779 (962)
Q Consensus 736 ~~~~~ql~~I~~~lG~p~~~~~~~~~~~-----~~~--------------~~~---~~~l~~~~p-----------~--- 779 (962)
.++.+++..|...+|.|+...+...... ..+ .+. ...+...++ .
T Consensus 261 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 340 (382)
T 2vx3_A 261 ANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESG 340 (382)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTT
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCcccccccc
Confidence 6788999999999999887654322110 000 000 011111110 0
Q ss_pred ----CCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 780 ----ASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 780 ----~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.+++++|||.+||++||++|||++++|+.
T Consensus 341 ~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~h 373 (382)
T 2vx3_A 341 HTVADYLKFKDLILRMLDYDPKTRIQPYYALQH 373 (382)
T ss_dssp CCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccchhhHHHHHHHHHhcCCChhhCCCHHHHhcC
Confidence 01478999999999999999999999984
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=6.7e-15 Score=162.40 Aligned_cols=120 Identities=13% Similarity=0.040 Sum_probs=81.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----c---eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----Q---TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~---~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
|-||++||++ +.+||+|||++.. . .....+||++||+||.+.. ..|+.++||||+|||+|
T Consensus 152 RDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl~-------- 221 (299)
T 4asz_A 152 RDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLW-------- 221 (299)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHH--------
T ss_pred CccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHHH--------
Confidence 6789999999 8999999999753 1 1222479999999998865 45999999999999996
Q ss_pred HHHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
+++ ..|.+|-......... ....-...+. -+.+++++.+|+.+||+.||++|||+.++++
T Consensus 222 -Ell-t~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~ 282 (299)
T 4asz_A 222 -EIF-TYGKQPWYQLSNNEVIECITQGRVLQR---PRTCPQEVYELMLGCWQREPHMRKNIKGIHT 282 (299)
T ss_dssp -HHH-TTTCCTTTTSCHHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHH-cCCCCCCCCCCHHHHHHHHHcCCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 121 1244331111000000 0000000001 1357899999999999999999999999854
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.41 E-value=6.7e-14 Score=154.44 Aligned_cols=134 Identities=20% Similarity=0.273 Sum_probs=105.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------c
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------G 735 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G 735 (962)
+.||..||++ |.++|.|||++.. ......+||+.|++||.+.. ..|+.++||||+|||++ +
T Consensus 144 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~ 221 (326)
T 1blx_A 144 RDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRG 221 (326)
T ss_dssp CCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccCCHHHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 4679999999 8999999999865 22334589999999988754 35899999999999998 5
Q ss_pred CCchhHHHHHHHhcCCCchhhhcccccc---cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 736 TERLKSSYILLHTLPLYTCYTLASNMNF---KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 736 ~~~~~ql~~I~~~lG~p~~~~~~~~~~~---~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++.+++..|...+|.|+...++..... .+......++....+.+++++.+||.+||..||.+||++.++|+.
T Consensus 222 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 222 SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp SSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 6777889999999999887765443221 122223344556667899999999999999999999999999973
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=1.3e-13 Score=161.97 Aligned_cols=113 Identities=22% Similarity=0.226 Sum_probs=79.9
Q ss_pred cccceeeEEE------EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee--------
Q psy501 673 ERLKSSYILL------HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA-------- 734 (962)
Q Consensus 673 ~~~~~~~~~~------~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~-------- 734 (962)
+-||+.||++ +.++|.|||++.. ......+||+.|++||++. | .|+.++||||+|||++
T Consensus 145 ~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~--~~~~~~DiwslG~il~~ll~g~~p 221 (486)
T 3mwu_A 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-G--TYDEKCDVWSAGVILYILLSGTPP 221 (486)
T ss_dssp SCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGG-S--CCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhC-C--CCCchhhHHHHHHHHHHHHhCCCC
Confidence 5689999999 4699999998764 3334558999999999764 3 4999999999999997
Q ss_pred --cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 --GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 --G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.+..+.+..+.... .. + ....| +.++++++|||++||++||.+|||+.++|+.
T Consensus 222 f~~~~~~~~~~~i~~~~-----------~~--~---~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 222 FYGKNEYDILKRVETGK-----------YA--F---DLPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SCCSSHHHHHHHHHHTC-----------CC--S---CSGGG----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCCHHHHHHHHHhCC-----------CC--C---CCccc----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 222222222222110 00 0 11112 3678999999999999999999999999973
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=3.5e-13 Score=145.17 Aligned_cols=95 Identities=18% Similarity=0.246 Sum_probs=76.2
Q ss_pred HHHHHHHHHHhcCCCCc--ccEEEEEEeCCEEEEEEecCC--C----CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcc
Q psy501 350 VVCFYRKSLKKLSHANL--VKLKEVIRENDTLYFVFEYMK--E----NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMH 421 (962)
Q Consensus 350 ~~~~Ei~iL~~L~HpnI--v~l~~~~~~~~~~~LV~Ey~~--g----~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH 421 (962)
.+.+|+.+|.++.|+++ +.+++. ...+|||||++ | .|.+.... .++..+..++.|++.||.|||
T Consensus 116 ~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 116 WTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHH
Confidence 58899999999988754 445543 24689999995 2 44443322 235578899999999999999
Q ss_pred -cceeeeccCCCcccccccccceeeecccccccc
Q psy501 422 -RHGFFHRDMKPENLLCMGTELVKIADFGLAREI 454 (962)
Q Consensus 422 -~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~ 454 (962)
+.||+||||||+|||++. .++|+|||+|...
T Consensus 188 ~~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 188 QEAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999999988 8999999999754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=4.6e-14 Score=158.07 Aligned_cols=135 Identities=15% Similarity=0.200 Sum_probs=98.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCC---------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI---------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA------ 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~---------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~------ 734 (962)
+-||+.||++ |.++|.|||++.. ......+||+.|++||++. +...|+.++||||+|||++
T Consensus 148 ~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~ 226 (351)
T 3mi9_A 148 RDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL-GERDYGPPIDLWGAGCIMAEMWTRS 226 (351)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHT-TCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhc-CCCCCCcHhHHHHHHHHHHHHHhCC
Confidence 4689999999 8999999998642 2223447888888888764 5567999999999999998
Q ss_pred ----cCCchhHHHHHHHhcCCCchhhhccccccc------CCCcccCCccccCC--CCCHHHHHHHHHhhccCCCCCcch
Q psy501 735 ----GTERLKSSYILLHTLPLYTCYTLASNMNFK------FPQFRRVPFTSIIP--HASPDAIHLMESMLAYNPSKRPTA 802 (962)
Q Consensus 735 ----G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~------~~~~~~~~l~~~~p--~~s~~a~DLL~kmL~~dP~kR~sa 802 (962)
+.++.+++..|...+|.++...++...... ........+...+. ..+++++|||++||++||.+|||+
T Consensus 227 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 306 (351)
T 3mi9_A 227 PIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 306 (351)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCH
Confidence 667788999999999988766544322211 00000111111111 147889999999999999999999
Q ss_pred hhhhhh
Q psy501 803 QQSLSI 808 (962)
Q Consensus 803 ~~~L~~ 808 (962)
+++|+.
T Consensus 307 ~e~l~h 312 (351)
T 3mi9_A 307 DDALNH 312 (351)
T ss_dssp HHHHTS
T ss_pred HHHhCC
Confidence 999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=3.2e-14 Score=159.04 Aligned_cols=134 Identities=20% Similarity=0.387 Sum_probs=102.6
Q ss_pred cccceeeEEE---EEEeeeeeecCCCce---------------eeeccCCCcccccceeeecCCCCCCCCCceeeeeEee
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQT---------------TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~---------------~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~ 734 (962)
+-||..||++ |.++|.|||++.... ....+||+.|++||++.. ...|+.++||||+|||++
T Consensus 136 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~Di~slG~il~ 214 (353)
T 2b9h_A 136 RDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT-SAKYSRAMDVWSCGCILA 214 (353)
T ss_dssp SCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHS-CCCCCHHHHHHHHHHHHH
T ss_pred CCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeecc-CCCccchhhHHHHHHHHH
Confidence 5689999999 889999999875411 122478999999988754 356999999999999998
Q ss_pred ----------cCCchhHHHHHHHhcCCCchhhhccccc--------ccCCCcccCCccccCCCCCHHHHHHHHHhhccCC
Q psy501 735 ----------GTERLKSSYILLHTLPLYTCYTLASNMN--------FKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNP 796 (962)
Q Consensus 735 ----------G~~~~~ql~~I~~~lG~p~~~~~~~~~~--------~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP 796 (962)
+.+..+++..++..+|.|.......... ...+..+..++...++.+++++.+||++||..||
T Consensus 215 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 294 (353)
T 2b9h_A 215 ELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294 (353)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSG
T ss_pred HHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCc
Confidence 5667788899999999887432211100 0123334455666678899999999999999999
Q ss_pred CCCcchhhhhh
Q psy501 797 SKRPTAQQSLS 807 (962)
Q Consensus 797 ~kR~sa~~~L~ 807 (962)
.+|||+.++|+
T Consensus 295 ~~Rpt~~ell~ 305 (353)
T 2b9h_A 295 AKRITAKEALE 305 (353)
T ss_dssp GGSCCHHHHHT
T ss_pred ccCCCHHHHhc
Confidence 99999999996
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=4.5e-14 Score=158.68 Aligned_cols=135 Identities=16% Similarity=0.297 Sum_probs=99.5
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------c
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------G 735 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G 735 (962)
+-||++||++ +.++|.|||++.. ......+||+.|++||.+. +...|+.++||||+|||++ +
T Consensus 158 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 158 RDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVM-QFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp CCCCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHT-TCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhc-CCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 4679999999 8899999999864 2223347888888877765 4456999999999999998 5
Q ss_pred CCchhHHHHHHHhcCCCchhhhccccc--------ccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 736 TERLKSSYILLHTLPLYTCYTLASNMN--------FKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 736 ~~~~~ql~~I~~~lG~p~~~~~~~~~~--------~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.+..+++..+...+|.|.......... ......+...|....+..++++.+||.+||.+||.+|||+.++|+
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 677889999999999988665322111 112233445566667889999999999999999999999999997
Q ss_pred h
Q psy501 808 I 808 (962)
Q Consensus 808 ~ 808 (962)
+
T Consensus 317 h 317 (362)
T 3pg1_A 317 H 317 (362)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=8e-14 Score=164.09 Aligned_cols=113 Identities=19% Similarity=0.245 Sum_probs=81.2
Q ss_pred cccceeeEEE------EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee--------
Q psy501 673 ERLKSSYILL------HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA-------- 734 (962)
Q Consensus 673 ~~~~~~~~~~------~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~-------- 734 (962)
+-||+.||++ +.++|.|||++.. ......+||+.|++||++. ..|+.++||||+|||++
T Consensus 160 ~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~DiwslG~il~~ll~g~~p 236 (494)
T 3lij_A 160 RDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR---KKYDEKCDVWSIGVILFILLAGYPP 236 (494)
T ss_dssp SCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT---TCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc---ccCCCchhHHHHHHHHHHHHhCCCC
Confidence 5689999999 3499999998754 3344558999999999753 45999999999999997
Q ss_pred --cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 --GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 --G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.+..+.+..|.... + .+....| +.+++++.|||++||++||.+|||+.++|++
T Consensus 237 f~~~~~~~~~~~i~~~~---------------~-~~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 237 FGGQTDQEILRKVEKGK---------------Y-TFDSPEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SCCSSHHHHHHHHHHTC---------------C-CCCSGGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCCCCHHHHHHHHHhCC---------------C-CCCchhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 112222222222110 0 0111112 4689999999999999999999999999973
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.6e-13 Score=152.57 Aligned_cols=135 Identities=19% Similarity=0.260 Sum_probs=99.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
+-||..||++ |.++|.|||++.. ......+||+.|++||.+. +...|+.++||||+|||++
T Consensus 148 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (331)
T 4aaa_A 148 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLV-GDVKYGKAVDVWAIGCLVTEMFMGEPLFP 226 (331)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHT-TCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCccccc-CCCCcchHHHHHHHHHHHHHHHhCCCCCC
Confidence 4679999999 8999999998754 2233458999988888765 5457999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhc---c---cccccCCCc-ccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLA---S---NMNFKFPQF-RRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~---~---~~~~~~~~~-~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
+.++.+++..+...+|.+.+.... . ......+.. ...++....+.+++++.+||.+||++||.+|||+.++|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 227 GDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 566778888898888886654321 1 111112222 233445556788999999999999999999999999998
Q ss_pred h
Q psy501 808 I 808 (962)
Q Consensus 808 ~ 808 (962)
.
T Consensus 307 h 307 (331)
T 4aaa_A 307 H 307 (331)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.6e-13 Score=161.92 Aligned_cols=113 Identities=19% Similarity=0.221 Sum_probs=80.8
Q ss_pred cccceeeEEE---E---EEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee--------
Q psy501 673 ERLKSSYILL---H---TLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA-------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~---~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~-------- 734 (962)
+-||+.||++ + .++|.|||++.. ......+||+.|++||++. ..|+.++||||+|||++
T Consensus 170 ~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~p 246 (504)
T 3q5i_A 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK---KKYNEKCDVWSCGVIMYILLCGYPP 246 (504)
T ss_dssp SCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT---TCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc---cCCCchHHHHHHHHHHHHHHhCCCC
Confidence 5689999999 2 599999998753 3344558999999999753 35999999999999997
Q ss_pred --cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 --GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 --G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.+..+.+..|.... + .++...| +.++++++|||++||++||.+|||++++|+.
T Consensus 247 f~~~~~~~~~~~i~~~~---------------~-~~~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 247 FGGQNDQDIIKKVEKGK---------------Y-YFDFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp SCCSSHHHHHHHHHHCC---------------C-CCCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCHHHHHHHHHcCC---------------C-CCCcccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 112222222221100 0 0111111 4689999999999999999999999999973
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.36 E-value=8.4e-14 Score=154.09 Aligned_cols=136 Identities=18% Similarity=0.364 Sum_probs=98.3
Q ss_pred cccceeeEEEE----EEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILLH----TLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~~----~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
+-||..||++. .++|.|||++.. ......+||+.|++||++. +...|+.++||||+|||++
T Consensus 154 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 154 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp CCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhc-CCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 46799999993 899999998743 3344558888888887764 5567999999999999998
Q ss_pred -cCCchhHHHHHHHhcCCCchhhhccccccc--------CCCcccCCccccCC-----CCCHHHHHHHHHhhccCCCCCc
Q psy501 735 -GTERLKSSYILLHTLPLYTCYTLASNMNFK--------FPQFRRVPFTSIIP-----HASPDAIHLMESMLAYNPSKRP 800 (962)
Q Consensus 735 -G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~--------~~~~~~~~l~~~~p-----~~s~~a~DLL~kmL~~dP~kR~ 800 (962)
+.+..+++..+...+|.+............ ........|...++ .+++++.|||.+||++||.+||
T Consensus 233 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 312 (330)
T 3nsz_A 233 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 312 (330)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSC
T ss_pred cCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCC
Confidence 456778888888888876543322111111 01112233333332 3789999999999999999999
Q ss_pred chhhhhhhh
Q psy501 801 TAQQSLSIK 809 (962)
Q Consensus 801 sa~~~L~~~ 809 (962)
|++++|++.
T Consensus 313 ta~e~l~hp 321 (330)
T 3nsz_A 313 TAREAMEHP 321 (330)
T ss_dssp CHHHHHTSG
T ss_pred CHHHHhcCc
Confidence 999999743
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=9.7e-14 Score=152.26 Aligned_cols=135 Identities=21% Similarity=0.246 Sum_probs=95.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
+-||+.||++ |.++|.|||.+.. ......+||+.|++||.+. +...|+.++||||+||+++
T Consensus 126 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~ 204 (311)
T 4agu_A 126 RDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLV-GDTQYGPPVDVWAIGCVFAELLSGVPLWP 204 (311)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHH-TCSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHh-cCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 4689999999 8899999998753 2233448888888887765 5567999999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhccc---c---cccCCCc-ccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASN---M---NFKFPQF-RRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~---~---~~~~~~~-~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
+.+..+++..+...+|.+........ . ....+.. ...++...++.+++++.+||++||.+||.+|||++++|+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 205 GKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 56677888888888888665432111 0 0111111 122344456789999999999999999999999999997
Q ss_pred h
Q psy501 808 I 808 (962)
Q Consensus 808 ~ 808 (962)
.
T Consensus 285 h 285 (311)
T 4agu_A 285 H 285 (311)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=1.1e-13 Score=162.40 Aligned_cols=113 Identities=20% Similarity=0.237 Sum_probs=81.3
Q ss_pred cccceeeEEE------EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee--------
Q psy501 673 ERLKSSYILL------HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA-------- 734 (962)
Q Consensus 673 ~~~~~~~~~~------~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~-------- 734 (962)
+-||+.||++ +.++|.|||++.. ......+||+.|++||++. | .|+.++||||+|||++
T Consensus 150 ~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~--~~~~~~DiwslG~il~~ll~g~~p 226 (484)
T 3nyv_A 150 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-G--TYDEKCDVWSTGVILYILLSGCPP 226 (484)
T ss_dssp SCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHH-T--CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeec-C--CCCCcceeHHHHHHHHHHHHCCCC
Confidence 5689999999 6899999997643 3334458999999999763 4 5999999999999997
Q ss_pred --cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 --GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 --G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.++.+.+..|.... .. .+...| +.++++++|||++||++||.+|||+.++|++
T Consensus 227 f~~~~~~~~~~~i~~~~-----------~~-----~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 227 FNGANEYDILKKVEKGK-----------YT-----FELPQW----KKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp SCCSSHHHHHHHHHHCC-----------CC-----CCSGGG----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCHHHHHHHHHcCC-----------CC-----CCCccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 222222222222110 00 011112 3678999999999999999999999999973
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=6.4e-13 Score=154.57 Aligned_cols=114 Identities=25% Similarity=0.270 Sum_probs=81.5
Q ss_pred cccceeeEEE------EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cC-
Q psy501 673 ERLKSSYILL------HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GT- 736 (962)
Q Consensus 673 ~~~~~~~~~~------~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~- 736 (962)
+-||+.||++ +.++|.|||++.. ......+||+.|++||++. + ..|+.++||||+|||++ |.
T Consensus 134 rDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~-~-~~~~~~~DIwSlGvilyell~G~~ 211 (444)
T 3soa_A 134 RNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR-K-DPYGKPVDLWACGVILYILLVGYP 211 (444)
T ss_dssp CCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHT-T-CCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhc-C-CCCCCccccHHHHHHHHHHHhCCC
Confidence 5689999999 4699999999854 2234458999999999764 3 46999999999999997 11
Q ss_pred -----CchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 737 -----ERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 737 -----~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+..+.+..|... ....+...| +.+++++.|||.+||+.||.+|||+.++|+.
T Consensus 212 Pf~~~~~~~~~~~i~~~----------------~~~~~~~~~----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 212 PFWDEDQHRLYQQIKAG----------------AYDFPSPEW----DTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp SCCCSSHHHHHHHHHHT----------------CCCCCTTTT----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCccHHHHHHHHHhC----------------CCCCCcccc----ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111111111110 001111112 4689999999999999999999999999973
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.5e-13 Score=154.33 Aligned_cols=124 Identities=11% Similarity=0.164 Sum_probs=86.8
Q ss_pred EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------cCCchhHHHHHHHhcC
Q psy501 683 HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------GTERLKSSYILLHTLP 750 (962)
Q Consensus 683 ~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G~~~~~ql~~I~~~lG 750 (962)
+.++|.|||++.. ......+||+.|++||++. + ..|+.++||||+|||++ +.+..+++..+...++
T Consensus 199 ~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 276 (360)
T 3llt_A 199 TGIKLIDFGCATFKSDYHGSIINTRQYRAPEVIL-N-LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQ 276 (360)
T ss_dssp CCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHT-T-CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTC
T ss_pred CCEEEEeccCceecCCCCcCccCcccccCcHHHc-C-CCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcC
Confidence 4699999999864 3334558999998888775 4 35999999999999998 5567788899999999
Q ss_pred CCchhhhcccccccCCCc-----ccCCcc-------------ccC----CCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 751 LYTCYTLASNMNFKFPQF-----RRVPFT-------------SII----PHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 751 ~p~~~~~~~~~~~~~~~~-----~~~~l~-------------~~~----p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+++..............+ ....|. ... ...++++.|||.+||++||.+|||+.++|+.
T Consensus 277 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 277 PIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp CCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 887665322111000000 000000 000 1235788899999999999999999999974
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=3.4e-14 Score=157.04 Aligned_cols=124 Identities=15% Similarity=-0.008 Sum_probs=75.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----c----eeeeccCCCcccccceeeecC----CCCCCCCCceeeeeEeecC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----Q----TTCLLAGTERLKSSYILLHTL----PLYTYHVPPIQTTCLLAGT 736 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~----~~~~~~gt~~~~~~~~lLlg~----~~Y~~~vDIWSlGCIl~G~ 736 (962)
|-||++|||+ |.+||+|||++.. . ...+.+||+.|||||++.-.. ..|+.++||||+|||++
T Consensus 132 RDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~-- 209 (303)
T 3hmm_A 132 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW-- 209 (303)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHH--
T ss_pred ccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHH--
Confidence 6889999999 8999999999743 1 122358999999999886321 24788999999999996
Q ss_pred CchhHHHHHHHhcCCCchhhhcc--cccccC---------------CCcccCCccccCC--CCCHHHHHHHHHhhccCCC
Q psy501 737 ERLKSSYILLHTLPLYTCYTLAS--NMNFKF---------------PQFRRVPFTSIIP--HASPDAIHLMESMLAYNPS 797 (962)
Q Consensus 737 ~~~~ql~~I~~~lG~p~~~~~~~--~~~~~~---------------~~~~~~~l~~~~p--~~s~~a~DLL~kmL~~dP~ 797 (962)
+++. |.|+...... .+.... ......++....+ ...+...+|+.+||..||+
T Consensus 210 -------El~t--g~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~ 280 (303)
T 3hmm_A 210 -------EIAR--RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 280 (303)
T ss_dssp -------HHHH--TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGG
T ss_pred -------HHHH--CCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHh
Confidence 2222 2221100000 000000 0000000100001 1223578999999999999
Q ss_pred CCcchhhhhh
Q psy501 798 KRPTAQQSLS 807 (962)
Q Consensus 798 kR~sa~~~L~ 807 (962)
+|||+.++++
T Consensus 281 ~RPt~~ei~~ 290 (303)
T 3hmm_A 281 ARLTALRIKK 290 (303)
T ss_dssp GSCCHHHHHH
T ss_pred HCcCHHHHHH
Confidence 9999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=2.4e-13 Score=151.35 Aligned_cols=134 Identities=16% Similarity=0.238 Sum_probs=95.2
Q ss_pred cccceeeEEE----------------------EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCcee
Q psy501 673 ERLKSSYILL----------------------HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQ 728 (962)
Q Consensus 673 ~~~~~~~~~~----------------------~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWS 728 (962)
+-||..||++ +.++|.|||++.. ......+||+.|++||++. + ..|+.++||||
T Consensus 147 ~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~Di~s 224 (355)
T 2eu9_A 147 TDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVIL-E-LGWAQPCDVWS 224 (355)
T ss_dssp CCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHT-T-CCCCTHHHHHH
T ss_pred CCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeee-c-CCCCCccchHH
Confidence 4678888887 6799999999864 3334558999999998876 3 45999999999
Q ss_pred eeeEee----------cCCchhHHHHHHHhcCCCchhhhcccccccCC-----Ccc------------cCCccccC---C
Q psy501 729 TTCLLA----------GTERLKSSYILLHTLPLYTCYTLASNMNFKFP-----QFR------------RVPFTSII---P 778 (962)
Q Consensus 729 lGCIl~----------G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~-----~~~------------~~~l~~~~---p 778 (962)
+|||++ +.+..+++..+...+|+++...+.......+. .+. ..++.... .
T Consensus 225 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (355)
T 2eu9_A 225 IGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDS 304 (355)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCS
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccc
Confidence 999998 45667788888899998877654332111000 000 00111111 1
Q ss_pred CCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 779 HASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 779 ~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
..++++.+||++||.+||++|||+.++|+.
T Consensus 305 ~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 305 LEHVQLFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 124578899999999999999999999974
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.31 E-value=1.9e-13 Score=152.51 Aligned_cols=119 Identities=16% Similarity=0.108 Sum_probs=80.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 745 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I 745 (962)
+-||++||++ |.++|.|||++.. ....+.+||+.|++||++. +...++.++||||+|||++ .+
T Consensus 138 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~---------el 207 (328)
T 3fe3_A 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQ-GKKYDGPEVDVWSLGVILY---------TL 207 (328)
T ss_dssp SCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHH-TCCCCSHHHHHHHHHHHHH---------HH
T ss_pred cCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCccccc-CCCcCCchhhhhhhHHHHH---------HH
Confidence 5689999999 8999999998753 3344558999998888765 5454568999999999997 11
Q ss_pred HHhcCCCchhh--hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 746 LHTLPLYTCYT--LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 746 ~~~lG~p~~~~--~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+. |.+|-.. ........... ...+ -..+++++.|||++||.+||.+|||++++|++
T Consensus 208 l~--g~~pf~~~~~~~~~~~i~~~--~~~~---p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 208 VS--GSLPFDGQNLKELRERVLRG--KYRI---PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HH--SSCSSCCSSHHHHHHHHHHC--CCCC---CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred Hh--CCCCCCCCCHHHHHHHHHhC--CCCC---CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 2222100 00000000000 0000 02478999999999999999999999999973
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=1.9e-13 Score=151.02 Aligned_cols=134 Identities=16% Similarity=0.255 Sum_probs=94.1
Q ss_pred cccceeeEEEE----------------------EEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCcee
Q psy501 673 ERLKSSYILLH----------------------TLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQ 728 (962)
Q Consensus 673 ~~~~~~~~~~~----------------------~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWS 728 (962)
+-||++||++. .++|.|||.+.. ......+||+.|++||.+. + ..|+.++||||
T Consensus 142 ~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~Di~s 219 (339)
T 1z57_A 142 TDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVIL-A-LGWSQPCDVWS 219 (339)
T ss_dssp CCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHT-T-SCCCTHHHHHH
T ss_pred CCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccccccccCCccccChHHhh-C-CCCCcchhhHH
Confidence 45788888872 489999998765 2334458999999888875 3 45999999999
Q ss_pred eeeEee----------cCCchhHHHHHHHhcCCCchhhhcccccccCC-----Ccc------------cCCccccC---C
Q psy501 729 TTCLLA----------GTERLKSSYILLHTLPLYTCYTLASNMNFKFP-----QFR------------RVPFTSII---P 778 (962)
Q Consensus 729 lGCIl~----------G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~-----~~~------------~~~l~~~~---p 778 (962)
+||+++ +.+..+++..+..++|+++...+.......+. .|. ..++.... +
T Consensus 220 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (339)
T 1z57_A 220 IGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQD 299 (339)
T ss_dssp HHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCS
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccch
Confidence 999998 45667788888888998776653322111000 000 01111111 1
Q ss_pred CCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 779 HASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 779 ~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
..++++.+||.+||++||.+|||+.++|+.
T Consensus 300 ~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 300 VEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 235678999999999999999999999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=3.8e-13 Score=152.28 Aligned_cols=123 Identities=13% Similarity=0.105 Sum_probs=84.9
Q ss_pred EEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cCC------------chhHHHHH
Q psy501 684 TLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GTE------------RLKSSYIL 745 (962)
Q Consensus 684 ~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~~------------~~~ql~~I 745 (962)
.++|.|||.+.. ......+||+.|++||++. + ..|+.++||||+|||++ |.. +.+++..+
T Consensus 234 ~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 311 (397)
T 1wak_A 234 KVKIADLGNACWVHKHFTEDIQTRQYRSLEVLI-G-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALI 311 (397)
T ss_dssp CEEECCGGGCEETTBCSCSCCSCGGGCCHHHHH-T-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHH
T ss_pred ceEeccccccccccccCccCCCCCcccCChhhc-C-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHH
Confidence 799999999754 3334458999998888765 4 34999999999999998 321 56788999
Q ss_pred HHhcCCCchhhhcccc-ccc----------CCCcccCCcc----ccC---CCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 746 LHTLPLYTCYTLASNM-NFK----------FPQFRRVPFT----SII---PHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 746 ~~~lG~p~~~~~~~~~-~~~----------~~~~~~~~l~----~~~---p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
...+|.++...+.... ... .....+..+. ..+ +..+++++|||.+||++||++|||++++|+
T Consensus 312 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 312 IELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred HHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 9999998876532211 000 0000010000 000 123457889999999999999999999997
Q ss_pred h
Q psy501 808 I 808 (962)
Q Consensus 808 ~ 808 (962)
+
T Consensus 392 h 392 (397)
T 1wak_A 392 H 392 (397)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=3.9e-13 Score=152.08 Aligned_cols=114 Identities=16% Similarity=0.155 Sum_probs=82.1
Q ss_pred cccceeeEEE---E----EEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----c--
Q psy501 673 ERLKSSYILL---H----TLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----G-- 735 (962)
Q Consensus 673 ~~~~~~~~~~---~----~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G-- 735 (962)
+-||..||++ + .++|.|||++.. ......+||+.|++||++.. ..|+.++||||+|||++ |
T Consensus 139 rDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~~ll~g~~ 216 (361)
T 2yab_A 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGAS 216 (361)
T ss_dssp CCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCC
T ss_pred CCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcC--CCCCccccHHHHHHHHHHHHhCCC
Confidence 4689999999 3 699999998754 33445689999999997653 45999999999999997 1
Q ss_pred ----CCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 736 ----TERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 736 ----~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.+..+.+..|.... +.++ . ..++.++++++|||++||..||.+|||++++|++
T Consensus 217 Pf~~~~~~~~~~~i~~~~-------------~~~~---~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 217 PFLGDTKQETLANITAVS-------------YDFD---E----EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp SSCCSSHHHHHHHHHTTC-------------CCCC---H----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCCCHHHHHHHHHhcC-------------CCCC---c----hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 12222222221110 0011 1 1125789999999999999999999999999974
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=6.1e-13 Score=145.78 Aligned_cols=113 Identities=18% Similarity=0.212 Sum_probs=80.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cC----
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GT---- 736 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~---- 736 (962)
+-||..||++ |.++|.|||++.. ......+||+.|++||.+.. ..|+.++||||+||+++ |.
T Consensus 140 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~ 217 (297)
T 3fxz_A 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (297)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4689999999 8999999998543 23345589999999997653 45999999999999997 11
Q ss_pred --CchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 737 --ERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 737 --~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+..+.+..+... + .+.. .. -+.+++++.|||.+||+.||.+|||++++|+.
T Consensus 218 ~~~~~~~~~~~~~~-~--------------~~~~---~~---~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 218 NENPLRALYLIATN-G--------------TPEL---QN---PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp TSCHHHHHHHHHHH-C--------------SCCC---SC---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCHHHHHHHHHhC-C--------------CCCC---CC---ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111111111110 0 0000 00 13578899999999999999999999999973
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=5e-13 Score=151.12 Aligned_cols=125 Identities=7% Similarity=-0.028 Sum_probs=84.9
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLH 747 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I~~ 747 (962)
+-||+.||++ |.+||.|||++.. .......||+.|++||.+..+...|+.++||||+|||++ .++.
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~---------ellt 288 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIY---------RVWC 288 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHH---------HHHH
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHH---------HHHh
Confidence 6789999999 8999999999766 222245788888888888654457999999999999996 2222
Q ss_pred hcCCCchhhh-cc-ccccc---CCCcccCCc-cccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 748 TLPLYTCYTL-AS-NMNFK---FPQFRRVPF-TSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 748 ~lG~p~~~~~-~~-~~~~~---~~~~~~~~l-~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
|.+|-... .. ...+. ........+ ....+.+++++.+||.+||++||.+|||+.++|+.
T Consensus 289 --g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 289 --LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp --SSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred --CCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 44332111 00 00000 000000011 01124789999999999999999999999999973
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.25 E-value=4.5e-13 Score=150.12 Aligned_cols=119 Identities=16% Similarity=0.161 Sum_probs=82.6
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 745 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I 745 (962)
+-||..||++ +.++|.|||++.. ....+.+||+.|++||++. |...+++++||||+|||++ .+
T Consensus 132 ~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~---------~l 201 (336)
T 3h4j_B 132 RDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN-GKLYAGPEVDVWSCGIVLY---------VM 201 (336)
T ss_dssp CCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSC-CSGGGCHHHHHHHHHHHHH---------HH
T ss_pred cCCchhhEEEcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHc-CCCCCCCccchhHHHHHHH---------HH
Confidence 4679999999 8999999998754 3345568999999998875 4444578999999999996 22
Q ss_pred HHhcCCCchhh--hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 746 LHTLPLYTCYT--LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 746 ~~~lG~p~~~~--~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+ .|.+|-.. .... +...... ....-+.+++++.+||++||+.||.+|||++++|+.
T Consensus 202 l--~g~~Pf~~~~~~~~----~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 202 L--VGRLPFDDEFIPNL----FKKVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp H--HSSCSSBCSSSTTC----BCCCCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred H--hCCCCCCCccHHHH----HHHHHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 2 24433111 1110 0000000 001113578999999999999999999999999973
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=5.5e-13 Score=150.35 Aligned_cols=110 Identities=23% Similarity=0.221 Sum_probs=77.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
|-||..||++ |.++|.|||++.. ....+.|||+.|++||++.. ..|+.++||||+|||++
T Consensus 148 rDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~ 225 (353)
T 3txo_A 148 RDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE--MLYGPAVDWWAMGVLLYEMLCGHAPFE 225 (353)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHH--HHCTTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCC--CCcCCccCCCcchHHHHHHHhCCCCCC
Confidence 6789999999 8999999998754 34455699999999997753 35999999999999997
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcch------hhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTA------QQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa------~~~L~~ 808 (962)
+.+..+.+..|... ...++ +.+++++.|||++||+.||.+|+++ ++++++
T Consensus 226 ~~~~~~~~~~i~~~-------------~~~~p-----------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 226 AENEDDLFEAILND-------------EVVYP-----------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp CSSHHHHHHHHHHC-------------CCCCC-----------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CCCHHHHHHHHHcC-------------CCCCC-----------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 12222222222210 00011 2478999999999999999999998 667763
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.25 E-value=2.2e-12 Score=145.77 Aligned_cols=118 Identities=26% Similarity=0.294 Sum_probs=80.6
Q ss_pred cccceeeEEE------EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL------HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~------~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||..||++ +.++|.|||++.. ......+||+.|++||++. + ..|+.++||||+|||++
T Consensus 152 ~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~DiwslG~il~-------- 221 (362)
T 2bdw_A 152 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK-K-DPYSKPVDIWACGVILY-------- 221 (362)
T ss_dssp CCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHT-T-CCCCTHHHHHHHHHHHH--------
T ss_pred ccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHc-c-CCCCchhhHHHHHHHHH--------
Confidence 5689999999 3599999999755 2233458999999999764 3 46999999999999997
Q ss_pred HHHHHhcCCCchh--h----hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 743 YILLHTLPLYTCY--T----LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 743 ~~I~~~lG~p~~~--~----~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++ .|.+|-. . ....... ...++...| +.+++++.|||.+||..||.+||++.++|+.
T Consensus 222 -~ll--~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 222 -ILL--VGYPPFWDEDQHRLYAQIKAG-AYDYPSPEW----DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -HHH--HSSCSSCCSSHHHHHHHHHHT-CCCCCTTGG----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -HHH--HCCCCCCCCCHHHHHHHHHhC-CCCCCcccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111 1222100 0 0000000 001111112 3578999999999999999999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=1.1e-12 Score=147.49 Aligned_cols=118 Identities=19% Similarity=0.132 Sum_probs=83.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-ceeeeccCCCcccccceeee-cCCCCCCCCCceeeeeEeecCCchhHHHHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-QTTCLLAGTERLKSSYILLH-TLPLYTYHVPPIQTTCLLAGTERLKSSYILLH 747 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-~~~~~~~gt~~~~~~~~lLl-g~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I~~ 747 (962)
+.||++||++ |.++|.|||++.. ......+||+.|++||+++. ....|+.++||||+|||++ .++
T Consensus 178 ~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~---------ell- 247 (348)
T 1u5q_A 178 RDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI---------ELA- 247 (348)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHH---------HHH-
T ss_pred CCCCHHHEEECCCCCEEEeeccCceecCCCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHH---------HHH-
Confidence 5689999999 8899999999866 44445689999999998863 2456999999999999997 111
Q ss_pred hcCCCchhhh------cccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 748 TLPLYTCYTL------ASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 748 ~lG~p~~~~~------~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.|.++-... ........+.. ....+++++.+||.+||..||.+|||++++|+.
T Consensus 248 -~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 248 -ERKPPLFNMNAMSALYHIAQNESPAL-------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp -HSSCTTTTSCHHHHHHHHHHSCCCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -hCCCCCCCCChHHHHHHHHhcCCCCC-------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 122221000 00000000100 013568899999999999999999999999973
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.25 E-value=5.9e-13 Score=151.41 Aligned_cols=136 Identities=18% Similarity=0.087 Sum_probs=81.6
Q ss_pred cccceeeEEE---EEEeeeeeecCCC------------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee---
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI------------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA--- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~------------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~--- 734 (962)
+-||..||++ |.++|.|||.... ......+||+.|++||++..+...|+.++||||+|||++
T Consensus 152 rDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~ 231 (389)
T 3gni_B 152 RSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231 (389)
T ss_dssp CCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHH
Confidence 5689999999 8999999987632 111223899999999988765567999999999999998
Q ss_pred -------cCCchhHHHHHHHhc--------CCCchhhhcc------------cccc--cCCCcccCCccccCCCCCHHHH
Q psy501 735 -------GTERLKSSYILLHTL--------PLYTCYTLAS------------NMNF--KFPQFRRVPFTSIIPHASPDAI 785 (962)
Q Consensus 735 -------G~~~~~ql~~I~~~l--------G~p~~~~~~~------------~~~~--~~~~~~~~~l~~~~p~~s~~a~ 785 (962)
+.+..+++..+.... +.+..+.... .... ..+.....+.....+.+++++.
T Consensus 232 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 311 (389)
T 3gni_B 232 NGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311 (389)
T ss_dssp HSSCTTTTCCSTTHHHHC--------------------------------------------------------CCHHHH
T ss_pred HCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHH
Confidence 223333333222110 0000000000 0000 0000000011112245789999
Q ss_pred HHHHHhhccCCCCCcchhhhhhh
Q psy501 786 HLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 786 DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
|||++||++||.+|||++++|+.
T Consensus 312 ~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 312 HFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHHhhcCcccCCCHHHHhcC
Confidence 99999999999999999999974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=4.8e-13 Score=146.66 Aligned_cols=136 Identities=21% Similarity=0.334 Sum_probs=98.9
Q ss_pred cccceeeEEE----EEEeeeeeecCCCc--------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee------
Q psy501 673 ERLKSSYILL----HTLPLYTYHVPPIQ--------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA------ 734 (962)
Q Consensus 673 ~~~~~~~~~~----~~~~~~~~~~~~~~--------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~------ 734 (962)
+-||.+||++ +.++|.|||++... ......||+.|++||++. +...|+.++||||+||+++
T Consensus 144 ~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~el~~g~ 222 (320)
T 2i6l_A 144 RDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGK 222 (320)
T ss_dssp CCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHH-CTTCCCHHHHHHHHHHHHHHHHHSS
T ss_pred CCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhc-CcccCCchhhhHhHHHHHHHHHhCC
Confidence 4679999999 48999999997642 122336788888888765 4456999999999999998
Q ss_pred ----cCCchhHHHHHHHhcCCCchhhhcccccc------cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhh
Q psy501 735 ----GTERLKSSYILLHTLPLYTCYTLASNMNF------KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQ 804 (962)
Q Consensus 735 ----G~~~~~ql~~I~~~lG~p~~~~~~~~~~~------~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~ 804 (962)
+.++.+++..+....+.+..+........ .....+..++....+.+++++.+||++||..||.+|||+++
T Consensus 223 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (320)
T 2i6l_A 223 TLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEE 302 (320)
T ss_dssp CSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHH
Confidence 45667778888887777665443221110 00111234455566789999999999999999999999999
Q ss_pred hhhhh
Q psy501 805 SLSIK 809 (962)
Q Consensus 805 ~L~~~ 809 (962)
+|+..
T Consensus 303 ll~hp 307 (320)
T 2i6l_A 303 ALSHP 307 (320)
T ss_dssp HHTSH
T ss_pred HhCCc
Confidence 99743
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.25 E-value=4.7e-13 Score=150.55 Aligned_cols=134 Identities=15% Similarity=0.219 Sum_probs=94.8
Q ss_pred cccceeeEEEE---------EEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cC-
Q psy501 673 ERLKSSYILLH---------TLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GT- 736 (962)
Q Consensus 673 ~~~~~~~~~~~---------~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~- 736 (962)
+-||..||++. .++|.|||++.. ......+||+.|++||.+. + ..|+.++||||+|||++ |.
T Consensus 156 ~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~-~-~~~~~~~Di~slG~il~el~~g~~ 233 (373)
T 1q8y_A 156 TDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLL-G-APWGCGADIWSTACLIFELITGDF 233 (373)
T ss_dssp SCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHH-T-CCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCChHHeEEeccCCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHh-C-CCCCchHhHHHHHHHHHHHHhCCC
Confidence 56899999982 799999999754 3334458999999998875 3 35899999999999998 32
Q ss_pred -----------CchhHHHHHHHhcCCCchhhhcccccc-----------cCCCcccCCcccc------C-CCCCHHHHHH
Q psy501 737 -----------ERLKSSYILLHTLPLYTCYTLASNMNF-----------KFPQFRRVPFTSI------I-PHASPDAIHL 787 (962)
Q Consensus 737 -----------~~~~ql~~I~~~lG~p~~~~~~~~~~~-----------~~~~~~~~~l~~~------~-p~~s~~a~DL 787 (962)
.+.+++..++..+|.++...+...... ........++... + +..++++.||
T Consensus 234 pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 313 (373)
T 1q8y_A 234 LFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313 (373)
T ss_dssp CC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred CCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHH
Confidence 256788899999999886643221100 0000011111110 1 1345678999
Q ss_pred HHHhhccCCCCCcchhhhhhh
Q psy501 788 MESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 788 L~kmL~~dP~kR~sa~~~L~~ 808 (962)
|++||++||.+|||++++|+.
T Consensus 314 i~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 314 LSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HGGGGCSSTTTCBCHHHHHTC
T ss_pred HHHHhccCccccCCHHHHhhC
Confidence 999999999999999999973
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.3e-12 Score=145.01 Aligned_cols=111 Identities=19% Similarity=0.234 Sum_probs=81.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cC------C
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GT------E 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~------~ 737 (962)
+-||..||++ |.++|.|||++.. ....+.+||+.|++||++. + ..|+.++||||+|||++ |. +
T Consensus 130 rDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 130 RDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVS-T-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp CCCCGGGEEECTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHT-T-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cCCChheEEEcCCCCEEEeecCcceecCCccccccCCccccCHhHhc-C-CCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 5789999999 8999999999865 4455679999999999765 3 46999999999999997 11 1
Q ss_pred chhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCc-----chhhhhhhh
Q psy501 738 RLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRP-----TAQQSLSIK 809 (962)
Q Consensus 738 ~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~-----sa~~~L~~~ 809 (962)
..+....|... . ..+ -+.+++++.|||++||+.||.+|+ ++++++++.
T Consensus 208 ~~~~~~~i~~~----------------~-----~~~---p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 208 TMKTYEKILNA----------------E-----LRF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp HHHHHHHHHHC----------------C-----CCC---CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHHHHHHHHhC----------------C-----CCC---CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 11111111110 0 001 135789999999999999999999 888888743
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.24 E-value=6.5e-13 Score=147.52 Aligned_cols=114 Identities=13% Similarity=0.146 Sum_probs=82.2
Q ss_pred cccceeeEEE-----EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----c----
Q psy501 673 ERLKSSYILL-----HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----G---- 735 (962)
Q Consensus 673 ~~~~~~~~~~-----~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G---- 735 (962)
+-||+.||++ +.++|.|||++.. ......+||+.|++||++.. ..|+.++||||+|||++ |
T Consensus 126 ~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf 203 (321)
T 1tki_A 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPF 203 (321)
T ss_dssp CCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 5689999998 5799999998754 34455689999999987653 35899999999999997 1
Q ss_pred --CCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 736 --TERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 736 --~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.+..+.+..|..... .++. ..++.+++++.|||.+||..||.+|||+.++|+.
T Consensus 204 ~~~~~~~~~~~i~~~~~----------------~~~~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 204 LAETNQQIIENIMNAEY----------------TFDE----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCSSHHHHHHHHHHTCC----------------CCCH----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCHHHHHHHHHcCCC----------------CCCh----hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 112222222221110 0111 1225789999999999999999999999999973
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.1e-12 Score=144.72 Aligned_cols=135 Identities=10% Similarity=0.039 Sum_probs=85.2
Q ss_pred cccceeeEEE-------EEEeeeeeecCCC----ceeeeccCCCcccccceeeec------CCCCCCCCCceeeeeEee-
Q psy501 673 ERLKSSYILL-------HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHT------LPLYTYHVPPIQTTCLLA- 734 (962)
Q Consensus 673 ~~~~~~~~~~-------~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg------~~~Y~~~vDIWSlGCIl~- 734 (962)
+-||+.||++ +.++|.|||++.. ....+.+||+.|++||++... ...|+.++||||+|||++
T Consensus 136 ~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~e 215 (319)
T 4euu_A 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYH 215 (319)
T ss_dssp SCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHH
T ss_pred CCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHH
Confidence 4689999987 6799999999744 333455899999999987531 357999999999999998
Q ss_pred ---cCC-------chhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccC-------CCCCHHHHHHHHHhhccCCC
Q psy501 735 ---GTE-------RLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSII-------PHASPDAIHLMESMLAYNPS 797 (962)
Q Consensus 735 ---G~~-------~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~-------p~~s~~a~DLL~kmL~~dP~ 797 (962)
|.. .......+..+++..+...+....... .....|...+ ..+++.+.+||++||++||.
T Consensus 216 l~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 292 (319)
T 4euu_A 216 AATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAE---NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292 (319)
T ss_dssp HHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECST---TCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTT
T ss_pred HHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhccc---CCccccCccCCcccccchhHHHHhHHHHHHhccCChh
Confidence 321 112222223332222221111111100 0011111111 12456788999999999999
Q ss_pred CCcchhhhhhhhh
Q psy501 798 KRPTAQQSLSIKR 810 (962)
Q Consensus 798 kR~sa~~~L~~~~ 810 (962)
+|||++|+|+...
T Consensus 293 ~R~s~~ell~h~~ 305 (319)
T 4euu_A 293 KCWGFDQFFAETS 305 (319)
T ss_dssp TSCCHHHHHHHHH
T ss_pred hhccHHHhhhccH
Confidence 9999999997443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=1.3e-12 Score=146.90 Aligned_cols=115 Identities=20% Similarity=0.162 Sum_probs=81.5
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
+-||..||++ |.++|.|||++.. ..+.+.|||+.|++||++.. ..|+.++||||+|||++ .
T Consensus 142 rDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~---------e 210 (345)
T 1xjd_A 142 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLY---------E 210 (345)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHH---------H
T ss_pred CCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcC--CCCCChhhhHHHHHHHH---------H
Confidence 5789999999 8999999998753 34556699999999998753 45999999999999997 1
Q ss_pred HHHhcCCCchhh------hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchh-hhhhhh
Q psy501 745 LLHTLPLYTCYT------LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQ-QSLSIK 809 (962)
Q Consensus 745 I~~~lG~p~~~~------~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~-~~L~~~ 809 (962)
++ .|.++-.. +..... ..+. +. +.+++++.|||++||+.||.+|+++. +++++.
T Consensus 211 ll--~g~~Pf~~~~~~~~~~~i~~-~~~~-----~p---~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp 271 (345)
T 1xjd_A 211 ML--IGQSPFHGQDEEELFHSIRM-DNPF-----YP---RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 271 (345)
T ss_dssp HH--HSSCSSCCSSHHHHHHHHHH-CCCC-----CC---TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred Hh--cCCCCCCCCCHHHHHHHHHh-CCCC-----CC---cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCc
Confidence 11 12222100 000000 0001 10 24789999999999999999999998 777643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=8.7e-13 Score=149.77 Aligned_cols=114 Identities=13% Similarity=0.113 Sum_probs=83.7
Q ss_pred cccceeeEEE-----EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee---------
Q psy501 673 ERLKSSYILL-----HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA--------- 734 (962)
Q Consensus 673 ~~~~~~~~~~-----~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~--------- 734 (962)
+-||+.||++ +.++|.|||++.. ......+||+.|++||++.. ..|+.++||||+|||++
T Consensus 211 ~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf 288 (373)
T 2x4f_A 211 LDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPF 288 (373)
T ss_dssp CCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCC
Confidence 4679999998 4699999998753 33344589999999997643 46899999999999997
Q ss_pred -cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 -GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 -G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.++.+++..|...... ++ ...++.+++++.|||.+||+.||.+||+++++|+.
T Consensus 289 ~~~~~~~~~~~i~~~~~~-------------~~-------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 289 LGDNDAETLNNILACRWD-------------LE-------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp CCSSHHHHHHHHHHTCCC-------------SC-------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCHHHHHHHHHhccCC-------------CC-------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 22333333333321110 10 11225789999999999999999999999999973
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=5.8e-13 Score=154.60 Aligned_cols=118 Identities=14% Similarity=0.138 Sum_probs=84.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCC------ceeeeccCCCcccccceeee---cCCCCCCCCCceeeeeEee------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI------QTTCLLAGTERLKSSYILLH---TLPLYTYHVPPIQTTCLLA------ 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~gt~~~~~~~~lLl---g~~~Y~~~vDIWSlGCIl~------ 734 (962)
|-||+.||++ |.+||.|||++.. ....+.+||+.|++||++.. |...|+.++||||+|||++
T Consensus 199 rDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~ 278 (437)
T 4aw2_A 199 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278 (437)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSS
T ss_pred cccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCC
Confidence 6789999999 8999999998732 12233589999999998873 3456999999999999997
Q ss_pred ----cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCC--Ccchhhhhhh
Q psy501 735 ----GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSK--RPTAQQSLSI 808 (962)
Q Consensus 735 ----G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~k--R~sa~~~L~~ 808 (962)
+.+..+....|+... ....+| ...+.++++++|||++||+.+|++ |+++++++++
T Consensus 279 ~Pf~~~~~~~~~~~i~~~~-----------~~~~~p--------~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 279 TPFYAESLVETYGKIMNHK-----------ERFQFP--------TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CTTCCSSHHHHHHHHHTHH-----------HHCCCC--------SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred CCCCCCChhHHHHhhhhcc-----------ccccCC--------cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 222223333332100 000111 122468999999999999999998 9999999974
Q ss_pred h
Q psy501 809 K 809 (962)
Q Consensus 809 ~ 809 (962)
.
T Consensus 340 p 340 (437)
T 4aw2_A 340 P 340 (437)
T ss_dssp G
T ss_pred C
Confidence 3
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.5e-12 Score=144.64 Aligned_cols=114 Identities=17% Similarity=0.180 Sum_probs=81.1
Q ss_pred cccceeeEEE---E----EEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cC-
Q psy501 673 ERLKSSYILL---H----TLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GT- 736 (962)
Q Consensus 673 ~~~~~~~~~~---~----~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~- 736 (962)
+.||+.||++ + .++|.|||++.. ......+||+.|++||++.. ..|+.++||||+|||++ |.
T Consensus 138 ~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~ 215 (326)
T 2y0a_A 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGAS 215 (326)
T ss_dssp CCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCC
T ss_pred CCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcC
Confidence 5689999999 4 699999998754 33344589999999997643 46999999999999997 11
Q ss_pred -----CchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 737 -----ERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 737 -----~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+..+.+..+.... ..++ ...++.+++++.|||++||+.||.+|||++++|+.
T Consensus 216 pf~~~~~~~~~~~~~~~~-------------~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 216 PFLGDTKQETLANVSAVN-------------YEFE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp SSCCSSHHHHHHHHHHTC-------------CCCC-------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCCCHHHHHHHHHhcC-------------CCcC-------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111111100 0010 11225678999999999999999999999999974
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.21 E-value=3e-12 Score=143.37 Aligned_cols=119 Identities=15% Similarity=0.208 Sum_probs=81.9
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
+-||..||++ |.++|.|||++.. ....+.+||+.|++||++. + ..|+.++||||+|||++ .
T Consensus 129 rDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~DiwslG~il~---------e 197 (337)
T 1o6l_A 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE-D-NDYGRAVDWWGLGVVMY---------E 197 (337)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGS-S-SCBCTTHHHHHHHHHHH---------H
T ss_pred CcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhc-C-CCCCchhhcccchhHHH---------H
Confidence 5789999999 8999999998753 3455669999999999865 3 46999999999999997 1
Q ss_pred HHHhcCCCchhh--hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCc-----chhhhhhhh
Q psy501 745 LLHTLPLYTCYT--LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRP-----TAQQSLSIK 809 (962)
Q Consensus 745 I~~~lG~p~~~~--~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~-----sa~~~L~~~ 809 (962)
++ .|.+|-.. ....... . ......+ -+.+++++.+||++||+.||.+|+ ++++++++.
T Consensus 198 ll--~g~~Pf~~~~~~~~~~~-i-~~~~~~~---p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 198 MM--CGRLPFYNQDHERLFEL-I-LMEEIRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp HH--HSSCSSCCSSHHHHHHH-H-HHCCCCC---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred Hh--cCCCCCCCCCHHHHHHH-H-HcCCCCC---CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 11 12222100 0000000 0 0000001 135789999999999999999999 889988744
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.21 E-value=2.7e-12 Score=142.64 Aligned_cols=117 Identities=15% Similarity=0.150 Sum_probs=66.0
Q ss_pred cccceeeEEE---E---EEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL---H---TLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~---~---~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
+-||.+||++ + .++|.|||++.. ....+.+||+.|++||++. + ..|+.++||||+|||++
T Consensus 130 ~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~-~-~~~~~~~DiwslG~il~------- 200 (325)
T 3kn6_A 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN-Q-NGYDESCDLWSLGVILY------- 200 (325)
T ss_dssp CCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHH-------
T ss_pred cCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhc-C-CCCCCccchHHHHHHHH-------
Confidence 5689999999 4 799999998753 3334558999999998764 3 45999999999999996
Q ss_pred HHHHHHhcCCCchhh-------------hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 742 SYILLHTLPLYTCYT-------------LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 742 l~~I~~~lG~p~~~~-------------~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. |.+|-.. +.......+ ..+... .+.+++++.|||.+||++||.+|||+.++|+
T Consensus 201 --~ll~--g~~pf~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 201 --TMLS--GQVPFQSHDRSLTCTSAVEIMKKIKKGDF-SFEGEA----WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp --HHHH--SSCTTC-------CCCHHHHHHHHTTTCC-CCCSHH----HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred --HHHh--CCCCCCCCccccccccHHHHHHHHHcCCC-CCCccc----ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 1111 3222110 000000000 011111 1367999999999999999999999999996
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.5e-12 Score=144.82 Aligned_cols=116 Identities=20% Similarity=0.181 Sum_probs=80.9
Q ss_pred cccceeeEEE---E--EEeeeeeecCCCc---------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----
Q psy501 673 ERLKSSYILL---H--TLPLYTYHVPPIQ---------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~--~~~~~~~~~~~~~---------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---- 734 (962)
+-||..||++ + .++|.|||++..- .....+||+.|++||.+......|+.++||||+|||++
T Consensus 192 ~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~ 271 (345)
T 3hko_A 192 RDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271 (345)
T ss_dssp CCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHH
T ss_pred cCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHH
Confidence 5689999999 3 7999999987531 23455899999999988765577999999999999997
Q ss_pred c------CCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 G------TERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G------~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
| .+..+.+..+.... ...+... .+.+++++.+||++||..||.+||++.++|+.
T Consensus 272 g~~pf~~~~~~~~~~~~~~~~----------------~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 272 GAVPFPGVNDADTISQVLNKK----------------LCFENPN----YNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp SSCSSCCSSHHHHHHHHHHCC----------------CCTTSGG----GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred CCCCCCCCChHHHHHHHHhcc----------------cccCCcc----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1 11222222221100 0000011 13578999999999999999999999999973
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=2.5e-12 Score=144.96 Aligned_cols=114 Identities=18% Similarity=0.138 Sum_probs=80.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
+-||..||++ |.++|.|||++.. ....+.|||+.|++||++.. ..|+.++||||+|||++ .
T Consensus 145 rDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~---------e 213 (353)
T 2i0e_A 145 RDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLY---------E 213 (353)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT--CCBSTHHHHHHHHHHHH---------H
T ss_pred ccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcC--CCcCCcccccchHHHHH---------H
Confidence 5689999999 8999999998754 34556699999999998753 45999999999999997 1
Q ss_pred HHHhcCCCchhh------hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcc-----hhhhhhh
Q psy501 745 LLHTLPLYTCYT------LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPT-----AQQSLSI 808 (962)
Q Consensus 745 I~~~lG~p~~~~------~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~s-----a~~~L~~ 808 (962)
++ .|.+|-.. ....... ... + -+.+++++.+||++||+.||.+|++ +++++++
T Consensus 214 ll--~G~~Pf~~~~~~~~~~~i~~~-~~~-----~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 214 ML--AGQAPFEGEDEDELFQSIMEH-NVA-----Y---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HH--HSSCSSCCSSHHHHHHHHHHC-CCC-----C---CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HH--cCCCCCCCCCHHHHHHHHHhC-CCC-----C---CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11 12222100 0000000 000 1 1357899999999999999999995 5777764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=2.8e-12 Score=139.99 Aligned_cols=116 Identities=17% Similarity=0.187 Sum_probs=80.5
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCC-CCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLP-LYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~-~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+-||..||++ |.++|.|||++.. ......+||+.|++||.+..+.. .++.++||||+||+++
T Consensus 161 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~--------- 231 (298)
T 2zv2_A 161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY--------- 231 (298)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHH---------
T ss_pred cCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHH---------
Confidence 4689999999 8899999998754 22334589999999998764432 2578899999999996
Q ss_pred HHHHhcCCCchhh-----h-cc--cccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 744 ILLHTLPLYTCYT-----L-AS--NMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 744 ~I~~~lG~p~~~~-----~-~~--~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++ .|.+|-.. + .. .....++. .+.+++++.+||.+||..||.+|||+.++|++
T Consensus 232 ~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 232 CFV--FGQCPFMDERIMCLHSKIKSQALEFPD---------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHH--HSSCSSCCSSHHHHHHHHHHCCCCCCS---------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHH--HCCCCCCCccHHHHHHHHhcccCCCCC---------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 111 12222100 0 00 00000111 14678999999999999999999999999973
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.20 E-value=1.4e-12 Score=150.44 Aligned_cols=125 Identities=18% Similarity=0.201 Sum_probs=77.5
Q ss_pred cccceeeEEE---E---EEeeeeeecCCC----ceeeeccCCCcccccceeee-cCCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL---H---TLPLYTYHVPPI----QTTCLLAGTERLKSSYILLH-TLPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~---~---~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLl-g~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
+-||.+||++ + .++|.|||++.. ....+.+||+.|++||++.. +...|+.++||||+|||++
T Consensus 263 rDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~------- 335 (419)
T 3i6u_A 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF------- 335 (419)
T ss_dssp SCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHH-------
T ss_pred cCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHH-------
Confidence 5689999999 3 499999999865 23345689999999998763 4567999999999999996
Q ss_pred HHHHHHhcCCCchhhhcccccc--cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 742 SYILLHTLPLYTCYTLASNMNF--KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 742 l~~I~~~lG~p~~~~~~~~~~~--~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++ .|.++-......... ..............+.+++++.+||++||++||.+||+++++|++
T Consensus 336 --~ll--tg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 336 --ICL--SGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp --HHH--HSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HHH--HCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 121 233321100000000 000000001112224689999999999999999999999999974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.4e-12 Score=143.80 Aligned_cols=117 Identities=15% Similarity=0.072 Sum_probs=79.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 745 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I 745 (962)
+-||++||++ +.++|.|||++.. ......+||+.|++||++. | .|+.++||||+|||++ .+
T Consensus 181 ~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~--~~~~~~DiwslG~il~---------el 248 (311)
T 3p1a_A 181 LDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ-G--SYGTAADVFSLGLTIL---------EV 248 (311)
T ss_dssp CCCSGGGEEECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGG-T--CCSTHHHHHHHHHHHH---------HH
T ss_pred CCCCHHHEEECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhc-C--CCCchhhHHHHHHHHH---------HH
Confidence 5689999999 8999999998643 2333447999999999654 4 5999999999999996 22
Q ss_pred HHhcCCCchhh-hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 746 LHTLPLYTCYT-LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 746 ~~~lG~p~~~~-~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+...-.|.... +........ +. ...+.+++++.+||.+||++||.+|||++++|+.
T Consensus 249 ~~g~~~~~~~~~~~~~~~~~~----~~---~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 249 ACNMELPHGGEGWQQLRQGYL----PP---EFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHTCCCCSSHHHHHHHTTTCC----CH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhCCCCCCCccHHHHHhccCC----Cc---ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 21111111110 111100000 00 1124678999999999999999999999999973
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.20 E-value=2.2e-12 Score=145.22 Aligned_cols=115 Identities=19% Similarity=0.163 Sum_probs=81.5
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLH 747 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I~~ 747 (962)
+-||..||++ |.++|.|||++.. ....+.+||+.|++||++.. ..|+.++||||+|||++ .++
T Consensus 165 rDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~---------ell- 232 (350)
T 1rdq_E 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIY---------EMA- 232 (350)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHH---------HHH-
T ss_pred ccCccceEEECCCCCEEEcccccceeccCCcccccCCccccCHHHhcC--CCCCCcCCEecccHhHh---------HHh-
Confidence 5789999999 8999999999864 44456699999999998763 45999999999999997 111
Q ss_pred hcCCCchhh------hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcc-----hhhhhhhh
Q psy501 748 TLPLYTCYT------LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPT-----AQQSLSIK 809 (962)
Q Consensus 748 ~lG~p~~~~------~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~s-----a~~~L~~~ 809 (962)
.|.++-.. ....... . ..+ -+.+++++.|||++||+.||.+|++ +++++++.
T Consensus 233 -~g~~Pf~~~~~~~~~~~i~~~-~-----~~~---p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 233 -AGYPPFFADQPIQIYEKIVSG-K-----VRF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp -HSSCSSCCSSHHHHHHHHHHC-C-----CCC---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred -hCCCCCCCCCHHHHHHHHHcC-C-----CCC---CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 12222100 0000000 0 001 1357899999999999999999998 77877643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=3.2e-12 Score=148.34 Aligned_cols=119 Identities=15% Similarity=0.206 Sum_probs=80.6
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
+-||++||++ |.++|.|||++.. ....+.+||+.|++||++. + ..|+.++||||+|||++ .
T Consensus 273 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~DiwslG~il~---------e 341 (446)
T 4ejn_A 273 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE-D-NDYGRAVDWWGLGVVMY---------E 341 (446)
T ss_dssp CCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHH-T-SCCCTHHHHHHHHHHHH---------H
T ss_pred CCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcC-C-CCCCCccchhhhHHHHH---------H
Confidence 5689999999 8999999998754 3344569999999999764 3 46999999999999997 1
Q ss_pred HHHhcCCCchhh--hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCc-----chhhhhhhh
Q psy501 745 LLHTLPLYTCYT--LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRP-----TAQQSLSIK 809 (962)
Q Consensus 745 I~~~lG~p~~~~--~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~-----sa~~~L~~~ 809 (962)
++ .|.+|-.. ....... . ......+ -+.+++++.+||.+||..||.+|| +++++|++.
T Consensus 342 ll--~g~~Pf~~~~~~~~~~~-i-~~~~~~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 342 MM--CGRLPFYNQDHEKLFEL-I-LMEEIRF---PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp HH--HSSCSSCCSSHHHHHHH-H-HHCCCCC---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred Hh--hCCCCCCCCCHHHHHHH-H-HhCCCCC---CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 11 12222100 0000000 0 0000001 135789999999999999999999 999999744
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.19 E-value=2.8e-12 Score=146.90 Aligned_cols=119 Identities=19% Similarity=0.180 Sum_probs=80.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
|-||..||++ |.++|.|||++.. ..+.+.|||+.|++||++. + ..|+.++||||+|||++ .
T Consensus 177 rDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~-~-~~~~~~~DiwslGvlly---------e 245 (396)
T 4dc2_A 177 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR-G-EDYGFSVDWWALGVLMF---------E 245 (396)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHT-T-CCBCTHHHHHHHHHHHH---------H
T ss_pred ccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhc-C-CCCChHHHHHHHHHHHH---------H
Confidence 6789999999 8999999998753 4556679999999999775 3 46999999999999996 1
Q ss_pred HHHhcCCCchhhhc--ccccc-----cCCC--cccCCccccCCCCCHHHHHHHHHhhccCCCCCcch------hhhhh
Q psy501 745 LLHTLPLYTCYTLA--SNMNF-----KFPQ--FRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTA------QQSLS 807 (962)
Q Consensus 745 I~~~lG~p~~~~~~--~~~~~-----~~~~--~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa------~~~L~ 807 (962)
++ .|.+|-.... ..... .+.. .....+ -+.+++++.|||++||+.||.+|+++ +++++
T Consensus 246 ll--~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 246 MM--AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp HH--HSSCSSTTTTC------CCHHHHHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred HH--hCCCCCcccccccccchhhHHHHHHHHhccccCC---CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 21 1333211000 00000 0000 000011 13579999999999999999999997 46665
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=9.1e-13 Score=147.34 Aligned_cols=122 Identities=13% Similarity=0.145 Sum_probs=77.8
Q ss_pred cccceeeEEE--EEEeeeeeecCCCc-------eeeeccCCCcccccceeee---------cCCCCCCCCCceeeeeEee
Q psy501 673 ERLKSSYILL--HTLPLYTYHVPPIQ-------TTCLLAGTERLKSSYILLH---------TLPLYTYHVPPIQTTCLLA 734 (962)
Q Consensus 673 ~~~~~~~~~~--~~~~~~~~~~~~~~-------~~~~~~gt~~~~~~~~lLl---------g~~~Y~~~vDIWSlGCIl~ 734 (962)
+-||+.||++ +.++|.|||++... .....+||+.|++||.+.. +...|+.++||||+|||++
T Consensus 132 rDikp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ 211 (343)
T 3dbq_A 132 SDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 211 (343)
T ss_dssp CCCCGGGEEEETTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHH
T ss_pred CCCCcceEEEECCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHH
Confidence 6789999999 88999999998651 1234589999999998753 2356899999999999997
Q ss_pred cCCchhHHHHHHHhcCCCchhhhccc-ccc--cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASN-MNF--KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~-~~~--~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.+ +.|.+|-...... ... .........+ -...++++.+||.+||..||.+|||+.++|+.
T Consensus 212 ---------el--l~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 212 ---------YM--TYGKTPFQQIINQISKLHAIIDPNHEIEF---PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ---------HH--HHSSCTTTTCCSHHHHHHHHHCTTSCCCC---CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------HH--HhCCCcchhhhhHHHHHHHHhcCCcccCC---cccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11 1232221100000 000 0000000011 12356789999999999999999999999973
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=2e-12 Score=147.60 Aligned_cols=122 Identities=12% Similarity=0.147 Sum_probs=79.0
Q ss_pred cccceeeEEE--EEEeeeeeecCCCc-------eeeeccCCCcccccceeee---------cCCCCCCCCCceeeeeEee
Q psy501 673 ERLKSSYILL--HTLPLYTYHVPPIQ-------TTCLLAGTERLKSSYILLH---------TLPLYTYHVPPIQTTCLLA 734 (962)
Q Consensus 673 ~~~~~~~~~~--~~~~~~~~~~~~~~-------~~~~~~gt~~~~~~~~lLl---------g~~~Y~~~vDIWSlGCIl~ 734 (962)
+-||+.||++ +.+||.|||++..- ...+.+||+.|++||++.. +...|+.++||||+|||++
T Consensus 179 rDlkp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ 258 (390)
T 2zmd_A 179 SDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258 (390)
T ss_dssp CCCCGGGEEESSSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHH
T ss_pred cCCCHHHEEEECCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHH
Confidence 5689999999 89999999998641 1234589999999998763 1246999999999999997
Q ss_pred cCCchhHHHHHHHhcCCCchhhhccc-ccc--cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASN-MNF--KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~-~~~--~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.+ +.|.+|-...... ... .........+. ...++++.+||.+||..||.+||++.++|+.
T Consensus 259 ---------el--l~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 259 ---------YM--TYGKTPFQQIINQISKLHAIIDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---------HH--HHSSCTTTTCCCHHHHHHHHHCTTSCCCCC---CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------HH--HHCCCcchhhhHHHHHHHHHhCccccCCCC---ccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11 1122221100000 000 00000000110 2347789999999999999999999999974
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.19 E-value=1.9e-12 Score=148.41 Aligned_cols=118 Identities=15% Similarity=0.136 Sum_probs=76.3
Q ss_pred cccceeeEEE------EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL------HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~------~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||..||++ |.+||.|||++.. ....+.+||+.|++||++.. ..|+.++||||+|||++
T Consensus 185 rDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~-------- 254 (400)
T 1nxk_A 185 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMY-------- 254 (400)
T ss_dssp CCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCC--CCSSSHHHHHHHHHHHH--------
T ss_pred cCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHH--------
Confidence 5689999999 4699999998754 23345689999999997643 56999999999999996
Q ss_pred HHHHHhcCCCchhhhcc----------cccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 743 YILLHTLPLYTCYTLAS----------NMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~----------~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++ .|.++-..... .....+ ..+... .+.+++++.|||++||+.||.+|||+.++|++
T Consensus 255 -ell--~g~~pf~~~~~~~~~~~~~~~i~~~~~-~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 255 -ILL--CGYPPFYSNHGLAISPGMKTRIRMGQY-EFPNPE----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -HHH--HSSCSCCCCTTCSSCCSHHHHHHHTCC-CCCTTT----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -HHH--hCCCCCCCCccccccHHHHHHHHcCcc-cCCCcc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111 13222100000 000000 011111 14689999999999999999999999999973
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.18 E-value=2.6e-12 Score=150.69 Aligned_cols=119 Identities=16% Similarity=0.157 Sum_probs=81.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 745 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I 745 (962)
+-||..||++ |.++|.|||++.. ....+.|||+.|++||++. |...++.++||||+|||++ .+
T Consensus 140 rDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwSlGvil~---------el 209 (476)
T 2y94_A 140 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS-GRLYAGPEVDIWSSGVILY---------AL 209 (476)
T ss_dssp SCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHT-TCCBCSHHHHHHHHHHHHH---------HH
T ss_pred ccccHHHEEEecCCCeEEEeccchhhccccccccccCCCcCeEChhhcc-CCCCCCCcceehhhHHHHH---------HH
Confidence 5789999999 8999999998754 3344568999999888765 4444578999999999996 11
Q ss_pred HHhcCCCchhh--hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 746 LHTLPLYTCYT--LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 746 ~~~lG~p~~~~--~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+ .|.++-.. ...... ......+ ..-..+++++.|||++||+.||.+|||++++++.
T Consensus 210 l--tG~~Pf~~~~~~~~~~----~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 210 L--CGTLPFDDDHVPTLFK----KICDGIF-YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp H--HSSCSSCCSSSHHHHH----HHHTTCC-CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred h--hCCCCCCCCCHHHHHH----HHhcCCc-CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1 13222100 000000 0000000 0012578999999999999999999999999963
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.18 E-value=1.4e-12 Score=147.21 Aligned_cols=115 Identities=17% Similarity=0.197 Sum_probs=71.8
Q ss_pred cccceeeEEE---E--EEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---H--TLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~--~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+-||.+||++ + .++|.|||++.. ......+||+.|++||++. +...++.++||||+|||++
T Consensus 140 ~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~--------- 209 (361)
T 3uc3_A 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RQEYDGKIADVWSCGVTLY--------- 209 (361)
T ss_dssp CCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHH-CSSCCHHHHHHHHHHHHHH---------
T ss_pred CCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhc-CCCCCCCeeeeehhHHHHH---------
Confidence 4679999999 3 399999998763 3334458999999998876 4343445599999999997
Q ss_pred HHHHhcCCCchhhhcc----------c--ccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 744 ILLHTLPLYTCYTLAS----------N--MNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~~----------~--~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++ .|.++-..... . ..+.++. ...+++++.+||++||+.||.+|||+.++|++
T Consensus 210 ell--~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 210 VML--VGAYPFEDPEEPRDYRKTIQRILSVKYSIPD---------DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHH--HSSCSCC----CCCHHHHHHHHHTTCCCCCT---------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHH--hCCCCCCCCccHHHHHHHHHHHhcCCCCCCC---------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 111 13222110000 0 0000111 02578999999999999999999999999974
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.8e-12 Score=144.72 Aligned_cols=115 Identities=15% Similarity=0.161 Sum_probs=81.9
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 745 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I 745 (962)
+-||..||++ |.++|.|||++.. ....+.+||+.|++||++. +...++.++||||+|||++ .+
T Consensus 154 ~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~---------el 223 (335)
T 3dls_A 154 RDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM-GNPYRGPELEMWSLGVTLY---------TL 223 (335)
T ss_dssp SCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHT-TCCBCSHHHHHHHHHHHHH---------HH
T ss_pred eccCHHHEEEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhc-CCCCCCCcccchhHHHHHH---------HH
Confidence 4679999999 7999999998753 3344568999999998765 4454589999999999996 22
Q ss_pred HHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 746 LHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 746 ~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+ .|.++-............ .-..+++++.+||.+||..||.+|||++++|+.
T Consensus 224 ~--~g~~pf~~~~~~~~~~~~---------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 224 V--FEENPFCELEETVEAAIH---------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp H--HSSCSCSSGGGGTTTCCC---------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred H--hCCCchhhHHHHHhhccC---------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 243332111111100000 002478999999999999999999999999974
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.18 E-value=6.7e-12 Score=141.02 Aligned_cols=118 Identities=21% Similarity=0.232 Sum_probs=80.3
Q ss_pred cccceeeEEE---E---EEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL---H---TLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~---~---~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
+-||..||++ + .++|.|||++.. ......+||+.|++||++.. ..|+.++||||+|||++
T Consensus 154 rDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~------- 224 (351)
T 3c0i_A 154 RDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVILF------- 224 (351)
T ss_dssp SCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHH-------
T ss_pred ccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHHH-------
Confidence 6789999999 2 399999999754 12334589999999998653 45899999999999997
Q ss_pred HHHHHHhcCCCchhh-----hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 742 SYILLHTLPLYTCYT-----LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 742 l~~I~~~lG~p~~~~-----~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++ .|.++-.. ........+ ...+. ..+.+++++.|||.+||..||.+|||+.++|+.
T Consensus 225 --~ll--~g~~pf~~~~~~~~~~i~~~~~-~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 225 --ILL--SGCLPFYGTKERLFEGIIKGKY-KMNPR----QWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp --HHH--HSSCSSCSSHHHHHHHHHHTCC-CCCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHH--HCCCCCCCcHHHHHHHHHcCCC-CCCcc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111 12211000 000000000 00111 124678999999999999999999999999973
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.17 E-value=5.8e-12 Score=143.75 Aligned_cols=123 Identities=15% Similarity=0.170 Sum_probs=81.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeec-CCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHT-LPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg-~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
+-||..||++ |.++|.|||++.. ....+.+||+.|++||++... ...|+.++||||+|||++ .
T Consensus 139 rDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~---------e 209 (384)
T 4fr4_A 139 RDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAY---------E 209 (384)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHH---------H
T ss_pred ccCcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHH---------H
Confidence 5689999999 8999999998753 445567999999999988643 245999999999999997 1
Q ss_pred HHHhcCCCchhhhccccccc-CCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcc-hhhhhh
Q psy501 745 LLHTLPLYTCYTLASNMNFK-FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPT-AQQSLS 807 (962)
Q Consensus 745 I~~~lG~p~~~~~~~~~~~~-~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~s-a~~~L~ 807 (962)
++ .|.+|-.......... ....... ....-+.+++++.+||++||..||.+|++ ++++++
T Consensus 210 ll--tG~~Pf~~~~~~~~~~~~~~~~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 210 LL--RGRRPYHIRSSTSSKEIVHTFETT-VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HH--HSSCSSCCCTTSCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HH--hCCCCCCCCCCccHHHHHHHHhhc-ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11 1332211000000000 0000000 00011357899999999999999999998 666665
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.17 E-value=1.9e-12 Score=147.80 Aligned_cols=114 Identities=15% Similarity=0.232 Sum_probs=81.9
Q ss_pred cccceeeEEE-----EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----c----
Q psy501 673 ERLKSSYILL-----HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----G---- 735 (962)
Q Consensus 673 ~~~~~~~~~~-----~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G---- 735 (962)
+-||.+||++ +.++|.|||++.. ......+||+.|++||++.. ..|+.++||||+|||++ |
T Consensus 173 rDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf 250 (387)
T 1kob_A 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPF 250 (387)
T ss_dssp CCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred cccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccC--CCCCCcccEeeHhHHHHHHHhCCCCC
Confidence 5689999999 5699999998754 23344589999999997653 45899999999999997 1
Q ss_pred --CCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 736 --TERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 736 --~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.+..+.+..+... .+.++ ...++.+++++.|||++||+.||.+|||+.++|+.
T Consensus 251 ~~~~~~~~~~~i~~~-------------~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 251 AGEDDLETLQNVKRC-------------DWEFD-------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCSSHHHHHHHHHHC-------------CCCCC-------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHhC-------------CCCCC-------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1122222222110 00011 11235689999999999999999999999999974
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.17 E-value=1.2e-12 Score=146.84 Aligned_cols=118 Identities=19% Similarity=0.164 Sum_probs=81.0
Q ss_pred cccceeeEEE----E---EEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cC
Q psy501 673 ERLKSSYILL----H---TLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GT 736 (962)
Q Consensus 673 ~~~~~~~~~~----~---~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~ 736 (962)
+-||..||++ + .++|.|||++.. ....+.+||+.|++||++.. ..|+.++||||+|||++ |.
T Consensus 140 rDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~ 217 (342)
T 2qr7_A 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGY 217 (342)
T ss_dssp SCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHHHHHHHSS
T ss_pred ccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcC--CCCCCccCeeeHhHHHHHHhcCC
Confidence 5689999998 2 499999998753 33456699999999998754 34899999999999997 21
Q ss_pred Cch-----hHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 737 ERL-----KSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 737 ~~~-----~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
... +....++..++ ... +. .... ..+.+++++.|||++||..||.+||++.++|++
T Consensus 218 ~Pf~~~~~~~~~~~~~~i~---------~~~--~~-~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 218 TPFANGPDDTPEEILARIG---------SGK--FS-LSGG----YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CSSCSSTTSCHHHHHHHHH---------HCC--CC-CCST----TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCCCCCcCCHHHHHHHHc---------cCC--cc-cCcc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111 01111111000 000 10 1111 124689999999999999999999999999973
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.17 E-value=4.1e-12 Score=155.35 Aligned_cols=111 Identities=16% Similarity=0.157 Sum_probs=82.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
|-||..||++ |.++|.|||++.. ..+.+.+||+.|++||++.. ..|+.++||||+|||+|
T Consensus 466 rDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~ 543 (674)
T 3pfq_A 466 RDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFE 543 (674)
T ss_dssp CCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTC--CCBSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcC--CCCCccceEechHHHHHHHHcCCCCCC
Confidence 5689999999 8999999998653 44556799999999998743 46999999999999997
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcch-----hhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTA-----QQSLSIK 809 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa-----~~~L~~~ 809 (962)
+.+..+.+..|... ... + -+.+++++.|||++||+.||.+|+++ ++++++.
T Consensus 544 ~~~~~~~~~~i~~~----------------~~~-----~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ 599 (674)
T 3pfq_A 544 GEDEDELFQSIMEH----------------NVA-----Y---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 599 (674)
T ss_dssp CSSHHHHHHHHHSS----------------CCC-----C---CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSG
T ss_pred CCCHHHHHHHHHhC----------------CCC-----C---CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCc
Confidence 22222222222210 000 1 13579999999999999999999998 6777543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=2.1e-12 Score=145.11 Aligned_cols=120 Identities=18% Similarity=0.187 Sum_probs=80.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
+-||..||++ |.++|.|||++.. ....+.+||+.|++||++. + ..|+.++||||+|||++ .
T Consensus 134 rDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~DiwslG~il~---------e 202 (345)
T 3a8x_A 134 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR-G-EDYGFSVDWWALGVLMF---------E 202 (345)
T ss_dssp CCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHT-T-CCBCTHHHHHHHHHHHH---------H
T ss_pred cCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccC-C-CCCChHHhHHHHHHHHH---------H
Confidence 5789999999 8999999998753 3455669999999999775 3 46999999999999997 1
Q ss_pred HHHhcCCCchhhhc-------ccccccCCC--cccCCccccCCCCCHHHHHHHHHhhccCCCCCcch------hhhhhh
Q psy501 745 LLHTLPLYTCYTLA-------SNMNFKFPQ--FRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTA------QQSLSI 808 (962)
Q Consensus 745 I~~~lG~p~~~~~~-------~~~~~~~~~--~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa------~~~L~~ 808 (962)
++ .|.++-.... ......+.. .....+ -+.+++++.|||++||+.||.+|+++ ++++++
T Consensus 203 ll--~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 203 MM--AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HH--HSSCTTTTTTC-------CHHHHHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HH--hCCCCcCCcccccccccccHHHHHHHHHcCCCCC---CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 11 1322211000 000000000 000011 13578999999999999999999997 466653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=1.6e-12 Score=149.58 Aligned_cols=117 Identities=15% Similarity=0.111 Sum_probs=83.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCC------ceeeeccCCCcccccceeeecC--CCCCCCCCceeeeeEee-------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI------QTTCLLAGTERLKSSYILLHTL--PLYTYHVPPIQTTCLLA------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~gt~~~~~~~~lLlg~--~~Y~~~vDIWSlGCIl~------- 734 (962)
|-||..||++ |.++|.|||++.. ....+.|||+.|++||++.... ..|+.++||||+|||++
T Consensus 192 rDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~ 271 (410)
T 3v8s_A 192 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271 (410)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCC
Confidence 6789999999 8999999999743 1233669999999999887532 23899999999999997
Q ss_pred ---cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCC--Ccchhhhhhhh
Q psy501 735 ---GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSK--RPTAQQSLSIK 809 (962)
Q Consensus 735 ---G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~k--R~sa~~~L~~~ 809 (962)
+.+..+....|... .....++.. +.++++++|||++||+.+|.+ |+++++++++.
T Consensus 272 Pf~~~~~~~~~~~i~~~-----------~~~~~~p~~---------~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 272 PFYADSLVGTYSKIMNH-----------KNSLTFPDD---------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp TTCCSSHHHHHHHHHTH-----------HHHCCCCTT---------CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred CCCCCChhhHHHHHHhc-----------cccccCCCc---------ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 12222222222210 000012211 368999999999999999988 99999999744
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.16 E-value=2.7e-12 Score=138.90 Aligned_cols=118 Identities=14% Similarity=0.132 Sum_probs=74.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceee--ecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILL--HTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lL--lg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+-||+.||++ +.++|.|||++.. ......+||+.|++||.+- ++...|+.++||||+|||++
T Consensus 134 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~--------- 204 (290)
T 3fme_A 134 RDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMI--------- 204 (290)
T ss_dssp CCCSGGGCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHH---------
T ss_pred CCCCHHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHH---------
Confidence 4689999999 8899999998754 2233348999999999873 23456999999999999996
Q ss_pred HHHHhcCCCchhh-------hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 744 ILLHTLPLYTCYT-------LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 744 ~I~~~lG~p~~~~-------~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++ .|.++-.. +........+.. ....+++++.+||.+||+.||.+|||+.++|+.
T Consensus 205 ~l~--~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 205 ELA--ILRFPYDSWGTPFQQLKQVVEEPSPQL-------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp HHH--HTSCSSCCCSCHHHHHHHHHHSCCCCC-------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHH--HCCCCccccCchHHHHHHHhccCCCCc-------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 111 12221100 000000000000 013578999999999999999999999999973
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.16 E-value=4.5e-12 Score=143.67 Aligned_cols=117 Identities=11% Similarity=0.010 Sum_probs=82.5
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--ceeeeccCCCcccccceeeec---------CCCCCCCCCceeeeeEeecCCc
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHT---------LPLYTYHVPPIQTTCLLAGTER 738 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg---------~~~Y~~~vDIWSlGCIl~G~~~ 738 (962)
+-||.+||++ |.+||.|||++.. ....+.+| +.|++||.+..+ ...|+.++||||+|||++
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~---- 304 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY---- 304 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH----
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH----
Confidence 5789999999 8999999999865 34455588 888888877654 025999999999999996
Q ss_pred hhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 739 LKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 739 ~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++. |.+|-........ . .......+.+++++.+||.+||..||.+||++.++|+.
T Consensus 305 -----ellt--g~~Pf~~~~~~~~--~-----~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 305 -----WIWC--ADLPITKDAALGG--S-----EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp -----HHHH--SSCCC------CC--S-----GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred -----HHHH--CCCCCcccccccc--h-----hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 2222 4433111000000 0 00011125789999999999999999999999999973
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=4.2e-12 Score=140.91 Aligned_cols=114 Identities=20% Similarity=0.160 Sum_probs=79.0
Q ss_pred cccceeeEEE------EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----c---
Q psy501 673 ERLKSSYILL------HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----G--- 735 (962)
Q Consensus 673 ~~~~~~~~~~------~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G--- 735 (962)
+-||..||++ +.++|.|||++.. ......+||+.|++||.+.. ..|+.++||||+|||++ |
T Consensus 155 ~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p 232 (327)
T 3lm5_A 155 LDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSP 232 (327)
T ss_dssp SCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCC
Confidence 4689999997 5799999999854 22334589999999987643 45899999999999997 1
Q ss_pred ---CCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 736 ---TERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 736 ---~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.+..+.+..+...... . ....++.+++++.+||.+||+.||.+|||++++|+.
T Consensus 233 f~~~~~~~~~~~i~~~~~~----------------~----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 233 FVGEDNQETYLNISQVNVD----------------Y----SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp SCCSSHHHHHHHHHHTCCC----------------C----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred CCCCCchHHHHHHHhcccc----------------c----CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1111222222111100 0 011225678999999999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.15 E-value=7.4e-12 Score=141.47 Aligned_cols=116 Identities=23% Similarity=0.297 Sum_probs=81.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeec----CCCCCCCCCceeeeeEee----cCC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHT----LPLYTYHVPPIQTTCLLA----GTE 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg----~~~Y~~~vDIWSlGCIl~----G~~ 737 (962)
+-||+.||++ |.++|.|||+... ......+||+.|++||++..+ ...|+.++||||+|||++ |..
T Consensus 224 ~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~ 303 (365)
T 2y7j_A 224 RDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303 (365)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred CCCCHHHEEECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCC
Confidence 4689999999 8999999997643 334456899999999987643 235899999999999997 211
Q ss_pred ------chhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 738 ------RLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 738 ------~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
..+.+..+... . + ......| +.+++++.+||++||..||.+|||+.++|+.
T Consensus 304 pf~~~~~~~~~~~i~~~-----------~----~-~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 304 PFWHRRQILMLRMIMEG-----------Q----Y-QFSSPEW----DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp SSCCSSHHHHHHHHHHT-----------C----C-CCCHHHH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCCHHHHHHHHHhC-----------C----C-CCCCccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111111110 0 0 0000111 3678899999999999999999999999973
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=5.2e-12 Score=143.52 Aligned_cols=110 Identities=25% Similarity=0.296 Sum_probs=78.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
+-||..||++ |.++|.|||++.. ..+.+.|||+.|++||++. + ..|+.++||||+|||++ .
T Consensus 163 rDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~DiwslG~il~---------e 231 (373)
T 2r5t_A 163 RDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH-K-QPYDRTVDWWCLGAVLY---------E 231 (373)
T ss_dssp CCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHT-T-CCCCTHHHHHHHHHHHH---------H
T ss_pred cCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhC-C-CCCCchhhhHHHHHHHH---------H
Confidence 5679999999 8999999998754 3455669999999999875 3 46999999999999997 1
Q ss_pred HHHhcCCCchhh------hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhh
Q psy501 745 LLHTLPLYTCYT------LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQ 804 (962)
Q Consensus 745 I~~~lG~p~~~~------~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~ 804 (962)
++ .|.++-.. ...... ....+ -+.+++++.|||++||+.||.+|+++.+
T Consensus 232 ll--~G~~Pf~~~~~~~~~~~i~~------~~~~~---~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 232 ML--YGLPPFYSRNTAEMYDNILN------KPLQL---KPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp HH--HSSCTTCCSBHHHHHHHHHH------SCCCC---CSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred HH--cCCCCCCCCCHHHHHHHHHh------cccCC---CCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 11 12222100 000000 00011 1467899999999999999999999853
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=4.4e-12 Score=140.97 Aligned_cols=110 Identities=22% Similarity=0.227 Sum_probs=77.6
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cC----
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GT---- 736 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~---- 736 (962)
+-||..||++ |.++|.|||++.. ......+||+.|++||++.. ..|+.++||||+|||++ |.
T Consensus 145 ~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~ 222 (327)
T 3a62_A 145 RDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFT 222 (327)
T ss_dssp CCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCC
Confidence 5789999999 8999999998754 22344589999999998753 45899999999999997 11
Q ss_pred --CchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCc-----chhhhhhh
Q psy501 737 --ERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRP-----TAQQSLSI 808 (962)
Q Consensus 737 --~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~-----sa~~~L~~ 808 (962)
+..+.+..|... .. .+ -+.+++++.|||++||..||.+|| +++++|++
T Consensus 223 ~~~~~~~~~~i~~~---------------~~------~~---p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 223 GENRKKTIDKILKC---------------KL------NL---PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp CSSHHHHHHHHHHT---------------CC------CC---CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred CCCHHHHHHHHHhC---------------CC------CC---CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 111111122110 00 01 135789999999999999999999 66787763
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.14 E-value=1.5e-12 Score=143.54 Aligned_cols=119 Identities=19% Similarity=0.240 Sum_probs=79.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-----------------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeE
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-----------------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCL 732 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-----------------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCI 732 (962)
+-||..||++ |.++|.|||++..- .....+||+.|++||.+.. ..|+.++||||+|||
T Consensus 188 ~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~i 265 (332)
T 3qd2_B 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG--NNYSHKVDIFSLGLI 265 (332)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHC--CCCCTHHHHHHHHHH
T ss_pred cCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcC--CCCcchhhHHHHHHH
Confidence 5789999999 89999999987541 1223479999999998653 459999999999999
Q ss_pred eecCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 733 LAGTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 733 l~G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
++ .++ .|.++......... ......+...++..++++.+||.+||..||.+|||+.++|+.
T Consensus 266 l~---------el~--~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 266 LF---------ELL--YSFSTQMERVRIIT----DVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HH---------HHH--SCCCCHHHHHHHHH----HHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HH---------HHH--HcCCChhHHHHHHH----HhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 97 111 13222211100000 000001111113457789999999999999999999999974
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=1e-11 Score=133.76 Aligned_cols=113 Identities=20% Similarity=0.208 Sum_probs=79.2
Q ss_pred cccceeeEEE------EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cC--
Q psy501 673 ERLKSSYILL------HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GT-- 736 (962)
Q Consensus 673 ~~~~~~~~~~------~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~-- 736 (962)
+.||+.||++ +.++|.|||.+.. ......+||+.|++||.+. + .|+.++||||+||+++ |.
T Consensus 130 ~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~-~--~~~~~~Di~slG~~l~~l~~g~~p 206 (277)
T 3f3z_A 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE-G--LYGPECDEWSAGVMMYVLLCGYPP 206 (277)
T ss_dssp CCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-T--CBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhc-c--cCCchhhehhHHHHHHHHHHCCCC
Confidence 4679999998 6799999998643 3444558999999998653 3 3899999999999996 11
Q ss_pred ----CchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 737 ----ERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 737 ----~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+..+.+..+.... ...+.. ..+.+++++.+||.+||..||.+|||+.++|+.
T Consensus 207 ~~~~~~~~~~~~~~~~~----------------~~~~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 207 FSAPTDSEVMLKIREGT----------------FTFPEK----DWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp SCCSSHHHHHHHHHHCC----------------CCCCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCCCHHHHHHHHHhCC----------------CCCCch----hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111111100 001111 113678999999999999999999999999973
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=3.6e-12 Score=141.51 Aligned_cols=120 Identities=16% Similarity=0.163 Sum_probs=81.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||..||++ +.++|.|||++.. ......+||+.|++||++. +...++.++||||+|||++
T Consensus 129 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~-------- 199 (323)
T 3tki_A 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLT-------- 199 (323)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHH-CSSBCHHHHHHHHHHHHHH--------
T ss_pred cccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhc-cCCCCCCcccHHHHHHHHH--------
Confidence 5689999999 8899999999853 1223458999999998876 4344688999999999996
Q ss_pred HHHHHhcCCCchhhhcc----cccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 743 YILLHTLPLYTCYTLAS----NMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~----~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++ .|.++-..... ...+........++ ..+++++.+||.+||.+||.+|||++++|+.
T Consensus 200 -~ll--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 200 -AML--AGELPWDQPSDSCQEYSDWKEKKTYLNPW----KKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -HHH--HSSCSCSSSCTTSHHHHHHHTTCTTSTTG----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -HHH--hCCCCCCCCchHHHHHHHHhcccccCCcc----ccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 111 13322110000 00000000001111 3578999999999999999999999999963
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=5.3e-12 Score=139.28 Aligned_cols=116 Identities=18% Similarity=0.226 Sum_probs=73.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-----eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-----TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-----~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
+-||.+||++ +.++|.|||++... .....+||+.|++||.+. + ..|+.++||||+||+++ .
T Consensus 163 ~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~DiwslG~il~---------e 231 (309)
T 3p86_A 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR-D-EPSNEKSDVYSFGVILW---------E 231 (309)
T ss_dssp TTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHT-T-CCCCTTHHHHHHHHHHH---------H
T ss_pred CCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhc-C-CCCCchhhHHHHHHHHH---------H
Confidence 5689999999 89999999997541 233458999999998765 3 45899999999999996 1
Q ss_pred HHHhcCCCchhh-----hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 745 LLHTLPLYTCYT-----LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 745 I~~~lG~p~~~~-----~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
++ .|.++-.. ......... ... ..-+.+++++.+||.+||..||.+|||+.++++
T Consensus 232 ll--tg~~Pf~~~~~~~~~~~~~~~~---~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 232 LA--TLQQPWGNLNPAQVVAAVGFKC---KRL---EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HH--HCCCTTTTSCHHHHHHHHHHSC---CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH--hCCCCCCCCCHHHHHHHHHhcC---CCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11 12211100 000000000 000 111467899999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=5.2e-12 Score=136.76 Aligned_cols=124 Identities=15% Similarity=0.112 Sum_probs=82.0
Q ss_pred cccceeeEEE---EE-----EeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HT-----LPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~-----~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||.+||++ +. ++|.|||++.. ......+||+.|++||.+......|+.++||||+||+++
T Consensus 148 ~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~-------- 219 (287)
T 4f0f_A 148 RDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILY-------- 219 (287)
T ss_dssp SCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHH--------
T ss_pred CCCCcceEEEeccCCCCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHH--------
Confidence 4689999999 33 99999999865 334445899999999987555567899999999999996
Q ss_pred HHHHHhcCCCchhhhcccccccCCCcccCCcc-ccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFT-SIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~-~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. |.++-..................+. ...+.+++++.+||.+||..||.+|||+.++++
T Consensus 220 -~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 220 -TILT--GEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp -HHHH--SSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHc--CCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1111 3222110000000000000000000 111467889999999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.13 E-value=3.6e-12 Score=143.17 Aligned_cols=118 Identities=22% Similarity=0.245 Sum_probs=73.7
Q ss_pred cccceeeEEE------EEEeeeeeecCCCc----eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL------HTLPLYTYHVPPIQ----TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~------~~~~~~~~~~~~~~----~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||+.||++ +.++|.|||++... .....+||+.|++||.+. + ..|+.++||||+|||++
T Consensus 172 ~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~DiwslG~il~-------- 241 (349)
T 2w4o_A 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILR-G-CAYGPEVDMWSVGIITY-------- 241 (349)
T ss_dssp CCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHT-T-CCCCTHHHHHHHHHHHH--------
T ss_pred cCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhc-C-CCCCcccchHHHHHHHH--------
Confidence 4679999998 57999999997652 233458999999998765 3 45999999999999997
Q ss_pred HHHHHhcCCCchhh-------hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 743 YILLHTLPLYTCYT-------LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 743 ~~I~~~lG~p~~~~-------~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++ .|.++-.. +......... . . ....+.+++++.|||++||..||.+|||+.++|+.
T Consensus 242 -ell--~g~~pf~~~~~~~~~~~~i~~~~~~-~-~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 242 -ILL--CGFEPFYDERGDQFMFRRILNCEYY-F-I---SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -HHH--HSSCTTCCTTCHHHHHHHHHTTCCC-C-C---TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -HHH--hCCCCCCCCcccHHHHHHHHhCCCc-c-C---CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 12111000 0000000000 0 0 11124688999999999999999999999999973
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=5.7e-12 Score=139.68 Aligned_cols=117 Identities=21% Similarity=0.231 Sum_probs=80.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
+-||+.||++ |.++|.|||++.. ......+||+.|++||.+.. ..|+.++||||+|||++ .
T Consensus 165 ~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~---------e 233 (321)
T 2c30_A 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVI---------E 233 (321)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHH---------H
T ss_pred CCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcC--CCCCchhhHHHHHHHHH---------H
Confidence 5789999999 8999999998643 12334589999999997743 45899999999999997 1
Q ss_pred HHHhcCCCchhh------hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 745 LLHTLPLYTCYT------LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 745 I~~~lG~p~~~~------~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
++. |.++-.. +........+.. . ....+++++.+||.+||+.||.+|||+.++|+.
T Consensus 234 l~~--g~~pf~~~~~~~~~~~~~~~~~~~~-----~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 234 MVD--GEPPYFSDSPVQAMKRLRDSPPPKL-----K-NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHH--SSCTTTTSCHHHHHHHHHHSSCCCC-----T-TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHh--CCCCCCCCCHHHHHHHHhcCCCCCc-----C-ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 2221100 000000000000 0 012468899999999999999999999999973
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=1.8e-12 Score=139.54 Aligned_cols=119 Identities=13% Similarity=0.063 Sum_probs=81.3
Q ss_pred cccceeeEEEE----------------------EEeeeeeecCCC-ceeeeccCCCcccccceeeecCCCCCCCCCceee
Q psy501 673 ERLKSSYILLH----------------------TLPLYTYHVPPI-QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQT 729 (962)
Q Consensus 673 ~~~~~~~~~~~----------------------~~~~~~~~~~~~-~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSl 729 (962)
+-||++||++. .++|.|||.+.. ......+||+.|++||++. +...|+.++||||+
T Consensus 139 ~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~Di~sl 217 (289)
T 1x8b_A 139 MDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQ-ENYTHLPKADIFAL 217 (289)
T ss_dssp SCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHT-TCCTTHHHHHHHHH
T ss_pred cCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCccccCCCccccChhHhc-CCCCCCchhhHHHH
Confidence 46799999983 689999998765 3344457999999988776 44567889999999
Q ss_pred eeEeecCCchhHHHHHHHhc-CCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 730 TCLLAGTERLKSSYILLHTL-PLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 730 GCIl~G~~~~~ql~~I~~~l-G~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
||+++ .++ |.|+......... .....+..+-+.+++++.+||.+||..||.+|||+.++|+.
T Consensus 218 G~il~------------~l~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 218 ALTVV------------CAAGAEPLPRNGDQWHE-----IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHHH------------HHTTCCCCCSSSHHHHH-----HHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHH------------HHhcCCCCCcchhHHHH-----HHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 99996 222 2222110000000 00001111124678999999999999999999999999974
Q ss_pred h
Q psy501 809 K 809 (962)
Q Consensus 809 ~ 809 (962)
.
T Consensus 281 ~ 281 (289)
T 1x8b_A 281 S 281 (289)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.13 E-value=1e-11 Score=134.91 Aligned_cols=117 Identities=20% Similarity=0.325 Sum_probs=76.9
Q ss_pred cccceeeEEE------EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL------HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~------~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||+.||++ +.++|.|||++.. ......+||+.|++||.+- ..|+.++||||+|||++
T Consensus 148 ~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~Di~slG~il~-------- 216 (285)
T 3is5_A 148 KDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK---RDVTFKCDIWSAGVVMY-------- 216 (285)
T ss_dssp CCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT---TCCCHHHHHHHHHHHHH--------
T ss_pred CCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc---cCCCcccCeehHHHHHH--------
Confidence 4679999999 6799999999864 2334458999999999752 45899999999999996
Q ss_pred HHHHHhcCCCchh-----hhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 743 YILLHTLPLYTCY-----TLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 743 ~~I~~~lG~p~~~-----~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++. |.++-. ..........+ .+......+++++.+||.+||+.||.+|||+.++|+.
T Consensus 217 -~ll~--g~~pf~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 217 -FLLT--GCLPFTGTSLEEVQQKATYKEP-----NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -HHHH--SSCSSCCSSHHHHHHHHHHCCC-----CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -HHHh--CCCCCCCCCHHHHHhhhccCCc-----ccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 222100 00000000000 0111113478999999999999999999999999973
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=1.2e-12 Score=145.16 Aligned_cols=132 Identities=11% Similarity=-0.041 Sum_probs=78.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeecC---CCCCCCCCceeeeeEee----c
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTL---PLYTYHVPPIQTTCLLA----G 735 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~---~~Y~~~vDIWSlGCIl~----G 735 (962)
+-||++||++ +.+||.|||++.. ......+||+.|++||.+..+. ..|+.++||||+|||++ |
T Consensus 155 ~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg 234 (322)
T 3soc_A 155 RDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234 (322)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhC
Confidence 4689999999 8999999999832 2233358999999998876421 24667889999999997 1
Q ss_pred CC------chhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCC--CCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 736 TE------RLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIP--HASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 736 ~~------~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p--~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.. +..++.......+.|....+..... .......+...++ ..++++.+||.+||+.||.+|||+.++++
T Consensus 235 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 235 CTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV---HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp BTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHT---TSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCcchhccchhhhhccCCchhhhhhhhh---cccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11 0001111111111222111111000 0000111111111 12346899999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=8.5e-12 Score=134.73 Aligned_cols=119 Identities=26% Similarity=0.300 Sum_probs=78.8
Q ss_pred cccceeeEEE---E---EEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---H---TLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~---~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||++||++ + .++|.|||.+.. ......+||+.|++||.+. + ..|+.++||||+||+++
T Consensus 129 ~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~~Di~slG~~l~-------- 198 (284)
T 3kk8_A 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK-K-DPYSKPVDIWACGVILY-------- 198 (284)
T ss_dssp SCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHT-T-CCBCTHHHHHHHHHHHH--------
T ss_pred CCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhc-C-CCCCcccchHHHHHHHH--------
Confidence 4589999999 3 399999998744 2223348999999988765 3 45899999999999996
Q ss_pred HHHHHhcCCCchh--h---hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 743 YILLHTLPLYTCY--T---LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 743 ~~I~~~lG~p~~~--~---~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++ .|.++-. . ............+.. ..+.+++++.+||.+||+.||.+|||++++|+.
T Consensus 199 -~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 199 -ILL--VGYPPFWDEDQHRLYAQIKAGAYDYPSP----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -HHH--HSSCSSCCSSHHHHHHHHHHTCCCCCTT----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -HHH--HCCCCCCCCchhHHHHHHHhccccCCch----hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111 1221100 0 000000000001111 124678999999999999999999999999973
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.12 E-value=5.8e-12 Score=136.95 Aligned_cols=117 Identities=15% Similarity=0.169 Sum_probs=75.5
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeee-cCCCCCCCCCceeeeeEee----cC-
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLH-TLPLYTYHVPPIQTTCLLA----GT- 736 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLl-g~~~Y~~~vDIWSlGCIl~----G~- 736 (962)
+-||.+||++ +.++|.|||++.. ......+||+.|++||.+.. +...|+.++||||+||+++ |.
T Consensus 144 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 223 (289)
T 3og7_A 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 223 (289)
T ss_dssp SCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCC
Confidence 4679999999 7899999998753 22233479999999998763 2456899999999999997 11
Q ss_pred -----CchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 737 -----ERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 737 -----~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
...+++..+... ......+..+.+.+++++.+||.+||..||.+|||+.++++
T Consensus 224 p~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 224 PYSNINNRDQIIEMVGR------------------GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TTSSCCCHHHHHHHHHH------------------TSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CccccchHHHHHHHhcc------------------cccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111111111110 00011122223467899999999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.11 E-value=7e-12 Score=138.57 Aligned_cols=115 Identities=17% Similarity=0.170 Sum_probs=80.8
Q ss_pred cccceeeEEE---E----EEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cC-
Q psy501 673 ERLKSSYILL---H----TLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GT- 736 (962)
Q Consensus 673 ~~~~~~~~~~---~----~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~- 736 (962)
+-||..||++ + .++|.|||++.. ......+||+.|++||.+.. ..|+.++||||+|||++ |.
T Consensus 139 ~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~ 216 (321)
T 2a2a_A 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGAS 216 (321)
T ss_dssp CCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCC
T ss_pred CCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCC
Confidence 4579999999 4 699999998754 22344579999999997643 45899999999999997 11
Q ss_pred -----CchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 737 -----ERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 737 -----~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
+..+.+..+.... . ..+ ....+.+++++.+||.+||..||.+|||++++|+..
T Consensus 217 pf~~~~~~~~~~~i~~~~---------------~-~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp 274 (321)
T 2a2a_A 217 PFLGDTKQETLANITSVS---------------Y-DFD----EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (321)
T ss_dssp SSCCSSHHHHHHHHHTTC---------------C-CCC----HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred CCCCCCHHHHHHHHHhcc---------------c-ccC----hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 1111221111110 0 000 112246789999999999999999999999999743
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.11 E-value=3.2e-12 Score=147.19 Aligned_cols=117 Identities=16% Similarity=0.133 Sum_probs=81.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----c--eeeeccCCCcccccceeee-----cCCCCCCCCCceeeeeEee----
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----Q--TTCLLAGTERLKSSYILLH-----TLPLYTYHVPPIQTTCLLA---- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~--~~~~~~gt~~~~~~~~lLl-----g~~~Y~~~vDIWSlGCIl~---- 734 (962)
|-||..||++ |.+||.|||++.. . ...+.|||+.|++||++.. +...|+.++||||+|||++
T Consensus 186 rDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyellt 265 (412)
T 2vd5_A 186 RDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265 (412)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHH
T ss_pred cccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHh
Confidence 5789999999 8999999998743 1 2234599999999999873 2356999999999999997
Q ss_pred c------CCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCc---chhhh
Q psy501 735 G------TERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRP---TAQQS 805 (962)
Q Consensus 735 G------~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~---sa~~~ 805 (962)
| .+..+....|...- ....++ ...+.++++++|||++||+ +|.+|+ +++++
T Consensus 266 G~~Pf~~~~~~~~~~~i~~~~-----------~~~~~p--------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei 325 (412)
T 2vd5_A 266 GQTPFYADSTAETYGKIVHYK-----------EHLSLP--------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDF 325 (412)
T ss_dssp SSCTTCCSSHHHHHHHHHTHH-----------HHCCCC------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhcc-----------cCcCCC--------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH
Confidence 1 12222222222100 000011 1113689999999999999 999984 88998
Q ss_pred hhhh
Q psy501 806 LSIK 809 (962)
Q Consensus 806 L~~~ 809 (962)
+++.
T Consensus 326 ~~Hp 329 (412)
T 2vd5_A 326 RTHP 329 (412)
T ss_dssp HTSG
T ss_pred hcCC
Confidence 8744
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.11 E-value=1e-11 Score=135.83 Aligned_cols=114 Identities=17% Similarity=0.211 Sum_probs=80.1
Q ss_pred cccceeeEEE------EEEeeeeeecCCCce---eeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cCC--
Q psy501 673 ERLKSSYILL------HTLPLYTYHVPPIQT---TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GTE-- 737 (962)
Q Consensus 673 ~~~~~~~~~~------~~~~~~~~~~~~~~~---~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~~-- 737 (962)
+-||..||++ +.++|.|||++.... ....+||+.|++||.+.. ..|+.++||||+||+++ |..
T Consensus 130 ~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf 207 (304)
T 2jam_A 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPF 207 (304)
T ss_dssp CSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCCCHHHEEEecCCCCCCEEEccCCcceecCCCccccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 4679999998 679999999976522 233479999999997753 45899999999999997 211
Q ss_pred ----chhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 738 ----RLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 738 ----~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
..+.+..+... ...++. ...+.+++++.+||.+||..||.+||+++++|+.
T Consensus 208 ~~~~~~~~~~~i~~~----------------~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 208 YEETESKLFEKIKEG----------------YYEFES----PFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTSCHHHHHHHHHHC----------------CCCCCT----TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHcC----------------CCCCCc----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111111110 000111 1124678999999999999999999999999973
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.1e-12 Score=145.58 Aligned_cols=132 Identities=14% Similarity=0.029 Sum_probs=77.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------------ceeeeccCCCcccccceeeecC-----CCCCCCCCceeeee
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------------QTTCLLAGTERLKSSYILLHTL-----PLYTYHVPPIQTTC 731 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------------~~~~~~~gt~~~~~~~~lLlg~-----~~Y~~~vDIWSlGC 731 (962)
+-||.+||++ |.++|.|||++.. ......+||+.|++||.+..+. ..|+.++||||+||
T Consensus 144 ~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~ 223 (336)
T 3g2f_A 144 RDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223 (336)
T ss_dssp SSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHH
T ss_pred cccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHH
Confidence 5789999999 8899999999742 2222447999999999876421 34678999999999
Q ss_pred Eee----cCCc-------hhHHHHHH-HhcCCCchhhhcccccccCCCcccCCccccCC---CCCHHHHHHHHHhhccCC
Q psy501 732 LLA----GTER-------LKSSYILL-HTLPLYTCYTLASNMNFKFPQFRRVPFTSIIP---HASPDAIHLMESMLAYNP 796 (962)
Q Consensus 732 Il~----G~~~-------~~ql~~I~-~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p---~~s~~a~DLL~kmL~~dP 796 (962)
|++ |... .+....+. ...+.|..+.+..... .......+...++ .+++++.+||.+||..||
T Consensus 224 il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 300 (336)
T 3g2f_A 224 IYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVS---REKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300 (336)
T ss_dssp HHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHT---TSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSG
T ss_pred HHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhc---ccccCCCCCcccccccchHHHHHHHHHHHhcCCh
Confidence 997 1000 00000000 0001111111000000 0000011111111 244579999999999999
Q ss_pred CCCcchhhhhh
Q psy501 797 SKRPTAQQSLS 807 (962)
Q Consensus 797 ~kR~sa~~~L~ 807 (962)
.+|||+.++++
T Consensus 301 ~~Rps~~e~l~ 311 (336)
T 3g2f_A 301 EARLTAQXAEE 311 (336)
T ss_dssp GGSCCHHHHHH
T ss_pred hhCcchHHHHH
Confidence 99999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.10 E-value=6.6e-12 Score=144.42 Aligned_cols=116 Identities=13% Similarity=0.039 Sum_probs=81.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--ceeeeccCCCcccccceeee--------cCCCCCCCCCceeeeeEeecCCch
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLH--------TLPLYTYHVPPIQTTCLLAGTERL 739 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLl--------g~~~Y~~~vDIWSlGCIl~G~~~~ 739 (962)
|-||++||++ |.+||.|||+... ....+.+| +.|++||.+.. ....|+.++||||+|||++
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~----- 308 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY----- 308 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH-----
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH-----
Confidence 6789999999 8899999999655 44555689 99998888742 2235888999999999996
Q ss_pred hHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 740 KSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 740 ~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. |.+|-......... ...+ ...+.+++++.+||.+||..||.+||++.++|+
T Consensus 309 ----ellt--g~~Pf~~~~~~~~~------~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 ----WIWC--ADLPNTDDAALGGS------EWIF-RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp ----HHHH--SSCCCCTTGGGSCS------GGGG-SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----HHHH--CCCCCCCcchhhhH------HHHH-hhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 2222 33321110000000 0000 011367899999999999999999999999997
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.10 E-value=2.2e-11 Score=134.35 Aligned_cols=123 Identities=15% Similarity=0.118 Sum_probs=75.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-----eeeeccCCCcccccceeeec---CCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-----TTCLLAGTERLKSSYILLHT---LPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-----~~~~~~gt~~~~~~~~lLlg---~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
+-||..||++ |.++|.|||++... .....+||+.|++||.+... ...|+.++||||+|||++
T Consensus 153 ~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~------- 225 (326)
T 2x7f_A 153 RDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAI------- 225 (326)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHH-------
T ss_pred cCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHH-------
Confidence 4689999999 88999999987651 22344799999999987632 356899999999999997
Q ss_pred HHHHHHhcCCCchhhhcccc-cccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 742 SYILLHTLPLYTCYTLASNM-NFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 742 l~~I~~~lG~p~~~~~~~~~-~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++ .|.++-....... ...........+ ..+.+++++.+||.+||..||.+||++.++|+.
T Consensus 226 --~l~--~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 226 --EMA--EGAPPLCDMHPMRALFLIPRNPAPRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp --HHH--HSSCTTTTSCHHHHHHHHHHSCCCCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred --HHH--hCCCCCCCCcHHHHHHHhhcCccccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111 1222110000000 000000000000 113578899999999999999999999999974
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.10 E-value=8.9e-12 Score=140.21 Aligned_cols=122 Identities=17% Similarity=0.090 Sum_probs=80.5
Q ss_pred cccceeeEEE---EEEeeeeeecCCC------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+-||+.||++ |.++|.|||++.. ......+||+.|++||.+..+...|+.++||||+|||++
T Consensus 183 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~--------- 253 (355)
T 1vzo_A 183 RDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMY--------- 253 (355)
T ss_dssp CCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHH---------
T ss_pred CCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHH---------
Confidence 5689999999 8899999998643 223345899999999988765667899999999999996
Q ss_pred HHHHhcCCCchhhhccccc---c--cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCc-----chhhhhhhh
Q psy501 744 ILLHTLPLYTCYTLASNMN---F--KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRP-----TAQQSLSIK 809 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~~~~~---~--~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~-----sa~~~L~~~ 809 (962)
.++. |.++-........ . .... ...+ ..+.+++.+.+||.+||..||.+|| +++++|+..
T Consensus 254 ell~--g~~pf~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 254 ELLT--GASPFTVDGEKNSQAEISRRILK-SEPP---YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHHH--SSCTTSCTTSCCCHHHHHHHHHH-CCCC---CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HHHH--CCCCCccCCccchHHHHHHHHhc-cCCC---CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1111 3222100000000 0 0000 0001 1145788999999999999999999 899998743
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.09 E-value=1.4e-11 Score=133.80 Aligned_cols=119 Identities=13% Similarity=0.122 Sum_probs=79.2
Q ss_pred cccceeeEEE----EEEeeeeeecCCC---ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHH
Q psy501 673 ERLKSSYILL----HTLPLYTYHVPPI---QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 745 (962)
Q Consensus 673 ~~~~~~~~~~----~~~~~~~~~~~~~---~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I 745 (962)
+-||+.||++ +.++|.|||++.. ......+||+.|++||.+- ..|+.++||||+||+++ .+
T Consensus 155 ~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~Di~slG~~l~---------~l 222 (290)
T 1t4h_A 155 RDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE---EKYDESVDVYAFGMCML---------EM 222 (290)
T ss_dssp SCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGG---TCCCTHHHHHHHHHHHH---------HH
T ss_pred CCCCHHHEEEECCCCCEEEeeCCCcccccccccccccCCcCcCCHHHHh---ccCCCcchHHHHHHHHH---------HH
Confidence 4689999999 5899999998754 3334558999999999553 34999999999999996 11
Q ss_pred HHhcCCCchhhhcc---cccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 746 LHTLPLYTCYTLAS---NMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 746 ~~~lG~p~~~~~~~---~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+. |.++-..... ..........+..+ -...++++.+||.+||..||.+|||++++|+.
T Consensus 223 ~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 223 AT--SEYPYSECQNAAQIYRRVTSGVKPASF---DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HH--SSCTTTTCSSHHHHHHHHTTTCCCGGG---GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred Hh--CCCCCCCcCcHHHHHHHHhccCCcccc---CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11 2221110000 00000000001111 13467899999999999999999999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.09 E-value=1.1e-11 Score=133.86 Aligned_cols=118 Identities=17% Similarity=0.172 Sum_probs=77.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCC---ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI---QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILL 746 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I~ 746 (962)
+-||..||++ |.++|.|||++.. ......+||+.|++||.+. + ..|+.++||||+||+++ .++
T Consensus 133 ~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~~Di~slG~il~---------~l~ 201 (279)
T 3fdn_A 133 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIE-G-RMHDEKVDLWSLGVLCY---------EFL 201 (279)
T ss_dssp CCCCGGGEEECTTSCEEECSCCEESCC--------CCCCTTCCHHHHT-T-CCCCTTHHHHHHHHHHH---------HHH
T ss_pred ccCChHhEEEcCCCCEEEEeccccccCCcccccccCCCCCccCHhHhc-c-CCCCccchhHhHHHHHH---------HHH
Confidence 4579999999 8899999998654 2234458999999988764 3 46899999999999996 111
Q ss_pred HhcCCCchhh--hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 747 HTLPLYTCYT--LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 747 ~~lG~p~~~~--~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.|.++-.. ...... .... ....+ -..+++++.+||.+||..||.+||++.++|+.
T Consensus 202 --~g~~p~~~~~~~~~~~-~~~~-~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 202 --VGKPPFEANTYQETYK-RISR-VEFTF---PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --HSSCTTCCSSHHHHHH-HHHH-TCCCC---CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --HCCCCCCCCcHHHHHH-HHHh-CCCCC---CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 12222100 000000 0000 00001 13468899999999999999999999999973
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=1.2e-11 Score=137.88 Aligned_cols=119 Identities=18% Similarity=0.149 Sum_probs=65.8
Q ss_pred cccceeeEEE------EEEeeeeeecCCC---ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL------HTLPLYTYHVPPI---QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~------~~~~~~~~~~~~~---~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+-||..||++ +.++|.|||++.. ......+||+.|++||.+.. ..|+.++||||+||+++
T Consensus 152 ~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~--------- 220 (336)
T 3fhr_A 152 RDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMY--------- 220 (336)
T ss_dssp SCCSGGGEEESCSSTTCCEEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHH---------
T ss_pred CCCCHHHEEEEecCCCceEEEeccccceeccccccccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHH---------
Confidence 4689999999 3499999998754 23344589999999998643 45899999999999996
Q ss_pred HHHHhcCCCchhhhcc-c--------ccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 744 ILLHTLPLYTCYTLAS-N--------MNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~~-~--------~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++ .|.++-..... . ........+.. ..+.+++++.+||.+||..||.+|||++++|+.
T Consensus 221 ~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 221 ILL--CGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP----EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp HHH--HSSCCC---------------------CCCTT----TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHH--HCCCCCCCccchhhhhhHHHhhhccccccCch----hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111 13322111000 0 00000000111 114679999999999999999999999999973
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.09 E-value=8e-12 Score=140.28 Aligned_cols=134 Identities=16% Similarity=0.106 Sum_probs=79.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCC---ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cC-----C
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI---QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GT-----E 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~-----~ 737 (962)
+-||..||++ |.++|.|||++.. ......+||+.|++||.+. + ..|+.++||||+|||++ |. .
T Consensus 156 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ-G-THYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp SCCSGGGEEECTTCCEEECCCCCCHHHHHHC----CCCCTTCCHHHHT-T-CCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred CCccHHHEEECCCCCEEEEECCCCcccccccccCCCCCCCeECHHHHc-C-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 5689999999 8999999998753 3334458999999998765 3 46999999999999998 22 2
Q ss_pred chhHHHHHHH--hcCCCchhhhc-cccc-----ccCCCccc------------CCcccc-CCCCCHHHHHHHHHhhccCC
Q psy501 738 RLKSSYILLH--TLPLYTCYTLA-SNMN-----FKFPQFRR------------VPFTSI-IPHASPDAIHLMESMLAYNP 796 (962)
Q Consensus 738 ~~~ql~~I~~--~lG~p~~~~~~-~~~~-----~~~~~~~~------------~~l~~~-~p~~s~~a~DLL~kmL~~dP 796 (962)
..+.+..++. ..|.+...... .... +.....+. ...... -..+++++.|||++||++||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 313 (360)
T 3eqc_A 234 DAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 313 (360)
T ss_dssp CHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSST
T ss_pred CHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcCh
Confidence 2222222221 11111100000 0000 00000000 000000 02368899999999999999
Q ss_pred CCCcchhhhhhh
Q psy501 797 SKRPTAQQSLSI 808 (962)
Q Consensus 797 ~kR~sa~~~L~~ 808 (962)
.+|||++++|++
T Consensus 314 ~~Rpt~~ell~h 325 (360)
T 3eqc_A 314 AERADLKQLMVH 325 (360)
T ss_dssp TTSCCHHHHHTS
T ss_pred hhCCCHHHHhhC
Confidence 999999999974
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.09 E-value=7.7e-12 Score=135.72 Aligned_cols=119 Identities=14% Similarity=0.153 Sum_probs=75.6
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-------------------eeeeccCCCcccccceeeecCCCCCCCCCceeee
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-------------------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTT 730 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-------------------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlG 730 (962)
+.||+.||++ |.++|.|||++... .....+||+.|++||.+. +...|+.++||||+|
T Consensus 140 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG 218 (303)
T 1zy4_A 140 RDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD-GTGHYNEKIDMYSLG 218 (303)
T ss_dssp SCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHT-SCSCCCTHHHHHHHH
T ss_pred ccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCccccc-CCCCCcchhhHHHHH
Confidence 4679999999 88999999987642 123447999999888765 445799999999999
Q ss_pred eEeecCCchhHHHHHHHhcCCCchhh----hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhh
Q psy501 731 CLLAGTERLKSSYILLHTLPLYTCYT----LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSL 806 (962)
Q Consensus 731 CIl~G~~~~~ql~~I~~~lG~p~~~~----~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L 806 (962)
|+++ .++. +..+... ....... ...+ +.. ..+..++.+.+||++||..||.+|||+.++|
T Consensus 219 ~il~---------~l~~--p~~~~~~~~~~~~~~~~~-~~~~-~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 282 (303)
T 1zy4_A 219 IIFF---------EMIY--PFSTGMERVNILKKLRSV-SIEF-PPD---FDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282 (303)
T ss_dssp HHHH---------HHHS--CCSSHHHHHHHHHHHHST-TCCC-CTT---CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHH---------HHHh--ccCCchhHHHHHHhcccc-cccc-Ccc---ccccchHHHHHHHHHHHhcCcccCcCHHHHh
Confidence 9996 1111 1111100 0000000 0001 011 1135677899999999999999999999999
Q ss_pred hh
Q psy501 807 SI 808 (962)
Q Consensus 807 ~~ 808 (962)
+.
T Consensus 283 ~h 284 (303)
T 1zy4_A 283 NS 284 (303)
T ss_dssp HS
T ss_pred CC
Confidence 73
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=3.4e-12 Score=139.11 Aligned_cols=130 Identities=11% Similarity=0.112 Sum_probs=83.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc--------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cCC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ--------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GTE 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~--------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~~ 737 (962)
+-||++||++ |.++|.|||++... ......||+.|++||.+.. ..|+.++||||+||+++ |..
T Consensus 150 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~ 227 (302)
T 4e5w_A 150 RDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ--SKFYIASDVWSFGVTLHELLTYCD 227 (302)
T ss_dssp SCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecC--CCCCcchhHHHHHHHHHHHHHccC
Confidence 4689999999 78999999987541 1223478888888887653 35889999999999997 322
Q ss_pred -chhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 738 -RLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 738 -~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.......+....+++................... ...+.+++++.+||.+||..||.+|||+.++++
T Consensus 228 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 228 SDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL---PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCcchhhHHhhccCCcccccCHHHHHHHHhccCCC---CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 2222333333333332221000000000000000 112467899999999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.08 E-value=1.4e-11 Score=137.17 Aligned_cols=131 Identities=16% Similarity=0.105 Sum_probs=81.9
Q ss_pred cccceeeEEE---EEEeeeeeecCCC---ceeeeccCCCcccccceeeecCCCCCC-CCCceeeeeEee----cCC----
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI---QTTCLLAGTERLKSSYILLHTLPLYTY-HVPPIQTTCLLA----GTE---- 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~gt~~~~~~~~lLlg~~~Y~~-~vDIWSlGCIl~----G~~---- 737 (962)
+.||+.||++ +.++|.|||.+.. ......+||+.|++||.+..+ ..|+. ++||||+|||++ |..
T Consensus 176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~ 254 (348)
T 2pml_X 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSL 254 (348)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCChHhEEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4689999999 8899999999864 334455899999888876643 35776 999999999997 221
Q ss_pred --c-hhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 738 --R-LKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 738 --~-~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
. .+.+..+.......+ ...................+.+++++.+||.+||..||.+|||+.++|+..
T Consensus 255 ~~~~~~~~~~i~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 255 KISLVELFNNIRTKNIEYP-----LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp SSCSHHHHHHHTSCCCCCC-----CSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred CCcHHHHHHHHhccCcCCc-----cchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 1 122222211100000 000000000111111122256889999999999999999999999999844
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=6.1e-12 Score=150.42 Aligned_cols=121 Identities=18% Similarity=0.168 Sum_probs=82.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 745 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I 745 (962)
+-||..||++ |.++|.|||++.. ....+.+||+.|++||++.. ..|+.++||||+|||++ .+
T Consensus 310 rDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvily---------eL 378 (576)
T 2acx_A 310 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLY---------EM 378 (576)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHH---------HH
T ss_pred cCCchheEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHcC--CCCCccchHHHHHHHHH---------HH
Confidence 5679999999 8999999998753 34455699999999998753 45999999999999996 11
Q ss_pred HHhcCCCchhhhccccc----ccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCc-----chhhhhhhh
Q psy501 746 LHTLPLYTCYTLASNMN----FKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRP-----TAQQSLSIK 809 (962)
Q Consensus 746 ~~~lG~p~~~~~~~~~~----~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~-----sa~~~L~~~ 809 (962)
+ .|.+|-........ .......+..+ -+.+++++.|||++||+.||.+|+ ++++++++.
T Consensus 379 l--tG~~PF~~~~~~~~~~~i~~~i~~~~~~~---p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 379 I--AGQSPFQQRKKKIKREEVERLVKEVPEEY---SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp H--HSSCSSSCSSSCCCHHHHHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred H--hCCCCCcccccchhHHHHHHHhhcccccC---CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 1 13322110000000 00000000011 135799999999999999999999 789998643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=1.2e-11 Score=134.63 Aligned_cols=117 Identities=22% Similarity=0.290 Sum_probs=81.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeee----cCCCCCCCCCceeeeeEee----cC-
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLH----TLPLYTYHVPPIQTTCLLA----GT- 736 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLl----g~~~Y~~~vDIWSlGCIl~----G~- 736 (962)
+.||+.||++ |.++|.|||++.. ......+||+.|++||++.. +...|+.++||||+||+++ |.
T Consensus 148 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 227 (298)
T 1phk_A 148 RDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227 (298)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCcceEEEcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCC
Confidence 4689999999 8899999998743 33444589999999998753 2356899999999999997 11
Q ss_pred -----CchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 737 -----ERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 737 -----~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
+..+.+..+... . . ......+ +.+++++.+||.+||..||.+|||+.++|+..
T Consensus 228 p~~~~~~~~~~~~~~~~-------------~--~-~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (298)
T 1phk_A 228 PFWHRKQMLMLRMIMSG-------------N--Y-QFGSPEW----DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285 (298)
T ss_dssp SSCCSSHHHHHHHHHHT-------------C--C-CCCTTTG----GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred CCcCccHHHHHHHHhcC-------------C--c-ccCcccc----cccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence 111111111110 0 0 0111111 35788999999999999999999999999744
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=1.9e-11 Score=135.15 Aligned_cols=125 Identities=18% Similarity=0.110 Sum_probs=67.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc----eeeeccCCCcccccceeee--cCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ----TTCLLAGTERLKSSYILLH--TLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~----~~~~~~gt~~~~~~~~lLl--g~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+.||+.||++ |.++|.|||++... .....+||+.|++||.+.. ....|+.++||||+|||++
T Consensus 150 ~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~--------- 220 (327)
T 3aln_A 150 RDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY--------- 220 (327)
T ss_dssp SCCCGGGEEEETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHH---------
T ss_pred CCCCHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHH---------
Confidence 5689999999 88999999998651 2223379999999998742 2345899999999999996
Q ss_pred HHHHhcCCCchhhhcccccc--cCCCcccCCcc-ccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 744 ILLHTLPLYTCYTLASNMNF--KFPQFRRVPFT-SIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~~~~~~--~~~~~~~~~l~-~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++. |.++-......... .........+. ...+.+++++.+||.+||..||.+||++.++|+.
T Consensus 221 ~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 221 ELAT--GRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp HHHH--SCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHH--CCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 2221 33221110000000 00000001111 1124578999999999999999999999999973
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.08 E-value=7.6e-12 Score=137.42 Aligned_cols=120 Identities=18% Similarity=0.138 Sum_probs=77.4
Q ss_pred cccceeeEEE---EE---EeeeeeecCCCc------------eeeeccCCCcccccceeeec---CCCCCCCCCceeeee
Q psy501 673 ERLKSSYILL---HT---LPLYTYHVPPIQ------------TTCLLAGTERLKSSYILLHT---LPLYTYHVPPIQTTC 731 (962)
Q Consensus 673 ~~~~~~~~~~---~~---~~~~~~~~~~~~------------~~~~~~gt~~~~~~~~lLlg---~~~Y~~~vDIWSlGC 731 (962)
+-||..||++ +. ++|.|||++... ...+.+||+.|++||++... ...|+.++||||+||
T Consensus 135 ~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~ 214 (316)
T 2ac3_A 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV 214 (316)
T ss_dssp CCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHH
T ss_pred CCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHH
Confidence 4689999999 33 999999987642 12234799999999987641 234899999999999
Q ss_pred EeecCCchhHHHHHHHhcCCCchhhh---------------------cccccccCCCcccCCccccCCCCCHHHHHHHHH
Q psy501 732 LLAGTERLKSSYILLHTLPLYTCYTL---------------------ASNMNFKFPQFRRVPFTSIIPHASPDAIHLMES 790 (962)
Q Consensus 732 Il~G~~~~~ql~~I~~~lG~p~~~~~---------------------~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~k 790 (962)
|++ .++. |.++-... ..... .....+. ...+.+++++.+||++
T Consensus 215 il~---------~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~~~~~~~----~~~~~~~~~~~~li~~ 278 (316)
T 2ac3_A 215 ILY---------ILLS--GYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE-GKYEFPD----KDWAHISCAAKDLISK 278 (316)
T ss_dssp HHH---------HHHH--SSCSCCCCCCSCSCC----CCHHHHHHHHHHHHH-CCCCCCH----HHHTTSCHHHHHHHHH
T ss_pred HHH---------HHHH--CCCCCcccccccccccccccchhHHHHHHHHHhc-cCcccCc----hhcccCCHHHHHHHHH
Confidence 997 1111 22211000 00000 0000000 0113678999999999
Q ss_pred hhccCCCCCcchhhhhhh
Q psy501 791 MLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 791 mL~~dP~kR~sa~~~L~~ 808 (962)
||..||.+|||++++|+.
T Consensus 279 ~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 279 LLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HSCSSTTTSCCHHHHHHS
T ss_pred HhhCChhhCCCHHHHhcC
Confidence 999999999999999974
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.07 E-value=1.5e-11 Score=133.11 Aligned_cols=114 Identities=15% Similarity=0.159 Sum_probs=79.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCC---ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI---QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILL 746 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I~ 746 (962)
+.||.+||++ |.++|.|||++.. ......+||+.|++||.+. + ..|+.++||||+||+++ .++
T Consensus 138 ~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~~Di~slG~il~---------~l~ 206 (284)
T 2vgo_A 138 RDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIE-G-KTHDEKVDLWCAGVLCY---------EFL 206 (284)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHT-T-CCBCTTHHHHHHHHHHH---------HHH
T ss_pred cCCCHHHEEEcCCCCEEEecccccccCcccccccccCCCCcCCHHHhc-c-CCCCcccchhhHHHHHH---------HHH
Confidence 4689999999 8899999998743 2334458999999998765 3 45899999999999996 111
Q ss_pred HhcCCCchhh------hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 747 HTLPLYTCYT------LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 747 ~~lG~p~~~~------~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.|.++-.. ......... .+ -+.+++++.+||++||..||.+||+++++|+.
T Consensus 207 --~g~~pf~~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 207 --VGMPPFDSPSHTETHRRIVNVDL------KF---PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp --HSSCTTCCSSHHHHHHHHHTTCC------CC---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred --HCCCCCCCCCHhHHHHHHhcccc------CC---CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 12221100 000000000 01 13578999999999999999999999999973
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=1.1e-11 Score=132.55 Aligned_cols=121 Identities=17% Similarity=0.061 Sum_probs=80.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCCceeeeccCCCcccccceeeecC-CCCCCCCCceeeeeEeecCCchhHHHHHHHh
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL-PLYTYHVPPIQTTCLLAGTERLKSSYILLHT 748 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~gt~~~~~~~~lLlg~-~~Y~~~vDIWSlGCIl~G~~~~~ql~~I~~~ 748 (962)
+-||++||++ |.+++.|||++........+||+.|++||.+..+. ..|+.++||||+||+++ .++.
T Consensus 137 ~dikp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~---------el~~- 206 (271)
T 3kmu_A 137 HALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLW---------ELVT- 206 (271)
T ss_dssp CCCSGGGEEECTTSCEEEEGGGSCCTTSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHH---------HHHH-
T ss_pred CCCccceEEEcCCcceeEEeccceeeecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHH---------HHHh-
Confidence 4689999999 67888888887776666678999999999876431 22344899999999996 1211
Q ss_pred cCCCchhhhccccc-cc-CCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 749 LPLYTCYTLASNMN-FK-FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 749 lG~p~~~~~~~~~~-~~-~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
|.++-........ .. ....... ...+.+++++.+||.+||..||.+|||++++++
T Consensus 207 -g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 207 -REVPFADLSNMEIGMKVALEGLRP---TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -CSCTTTTSCHHHHHHHHHHSCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCccccChHHHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3322111000000 00 0000000 111467899999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.06 E-value=5.4e-12 Score=146.21 Aligned_cols=126 Identities=21% Similarity=0.202 Sum_probs=76.4
Q ss_pred cccceeeEEEE--------EEeeeeeecCCC--------ceeeeccCCCcccccceeeec-CCCCCCCCCceeeeeEeec
Q psy501 673 ERLKSSYILLH--------TLPLYTYHVPPI--------QTTCLLAGTERLKSSYILLHT-LPLYTYHVPPIQTTCLLAG 735 (962)
Q Consensus 673 ~~~~~~~~~~~--------~~~~~~~~~~~~--------~~~~~~~gt~~~~~~~~lLlg-~~~Y~~~vDIWSlGCIl~G 735 (962)
+-||++||++. .++|.|||++.. ......+||+.|++||++... ...|+.++||||+|||++
T Consensus 142 rDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~- 220 (432)
T 3p23_A 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFY- 220 (432)
T ss_dssp CCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHH-
T ss_pred CCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHH-
Confidence 56799999992 478999998754 123345899999999987642 345788999999999996
Q ss_pred CCchhHHHHHHHhcCCCchhh-hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 736 TERLKSSYILLHTLPLYTCYT-LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 736 ~~~~~ql~~I~~~lG~p~~~~-~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
.++. -|.++-.. ................+. .....++.+.|||.+||+.||.+|||+.++|++.
T Consensus 221 --------ellt-~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp 285 (432)
T 3p23_A 221 --------YVIS-EGSHPFGKSLQRQANILLGACSLDCLH-PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285 (432)
T ss_dssp --------HHHT-TSCBTTBSTTTHHHHHHTTCCCCTTSC-TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred --------HHHc-CCCCCcchhhHHHHHHHhccCCccccC-ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence 1111 13322110 000000000000000000 0012356789999999999999999999999743
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.06 E-value=2.1e-11 Score=131.35 Aligned_cols=120 Identities=18% Similarity=0.187 Sum_probs=63.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
+.||+.||++ +.++|.|||.+.. ......+||+.|++||.+.. ..|+.++||||+||+++ .
T Consensus 136 ~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~---------~ 204 (278)
T 3cok_A 136 RDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR--SAHGLESDVWSLGCMFY---------T 204 (278)
T ss_dssp SSCCGGGEEECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHH---------H
T ss_pred CCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcC--CCCCchhhHHHHHHHHH---------H
Confidence 3589999999 8899999998754 22234589999999987653 45899999999999996 2
Q ss_pred HHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 745 LLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 745 I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
++ .|.++-........ ........+ ..-..+++++.+||.+||..||.+|||++++|+.
T Consensus 205 l~--~g~~p~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 205 LL--IGRPPFDTDTVKNT--LNKVVLADY-EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp HH--HSSCSSCCCSCC-------CCSSCC-CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HH--hCCCCCCChhHHHH--HHHHhhccc-CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 22 23332111000000 000000000 0113578899999999999999999999999974
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=1.4e-11 Score=135.43 Aligned_cols=122 Identities=14% Similarity=0.134 Sum_probs=75.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
+-||..||++ +.++|.|||++.. ......+||+.|++||.+. + ..|+.++||||+||+++
T Consensus 140 ~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~Di~slG~~l~------- 210 (311)
T 3ork_A 140 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR-G-DSVDARSDVYSLGCVLY------- 210 (311)
T ss_dssp CCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHH-T-CCCCHHHHHHHHHHHHH-------
T ss_pred CCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhc-C-CCCCchHhHHHHHHHHH-------
Confidence 4679999999 8899999999754 1223347999999999875 3 45999999999999997
Q ss_pred HHHHHHhcCCCchhhhc-ccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 742 SYILLHTLPLYTCYTLA-SNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 742 l~~I~~~lG~p~~~~~~-~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. |.++-.... .............+.....+.+++++.+||.+||..||.+||++.++|.
T Consensus 211 --~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 211 --EVLT--GEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp --HHHH--SSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred --HHHh--CCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 1111 222100000 0000000000001111122468999999999999999999999988885
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=8.6e-12 Score=137.78 Aligned_cols=125 Identities=18% Similarity=0.192 Sum_probs=81.7
Q ss_pred cccceeeEEE---E---EEeeeeeecCCCce----eeeccCCCcccccceee-ecCCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL---H---TLPLYTYHVPPIQT----TCLLAGTERLKSSYILL-HTLPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~---~---~~~~~~~~~~~~~~----~~~~~gt~~~~~~~~lL-lg~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
+-||..||++ + .++|.|||++.... ....+||+.|++||.+. .+...|+.++||||+|||++
T Consensus 138 ~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~------- 210 (322)
T 2ycf_A 138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF------- 210 (322)
T ss_dssp CCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHH-------
T ss_pred cCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHH-------
Confidence 4689999999 2 39999999975421 22347999999999875 34567999999999999996
Q ss_pred HHHHHHhcCCCchhhhcccccc--cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 742 SYILLHTLPLYTCYTLASNMNF--KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 742 l~~I~~~lG~p~~~~~~~~~~~--~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++ .|.++-......... ...........+..+.+++++.+||++||..||.+||+++++|+.
T Consensus 211 --~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 211 --ICL--SGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp --HHH--HSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHH--hCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 111 132221100000000 000000000111224678999999999999999999999999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.05 E-value=2.9e-11 Score=132.63 Aligned_cols=119 Identities=18% Similarity=0.128 Sum_probs=74.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeee---cCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLH---TLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLl---g~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+.||+.||++ +.++|.|||++.. ......+||+.|++||.+.. +...|+.++||||+|||++
T Consensus 149 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~-------- 220 (318)
T 2dyl_A 149 RDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLV-------- 220 (318)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHH--------
T ss_pred CCCCHHHEEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHH--------
Confidence 4689999999 8899999998754 22334489999999998753 2356899999999999996
Q ss_pred HHHHHhcCCCchhh-------hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 743 YILLHTLPLYTCYT-------LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 743 ~~I~~~lG~p~~~~-------~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++. |.++-.. +........+..+ ....+++++.+||.+||..||.+||+++++|+.
T Consensus 221 -~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 221 -ELAT--GQFPYKNCKTDFEVLTKVLQEEPPLLP------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -HHHH--SSCTTTTCCSHHHHHHHHHHSCCCCCC------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -HHHh--CCCCCCCCCccHHHHHHHhccCCCCCC------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111 2211100 0000000000000 013578999999999999999999999999973
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.05 E-value=2.1e-11 Score=132.40 Aligned_cols=120 Identities=17% Similarity=0.074 Sum_probs=79.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC---------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchh
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI---------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK 740 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~---------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ 740 (962)
+-||.+||++ |.++|.|||++.. .......||+.|++||.+. + ..|+.++||||+||+++
T Consensus 148 ~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~~Di~slG~il~------ 219 (298)
T 3pls_A 148 RDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ-T-YRFTTKSDVWSFGVLLW------ 219 (298)
T ss_dssp SCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHT-T-CCCCHHHHHHHHHHHHH------
T ss_pred CCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhc-c-CCCChhhchhhHHHHHH------
Confidence 4689999999 8999999999853 2233347888888888774 3 45899999999999996
Q ss_pred HHHHHHHhcCCCchhhhccccccc-CCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 741 SSYILLHTLPLYTCYTLASNMNFK-FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 741 ql~~I~~~lG~p~~~~~~~~~~~~-~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. -|.|+........... .......+ ....+++++.+||.+||..||.+|||+.++++
T Consensus 220 ---~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 220 ---ELLT-RGAPPYRHIDPFDLTHFLAQGRRLP---QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp ---HHHH-TSCCTTTTSCGGGHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHhh-CCCCCCccCCHHHHHHHhhcCCCCC---CCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1111 1222211100000000 00000000 11357889999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=4.5e-12 Score=137.99 Aligned_cols=126 Identities=17% Similarity=0.084 Sum_probs=76.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ce----eeeccCCCcccccceeeecCC----CCCCCCCceeeeeEeecC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QT----TCLLAGTERLKSSYILLHTLP----LYTYHVPPIQTTCLLAGT 736 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~----~~~~~gt~~~~~~~~lLlg~~----~Y~~~vDIWSlGCIl~G~ 736 (962)
+-||++||++ +.++|.|||++.. .. ....+||+.|++||.+..+.. .|+.++||||+||+++
T Consensus 137 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~-- 214 (301)
T 3q4u_A 137 RDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLW-- 214 (301)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHH--
T ss_pred CCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHH--
Confidence 5689999999 8999999998742 11 122389999999988764422 3557999999999996
Q ss_pred CchhHHHHHHHhc---------CCCchhhhcccccc------cCCCcccCCcc-ccC-CCCCHHHHHHHHHhhccCCCCC
Q psy501 737 ERLKSSYILLHTL---------PLYTCYTLASNMNF------KFPQFRRVPFT-SII-PHASPDAIHLMESMLAYNPSKR 799 (962)
Q Consensus 737 ~~~~ql~~I~~~l---------G~p~~~~~~~~~~~------~~~~~~~~~l~-~~~-p~~s~~a~DLL~kmL~~dP~kR 799 (962)
.++... ..|........... .........+. ..+ ...++++.+||.+||..||.+|
T Consensus 215 -------el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 287 (301)
T 3q4u_A 215 -------EVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287 (301)
T ss_dssp -------HHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGS
T ss_pred -------HHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhC
Confidence 111110 11111000000000 00000000000 000 1244679999999999999999
Q ss_pred cchhhhhh
Q psy501 800 PTAQQSLS 807 (962)
Q Consensus 800 ~sa~~~L~ 807 (962)
||+.++++
T Consensus 288 ps~~~i~~ 295 (301)
T 3q4u_A 288 LTALRIKK 295 (301)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHHH
Confidence 99999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=1.2e-11 Score=134.39 Aligned_cols=122 Identities=11% Similarity=0.087 Sum_probs=81.2
Q ss_pred cccceeeEEE---EE-----EeeeeeecCCCc------------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeE
Q psy501 673 ERLKSSYILL---HT-----LPLYTYHVPPIQ------------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCL 732 (962)
Q Consensus 673 ~~~~~~~~~~---~~-----~~~~~~~~~~~~------------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCI 732 (962)
+-||++||++ |. ++|.|||++..- .....+||+.|++||.+. + ..|+.++||||+|||
T Consensus 130 ~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~Di~slG~i 207 (298)
T 1csn_A 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL-G-REQSRRDDLEALGHV 207 (298)
T ss_dssp CCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-T-CCCCHHHHHHHHHHH
T ss_pred CCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhc-C-CCCChHHHHHHHHHH
Confidence 4689999999 33 999999987531 123458999999999754 3 458999999999999
Q ss_pred eecCCchhHHHHHHHhcCCCchhhhccccc---c-cC-CCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 733 LAGTERLKSSYILLHTLPLYTCYTLASNMN---F-KF-PQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 733 l~G~~~~~ql~~I~~~lG~p~~~~~~~~~~---~-~~-~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
++ .++ .|.+|-........ + .. ......++....+.+++++.+||.+||..||.+||+++++++
T Consensus 208 l~---------el~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 208 FM---------YFL--RGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HH---------HHH--HSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HH---------HHH--cCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 96 111 22222110000000 0 00 000112233344578999999999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.05 E-value=1.1e-11 Score=134.29 Aligned_cols=122 Identities=11% Similarity=0.056 Sum_probs=81.3
Q ss_pred cccceeeEEE------EEEeeeeeecCCCc------------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee
Q psy501 673 ERLKSSYILL------HTLPLYTYHVPPIQ------------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 734 (962)
Q Consensus 673 ~~~~~~~~~~------~~~~~~~~~~~~~~------------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~ 734 (962)
+-||++||++ +.++|.|||++..- .....+||+.|++||.+. + ..|+.++||||+|||++
T Consensus 129 ~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~Di~slG~il~ 206 (296)
T 4hgt_A 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL-G-IEQSRRDDLESLGYVLM 206 (296)
T ss_dssp SCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHT-T-CCCCHHHHHHHHHHHHH
T ss_pred CCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhc-C-CCCCchhHHHHHHHHHH
Confidence 5689999998 67999999997541 122458999999988765 3 35899999999999996
Q ss_pred cCCchhHHHHHHHhcCCCchhhhccccccc-C----CCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNFK-F----PQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~-~----~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.+ +.|.+|-.......... . ......+.....+.+++++.+||.+||..||.+||+++++++
T Consensus 207 ---------~l--~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 207 ---------YF--NLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ---------HH--HHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ---------HH--hcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11 12332211100000000 0 000011222233567899999999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.04 E-value=2.7e-11 Score=132.16 Aligned_cols=120 Identities=19% Similarity=0.204 Sum_probs=79.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+.||.+||++ |.++|.|||++.. .......||+.|++||.+......++.++||||+||+++
T Consensus 133 ~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~-------- 204 (305)
T 2wtk_C 133 KDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLY-------- 204 (305)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHH--------
T ss_pred cCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHH--------
Confidence 4689999999 8999999999743 223344799999999877644445678999999999996
Q ss_pred HHHHHhcCCCchhh--hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 743 YILLHTLPLYTCYT--LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 743 ~~I~~~lG~p~~~~--~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++. |.++-.. ...... .... .... ..+.+++++.+||++||..||.+|||++++|+.
T Consensus 205 -~l~~--g~~p~~~~~~~~~~~-~i~~-~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 205 -NITT--GLYPFEGDNIYKLFE-NIGK-GSYA---IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -HHHH--SSCSCCCSSHHHHHH-HHHH-CCCC---CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -HHHh--CCCCCCCchHHHHHH-HHhc-CCCC---CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111 2211000 000000 0000 0000 113578899999999999999999999999963
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.04 E-value=2.5e-11 Score=135.76 Aligned_cols=122 Identities=11% Similarity=0.000 Sum_probs=80.3
Q ss_pred cccceeeEEE---E--EEeeeeeecCCC------------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeec
Q psy501 673 ERLKSSYILL---H--TLPLYTYHVPPI------------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 735 (962)
Q Consensus 673 ~~~~~~~~~~---~--~~~~~~~~~~~~------------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G 735 (962)
+-||++||++ + .++|.|||++.. ......+||+.|++||.+. + ..|+.++||||+|||++
T Consensus 175 ~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~Di~slG~il~- 251 (345)
T 2v62_A 175 GDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK-G-VALSRRSDVEILGYCML- 251 (345)
T ss_dssp SCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH-T-CCCCHHHHHHHHHHHHH-
T ss_pred CCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhc-C-CCCCchhhHHHHHHHHH-
Confidence 5689999999 4 899999999843 1113458999999998765 3 46999999999999996
Q ss_pred CCchhHHHHHHHhcCCCchhh-hcccc-----cccCCCcccCCccccCC--CCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 736 TERLKSSYILLHTLPLYTCYT-LASNM-----NFKFPQFRRVPFTSIIP--HASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 736 ~~~~~ql~~I~~~lG~p~~~~-~~~~~-----~~~~~~~~~~~l~~~~p--~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. |.++-.. ..... ........+..+....+ .+++++.+||.+||..||.+||+++++++
T Consensus 252 --------ell~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 252 --------RWLC--GKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp --------HHHH--SSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred --------HHHh--CCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 1111 3322110 00000 00000000111111222 67889999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.04 E-value=1.4e-11 Score=133.61 Aligned_cols=122 Identities=11% Similarity=0.041 Sum_probs=80.8
Q ss_pred cccceeeEEE------EEEeeeeeecCCCc------------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee
Q psy501 673 ERLKSSYILL------HTLPLYTYHVPPIQ------------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 734 (962)
Q Consensus 673 ~~~~~~~~~~------~~~~~~~~~~~~~~------------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~ 734 (962)
+-||+.||++ +.++|.|||++... .....+||+.|++||.+. + ..|+.++||||+|||++
T Consensus 129 ~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~Di~slG~il~ 206 (296)
T 3uzp_A 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL-G-IEQSRRDDLESLGYVLM 206 (296)
T ss_dssp SCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHT-T-CCCCHHHHHHHHHHHHH
T ss_pred CCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhc-C-CCCCcchhhHHHHHHHH
Confidence 4689999998 46999999997541 123458999999998865 3 34899999999999996
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcccccc----cCC-CcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNF----KFP-QFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~----~~~-~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ .|.++-......... ... .....+.....+.+++++.+||++||..||.+||++.++++
T Consensus 207 ---------~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 207 ---------YFN--LGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ---------HHH--HSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ---------HHH--hCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 121 233221110000000 000 00011122223567899999999999999999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.03 E-value=2.3e-11 Score=132.47 Aligned_cols=122 Identities=17% Similarity=0.134 Sum_probs=77.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeee---cCCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLH---TLPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLl---g~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
+.||..||++ +.++|.|||++.. ......+||+.|++||.+.. +...|+.++||||+|||++
T Consensus 141 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~------- 213 (302)
T 2j7t_A 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI------- 213 (302)
T ss_dssp CCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHH-------
T ss_pred CCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHH-------
Confidence 4689999999 8899999998532 22334579999999998752 3456899999999999997
Q ss_pred HHHHHHhcCCCchhhhccc---ccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 742 SYILLHTLPLYTCYTLASN---MNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 742 l~~I~~~lG~p~~~~~~~~---~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++ .|.++-...... ........+.... -+.+++++.+||.+||..||.+|||+.++|+.
T Consensus 214 --~l~--~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 214 --EMA--QIEPPHHELNPMRVLLKIAKSDPPTLLT---PSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp --HHH--HSSCTTTTSCHHHHHHHHHHSCCCCCSS---GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred --HHh--cCCCCCccCCHHHHHHHHhccCCcccCC---ccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111 122211100000 0000000000000 02468899999999999999999999999974
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.03 E-value=2.2e-11 Score=131.73 Aligned_cols=120 Identities=14% Similarity=0.157 Sum_probs=72.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+-||++||++ +.++|.|||++... ......||+.|++||.+.. ..|+.++||||+||+++
T Consensus 140 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~--------- 208 (281)
T 1mp8_A 140 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMW--------- 208 (281)
T ss_dssp SCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHH---------
T ss_pred ccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhccc--CCCCCccCchHHHHHHH---------
Confidence 4689999999 78999999987652 1222367778988887753 45899999999999996
Q ss_pred HHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 744 ILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.++-......... ........+ ..+.+++++.+||.+||..||.+|||+.++++
T Consensus 209 ell-~~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 209 EIL-MHGVKPFQGVKNNDVIGRIENGERLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp HHH-TTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHH-hcCCCCCCcCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111 1133321110000000 000000011 12467899999999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.03 E-value=2e-11 Score=141.42 Aligned_cols=123 Identities=17% Similarity=0.193 Sum_probs=77.5
Q ss_pred cccceeeEEEE----------------EEeeeeeecCCCc---------eeeeccCCCcccccceeeec-----CCCCCC
Q psy501 673 ERLKSSYILLH----------------TLPLYTYHVPPIQ---------TTCLLAGTERLKSSYILLHT-----LPLYTY 722 (962)
Q Consensus 673 ~~~~~~~~~~~----------------~~~~~~~~~~~~~---------~~~~~~gt~~~~~~~~lLlg-----~~~Y~~ 722 (962)
+.||++||++. .++|.|||++... .....+||+.|++||++..+ ...|+.
T Consensus 139 rDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 218 (434)
T 2rio_A 139 RDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTR 218 (434)
T ss_dssp CCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCT
T ss_pred cCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcch
Confidence 56899999993 7999999987541 12345899999999988642 356999
Q ss_pred CCCceeeeeEeecCCchhHHHHHHHhcCCCchhh-hcc-----cccccCCCcccCCccccCCCCCHHHHHHHHHhhccCC
Q psy501 723 HVPPIQTTCLLAGTERLKSSYILLHTLPLYTCYT-LAS-----NMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNP 796 (962)
Q Consensus 723 ~vDIWSlGCIl~G~~~~~ql~~I~~~lG~p~~~~-~~~-----~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP 796 (962)
++||||+|||++ .++. .|.++-.. ... ......+..+. +. -+.+++++.|||.+||+.||
T Consensus 219 ~~DiwSlG~il~---------ellt-~g~~Pf~~~~~~~~~i~~~~~~~~~~~~--~~--~~~~~~~~~~li~~~L~~dP 284 (434)
T 2rio_A 219 SIDIFSMGCVFY---------YILS-KGKHPFGDKYSRESNIIRGIFSLDEMKC--LH--DRSLIAEATDLISQMIDHDP 284 (434)
T ss_dssp HHHHHHHHHHHH---------HHHT-TSCCTTCSTTTHHHHHHHTCCCCCCCTT--CC--CHHHHHHHHHHHHHHTCSSG
T ss_pred hhhhHhHHHHHH---------HHHh-CCCCCCCCchhhHHHHhcCCCCcccccc--cc--cccchHHHHHHHHHHhhCCh
Confidence 999999999996 1111 13322110 000 00000111100 00 01346789999999999999
Q ss_pred CCCcchhhhhhhh
Q psy501 797 SKRPTAQQSLSIK 809 (962)
Q Consensus 797 ~kR~sa~~~L~~~ 809 (962)
.+|||+.++|++.
T Consensus 285 ~~Rps~~eil~hp 297 (434)
T 2rio_A 285 LKRPTAMKVLRHP 297 (434)
T ss_dssp GGSCCHHHHHTSG
T ss_pred hhCCCHHHHHhCC
Confidence 9999999999743
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.03 E-value=2.2e-11 Score=136.29 Aligned_cols=120 Identities=14% Similarity=0.120 Sum_probs=79.6
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||.+||++ +.++|.|||++.. .......||+.|++||.+. + ..|+.++||||+|||++
T Consensus 217 ~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~-~~~~~~~Di~slG~il~-------- 286 (359)
T 3vhe_A 217 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-D-RVYTIQSDVWSFGVLLW-------- 286 (359)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHH-H-CCCCHHHHHHHHHHHHH--------
T ss_pred CCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhc-C-CCCCchhhhhhHHHHHH--------
Confidence 5689999999 8899999998753 1233347888899988776 3 45999999999999996
Q ss_pred HHHHHh--cCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHT--LPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~--lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.+ +|.++-......... ...............+++++.+||.+||..||.+|||+.++++
T Consensus 287 ----ellt~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 348 (359)
T 3vhe_A 287 ----EIFSLGASPYPGVKIDEEF-CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 348 (359)
T ss_dssp ----HHTTTSCCSSTTCCCSHHH-HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----HHHhcCCCCCCccchhHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 22 244332110000000 0000000000011357889999999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.03 E-value=1.3e-11 Score=135.33 Aligned_cols=120 Identities=14% Similarity=0.176 Sum_probs=80.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-------------------eeeeccCCCcccccceeeecCCCCCCCCCceeee
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-------------------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTT 730 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-------------------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlG 730 (962)
+-||.+||++ +.++|.|||++... ...+.+||+.|++||.+. + ..|+.++||||+|
T Consensus 132 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~Di~slG 209 (310)
T 3s95_A 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN-G-RSYDEKVDVFSFG 209 (310)
T ss_dssp SCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHT-T-CCCCTHHHHHHHH
T ss_pred CCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhc-C-CCCCcHHHHHHHH
Confidence 4589999999 78999999997531 112458999999999765 3 5699999999999
Q ss_pred eEeecCCchhHHHHHHHhcCCCc-hhhhcccccccCCCcccCCccc-cCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 731 CLLAGTERLKSSYILLHTLPLYT-CYTLASNMNFKFPQFRRVPFTS-IIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 731 CIl~G~~~~~ql~~I~~~lG~p~-~~~~~~~~~~~~~~~~~~~l~~-~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
|+++ .++. |.++ ............ .....+.. .-+.+++++.+||.+||..||.+|||+.++++
T Consensus 210 ~~l~---------el~~--g~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 210 IVLC---------EIIG--RVNADPDYLPRTMDFGL--NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHH---------HHHH--TCCSSTTTSCBCTTSSB--CHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHH---------HHhc--CCCCCcchhhhHHHHhh--hhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9996 2222 2222 111111111000 00000001 12467889999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.02 E-value=1.9e-11 Score=131.01 Aligned_cols=118 Identities=19% Similarity=0.207 Sum_probs=74.0
Q ss_pred cccceeeEEEE-----------EEeeeeeecCCC---ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCc
Q psy501 673 ERLKSSYILLH-----------TLPLYTYHVPPI---QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTER 738 (962)
Q Consensus 673 ~~~~~~~~~~~-----------~~~~~~~~~~~~---~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~ 738 (962)
+-||+.||++. .++|.|||.+.. ......+||+.|++||.+. + ..|+.++||||+||+++
T Consensus 132 ~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~~Di~slG~~l~---- 205 (271)
T 3dtc_A 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIR-A-SMFSKGSDVWSYGVLLW---- 205 (271)
T ss_dssp SCCSGGGEEESSCCSSSCCSSCCEEECCCCC-------------CCGGGSCHHHHH-H-CCCSHHHHHHHHHHHHH----
T ss_pred cCCchHHEEEecccccccccCcceEEccCCcccccccccccCCCCccceeCHHHhc-c-CCCCchhhHHHHHHHHH----
Confidence 56899999984 499999999864 2333458999999988765 3 45899999999999996
Q ss_pred hhHHHHHHHhcCCCchhhhccc---ccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 739 LKSSYILLHTLPLYTCYTLASN---MNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 739 ~~ql~~I~~~lG~p~~~~~~~~---~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. |.++-...... ........ ..+ ....+++++.+||.+||..||.+|||+.++++
T Consensus 206 -----~l~~--g~~p~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 266 (271)
T 3dtc_A 206 -----ELLT--GEVPFRGIDGLAVAYGVAMNKL-ALP---IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILD 266 (271)
T ss_dssp -----HHHH--CCCTTTTSCHHHHHHHHHTSCC-CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----HHHh--CCCCCCCCCHHHHHHhhhcCCC-CCC---CCcccCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1111 32221100000 00000000 001 11357889999999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.02 E-value=2.4e-11 Score=134.06 Aligned_cols=120 Identities=13% Similarity=0.066 Sum_probs=75.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||.+||++ |.++|.|||++.. ...+...||+.|++||.+.- ..|+.++||||+|||++
T Consensus 161 ~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~-------- 230 (323)
T 3qup_A 161 RDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMW-------- 230 (323)
T ss_dssp SCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHH--------
T ss_pred CCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcC--CCCCCccchhhHHHHHH--------
Confidence 5689999999 7999999999854 12233367778888887653 45999999999999996
Q ss_pred HHHHHhc-CCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTL-PLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~l-G~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.+ +. |.++-.......... ...........+.+++++.+||.+||..||.+|||+.++++
T Consensus 231 -el--l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 291 (323)
T 3qup_A 231 -EI--MTRGQTPYAGIENAEIYN--YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRM 291 (323)
T ss_dssp -HH--HTTSCCTTTTCCGGGHHH--HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred -HH--HhCCCCCccccChHHHHH--HHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11 12 333321110000000 00000000112467899999999999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.02 E-value=4.3e-11 Score=142.44 Aligned_cols=119 Identities=18% Similarity=0.167 Sum_probs=78.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
|-||..||++ |.++|.|||++.. ..+.+.+||+.|++||++. + ..|+.++||||+|||+| .
T Consensus 313 rDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~-~-~~~~~~~DiwSlGvily---------e 381 (543)
T 3c4z_A 313 RDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL-G-EEYDFSVDYFALGVTLY---------E 381 (543)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHT-T-CCBCTHHHHHHHHHHHH---------H
T ss_pred cCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhc-C-CCCChHHhcCcchHHHH---------H
Confidence 5679999999 8999999999753 2233459999999999875 3 46999999999999997 1
Q ss_pred HHHhcCCCchhhhccccc---c-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcch-----hhhhh
Q psy501 745 LLHTLPLYTCYTLASNMN---F-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTA-----QQSLS 807 (962)
Q Consensus 745 I~~~lG~p~~~~~~~~~~---~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa-----~~~L~ 807 (962)
++ .|.+|-........ . .........+ -+.+++++.|||++||+.||.+||++ +++++
T Consensus 382 ll--tG~~PF~~~~~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 382 MI--AARGPFRARGEKVENKELKQRVLEQAVTY---PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HH--HSSCSSCCTTCCCCHHHHHHHHHHCCCCC---CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred HH--hCCCCCCCCccchhHHHHHHHHhhcccCC---CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 21 13322100000000 0 0000000011 13679999999999999999999964 56665
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.02 E-value=2.7e-11 Score=133.68 Aligned_cols=119 Identities=16% Similarity=0.106 Sum_probs=66.5
Q ss_pred cccceeeEEE---EEEeeeeeecCCCce-----------------eeeccCCCcccccceeee-cCCCCCCCCCceeeee
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQT-----------------TCLLAGTERLKSSYILLH-TLPLYTYHVPPIQTTC 731 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~-----------------~~~~~gt~~~~~~~~lLl-g~~~Y~~~vDIWSlGC 731 (962)
+-||..||++ +.++|.|||++..-. ....+||+.|++||.+.. ....|+.++||||+||
T Consensus 162 ~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~ 241 (337)
T 3ll6_A 162 RDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGC 241 (337)
T ss_dssp CCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHH
T ss_pred ccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHH
Confidence 5689999999 889999999975411 114479999999998842 3456899999999999
Q ss_pred EeecCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 732 LLAGTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 732 Il~G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
|++ .++ .|.++-......... ..... .+ .....++++.+||.+||+.||.+||++.++++
T Consensus 242 il~---------el~--~g~~p~~~~~~~~~~-~~~~~-~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 301 (337)
T 3ll6_A 242 ILY---------LLC--FRQHPFEDGAKLRIV-NGKYS-IP---PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVH 301 (337)
T ss_dssp HHH---------HHH--HSSCCC-------------CC-CC---TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHH---------HHH--hCCCCCcchhHHHhh-cCccc-CC---cccccchHHHHHHHHHccCChhhCcCHHHHHH
Confidence 996 121 233221110000000 00000 00 01345678999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.02 E-value=1.4e-11 Score=133.41 Aligned_cols=120 Identities=13% Similarity=0.095 Sum_probs=79.0
Q ss_pred cccceeeEEE---EE--------EeeeeeecCCC-ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchh
Q psy501 673 ERLKSSYILL---HT--------LPLYTYHVPPI-QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK 740 (962)
Q Consensus 673 ~~~~~~~~~~---~~--------~~~~~~~~~~~-~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ 740 (962)
+-||+.||++ +. ++|.|||++.. .......||+.|++||.+. +...|+.++||||+||+++
T Consensus 137 ~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~------ 209 (289)
T 4fvq_A 137 GNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIE-NPKNLNLATDKWSFGTTLW------ 209 (289)
T ss_dssp CCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCHHHHHHTTTTSCHHHHH-CGGGCCHHHHHHHHHHHHH------
T ss_pred CCcCcceEEEecCCcccccccceeeeccCcccccccCccccCCcCcccCHHHhC-CCCCCCchhHHHHHHHHHH------
Confidence 4679999999 33 99999999865 3334457899999888776 4356999999999999996
Q ss_pred HHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 741 SSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 741 ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. -|.|+.............. .... ..+..++++.+||.+||..||.+|||+.++++
T Consensus 210 ---el~~-g~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 268 (289)
T 4fvq_A 210 ---EICS-GGDKPLSALDSQRKLQFYE-DRHQ---LPAPKAAELANLINNCMDYEPDHRPSFRAIIR 268 (289)
T ss_dssp ---HHHT-TTCCTTTTSCHHHHHHHHH-TTCC---CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---HHHc-CCCCCccccchHHHHHHhh-ccCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1111 0222211100000000000 0000 11245778999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.02 E-value=1.8e-11 Score=135.33 Aligned_cols=115 Identities=18% Similarity=0.113 Sum_probs=80.3
Q ss_pred cccceeeEEE----EEEeeeeeecCCC---ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHH
Q psy501 673 ERLKSSYILL----HTLPLYTYHVPPI---QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 745 (962)
Q Consensus 673 ~~~~~~~~~~----~~~~~~~~~~~~~---~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I 745 (962)
+-||..||++ +.++|.|||++.. ......+||+.|++||.+. +...++.++||||+|||++ .+
T Consensus 173 ~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~Di~slG~il~---------el 242 (320)
T 3a99_A 173 RDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR-YHRYHGRSAAVWSLGILLY---------DM 242 (320)
T ss_dssp CCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHH-HSCBCHHHHHHHHHHHHHH---------HH
T ss_pred CCCCHHHEEEeCCCCCEEEeeCccccccccccccCCCCCccCCChHHhc-cCCCCCccchHHhHHHHHH---------HH
Confidence 4689999999 5899999998754 2333457999999998775 4455678999999999996 12
Q ss_pred HHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 746 LHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 746 ~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+. |.++-......... . ..+ -+.+++++.+||++||..||.+|||++++|+.
T Consensus 243 ~~--g~~pf~~~~~~~~~-~-----~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 243 VC--GDIPFEHDEEIIRG-Q-----VFF---RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HH--SSCSCCSHHHHHHC-C-----CCC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HH--CCCCCCChhhhhcc-c-----ccc---cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 21 33221100000000 0 001 13578999999999999999999999999974
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.01 E-value=3.1e-11 Score=129.62 Aligned_cols=120 Identities=16% Similarity=0.138 Sum_probs=79.5
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+.||..||++ |.++|.|||.+..- .....+||+.|++||.+. +...++.++||||+||+++
T Consensus 129 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~-------- 199 (276)
T 2yex_A 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLT-------- 199 (276)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGT-CSSBCHHHHHHHHHHHHHH--------
T ss_pred cCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHh-cCCCCCCcchHHHHHHHHH--------
Confidence 4689999999 88999999987531 123458999999888765 4344578999999999996
Q ss_pred HHHHHhcCCCchhhhcc----cccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 743 YILLHTLPLYTCYTLAS----NMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~----~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++. |.++-..... ...+........+ .+.+++++.+||++||..||.+|||++++|+.
T Consensus 200 -~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 200 -AMLA--GELPWDQPSDSCQEYSDWKEKKTYLNP----WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -HHHH--SSCCCSCSCTTSHHHHHHHTTCTTSTT----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -HHHh--CCCCCCCCchHHHHHHHhhhcccccCc----hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 1111 2222110000 0000000000001 13578999999999999999999999999974
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.01 E-value=1.3e-11 Score=133.96 Aligned_cols=123 Identities=18% Similarity=0.168 Sum_probs=81.6
Q ss_pred cccceeeEEE----EEEeeeeeecCCCc-----eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL----HTLPLYTYHVPPIQ-----TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~----~~~~~~~~~~~~~~-----~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+.||.+||++ +.++|.|||++... .....+||+.|++||++..+...|+.++||||+||+++
T Consensus 146 ~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~--------- 216 (295)
T 2clq_A 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTII--------- 216 (295)
T ss_dssp CCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHH---------
T ss_pred cCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHH---------
Confidence 4689999999 57999999987541 12345899999999998766556899999999999996
Q ss_pred HHHHhcCCCchhhhcccc--cccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 744 ILLHTLPLYTCYTLASNM--NFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~~~~--~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++. |.++-....... ....... .....+.+.+++++.+||.+||..||.+||++.++|..
T Consensus 217 ~l~~--g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 217 EMAT--GKPPFYELGEPQAAMFKVGMF--KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHH--TSCTTGGGSSHHHHHHHHHHH--CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHHH--CCCCccCCCchhHHHHhhccc--cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111 332211000000 0000000 00001113578999999999999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.01 E-value=1.6e-11 Score=133.55 Aligned_cols=130 Identities=9% Similarity=0.015 Sum_probs=77.5
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc--------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cCC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ--------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GTE 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~--------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~~ 737 (962)
+-||+.||++ +.++|.|||++... ......||+.|++||.+. + ..|+.++||||+||+++ |..
T Consensus 138 ~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~~Di~slG~~l~~l~~g~~ 215 (295)
T 3ugc_A 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT-E-SKFSVASDVWSFGVVLYELFTYIE 215 (295)
T ss_dssp SCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHH-H-CCCCHHHHHHHHHHHHHHHHHTTC
T ss_pred CCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhc-C-CCCChHHHHHHHHHHHHHHHhccc
Confidence 5689999999 78999999998652 112225667788887665 4 35899999999999997 211
Q ss_pred ch-hHHHHHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 738 RL-KSSYILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 738 ~~-~ql~~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.. .........++..+.......... ........+ ..+.+++++.+||.+||..||.+|||+.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 216 KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp TTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 10 011111112222111000000000 000000001 11357899999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.01 E-value=4.3e-11 Score=134.11 Aligned_cols=120 Identities=10% Similarity=-0.008 Sum_probs=78.6
Q ss_pred cccceeeEEE---E--EEeeeeeecCCCc------------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeec
Q psy501 673 ERLKSSYILL---H--TLPLYTYHVPPIQ------------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 735 (962)
Q Consensus 673 ~~~~~~~~~~---~--~~~~~~~~~~~~~------------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G 735 (962)
+-||++||++ + .++|.|||++..- .....+||+.|++||.+. + ..|+.++||||+|||++
T Consensus 183 ~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~Di~slG~il~- 259 (352)
T 2jii_A 183 GNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK-G-CGPSRRSDLQSLGYCML- 259 (352)
T ss_dssp SCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT-T-CCCCHHHHHHHHHHHHH-
T ss_pred CCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc-c-CCCCchhhHHHHHHHHH-
Confidence 5689999999 5 8999999998431 113348999999998765 3 45999999999999997
Q ss_pred CCchhHHHHHHHhcCCCchhhhc-------cc-ccc--cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhh
Q psy501 736 TERLKSSYILLHTLPLYTCYTLA-------SN-MNF--KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQS 805 (962)
Q Consensus 736 ~~~~~ql~~I~~~lG~p~~~~~~-------~~-~~~--~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~ 805 (962)
.++ .|.++-.... .. ..+ ..+...... .....+++++.+||.+||..||.+||+++++
T Consensus 260 --------el~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 327 (352)
T 2jii_A 260 --------KWL--YGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPC--GHWIRPSETLQKYLKVVMALTYEEKPPYAML 327 (352)
T ss_dssp --------HHH--HSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTT--SCEECCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred --------HHH--hCCCCcccCCcCHHHHHHHHHhccCChhhhhhhc--cccCCCcHHHHHHHHHHHhCChhhCCCHHHH
Confidence 111 1221111000 00 000 000000000 0012568999999999999999999999999
Q ss_pred hh
Q psy501 806 LS 807 (962)
Q Consensus 806 L~ 807 (962)
++
T Consensus 328 ~~ 329 (352)
T 2jii_A 328 RN 329 (352)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=3.9e-11 Score=131.82 Aligned_cols=122 Identities=12% Similarity=0.134 Sum_probs=76.4
Q ss_pred cccceeeEEE--EEEeeeeeecCCCce-------eeeccCCCcccccceeee---------cCCCCCCCCCceeeeeEee
Q psy501 673 ERLKSSYILL--HTLPLYTYHVPPIQT-------TCLLAGTERLKSSYILLH---------TLPLYTYHVPPIQTTCLLA 734 (962)
Q Consensus 673 ~~~~~~~~~~--~~~~~~~~~~~~~~~-------~~~~~gt~~~~~~~~lLl---------g~~~Y~~~vDIWSlGCIl~ 734 (962)
+-||+.||++ +.++|.|||++.... ....+||+.|++||.+.. ....|+.++||||+||+++
T Consensus 151 ~dlkp~NIl~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~ 230 (313)
T 3cek_A 151 SDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230 (313)
T ss_dssp CCCCGGGEEEETTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHH
T ss_pred cCCCcccEEEECCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHH
Confidence 4689999999 889999999986521 123479999999998753 1246899999999999997
Q ss_pred cCCchhHHHHHHHhcCCCchhhhccc-ccc--cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASN-MNF--KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~-~~~--~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++ .|.++-...... ... .........+ ....++++.+||.+||..||.+||++.++|+.
T Consensus 231 ---------el~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 231 ---------YMT--YGKTPFQQIINQISKLHAIIDPNHEIEF---PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ---------HHH--HSSCTTTTCCSHHHHHHHHHCTTSCCCC---CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------HHH--hCCCchhhHHHHHHHHHHHHhcccccCC---cccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111 122211100000 000 0000000011 12457889999999999999999999999973
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=1.5e-11 Score=135.92 Aligned_cols=122 Identities=15% Similarity=0.117 Sum_probs=78.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCC------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+-||+.||++ +.++|.|||++.. ......+||+.|++||.+.. ..|+.++||||+|||++
T Consensus 158 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~--------- 226 (326)
T 3uim_A 158 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLL--------- 226 (326)
T ss_dssp CCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHHH---------
T ss_pred CCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhcc--CCCCccccchhHHHHHH---------
Confidence 4689999999 7999999999753 22333479999999997754 34899999999999996
Q ss_pred HHHHhcCCCchhh--hccc-------------ccccCCCcccCCccc-cCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 744 ILLHTLPLYTCYT--LASN-------------MNFKFPQFRRVPFTS-IIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 744 ~I~~~lG~p~~~~--~~~~-------------~~~~~~~~~~~~l~~-~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ .|.++-.. .... ............+.. ..+..++++.+|+.+||..||.+|||+.++++
T Consensus 227 ~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 304 (326)
T 3uim_A 227 ELI--TGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304 (326)
T ss_dssp HHH--HCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred HHH--hCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHH
Confidence 111 13222110 0000 000000000000100 00123467899999999999999999999996
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.01 E-value=5.7e-10 Score=126.60 Aligned_cols=134 Identities=9% Similarity=0.059 Sum_probs=87.8
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc-----------------hh--------HHHHHHHHHHHHhcCCCCcc
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----------------RD--------EMVVCFYRKSLKKLSHANLV 367 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----------------~~--------~~~~~~Ei~iL~~L~HpnIv 367 (962)
+.++..++.|+.+.||.+.......++.+.... .. .....+|...|.++.+..+.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 455556666666778888765544433331100 00 01235677888888655443
Q ss_pred cEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc------
Q psy501 368 KLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE------ 441 (962)
Q Consensus 368 ~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g------ 441 (962)
-..-+.... .+|||||++|..+..+. .......++.||+.+|.+||+.|||||||||.|||++++|
T Consensus 177 vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~ 248 (397)
T 4gyi_A 177 VPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPS 248 (397)
T ss_dssp CCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTT
T ss_pred CCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccccc
Confidence 222222222 37999999975443221 2234567889999999999999999999999999998877
Q ss_pred ----ceeeecccccccc
Q psy501 442 ----LVKIADFGLAREI 454 (962)
Q Consensus 442 ----~vKL~DFGla~~~ 454 (962)
.+.|+||+-+...
T Consensus 249 ~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 249 SITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SEEEEEEECCCTTCEET
T ss_pred ccccceEEEEeCCcccC
Confidence 3889999988654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.00 E-value=3.2e-11 Score=129.88 Aligned_cols=115 Identities=20% Similarity=0.196 Sum_probs=78.9
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 745 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I 745 (962)
+.||..||++ +.++|.|||++.. ......+||+.|++||.+.. ..|+.++||||+||+++ .+
T Consensus 146 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~---------~l 214 (284)
T 2a19_B 146 RDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS--QDYGKEVDLYALGLILA---------EL 214 (284)
T ss_dssp SCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHHH---------HH
T ss_pred ccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhcc--CCCcchhhhHHHHHHHH---------HH
Confidence 4689999999 7899999998654 22334579999999997753 45899999999999996 11
Q ss_pred HHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 746 LHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 746 ~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
+ .|.++......... ......+ -+.+++++.+||.+||..||.+||++.++++
T Consensus 215 ~--~~~~~~~~~~~~~~----~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 267 (284)
T 2a19_B 215 L--HVCDTAFETSKFFT----DLRDGII---SDIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267 (284)
T ss_dssp H--SCCSSHHHHHHHHH----HHHTTCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H--hcCCcchhHHHHHH----Hhhcccc---cccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1 12222111000000 0000001 1346889999999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=3.1e-11 Score=131.29 Aligned_cols=125 Identities=16% Similarity=0.181 Sum_probs=78.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCch
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERL 739 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~ 739 (962)
+.||+.||++ |.++|.|||.+.. ......+||+.|++||.+..+ ..|+.++||||+|||++
T Consensus 145 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~----- 218 (303)
T 2vwi_A 145 RDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAI----- 218 (303)
T ss_dssp CCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHH-----
T ss_pred CCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHH-----
Confidence 4579999999 8999999997532 112334799999999877543 45899999999999997
Q ss_pred hHHHHHHHhcCCCchhhhcc------cccccCCCc-ccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 740 KSSYILLHTLPLYTCYTLAS------NMNFKFPQF-RRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 740 ~ql~~I~~~lG~p~~~~~~~------~~~~~~~~~-~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
.++. |.++-..... ......+.. .........+.+++++.+||.+||..||.+||++.++|+..
T Consensus 219 ----~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 219 ----ELAT--GAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp ----HHHH--SSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred ----HHHh--CCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 1111 2221110000 000000000 00111223356889999999999999999999999999743
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.00 E-value=2.6e-11 Score=137.11 Aligned_cols=121 Identities=10% Similarity=0.068 Sum_probs=78.8
Q ss_pred cccceeeEEEE------EEeeeeeecCCC-------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCch
Q psy501 673 ERLKSSYILLH------TLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERL 739 (962)
Q Consensus 673 ~~~~~~~~~~~------~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~ 739 (962)
+-||..||++. .++|+|||++.. ......+||+.|++||.+.. ..|+.++||||+|||++
T Consensus 205 rDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~----- 277 (367)
T 3l9p_A 205 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLW----- 277 (367)
T ss_dssp SCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHH-----
T ss_pred CCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC--CCCCcHHHHHHHHHHHH-----
Confidence 56899999993 499999998742 22233478889999887764 35999999999999996
Q ss_pred hHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 740 KSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 740 ~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.++-........... ............+++++.+||.+||..||.+||++.++++
T Consensus 278 ----ell-t~g~~pf~~~~~~~~~~~--i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~ 338 (367)
T 3l9p_A 278 ----EIF-SLGYMPYPSKSNQEVLEF--VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 338 (367)
T ss_dssp ----HHH-TTSCCSSTTCCHHHHHHH--HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----HHH-hCCCCCCCCCCHHHHHHH--HHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 111 124332111000000000 0000000011357889999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.00 E-value=3.2e-11 Score=133.98 Aligned_cols=120 Identities=12% Similarity=0.104 Sum_probs=76.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||.+||++ +.++|.|||++... ......||+.|++||.+. + ..|+.++||||+|||++
T Consensus 141 ~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~-~~~~~~~Di~slG~il~-------- 210 (327)
T 3lzb_A 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL-H-RIYTHQSDVWSYGVTVW-------- 210 (327)
T ss_dssp SCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHH-H-CCCCHHHHHHHHHHHHH--------
T ss_pred CCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHc-C-CCCChHHHHHHHHHHHH--------
Confidence 5689999999 78999999998541 122236677898888776 3 45999999999999996
Q ss_pred HHHHHhcCCCchhhhccccccc-CCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNFK-FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~~-~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.++-.......... .......+ ..+.+++++.+||.+||..||.+||++.++++
T Consensus 211 -ell-~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 211 -ELM-TFGSKPYDGIPASEISSILEKGERLP---QPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp -HHH-TTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHH-HCCCCCCCCCCHHHHHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111 11443321110000000 00000000 11357889999999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.00 E-value=4.9e-11 Score=130.82 Aligned_cols=122 Identities=16% Similarity=0.079 Sum_probs=79.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
+.||..||++ |.++|.|||++.. ......+||+.|++||.+.. ..|+.++||||+|||++ .
T Consensus 149 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~---------~ 217 (314)
T 3com_A 149 RDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLGITAI---------E 217 (314)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSS--SCBCTTHHHHHHHHHHH---------H
T ss_pred CCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCC--CCCCccccHHHHHHHHH---------H
Confidence 4679999999 8999999998743 12234479999999887653 35899999999999997 1
Q ss_pred HHHhcCCCchhhhcccc-cccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 745 LLHTLPLYTCYTLASNM-NFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 745 I~~~lG~p~~~~~~~~~-~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
++ .|.++-....... ...........+. ..+.+++++.+||.+||..||.+|||+.++|+.
T Consensus 218 l~--~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 218 MA--EGKPPYADIHPMRAIFMIPTNPPPTFR-KPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HH--HSSCTTTTSCHHHHHHHHHHSCCCCCS-SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HH--hCCCCCCCCChHHHHHHHhcCCCcccC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11 1222111000000 0000000000000 012468899999999999999999999999974
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.00 E-value=3.5e-11 Score=136.63 Aligned_cols=121 Identities=15% Similarity=0.107 Sum_probs=79.5
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||.+||++ +.++|.|||++... ......||+.|++||.+. + ..|+.++||||+|||++
T Consensus 215 ~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~-~~~~~~~DiwslG~il~-------- 284 (382)
T 3tt0_A 215 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-D-RIYTHQSDVWSFGVLLW-------- 284 (382)
T ss_dssp SCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH-S-CCCCHHHHHHHHHHHHH--------
T ss_pred CCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhc-C-CCCCchhHHHHHHHHHH--------
Confidence 5689999999 89999999998641 222336778898888775 4 46999999999999996
Q ss_pred HHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.++-.......... .............+++++.+||.+||..||.+|||+.++++
T Consensus 285 -ellt-~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 345 (382)
T 3tt0_A 285 -EIFT-LGGSPYPGVPVEELFK--LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345 (382)
T ss_dssp -HHHT-TSCCSSTTCCHHHHHH--HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHh-CCCCCCCCCCHHHHHH--HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 1332211000000000 00000000011357899999999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.00 E-value=3.1e-11 Score=130.18 Aligned_cols=118 Identities=19% Similarity=0.183 Sum_probs=77.5
Q ss_pred cccceeeEEE---E----EEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL---H----TLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~---~----~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
+.||+.||++ + .++|.|||.+.. ......+||+.|++||.+.. ..|+.++||||+|||++
T Consensus 132 ~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~------- 202 (283)
T 3bhy_A 132 FDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITY------- 202 (283)
T ss_dssp SCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHH-------
T ss_pred CCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecC--CCCCcchhhhhHHHHHH-------
Confidence 4679999999 3 699999998754 22234479999999987643 45899999999999996
Q ss_pred HHHHHHhcCCCchhh------hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 742 SYILLHTLPLYTCYT------LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 742 l~~I~~~lG~p~~~~------~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++. |.++-.. ......... .. .....+.+++++.+||++||..||.+||++.++|+.
T Consensus 203 --~l~~--g~~p~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 203 --ILLS--GASPFLGETKQETLTNISAVNY-DF----DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp --HHHH--SSCTTCCSSHHHHHHHHHTTCC-CC----CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred --HHHH--CCCCCCCcchHHHHHHhHhccc-CC----cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 1111 2211000 000000000 00 011225678999999999999999999999999973
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.00 E-value=1.6e-11 Score=140.33 Aligned_cols=132 Identities=10% Similarity=0.047 Sum_probs=82.5
Q ss_pred cccceeeEEE-------EEEeeeeeecCCC----ceeeeccCCCcccccceeeec------CCCCCCCCCceeeeeEee-
Q psy501 673 ERLKSSYILL-------HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHT------LPLYTYHVPPIQTTCLLA- 734 (962)
Q Consensus 673 ~~~~~~~~~~-------~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg------~~~Y~~~vDIWSlGCIl~- 734 (962)
+-||..||++ +.++|.|||++.. ....+.+||+.|++||.+... ...|+.++||||+||+++
T Consensus 136 ~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~e 215 (396)
T 4eut_A 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYH 215 (396)
T ss_dssp CCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHH
T ss_pred CCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHH
Confidence 5689999987 6699999999854 333455899999999987531 145889999999999998
Q ss_pred ---cCCc-------hhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccC-------CCCCHHHHHHHHHhhccCCC
Q psy501 735 ---GTER-------LKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSII-------PHASPDAIHLMESMLAYNPS 797 (962)
Q Consensus 735 ---G~~~-------~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~-------p~~s~~a~DLL~kmL~~dP~ 797 (962)
|... ......+..+++..+...+....... .....|...+ ..+++.+.+||.+||.+||.
T Consensus 216 l~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~ 292 (396)
T 4eut_A 216 AATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAE---NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292 (396)
T ss_dssp HHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECST---TCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTT
T ss_pred HHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheecc---CCCcccCccCCcccccchHHHhhchHHHHHhhccChh
Confidence 3211 11222233333222222111111000 0001111111 12445788999999999999
Q ss_pred CCcchhhhhh
Q psy501 798 KRPTAQQSLS 807 (962)
Q Consensus 798 kR~sa~~~L~ 807 (962)
+|++++++++
T Consensus 293 ~R~s~~e~l~ 302 (396)
T 4eut_A 293 KCWGFDQFFA 302 (396)
T ss_dssp TSCCHHHHHH
T ss_pred hhccHHHHHH
Confidence 9999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.99 E-value=2.7e-11 Score=134.46 Aligned_cols=120 Identities=12% Similarity=0.062 Sum_probs=77.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc--------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ--------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~--------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
+-||..||++ +.++|.|||++... ......||+.|++||.+.. ..|+.++||||+|||++
T Consensus 175 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~------- 245 (325)
T 3kul_A 175 RDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMW------- 245 (325)
T ss_dssp SCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHH--CEECHHHHHHHHHHHHH-------
T ss_pred CCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcC--CCCCcHHHHHHHHHHHH-------
Confidence 4689999999 89999999997541 1222256778998887753 35899999999999996
Q ss_pred HHHHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 742 SYILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 742 l~~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.++-......... ........+ ....+++++.+||.+||..||.+|||+.++++
T Consensus 246 --ell-~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 246 --EVL-AYGERPYWNMTNRDVISSVEEGYRLP---APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp --HHH-TTSCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHH-cCCCCCcccCCHHHHHHHHHcCCCCC---CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111 1133331110000000 000000000 11357889999999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=98.99 E-value=3.8e-11 Score=136.00 Aligned_cols=121 Identities=14% Similarity=0.103 Sum_probs=79.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||..||++ |.+||.|||++..- ......||+.|++||++. + ..|+.++||||+|||++
T Consensus 227 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~-~~~~~~~DvwslG~il~-------- 296 (370)
T 2psq_A 227 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-D-RVYTHQSDVWSFGVLMW-------- 296 (370)
T ss_dssp SCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH-T-CCCCHHHHHHHHHHHHH--------
T ss_pred cccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhc-C-CCCCcHHHHHHHHHHHH--------
Confidence 6789999999 89999999987531 122236778899888775 3 45999999999999996
Q ss_pred HHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.++-........+. ..........-..+++++.+||.+||..||.+||++.++++
T Consensus 297 -ellt-~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 297 -EIFT-LGGSPYPGIPVEELFK--LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp -HHHT-TSCCSSTTCCGGGHHH--HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHc-CCCCCCCCCCHHHHHH--HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1211 2333311100000000 00000000111357889999999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=7.3e-11 Score=131.37 Aligned_cols=118 Identities=21% Similarity=0.271 Sum_probs=79.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
+.||..||++ +.++|.|||+... ......+||+.|++||.+. + ..|+.++||||+||+++ .
T Consensus 165 ~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~Di~slG~il~---------~ 233 (335)
T 2owb_A 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS-K-KGHSFEVDVWSIGCIMY---------T 233 (335)
T ss_dssp SCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHH-T-SCBCTHHHHHHHHHHHH---------H
T ss_pred cCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhc-c-CCCCchhhHHHHHHHHH---------H
Confidence 4589999999 7899999999753 2334458999999998765 3 45899999999999996 1
Q ss_pred HHHhcCCCchhh--hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 745 LLHTLPLYTCYT--LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 745 I~~~lG~p~~~~--~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
++. |.++-.. ...... ... ..... +-..+++++.+||++||..||.+||+++++|+.
T Consensus 234 l~~--g~~pf~~~~~~~~~~-~~~-~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 234 LLV--GKPPFETSCLKETYL-RIK-KNEYS---IPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHH--SSCTTCCSSHHHHHH-HHH-HTCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHH--CcCCCCCCCHHHHHH-HHh-cCCCC---CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 2221100 000000 000 00000 113578899999999999999999999999973
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=98.99 E-value=3.8e-11 Score=130.70 Aligned_cols=120 Identities=13% Similarity=-0.021 Sum_probs=77.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCC---------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchh
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI---------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK 740 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~---------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ 740 (962)
+-||++||++ |.++|.|||++.. .......||+.|++||.+.. ..|+.++||||+||+++
T Consensus 152 ~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~------ 223 (298)
T 3f66_A 152 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLW------ 223 (298)
T ss_dssp SCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHHH------
T ss_pred CCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcC--CCCChHHHHHHHHHHHH------
Confidence 5689999999 8999999999864 11223367788988887743 45899999999999996
Q ss_pred HHHHHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 741 SSYILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 741 ql~~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. -|.|+-......... ......... .-..+++++.+||.+||..||.+|||+.++++
T Consensus 224 ---~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 224 ---ELMT-RGAPPYPDVNTFDITVYLLQGRRLL---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ---HHHT-TSCCSSTTSCTTTHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHHh-CCCCCCccCCHHHHHHHHhcCCCCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 122221110000000 000000000 01346789999999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.98 E-value=2.3e-11 Score=133.70 Aligned_cols=122 Identities=12% Similarity=0.088 Sum_probs=74.4
Q ss_pred cccceeeEEE---E-EEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHHH
Q psy501 673 ERLKSSYILL---H-TLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILL 746 (962)
Q Consensus 673 ~~~~~~~~~~---~-~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I~ 746 (962)
+-||++||++ + .++|.|||++.. ......+||+.|++||.+. + ..|+.++||||+||+++ .++
T Consensus 129 ~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~Di~slG~il~---------el~ 197 (307)
T 2eva_A 129 RDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFE-G-SNYSEKCDVFSWGIILW---------EVI 197 (307)
T ss_dssp CCCSGGGEEEETTTTEEEECCCCC------------CCTTSSCHHHHT-C-CCCCTHHHHHHHHHHHH---------HHH
T ss_pred CCCChhHEEEeCCCCEEEEcccccccccccccccCCCCCceEChhhhC-C-CCCCcHHHHHHHHHHHH---------HHH
Confidence 4689999999 3 489999999765 2233447999999999765 3 46999999999999996 111
Q ss_pred HhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 747 HTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 747 ~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.|.++-.......................+.+++++.+||.+||..||.+|||++++++
T Consensus 198 --~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 198 --TRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp --HTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 12222110000000000000000000112467889999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=98.98 E-value=3.5e-11 Score=133.47 Aligned_cols=120 Identities=13% Similarity=0.115 Sum_probs=77.5
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||++||++ +.++|.|||++.. .......||+.|++||.+.. ..|+.++||||+|||++
T Consensus 141 ~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~-------- 210 (327)
T 3poz_A 141 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVW-------- 210 (327)
T ss_dssp SCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHH--------
T ss_pred CCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhcc--CCCCchhhhhhhHHHHH--------
Confidence 5689999999 7899999998642 12223367788999888764 45999999999999996
Q ss_pred HHHHHhcCCCchhhhccccccc-CCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNFK-FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~~-~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.++-.......... .......+ ..+.+++++.+|+.+||+.||.+||++.++++
T Consensus 211 -ell-t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 271 (327)
T 3poz_A 211 -ELM-TFGSKPYDGIPASEISSILEKGERLP---QPPICTIDVYMIMVKCWMIDADSRPKFRELII 271 (327)
T ss_dssp -HHH-TTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred -HHH-hcCCCCccCCCHHHHHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 111 11443321110000000 00000000 11357889999999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=98.98 E-value=9e-11 Score=127.58 Aligned_cols=118 Identities=19% Similarity=0.245 Sum_probs=79.6
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
+.||..||++ |.++|.|||++.. ......+||+.|++||.+. + ..|+.++||||+||+++ .
T Consensus 139 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~~Di~slG~~l~---------~ 207 (294)
T 2rku_A 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS-K-KGHSFEVDVWSIGCIMY---------T 207 (294)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHT-T-SCBCTHHHHHHHHHHHH---------H
T ss_pred cCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhc-c-CCCCchhhHHHHHHHHH---------H
Confidence 4689999999 7899999998753 2233458999999998764 3 45899999999999996 1
Q ss_pred HHHhcCCCchhhh--cccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 745 LLHTLPLYTCYTL--ASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 745 I~~~lG~p~~~~~--~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
++. |.++-... ..... ... .....+ -..+++++.+||++||..||.+|||++++|+.
T Consensus 208 l~~--g~~p~~~~~~~~~~~-~~~-~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 208 LLV--GKPPFETSCLKETYL-RIK-KNEYSI---PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHH--SSCTTCCSSHHHHHH-HHH-TTCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHh--CCCCCCCCCHHHHHH-HHh-hccCCC---ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111 22221100 00000 000 000001 13578899999999999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.98 E-value=5.9e-11 Score=130.36 Aligned_cols=117 Identities=12% Similarity=0.073 Sum_probs=77.2
Q ss_pred cccceeeEEE--EEEeeeeeecCCC----------ceeeeccCCCcccccceeeec-------CCCCCCCCCceeeeeEe
Q psy501 673 ERLKSSYILL--HTLPLYTYHVPPI----------QTTCLLAGTERLKSSYILLHT-------LPLYTYHVPPIQTTCLL 733 (962)
Q Consensus 673 ~~~~~~~~~~--~~~~~~~~~~~~~----------~~~~~~~gt~~~~~~~~lLlg-------~~~Y~~~vDIWSlGCIl 733 (962)
+-||..||++ |.++|.|||++.. .......||+.|++||++... ...|+.++||||+|||+
T Consensus 154 ~dlkp~NIl~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il 233 (319)
T 2y4i_B 154 KDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIW 233 (319)
T ss_dssp CCCCSTTEEEC--CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHH
T ss_pred cCCChhhEEEeCCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHH
Confidence 4579999999 8999999998543 122233699999999987642 34689999999999999
Q ss_pred ecCCchhHHHHHHHhcCCCchhh-----hc-ccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 734 AGTERLKSSYILLHTLPLYTCYT-----LA-SNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 734 ~G~~~~~ql~~I~~~lG~p~~~~-----~~-~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
+ .++. |.++-.. .. .......+.. ....+++++.+||.+||..||.+|||+.++++
T Consensus 234 ~---------el~~--g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 234 Y---------ELHA--REWPFKTQPAEAIIWQMGTGMKPNL-------SQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp H---------HHHH--SSCSSSSCCHHHHHHHHHTTCCCCC-------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred H---------HHHh--CCCCCCCCCHHHHHHHhccCCCCCC-------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 6 1111 2211100 00 0000000000 01246788999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.97 E-value=4.5e-11 Score=133.01 Aligned_cols=120 Identities=16% Similarity=0.152 Sum_probs=79.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||..||++ +.++|.|||++... ......||+.|++||.+.- ..|+.++||||+|||++
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~-------- 265 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLW-------- 265 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHH--------
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHH--------
Confidence 4789999999 78999999998641 1223367788998887754 45999999999999996
Q ss_pred HHHHHhcCCCchhhhcccccc-c-CCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNF-K-FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~-~-~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.++-......... . ........ .-+.+++++.+||.+||..||.+|||+.++++
T Consensus 266 -el~-t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 327 (344)
T 1rjb_A 266 -EIF-SLGVNPYPGIPVDANFYKLIQNGFKMD---QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 327 (344)
T ss_dssp -HHT-TTSCCSSTTCCCSHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHH-cCCCCCcccCCcHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 111 0244331111000000 0 00000000 11356889999999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=5.3e-11 Score=127.88 Aligned_cols=119 Identities=14% Similarity=0.087 Sum_probs=71.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 745 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I 745 (962)
+.||..||++ +.++|.|||++.. ......+||+.|++||.+. +...++.++||||+||+++ .+
T Consensus 135 ~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~~l~---------~l 204 (276)
T 2h6d_A 135 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS-GRLYAGPEVDIWSCGVILY---------AL 204 (276)
T ss_dssp CCCCGGGEEECTTSCEEECCCCGGGCCCC-------------CCTGGGT-TSCCCHHHHHHHHHHHHHH---------HH
T ss_pred CCCChhhEEECCCCCEEEeecccccccCCCcceecccCCccccCHHHHc-CCCCCCccchHHHHHHHHH---------HH
Confidence 4689999999 7899999998765 2223448999999888765 4444578999999999996 11
Q ss_pred HHhcCCCchhh--hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 746 LHTLPLYTCYT--LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 746 ~~~lG~p~~~~--~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+. |.++-.. ...... ... .....+ -..+++++.+||.+||..||.+|||+.++|+.
T Consensus 205 ~~--g~~p~~~~~~~~~~~-~~~-~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 205 LC--GTLPFDDEHVPTLFK-KIR-GGVFYI---PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HH--SSCSSCCSSHHHHHH-HHH-HCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Hh--CCCCCCCCcHHHHHH-Hhh-cCcccC---chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 2221100 000000 000 000001 12468899999999999999999999999974
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=1.9e-11 Score=133.81 Aligned_cols=121 Identities=14% Similarity=0.083 Sum_probs=79.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+.||++||++ +.++|.|||++... ......||+.|++||.+.- ..|+.++||||+|||++
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~-------- 243 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLW-------- 243 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHHH--------
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC--CCcCchhhHHHHHHHHH--------
Confidence 4689999999 68999999987431 1222367788999888753 45899999999999996
Q ss_pred HHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.++-.......... ...........+.+++++.+||.+||..||.+||++.++++
T Consensus 244 -el~t-~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~ 304 (314)
T 2ivs_A 244 -EIVT-LGGNPYPGIPPERLFN--LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304 (314)
T ss_dssp -HHHT-TSCCSSTTCCGGGHHH--HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHh-CCCCCCCCCCHHHHHH--HhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1211 1333211100000000 00000000112467899999999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=98.96 E-value=5.5e-11 Score=130.10 Aligned_cols=121 Identities=17% Similarity=0.174 Sum_probs=78.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||++||++ +.++|.|||++... ......||+.|++||.+.. ..|+.++||||+|||++
T Consensus 169 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~-------- 238 (313)
T 1t46_A 169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLW-------- 238 (313)
T ss_dssp SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHH--------
T ss_pred CCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHH--------
Confidence 4689999999 78999999987641 1122356778888887653 45999999999999996
Q ss_pred HHHHHhcCCCchhhhcccccccCCCcccCCccc-cCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFTS-IIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~-~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.++-......... .......+.. ..+.+++++.+||.+||..||.+|||+.++++
T Consensus 239 -ellt-~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 239 -ELFS-LGSSPYPGMPVDSKF--YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp -HHHT-TTCCSSTTCCSSHHH--HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHh-CCCCCCCcccchhHH--HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1111 143331110000000 0000000000 01357889999999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=98.96 E-value=3.5e-11 Score=129.07 Aligned_cols=120 Identities=11% Similarity=0.053 Sum_probs=77.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+-||++||++ +.++|.|||++... ......||+.|++||.+.. ..|+.++||||+||+++
T Consensus 130 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~--------- 198 (269)
T 4hcu_A 130 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMW--------- 198 (269)
T ss_dssp SCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHH---------
T ss_pred CCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcC--CCCCchhhhHHHHHHHH---------
Confidence 4679999999 78999999987541 2222366778888887643 45999999999999996
Q ss_pred HHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 744 ILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.++-......... ......... .-...++++.+||.+||..||.+||++.++++
T Consensus 199 ~ll~-~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 259 (269)
T 4hcu_A 199 EVFS-EGKIPYENRSNSEVVEDISTGFRLY---KPRLASTHVYQIMNHCWRERPEDRPAFSRLLR 259 (269)
T ss_dssp HHHT-TSCCTTTTCCHHHHHHHHHTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhc-CCCCCCCCCCHHHHHHHHhcCccCC---CCCcCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1110 133321110000000 000000000 01246889999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=98.96 E-value=6.9e-11 Score=127.63 Aligned_cols=120 Identities=14% Similarity=0.117 Sum_probs=77.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCCce------eeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQT------TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~------~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+.||++||++ +.++|.|||++.... .....||+.|++||.+. + ..|+.++||||+|||++
T Consensus 137 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~~Di~slG~il~--------- 205 (281)
T 3cc6_A 137 RDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN-F-RRFTTASDVWMFAVCMW--------- 205 (281)
T ss_dssp CCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHH-H-CCCCHHHHHHHHHHHHH---------
T ss_pred CCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhc-c-CCCCchhccHHHHHHHH---------
Confidence 4689999999 679999999876521 22336777888888764 3 45899999999999996
Q ss_pred HHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 744 ILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.++-......... ........+ ..+.+++++.+||.+||..||.+||++.++++
T Consensus 206 ~llt-~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 266 (281)
T 3cc6_A 206 EILS-FGKQPFFWLENKDVIGVLEKGDRLP---KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVC 266 (281)
T ss_dssp HHHT-TTCCTTTTSCGGGHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHh-CCCCCcccCChHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 1111 244332110000000 000000000 11357889999999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=98.96 E-value=3.1e-11 Score=130.14 Aligned_cols=120 Identities=9% Similarity=0.031 Sum_probs=75.6
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLH 747 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I~~ 747 (962)
+.||++||++ +.++|.|||++.. .......||+.|++||.+. + ..|+.++||||+||+++ .++
T Consensus 141 ~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~~Di~slG~il~---------~l~- 208 (278)
T 1byg_A 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALR-E-KKFSTKSDVWSFGILLW---------EIY- 208 (278)
T ss_dssp SCCSGGGEEECTTSCEEECCCCC------------CCTTTSCHHHHH-H-CCCCHHHHHHHHHHHHH---------HHH-
T ss_pred cCCCcceEEEeCCCcEEEeeccccccccccccCCCccccccCHHHhC-C-CCCCchhcHHHHHHHHH---------HHH-
Confidence 4689999999 8899999998765 2233347888898888765 3 45899999999999996 111
Q ss_pred hcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 748 TLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 748 ~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
..|.++-......... ....... ....+.+++++.+||++||..||.+||++.++++
T Consensus 209 t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 209 SFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp TTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 1244332111000000 0000000 0111467899999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=98.95 E-value=4.4e-11 Score=132.50 Aligned_cols=120 Identities=13% Similarity=0.033 Sum_probs=76.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||.+||++ |.++|.|||++.. .......||..|++||.+.. ..|+.++||||+|||++
T Consensus 139 ~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~-------- 208 (325)
T 3kex_A 139 RNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF--GKYTHQSDVWSYGVTVW-------- 208 (325)
T ss_dssp SCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHH--------
T ss_pred CccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhcc--CCCChhhHhHHhHHHHH--------
Confidence 5689999999 8899999999753 12233367778888887754 34999999999999996
Q ss_pred HHHHHhcCCCchhhhccccccc-CCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNFK-FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~~-~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.++-.......... ........ .-..+++++.+||.+||..||.+||++.++++
T Consensus 209 -el~-~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~ 269 (325)
T 3kex_A 209 -ELM-TFGAEPYAGLRLAEVPDLLEKGERLA---QPQICTIDVYMVMVKCWMIDENIRPTFKELAN 269 (325)
T ss_dssp -HHH-TTSCCTTTTSCTTHHHHHHHTTCBCC---CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHH
T ss_pred -HHH-hCCCCCccccCHHHHHHHHHcCCCCC---CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111 12443321100000000 00000000 01246778999999999999999999999976
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=98.95 E-value=4e-11 Score=130.01 Aligned_cols=113 Identities=24% Similarity=0.268 Sum_probs=77.0
Q ss_pred cccceeeEEE------EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cC--
Q psy501 673 ERLKSSYILL------HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GT-- 736 (962)
Q Consensus 673 ~~~~~~~~~~------~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~-- 736 (962)
+.||..||++ +.++|.|||++.. ......+||+.|++||.+. | .|+.++||||+||+++ |.
T Consensus 145 ~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~--~~~~~~Di~slG~~l~~l~~g~~p 221 (287)
T 2wei_A 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-G--TYDEKCDVWSAGVILYILLSGTPP 221 (287)
T ss_dssp SCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHT-T--CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhc-C--CCCCchhhHhHHHHHHHHHhCCCC
Confidence 3579999999 3699999998754 2223346888999888653 3 3899999999999996 11
Q ss_pred ----CchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 737 ----ERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 737 ----~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+..+.+..+.. .......+ ..+.+++++.+||.+||..||.+|||+.++|+.
T Consensus 222 ~~~~~~~~~~~~~~~-----------~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 222 FYGKNEYDILKRVET-----------GKYAFDLP---------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp SCCSSHHHHHHHHHH-----------CCCCCCSG---------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCCCCHHHHHHHHHc-----------CCCCCCch---------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 11111111111 00000011 114678999999999999999999999999973
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.95 E-value=6.7e-11 Score=129.74 Aligned_cols=115 Identities=17% Similarity=0.138 Sum_probs=78.8
Q ss_pred cccceeeEEE----EEEeeeeeecCCC---ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHH
Q psy501 673 ERLKSSYILL----HTLPLYTYHVPPI---QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 745 (962)
Q Consensus 673 ~~~~~~~~~~----~~~~~~~~~~~~~---~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I 745 (962)
+.||..||++ |.++|.|||++.. ......+||+.|++||.+. +...++.++||||+|||++ .+
T Consensus 163 ~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~---------~l 232 (312)
T 2iwi_A 163 RDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWIS-RHQYHALPATVWSLGILLY---------DM 232 (312)
T ss_dssp CCCSGGGEEEETTTTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHH-HSCBCHHHHHHHHHHHHHH---------HH
T ss_pred cCCChhhEEEeCCCCeEEEEEcchhhhcccCcccccCCcccccCceeee-cCCCCCccchHHHHHHHHH---------HH
Confidence 3579999999 5799999998754 3334458999999888765 4344566899999999996 11
Q ss_pred HHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 746 LHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 746 ~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+. |.++-......... . .. +-+.+++++.+||.+||..||.+|||++++|+.
T Consensus 233 ~~--g~~pf~~~~~~~~~-~-----~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 233 VC--GDIPFERDQEILEA-E-----LH---FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HH--SSCSCCSHHHHHHT-C-----CC---CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HH--CCCCCCChHHHhhh-c-----cC---CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 32221100000000 0 00 113678999999999999999999999999973
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=98.95 E-value=2e-11 Score=135.07 Aligned_cols=120 Identities=18% Similarity=0.136 Sum_probs=77.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCCcee----eeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQTT----CLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 745 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~~----~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I 745 (962)
+.||.+||++ +.++|.|||++..... ....||+.|++||.+. + ..|+.++||||+|||++ .+
T Consensus 166 ~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~~Di~slG~il~---------el 234 (327)
T 1fvr_A 166 RDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN-Y-SVYTTNSDVWSYGVLLW---------EI 234 (327)
T ss_dssp SCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHH-H-CEECHHHHHHHHHHHHH---------HH
T ss_pred CCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhc-c-ccCCchhcchHHHHHHH---------HH
Confidence 4689999999 7899999998764221 2236778898888764 3 45899999999999996 11
Q ss_pred HHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 746 LHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 746 ~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
+ ..|.++-......... ........ .....+++++.+||.+||..||.+|||++++++
T Consensus 235 l-t~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 293 (327)
T 1fvr_A 235 V-SLGGTPYCGMTCAELYEKLPQGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 293 (327)
T ss_dssp H-TTSCCTTTTCCHHHHHHHGGGTCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H-cCCCCCCCCCcHHHHHHHhhcCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1 1244331110000000 00000000 011357899999999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=98.95 E-value=7.5e-11 Score=129.40 Aligned_cols=119 Identities=11% Similarity=0.026 Sum_probs=75.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+.||.+||++ +.++|.|||++..- ......||+.|++||.+. + ..|+.++||||+|||++
T Consensus 171 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~~Di~slG~il~-------- 240 (313)
T 3brb_A 171 RDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA-D-RVYTSKSDVWAFGVTMW-------- 240 (313)
T ss_dssp CCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHH-S-SCCCHHHHHHHHHHHHH--------
T ss_pred CCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhc-C-CCccchhhhHHHHHHHH--------
Confidence 5789999999 78999999997641 112236777888888764 3 46999999999999996
Q ss_pred HHHHHhcCCCchhhhcccccc--cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNF--KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~--~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.++-......... ..... .. ...+.+++++.+||.+||..||.+||++.++++
T Consensus 241 -el~~-~g~~p~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 301 (313)
T 3brb_A 241 -EIAT-RGMTPYPGVQNHEMYDYLLHGH-RL---KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL 301 (313)
T ss_dssp -HHHT-TSCCSSTTCCGGGHHHHHHTTC-CC---CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred -HHHh-cCCCCCccCCHHHHHHHHHcCC-CC---CCCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 133221110000000 00000 00 011467889999999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=98.94 E-value=1.5e-10 Score=126.38 Aligned_cols=120 Identities=18% Similarity=0.140 Sum_probs=80.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
+.||..||++ |.++|.|||++.. ......+||+.|++||.+.. ..|+.++||||+|||++ .
T Consensus 143 ~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~---------~ 211 (303)
T 3a7i_A 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAI---------E 211 (303)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHH---------H
T ss_pred CCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhc--CCCCchhhhHHHHHHHH---------H
Confidence 4689999999 8899999998744 12334479999999887653 45899999999999996 1
Q ss_pred HHHhcCCCchhhhccccc-ccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 745 LLHTLPLYTCYTLASNMN-FKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 745 I~~~lG~p~~~~~~~~~~-~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
++ .|.++-........ ......... .+...+++++.+||.+||..||.+|||+.++|+.
T Consensus 212 l~--~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 212 LA--RGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HH--HSSCTTTTSCHHHHHHHHHHSCCC---CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred Hc--cCCCCCCCcCHHHHHHHhhcCCCC---CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11 12222110000000 000000000 1124678899999999999999999999999973
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=98.94 E-value=6.8e-11 Score=129.50 Aligned_cols=122 Identities=14% Similarity=0.127 Sum_probs=79.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+.||..||++ +.++|.|||++... ......||+.|++||.+. + ..|+.++||||+|||++
T Consensus 172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~-~~~~~~~Di~slG~il~-------- 241 (316)
T 2xir_A 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-D-RVYTIQSDVWSFGVLLW-------- 241 (316)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-H-CCCCHHHHHHHHHHHHH--------
T ss_pred ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhc-c-ccccchhHHHHHHHHHH--------
Confidence 4689999999 78999999987541 122346788899888775 3 45899999999999996
Q ss_pred HHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.++-......... .............+.+++++.+||.+||..||.+|||+.++++
T Consensus 242 -~l~-t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 303 (316)
T 2xir_A 242 -EIF-SLGASPYPGVKIDEEF-CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303 (316)
T ss_dssp -HHH-TTSCCSSTTCCCSHHH-HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHH-hCCCCCCcccchhHHH-HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111 1244331110000000 0000000000011357889999999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=5.1e-11 Score=128.24 Aligned_cols=121 Identities=18% Similarity=0.184 Sum_probs=78.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCCce-----eeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQT-----TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~-----~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
+.||.+||++ +.++|.|||.+.... ....+||+.|++||.+.. ..|+.++||||+|||++ .
T Consensus 140 ~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~---------~ 208 (279)
T 2w5a_A 140 RDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLY---------E 208 (279)
T ss_dssp CCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHHH---------H
T ss_pred eccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhcc--CCCCchhhHHHHHHHHH---------H
Confidence 4589999999 789999999864411 223479999999998753 35899999999999996 1
Q ss_pred HHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 745 LLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 745 I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
++. |.++-........ ........+..+-..+++++.+||.+||..||.+||++.++|+.
T Consensus 209 l~~--g~~p~~~~~~~~~--~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 268 (279)
T 2w5a_A 209 LCA--LMPPFTAFSQKEL--AGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268 (279)
T ss_dssp HHH--SSCSSCCSSHHHH--HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHH--CCCCCcccCHHHH--HHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 111 2221100000000 00000000001113578899999999999999999999999973
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=98.93 E-value=6.4e-11 Score=129.33 Aligned_cols=121 Identities=13% Similarity=0.006 Sum_probs=74.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+-||+.||++ |.++|.|||++..- .....+||+.|++||.+. + ..|+.++||||+||+++
T Consensus 135 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~Di~slG~~l~--------- 203 (294)
T 4eqm_A 135 RDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK-G-EATDECTDIYSIGIVLY--------- 203 (294)
T ss_dssp CCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHH-T-CCCCTTHHHHHHHHHHH---------
T ss_pred CCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhc-C-CCCCchHhHHHHHHHHH---------
Confidence 4689999999 88999999998641 222347999999999765 3 45899999999999996
Q ss_pred HHHHhcCCCchhhhc--ccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCc-chhhhh
Q psy501 744 ILLHTLPLYTCYTLA--SNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRP-TAQQSL 806 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~--~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~-sa~~~L 806 (962)
.++. |.+|-.... ...........+.......+.+++.+.++|.+||..||.+|| ++++++
T Consensus 204 ~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~ 267 (294)
T 4eqm_A 204 EMLV--GEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMK 267 (294)
T ss_dssp HHHH--SSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHH
T ss_pred HHHh--CCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHH
Confidence 1111 332210000 000000000000011122356789999999999999999999 555444
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=5.6e-11 Score=127.30 Aligned_cols=120 Identities=18% Similarity=0.073 Sum_probs=76.5
Q ss_pred cccceeeEEE---EEEeeeeeecCCC---ce---eeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI---QT---TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~---~~---~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+-||++||++ +.++|.|||++.. .. .....||+.|++||.+. + ..|+.++||||+||+++
T Consensus 128 ~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~~Di~slG~il~--------- 196 (268)
T 3sxs_A 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFH-Y-FKYSSKSDVWAFGILMW--------- 196 (268)
T ss_dssp SSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHH-H-SEEETTHHHHHHHHHHH---------
T ss_pred CCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHh-c-cCCchhhhhHHHHHHHH---------
Confidence 4689999999 8899999998643 11 11225566788888764 3 34899999999999996
Q ss_pred HHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 744 ILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.+|-......... .......... -...++++.+||.+||..||.+|||+.++++
T Consensus 197 ~l~-~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (268)
T 3sxs_A 197 EVF-SLGKMPYDLYTNSEVVLKVSQGHRLYR---PHLASDTIYQIMYSCWHELPEKRPTFQQLLS 257 (268)
T ss_dssp HHH-TTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHH-cCCCCCccccChHHHHHHHHcCCCCCC---CCcChHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111 1244332110000000 0000000000 0246889999999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=1.8e-11 Score=135.17 Aligned_cols=122 Identities=16% Similarity=0.118 Sum_probs=77.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+.||+.||++ +.++|.|||++.. ......+||+.|++||.+..+ .|+.++||||+||+++
T Consensus 163 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~-------- 232 (321)
T 2qkw_B 163 RDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG--RLTEKSDVYSFGVVLF-------- 232 (321)
T ss_dssp SCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHC--BCCTHHHHHHHHHHHH--------
T ss_pred CCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCC--CCCcccchHhHHHHHH--------
Confidence 4689999999 8999999998743 112234689999999987643 5899999999999996
Q ss_pred HHHHHhcCCCchhh-hccc------------ccccCCCcccCCccc-cCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYT-LASN------------MNFKFPQFRRVPFTS-IIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~-~~~~------------~~~~~~~~~~~~l~~-~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ .|.++-.. .+.. ....+.......+.. .-+..++++.+|+.+||..||.+|||+.++++
T Consensus 233 -ell--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 308 (321)
T 2qkw_B 233 -EVL--CARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308 (321)
T ss_dssp -HHH--HCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHH--hCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111 12211000 0000 000000000011111 11234557889999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=98.92 E-value=2e-10 Score=126.25 Aligned_cols=121 Identities=18% Similarity=0.088 Sum_probs=71.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCCce------eeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQT------TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~------~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+.||..||++ +.++|.|||++.... ....+||+.|++||.+.- ..|+.++||||+||+++
T Consensus 158 ~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~--------- 226 (309)
T 2h34_A 158 RDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLY--------- 226 (309)
T ss_dssp SCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC------CCCHHHHHHHHHH---------
T ss_pred CCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcC--CCCCchHhHHHHHHHHH---------
Confidence 4689999999 889999999875421 223479999999997753 45899999999999997
Q ss_pred HHHHhcCCCchhhhc-ccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCc-chhhhhh
Q psy501 744 ILLHTLPLYTCYTLA-SNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRP-TAQQSLS 807 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~-~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~-sa~~~L~ 807 (962)
.++. |.++-.... ......... .........+.+++++.+||.+||..||.+|| ++++++.
T Consensus 227 ~l~~--g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 227 ECLT--GSPPYQGDQLSVMGAHINQ-AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHH--SSCSSCSCHHHHHHHHHHS-CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHH--CCCCCCCchHHHHHHHhcc-CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 1111 222110000 000000000 00011122356888999999999999999999 7888775
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=98.92 E-value=9.2e-11 Score=129.88 Aligned_cols=119 Identities=17% Similarity=0.160 Sum_probs=77.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||++||++ +.++|.|||++... ......||+.|++||.+. + ..|+.++||||+|||++
T Consensus 188 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~~Di~slG~il~-------- 257 (333)
T 2i1m_A 188 RDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF-D-CVYTVQSDVWSYGILLW-------- 257 (333)
T ss_dssp SCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH-H-CCCCHHHHHHHHHHHHH--------
T ss_pred CCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhc-c-CCCChHHHHHHHHHHHH--------
Confidence 4689999999 78999999998641 112235677888888765 3 45999999999999996
Q ss_pred HHHHHhc--CCCchhhhcccccccCCCcccCCcc-ccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTL--PLYTCYTLASNMNFKFPQFRRVPFT-SIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~l--G~p~~~~~~~~~~~~~~~~~~~~l~-~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ |.++-......... ......... ...+..++++.+||.+||..||.+|||+.++++
T Consensus 258 ----el~t~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 258 ----EIFSLGLNPYPGILVNSKF--YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp ----HHTTTSCCSSTTCCSSHHH--HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----HHHcCCCCCCcccchhHHH--HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 222 43321110000000 000000000 001246789999999999999999999999976
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=98.92 E-value=4.4e-11 Score=132.65 Aligned_cols=121 Identities=12% Similarity=0.104 Sum_probs=77.5
Q ss_pred cccceeeEEE---EE-----EeeeeeecCCCc------------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeE
Q psy501 673 ERLKSSYILL---HT-----LPLYTYHVPPIQ------------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCL 732 (962)
Q Consensus 673 ~~~~~~~~~~---~~-----~~~~~~~~~~~~------------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCI 732 (962)
+-||++||++ +. ++|.|||++..- .....+||+.|++||.+.. ..|+.++||||+|||
T Consensus 129 rDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~i 206 (330)
T 2izr_A 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHM 206 (330)
T ss_dssp CCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHH
T ss_pred cCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHH
Confidence 5689999999 44 999999998631 1235589999999997653 458999999999999
Q ss_pred eecCCchhHHHHHHHhcCCCchhhhccccc---c-cCC-CcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 733 LAGTERLKSSYILLHTLPLYTCYTLASNMN---F-KFP-QFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 733 l~G~~~~~ql~~I~~~lG~p~~~~~~~~~~---~-~~~-~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
++ .++ .|.+|-........ + ... .....+.+...+. .+++.+||.+||..||.+||+++++++
T Consensus 207 l~---------ell--~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~-~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 207 FM---------YFL--RGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCEN-FPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HH---------HHH--HSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTT-CHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HH---------HHh--cCCCCccccccccHHHHHHHHHhhhccCCHHHHhcc-ChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 96 111 13222110000000 0 000 0000111111122 348999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=98.92 E-value=6e-11 Score=128.10 Aligned_cols=120 Identities=14% Similarity=0.062 Sum_probs=77.6
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+-||+.||++ +.++|.|||++... ......||+.|++||.+.. ..|+.++||||+||+++
T Consensus 144 ~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~--------- 212 (283)
T 3gen_A 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMW--------- 212 (283)
T ss_dssp SSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHH---------
T ss_pred CCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhcc--CCCCchhhHHHHHHHHH---------
Confidence 4679999999 78999999987541 1222356778888887663 34899999999999996
Q ss_pred HHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 744 ILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.++-......... .......... -...++++.+||.+||..||.+|||+.++|+
T Consensus 213 ~l~-t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 273 (283)
T 3gen_A 213 EIY-SLGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVYTIMYSCWHEKADERPTFKILLS 273 (283)
T ss_dssp HHH-TTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHH-hCCCCCccccChhHHHHHHhcccCCCC---CCcCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 111 1244331110000000 0000000000 0246789999999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.92 E-value=9.4e-11 Score=133.04 Aligned_cols=120 Identities=13% Similarity=-0.027 Sum_probs=73.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc---------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchh
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ---------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK 740 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~---------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ 740 (962)
+-||..||++ +.++|.|||++... ......||+.|++||.+.. ..|+.++||||+||+++
T Consensus 216 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~------ 287 (373)
T 3c1x_A 216 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLW------ 287 (373)
T ss_dssp SCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHH------
T ss_pred CccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHH------
Confidence 4679999999 89999999998631 1122367788999988753 45899999999999996
Q ss_pred HHHHHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 741 SSYILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 741 ql~~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.|+-......... ......... .-+.+++++.+||.+||..||.+||++.++++
T Consensus 288 ---ellt-~~~~p~~~~~~~~~~~~~~~~~~~~---~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 288 ---ELMT-RGAPPYPDVNTFDITVYLLQGRRLL---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp ---HHHT-TSCCSCTTSCSSCHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHHh-CcCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 133331111000000 000000000 01357889999999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.92 E-value=6.2e-11 Score=131.55 Aligned_cols=121 Identities=13% Similarity=0.064 Sum_probs=78.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||..||++ +.++|.|||++.. .......||+.|++||.+.. ..|+.++||||+|||++
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~-------- 267 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLW-------- 267 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHH--------
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc--CCcCcccccHHHHHHHH--------
Confidence 4689999999 7999999998643 22234478889999987764 34999999999999996
Q ss_pred HHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.++-.......... ..........-+.+++++.+||++||..||.+||++.++++
T Consensus 268 -el~t-~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 268 -EIFS-YGLQPYYGMAHEEVIY--YVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp -HHHT-TTCCTTTTSCHHHHHH--HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHh-cCCCcCCCCChHHHHH--HHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1111 1332211100000000 00000000111357889999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=98.92 E-value=8.3e-11 Score=129.48 Aligned_cols=121 Identities=14% Similarity=0.048 Sum_probs=79.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCCce-------eeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQT-------TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~-------~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||..||++ |.++|.|||++.... ....+||+.|++||.+. + ..|+.++||||+||+++
T Consensus 162 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~~Di~slG~il~-------- 231 (322)
T 1p4o_A 162 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK-D-GVFTTYSDVWSFGVVLW-------- 231 (322)
T ss_dssp SCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH-H-CCCCHHHHHHHHHHHHH--------
T ss_pred CCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhc-c-CCCCchhhHHHHHHHHH--------
Confidence 4689999999 899999999986411 12236788899888765 3 45899999999999996
Q ss_pred HHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.++-.......... ......+....+.+++++.+||.+||..||.+|||+.++++
T Consensus 232 -el~~-~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~ 292 (322)
T 1p4o_A 232 -EIAT-LAEQPYQGLSNEQVLR--FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292 (322)
T ss_dssp -HHHH-TSCCTTTTSCHHHHHH--HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHh-cCCCccccCCHHHHHH--HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1111 1332211100000000 00000011112467889999999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.91 E-value=9.8e-11 Score=129.46 Aligned_cols=121 Identities=21% Similarity=0.138 Sum_probs=74.6
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc---e------eeeccCCCcccccceeeecCCCCCCC------CCceeeeeEee
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ---T------TCLLAGTERLKSSYILLHTLPLYTYH------VPPIQTTCLLA 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~---~------~~~~~gt~~~~~~~~lLlg~~~Y~~~------vDIWSlGCIl~ 734 (962)
+-||.+||++ +.++|.|||++..- . ..+.+||+.|++||.+..+ .++.. +||||+|||++
T Consensus 166 ~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~DiwslG~il~ 243 (337)
T 3mdy_A 166 RDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES--LNRNHFQSYIMADMYSFGLILW 243 (337)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC--CCTTCTHHHHHHHHHHHHHHHH
T ss_pred cccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccc--cCCccccCccccchHHHHHHHH
Confidence 5689999999 89999999997431 1 1244899999999887643 24444 89999999996
Q ss_pred cCCchhHHHHHHHhcCCCc-----------hhhhcccccc-------cCCCcccCCcccc--CCCCCHHHHHHHHHhhcc
Q psy501 735 GTERLKSSYILLHTLPLYT-----------CYTLASNMNF-------KFPQFRRVPFTSI--IPHASPDAIHLMESMLAY 794 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~-----------~~~~~~~~~~-------~~~~~~~~~l~~~--~p~~s~~a~DLL~kmL~~ 794 (962)
.++ .|..+ .........+ ..... ...+... -..+++++.+||.+||..
T Consensus 244 ---------el~--tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~ 311 (337)
T 3mdy_A 244 ---------EVA--RRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKL-RPSFPNRWSSDECLRQMGKLMTECWAH 311 (337)
T ss_dssp ---------HHH--TTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC-CCCCCGGGGGSHHHHHHHHHHHHHSCS
T ss_pred ---------HHH--hccCcccccccccccHhhhcCCCCchhhhHHHHhhhcc-CccccccchhhHHHHHHHHHHHHhhhh
Confidence 111 12111 0000000000 00000 0000000 013456789999999999
Q ss_pred CCCCCcchhhhhh
Q psy501 795 NPSKRPTAQQSLS 807 (962)
Q Consensus 795 dP~kR~sa~~~L~ 807 (962)
||.+|||+.++++
T Consensus 312 dP~~Rps~~ell~ 324 (337)
T 3mdy_A 312 NPASRLTALRVKK 324 (337)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhhCCCHHHHHH
Confidence 9999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=98.91 E-value=9e-11 Score=126.89 Aligned_cols=119 Identities=12% Similarity=0.102 Sum_probs=77.9
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+.||..||++ +.++|.|||++... ......||+.|++||.+.. ..|+.++||||+|||++
T Consensus 135 ~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~--------- 203 (288)
T 3kfa_A 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLW--------- 203 (288)
T ss_dssp SCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHH---------
T ss_pred CCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhcc--CCCCchhhHHHHHHHHH---------
Confidence 4579999999 78999999987541 1222366778888887654 35899999999999996
Q ss_pred HHHHhcCCCchhhhc--ccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 744 ILLHTLPLYTCYTLA--SNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~--~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.++-.... ........... ....+.+++++.+||.+||..||.+|||+.++++
T Consensus 204 ~ll~-~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 204 EIAT-YGMSPYPGIDLSQVYELLEKDYR----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHT-TSCCSSTTCCGGGHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHh-CCCCCCCCCCHHHHHHHHhccCC----CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 1111 1333211100 00000000000 0011357889999999999999999999999976
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=98.91 E-value=8.7e-11 Score=136.69 Aligned_cols=114 Identities=12% Similarity=0.124 Sum_probs=78.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+-||+.||++ +.+||.|||++... ......||..|++||.+.. ..|+.++||||+||+++
T Consensus 308 rDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~--------- 376 (454)
T 1qcf_A 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLM--------- 376 (454)
T ss_dssp SSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHH---------
T ss_pred CCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhcc--CCCCcHHHHHhHHHHHH---------
Confidence 5689999999 89999999998651 1122356778999998764 35999999999999996
Q ss_pred HHHHhcCCCchhhh-----ccc--ccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 744 ILLHTLPLYTCYTL-----ASN--MNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 744 ~I~~~lG~p~~~~~-----~~~--~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.+|-... ... .....+. -..+++++.+||.+||..||.+|||++++++
T Consensus 377 el~-t~g~~P~~~~~~~~~~~~i~~~~~~~~---------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 377 EIV-TYGRIPYPGMSNPEVIRALERGYRMPR---------PENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHH-TTSCCSSTTCCHHHHHHHHHHTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHH-hCCCCCCCCCCHHHHHHHHHcCCCCCC---------CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 111 1133221100 000 0000110 1357889999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=4.6e-11 Score=131.92 Aligned_cols=129 Identities=12% Similarity=0.072 Sum_probs=78.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc--------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cCC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ--------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GTE 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~--------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~~ 737 (962)
+-||..||++ +.++|.|||++... ......||+.|++||.+. + ..|+.++||||+|||++ |..
T Consensus 158 ~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~~Di~slG~il~~ll~g~~ 235 (318)
T 3lxp_A 158 RDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK-E-YKFYYASDVWSFGVTLYELLTHCD 235 (318)
T ss_dssp SCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHH-H-CEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhc-C-CCCCcHHHHHHHHHHHHHHHhCCC
Confidence 4689999999 88999999997541 122336777888888765 3 35889999999999997 222
Q ss_pred chhH-HHHHHHhcCCCchhh-hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 738 RLKS-SYILLHTLPLYTCYT-LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 738 ~~~q-l~~I~~~lG~p~~~~-~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.... ........+...... ....... ....... ...+.+++++.+||++||..||.+|||+.++++
T Consensus 236 p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 236 SSQSPPTKFLELIGIAQGQMTVLRLTEL-LERGERL---PRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp GGGSHHHHHHHHHCSCCHHHHHHHHHHH-HHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccccchhhhhhhcccccchhHHHHHHH-HhcccCC---CCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1111 111111111111000 0000000 0000000 011357899999999999999999999999985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=98.90 E-value=4.9e-11 Score=134.34 Aligned_cols=122 Identities=11% Similarity=0.032 Sum_probs=78.6
Q ss_pred cccceeeEEE-----EEEeeeeeecCCC------------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeec
Q psy501 673 ERLKSSYILL-----HTLPLYTYHVPPI------------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 735 (962)
Q Consensus 673 ~~~~~~~~~~-----~~~~~~~~~~~~~------------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G 735 (962)
+-||++||++ +.++|.|||++.. ......+||+.|++||.+. + ..|+.++||||+|||++
T Consensus 176 rDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~Di~slG~~l~- 252 (364)
T 3op5_A 176 GDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN-G-VAPSRRGDLEILGYCMI- 252 (364)
T ss_dssp CCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT-T-CCCCHHHHHHHHHHHHH-
T ss_pred ecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC-C-CCCCchhhHHHHHHHHH-
Confidence 5789999999 4799999999833 1113346999999999765 3 34999999999999996
Q ss_pred CCchhHHHHHHHhcCCCchhhhccc------ccccCCCcccCCccccC--CCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 736 TERLKSSYILLHTLPLYTCYTLASN------MNFKFPQFRRVPFTSII--PHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 736 ~~~~~ql~~I~~~lG~p~~~~~~~~------~~~~~~~~~~~~l~~~~--p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. |.+|-...... ....+.......+...+ +.+++++.+||.+||..||.+||++.++++
T Consensus 253 --------el~~--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 253 --------QWLT--GHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp --------HHHH--SCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred --------HHHh--CCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1211 33221100000 00000000000000001 367889999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=98.90 E-value=2.8e-11 Score=132.36 Aligned_cols=121 Identities=14% Similarity=0.103 Sum_probs=76.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+.||.+||++ +.++|.|||++... .....+||+.|++||.+. | .|+.++||||+||+++
T Consensus 157 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~--~~~~~~Dv~slG~il~-------- 225 (307)
T 2nru_A 157 RDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-G--EITPKSDIYSFGVVLL-------- 225 (307)
T ss_dssp SCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-T--EECTHHHHHHHHHHHH--------
T ss_pred CCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-C--CCCccchhHHHHHHHH--------
Confidence 4689999999 78999999986431 122347999999999653 3 4899999999999996
Q ss_pred HHHHHhcCCCchhhhcccccc------------cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNF------------KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~------------~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. |.++-......... .+..+....+....+..++++.+|+.+||..||.+||++.++++
T Consensus 226 -~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 226 -EIIT--GLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp -HHHH--CCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -HHHH--CCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1111 32221110000000 00000000011111123457889999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=98.90 E-value=1.2e-10 Score=135.44 Aligned_cols=121 Identities=10% Similarity=0.016 Sum_probs=78.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLH 747 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I~~ 747 (962)
+-||+.||++ +.+||.|||++.. ....+..+|..|++||.+.. ..|+.++||||+||+++ .++.
T Consensus 313 rDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~---------el~t 381 (450)
T 1k9a_A 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLW---------EIYS 381 (450)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTCEECC------CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHH---------HHHT
T ss_pred CCCCHhhEEECCCCCEEEeeCCCcccccccccCCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHH---------HHHh
Confidence 5689999999 7899999999764 22223378889999998753 45999999999999996 2211
Q ss_pred hcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 748 TLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 748 ~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.|.+|-............ .....+ ..-+.+++++.+||++||..||.+|||+.++++
T Consensus 382 -~g~~P~~~~~~~~~~~~i-~~~~~~-~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 382 -FGRVPYPRIPLKDVVPRV-EKGYKM-DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp -TTCCSSTTSCTTTHHHHH-HTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHH-HcCCCC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 244331111000000000 000000 011357899999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.90 E-value=4e-11 Score=130.07 Aligned_cols=121 Identities=10% Similarity=0.030 Sum_probs=78.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc--------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ--------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~--------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
+.||++||++ +.++|.|||++... ......||+.|++||.+.. ..|+.++||||+|||++
T Consensus 134 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~------- 204 (287)
T 1u59_A 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMW------- 204 (287)
T ss_dssp CCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHH-------
T ss_pred CCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhcc--CCCCchhhHHHHHHHHH-------
Confidence 4689999999 78999999987531 1122366888999987753 45899999999999996
Q ss_pred HHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 742 SYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 742 l~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.++-.......... ...........+.+++++.+||.+||..||.+||++.++++
T Consensus 205 --ellt-~g~~p~~~~~~~~~~~--~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 265 (287)
T 1u59_A 205 --EALS-YGQKPYKKMKGPEVMA--FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 265 (287)
T ss_dssp --HHHT-TSCCTTTTCCTHHHHH--HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred --HHHc-CCCCCcccCCHHHHHH--HHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 1443311100000000 00000000112467899999999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=98.90 E-value=5.1e-11 Score=131.87 Aligned_cols=129 Identities=12% Similarity=0.060 Sum_probs=77.9
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc--------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cCC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ--------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GTE 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~--------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~~ 737 (962)
+-||..||++ |.++|.|||++... ......||+.|++||.+. + ..|+.++||||+||+++ |..
T Consensus 151 ~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~~Di~slG~il~~ll~g~~ 228 (327)
T 3lxl_A 151 RDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS-D-NIFSRQSDVWSFGVVLYELFTYCD 228 (327)
T ss_dssp SCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHH-H-CEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhc-c-CCCChHHhHHHHHHHHHHHHhCCC
Confidence 5689999999 78999999987531 112236777888888764 3 45899999999999997 221
Q ss_pred chhH-HHHHHHhcCCCchhh-hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 738 RLKS-SYILLHTLPLYTCYT-LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 738 ~~~q-l~~I~~~lG~p~~~~-~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.... ........+...... ...... ...........+.+++++.+||.+||..||.+|||+.++++
T Consensus 229 p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 229 KSCSPSAEFLRMMGCERDVPALSRLLE----LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp GGGSHHHHHHHHCC----CCHHHHHHH----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCccccchhhhhcccccccccHHHHHH----HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1110 001111111000000 000000 00000000112467899999999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=98.89 E-value=7.9e-11 Score=127.41 Aligned_cols=120 Identities=14% Similarity=0.052 Sum_probs=75.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc--------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ--------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~--------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
+.||..||++ +.++|.|||++... ......||..|++||.+. + ..|+.++||||+|||++
T Consensus 145 ~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~~Di~slG~il~------- 215 (291)
T 1u46_A 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK-T-RTFSHASDTWMFGVTLW------- 215 (291)
T ss_dssp SCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHH-H-CEEEHHHHHHHHHHHHH-------
T ss_pred CCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhc-C-CCCCchhhHHHHHHHHH-------
Confidence 3689999999 78999999986541 112236777888888764 3 45899999999999996
Q ss_pred HHHHHHhcCCCchhhhcccccc-cC-CCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 742 SYILLHTLPLYTCYTLASNMNF-KF-PQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 742 l~~I~~~lG~p~~~~~~~~~~~-~~-~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.++-......... .. ......+ ..+.+++++.+||.+||..||.+||++.++++
T Consensus 216 --~l~~-~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 216 --EMFT-YGQEPWIGLNGSQILHKIDKEGERLP---RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp --HHHT-TSCCTTTTCCHHHHHHHHHTSCCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHHh-CCCCCcccCCHHHHHHHHHccCCCCC---CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1111 133331110000000 00 0000000 11367899999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=98.88 E-value=8.6e-11 Score=138.04 Aligned_cols=122 Identities=11% Similarity=0.054 Sum_probs=80.8
Q ss_pred cccceeeEEE------EEEeeeeeecCCCc------------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee
Q psy501 673 ERLKSSYILL------HTLPLYTYHVPPIQ------------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 734 (962)
Q Consensus 673 ~~~~~~~~~~------~~~~~~~~~~~~~~------------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~ 734 (962)
+-||..||++ +.++|.|||++..- .....+||+.|++||.+.. ..|+.++||||+|||++
T Consensus 127 rDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDvwSlGvil~ 204 (483)
T 3sv0_A 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG--IEQSRRDDLESLGYVLM 204 (483)
T ss_dssp CCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHH
T ss_pred cccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcC--CCCChHHHHHHHHHHHH
Confidence 5789999999 56999999997531 1125589999999988653 35899999999999996
Q ss_pred cCCchhHHHHHHHhcCCCchhhhccccc---c-cC-CCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMN---F-KF-PQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~---~-~~-~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ .|.++-........ + .. .......++.+...+++++.+||.+||..||.+||+++++++
T Consensus 205 ---------ell--tG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 205 ---------YFL--RGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp ---------HHH--HSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ---------HHH--hCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111 13322110000000 0 00 000011222233567899999999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.88 E-value=6.7e-11 Score=129.89 Aligned_cols=121 Identities=17% Similarity=0.147 Sum_probs=78.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCCcee--------------eeccCCCcccccceeeecC-CCCCCCCCceeeeeEee
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQTT--------------CLLAGTERLKSSYILLHTL-PLYTYHVPPIQTTCLLA 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~~--------------~~~~gt~~~~~~~~lLlg~-~~Y~~~vDIWSlGCIl~ 734 (962)
+-||..||++ +.++|.|||....... ....||+.|++||.+.... ..|+.++||||+|||++
T Consensus 158 ~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~ 237 (317)
T 2buj_A 158 RDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLY 237 (317)
T ss_dssp CCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHH
Confidence 3689999999 8899999997544211 1236789999988765332 23789999999999996
Q ss_pred cCCchhHHHHHHHhcCCCchhhhccc-ccc--cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASN-MNF--KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~-~~~--~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ .|.++-...... ... ........+ ..+.+++++.+||.+||..||.+||++.++++
T Consensus 238 ---------el~--~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 299 (317)
T 2buj_A 238 ---------AMM--FGEGPYDMVFQKGDSVALAVQNQLSIP---QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS 299 (317)
T ss_dssp ---------HHH--HSSCTTHHHHHTTSCHHHHHHCC--CC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------HHH--hCCCChhhhhcccchhhHHhhccCCCC---ccccCCHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 111 232221110000 000 000000000 01467899999999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=98.88 E-value=8.4e-11 Score=133.34 Aligned_cols=120 Identities=16% Similarity=0.136 Sum_probs=77.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--ceeee-----ccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--QTTCL-----LAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~-----~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||+.||++ +.+||.|||++.. ..... ..+|+.|++||.+.. ..|+.++||||+||+++
T Consensus 237 rDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~-------- 306 (377)
T 3cbl_A 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLW-------- 306 (377)
T ss_dssp SCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHH--------
T ss_pred cccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHH--------
Confidence 4689999999 8899999999754 11111 134667998887754 35899999999999996
Q ss_pred HHHHHhcCCCchhhhccccccc-CCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNFK-FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~~-~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.+|-.......... .......+. -..+++++.+||.+||..||.+|||++++++
T Consensus 307 -el~t-~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 307 -ETFS-LGASPYPNLSNQQTREFVEKGGRLPC---PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp -HHHT-TSCCSSTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHh-CCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2211 2433311110000000 000000011 1246789999999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=98.87 E-value=1.7e-10 Score=134.15 Aligned_cols=120 Identities=14% Similarity=0.086 Sum_probs=76.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+-||+.||++ +.+||.|||++... ......||..|++||.+..+ .|+.++||||+||+++
T Consensus 304 rDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~--------- 372 (452)
T 1fmk_A 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLT--------- 372 (452)
T ss_dssp SCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHH---------
T ss_pred CCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcC--CCCccccHHhHHHHHH---------
Confidence 5689999999 78999999998652 11223677889999987643 5999999999999996
Q ss_pred HHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 744 ILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.+|-......... ........+. -+.+++++.+||.+||..||.+|||++++++
T Consensus 373 el~t-~g~~P~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 373 ELTT-KGRVPYPGMVNREVLDQVERGYRMPC---PPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHT-TTCCSSTTCCHHHHHHHHHTTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHh-CCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1111 133221100000000 0000000000 1357889999999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=98.87 E-value=2.4e-10 Score=139.20 Aligned_cols=120 Identities=14% Similarity=0.156 Sum_probs=77.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCCce------eeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQT------TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~------~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+-||+.||++ |.++|.|||++.... .....||+.|++||.+.. ..|+.++||||+|||++
T Consensus 515 rDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~--------- 583 (656)
T 2j0j_A 515 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMW--------- 583 (656)
T ss_dssp SCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHH---------
T ss_pred cccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcC--CCCCchhhHHHHHHHHH---------
Confidence 4579999999 789999999986521 122367788999987753 46999999999999996
Q ss_pred HHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 744 ILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.+|-......... ........+ ..+.+++++.+||.+||..||.+||++.++++
T Consensus 584 ell-t~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 584 EIL-MHGVKPFQGVKNNDVIGRIENGERLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHH-TTSCCTTTTCCHHHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHH-HcCCCCCCCCCHHHHHHHHHcCCCCC---CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111 1133321100000000 000000001 11467899999999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.87 E-value=2.5e-10 Score=126.95 Aligned_cols=120 Identities=13% Similarity=0.068 Sum_probs=74.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCCce--------eeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQT--------TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~--------~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
+-||..||++ +.++|.|||++.... .....||+.|++||.+.. ..|+.++||||+|||++
T Consensus 171 ~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~------- 241 (333)
T 1mqb_A 171 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMW------- 241 (333)
T ss_dssp SCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHH-------
T ss_pred CCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHH-------
Confidence 4689999999 899999999976521 112256778988887753 45899999999999996
Q ss_pred HHHHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 742 SYILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 742 l~~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.++-......... ........+ ....+++++.+||.+||..||.+||++.++++
T Consensus 242 --ell-t~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 242 --EVM-TYGERPYWELSNHEVMKAINDGFRLP---TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp --HHH-TTSCCTTTTCCHHHHHHHHHTTCCCC---CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --HHH-cCCCCCcccCCHHHHHHHHHCCCcCC---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111 1133321110000000 000000000 01357889999999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=98.86 E-value=1.5e-10 Score=128.49 Aligned_cols=121 Identities=14% Similarity=0.104 Sum_probs=78.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||..||++ +.++|.|||++... ......||+.|++||++.- ..|+.++||||+|||++
T Consensus 181 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~-------- 250 (334)
T 2pvf_A 181 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMW-------- 250 (334)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHH--------
T ss_pred CCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHHH--------
Confidence 4689999999 88999999987531 1222367788999887753 45899999999999996
Q ss_pred HHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.++-.......... ...........+.+++++.+||.+||..||.+||++.++++
T Consensus 251 -ellt-~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 311 (334)
T 2pvf_A 251 -EIFT-LGGSPYPGIPVEELFK--LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311 (334)
T ss_dssp -HHHT-TSCCSSTTCCHHHHHH--HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHh-CCCCCcCcCCHHHHHH--HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1111 1332211000000000 00000000011357889999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=98.86 E-value=1.3e-10 Score=124.03 Aligned_cols=120 Identities=11% Similarity=0.053 Sum_probs=77.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+.||+.||++ +.++|.|||++... ......||+.|++||.+.. ..|+.++||||+||+++
T Consensus 128 ~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~--------- 196 (267)
T 3t9t_A 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMW--------- 196 (267)
T ss_dssp SSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHH---------
T ss_pred CCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcC--CCccchhchhhhHHHHH---------
Confidence 4579999999 78999999987642 1122367778888887653 45899999999999996
Q ss_pred HHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 744 ILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.++-......... ......... .-+..++++.+||.+||..||.+||++.++++
T Consensus 197 ~l~~-~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (267)
T 3t9t_A 197 EVFS-EGKIPYENRSNSEVVEDISTGFRLY---KPRLASTHVYQIMNHCWRERPEDRPAFSRLLR 257 (267)
T ss_dssp HHHT-TSCCTTTTCCHHHHHHHHHTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhc-cCCCCCCCCCHHHHHHHHhcCCcCC---CCccCcHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1110 133321110000000 000000000 01246889999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=98.86 E-value=1.9e-10 Score=124.90 Aligned_cols=120 Identities=9% Similarity=0.005 Sum_probs=76.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc--------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ--------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~--------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
+.||++||++ +.++|.|||++... ......||+.|++||.+.. ..|+.++||||+||+++
T Consensus 141 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~------- 211 (291)
T 1xbb_A 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMW------- 211 (291)
T ss_dssp SCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHH-------
T ss_pred CCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhcc--CCCChhhhHHHHHHHHH-------
Confidence 4689999999 78999999987531 1122256788998887753 34899999999999996
Q ss_pred HHHHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 742 SYILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 742 l~~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.++-......... ....... ....+.+++++.+||.+||..||.+||++.++++
T Consensus 212 --~l~~-~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 212 --EAFS-YGQKPYRGMKGSEVTAMLEKGER---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp --HHHT-TTCCSSTTCCHHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --HHHh-cCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 133321110000000 0000000 0111467899999999999999999999999885
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=98.86 E-value=2.6e-10 Score=124.86 Aligned_cols=115 Identities=18% Similarity=0.256 Sum_probs=71.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
+.||..||++ |.++|.|||++.. .......||+.|++||.+.. ..|+.++||||+||+++ .
T Consensus 160 ~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~---------~ 228 (310)
T 2wqm_A 160 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLY---------E 228 (310)
T ss_dssp CCCCGGGEEECTTSCEEECCC------------------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHH---------H
T ss_pred CCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHH---------H
Confidence 4579999999 7899999998754 12233479999999987653 45899999999999996 1
Q ss_pred HHHhcCCCchh--h-----h-cccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 745 LLHTLPLYTCY--T-----L-ASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 745 I~~~lG~p~~~--~-----~-~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
++. |.++-. . + .......++.. + ...+++++.+||.+||..||.+||++.++++
T Consensus 229 l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~---~----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 229 MAA--LQSPFYGDKMNLYSLCKKIEQCDYPPL---P----SDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHH--SSCTTC---CCHHHHHHHHHTTCSCCC---C----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHh--CCCCCcccchhHHHHHHHhhcccCCCC---c----ccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 111 111100 0 0 00000001111 0 1357889999999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=2.6e-10 Score=138.06 Aligned_cols=121 Identities=15% Similarity=0.082 Sum_probs=75.5
Q ss_pred cccceeeEEEE------EEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILLH------TLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~~------~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
+-||+.||++. .++|.|||++.. ......+||+.|++||.+. + ..|+.++||||+||+++
T Consensus 145 rDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~-~-~~~s~ksDIwSLGviLy-------- 214 (676)
T 3qa8_A 145 RDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLE-Q-KKYTVTVDYWSFGTLAF-------- 214 (676)
T ss_dssp CCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSC-C-SCCSTTHHHHHHHHHHH--------
T ss_pred CCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhc-c-CCCCchhHHHHHHHHHH--------
Confidence 46899999994 489999999865 2233448999999998765 3 45999999999999997
Q ss_pred HHHHHhcCCCchh------hhcc---------ccc-------ccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCc
Q psy501 743 YILLHTLPLYTCY------TLAS---------NMN-------FKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRP 800 (962)
Q Consensus 743 ~~I~~~lG~p~~~------~~~~---------~~~-------~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~ 800 (962)
.+ +.|.+|-. .+.. ... ..+....+ ....+.+.+++++.+||.+||.+||.+||
T Consensus 215 -eL--ltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp-~p~~l~~~ls~~L~dLI~~mL~~DP~kRP 290 (676)
T 3qa8_A 215 -EC--ITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLP-TPNHLSGILAGKLERWLQCMLMWHQRQRG 290 (676)
T ss_dssp -HH--HSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSC-CSCCCCGGGHHHHHHHHHHHSCSSCC---
T ss_pred -HH--HHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccC-CchhhchhhhHHHHHHHHHHccCCHhhCc
Confidence 11 11221100 0000 000 00100000 00111234567899999999999999999
Q ss_pred chhhhhh
Q psy501 801 TAQQSLS 807 (962)
Q Consensus 801 sa~~~L~ 807 (962)
|+.++|.
T Consensus 291 Ta~elL~ 297 (676)
T 3qa8_A 291 TDPQNPN 297 (676)
T ss_dssp CCTTCCC
T ss_pred CHHHHhc
Confidence 9999885
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=1.5e-10 Score=128.04 Aligned_cols=121 Identities=10% Similarity=0.068 Sum_probs=77.5
Q ss_pred cccceeeEEEE------EEeeeeeecCCC-------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCch
Q psy501 673 ERLKSSYILLH------TLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERL 739 (962)
Q Consensus 673 ~~~~~~~~~~~------~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~ 739 (962)
+.||..||++. .++|.|||++.. .......||+.|++||.+.- ..|+.++||||+|||++
T Consensus 164 ~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~----- 236 (327)
T 2yfx_A 164 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLW----- 236 (327)
T ss_dssp SCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHH-----
T ss_pred CcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC--CCCCchhhHHHHHHHHH-----
Confidence 46899999993 499999998642 11223467889999887754 35899999999999996
Q ss_pred hHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 740 KSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 740 ~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.++-........... ..........+.+++++.+||.+||..||.+||++.++++
T Consensus 237 ----ell-t~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 297 (327)
T 2yfx_A 237 ----EIF-SLGYMPYPSKSNQEVLEF--VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 297 (327)
T ss_dssp ----HHH-TTSCCSSTTCCHHHHHHH--HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----HHH-cCCCCCCCCcCHHHHHHH--HhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111 123322111000000000 0000000011367889999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=98.85 E-value=1.8e-10 Score=130.52 Aligned_cols=119 Identities=14% Similarity=0.084 Sum_probs=70.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCCce--------eeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQT--------TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~--------~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
+-||++||++ +.++|.|||++.... .....||+.|++||.+.. ..|+.++||||+|||++
T Consensus 171 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~------- 241 (373)
T 2qol_A 171 RDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLW------- 241 (373)
T ss_dssp SCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHH--CCCCHHHHHHHHHHHHH-------
T ss_pred CCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHH-------
Confidence 5689999999 899999999976411 111245678999987753 45999999999999996
Q ss_pred HHHHHHhcCCCchhhhccccccc--CCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 742 SYILLHTLPLYTCYTLASNMNFK--FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 742 l~~I~~~lG~p~~~~~~~~~~~~--~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.++-.......... ..... .+ ....+++++.+||.+||..||.+||++.++++
T Consensus 242 --ell-t~g~~P~~~~~~~~~~~~i~~~~~-~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 242 --EVM-SYGERPYWEMSNQDVIKAVDEGYR-LP---PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp --HHH-TTC-CTTTTCCHHHHHHHHHTTEE-CC---CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHH-hCCCCCCCCCCHHHHHHHHHcCCC-CC---CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 111 12433311100000000 00000 00 01256788999999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=98.84 E-value=2.1e-10 Score=139.17 Aligned_cols=120 Identities=9% Similarity=0.014 Sum_probs=75.6
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
+-||.+||++ +.+||.|||++.. .......||+.|++||++.. ..|+.++||||+|||++
T Consensus 493 rDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~------- 563 (635)
T 4fl3_A 493 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMW------- 563 (635)
T ss_dssp SCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHH-------
T ss_pred CCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHH-------
Confidence 4569999999 7899999998642 11222367788999998754 45999999999999996
Q ss_pred HHHHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 742 SYILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 742 l~~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.++-......... ......... .-..+++++.+||.+||..||.+||++.++++
T Consensus 564 --ellt-~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 564 --EAFS-YGQKPYRGMKGSEVTAMLEKGERMG---CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp --HHHT-TTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --HHHh-CCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1111 133331110000000 000000000 11357899999999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=98.82 E-value=2.2e-10 Score=123.38 Aligned_cols=120 Identities=12% Similarity=0.048 Sum_probs=76.9
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+-||+.||++ +.++|.|||.+... ......||+.|++||.+.. ..|+.++||||+|||++
T Consensus 133 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~--------- 201 (279)
T 1qpc_A 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLT--------- 201 (279)
T ss_dssp SCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHH---------
T ss_pred cCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhcc--CCCCchhhhHHHHHHHH---------
Confidence 4589999999 78999999987541 1122256778888887753 35899999999999996
Q ss_pred HHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 744 ILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.++-......... ......... ....+++++.+||.+||..||.+|||+.++++
T Consensus 202 el~~-~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 202 EIVT-HGRIPYPGMTNPEVIQNLERGYRMV---RPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHT-TTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHh-CCCCCCcccCHHHHHHHHhcccCCC---CcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1111 133221100000000 000000000 11357889999999999999999999999876
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=98.82 E-value=2.1e-10 Score=135.12 Aligned_cols=119 Identities=13% Similarity=0.141 Sum_probs=78.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc---e---eeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ---T---TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~---~---~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+-||..||++ +.+||.|||++... . .....||..|++||.+.. ..|+.++||||+||+++
T Consensus 342 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~--------- 410 (495)
T 1opk_A 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLW--------- 410 (495)
T ss_dssp SCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHH---------
T ss_pred CCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHHH---------
Confidence 5689999999 88999999987541 1 112256678999998754 35899999999999996
Q ss_pred HHHHhcCCCchhhhccccccc-C-CCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 744 ILLHTLPLYTCYTLASNMNFK-F-PQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~~~~~~~-~-~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.++-.......... . .... + ..-..+++++.+||.+||+.||.+|||+.++++
T Consensus 411 el~t-~g~~p~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 411 EIAT-YGMSPYPGIDLSQVYELLEKDYR---M-ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHT-TSCCSSTTCCGGGHHHHHHTTCC---C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHh-CCCCCCCCCCHHHHHHHHHcCCC---C-CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 1211 2333211100000000 0 0000 0 011357889999999999999999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.82 E-value=1.2e-10 Score=129.04 Aligned_cols=129 Identities=10% Similarity=0.051 Sum_probs=79.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCCce--------eeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cCC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQT--------TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GTE 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~--------~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~~ 737 (962)
+.||..||++ +.++|.|||++.... .....||+.|++||.+. + ..|+.++||||+|||++ |..
T Consensus 169 ~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~~Di~slG~il~el~tg~~ 246 (326)
T 2w1i_A 169 RDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT-E-SKFSVASDVWSFGVVLYELFTYIE 246 (326)
T ss_dssp SCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHH-H-CEEEHHHHHHHHHHHHHHHHHTTC
T ss_pred cCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhc-C-CCCCchhhHHHHHHHHHHHHhcCC
Confidence 4689999999 689999999875411 11235667788887765 3 34899999999999997 322
Q ss_pred chh-HHHHHHHhcCCCchhhhcc--cccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 738 RLK-SSYILLHTLPLYTCYTLAS--NMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 738 ~~~-ql~~I~~~lG~p~~~~~~~--~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
... ....+...+|......... .... .......+ ..+.+++++.+||++||..||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 247 KSKSPPAEFMRMIGNDKQGQMIVFHLIEL-LKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp GGGSHHHHHHHHHCTTCCTHHHHHHHHHH-HHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHhhccccchhhhHHHHHHH-hhcCCCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 211 1122222333322111000 0000 00000001 11467899999999999999999999999886
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.81 E-value=8.2e-10 Score=124.26 Aligned_cols=113 Identities=11% Similarity=0.041 Sum_probs=75.8
Q ss_pred cccceeeEEE--------------EEEeeeeeecCC-------CceeeeccCCCcccccceeeecCCCCCCCCCceeeee
Q psy501 673 ERLKSSYILL--------------HTLPLYTYHVPP-------IQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTC 731 (962)
Q Consensus 673 ~~~~~~~~~~--------------~~~~~~~~~~~~-------~~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGC 731 (962)
+-||.+||++ +.++|.|||++. .......+||+.|++||.+. | ..|+.++||||+||
T Consensus 196 rDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~DiwslG~ 273 (365)
T 3e7e_A 196 GDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS-N-KPWNYQIDYFGVAA 273 (365)
T ss_dssp CCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT-T-CCBSTHHHHHHHHH
T ss_pred CCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhc-C-CCCCccccHHHHHH
Confidence 5689999999 459999999983 23445568999999999775 3 34999999999999
Q ss_pred EeecCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCC--CCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 732 LLAGTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIP--HASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 732 Il~G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p--~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
|++ .+ +.|.++...... ..+. +...++ ..++...+++.+||..+|.+|++..+.|.
T Consensus 274 il~---------el--ltg~~pf~~~~~-~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 274 TVY---------CM--LFGTYMKVKNEG-GECK--------PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp HHH---------HH--HHSSCCCEEEET-TEEE--------ECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred HHH---------HH--HhCCCccccCCC-Ccee--------echhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 996 22 234432110000 0000 001111 13556789999999999999977665554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.81 E-value=5.7e-10 Score=134.92 Aligned_cols=120 Identities=12% Similarity=0.065 Sum_probs=76.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCCce--------eeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQT--------TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~~--------~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
+-||..||++ +.+||.|||++.... .....||+.|++||.+.. ..|+.++||||+|||++
T Consensus 460 rDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~------- 530 (613)
T 2ozo_A 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMW------- 530 (613)
T ss_dssp SCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHH--CCCCHHHHHHHHHHHHH-------
T ss_pred CcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHH-------
Confidence 4569999999 789999999986521 112256688999998754 45999999999999996
Q ss_pred HHHHHHhcCCCchhhhccccccc-CCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 742 SYILLHTLPLYTCYTLASNMNFK-FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 742 l~~I~~~lG~p~~~~~~~~~~~~-~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.++-.......... ........ .-+.+++++.+||.+||..||.+||++.++++
T Consensus 531 --ellt-~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 531 --EALS-YGQKPYKKMKGPEVMAFIEQGKRME---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp --HHHT-TSCCTTTTCCSHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred --HHHH-CCCCCCCCCCHHHHHHHHHcCCCCC---CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1111 1443311100000000 00000000 11357899999999999999999999999875
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=1.4e-08 Score=108.50 Aligned_cols=122 Identities=12% Similarity=0.111 Sum_probs=90.4
Q ss_pred ccEEEEEecCCceEEEEeccc---hhHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCC
Q psy501 325 LPLYTCNLDQDNHILSRHVSS---RDEMVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKF 400 (962)
Q Consensus 325 ~~Vy~~~~~~~~kvv~~k~~~---~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~~~ 400 (962)
..||.+.... ..++.+.... .....+.+|+.+++.+. +..+.++++++.+++..|+|||+++|..+.....
T Consensus 28 ~~v~~~~~~~-~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~---- 102 (263)
T 3tm0_A 28 AKVYKLVGEN-ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE---- 102 (263)
T ss_dssp SEEEEEECSS-CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC----
T ss_pred CeEEEEECCC-CcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC----
Confidence 3477776543 3333333222 23346899999999995 6778899999999999999999999865543311
Q ss_pred CCHHHHHHHHHHHHHHHhhccc----------------------------------------------------------
Q psy501 401 LPESIIRNMMYQVLQGLAFMHR---------------------------------------------------------- 422 (962)
Q Consensus 401 ls~~~i~~i~~qI~~aL~yLH~---------------------------------------------------------- 422 (962)
+......++.+++.+|..||+
T Consensus 103 -~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 181 (263)
T 3tm0_A 103 -DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEE 181 (263)
T ss_dssp -TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCC
T ss_pred -CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCC
Confidence 122344678889999999998
Q ss_pred -ceeeeccCCCcccccccccceeeecccccc
Q psy501 423 -HGFFHRDMKPENLLCMGTELVKIADFGLAR 452 (962)
Q Consensus 423 -~gIvHrDLkp~NILl~~~g~vKL~DFGla~ 452 (962)
..++|+|++|.||++++.+.+.|+||+.+.
T Consensus 182 ~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 182 ELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 569999999999999876667799999874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 962 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-34 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 0.002 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-32 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-04 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-32 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-04 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-31 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-04 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-30 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-05 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-28 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 0.001 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-27 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-04 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-27 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 0.002 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-27 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-04 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-27 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 0.003 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-27 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-07 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-26 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-04 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-26 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-04 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-26 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-25 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-07 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-25 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 0.002 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-25 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-05 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-25 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 0.001 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-24 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-24 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-04 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 0.002 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-07 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-23 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-08 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-23 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-08 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-23 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-04 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-23 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-23 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-04 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-23 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-23 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 0.004 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-23 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-23 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-22 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-22 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-22 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-22 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-22 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-07 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-22 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 0.001 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-22 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-04 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-21 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-21 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-21 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-21 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-05 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-21 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-21 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 0.002 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-20 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-20 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-06 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-20 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 0.001 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-20 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-20 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-20 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-20 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-19 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-05 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-19 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-18 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 0.002 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-18 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-08 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-17 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-04 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-16 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 0.002 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-15 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-10 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-04 | |
| d1ru4a_ | 400 | b.80.1.9 (A:) Pectate transeliminase {Erwinia chry | 6e-04 | |
| d1ofla_ | 481 | b.80.1.4 (A:) Chondroitinase B {Pedobacter heparin | 0.004 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 5e-34
Identities = 31/139 (22%), Positives = 62/139 (44%), Gaps = 3/139 (2%)
Query: 342 HVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDK 399
H+ + + R + L + + +V + + E+M + +
Sbjct: 40 HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG 99
Query: 400 FLPESIIRNMMYQVLQGLAFMH-RHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP 458
+PE I+ + V++GL ++ +H HRD+KP N+L +K+ DFG++ ++
Sbjct: 100 RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159
Query: 459 YTDYVSTRWYRAPEVLLHS 477
+V TR Y +PE L +
Sbjct: 160 ANSFVGTRSYMSPERLQGT 178
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (91), Expect = 0.002
Identities = 6/27 (22%), Positives = 12/27 (44%)
Query: 781 SPDAIHLMESMLAYNPSKRPTAQQSLS 807
S + + L NP++R +Q +
Sbjct: 271 SLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 2e-32
Identities = 33/141 (23%), Positives = 55/141 (39%), Gaps = 2/141 (1%)
Query: 338 ILSRHVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIR 395
+L + + + R + L H N+++L + +Y + EY
Sbjct: 38 VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL 97
Query: 396 DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR 455
+ E + ++ L++ H HRD+KPENLL +KIADFG +
Sbjct: 98 QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157
Query: 456 SRPYTDYVSTRWYRAPEVLLH 476
S T T Y PE++
Sbjct: 158 SSRRTTLCGTLDYLPPEMIEG 178
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (96), Expect = 4e-04
Identities = 17/65 (26%), Positives = 28/65 (43%), Gaps = 5/65 (7%)
Query: 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTA 802
Y L P + A+ + + RV FT + A L+ +L +NPS+RP
Sbjct: 195 YEFLVGKPPFE----ANTYQETYKRISRVEFT-FPDFVTEGARDLISRLLKHNPSQRPML 249
Query: 803 QQSLS 807
++ L
Sbjct: 250 REVLE 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 125 bits (315), Expect = 4e-32
Identities = 44/140 (31%), Positives = 67/140 (47%), Gaps = 4/140 (2%)
Query: 338 ILSRHVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIR 395
+S +E + + L+KL H N ++ + T + V EY + L+
Sbjct: 47 KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE 106
Query: 396 DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR 455
K L E I + + LQGLA++H H HRD+K N+L LVK+ DFG A +
Sbjct: 107 VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM- 165
Query: 456 SRPYTDYVSTRWYRAPEVLL 475
P +V T ++ APEV+L
Sbjct: 166 -APANSFVGTPYWMAPEVIL 184
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.8 bits (95), Expect = 6e-04
Identities = 14/66 (21%), Positives = 30/66 (45%), Gaps = 12/66 (18%)
Query: 778 PHASPDAIHLMESMLAYNPSKRPTAQQSLS---IKREVSLSFVL---------LKKLNRL 825
H S + ++S L P RPT++ L + RE + ++ +++L+ L
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNL 296
Query: 826 EKYRLK 831
+ ++K
Sbjct: 297 QYRKMK 302
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-31
Identities = 35/146 (23%), Positives = 71/146 (48%), Gaps = 5/146 (3%)
Query: 344 SSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKEN-LYQLIRDRDKF 400
+ +E + + L H N+VKL + + L+ + E+ + ++ + ++
Sbjct: 47 TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP 106
Query: 401 LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RP 458
L ES I+ + Q L L ++H + HRD+K N+L +K+ADFG++ + +
Sbjct: 107 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166
Query: 459 YTDYVSTRWYRAPEVLLHSTAYSAPI 484
++ T ++ APEV++ T+ P
Sbjct: 167 RDSFIGTPYWMAPEVVMCETSKDRPY 192
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (96), Expect = 3e-04
Identities = 8/36 (22%), Positives = 12/36 (33%)
Query: 772 PFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
P + S + ++ L N R T Q L
Sbjct: 233 PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-30
Identities = 43/133 (32%), Positives = 64/133 (48%), Gaps = 4/133 (3%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
K L+H N+VK RE + Y EY + D +PE + +Q++ G+
Sbjct: 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 116
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI----RSRPYTDYVSTRWYRAPEV 473
++H G HRD+KPENLL + +KI+DFGLA R R T Y APE+
Sbjct: 117 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 474 LLHSTAYSAPIHL 486
L ++ P+ +
Sbjct: 177 LKRREFHAEPVDV 189
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.1 bits (101), Expect = 9e-05
Identities = 10/65 (15%), Positives = 23/65 (35%), Gaps = 1/65 (1%)
Query: 744 ILLHTLPLYTCYTLASNMNFKFPQFR-RVPFTSIIPHASPDAIHLMESMLAYNPSKRPTA 802
+L L + S+ ++ ++ + + + + L+ +L NPS R T
Sbjct: 195 VLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITI 254
Query: 803 QQSLS 807
Sbjct: 255 PDIKK 259
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 2e-28
Identities = 39/146 (26%), Positives = 64/146 (43%), Gaps = 6/146 (4%)
Query: 338 ILSRHVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIR 395
IL + ++ V R + +L H VKL ++++ LYF Y K
Sbjct: 40 ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI 99
Query: 396 DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAR--- 452
+ E+ R +++ L ++H G HRD+KPEN+L ++I DFG A+
Sbjct: 100 RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159
Query: 453 -EIRSRPYTDYVSTRWYRAPEVLLHS 477
E + +V T Y +PE+L
Sbjct: 160 PESKQARANSFVGTAQYVSPELLTEK 185
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (91), Expect = 0.001
Identities = 7/35 (20%), Positives = 13/35 (37%)
Query: 775 SIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809
P A L+E +L + +KR ++
Sbjct: 228 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 262
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 112 bits (282), Expect = 2e-27
Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 4/126 (3%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVL 414
+ +L H L+ L + + + + E++ L+ I D + E+ + N M Q
Sbjct: 78 SIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 137
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTEL--VKIADFGLAREIRS-RPYTDYVSTRWYRAP 471
+GL MH H H D+KPEN++C + VKI DFGLA ++ +T + AP
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 197
Query: 472 EVLLHS 477
E++
Sbjct: 198 EIVDRE 203
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 42.4 bits (99), Expect = 2e-04
Identities = 19/116 (16%), Positives = 40/116 (34%), Gaps = 10/116 (8%)
Query: 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTA 802
Y+LL L + + + SP+A ++++L P KR T
Sbjct: 219 YVLLSGLSPFAGEDDLETL-QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 277
Query: 803 QQSLS---IKREVSLSFVLLKKLNRLEKYRLKNARETLQAKKSKVDSFNLQLQNLK 855
+L +K + S +R+ R R+ ++ K + + + +
Sbjct: 278 HDALEHPWLKGDHS------NLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIA 327
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-27
Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 7/126 (5%)
Query: 356 KSLKKLSHANLVKLKEV----IRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMY 411
+ LK L H N+V+ + ++ + V E M + R K + ++R+
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR 119
Query: 412 QVLQGLAFMHRHG--FFHRDMKPEN-LLCMGTELVKIADFGLAREIRSRPYTDYVSTRWY 468
Q+L+GL F+H HRD+K +N + T VKI D GLA R+ + T +
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEF 179
Query: 469 RAPEVL 474
APE+
Sbjct: 180 MAPEMY 185
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (91), Expect = 0.002
Identities = 8/39 (20%), Positives = 16/39 (41%)
Query: 769 RRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
V S A P+ ++E + N +R + + L+
Sbjct: 227 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 109 bits (274), Expect = 4e-27
Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 6/159 (3%)
Query: 336 NHILSRHVSSRDEMVVCFYR--KSLKKLS-HANLVKLKEVIRENDTLYFVFEYMK-ENLY 391
S E+ + L+K+S H N+++LK+ N + VF+ MK L+
Sbjct: 39 TGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF 98
Query: 392 QLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLA 451
+ ++ L E R +M +L+ + +H+ HRD+KPEN+L +K+ DFG +
Sbjct: 99 DYLTEKVT-LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 157
Query: 452 REI-RSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRS 489
++ + T Y APE++ S + P +
Sbjct: 158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEV 196
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 40.4 bits (94), Expect = 7e-04
Identities = 9/32 (28%), Positives = 14/32 (43%)
Query: 776 IIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
S L+ L P KR TA+++L+
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 6e-27
Identities = 31/143 (21%), Positives = 55/143 (38%), Gaps = 8/143 (5%)
Query: 341 RHVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDR 397
+ + + F L+K H N++ L V ++ + +LY +
Sbjct: 39 NVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII 97
Query: 398 DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI--- 454
+ + ++ Q QG+ ++H HRD+K N+ VKI DFGLA
Sbjct: 98 ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157
Query: 455 -RSRPYTDYVSTRWYRAPEVLLH 476
S + + + APEV+
Sbjct: 158 SGSHQFEQLSGSILWMAPEVIRM 180
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (89), Expect = 0.003
Identities = 7/41 (17%), Positives = 13/41 (31%)
Query: 767 QFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
+ + + + LM L +RP Q L+
Sbjct: 225 GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 7e-27
Identities = 59/168 (35%), Positives = 88/168 (52%), Gaps = 4/168 (2%)
Query: 339 LSRHVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRD 396
L ++D + R K L++LSH N++ L + + VF++M+ +L +I+D
Sbjct: 33 LGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD 92
Query: 397 RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS 456
L S I+ M LQGL ++H+H HRD+KP NLL ++K+ADFGLA+ S
Sbjct: 93 NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 152
Query: 457 --RPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPP 502
R YT V TRWYRAPE+L + Y + + L + VP
Sbjct: 153 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.6 bits (120), Expect = 4e-07
Identities = 14/47 (29%), Positives = 21/47 (44%)
Query: 760 NMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSL 806
F F +P I A D + L++ + +NP R TA Q+L
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 110 bits (276), Expect = 1e-26
Identities = 33/126 (26%), Positives = 60/126 (47%), Gaps = 4/126 (3%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDRDKFLPESIIRNMMYQVL 414
+++ L H LV L + +++ + ++E+M L++ + D + E M QV
Sbjct: 75 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134
Query: 415 QGLAFMHRHGFFHRDMKPENLLCM--GTELVKIADFGLAREIRSRPYTD-YVSTRWYRAP 471
+GL MH + + H D+KPEN++ + +K+ DFGL + + T + AP
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194
Query: 472 EVLLHS 477
EV
Sbjct: 195 EVAEGK 200
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 42.4 bits (99), Expect = 2e-04
Identities = 14/65 (21%), Positives = 21/65 (32%), Gaps = 1/65 (1%)
Query: 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTA 802
YILL L + + S S D + +L +P+ R T
Sbjct: 216 YILLSGLSPFGGENDDETL-RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTI 274
Query: 803 QQSLS 807
Q+L
Sbjct: 275 HQALE 279
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 2e-26
Identities = 46/151 (30%), Positives = 69/151 (45%), Gaps = 15/151 (9%)
Query: 341 RHVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVI--RENDTLYFVFEYM-KENLYQLIR 395
+ S + L++L H N+V+ + I R N TLY V EY +L +I
Sbjct: 38 DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT 97
Query: 396 DRDK---FLPESIIRNMMYQVLQGLAFMHR-----HGFFHRDMKPENLLCMGTELVKIAD 447
K +L E + +M Q+ L HR H HRD+KP N+ G + VK+ D
Sbjct: 98 KGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157
Query: 448 FGLAREIR--SRPYTDYVSTRWYRAPEVLLH 476
FGLAR + + +V T +Y +PE +
Sbjct: 158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNR 188
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (100), Expect = 1e-04
Identities = 13/64 (20%), Positives = 24/64 (37%), Gaps = 4/64 (6%)
Query: 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTA 802
Y L +P +T ++ + R F I S + ++ ML RP+
Sbjct: 205 YELCALMPPFTAFSQKELAG----KIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSV 260
Query: 803 QQSL 806
++ L
Sbjct: 261 EEIL 264
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 108 bits (270), Expect = 6e-26
Identities = 33/127 (25%), Positives = 52/127 (40%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
+ +V + D L F+ + M + E+ +R +++ GL
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHS 477
MH +RD+KP N+L V+I+D GLA + + V T Y APEVL
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 180
Query: 478 TAYSAPI 484
AY +
Sbjct: 181 VAYDSSA 187
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 106 bits (264), Expect = 1e-25
Identities = 54/132 (40%), Positives = 77/132 (58%), Gaps = 2/132 (1%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVL 414
LK+L H+N+VKL +VI L VFE++ ++L +L+ + L ++ + Q+L
Sbjct: 51 ISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLL 110
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAPE 472
G+A+ H HRD+KP+NLL +KIADFGLAR R YT + T WYRAP+
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170
Query: 473 VLLHSTAYSAPI 484
VL+ S YS I
Sbjct: 171 VLMGSKKYSTTI 182
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 50.7 bits (120), Expect = 3e-07
Identities = 13/48 (27%), Positives = 24/48 (50%)
Query: 760 NMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
+ F + +P+ S + I L+ ML +P++R TA+Q+L
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 1e-25
Identities = 40/137 (29%), Positives = 61/137 (44%), Gaps = 6/137 (4%)
Query: 345 SRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDT-LYFVFEYMKE-NLYQLIRDRDK- 399
D F + +L H+NLV+L VI E LY V EYM + +L +R R +
Sbjct: 39 KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 98
Query: 400 FLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY 459
L + V + + ++ + F HRD+ N+L + K++DFGL +E S
Sbjct: 99 VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 158
Query: 460 TDYVSTRWYRAPEVLLH 476
T + APE L
Sbjct: 159 T-GKLPVKWTAPEALRE 174
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (90), Expect = 0.002
Identities = 9/66 (13%), Positives = 22/66 (33%), Gaps = 13/66 (19%)
Query: 765 FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIKREVSLSFVLLKKLNR 824
P+ + P +M++ + + RP+ Q L ++L
Sbjct: 210 VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQ-------------LREQLEH 256
Query: 825 LEKYRL 830
++ + L
Sbjct: 257 IKTHEL 262
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 3e-25
Identities = 54/178 (30%), Positives = 83/178 (46%), Gaps = 16/178 (8%)
Query: 341 RHVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRE--------NDTLYFVFEYMKENL 390
+ ++ + R K L+ L H N+V L E+ R ++Y VF++ + +L
Sbjct: 44 LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL 103
Query: 391 YQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGL 450
L+ + S I+ +M +L GL ++HR+ HRDMK N+L ++K+ADFGL
Sbjct: 104 AGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 163
Query: 451 AREIRS------RPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPP 502
AR YT+ V T WYR PE+LL Y PI L + + P
Sbjct: 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (108), Expect = 1e-05
Identities = 13/61 (21%), Positives = 25/61 (40%)
Query: 747 HTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSL 806
P Y L + Q R+V P A+ L++ +L +P++R + +L
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
Query: 807 S 807
+
Sbjct: 304 N 304
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 3e-25
Identities = 32/122 (26%), Positives = 54/122 (44%), Gaps = 3/122 (2%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
+++ + N+V + D L+ V EY+ + E I + + LQ L
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQAL 129
Query: 418 AFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI--RSRPYTDYVSTRWYRAPEVLL 475
F+H + HRD+K +N+L VK+ DFG +I + V T ++ APEV+
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 476 HS 477
Sbjct: 190 RK 191
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (92), Expect = 0.001
Identities = 7/39 (17%), Positives = 12/39 (30%)
Query: 769 RRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
P S + L + KR +A++ L
Sbjct: 231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 1e-24
Identities = 44/171 (25%), Positives = 71/171 (41%), Gaps = 8/171 (4%)
Query: 338 ILSRHVSSRDEMVVCFYRKS---LKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQL 393
L + V D+ V C + H L + + + L+FV EY+ +L
Sbjct: 34 ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYH 93
Query: 394 IRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLARE 453
I+ KF S +++ GL F+H G +RD+K +N+L +KIADFG+ +E
Sbjct: 94 IQSCHKF-DLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 152
Query: 454 IRSR--PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPP 502
+ T Y APE+LL Y+ + L+ + P
Sbjct: 153 NMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 3e-24
Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 11/170 (6%)
Query: 358 LKKLSHANLVKLKEVIR----ENDTLYFVFEYMK-ENLYQLIRDR-DKFLPESIIRNMMY 411
+ ++V++ +V L V E + L+ I+DR D+ E +M
Sbjct: 59 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118
Query: 412 QVLQGLAFMHRHGFFHRDMKPENLL---CMGTELVKIADFGLAREIRS-RPYTDYVSTRW 467
+ + + ++H HRD+KPENLL ++K+ DFG A+E S T T +
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 178
Query: 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKS 517
Y APEV L Y + ++ + PP + LA + +K+
Sbjct: 179 YVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 227
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (97), Expect = 3e-04
Identities = 12/83 (14%), Positives = 34/83 (40%), Gaps = 4/83 (4%)
Query: 778 PHASPDAIHLMESMLAYNPSKRPTAQQSLS---IKREVSLSFVLLKKLNRLEKYRLKNAR 834
S + L+ ++L P++R T + ++ I + + L +R+ K +
Sbjct: 242 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL-HTSRVLKEDKERWE 300
Query: 835 ETLQAKKSKVDSFNLQLQNLKYE 857
+ + S + + + + +K +
Sbjct: 301 DVKEEMTSALATMRVDYEQIKIK 323
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 4e-24
Identities = 39/153 (25%), Positives = 71/153 (46%), Gaps = 6/153 (3%)
Query: 355 RKSLKKLS--HANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMM 410
LKK+S + +++L + D+ + E + ++L+ I +R L E + R+
Sbjct: 58 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF 116
Query: 411 YQVLQGLAFMHRHGFFHRDMKPEN-LLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYR 469
+QVL+ + H G HRD+K EN L+ + +K+ DFG ++ YTD+ TR Y
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYS 176
Query: 470 APEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPP 502
PE + + + + L+ + P
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (90), Expect = 0.002
Identities = 10/30 (33%), Positives = 15/30 (50%)
Query: 778 PHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
S + HL+ LA PS RPT ++ +
Sbjct: 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 7e-24
Identities = 49/158 (31%), Positives = 87/158 (55%), Gaps = 11/158 (6%)
Query: 356 KSLKKLSHANLVKLKEVIRENDT------LYFVFEYMKENLYQLIRDRDKF---LPESII 406
+ ++KL H N+V+L+ + L V +Y+ E +Y++ R + LP +
Sbjct: 65 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 407 RNMMYQVLQGLAFMHRHGFFHRDMKPENL-LCMGTELVKIADFGLAREI-RSRPYTDYVS 464
+ MYQ+ + LA++H G HRD+KP+NL L T ++K+ DFG A+++ R P Y+
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPP 502
+R+YRAPE++ +T Y++ I + + L + P
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (122), Expect = 3e-07
Identities = 18/65 (27%), Positives = 29/65 (44%), Gaps = 1/65 (1%)
Query: 744 ILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSII-PHASPDAIHLMESMLAYNPSKRPTA 802
+L + FKFPQ + P+T + P P+AI L +L Y P+ R T
Sbjct: 238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297
Query: 803 QQSLS 807
++ +
Sbjct: 298 LEACA 302
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 1e-23
Identities = 52/139 (37%), Positives = 77/139 (55%), Gaps = 12/139 (8%)
Query: 356 KSLKKLSHANLVKLKEVIRENDT-----LYFVFEYMKENLYQLIRDRDKFLPESIIRNMM 410
K L + H N++ + ++IR +Y V M +LY+L++ + L I +
Sbjct: 58 KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFL 115
Query: 411 YQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS-----RPYTDYVST 465
YQ+L+GL ++H HRD+KP NLL T +KI DFGLAR T+YV+T
Sbjct: 116 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175
Query: 466 RWYRAPEVLLHSTAYSAPI 484
RWYRAPE++L+S Y+ I
Sbjct: 176 RWYRAPEIMLNSKGYTKSI 194
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.1 bits (129), Expect = 4e-08
Identities = 17/50 (34%), Positives = 28/50 (56%)
Query: 758 ASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
A N P +VP+ + P+A A+ L++ ML +NP KR +Q+L+
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 1e-23
Identities = 54/153 (35%), Positives = 82/153 (53%), Gaps = 9/153 (5%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTL------YFVFEYMKENLYQLIRDRDKFLPESIIRNM 409
+ LK + H N++ L +V ++TL Y V +M +L +L++ L E I+ +
Sbjct: 69 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDRIQFL 126
Query: 410 MYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYR 469
+YQ+L+GL ++H G HRD+KP NL +KI DFGLAR+ S T YV TRWYR
Sbjct: 127 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-MTGYVVTRWYR 185
Query: 470 APEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPP 502
APEV+L+ Y+ + + + I
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.6 bits (133), Expect = 1e-08
Identities = 22/91 (24%), Positives = 38/91 (41%)
Query: 717 LPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSI 776
+ T + L E +K + A N P+ + F SI
Sbjct: 210 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI 269
Query: 777 IPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
+ +ASP A++L+E ML + +R TA ++L+
Sbjct: 270 LTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 1e-23
Identities = 38/139 (27%), Positives = 68/139 (48%), Gaps = 4/139 (2%)
Query: 342 HVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKF 400
V D+++V L H N++ L E + L +FE++ ++++ I
Sbjct: 39 KVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE 98
Query: 401 LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM--GTELVKIADFGLAREIR-SR 457
L E I + ++QV + L F+H H H D++PEN++ + +KI +FG AR+++
Sbjct: 99 LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158
Query: 458 PYTDYVSTRWYRAPEVLLH 476
+ + Y APEV H
Sbjct: 159 NFRLLFTAPEYYAPEVHQH 177
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (98), Expect = 2e-04
Identities = 15/104 (14%), Positives = 37/104 (35%), Gaps = 5/104 (4%)
Query: 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTA 802
Y+LL + + T + S +A+ ++ +L R TA
Sbjct: 194 YVLLSGINPFLAETNQQIIE-NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTA 252
Query: 803 QQSLS---IKREVS-LSFVLLKKLNRLEKYRLKNARETLQAKKS 842
++L +K+++ +S +++ L Y ++ +
Sbjct: 253 SEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSA 296
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 100 bits (249), Expect = 2e-23
Identities = 31/139 (22%), Positives = 64/139 (46%), Gaps = 3/139 (2%)
Query: 338 ILSRHVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIR 395
+L + + R + V L ++H ++++ ++ ++ + +Y++ +
Sbjct: 36 VLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL 95
Query: 396 DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR 455
+ + P + + +V L ++H +RD+KPEN+L +KI DFG A+ +
Sbjct: 96 RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155
Query: 456 SRPYTDYVSTRWYRAPEVL 474
YT T Y APEV+
Sbjct: 156 DVTYT-LCGTPDYIAPEVV 173
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 100 bits (249), Expect = 2e-23
Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 7/170 (4%)
Query: 338 ILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRD 396
+++ E + L K+ H N+V L ++ LY + + + L+ I +
Sbjct: 41 CIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE 100
Query: 397 RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLC---MGTELVKIADFGLARE 453
+ F E +++QVL + ++H G HRD+KPENLL + I+DFGL++
Sbjct: 101 K-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159
Query: 454 I-RSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPP 502
+ T Y APEVL YS + + + PP
Sbjct: 160 EDPGSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.7 bits (100), Expect = 1e-04
Identities = 18/99 (18%), Positives = 39/99 (39%), Gaps = 6/99 (6%)
Query: 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTA 802
YILL P + A + + + + S A + ++ +P KR T
Sbjct: 200 YILLCGYPPFYDENDA-KLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTC 258
Query: 803 QQSLS---IKREVSLSFVLLKKLNRLEKYRLKNARETLQ 838
+Q+L I + +L + + ++ E+ + A+ +
Sbjct: 259 EQALQHPWIAGDTALDKNIHQSVS--EQIKKNFAKSKWK 295
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 2e-23
Identities = 29/143 (20%), Positives = 61/143 (42%), Gaps = 9/143 (6%)
Query: 342 HVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRD 398
+ R + + +L + +V+L V + + L V E L++ + +
Sbjct: 45 KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR 103
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP 458
+ +P S + +++QV G+ ++ F HRD+ N+L + KI+DFGL++ + +
Sbjct: 104 EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163
Query: 459 YTDYVS-----TRWYRAPEVLLH 476
+ APE +
Sbjct: 164 SYYTARSAGKWPLKWYAPECINF 186
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 5e-23
Identities = 37/154 (24%), Positives = 59/154 (38%), Gaps = 8/154 (5%)
Query: 338 ILSRHVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLI 394
L V S+ E + F R ++ L H NL++L V+ + V E +L +
Sbjct: 43 CLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRL 101
Query: 395 RDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI 454
R + QV +G+ ++ F HRD+ NLL +LVKI DFGL R +
Sbjct: 102 RKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161
Query: 455 RSRPYTDYVSTR----WYRAPEVLLHSTAYSAPI 484
+ + L + +S
Sbjct: 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS 195
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (87), Expect = 0.004
Identities = 8/37 (21%), Positives = 11/37 (29%)
Query: 776 IIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIKREV 812
D ++M A+ P RPT E
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 6e-23
Identities = 44/169 (26%), Positives = 68/169 (40%), Gaps = 5/169 (2%)
Query: 338 ILSRHVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIR 395
IL + V + V + L+ H L LK + +D L FV EY
Sbjct: 37 ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL 96
Query: 396 DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR 455
R++ E R +++ L ++H +RD+K ENL+ +KI DFGL +E
Sbjct: 97 SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156
Query: 456 SRPYT--DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPP 502
S T + T Y APEVL + Y + ++ + P
Sbjct: 157 SDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.1 bits (241), Expect = 6e-23
Identities = 37/144 (25%), Positives = 62/144 (43%), Gaps = 6/144 (4%)
Query: 338 ILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRD 396
++ S DE + K + LSH LV+L V + ++ + EYM L +R+
Sbjct: 35 MIKEGSMSEDEFIEE--AKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE 92
Query: 397 RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS 456
+ M V + + ++ F HRD+ N L +VK++DFGL+R +
Sbjct: 93 MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152
Query: 457 RPY---TDYVSTRWYRAPEVLLHS 477
Y + PEVL++S
Sbjct: 153 DEYTSSVGSKFPVRWSPPEVLMYS 176
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 1e-22
Identities = 41/168 (24%), Positives = 65/168 (38%), Gaps = 28/168 (16%)
Query: 338 ILSRHVSSRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIR 395
+L S + + K + +L SH N+V L + +Y +FEY +L +R
Sbjct: 74 MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 133
Query: 396 DRDK----------------------FLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPE 433
+ + L + YQV +G+ F+ HRD+
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193
Query: 434 NLLCMGTELVKIADFGLAREIRSRPY----TDYVSTRWYRAPEVLLHS 477
N+L ++VKI DFGLAR+I S + + APE L
Sbjct: 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 241
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.6 bits (240), Expect = 1e-22
Identities = 38/126 (30%), Positives = 60/126 (47%), Gaps = 6/126 (4%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQ--LIRDRDKFLPESIIRNMMYQV 413
+K+L H LV+L V+ + +Y + EYM+ L L + + +M Q+
Sbjct: 60 NLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY---TDYVSTRWYRA 470
+G+AF+ + HRD++ N+L T KIADFGLAR I Y + A
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178
Query: 471 PEVLLH 476
PE + +
Sbjct: 179 PEAINY 184
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.5 bits (237), Expect = 2e-22
Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 4/126 (3%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVL 414
+ + KLSH LV+L V E + VFE+M+ L +R + + M V
Sbjct: 52 EVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 111
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTD---YVSTRWYRAP 471
+G+A++ HRD+ N L +++K++DFG+ R + YT + +P
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171
Query: 472 EVLLHS 477
EV S
Sbjct: 172 EVFSFS 177
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.9 bits (238), Expect = 2e-22
Identities = 27/133 (20%), Positives = 60/133 (45%), Gaps = 6/133 (4%)
Query: 355 RKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVL 414
+++L + +V++ + E ++ V E + +++ + + I +++QV
Sbjct: 59 ANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117
Query: 415 QGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY-----TDYVSTRWYR 469
G+ ++ F HRD+ N+L + KI+DFGL++ +R+ T +
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 470 APEVLLHSTAYSA 482
APE + + S
Sbjct: 178 APECINYYKFSSK 190
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.5 bits (239), Expect = 2e-22
Identities = 60/149 (40%), Positives = 87/149 (58%), Gaps = 5/149 (3%)
Query: 341 RHVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRD 398
R + + + R LK+L+H N+VKL +VI + LY VFE++ ++L + +
Sbjct: 36 RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA 95
Query: 399 -KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI--R 455
+P +I++ ++Q+LQGLAF H H HRD+KP+NLL +K+ADFGLAR
Sbjct: 96 LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155
Query: 456 SRPYTDYVSTRWYRAPEVLLHSTAYSAPI 484
R YT V T WYRAPE+LL YS +
Sbjct: 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.2 bits (124), Expect = 1e-07
Identities = 16/57 (28%), Positives = 31/57 (54%)
Query: 751 LYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
++ T + FP++ R F+ ++P D L+ ML Y+P+KR +A+ +L+
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.4 bits (234), Expect = 7e-22
Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 7/151 (4%)
Query: 338 ILSRHVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLI 394
I + + D + F + ++++ H ++VKL VI EN ++ + E L +
Sbjct: 40 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL 98
Query: 395 RDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI 454
+ R L + + YQ+ LA++ F HRD+ N+L + VK+ DFGL+R +
Sbjct: 99 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158
Query: 455 RSRPY---TDYVSTRWYRAPEVLLHSTAYSA 482
Y + + APE + SA
Sbjct: 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSA 189
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (92), Expect = 0.001
Identities = 15/89 (16%), Positives = 26/89 (29%)
Query: 716 TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTS 775
LP+ I + ++ + L N +
Sbjct: 170 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 229
Query: 776 IIPHASPDAIHLMESMLAYNPSKRPTAQQ 804
+ P+ P LM AY+PS+RP +
Sbjct: 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTE 258
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.8 bits (235), Expect = 7e-22
Identities = 32/125 (25%), Positives = 57/125 (45%), Gaps = 5/125 (4%)
Query: 358 LKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGL 417
LK++ H N++ L EV + + E + + L E + Q+L G+
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 418 AFMHRHGFFHRDMKPENLLC----MGTELVKIADFGLAREI-RSRPYTDYVSTRWYRAPE 472
++H H D+KPEN++ + +KI DFGLA +I + + T + APE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 473 VLLHS 477
++ +
Sbjct: 187 IVNYE 191
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 4e-04
Identities = 10/32 (31%), Positives = 14/32 (43%)
Query: 776 IIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
+ S A + +L +P KR T Q SL
Sbjct: 239 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.1 bits (233), Expect = 2e-21
Identities = 25/143 (17%), Positives = 52/143 (36%), Gaps = 4/143 (2%)
Query: 338 ILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDR 397
L S + + + + + ++ +L + + L +R+
Sbjct: 45 ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH 104
Query: 398 DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR 457
+ + N Q+ +G+ ++ HRD+ N+L + VKI DFGLA+ + +
Sbjct: 105 KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164
Query: 458 PY----TDYVSTRWYRAPEVLLH 476
+ A E +LH
Sbjct: 165 EKEYHAEGGKVPIKWMALESILH 187
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (230), Expect = 2e-21
Identities = 33/149 (22%), Positives = 67/149 (44%), Gaps = 8/149 (5%)
Query: 342 HVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLY-QLIRDRD 398
++ V F + + SH N+++L+ VI + + + EYM+ + +R++D
Sbjct: 45 KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD 104
Query: 399 KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP 458
+ M+ + G+ ++ + HRD+ N+L + K++DFGL+R + P
Sbjct: 105 GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164
Query: 459 YTDYVS-----TRWYRAPEVLLHSTAYSA 482
Y + + APE + + SA
Sbjct: 165 EATYTTSGGKIPIRWTAPEAISYRKFTSA 193
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 93.4 bits (231), Expect = 3e-21
Identities = 31/135 (22%), Positives = 51/135 (37%), Gaps = 13/135 (9%)
Query: 355 RKSLKKLSHANLVK-LKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQV 413
K K + + ++ E D V E + +L L + + + Q+
Sbjct: 53 SKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQM 112
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCM---GTELVKIADFGLAREIRS---------RPYTD 461
+ + ++H F HRD+KP+N L LV I DFGLA++ R R +
Sbjct: 113 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 462 YVSTRWYRAPEVLLH 476
T Y + L
Sbjct: 173 LTGTARYASINTHLG 187
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.1 bits (230), Expect = 3e-21
Identities = 49/131 (37%), Positives = 75/131 (57%), Gaps = 2/131 (1%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQ 415
LK+L H N+V+L +V+ + L VFE+ ++L + + L I+++ ++Q+L+
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 416 GLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS--RPYTDYVSTRWYRAPEV 473
GL F H HRD+KP+NLL +K+A+FGLAR R Y+ V T WYR P+V
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 474 LLHSTAYSAPI 484
L + YS I
Sbjct: 173 LFGAKLYSTSI 183
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (104), Expect = 3e-05
Identities = 8/39 (20%), Positives = 21/39 (53%)
Query: 769 RRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
+++P + L++++L NP +R +A+++L
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 92.9 bits (230), Expect = 4e-21
Identities = 28/153 (18%), Positives = 62/153 (40%), Gaps = 8/153 (5%)
Query: 338 ILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRD 396
L + + + + H N++ L+ V+ ++ + + E+M+ +L +R
Sbjct: 61 TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120
Query: 397 RDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS 456
D + M+ + G+ ++ + HRD+ N+L + K++DFGL+R +
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 457 RPYTDYVS-------TRWYRAPEVLLHSTAYSA 482
+ + APE + + SA
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA 213
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 92.5 bits (229), Expect = 4e-21
Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 5/126 (3%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQV 413
+K++ H NLV+L V Y + E+M L L + + ++ M Q+
Sbjct: 65 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTR---WYRA 470
+ ++ + F HRD+ N L LVK+ADFGL+R + YT + + + A
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 471 PEVLLH 476
PE L +
Sbjct: 185 PESLAY 190
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 39.3 bits (91), Expect = 0.002
Identities = 12/49 (24%), Positives = 22/49 (44%), Gaps = 4/49 (8%)
Query: 778 PHASPDAIHLMESMLAYNPSKRPTAQQSL----SIKREVSLSFVLLKKL 822
LM + +NPS RP+ + ++ +E S+S + K+L
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 287
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 90.6 bits (224), Expect = 1e-20
Identities = 35/156 (22%), Positives = 62/156 (39%), Gaps = 11/156 (7%)
Query: 338 ILSRHVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDT----LYFVFEYMKENLY 391
+L ++ + F R ++ L+H +V + + Y V EY+
Sbjct: 39 VLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL 98
Query: 392 QLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLA 451
+ I + + ++ Q L F H++G HRD+KP N++ T VK+ DFG+A
Sbjct: 99 RDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 158
Query: 452 REI-----RSRPYTDYVSTRWYRAPEVLLHSTAYSA 482
R I + T Y +PE + +
Sbjct: 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR 194
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.1 bits (225), Expect = 2e-20
Identities = 53/136 (38%), Positives = 81/136 (59%), Gaps = 8/136 (5%)
Query: 356 KSLKKLSHANLVKLKEVIRENDT-----LYFVFEYM-KENLYQLIRDRDKFLPESIIRNM 409
+ L+ H N+V+L +V + T L VFE++ ++ L + + +P I++M
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 410 MYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS-RPYTDYVSTRWY 468
M+Q+L+GL F+H H HRD+KP+N+L + +K+ADFGLAR T V T WY
Sbjct: 122 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 181
Query: 469 RAPEVLLHSTAYSAPI 484
RAPEVLL S+ Y+ P+
Sbjct: 182 RAPEVLLQSS-YATPV 196
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.8 bits (110), Expect = 7e-06
Identities = 11/63 (17%), Positives = 20/63 (31%)
Query: 745 LLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQ 804
++ + F P + L+ L +NP+KR +A
Sbjct: 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289
Query: 805 SLS 807
+LS
Sbjct: 290 ALS 292
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (221), Expect = 6e-20
Identities = 37/171 (21%), Positives = 59/171 (34%), Gaps = 25/171 (14%)
Query: 342 HVSSRDEMVVCFYR--KSLKKLS-HANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRDR 397
S+ K L L H N+V L + EY +L +R +
Sbjct: 62 KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 398 -----------------DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT 440
+ L + + YQV +G+AF+ HRD+ N+L
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181
Query: 441 ELVKIADFGLAREIRSRPY----TDYVSTRWYRAPEVLLHSTAYSAPIHLS 487
+ KI DFGLAR+I++ + + APE + + S
Sbjct: 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 232
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (91), Expect = 0.001
Identities = 18/74 (24%), Positives = 35/74 (47%), Gaps = 2/74 (2%)
Query: 744 ILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIP-HASPDAIHLMESMLAYNPSKRPTA 802
L L + ++ KF + + F + P HA + +M++ +P KRPT
Sbjct: 236 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF 295
Query: 803 QQSLS-IKREVSLS 815
+Q + I++++S S
Sbjct: 296 KQIVQLIEKQISES 309
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 90.2 bits (223), Expect = 6e-20
Identities = 37/141 (26%), Positives = 64/141 (45%), Gaps = 3/141 (2%)
Query: 338 ILSRHVSSRDEMVVCFYR--KSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIR 395
IL + + + + + L+ ++ LVKL+ ++N LY V EY+
Sbjct: 73 ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 396 DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR 455
R E R Q++ ++H +RD+KPENLL +++ DFG A+ ++
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 456 SRPYTDYVSTRWYRAPEVLLH 476
R +T T APE++L
Sbjct: 193 GRTWT-LCGTPEALAPEIILS 212
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 8e-20
Identities = 32/156 (20%), Positives = 56/156 (35%), Gaps = 17/156 (10%)
Query: 356 KSLKKLSHANLVKLKEVIREND----TLYFVFEYMK-ENLYQLIRDRDKFLPE------S 404
L H N++ +++ L+ V +Y + +L+ + + S
Sbjct: 49 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS 108
Query: 405 IIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT---- 460
+ + ++ + + HRD+K +N+L IAD GLA S T
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 168
Query: 461 --DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLF 494
V T+ Y APEVL S R+ +
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 88.7 bits (219), Expect = 8e-20
Identities = 23/134 (17%), Positives = 46/134 (34%), Gaps = 15/134 (11%)
Query: 358 LKKLSHAN-LVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQG 416
K L+ + + +E V + + +L L+ + + Q+L
Sbjct: 54 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLAR 113
Query: 417 LAFMHRHGFFHRDMKPENLL-----CMGTELVKIADFGLAREIRS---------RPYTDY 462
+ +H +RD+KP+N L ++ + DFG+ + R R +
Sbjct: 114 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173
Query: 463 VSTRWYRAPEVLLH 476
T Y + L
Sbjct: 174 SGTARYMSINTHLG 187
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.2 bits (218), Expect = 9e-20
Identities = 41/127 (32%), Positives = 63/127 (49%), Gaps = 6/127 (4%)
Query: 356 KSLKKLSHANLVKLKEVIRENDTLYFVFEYMK--ENLYQLIRDRDKFLPESIIRNMMYQV 413
+ +KKL H LV+L V+ + +Y V EYM L L + K+L + +M Q+
Sbjct: 64 QVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 122
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY---TDYVSTRWYRA 470
G+A++ R + HRD++ N+L + K+ADFGLAR I Y + A
Sbjct: 123 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 182
Query: 471 PEVLLHS 477
PE L+
Sbjct: 183 PEAALYG 189
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 88.7 bits (219), Expect = 1e-19
Identities = 38/153 (24%), Positives = 74/153 (48%), Gaps = 8/153 (5%)
Query: 356 KSLKKLS-HANLVKLKEVIRE--NDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQ 412
K L+ L N++ L +++++ + T VFE++ + + + L + IR MY+
Sbjct: 81 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF---KQLYQTLTDYDIRFYMYE 137
Query: 413 VLQGLAFMHRHGFFHRDMKPEN-LLCMGTELVKIADFGLAREIRS-RPYTDYVSTRWYRA 470
+L+ L + H G HRD+KP N ++ +++ D+GLA + Y V++R+++
Sbjct: 138 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 197
Query: 471 PEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPI 503
PE+L+ Y + + L I P
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 46.0 bits (108), Expect = 1e-05
Identities = 9/46 (19%), Positives = 22/46 (47%)
Query: 762 NFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807
++ R + SP+A+ ++ +L Y+ R TA++++
Sbjct: 273 RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 87.6 bits (216), Expect = 2e-19
Identities = 38/167 (22%), Positives = 62/167 (37%), Gaps = 28/167 (16%)
Query: 338 ILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM-KENLYQLIRD 396
+L S+ + + + + N+VKL V + +FEYM +L + +R
Sbjct: 50 MLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRS 109
Query: 397 RDKF-----------------------LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPE 433
L + + QV G+A++ F HRD+
Sbjct: 110 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169
Query: 434 NLLCMGTELVKIADFGLAREIRSRPY----TDYVSTRWYRAPEVLLH 476
N L +VKIADFGL+R I S Y + + PE + +
Sbjct: 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (208), Expect = 3e-18
Identities = 37/158 (23%), Positives = 56/158 (35%), Gaps = 18/158 (11%)
Query: 338 ILSRHVSSRDEMVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIR 395
+ + S D + L KL H N++ L LY EY NL +R
Sbjct: 44 RMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR 103
Query: 396 DRDKF---------------LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT 440
L + + V +G+ ++ + F HRD+ N+L
Sbjct: 104 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163
Query: 441 ELVKIADFGLAREIRS-RPYTDYVSTRWYRAPEVLLHS 477
+ KIADFGL+R T + A E L +S
Sbjct: 164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS 201
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 0.002
Identities = 19/100 (19%), Positives = 33/100 (33%), Gaps = 16/100 (16%)
Query: 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTA 802
+ ++ C + + K PQ R+ + + LM P +RP+
Sbjct: 217 WEIVSLGGTPYCGMTCAELYEKLPQGYRLE---KPLNCDDEVYDLMRQCWREKPYERPSF 273
Query: 803 QQSLSIKREVSLSFVLLKKLNRLEKYRLKNARETLQAKKS 842
Q +L LNR+ + R TL K +
Sbjct: 274 AQ-------------ILVSLNRMLEERKTYVNTTLYEKFT 300
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (209), Expect = 4e-18
Identities = 43/135 (31%), Positives = 71/135 (52%), Gaps = 9/135 (6%)
Query: 356 KSLKKLSHANLVKLKEVIR------ENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNM 409
+ LK + H N++ L +V E + +Y V M +L +++ + L + ++ +
Sbjct: 69 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFL 126
Query: 410 MYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYR 469
+YQ+L+GL ++H HRD+KP NL +KI DFGLAR TRWYR
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-TRWYR 185
Query: 470 APEVLLHSTAYSAPI 484
APE++L+ Y+ +
Sbjct: 186 APEIMLNWMHYNQTV 200
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (127), Expect = 6e-08
Identities = 19/69 (27%), Positives = 30/69 (43%)
Query: 739 LKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSK 798
L+ L A N Q ++ F ++ A+P A+ L+E ML + K
Sbjct: 232 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291
Query: 799 RPTAQQSLS 807
R TA Q+L+
Sbjct: 292 RITAAQALA 300
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (204), Expect = 1e-17
Identities = 36/149 (24%), Positives = 59/149 (39%), Gaps = 10/149 (6%)
Query: 344 SSRDEMVVCFYR--KSLKKLSHANLVKLKEVIREND-TLYFVFEYMKE-NLYQLIRDRDK 399
+ V F +K SH N++ L + ++ + V YMK +L IR+
Sbjct: 66 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 125
Query: 400 FLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY 459
+ QV +G+ F+ F HRD+ N + VK+ADFGLAR++ + +
Sbjct: 126 NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185
Query: 460 ------TDYVSTRWYRAPEVLLHSTAYSA 482
T + A E L +
Sbjct: 186 DSVHNKTGAKLPVKWMALESLQTQKFTTK 214
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 4e-17
Identities = 31/155 (20%), Positives = 61/155 (39%), Gaps = 14/155 (9%)
Query: 338 ILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIRD 396
++ S R+ + +K+ + ++V+L V+ + + E M +L +R
Sbjct: 57 TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS 116
Query: 397 RDKF---------LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIAD 447
S + M ++ G+A+++ + F HRD+ N + VKI D
Sbjct: 117 LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176
Query: 448 FGLAREIRSRPY----TDYVSTRWYRAPEVLLHST 478
FG+ R+I Y + + +PE L
Sbjct: 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV 211
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.8 bits (198), Expect = 9e-17
Identities = 47/126 (37%), Positives = 67/126 (53%), Gaps = 10/126 (7%)
Query: 358 LKKLSHANLVKLKEVIR------ENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMY 411
+K ++H N++ L V E +Y V E M NL Q+I+ + ++Y
Sbjct: 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLY 126
Query: 412 QVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR-SRPYTDYVSTRWYRA 470
Q+L G+ +H G HRD+KP N++ +KI DFGLAR S T YV TR+YRA
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 471 PEVLLH 476
PEV+L
Sbjct: 187 PEVILG 192
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (100), Expect = 1e-04
Identities = 12/66 (18%), Positives = 23/66 (34%), Gaps = 12/66 (18%)
Query: 754 CYTLASNMNFKFPQFRRVPFTSIIPHA------------SPDAIHLMESMLAYNPSKRPT 801
N P++ + F + P + + A L+ ML +P+KR +
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
Query: 802 AQQSLS 807
+L
Sbjct: 305 VDDALQ 310
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.2 bits (189), Expect = 6e-16
Identities = 38/160 (23%), Positives = 68/160 (42%), Gaps = 21/160 (13%)
Query: 338 ILSRHVSSRDEMVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMKE-NLYQLIR 395
+L + +D + + +K + H N++ L ++ LY + EY + NL + ++
Sbjct: 52 MLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ 111
Query: 396 DR---------------DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT 440
R ++ L + + YQV +G+ ++ HRD+ N+L
Sbjct: 112 ARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 171
Query: 441 ELVKIADFGLAREIRSRPYTD----YVSTRWYRAPEVLLH 476
++KIADFGLAR+I Y + APE L
Sbjct: 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 211
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (90), Expect = 0.002
Identities = 11/52 (21%), Positives = 22/52 (42%), Gaps = 1/52 (1%)
Query: 765 FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS-IKREVSLS 815
F + + + + +M PS+RPT +Q + + R V+L+
Sbjct: 247 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.8 bits (188), Expect = 1e-15
Identities = 41/187 (21%), Positives = 63/187 (33%), Gaps = 22/187 (11%)
Query: 338 ILSRHVSSRDEMVVCFYRKSLKKLSH-ANLVKLKEVIRE-NDTLYFVFEYMKE-NLYQLI 394
+L + + + K L + H N+V L + L + E+ K NL +
Sbjct: 50 MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 109
Query: 395 RDRDK---------------FLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG 439
R + FL + +QV +G+ F+ HRD+ N+L
Sbjct: 110 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169
Query: 440 TELVKIADFGLAREIRSRPY----TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFY 495
+VKI DFGLAR+I P D + APE + S
Sbjct: 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 229
Query: 496 SIDHVPP 502
P
Sbjct: 230 FSLGASP 236
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.4 bits (187), Expect = 2e-15
Identities = 26/130 (20%), Positives = 56/130 (43%), Gaps = 4/130 (3%)
Query: 355 RKSLKKLSHA-NLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQV 413
R+ L+ + + LV L + L+ + +Y+ + + E ++ + ++
Sbjct: 79 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 138
Query: 414 LQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTR---WYRA 470
+ L +H+ G +RD+K EN+L V + DFGL++E + Y A
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 471 PEVLLHSTAY 480
P+++ +
Sbjct: 199 PDIVRGGDSG 208
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 69.0 bits (168), Expect = 6e-14
Identities = 21/157 (13%), Positives = 47/157 (29%), Gaps = 21/157 (13%)
Query: 331 NLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENL 390
+ + H S ++L+KL + K+ + E +
Sbjct: 41 KVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGN----AVLMELI---- 92
Query: 391 YQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGL 450
+ ++ +L+ +A + G H D+ N+L + I DF
Sbjct: 93 ---DAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQ 148
Query: 451 AREI---RSRPYTD---YVSTRWYR---APEVLLHST 478
+ E+ R + ++ E ++S
Sbjct: 149 SVEVGEEGWREILERDVRNIITYFSRTYRTEKDINSA 185
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 61.2 bits (147), Expect = 2e-10
Identities = 41/170 (24%), Positives = 69/170 (40%), Gaps = 25/170 (14%)
Query: 356 KSLKKLSHANLVKLKEVIREND-TLYFVFEYMKEN---------------LYQLIRDRDK 399
K L++++ A+ K + + L F + N L + + +
Sbjct: 61 KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 120
Query: 400 FLPESIIRNMMYQVLQGLAFMH-RHGFFHRDMKPENLL------CMGTELVKIADFGLAR 452
+P ++ + Q+L GL +MH R G H D+KPEN+L +KIAD G A
Sbjct: 121 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180
Query: 453 EIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPP 502
+ + TR YR+PEVLL + + + + +F I
Sbjct: 181 WYDEHYT-NSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFL 228
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 42.3 bits (98), Expect = 2e-04
Identities = 16/115 (13%), Positives = 35/115 (30%), Gaps = 15/115 (13%)
Query: 707 LKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT--------CYTLA 758
+ S+ L+ L + P + + + LL LP Y + +
Sbjct: 212 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNS 271
Query: 759 SNMNFKFPQFRRVPFTSII-------PHASPDAIHLMESMLAYNPSKRPTAQQSL 806
+ + + P ++ + + + ML +P KR A +
Sbjct: 272 RGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326
|
| >d1ru4a_ b.80.1.9 (A:) Pectate transeliminase {Erwinia chrysanthemi [TaxId: 556]} Length = 400 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Single-stranded right-handed beta-helix superfamily: Pectin lyase-like family: Pectate transeliminase domain: Pectate transeliminase species: Erwinia chrysanthemi [TaxId: 556]
Score = 40.9 bits (94), Expect = 6e-04
Identities = 25/175 (14%), Positives = 45/175 (25%), Gaps = 7/175 (4%)
Query: 123 NVLPQPVTLYSHDYDILLSNPANSMLANNSMVSTNNAVYVNQNPHNNNPNISQYNNPNNY 182
N + D L + ++ NS N Y N + N N +
Sbjct: 196 NRFVGCRAWENSDDGFDLFDSPQKVVIENSWAFRNGINYWNDSAFAGNGNGFKLGGNQAV 255
Query: 183 DPTTSQNNNISQYMPNNTSQNN---NNTQYNPNSSQNMPNNISQNANNTQNNPNNSHYNP 239
+ + QNN T N S +N N + HY
Sbjct: 256 GNHRITRSVAFGNVSKGFDQNNNAGGVTVINNTSYKNGINYG----FGSNVQSGQKHYFR 311
Query: 240 NNIQNNPNNFSQNNISQNNTNNTQINKTTQYNPPPYPININKENTPAWLTNSATD 294
NN+ + + N +++N+ +T + +
Sbjct: 312 NNVSLSASVTVSNADAKSNSWDTGPAASASDFVSLDTSLATVSRDNDGTLPETSL 366
|
| >d1ofla_ b.80.1.4 (A:) Chondroitinase B {Pedobacter heparinus [TaxId: 984]} Length = 481 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Single-stranded right-handed beta-helix superfamily: Pectin lyase-like family: Chondroitinase B domain: Chondroitinase B species: Pedobacter heparinus [TaxId: 984]
Score = 38.3 bits (88), Expect = 0.004
Identities = 22/187 (11%), Positives = 45/187 (24%), Gaps = 23/187 (12%)
Query: 130 TLYSHDYDILLSNPANSMLANN--------------SMVSTNNAVYVNQNPHNNNPNISQ 175
T + + + + + NN + + + + N +
Sbjct: 235 TYLNCQGTMNFRHGDHQVAINNFYIGNDQRFGYGGMFVWGSRHVIACNYFELSETIKSRG 294
Query: 176 ----YNNPNNYDPTTSQNNNISQYMPNNTSQNNNNTQYNPNSSQNMPNNISQNANNTQNN 231
Y NP + ++ + NN N N + N
Sbjct: 295 NAALYLNPGAMASEHALAFDM--LIANNAFINVNGYAIHFNPLDERRKEYCAANRLKFET 352
Query: 232 PNNSHYNPNNIQNN-PNNFS-QNNISQNNTNNTQINKTTQYNPPPYPININKENTPAWLT 289
P+ N + P + + N+ P+NI+ N A+
Sbjct: 353 PHQLMLKGNLFFKDKPYVYPFFKDDYFIAGKNSWTGNVALGVEKGIPVNIS-ANRSAYKP 411
Query: 290 NSATDGD 296
D
Sbjct: 412 VKIKDIQ 418
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 962 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.76 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.72 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.66 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.66 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.64 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.64 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.62 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.6 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.6 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.59 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.59 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.59 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.58 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.57 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.56 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.56 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.56 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.56 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.55 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.54 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.53 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.52 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.52 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.52 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.52 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.5 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.5 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.49 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.49 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.49 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.46 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.46 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.46 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.44 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.44 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.43 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.43 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.42 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.4 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.4 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.39 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.38 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.37 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.36 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.36 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.35 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.35 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.34 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.33 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.33 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.33 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.32 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.32 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.29 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.27 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.25 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.24 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.24 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.2 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.19 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.18 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.17 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.05 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.59 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.39 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 96.25 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.99 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 93.78 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.09 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 92.3 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=373.01 Aligned_cols=244 Identities=19% Similarity=0.220 Sum_probs=208.1
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
.+.....++.|+.+.||.|....+++.++.|+... ....+.+|+++|++++||||+++++++.+++.+|+|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 45555556666666799999888777666655321 23568999999999999999999999999999999999
Q ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCccccc
Q psy501 385 YMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYV 463 (962)
Q Consensus 385 y~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 463 (962)
||+| +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|............
T Consensus 87 y~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 165 (263)
T d2j4za1 87 YAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC 165 (263)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCEETT
T ss_pred ecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCcccccC
Confidence 9984 676666654 45999999999999999999999999999999999999999999999999999887776667788
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccC
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
||+.|||||++.+ ..++.++|||||||+||||++|++||.+.+.......+.......+ ...+..+..++..||..+
T Consensus 166 Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~L~~d 242 (263)
T d2j4za1 166 GTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLISRLLKHN 242 (263)
T ss_dssp EEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC--TTSCHHHHHHHHHHTCSS
T ss_pred CCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--ccCCHHHHHHHHHHccCC
Confidence 9999999999976 4789999999999999999999999999888888787777654433 457778899999999999
Q ss_pred CCCCCcHHHHHhhcccc
Q psy501 544 TERLKSSYILLHTLPLY 560 (962)
Q Consensus 544 perRPs~~~Ll~~l~~~ 560 (962)
|++||++.++++. ||+
T Consensus 243 p~~R~t~~eil~h-p~~ 258 (263)
T d2j4za1 243 PSQRPMLREVLEH-PWI 258 (263)
T ss_dssp GGGSCCHHHHHTC-HHH
T ss_pred HhHCcCHHHHHcC-cCc
Confidence 9999999988864 344
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=372.10 Aligned_cols=248 Identities=18% Similarity=0.232 Sum_probs=204.3
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE 388 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g 388 (962)
|.....++.|+.+.||+|....+++.++.|.. ....+.+.+|+++|++++|||||++++++.+++.+|+|||||+|
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 34444555555666888888777766555442 23345689999999999999999999999999999999999985
Q ss_pred -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCC
Q psy501 389 -NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVST 465 (962)
Q Consensus 389 -~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt 465 (962)
+|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|...... ......||
T Consensus 94 g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt 173 (288)
T d2jfla1 94 GAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT 173 (288)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSC
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccccccc
Confidence 666666666777999999999999999999999999999999999999999999999999999765432 33456899
Q ss_pred ccccChhhhc----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-cCCCCCCCCcHHHHHHHh
Q psy501 466 RWYRAPEVLL----HSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL-HTLPLYTYHVPPIQTTCL 540 (962)
Q Consensus 466 ~~Y~APE~l~----~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~s~~l~~li~~Cl 540 (962)
+.|+|||++. ....|+.++|||||||++|||++|++||.+.........+..+.... ...+.++..+..++..||
T Consensus 174 ~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L 253 (288)
T d2jfla1 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCL 253 (288)
T ss_dssp CTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHS
T ss_pred cccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHc
Confidence 9999999985 23468999999999999999999999999988888777777664332 223466778889999999
Q ss_pred ccCCCCCCcHHHHHhhccccc
Q psy501 541 LAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 541 ~~dperRPs~~~Ll~~l~~~~ 561 (962)
..+|++||++.++++. +|++
T Consensus 254 ~~dp~~R~t~~ell~h-p~~~ 273 (288)
T d2jfla1 254 EKNVDARWTTSQLLQH-PFVT 273 (288)
T ss_dssp CSSTTTSCCHHHHTTS-GGGC
T ss_pred cCChhHCcCHHHHhcC-cccC
Confidence 9999999999988874 4554
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-42 Score=371.02 Aligned_cols=250 Identities=20% Similarity=0.189 Sum_probs=197.7
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecC
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
.|.....++.|+.+.||.|....+++.++.|+.. ...+.+.+|+++|++++||||+++++++.+++.+|||||||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 3455555555556668888887766665554422 12345899999999999999999999999999999999999
Q ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----Cccc
Q psy501 387 KE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PYTD 461 (962)
Q Consensus 387 ~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~~ 461 (962)
+| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... ....
T Consensus 86 ~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 164 (271)
T d1nvra_ 86 SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164 (271)
T ss_dssp TTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred CCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccc
Confidence 85 67766644 456999999999999999999999999999999999999999999999999999876432 3445
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh-HHHHHhccccccCCCCCCCCcHHHHHHHh
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG-TERLKSSYILLHTLPLYTYHVPPIQTTCL 540 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~s~~l~~li~~Cl 540 (962)
.+||+.|||||++.+...++.++|||||||++|||++|++||........ ...+..........+..+....+++..||
T Consensus 165 ~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 244 (271)
T d1nvra_ 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 244 (271)
T ss_dssp CCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHS
T ss_pred eeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHc
Confidence 68999999999998765567899999999999999999999987654433 23333333333333456777888999999
Q ss_pred ccCCCCCCcHHHHHhhccccccC
Q psy501 541 LAGTERLKSSYILLHTLPLYTYH 563 (962)
Q Consensus 541 ~~dperRPs~~~Ll~~l~~~~~~ 563 (962)
..+|++||++.++++. ||+...
T Consensus 245 ~~dP~~R~t~~eil~h-pwf~~~ 266 (271)
T d1nvra_ 245 VENPSARITIPDIKKD-RWYNKP 266 (271)
T ss_dssp CSSTTTSCCHHHHTTC-TTTTCC
T ss_pred CCChhHCcCHHHHhcC-HhhCcC
Confidence 9999999999888764 465443
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=370.37 Aligned_cols=243 Identities=20% Similarity=0.250 Sum_probs=197.6
Q ss_pred EEEecCCcccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHH
Q psy501 317 FSYILPHTLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLY 391 (962)
Q Consensus 317 ~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll 391 (962)
..++.|+.+.||+|....+++.++.|... ...+.+.+|+++|++++||||++++++|.+++.+|+|||||+| +|.
T Consensus 26 ~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~ 105 (293)
T d1yhwa1 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105 (293)
T ss_dssp EECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred EEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHH
Confidence 33333444558888877666655544322 2345799999999999999999999999999999999999985 555
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCcccc
Q psy501 392 QLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYR 469 (962)
Q Consensus 392 ~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~ 469 (962)
+.+. . ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+... .....+||+.|+
T Consensus 106 ~~~~-~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~ 183 (293)
T d1yhwa1 106 DVVT-E-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183 (293)
T ss_dssp HHHH-H-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGC
T ss_pred HHhh-c-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCcc
Confidence 5443 3 35999999999999999999999999999999999999999999999999999877543 445568999999
Q ss_pred ChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcc-ccccCCCCCCCCcHHHHHHHhccCCCCCC
Q psy501 470 APEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSY-ILLHTLPLYTYHVPPIQTTCLLAGTERLK 548 (962)
Q Consensus 470 APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~l~~li~~Cl~~dperRP 548 (962)
|||++.+ ..++.++|||||||++|+|++|++||.+.........+.... ......+.++..+..++..||..+|++||
T Consensus 184 aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 262 (293)
T d1yhwa1 184 APEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG 262 (293)
T ss_dssp CHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSC
T ss_pred ChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCc
Confidence 9999976 478999999999999999999999999887766665554442 23333456777889999999999999999
Q ss_pred cHHHHHhhccccccC
Q psy501 549 SSYILLHTLPLYTYH 563 (962)
Q Consensus 549 s~~~Ll~~l~~~~~~ 563 (962)
++.++++. +|+...
T Consensus 263 s~~eil~H-p~~~~~ 276 (293)
T d1yhwa1 263 SAKELLQH-QFLKIA 276 (293)
T ss_dssp CHHHHTTC-GGGGGC
T ss_pred CHHHHhcC-HhhCCC
Confidence 99988764 455443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-41 Score=372.93 Aligned_cols=248 Identities=21% Similarity=0.251 Sum_probs=206.8
Q ss_pred eEEEEecCCcccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 315 LKFSYILPHTLPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 315 ~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
....++.|+.+.||+|....+++.++.|... .....+.+|+++|++++|||||++++++.+++.+|+|||||.
T Consensus 19 ~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 98 (309)
T d1u5ra_ 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98 (309)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecC
Confidence 3344455555569999887777766554421 112458899999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCcc
Q psy501 388 ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRW 467 (962)
Q Consensus 388 g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~ 467 (962)
|+++..+....+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..... .....||+.
T Consensus 99 ~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--~~~~~GT~~ 176 (309)
T d1u5ra_ 99 GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANSFVGTPY 176 (309)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--BCCCCSCGG
T ss_pred CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--CCccccCcc
Confidence 887777766677899999999999999999999999999999999999999999999999999986543 345689999
Q ss_pred ccChhhhccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCC
Q psy501 468 YRAPEVLLHS--TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTE 545 (962)
Q Consensus 468 Y~APE~l~~~--~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dpe 545 (962)
|||||++.+. ..|+.++|||||||++|||++|+.||.+.........+............++..+..++..||..+|+
T Consensus 177 Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 256 (309)
T d1u5ra_ 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQ 256 (309)
T ss_dssp GCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGG
T ss_pred ccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChh
Confidence 9999999642 35899999999999999999999999998887777777766555554556778899999999999999
Q ss_pred CCCcHHHHHhhccccccCCC
Q psy501 546 RLKSSYILLHTLPLYTYHVP 565 (962)
Q Consensus 546 rRPs~~~Ll~~l~~~~~~~~ 565 (962)
+||++.++++. +|+....+
T Consensus 257 ~Rpt~~ell~H-p~~~~~~~ 275 (309)
T d1u5ra_ 257 DRPTSEVLLKH-RFVLRERP 275 (309)
T ss_dssp GSCCHHHHTTC-HHHHSCCC
T ss_pred HCcCHHHHHhC-HHhcCCCC
Confidence 99999988774 45554443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-41 Score=362.02 Aligned_cols=239 Identities=20% Similarity=0.200 Sum_probs=192.6
Q ss_pred eEEEEecCCcccEEEEEecCCceEEEEecc------chhHHHHHHHHHHHHhcCCCCcccEEEEEEe----CCEEEEEEe
Q psy501 315 LKFSYILPHTLPLYTCNLDQDNHILSRHVS------SRDEMVVCFYRKSLKKLSHANLVKLKEVIRE----NDTLYFVFE 384 (962)
Q Consensus 315 ~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~----~~~~~LV~E 384 (962)
+...++.|+.+.||++....+++.++.|.. ..+.+.+.+|+++|++++||||++++++|.+ +..+|+|||
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE 92 (270)
T d1t4ha_ 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 92 (270)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEe
Confidence 333455555666999988777665544332 1233568999999999999999999999975 456899999
Q ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccce--eeeccCCCcccccc-cccceeeecccccccccCCCcc
Q psy501 385 YMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHG--FFHRDMKPENLLCM-GTELVKIADFGLAREIRSRPYT 460 (962)
Q Consensus 385 y~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~g--IvHrDLkp~NILl~-~~g~vKL~DFGla~~~~~~~~~ 460 (962)
||+| +|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+........
T Consensus 93 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~~ 171 (270)
T d1t4ha_ 93 LMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK 171 (270)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBE
T ss_pred CCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCccC
Confidence 9985 666666554 56999999999999999999999998 99999999999996 5789999999999877666667
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChh-hhHHHHHhccccccCCCCCCCCcHHHHHHH
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL-AGTERLKSSYILLHTLPLYTYHVPPIQTTC 539 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~~l~~li~~C 539 (962)
..+||+.|||||++.+ .++.++|||||||++|||++|+.||.+.... .....+..+..........+..+..++..|
T Consensus 172 ~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~ 249 (270)
T d1t4ha_ 172 AVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC 249 (270)
T ss_dssp ESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHH
T ss_pred CcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHH
Confidence 7899999999999864 5999999999999999999999999875443 344555544333333335566788999999
Q ss_pred hccCCCCCCcHHHHHhh
Q psy501 540 LLAGTERLKSSYILLHT 556 (962)
Q Consensus 540 l~~dperRPs~~~Ll~~ 556 (962)
|..+|++||++.++++.
T Consensus 250 l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 250 IRQNKDERYSIKDLLNH 266 (270)
T ss_dssp SCSSGGGSCCHHHHHTS
T ss_pred ccCCHhHCcCHHHHhCC
Confidence 99999999999888863
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-41 Score=367.13 Aligned_cols=238 Identities=18% Similarity=0.245 Sum_probs=199.1
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
+|.....++.|+.+.||+|....+++.++.|+... ....+.+|+++|++++||||+++++++.+++.+|+|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 35555555666666799998887777666555322 23468999999999999999999999999999999999
Q ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----Cc
Q psy501 385 YMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PY 459 (962)
Q Consensus 385 y~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~ 459 (962)
||+| +|.+++... +.+++..++.++.|++.||+|||+.||+||||||+||+++.+|.+||+|||+|+.+... ..
T Consensus 89 y~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 167 (288)
T d1uu3a_ 89 YAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167 (288)
T ss_dssp CCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred ccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccccc
Confidence 9985 676666554 56999999999999999999999999999999999999999999999999999876533 33
Q ss_pred ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHH
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTC 539 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~C 539 (962)
...+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+......++..+...++ ..++..+.+++..|
T Consensus 168 ~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~ 244 (288)
T d1uu3a_ 168 NSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP--EKFFPKARDLVEKL 244 (288)
T ss_dssp --CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC--TTCCHHHHHHHHTT
T ss_pred ccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC--ccCCHHHHHHHHHH
Confidence 456899999999999764 799999999999999999999999999888888888877754433 46777888999999
Q ss_pred hccCCCCCCcHHHH
Q psy501 540 LLAGTERLKSSYIL 553 (962)
Q Consensus 540 l~~dperRPs~~~L 553 (962)
|..+|++|||++++
T Consensus 245 L~~dP~~R~t~~e~ 258 (288)
T d1uu3a_ 245 LVLDATKRLGCEEM 258 (288)
T ss_dssp SCSSGGGSTTSGGG
T ss_pred ccCCHhHCcCHHHH
Confidence 99999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-41 Score=363.14 Aligned_cols=243 Identities=23% Similarity=0.306 Sum_probs=189.8
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEecc------chhHHHHHHHHHHHHhcCCCCcccEEEEEEe--CCEEEEEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVS------SRDEMVVCFYRKSLKKLSHANLVKLKEVIRE--NDTLYFVF 383 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~LV~ 383 (962)
+|.....++.|+.+.||+|....+++.++.|.. ..+...+.+|+++|++++||||+++++++.+ ++.+|+||
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 344455555556667999988877766555432 1223468999999999999999999999964 45689999
Q ss_pred ecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHhhcccce-----eeeccCCCcccccccccceeeecccccccc
Q psy501 384 EYMK-ENLYQLIRD---RDKFLPESIIRNMMYQVLQGLAFMHRHG-----FFHRDMKPENLLCMGTELVKIADFGLAREI 454 (962)
Q Consensus 384 Ey~~-g~Ll~~l~~---~~~~ls~~~i~~i~~qI~~aL~yLH~~g-----IvHrDLkp~NILl~~~g~vKL~DFGla~~~ 454 (962)
|||+ |+|.+.+.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence 9998 577776643 3467999999999999999999999976 999999999999999999999999999877
Q ss_pred cCC--CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCc
Q psy501 455 RSR--PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHV 532 (962)
Q Consensus 455 ~~~--~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 532 (962)
... ......||+.|||||++.+ ..|+.++|||||||++|||+||++||.+.+.......+..+... +....++..+
T Consensus 165 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~s~~l 242 (269)
T d2java1 165 NHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYRYSDEL 242 (269)
T ss_dssp -----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHHH
T ss_pred ccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-CCCcccCHHH
Confidence 543 3345789999999999965 47999999999999999999999999998888877777766443 2334677889
Q ss_pred HHHHHHHhccCCCCCCcHHHHHhh
Q psy501 533 PPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 533 ~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
..++..||..+|++||++.++++.
T Consensus 243 ~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 243 NEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCChhHCcCHHHHHhC
Confidence 999999999999999999888763
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-41 Score=371.90 Aligned_cols=241 Identities=17% Similarity=0.222 Sum_probs=190.9
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEecc-----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecC
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVS-----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
.|.....++.|+.+.||+|....+++.++.|.. ......+.+|+.+|++++|||||+++++|.+++.+|+|||||
T Consensus 7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~ 86 (322)
T d1s9ja_ 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 86 (322)
T ss_dssp GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 445555555555566999988877776665543 233457899999999999999999999999999999999999
Q ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccc-eeeeccCCCcccccccccceeeecccccccccCCCcccccC
Q psy501 387 KE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRH-GFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVS 464 (962)
Q Consensus 387 ~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~-gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~g 464 (962)
+| +|.+.+... +.+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+|+..........+|
T Consensus 87 ~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~G 165 (322)
T d1s9ja_ 87 DGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 165 (322)
T ss_dssp TTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---CC
T ss_pred CCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCccccccC
Confidence 95 666666554 4699999999999999999999974 89999999999999999999999999998776666667799
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHH------------------------------
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTER------------------------------ 514 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~------------------------------ 514 (962)
|+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+.......
T Consensus 166 T~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T d1s9ja_ 166 TRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244 (322)
T ss_dssp SSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------------
T ss_pred CccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccccccc
Confidence 9999999999874 799999999999999999999999987543221100
Q ss_pred ------------HHhccccccCC--CCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 515 ------------LKSSYILLHTL--PLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 515 ------------i~~~~~~~~~~--~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
+... .++.. ..++..+.+++..||..||++|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 245 RPPMAIFELLDYIVNE--PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -CCCCHHHHHHHHHTS--CCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccchhHHHHHhhhhcc--CCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000 00111 1234457789999999999999999988875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-41 Score=362.78 Aligned_cols=245 Identities=16% Similarity=0.199 Sum_probs=189.3
Q ss_pred EEecCCcccEEEEEecCCceEEEEec-----cchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHH
Q psy501 318 SYILPHTLPLYTCNLDQDNHILSRHV-----SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLY 391 (962)
Q Consensus 318 ~~i~~~~~~Vy~~~~~~~~kvv~~k~-----~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll 391 (962)
.++.|+.+.||+++... .++.+.+ .......+.+|+++|++++||||+++++++.+ ..+++|||||+ |+|.
T Consensus 15 ~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~ 91 (276)
T d1uwha_ 15 RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLY 91 (276)
T ss_dssp EEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHH
T ss_pred EEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHH
Confidence 34444445577776443 2332222 22334678999999999999999999998754 56899999999 6888
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----CcccccCCcc
Q psy501 392 QLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----PYTDYVSTRW 467 (962)
Q Consensus 392 ~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----~~~~~~gt~~ 467 (962)
+++......+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||+|+..... ......||+.
T Consensus 92 ~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~ 171 (276)
T d1uwha_ 92 HHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171 (276)
T ss_dssp HHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGG
T ss_pred HHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcc
Confidence 888777778999999999999999999999999999999999999999999999999999776432 3345679999
Q ss_pred ccChhhhccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHH-HHHhccccc---cCCCCCCCCcHHHHHHHhc
Q psy501 468 YRAPEVLLHS--TAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTE-RLKSSYILL---HTLPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 468 Y~APE~l~~~--~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~-~i~~~~~~~---~~~~~~s~~l~~li~~Cl~ 541 (962)
|||||++.+. ..|+.++|||||||+||||+||+.||.+........ .+..+...+ ...+.++..+..++..||.
T Consensus 172 y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~ 251 (276)
T d1uwha_ 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLK 251 (276)
T ss_dssp GCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTC
T ss_pred cCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcC
Confidence 9999999643 358999999999999999999999998866554433 333332221 1234567788899999999
Q ss_pred cCCCCCCcHHHHHhhccccccCCC
Q psy501 542 AGTERLKSSYILLHTLPLYTYHVP 565 (962)
Q Consensus 542 ~dperRPs~~~Ll~~l~~~~~~~~ 565 (962)
.+|++|||+.+++..|......+|
T Consensus 252 ~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 252 KKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCHhHCcCHHHHHHHHHHHHHcCC
Confidence 999999999999998765544443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=355.52 Aligned_cols=243 Identities=20% Similarity=0.246 Sum_probs=192.1
Q ss_pred eeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCH
Q psy501 314 RLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENL 390 (962)
Q Consensus 314 ~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~L 390 (962)
.....++.|+.+.||++.......++.+.+.. ...+.+.+|++++++++||||+++++++.+++..++|||||+ |+|
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L 87 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 87 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcH
Confidence 33444445555569999887665555554432 345679999999999999999999999999999999999998 678
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---CcccccCCcc
Q psy501 391 YQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYVSTRW 467 (962)
Q Consensus 391 l~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~gt~~ 467 (962)
.+++......+++..++.++.||+.||+|||+.+|+||||||+||+++.++.+||+|||+|+..... ......||+.
T Consensus 88 ~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~ 167 (263)
T d1sm2a_ 88 SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 167 (263)
T ss_dssp HHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------------CTT
T ss_pred HHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcc
Confidence 8877777778999999999999999999999999999999999999999999999999999876543 2234578999
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCC
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTER 546 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dper 546 (962)
|+|||++.+. .++.++|||||||++|||+| |.+||...........+..+. ....+..++..+..++..||..+|++
T Consensus 168 y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~p~~ 245 (263)
T d1sm2a_ 168 WASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLYKPRLASTHVYQIMNHCWKERPED 245 (263)
T ss_dssp SCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred cCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC-CCCCccccCHHHHHHHHHHccCCHhH
Confidence 9999999764 69999999999999999999 577777777766666666653 23334466778889999999999999
Q ss_pred CCcHHHHHhhcc
Q psy501 547 LKSSYILLHTLP 558 (962)
Q Consensus 547 RPs~~~Ll~~l~ 558 (962)
||++.++++.|.
T Consensus 246 Rps~~~il~~L~ 257 (263)
T d1sm2a_ 246 RPAFSRLLRQLA 257 (263)
T ss_dssp SCCHHHHHHHHH
T ss_pred CcCHHHHHHHHH
Confidence 999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-40 Score=363.04 Aligned_cols=246 Identities=13% Similarity=0.201 Sum_probs=190.9
Q ss_pred CceeeEEEEecCCcccEEEEEecCCce---EEEEec-c----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNH---ILSRHV-S----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~k---vv~~k~-~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
..+.....++.|+.+.||++....+++ .++.+. . ......+.+|+++|++++|||||++++++.+++.+++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 344555555555566699987754432 233332 1 22345689999999999999999999999999999999
Q ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC---
Q psy501 383 FEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP--- 458 (962)
Q Consensus 383 ~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~--- 458 (962)
||||+| +|.+++....+.+++.+++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~ 185 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcc
Confidence 999985 5666666666779999999999999999999999999999999999999999999999999998765431
Q ss_pred ----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcH
Q psy501 459 ----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVP 533 (962)
Q Consensus 459 ----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~ 533 (962)
.....||+.|||||++.+. .++.++|||||||+||||+| |++||.+.........+..+. .++....++..+.
T Consensus 186 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~ 263 (299)
T d1jpaa_ 186 TYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY-RLPPPMDCPSALH 263 (299)
T ss_dssp ----------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCCTTCCHHHH
T ss_pred eeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCccchHHHH
Confidence 1224578999999999764 79999999999999999998 899999988877777776653 3344456778889
Q ss_pred HHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 534 PIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 534 ~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
.++..||..+|++||++.++++.|.
T Consensus 264 ~li~~cl~~~P~~RPs~~ei~~~L~ 288 (299)
T d1jpaa_ 264 QLMLDCWQKDRNHRPKFGQIVNTLD 288 (299)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 9999999999999999999998774
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-40 Score=365.52 Aligned_cols=246 Identities=19% Similarity=0.254 Sum_probs=188.1
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
|.....++.|+.+.||+|....+++.++.|... .....+.+|+++|++++||||+++++++.+++.+|||||||+
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 444444444444559999887777665555432 223457899999999999999999999999999999999998
Q ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccc---cccceeeecccccccccCC-Ccccc
Q psy501 388 -ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM---GTELVKIADFGLAREIRSR-PYTDY 462 (962)
Q Consensus 388 -g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~---~~g~vKL~DFGla~~~~~~-~~~~~ 462 (962)
|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||++. .++.+||+|||+|+..... .....
T Consensus 91 gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~ 169 (307)
T d1a06a_ 91 GGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA 169 (307)
T ss_dssp SCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------------
T ss_pred CCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeee
Confidence 577777765 45699999999999999999999999999999999999995 5789999999999876544 34556
Q ss_pred cCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--CCCCCCCCcHHHHHHHh
Q psy501 463 VSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--TLPLYTYHVPPIQTTCL 540 (962)
Q Consensus 463 ~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l~~li~~Cl 540 (962)
+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.........+......++ ..+..|..+.+++..||
T Consensus 170 ~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 248 (307)
T d1a06a_ 170 CGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLM 248 (307)
T ss_dssp ---CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHS
T ss_pred eeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHc
Confidence 89999999999976 4799999999999999999999999999888888888877655443 23456777889999999
Q ss_pred ccCCCCCCcHHHHHhhccccc
Q psy501 541 LAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 541 ~~dperRPs~~~Ll~~l~~~~ 561 (962)
..+|++||++.++++. ||+.
T Consensus 249 ~~dP~~R~s~~eil~h-p~~~ 268 (307)
T d1a06a_ 249 EKDPEKRFTCEQALQH-PWIA 268 (307)
T ss_dssp CSSGGGSCCHHHHHHS-TTTT
T ss_pred cCCHhHCcCHHHHhcC-HhhC
Confidence 9999999998888874 3443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.4e-40 Score=368.00 Aligned_cols=249 Identities=18% Similarity=0.223 Sum_probs=207.8
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecC
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
..|.....++.|+.+.||+|....+++.++.|+.. .+.+.+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 35666666666666679999887777665554422 23456899999999999999999999999999999999999
Q ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc--ccceeeecccccccccCC-Ccccc
Q psy501 387 K-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG--TELVKIADFGLAREIRSR-PYTDY 462 (962)
Q Consensus 387 ~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~--~g~vKL~DFGla~~~~~~-~~~~~ 462 (962)
+ |+|.+.+....+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+.+... .....
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 185 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEE
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccccee
Confidence 8 5788888666677999999999999999999999999999999999999964 578999999999877654 44457
Q ss_pred cCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC--CCCCCCCcHHHHHHHh
Q psy501 463 VSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT--LPLYTYHVPPIQTTCL 540 (962)
Q Consensus 463 ~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l~~li~~Cl 540 (962)
.||+.|||||++.+ ..++.++|||||||++|||++|+.||.+.+.......+.......+. .+..+..+.+++..||
T Consensus 186 ~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 264 (350)
T d1koaa2 186 TGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 264 (350)
T ss_dssp CSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHC
T ss_pred cCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHc
Confidence 89999999999976 47899999999999999999999999998888888887776544332 2356777889999999
Q ss_pred ccCCCCCCcHHHHHhhccccc
Q psy501 541 LAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 541 ~~dperRPs~~~Ll~~l~~~~ 561 (962)
..||++||++.+++.. +|+.
T Consensus 265 ~~dP~~R~t~~eil~h-p~~~ 284 (350)
T d1koaa2 265 LADPNTRMTIHQALEH-PWLT 284 (350)
T ss_dssp CSSGGGSCCHHHHHHS-TTTS
T ss_pred cCChhHCcCHHHHhcC-cccC
Confidence 9999999998888764 3443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.7e-40 Score=369.32 Aligned_cols=244 Identities=18% Similarity=0.228 Sum_probs=207.0
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
.|.....++.|+.+.||+|....+++.++.|+.. .+...+.+|+++|++++||||++++++|.+++.+|||||||+
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4555556666666679999887777666555432 234568899999999999999999999999999999999998
Q ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccc--cccceeeecccccccccCC-Cccccc
Q psy501 388 -ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM--GTELVKIADFGLAREIRSR-PYTDYV 463 (962)
Q Consensus 388 -g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~--~~g~vKL~DFGla~~~~~~-~~~~~~ 463 (962)
|+|.+.+......+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|...... ......
T Consensus 110 gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 189 (352)
T d1koba_ 110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 189 (352)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEEC
T ss_pred CChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeecc
Confidence 567777777666799999999999999999999999999999999999997 5789999999999887655 445568
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC--CCCCCCCcHHHHHHHhc
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT--LPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l~~li~~Cl~ 541 (962)
||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.........+..+...++. .+..+..+.+++..||.
T Consensus 190 gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 268 (352)
T d1koba_ 190 ATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQ 268 (352)
T ss_dssp SSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSC
T ss_pred CcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcc
Confidence 9999999999965 47999999999999999999999999999888888888776654432 34667788999999999
Q ss_pred cCCCCCCcHHHHHhh
Q psy501 542 AGTERLKSSYILLHT 556 (962)
Q Consensus 542 ~dperRPs~~~Ll~~ 556 (962)
.+|++||++.++++.
T Consensus 269 ~dp~~R~s~~eil~H 283 (352)
T d1koba_ 269 KEPRKRLTVHDALEH 283 (352)
T ss_dssp SSGGGSCCHHHHHTS
T ss_pred CChhHCcCHHHHhcC
Confidence 999999999888764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-40 Score=360.18 Aligned_cols=240 Identities=19% Similarity=0.198 Sum_probs=195.0
Q ss_pred EEEEecCCcccEEEEEecCCceEEEEeccc---hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHH
Q psy501 316 KFSYILPHTLPLYTCNLDQDNHILSRHVSS---RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLY 391 (962)
Q Consensus 316 ~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~---~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll 391 (962)
...++.|+.+.||++....+++.++.|... .+.+.+.+|+++|++++|||||+++++|.+++.+++|||||+ |++.
T Consensus 22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~ 101 (287)
T d1opja_ 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 101 (287)
T ss_dssp EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred eeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchH
Confidence 333334444569999888777665554432 335679999999999999999999999999999999999998 6777
Q ss_pred HHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCc---ccccCCcc
Q psy501 392 QLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPY---TDYVSTRW 467 (962)
Q Consensus 392 ~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~---~~~~gt~~ 467 (962)
+.+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... ....|++.
T Consensus 102 ~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~ 181 (287)
T d1opja_ 102 DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 181 (287)
T ss_dssp HHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGG
T ss_pred HHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeecccccccc
Confidence 777653 45799999999999999999999999999999999999999999999999999987655422 23457889
Q ss_pred ccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCC-CCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCC
Q psy501 468 YRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPI-QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTER 546 (962)
Q Consensus 468 Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dper 546 (962)
|+|||++.+. .|+.++|||||||++|||++|..|| .+.+.......+..+ ..++.+..++..+..++..||..+|++
T Consensus 182 y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~ 259 (287)
T d1opja_ 182 WTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPEGCPEKVYELMRACWQWNPSD 259 (287)
T ss_dssp GCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred ccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CCCCCCccchHHHHHHHHHHcCCCHhH
Confidence 9999999764 7999999999999999999966555 444444444444433 445555677888999999999999999
Q ss_pred CCcHHHHHhhc
Q psy501 547 LKSSYILLHTL 557 (962)
Q Consensus 547 RPs~~~Ll~~l 557 (962)
||++.++++.|
T Consensus 260 Rps~~ei~~~L 270 (287)
T d1opja_ 260 RPSFAEIHQAF 270 (287)
T ss_dssp SCCHHHHHHHH
T ss_pred CcCHHHHHHHH
Confidence 99999998865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=364.06 Aligned_cols=241 Identities=17% Similarity=0.177 Sum_probs=203.9
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
..+.....++.|+.+.||+|+...+++.++.|+... ....+.+|+.+|++++||||++++++|.+++.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 345555566666666799999888887776665432 2356899999999999999999999999999999999
Q ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--Ccc
Q psy501 384 EYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYT 460 (962)
Q Consensus 384 Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~ 460 (962)
|||+| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... ...
T Consensus 85 ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~ 163 (337)
T d1o6la_ 85 EYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163 (337)
T ss_dssp ECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBC
T ss_pred eccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccc
Confidence 99985 56565554 456999999999999999999999999999999999999999999999999999876443 445
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHh
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCL 540 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl 540 (962)
..+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+.......+..+.+.++ ..++....+++..||
T Consensus 164 ~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~dli~~~L 240 (337)
T d1o6la_ 164 TFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKSLLAGLL 240 (337)
T ss_dssp CCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHT
T ss_pred cceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC--ccCCHHHHHHHHhhc
Confidence 67899999999999764 799999999999999999999999999998888888887765443 467778899999999
Q ss_pred ccCCCCCCc-----HHHHHh
Q psy501 541 LAGTERLKS-----SYILLH 555 (962)
Q Consensus 541 ~~dperRPs-----~~~Ll~ 555 (962)
..+|.+|++ ++++++
T Consensus 241 ~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 241 KKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CSSTTTSTTCSTTTHHHHHT
T ss_pred cCCchhhcccccccHHHHHc
Confidence 999999994 566554
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-39 Score=359.38 Aligned_cols=241 Identities=14% Similarity=0.215 Sum_probs=204.3
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
.+.....++.|+.+.||+|....+++.++.|+... ....+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 34555556666666799999887777766665332 23568899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccC
Q psy501 385 YMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVS 464 (962)
Q Consensus 385 y~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~g 464 (962)
||.|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... ....+|
T Consensus 85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-~~~~~G 163 (316)
T d1fota_ 85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-TYTLCG 163 (316)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-BCCCCS
T ss_pred ecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-cccccC
Confidence 9997666666666677999999999999999999999999999999999999999999999999999876544 345789
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCC
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGT 544 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dp 544 (962)
|+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+.......+..+.... ++..+..+.+++..||..+|
T Consensus 164 t~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~li~~~L~~dp 240 (316)
T d1fota_ 164 TPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF--PPFFNEDVKDLLSRLITRDL 240 (316)
T ss_dssp CTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC--CTTSCHHHHHHHHHHTCSCT
T ss_pred cccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC--CCCCCHHHHHHHHHHhhhCH
Confidence 999999999965 479999999999999999999999999998888888887775443 35677888999999999999
Q ss_pred CCCC-----cHHHHHhh
Q psy501 545 ERLK-----SSYILLHT 556 (962)
Q Consensus 545 erRP-----s~~~Ll~~ 556 (962)
.+|+ +++++++.
T Consensus 241 ~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 241 SQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp TTCTTSSTTTTHHHHTS
T ss_pred HhccccchhhHHHHHcC
Confidence 9995 77776643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=357.97 Aligned_cols=237 Identities=26% Similarity=0.383 Sum_probs=194.1
Q ss_pred cccEEEEEecCCceEEEEeccchh---------HHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHH
Q psy501 324 TLPLYTCNLDQDNHILSRHVSSRD---------EMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLI 394 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~~~~~---------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l 394 (962)
.+.||+|....+++.++.|..... ...+.+|+++|++++|||||++++++.+++.+|+|||||.|+++..+
T Consensus 11 fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~ 90 (299)
T d1ua2a_ 11 FATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVII 90 (299)
T ss_dssp TEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHH
T ss_pred CeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhh
Confidence 345788877666665555443211 23588999999999999999999999999999999999999988888
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCCccccChh
Q psy501 395 RDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVSTRWYRAPE 472 (962)
Q Consensus 395 ~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt~~Y~APE 472 (962)
......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... .....+||+.|+|||
T Consensus 91 ~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE 170 (299)
T d1ua2a_ 91 KDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 170 (299)
T ss_dssp TTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHH
T ss_pred hhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHH
Confidence 887788999999999999999999999999999999999999999999999999999876554 334568999999999
Q ss_pred hhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC--------------------------CC
Q psy501 473 VLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT--------------------------LP 526 (962)
Q Consensus 473 ~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--------------------------~~ 526 (962)
++.+...|+.++|||||||++|||++|.+||.+.+..+....+......+.. .+
T Consensus 171 ~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
T d1ua2a_ 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFS 250 (299)
T ss_dssp HHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCT
T ss_pred HHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcc
Confidence 9987777999999999999999999999999998877766665543111100 11
Q ss_pred CCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 527 LYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 527 ~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
..+..+.+++..||..||++|||+.++++. +|+.
T Consensus 251 ~~s~~~~dll~~~L~~dP~~R~sa~e~L~H-p~f~ 284 (299)
T d1ua2a_ 251 AAGDDLLDLIQGLFLFNPCARITATQALKM-KYFS 284 (299)
T ss_dssp TCCHHHHHHHHHHHCSSTTTSCCHHHHHTS-GGGT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhCC-HhhC
Confidence 234456779999999999999999888764 3443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=356.05 Aligned_cols=243 Identities=15% Similarity=0.208 Sum_probs=202.7
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccc----------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS----------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYF 381 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~----------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~L 381 (962)
.|.....++.|+.+.||+|....+++.++.|+.. ...+.+.+|+++|++++|||||+++++|.+++.+||
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4555666666666678999887776665554321 124578999999999999999999999999999999
Q ss_pred EEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc----ceeeecccccccccC
Q psy501 382 VFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE----LVKIADFGLAREIRS 456 (962)
Q Consensus 382 V~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g----~vKL~DFGla~~~~~ 456 (962)
|||||+| +|.+.+... +.+++..++.++.||+.||+|||+.||+||||||+||+++.++ .+||+|||+|.....
T Consensus 91 v~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 9999985 677766554 4699999999999999999999999999999999999998776 499999999987754
Q ss_pred C-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--CCCCCCCCcH
Q psy501 457 R-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--TLPLYTYHVP 533 (962)
Q Consensus 457 ~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l~ 533 (962)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+.......+ ..+..+..+.
T Consensus 170 ~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 248 (293)
T d1jksa_ 170 GNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248 (293)
T ss_dssp SCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred CccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHH
Confidence 4 4555789999999999975 4799999999999999999999999999888888777777654432 2245677788
Q ss_pred HHHHHHhccCCCCCCcHHHHHhh
Q psy501 534 PIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 534 ~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
++++.||..+|++||++.++++.
T Consensus 249 ~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 249 DFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999998888764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-40 Score=365.09 Aligned_cols=244 Identities=21% Similarity=0.236 Sum_probs=196.6
Q ss_pred eeeEEEEecCCcccEEEEEecCCc------eEEEEecc----chhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEE
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDN------HILSRHVS----SRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYF 381 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~------kvv~~k~~----~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~L 381 (962)
+..+..++.|+.+.||++...... +++.+.+. ......+.+|+.+|+++ +|||||++++++.+.+.+++
T Consensus 39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (325)
T d1rjba_ 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 118 (325)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEE
Confidence 334444555555568888654432 23333221 22334689999999998 89999999999999999999
Q ss_pred EEecCC-CCHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccc
Q psy501 382 VFEYMK-ENLYQLIRDRD----------------------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM 438 (962)
Q Consensus 382 V~Ey~~-g~Ll~~l~~~~----------------------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~ 438 (962)
|||||+ |+|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+||+++
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~ 198 (325)
T d1rjba_ 119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT 198 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEE
T ss_pred EEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccc
Confidence 999998 68888876543 3489999999999999999999999999999999999999
Q ss_pred cccceeeecccccccccCCC----cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHH
Q psy501 439 GTELVKIADFGLAREIRSRP----YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTE 513 (962)
Q Consensus 439 ~~g~vKL~DFGla~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~ 513 (962)
.++.+||+|||+|+...... .....||+.|||||++.+. .++.++|||||||++|||+| |++||.+........
T Consensus 199 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~ 277 (325)
T d1rjba_ 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277 (325)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999998765442 2345679999999999764 79999999999999999998 899999877766666
Q ss_pred HHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 514 RLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 514 ~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
++......++.+..++..+..|+..||..+|++|||+.+|++.|
T Consensus 278 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 278 KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 66655555666667888899999999999999999999999866
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-40 Score=356.89 Aligned_cols=235 Identities=15% Similarity=0.191 Sum_probs=191.0
Q ss_pred ecCCcccEEEEEecCC--ceEEEEec-----cchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-CHH
Q psy501 320 ILPHTLPLYTCNLDQD--NHILSRHV-----SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-NLY 391 (962)
Q Consensus 320 i~~~~~~Vy~~~~~~~--~kvv~~k~-----~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~Ll 391 (962)
+.|+.+.||++..... ...++.|. .......+.+|+++|++++|||||++++++.+ +.+|+|||||+| +|.
T Consensus 18 G~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~ 96 (285)
T d1u59a_ 18 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLH 96 (285)
T ss_dssp ECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHH
T ss_pred ecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHH
Confidence 3344445888855432 22333322 12234578999999999999999999999875 458999999995 677
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-----CcccccCCc
Q psy501 392 QLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-----PYTDYVSTR 466 (962)
Q Consensus 392 ~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-----~~~~~~gt~ 466 (962)
+++......+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||+|+.+... ......||+
T Consensus 97 ~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~ 176 (285)
T d1u59a_ 97 KFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176 (285)
T ss_dssp HHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCG
T ss_pred HHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCc
Confidence 777666677999999999999999999999999999999999999999999999999999876543 223456889
Q ss_pred cccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCC
Q psy501 467 WYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTE 545 (962)
Q Consensus 467 ~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dpe 545 (962)
.|+|||++.++ .++.++|||||||++|||+| |+.||.+.........+..+.. ++.++.+|..+..++..||..+|+
T Consensus 177 ~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~-~~~p~~~~~~l~~li~~cl~~~p~ 254 (285)
T d1u59a_ 177 KWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-MECPPECPPELYALMSDCWIYKWE 254 (285)
T ss_dssp GGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGG
T ss_pred cccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCcCCHHHHHHHHHHcCCCHh
Confidence 99999999764 79999999999999999998 9999998887777777766543 344467788899999999999999
Q ss_pred CCCcHHHHHhhc
Q psy501 546 RLKSSYILLHTL 557 (962)
Q Consensus 546 rRPs~~~Ll~~l 557 (962)
+||++.++.+.|
T Consensus 255 ~RPs~~~i~~~L 266 (285)
T d1u59a_ 255 DRPDFLTVEQRM 266 (285)
T ss_dssp GSCCHHHHHHHH
T ss_pred HCcCHHHHHHHH
Confidence 999999887765
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-39 Score=350.99 Aligned_cols=235 Identities=14% Similarity=0.157 Sum_probs=187.0
Q ss_pred EecCCcccEEEEEecC--CceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-C
Q psy501 319 YILPHTLPLYTCNLDQ--DNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE-N 389 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~--~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g-~ 389 (962)
++.|+.+.||++.... ..+.++.|... .....+.+|+++|++++|||||++++++.++ ..+||||||+| +
T Consensus 15 iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~ 93 (277)
T d1xbba_ 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGP 93 (277)
T ss_dssp EEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEE
T ss_pred cccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCc
Confidence 3344444588876432 33334333221 1235699999999999999999999999654 57899999985 5
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-----CcccccC
Q psy501 390 LYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-----PYTDYVS 464 (962)
Q Consensus 390 Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-----~~~~~~g 464 (962)
|.+++. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+..... ......|
T Consensus 94 L~~~l~-~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~g 172 (277)
T d1xbba_ 94 LNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172 (277)
T ss_dssp HHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CC
T ss_pred HHHHHh-hccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCC
Confidence 666554 4466999999999999999999999999999999999999999999999999999876543 2233568
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccC
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
|+.|+|||++.+. .++.++|||||||++|||+| |++||.+.........+..+. .++.+..+|..+..++..||..+
T Consensus 173 t~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~~~~~li~~cl~~d 250 (277)
T d1xbba_ 173 PVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGCPAGCPREMYDLMNLCWTYD 250 (277)
T ss_dssp CGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC-CCCCCcccCHHHHHHHHHHcCCC
Confidence 9999999999764 68999999999999999998 899999988777777776653 33444567888999999999999
Q ss_pred CCCCCcHHHHHhhc
Q psy501 544 TERLKSSYILLHTL 557 (962)
Q Consensus 544 perRPs~~~Ll~~l 557 (962)
|++||++.++...|
T Consensus 251 p~~RPs~~~i~~~L 264 (277)
T d1xbba_ 251 VENRPGFAAVELRL 264 (277)
T ss_dssp TTTSCCHHHHHHHH
T ss_pred HhHCcCHHHHHHHh
Confidence 99999999886544
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.6e-39 Score=362.23 Aligned_cols=244 Identities=18% Similarity=0.195 Sum_probs=196.1
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccchh-------HHHHHHH---HHHHHhcCCCCcccEEEEEEeCCEEEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD-------EMVVCFY---RKSLKKLSHANLVKLKEVIRENDTLYF 381 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~-------~~~~~~E---i~iL~~L~HpnIv~l~~~~~~~~~~~L 381 (962)
.|.....++.|+.+.||+|....+++.++.|+.... ...+.+| +++++.++|||||+++++|.+++.+|+
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 455555666666667999998887777666653321 2234444 667777889999999999999999999
Q ss_pred EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcc
Q psy501 382 VFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYT 460 (962)
Q Consensus 382 V~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~ 460 (962)
|||||+ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+......
T Consensus 85 vmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~~ 163 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 163 (364)
T ss_dssp EECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCCC
T ss_pred EEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCccc
Confidence 999998 5676666554 56899999999999999999999999999999999999999999999999999988777777
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc-cccCCCCCCCCcHHHHHHH
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI-LLHTLPLYTYHVPPIQTTC 539 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~s~~l~~li~~C 539 (962)
...||+.|+|||++.++..|+.++|||||||+||||+||+.||.+............... .......++..+..++..|
T Consensus 164 ~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 243 (364)
T d1omwa3 164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 243 (364)
T ss_dssp SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHH
T ss_pred ccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHH
Confidence 789999999999997766799999999999999999999999987654433332222211 2222346777889999999
Q ss_pred hccCCCCCCc-----HHHHHhh
Q psy501 540 LLAGTERLKS-----SYILLHT 556 (962)
Q Consensus 540 l~~dperRPs-----~~~Ll~~ 556 (962)
|..+|++||+ ++++++.
T Consensus 244 L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 244 LQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp TCSSTTTSTTTSSSTHHHHHTS
T ss_pred cccCHHHhCCCcccCHHHHHcC
Confidence 9999999998 5666653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-39 Score=347.85 Aligned_cols=232 Identities=20% Similarity=0.253 Sum_probs=196.2
Q ss_pred cccEEEEEecCCceEEEEec--cchhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCC
Q psy501 324 TLPLYTCNLDQDNHILSRHV--SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLIRDRDKF 400 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kvv~~k~--~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l~~~~~~ 400 (962)
.+.||++.......++.+.+ .....+.+.+|+.++++++||||+++++++.+++.+++||||++ |++..++......
T Consensus 17 fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~ 96 (258)
T d1k2pa_ 17 FGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR 96 (258)
T ss_dssp TEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGC
T ss_pred CeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccC
Confidence 33578887654444433322 33456679999999999999999999999999999999999998 6677777777777
Q ss_pred CCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---CcccccCCccccChhhhccC
Q psy501 401 LPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYVSTRWYRAPEVLLHS 477 (962)
Q Consensus 401 ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~gt~~Y~APE~l~~~ 477 (962)
+++..++.++.|+++||.|||+.||+||||||+||+++.++.+||+|||+|+..... ......||+.|+|||++.+.
T Consensus 97 ~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 176 (258)
T d1k2pa_ 97 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176 (258)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHC
T ss_pred CcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCC
Confidence 999999999999999999999999999999999999999999999999999866543 23345789999999999764
Q ss_pred CCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 478 TAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 478 ~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.++.++|||||||++|||+| |+.||.+.........+..+. ..+.+...+..+..++..||..+|++||++.+++..
T Consensus 177 -~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 177 -KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC-CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 69999999999999999998 899999998888888787654 334445677788999999999999999999999886
Q ss_pred c
Q psy501 557 L 557 (962)
Q Consensus 557 l 557 (962)
|
T Consensus 255 L 255 (258)
T d1k2pa_ 255 I 255 (258)
T ss_dssp H
T ss_pred h
Confidence 5
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.5e-39 Score=347.95 Aligned_cols=247 Identities=17% Similarity=0.180 Sum_probs=195.8
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc-------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC----
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-------RDEMVVCFYRKSLKKLSHANLVKLKEVIREND---- 377 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---- 377 (962)
+.+.|.....++.|+.+.||+|....+++.++.|+.. .....+.+|+++|++++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 3456777767777777779999988777766655431 12346899999999999999999999997643
Q ss_pred EEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC
Q psy501 378 TLYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS 456 (962)
Q Consensus 378 ~~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~ 456 (962)
.+|+|||||+| +|.+.+.. .+.+++.+++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||.+.....
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred eEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 48999999996 45555544 45699999999999999999999999999999999999999999999999999876543
Q ss_pred C-----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--CCCCCC
Q psy501 457 R-----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--TLPLYT 529 (962)
Q Consensus 457 ~-----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s 529 (962)
. .....+||+.|+|||++.+ ..++.++|||||||++|||+||++||.+.........+......++ ..+..|
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242 (277)
T ss_dssp ---------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred ccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence 2 3445679999999999965 4799999999999999999999999999887777666655544332 234667
Q ss_pred CCcHHHHHHHhccCCCCCC-cHHHHHhhc
Q psy501 530 YHVPPIQTTCLLAGTERLK-SSYILLHTL 557 (962)
Q Consensus 530 ~~l~~li~~Cl~~dperRP-s~~~Ll~~l 557 (962)
..+..++..||..+|++|| ++++|++.|
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l 271 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEMRADL 271 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHHHHHH
Confidence 7889999999999999999 789998866
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-39 Score=349.10 Aligned_cols=243 Identities=20% Similarity=0.240 Sum_probs=194.8
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEecc--chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC-C
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVS--SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK-E 388 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~--~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~-g 388 (962)
.+.....++.|+.+.||++......+++.+.+. ....+.+.+|+++|++++|||||++++++.+ +..++|||||+ |
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g 92 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENG 92 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCC
Confidence 344444555566667999987765555555443 2345679999999999999999999998754 56799999998 5
Q ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---CcccccC
Q psy501 389 NLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYVS 464 (962)
Q Consensus 389 ~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~g 464 (962)
+|.+.+.... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+..... ......|
T Consensus 93 ~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~g 172 (272)
T d1qpca_ 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 172 (272)
T ss_dssp BHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCC
T ss_pred cHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccccccccCC
Confidence 6666554332 35999999999999999999999999999999999999999999999999999877544 3344578
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccC
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDH-VPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
|+.|+|||++.+. .++.++|||||||++|||+|| .+||...........+..+ ..+..+..++..+..++..||..+
T Consensus 173 t~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~~ 250 (272)
T d1qpca_ 173 PIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRPDNCPEELYQLMRLCWKER 250 (272)
T ss_dssp CTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred cccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCCcccChHHHHHHHHHHcCCC
Confidence 9999999999764 689999999999999999995 5666666666666666655 333344567788999999999999
Q ss_pred CCCCCcHHHHHhhc
Q psy501 544 TERLKSSYILLHTL 557 (962)
Q Consensus 544 perRPs~~~Ll~~l 557 (962)
|++||++.++++.|
T Consensus 251 P~~Rpt~~ei~~~L 264 (272)
T d1qpca_ 251 PEDRPTFDYLRSVL 264 (272)
T ss_dssp GGGSCCHHHHHHHH
T ss_pred HhHCcCHHHHHHHh
Confidence 99999999988755
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-39 Score=349.64 Aligned_cols=241 Identities=15% Similarity=0.218 Sum_probs=184.8
Q ss_pred EEEEecCCcccEEEEEecCCc-----eEEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecC
Q psy501 316 KFSYILPHTLPLYTCNLDQDN-----HILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 316 ~~~~i~~~~~~Vy~~~~~~~~-----kvv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
...++.|+.+.||++...... .++.+.+. ......+.+|+++|++++|||||++++++.+++..++|||||
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence 333444445558888765432 23333321 223346889999999999999999999999999999999999
Q ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-----Ccc
Q psy501 387 KE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-----PYT 460 (962)
Q Consensus 387 ~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-----~~~ 460 (962)
.+ ++.+.+......+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+|+..... ...
T Consensus 92 ~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 171 (283)
T d1mqba_ 92 ENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171 (283)
T ss_dssp TTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------------
T ss_pred ccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEec
Confidence 85 566666666678999999999999999999999999999999999999999999999999999876443 223
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHH
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDH-VPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTC 539 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~C 539 (962)
...||+.|+|||++.+. .++.++|||||||++|||++| .+||...........+..+ ..++....++..+..++..|
T Consensus 172 ~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~c 249 (283)
T d1mqba_ 172 GGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPTPMDCPSAIYQLMMQC 249 (283)
T ss_dssp --CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTCBHHHHHHHHHH
T ss_pred cCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-CCCCCchhhHHHHHHHHHHH
Confidence 34689999999999764 799999999999999999995 5555555555555555554 34444456777889999999
Q ss_pred hccCCCCCCcHHHHHhhcc
Q psy501 540 LLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 540 l~~dperRPs~~~Ll~~l~ 558 (962)
|..+|++||++.++++.|.
T Consensus 250 l~~~p~~RPt~~eil~~L~ 268 (283)
T d1mqba_ 250 WQQERARRPKFADIVSILD 268 (283)
T ss_dssp TCSSTTTSCCHHHHHHHHH
T ss_pred CcCCHhHCcCHHHHHHHHH
Confidence 9999999999999988663
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-38 Score=358.04 Aligned_cols=240 Identities=17% Similarity=0.231 Sum_probs=203.5
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
..+.....++.|+.+.||+|....+++.++.|+... ....+.+|+++|++++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 345556666666666799999887777766654332 2346889999999999999999999999999999999
Q ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccc
Q psy501 384 EYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDY 462 (962)
Q Consensus 384 Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 462 (962)
||+.| ++...+... +.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+..... ....
T Consensus 121 e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-~~~~ 198 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TWTL 198 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-BCCC
T ss_pred ccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-cccc
Confidence 99985 566666554 46999999999999999999999999999999999999999999999999999877554 3456
Q ss_pred cCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhcc
Q psy501 463 VSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 542 (962)
Q Consensus 463 ~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~ 542 (962)
.||+.|||||++.+ ..++.++|||||||++|||+||++||.+.+.......+..+....+ +.++..+..+++.||..
T Consensus 199 ~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~L~~ 275 (350)
T d1rdqe_ 199 CGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP--SHFSSDLKDLLRNLLQV 275 (350)
T ss_dssp EECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTCCHHHHHHHHHHSCS
T ss_pred cCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC--ccCCHHHHHHHHHHhhh
Confidence 89999999999976 4799999999999999999999999999988888888877754443 56778899999999999
Q ss_pred CCCCCC-----cHHHHHh
Q psy501 543 GTERLK-----SSYILLH 555 (962)
Q Consensus 543 dperRP-----s~~~Ll~ 555 (962)
||.+|+ ++.++++
T Consensus 276 dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 276 DLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CTTTCTTSSTTTTHHHHT
T ss_pred CHHhccccccccHHHHHc
Confidence 999994 7777765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-38 Score=345.45 Aligned_cols=243 Identities=19% Similarity=0.275 Sum_probs=203.5
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccch-------------hHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCE
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------------DEMVVCFYRKSLKKLS-HANLVKLKEVIRENDT 378 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------------~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~ 378 (962)
|.....++.|+.+.||+|+...+++.++.|+... ..+.+.+|+.+|++++ ||||+++++++.+++.
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence 4444455555666799998877777666554221 1235889999999997 9999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC
Q psy501 379 LYFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR 457 (962)
Q Consensus 379 ~~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~ 457 (962)
+|||||||+ |+|.+.+... +.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+|+.+...
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 163 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 163 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred eEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCC
Confidence 999999998 5788887665 46999999999999999999999999999999999999999999999999999877644
Q ss_pred -CcccccCCccccChhhhcc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc--CCCCCC
Q psy501 458 -PYTDYVSTRWYRAPEVLLH-----STAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--TLPLYT 529 (962)
Q Consensus 458 -~~~~~~gt~~Y~APE~l~~-----~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s 529 (962)
......||+.|+|||++.+ ...++.++||||+||++|||++|+.||.+.........+..+....+ ..+.+|
T Consensus 164 ~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 243 (277)
T d1phka_ 164 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 243 (277)
T ss_dssp CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSC
T ss_pred CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCC
Confidence 4455789999999999863 33578999999999999999999999999988888777777655433 233677
Q ss_pred CCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 530 YHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 530 ~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
..+.++++.||..+|++||++.++++.
T Consensus 244 ~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 244 DTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 788999999999999999998888774
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=353.76 Aligned_cols=249 Identities=18% Similarity=0.236 Sum_probs=206.9
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc---hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS---RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~---~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
+.|.....++.|+.+.||+|....+++.++.|... .+...+.+|+++|++++||||++++++|.+++.+|||||||+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 34555556666666679999888777765555433 234568899999999999999999999999999999999998
Q ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccc--cceeeecccccccccCC-Cccccc
Q psy501 388 -ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGT--ELVKIADFGLAREIRSR-PYTDYV 463 (962)
Q Consensus 388 -g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~--g~vKL~DFGla~~~~~~-~~~~~~ 463 (962)
|+|.+.+...+..+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++...... ......
T Consensus 85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~ 164 (321)
T d1tkia_ 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEE
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccccc
Confidence 57888887766679999999999999999999999999999999999999854 47999999999876544 345567
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC--CCCCCCCcHHHHHHHhc
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT--LPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~l~~li~~Cl~ 541 (962)
+|+.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.........+..+...++. .+.++..+.+++..||.
T Consensus 165 ~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 243 (321)
T d1tkia_ 165 TAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLV 243 (321)
T ss_dssp SCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSC
T ss_pred cccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHcc
Confidence 8999999999865 47999999999999999999999999999888888888776554432 23567778899999999
Q ss_pred cCCCCCCcHHHHHhhccccc
Q psy501 542 AGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 542 ~dperRPs~~~Ll~~l~~~~ 561 (962)
.||++||++.++++. ||+.
T Consensus 244 ~dp~~R~s~~eil~h-p~~~ 262 (321)
T d1tkia_ 244 KERKSRMTASEALQH-PWLK 262 (321)
T ss_dssp SSGGGSCCHHHHHHS-HHHH
T ss_pred CChhHCcCHHHHhcC-Hhhc
Confidence 999999998888753 3443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-38 Score=344.52 Aligned_cols=244 Identities=26% Similarity=0.344 Sum_probs=196.8
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccch------hHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR------DEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
|.....++.|+.+.||+|....+++.++.|+... ....+.+|+++|++++||||+++++++.+++.+|+||||+
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 3444455555566699998877666655544221 2356899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--Cccccc
Q psy501 387 KENLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYV 463 (962)
Q Consensus 387 ~g~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~ 463 (962)
.|++...+... ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||.|+..... ......
T Consensus 84 ~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 163 (298)
T d1gz8a_ 84 HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 163 (298)
T ss_dssp SEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCB
T ss_pred CCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccceeec
Confidence 99888777544 467999999999999999999999999999999999999999999999999999876543 444568
Q ss_pred CCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccC-------------------
Q psy501 464 STRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHT------------------- 524 (962)
Q Consensus 464 gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~------------------- 524 (962)
||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+.......+......+..
T Consensus 164 gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T d1gz8a_ 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243 (298)
T ss_dssp CCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCC
T ss_pred ccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccc
Confidence 9999999999887766799999999999999999999999988766655554332111110
Q ss_pred --------CCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 525 --------LPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 525 --------~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.+..+..+.++++.||..+|++|||+.++++.
T Consensus 244 ~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11223345678999999999999999988875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=343.60 Aligned_cols=244 Identities=17% Similarity=0.173 Sum_probs=188.9
Q ss_pred ceeeEEEEecCCcccEEEEEecCCc---eEEEEecc-----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDN---HILSRHVS-----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVF 383 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~---kvv~~k~~-----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~ 383 (962)
.+..+..++.|+.+.||++...... ..++.+.. ......+.+|+++|++++||||+++++++. ++.+|+||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence 3444555555555668888765432 22333322 122356899999999999999999999996 46789999
Q ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---Cc
Q psy501 384 EYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PY 459 (962)
Q Consensus 384 Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~ 459 (962)
||++ |++.+++......+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||+|+..... ..
T Consensus 87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~ 166 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 166 (273)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------------
T ss_pred EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcceec
Confidence 9998 5677777776778999999999999999999999999999999999999999999999999999876543 33
Q ss_pred ccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHH
Q psy501 460 TDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTT 538 (962)
Q Consensus 460 ~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~ 538 (962)
....||+.|+|||++.+. .++.++|||||||++|||++ |.+||.+.........+..+.. .+.++.+|..+..++..
T Consensus 167 ~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~li~~ 244 (273)
T d1mp8a_ 167 SKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-LPMPPNCPPTLYSLMTK 244 (273)
T ss_dssp ----CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-CCCCTTCCHHHHHHHHH
T ss_pred cceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHH
Confidence 445688999999999764 79999999999999999998 8999999888888777776643 34456788889999999
Q ss_pred HhccCCCCCCcHHHHHhhcc
Q psy501 539 CLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 539 Cl~~dperRPs~~~Ll~~l~ 558 (962)
||..+|++||++.+|++.|.
T Consensus 245 cl~~dp~~Rps~~ei~~~L~ 264 (273)
T d1mp8a_ 245 CWAYDPSRRPRFTELKAQLS 264 (273)
T ss_dssp HTCSSGGGSCCHHHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHHHH
Confidence 99999999999999998763
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-39 Score=346.92 Aligned_cols=241 Identities=20% Similarity=0.246 Sum_probs=196.6
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh----------HHHHHHHHHHHHhcC--CCCcccEEEEEEeCC
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD----------EMVVCFYRKSLKKLS--HANLVKLKEVIREND 377 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~----------~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~~ 377 (962)
.+.|..+..++.|+.+.||+|....+++.++.|....+ ...+.+|+.+|++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35566666666666667999988777766555543221 123678999999997 899999999999999
Q ss_pred EEEEEEecCCC--CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc-ccceeeecccccccc
Q psy501 378 TLYFVFEYMKE--NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG-TELVKIADFGLAREI 454 (962)
Q Consensus 378 ~~~LV~Ey~~g--~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~-~g~vKL~DFGla~~~ 454 (962)
..++||||+.| ++.+.+... ..+++..++.++.||+.||+|||++||+||||||+||+++. .+.+||+|||+|...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 99999999974 455555544 56999999999999999999999999999999999999985 479999999999887
Q ss_pred cCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHH
Q psy501 455 RSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPP 534 (962)
Q Consensus 455 ~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~ 534 (962)
.........||+.|+|||++.+...++.++|||||||++|||++|+.||.+.. .+..+.... .+.+|..+.+
T Consensus 162 ~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~--~~~~s~~~~~ 233 (273)
T d1xwsa_ 162 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFF--RQRVSSECQH 233 (273)
T ss_dssp CSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCC--SSCCCHHHHH
T ss_pred ccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCC--CCCCCHHHHH
Confidence 77667778999999999999876566788999999999999999999997642 333443332 3567888999
Q ss_pred HHHHHhccCCCCCCcHHHHHhhcccc
Q psy501 535 IQTTCLLAGTERLKSSYILLHTLPLY 560 (962)
Q Consensus 535 li~~Cl~~dperRPs~~~Ll~~l~~~ 560 (962)
++..||..+|++|||+.++++. ||+
T Consensus 234 li~~~L~~dp~~R~s~~eil~h-p~~ 258 (273)
T d1xwsa_ 234 LIRWCLALRPSDRPTFEEIQNH-PWM 258 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTS-GGG
T ss_pred HHHHHccCCHhHCcCHHHHhcC-Hhh
Confidence 9999999999999999888764 344
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-38 Score=349.47 Aligned_cols=245 Identities=14% Similarity=0.159 Sum_probs=196.3
Q ss_pred ceeeEEEEecCCcccEEEEEecCCc-----eEEEEecc----chhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDN-----HILSRHVS----SRDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~-----kvv~~k~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
++.....++.|+.+.||++....++ +++.+.+. ......+.+|+++|++++|||||++++++.++.. +++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~-~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSE-EEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe-eEE
Confidence 4555555555666668888765544 34333332 2235579999999999999999999999987654 556
Q ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC----
Q psy501 383 FEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---- 457 (962)
Q Consensus 383 ~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---- 457 (962)
+|++. |+|.+.+......+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||+|+.....
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 168 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 168 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccccc
Confidence 66665 7899988888888999999999999999999999999999999999999999999999999999876543
Q ss_pred CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHH
Q psy501 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQ 536 (962)
Q Consensus 458 ~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li 536 (962)
......||+.|+|||++.++ .++.++|||||||++|||+| |.+||.+.........+..+. .++.++.++..+..++
T Consensus 169 ~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~~p~~~~~~~~~li 246 (317)
T d1xkka_ 169 HAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQPPICTIDVYMIM 246 (317)
T ss_dssp ------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-CCCCCTTBCHHHHHHH
T ss_pred cccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCCCCcccCHHHHHHH
Confidence 22334689999999999775 79999999999999999998 899999887777666666553 3344567778889999
Q ss_pred HHHhccCCCCCCcHHHHHhhccc
Q psy501 537 TTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 537 ~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
..||..+|++||++.++++.+..
T Consensus 247 ~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 247 VKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhCCCChhhCcCHHHHHHHHHH
Confidence 99999999999999999887643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=351.37 Aligned_cols=238 Identities=18% Similarity=0.219 Sum_probs=198.5
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccch-------hHHHHHHHHHHHH-hcCCCCcccEEEEEEeCCEEEEEEe
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSR-------DEMVVCFYRKSLK-KLSHANLVKLKEVIRENDTLYFVFE 384 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~-------~~~~~~~Ei~iL~-~L~HpnIv~l~~~~~~~~~~~LV~E 384 (962)
|.+...++.|+.+.||+|....+++.++.|+... ..+.+.+|+.++. .++||||+++++++.+++.+|||||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 4445555555666799999888888777665432 2335677777765 6899999999999999999999999
Q ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--Cccc
Q psy501 385 YMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTD 461 (962)
Q Consensus 385 y~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~ 461 (962)
||+| +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++..+.+||+|||+|+..... ....
T Consensus 84 y~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~ 162 (320)
T d1xjda_ 84 YLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT 162 (320)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCC
T ss_pred ecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccccc
Confidence 9985 666666544 56999999999999999999999999999999999999999999999999999866543 4455
Q ss_pred ccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhc
Q psy501 462 YVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 462 ~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~ 541 (962)
..||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+..+....+ ...+..+.+++..||.
T Consensus 163 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p--~~~s~~~~dli~~~L~ 239 (320)
T d1xjda_ 163 FCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP--RWLEKEAKDLLVKLFV 239 (320)
T ss_dssp CCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHSC
T ss_pred cCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--ccCCHHHHHHHHHhcc
Confidence 6899999999999764 799999999999999999999999999988888888877654333 4567888999999999
Q ss_pred cCCCCCCcHH-HHH
Q psy501 542 AGTERLKSSY-ILL 554 (962)
Q Consensus 542 ~dperRPs~~-~Ll 554 (962)
.+|++||++. +|+
T Consensus 240 ~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 240 REPEKRLGVRGDIR 253 (320)
T ss_dssp SSGGGSBTTBSCGG
T ss_pred cCCCCCcCHHHHHH
Confidence 9999999974 454
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-38 Score=343.85 Aligned_cols=246 Identities=18% Similarity=0.136 Sum_probs=196.9
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCc---eEEEEeccc-------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEE
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDN---HILSRHVSS-------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTL 379 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~---kvv~~k~~~-------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 379 (962)
..++.....++.|+.+.||++...... ..++.|... ...+.+.+|+++|++++||||+++++++.++ ..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-ch
Confidence 344455445555555569998754332 123333221 1234689999999999999999999999754 67
Q ss_pred EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-
Q psy501 380 YFVFEYMK-ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457 (962)
Q Consensus 380 ~LV~Ey~~-g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~- 457 (962)
++|||||+ |++.+.+....+.+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 89999998 6788877777777999999999999999999999999999999999999999999999999999876543
Q ss_pred ----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCc
Q psy501 458 ----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHV 532 (962)
Q Consensus 458 ----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l 532 (962)
......|+..|+|||++.+ ..++.++|||||||++|||+| |++||.+.+.......+......++..+.+|..+
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 2233467889999999976 479999999999999999998 8999999988888888877766666667788889
Q ss_pred HHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 533 PPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 533 ~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
..++..||..+|++||++.+|...|
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~~~L 269 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALRDFL 269 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9999999999999999999988755
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-38 Score=341.11 Aligned_cols=243 Identities=20% Similarity=0.270 Sum_probs=192.2
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCC-
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKE- 388 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g- 388 (962)
.+.....++.|+.+.||++......+++.+.+.. ...+.+.+|+.+|++++|||||++++++.+ +..++|||||++
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g 96 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 96 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCC
Confidence 4556666666667779999888776665554432 235679999999999999999999999854 567899999985
Q ss_pred CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC---CcccccC
Q psy501 389 NLYQLIRDR-DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR---PYTDYVS 464 (962)
Q Consensus 389 ~Ll~~l~~~-~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~---~~~~~~g 464 (962)
++...+... ...+++.+++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+..... ......|
T Consensus 97 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 176 (285)
T d1fmka3 97 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 176 (285)
T ss_dssp BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------C
T ss_pred chhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccc
Confidence 566666443 356999999999999999999999999999999999999999999999999999876433 2334578
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccC
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDH-VPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAG 543 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~d 543 (962)
|+.|+|||++.++ .++.++|||||||++|||++| .+||.+.........+..+ ...+..+.++..+..++..||..+
T Consensus 177 t~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~d 254 (285)
T d1fmka3 177 PIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCWRKE 254 (285)
T ss_dssp CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred cccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCCCcccCHHHHHHHHHHcccC
Confidence 9999999999764 689999999999999999995 5556666666566666554 334455677888999999999999
Q ss_pred CCCCCcHHHHHhhc
Q psy501 544 TERLKSSYILLHTL 557 (962)
Q Consensus 544 perRPs~~~Ll~~l 557 (962)
|++||++.+++..|
T Consensus 255 P~~Rps~~~i~~~L 268 (285)
T d1fmka3 255 PEERPTFEYLQAFL 268 (285)
T ss_dssp GGGSCCHHHHHHHH
T ss_pred HhHCcCHHHHHHHH
Confidence 99999999988755
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-38 Score=349.59 Aligned_cols=244 Identities=18% Similarity=0.227 Sum_probs=191.0
Q ss_pred CceeeEEE-EecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhc-CCCCcccEEEEEEe----CCEEEEEEe
Q psy501 311 GTERLKFS-YILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKL-SHANLVKLKEVIRE----NDTLYFVFE 384 (962)
Q Consensus 311 g~~~~~~~-~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~----~~~~~LV~E 384 (962)
+.|..... ++.|+.+.||+|....+++.++.|+... ...+.+|++++.++ +||||++++++|++ +..+|+|||
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE 89 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 89 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence 45555444 4555566699999887777776666543 34588999997655 89999999999976 467999999
Q ss_pred cCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc---ccceeeecccccccccCC-C
Q psy501 385 YMK-ENLYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG---TELVKIADFGLAREIRSR-P 458 (962)
Q Consensus 385 y~~-g~Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~---~g~vKL~DFGla~~~~~~-~ 458 (962)
||+ |+|.+++...+ ..+++.+++.++.||+.||+|||+.||+||||||+|||++. .+.+||+|||+|+..... .
T Consensus 90 y~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~ 169 (335)
T d2ozaa1 90 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169 (335)
T ss_dssp CCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC
T ss_pred CCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCc
Confidence 998 58888887653 56999999999999999999999999999999999999975 457999999999876543 4
Q ss_pred cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHH----hccccccCC--CCCCCCc
Q psy501 459 YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLK----SSYILLHTL--PLYTYHV 532 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~----~~~~~~~~~--~~~s~~l 532 (962)
.....||+.|+|||++.+ ..|+.++|||||||+||+|+||++||.+.........+. .+...++.. +.++..+
T Consensus 170 ~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 248 (335)
T d2ozaa1 170 LTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248 (335)
T ss_dssp CCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHH
T ss_pred cccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHH
Confidence 556789999999999965 479999999999999999999999998766544433322 222222211 2456678
Q ss_pred HHHHHHHhccCCCCCCcHHHHHhh
Q psy501 533 PPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 533 ~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.+++..||..+|++||++.++++.
T Consensus 249 ~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 249 KMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHccCChhHCcCHHHHHcC
Confidence 889999999999999998887764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-37 Score=337.62 Aligned_cols=244 Identities=24% Similarity=0.274 Sum_probs=194.0
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMK 387 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~ 387 (962)
|.....++.|+.+.||+|....+..++.+.+.. .....+.+|+.+|++++||||+++++++.+++..+++||++.
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence 333444445555669999876554444444322 124578999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccCC
Q psy501 388 ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVST 465 (962)
Q Consensus 388 g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~gt 465 (962)
|+++..+....+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||.|...... ......++
T Consensus 84 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 163 (286)
T d1ob3a_ 84 QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT 163 (286)
T ss_dssp EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CC
T ss_pred hhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccceeccc
Confidence 9999999888888999999999999999999999999999999999999999999999999999876544 33445789
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-----------------------
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL----------------------- 522 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------------------- 522 (962)
+.|+|||.+.+...++.++|||||||++|||++|++||.+........++......+
T Consensus 164 ~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (286)
T d1ob3a_ 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243 (286)
T ss_dssp CTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCC
T ss_pred chhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccC
Confidence 999999999877778999999999999999999999999877666555543211110
Q ss_pred ----cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 523 ----HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 523 ----~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
...+..+..+.++++.||..||++|||+.++++.
T Consensus 244 ~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0012233345689999999999999999888864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-38 Score=336.63 Aligned_cols=242 Identities=20% Similarity=0.237 Sum_probs=189.1
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEecc-chhHHHHHHHHHHHHhcCCCCcccEEEEEEe-CCEEEEEEecCC-CC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVS-SRDEMVVCFYRKSLKKLSHANLVKLKEVIRE-NDTLYFVFEYMK-EN 389 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-~~~~~LV~Ey~~-g~ 389 (962)
+.....++.|+.+.||++..... +++.+.+. ....+.+.+|+++|++++||||+++++++.+ .+.+|+||||++ |+
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~-~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~ 87 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYRGN-KVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEETTE-EEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred eEEeEEEecCCCeEEEEEEECCe-EEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence 33444455555566888887543 44444443 3335679999999999999999999999854 456899999998 57
Q ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCCcccccCCccc
Q psy501 390 LYQLIRDRD-KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWY 468 (962)
Q Consensus 390 Ll~~l~~~~-~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y 468 (962)
|.+++.... ..+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||+++..... .....++..|
T Consensus 88 L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-~~~~~~~~~y 166 (262)
T d1byga_ 88 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-QDTGKLPVKW 166 (262)
T ss_dssp HHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------------CCTTT
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-CccccccccC
Confidence 777775442 35899999999999999999999999999999999999999999999999999865443 3345688999
Q ss_pred cChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhccCCCCC
Q psy501 469 RAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERL 547 (962)
Q Consensus 469 ~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperR 547 (962)
+|||++.+. .++.++|||||||++|||+| |++||......+....+..+ ..++.++.++..+..++..||..+|.+|
T Consensus 167 ~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~R 244 (262)
T d1byga_ 167 TAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYEVMKNCWHLDAAMR 244 (262)
T ss_dssp SCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCccCCHHHHHHHHHHcccCHhHC
Confidence 999999765 79999999999999999998 79999988887777777655 3444456677889999999999999999
Q ss_pred CcHHHHHhhcc
Q psy501 548 KSSYILLHTLP 558 (962)
Q Consensus 548 Ps~~~Ll~~l~ 558 (962)
|++.+|++.|.
T Consensus 245 ps~~~l~~~L~ 255 (262)
T d1byga_ 245 PSFLQLREQLE 255 (262)
T ss_dssp CCHHHHHHHHH
T ss_pred cCHHHHHHHHH
Confidence 99999998763
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-37 Score=344.30 Aligned_cols=245 Identities=21% Similarity=0.300 Sum_probs=196.4
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcCCCCcccEEEEEEeC------CEEEEEEec
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLSHANLVKLKEVIREN------DTLYFVFEY 385 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------~~~~LV~Ey 385 (962)
+|.....++.|+.+.||+|....+++.++.|....+.....+|+++|++++||||++++++|... .++||||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 34444455555566699999888887777766555555567899999999999999999999543 368999999
Q ss_pred CCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc-ceeeecccccccccCC-Ccc
Q psy501 386 MKENLYQLIR---DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE-LVKIADFGLAREIRSR-PYT 460 (962)
Q Consensus 386 ~~g~Ll~~l~---~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g-~vKL~DFGla~~~~~~-~~~ 460 (962)
|++++...+. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|...... ...
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~ 180 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCC
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcccc
Confidence 9988766654 3456799999999999999999999999999999999999999775 8999999999876543 455
Q ss_pred cccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccc-----------------ccc
Q psy501 461 DYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYI-----------------LLH 523 (962)
Q Consensus 461 ~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------~~~ 523 (962)
...||..|+|||.+.+...++.++|||||||++|||++|++||...........+..... ..+
T Consensus 181 ~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 260 (350)
T d1q5ka_ 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 260 (350)
T ss_dssp SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCC
T ss_pred cccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcccc
Confidence 578999999999998777899999999999999999999999998776655544432100 000
Q ss_pred ----------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 524 ----------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 524 ----------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
..+..+..+.+++..||..||++|||+.++++.
T Consensus 261 ~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 261 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112344457789999999999999998888864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-37 Score=335.73 Aligned_cols=243 Identities=18% Similarity=0.165 Sum_probs=196.4
Q ss_pred eeeEEEEecCCcccEEEEEecC-----CceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEE
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQ-----DNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFV 382 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~-----~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 382 (962)
+.....++.|+.+.||+++... +.+.++.|... .....+.+|+++|++++||||+++++++.+++..++|
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 3444455556666788887643 23334433321 1245699999999999999999999999999999999
Q ss_pred EecCC-CCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccc
Q psy501 383 FEYMK-ENLYQLIRDRD-----------------------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCM 438 (962)
Q Consensus 383 ~Ey~~-g~Ll~~l~~~~-----------------------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~ 438 (962)
|||++ |+|.+++.... ..+++..++.++.|++.||+|||+++||||||||+|||++
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld 174 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG 174 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEEC
Confidence 99998 67777775421 2489999999999999999999999999999999999999
Q ss_pred cccceeeecccccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCC-CCCCCcChhhhHH
Q psy501 439 GTELVKIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHV-PPIQTTCLLAGTE 513 (962)
Q Consensus 439 ~~g~vKL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~-~Pf~~~~~~~~~~ 513 (962)
.++.+||+|||+|+..... ......|++.|+|||++.+ ..++.++|||||||++|||++|. +||.+....+...
T Consensus 175 ~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~ 253 (301)
T d1lufa_ 175 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIY 253 (301)
T ss_dssp GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHH
Confidence 9999999999999865433 2334578899999999976 47999999999999999999984 7899888888888
Q ss_pred HHHhccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 514 RLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 514 ~i~~~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.+..+.. ++.+..++..+..|+..||..+|++||++.++++.|
T Consensus 254 ~v~~~~~-~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L 296 (301)
T d1lufa_ 254 YVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296 (301)
T ss_dssp HHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHcCCC-CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 7777643 333446777889999999999999999999998865
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-36 Score=331.57 Aligned_cols=247 Identities=23% Similarity=0.276 Sum_probs=198.7
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEe--------
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRE-------- 375 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-------- 375 (962)
.+.|.....++.|+.+.||+|....+++.++.|+.. .....+.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 467777777777777789999988777766665422 223468899999999999999999999854
Q ss_pred CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccccccc
Q psy501 376 NDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIR 455 (962)
Q Consensus 376 ~~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~ 455 (962)
.+.+|+||||+.++++.........+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 34689999999999888887777789999999999999999999999999999999999999999999999999997664
Q ss_pred CC------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccccCCC--C
Q psy501 456 SR------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLHTLP--L 527 (962)
Q Consensus 456 ~~------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~ 527 (962)
.. .....+||+.|+|||++.+...++.++|||||||++|||++|++||.+.........+......+.... .
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 32 233457999999999998777899999999999999999999999998777666555544322221110 0
Q ss_pred ----------------------------CCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 528 ----------------------------YTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 528 ----------------------------~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
.+..+.+++..||..||++|||+.+++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 01123458999999999999998887654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-37 Score=335.09 Aligned_cols=246 Identities=19% Similarity=0.199 Sum_probs=185.0
Q ss_pred ceeeEEEEecCCcccEEEEEecC-----CceEEEEecc-----chhHHHHHHHHHHHHhc-CCCCcccEEEEEEeC-CEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQ-----DNHILSRHVS-----SRDEMVVCFYRKSLKKL-SHANLVKLKEVIREN-DTL 379 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~-----~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~-~~~ 379 (962)
.+.....++.|+.+.||++.... +.+.++.|.. ..+...+.+|..++.++ +||+|+.+++++..+ ..+
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~ 93 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 93 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeE
Confidence 34444455555555688887543 2244443332 22344678888888887 689999999998654 468
Q ss_pred EEEEecCC-CCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccce
Q psy501 380 YFVFEYMK-ENLYQLIRDR---------------DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELV 443 (962)
Q Consensus 380 ~LV~Ey~~-g~Ll~~l~~~---------------~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~v 443 (962)
++|||||+ |+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus 94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~ 173 (299)
T d1ywna1 94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 173 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCE
T ss_pred EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcE
Confidence 99999998 6777777543 2358999999999999999999999999999999999999999999
Q ss_pred eeecccccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCcChhhhHHHHHhc
Q psy501 444 KIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDH-VPPIQTTCLLAGTERLKSS 518 (962)
Q Consensus 444 KL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG-~~Pf~~~~~~~~~~~i~~~ 518 (962)
||+|||+|+..... ......||+.|+|||++.+. .++.++|||||||++|||++| .+||.+.............
T Consensus 174 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~ 252 (299)
T d1ywna1 174 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 252 (299)
T ss_dssp EECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHH
T ss_pred EEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 99999999865433 23345799999999999764 799999999999999999986 5788876655544444333
Q ss_pred cccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 519 YILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 519 ~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
...++.+..++..+..++..||..+|++||++.++++.|.
T Consensus 253 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~ 292 (299)
T d1ywna1 253 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292 (299)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 3444445567778899999999999999999999998763
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-36 Score=333.43 Aligned_cols=244 Identities=20% Similarity=0.214 Sum_probs=194.4
Q ss_pred ceeeEEEEecCCcccEEEEEecCCc-------eEEEEecc-----chhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDN-------HILSRHVS-----SRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDT 378 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~-------kvv~~k~~-----~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 378 (962)
.+..+..++.|+.+.||.++..... ..++.|.. ......+.+|...+.++ +|||||++++++.+++.
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 3333444444444558888654432 23333332 12335688899999888 79999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccc
Q psy501 379 LYFVFEYMK-ENLYQLIRDRD---------------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL 442 (962)
Q Consensus 379 ~~LV~Ey~~-g~Ll~~l~~~~---------------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~ 442 (962)
.++|||||+ |++.+++.... ..+++.+++.++.||+.||+|||+.+||||||||+|||++.++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~ 173 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 173 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCC
Confidence 999999998 67777775442 35899999999999999999999999999999999999999999
Q ss_pred eeeecccccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHh
Q psy501 443 VKIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKS 517 (962)
Q Consensus 443 vKL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~ 517 (962)
+||+|||+++..... ......+++.|+|||.+.++ .|+.++|||||||++|||++ |.+||.+.........+..
T Consensus 174 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~ 252 (299)
T d1fgka_ 174 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 252 (299)
T ss_dssp EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred eEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHc
Confidence 999999999876544 23345789999999999764 79999999999999999998 7999998888777766665
Q ss_pred ccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 518 SYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 518 ~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+ ..++.+..++..+..++..||..+|++|||+.++++.|
T Consensus 253 ~-~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 253 G-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp T-CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred C-CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 5 34444556778899999999999999999999999876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-36 Score=336.09 Aligned_cols=234 Identities=21% Similarity=0.218 Sum_probs=187.9
Q ss_pred cccEEEEEecCCceE--EEEec-----cchhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEEEEEecCC-CCHHHHH
Q psy501 324 TLPLYTCNLDQDNHI--LSRHV-----SSRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLYFVFEYMK-ENLYQLI 394 (962)
Q Consensus 324 ~~~Vy~~~~~~~~kv--v~~k~-----~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~Ey~~-g~Ll~~l 394 (962)
.+.||++....++.. ++.+. .....+.+.+|+++|+++ +||||+++++++.+++.+++||||++ |+|.+++
T Consensus 23 fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l 102 (309)
T d1fvra_ 23 FGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 102 (309)
T ss_dssp GCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHH
T ss_pred CcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHH
Confidence 334777766554321 22221 122344689999999999 79999999999999999999999998 6777777
Q ss_pred Hhc---------------CCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-C
Q psy501 395 RDR---------------DKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR-P 458 (962)
Q Consensus 395 ~~~---------------~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~-~ 458 (962)
... ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+|+..... .
T Consensus 103 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~ 182 (309)
T d1fvra_ 103 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 182 (309)
T ss_dssp HTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECC
T ss_pred hhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEcccccccccccccc
Confidence 543 356999999999999999999999999999999999999999999999999999765543 3
Q ss_pred cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCcChhhhHHHHHhccccccCCCCCCCCcHHHHH
Q psy501 459 YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDH-VPPIQTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQT 537 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~ 537 (962)
.....||..|+|||.+.++ .++.++|||||||++|||++| .+||.+.+.......+..+. .++.+..++..+..++.
T Consensus 183 ~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~ 260 (309)
T d1fvra_ 183 KTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEKPLNCDDEVYDLMR 260 (309)
T ss_dssp C----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-CCCCCTTBCHHHHHHHH
T ss_pred ccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-CCCCCccCCHHHHHHHH
Confidence 3345689999999999764 799999999999999999996 56888888777777776653 34444567788999999
Q ss_pred HHhccCCCCCCcHHHHHhhccc
Q psy501 538 TCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 538 ~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
.||..+|++||++.++++.|..
T Consensus 261 ~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 261 QCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHcCCChhHCcCHHHHHHHHHH
Confidence 9999999999999999987744
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-36 Score=332.79 Aligned_cols=245 Identities=24% Similarity=0.343 Sum_probs=190.6
Q ss_pred CceeeEEEEecCCcccEEEEEecCC-ceEEEEeccc------hhHHHHHHHHHHHHhc---CCCCcccEEEEEEe-----
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQD-NHILSRHVSS------RDEMVVCFYRKSLKKL---SHANLVKLKEVIRE----- 375 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~-~kvv~~k~~~------~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~----- 375 (962)
..|.....++.|+.+.||+|....+ .+.++.|... .....+.+|+.+|+.| +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 4556666666666677999987543 4544443321 1223467888887776 79999999999863
Q ss_pred CCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccc
Q psy501 376 NDTLYFVFEYMKENLYQLIR-DRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREI 454 (962)
Q Consensus 376 ~~~~~LV~Ey~~g~Ll~~l~-~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~ 454 (962)
...++++|||++|+++.... .....+++..++.++.|++.||+|||++||+||||||+|||++..+.+||+|||++...
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 34789999999988776554 34467999999999999999999999999999999999999999999999999999765
Q ss_pred cCC-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc-----------
Q psy501 455 RSR-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL----------- 522 (962)
Q Consensus 455 ~~~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------- 522 (962)
... ......||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+.......+......+
T Consensus 167 ~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 245 (305)
T d1blxa_ 167 SFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245 (305)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred cccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccc
Confidence 433 4456789999999999976 479999999999999999999999999887766655554321100
Q ss_pred --------------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 523 --------------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 523 --------------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
...+..+..+.+|+..||..||++|||+.++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0112334456779999999999999998888774
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-36 Score=333.04 Aligned_cols=238 Identities=19% Similarity=0.180 Sum_probs=185.1
Q ss_pred EecCCcccEEEEEecCCc---eEEE-Eec----cchhHHHHHHHHHHHHhcCCCCcccEEEEEEe-CCEEEEEEecCC-C
Q psy501 319 YILPHTLPLYTCNLDQDN---HILS-RHV----SSRDEMVVCFYRKSLKKLSHANLVKLKEVIRE-NDTLYFVFEYMK-E 388 (962)
Q Consensus 319 ~i~~~~~~Vy~~~~~~~~---kvv~-~k~----~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-~~~~~LV~Ey~~-g 388 (962)
++.|+.+.||++...... ..++ +.+ ...+...+.+|+++|++++||||+++++++.+ ++..++|||||+ |
T Consensus 35 iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g 114 (311)
T d1r0pa_ 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 114 (311)
T ss_dssp EEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTC
T ss_pred EeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecC
Confidence 344444558887764432 1222 222 22234579999999999999999999999875 568999999999 5
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC------Ccccc
Q psy501 389 NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR------PYTDY 462 (962)
Q Consensus 389 ~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~------~~~~~ 462 (962)
++.+++......+++..++.++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++..... .....
T Consensus 115 ~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~ 194 (311)
T d1r0pa_ 115 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194 (311)
T ss_dssp BHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCS
T ss_pred chhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccc
Confidence 666666666667889999999999999999999999999999999999999999999999999876433 22335
Q ss_pred cCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCc-ChhhhHHHHHhccccccCCCCCCCCcHHHHHHHhc
Q psy501 463 VSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTT-CLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLL 541 (962)
Q Consensus 463 ~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~s~~l~~li~~Cl~ 541 (962)
.||+.|+|||.+.+. .++.++|||||||++|||+||..||... ........+..+. .+..++.++..+..++..||.
T Consensus 195 ~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~-~~~~p~~~~~~l~~li~~cl~ 272 (311)
T d1r0pa_ 195 KLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 272 (311)
T ss_dssp SCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC-CCCCCTTCCHHHHHHHHHHTC
T ss_pred cccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCCCcccCcHHHHHHHHHHcC
Confidence 689999999999764 6999999999999999999976666543 3444455555553 333445667789999999999
Q ss_pred cCCCCCCcHHHHHhhcc
Q psy501 542 AGTERLKSSYILLHTLP 558 (962)
Q Consensus 542 ~dperRPs~~~Ll~~l~ 558 (962)
.+|++||++.++++.|.
T Consensus 273 ~dP~~RPs~~ei~~~L~ 289 (311)
T d1r0pa_ 273 PKAEMRPSFSELVSRIS 289 (311)
T ss_dssp SSGGGSCCHHHHHHHHH
T ss_pred CCHhHCcCHHHHHHHHH
Confidence 99999999999998763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-36 Score=334.87 Aligned_cols=246 Identities=17% Similarity=0.186 Sum_probs=195.6
Q ss_pred ceeeEEEEecCCcccEEEEEec-----CCceEEEEecc-----chhHHHHHHHHHHHHhc-CCCCcccEEEEEEeCCEEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLD-----QDNHILSRHVS-----SRDEMVVCFYRKSLKKL-SHANLVKLKEVIRENDTLY 380 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~-----~~~kvv~~k~~-----~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~ 380 (962)
.+.++..++.|+.+.||++... ...+.++.|.. ..+...+.+|+.+++++ +|||||++++++.++...+
T Consensus 24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~ 103 (311)
T d1t46a_ 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (311)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEE
Confidence 3344444555555568887642 23333333332 12344688999999999 6999999999999999999
Q ss_pred EEEecCC-CCHHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccc
Q psy501 381 FVFEYMK-ENLYQLIRDRD-----------------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTEL 442 (962)
Q Consensus 381 LV~Ey~~-g~Ll~~l~~~~-----------------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~ 442 (962)
+|||||+ |++.+++.... ..+++..+..++.||+.||+|||+++++||||||+||+++.++.
T Consensus 104 lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~ 183 (311)
T d1t46a_ 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183 (311)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTE
T ss_pred EEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCc
Confidence 9999998 56777665432 25899999999999999999999999999999999999999999
Q ss_pred eeeecccccccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCcChhhhHHHHHh
Q psy501 443 VKIADFGLAREIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSID-HVPPIQTTCLLAGTERLKS 517 (962)
Q Consensus 443 vKL~DFGla~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~ellt-G~~Pf~~~~~~~~~~~i~~ 517 (962)
+||+|||.++..... ......||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+........++..
T Consensus 184 ~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~ 262 (311)
T d1t46a_ 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262 (311)
T ss_dssp EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH
T ss_pred ccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 999999999876543 22345789999999999764 79999999999999999998 6777777766665555555
Q ss_pred ccccccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhcc
Q psy501 518 SYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLP 558 (962)
Q Consensus 518 ~~~~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~ 558 (962)
....+......+..+..|+..||..+|++||++.++++.|.
T Consensus 263 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~ 303 (311)
T d1t46a_ 263 EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (311)
T ss_dssp HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 54555555677788999999999999999999999998663
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-36 Score=335.32 Aligned_cols=244 Identities=24% Similarity=0.286 Sum_probs=191.2
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCC------
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIREND------ 377 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 377 (962)
...|.....++.|+.+.||+|....+++.++.|... .....+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 345555555555566669999988777766655532 12346889999999999999999999997654
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC
Q psy501 378 TLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR 457 (962)
Q Consensus 378 ~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~ 457 (962)
.+|+|||||++++...... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 97 ~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~ 174 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174 (346)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred eEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc
Confidence 5799999997777666544 35999999999999999999999999999999999999999999999999999876543
Q ss_pred CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhccccc---------------
Q psy501 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILL--------------- 522 (962)
Q Consensus 458 ~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------------- 522 (962)
.....||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+......+
T Consensus 175 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (346)
T d1cm8a_ 175 -MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253 (346)
T ss_dssp -CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred -cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhh
Confidence 4557899999999999877778999999999999999999999999876655544333211110
Q ss_pred --------------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 523 --------------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 523 --------------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
...+..+..+.+|+..||..+|++|||+.++++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1112334556679999999999999998888764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2e-35 Score=323.19 Aligned_cols=248 Identities=13% Similarity=0.072 Sum_probs=201.9
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCC-CCcccEEEEEEeCCEEEEEEec
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSH-ANLVKLKEVIRENDTLYFVFEY 385 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~~~~~~LV~Ey 385 (962)
+.+.|.+...++.|+.+.||+|....+++.++.|+.. .+...+.+|+++++.+.| ++++.+++++.++...++||||
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 3567777777777777789999988888777666543 234458899999999975 8999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc-----ccceeeecccccccccCC---
Q psy501 386 MKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG-----TELVKIADFGLAREIRSR--- 457 (962)
Q Consensus 386 ~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~-----~g~vKL~DFGla~~~~~~--- 457 (962)
++|+|.+.+...+..+++.++..++.|++.||+|||++||+||||||+||+++. .+.+||+|||+|+.....
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (293)
T d1csna_ 83 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 162 (293)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred cCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccc
Confidence 999999998887778999999999999999999999999999999999999974 568999999999876432
Q ss_pred ------CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh---HHHHHhcccc---ccCC
Q psy501 458 ------PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG---TERLKSSYIL---LHTL 525 (962)
Q Consensus 458 ------~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~---~~~i~~~~~~---~~~~ 525 (962)
......||+.|||||++.+ ..++.++|||||||++|||++|+.||.+...... ...+...... ....
T Consensus 163 ~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (293)
T d1csna_ 163 QHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241 (293)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHT
T ss_pred cceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhc
Confidence 2334579999999999976 4799999999999999999999999986544322 2222222111 1122
Q ss_pred CCCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 526 PLYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 526 ~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
+.+|..+..++..|+..+|+.||+.+.|.+.+
T Consensus 242 ~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l 273 (293)
T d1csna_ 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273 (293)
T ss_dssp TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 45677889999999999999999877766654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-35 Score=323.85 Aligned_cols=247 Identities=17% Similarity=0.138 Sum_probs=193.4
Q ss_pred cCceeeEEEEecCCcccEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCCCC-cccEEEEEEeCCEEEEEEecC
Q psy501 310 AGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSHAN-LVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 310 ~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~~~LV~Ey~ 386 (962)
.+.|.+...++.|+.+.||.+....+++.++.|+.. .....+.+|++++++++|++ |+.+.+++.+++..++||||+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 456777777777777779999988777776665432 23346889999999998766 555566668888999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccc---ccceeeecccccccccCC------
Q psy501 387 KENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMG---TELVKIADFGLAREIRSR------ 457 (962)
Q Consensus 387 ~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~---~g~vKL~DFGla~~~~~~------ 457 (962)
+|++...+......+++..+..++.|++.||+|||++||+||||||+||+++. +..+||+|||+|+.+...
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~ 165 (299)
T d1ckia_ 86 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165 (299)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBC
T ss_pred CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccce
Confidence 99999988887888999999999999999999999999999999999998754 447999999999876532
Q ss_pred ---CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHH---hccc---cccCCCCC
Q psy501 458 ---PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLK---SSYI---LLHTLPLY 528 (962)
Q Consensus 458 ---~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~---~~~~---~~~~~~~~ 528 (962)
......||+.|||||++.+. .++.++|||||||++|||++|+.||...........+. .... .....+.+
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
T d1ckia_ 166 PYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244 (299)
T ss_dssp CCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTS
T ss_pred eccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCC
Confidence 22345799999999999764 69999999999999999999999998765443332221 1111 11123467
Q ss_pred CCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 529 TYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 529 s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
|..+..++..||..+|++||++..|.+.|
T Consensus 245 p~~~~~li~~cl~~~p~~RP~~~~i~~~l 273 (299)
T d1ckia_ 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLF 273 (299)
T ss_dssp CHHHHHHHHHHHHSCTTCCCCHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 77888999999999999999987665544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-35 Score=317.85 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=198.4
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecC
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYM 386 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~ 386 (962)
|.....++.|+.+.||+|....+++.++.|+.. .....+.+|+.+|++++||||+++++++.+....++|+|++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 445555555666679999988777766655421 22457899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC--CcccccC
Q psy501 387 KENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR--PYTDYVS 464 (962)
Q Consensus 387 ~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~--~~~~~~g 464 (962)
.|+++..+....+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|...... ......+
T Consensus 84 ~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 163 (292)
T d1unla_ 84 DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV 163 (292)
T ss_dssp SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCS
T ss_pred cccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceeecc
Confidence 98888888777788999999999999999999999999999999999999999999999999999876544 3344567
Q ss_pred CccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCC-cChhhhHHHHHhcccccc--------------------
Q psy501 465 TRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQT-TCLLAGTERLKSSYILLH-------------------- 523 (962)
Q Consensus 465 t~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~-------------------- 523 (962)
++.|+|||++.+...++.++|||||||++|||++|+.||.. .+.......+......+.
T Consensus 164 ~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T d1unla_ 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243 (292)
T ss_dssp CGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCC
T ss_pred ccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccccccc
Confidence 88899999998776789999999999999999999988644 444444444332211110
Q ss_pred -------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccccCC
Q psy501 524 -------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYTYHV 564 (962)
Q Consensus 524 -------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~~~~ 564 (962)
..+..+..+.++++.||..||.+|||++++++. ||++-..
T Consensus 244 ~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H-p~f~~~~ 290 (292)
T d1unla_ 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH-PYFSDFC 290 (292)
T ss_dssp TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS-GGGSSCS
T ss_pred ccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC-hhhcCCC
Confidence 111223345678999999999999999988865 3554333
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-36 Score=329.02 Aligned_cols=244 Identities=15% Similarity=0.165 Sum_probs=197.2
Q ss_pred ceeeEEEEecCCcccEEEEEecC------CceEEEEeccc----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeCCEEEE
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQ------DNHILSRHVSS----RDEMVVCFYRKSLKKLSHANLVKLKEVIRENDTLYF 381 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~------~~kvv~~k~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~L 381 (962)
.+..+..++.|+.+.||++.... ..+++.+.+.. .+...+.+|++++++++||||+++++++..+...++
T Consensus 21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 100 (308)
T d1p4oa_ 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 100 (308)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeE
Confidence 33444455555566688886542 12333333322 223458999999999999999999999999999999
Q ss_pred EEecCC-CCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeeccccc
Q psy501 382 VFEYMK-ENLYQLIRDRD---------KFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLA 451 (962)
Q Consensus 382 V~Ey~~-g~Ll~~l~~~~---------~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla 451 (962)
|||||+ |++.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|
T Consensus 101 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla 180 (308)
T d1p4oa_ 101 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 180 (308)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred EEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccc
Confidence 999998 67777765431 34789999999999999999999999999999999999999999999999999
Q ss_pred ccccCC----CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCcChhhhHHHHHhccccccCCC
Q psy501 452 REIRSR----PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDH-VPPIQTTCLLAGTERLKSSYILLHTLP 526 (962)
Q Consensus 452 ~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 526 (962)
+..... ......||+.|+|||.+.++ .++.++|||||||++|||+|| ++||.+.........+..+.. ++.++
T Consensus 181 ~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~-~~~p~ 258 (308)
T d1p4oa_ 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-LDKPD 258 (308)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-CCCCT
T ss_pred eeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC-CCCcc
Confidence 866443 22334689999999999764 789999999999999999998 688988888887777776643 34445
Q ss_pred CCCCCcHHHHHHHhccCCCCCCcHHHHHhhc
Q psy501 527 LYTYHVPPIQTTCLLAGTERLKSSYILLHTL 557 (962)
Q Consensus 527 ~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l 557 (962)
.++..+..++..||..+|++||++.+|++.|
T Consensus 259 ~~~~~l~~li~~cl~~~P~~RPs~~~il~~L 289 (308)
T d1p4oa_ 259 NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289 (308)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 7778899999999999999999999999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-35 Score=329.45 Aligned_cols=242 Identities=25% Similarity=0.323 Sum_probs=188.3
Q ss_pred eeeEEEEecCCcccEEEEEecCCceEEEEeccc-----hhHHHHHHHHHHHHhcCCCCcccEEEEEEeC-----CEEEEE
Q psy501 313 ERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS-----RDEMVVCFYRKSLKKLSHANLVKLKEVIREN-----DTLYFV 382 (962)
Q Consensus 313 ~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~-----~~~~LV 382 (962)
|.....++.|+.+.||+|....+++.++.|... .....+.+|+++|++++||+|+++++++... ..+|++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 444444444555569999887777766655432 1234688999999999999999999999754 347788
Q ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC-----
Q psy501 383 FEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR----- 457 (962)
Q Consensus 383 ~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~----- 457 (962)
+++++|+|.+.+... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 90 ~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~ 167 (345)
T d1pmea_ 90 THLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 167 (345)
T ss_dssp EECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCC
T ss_pred EeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccce
Confidence 777778999888654 5999999999999999999999999999999999999999999999999999765432
Q ss_pred CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc----------------
Q psy501 458 PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL---------------- 521 (962)
Q Consensus 458 ~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------- 521 (962)
.....+||+.|+|||++.....++.++||||+||++|||++|+.||.+................
T Consensus 168 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T d1pmea_ 168 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247 (345)
T ss_dssp TTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHH
T ss_pred eeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhc
Confidence 2344679999999999977777899999999999999999999999887654443333211000
Q ss_pred ----c---------cCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 522 ----L---------HTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 522 ----~---------~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
. ...+..+..+.+++..||..||++||++.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0122334457789999999999999999988864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-35 Score=319.30 Aligned_cols=243 Identities=19% Similarity=0.181 Sum_probs=175.7
Q ss_pred eeEEEEecCCcccEEEEEecCCceEEEEeccchhHHHHHHHHH--HHHhcCCCCcccEEEEEEeCC----EEEEEEecCC
Q psy501 314 RLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRDEMVVCFYRK--SLKKLSHANLVKLKEVIREND----TLYFVFEYMK 387 (962)
Q Consensus 314 ~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~--iL~~L~HpnIv~l~~~~~~~~----~~~LV~Ey~~ 387 (962)
-....++.|+.+.||+++.. +.+++.+.+..+......+|.+ .+++++||||+++++++.+.+ .+|+|||||.
T Consensus 6 ~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ 84 (303)
T d1vjya_ 6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEeccc
Confidence 33444555555669999864 3445445554555555445544 556789999999999997643 6899999998
Q ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhccc--------ceeeeccCCCcccccccccceeeecccccccccCC-
Q psy501 388 -ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHR--------HGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR- 457 (962)
Q Consensus 388 -g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~--------~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~- 457 (962)
|+|.+.+.+. .+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~ 162 (303)
T d1vjya_ 85 HGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp TCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCC
Confidence 5777777654 48999999999999999999996 59999999999999999999999999999876443
Q ss_pred -----CcccccCCccccChhhhccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCcChh--------------hhHH
Q psy501 458 -----PYTDYVSTRWYRAPEVLLHST-----AYSAPIHLSRSQQFLFYSIDHVPPIQTTCLL--------------AGTE 513 (962)
Q Consensus 458 -----~~~~~~gt~~Y~APE~l~~~~-----~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~--------------~~~~ 513 (962)
......||+.|+|||++.+.. .++.++|||||||+||||+||.+||...... ....
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T d1vjya_ 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242 (303)
T ss_dssp TEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHH
T ss_pred cceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHH
Confidence 233467999999999986532 2577999999999999999998887542211 1111
Q ss_pred HHHhccccccCCCCC------CCCcHHHHHHHhccCCCCCCcHHHHHhhccc
Q psy501 514 RLKSSYILLHTLPLY------TYHVPPIQTTCLLAGTERLKSSYILLHTLPL 559 (962)
Q Consensus 514 ~i~~~~~~~~~~~~~------s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~ 559 (962)
.........+..+.. +..+..++..||..+|++||++.+|++.|..
T Consensus 243 ~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp HHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 111111111111111 1125678999999999999999999887743
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-34 Score=320.56 Aligned_cols=242 Identities=18% Similarity=0.232 Sum_probs=188.7
Q ss_pred ceeeEEEEecCCcccEEEEEecCCceEEEEec-cchhHHHHHHHHHHHHhcC-CCCcccEEEEEEeC--CEEEEEEecCC
Q psy501 312 TERLKFSYILPHTLPLYTCNLDQDNHILSRHV-SSRDEMVVCFYRKSLKKLS-HANLVKLKEVIREN--DTLYFVFEYMK 387 (962)
Q Consensus 312 ~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~-~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~--~~~~LV~Ey~~ 387 (962)
.|.....++.|+.+.||+|....+++.++.|+ .......+.+|+++|+++. ||||++++++|... ..+++|||||.
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~ 115 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 115 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecC
Confidence 45566666666667799999888777766554 4445667899999999995 99999999999853 56999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCccccccccc-ceeeecccccccccCC-CcccccCC
Q psy501 388 ENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTE-LVKIADFGLAREIRSR-PYTDYVST 465 (962)
Q Consensus 388 g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g-~vKL~DFGla~~~~~~-~~~~~~gt 465 (962)
++.+..+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|...... ......+|
T Consensus 116 ~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t 192 (328)
T d3bqca1 116 NTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 192 (328)
T ss_dssp SCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSC
T ss_pred CCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcccccccC
Confidence 6544333 24599999999999999999999999999999999999998655 6999999999876544 45567899
Q ss_pred ccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhh-HHHHHhc-------------cc-----------
Q psy501 466 RWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAG-TERLKSS-------------YI----------- 520 (962)
Q Consensus 466 ~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~-~~~i~~~-------------~~----------- 520 (962)
+.|+|||.+.+...++.++||||+||++|||++|+.||........ ...+... ..
T Consensus 193 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 272 (328)
T d3bqca1 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILG 272 (328)
T ss_dssp GGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCC
T ss_pred ccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcc
Confidence 9999999998877789999999999999999999999976543221 1111100 00
Q ss_pred -----------cccCCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhh
Q psy501 521 -----------LLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILLHT 556 (962)
Q Consensus 521 -----------~~~~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~ 556 (962)
........+..+.+|++.||..+|++|||++++++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 273 RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000001233346679999999999999999888764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-35 Score=322.60 Aligned_cols=244 Identities=14% Similarity=0.186 Sum_probs=190.3
Q ss_pred CceeeEEEEecCCcccEEEEEecC---CceEEEEecc--------chhHHHHHHHHHHHHhcCC-CCcccEEEEEEeCCE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQ---DNHILSRHVS--------SRDEMVVCFYRKSLKKLSH-ANLVKLKEVIRENDT 378 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~---~~kvv~~k~~--------~~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~~~~ 378 (962)
.+|.....++.|+.+.||+|.... +++.++.|.. ......+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 345555566666666688876532 3444433321 1223468899999999976 899999999999999
Q ss_pred EEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCC
Q psy501 379 LYFVFEYMKE-NLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSR 457 (962)
Q Consensus 379 ~~LV~Ey~~g-~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~ 457 (962)
+++||||+.| +|.+.+... +.+++..++.++.||+.||.|||+.+|+||||||+||+++.+|.+||+|||+|+.+...
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 9999999985 666666554 45889999999999999999999999999999999999999999999999999876443
Q ss_pred ---CcccccCCccccChhhhccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc--ccCCCCCCCC
Q psy501 458 ---PYTDYVSTRWYRAPEVLLHST-AYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL--LHTLPLYTYH 531 (962)
Q Consensus 458 ---~~~~~~gt~~Y~APE~l~~~~-~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~s~~ 531 (962)
......|++.|+|||.+.+.. .++.++|||||||+||||++|+.||.+.........+...... ++.+..++..
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 262 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 262 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHH
Confidence 334567999999999997543 4788999999999999999999999887666655555443322 2223457778
Q ss_pred cHHHHHHHhccCCCCCCc-----HHHHHh
Q psy501 532 VPPIQTTCLLAGTERLKS-----SYILLH 555 (962)
Q Consensus 532 l~~li~~Cl~~dperRPs-----~~~Ll~ 555 (962)
+..+++.||..+|++||+ ++++++
T Consensus 263 ~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 889999999999999994 566655
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-34 Score=320.91 Aligned_cols=247 Identities=20% Similarity=0.253 Sum_probs=190.0
Q ss_pred CceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEeC------CE
Q psy501 311 GTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIREN------DT 378 (962)
Q Consensus 311 g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------~~ 378 (962)
..|.....++.|+.+.||+|....+++.++.|+.. .....+.+|+++|++++||||+++++++... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 34555555555566669999988877777666532 2234688999999999999999999999632 33
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccCCC
Q psy501 379 LYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRSRP 458 (962)
Q Consensus 379 ~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~~~ 458 (962)
.++++++++|+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||.|..... .
T Consensus 98 ~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-~ 174 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-E 174 (348)
T ss_dssp CEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-G
T ss_pred EEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-c
Confidence 555555555777776643 4599999999999999999999999999999999999999999999999999976543 3
Q ss_pred cccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccccc---------------
Q psy501 459 YTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYILLH--------------- 523 (962)
Q Consensus 459 ~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------- 523 (962)
.....|++.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+........
T Consensus 175 ~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 254 (348)
T d2gfsa1 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254 (348)
T ss_dssp GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHH
T ss_pred cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhh
Confidence 34567899999999988776789999999999999999999999998877666655543322111
Q ss_pred --------------CCCCCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 524 --------------TLPLYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 524 --------------~~~~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
.....+..+.+|+..||..||++|||+.++++. +|+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H-p~f~ 305 (348)
T d2gfsa1 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH-AYFA 305 (348)
T ss_dssp HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS-GGGT
T ss_pred hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC-HhhC
Confidence 012344556789999999999999999888875 4554
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-34 Score=322.74 Aligned_cols=248 Identities=22% Similarity=0.255 Sum_probs=185.9
Q ss_pred ecCceeeEEEEecCCcccEEEEEecCCceEEEEeccc------hhHHHHHHHHHHHHhcCCCCcccEEEEEEe------C
Q psy501 309 LAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSS------RDEMVVCFYRKSLKKLSHANLVKLKEVIRE------N 376 (962)
Q Consensus 309 ~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~------~ 376 (962)
+...|.....++.|+.+.||+|....++..++.|+.. .....+.+|+.+|++++||||++++++|.. .
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 3345666666666666679999988777776666532 223468899999999999999999999963 4
Q ss_pred CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeeccCCCcccccccccceeeecccccccccC
Q psy501 377 DTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRDMKPENLLCMGTELVKIADFGLAREIRS 456 (962)
Q Consensus 377 ~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrDLkp~NILl~~~g~vKL~DFGla~~~~~ 456 (962)
.++|+|||||.|++++.+. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+|++|||+++....
T Consensus 95 ~~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 6899999999999888774 3489999999999999999999999999999999999999999999999999876654
Q ss_pred C-CcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcChhhhHHHHHhcccc--------------
Q psy501 457 R-PYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTCLLAGTERLKSSYIL-------------- 521 (962)
Q Consensus 457 ~-~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------- 521 (962)
. ......+|+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+.......+......
T Consensus 172 ~~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 172 SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ---------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred ccccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 4 4455679999999999976 47999999999999999999999999887765554444321110
Q ss_pred --------ccCC-----------C-------CCCCCcHHHHHHHhccCCCCCCcHHHHHhhccccc
Q psy501 522 --------LHTL-----------P-------LYTYHVPPIQTTCLLAGTERLKSSYILLHTLPLYT 561 (962)
Q Consensus 522 --------~~~~-----------~-------~~s~~l~~li~~Cl~~dperRPs~~~Ll~~l~~~~ 561 (962)
.... + ..+..+.++++.||..||++|||++++++.- |+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp-w~~ 315 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP-YIN 315 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST-TTG
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc-ccC
Confidence 0000 0 0112345689999999999999999888753 443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=1.6e-29 Score=283.03 Aligned_cols=201 Identities=24% Similarity=0.302 Sum_probs=157.2
Q ss_pred ceEEecCceeeEEEEecCCcccEEEEEecCCceEEEEeccchh---HHHHHHHHHHHHhcC-----------CCCcccEE
Q psy501 305 TTCLLAGTERLKFSYILPHTLPLYTCNLDQDNHILSRHVSSRD---EMVVCFYRKSLKKLS-----------HANLVKLK 370 (962)
Q Consensus 305 ~~~l~~g~~~~~~~~i~~~~~~Vy~~~~~~~~kvv~~k~~~~~---~~~~~~Ei~iL~~L~-----------HpnIv~l~ 370 (962)
+..+..|.|.+...++.|+.+.||+|+...+++.++.|+...+ ...+.+|+++++.+. ||||++++
T Consensus 7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 3344456688887887787888999998887777666654433 346788999998875 57899999
Q ss_pred EEEEe--CCEEEEEEecCC--CCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHhhccc-ceeeeccCCCccccccccc---
Q psy501 371 EVIRE--NDTLYFVFEYMK--ENLYQLI-RDRDKFLPESIIRNMMYQVLQGLAFMHR-HGFFHRDMKPENLLCMGTE--- 441 (962)
Q Consensus 371 ~~~~~--~~~~~LV~Ey~~--g~Ll~~l-~~~~~~ls~~~i~~i~~qI~~aL~yLH~-~gIvHrDLkp~NILl~~~g--- 441 (962)
+++.. ....+++|+++. ++..... ......+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 99854 456667777665 3333333 3344679999999999999999999997 8999999999999998765
Q ss_pred ---ceeeecccccccccCCCcccccCCccccChhhhccCCCCCchhHHHHHHHHHHHHHcCCCCCCCcC
Q psy501 442 ---LVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQFLFYSIDHVPPIQTTC 507 (962)
Q Consensus 442 ---~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvlL~elltG~~Pf~~~~ 507 (962)
.++++|||.|...... .....||+.|+|||++.+ ..++.++||||+||++++|++|+.||....
T Consensus 167 ~~~~~kl~dfg~s~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp TEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ccceeeEeecccccccccc-cccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 4999999999865443 345689999999999976 468999999999999999999999997643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=4.6e-20 Score=200.67 Aligned_cols=136 Identities=24% Similarity=0.348 Sum_probs=112.1
Q ss_pred ccccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee---------
Q psy501 672 TERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA--------- 734 (962)
Q Consensus 672 ~~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~--------- 734 (962)
-|-||..||++ |.+||+|||++.. ....+.+||+.|++||++. +...|+.++||||+|||++
T Consensus 123 HrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwSlGvil~el~~g~~pf 201 (299)
T d1ua2a_ 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF-GARMYGVGVDMWAVGCILAELLLRVPFL 201 (299)
T ss_dssp CCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHT-TCSCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred cccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHc-cCCCCChhhhhhhcchHHHHHHhCcCCC
Confidence 46789999999 9999999999854 2334458999998888776 4467999999999999998
Q ss_pred -cCCchhHHHHHHHhcCCCchhhhcccccc----cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 -GTERLKSSYILLHTLPLYTCYTLASNMNF----KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 -G~~~~~ql~~I~~~lG~p~~~~~~~~~~~----~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
|.++.+++..|++.+|+|+.+.+...... .+...+..++..+++.++++++|||++||++||++||||+|+|++
T Consensus 202 ~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 202 PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 67899999999999999988765543322 233344566777788999999999999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=6e-19 Score=191.98 Aligned_cols=134 Identities=20% Similarity=0.273 Sum_probs=110.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------c
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------G 735 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G 735 (962)
|-||++||++ |.+||.|||++.. ....+.+||+.|+|||++.. ..|++++||||+|||++ |
T Consensus 140 rDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~ 217 (305)
T d1blxa_ 140 RDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRG 217 (305)
T ss_dssp CCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCCccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcC--CCCChhehhhchHHHHHHHHHCCCCCCC
Confidence 6789999999 9999999999776 33445599999999998763 45999999999999998 6
Q ss_pred CCchhHHHHHHHhcCCCchhhhcccccc---cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 736 TERLKSSYILLHTLPLYTCYTLASNMNF---KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 736 ~~~~~ql~~I~~~lG~p~~~~~~~~~~~---~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++.+++..|+..+|.|....++..... .+......++....+.++++++|||++||++||++||||+|+|++
T Consensus 218 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 218 SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 6788999999999999988766543322 122333455666677899999999999999999999999999984
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=6.7e-18 Score=187.21 Aligned_cols=135 Identities=21% Similarity=0.304 Sum_probs=111.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------cCC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------GTE 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G~~ 737 (962)
|-||++||++ +.+|+.|||.+.. ......+||+.|++||+++ +...|+.++||||+|||++ +.+
T Consensus 145 rDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 145 RDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHH-TTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccCcchhhcccccccccccccceeccCCccccccccccccCHHHHc-CCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 6789999999 9999999999876 4445568988888888775 5567899999999999998 667
Q ss_pred chhHHHHHHHhcCCCchhhhccccc-------ccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 738 RLKSSYILLHTLPLYTCYTLASNMN-------FKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 738 ~~~ql~~I~~~lG~p~~~~~~~~~~-------~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
..+++..+....|.|+.+.+..... ...+......+...++.++++++|||.+||++||++||||+|+|++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 224 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 8899999999999998776433221 1244555677788888999999999999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=4.7e-18 Score=188.95 Aligned_cols=135 Identities=22% Similarity=0.378 Sum_probs=108.1
Q ss_pred cccceeeEEE----EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL----HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~----~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
|-||.+||++ +.+||+|||++.. +...+.+||+.|++||+++. ...|+.++||||+|||++
T Consensus 146 rDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DIwSlG~il~el~~g~~pf~ 224 (350)
T d1q5ka_ 146 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQPIFP 224 (350)
T ss_dssp CCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred cCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhc-ccCCCcceeecccceEEEehhhCCCCCC
Confidence 5689999999 4899999998753 44556699999999998874 457999999999999999
Q ss_pred cCCchhHHHHHHHhcCCCchhhhccc----ccccCCCcccCCcccc-CCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASN----MNFKFPQFRRVPFTSI-IPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~----~~~~~~~~~~~~l~~~-~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.+..+++..|++.+|+|+.+.+... ....++.....++... .+..+++++|||++||++||.+||||.|+|++
T Consensus 225 ~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 225 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 56788999999999999987765332 2223444444455443 35689999999999999999999999999974
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.64 E-value=5.2e-17 Score=164.63 Aligned_cols=129 Identities=13% Similarity=0.123 Sum_probs=93.1
Q ss_pred HHHHHHHHHHhcCCCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHhhcccceeeecc
Q psy501 350 VVCFYRKSLKKLSHANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLPESIIRNMMYQVLQGLAFMHRHGFFHRD 429 (962)
Q Consensus 350 ~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~~~ls~~~i~~i~~qI~~aL~yLH~~gIvHrD 429 (962)
...+|...+.++.|++++..+++. . .++||||+++.... .++...+..++.|++.||.|||++||+|||
T Consensus 60 ~~~~e~~~l~~l~~~~v~~~~~~~--~--~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrD 128 (191)
T d1zara2 60 SARNEFRALQKLQGLAVPKVYAWE--G--NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGD 128 (191)
T ss_dssp HHHHHHHHHHHTTTSSSCCEEEEE--T--TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHHHHccCCCcceEEEec--C--CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEcc
Confidence 356788999999999999988763 2 27999999975332 255666788999999999999999999999
Q ss_pred CCCcccccccccceeeecccccccccCCCcccccCCccccChhhhccCCCCCchhHHHHHHHH
Q psy501 430 MKPENLLCMGTELVKIADFGLAREIRSRPYTDYVSTRWYRAPEVLLHSTAYSAPIHLSRSQQF 492 (962)
Q Consensus 430 Lkp~NILl~~~g~vKL~DFGla~~~~~~~~~~~~gt~~Y~APE~l~~~~~~t~ksDIwSLGvl 492 (962)
|||+|||+++++ ++|+|||.|.....+........-.-.-.+.+. +.|+.++|+||+.--
T Consensus 129 iKP~NILv~~~~-~~liDFG~a~~~~~~~~~~~l~rd~~~~~~~f~--r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 129 LSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIITYFS--RTYRTEKDINSAIDR 188 (191)
T ss_dssp CSTTSEEEETTE-EEECCCTTCEETTSTTHHHHHHHHHHHHHHHHH--HHHCCCCCHHHHHHH
T ss_pred CChhheeeeCCC-EEEEECCCcccCCCCCcHHHHHHHHHHHHHHHc--CCCCCcccHHHHHHH
Confidence 999999998755 889999999765433221110000000012232 357899999997543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.64 E-value=1.5e-17 Score=179.42 Aligned_cols=135 Identities=18% Similarity=0.292 Sum_probs=105.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
|-||++||++ |.+|+.|||++.. ......+||+.|++||++. +...|++++||||+||+++
T Consensus 124 rDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~-~~~~~~~~~DiwslGv~l~el~~G~~pf~ 202 (286)
T d1ob3a_ 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM-GSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (286)
T ss_dssp SCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHT-TCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHh-CCCCCCcceeehhcCcHHHHHHHCCCCCC
Confidence 5679999999 9999999999644 2344447888998888876 4467899999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcccccc-----cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNF-----KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~-----~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.++.+++..|+..+|.|+...+...... .+....+.++...++.++++++|||++||++||++||||.|+|++
T Consensus 203 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 203 GVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 56778899999999999887765432221 233344566777778899999999999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=2.1e-17 Score=179.43 Aligned_cols=135 Identities=23% Similarity=0.378 Sum_probs=107.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
|-||..||++ +.+||+|||++.. ......+||+.|++||++... ..|+.++||||+||+++
T Consensus 126 rDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~ 204 (298)
T d1gz8a_ 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFP 204 (298)
T ss_dssp SCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCC
Confidence 4579999999 8999999998743 333444899999888877644 56789999999999999
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcccccc-----cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNF-----KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~-----~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
|.+..+++..|+..+|.|....+...... .++.+....+...++.+|++++|||++||++||.+|||++|+|++
T Consensus 205 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 205 GDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 56778999999999999887654432221 233334455566678899999999999999999999999999984
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=3.6e-17 Score=178.97 Aligned_cols=136 Identities=15% Similarity=0.200 Sum_probs=100.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC---------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI---------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA------ 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~---------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~------ 734 (962)
|-||.+||++ +.+|+.|||++.. ....+.+||+.|++||+++ +...|++++||||+|||++
T Consensus 141 rDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~-~~~~~~~k~DiwSlGvil~el~~g~ 219 (318)
T d3blha1 141 RDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL-GERDYGPPIDLWGAGCIMAEMWTRS 219 (318)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHT-TCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred cCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHc-CCCCCCcHHHcccCCceeeeHhhCC
Confidence 5579999999 8999999999732 2333347888888877765 5567999999999999998
Q ss_pred ----cCCchhHHHHHHHhcCCCchhhhccccccc------CCCcccCCccccCC--CCCHHHHHHHHHhhccCCCCCcch
Q psy501 735 ----GTERLKSSYILLHTLPLYTCYTLASNMNFK------FPQFRRVPFTSIIP--HASPDAIHLMESMLAYNPSKRPTA 802 (962)
Q Consensus 735 ----G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~------~~~~~~~~l~~~~p--~~s~~a~DLL~kmL~~dP~kR~sa 802 (962)
|.++.+++..|...+|.++.+......... ........+...++ ..+++++|||.+||++||++|+||
T Consensus 220 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa 299 (318)
T d3blha1 220 PIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299 (318)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCH
Confidence 678889999999999998876543322211 01111111111111 258899999999999999999999
Q ss_pred hhhhhhh
Q psy501 803 QQSLSIK 809 (962)
Q Consensus 803 ~~~L~~~ 809 (962)
+|+|++.
T Consensus 300 ~elL~Hp 306 (318)
T d3blha1 300 DDALNHD 306 (318)
T ss_dssp HHHHHSG
T ss_pred HHHHcCh
Confidence 9999743
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=2.9e-17 Score=180.49 Aligned_cols=134 Identities=15% Similarity=0.048 Sum_probs=82.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCC---ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cC------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI---QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GT------ 736 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~------ 736 (962)
|-||+.||++ |.+||+|||++.. ....+.+||+.|+|||++. | ..|++++||||+|||+| |.
T Consensus 129 RDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~-~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ-G-THYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp SCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---CCSSCCCCHHHHH-C-SCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred cccCHHHeeECCCCCEEEeeCCCccccCCCccccccCCccccCchHHc-C-CCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 7789999999 9999999999875 3445669999999988776 4 45999999999999998 32
Q ss_pred -CchhHHHHHHHhcCCCchhhhcc----ccccc--CCCccc------------CCccccC-CCCCHHHHHHHHHhhccCC
Q psy501 737 -ERLKSSYILLHTLPLYTCYTLAS----NMNFK--FPQFRR------------VPFTSII-PHASPDAIHLMESMLAYNP 796 (962)
Q Consensus 737 -~~~~ql~~I~~~lG~p~~~~~~~----~~~~~--~~~~~~------------~~l~~~~-p~~s~~a~DLL~kmL~~dP 796 (962)
....++..+..+.|.+....... ..... ....+. .+...+. ...|++++|||++||++||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP 286 (322)
T d1s9ja_ 207 DAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 286 (322)
T ss_dssp CTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCCh
Confidence 22334444444455433221000 00000 000000 0000000 1368899999999999999
Q ss_pred CCCcchhhhhhh
Q psy501 797 SKRPTAQQSLSI 808 (962)
Q Consensus 797 ~kR~sa~~~L~~ 808 (962)
.+||||+|+|++
T Consensus 287 ~~R~ta~e~L~H 298 (322)
T d1s9ja_ 287 AERADLKQLMVH 298 (322)
T ss_dssp TTSCCHHHHHTS
T ss_pred hHCcCHHHHhhC
Confidence 999999999984
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=7.6e-17 Score=178.73 Aligned_cols=135 Identities=26% Similarity=0.422 Sum_probs=108.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc--------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee-------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ--------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~--------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~------- 734 (962)
|-||++||++ |.+||.|||++... .....+||+.|++||++..+ ..|+.++||||+|||++
T Consensus 133 RDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~ 211 (345)
T d1pmea_ 133 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRP 211 (345)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCC
Confidence 6789999999 99999999987541 12344798899888877655 56899999999999999
Q ss_pred ---cCCchhHHHHHHHhcCCCchhhhcccccc-------cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhh
Q psy501 735 ---GTERLKSSYILLHTLPLYTCYTLASNMNF-------KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQ 804 (962)
Q Consensus 735 ---G~~~~~ql~~I~~~lG~p~~~~~~~~~~~-------~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~ 804 (962)
+.+..++...+..+++.|+.......... ..+.....+|...++.+|++++|||.+||++||++||||++
T Consensus 212 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e 291 (345)
T d1pmea_ 212 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 291 (345)
T ss_dssp SCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 45677888999999998887653332111 24444566788888999999999999999999999999999
Q ss_pred hhhh
Q psy501 805 SLSI 808 (962)
Q Consensus 805 ~L~~ 808 (962)
+|++
T Consensus 292 ~L~h 295 (345)
T d1pmea_ 292 ALAH 295 (345)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.59 E-value=7.8e-17 Score=176.08 Aligned_cols=114 Identities=19% Similarity=0.202 Sum_probs=85.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-ceeeeccCCCcccccceeeec-CCCCCCCCCceeeeeEee----c------CC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-QTTCLLAGTERLKSSYILLHT-LPLYTYHVPPIQTTCLLA----G------TE 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-~~~~~~~gt~~~~~~~~lLlg-~~~Y~~~vDIWSlGCIl~----G------~~ 737 (962)
|-||++||++ |.+||+|||++.. ....+.+||+.|+|||++... ...|+.++||||+||++| | .+
T Consensus 139 rDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~ 218 (309)
T d1u5ra_ 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (309)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cCCCcceEEECCCCCEEEeecccccccCCCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 6789999999 8999999999886 445566999999999998643 356999999999999997 1 11
Q ss_pred chhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 738 RLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 738 ~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
..+.+..|... ..+... -+.+|+++.|||.+||+.||.+|||++++|++
T Consensus 219 ~~~~~~~i~~~---------------~~~~~~-------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 219 AMSALYHIAQN---------------ESPALQ-------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHHHHHHHHS---------------CCCCCS-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHHhC---------------CCCCCC-------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 22222222110 011110 13578999999999999999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=8.8e-17 Score=173.16 Aligned_cols=136 Identities=17% Similarity=0.256 Sum_probs=104.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee-----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------- 734 (962)
|-||++||++ +.+||.|||.+.. .......+++.|++||+++.+...|+.++||||+|||++
T Consensus 125 rDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred ecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 5679999999 8999999999865 223334667778888888888778899999999999998
Q ss_pred cCCchhHHHHHHHhcCCCchhhhccccccc----CCCc-ccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNFK----FPQF-RRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~----~~~~-~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
|.+..+++..+....|.|+...++...... .+.. .........+.++++++|||.+||++||++||||+|+|++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 205 GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 556788899999999998876544322211 1111 1223344556789999999999999999999999999984
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.58 E-value=7.5e-17 Score=177.22 Aligned_cols=136 Identities=18% Similarity=0.364 Sum_probs=101.2
Q ss_pred cccceeeEEE----EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL----HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~----~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
|-||.+||++ +.++|.|||++.. +.....+||+.|++||+++ +...|++++||||+||+++
T Consensus 153 rDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~~l~e~~~g~~pf~ 231 (328)
T d3bqca1 153 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFF 231 (328)
T ss_dssp CCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred ccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCccccc-CCCCCCcccchhhhhhhhHHhccCCCCCC
Confidence 6789999999 4699999999743 4455668999988888765 5567999999999999998
Q ss_pred -cCCchhHHHHHHHhcCCCchhhhccccccc--------CCCcccCCccccC-----CCCCHHHHHHHHHhhccCCCCCc
Q psy501 735 -GTERLKSSYILLHTLPLYTCYTLASNMNFK--------FPQFRRVPFTSII-----PHASPDAIHLMESMLAYNPSKRP 800 (962)
Q Consensus 735 -G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~--------~~~~~~~~l~~~~-----p~~s~~a~DLL~kmL~~dP~kR~ 800 (962)
+.++.++...|...+|.|....+....... ........+...+ ..+|++++|||++||++||++|+
T Consensus 232 ~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 311 (328)
T d3bqca1 232 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 311 (328)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSC
T ss_pred CCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCc
Confidence 456778999999999987655432211110 1111122222222 24789999999999999999999
Q ss_pred chhhhhhhh
Q psy501 801 TAQQSLSIK 809 (962)
Q Consensus 801 sa~~~L~~~ 809 (962)
||+|+|++.
T Consensus 312 ta~e~L~Hp 320 (328)
T d3bqca1 312 TAREAMEHP 320 (328)
T ss_dssp CHHHHHTSG
T ss_pred CHHHHhcCc
Confidence 999999843
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=1.2e-16 Score=170.60 Aligned_cols=110 Identities=19% Similarity=0.230 Sum_probs=82.9
Q ss_pred cccceeeEEE---EEEeeeeeecCCC---ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cC------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI---QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GT------ 736 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~------ 736 (962)
|-||++||++ |.+||.|||++.. ......+||+.|+|||++. | ..|+.++||||+||++| |.
T Consensus 130 rDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~-~-~~~~~~~DiwSlGvilyell~G~~Pf~~~ 207 (263)
T d2j4za1 130 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIE-G-RMHDEKVDLWSLGVLCYEFLVGKPPFEAN 207 (263)
T ss_dssp CCCCGGGEEECTTSCEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHT-T-CCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred eeeccccceecCCCCEeecccceeeecCCCcccccCCCCcccCHHHHc-C-CCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence 5789999999 8999999999865 3445569999999999775 3 46999999999999997 21
Q ss_pred CchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 737 ERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 737 ~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+..+.+..|.. . .+ .+. +.+++++.|||.+||+.||++|||++|+|++
T Consensus 208 ~~~~~~~~i~~-------------~--~~------~~p---~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 208 TYQETYKRISR-------------V--EF------TFP---DFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp SHHHHHHHHHT-------------T--CC------CCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CHHHHHHHHHc-------------C--CC------CCC---ccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 11111111111 0 00 010 3578999999999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=1.1e-16 Score=177.06 Aligned_cols=135 Identities=22% Similarity=0.313 Sum_probs=107.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------cCC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------GTE 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G~~ 737 (962)
|-||.+||++ |.+++.|||.+.. ....+.+||+.|++||+++ +...|+.++||||+||++| |.+
T Consensus 145 rDiKp~NILi~~~~~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~-~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 145 RDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp CCCCGGGEEECTTCCEEECCC----CCTGGGSSSCHHHHTSCHHHHT-TCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccCCccccccccccccccccchhcccCcccccccccccccCchhhc-CCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 6789999999 8999999999866 5555668999999888876 5567899999999999998 677
Q ss_pred chhHHHHHHHhcCCCchhhhccccc-------ccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 738 RLKSSYILLHTLPLYTCYTLASNMN-------FKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 738 ~~~ql~~I~~~lG~p~~~~~~~~~~-------~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.++...|....|.++.+....... ......+...+...++.++++++|||++||++||.+|+||+|+|++
T Consensus 224 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 224 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 8889999999999988765432211 1233445566777778899999999999999999999999999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=1.7e-16 Score=169.97 Aligned_cols=119 Identities=13% Similarity=0.135 Sum_probs=82.0
Q ss_pred cccceeeEEE----EEEeeeeeecCCC---ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHH
Q psy501 673 ERLKSSYILL----HTLPLYTYHVPPI---QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 745 (962)
Q Consensus 673 ~~~~~~~~~~----~~~~~~~~~~~~~---~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I 745 (962)
|-||++||++ +.+||+|||++.. ....+.+||+.|++||++- ..|+.++||||+|||+| .+
T Consensus 138 rDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~---~~~~~~~DIwSlGvily---------el 205 (270)
T d1t4ha_ 138 RDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE---EKYDESVDVYAFGMCML---------EM 205 (270)
T ss_dssp SCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGG---TCCCTHHHHHHHHHHHH---------HH
T ss_pred CCcChhhceeeCCCCCEEEeecCcceeccCCccCCcccCccccCHHHhC---CCCCCcCchhhHHHHHH---------HH
Confidence 6899999999 6899999999864 4455679999999999652 35999999999999997 11
Q ss_pred HHhcCCCchhhh---cccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 746 LHTLPLYTCYTL---ASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 746 ~~~lG~p~~~~~---~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+ .|.+|-... ......-....++..+. +..++++.|||.+||..||++|||++|+|++
T Consensus 206 ~--~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 206 A--TSEYPYSECQNAAQIYRRVTSGVKPASFD---KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp H--HSSCTTTTCSSHHHHHHHHTTTCCCGGGG---GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred H--HCCCCCCCcccHHHHHHHHHcCCCCcccC---ccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1 122210000 00000000000111111 3578999999999999999999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=1.4e-16 Score=172.37 Aligned_cols=115 Identities=17% Similarity=0.161 Sum_probs=84.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeee---cCCCCCCCCCceeeeeEee-------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLH---TLPLYTYHVPPIQTTCLLA------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLl---g~~~Y~~~vDIWSlGCIl~------- 734 (962)
|-||++||++ |.+||+|||++.. ....+.+||+.|++||++.. ....|+.++||||+||++|
T Consensus 134 rDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~ 213 (288)
T d2jfla1 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 213 (288)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSC
T ss_pred eecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCC
Confidence 6789999999 8999999999754 22345689999999999864 2356999999999999997
Q ss_pred ---cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 ---GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 ---G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.+..+.+..|... ..+.. . ..+.+|+++.|||++||+.||++|||++|+|++
T Consensus 214 Pf~~~~~~~~~~~i~~~---------------~~~~~---~---~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 214 PHHELNPMRVLLKIAKS---------------EPPTL---A---QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp TTTTSCGGGHHHHHHHS---------------CCCCC---S---SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCCCCHHHHHHHHHcC---------------CCCCC---C---ccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12222222222210 00000 0 013578999999999999999999999999984
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=1.2e-16 Score=171.23 Aligned_cols=120 Identities=16% Similarity=0.169 Sum_probs=83.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
|-||++||++ |.+||+|||++.. ....+.+||+.|+|||++. +...|+.++||||+|||+|
T Consensus 127 rDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~~~~~DiwSlGvily-------- 197 (271)
T d1nvra_ 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLT-------- 197 (271)
T ss_dssp SCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHH-CSSBCHHHHHHHHHHHHHH--------
T ss_pred CcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhc-CCCCCCCceeeeHhHHHHH--------
Confidence 6789999999 8999999999864 1234458999999999865 4455678999999999997
Q ss_pred HHHHHhcCCCchhhhccc----ccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 743 YILLHTLPLYTCYTLASN----MNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~----~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.++ .|.+|-...... ...........++ +.+|++++|||.+||+.||++|||++|+|++
T Consensus 198 -eml--~G~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 198 -AML--AGELPWDQPSDSCQEYSDWKEKKTYLNPW----KKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp -HHH--HSSCSCSSSSTTSHHHHHHHTTCTTSTTG----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -HHH--hCCCCCCCCChHHHHHHHHhcCCCCCCcc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 121 233321100000 0000000011111 4679999999999999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=3.6e-16 Score=169.43 Aligned_cols=113 Identities=18% Similarity=0.211 Sum_probs=84.5
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----c-----
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----G----- 735 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G----- 735 (962)
|-||.+||++ |.+||.|||++.. ......+||+.|++||++.. ..|+.++||||+||++| |
T Consensus 140 rDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~ 217 (293)
T d1yhwa1 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (293)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCC
Confidence 6789999999 8999999999753 34455689999999998764 45999999999999997 2
Q ss_pred -CCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 736 -TERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 736 -~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.+..+++..+... + .+.. .. .+.++++++|||.+||+.||.+|||++|+|++
T Consensus 218 ~~~~~~~~~~~~~~-~--------------~~~~---~~---~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 218 NENPLRALYLIATN-G--------------TPEL---QN---PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp TSCHHHHHHHHHHH-C--------------SCCC---SS---GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCHHHHHHHHHhC-C--------------CCCC---CC---cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2223333333211 0 0000 00 13578999999999999999999999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=2.3e-16 Score=172.09 Aligned_cols=114 Identities=18% Similarity=0.246 Sum_probs=73.8
Q ss_pred cccceeeEEE------EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cC--
Q psy501 673 ERLKSSYILL------HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GT-- 736 (962)
Q Consensus 673 ~~~~~~~~~~------~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~-- 736 (962)
|-||+.||++ |.+||.|||++.. ....+.+||+.|+|||++. + ..|++++||||+||++| |.
T Consensus 131 rDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~-~-~~~~~~~DiwSlGvilyell~g~~P 208 (307)
T d1a06a_ 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA-Q-KPYSKAVDCWSIGVIAYILLCGYPP 208 (307)
T ss_dssp SCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHT-T-CCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHc-C-CCCCcHHHhhhhhHHHHHHHhCCCC
Confidence 6789999998 6799999999864 4445669999999999865 3 46999999999999997 11
Q ss_pred ----CchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 737 ----ERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 737 ----~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+..+....|... .. ..+ ....+.+|+++.|||++||+.||++|||++|+|++
T Consensus 209 f~~~~~~~~~~~i~~~---------------~~-~~~----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 209 FYDENDAKLFEQILKA---------------EY-EFD----SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCCSSHHHHHHHHHTT---------------CC-CCC----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCCHHHHHHHHhcc---------------CC-CCC----CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111111111110 00 000 01225789999999999999999999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.53 E-value=5e-16 Score=173.44 Aligned_cols=123 Identities=18% Similarity=0.139 Sum_probs=85.2
Q ss_pred ccccceeeEEE---EEEeeeeeecCCC---ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHH
Q psy501 672 TERLKSSYILL---HTLPLYTYHVPPI---QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 745 (962)
Q Consensus 672 ~~~~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I 745 (962)
-|-||.+||++ |.+||+|||++.. ..+.+.+||+.|+|||++.-+ ..|+.++||||+|||+| .+
T Consensus 130 HrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvily---------em 199 (364)
T d1omwa3 130 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLF---------KL 199 (364)
T ss_dssp CCCCSGGGEEECSSSCEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHH---------HH
T ss_pred ceeeccceeEEcCCCcEEEeeeceeeecCCCcccccccccccchhHHhhcC-CCCCcccchhHHHHHHH---------HH
Confidence 36789999999 8999999999764 445566999999999998755 56999999999999997 11
Q ss_pred HHhcCCCchhhh--ccccc-ccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcc-----hhhhhhhh
Q psy501 746 LHTLPLYTCYTL--ASNMN-FKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPT-----AQQSLSIK 809 (962)
Q Consensus 746 ~~~lG~p~~~~~--~~~~~-~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~s-----a~~~L~~~ 809 (962)
+ .|.+|-... ..... .......+.. ..+.+|+++.|||.+||+.||.+|+| |+++|++.
T Consensus 200 l--tG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp 266 (364)
T d1omwa3 200 L--RGHSPFRQHKTKDKHEIDRMTLTMAVE---LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 266 (364)
T ss_dssp H--HSSCSSCSSCSSCHHHHHHHSSSCCCC---CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSG
T ss_pred H--hCCCCCCCCCHHHHHHHHHhcccCCCC---CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCc
Confidence 1 233221100 00000 0000000001 11368999999999999999999999 68888743
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.52 E-value=3.3e-16 Score=174.04 Aligned_cols=114 Identities=18% Similarity=0.152 Sum_probs=86.4
Q ss_pred cccceeeEEE-----EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee---------
Q psy501 673 ERLKSSYILL-----HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA--------- 734 (962)
Q Consensus 673 ~~~~~~~~~~-----~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~--------- 734 (962)
|-||.+||++ |.+||+|||++.. ....+.+||+.|++||++. | ..|+.++||||+|||+|
T Consensus 148 rDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~-~-~~~~~~~DiwSlGvilyell~G~~Pf 225 (350)
T d1koaa2 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE-G-KPVGYYTDMWSVGVLSYILLSGLSPF 225 (350)
T ss_dssp CCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHH-T-CCBCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred eeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHc-C-CCCChhHhhhhhhHHHHHHHhCCCCC
Confidence 6789999999 6799999998753 5555679999999999765 4 46999999999999997
Q ss_pred -cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 -GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 -G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
|.+..+.+..|...-.. ++ ...++.+|++++|||++||++||++|||++|+|++
T Consensus 226 ~~~~~~~~~~~i~~~~~~-------------~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 226 GGENDDETLRNVKSCDWN-------------MD-------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCSSHHHHHHHHHHTCCC-------------SC-------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCCHHHHHHHHHhCCCC-------------CC-------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 23333444444322111 11 11224689999999999999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=3.1e-16 Score=167.88 Aligned_cols=121 Identities=18% Similarity=0.180 Sum_probs=77.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
|-||++||++ |.+||+|||++.. ....+.+||+.|++||++. + ..|+.++||||+|||+| .
T Consensus 138 rDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~-~-~~~~~~~DIwSlGvily---------e 206 (269)
T d2java1 138 RDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN-R-MSYNEKSDIWSLGCLLY---------E 206 (269)
T ss_dssp --CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHT-T-CCCCHHHHHHHHHHHHH---------H
T ss_pred CcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHc-C-CCCChHHHHHhhCHHHH---------H
Confidence 6789999999 8999999998753 2334569999999999864 3 46999999999999997 1
Q ss_pred HHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 745 LLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 745 I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
++. |.+|-........ ........+..+-..+|+++.|||.+||+.||.+|||++|+|++
T Consensus 207 l~t--g~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 207 LCA--LMPPFTAFSQKEL--AGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHH--SSCSCCCSSHHHH--HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred Hhh--CCCCCCCCCHHHH--HHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 111 2221000000000 00000000111113679999999999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=3.4e-16 Score=169.21 Aligned_cols=110 Identities=17% Similarity=0.250 Sum_probs=80.2
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee--------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA-------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~-------- 734 (962)
|-||.+||++ |.+||+|||++.. ....+.+||+.|+|||++. + ..|+.++||||+|||+|
T Consensus 132 rDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~-~~~~~~~DiwSlGvilyell~g~~P 209 (288)
T d1uu3a_ 132 RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT-E-KSACKSSDLWALGCIIYQLVAGLPP 209 (288)
T ss_dssp SCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHH-T-CCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeec-c-CCCCcccceehhhHHHHHHhhCCCC
Confidence 6789999999 8999999999753 2334568999999999865 3 46999999999999997
Q ss_pred --cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 --GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 --G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.+..+.+..|... ...++ ..++++++|||++||+.||.+|||++|+++.
T Consensus 210 f~~~~~~~~~~~i~~~-------------~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 210 FRAGNEYLIFQKIIKL-------------EYDFP-----------EKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp SCCSSHHHHHHHHHTT-------------CCCCC-----------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCCcCHHHHHHHHHcC-------------CCCCC-----------ccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 22222222222210 00011 3579999999999999999999999998763
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=9.4e-16 Score=169.40 Aligned_cols=118 Identities=15% Similarity=0.199 Sum_probs=81.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYI 744 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~ 744 (962)
|-||.+||++ |.+||+|||++.. ....+.|||+.|+|||++. | ..|+.++||||+|||+| .
T Consensus 129 RDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~-~-~~y~~~~DiwSlGvily---------e 197 (337)
T d1o6la_ 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE-D-NDYGRAVDWWGLGVVMY---------E 197 (337)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGS-S-SCBCTTHHHHHHHHHHH---------H
T ss_pred cccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhcc-C-CCCChhhcccchhhHHH---------H
Confidence 6789999999 9999999999853 3455679999999998765 3 45999999999999997 1
Q ss_pred HHHhcCCCchhh--hcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcc-----hhhhhhh
Q psy501 745 LLHTLPLYTCYT--LASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPT-----AQQSLSI 808 (962)
Q Consensus 745 I~~~lG~p~~~~--~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~s-----a~~~L~~ 808 (962)
++ .|.++-.. ....... . ......+ -+.+|++++|||++||+.||++|++ +++++++
T Consensus 198 ml--~G~~pf~~~~~~~~~~~-i-~~~~~~~---p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 198 MM--CGRLPFYNQDHERLFEL-I-LMEEIRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HH--HSSCSSCCSSHHHHHHH-H-HHCCCCC---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HH--HCCCCCCCcCHHHHHHH-H-hcCCCCC---CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11 12222100 0000000 0 0000001 1358999999999999999999995 7777763
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.50 E-value=5.5e-16 Score=172.28 Aligned_cols=114 Identities=15% Similarity=0.175 Sum_probs=86.7
Q ss_pred cccceeeEEE-----EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee---------
Q psy501 673 ERLKSSYILL-----HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA--------- 734 (962)
Q Consensus 673 ~~~~~~~~~~-----~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~--------- 734 (962)
|-||..||++ |.+||+|||++.. ....+.+||+.|++||++. + ..|+.++||||+||++|
T Consensus 151 RDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~DiwSlGvilyelltG~~Pf 228 (352)
T d1koba_ 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD-R-EPVGFYTDMWAIGVLGYVLLSGLSPF 228 (352)
T ss_dssp CCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHT-T-CCBCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred cccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHc-C-CCCCCccchHHHHHHHHHHHhCCCCC
Confidence 6789999998 7899999999754 4455669999999998764 4 46999999999999997
Q ss_pred -cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 -GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 -G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
|.+..+.+..|...-.. ++ ...++.+++++.|||++||++||.+|||++|+|++
T Consensus 229 ~~~~~~~~~~~i~~~~~~-------------~~-------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 229 AGEDDLETLQNVKRCDWE-------------FD-------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCSSHHHHHHHHHHCCCC-------------CC-------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHhCCCC-------------CC-------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 23333444444332111 11 11235789999999999999999999999999974
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.50 E-value=9.6e-16 Score=170.20 Aligned_cols=111 Identities=19% Similarity=0.189 Sum_probs=84.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------cCC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------GTE 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G~~ 737 (962)
|-||.+||++ |.+||+|||++.. +...+.+||+.|++||++. | ..|+.++||||+|||+| |.+
T Consensus 165 RDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~~-~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 242 (350)
T d1rdqe_ 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIIL-S-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp CCCSGGGEEECTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHT-T-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CcCCHHHcccCCCCCEEeeeceeeeecccccccccCccccCCHHHHc-C-CCCCccccccchhHHHHHHHhCCCCCCCcC
Confidence 7789999999 8999999999865 4556679999999999775 4 56999999999999997 222
Q ss_pred chhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCc-----chhhhhhhh
Q psy501 738 RLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRP-----TAQQSLSIK 809 (962)
Q Consensus 738 ~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~-----sa~~~L~~~ 809 (962)
....+..|... .+.. .+.+++++.|||++||+.||.+|+ |++++|++.
T Consensus 243 ~~~~~~~i~~~----------------~~~~--------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp 295 (350)
T d1rdqe_ 243 PIQIYEKIVSG----------------KVRF--------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp HHHHHHHHHHC----------------CCCC--------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHHHHHHHhcC----------------CCCC--------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCc
Confidence 22222222210 0000 136799999999999999999995 899998743
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=6.1e-16 Score=165.73 Aligned_cols=116 Identities=18% Similarity=0.127 Sum_probs=82.9
Q ss_pred cccceeeEEE----EEEeeeeeecCCC---ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHH
Q psy501 673 ERLKSSYILL----HTLPLYTYHVPPI---QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 745 (962)
Q Consensus 673 ~~~~~~~~~~----~~~~~~~~~~~~~---~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I 745 (962)
|-||++||++ +.+||.|||++.. ....+.+||+.|++||++. +.+.|+.++||||+||++| .+
T Consensus 134 rDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~-~~~~~~~~~DiwSlGvily---------el 203 (273)
T d1xwsa_ 134 RDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR-YHRYHGRSAAVWSLGILLY---------DM 203 (273)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHH-HSCBCHHHHHHHHHHHHHH---------HH
T ss_pred ccCcccceEEecCCCeEEECccccceecccccccccccCCCcCCHHHHc-CCCCCCcccccccceeeeh---------hH
Confidence 6789999999 5899999999854 3445568999999888776 4456788999999999997 11
Q ss_pred HHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhhh
Q psy501 746 LHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 746 ~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~~ 809 (962)
+ .|.+|-......... ...+. +.+|+++.|||++||++||++|||++|+|+..
T Consensus 204 l--~g~~Pf~~~~~i~~~------~~~~~---~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 256 (273)
T d1xwsa_ 204 V--CGDIPFEHDEEIIRG------QVFFR---QRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 256 (273)
T ss_dssp H--HSSCSCCSHHHHHHC------CCCCS---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred h--hCCCCCCCchHHhhc------ccCCC---CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 1 233221100000000 00111 36899999999999999999999999999843
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.49 E-value=1.7e-15 Score=165.87 Aligned_cols=111 Identities=19% Similarity=0.260 Sum_probs=83.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----c------CC
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----G------TE 737 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G------~~ 737 (962)
|-||++||++ |.+||+|||++.. +...+.+||+.|++||++. | ..|+.++||||+|||+| | .+
T Consensus 128 rDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~Gt~~Y~APE~l~-~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 128 RDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVS-T-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp CCCCGGGEEECTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHT-T-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccCchheeEcCCCCEEEecCccceEeccccccccCcccccCHHHHc-C-CCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence 6789999999 9999999999876 5556679999999999764 3 46999999999999997 2 12
Q ss_pred chhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCc-----chhhhhhhh
Q psy501 738 RLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRP-----TAQQSLSIK 809 (962)
Q Consensus 738 ~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~-----sa~~~L~~~ 809 (962)
..+.+..|... .. .+ -+.+++++.|||.+||+.||.+|+ |++++|++.
T Consensus 206 ~~~~~~~i~~~---------------~~------~~---p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp 258 (316)
T d1fota_ 206 TMKTYEKILNA---------------EL------RF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 258 (316)
T ss_dssp HHHHHHHHHHC---------------CC------CC---CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHHHHHHHHcC---------------CC------CC---CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCc
Confidence 22222222210 00 01 146789999999999999999996 888888743
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=6.2e-16 Score=170.71 Aligned_cols=119 Identities=14% Similarity=0.124 Sum_probs=82.6
Q ss_pred cccceeeEEE------EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL------HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~------~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
|-||.+||++ +.+||+|||++.. ....+.+||+.|+|||++. + ..|+.++||||+|||+|
T Consensus 135 RDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~y~~~~DiwSlGvily-------- 204 (335)
T d2ozaa1 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG-P-EKYDKSCDMWSLGVIMY-------- 204 (335)
T ss_dssp CCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCC-G-GGGSHHHHHHHHHHHHH--------
T ss_pred ccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHc-C-CCCCHHHHHHhhchhHH--------
Confidence 6789999999 5699999999753 4455669999999999765 3 45999999999999997
Q ss_pred HHHHHhcCCCchhhhc------cccc-cc--CCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 743 YILLHTLPLYTCYTLA------SNMN-FK--FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~------~~~~-~~--~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
.+ +.|.+|-.... .... .. ...++... .+.+|++++|||++||++||++|||+.++|++
T Consensus 205 -~l--ltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 205 -IL--LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -HH--TTSSCSCEETTCC--------CCCSCSSSCCTTH----HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HH--hhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc----cccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11 23333211000 0000 00 00011111 13579999999999999999999999999974
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=2.2e-15 Score=161.73 Aligned_cols=124 Identities=15% Similarity=0.161 Sum_probs=82.5
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeec-CCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHT-LPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg-~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
|-||++||++ +.+||+|||++.. ....+.+||+.|+|||++... ...|+.++||||+||+++
T Consensus 128 rDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~------- 200 (276)
T d1uwha_ 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLY------- 200 (276)
T ss_dssp SCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHH-------
T ss_pred cccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHH-------
Confidence 6789999999 8999999999754 122345899999999988654 346999999999999997
Q ss_pred HHHHHHhcCCCchhhhccc---ccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 742 SYILLHTLPLYTCYTLASN---MNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 742 l~~I~~~lG~p~~~~~~~~---~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. |.+|-...... ............+...-+.+++++.+||.+||..||++|||+.++++
T Consensus 201 --el~t--g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~ 265 (276)
T d1uwha_ 201 --ELMT--GQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265 (276)
T ss_dssp --HHHH--SSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHHH--CCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1211 22221000000 00000000011122233568899999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=2.8e-15 Score=166.61 Aligned_cols=135 Identities=17% Similarity=0.255 Sum_probs=93.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc----eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------c
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ----TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----------G 735 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~----~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----------G 735 (962)
|-||+.||++ +.+++.|||+.... .....+||+.|+|||++ .| ..|++++||||+||+++ |
T Consensus 143 rDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l-~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~ 220 (355)
T d2b1pa1 143 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI-LG-MGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_dssp SCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHH-TT-CCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCccccccccccceeeechhhhhccccccccccccccccccChhhh-cC-CCCCCCcccccccchHHHHhhCCCCCCC
Confidence 6679999999 88999999987762 22334899988888865 45 46999999999999998 6
Q ss_pred CCchhHHHHHHHhcCCCchhhhcccccc------cCCCcccCCccccCC------------CCCHHHHHHHHHhhccCCC
Q psy501 736 TERLKSSYILLHTLPLYTCYTLASNMNF------KFPQFRRVPFTSIIP------------HASPDAIHLMESMLAYNPS 797 (962)
Q Consensus 736 ~~~~~ql~~I~~~lG~p~~~~~~~~~~~------~~~~~~~~~l~~~~p------------~~s~~a~DLL~kmL~~dP~ 797 (962)
.++.+++.+|+..++.|..+.+...... ..+......+...++ ..+++++|||++||++||+
T Consensus 221 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~ 300 (355)
T d2b1pa1 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTT
T ss_pred CCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChh
Confidence 6788999999999999877654332110 011111111111111 2467899999999999999
Q ss_pred CCcchhhhhhhh
Q psy501 798 KRPTAQQSLSIK 809 (962)
Q Consensus 798 kR~sa~~~L~~~ 809 (962)
+||||+|+|++.
T Consensus 301 ~R~ta~elL~Hp 312 (355)
T d2b1pa1 301 KRISVDDALQHP 312 (355)
T ss_dssp TSCCHHHHHTST
T ss_pred HCcCHHHHhcCc
Confidence 999999999743
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=2.1e-15 Score=163.15 Aligned_cols=114 Identities=17% Similarity=0.143 Sum_probs=84.1
Q ss_pred cccceeeEEE---E----EEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee-------
Q psy501 673 ERLKSSYILL---H----TLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~----~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~------- 734 (962)
|-||..||++ + .+||.|||++.. ....+.+||+.|+|||++.. ..|+.++||||+|||+|
T Consensus 137 rDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~ 214 (293)
T d1jksa_ 137 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGAS 214 (293)
T ss_dssp CCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcC--CCCCCcccchhhhHHHHHHHcCCC
Confidence 5689999999 3 599999999754 44455699999999998753 46999999999999997
Q ss_pred ---cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 ---GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 ---G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
|.+..+.+..|...-.. ++ ....+.+|++++|||++||+.||++|||++++|++
T Consensus 215 Pf~~~~~~~~~~~i~~~~~~-------------~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 215 PFLGDTKQETLANVSAVNYE-------------FE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp SSCCSSHHHHHHHHHTTCCC-------------CC-------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCCCHHHHHHHHHhcCCC-------------CC-------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22333333333221000 00 11225789999999999999999999999999973
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=3.1e-15 Score=162.02 Aligned_cols=122 Identities=14% Similarity=0.099 Sum_probs=77.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
|-||++||++ |.+||+|||++.. ....+.+||+.|++||++.- ..|+.++||||+|||++
T Consensus 158 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~-------- 227 (299)
T d1ywna1 158 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLW-------- 227 (299)
T ss_dssp SCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHH--------
T ss_pred CcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc--CCCCcccceeehHHHHH--------
Confidence 6789999999 8999999999743 12234489999999998764 45999999999999996
Q ss_pred HHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .+.|+-........+.........+ ..-+.+++++.|||.+||..||++|||++++++
T Consensus 228 -ellt-~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~ 289 (299)
T d1ywna1 228 -EIFS-LGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289 (299)
T ss_dssp -HHHT-TSCCSSTTCCCSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHh-CCCCCCCCCCHHHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2211 1222211100000000000000000 011357899999999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=3.3e-15 Score=164.06 Aligned_cols=119 Identities=16% Similarity=0.173 Sum_probs=81.5
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
|-||++||++ |.+||+|||++... ...+.+||+.|+|||++.- ..|+.++||||+|||++
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~-------- 257 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLW-------- 257 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHH--------
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC--CCCCcceeccchhHHHH--------
Confidence 7899999999 89999999997541 1224478999999998764 45999999999999997
Q ss_pred HHHHHhcCCCchhhhccccc-cc--CCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMN-FK--FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~-~~--~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.+|-........ .. .... ..+. -+.+++++.+||.+||+.||++|||++++++
T Consensus 258 -eml-t~g~~Pf~~~~~~~~~~~~~~~~~-~~~~---p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 319 (325)
T d1rjba_ 258 -EIF-SLGVNPYPGIPVDANFYKLIQNGF-KMDQ---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319 (325)
T ss_dssp -HHT-TTSCCSSTTCCCSHHHHHHHHTTC-CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHH-hCCCCCCCCCCHHHHHHHHHhcCC-CCCC---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111 123333111000000 00 0000 0000 1367899999999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=6.7e-15 Score=161.30 Aligned_cols=110 Identities=20% Similarity=0.172 Sum_probs=81.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----------
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA---------- 734 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~---------- 734 (962)
|-||++||++ |.+||+|||++.. ......+||+.|++||++.. ..|++++||||+|||+|
T Consensus 127 rDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~ 204 (320)
T d1xjda_ 127 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFH 204 (320)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcC--CCCCchhhhhhhhHHHHHHHhCCCCCC
Confidence 5689999999 9999999999753 33334599999999998864 45999999999999997
Q ss_pred cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchh-hhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQ-QSLSI 808 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~-~~L~~ 808 (962)
|.+..+.+..|.. + .+.. -+.+|+++.|||++||+.||++||+++ +++++
T Consensus 205 ~~~~~~~~~~i~~--~--------------~~~~--------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 205 GQDEEELFHSIRM--D--------------NPFY--------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp CSSHHHHHHHHHH--C--------------CCCC--------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CCCHHHHHHHHHc--C--------------CCCC--------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 2222222222211 0 0111 135799999999999999999999996 67763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=4e-15 Score=163.20 Aligned_cols=114 Identities=12% Similarity=0.121 Sum_probs=84.8
Q ss_pred cccceeeEEE-----EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee---------
Q psy501 673 ERLKSSYILL-----HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA--------- 734 (962)
Q Consensus 673 ~~~~~~~~~~-----~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~--------- 734 (962)
|-||..||++ +.++|.|||++.. ....+.+||+.|++||++.. ..|+.++||||+|||+|
T Consensus 126 rDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~--~~~~~~~DiWSlGvily~ll~G~~Pf 203 (321)
T d1tkia_ 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPF 203 (321)
T ss_dssp CCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccC--CCCCchhhcccHHHHHHHHHhCCCCC
Confidence 6789999999 4799999999765 44556699999999997653 45999999999999997
Q ss_pred -cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 -GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 -G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.+..+.+..|...-.. ++ ...++.+|++++|||++||+.||.+|||++|+|++
T Consensus 204 ~~~~~~~~~~~i~~~~~~-------------~~-------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 204 LAETNQQIIENIMNAEYT-------------FD-------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCSSHHHHHHHHHHTCCC-------------CC-------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCHHHHHHHHHhCCCC-------------CC-------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22222333333221100 11 11225789999999999999999999999999973
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.42 E-value=7.6e-15 Score=162.71 Aligned_cols=135 Identities=15% Similarity=0.202 Sum_probs=96.7
Q ss_pred cccceeeEEE---------EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----cC-
Q psy501 673 ERLKSSYILL---------HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----GT- 736 (962)
Q Consensus 673 ~~~~~~~~~~---------~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G~- 736 (962)
|-||.+||++ +.+++.|||.+.. ......+||+.|++||++.. ..|+.++||||+|||++ |.
T Consensus 150 rDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~ 227 (362)
T d1q8ya_ 150 TDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDF 227 (362)
T ss_dssp SCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCChhHeeeeccCcccccceeeEeecccccccccccccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCC
Confidence 4689999999 2499999999765 44455589999999997663 45999999999999987 32
Q ss_pred -----------CchhHHHHHHHhcCCCchhhhcccccc-----------cCCCcccCCcccc-------CCCCCHHHHHH
Q psy501 737 -----------ERLKSSYILLHTLPLYTCYTLASNMNF-----------KFPQFRRVPFTSI-------IPHASPDAIHL 787 (962)
Q Consensus 737 -----------~~~~ql~~I~~~lG~p~~~~~~~~~~~-----------~~~~~~~~~l~~~-------~p~~s~~a~DL 787 (962)
...+++..++.++|+++.+........ ........++... .+..+++++||
T Consensus 228 pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 307 (362)
T d1q8ya_ 228 LFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307 (362)
T ss_dssp CC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred CCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHH
Confidence 245678888999999887654221110 0111111111111 11346789999
Q ss_pred HHHhhccCCCCCcchhhhhhhh
Q psy501 788 MESMLAYNPSKRPTAQQSLSIK 809 (962)
Q Consensus 788 L~kmL~~dP~kR~sa~~~L~~~ 809 (962)
|.+||++||.+||||+|+|++.
T Consensus 308 l~~mL~~dP~~Rpta~e~L~Hp 329 (362)
T d1q8ya_ 308 LSPMLQLDPRKRADAGGLVNHP 329 (362)
T ss_dssp HGGGGCSSTTTCBCHHHHHTCG
T ss_pred HHHHCCCChhHCcCHHHHhcCc
Confidence 9999999999999999999743
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.40 E-value=1.1e-14 Score=156.24 Aligned_cols=117 Identities=21% Similarity=0.245 Sum_probs=86.0
Q ss_pred ccccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeec----CCCCCCCCCceeeeeEee------
Q psy501 672 TERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHT----LPLYTYHVPPIQTTCLLA------ 734 (962)
Q Consensus 672 ~~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg----~~~Y~~~vDIWSlGCIl~------ 734 (962)
-|-||+.||++ +.+||.|||++.. ......+||+.|++||.+... ...|+.++||||+|||++
T Consensus 133 HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~ 212 (277)
T d1phka_ 133 HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212 (277)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ccccccceEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCC
Confidence 46789999999 8999999999743 234445899999999988632 345899999999999997
Q ss_pred ----cCCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhhh
Q psy501 735 ----GTERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLSI 808 (962)
Q Consensus 735 ----G~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~~ 808 (962)
+.+..+.+..|... . . .++.. ..+++|++++|||++||+.||++|||++++|++
T Consensus 213 ~Pf~~~~~~~~~~~i~~~-----------~----~-~~~~~----~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 213 PPFWHRKQMLMLRMIMSG-----------N----Y-QFGSP----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CSSCCSSHHHHHHHHHHT-----------C----C-CCCTT----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCHHHHHHHHHhC-----------C----C-CCCCc----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 22333333333221 0 0 01111 124789999999999999999999999999984
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=9.7e-15 Score=155.36 Aligned_cols=120 Identities=11% Similarity=0.059 Sum_probs=74.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCC------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
|-||++||++ +.+||+|||++.. ......+||+.|++||++.. ..|+.++||||+||+++
T Consensus 125 rDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~--------- 193 (263)
T d1sm2a_ 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMW--------- 193 (263)
T ss_dssp TTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTT--CCCCHHHHHHHHHHHHH---------
T ss_pred cccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcC--CCCCchhhhcchHHHHH---------
Confidence 6789999999 8999999999864 12223489999999998653 45999999999999996
Q ss_pred HHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 744 ILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.|+.......... .......... -..+++++.+|+.+||+.||++|||++++|+
T Consensus 194 el~-t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~~p~~Rps~~~il~ 254 (263)
T d1sm2a_ 194 EVF-SEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQIMNHCWKERPEDRPAFSRLLR 254 (263)
T ss_dssp HHH-TTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHH-HCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 111 1133322110000000 0000000000 0246889999999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.39 E-value=1.2e-14 Score=156.70 Aligned_cols=119 Identities=12% Similarity=0.099 Sum_probs=80.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
|-||++||++ |.+||+|||++... ..+...||+.|++||++.- ..|+.++||||+||+++
T Consensus 139 rDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l~--------- 207 (287)
T d1opja_ 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLW--------- 207 (287)
T ss_dssp SCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHHH---------
T ss_pred CccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcC--CCCCchhhhhhHHHHHH---------
Confidence 6689999999 89999999998651 1222368899999998764 35999999999999996
Q ss_pred HHHHhcCCCchhhhc--ccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 744 ILLHTLPLYTCYTLA--SNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~--~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.|+..... .....-...... ...+.+++++.+||.+||..||++|||++++++
T Consensus 208 ell~-~~~p~~~~~~~~~~~~~i~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 208 EIAT-YGMSPYPGIDLSQVYELLEKDYRM----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHT-TSCCSSTTCCHHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHh-CCCCCCCcchHHHHHHHHhcCCCC----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1111 1222211100 000000000000 011367899999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=1.6e-14 Score=154.35 Aligned_cols=120 Identities=14% Similarity=0.155 Sum_probs=75.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCC------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
|-||++||++ +.+||+|||++.. ......+||+.|++||++.. ..|+.++||||+||++|
T Consensus 132 rDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~--------- 200 (273)
T d1mp8a_ 132 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMW--------- 200 (273)
T ss_dssp SCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHH---------
T ss_pred cccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhcc--CCCCCccccccchHHHH---------
Confidence 7789999999 8899999999764 12233478888988887764 45999999999999996
Q ss_pred HHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 744 ILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.||-......... ........+ ..+.+++++.+||.+||..||.+|||++++++
T Consensus 201 e~l-t~g~~P~~~~~~~~~~~~i~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~ 261 (273)
T d1mp8a_ 201 EIL-MHGVKPFQGVKNNDVIGRIENGERLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261 (273)
T ss_dssp HHH-TTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHH-hcCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 221 1255443221110000 000000011 12578999999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=2.7e-14 Score=153.56 Aligned_cols=121 Identities=13% Similarity=0.080 Sum_probs=77.5
Q ss_pred ccccceeeEEE---EEEeeeeeecCCC-----c---eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchh
Q psy501 672 TERLKSSYILL---HTLPLYTYHVPPI-----Q---TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK 740 (962)
Q Consensus 672 ~~~~~~~~~~~---~~~~~~~~~~~~~-----~---~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ 740 (962)
-|-||++||++ +.+||+|||++.. + .....+||++|++||.+.. ..|+.++||||+||+++
T Consensus 133 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~------ 204 (283)
T d1mqba_ 133 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMW------ 204 (283)
T ss_dssp CSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHH------
T ss_pred cCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHH------
Confidence 36789999999 8999999999853 1 1222378999999997653 46999999999999996
Q ss_pred HHHHHHHhcCCCchhhhccccccc-CCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 741 SSYILLHTLPLYTCYTLASNMNFK-FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 741 ql~~I~~~lG~p~~~~~~~~~~~~-~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .|.|+........... .......+. -..+++++.+||.+||..||++|||+.++++
T Consensus 205 ---el~t-~~~~~~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 205 ---EVMT-YGERPYWELSNHEVMKAINDGFRLPT---PMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ---HHHT-TSCCTTTTCCHHHHHHHHHTTCCCCC---CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---HHHh-CCCCccccCCHHHHHHHHhccCCCCC---chhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 1211 1233221110000000 000000011 1357789999999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=1.2e-14 Score=159.41 Aligned_cols=122 Identities=17% Similarity=0.053 Sum_probs=81.9
Q ss_pred cccceeeEEE---EEEeeeeeecCCC------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
|-||.+||++ |.++|.|||++.. ....+.+||+.|++||+++.+...|+.++||||+||++|
T Consensus 153 rDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLy--------- 223 (322)
T d1vzoa_ 153 RDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMY--------- 223 (322)
T ss_dssp CCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHH---------
T ss_pred ccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHH---------
Confidence 6789999999 9999999998643 344556999999999999876667899999999999997
Q ss_pred HHHHhcCCCchhh--hccccc--ccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcc-----hhhhhhh
Q psy501 744 ILLHTLPLYTCYT--LASNMN--FKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPT-----AQQSLSI 808 (962)
Q Consensus 744 ~I~~~lG~p~~~~--~~~~~~--~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~s-----a~~~L~~ 808 (962)
.++ .|.+|-.. ...... .........+ ..+.+|++++|||++||++||.+|+| ++|+|++
T Consensus 224 ell--tG~~PF~~~~~~~~~~~i~~~~~~~~~~---~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 224 ELL--TGASPFTVDGEKNSQAEISRRILKSEPP---YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp HHH--HSSCTTSCTTSCCCHHHHHHHHHHCCCC---CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHH--hCCCCCCCCCHHHHHHHHHHhcccCCCC---CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 121 13322000 000000 0000000001 11368999999999999999999995 7888873
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.36 E-value=3.3e-14 Score=154.13 Aligned_cols=121 Identities=11% Similarity=0.037 Sum_probs=74.5
Q ss_pred ccccceeeEEE---EEEeeeeeecCCCc----e------eeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCc
Q psy501 672 TERLKSSYILL---HTLPLYTYHVPPIQ----T------TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTER 738 (962)
Q Consensus 672 ~~~~~~~~~~~---~~~~~~~~~~~~~~----~------~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~ 738 (962)
-|-||++||++ |.+||+|||++..- . ....+||+.|++||.+.. ..|+.++||||+|||++
T Consensus 151 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~---- 224 (299)
T d1jpaa_ 151 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMW---- 224 (299)
T ss_dssp CSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHH----
T ss_pred cCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHH----
Confidence 36789999999 89999999997531 1 111268999999998654 46999999999999996
Q ss_pred hhHHHHHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 739 LKSSYILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 739 ~~ql~~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.+|-......... ....-...+. -+.+++++.+|+.+||..||++|||+.++++
T Consensus 225 -----el~-t~g~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~ 285 (299)
T d1jpaa_ 225 -----EVM-SYGERPYWDMTNQDVINAIEQDYRLPP---PMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285 (299)
T ss_dssp -----HHH-TTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----HHH-hCCCCCCCCCCHHHHHHHHHcCCCCCC---CccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 121 1244331111000000 0000000000 1357889999999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=1.8e-14 Score=154.03 Aligned_cols=120 Identities=13% Similarity=0.059 Sum_probs=80.6
Q ss_pred cccceeeEEE---EEEeeeeeecCCC------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
|-||++||++ +.+||+|||++.. ......+||+.|++||++.. ..|+.++||||+|||++
T Consensus 133 rDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~--------- 201 (272)
T d1qpca_ 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLT--------- 201 (272)
T ss_dssp SCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHH---------
T ss_pred CccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhC--CCCCchhhhhhhHHHHH---------
Confidence 5789999999 8999999999854 12223489999999998754 35999999999999996
Q ss_pred HHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 744 ILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.|+.......... .......... -+.+++++.+|+.+||..||++|||++++++
T Consensus 202 ell-t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~ 262 (272)
T d1qpca_ 202 EIV-THGRIPYPGMTNPEVIQNLERGYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (272)
T ss_dssp HHH-TTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHH-hCCCCCCCCCCHHHHHHHHHhcCCCCC---cccChHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 111 1123322110000000 0000000000 1357889999999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=3.8e-14 Score=150.44 Aligned_cols=120 Identities=14% Similarity=0.071 Sum_probs=79.6
Q ss_pred cccceeeEEE---EEEeeeeeecCCC------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+.||++||++ +.+||+|||++.. ...+..+||++|++||++.. ..|+.++||||+||+++
T Consensus 124 ~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l~--------- 192 (258)
T d1k2pa_ 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMW--------- 192 (258)
T ss_dssp SCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHH---------
T ss_pred ccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcC--CCCCcceeecccchhhH---------
Confidence 5689999999 8999999999853 22233478889988887664 45999999999999996
Q ss_pred HHHHhcCCCchhhhccc-ccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 744 ILLHTLPLYTCYTLASN-MNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~~~-~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.|+ ..|.+|-...... ...........+.. ..+++++.|||++||+.||++|||++++|+
T Consensus 193 el~-t~g~~Pf~~~~~~~~~~~i~~~~~~~~p---~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 253 (258)
T d1k2pa_ 193 EIY-SLGKMPYERFTNSETAEHIAQGLRLYRP---HLASEKVYTIMYSCWHEKADERPTFKILLS 253 (258)
T ss_dssp HHH-TTSCCTTTTSCHHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred hHH-hcCCCCCCCCCHHHHHHHHHhCCCCCCc---ccccHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 121 1133221110000 00000000000000 246789999999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=3.3e-14 Score=153.18 Aligned_cols=119 Identities=15% Similarity=0.109 Sum_probs=77.8
Q ss_pred cccceeeEEE---EEEeeeeeecCCC------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSY 743 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~ 743 (962)
+-||++||++ +.+||+|||++.. ......+||+.|++||++.- ..|+.++||||+|||++
T Consensus 137 ~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~--------- 205 (285)
T d1fmka3 137 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLT--------- 205 (285)
T ss_dssp SCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHH---------
T ss_pred ccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhC--CCCCcHHhhhcchHHHH---------
Confidence 5789999999 8999999999854 23334589999999998764 45899999999999997
Q ss_pred HHHHhcCCCchhhhcc--cccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 744 ILLHTLPLYTCYTLAS--NMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 744 ~I~~~lG~p~~~~~~~--~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ .-|.|+...... ....-.... ..+ ..+.+++++.+||++||+.||++|||++++++
T Consensus 206 el~-t~~~p~~~~~~~~~~~~~i~~~~-~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 266 (285)
T d1fmka3 206 ELT-TKGRVPYPGMVNREVLDQVERGY-RMP---CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 266 (285)
T ss_dssp HHH-TTTCCSSTTCCHHHHHHHHHTTC-CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHH-hCCCCCCCCCCHHHHHHHHHhcC-CCC---CCcccCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 111 112222111000 000000000 001 11467899999999999999999999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.33 E-value=4.3e-14 Score=151.28 Aligned_cols=113 Identities=18% Similarity=0.212 Sum_probs=74.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee----c--
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA----G-- 735 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~----G-- 735 (962)
|-||.+||++ +..++.|||+... ....+.+||+.|++||++. + ..|++++||||+|||+| |
T Consensus 135 rDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~-~~~~~~~DiwSlGvilyelltG~~ 212 (277)
T d1o6ya_ 135 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR-G-DSVDARSDVYSLGCVLYEVLTGEP 212 (277)
T ss_dssp CCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHT-T-CCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHc-C-CCCCcceecccchHHHHHHHhCCC
Confidence 6789999999 8999999997643 2334458999999999864 3 46999999999999997 2
Q ss_pred ----CCchhHHHHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCc-chhhhhh
Q psy501 736 ----TERLKSSYILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRP-TAQQSLS 807 (962)
Q Consensus 736 ----~~~~~ql~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~-sa~~~L~ 807 (962)
.+..+.+..+... .+.+.....+.+|+++.+||.+||..||.+|| |+++++.
T Consensus 213 Pf~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~ 269 (277)
T d1o6ya_ 213 PFTGDSPVSVAYQHVRE--------------------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 269 (277)
T ss_dssp SCCCSSHHHHHHHHHHC--------------------CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCCCcCHHHHHHHHHhc--------------------CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHH
Confidence 1222222222210 00111122357899999999999999999999 6676654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.33 E-value=4.2e-14 Score=153.35 Aligned_cols=121 Identities=13% Similarity=0.064 Sum_probs=79.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
|-||++||++ +.+||+|||++.. ....+.+||+.|++||.+.. ..|+.++||||+|||++
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~t~ksDVwS~Gvvl~-------- 233 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLW-------- 233 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHH--------
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc--CCCChhhhhccchhhHH--------
Confidence 7799999999 8899999999642 22334588899988888764 45999999999999996
Q ss_pred HHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++. .+.|+-.......... ..........-+.+++++.+||.+||+.||++|||+.++++
T Consensus 234 -ell~-~~~~p~~~~~~~e~~~--~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 234 -EIFS-YGLQPYYGMAHEEVIY--YVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp -HHHT-TTCCTTTTSCHHHHHH--HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHc-cCCCCCCCCCHHHHHH--HHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2221 1112211100000000 00000000111367899999999999999999999999865
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=3.8e-14 Score=154.85 Aligned_cols=120 Identities=13% Similarity=0.115 Sum_probs=79.3
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
|-||+.||++ +.+||+|||++.. ..++...||++|++||++..+ .|+.++||||+||+++
T Consensus 135 rDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDvwS~Gvil~-------- 204 (317)
T d1xkka_ 135 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVW-------- 204 (317)
T ss_dssp SCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHH--------
T ss_pred CcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcC--CCChhhhhhhHHHHHH--------
Confidence 5689999999 7899999998653 223344799999999987654 5999999999999996
Q ss_pred HHHHHhcCCCchhhhccccccc-CCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNFK-FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~~-~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.++-.......... .......+. -+.+++++.+|+.+||..||.+|||+.++++
T Consensus 205 -el~-t~g~~p~~~~~~~~~~~~i~~~~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 265 (317)
T d1xkka_ 205 -ELM-TFGSKPYDGIPASEISSILEKGERLPQ---PPICTIDVYMIMVKCWMIDADSRPKFRELII 265 (317)
T ss_dssp -HHH-TTSCCTTTTSCGGGHHHHHHHTCCCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHH-HCCCCCCCCCCHHHHHHHHHcCCCCCC---CcccCHHHHHHHHHhCCCChhhCcCHHHHHH
Confidence 111 12444422111100000 000000011 1367899999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=3.9e-14 Score=151.86 Aligned_cols=120 Identities=9% Similarity=0.019 Sum_probs=79.4
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
|-||++||++ |.+||.|||++.. ......+||++|+|||.+.- ..|+.++||||+||+++
T Consensus 131 rDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l~------- 201 (277)
T d1xbba_ 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMW------- 201 (277)
T ss_dssp SCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHH-------
T ss_pred CCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcC--CCCCchhhhccchhhhh-------
Confidence 5789999999 7899999999753 11223389999999998764 35899999999999996
Q ss_pred HHHHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 742 SYILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 742 l~~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.+|-......... ....-...++ -+.+++++.|||.+||..||++|||++++++
T Consensus 202 --ell-t~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~ 262 (277)
T d1xbba_ 202 --EAF-SYGQKPYRGMKGSEVTAMLEKGERMGC---PAGCPREMYDLMNLCWTYDVENRPGFAAVEL 262 (277)
T ss_dssp --HHH-TTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --HHh-hCCCCCCCCCCHHHHHHHHHcCCCCCC---CcccCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 121 1244331111000000 0000000111 1357899999999999999999999999854
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=4.5e-14 Score=152.12 Aligned_cols=120 Identities=12% Similarity=0.073 Sum_probs=80.9
Q ss_pred cccceeeEEE---EEEeeeeeecCCC--------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI--------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~--------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
|-||++||++ +.+||+|||++.. ......+||++|++||++..+ .|+.++||||+||+++
T Consensus 133 rDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gv~l~------- 203 (285)
T d1u59a_ 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMW------- 203 (285)
T ss_dssp CCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHH-------
T ss_pred CcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCC--CCCccchhhcchHHHH-------
Confidence 6789999999 8999999999753 111233799999999987543 5999999999999996
Q ss_pred HHHHHHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 742 SYILLHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 742 l~~I~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.+|-......... ....-... ..-+.+++++.+||++||..||++|||+.++++
T Consensus 204 --E~l-t~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~ 264 (285)
T d1u59a_ 204 --EAL-SYGQKPYKKMKGPEVMAFIEQGKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 264 (285)
T ss_dssp --HHH-TTSCCTTTTCCTHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred --HHH-hCCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 121 1244331111000000 00000000 111468899999999999999999999999865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=3.7e-14 Score=154.35 Aligned_cols=120 Identities=18% Similarity=0.118 Sum_probs=79.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCC----ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI----QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYIL 745 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I 745 (962)
|-||++||++ +.+||+|||++.. ......+||+.|++||++.- ..|+.++||||+|||++ .+
T Consensus 151 rDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~---------el 219 (309)
T d1fvra_ 151 RDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLW---------EI 219 (309)
T ss_dssp SCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHH---------HH
T ss_pred cccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhcc--CCCCccceeehhHHHHH---------HH
Confidence 7789999999 8999999999754 22334479999999998764 45999999999999996 22
Q ss_pred HHhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 746 LHTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 746 ~~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
+. .|.|+-......... ........+ .-+.+++++.+||++||..||++|||+.++|+
T Consensus 220 l~-~~~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 278 (309)
T d1fvra_ 220 VS-LGGTPYCGMTCAELYEKLPQGYRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 278 (309)
T ss_dssp HT-TSCCTTTTCCHHHHHHHGGGTCCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Hh-cCCCCCCCCCHHHHHHHHHhcCCCC---CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 21 122221110000000 000000000 11357899999999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=1.7e-13 Score=148.28 Aligned_cols=120 Identities=17% Similarity=0.136 Sum_probs=82.6
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
|-||++||++ +.+||.|||++... ..+..+||+.|++||.+.- +.|+.++||||+|||++
T Consensus 159 rDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~-------- 228 (299)
T d1fgka_ 159 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLW-------- 228 (299)
T ss_dssp SCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHH--------
T ss_pred eeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHH--------
Confidence 6789999999 89999999998751 2333589999999998754 46999999999999996
Q ss_pred HHHHHhcCCCchhhhccccccc-CCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNFK-FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~~-~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.|+-........+. .......++ -+.+++++.+||.+||++||.+|||+.++|+
T Consensus 229 -ell-~~g~~p~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 229 -EIF-TLGGSPYPGVPVEELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp -HHH-TTSCCSSTTCCHHHHHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -Hhc-cCCCCCCCCCCHHHHHHHHHcCCCCCC---CccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 111 12343322110000000 000000011 1357899999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.25 E-value=2.2e-13 Score=148.28 Aligned_cols=121 Identities=17% Similarity=0.197 Sum_probs=82.1
Q ss_pred cccceeeEEE---EEEeeeeeecCCC-------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI-------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
|.||+.||++ +.+++.|||++.. ......+||+.|++||++.- ..|+.++||||+||+++
T Consensus 169 rDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~-------- 238 (311)
T d1t46a_ 169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLW-------- 238 (311)
T ss_dssp SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHH--------
T ss_pred cccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHH--------
Confidence 5789999999 8999999999864 11122489999999998864 45999999999999996
Q ss_pred HHHHHhcCCCchhhhcccccccCCCcccCCccccC-CCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSII-PHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~-p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.|+.........+. ..-...++... +.+++++.|||.+||.+||++|||++++|+
T Consensus 239 -ell-t~g~p~~~~~~~~~~~~--~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 239 -ELF-SLGSSPYPGMPVDSKFY--KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp -HHH-TTTCCSSTTCCSSHHHH--HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHH-hCCCCCCCCCCHHHHHH--HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 221 12444322111100000 00000000011 357889999999999999999999999985
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=2.2e-13 Score=144.87 Aligned_cols=121 Identities=9% Similarity=0.033 Sum_probs=78.5
Q ss_pred ccccceeeEEE---EEEeeeeeecCCC--ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHHHHHH
Q psy501 672 TERLKSSYILL---HTLPLYTYHVPPI--QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSSYILL 746 (962)
Q Consensus 672 ~~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql~~I~ 746 (962)
-+-||++||++ |.++++|||++.. ....+.+||+.|++||++.- ..|+.++||||+||+++ +++
T Consensus 126 H~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~---------el~ 194 (262)
T d1byga_ 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLW---------EIY 194 (262)
T ss_dssp CSCCSGGGEEECTTSCEEECCCCC------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHH---------HHH
T ss_pred ccccchHhheecCCCCEeecccccceecCCCCccccccccCCChHHHhC--CCCChHHHHHhHHHHHH---------HHH
Confidence 36789999999 8999999999887 44444589999999988764 35999999999999996 222
Q ss_pred HhcCCCchhhhcccccc-cCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 747 HTLPLYTCYTLASNMNF-KFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 747 ~~lG~p~~~~~~~~~~~-~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
. .|.|+.......... ........ .+.+.+++++.+||++||..||.+|||+.++++
T Consensus 195 t-~~~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 195 S-FGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp T-TSCCSCTTSCGGGHHHHHTTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H-CCCCCCCCCCHHHHHHHHHcCCCC---CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1 244432221110000 00000001 112467899999999999999999999999876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=2.2e-13 Score=148.16 Aligned_cols=121 Identities=13% Similarity=0.020 Sum_probs=82.0
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhHH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKSS 742 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ql 742 (962)
|.||++||++ +.+||+|||++... ..+..+||+.|++||.+.- ..|+.++||||+||+++
T Consensus 157 rDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il~-------- 226 (308)
T d1p4oa_ 157 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLW-------- 226 (308)
T ss_dssp SCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHH--------
T ss_pred ceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHcc--CCCCcccccccHHHHHH--------
Confidence 7899999999 99999999998741 2233379999999998764 45899999999999996
Q ss_pred HHHHHhcCCCchhhhcccccccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 743 YILLHTLPLYTCYTLASNMNFKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 743 ~~I~~~lG~p~~~~~~~~~~~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++....+|-.. ......+. ..........-+.+++++.+||.+||+.||.+|||++++++
T Consensus 227 -El~t~~~~p~~~-~~~~~~~~--~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 227 -EIATLAEQPYQG-LSNEQVLR--FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp -HHHHTSCCTTTT-SCHHHHHH--HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HHHhCCCCCCCC-CCHHHHHH--HHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 222211122111 10000000 00000000111467889999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.20 E-value=3.2e-13 Score=144.34 Aligned_cols=121 Identities=13% Similarity=0.013 Sum_probs=76.9
Q ss_pred cccceeeEEE---EEEeeeeeecCCCc-----e---eeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchhH
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPIQ-----T---TCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLKS 741 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~~-----~---~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~q 741 (962)
|-||++||++ +.+||.|||++..- . ....+||..|++||++- + ..|+.++||||+||+++
T Consensus 135 rDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~-~~~~~~~Di~S~Gvil~------- 205 (273)
T d1u46a_ 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK-T-RTFSHASDTWMFGVTLW------- 205 (273)
T ss_dssp SCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHH-H-CEEEHHHHHHHHHHHHH-------
T ss_pred eeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHh-C-CCCCcchhhhhhHHHHH-------
Confidence 4789999999 88999999997641 1 11225666777777664 4 46999999999999996
Q ss_pred HHHHHHhcCCCchhhhccccc-ccCCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 742 SYILLHTLPLYTCYTLASNMN-FKFPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 742 l~~I~~~lG~p~~~~~~~~~~-~~~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ ..|.+|-........ ...... ...+ ...+.+++++.+||++||..||++|||+.++++
T Consensus 206 --eml-t~G~~Pf~~~~~~~~~~~i~~~-~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 206 --EMF-TYGQEPWIGLNGSQILHKIDKE-GERL-PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp --HHH-TTSCCTTTTCCHHHHHHHHHTS-CCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHH-hCCCCCCCCcCHHHHHHHHHhC-CCCC-CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 221 124443211000000 000000 0000 011467899999999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.19 E-value=4e-13 Score=145.06 Aligned_cols=122 Identities=11% Similarity=0.051 Sum_probs=81.6
Q ss_pred cccceeeEEEE------EEeeeeeecCCC------------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeEee
Q psy501 673 ERLKSSYILLH------TLPLYTYHVPPI------------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLA 734 (962)
Q Consensus 673 ~~~~~~~~~~~------~~~~~~~~~~~~------------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~ 734 (962)
|-||++||+++ .++|.|||++.. ....+.+||+.|+|||.+. | ..|+.++||||+||+++
T Consensus 127 rDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~~DiwSlG~~l~ 204 (299)
T d1ckia_ 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL-G-IEQSRRDDLESLGYVLM 204 (299)
T ss_dssp SCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHT-T-BCCCHHHHHHHHHHHHH
T ss_pred ccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHh-C-CCCCChhhEEecCHHHH
Confidence 56799999973 599999999764 1223458999999999866 4 35999999999999996
Q ss_pred cCCchhHHHHHHHhcCCCchhhhccc-ccccC----CCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 735 GTERLKSSYILLHTLPLYTCYTLASN-MNFKF----PQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 735 G~~~~~ql~~I~~~lG~p~~~~~~~~-~~~~~----~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.++ .|.+|-...... ..... ......+.+...+.+++++.+||++||..||.+||++.++.+
T Consensus 205 ---------el~--tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~ 271 (299)
T d1ckia_ 205 ---------YFN--LGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271 (299)
T ss_dssp ---------HHH--HSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHH
T ss_pred ---------HHH--hCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 222 233321110000 00000 000112333444678999999999999999999999987643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.18 E-value=9.2e-14 Score=150.85 Aligned_cols=125 Identities=14% Similarity=-0.020 Sum_probs=75.7
Q ss_pred ccccceeeEEE---EEEeeeeeecCCC----c-----eeeeccCCCcccccceeeecC----CCCCCCCCceeeeeEeec
Q psy501 672 TERLKSSYILL---HTLPLYTYHVPPI----Q-----TTCLLAGTERLKSSYILLHTL----PLYTYHVPPIQTTCLLAG 735 (962)
Q Consensus 672 ~~~~~~~~~~~---~~~~~~~~~~~~~----~-----~~~~~~gt~~~~~~~~lLlg~----~~Y~~~vDIWSlGCIl~G 735 (962)
-|-||++||++ |.+||+|||++.. . .....+||+.|+|||.+.-.. ..|+.++||||+||+++
T Consensus 131 HrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~- 209 (303)
T d1vjya_ 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW- 209 (303)
T ss_dssp CSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHH-
T ss_pred ccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHH-
Confidence 46799999999 9999999998754 1 122348999999999754321 13678999999999996
Q ss_pred CCchhHHHHHHHhcCCCchhhhc--cccccc---------------CCCcccCCccccCC--CCCHHHHHHHHHhhccCC
Q psy501 736 TERLKSSYILLHTLPLYTCYTLA--SNMNFK---------------FPQFRRVPFTSIIP--HASPDAIHLMESMLAYNP 796 (962)
Q Consensus 736 ~~~~~ql~~I~~~lG~p~~~~~~--~~~~~~---------------~~~~~~~~l~~~~p--~~s~~a~DLL~kmL~~dP 796 (962)
.++. |.++..... ...... .......++..... ....+..+|+.+||++||
T Consensus 210 --------el~t--g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp 279 (303)
T d1vjya_ 210 --------EIAR--RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 279 (303)
T ss_dssp --------HHHH--TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSG
T ss_pred --------HHhh--CCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCH
Confidence 2222 222111000 000000 00000001100000 122357899999999999
Q ss_pred CCCcchhhhhh
Q psy501 797 SKRPTAQQSLS 807 (962)
Q Consensus 797 ~kR~sa~~~L~ 807 (962)
++|||+.|+++
T Consensus 280 ~~Rps~~ei~~ 290 (303)
T d1vjya_ 280 AARLTALRIKK 290 (303)
T ss_dssp GGSCCHHHHHH
T ss_pred hHCcCHHHHHH
Confidence 99999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.17 E-value=6.9e-13 Score=144.41 Aligned_cols=120 Identities=13% Similarity=-0.013 Sum_probs=80.7
Q ss_pred cccceeeEEE---EEEeeeeeecCCC---c------eeeeccCCCcccccceeeecCCCCCCCCCceeeeeEeecCCchh
Q psy501 673 ERLKSSYILL---HTLPLYTYHVPPI---Q------TTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCLLAGTERLK 740 (962)
Q Consensus 673 ~~~~~~~~~~---~~~~~~~~~~~~~---~------~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCIl~G~~~~~ 740 (962)
|-||++||++ +.+||+|||++.. . ......||+.|++||++.. ..|+.++||||+||+++
T Consensus 154 rDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~------ 225 (311)
T d1r0pa_ 154 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLW------ 225 (311)
T ss_dssp SCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHH------
T ss_pred CCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhc--CCCCChhHhhhhHHHHH------
Confidence 6789999999 8999999999864 1 1112378999999988765 35999999999999996
Q ss_pred HHHHHHHhcCCCchhhhccccccc-CCCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhhh
Q psy501 741 SSYILLHTLPLYTCYTLASNMNFK-FPQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSLS 807 (962)
Q Consensus 741 ql~~I~~~lG~p~~~~~~~~~~~~-~~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L~ 807 (962)
.|+ ..|.|+........... ...-..... -+.+++++.+|+.+||..||++||++.|+++
T Consensus 226 ---El~-t~~~p~~~~~~~~~~~~~i~~g~~~~~---p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 286 (311)
T d1r0pa_ 226 ---ELM-TRGAPPYPDVNTFDITVYLLQGRRLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286 (311)
T ss_dssp ---HHH-TTSCCSCC------CHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHH-HCCCCCCCCCCHHHHHHHHHcCCCCCC---cccCcHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 222 12333322111100000 000000001 1357889999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.05 E-value=5.2e-12 Score=136.02 Aligned_cols=121 Identities=11% Similarity=0.077 Sum_probs=81.2
Q ss_pred cccceeeEEE--------EEEeeeeeecCCC------------ceeeeccCCCcccccceeeecCCCCCCCCCceeeeeE
Q psy501 673 ERLKSSYILL--------HTLPLYTYHVPPI------------QTTCLLAGTERLKSSYILLHTLPLYTYHVPPIQTTCL 732 (962)
Q Consensus 673 ~~~~~~~~~~--------~~~~~~~~~~~~~------------~~~~~~~gt~~~~~~~~lLlg~~~Y~~~vDIWSlGCI 732 (962)
|-||++||++ +.++|.|||++.. ....+.+||+.|+|||.+. + ..|+.++||||+||+
T Consensus 125 rDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~-~-~~~~~~~DiwSlG~~ 202 (293)
T d1csna_ 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL-G-REQSRRDDLEALGHV 202 (293)
T ss_dssp CCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-T-CCCCHHHHHHHHHHH
T ss_pred ccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhc-C-CCCChHHHHHHhhHH
Confidence 5679999999 3599999999853 1233458999999999876 3 569999999999999
Q ss_pred eecCCchhHHHHHHHhcCCCchhhhccc-c--cc-cC-CCcccCCccccCCCCCHHHHHHHHHhhccCCCCCcchhhhh
Q psy501 733 LAGTERLKSSYILLHTLPLYTCYTLASN-M--NF-KF-PQFRRVPFTSIIPHASPDAIHLMESMLAYNPSKRPTAQQSL 806 (962)
Q Consensus 733 l~G~~~~~ql~~I~~~lG~p~~~~~~~~-~--~~-~~-~~~~~~~l~~~~p~~s~~a~DLL~kmL~~dP~kR~sa~~~L 806 (962)
++ .++ .|.+|-...... . .. .. ......+.+++.+.+++++.+|++.|+..+|.+||+.+.+.
T Consensus 203 l~---------ell--tg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 203 FM---------YFL--RGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HH---------HHH--HSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred HH---------HHH--hCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 96 111 133221100000 0 00 00 00012234445567889999999999999999999876653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.59 E-value=0.0001 Score=75.63 Aligned_cols=123 Identities=13% Similarity=0.109 Sum_probs=75.6
Q ss_pred cEEEEEecCCceEEEEeccch--hHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCC
Q psy501 326 PLYTCNLDQDNHILSRHVSSR--DEMVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMKENLYQLIRDRDKFLP 402 (962)
Q Consensus 326 ~Vy~~~~~~~~kvv~~k~~~~--~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey~~g~Ll~~l~~~~~~ls 402 (962)
.||.+.......+++...... ....+.+|...+..+. +--+.+++.+...++..++||++++|.......... ..
T Consensus 29 ~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~--~~ 106 (263)
T d1j7la_ 29 KVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE--QS 106 (263)
T ss_dssp EEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC--SC
T ss_pred cEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc--cc
Confidence 477776444444433322221 2335788999988874 444688889888899999999999985443221110 01
Q ss_pred HHHHHHHHHHHHHHHhhcc-----------------------------------------------------------cc
Q psy501 403 ESIIRNMMYQVLQGLAFMH-----------------------------------------------------------RH 423 (962)
Q Consensus 403 ~~~i~~i~~qI~~aL~yLH-----------------------------------------------------------~~ 423 (962)
...++.+++..+..|| ..
T Consensus 107 ---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 183 (263)
T d1j7la_ 107 ---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEEL 183 (263)
T ss_dssp ---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCE
T ss_pred ---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCc
Confidence 1111222222222222 12
Q ss_pred eeeeccCCCcccccccccceeeeccccccc
Q psy501 424 GFFHRDMKPENLLCMGTELVKIADFGLARE 453 (962)
Q Consensus 424 gIvHrDLkp~NILl~~~g~vKL~DFGla~~ 453 (962)
.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EEEEeeccCcceeecCCceEEEeechhccc
Confidence 489999999999999877677999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.39 E-value=0.00014 Score=74.08 Aligned_cols=63 Identities=8% Similarity=0.025 Sum_probs=44.9
Q ss_pred cEEEEEecCCceEEEEeccchhHHHHHHHHHHHHhcC--CCCcccEEEEEEeCCEEEEEEecCCC
Q psy501 326 PLYTCNLDQDNHILSRHVSSRDEMVVCFYRKSLKKLS--HANLVKLKEVIRENDTLYFVFEYMKE 388 (962)
Q Consensus 326 ~Vy~~~~~~~~kvv~~k~~~~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~~~~~LV~Ey~~g 388 (962)
.||++.......++.+.........+..|...|+.+. .-.+.+++.+..+++..++||++++|
T Consensus 26 ~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 26 AVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp EEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred eEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 4677776555555544444444445888999888774 23367788888888889999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=96.25 E-value=0.0012 Score=64.46 Aligned_cols=62 Identities=16% Similarity=0.056 Sum_probs=46.1
Q ss_pred cccccCCeeEEEEeeeeccCCCCCCCCCCCEEEEE-Eecc---ccC--------------hhhhhhhHHHHHHhccCCCC
Q psy501 8 RGNCNGQGLIVPKSKEEDRIGGKPAVPNGPSISIK-MKRK---YYS--------------WEEAMNLREVKSLKKLSHAN 69 (962)
Q Consensus 8 ~~~~~g~~~~~~~~~~~~~~~~~~~~~tg~~VAiK-i~~~---~~~--------------~~~~~~lREi~~L~~l~HpN 69 (962)
..+.||+|++|.||.+.+. +|+.|||| ++.. +.. .....+.+|+..|.++.|++
T Consensus 4 vg~~IG~G~~g~Vy~a~~~--------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 75 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSE--------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA 75 (191)
T ss_dssp EEEEEEECSSEEEEEEEET--------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred hCCEeeeCcceEEEEEECC--------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC
Confidence 4679999999999999776 78999999 5421 100 01123467999999999999
Q ss_pred eeeeeeee
Q psy501 70 LVKLKEVI 77 (962)
Q Consensus 70 IV~l~dv~ 77 (962)
|+...++.
T Consensus 76 v~~~~~~~ 83 (191)
T d1zara2 76 VPKVYAWE 83 (191)
T ss_dssp SCCEEEEE
T ss_pred cceEEEec
Confidence 99887653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.99 E-value=0.0081 Score=65.44 Aligned_cols=29 Identities=21% Similarity=0.297 Sum_probs=25.3
Q ss_pred eeeeccCCCcccccccccceeeeccccccc
Q psy501 424 GFFHRDMKPENLLCMGTELVKIADFGLARE 453 (962)
Q Consensus 424 gIvHrDLkp~NILl~~~g~vKL~DFGla~~ 453 (962)
.++|+|++|.|||+++++ ++|+||..|..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 599999999999998765 89999988754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=93.78 E-value=0.065 Score=57.85 Aligned_cols=63 Identities=21% Similarity=0.144 Sum_probs=38.5
Q ss_pred CCcccEEEEEecCC--------ceEEEEecc-chhHHHHHHHHHHHHhcC-CCCcccEEEEEEeCCEEEEEEecCCC
Q psy501 322 PHTLPLYTCNLDQD--------NHILSRHVS-SRDEMVVCFYRKSLKKLS-HANLVKLKEVIRENDTLYFVFEYMKE 388 (962)
Q Consensus 322 ~~~~~Vy~~~~~~~--------~kvv~~k~~-~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~Ey~~g 388 (962)
|-+-.+|.+..... .+++.+... ........+|..+++.+. +.-..++++++.+ .+|+||++|
T Consensus 53 GltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g 125 (395)
T d1nw1a_ 53 GMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPS 125 (395)
T ss_dssp CTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCE
T ss_pred ccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEecc
Confidence 33444888775432 234333322 223345678999998885 5445678887743 589999986
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.09 E-value=0.2 Score=51.60 Aligned_cols=31 Identities=32% Similarity=0.557 Sum_probs=27.9
Q ss_pred cceeeeccCCCcccccccccceeeecccccc
Q psy501 422 RHGFFHRDMKPENLLCMGTELVKIADFGLAR 452 (962)
Q Consensus 422 ~~gIvHrDLkp~NILl~~~g~vKL~DFGla~ 452 (962)
..|+||+|+.++||+++.+...-|+||+.|.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3589999999999999988878899999985
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=92.30 E-value=0.32 Score=50.64 Aligned_cols=63 Identities=8% Similarity=0.115 Sum_probs=37.7
Q ss_pred cEEEEEecCCceEEEEeccc--hhHHHHHHHHHHHHhcCC---C--CcccE--EEEEEeCCEEEEEEecCCC
Q psy501 326 PLYTCNLDQDNHILSRHVSS--RDEMVVCFYRKSLKKLSH---A--NLVKL--KEVIRENDTLYFVFEYMKE 388 (962)
Q Consensus 326 ~Vy~~~~~~~~kvv~~k~~~--~~~~~~~~Ei~iL~~L~H---p--nIv~l--~~~~~~~~~~~LV~Ey~~g 388 (962)
.||.+....+..++.+...+ ...+++..|...+..|.. | ..+.. -..+..++..+.++++++|
T Consensus 37 ~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 37 RVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp EEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred eeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 48888776665554443222 245668889988888742 2 11111 1123456778899999886
|